From ed24d76d8f3f150b3001dca2830675c45a15cecb Mon Sep 17 00:00:00 2001 From: ChangdongOh Date: Thu, 29 Dec 2016 12:03:17 +0900 Subject: [PATCH] Script & Data for KDI 20161229 Workshopo --- .../Astrazeneca CEO Msg.docx | Bin 0 -> 75247 bytes .../Astrazeneca CEO msg_2010-2014.docx | Bin 0 -> 32827 bytes .../Baxter CEO msg.doc | Bin 0 -> 89088 bytes .../Baxter CEO msg_2012-2013.docx | Bin 0 -> 15737 bytes .../GlaxoSmithKline CEO msg_2012-2014.docx | Bin 0 -> 18164 bytes .../Glaxosmithkline CEO msg.doc | Bin 0 -> 84992 bytes .../Norvatis CEO msg_2013.docx | Bin 0 -> 16616 bytes .../Novartis CEO msg.doc | Bin 0 -> 290304 bytes .../Roche CEO msg.doc | Bin 0 -> 229376 bytes .../Roche CEO msg_2013-2014.docx | Bin 0 -> 18690 bytes .../eng/Health Management Industry/merged.txt | 3140 + Data/kor/minjoo2016.csv | 200 + Result/healthmgmt.graphml | 94457 ++++++++++++++++ beginnersR.Rmd | 127 + korean.Rmd | 107 + network.Rmd | 125 + networkproperty.csv | 2 + preprocess.Rmd | 104 + top30centralitywords.csv | 7 + 19 files changed, 98269 insertions(+) create mode 100644 Data/eng/Health Management Industry/Astrazeneca CEO Msg.docx create mode 100644 Data/eng/Health Management Industry/Astrazeneca CEO msg_2010-2014.docx create mode 100644 Data/eng/Health Management Industry/Baxter CEO msg.doc create mode 100644 Data/eng/Health Management Industry/Baxter CEO msg_2012-2013.docx create mode 100644 Data/eng/Health Management Industry/GlaxoSmithKline CEO msg_2012-2014.docx create mode 100644 Data/eng/Health Management Industry/Glaxosmithkline CEO msg.doc create mode 100644 Data/eng/Health Management Industry/Norvatis CEO msg_2013.docx create mode 100644 Data/eng/Health Management Industry/Novartis CEO msg.doc create mode 100644 Data/eng/Health Management Industry/Roche CEO msg.doc create mode 100644 Data/eng/Health Management Industry/Roche CEO msg_2013-2014.docx create mode 100644 Data/eng/Health Management Industry/merged.txt create mode 100644 Data/kor/minjoo2016.csv create mode 100644 Result/healthmgmt.graphml create mode 100644 beginnersR.Rmd create mode 100644 korean.Rmd create mode 100644 network.Rmd create mode 100644 networkproperty.csv create mode 100644 preprocess.Rmd create mode 100644 top30centralitywords.csv diff --git a/Data/eng/Health Management Industry/Astrazeneca CEO Msg.docx b/Data/eng/Health Management Industry/Astrazeneca CEO Msg.docx new file mode 100644 index 0000000000000000000000000000000000000000..284d215a33c071acaba28dd92d61823ac49026c0 GIT binary patch literal 75247 zcmeFY<99Dn(=8g?c6MyrJGO1xc6Myrwr%X#c7CyKCp$TL-glgF&mH&v2k%)Q`b)1K zqgHjzs+!fa6{JDI(10L-pn!mYh=8C;!vX_R?d@Dl?OgO#JRMA( zb?H59ZGIJkfl%fHf&A?Mzw3Xn2bz;*<%51Bh2D^VK{l#`0=yVUlArUR%4MtXy6J`2 z$NWspKb~&zrKBqhO0;_7|1#fvOu@1Q%}b@tgYZ&YE3L?T(SnfJmQK-{)-8^{rix+( zkBeBs7u&#(i49Ih^}AdFkyNs$Hxh%nk8(|bH2)pqW^_r^t`p7I7C4X_Lu3N=+q&3t zu#^Qt-B+-z-`fRtVqy?x)tf)a91@P8?X1(U?p7ktrb$5yka!y~+0ogr5f)0xa<5lF zsDlc+QwuvktnY8V&M3U24zeKj@j%IBd|h~tHdmWrdy27s|l@7DRx%K)Jo4vf4tu+EJk#@kB`EcXKDeIjB4qI4<>jvG?`7n33F^Sb&Fp=qYmG~I^ zF1*?bEUz@i;ezC+v``ZPgtNsqd(T`WR$iqFuIx{909;<7fq=fhL4g$hU&tj$z-fE< z2}ijfV8Z?&SKrCh#+iZsKiB_@*#E&W{XdQ#od}Qu6@&}D0pBqk^W^}*5HGB6OBA>h zUw{T@TmrizOcihR_7wfB5Kb}m=uVe*fE%B7`Lev>*F6Xah8Hn##d)T%`K`LmD zX=etS!;8<P=+!UKW=cDHvjVfb&LnAjV;+Wr)}|5UjD4I1E|GWWCl zfA*?Ql9dl;{O>fs(1oU^8?)Ys$+liqd$&oaY!RI5GJ^QkgWd!)Q3y#dYnItNyC~VE z)witr2tp9k6jAl02^TMrG9TGTZT7t;xae0pmtrE zJF0FiwQnOAp}w~D?UmAVtQU;Puk(!X{}*EhF4`3Vk3c}>r?5cCKcVwqG4_8(*QGBY z79f#%{14;zUca-rg z$aJ-{U-xHMhg~cT(;BSC1<|ih>wNOFUxVLy-v>LZ3}(z@>bw)YI>b`?)d#!pHW{XO zQDyRr2IK0qeEJc;5-PIIPXcuKQXV>>UKd+r%;f9n=^2)G_C+9gW$(N>XgiJ1G(9_1 zU#ysqk^QXclh7v@oHJ;1Yc=k<;waj^rkI(~3&yS;ucGX$CdV$Ccq8>k$jIt z9fgkwmpKv<(0TmYUXL&Cq09AsGH;PyeigY;?bBg*s)I&Mo~K^>#e{dMYWUjW>+|1y zZigO*-R`;$tQZVG2j)y(d0;i|OIOuqb@&@;l8GQZEb#=PE zT%SGxX<3;14_uRj)gLoq8`9?!gedPMF`7WoBW&xu2QH$WDwL<#y66I8-|f?97@E1` zO=XWQgrGj>u_3GG5gN2j`@_ZUCiiM$no{aApunxZC^WfVH*XtVDKrq!+I?m^4CVT0=ii{%6UFamZT1Y?dOB!*IbSM0@0Wn{6x>c|*Q8-<`Mcdyj5~9kZR&Za zY5+O6D43c)cW?#^27B%j5^hqF2928(0%lFBnsZ6aeRRX3h{rlMUW{K zqa`BXVp20Zq>rynA6OiTBfM||X0#Qraqa}9)vdg)-=>*lmlOnd{(Pr~-4SNsEN4V9 z=ZXsH^XR`38wQ(3l8Cm5pT9EqD%Z+E8>~oV^ zR035rK8_zcYxu@j>%MNEpDxZ1%HB!u>fQM3jkU4|$3ZgyStYy9H`AB|hZ*e$eV?DR zOF`c<>wzz7&2{54%9$f%Ec)(M#jdKHw`@tS@f4DKi{eAtpHH|@6)-Xrr=}k>AJ05Z zgb%D;CBH6oS*?32u)Fb>8K0qTs1bNGSDrgGm1YR{zfPqwX9NFMARGh-LY)&=DZb-Cw?w06a3l+t zkQ)yeT}UPgdC>z={asDpSkg(5c%L$cRvs_;c}#tr@v92C-=Lf@+_Uih&*m7a{q&vc zCX5|Ds$%R%%676hQJ&}G$9*8QdS9eJzI`Lm$Z4!M)tHc7xgFUwD9EoF!ci<+^x+Bx zo-|Lq(N*OTx6uR%V(Q`B*R*uVkU+suqBtb=aQ)Her9{)*{pplw zkccvyGNc6TuJiHp8^4@v>vyD;%_+)TYMqi1|Ep$YmtAH^*+tOJkr5(4e%V$L z3K=&U<4l!IJ(vN%4jwC14Wo%k-il)SS%8z!QeLWD)jJr>QL z&0l=wBPij@{e>J-%rp{IT;)MK!Z#dYfNj@RuT~+!vI*#T0p-U%loXOU3KJOvLn?St z(p~@f-4}dQCfyM`b~+p`)qQfZ9V7D_Lbvua14aAM&)xaM`(2E5oIX&iQ@9?SRx-N9|RV^H${!LNLNaGRXI3 z07?h^u7s(y%vGJ&ZF4u7K?E(qVsD=`hCtm%;AI;*Ly|m@*JK05-dzo4i-7b z>7D$VO0YJrPY6fah?x=O4;@$)8TJ_}1H8x3Z8AFQ*-75th`&pfeZ!t0g83JojzVp) zgH^AhjP#@Ul+ti@O1v1ZRmt&G(tSoA+!Z>G_C!Z;nDMZ;5CUA&EdQo@ks(5jrkOu0<69TP}`gU@HVBJ;_gKmlu|ZJGjK|2H+672c>i{bcah- zRGko7J43{=kH2$g~MN1S0Q~m%?;sS~;kY+>(kUwG7UIlRZ z8wvyj{J%Ur+??+|mj|16AWfO+J%Ea(U(xojk--t`{AUtCw`t}jl6G;h0`=2}g8OR{ z^C-KiF0T@Iyn&;VqXO;yNnl8&d?p+Ybe#~Oj}93RBC?Mr&~v^2BwB|v;|+8Xm+KLW z!cxgT+(Uhh9YE!tnUB5f&#)V|Fpoo7r#q>oXsVqrKvleG(gjQ5cQ0FX9nnOtO7qS` zB6A`%@y?<`Vf>|R97ZZ2Cg*wi$`TP25mm$>g6$c-PKQ!;BBP8Sq#=Aj_xbE`pQPee z83>3=q^x;kMaNF$T0*0?$fQm|WUP?I^#mYgQoEM}M^4Ax0EcBuZW$}N3w2J5bJHV0 zO^oRU`@{ySYZjAQd-$?KbAxWBBO(a*Qw&z0UT70MiFE!YK!#zBWK^GUsN9UacTUl@eH7t(q8kaEqMSybQ65efjfL2S=o9}1 zMJ55or|KlaXrEx{_(@7UCM(rv;sPrY>Hf5(MpH9>9Hwo=tVV5OMzb`8b8MmC{du}~ zC|JHtch9&4h9?+aPMRM$DyDZW%9ZH;tB_K#ny4Ghik%>{X%7Q%i%0kk5p=7!NXtJtPdX&;=&&@ouInUNTKRz-Pu3F3?mMMs|Btt> zNvwnMpSSiqlap;gPRH3uUIHYY6~bR3Vt!1Z4nx7#?U>D7Uc@_V{ezipga)yDPanLu z-^7~zlTDEGd{zy#QB-KwRKH$_?!r*V{B)~t0V6P@GVc*-rjRZnpZ{7h-qMFE#PFwj z6`DVWv`q&wb)LQ$I}COVA6B*H$r9I2fhF>AHe;^yvK+t(ZZ>(r%C=AW}f=>aJBuCKbE~-2@#N%_?_l%_( z2U7$oTQM+}tY^RT%0bR>J2Htea#M)hRjf_F z4pwGTUT)I_yzQAFkipT!FnhR6hV2v*VTXh}adbhUrnL!6fDip0>mEokyc5MUzj^&% zudZx7+9Vssdlic+MisA1+^le-GaA5p;NcMuNY^ACcEE8V6LyhoE84Pg^4~5&y}tDe z=HHrd;%IMY=T9iS3kzhl8LbkH2L@vE<+H^Tlu1Bwv^a{^q*nt~}Il zq`VOeO$w1?P#4=P9Cs%TZ(D9=bcW+3b`H|U_3njlQY)S9l;EKgXWsPqJbPy{4RbPY z7pi3F5QxcHRY98Z78BeNvu}+QOJr63ezJ~RMzVMR_3ai}e@~F77RWL@#ysqR1cQ=~ zo)_Uia#``jojq@pdqLziHL%B|%{+FHcUYN&dJ5~^e8e}3w$`ID^~aHv9{Q@9j5Onq zU>4ogNyV%^C*?8I^cpa)hiMIgY$M`tP*;?H2^fDab0YH`AIE?>!4?FG@-j_n$m7RE zSNFR-iPd9nr;qG0PVCi!V7iQDaB=`HReS+(Rla7VOD#24+cePGcvX(68uTJ;5|?a6 zamfH@5r1IF%Q&LLy0vN%!EnQZ^A5&wmijsrE!!M#JE8bRUP_BnW}-kMVS zb}d(8k7Che@BAsE$i|H_OpiWaco>4?-e7+Bl@?(e=aEE)2jDsrjC+1 z3^hRwI%8xp7T9ZVy6L@ZAu=@E`LK&4!QRiW5-s2xZvceZ%F$H+eXhG9QJwR`)7~Fs zg>D`WvrMG8nKIZ}iLgX5vI^Cr$0v~5k;K7#*iA}+HrH(A7Tx0wcizFcnyxRr5~&4c zOJ;Z^-Oht%Iip#2r0L6iT;D%r8>iWjoHE!m(8JEGA&@}3dVa{fAKzG{k4uI^NR<^v zDrm)32&1dfhaJv9eNAk*@0fTp5%d?{NeJM-Q1D@%^U&&6yz2NqXiZUwTM&IGRfa@7T-zO1M3Lu zQdXg%HvGq6(WG-B#qV}ICDIIQOuoHIvcBt^Gb9;?ZVRx-fRe&?$RMi!~ZOQm@Gwz-zoUg50|6J}uWd~CyF6rC|q ztfOitp{zIXVu1? zG4FKWv+7|E?}9gjT%L!A&;6;g#izhe1Ai=OGMp2Zzk5OflaA(C0s0v_V)W^cRJCspc+zbpWLd`6e8kD0&P z9AERv@k956(sKL^_};4%r(^9Gi##uBc0F*Ur_yCbDd7a?H{6=fc>u>ync1u+0(S=7 znPpuWP39fSp>qdGs%oX6#uxLKeKtf4abPTPsj|us4is7G;q%F|$(4>cZJsRJnTP3T z$5KY2)Vq>6v#cx#{;SEd!cl@p6{=;F*}jg2GaajOAfk_1oDK69k4KZs!y(v2YCE`p z%*JfnIzOtat0}nHBR5tqEiu+tLj6aBpwIqR`wJzhOxX#L{%>ASSdjjm)mp}@WV8Yy z%I#TJYLUrdUMLw(guI*Z+B|9#NeT6!f(4mpeLp92n-7|Mq1YA{V&?TCoRQYBbTgei z6=BWLj}-c>AY>PM4IeuJXG_l&55I2Ap^0`>njN|2^p0P>&J`UtBlQ+A)Nmar+Ara< zI930+PSrZ)h6D1rw2&DJBzw;p$w#8d&qBkuWrxQncjXvuc3XRdg1A!0&lc3(&y+>f zLut$2p`$L4C*jG8Lpp+lIENu0_IMsuX6Y@f-OXn>x!4qZoQ1OTNW+}f2v$huo;2Cm zQ9ywy$NcWJT)1QMWoqHlAATT zxgC>ey{fDy$&$g1jeX0pCNmT50%N`3W1&;JPJW~>(1 znH#{-0qN#4a=OKD>dx?y;2U%Np=@Z(Rr#QmeE=(Q{rcfztU(L5ltq#YH`Dn=Id`rL zP<;2#hj(TRo0c#0MeAtk4)qq9ov?+Vt*3Y67VCIZyuvK&lXBMUP#LT2r8$qfac07U ztwEmdUoV^ScGjbR_kUgIJ~8#~hc;&*vgehmP-d}2<$y`f#$#Q*ZFH)OnffY&D`TxG zhrnS6Te0ksN>6!B9Hp7VVrLxaxNVd^g*VR!!aYM5z`;dSh9wylyU2CM49oEn>Iil) z1(gMvKCHlTKX?2sc+4q2v&lv`h4>S8KR*|8l_M%%W-Rzo3gtLf_}EPpBfrXEq}7e5 zZY^jfEm)a`lOqmg;g);Jb zW-g@0{cnRYi7&kY$Syu%9ETT_cDCS&OBuO>#JAlrM@ptVBXjv7c+Jw5wDQdS@1mkDrn`X;5javx`wWoo8i+e!8$F+!}Xm08UA4QUtJ zi`9|^XT4>nnH2c>s&RG{$3V|gq%;ra#PEms^4GZK)pxfENg)=Bd)+Bn1U5)AT(w6Y z_@eJF0rhX%Qj>P!`bpmZmWD)&`h%=cm$1UAKLoGl4k?8^<6xkh2k&eLp^m7 zW{NCuuD%!y6Z}!qxVUutA`@>}!5emsA6Py7QNcC*X0+oIp@f4rYBZ!Z-L|xs4C^Eco91LJRA^m{kCuN|)NoYMPeLr^y@y)ve&Qk((UWi9W!p+t8RwSKSgggic!i+ za%|bQkZ#%bUE)0TzLnKSpCn0htZITTJP|;c9V#`{mxpPl$xQw(K{(IMMWUTo*1f~F)^YM?`E^}jaHdf% zUB;dhqsCm!%TNu$CW2V`sMg8&`QM1Uu-`eAgw~5&6@I6ZeGJZvcMJWYwwCQjb`2}= z=`Mzi{mk(Z=!iFb$Xj=;+IM3v<{aq;fE7GW`|XtX-nGFsHPN?Bh)uOnHP=>Fg+atB*Y+_Ww*(cN z(#)`2gylUJ4|4Q!)+;{Vuu-vY8MX;?grU1DHuVc3Iof&Yu%wFtHY9TL-NAdx1Ri1# zjl2jpj$>gP-rA9RrY7Sw$!(~2EE6p=eBFxhbsxH)<};ahkL$KRU8&952oo=wqM~pI z5f-j$omSACIsVuZ*z;^*d3EDce`vr@o6z0XMxcAXVTl)J_6jS$^8d;I{-!D-^^_6b;^u61hh6`D`n|vbZO8=WJ z$e;bbhs=vVh<*T$ZhEr4&4d8t+6X57258AtKA4Af?kgU_3KK%q|6P_c$v7KeOqW~4 zwbbgkOW`3bhys3!>0>^?mCei|oiGxYXBM}beIy8tvkdc&Qk%3=>bSLmouucn$RjvA zh<`>o+w@}V2{YVj5U^DdOtQ0lw*VN-WD>-;?59XVGAtZiaxQ)RZk=f>yOW9o^qQ7+ z$Ti3xcpuU4=KAaRrlv0Qn7aLj^z3k$G4V{K;{Ds4xx$=$$zx zuk=3(#~(P6nUU9f_WI3f4o=m2AIEm+;8H`)f}Z}6E6pt25vE(Ohi@0O&T$*ofgaw# zwRr@!th?|Qm@ZJHnY!^MJ5U_EGJVf(x^Q7l*k8;DFbJm#po6w$s=Q*X)U%>xuhjFI zKA}Zyx*io+(o<6Zik~B-ojnw1b$M8|cZlG@*f$pKI(W``xpFrXIJR_yrKR!4oYu0p z3zB1><-F1>4Cqi0`Fy`Te>)~@^9;v4<%rZrJr^R%J6MU5Cv*9C(KKm4`4v;#zPAH( z)u-@{{<0jFHq^XNe(;~lO$vOp?h7Y`39aobGOD1ald`Q~V|yF_dIwPSe7d~9GFz!% zU(j#CwgIK=De7?K&D|p!GJpYqKjmcqL7k@E^EQu&A~+C74}?oi7<=59HGqkU>(qL# zS$w$~>TX36zA=2Y9FejAjZJ%6YJJcCu2i7o{#P)rt*G(DSBP8d!uXT7RQofg`ba9k zkIlgCC$+KZkhQL>htqNUi2S@v8E463g&A(9y0h+^6|&6MlZ~s^o7!Nk$_Kx(Qf5Q! z_sHlQGE33ow45dB*-f4%bq??6=*@FSKyL!Tsb^V1*4;=C^Ff_ftA6g)ry86cpK`A0 zk8Nn_br!)I;td)-C8ICTf`MRL4c!|46}{E?WWeM0chw%-p4!L) zU8wat(|Rp>)(SYIMxOv+czvc-if@ElT+Q8tGj58WigW2U?C$Q(;HfpH!EUqQxMx!G zs@Ij|V7C3#!&-f>w#Di6YVp?GhaALg-p^K-o6cDkUqvzQT2YkNmoD>+Ps;bK0Un_y z@jTZhR?4icApMvL%lUCqyV*-AX(Gh*xC7PUeEv$LCqn^;9y};z{k?l4!jtZB#T)BO zhqRRNjprxTBlc*e0Iv6K_>N;I@?W9>pWy&@e5HmSijt!Jd$rZ4-;N&~msSh5UI}GE zY3NB2L2tI}p}MlyTF3pB@F>C^7c$y>B#v9D>UB&-_H*rC*r{AhqrX&^>*iRz?(%SR z&0b1Q23)*0#zQCRtTdZT|MZ?5KBSXQU>haEp)<@|5Hf_{)K2ttu$FmT)Sy-fV`yNxz!nZv|;MKrEtMsX;5o# zW#x6cl9t|%#o||UpZOj37W<9yW3~k=J-sF^6 z!BF!#qB11}?}!HNuO@zyKR<3c~qf!23_Y+AZ#V_Ji~|iP7y*$zQ)_{HYXIkFuBv zlF@J}Oe$s9PL0JI^N6Fy#kRSfaNeK;sGmwbh(jIgm1dYaP6yBi+P`xzxP6;;>{->{ zf5VqKLWGL*21PVScbI0_P_EBRE^Cji661BHXUQ3ihNfsVqCRer0_MW@>eA1$EFqID zyi&^PPG|DnjhA~x(agM@UGxL5;oZe;iE2kKycf<2ZSY>#Hm(kH54W16 z2i9dli|msMClO8O;`Qg21f!)NFa3#jnt;Cn@6O`jyf2sew=9e1wOaYf+7C+3>zNnr z%!}sMZJ{zrLKkx_au${1uaa5JZ4R`O!ai0kvq0U4}RZM~L?Np?}4IIL97aOhbsD>WDMeAI(0tFhqBag8Eagl@50 z6kXs(4DXS(XQ~~&k85UrTQEd0Ig=kJZhD6vT{MgLW*$vcz;3$d?#d zkEaBxkDMA%ml=+82d(yA)*@A>j2)Mc13#_tP&Y)#8l|8}?2xvnPxjdUcB=C77|{Zj-t}Q^Q;qVSgJ)jZu3CDl_mBM3uM;li zR`vA)4K&s~3Ro=EiZ|MPD985mmT$F*7rxLftZG-%W<&Ls0!BGAzTZFMnMA~h_k$Xd z$MYKf`u}QJk~Hp?yk}RpYjhe;;cjU4#m=tX16^J)e~GV}XP5kETJ|IO;0b^;4UF1i zdJNGm|BmGFT41IAx4CiZbmlS}w$}t62XcVR0Fh+bS!at|A}7#9;GI*wI!GTScJ;V+ zrOj@&YMHZ00+967ogh=w&mhRj&gNqP_om!(lX_RE{HO2t6{cHpc-WXE!@a0R1AP8N zaI(UF5i(j@nAaD(qtFdP*$h`CP0Ceh$F;cOw9YKfNlEw~n0t7&_5j>2%dLs7cZ9n2 zVr8x9c(h%VGtVMkqbC;Z{?%;jf&Ll4hKr;9L74Vwl{v*d1Aw@7MJvuhx<*ZU@`<+9o_En3$NYfg5Cc$2 z6_fk?pI%}m$$ahYf>J@qOz&cDCiRBAqtetZ8`*X{9P5r0ZAY=Dw zR-1z4rYI~ZEVi9gteGNK2|Ie1+R-1$A#C+*Ua9taxxKk58`+d?dZl{(mpwftKYViZ z^K{Y*V6-*f{-kkn*qs|Wgf;Tp$E@8Pr+Oy!>0F*0T$?9+cKt;iVM)$XyOCrqPOiehHltYn z-|Y_*po7b>z~@Bxip=%Ms6F{Vv!UI@|ICIkit(mR+vYCU(sue@pPwKljzpCnh`W#Q<8Cv0x!ZFo{}mfBhiX}-oFB{ z@XI~?Q0!mP6p(YD{}}8%LyMrGlrNAGtL5LR%U3*9M`!nMdBviB0mj;M~ld!Kmd_OIT7#5`=0WM zv7G^?dNxk3QdbY!=qsQq|ES_#bxd0K#+Rdq6yC2`H+@qyHrQ>w3g1FY5hgbuHPhT2 zwgmB>DBG01!!~IDEJmBG-;Yh30OlwRD0V)yY%#rR^i5!@>D(xBAU52aKmQM6S6<<;M(ex73kbxuUQ^=g;gVu>7^`9uu-!H9pjORrYf-5B^4&lb`7qxr($amoJaHLH7Q-W{v~Oxtn(^ zJ1&527N@%_SQ(m-YsreMS}lgpXLT77?5{9X1{;=5iX6x1WV^Ol@PtTo+ey>o`LsTV z{SI4LckaDbf-5(z>s~mwpgFhGI=zY05rq0sk10nN--&!=i;k25hKZDcq;ovNEH{|Z zh~x(j=o*ZfYvb@+V#BI9Z0Sa)wid%l@%PRgxszGBz#S15;c?p+yIdtiKYhJ2W+Yx~ z4T=NrI*Lr(9iIc(YQ9+!%jYScIwjAPD*HZ~0%Y&aiE+o9^6HFA=U=5974J=PilqE# z;-jSXIFrzHq0E-i*+;Eo7RAQ4|qgXuJ3cAgSyhOJrfMJ!-+_mYqs=IB^UyuKALtNkqIpG7m zr675Os&&AzGQb%jx3p)=xaezWkSEs=dCfcbVf@d$qvat%Dud(7^wWB-dyvbEwl1i* z8Cc{!*ZZg#egq)Sh^`eXQy%;Cv0}?2 zyRJ0TaY(|Cq_*y~E3v7G)IHYWH%t{5bjl`Y7K}hlv$TkfOOwUw1hRQv7Olm9FggG6 zeQogASRm=~#f(0s*|KfEPvGC+Y1s25lwdD+`3(>fr*s@4C#TQy|HbW<;{2!vV;H28 zg+~U??WodwTRZCVd%Ol_=S!s`2^D7LvPl=$YUWZ{6b`bxY8Je4=V~!4|MeI3h(Us33{qr5X7yzr2zfN`2T^mT>%WtI+Lgj7pc1LuPyKotG>f+MuqAPRUNy0qb3zt~BkxL|viXl)MJ+qP&w?pR~9105+ zBXOhw2weK8egW@8$3bd_b?7BBVnP;3%TolK%a$a(%-yXg2LB2m@vLXfO!uIIPYne3e=NR>kq zF^EpcR_!B+H*y`7`1Q2v3?nA==Auj}k@RV)G6r$M-w>SldeC;J;`Mq4ryvn(G)wai zS&Af;LrsXr_jrWFLkMb6!E_=J$?J#;TnY39>VAe~>}}wvP?vv{sM(@`-Oh)Q9$!Q8 zSet6O{Oo0ZMr#V))QV9%zz*X}#eYdCiJ`UOImy5#Iz$%K_bHT%Ju1n6o87a>&;!YT zfd_Q%a*`@@L7ZYzqi9qJV|a(+A+zfo0nhb>KVV-n_w);+p;Ok1ldmtRv3C_6oNAp= zamrp+L|g|v`52szS6NNQ1U5OQJahcjrBtYJ6)o>A1pG0rdfm~pFQQ)9{3XH|`bw+m zFrmq$f;RwSd6E)zUxd zefK3lM)}-{lIG#8!(Dhn(sPP;l=)J~IWzB0qV6>fhyqR#CKU8r;>tenP!O(NEiW3s0my^Gc!9}Jg6v~!$V31=Zjupevpe36?h=T z=BChuW)()K-UPEso+k@a9w;VhxWX{PvOwEE7zr@LHOlNVJoMuTzk5mH`)qh_Rov!7 zLpU-^iNW$Kq)*PJ+Tb?{sz|p$e;Y9`L<=01scUO^Sm_>dJGmbA!E24ufUzj+t}&Xw9wL<`W`i*82Rq_BgJ}J zq?qV;WtGcNf9L{zAeW$Dh{=M;mQ-^=c*uz?V9IErM30$7Jwk*TRqCByC0U;q(+o*( zuVDCsg^J{u)YOWTom8;p!>oVt=DY&~QIVuY=&9wAqrfA7k1_cR+(Z4bPydB!lWkQG zyk{XXfMCu_@Y{$k3CWUaBMCYtk7>zTvP8?{qm*0Bf#^Z0A$$n0fG1mp7`XzK7K_;* z4UFGr!rU}cz9z#1er{hY->WGJ8b;fnKNsu+BwF1Scjl@bOwLZo~!v|i56-pI)cYo*_|K$GU%H)E5VlRD^x z0TKlp^0u*}SthM$(~Qd%^A(i|ykuiJk;-X1|9T}1b_&MOjjSRfcgEx+A)1|<@wsRt z4FHNLFsoQdWmqB3DwV3Lw4&BjyPIwVa4j^fNlyBZr`*3+fjfDCwpK*}6dkl$+KO4U zE|#-rGr8SGf=JPjg}A5C?_ggynIUP3WVb7=DbTbVxvMRSs8`Y?Ibo44h4bTo?SPW1;-&1IAgbYBE2Pp>lY!6 z30P&(D6&KSPvJdChJapqI@RVHgmkHhi2ZLjy`y5$9=i%GqeYhxl;c`ej)o(X zNHcYl^hzNgTN{QkH@-*o7phHWBMg+ z13G9STQt)vw7#ib^eGp~dJv#sO7x1g(I`s<8W@Bw%R6{ug7=K1%!76=27@n71>GzD zw6=QUb6fb1BZz6ijp|cV?}{@9X#eU&tp<*veta7vc^$lRMBApAQJY{9>OadNu2%Ag ze1}0grhGNYr2zLeJ;MB6!xYoW)74o*Kv`?b^coeKc4~Tvb$6@TDBjBESvesbdAur` zK1FWaGV4yPVcrh*uehSsnAdFPM7w97R(>=wL`e4|&d# z1o_SCFbEyR>2(4&!22uhbeNPB)~QG<6wOF+NN=sNXoDUaXh4TzqdcjRb)#=qPs(eIe z!GeSpnUg_{G=2j;#OMjV@$PqGz@3>jR{@!(#HrL;@x<61W7ei4t9D%)h&I7e3EKWC znzKegb&~E{1a+>`cM^!eSV4k!5W$h*JibObgzREVYC6{g0PqiJV2coJ7}&IB$1{`EO<(1iYAR-b2W39ATi;+0%7H*f9*aJ0aB?PppqEN zK~op`Pvi)KSj->K^v-I&KnUcRd2Et^_8d`otoWAq924fgSVt?B z{zxkWA;I)7q!kfPt;&+mS#(RQ_7>yxvSimuF2VO-QJeg=E4&4vU#K=iQge(iGs2qP zOsOnMLswMdm+^D0JT~%W2U4n^3TWS|G`q=*qh`zeE|vL7KvZy;f_~`p!r|&DfgB|v z82V8xmm+M`yqz75_Ts@zxqln0K`5gSa@rKwh!KHR{B13_;b)dJ?0Fc<@r#CE57V_R zbq9x>xl14&#nuxO-(;SSg=nmGnN7N>$lBi`Kr4HOk=b&dAlQ5W*mvU0`~3YRLliBO zXaT>KFZURJ}r{AkO+3-)hYYlTs#m3I&e$)NV6egw!HBm~r3UuzDk)Tj*o9!7(g&Hh;7`mLWTcnzx7TwTRfj-z z^rqqL(A)#z`!8rk_wB5WLK|u#A-d6vK=ff`r5!k#ca-9Dt$kvW1ea{@mg*96M0&%T zt}L-lr%07$FX_~Q1q`E-yD$zTNG&5A##~`$k76uhAjJ$OH03*ztDHD_`O@{nAk^>= zQEwlG%9e7Fqf?Q6Nk+mcOO2ScX{D6#cWFXf30OsBRsqJoiai4!z9dkPk*LBglxjap zwrXDO##g?LdKkcLK=GVgr+aUGwpG}DKSkp%{zt*`UWN5tV@pU)2kKHT5` zZgThQu`OQD_@)LoMx6p`Ex3E+?BQzw(kcXGHjvSgxtBSslSUb}M5$&|ro-b>`p4>5eCQamZINc^WpM?a@E~ zAZy5|y|BC&(iR20)AN`)G}?nE+Lm7h8w*IyI4N0KHWd%6rEe>+dr!zqm(nXsyvyL2 z*#{^wzfyvXNN~@fCAjTwiLCd~Y|y7W&UuaXCEF`e*W>YBN9NXE@o4rzx05mK0+Kgs zF6;J!MRNof`4PKgt)RjGtxckI-lA4E|KqCmT$2jEUY8|t3b%CT36A| zwP;dk4Th497UWD1kbBM+2es3de4zu)ET*k*Bp)ECU(;nrFDRFQg<*o-8h{4*>H3W( zqx@inj~iO*4lN+*qdOR%FJbgv`TLQK(mmL!x@Z=;*3-j`8Hq^|O_s#K_Q1GM4rr=T z;*?&HAcBdtU~c|s1xYykF91R4xr$-&mQ6)6=F*L$+#S`n@l;WFeauEne{v6B(W6>{SEWwDq+IZ4w!C6bqj zoGbn$H*`T=otCkD&HI|4V>Lt2hm$D(W=}n1_^3%06cn->^+lRXiNQ{romEd$u`h89 zkXP^o(rGjZS{9nMjTR8%!0BxTrwI_&NoX_~$EQw_`c&3g2m_~#w_-y^i(CUHgs(Um z0Yi6#m=&m4DV0Ijs1Jfh@neKvliwG03-2p(D=|1@V4>DnIiXv5T@s3ggm9LN{M(G} z6N+^tScKrD#S~py-^w!fxgQLC!nW{F_MSZ1|71sy3;`F8YY$01Szr(3Ha*E>fd5zz znerm}0RZJda;NGaojl?JKc6JRm8qyQ>7C0|O;Hr?u&pSvnd~^$2cwO7J^j8pCn}76$ zeB~3`uBXZ9TJG>Y>36Pm2X&6LAlz`42ZsdwMYoqjLVMQ(JnnW4454wpTr>n5cy)h-BeOs=%Va1E@c^l^D(45@1xzyI$h2QFT zee;hl1z~;adrvm1e&I*?GJ{+*hoG@1W0j=&&dYKx@m^%{ zyZ{!IEE9v`9QSG7E-~2W&coucbESs;Sia##=b^*gnN&ulx`0rCnMTPu50Vh_547Al zF4t!r?o2f0OdLVMl-(!~nJ(tf3F2{+6w;QSh+;a)orjMq_WnJ^!T-xR+H6m?ZCBAHCa`bAtx`Zjqz{un1b_wWjx@&dy-01xk zX3YQ^##@_f72A>{+`LS?bHlm$N1v@QKSw@xEJGW|Xq5C^2D#R3#l}<>r)EF7jH5Fn z5GUsq4Ou1*D^UYmBXO&pMWf?t9dar(;85ewv4t8X{rYrjTLQ<;&ccce@mkVxt6=3S z7bC$Vh}rEvD=gLMio&c~(mk~*++kXx(zQNU$qo^5*mAnIs04vVhHEibTzlIb0G^W1U@mmVI*_6K%oyIbr>FNy4<*Sobw>gfXH=h(_4e z`GU)9$NdLp)N3;?j_G`MUh3vm%t06$HSNZk@kVC?+iC(c1l(qv{RKE|IhBe)H6yQx zG6hQv)VT_x0qv`cR%2ByIw zu}(sxEkY9Mg6LJ#l;jahOKCajV3%JvAiq8ksZzA%5zbL@Kh^yi`N)Ry{|d!bL@>)r zT#~)5NjBxzK=xMlX2pyfoM)rwBe_IP656O`m8GaN4VOxgN=(*TjB-!0_64P9mzIp^ z%Z_C=t&ZQK*NQAO51}dxnXbU>oM|}Iz%&>wuuejwvuqiyxM0Kv?l4iK*1TZ=izu1v z$}ZXY^_7;?TKiySwSNSL`^|O8lcuyyZEr3@!@^TKR_k2 zkcAxa7Lf;a^@tdY(Or%%S)bgCSa!mmrDVoaIGfo{o1xb;u$*V3Gb+3Qd%vhLOeIrOb6SlJ|Il=1EdAVm1~+DARh5xW)B~b<68I5Y))|47{d=LI(^pVJ6qURTTq07#be5*w9dr)O~Rd+l~2qjl^Lh1 z08z@xkxe};zvpN%5#_h2TSz4|`Djwf?4tOs`nQ+rlEDc=e zYdhF7TAZ_Nr6j~G5G|HQDIFinIGnHCR$qye2>i6SMU)wFjeW8RmPSgEF2os2aLpOU zdd%BRs=Su)mNUIi=P9?G&WZ)JLGoUrEuAXYgbX^7|;TU~_* z;t;6Lx_$75fU~syMtQ8tq*i=vv|A)IC^&P0XI!M~RcsOR)Dn@oQ5c7#e59HPqac`g zvGzKRc7|mNE?ll0E*s(;5y=SB@?2PFqS5X#4bJjNt-;kyTjUmx7_MNohhzldL;y$J zB;A_e-I(gy^=4ec_@|=i-?g{CG};lOfkXevKLbi*bM|-~g=|ig`Y9N7ftg&=xTbe( zNSaWMHg8XgkcFd=;XAPfnaN8oY~HL(nO9DkHwj@nWbKn6?!hQX)j1j-JvB~XnI4k=}vGSX2r;eR#)fz10iC`A!-7gmNhJsFYE^cKaVEQ z9_;Mc@`A^;ha@{2AE)vMX?#ymj*HLy0S!W4^nkyMq}#IxPd=&s(a9qo@bgJhEGINS zoxVtb6JlQwjhhAjud$ym^@40xWf#367 z8?f&{aR6o>bT_OpkD77JwV3k3+6}u+Px5t-U#N9JiiT{t*!4EuOQ=q!mqa3bZGQEO z7dtO@c8qJAdY_*@EgzY#sx^;s3e~C9yw7bq8b0O_{>HNhfuBuUS?HV3WiDj;d7pf8 z_4As?%Fj!#HGj(Y(XIZ^v%=UM(3FwMD5`6_Zpz)<)mZ&a5C=Vfsf(Ph^4pY4oPS_6 zY*|&x_TNfQ?IS2cn*^A=7f8k@xqSrw zk;(L9wKP6-AczA&1O(xDSPpegoIFeY(KLc=gfT1#A7=9dr#>`%= zL_f5=OE}S~6nNKRjG0do7*=cnXVFk3e+um?Ne!t0R}dgfm5jn(eJ1T&I^IIIW_izQa@>eV&li-h!pH!dad zyaAi@t}f)2tx%K~Y&mDQfy;K*LIGU1)6{II)(tNQ+>IViOqDJ2yvRIx`(uiU2%!Ie~Bv9d0xmlOh4mS0(8fz+A8gmK({0ObVn0;n%q$jp`l z*;tmtb;AgCZYgb4$z6BFVee-k>8N5&Clk!mgw(2pD9R(F83W;vdMQx^-pj}G*W&jD zM!&U=Du%tcRxakk%gW)UA@#>>CE93bFo9<9*!yJw4^4!X1Wm|TGs7M>fdQsU;0YT) z0qFq50UCh86@ieKzBAg#g1v+5ja(h?WV`2dFA`2!@O}wFh9`HJzoC`3=fOGP{aPe&iyc!!gdd5|c@J4b4ar3JI*(M8fb%m>fK-tImQy%A zz7kn<{d$^2GlL}Ww_#V^tXSQ+8@A#Nqpw=}A(wSC%^zhW>0WJ3C! ze)bkW&%AqI5PY8nNB|v!T7;M;b?0Gl0kscILSBESudASsx|DY>$~CJK_(Aat`JIG> zdMC6FeLVK|O#vpOA`dl+kRbxnD3Oq$0&i)YNBozNavod~#SGm^5>SXuy*$%Vqe=0j zqKKF3P%@!k-$Oph=TXvyxkSnUu!CyaBp}LVbc^vf{tWbzBoH*J`j2;U`KHS^v7T+x zBgatuQ9>nF%ND80G8l+FIPejb3VqqqY!W-k{R+hNyKnzGmY}`&q!kRM&M}s~6((fX3zlrM^+!xPXd1=^lA78 z;6H^zw z-wdK|M$Nb2yVPzM3=@hqT-;t~iB!proR4L2+hs*f&5FJZ6#bs=mmrUjv_#PY%{MFu z;SR#e2caQYwMi7WOV4S*aAqJQ6DF&U5LK7VSPK6)CkD2A^GnUiPr%fISWr4iqelt< zA=<>=)15ymv+WwFz_Zl^WE+&v{8aJI{JyCFPzw68&@h$2v>~kdImN*=L)U_#002yp zAkE`+oI=N?oub$_5=50=f+Rb%$`mi2Y4}M7L?<6x z9Lh44;U$b3f55+K%qE34j#`Ko;~*Ks7?bb& z0J;dCTvVo%0F2rNIvv%qp=WE|Fo(NrEAAq)05e;a=2Se*0bi_RKj%s}w6;spcRQoF zo7pzI=mMMJ2z4srOz5EnfK3Znh$=(G_Cx>!%2~?1V8x)74#AXwVx0u%09SN??uM;+ z!#0I%vU>^wrh5Y(N<%4x_wC0l4~Q5`64JStlcbds(o2(PYQj;=M|i1OYf1jegl;$x z3L7P)`FZjY5>+#GNVPffQ-nBC?h4Qc6M7iGgjGEX)9{<8dX_#v5=i}7m)?l^JmotS z+<0c5-c7uLkXQxkVdU{7?@_O+J3zqkTu^H0E+_~aA35-qoC(+1>t2>1!@FLgx4n+^OhlG!ZH>jT#gTdQ)O z6YnH-*}TGr<7vgG1sB$gIBqNmL%~=IIbCd3ka$(t)|01yqyZc-NhY{r8fcXg0P$JkWbiIz6oepX;(k-XBuz`Uj(9p96d2?x#8k9W zHAhi5%pd|M!%gq3w=B*TOieAApe4K&x2c#sLvzTlgv`g`FU!&Z3&N5prGjXHhn+B+ zGoUI81&<)_FGhQKlpj`svbw%Q%^oRcR4uu_kf3DZF&HBml2%)VE{mmCRw%%zub0%S zCu2Y&Kq31M$_)lOaif;c%JI(Nhn^^u4BDwo zGfXbW>_Obj0;X$c-;J(cigJUUA*Z5Z)-k=7evmQ0heo01P<4wg*MOAnp+F9>M|9Rx z16%wYk73q}@CJ35L%KUi8G;(v^D)lUw$;?|=9bfKw5`2G>a1={ApS=cw|WQ`wGI%(f^bn4sn`wo%9NKkRB(>?Xg@vIS7$L zfd)RGG<^jMfux3?mJjsUdrq2{mq3cMFQ@VW7k{e?op~l-*l?zePPOV0VqDHToONIw z>MncMVQ4fGP>q~)S@$)RP{owF*{@q60D@3=1Mlm+FLjAj3*IDzK3_C8O=>4$$hvJV zgIhU+YY1vRNvwm=X#1%;Jd6xvRk1uL<+E;yvyByP!`-kIZ`j5VWv2+!RilyGNH8=i zHi5!~KcPKf6PXkpW6}Ev)fSexLyx6;?9=^4G?gE;HqGTiT{5*$&!eNn>tiTyN4$qk z5p)M_<%8CcsO1YpIt2`3cacH#NkupM30JkjR zKsqu9!qg^c$*_fXhYbB;3Q-8VA<32KB=r_@!}MzlA+mZOXe!WBttprSt`a|W9tATj zme+^}m=9tFoeh)a@G>+~=obr??^7bOfFNCE%Av}L`@t}Yi0Y<2OzN~kcS$g3P{K^NuAxS^s zZ+jAt>9Qgi(#%zAgf$661q0i;0212XS4mEnltw5kOT>!cE>DfDdLsdY$8;mTpFVZu zFh>q^x<8~8>v6}yfhB+?7dB0y(J)Clk|jAj!aRX!QAm}a z0VI-%6k0t>el6;b0vJ&tS{|zU*QS&(%e)2esQ2tDl!V_>BBAW}7TAFTWay8xYX@~V zbF?VjBBWb~1rs)4u_)T|q;m|&Nmo5>J-BZ>Ugs-WD|M2x9_mUkQ0PF+RxEr9CQ9c) z9>Hm3Aey{bC~- zc}FjaXdD-j^u>#v7dt!VcTaEfPoI{L>`4-&G1olCO;rS3Zf@a0Z?nAQm!ld))(6*R z(#k^Ld@ge#)6Z+r`HRo8Z>FF33SvLM?0od${|EXzMrU3+a$>XxwZZP|!*yYgT=;C> zWBtL2T?Hqm;bYd`a0jrZQ&uq(l==BMt>hn4L? z-+lW#73=~e5zPXr(WVgYr8cM0DS9IYAaKr}jLlwGmwuK1c}=zaZ4Bakkl;8IuDj{8L& zT^3NL!oR22wkQeE6}}~b!MgBe!hH?!DXzP?8I3Q28WPzDsKi;{dZXP}y+Nv(uid`? z?%Us6_rh7gip$?^AJDNJV(BHf*JaGK2k&X1*gbmF@%D~7ZSRZLt2gbF&sH`G_qD&T z?{{Cn_CG$G{QThXwEcPK;Pfl6b-3@nJox;j*FJrDu-AI!ot*MetFwRNj>CG@&xUvb zIS!rn$#Hw{)O&H%@lId1y@SL311JG+I1X|?_(!{Q!fA0wVr!1X(J@?*_KEEU7UYa4 z^rXsOV;TLe*l?Teyp?%R(lB`V@`#H&{p#Uq=grBfb*vX$V>7BivF4LE$Hzw^WlwYiiu-?)o$(Mx?dg~d(Xe}+JDx1ef+BJwNAa(t5@Eu_809} zwt>4Ze(@K-%)PO^Ug-*5A!HYb_bwWo!q0#Dvxhr7JLQIJRcKz>CAx2a6YHVcEQSiv zBRZkdIU+sbj=*{eZ$rRSF5?_skoe3x4~@s9a#_KI5}6|ljv*9 za?~m*d}w(_uI@H#dT^9^0~;$|+5%q8?1hw|jaAFv=GEN@zpmG;MQWaT!<;i(h$<`T zA&AjV?SW;CgM{G`RT_vG^+Qhf2%h6~y_Q#qI*Sa(*FqK+#ez!y0O~w@r}t7PrxXN(y)0Wa(R)Dlxp=9lj+mXDgD}Py zgixLn*1eq-`{+cgdDa8orn7Ud{1f4lV#&q))MQs2r?^VK8S$Dyd>*Drtb=~hbc#td z-$HTR2coyn;?`1-_aa1BW`snbDD0}=o;&VQNcmsk#nm;m*x=-g)c4qD_n<+2nA8j+ z9^x1>TUB{Y2bM55G`&7H`DY0}xfz7v^Q-VrvL$Z;HjxqZJbV-P04rZMu zNoqgnMXcoV_`FTV!uS&ScY62m#A5FdlmRgRO34fvi)O-BXfU zBKfW=hGS~Ccp_+;B3J>hysR1%M%!6yJ&AhdG_=zG3{tDZM0@y#u^Z`a|VDMQ47_{G9o{*Zkf}t8|>Oj#QMh1yHHB zchGnGrDUbJe+*_g92XJdotq#f6x-qsFv_tK&&GsB)CKaRZtA0!JjF7ya1_#~mM7)a$wlk}jte+0;4BI_!h00FkJS~a z+E~>dlYC8>%?Sa?ayKsSY-`*h6|qi2qXSPr@S}nVr8|b9U%=dl38m&T7|?qHT!{rkA!;XZtIRqut6~IvWH?6h3Pp{07OH?%@JjnJErDBxtdg9L$Vfz9bir16 zSg4a}i7@Cwe%rgj@S>YjWb8*4#mY9_f-LD~I6oW9fZe#f5qEcQ?rK-yDs$TsyxmH` zYu5>08`rL^>9~U-&l@dR+|@aqZ-O}JUAvn|FLD~vHsuoM=P^s}WxX4>x=F5MZvOx2 zr#sJg_8yc@xE87HXLP$s@sPT0@;()%Jp=tf4CHe4)X;V;_jSmP{cRHn#WP;<%7pMt zPFP->R9zn-y7B9ra@DSUN2T1!{8OC7%wmL*DC{as*Yn3l)kdhPg{+C_k7d13m)8nH zJ_&lmn6>j~@*17>P~2}AL}L#;r{I?}|2Tmt^bkJmAV{YIWcA$4Jwy5bD z2PiyXbM+Z?*+LHAQ;k$bA}lhsWqw9@x<^mvu~$e{(&{i~JrDy1>YvIQKCC8_%D_^e z#htbU%m+%xiAtx*+@Au`9 zkh=GVVKDI8?}8pNn!$;q!GJ}~WM>DSKf-Wz9?9=UXeUjQGX@EX${JC#AV!ar%= z62-xC(zN_JqjgyPkdG**P>Ikc@`F4iyJgYe+#wH^AM#3 zNpi%r%FK&e#>mM!{<7mQJO1(<{_+vl@;nDe5zXb}DHF(h?Z^I^p$h%z`SI%?djq^+ zpcEt|Br|WSwJcF6PU1(khuD=$Wq<#8h`|i3FbHx4j}Rq>hHt`3fh0$PA|51%I`S5hBQiKDgV|m zI%iSRrDB_=m9l0h4Wi)OXO@9Nju+9YlHV2ai&Sq?uD?)l)kP640YHp4iR=-PpVADK zKWie&&hFN;yG8&ak)KUE0rUUJZy!_HJg2aDtFZoLmtLlIMjD+j7C>U*E5sA@Kq=Xj zB?C2zo>OLQi-pcEn~oA1MLJlmyx>`~VZeH!{;+5$>TCBr+D z*$jO)zDQY9`z`2qQ}UfrlSncoDUfmEk}VZfXMN4@kJ!WA$;d(FWVd->u(N`|t z3I=d`P8UjMW~mf-2RMhlx6^fLwYpN?yDTH+6Zoz`Sj&qq04g@GwoV3?M_O=Q%_ywl z&NHqQKlb*_YHEzeEEt?zBx+@lF4f{LC>jK45t`v-C`^0#j~JVoWjXNV6-+b2HY^A# zSzy*$D+=0UQ0km_r~T#0QndiOOEH&-c_Zu~MSEZV{L!aR|LDi%itIEPL{Nn@NHYlx z7Pa|;?=RpEe;tSoBWTV9m7uNo3~U}U4ZmvuDBKnEA2C@k14tv8v8=m~Ox6TfQi(#h zNfXGGx=BjJCfFX#)67+laS+U|R_i`hbHZ^*%_DSy(QDEa>Ggl)$OJAjzSP`di^%1LR?l?4Fjc@`Cp z9NKq3fHBUpBIEJ=eqR~q96gyumqbbXXyj_8zU*V~AZBqGte$h+rILZPdFDq_I74z^ znGx<;$3yBZwH|vXWFj3GXb~O7>2?Eg@D+PVVPCU|i~*Gzk+2_RJyw;8p>&bEb?14l z^X!nnm65+Y3NdSy;`66Vo_CH~`=&sb>il`@1P#KY4&;i%qc2*g2S; zwF!b=oR7Nvyk6t4ayW%%3V=9SjSdjfWf~JOgi?;WORj1hjW0Lz1Ytw(1;PW5vz)E zl|&)>l?JAVeiipZq7eTC&d&`+Gf4LT`_<90(C)uH>b%;w9HKi5n{pObETU!7 zxh#)09=xM_i=)5rFV)dr3`1H%HA1fvXH>k{5a6knaQhM+5`qKHS9e@R+Eqb6Mjx1} zVah)*DVCU5cIRsw_yO}P_ZFQ$T8dK5N<`OUSJI1d7$rJ+?!)^|L`_J7eVf-LX-VpNj&Ml%c|sy$z$tRQ16- zXaidzEbEO2Z6rDnb zdmUc97NE4?1Z`Ru<$Wqd+hjAv<|65Usvf?ODj$1C5{}-D$?||}vwSSmXxcHA0Mp^I zJ;TK$EVTwHyTD`bbM_7YV7)eI}F@0KpL;kE@+m`bczD{fRL1 zic0~7=JN3jd_u0jPv4!+@RE~7pE~SgEkEK?l9f}EjRdBJt+e;*;C1V??d`p69kM%> zKVH3R^EWFsaR*{k4#cYH^g*mnUs{3mXqnXnOenRr0;(W!<>N#ekD>!Z=Ekh2@J@SC zIFhLY84zHWld>kGgE>f(kpj}ie9?t3eAqL}C$uS5R8wCeEFKn85@0;x?eHrGeovG- z32>|gkvB;QNU1x6>mk?;!6(A_(GaHfwZyyTfD+)vSz z)C`bLKDX$x_Yw(7FbsqEN9_E-v;-6MAg?K<4Kv1QBXA4s7A9ZMzOT;Juk7j@VrCh0 zFqX$%P);@jRmXTF@K9k4M~uGd!ceg{2}*pSkUF8dz&NGq&_1mxkgD}m)o5I1%LzI2 z*;eyWuy}jyr%DRpmvR*hEQjsx=6 zG^{(qrB;O@mJ*EmsXGqITF1d9rz^Jk*H$Xp~11Pf-=MAGZMj#AL3+n)3%sve@G75!9pfLp}@KMi{Ndg=C$dfrolLu z{$dG!%Nx>gEX9-!lgC~i-4Dj_eYjLn&EdL$4dh-HGCNuq=-wv^6v5Mr+r1}3IB_8q zA?slDXZS?4T+>9BoXZ23viu5}bkBEo>Tqv%qzNz2ItmNwq-Fqe*ee2}m}XmS0dGWA zPzZ}E`$5PC;u6?P5Tp4ceoH6WS~7C_=d_f1e&tk3VgjBC)&j;TR^{REbNRav_6n)1 zQ6Tek)=gd}F75{dA7Q;`4|aBn1$&4fr>tl?u05n0$;T>{oY6K@NBfyS;Ieqp1AaiH zx1X_YxcWyYk9fe(C&>dNs&0NdeF46LoBhnsdSUqN!D%?czaGMx=x9F3Gs6}OqUJu+ z%dS4GZ@x-Yk$Yl33(@4N==0_k>f1D?Es$9-xpbwptDT(K?w?+KmVL7)&a{^OItuGGtJyd);?Zd;?;mV=GniJyJNL1)-Z@k#Z`g!l=LHmW*{F&fFZ({`Pn|yc@c;8pU^tr<%rd5PP*Z=s-W=_NRrkX7 zGuwOQma$Y5(d;|+vF_z<*}^(DT6!?+zKEx~Hy>6Otbh0I?+&~#TZgA!>*Tc4`t$Z- zd#~l49<6LO)@7F0UW;t@!T7MIbZ_qHv;dw-Xo{=9cVGYWw)aKr)tmM{U%%J#PM~`4 zNg`8;Qj*rZZtoxL9UQh#kSA%KdN13rj(J+ON?yoTP_OklYeG+W=FRKYp|^i<(ni|y zq1QUx=OB6fiqp;;R#WV&+NDUGeA$w=gZJgjgT0sDmq?x*>03Yk?%UtHbGHtrxs0Fw zNH*y*Dhqh~P#M+khsd2QBO@S{?pjdEohLi(oj-YSo1W@JW|%YgWA@56=`vMe`lF%bR>+sht0f-6@+%qds}^{{H`d`-flu zx6UIC^vuZwn5>inr?BKWt>0?@IPg zIvadVyFdK5|MLAm{5}8ohu{A5AAa-OfBC2XIO{`hGyHyxFKCm$oj?5N|NV#G{5{{x zoU-11FDvl-KkPx<{g;3GOJ^o)j9Yx@uj3#8`iI~A`iEa%$$vK8Mm9NI?*8GgfAhod z|Jm8e{jrlD{`OnUZD&&ENg-->=~Io9?_G+nLug4a6E@%f>6U zS6H-S<-V-fE4)<_W%tIIQi(Xuy;F7{y1;K|9<1Fy`9hC1R$jtf9P~Z)QNz`X^p9>}*UgV@O%(9-aoM!ppwpL}E5=?emW>Glebz+sj z$RpI~4shEsTfll4ugc>EXzRsB5Kmr&$lb~1C=tCo^t1McVKDGsRAJ$0FkoTk653hr z{P>Z`d=x2X0SJOYS%30ziO*EYXf_fn2BR>{xt&c&s%aV~#my8NIdSY2D00 z^W-YW_`c~ZH`MpHhhV{ck!A~|8u42ixQzT`vdEG7iIBRlwCKDi`Y2D-8N>Qhnk?o) z7ETCl%9#X%pm!d8`;`<`6{suZVZ=y+NNHn}_|$Ff)a^o2(M@Z40g`IHuFc3IZr}fI z_fdc-?}Ye%H#i0Pu}o9*;1r8AwnU3R>}cA^%+;gmbTPYfq*4=?t+2^Pn0?dmyGtCS zB%d>+jAzUdoaN&ReNa|dGmg$!Vj>@Wg%Gm?AV}=k14FXGGh)r#k9Y5tOJ;{`QnOmj zs4D4mv!ay>3c$$D-7vvElMC$!Z-4jbQ80DO%|5{og~9E6-#)HhMMt_etI)5;RI4sO zpCdlo#nrfnX7IZbySie9Fwt^#!D-c+o7T$1m$P0Te`PD@_#feP{=+kt?pxNKO($Nu zc$|77>F?X$lq*$|=M8J-9sIUBc+%;{N@($Go0AU>7wG@nY^=sL`_;eZ>i0Kn%^TL4 zB=I=Xj8;Mz0wH1Cluqy*23!~O?js=ZVi&mqShpYSe*17o!bEiXko_Oji481 zG4%lj_4Ps&XN|X1QQ#W0EIdB=K76nn3BlgIyMjBGBN=UlL==ap3#nKWPlEv?jRyjt zwUX}bKKLg1=c8|Tzhx`1&US*6!+!;jcOTvR+V;k)luD%PO(&}EXoZ2c^)&T?3KFZW zI+&t2y|COq?(mPl4gUGvgWbEe!+Y=aF%pEAgfKNaRachk{oQ+azgEq9xni+$-+k4D zY%jUq%>ZR6=sF5PKg`B#CbDYHZ#5nO`=?$~Rk0V0b2KK4#;*6+mNqhpTUKsDHz~=! z%D>+k+qyGA2kuukvtcba+UYN`kLaD_+!8=9 z06$WV5-mWUy44VVql`6;Mnwtqc2(@sdyZk5EqWqfDp~F=GA0F5vYJKFz*8JQ!3=B< zL3JO3YOhKE&J#K4Ba~;2HqEPA17&Nh%Kee=g#T;l-Yp(Ai3`&8!}W zOp~4^X8}dqum^E}EFc=Jnsx>82!zG+=wk}FL+mqu-2tJT+AwJr1IHN0{jseRA{+-; z&ck!YNke3}ny<|FjK%;#BM}%mgQx|Xs|J<bsx^8Z?mp?WmYY9?v65~+DFrS7kXZ$O|7Srh?Tg(vf$$(F%G1grlox=EXJ-${$ons_v z5vpO)WlxYR9zhIZWVicmGqA1+E{%p0;%u4SUP7!OJ08#UqqDqPVLD%W9b}(rjEg38 zL~x265rdDXu!-XJlOJ&vIo^jnU>fCtyg;8$I>qn1ki;?Y?rh9mamidjUqSvz#nmi+ zCq&+^-rWuzzd7`r`(a)#?5nHF+)ETvF&iyUic^h3ogC)^gvA(iopY`_T6N<5gOZ$x z%XZ!JZ;BS&N=5-_3>6-w#f!|VJbOyUR{axcFfoqyf^(g85gdLEp;m$3^4{Cwi zRn7 z>S3%m*7y!Y zIh~z5R%bW>fbxiFXM1BVSt`9nY)Py`PRL>>aiqMr9v~frQwW!XQPfHNVG?HfG2ktU z{NQx}Xh4_0IEtPUTD-9+CEwd8D(oeL^WZerv)o~mgJyks0F#l+{XZbSv8hSu{PxXvIwM*Y8P|-Va(|iw)KQRjXogv zSwv4f&FV#$OA(vfI@0TPqP~YhJQOm!_2~mOVMbCO?FtlPMPq4V;&oMi%v|Ygi49v3 zaza@#U2ZsDD>Njm)K?W3@d9}E0c?;WOpv)gOVSC2y%Kd+$xp`G>0IP8w)`k{wt38+ z9z=72nHE#TgsRAGy6PJVxy!Z5#mA&%IdqkQ{rcfTN{F`U^>e?T*gxs6AT*hch=Ms= z2XN;RFZJ^Uhu~@zpODAnz4Wzc8l@JdOvCgIXSC$XG;W2ZhIY7;cgPQv_NOpNa!1uI z$rHOBOVW$!W9h<@xggrb3ah_J0J3vqrBxevPCM;1>__zaiII?DERqz{C7Pt! zB{rT&2=mn0CWVt_U$58~xLENf>sV3IK0ebPH&TNAI-fCJNeCXs*oY(-sW4d|OXJa) zxVWE6h)1@mG&N=mQ$QP;w2~56k8&stVH;)_dd}T%(n5b8WD7GpqKROpbo7QH*_>n_ z3oj9o=_+c~o?RZ!25ty+H)^=;tK212&q6xM0}#C#8r8;4nUlQZMiHbY$ztimQ*Hta zfd7@tr}G?=1RrqjTM1mbHtJ|MOCNU3ED8QxK;9ARZTXv(8#6qaz7v*5nF)&_>e=$|JJ7G9Po`dk=;h=TIbucHl94A($w;)ZsZE9^J0VmNb73gg+26%oFgp zo{~D-ll;~hVThfflqmIX23-|`bIEyDrpa$zP@D5f-RDi}WP{3e*04q1N3ZFl{S905 zhIKor@zV}IHzmhUJMhyEz7>e1*K> zp-bPkxut~6?gPa4{d4-O5?z-+s<+zfY0v@K>mc~q<4|%~T zb+$z5TgJ&WRznL?w>hG@fKh@49QQafl35UZ`JDKA-6^JC+_ZMfx} z*c37%TQd(%`biEib{xD;FyOnvb63x@iX7V-K`Xc{6%8_|T11rOw z^FZ}9PYUrQH&1d~nI4BRotrz?x zkFq+vb`OhUg)UJe+XFCW#fp}<|I-WE{e7rF6XObIA*>6r4y2U@hvE#fVG(qNvp0cy zxG~|crRTD#q4-mA_0fN6M2Ia(*#<@9!X^$GfWE1Z^u_=Czi?)ogS$5Si6W_F;1g82 zJeto*wM^NLyy|5#yVH_ciT_(FCEmNg1ab?|&N_u-Q37osfXK&U6gMUc$gva@m{LLy z{#0=&OY=2*I))<{!eG*xGc_jt0_R6=|29l5`gHCJKQ@i?oK|Kl*OnpVPGNm$uYnnr zByaRh{j_3JLC>`Ty%t?ER6b799i4i_91`oox#T7o>yhBg5i0rJeKm_M4dl;B6#PtY z;Vk+~Y%Q*a6IZTkceN#5UEWhce<7qrsy&W4MiUxbwJO7{TsFZqX)x4qeSv#)2KQWn zw$fNxV;>#+=-5Zc7oy|$^n$lXKu4yfKJ-1zE-$qt-5wQV(Z zX6RzOMz_KDjr~)*Iv-nnDOFZLrA*QS2I5IQS3%-5LexO{hs_{TBHZl%H=RMU3nw9` z=6@v*`a+vzK#^q>eg45y&DPL&T&HEl#wdCnYrT(Fhp==>1RyCk=qD<^Q z%q65zp#X1KS(eaxOc$s@awI!s z-*6Dl$?V{myZ|LlQN-$yVn!d;tzr6bO=p;Bf zc>eq0(dmBlR|nu^AWv+?1Oy8!SkcTAA`exA0GUAdi2|2@ao4Oj}8uxDcPI^ z$A`Zi9sYi`_h>%nx;bgSvyJAYc?bNK(N_85TV~CsJF`^0$ux&Mq>7x-gSEGb z3$j+$hqs>1EppRh>-K_3ji+U~^wE{1iua=i#iF=r7rz%y8>{^N3HgO|>4sia`y&lZ zITe<}0!EGF(Ny|n)AQiOn0Phv;c2O!CMZ%sNklJsa&FU0L~<8EVwfRhxeAuk3#Eh& zNXrt?6F34(5EReGEDE=)kjy#?(*#I-%(iBE!r!npZ&G#dY zuyB7bM*SHHYT3w1>7b|(h=n^+(aCi+G(?$Q)q;15vn}jN1@c3!qQe0)zf_|IxN;GF zjh*djG_B6wiJNk&OPR@H>_dVirB3=P1AoQnhZ}0+_mXrJ&i;<64>$D!y(jqlxzxq8 zE&)&iD+8?gtIWwVs6ykYl0S~RPDQ{V|rocR0 z4qM8X!?)xltrLf@)dzGfXA0EEa-FJZ>Tm%|7wSzxQwchktOC=`QSVP5EoYJRo3rb1 zymHWU95XY}Ax2Yp9ZE1n=ZyZ8zGJ_0m3QuDTFJDF>s;7nl;&{rEmrR1YYEyPJ7f?55^tX+HyP^A~ z-8EVRj#__ga-c9S8>}%ozawuK;Xb5M#SLPK6k`1v(&4-n@5rAy8eGB9v32K~dGMHZ z|98ncB}!imnM&XU9ID0Xl573h$L`Ugbgr}L#g#=&&gvc;NBM_kx#q9O>dnQDE=Rz& zjZ9r=y6UFpx0Q8Nuhq5o?Phq>C1Y);an&B#+bU#lQwuJ|0G5D$-Ny3X=*o-Xt4fsQ zi$ZcX1Q#TB$M85Cm0ZqfDjZQU>QqE%4}y6R?28Ht+|XdKnkiXiorvKTMGYkdbRIPO zTDE0KH7&=9imcGM^t^Ago%k-W$E z9{=-te4vM9c$lguAU~hON$w)%{vL^;J!jIMxrRjm>Fu#+;y;jRz~x9ZnNq9{tXfIv za&xHbSUZFX_+iY$WI$}fzi6O~hp3jG_vv6`UzU?KW#*!HeH70)YU6hLz+qbhhd#}Y z2yiuN!gm>*1bXay+vIJuHc#ynTi2`W}=hag$!`~k8nEw;hE*ojhM0}i0EjczHE)y zWZrJY>5d&YObnnU4kBwv7mv( zy%J(_Tsmdp?5t#gAWcE9GZ9>=#pdI(AX2bij4U#j_Lo3`#OyEGeiZpl=mE#i3pjRT z6Snis_TBzrUIB1N3a4uvBFpW7fBCjbP3o!$ri&nJz8AesX#TpAkEM&-2#g0s-(1S# zF=LxjHO65*A)F%7XPgd(@t`Q8qvbfwAn5w~RuoF!=j8PM5zL>>% zSu%2JV}CB<{u>*d;g*#mr+%FF7gP1*^=;P1m2|&uuB(a`q}zL)t+NrU%k^>0$b*I{ zt(65luu~940p@K+CQBzA#RA~5IvFyM=J%Ju0PmEI7NXae7Kk`J2KlG;lNf?-PbRxe zN^xq&NA;;#^24z4(Wv3bT5K|4g(hU<8TdeR%|O%Nur+U3SK6@mPEL;xU;cFZ{P5+` z%bx=N8@xVxefZ1K%R|3o!kJ^btRqIFo$^J+rq(%GNfFxgkhx}jV4pF!#fXm!-Evgb zUHAOzWJeRdT@Hwx(~b}YM@L8Mw|6Z7SY_pCRWpkk76!=z6;b=edv_fZWvJoH@&$w_ zu4T^+%&i1`%$^s=$IicvCdu5?b*m$rf4TqA@mx^kCD$aDrKTID@&`p{AQ+uGCR6}6 z-!z9`SNJBTk?{sJRVN>`5*b-VtcX@c0Jo}KtyLOGPi{a zt3h*ZUxFR%sWc&HFx?F6eM;WNYDEe(RLI~TH8;^Wle$>CkUDzv1wN6WSTJiR~fPZx5Dwu+)R47Y01$?O-Xh@xadh04bG{ehot-aDyRT zD+>xQQ>14!X}~n=-)>I1b%Dx^LCS_^hFP)*BM9ow2b z(bVJa-z9tegUE9bDdKdoYU7r8$ZT!MY(o+^QTH25p~akUOhF0x#KcWq-;qz$&~W`% zz(`HL%aXSDi$4hXx$3TUlqFS3KV0kjI%YHXdZkT;JHLq*eXPll-0)MSoyfm-@CyxCrjq$eVBYF>}$V; zJb({?-z?;8bk?=3w=egL#2xy{q|k5BhJx)k>rWQ8*AnD*Ex>r1#x%B0?z}jU(kwWE zq}S^O2c@83!XfSywRHn0`LnUTT5fAc(=xf>Qe|?R;H(XOoLTrT98F>kakdK&i8Oon_Su&s%})oXooz~efJuT>X zkozsMty|(08K>Yra~8rL?Eb8YIJX3(wGHAI&6@}rSZApIzwQ6>>*2HD#o@D~ z1Ni+X-nf1oYSImQ%HDonmt!<0dyZHO;{ouq1fSAtgufsX5~FkbZ(yqTlhkHv!eVD! zeLn)8Q?pe~=<#eEBNeGR70eWXiLbt^emE!^M;+?GA1VVgwxF11m+&h?vF^{+W;hw# zDOplW0R?L&VA@O-6ql!#sx1|40@1hGB2v{viZir=4dUT2N+a3{ZT7*G9x*{5esO=? z;%-HsyQluT5<;wMn<-6d{(9n{->W z|5*VJe?O0Nwb#&zLp`sWb8C!9xp61SYJVOs(u6cl$CqXL^+du-cy8zqR*BFX%SxXD zfVYGulqgJ@pcfHioY6#=PxMQTh1(Ik{XR)wtIX)O4Cp3Y-bcktp*;d!^nfkRO%hO2 zyHV6gLvcOjnc<>_7*>0W!!X*isy>Cmj5*~cOe8u;NIe$RZ~J+m3!*6Jg`cYTf{vd;YAK#3pxbAbKZcDtB(FaJ1 zMRJu!rk|n6tf_qKGwii9?9H%Td)ov&DS6ELuE+aIY?Nf`g9i-f7=)I$oU+$mMmpq#G{#92YX2Sn8cY|t z@+BeGBgxN^>2NGliBQv?C5_O$khft{;SQN*rP^{9p4;ygC)dP_Nhmd~AT5M^egt)< zwdwniZr=FGt&pzG+;fRd?W9F*zZRB( z6ZUY>0U{waI6*6bN2@${%JUg#yTNfZQofsjb!Lm+G|n-ku5eRmjqlR2sS&9<0j*>ya#pMXxz9Ibwh-_u~tdcRngi*gH^>Bv}=*`a+koer8?8 z?WO^&w4h2Gb_n!`h&uA9Mu^NlpXxKm3N3uzBrq>l0vP~OuZ!6E9Plp4QOR9>w z>%2wK+9sO!$Ed?)h=C=hWkB2+4*npA$wfOE;FrAP@s8*7I-YK9-}W@lc^fDR6%Zhk zOX@qG){ue~(|f_w-jMM9<81TE`Lq|quDennW^)?f)q`k8`PUOm)Aa01A|WZ9f9&;1 z#W&)yf7B9hHvy}Uxf|we?*;HabA~mm!q)CFB4FauiKQxhGx(=pzFV<;PhRXFpRPRX zj;!IYC0U6#HRRhdf;e+2%~a7Z2AX*8Jg8t+8^M)om`e{sbrV=9d&NA6)iG8T=U_Y57(g0ty%Ni`fzPOji+?Fy<5ST+TCA8@44`{ z57<5tU2|=|h{h_q_FJcbz@w7Dmx3fp%WyUk2%glFAX=56` z!;R@8uXTZyAM5hcaojO5US;6OYtYahPq5+f>@69%p0^V7G(i}rJ{(L-W7$`Y9WQ2- zm*Un+tPY3qxgd2wDtn`!&HXl^+EM>w7T@JwURV-25Ox#hll;e&fKKFHbg2%n-) z6i$HlcfdCgsZbXSC)S>Gl)K6BElj(Dt>sqcA-heu z^5`xE;x`1QTGKi1_0bMWuVe%_QR7YrSFqTS*w9d{D z7IS`FP8^Oc2AZBXY<&5xW)GRKb#H5}8&RC7ABU64s$0HbDQ-f_zNVRIx131H2;wJB zA>bKDlld}#Wh))9O+ufP`lQq+r7gNKN3-B(lC~0; znp&I=@UaX*VG3V+BVSbMNQDb3c_~#p%S~`-eZfnvMrcA`D^ZM389r~y0J>1c4MF%e zjA=-sVv6~+#Xxvbnb6(f#l<#vzF)>52s`G8gjt^`ZSD$QT-&tZ3-OE=1a?{n(@1iy zrtVclx8-l*nXF;Pk&_q+(|-fPXp4!uF?CxVH_MqM!(l9L8tV*;c5H9jy=nKR{i11a zkCl#Q(c3s@=OK?_+I`ugFU1Pj5UOfrqP#_1w>tW3P`JVX+biv&fg3oG;Ek)&3i7-kvGXAiWQ4Ih$dO&G#arf z_M2%mr+Z~Lpqs}Mq7^T4A;RrwE?j__+msC}_#k6LTf0~$Vs}r}Z7GEn9xQw!8uC?+ zvM2vG9wq1uXZVRhG>mw;wzkX%nKA(c*uwfzny4cKhaS7iSq(HK= zF6k#`q_@NpGdW(XFbkQ++lp)w6Jru6HkQj}B=GJPn+w6WEvq)m;m(PfvIQ}EGHX0r zZwl5n1s9T)PIkNOT@0IBFKjai7Yq(xz`8ycP*y~u4zn_>3L*wFfS5_`6lii#G5%bH zDeN8P$x~<;wRdVg38Wu0P_jNP2{WVV(U+$Q8fHi(AsA*^LPfH z*2E`Co;gK6JUZtXZ{z4}7bek)NI&_zd(W)7Mb>mv(79oG5a&8uP>#;sv~x0cV<3fn z#EZz)vG+>H?1!BmrX2vffvf|Eh~Ak7X7eb0Q06{fLCKln0i^oj$}l}|M%FeXorp9q zi6~yNk_M?ddsvTbsfJ70oN!@F;T)64Vk8s-S%r1V7W27Uy5Kc1O~sMbtdF0+jjo2> zRNI&Jk6~(J)g(~4o(;luU?3s(RD?4FY^YFSpZJ5L7e{8IoEtX9mqtGA_i6u!=p%nH zPSS0SLIyP|Zb36(c&DO&mXXO4*#9Hx)k70JK2mntyu&n^HqyU<5Jk$`ifU{qi7N}5 z+t;4euay+#U7Nh9nPB?XN?^kWf%IzekRiY}MRLJF#);C>?{moNJW@n}K=~S^1qAFE4F5L&5 zTNQAUkq{SHnnk!-DW#a!X9&yEy${_TTX>cPlLYF4MBIPCoZQLAND7HmkKJRaW#=@5 zOgSHYmN1Fq#@V>c8_NsY2}YBo$2Zj&!cg7ZrHw~VUl@BLo~bk6jvi1N8_$wSLb8}e z>07$PTt=sW3cLA3SsL5a*xcQyt+a|mY0BD&0w@4ukpZ4B*Z{$Cl#${W3&C5R>q_dicT{FKiX=+kZ=6U756J|# zFV8*!{P337TV6W(w`r2sBsnK&jo2c|c|;%zDx4rOP+$d+5$W?FG7qyijs_g6w*$G) z!*@V|7Bjz+BtHSR2wgS7j8`N)5HYiEhaM)N2?+=E$;;P!|!z8G4a#SEa@<-atZKsi8vNPC7 zOGOZ+&XY||8flgwL%Qmj8~J!MFtkZ{Mr9k;wJY>$Y@(oD$eLg!bN)F;J2nRvaj1cC z4Qs=rUJesTL*=c$H(#U~3|}G~^k(}2!BHxW=W{_J`zl)hhc1%78@p(~goy^Psa3t9 zpidVXwWyVcndXZsN3#O~P559I=e)zuPx;J9r{uyZEk;0J7HTtZ@qzZ5fwsS4Yu>P~ znESnFuSEBJ`s>Nj%fpkC;Pm-naD4RB^V8t>{r_s1I==)qbP2S3e7HkI!H%XOV_KH% z1SOvllJ9_;)2vaH@MVnw76+j)X+xl=nBo#~XZ8%JvdnU0MO_jwbq^+UxIVlElf?3Vy!+G-VmoLOhV!%qcxE$FI{Tx9;A3 z`rS7_-hX)OQx1b(o9rNUK?1=-a?EvLsr_3)S2Qzju)$fY0kZcRYkQ3isU3*XbsclR zA*m9j;E8KxREk0ZQfT~GhOC0Gy4@+M*io$|vsB(-Cjpz1sY?${TkGIBm_#%mrP(;1 z8(u$xm7BV`l7dRZH$rX|s>oZFC9ejq>u6_!_~(-l&YMJd@Nckhhvy|HE{#=}Q!JAh zcdWo^y+ixBoNz<3fMpL`V?ne8f*r&}+L1HIx^!C*R(dju*p>8aY5FD2F$K+Yn1Yol zgLXA-qo5XBYHGVl(3`PEkl&dgsm1oQLm=@84x_2@q!ROF68Eht!v3Qq=~`y2^G}s; zS3{38t7yBZ-e@au45VKNlKcFJBkY-9%=Yc~ly`Mo$@3WE?`|fBF5A1wo z4s<%slT(dREBKkLi8UIc=mmSfsN+u^*MAnB@iT*_=8E@JYkR5Pb@TyBMm=-L^aaI_Bi7G9Oiy@iEETF-a$O z;QQ3CNSSj9A7eWeBcoia{Mh07_)^+Mal`meZNLhzDkh#nA^^#R*u?wjV#*lQ0c5Eq5+IphSNwilw6a;@z0mEz|2Hh9 zU)XCe>8=?GSNy?vB8db>?PkyxCdQ6UklT?J!IJGQ#{W zd+`5MxuS6ojjgZkLUl(wl3imX7IxU1pt4S*PO1fWTo+Mto( zAx)qPC+uT!_6;pk6go)szjfwUoypI3o+Y5qGw>v$tp#B-m;^cnJTo9EObBNMOk4>$ zyYr)8fWxL}?ePVH%RY8J_M4sI-uWKuZ+kX-eJ`@nDz|DoRRp8;W7lWVFr<^QMlUTm zr?2(W-TQYB?|y4gU_nXE=BPHxID8)tkuKpwxA?ajy`B&VCcMDdpTr@1=}no2 ztt?mP;IQibm;me~}$HC#h4-bAlJ^Jl1I6d5d5ga_f#m!FQq`!QVp)sUVs2|9-KroS{Q1Lwl9HHe0BOn2IZ=^&4ly`+UA*$zlS-9@KS4(-e;VCIuZlC`E! zXryg?h>vWlQ+TN<%3|Hmwr4eIB@`ksenU26%- z?p*6mb}xR|Xg2I+cE@T=t5ImvT7bnci=ZS`DO9cVr~P`kwLwV|2-|;txc{u-2YpVqRXN%31r-Dx6QXAgYzNye;GhLRn%^j9WbC5Gvio+0=2f9UV-E zsrb;ufaCLwcF0f)RTN?x%k?sBt$Sgc!rRT%RoR2S#CSM~&Bc>}9Lo+H0qBh+|!G4dDzIyp~>}|y+ljzPAt#qJl zIvt{vf4f#b4#{k;J|@ux8+DpB573@QJpjq_@SKOzUuX(9&rm;4^kdJHW0fPzS2)-1 z+Lqx}tvkcrnZ7vM+$PX=SDMF56Zn@;KVvdSG)^Xx81feOlUvw^c`3-d$KLGTaLwFj z`@bDM3yy=Q$A>Rp?!Rn=c|Po4JM8ZWH~Ers=GssH{oC8K_N&f?>)FFCyJ5xUw%nVC z_wV0-@JJmUk{#dh77#A-rb(%{7bow0(*Ii@4!vo2ZO=k{*ZbHorI%s5hqFP^mh>qv zgrr9z9oy-}OS&aDI2rHRh=Sfhw)Ut3-J#aG3bhOWqfL_X+z#G@-70+A0Ts#bYdJ7?#vD`W!LD!j#zr%q6<3dR7rNO;}=`?cnkwP!XL z0+Vu~HdgPaw9dtjyZ(~WQ=)u;TBk$Sg{v1px>yBe*->SSs_aOuz(M2!@N4L}A?;a0 zD~Th?R8#Bo7CD50(H=g2Kw!D93ar?o&-A4foAt*QJm`J= znH#zyFL9->oY}`=u<^uvISZR{f;VB?YQk=Rw|lSL5jz3a?BQ2iv@wn&2}okI8HgYm zg-m*rE)Fx!f>;`oz%_LN*GhQ%;qLvr!9Q<5*!}h)M!sR({We;A8?97lZ>U|}ld#X% zZXC_igi+Rk=t2;n6loh92l3N;_r7YZhEH5XA}{%LHH6g*=|=KZ#$XD*jLXFXBEgd6 zc^V_qgp4yC2kHWDT%X^zYj4{P3E*$v+x-S(e(&zX-N%@I6B#}^{8w=A{_frTUz;;{ zm6BEg-{ zr*s@BfYcUvbnouU*9)pE6kd9b3j9wnZGjC8={T~TF~y#`q0Xi2I-sFEM2E<&=Q&aq zkqbY5!J{R!JFu!v^0@YXwZR+&ardiImC(4x5PUO}Aaq-f@P&PZGNC*7&@a9(3Q{2W zD4|@L#s~Mls&bDXPfrf9m3MixgXmq;`S_@1&8WrSur+U3*Gglub4~_OEh|OSaiRI6 z1~S>!Xhuu0$yBT3p{$?u!+8iSXhU8w)>Lpz2FA4}tI#rLG6n4%As;z!4lOoqAx0!m zCg(EH#7y;WwJgx&Q*11tuzrvrM<8*-+WK|5_PX4V^aJm^>UdkPY)MM&L>_(#3cc*C za(!KCG@RIYm|lWjmv%=yv-bX6O;|RW+{N_T*Sb|E=w=;B+RO{u#ENkcp!;eDwMiB; z`pK+eo6!-j7F+aqTT_|fK9qZ6#0G{zHr1H4X~J2cNpA(xUYtyl5xQX$LFMY{CKa*y zZtP*Yv@9QzK~TdP=aq)@XhG{&U^CFe{+N7&P;e<8U7hzh3MctkjrbC~l$MOqPo1UVTQ>Fq-?SZMpz*$z>BmHycYX`Y8 zv6wa}po?{h!^_6WV$w_^{mNN;<+R%0%S8fiDqdaCP8xB>Mwd8ck1NR-?UjmRgTlv* zhFY@a6=iI{JJ#ME9kHvwuY~_jbI9>DMyX~Bz{|?!499A05WgVSUJx5%E{kN5z^<_% zHriqeQ&c1?UZ5&u&;@ zlHzpY7v`lZx~_fOaLy5`EBqvM)!71l1Bo)FB+DB6b_S}id67fJ19(~A)~}T+PW8Gg z%#{G8O(R-i)1b)lD}qAR<+8*Z)rTK)#rx=uXFz1NG$H13nXuROf= z4f>@alh3ef+b_K9mg$(l3^b<6Pi%3-?-dmOTq}BAF6vGI{T|dvNxP?xeU$!9%aVA% zp5IMf6Wj$0pRO`%n?pxdoVYB{m{g{`*g_##9ukWR3{~$7Qc{w$B3%Q_rSpaNc)t5R~;}epcEJGo;yeuu9I>b-%pbsp;pyGw$!g33J9JF-Ga#AWH(O{b;UxVzkjKTsL3L~vs z#M|_%_6sT#GLb5s`nvo_S#l4%tPQ(#BVpNV;Baok*M(dK%H9zkCwm~OF8a%^epc51 zKyLN5`6Q%jmp1cNziifCHWxC6ZbnQjg{%DI<^)RxUX9xmLUve6kQeBisg3eK6=g-P z54BQ5;Pme~tmP?cqAF4Yd6gZ+CcnCj!9da+MqV`qYa@pJl!CPFz^m?eN29GI9ce&- zwM1X*5<3=hwL?ZKkCnjbGORWxsUxhif{2x7*O6!~vZ_{IO8KI142MYvq3rm{t-E*q z4GSkvR;I?tm48wBt#vaQh#MHsKgd{ZzWvbL)wh!vaiCB(JXytGR!#_ENXTl;2< zahx(Pc&B8+i}!AMn`_`pqqlK%=DRM=zW<`cckLRJQ7|#OvRGFzY27oz8^tqXzCPHG zvH>++#%>yf;+AMao~||}FoEF^5j>>W4LDjN0EQ$?LuBYfZ~;92Y((=?^?AfmI8aF# z;Y4VzAWt!5LBGKKX=Vm#awsoVx+zS9EcDZ*xI!jVDZJYk3BuekTG(2o$J9QllqM86 z?OGU0Bjx;%ffczeN`_9nvF|yld%aoU7H+u;wm{v7S=PGvJh}jod)rb|CHwTU676=9 zYPPT=J=6lHdb&WhU-PY2Ea-()tfLY1tL==S*^Vm@)bGE~y8reLk`yvGhCcX7i0q86 z4mhv^mrK*hW_0=v9-sC2>=&KXc{59oYwHG+_52w1(uKO=6_1=m^E{gND2G^VO;tr> zf>g$%>590Ho(MuGi`1-j<7YyzJFgik6wl|;raHs}LexBoH}Zno0F51S zT07niz9b#mA-?TT7A8V@5tFuQQ$6Exx&cx(=}Q>~OLpq%&2FIe^S-rVoKRI>AADmy zo~!%IhhLvJ{G#XR*BNtHc_cdl7 znUUhneO6Y!%yoSL=L0w&z^#DhqHzoJ*_wY9lq=~8 zsaO(064-mMKi~S+x16#G9-3R?Qpxd4vgKeOC3_h+dkP*D9{@!F8sDVyc-?f z+K4dN){-oqb*oD6X{>H*CS%%;k%9sqLT-TcK&9tt+@&hbcJW3(Z}$im467cobY@|M zbQRP)&6cz<#m4&lMn_36w0B=zqND~N#AcQf1Q;&=1M{^LQiwPT!Dh=Psmvv*2L-7- zW7&0>dqhObo>20-MG+#zN;WkseKpVCMjvF&7zW)8iUaMwfDA>Dwms#QPx+-XMLii~ z{q#I382l@`2b!_>Eg+M}L{9`sBRni#(2A@;c4#mnXyO4plu&x{EG30gcE1|bk;&md zao85ZA#9X~cOKNkhwnle!_EIa8c%W;zW6}QY92@~Khiw6tCAKLqdk}R^;~MF7Pdm8 z&*e_=BfZZ$eC|*kCTK#^V@shb_YKu|z=aO=Pg#cs0g5xlGn+GV;pw!uZ^2kNF zqAPIu3c!*@mZx#1`-^-{Dr8n6^Rf1lRIrlswVB#RnObYcDx0x-BoUpZ_fy^)Cv(@O z0K(1B18Isc_#R$!Oaq#bHyFkf9nR+=!s7vRITNr^pABc1$by0BYR(at9DmNK`=d0= zR?=Ss&2hn_^a4^)t{fU;BqUS6pcSD(2mxHd02t9Q2Ai2{V(286*76eev3JYny&ja6 z)*Q6vphaCvP*<6Q0mmm4s!D|;ci$W~y!Kkhg)5m+5*^dM8cb7AuGx05ixyxyM^iL! z$O!U24;W-4>xkL{NQ)C9@c!JQ0F_$kmO>&05Ntw;H8ZIcF_ANffePSrh4p@ri><(w zoB#m3bFXur8!+`uvc3CeFjlk)jVf6*4f$7;ZCDG|+N#^94v03{=|nEk*vX?O2NySL3k8k&Wamoi=}EZ`vPcyC#I1d_yYp97D& zSz@wmi@I8roW)G1wOX)YeR(jT!%s59Xce#criOMt{)`GrCw#?~!gXds8+)Z#7oxoT~!hT_$V-qzOgrp1ay_xj3QT z;zQ53p2Z61G3Umg3<&AyTXJo=*SXzh>?XwDF%~jZ+W~MWum}&u11)A*Rsax%I+!78 z1UXCPwwGQe5}KEmM>IPm*dY>`MW<}Y%Q%fTl(t&JuCvB2g)7lJwBbE!0&h{KZ`Ek} z<}*Iu#EFdG=1n4d-Vxn$?qfPAtlxF~bj=&5X%gLZLZP0L>kPi+8|rzu^De`}UT8+u zqr<7XVuJm3V*353e|_@JgVM(0{Fkfeq44rIE1mV7|GC&R8CtXoW$1Agn~fLg{WWMw z9q5Z6j?f$Y{y{jOrJ4yw`saJmUjX(Z!hd@Wvdi7y5TNBcMz7FP-md(OuKY)hEBtBA zcHQVVWCLvKLqwEK=a)Ki7PY4p+mUa#!XCU+CV`tNPXvSGy_di4ADsNQe^gkXPjciQ zKYsk=ueoh*zOk*vHt6gP!x(L+r1EmFy3rc0>?be@xnnIq9EH&0X!U6o{!))~@R^^M zx15Cs^`S@TUfj&MZOxP{Z}mol%&s~1?ne#>*n4?Uuqi~uH|Ybf*rA)l@u522}_vy((wJ%G^Cd~ z{^+)~JaY{s9BU#Hf!PgVUobda5k2PvsUq&)Vb91ws5)6yo}%pBHVYpF^}`c{n9kxv zS^4BlB*82`P2vIl2M`N=d0g_Ur{b)l4!~{`6}lVt-ok8!e5~)|SVVYU!U-XyyAQDyMM`I1j24w^B{=d2x}yR z7!M~G3K~LY{8bLydUt{->Ca8BoCiZ^j~r{ZN}K7@@w3!4|2Przz;*PrXIDr|<<-r@ z_x9{I^z4@B1v=1YaVEVCcVHp2OU4RK+cWE&eP}b1Xn~>A1vY7K_^=zQn`W&CCugDh z=>VdU4(Dt{e<&?}?}Za1ixTLr9Ck5SQAS0(hCq2h8=wN={PU5ta;-9jAqRwXeW=1_ zU~+CDmw2U4f@~L1TaKXiL?$bw40amEL<)rK+^Et9@mg&@!g3tYl9a8tv**x<i60j zl+cvTA^aqoGPicLaq~y5b_d`PSc5l2dH<0%gX+oW2He0>63xeM`R1(nKj<6wEY==3irI{1N5NHWL z=8milW!q5pV~eI$e0(1J*9N-(*~_?SsFmyg^uei_(4|MBJI_uX0j7)h6y1WxPA0Bb z)PlV0=p{N+Q;M1Azr3$t&lPy%F@k$Dmxk5^+wglOIsH(erY5W_TMldGlo-o4MLT#( zGKH?nvSZbWCHaC%NLw$*3@|58p>n~6JS$qXwe~Jrm({wg)@7CGC+&8T>qbXpWODTe zK4ek!){d3ABSRbVo^XkS^x}!S_UsiToS-5~IYPBayJmAIH!z!VEJ+@sf6f_OavmW$ zPEE2<%JvvZ0gDkXt7E+a!*a27PL>&KDkUa|iLAaZgHdH#P&if8R7h_%gp8Y;(P`{D zxcw|;bH~Ll`3t^V!N9hFV`aec5_Ir^w&1(zlRB<8P}mGt1QX5hwu>Uj>Y1~GNb5B> z@|tzYTgq`puxX@hkdub1@}a}f0?5`df7j}wPxxd}&hH z2+j6-OEnqAuM0*W_`qpI4R4^|nocNyXgamf_PfI4Y0pW;bJ9MriVv*b0mSji(f;cn zPG0W6K6w2@V?&7fdJE5`ET}=%qJsS^aSt_(11ATQ{n5ee^%k18fwh)1`I)6 z8f7Om%E&&jbVlh!KQ81HnP!KSKWG^70)TZSUOs@Cn7_z!Qe$^K45d)UChGe+%j_)F z!zr)>Q4KZi(dP6K0Cqr$zmd}*FgKa3zWX%O2kl+JXAC6Q=xXs!WL)F@x={ol$T5gC zGe~N{GqsNJ0f=7eyTW+N!a+m{S2rOrE}pe;xV3$@WW)8f?l{73HX$e0 z4yyySSG#GZ(dnG&%PHK6Y~JPgiN45*)evu}G%^Yx;lJ}{8Ad}wmc|t9PE+QSFnJRr z;Z;^$>H&psCPrgU=2>&Tw^Y82?bO5{DQ9vVP1AqQqtV^CmnvKNO0lo4x`ehHuH41A z8~11|TU)yK21)f!VD8Dv9w-tCYq6{wZQ*j`zJ7Xd$*g`7Q=|y*TI+cGESQZ}vh!jz ze+4!FTKC$BA{}DvN*1WM^Iz!wko?c{$e<8ysDFrZe(LO2MEPjZ&p2U!LEzrD3dKWV&x^&A-=gfOgle9NVX#}y?cGEuk>NPS8 zRrkbUayq*BqaMzy>b?E@KmKdW_4?$0H_g>6xS`8J1k`sDHQP|)=Ug$z9nvhu|d^3B5f-GxS2=tw<%y1eLItTVQO zVSBpRrcN;bGod|Ct%+`k%Iecq8`k1fN_~SNhT_!i6y6tLZ%t02J)igWe16c`HRnKf z!;uDMgMsBvjFVB)=h%&{tFgz?;q+M#F1@vCsI~rI0w&iqx%1@fpWi@Ifn0x5{h9xDP3tQ-qZrq zIC)5o3O{IF_c6sN4YQLYwYXI0b!4!&N^il_M}Y0WlhXE~fLo+0-z(K2OM>NuiGoky znM>zNFR^!7PQ291ea*{0B#ZxGHkzZXFN}&l9f=T^V(AM0sm{k)D{{4wZMY&>tRM2Q zHZJUn`)UN<;Of+-dO?%LD4Zu$mnkEURm&FWw5)hX6rOz?tp4$pIC&hZZ|hpqW7`hK zk>+2iBN10>@)~lfntJsqT%*Xb86XHdD{h99b)7XXPS10?iQ_CVFAonKVhD;z8T9id7Y7vw>p*&L> z`S-v6)8ciV2I(fmGh@OP`$rXXFzs3su#;$jwjb}o@5lv~CxI&#Qe2Aj*UkiyemdBn zYRk+3*S)k${UTI9<(f$CS~u8?P?fa?Th;b(LQlaYm0FvsVbe&h8(A<<`jQEVvtiV4 zk)DmRxi&0mDAH5zd0v9?jMTJmrdg)eN*+Kfqj}#KMsUUaWGaoA-q2$;*=*h?j&UFh zMM(PjFEObWKKkC-P|t(^?M9P=pb zMcq{20q<`9{v3(=#48+*BBVaqX=~5BDK2}M?H#?j*1a{uTPylXu_My}0`yz@C3>7C zS{P_pKwb5JBq{S#N64U~R;f;kbQG`wqEQBa#r;brWo>iWJ1zHMl2T=52ge}HpjU{0 zNHSK}n-FHc-;_b{{v-C5GfyO4Gd3nY7E^+UHcr?mPFP7aYh>KZ?PE??5B_nqZieb% z_B-kl8ip{(CaQ0!LL!D>*qhHT!2>sm1++PG0ph(9>FCCjR9>?mVaKe21oNlG3i7{j zHsjEIB`Zs>S=j#_j9%CX?Ijb*7zGs7hVgtHG?xn6kJ-v>=;+-&a-cf6%UytkN0eB3 z74Bc?;1Tn6$$Z?!$>J-R&1Z3MiAJ>nhy5_2y&ftnRp8v(yq1e^AA@=0?(Syvbe928&UA{vHhonLCEi^Hm%v% zrhpHxqW-~nJWtk>fb#om1^_{$H4_eqlvCSQRyJi5N#b7f5H&ibp{so_JEts1s>y_<<=@b?8X^iTV@#q-^0Mhr zO4EKqYJLRJ?5{2r8M}~s$>~>xUDc*&l~c4!k#;@1Mb}jG8%>Rm&eD-TEGwj=amv(4 zo#`maV71CIHU73L^JFeD)TdUz#b*{fI9g?|K zH>_D|&iJk^HFCiVwK<2U)ASs7n7dL=)v3azR~9ZoGJxoU$fEad>paTVzui~=h8ZqI zI*oR4UId-mMRDRVj!C3ycT@rfZxO_Tjhe$VkX1-2F3+My5e=Y|LEQpSqlnEDR13F) zUVl2xBZ{}Zt#=NNuXVugxjy z@Or)!1mwjx31oM?4$D?RcpZ*qPzGSlcz%PEc}O;6smsIaO4L>CHw~QO`Q~l1i-&;B zEaI|!8K>QvKfXn)YHr=sMXP~G_6P@a_1?9xNei2_0YeFFLcl;jRYdmPUmUm`KH-FO z9y1XEu}5YMuwn@e=r!RNO(ayqIYU$+RPkEJl9l<(Xj75~GsMNnO(C;$Nm=SBl1W=m zG0PKaedbwwno^w*X|W#-A~7Xpirl9c{7)N++}B9tK4sc?Hip&9XDaMSF0A*!PMW-P zIE9ifs7!z67^#>$HFvrawzwl{$eVYZ3PSXL3(0m4o_iIt>G)rN+^`R*IJX|OO}RgJ z%3W9f*0cS+!&ho)|7m~sb+G&Td9eG#!B0iF{yKiE=A)`V0mr$H_=}lXOerZ1mXmOa z{tc7ru@FXrL9R2mn9^~9tAXTM&m!3|Js?-Xkh#X)qc}u}7E`gMH;%n1VNGbAXc;kFkB z5>X1t2k7Z4tKoq4CVl#z%taOShN2!HG`slQV$uhtltmFItug^yclVe@EkBTn=&HF!-&iI@D@)olQeq$bwDMbRDdV zY{=;-MVhcZptrhI7-np%J6zs$w{wj)3)*W^_IaO>&LPLsBP%k+F2*3($ldwkNME$a z_g0UuA}fnrc>LB>TpLlVA@H$|c6)kPtqio&s4AU~`S zP)};j!8&sfk5?2cYL3$LEPQKJM%JEG4?VLiAPQ3pKf{*|7uPyFRiDBUzYeZYXhSDU zp8^;j)f{ZtfZ9>IjgFanJ(CJ$O=5sqM-;4hhQBE6hep@uiDNF+++B+4?Ph*YQe&Xk zWyer(k#Jb-0kJwS%IG?b8FTQz4QVQu_-otK z^8E1NwNrsUJ~l<@qk|t_o&>+{{;#4xZTCd=J&{NHh4B9-Ypj)Hav{zK!MQ|mSM4$$ zm13F|zHqsOUEmukI*4gx#eyY=VaxQ>tmEBXHDd~(tTfPw+2wPZ5QqjH&jI#fpZE48 zOVfg(FM-g|HQF!fpH_IM<4G9G-v>UTY7Ql)kxP;|Z^GXzg|CZ^=fxqOr5RaFzFTJ4Zo-S7*DM_+}l&!AJH5XGC?d-;|g zN4c<3mO_i2wP^olXn*Td8tPNZQP@MPj4WUPBkRjH01YH02(uIxy_pM*P4h-TM;`C7 zX2cr;AZhyBJ%U(q{*p$G&Sh6wR|pLJhaYh5!5&SFTKzq8MA$B}!#?Q`dLxax?8nfi zP3RY!%wLCeRIq!%YmES7Qmrmz!DO?^oFOOIOfs=4wT<|dP$qa3#0BOT_=*2AY>WTM zg&2#1Z=r9LJCHV++$fo>O{8*yDUuGM?Zk8K5Zf`XL?|Pqa*^x2flqeME*#M5lWI3J zHHBvc;YJg&*>Y5mRQh!cFPS(~E>}b>Y6mb#-rU270azq$AkhXApPTDjkL2`u@eFMR z-~9E840XpSEHQ=A#DGT_IbME_0Ip^6F~ zUo}(v+uMkiQ$=Hi$iGb(D<_N%NtI-t3tOSlW%gB*KaKu5C-tG-UEYRcq>(9tMRodI zxqXF`gyICp)6SZ2RW~Q5!|0FhFrLUwsKVydwzt(N?&&W$i~;&DT}}Nfp}#0RhNf{E zVPMQ*qLYfj(GNzN%9zdUCm?s-=nFrq$GlM#96KYj|Bj{v74(A>7*zlM*Z;wTFEywN z%Y2;^UvnbOC+*s4$Z<@O2W5t2m*2L5+D3ueb&N%!7MJHhHMby@%YJ%L zUS;Vf%aNbJvRyf+pHB{c2~PHRUj<(s@1OiR*n7GA`iK4FB52(1 zjmn{8J>)IRYYirSqoz#sw)6CdT-wM+IkkVOm1D0UJlQ`Xk}+zcA{vb>O2GgXL0QVa zt73Cj+*c)WXia&B`)|9WbXKa#gLbwS^xvk&G>wpVMmoE_S*-ANP( z?+>Ytu!GtdtY?*^WtQ0K*AyF|MtgYZVDEug$SY~8oV~_D$+w4y8BMsUiK)yv} zZii@ySvUfZV6LcAr6ib7s5@m=Ft86)Q3{js1J+|=8O;w+9H&4Ydk`42XtX8Uqm+#& zuHqAfhn!5H;s9@-k)fR$hG!Sp3`+8*6`F#*@6X4J%G4In3p5JJ3DNXUbGXRX+~x{r zqHvsBA6VH3mL?tbYgHh@DC~q1!`_@$9&!lRJ*^344B13#fn&u=0x}?>fL5JY!>R@7 zz<6ll=i@f{YLl;4v93h1&ez~n{x*%xB*CSbq9&j$1@VEjBN%Zjv3A8&eFzqKy1C7~ z_w@hOqvoq#TfvX%FbUoW*c4=mK>Pw1d~RfqbXxG$a6V&58dJ2Y4G%Sk8}WhEEKt$y z4GSi&b#|4VU7Zs?AFOFdDOej*reZUy>mJQR@td_X)wgf3x#lm&41Sgq@L^+4_X$#f zZ`)cBO{dU{*jX0E5|Nk;x9h%PQe zQhk4~7NBOA)5NAjDZ+E?6Y|&u@{{GViaAl6rCpW5)A59a*Ktc!0q0wbkh1;3{HBiG z$?uV1C`SZ#T|v~dc%BoC_k&ktNLym6BgaepyhstW<^^L?5--&>%fF9v*GAC*n#Ky> zf+O!+)Z9Gyf-+b!4lG&u=0wUTJd-?KZa4o_{%>|MiN1eOM_8oX?3p*TVywe0aCop4 zPf{dJ8*1TxOVjni#CX}FZbco}x1*jXc+W%!BKNGVUfb7nz8ppJ8FbpnLZJDAIx03S zU~VQKnFV{pI2tTdns&KvQx>RmsK`4apDfHIv!q~=b+$`%t4p+w(*Ix@hkiZ|Sz9qK zYt#FR>HVj8V7p)c0h6G^FTBLPbtVIVNXf+`FDm4@giNI z#PoZ>rNs|N^AW!Y=d;v{{&+&d3vzSRXm3xzLJz7oFNqPawf%%AybK)uCKRw$WWBYT@-u*Ufi zwuDPz6-e2m{?_GbK`Zjs`RJfkV(M6mX;e=HHK{v)(VOpx+eie^dbe7>42YCytfmw* zqGQ48wN|Qe`YljdsnwY9nxL{mN-jJmMBR82_kn4Q^ePLpfb62=EN0%C3c9O9Me}dH zK+3$n063b^06q+(q&6Dng5!+yA*yU_6p({CAKfKZZD_Y``y2}SDZlCLcR#DWGzLph>|1iPBg0;Eo z4zFTkeun$|1pEEU&0}=R!UMRD0ddaO-@13Hb+;;&59E6-ZZX{Wz_YpYXw4Nnu(}b; zpV_4V3Tj1(nS;k_IF;g`3CxwG@8~5W#yuFO{_4PvTm66gL`eRt=7IuyF3M zhjndRTn}`Vun~GeVv+(|dumB+Zy2gC-*I3!TcH?XPzr2M0S(Wj0ks5OFytGGBFN zc+MyB-p73q0bu;$U6=xU|ZS@)ZC?Q}jl)S(=;$=e`{*B?{6+Vf&W>IgLq@(oo z0v-wT)Oq>bT&M5kGAd5jQCs}*1C$cO>090p*Zgwl^$z}d0J$UiBMiRE&egcZkAFtP zx(9#Gs3QuwXiN_FHPKz|U-nH-r7RHllzz}&CPfndb*3+1Uqtz`24TRI(e?f_6~V20 z^4rNhV{?P?UiLBWuyc}fv!jRq_~~xkOjW#tC5&iY~Gyuzt+bBIq1%fOl`7WmTmO9**^?7zmn<)b%c1}4Ch zl5{8ZVz-hx3gg`{f*V=%^5xs3rH1C^JL0k`TKV!@`tj#C2PgYS78qzxtgRhxt)xfo zYN?semDFssxSeNHMmHt1b^N~kW^a-C;9`~JuF4ptu;U&AZyX>sEEaK3AmoNuu0C z!5ECdnnkAs3Vw_$om8quCFz;z?mg^J5&us}m-@&dsRhdo6Cjhab|)LCO!7x0NSaTud{bQr+M<~w%A<%m0qq>n;x2K*zK~6(@o7pw zTm~G|j|LP~g&`W?$9<3m^7kQ4sd_`4D~Qd;;u&{zO*`pi7UP?^|21cHHzW2>vSn?h zOSK}&)uky*QJg)oRp@0jDY~=uePhW!@SW>q)UGSZ^lm8!*eH=J&u(g+rFT%$B@)X} zhXeh=+~}ltP5qnyGJa@9qBn=!`_uWUrmf5eA*!NN*(8JHwaQe|iMvx-GnQTOjZD&u zs5_lIHQ}8{Z79)(5^X3^A~E`_TF}qoGcmuYIMFUgUI9M|8EA!eo!Tme#elApG$Z#t z<2sCV#xzbmm*+9@i$1S6&(Dk^POG92*M%)HN2VZUGjP=C9o^{DF6ZCk4m-;8Dec>{ zV9`q7PtOz1djhS-^{^MbV_RgdTx7l!PSlaU{2mR;&f4U^R!=Ohx&sUfZ~4>iKhyH>&ng51-2KeNE+B zirvMEomV|r`{jKt@U>>Eve~+&(7j@s(|OI|n&QYt94}WW1h-fADi+9!2Xq1{A{kgl zZpljSaBbLxA6x6yQKq~}3}#7wPd&46Chf2<+@(H>PfRiDlOZsGzn+7;kJ2uxE2m!8 zYmrmiOZ5BYSd0Y#z>VOorG40gITH@J2@q3oh83f7pz5d%zA%r^B?RLuqRR5xaH_F6 zIdVWMpZeP-VWT{o+m&2Z#w?ZM1m1Xv^h^#3@MA9RvQP5R9XXwI6v*NBDEMz<17=xo zKs#teY%uE>Q((RHQhINT)tcIDy3MBBY`QF)j^LuIs)&yavy33XMqPQ%k@M*VC)IX!6nZyq zzN@37Knz>9j&{(gCDs!lgZ@Zu7!V_WX_zpUY?K#QL>xVfsds3GQM;J8S~zyYB%T2o zB??gScvdo4OtYCW<+^oN8#$}Gv?X*vH^?wx{F9uR0bUW1B;hb2&i1(8>T%_as@g|# z3go+GR4MGL3sl!j)DyD3-ZZ8vnkEk&SEn1NYZ&!P#%Q24wwttZb!MauU>MJPLnmH( zDc5vKy0_?3_s4>q4wutweM1TxXd3m?x#-4n?#vT{8k`mOQ;X_UMs-S)vfF3gR!qw} z@u08~8VxyM+<<9!=$E*4`$a&!kUoo$zD0{~$+9 zcd+`c`F6v?j$FJYJE7q0*pXcLY<}@3n)1eYI4a5d%uCW3?WwGID%%HE@qyJQLNchf zmonDQ%0xaZH6b87XAWH^`Qg0kI1Op4*@CITL62R7GY457iqbj-Kj#!079C+8QSfzz_S7)Uef| zUX6-6L~3xxTnPb2z$os~sHG6k5&3Wus#|FL1SHogM%dR`ToQ!@W}3ont-w?lqV;LX z?QZ(KyNM-p@Hq>GZ(nW@Tx@u1N_;G^#-6kGu82g9CYQ#ywP$0njXWX^ar6}bZkx#B z29<5VquD_)NYrSj{RZO;K*iq3$NI|;UVNIx5%%)cPh<)`J=o#Mb59ieTg>lEP};7v zY5U%D5)f(gP|VIj9E@PJfD8D}bIp#oC?a?hZNP=A<_Z! z34}w<`Hph~-)*z!6LmArW^lCf3H)IFg$A!rc(}pNqaB|O*_E%;8KaZbvAFxgs}{!C z2*zlmnubO-=22>%}Cx=8Aj6ihuacnLW zqseM2I1kpzVkQKGGS|QG}?^G#kbfkWbp&)cRUZXliLpx#8S^++LFol68+8xGk3ZSfi-qj@GPup*cPp zPe$oQBxHV_-0kZ+*nBl&c-s@4}(NtYmpgA#rv3jkwf>OX) zT&g(SuxZ$C`L6||r8m}$ zD83g?!Y=B6CQZiq)|pi=r#mSAB+A=RxI+U*nj?XQhw@Z%M4sJdAdJpY{AA=IjfAGkjkohTfm8XKQ= zp3p4;Mw=}dxnAGs-PC24lNfUNB}a3t0I-6XxIPWf|E64SghzuqshIPY83JKbo3#L8 zR{}!T)=ZUX9KKcd7=m@u$)z1a1C}l%?esDtUiQQTQtf8>q#byhZ5HMB?kta^FbC2E z*{u+4i||={yf^Jv-)zM+rWP??4Oa1!PrOJ+bpWR3p7;}@oYx6v+NY(bq{O>@TAw;l zZsy){hOP>!Ip1M8nLJ%6}9{xTbz|9~za^V!U*=eE;nga9U`VkVqc@YQ6-dLWo6R%ES+J?$Kwj z@F54CCsV@2n4+HJA?ezmkAvMA0**;^VY%3$N)?7eXVGlND|@3b9!r&g;Dax=wl~_& zgq&b2SZx=)|N93g@ffdNfIEBH&ud-c7=TJ#$kXP2oR2=Y5LE3 zG`b^qSk+Cq2u@LgW@R&Hf}=f|GKq;p=Av~Lk6IAeG-aQQT=e#fzdU{#jN#x)Z{{nP z+v!p%#7HIN&(%@u!cNGy$9>KG+qkT$aoNGZc<@eWuZzD^TfC{U8x7uFA)Z8uKkjZ?}OuU};R!Flj%(``mnEZzbm2AN-=epTQH!Bz5M z`8-s_%T@-N96A`%5ULWq%SK82zS!DG%4`(Lbe>Ix_02xGWe|=Vjc$9-Y;>#T0ckyh zweov`b{;Yt6Hj5mncPI!o8vZUQA`stBeRR7k048w-ILwD$Dk%=g%%xS2?EmYZsTGD zX}zG2=x$=tE5jO=dmM{DiYGDnK{t^^uy2Tx2PgzXSFQQ&JNJ!jTIZK|oSqeDVqJBs zt?|Ai+q>g;GJ2K6Ddm$M>2#b(+tSrUX}e=`GIPQ+QtGu`+=5tl0K^gwYR)wn#P6d1 z!@k-j>00ihpqw}VudUmq%)&g*?OUI!AkkrRI=c9y9?@dOdn=Er{{0{SW%mq)IhWUejXT{Xp<1%d|>(`ck!?rgbHd*~ZHM0>l3f=G_&0DR(# z*H7;L&$PM>aLDs%rqT6I9-n2G)`>78&tj4NF0h*nM~&Vsq$DXTcEcXhTBcZno;d&Y z$_ldhir4xG{L_~C-{s)N{k9PR=Cl@B&J-(%sY!Hrx7%^B+iDYL^?K`qRz!T zn6lkD1e)L?j%c~R!b=Kyn9t_01r*sh!hJ%`)224<>@44p7rsHQFA5G04pzSu0qZ%Z z`r={27hArZU%}IHQ}^<(9jwPu%7p*&WOaG38(uLwpVLHY%dzFep%tU9O*wu zG(s^-PC1^q$Wud|79No#b(E%WVd!0;zG8oqil%R9OBp_5q&;Zyxu|Uy@~b_=Ho877cNzq*urv1Dc4Qd z(XR`h^r|Xw{Yp+2W`yJMI(ozJOGbR%c9pwgELpx4wa|rbNdp`43VG|SS}^@)SP2(> z+vaz5*$JB=-YvI>XnEGrsdqqT&Xh0E=Wo1`;*)H6!T1IVGMK0Da-`iZa>X-?ZE9lJ zHrviElc$-Rnc&@gHf$fp&ep{=S3K37H|ZbuYP{h=(pzhQuZfYWy0A^BeaQ0&y&J?+ z!gXRwleO@%RnG1y24l`YJ$rTB=GSe0-R9Sq^XtwbCrTq|ih3_j9R_&XsB%7)almt& zJZz}_9ML@sXXRRV*NoiNCjP!)LNE3dJ9@1}%a*Gd$s76upaWM(u@qJS0$ML{XEF>z~1EkwT@Qb~xwL z**vjfwkoUe4<6SU6q%gxkj`hun$b4O#Cp+Xa9)o76pkl+O2F#k4Kgo^#vk z^Lbl+7H1qxM2skw(pZYj>0_xO0#DB*E4bAz(``2Ubm(Rrs`caL5ey^L9iwO#L}%&f zOy>-;BFe94tY@sAabG-fQHd2>H7Oj&;aEWeeqG^R)42k)a3xF1`Lr5na@jFMSx5s05-X}2V&xNz-)%pP4 zg^xD$*-nd^KU|1Bot=X|&SX zl8+h94Uo*pSv0-qhZhSig@^gTQD@XR)E4TmhWOJ6#1)ezlYv}AhPol@3{H|h^eG2_ zHxPCds|@MPg3R4sO6M8YWe*-dmJo|DP3NaWL`1M~dPA9saY_;btDhfv=}I)~^{@@r zbzN}u5aE5e-R`y99Ex;JtU%~RI3EN|79qtc~{w)Gm1TBdV?V;6VZ+j$oO2xakO?he{W zu}xsx1om8FDv1W-<~brqQF&Q0^V|-843predD5r#@pLQLU*x5~03AMj zgVQztxfMK*@xh8BgCjCetGj71Ag2&uG&`uf)~(hrHu(F0|G(krUM-~1F2%_BcnpDA6Ue#b zdCA%mw}qh3S_mq41=w{P4~6yZhFOf5&9mt|xilK=Qlwr}YTPbBD4ef&Z7Y`FUL$J1 z@AK9N5*%_u*?>03HaAu=_^ZX#v1>i2`dQ_}6(Yd3Zm}U-!2pad`WZ-NDal%`QjEyJ zG!dMhpq)qC!AnU&QXB|@=r9tIW;!StE5u_4im1$RDS~4XW^Lv^R79mZzt8)pHXZZ+ zY#mF@$^BC{4V$MA&^wGLZPwjp-EG!=IqUAcK>UjW=$1vlDC@;kRs>%y#{WtUSeDmIWCckyvYT$aMZe51C2!QAK;Dul9SV4@rrC z7(=av6lb*eHJ^70`Dshgrc-x!hfk^;JhEt7q0j$k@7j8r2%_*`A$`XzZGnb_O>8NI zClKPZ>5YpPmXs2dCloYBOf*pf7%)5#pN$yf@9~js|AXH-JKOGTm&>+O=(OvL>~sq= z-<Z0ETYY(O((HfpACG-(%xdfb*H%!CQid81>I8wu1SHn_sMYrRk=DJxwO`Okc zhMqJv%bY?4vN*JWbVF$!g(H$!j!LOQmr|j2e4>IZ{DQ<4z1DKn%per9JJ{QrY$z$F)KW-~ObgJS(zx z6q@S~4=yKmj@^SDzG#2y+Y>jnS85!>&oyJZ?x73Bm?frj8;6UaifZpmjZg}9(fu`e z4`hjSvWwN=m3b036k&DZ2(!o(lqsJ>K4&=x8y5X)sdN#}A`4R|3PEn8xFky4Q%cSy zjW&xHpSl;zP#B*w3EYtn5&P0h1nO~76;1#>cfnsbSxS zjusqDjziuq4it>QO+<}Dpv{w`l3a-tQh4t)j53$JE!PFp+&T*F&W8a^b8HkSQWq^P zRDKuy5J^7i27-Q*57s5aeygn|57JWLtAW$Z<&3!fqErZbL2&OcE_fd~+a(d@;A;FZ zWt^@M4n%8ud^C~F#sbv2{K@=e%rL|d5s*lUKQG{$9Kz#H8!^_WmEQI2Tr9MZ#ldXw za#kAiX>o@CbI3a@;YgB3EXNeY*%U^oZ`$mbmhL%^T&e3nL%&VWfzF7zEM|Qm^ z6nO9N#x?ZkTc#G0_~@Oze^L8(uj(*#+=KFT|8{@qhj0H73iNgD>~FLKZJfeU5XvG3 zu>b7V_g>pyPVMviW>`flxI?L)?DxqvHto8Jn>f@#i64~RF5%=Qd`a>+slas-CyE*m z3tMFj0IH3V{p0e zB8uC16OL{KXcN%8VBu7``GO#xN-p`6K1++=1)#2A(RxT9Q|Y?5;4f6@jajJjeL2dN zR~zdxrW5JM(~WYG+n7au{TgOzGXSQms~5;)GElb$UFFvqS209ZfKVQ7;_7D#rR1or zZb?QU0*p$oh_c-OnGRqF@Httk-Rc~$WHvdLNW}()!jkcLJTc}Ibv_h5x=?=IVad3W zHO2=VFb4yd5+lI8EGc6n&R58T9>5IglR>1gRLV#jnFdRGu#rDuY{XFK;_6-v4K~+S z)f#OwI6_xu;_)db^U5mXW-K%5k&$@1pCuXf#hS0UVu}>zO{g(ZEidli{q4!vNL=Kw zSMc*_3aIk_Z7id=G~TFM8yHUtu<1g==40Nf;Uvlr0}OQbhDimc_|) z@wmK&D-k)D&VR08;jY2$39|YS8lZQ0xM&q-Dmc06q}%6Ls|Cz5F~)O*!QiZ$ZHK&7 ze8oTDD_hjT)BFzr0RR6308mQ<1QY-U00;m803iS{-9ss;1^@u08vp0KE_iKh>{(B5+cp%x57>7gbZ=uPb{YqDirBH6ElnH5ZigOeiI&(< zqCnC~eH+^2fC0n0VTTpiZHHl7ffm@M`!v})Y#q?Aut!po#aLdFHrR@-J|q(P z8jq<@&`^`~Hge)U2Cs>ddcbF5ph**Fg~0{~b&Zfy*<}J9V%GM6Pr#3cq%ptxl)YY-O@oq6TCi8*})z+G=BS z*})r-#W&~hjm~DbyXxQ#$l_P$@ck>T)rN~Vpor1rU=FPv+V5x73&@zW?MnC>z}IRS ze1?K(D56WV81qCeinSQuDtGJLJo`AiPGto(^vx+|nRgsHI>fc$9RcN|3V3~T&k=YK ziHV{WoOhzw0q%0nI$Ts*VMp^SnRz%#!fNJXQpW9Ld|1W1ixbDcy-5mnGY?Bg@oq#M zG4~iw6b?y36w-72fRGC9?o#U5b(i{rOFmZUE=3(oD@`(_BPW_>i?(SDewkM34E}a( zvwH`1IIGfniyXR0$O_CVgdY;-nDIKEC>&Rj9O9Uj4SoZws7lDeRQP3FPb%a3y88|#j=N8<2DfSGh%^fjJu?v%zPwJj6TgEg8)ITh4HR{!R>w5? zyTZ*VRBp@R;tDsE$`@Zhu8{j}E!mr}dsXGk_K8Bh2zRnPcex1Y+h3ix@FdwIkP!1* z)Vt#Rt~h)D`Qp4NpD(^7&#EvKXx)q0M%%RA@xrcqOc@)fDI+(eX}l%uJwYD^^*VFn zB*iH#jo?vdGB9v(p}=Mh5?p;mRWyij3Qc?6(?mj>| zLx`;$602Pv*x?mDoS!ucGDfP<9B6Y!E1JMrnXO#Oh=Ojf!>q1_Iy1Mr5zQ1uhg+et zHnBOBgUJikV6d1Z5 zl*h`PB3cg{4Eo@Biq%ToTAJ(|a65~W%Iq2o*yY}P6EEcvJo6GzJDH9wDJLgO&{5lK zHJ6(n@^RYs#&AxC$2bMAOWj9e7Q$tduY?WzQTva8?LMclQwLHZ z)fSeK4GlAug#b%5CoBJQ6U=&13RG01vq`bC2Ep*JNdb0rT}#Ge;;XW=OC#EL_BAV| ze4>aLM8Odnv5DBn;C>ydpie+0Tz8m?pkLr_PFvedxy3n4y7G;f!P#-l(gvi08Gr73mO-OXH#y~eb1GS} z_u3rzr#l~;%%GH8hfPD1+rJR8Xb)z)s$FlE=X-Bi5j`<$vl@9;0JG9o(8|*OHAOh* zR%kIC53%)0ettC5)zt3sxqB(QfIk|X|#?CD4*xHUQ zG&OkkWQxMjI6uf3$C%G#X!NOi2?=@SRFv=%EKD4@6aWSQ2mk;8AprPqhx73R001Tm000pH004Jya%3-aWps3DZfA2Ycx`O7 zR#|V`I1qkcVE==m=XET}@)4m<;Y+*i#@nJwe*h)XHW6MRDJ$-;?~s(@7*T_w#Xgyu zQU%k7tb|)rQcI+U&VV;D5QLup#iKHtV}-~xKOB|&{R#71b5I;--KX;CY4x~ zP$X!_FbqbP0l|oUZjiyi))G_d`m>}M0a%kB6k^a>i@;NyPKEcVrse?^xe*eCP6&LS z#VurcL<*G#t6ZWI(AI(*C1@vCiT{LILzgN@qIbggtaYc>INRQ%v#5Z2SDJ6 zK~$dF_V`Xz*m_zk@+xsZOuSWaUPFG~FeG4p6{#?UN^x$^6lV}jPQKwKuRhk=5SSX* z>A&H@TMl4uEq{V(e>h8=VPtAZ+y7+DRVJfE?ub%Cec%=J%I_K*HR+|iuna40>ueui zgfLwh!Z6&(j8JtcS=ilcXuh$aOg(5OS%!1RJ!}O@p^w=dG7O$_y6~W!QPW`*8HwD_E>xE z&s=kzwHeMUQz^r~?p4T8Pg9NVHH5P!_AiSu&A5;ix7wu-TC)dQI@>8%N7HYw6)x+| zB&XVuSVr0J7k^bP$)b64^bV>zP&V)}JbHlYtKMv1&+Ro*(f!jh3A5O|%}1VUWY8A{#1S_* zKyCfUmb_-gbKg8MD-Iu0vB%aqs>Z53oFMZ3V0k{M5pz0L7Gq^2qareC7wMozg13vJ zJWwD*tq&s-f5?{SS-%z6^?cdCxcVu%+rSpH?uP++>haeY|Kz(t2xi1VDx%LnGWwNge91_)#4e3 zokvlDFM3~^*3Aou;&r|(#!%u4${g2q6f3A3Z*KR*77CZO?gw$_MtBkl6+6A^m6hTQ zpKM|?_LYDoO-fgNTWiU&@K(H{r_@Km$j2*UzVfW^q2~3Mc~``L8z1m9@T6g3K%he4 z59jak!9ia~;U7ap$Z(4|+*1sMFZEw|=xeK|V;_~-RzHy6d*pQvGPbuT?$>LTG%1v^ zoXLOi#;K1oF+9<|_8g+w2p9Z*IM3is0kT(ii*KGn3DfuK(0s~7W&#-)?n*?tg6n;q z#97p2L(#m;n0y+3wTjf4k2vZ@9TqU5{j>r!;S^7k6vflnh}>p75+8?9)rKB0ZXGGT z)-15}88Q z(P#txdl~EvIHj57b4P)aCly<5IKaBWczBy~S=YdD9qaWM+EOlkG51u+i$hOh(#dut zGH>+e+<~j|pJQr>G~y}?5IN|-0D*}9zGgPI@67aVUK!gO2^$#b>)QS`xF*ZlB)`Py zTI3nsY2MuyEh8=16YBXOJ?EJ8Ax~c>U1nWxo`4g%JLqDgz8aAlUf>7Oz8*@=)z z6@Fi}<>F0%z>e6*#F4%J^ai4fv=F#P#l5!vPoL^voDH0mX|zjVZmJAk8YZ6YEMA@W z&2H((@%ghHG(%EeTSRNEmK^Zbl7yCNF;GM{1}R2tN|x-u@(g?FR4MOCVs2MQk{U*> zd&wYX_n;ir=+z@PtVGR(;G_xLN4i=?wnTxv&e@~>a+D)oQr55&*pUUk$V%6!RbBYm zgwGE+j9pYYZI?+{1R0A2JHoAnW)eDJib>Dp5R*kaxv)g?P+Jg54NYTzeB6^aW$v)s z7#S@U;}zCEn`2K*;c&F*jUjN6?7$N!Wu0Pn(0UqYFN-r{$GkT$Txs!^1A6^x0Go<(72K|Fho_DzQV|MMd#PE%iic=MrR`N;iK~_s= z+A>HUPXq=Oiy2Fcl{EePV@2BjoiE(^%tkTD; z_tS@Ch2WuQ%^@l)ShirFegd>uq}>f1p#is=`Gh0fWDR@_HV`yl^;AXOHi8 zhVGT7?JiCH0f|Mwi(X5|Me-$iqPYF^%8(t_ z+PT*^7eu&qP=a--6z>as1xX)fb+>cO?sl5T31PlS`y8wwJ=9jYr3^vh%7e}~xpI5U zpB`K5=sHG}#kDFvyMM)p+^TBnMzX_Gspkt?dqK!_rkTZAp@qm2-S2w=!(0R|jkz%FoQVJ;40hFX!4 zVuEpso$ykZOd{BiQ+owzVoAk0HfZgH^Y)s86?s2AQg!}VH8KB!D(+z5QBG};^|^Iv z%32<~WeO=B?D(|VJih6E4vlKCWJ~Zn{M@yX#l&jzop8k#Vl%|eN~xyKl--VRT1XdU zL6Bm*nwUHXYWJxCmQMH4g}EkuTkc8LLd~%@?vpPa!!dKxQ^I{&)g?ZaH^TZg2qFb% z!hMQ$A<;UHpQGZpIzRPh&j_uIU@W|3EKFl<)ey`G?uuWZ^U1BP=Qh-ag(P}0;9t^a zxO&}G)$DF16DV9(XRrGnBVEt79tm6|kavCUQ%(xs9S9Pcd82T=&^VGQ{VEwc2ba3f ztiPk>pCRSh7?|oBB`P`1<0$i@@jgGuy;g2NhBP=ejD_Zhl?t*2`?!} z#*0q}a|@k~R!+&Q;Q}~3ThV0|8i1N?fv+z$w~BBk%Ib3EQ9%7LEn$I;k*GZWFmgXR zItcnX)RHt=+USo%%zB-Q7rfn0tfhEX2AK@kageN_Cuv!fX7oOPWh}BlB=SML6K)Ux zSF+Fd@5%!0{3-kEB7m{WtAWdV+KmFK3Fg!$df9-)dV9#YUY0Yt;b_z_pa(|$PrabhX ziXt1My)Hg_FTykBIuZ3iFGkHr{A=X4A#b*Vu@Gl6*#>3J#rNI|Gh!{GuguxUG7FFs z*~-`8*=WhH7^jJR)Wc=bG1Psb&x|lwie3w&U{v`oKm=t!Pv{~fzaV$SNX`%HJ9VG+ zLjDAYiO4S3LZkv?D@4kVi?}dPNXfhX2C+INNJPY*fiOF{W8?Hn-fryk9Ld#-WlAzM zzB(GR7dmZIhv2%>;mLW^R6Ez5DVjIE_?cU@-kKK6k0p)OD|DyV8Qj69$lIDd%$HA~ za14`T7wE-8ZXHIjWmctLjvsq2Kfqm8@+*H^elB{tu3u=m~<_z z^>3rM2U+kiG#MbE$p70vA@Wi(ZOo{R6no_PbF*xzZ2aT)SQ)7aKJ6F*>Y@z{g=ex+ zMYEr%&8sbNNoqRWhK7!9f~NT=K9dzm8*jD|5?-u=wix`NYj#W04( z+#OiFD`N_C$ejkVLeye|2x8^scGS&;engZsJIrF>CadQv8`t#f5p*AMu8mrybKaIz za(!>{bhXlXz%CWd7Htv2%-2F5yf$euu97=JhmiY(v#)XYnc}@B-nPE2rY6s`7ti5g zwD58#t7f>MKDJ70il)bSVWCxXzO8aNPq;V@eD{`o8h_AWPCc`8!?dWwY9Xj^l_!-{TB7)P3=7&zMU@DK1JZ#o%co+c@~?GvcX+$&|D7@~zy)(%bZ{O&u_m4G z>Uy>-Cz{d~NpIQ1lZFeav9?}%bfCv5#?h28=v(SSH`t=smLv%0Md$tZvhCrs1D-i; zp`zpR_nx>CN}=BmpYNBHEX{gFx6;EjGwa79{`Qh44n}26u1qnZZ0$Hi+n=lSp4roB_j^ZiIGP}dXg=>dk?Si5Q?##s9)WW4C`R==x`q$@=mX?F>+T>hbZjO4DdP9v3)gB|H8KHn1M9E4qQnFrASPfICV*JO2KFzd3r637?J0+Hp*pN=795jhe-d5loD;^=X!ukY7#sFb zW^LR5z8?}kK8s>}?@9JF%XH<1QIX5pklM?Wz(a>gcMYv;L%ipWq4HKYj(&j{l-FnF z)ErbcEw+@B5hVklZc?yFpf|et_#m-!ra(vV&1!dP=u$yUC5}Nf&$>Gu*syU6Eh&L8 zmfFK!wMqISnRC-}+4UEQPAsBC95-Q>*2?vYJIN|+O@E^+X*(2@=uN_`q~9cwlSmrG ztR&e0j6lFZT_=%4aa;>fbKwygYn|q9#ir31r%zh`$)VzK#+}v3!!xO?lFmzO7Lye9y+Xc zbe+*DyHRg8N;S>gV(2)QJvLaT*zQZ;RBiMSdsfKac1Zi@u*__y+?;l%r8)2AF81?CA%XiMhbrZ%}K`f=gwrkaFA zsDzH@$GK3jLA^L;wO?dlwy-a&JA5q{+Y^>QF$h~$$m}lS6?4pVT^fZmsT(&npD6oR zG#dP9bp8lOT2jT|gvh<3-MP?m&x`%uF%{#FXdxZoKj;086eltloA=*ndGL5h^<}4) zpg418hqX{|`N+nnx-Wl#lvJ>PLnvSDSvf&9L54W~PEzXZyBR2~te5D{Fkcn-mYaVX z+bx9Rwxmm7Z44WY`T-EC|8Ec)K|Zj%_F4DTb~R#6F8`OaGx@w?G#lz4wgqx{c1-vQDD(j( zOII>Mu|K)lo68VoO}M8^p$kn6^4u^Y-Q)orH5z{wY&p_GZ)`~Bkhpz1`UX} z4?tSg-Q;S07~Nim7|SO_z7Jx|J96cfV=EpC9#xf~Zkaz}T^nI<9_!Q=-%4-r+|IPF z$Ec!C?0mS(>N*YS8>He>wJ7BGjxgTpRr7#KY$FqSl~s|kP92^#drv9GzV5u4HBdYy z4d8@^?N2oCXHewdizRhr8ho(y_T)*;k|Hm6nQ2e=e7|(pPJF(yh=R>weTNt?(Lx;! zI)I@nCx2q7c)aH=h88~}{|F!Id1}c*{QO2$MZxMu5}}2|lhi10fsK!-TghZ6?0)Gt zB}oRmq)q5Mmk{dK&(V{pkjuWosc-|Vfj~_2w(OA1>;nCPlFEOOXtNHs=Sf1=Sgggd zIg@cP>02acYCpH8t|Y;Fp7jxVh{U|ZEr~WHEs!<|dKVz^hVk(>Bs8XzrOsvu0wXff z+Xc&w$2KR@zQfZ_4CyKAq(R*;))W6C(bk2jReUKp+W#fdsGB&K^M57L2?6;_Gk`+( zfiyYR-w$^KOAA{?Z5^|pD4G%@6*j|+({&Q-DpU-971e1Zf#yWi=ys%nuJE{MPpgSdFtVMdoSpoJDD3RUSeH@WrF%c)hdS?99<-dL5hSFXQZ!aQV%6uEb1=#pylN8oueg^I%=uD zQZb313rgn=4kfaB!xbY0u@c}^H&LdxeiWMt^Nro73+(Ucx06wl20qCrJBt;F!Zgn{ zN7TWW4%Bj~4^E0A{EEd@E>;z68DKE(rO^w0Mu}YB{?y4k)3=<^I`Y9wO!&@dcC6Mc z4V0v(jqI?4p1$MUM-f`G-y!g}NvcQOu7;@;SWKUquCMkwE)Fi%`l@#f9eLrxg9OL( zui3)gtb+Vy>GD^kAP7h9oz9Tfmcu1&7H5m9MOdU(6v#QjNe)^TohN-lMrZQq$VCQx zq+x{5DOtpvC;yXz!@&nF)C^gs^E2`sDwHJEejcfk9-jsIHc7EsyitUh(NhMG@ZL$B z`KiT4a4{IIJy$oZ`Y2G7D)?-Rp=yB*5lj3JMBniPOCCnhlPzEq3I>?poHZUTrn;zQC)jr$m!yNUm;eeC}RFtaz_w*IBcM-BQT~pmd!L zyjpaZ0li62D&H1?aq6D4+7(eQ5S`6sp_{Rg4G}iMkKro6vVYL;+&TW#C8mOfW%D3> zr6)=Y{c%+lCd}CoO%4n@Wd<8RTee9gzA(S`vQ{l1G(~dFNG11G5I`(rt~%oPC;smJH5(c2twK>aPeN6;iWC>2WFtHyv2NKU#8<*@ z9^PGZ^pmecJ6_(Dv>?;7$mnM6PQF6oQMF7NHW!HAp5={}gbne~>Udk9UfBgTE;-KW2Jl7+j=31Z_$sdjjz=P!H zI;+3Dftd|EbD$Bowg0PcRk^Ngt0O^;~KQ-<)GDdC*9?U-_E$CznuS|io2EnIoAL727yY+|Izke ZBfqS~J)oO`K&Zek63_*QZ~G$Xe*p56?-u|7 literal 0 HcmV?d00001 diff --git a/Data/eng/Health Management Industry/Astrazeneca CEO msg_2010-2014.docx b/Data/eng/Health Management Industry/Astrazeneca CEO msg_2010-2014.docx new file mode 100644 index 0000000000000000000000000000000000000000..383fd9fafaedd19ebf7dc64cbe7876ff3e21e993 GIT binary patch literal 32827 zcmeFYW0NjS5T@C-ZJoAl+d9psZQJhCwr$(CZQHiZeP<^&Vm5aF!AyRrFO?A$RdrvP z5tUhrGN52+KoCGsKtMpmK+vS20snx3fMURbfKY*;K(s{cY@JPPo%K{a>`k0>=-q9s zi3-3#DD!|o{`3Do_P_B7G$qL?1PUUB+>-x5HmHMcdNPhAz2rTY$yMEV(Tl8)`5K#j zKHuU?%T(kS1G?k-m~TI)U|9m^rBmlYc&V+FR}?&HLH^j3OwpRuE{?vXh+zedi(0@J zS;LQs4^Bq*J6{9+sbEiQAOUk5<(dF#>Ko!_bWYH!70c5SIFuhlWCHcwzTCFAkOM+J zP_(Gq-vf4JVh~}~oj=SN5(%g6sMV|LQYO!$Nk;o8`95I0t9?){BAlG*R;P$i3l(^; z7J6}1*WYrJUT{wxXinnoj*`Lnw(t>UrZ&U&9EX=`vESrTL(2M`objjzLSj-gS;RFj zoR0r1gaCJma(7E*xs7_gt3o;AfsnxO>PCQbSaDv|vQ~NR8i+($^jEg$C%{4dtWEVs zRAb0D3Id+i(GZFo^WoTpAz4`8k<51^xdaVL zzXEncm@3-n=`JMdP~6l#c{-g`Sjh~`T;eI^g{U>qT+Um|)R)+`a<^%XgjCcV)5-`i zgO`}8v#_;WVc?BV%IA$@sw_BY3=tybCoyHIE7T4i>rv^5!;^yk8yi1``y5r-(KGs_ z4w{i(vY`oYVRkFnJgUL2w}PO6mjy?uyV7E?hNNp`O;uvj7^-POn%{WVz z9dB3#!@g%xu>36gs}~s)ObeY49X|W$?UDrw&_#4!FYp+xNdO6dKp4mmIPC)On z>Jtb-bYnoV!vIO$#PJA50H3v;0=;GssSQ1inNS@@Ty^7N;WEBT!T>R?T%eLcAn}FwsNI-GpEjTGYe`r6*;5o zR?-L7^5N=h+rOU4-6y(1i2T|w2>*W?D}4<5cu@cXx}yaFLjF%W|F_2eS9M)wZ#!%& zB-0ciELy({^%C%Nf8HDKE~`4QMv8r;ec#{lP~Q1`4gCGt{jq`~JfE_1dxbP$cYW^f z%*^c1@7xq_d+kfuae4CaD7+Bzd%QRN>_;AP=0sOU68dev#p}G=q4SK4kZ({sih}jT{o*TwiY=QtZCN-k&b%*`HI_{>GTiRs=$> z{u1&j9p_B0;N_T($F%AW!t?J{kZrGgZ<9-eny3!_CL2o$#26<7CKo1T^p0BG^TvZvu z_2}7TO4_9JMA${&ZPE}*$r8(y;Soi$2L%Ef2kNEcoVghsLA7Y(bW+rC7Ds6GtS z2?-3t=)FAqp7TU}{PHl~)uhsm=1D_`mP@DXoAZ@jVW!6zx$=`?zYqA^)wzuj^r^Ej z+a3{x`}hRa5(2{tJW}HC?*2TO7T6{`3W*oqJe~rVljGbu(S_%fBR&@tjS->PPPeoI zY^`DnO!5xk9(^AlhmX}z-Rba?WuwSk@|94pGzpEtr=ujFVgo5j$Q@28Yq!$2a{w_y zIqjnEbp8`J`h7F57%8hmclOt;#Bo}gcHj%1@QET$xt3b~B%5&`x6lCJWI9bxd4YMf zmfRP>?78aXC^H1v>c$anJsJ!|PV(QQ=TNV|*&IRpJN=>FNPp5a9alKDxeGKC?4=9C zV_-t*A~{osU7y&;OO4#Z;_dNe0@4kXt;H6-xgT{qv+r3G1!-{VL5OHs>F)ckzp@hy3@VhA;F>)~E0%4dQdxx!>+ZXZ>PqX*A1hc&v^q8l(K4 z)(>O>bpjEihe19~Mzw`rLalJ7SgTH((&f=1<=Zj7`(9n@=O{K}mqAAMk-P%FnvzQu zk5qQOSr2Qsm2G85x!V;;1f+ze7XSDGR?!TN{nfSh?@Zwja6%urxO$m+bUeuOl=vj} z^X6)BBVE4TnQp%r3MIXM$o2Pu>7t>M8@k$ul9Ff>*oI@lrNL1+qea$OwPhT*aHwB5 zX&R8wiHb-W(U9{F2}Dg_e|OX}Y$OOBv&;A))lU1@J3j8BXUT&9%9f4WCuEn1<&1Y_ zu&pqqQthjG=D=;LsPZDFJjjw`G%}6Z+;?kEOt+V2yA`z~7f6^{urUv=OUOFS)Hi0d zBdAQK?WDcG8Ux|(>_+^0_FDzj5HVQgLMP;2X$aWr>oN*ZAaw*{WquzMj}T? zyH&+9x01V=6Bn_E50#5=i$!y=Nx25K&$2T?vYpUMbQ#@`XYOigIaXzE-4BPnwTjnR z#-em@?2>5*>CB!)`6EY<)3UXiyOc)hajr{?h_wV%$(7)Hfm_3E;uwxuBmx*T4v6g< zZ@|K~@reKoFOL|CBfI^eUE}Vf6b$CzIx=qh2WZ&xD*|}LL%rXxU3Ymru2#;S^YEHc zx>8PL>_AC{7 z774`@G%^uN)tQn-hY35oDS$`ouUcXBjQ@1~q|855U`#vCm;|SBX>Q`9dXW<_)Oc}Y zIK@5|nFy-*-m2wx`~#vY7#Q-zrEK{cl5&Ro7)}Hb7tBMK>|a268|82yl$>Z^(+~+e zF)rg_m*1S+-Fkv`orz3;6t{KY=JM){m!H$UEVi5m0)pNW;i*Z0PR!^K!1Sm^7WN!( zOywi^&U^G`;Cc8fy`Qny^)!PfYAVm7SZ)%R{~Y8`R5QPZxJXMNPsRy$k$D^On#8qS zi+mgM`I8 ziH9PLt($MZlI~qong5y28i!24xWFvz<9>E46FzDmyy<}BRW)^&Q%*Rm{kIAGw}-v{ z&IQew$ZQ`C-NRWn-9FT=chU+}WT}YNVDd}l7aiW7BL3C=z zM>N>}(&KcXP7q?NbbZ%W_7Eu&;kJ?fbLyZ>2UGW|$GQ1Wv{Ve<3WAu8;5^95F2s7u zKZQ>q9{8fBaycZ9P;H``VnJo6#%my%eQ*oWU#?{na*V$4LURQ44T+l0rUF|JSsbkT zDH2Ss5kYhx`GC|#K<;|G_sWA8&*cmB%JqLD6PVY6F zoN0EU#1HW#nAaZxZVp{Dux@ZOoVIEPwH$N0{^8zje}c+x-7}Lyq>Ppoi_Zly_D}V? zGLG8=iMlsioKnOLdnsgG%RGz-d13upb1|o9kEkLC zL@>~v_Df76nWyZd%9(4KLLg=y`u)VjB;vvg$DU~ z;pb_7!N%1ww&PF{9n`tPm5v!Jzi8>(ysXOzfG-$hM`ytX^~V{tw#bMLVi2}a^+ybw!E`-&_+u!CgT$BG68$hOM7KFd~KL4QMPi85fG=Ew8{xJYH?Lq z{xqbe?`v3p8V;Sn^4`aeL^MWVzG5kkkH>9}^M{Gbl^`Sr7*_?)2g&lx+)H2Zb^ImD zl^AUHB@PgDr^B9NcnRh@_R`bp8|8YP=_!5`?d}mp0B(xRVb^Gjaq`x#czrzZ99Y#c@ z!Y{@TzzQ#3)D^iNEPNHNcwZ)?Oy>Kq&SR%D(0UPMpEkzD4B@sh4bOqU`vON^BwjOlD(j$t8O2qI>(w!%7j z&pRf?R-gPl{cgh(8#U^p$^F|>%Ua(3ubkMSL7@?3)I}XX53DZBit@`|l+ir~BpM{4 z9FaR>?7j-6S2+s5E&QVkSy?g>w=;+VF=}bJd8BwBAY7#HKF(%L0TKLALvM%3XH(+c zKo*-WRp$7tyZsIm6Cx~mM*Q7gd-3gxZ&A#mqJyaH~h zHs_r2x_7^n#=4|OTuDk?W>_dcI;`Z??q=2F)Z16}<*sQiPcbe>-&*(k^8OXm@mkjK z`s6s7`6ToSKXlbmtE*4CtX514jP0K^yUQA-Di-7Zre>R zc$l^JdLa;i-#i?vRlyQoB@0QH@GYWHvG5i@$jaW`elOXSw39(@{_OP9+7<9YV`qZ# z>g?=%zB?bhJG2{D)mSd0p}8Y22spE4_|~OP4dyBRKp!4FL6aa%_>lx3bis~JaDCx2 zLhh3w7$nr^!55#iDcPJlCio)C)tndPK4R_UCXTf>{~HT6P?<$?^(qzr>m%-S=Ev#z zK2TBs&tH!ACeF70>2!A2WLUNWIHKmf5l?L!?|Hh;$X=ZZ!BSbN;=`)ITAT>KWHzPg z%}de_v-6&p3P5U*SUkFn&R*+F?7H`;l82RO50@twm&*Kda;I%d2MZW zWp+16KgN@PTNLiNnT}TRer+!{?9?xNVdvA|07skB`^5B>s$L^a$vB-=6~V($b31>< zhPRm>N3VWfH$OjJ@?Ok8@8$7xxORu6dwrr(j@JXJf6R|tbh<*CARDEkTyr6s6|}dj zoqu_a8_x#jAucNf7l;V=?}fnT$lV6cg6CfyL^i5?u^04t-*A&==Hi4@M1{43htx!> zKyy#(Bx4_$+U=bMTa)2`|FHgp-VCh{I<|oRQ)%^ksDP%dWBw@armm6nTQKIblegfq+rdm|xaHbsA^I`5eJ#yy*K__&B z9(9%kTlfdbYNYw2Kf!582e)c}kk&>)w=EcGGrfGKVMu}7D zsLw%xR(V6|@a7+R)xkh-Kb&RU$6WLXE4V#)Edi0rs!2~5zD~RB`b}}!Ajcb`Dec6c z;WH-*Cn4e>k?}rK67%QWNoeV%M8&dQSIBqw@}*(h*HeIDt}qH;>(Ol3xi~ChqbcIW znpMCtX+=552`El3-{owZmuSUYo5zZH0V=~;hJ}o@qPbePj6V*k3zt6l+BRZlV z@jR1;T7RG))(=JQ!PGZt(Y*Rm_Dr%9n~ zR$ZF#rHVF1d&B$n7rk>$A3el_Sw~-|O4Q5DUS$gj%I=kDj1X-GC2{6VvS#DyAtH+v zOE+g;Tnn&WY=zY8SABCYx}E8a5@MUo2ondJsy==ONB^BIUl;Gn+&*fb@!Cz7pD#$o zx`Uw}fHbtJKOQaRFh|$`27*y|I`8aI-Y%N8E^RVcoc~!vjAQvtet8J8U#RN4-Juah#s4@~YX63YG(t)-D;6)=HbgRHMiG7!= zFmY3hAO>gt+01$<^B@RZhOZFoSg1-WutMk|2YgWWwHBOXk+b97cUW5Uqx$vg_+Ja4 z60w-2pmVm|wP5s|_%|zlUc-#jr7oK&S;dG(%Vw-D$_UPGh-BWad|y%R!kp9T$B~<$ zoQ*YW*J=0aV2+7&ha6^DaCncsJ}(e;D}KnUmwRa2n#YBxr0csDCFVWZ1f+obQD-#A znD8epi6dh{Sl0h3cE4dGE_%xZ5_6U|-wcs+lCoRG=fZ0vN1BOETz~_u7v8LOs|@j2 z4+WLo%6>-T?npPA=QPbijb;aNEgA7}PN)}3Z{9Ai=K$gsmTE?wj%=~_J=UCXN$D+z zKG=NLLBJf@vJsQLjT6swQxk1ZW~WRhQErCGdHpp4stQ4KW?kQqMABMUS^HUYR1t^D z9My8R8p0_{91coRF*amPOqsq}N>ev7_v3hgWcpJrQ0r*ek@OyDjr}lUcMnqfH3(4K zdkY6!!Cvz)OqPv!OV1b$jsuU-?i7upGd__7eQY6+(}>B3m^cv&%?UD^M#~o(zvEB_ zD$cAP$Tz8C)l|u3HDC19S*7H;f3a&1Iy^GktocdF=C{ON?}?I%vQ4rWxRTl^4KFZX zU*vi-{_bFn7;tSY8FbUa278E2sfjqi2CX>SaTq!6hr+HV$>-}`0BO#hzFjwWM_ppN z2;;%9F>~+Q55I(3Ywa&t&dqp3#xa^0FJB0epKH+0e>b;`=Cg)9=8idqX#8aNeouXr zXm)oKtl>%eFVc`u_oQ3wG)TL!jwypvq8YU2m$|&S{xwRd^|)@uRd^5hM*0))SUzY= zlh&_?#1uzQ8LgXw#F{wpQCEyeg!eAZ5Yz zNa|qiREV)Z5h1NHyF+%w9YQq-r@v{*g@+i{MIQN5v$^Rpw)dG)mt0fZ%Vi25_9i?i zUj~&ieZ`EoJwqZRLoPeP*(T0Ip2f#p!x+HVPe%kAGcNr}`5doYDZ}Mlguy1-ZmAVN z;&F*4?80c*e;ds`8@+i@y$chxCc`Xn{;g553I4=dKC_~kQ*3Q1N&UH^5$KK{&JA;0Rgeap+y)2lvvtH@!hUt>M ztoHpEwWitZ8LIC5EDRp|Sgx96xv0YyuV@#fMmKWlT=q!0ROT(Dq)jBMGY|JAj;(z( z_-FvpYgR3`18!sW?j;z-1MjVQp2BJ?7Y4+OdxEl%2WGgtCaAngl>K%-dohsY`f^QJ zd5tT^KyhMLJ^|IXGJhz|7MX@UgBz0c9`uW&7>hU;0MP?;Vd3}HA^F!zj!ToGsMqpc zxBR`dd-<3HFMNesfQGfldGM&e7o;#JKCr<&VJjQw>L2)mRjj;26EXDRVs&Uo3?+)u zBIycN%FfP^TXiY4qw`_gTrm%kQaiT(HOhADmf_cC-N$!w$s0oZl6XtU1dJZL_6zxU z(6JUwpIm!I9@++BfIAJJ+|>~@XSLb6^T-EF4x+4zj~WDiKad1+|43Q%J?G8w1U>E3 z>P?H=_q7iFWM&P)!HNTbxzcJ-C2-av(MaVJ2%7ebXjO27tKd10f_22Oad@TCwc*<; z)h5)DT#ps-O<$GE#!_fmPj+PNM=UoGNHtaxN<6gqmL)Wjt-%t^-xF%ZZTTwQu@pKK z`NOT+l6xL!)S+eP`%JdSx??Tvfe0mTeP_=&Q86w1(p(QQ^h%0Q1zA` zRqw!dNM$c1o2udawHmbZ)brILBUT-fnc6Av?O=P1F~Mz+b#4>96f(7wEV-&fp8XLN zMEgWtI+oHVL`7lb5TTwQ?YiKdG0@Srx8qWgpN|9LQlLsrT@q0rMA{|fp+8M8+r}@S zc%OG|$*!F<)1(U7yN9yIX$_Z}L=9ySW!H3%?B(z4Wb*(t+fo&CVqdnoKni zW`7g&&OqRCy*WIkyy8m5jgAF@CXtdlNL3`PHCcE@w;uYzbl16&94?{3uxZjawWOYjszFlrUcPq{#T(Ttp9m20BsZ$^}u4}t=P)>C!>(s z+Muy^TIx;I-+}C+XCcyJUcoj*HgEx*&4xq(R(8Gwyn;wPD}9SGbPkS`(fSB^u!@rj zuXA%_8Ae@ydJYE;E0uF}K*=BzDX!dK3F*dvK!Lp%TKI$Bp4kas@Z}0cdI6YwvE!`2 zb!c=fBmn7)k@^rhBxFvD-g2&%Z@{W?u1X^xb$9uo(iqgiE`Bc6RIp+>b*thJ!?k;J zHYG?ieJcSj%02UKVxpi+RO~wdlBwzi>*yAT@i3xSho<9{>!Qz+=WgKyr(IEts09aW zyG@_$Ex=W8qbPBA`GH5hE@2wFyUn67KiUWgzd^1w`X?ZY9)5LW|8SMShC9}9Ki!rW z)oOqD*kzO0*tU_-MfdFgyhQtzr@8jzuxW|znea89~FP9E>vc9XQsZ_ zs;c`tlSlV6_|-3wmXx?#u2n640*Fy?tdFB5EMTb%p12ieGbcij*0lxNjV|AUwr6m@ z5|p>`(@TNiN&t>U5y*C#oV7uSIe<_Q*OlOk|EZV-Enwy}sT1bR)=M3iGqcq*A#3pv zMGL~)G!3C1x7_0%Dh$4(W&-C6CA6EvkyII4A&NbIs!1Jw|C@utyP@&|WV5@WT0ZrKE6oDJ)zYpYaaSQ}H-upw z`ZBq_ROV`v+Q6sj+5OZ3X{9CbZqt5sQ%RiVr%lMs$0;!=)R{nP?~8_}DWv6q6W8+R zSW330iI%?8yL6?h_hVV=A@Ms@LAR%Cb>};n@CO4_p-Y0;h@CIXe_`$^ffbJl$1{P{1?qfDWPz~y>^zup-w#y^-v=2O?^JGcG zwV?_XE#6wiS0W&|zUJR(2F^Ax4#~}`XP0?I{jL+7)xr^ZJGLJeM{C+ZwDa3y2CUu* zS~b9WEs0bV9s7vg+NfnA%z?uYH@Jf=y$bkE<&J)%h86_R7A#*V&#^t-`w1Gd4CyRQ`UbwB+CC5;_Ceb ztIS5jtiYnv_T;__wS82#wvIH0spmevjM}+Sq{7&E@nv>>ZK4OQD)EMg9J(WQ$IO%^ zHPDk7zls`?sPfgC8l^Px{u{K2kC9UnHTx4#R|11QACUN8K4(b6K1>K_$9tvg{a691OvO9T8TwqOBBNzYtrJ{P zAv&246>gBfj$Jm=-%9-H598Nk3ayw}2AHI8dCf~@-vw=D6!ltx!$4i-`Ea5fPa%_~ z9LbB?e6%(r8oO(2A(%I|R$u~ra%`|7$`^?wGF-oy5ucEsn2*U*(e03ZvaIK1{d!{PC3eK&@(FE$Vggr8iZD zp4hBjuKb0Sl$HVGxKW%mQlzKNXOoS$XD=h<-onBSGbJX*r@!Sc^H5yT#v2a;1>X=v z8*~o+;wbjdXsT)t+h+$LDO0KO(?FmN9H2pV*IHyC9*0ou4qm|%1zDCFI#=u!Zt2A% z_O~R^l%%U#&5kXrT}Q;XtwE>WPFxnpVD90g8q?JSWOa1;W-3$U1)1^#Uli1hHlwj9 zF-q6O7tC=)g7++J4w15k_K3~=q?$(WvFD%sP!mB$NdF5qadNp#6}-`_uQ1YWLX8i% z>-15mUQAK1tUyO2?t7pl6w7(g?@Q3HW9>J6A-HlZ;t5^n=aHTH*mi>oEbQI}pFeEO*-2oM+&>RYU*J&8Qz}AScjre_jwoxh z(5Gp)a*5v3?A5Y54C7epSqc+<8_RjF@^z(AeFL;GUGDhb@Mc;oTx)xDh=KOlXU8Al z5&5I;QD>th1i;Bnr264BF5o&(w&;VYh}R-=K#BCljl43%?jmu-tTFm1C^s_s1&g!Vu8`zX@F-X?)X$UsCFd{*L7sZ zu=$8$58l%K4_pjbRMJezc8;7@F$9O?J;8-}^PIL7yy6IzE~ZY5+?9Q~FNg=Rb^gC} z)1-hQMq%KEMSuDWv-H1{%@E}lP|X!3KKW%rHJL@r9krK? zVgEn`g%6?f`+MBgLW%n5`;GBtAo>Q}Ls8LuK`g5hlZ>fs|M(gU%fSR6FT-sA`yF#e zuod%?O|JQ(A~cEQHflfUDwKTpW2EHNq;=Bi8GwgLi6${q1uPg|_TYIX-43` zH+1eGXcL2EXLRzhwYJxM=EKJg;R4uQN{=y|>A$-24i-p1r7?d_sm72kxMX(9*G56^ z{mtLA3aa2AdGDKx=P_sR^zz3!-ArpHkJq5HCyuJMq~k6l`pj!Sx}teMYHROyfS8XF z(UF@RxoeUWan%wR;RkE1(&dqzuO?59Ks#d129BpUU->b5Fxko8CG+VA+o{GTAn0dRco`P}={acqcJp9J9Pp@1JV@wQC(!h?v){5{cI? z%}kHt%=VdF??is9ZR_r&dJRm^!|^Wt*!gTR;*ZoBcHbTS=sJ4kzb9h9@<-~Ee=sgk zb7#2T1_KPfM-=Vgp=eEpFs=q9V@*^VP~Slay=VRl6<_EP^YB>1CungS+8nA78iCS* zm-S*PB5{!0lE#3sOH>H$GKIRbmbH?>EvNNsT;to`!C}ctmBS+q{aGMHP#bvQ>Le^I z6!(GpS@|bLp<|Pk+;U_!Pclr#jcRk0z%J^{yhnBOp3VwMX)|yLB({W;2@{;Jr8t&L+0TOa*t6J_b?>6QljLy=J;)_kLq*0YvW46Q`1?lKGR^ljau z#2s{#MO5f3l?Y&?#B@;Gzqich2f#l8F`QhlG^{vY>w}q$PTpHiU(AM)C@$m%Bq-S# z)G^B~5W%droTZ{EQk+39`kQyX;9ZB`ox8t{;b<%7F2n{eLF)N=zjWr@!QeTg2;-4x zfKXN;a+YoYf`YT{08O>ntUHPijBG1uZvj+Pj8+W#bWZE9U+{@+-Q;VdoVd|*a z(-7YKLWj8|1dqR@h~L!;muMwgOW$AJIQM>}7eS8)LMDUX@h7yw?KszWjiEyM(FeW{ z9{Njpo#ZjI9v;3`6DF-FN5vTrZ-lG8eFX&cjQ7yn68MX#-_EV91t=;#1Cg8a@5q2s z79T3)>$(dW8u$PzhEJRj|IB>j60cO@P1*;rPJ8k;^4IiK*E*K6uS@{@)Ze~OHL`;u zx|2$bb|LEAxjvTZYze(yyDcbOGE$CzXP2@Dge5!o=l(fpjc`D>1G5WSm;? zJBr1pQm?ADo?bT*ko=I7alui<f-L3Cw;R^3~v(|g;eBnd?M;+ z<@&Csv57;g=)@Y-rCOc!Z7zH+{z@09IZ4U7UeLtGVeE9sFeEV*UD-`DPWO9ot@5!+uauH=0nB#* z&_*PmEo;jYR|;+Rb82Y|Tyk6It*OQ4xiMa(;!?tf{#NJW;B=X9Mxu4<(H{#wK0&c< zvoh`K3Gx%oApiwSCKw9;gpi_^(D_ckNQ%YX-nc=5wD&&Y{7MgXd-=iJYY6(ey_-8l z+%uHRYA+lGBYEIv8}}=`I%L(_=V`*Ma^Wc4=d4Nn41QAep&IE%?8rftyKkn@>c9J~ zr2`zP*pEFkFW68U%FZ(Q-z}#*$am#z%_+bUZfroP_Z?2#>*$_}`bZtuEQ%L!X|1j2QnQ4-PQ9VR zh|P6Y47ZFVa1gqEux187PF!)=0>;Tu;&r{@-P+UgN&- zsL8^$?jvIn-0e?^?BUxBeMP}JoD#G6$c+>ajc>C9(TOL z&ZP?|EodjeJ-DgTx)FSn)P}Gw6TO$M{@EhqrB|Q7)Tio5k%g)i$MoW&A=)woY^?^c z;+KwIRm0;lm}-t-ayRdkKVR&r>c|4=``01uyOf8y3u{VxBSu-SM=hutq~M5s1t69| zfbLOd33Dl7XxYEHDBr&j^g(6?y$xNq2oap)u5gIuW@5U}SzA(u{>7m(Uu)Yfg&RU! z)S!YiVw^$GqX!x!pr2+BmVhgYnlh?+4lO4++`Hxf5QpvRef?fpynPkHygYNuAi9eZ zzxvdQ&AAC7?6g1CIdED&c;X>IjX7e%(TG-|Ngo3sI9bdT_q}bnl7IS-T>GAuZ z{Cd;E(?S=Tg;Ps;`FQ{SlJ@G{bze;e3-^Iaq%hlf(tb?r?A&$UxO!chy^7n9SIw9HO!iKb36vcN3pu&e29hcIVj%p8*@j| zSCu0niVz;48iEw48=6eRXb>h$h>i0j_88MO3Q%3D9TDR*)k2ICF2Oxt!ec37484s< zd*3x1=k)wWsQs_#_q81jWLRHW{rTg2xPs9ae_}+et<^fBsnOO>>oZBCm#p3S=WV|( zLM%YnDm)W3-B!#`j=zLu_5J~h0eOo@7(B5tk;r@z_tu)Di)BN_!#Nx&Cqft+*hTgU zA0t1J!|eU|OhniVhw8Q2^|(eCFHy=Yv01H+>(*u;|J`$E`}$VhDiFvG>@5V%MwoZ# za{n7Sd{6IG!^qb?Ul^_WUaC;fwn6b_@0&|jXJK3qm(8!y?O9bj#tEdp_6pDXrKD#( zPAwiHZh*tnCF@25E?qlu_ zuJ+|;dfZb}p5RQOK`J%K0{m0p;5ZjES1he{^M{zE;zgj<^&7s_aAnsU)VFapnQfe6 z-6?|MHB#s<<$=9op}tBEv{b7hfvi3EDoorzcpc)HQ3k-ddsF7p}K^9z`Z(_`x`igBQG z0nxd5vZ2hktH%~YH8-a+Li`qisB~pway>;BG0g=`|G=Hb)eGmfm;TstLF6^V&-}(< zk6V%I7%u>prd0M~5;ir#6?uNq9f#0p@IU`=B83)|mSc;9kA!lUti> zwvx^Z_qQL!5zVYut5+6QHJK1dR(WM5-Bj_CQPsQ|CoY*chI#zY|=8q+nZ z3$jYeeH+n5aw9YsH(%J2fkw|m#1+P{rjqb6<+d@Sd_R-1W)orD#nwFh`(u8Z8{2vu z!#9;F8sc};Gj^rPGXAr{iF^gx3uVp#nz4ASnOLuW7^L1|E-BmlLJxnW0T;T-pO>a9 zFtzLr$9Y`x(skQK-4(FEy1})jdVie1hdh~o?{RbQ>s0J~cL02;2Pu#{+q#RJooTAA ze$Bc+U8yb{0nLq#t*>{T;qA3#1#p#`_FAH-pRk(h~hM_g!fuN49 zTW<*-dvkRd<49(To&s)b29O~ddWj~vbFDSj_ z>21?%M-4axtZDEf6`eL?_#DGzl9VdjXJN{WVXh9;R0hT^g_-d7i^a3rN^sjeFz_A{ zjrhUqN&7=I5cb@a1YfMCP&<%BumBfD%eLW4+itsZDm`A&X~VQ!6XdXY^ZIkC3?%LnUkZJ=Q%)#{@#ANKIQ%Z=dYpSY37%S zkuKy~CX=*%mE8W*s{EQDh z1%5r~VZP+>2jECH9795y_P-9((6)Wc4|oEeED=>NO1!1O5fH&B(<3T|;p-6IY^2q7 zIxs+sx)m&n`cyKo(z6&Qaf&ym-MRHHZ9&rS7kTTimTa`aBq`e;%>brd=lu zS>d2K*tF_4%a6c2#5RGpEsN|kbq$(%L#?Ph&q36|7WfZNXx|!)leH$*my~L{B>)+F zp0cJHA-4MG-~z^OW{9VQCwQ&LiI0Y%+;7qD2p?{jmJ$X)@*G1UXI$Bh0{n$fs81lF z*fg|oehxixel}L!`N6lgV$&Av*{<)=mZ^av!l?Lr`m&of;QQ(7XHJO)EuKssx%>dBn>pEP+4`|{LG-a~)}0(yT>=Ow)Xwyc z&B@!!yTh`1aOQFOMUvSgGZ)}7GYFzd{BRLDc6bRUf9amMr(PoXSLpwKC<H<6F!BO!u-SQ8uoxEuj1o5mx7-Tbx&nRI#HCS!(npk5oxF&8$ zJ$DHL1tYn4Oa;#8V>!W-I0$q=S;A)lNn~8L4a`<`v@t^MN7>SbBRK`QgblMx?4mvDjVR2I)r0Q@UZu(Q!YqPJN z-h@!x@HZzFzozv0>uX1`tC?o4GjEE?sy7YulMT#dG%V?3i$VP{j2=?77|zHkp6o+^ zoOmZ6)egzva!^1%HWBjMX)SRiPUUDAe5hAc5jf$!<>%rO2`k&`w07TvdK)k@YFu+( zhxlR~2;>=_(EIJ3@qijZA0-Z&Mz*kkgfx}F5c3tLcTpg#UTl)SOKyr#cOA+&zvpK` zoQjXGa6DfKFoOqyAag$fli~b(w3LqWcS^UtyN;$iFQZ8gC z)YQOZ=@_FknKnu5zO)=4Q#FJ%~{0#7^0+G{&$RAa{g;}yXCdf)9dQ&Hh&6e{Q+s5+5A$#}W2vxQaZ5Q} z!1OS=qp@kU%8H7cfo=9B=bsi=+8LS?s~Fz00mD&rbufjYETjf&F zbv^af>xEPYQs3q;;y*kDvcBamEbo^clf|l_5w>n83)=YXNV3|&A{X}O$N*y_G@clU za!=|`kKMwFgI^P%O~yC6Sz04lEpO+UIS_j$y#K4cckr%k+2Vhbj?pnXwrzIobZpzU z*-6K?ZQHihv28mY{C1yv&pY>=d&hh45BMcxq$=5Ce)ml6wN`y<&02G^s`I+V;y2;p zb~SOAT`PDU6dtC~`Na6m(!h;UPtA-#Sgf!t8lK4WT2)nA(Q!50M@*nYI~Z9TYCW+YeOJRNOldn8Z)D6er7;3VwYW|+H?Om;MYGM3t?3KpQyBfEnbnxSPTl<8#J~625 z2GU1eV?EVG(GrA-8)@8@4Vo_QRgpLcNGV0egRRP>PDQ z)>Ok(G>Jl9Gi-WTRPcq0Q2bf8fP0@#O65~!v>PFq?0Cf_86VQ(wvjQ+r1zZgd&iEC@q8_>m^jHf_$1L?9OZ9#sZ$w98>92h1SbWMAi4%`4(!5G&QvN%)0c zf{#LyEfQEl>kY-N7Sfn9;4_~Zj|pIxHyjj4ln+`F@qRKj7-}2F2+&g0;Ds(Mro!8- zDzLb#BU{sibiSevdzTDZb{@OOZ5+~NRW5>dYv5Hn{=ev%&l(KMpQ910$)Z^`dkEd#9TaaES~>qN~?5Yj{_2dh&aHw z&Xrfe4bj!UgWQmKZcMSS=E>B^+faAf+slnNpLvmrS9fQa&Dek(7@J18z(}Kc<%Q^a zeP1i|%b zV;Nm&k7PI*678RPTPZwUsXxm0mmaq_AR-Q)vNzC>zRIl`KVEQ*e!N(d;v4nTr;L!H zAV<%hGJ9yg=3NyEq|bd;GJ>cZD4{F8BE``8o-vXf&1KtGS8!%l$uS~D{AeIzKP0`& z#oUtK@ zeyJh17Hs+K>ZpSQ{=^_Yd4q69t{p^%CHus?W4MtdQwg8iRIY%^!b`z3197?e!TeOJ zQn0v-A=#pxv^hrV9OSD4=e}ekr)z#hAST9l(zFR zo!|-6G-?vB;TZHh%%wb6ExJBv&WYonR5HMub(hHLS)KfU|NVC8~i z^jWA_aug+xl{h{OLGw5U5ak_0swB!&D;zY(r^l(C7zU3FiWMlb*On<3Bs62Z$y1iL zj0P|#1y2~O!o)QZ@sVyTcR>cNQ-2nLPuo0PJFQhLj!B-rb8l;v8DlANwso2xC-Ic_ayc%&vWam!DTD8skj3Pr#8PaS{RxC@3uukpj0vKqJw=paZ~ix}Aw^FSA%OfxLL zj{-6eEMnJFNEe$y+am_XZE-4|C}F7_C5LH!pB*Pf6SGR~Ed^Uqe4`C4y;8DvSo=EpX+O$c#bN*fu`?I&G@-YRzAR8R)H07h9NLiJ1K|}!3m?kGEryHxfIz4i5m&S;Ab6ev-_@W9!;p1ll*9Oxj&rtzpel;rl}$jzpIzdl%>$Xdsk;HJA@Lb08+vn&R*krwY5k+v`Y}%W60iJ+QbJGvRW6B% zBvWJx42O*h*VLtVa&3PJt-P=WY^}I(7kO3O510jf;40*F5fV@fd|5xNyJsV}_Ld(+v(he}2!?N*Yn)rz$HomEtN)4*8_ zQ<+kMZbBI%DvVz}RAG2nP#KkiQS^66qhVO;R&;5{+`eL^m$82->;F0|CvLUc$>gM~ zTk6X9lSnBuSCsxBqgB?F)(IPYs1B{bgf#$8yHwwok}=(gec!4lzO<9KVGN@9=jOMc z*+r3zpx13MBi&;-;Y{mpw4=VZ%SH`aAr83kt~vceh~L;m74-9+5WsnlJN@t7b~9|C z{a_yE5l#uy9TW`f!I&X`G&nZ13Avhr$n4c(lk|5ALvaLy>qX3Um76rZuJO!}CjxKR zrmWpE$>vnlYKmZt93ZUOpzcH;Z6FYPyCL(Z6rW|h5!kzJ7ET;C?t!CjnH#HH$zkG*6p~82AlQ{Ah8<1V4SJhNd_Hid_Mi@@uFUFxS~2g>=4azmlHQ{8(;_u zS1vFeU9Lb+pXHJMDA_8g7(XQhD}$X;F8!aq?Yp%%U4dzjmfsWeOk2L;IQVV(!xN`w zVAcWea9id~UPC#XD?z5@sS$oe%(o({KUq$$upm&u8KaFG?5_5xJzurq$VI z)KlblQLclrRu@o%&M0UP^EtIDjs)}Yhm#LHr$ms{g9@}r)z47s!}?Bme}o8RThE$Y z*Dp;p3}XrlxJ8<{jW3sr>Y)ma7yR&ksB)jM!xw>7iFLw)#_@VI!4>%F`Ftvh z*ZP{-IH>RSU`Ie+A`kaP4yp=4%PHARn?%k)=0uk@nvT?~ zKy!5~=drNG2W2!jdC;iJ$#AZPDo|66z60Zzn$lp?CCh=#FW}_T>gf35+9`x~CmaVU z?Y=yD#0sQ=pSD@c=gLr~H?yWQ$8BuUo52Nl0%m?aY(lWT3#h&i3%~GDRgxsY*O;cD z;Z`hv|BxOT{njmoO8F8T(h^UEy)Hk6##NpXlrKu)HpZyL`5!>w%B;e@|n@N>kV z1R*om-ig#K0vDfifA2B(1v*@gHrwtoo6XYp^^xF1dvA7krM63Ntt+g%3hFqJ_y7ar zIMNl1Rfo_(3;WqRW1dxHrH~c7f$z@9IFVXq_4Er&y+KTrgPEgyhnw5{F767O8~*dI z1aHE!*vK~wdm0q;Z$x0u-$tp#U4|p=j(P0$L+bUu9HfK-1wlY61P5g)GT0oc73?t# zqEc{*ekCU_r|PhNkil&*gKI`bM3{JK$@0nKQQvis_s^}oPL9yx{$ZawG6}g7e>J7h zG{t>CWc0`Fw`9I*{a?$)fu*E~!!lT0V-_B({GDv0sk!k%T;w1T*BN+g4^6q*OtbZWusyZ&)ce#-W?r zu^O0Lq%xK+AtaT)SvaiwCL-GkkU7w3^)9nbh&hc+Y}QNk!oi;$ug$4p=aO=h?n&z0tQl~_CGv)X>U00}h%e3^$T{(}0B zlMGKH-9tQ1{y7)47!RWb4vP>2__|Fz9{Cd<)wIx5t1)(h^bJ%PncRJgvKmor=zvk* zMQErFPm0z7#plo93kH@^{O;+_5K|)HnjaGP8^;XCESQ#})ns~Z9`VTzsgOqqrn7wm z1wky|O+FDVHp05}h!>_nQ9xVoxa7H;2|=c1VaTRFxGsB>A|rn(x{<;&Rni4U#B&7GeZ5Wn;3ahV#PYE95cG{%R}IZz3sfM^KThxEizC%dylDpE$T*3$&^62dD9QZOtG2?rTqPH(s5$SeMA)#h`VGP-rP;LbPPh z=+2w(wJbUs+Ob|Di}_{Ex(Uw_RLiglLNC(E{fwa52QY1fOHO8_sB2t zP6#?2H3HIlBEl6sH1;|i`$c2z<)fmrxs^)l5o^)yZXL;{GVmgCbOQHsW9ip>cUlLh z1-H?r>MxWT1s4%7$R;tjvLtQ!ph1_7!sAN7E+f)XYN4+(Sdd@Udn5bXy@C@x>{yE8 zaU9pk3f#~J->CZLbST?!f{du$ouH9;Om^32&0xw*|kzu0Db%VW2 z;;`wXqJP2&b2d}F6F9fU+~P}-Th{C|T1*q)bcmV5SgIZ{T7j9j7DYN5EaRNO*adUJ zjL1kSaqq+|XUKylK{}=aF@<(4CR}#rMj=WQgJBqx;eD^Ako*U9$EkcCXfo8$w-`Os zKHJI6&83)}T86aj7E@aokTz%|1%f&fE2=fS8YQ9{h1z5M*bb!*BPDOHkr=n_8;7M; z_;ztRFNf+|>t0mpYXk z6_zt1&vt<5-X;53p=lB-@8g{GaTWeUyt@v~IcLVXH2C>Sj z-#-9(l>bK}%Dy}pu?TP=AT2B)Ak;sT1Ui};SsBs&@sr_q8p<;@DH|-|FP%i!cp@G) z24v2dqE4ktHGmy+c}p}WcI{jn8OF{gEKJfTSmuENpaKFY{eBW_?tFX&$~*GjQrVEu zCpudhDeL#r?aH&Pxu}500=a&*Z{pofKJ65&G6+HliH*iJs_^REB8Yq9P7_;tEC#(f zSm4G&lK~rZ6Ij_uTwm)6ytEofDl7og6>HQp2}t? z2FtosWf71*N{f61RM!aM|H+%3xG5p%OCq#(eMjoEt0WeB(v`bN|Ibe=NLrhojIH7L zOFFEK!t9g*3%?>30xSHxfazJHPVe27sQu1{A7(STjg>KB?K0nk6+KWjx%~@W zz3el(4Ig6O$UC+=ME&MeGkP?G$!fwCi*MCD;}a~{vaDee8pA<|db|Zg=YTLC5aw`o zE|mOSe0UAK+3Q&ky3hIt;Qc8R$MUj7$ogTedf zIJ`_=K#1gmo2T{mc4oaz)Wy3t9J|yiJ;10GS}Stb2;*ZlD(n4aENMPGC)oIe`|V}> zG7699?ckQTvr7ed6U9~W2fW!g;#LW`8QiEI`dw5NWJV-95r%Mj8U;(zoPMYUdCI3p z#l7q*X@)-3W;naAu7Z5XC7(LkTK37ggZqVMpd*v=mVhs8Cpk40-M4EKmF#bAV*}=U z2lB&L`<}8ToYBdoJw4)3TFEN(mm`An4ru#AdI`jX1zvDA$?|(!)8aY3*K<0zVxv%7 z#pNL8B$8l{herxAW>_N#Xy+)w2sR>ZoUOCrOq7&uVnEQLl>F2JZv=a>**b&Bpof&G zgV>FYf^>Q)OXcn9QN1x124l|7 zOL@6gzwzle^ntXs=O*1U3G@t}apZ6WANVUXf1iWaXo+S3tJ4ut)uM7TH*?BMHFJur z?==kGZa1q|bwwUT0PTZubwh zztYQCTcW3JMA3~zGjh_k2HKRF0L(h4BM_FrBKBjk5bSB@GYv*mNY!W$ZH4LP@=$rg zO$ebr0$7k~KdC;v;FD9S|5xAyTYf!Ge{WwdmUFAyQL9O{nFO0!*vU$RL=kq2rdFX_ ziAGz6p+LBUl6>4H<&rjrivcMH5+9Mm__-$^<=YhF$wwgc;#d84bfL(M>>&{ z=j%GgY7H@n;^au2jLhe8V?cU;v_e##bgT;^=C>Y`s$tPL?>-;$n4mI4-$yG{vK0lP zcvMyR`FPya48V%CcrC#)w|u~$QaLM0+6>=zG+73FGho$Wx+(cq&ni!kj=qy9x%N~n zIG1yTC8f34BMi8O>D7D*mT$i2e}O;qQG5zdW?sNLiN55w5x&a%ZVYY)qUJRThbzV= z*2eDNGeWy!I9pzBQ8y#*L9E>iIO<@%s&V^_zFli3Kkk=&7a-0Rq4|k&pZO!MF$0&ci8@u0;fykvw)IjFe(SJdd z8;%WqBYb*Ej->OCVa1owm5&y-CFXo`eLJO7vC0i$C@vHgBXH~u6PCqLAd3s3rR?R; z8cBr&b&6#)wkSU~`|14(`D=_Zx;2&3 zv;H;Hh1z%Z5r5MNu$}RsF~3msRMUqaM%+YHBbWt- zM59=r$UV@d3z%`jOQPGxeF?-WEqaqrFZ>btR8|bDd<}GHKhfF6lPvT1jT7yq#IR7} z01l^n5Az*a~2qp9&ys9W2mM|KQYymbXL*1PI(J#0fi7a#_jX}Wlm zO5oSsmKO8z``H<>ppa|su1nOu*Ulc8MC27z-(-%$r%vREAjeAF-%lRGehKzB9PS-H zF&!3RRfY9<#*Xl!B)lJ%w1stH=gyFBn@#ha-0%=q3u9{O+Hf^iN!KU#Ji(T{{m1T*;z_rT zt+kK`bz_7wXSA=ml~u141GG4HS-)7WH08dmuUdsDbC1l=g@)ozL3N_-c@SIN;9^I8 z&E}v_+#$a6O=HYlDp`xp$TND(ejwYB7W^z>x8&oqU0W7ZEYoaY?xRtb-HA#P`s*}z zxqLV8Q(Eey{raAo4T zo;YkD@9Kr6`fo-LUL=pQi|if6Ntb!T-DjG@3*%cVA(!R9h9B*M2H^VW!dl?TEvt*y zamxL9bCq4#M+!SE-D9_@cJ7UThb6gqM-Dn*H=kKcBAa*Ypm?{h9z>}&#Rm-~N7J;M zAvc0OksQHTdgNDeA{?lY$&L~madD7t!Y?5xN_x8JSZFx7cO8%hE8DoN);62%wU5VWZIs`xh9KQF-q(ruuA9+o1(oPyzE{? zo!;pFCmrWn&c!?dUdaMndr*P)E>?XSlm<*jy+Q zj0DWMLQj_v1+UyMs+_Ns({uAnv?zp@gPKh{n~PJhs)uO-MZ}{J>`jGyks2kL!u;HY zyEBL+61TS1E-C7zpwx7dwk?U0N@}w0cLq$5Ki6)2rIwE$7Iu?Ykz`7B{UwDuc+X=x z>nk(uE93nGUce+HlvK(1(9x~POW5eHlaqUn3fRhl9bCWh6-Q6QMk&vbC# zi8`3-W5qkN#mE0F`oIHt9`O|d2x#al5D?~{Bjw=eW@+T0V&-TnY;0^~;P}S{xjxNG zVU-KiqDA|4kV*As8o zk6$*ItcPX~NLN3BLFC*!Lpoa8CTpKOnI$?{;MLr*q3L2uG>wKbVMXm5kZ|#=40oam zcSlq|(8y+Y&7jSbsNMBTG?HP`77WLUrqxG?4b|MKauLi$OH% zeet#1ZZJL;9~Ls4z-DEc9|^plF6#XFW{9idqCYdW;&f+fRbnK5W$9U{qRmntZ*>SUwl>IGN3{YU#sZ#%{q3+;9C6Si8_zkiS>~B zKA;&Sz&AnGw}%d0j#9I^4-i7m_gAvnA*TYg3;jq-wo@207bo zN-#W&6d+^Z9<(2Own>jvnD5n zMmm$DYuJnjrj~X-*-&sW)YU5(O{ADRMLzgcMMrX8(l9F_DuGNpi+5(;vDvL`_NTp* zI`TiJg{k?_ZGja59$B?gEJe!t`OUrXsr1(N##v^h6fuJG1bc=&brLZG^BB+x0d$~` zuxG?v4}(R#xkQ;~TU-K$n43?O9CJ-T8mcda(D**i@YnOnPC_4c*Qx`)5>sn)m2NMr zZ$OL*caGauny2H!jR_};-D9pW5GmBb!WrKb(QDT!cCWf8$xfAYDO3qfW`+1JuE3SB z6+U4y95*Fo(43L#;_8fbABH##Wl4!Z?RH6;=xuOwW}K!hRPE?xa9lMOt6LW>sg30~ zO$F3^DCN7uJviUiCCavj=h?e1$S0i-cG>Cd>2a_GH^ngZIS8a$Agv6%DL9tO|J3Zy zkShk&6`()&$MtWFy4qw$Zv|vA4F4!Z#WBU(?lRMaSXsQU;q5Y<)$CcMfiriT7`Awn z2WM2<=WhY$yrw6r(xvi)@oNvR@IoOr-a~zb&YBE7?9s7K<|H}PACvQk=D-mVrepP_ z-pl`4%|;+3BrPjtAu)Y2r0$P^(c1JXUQ8EMGQp>?(rMvLdl;99;fogF9`qhFR{jge zeWjPXeAEe4Cn(u1$Pzsn(!@+ zh(9dcXm!AGIcJ2MC~g^gM!lQQ3;FtezSe!!B4?Qmk#Y}|b|;9EUaWwMJfZsl6V9L@Q zBB<|y&eu}|ylK^T@53U<$Ky~8M*2M(e@Xwu+gK;;1N>{k#@~(1Q8yq77;(#G|7fwC zdo`+Jbl_|PpgH)ZetW%K0z40J^AC6b9D`PRkAF$?iB%Cwr2g<@Bh1y?ia6PLc^1tXy0DE*Mm-9!a~6L~888jIl{k`eHRM%dmFuUX z&u)(w(V6~60iXkkH{Cy;tjHcG&y!1X>lfeha{`}N(OcD-s#wx z3_>4a*P5?=+3q(dIKM0KG91gv4(e@8$AG;YGM2GFiiwRNf7lU9#P?Eu#DWc}|I#1D zxdSqF#3VVukM~BmDj@rzogTUZsbfv6SL9Ck-F|opv>@{BEg<8pVeCXVer0C7il<@Y z`TZo4gS24E%uF;b$IT*m;=6*{F99qzeT!v>s@+xGCvq=}hYg#}>2ZfDXWw3utHyz` zZ|6*#huitvIVoPEm$GbiD|ax`o@O$w*xxx-!4IghUhQ$75ta(sZ;UAWeT)ZD*1Goi zuOdjyE162{mu^hERZ?2GFisoQnZQgo7%>{7WbP^*th|$elP5}<4)UOLy;AeIHE;5l z`Zkmg=WrCPSf?5d@wmn`x<)r=9|1L@{>R$w*Zz`?6o9PU0EMCu0Yz{CwMk^{ZEPLr z3~cO;ey`mC<)Z#?-Rm8t$xZx zv=2gcB~3PI1{pLa&PA5LLNx2NTn7OilKuYa97j41<-_%>>i&ECG!=4D?7M02x1wf+ z#;xz{t?<&3gN;^k&KpCJ&kC=d-tNbu5d{~{1HcI_Tk#sYoi#>F{H7VZ;w2h7IHRZ4 z#}S}*KG<4a36qw3bZu;ub=WddIWoKp)38D){_&Z%VeFeYNIxQf&B0L2Rg#GI_v;$CE)}Dg8w_W z{yqW$uEXkVPOD$OypL<9>?kjL&e8l{2=?L6U&?0^@msS5M(3hdjuTuin z^rLKj-o}ow!`mZ^bVEj2jJCFb*Ms5yYhobb&a(6Irlt?~OW$KYbS=4<&|u;_NZk7> zTi3_K%f+|Spa5|htl>R1Oxicql2=Q{7`^dXzD@*=vAc-~@>#y)r~&6#@PTt$UTEP| zh|nsx-uXU5o{Y?=f|O4N!j`PuhL^(4l4^yzulc$mjpU3Nx0=ce7xW7kLWui;kSX!* zvu66|1;A73Da&?avZH+hVl{GfcZQ@3c_9o1K~sfS8mUj(n3-DEOmd*7LJ*hM&SzaS zF=0YanO6Q8B!Q^u$aTjmC z%4#z`8r6=GpXC^0=nimqjSnbA--bl;l7S9@{r5Px^kYp+fkwGfZCDzl*GYE_%> zPTq;YH5>U%$hh1x60=OvOrxOc7Rra z6PBzfx=u(0??Ny!jd0FgP50({0(RPLAuOj51n&GPkL^J~5S8{_LwwS*{;{;5n*MYK zt%~ z-LS{sZUwsh!|;qYHZ1~hyGN(T4z3^>j*B=GDOV`n=4G-|r8qTXq% zhyJ`{wby@>9)0iwwAqziXoyt!TzHKOCJtyE#j-712KbEVwP_;IdUNl~ZkLttR6T$J zSu0Ief?n9ubr{VyPOFk}&D}C$7cTqIX7z;WN`0Z^Y&;fE$+N|1tv<8SIylW7D{A9p!``hEbY zZ@L;leJ90H7cRJq0P5@e7xgU;WS>nN@{q(WLjkBy><{Xzac{H8S^tCj8vaFnB6JSF zsZSk1eNK)M7ufSD5-BJxHVc7kX+ZiSyT9oS4uENYbg(zx04(+g=NOpd0651r;6`Z^ zYW`o;H(U9dCO7}sJ-SWTMAQvHGih0@4MF z>-rcL4q+33mhw5W#L1N?VA$1G;CH))2#xj7i>3TV7xV{7vi?Dm%)Teu@`wO9W2yg* zidT>YUnFSAtw-|*{n-9L-Dbp1m;LQN<8NWK-G2(R2TlL}fcAg8?T!Hpz%A|@O@h(z zzf1RRuhTK&{(-6Ng$w_})PE0!9$mX$#OuEyweJr|1u2HxfTXea$5e-Nf~>Fuz@2|D z_P?ZI2~>sSnE|8G|N9*TOxfFi2@if}69^jzANt7&7<)r*_MAUj)?}|n_bzgGkCXB| z$m(CPrCOg&d)!20tNr&ueX2iG-NleEba5GG>#_*?>x;VS7ClJ^Yrr?vc+AM*n^JU2 zH~Z48!&gfdIV0%Vxo;8o-0Prkka++VvcO5498Y3-4HkQA4r819JD9J?+((}hak(|r zt*Oq5hKy5`-#{X8yOzL%g4ym2VPDTob&nL?WW&FXHKGJ;-nX)cr~ z|Gt=_G!MazWUDx#MnjHajOVI3~-vI2C{PtF?t`7TXk(u)^gyjS>%Le^IJ zatf~xf0B_!Ao*;ejW^R?*3pd&sT@4kZ^z{nG0stRx^3*PwNt*4#_JfrX1?WejW5$` z)#a`oZzyHoe$8oY)3&-=JDJTC1UATfJyN+(^StH#pOb9-7I@+v0Q5=#H|ml8oMepw z^?Vie^ez7&z4q81>s9pFw}fhiWI(S-Wa3VQq9ZK4lG(>Nu$oy>@?Kuv{J5~ zhtY&~L7jF)RwCyKgOv@c?t!fYJxPPHU$n>+$e5{qiHAc56t>8mAb&wScL zqLot&dVRe*l%>N%%-iYX^?JttPmf`uk6 z7EeVfT!*DtqOw-}#VpX^9$`tI$WxoaZ~*fYR$D(w>JNuXbaF~i`{a$tq1yqeD#Ppm zky>pIEEHHU&=fE{RYpH)_kmw`6Im&P(C*-S(qh(eP3@8!X5#a}#2B4G#E0xbnLTHh zV)$u%Co;sOPd~b2gtP@WmhX3h$5vZv;;J9^7SGI z6LZI$fr)LMQG~2@nRTjo$3Z3lS;EbOM<;{le&Elbhh)3~aR0wS489p}`vGu_908UJ z2>-bl(6hDuziR=&N%QZobOpefLJ!*kzr_2cldU#`6z7x3K(zjmo(4$2)l}*?vR*^+ z=%3lkO=s1o4;Jg9;gRSn>&~e%QBk1JuVOv>21RvWU$V>94)*hhnV4r;M=g_{t==xq zq%s4^zY*25G>^l7xsiN-K`rlaI?C&fmV-e~e5Ms?(xo28aVGpmZbd$)z8NBxv&p#H zD6x}}0FRS8T$-EAr zw=^tZl{ejR60Kq+9KsOLu%y3b1ZBx*YvYCdRGz8>ghgNO+zW#-BFsY*Y7R%Ow^iYw zE{-^&_s%bF^WDn8+2M}xlnY2w()V>a+w+PN*ACpzyeGY%&Y$r zaXOjSV0p1uw% zsA#!XaOTJB!~OA)i*7u2FwwVD`SM8)HSq>eZM26ye19am{dr1rST>qB&DWq6MkSA* z^rljK#J1_zqKgUV>GTkoJcPAR4$V#t9Vaq}O(Aq6hL4Yw7p&4^>eG(ON^^J6vDlVJ z>eV?7nVdYxwo;KE>rn+Tj2f2GEIwo}ZLL_iv~*KsU|vIloOX^dyJ0(BfKUBj=L+yA z8bAo*e^*EU^Vs;a{U5c`WhMVE@b@Cke;WR7TLCAa&R->)|7rO5%C-M#xB=Kk^#4}J z_Mb}stWWxvmH;5c@L$zR|7rfuolAe2o2dQU{Ga=n{weX#;PGD)WV-*B_|H)CKh6Ic z9s0{W(D2{p|A-a+Q{kUclfM+IjQ(`sf5lM#sq^aVOapkl+LoO6aEJ z&a}EDGpF)6s-W@%+sL$QF zzX~rkq@H_ct01@zvTo!0T3kOis&sLm*XkkuI)BdpZV-rLPUBO5%ksG?&z)OC`@A@1 zKoAV)_pf>XT|PVi`EmPpJKsN%er?P}f4}pm>P`Q7xcW~&UjK}K_oQDx2R<5daRYa! z^QYQ59r&r9p*-U2@%{C`1)ubvuP1$NS-$&mEv-IZ|C#h_on@(bDbM)&{CGUQeek2x z&ZzD4X9-68^Vi4H=ylx_xcU2s0|$}Vt-uwO2ckdy`T9@NMgG26KL|FZR{z`IcX$8m z|N44;O&(urXO-%%bmZIj@b{no{l$Iy=Q@9Sdi0-*d*5H*fPPK&KbG*>xgG!8!`c5{ z+^4VFR<7;vKUfgxx-*5Z5xcVfU!#+W<`D#J1J@nZ#SdD*|@39&> zS5gg|o69 zVO@JUSD@EnYbjSO<=S%D^7hpOYr}AAwyr&wZ^#vzLOol~7Puegvl%*DZqBuaZP`rA z4q zZF)5&lq_!AYb@d?YTTQmmM8C84Ks*KkIn&URE97`T z)0P98yj;)lvgKO3I=P^B+VebBp4C4*xINdFWk^j7yCu_>&3E(<=NQzQvt_;NA>t6z zRty`8;hbDsb65uGnOq^`23Q+TX8@T(c@9{}mA4PGprfO$nW5=ct_-+=Jh#H;Y`#?^ z=2v~OP-d{DOkKVsq`!;^I1~)p6(efRXBdKB0jrs?rMuw1OqW%4v3;A9K4bERTIaM!ik>gv&je6FdvEn9#t915U-FjM0F0yxY- z9ZkHjP#_4}eSjg5}`}Ajy=vJ7FJ5MXw5>Nz|YFs_ZLJp8+K2vJSLImyw z+EvY>-g1AaGfOqDDIT4Z%jd&}Tw`Mv2({%vQ`kgr+8mEH6^rS91L2IPq*I{jOsOqb zpKFB_fKjf{-}*swEx9(q0I>BB>q}o!pgHi*K<6}fSSK2DB_u#ZtR0YQ*@+NHqU3mZ2@G5t zMopL7LHV3)MCpvJB(ez0vjqNfmR?YwxL5mYxM(6_!gIa`*Tl_YbLQ3A0h^dixuh!>U+J&+gAC1SwQe-;@9 zYuA7?mV_O5K=)m!q9|yQllVL+U zgM=6h^~F+2G+ILN7r4leVpG9MW(^0ZHDr04egL=GxiaF&5nLS%)sU@&y@2qprOY8Y zgq>4+MoQv~Vnc1Xcd;GJiJo|&r3l0_bwxM{m>8XDc$J(6N!6hoco0zm4*~Dy9893$ zWEx~ONCN5}l@*GxdX6qP!nP(C4PY`WB!`N0!+5|^YGXDJAJP{CtqIaOw4$0@iZD;6 zl~E#)G+tB?gEeGZOKHsdAqZfZvOpqWnGqzzNTY4RiV(3{Er!r+!9y11uVtp;+$|!u{28}twE~KbFe9Jh{cQ~BaamG znewPX!- z$&_RaNOt$H7Q#gYiK%AF+A)_Zp(AaW8%=P11hU8;GA?KURlvtYp{h#8=f$7_qcNYI z>%}I6Xl*Z{o-sV;h?fwl02H#+?;Pwu+taBocuPbQ1InWFv!uzIiV{)`eom%@t*l!} zgUAF74=UEldi63tl8snbu}oFNrl%$0t>-`%tI+GO!bXR|p(2L=aV%I6xh^&Rzju^xc)I;<1cBPcNhI^k#= zUYol4C`WP7IP$Rx-6~xrrS7B6eJ`dmCo2Af@w(c zkV6T$MharM<|V-aNK>ger>z;Q*OUhiAeHAc&XVL_djXCzc_h`?=q$R(@^z!FpH(Q% z0SCygQW2w9&tU^WYVCq|Lb)2Ylm`qV2S6e|v2-)xsK}(R&z>;}87Knb1##0DYqfex zw$z+yl{9zK+C;lVnCEKA6e(bg48*z9iY83-P=%52&2V7SDz7W@OQB!$wAHBkC%#C$ z9s`>UeTni+zOA{QXKKT-c$J-;G@bz2v*o!qV>MS0Jvfw^gg=&4f5KB{+u;G9f{RIyBA1B(;9a_XoE%~%_bkrKox zHg}?}87m&(n^15*Mwf0l5uJrJQ24@owtxyjS%6ad*N*X1XoD!5ieWqbM07$4v2hfe zJ}Cfz2#|y<>>v4Ph_jOU5?;_q0^zFTVlr@f@ABR8Z9$${^5$!c_826ckc(&L3~E$1 zQyZ$(`k2Xgl)2V#%BU^HcVVWb&WlcgC(|m@&tN&X;|SwGn{5TSL9%c}9nD#M2860F#ACLttsO_sXYfxSbRi7gPFcCKLHi>x04;=><8Z`CJzFtQgMD!C6k7(R$ccZZBk7avBWOrT!E` zfkqcbW$Uvobw~*_+yw>49g(b;>E#Ru)$4SU_hD0HYwAf5&NnDd1%@Kw)8B{aRP%KD z62%3_D+1zbhLXleyjn9UhDMpmT%H@5AJv-<9E_^U=Vi^tEvZ+MXzg+;9MaVnjZ6dT z?}9=SU&KXHc0?S)S)?#?vKy}emli8oFr)#quMs`^Dd7avG3gnXE@Ty}w7}8$Mb+(u zP&o=p!m)HouVJWmILU-SbClF2P{nwK{q!(9%R{GuAQJ%A4hmi6v2Zk*N&_wu7WFvo zi}}X6mPI6^E)gIplItQHv*8}K(`v)f>9Cnhk2dG}h9f*ln!k4lHAaXxD|}?JgrO`Y zy_af3E+&7{HgOPLUGS~~EoLzm4cQjmEUj{x+IGTkl5wd{;286q+ilnb2A+ba7vM_VX zXp8a4%!r{)#-ysQ>)hBWtW z8~zxEo}VEmLzsA{6&aq!r2Ulnj%;wTa;41Za;7mx zmbZ;@+kr8R)dv4L%FL8ob7m#bt-8nt5d>qxoG$S2zkpLmOdeRF9V`-TkQcc#x1t6` zZ<@JjqpRaFcOqHoYQ~e&bb#zLqn0>WF5+_a#WtYv5P@<%%-f(^dbsNZ13l>)*-sQB zJf<#1{&OY{8IRfm=J9E{f99Q`v-|izo(92%pFT^Uo!XOmms>j#VW`6WQu!lfs6K zrfZ}hq#@(^3v;nxG(V5%$VAqHbIF7{t2I(gNDdc}5zr!Ix22V^t@$XXwqgiC5VE!9 z-!_;-Dt9iDnZ8<$fN^R{4bpX!Qj)r+S|k4vCF$db3}I>!JFG3-tu~xOJO*>4i0v_< z#GQZXbgkFS*h_<}tH(^8JTaU;Zge8-|32qiZPFh7j`Ptp_& zf?Z^tqOqZT^*XZ}#24EQCZ?nKfGCaNn<&jOq7glqN8-Sjj#LPk@*C;Eo6TTL5ici0 zb)|)wEp%)xf#z&xmghcfndU+?KSd^t(0{^6`#LqXAk$PqI3iquNO zY>|6Pe7k76>4qlyO&nKKfKW`N2jO2_$C9S8BrRcLkvX#=#k?C@1AI&9Fxw(vSOft_ zjqbrPHaS;A4GB>(6P=8}jdnJU3I>kzuz?rQZp^o*I-M(+TP}n}eyn1V0;B+iH_4zu z(|n*#x9P;GNh=*p4T=*o%&kNAntPM;ua_eZNVyEMFe8y_Y+`VQj^(| zGj(EQ>P9+D81^IBwI#t03Fb)9O8K9HWNRTRfXuFgew|m$5TlSPAUC;~$E6M%3FbL+ zlJyf$k~5JOp(++uYF)TXqR4)79HHzc#6Y&hRUCW}9lNLo)abtM!r{ff;DEFPzmHR(N4R-u|o z;`Xv}l$8Qv5;*(enlCZ|fvh3 zu`-$)M#{>>Qt}}5hvf;iiqc)9z{O_HJS1pIQLG}?LNpubj5F2hFmChiW;v))3Cm1_ zOCzB#G@6d@8!_{0BsPo|-1L)k>QQjkQH7UlFrNyFY|s+wtvxcaBG_aL2Nek~cJ|AK zFSFoLV?v>&cM#5tVt~8KH*;WOpwTS7Qi$R-se!`=4~Shwql$3gu%QEpfz1GnvW}hp z@M2QtFyXIEy=cgh` z)`5YMh&|(*OgJ0cTb(VHz-%S!_?f59#84Z44-QUsNF%jrP7vX;C&V2s<`x)OECC59 zFu^p(rn*moUR;!jm{6=fOe|ozbeaH{Op8)>)Kbh)u$hAWv6~T3mpdmC!kL2QfwT*! zne7f{CAU3$MgEaAU0Qa;q@lJLMw+Lh$qx_J*e8IBqnad6iA-nerYJZe zA3CD>GnYgqF>iuxJhaM`I~@=;rTA`qGW`Rm6YS|ffPl|#X5Wou#v#M3TqyHN)~`4H zG+JXY|GcwhY0H9d&Ey&>V$2M$G47TTJn%UyUp)8OV)M4t+W5s{9fW*!p6q~pN# zNKg@pH!K{`Ve$A%(iVvGOcqL=m9jae4Di;ZG))>FJ@*a5%|_hv&}0S zZxegeAu6MkzX}N>q#FZ`QI4cYdQ_>siNI`<9}8*p8#8LemQLQ_v|@Mo zJcCH2GTUNS9e7rMMo!*sx6vcU?lIaboVNF*QKKhAxsCWvRMy(w(u&R=UkE3(W0A!+ z8bZ6iS!#sgI6mTGiCV-nOx2J@nIRvQS*u>tB^qnf92zLav_T?D6U)|Aq$BEXJIqne zwU0$bAr1wiCOpkA%D9Ty&U}0l^&M#n9!#UCy8AYzPQV zmIMV`Gh)&_{LF&ceXW`iWqMcnUAQm}Su<+{^txP8t|i(Io1MWxK0bW~s8{-hu}+Jb zz{L@=GMzCS>oqYA=V~U){jzj0p)c*L((Kke6$v2GGDHza5nSY21WZ_>1xu^7h)EYt z8!>g7$b=qd<{A*=Py?4mvx*W(QOQim;z87hz6lqa0F4-G|iWpyvW=LUiNZv(TjU61g$J@*TFoaS?;C@m^Q&XKfpPCABNa{3g zBvFQ;BtSxp@l4s`=6kG9u1RKYB20>fj2Ilw`-dIrBvv=`5!WsQ*+dYqgpf5m7PCU^ zB*el!BDE+;{$yFv)D%s_Mu~Ku#?qQ8i_cr^K%>Vs2&J0Aw!TPsMQK(M zp(f8UdgBqd+6W#bhGK?y$}E;Zr)NgumC69q$-O^t2%^JJzME~#NC=$+JELnLMXk~c z7(>yrCvr$5p9q_+1(57OjA*=L?RY3MW8A4e|mz(gP~ELv>Dlm zmn84jlssaZIgu!C)K+X2Cdi|~?l&LBnYG5yEH8q#^BMBo&7?BYv*dnYH-67}>cM0u zlK~Q$7H#D=1FV^{=g6?1zA&bI2l4g}f{4v|fY6ZLlIUr^h1_JsZZxk@P?c0zG`)yN05?)8XIXkx_zh&6kjKJ1w_Qd{*z2|URi6%y}(Z?NX znfq@iKoU(y3V3nes>b9@yQtSuuMCsWp(F;mfiY@COQ3&WhMpg-78=s`4R#P*kuoir7LO5Ck7zr8r$tyMm$}|UZ z$OF%+0%E3|&FI{8;CAV}BPlB^AX_SuvRtFCnBRvW$T2Gu#l;5?q}x&Q82LyzcJQfp z(G?y}@}PWIB&rl%)o7aA!2zwYYM@Y)fm+fEFdTt@my_o%r7%L;9Wi8vhy<0$rt3Tz z&sY#VE%YLjFEPT@w9GA=UK0ISAVODBm>8#UK{T}{_s{3vY&W>3HIKYCDX^%Bpl=)H zqjeuzewRwiigd9I9CaO$!1O5%5yp)c>s8D%+v^4-Z|T^TD86MbFtCHsC5udI!SPxo z$Z&}9%hkdTWt6y{Sl*6O@PUf66uwasjh;*lGn3Uy^E1_80cUm94ffwSe~Sr>iDu$o z5&!W8v&v*6vXpbX!QtMcvA@H~W3a=+J;zTPYg4$>_Lw$395H^9e(yGZ&(YI(mWZum zPc(q@ko;VXj1381NL`rlcCYjO(pPxV0uHs|G*p)}DU1OH8Q?T<*tP>r&zgk<1Qp(J zR+vL?WM#P+U4{SGi3BxKW0i;!o!=gHnqS6Yc)Uu^V$KwVf18=(NNAe5nIcChBO<&` zWLH6Rv2jf;*1w4H&|FFGff?RT$3aq-N2%IV!3zmohG9{0tDk#X%FA*!w=yLqY*H2( zZ2zr>3h-2C#K>NmeVa-0e{nj3avi+VP@H6mDGAZg-J-mV3kn$!rMu$k-b9us1oJVq7g`5+9+K|8YV_5Bn!G#<4rNMwWl+;zQEJMH$iyPC6l989zHzmccwX&VuV;*D3xy5;8t z4tyGlq(d}aE;k0V!s2xZESJ8CtdjKdTEWz7#C8_?mZ&zpfMkwzaF!V2vE0f-0%;p%gzJ(cgWZOiyx-8uqk4j%-b#&5Mr@NXuT}6}GT6o`CEnhDe zPQj+o!*4f1?H6#=4{Ip0A4k3xDQOB{=aFv)aL#i@;WDyD( zOZu(!t|puKwJxa7j0CSKwJts#lhH8KvOP+Vwp}HFW7mQpyBxhw@Ar2f6CH>9YDN&5c#F5RGA@etwTyBb%}9W z*9hK0OXX0*j;0_CbFv`3#q12%Ogaqg;7$UB6my;qGlTDENYTh(A)-JtAs}3(Ms$Ks zqFP<@xNlDFx+xaFj)A^KX08wvEio_$%Wo~PB&7+!6aAtr?%3FO?V4X3wW$z0`1jjN z5aWlE8461`@uQ8lY?}>+-M|J6F13M_UnWt2VQPPcI>E$wBGGh&G10Or4aqg>07)cC z{xUKlW0EL?ypjx)RPHdjGs7gFlY5d_btcs$kBdkqX$>!t>$oO)HH&wf?S4D*shM~5 zL}yJQdFdom4jJm|n{7R6r4H#6$v0_|GQTCc)Fa6{wNmB{$=HUtbyt_`r?g9nJF3NN zD<@0yTx+&#swJd`EdMo7pO>MkQ7sB4PDV?gnAD`7?Mcq3 z^@rZg(}r5t2s^_|BVU{rbN!mb+tO5JMw6p9!NtAN22PxQkoIxkq?t6@26`cEK!=w2 zza+Y5E;^x0N$5Ie3T$06wyd*MWn@WJa3K;Oej)>&mcN0!F=E&8yN#b7?j45Vxbb7h z?M9g{*CPrG*ussl&~8hRWCGWV_mvwjc@}$GiouCdI`MeCA%Nyzd@Rv8VG$8kQ$!Y# zQk27V7A%*Jl%fC-EE-Xw zqtYeG1V{I>_B@A)8$BhsWJ2*=7klWb9~vPwMXx?j%L6lLli$Bm-WYU57XM6z?7 zMDRS7ww}ZXqGidBjPYk;B{};{{Mogi8J?GQC;m~-)RJnDB^3sPk$Khpw{aK-Bkiu^ zY+0|Kzr{myxK~2bIh#-YQ-4*flQ4p6yYY2rIH_Ghz}we)%h#8OLpxi9!j+&P>$^3! zHdVi?AuWm3S2rSuM`2d-&&kOKzDZhz!8pb_DHzB%+3vFYH9FmKQnXUCsSYPg58)YE z&Yk<{dg!FJZ&`2^{^Vikd$+IJ`B#uuZ)7)1stRW___c26C_wOYUW13Qhr4WR2WL+W zGYkg~X5*+Mf&FA)++;1~f8(sUPD^5BWXj531bk(B-zUja zc~ZXqM2mQeUljBg4RZ%2)$H_6x?YV;JSyzeLv^k6K=!}mGSP7*mH7TSe?T>g6U3(p zbx)+kxjB2i?e4KkT${3vy=OmTGX=v6e=$WcVAqg z9;Ita`>&1)s^Lw&r6-H@N%$A^od+q(Xfqf&*mw2S)vn~Smp0C0b-t?jeY(}?;4N6V zJHosqV+&8DEkaMroyVZwRDC5VYi#w_TRodVQ1VheujJ39*RyF&)aWFRqRP1^f8ee+d?BS;x2Y;&?E2&@n*167aFAdyy)I;IKajqgn zs$1A}vUcMz3`TQB5hqW{P7aRcn&hUWVAdp`bdI7$lJ%?eo|jZrUnw4>794&1>*8GL zB1diRt{|#sOGcThMRu6D*HeL$6JanS*po=zo_xAD^^UW*B(qhE#v(eG9pmM#B!?)^ z(U+)5wBmb|^t93{QR{+@;G}w;-VrZIN=SF5<>=z%w~O4VFVZx6yQ|z2MGN|!rEtPk zqmiAe$-z$iAfDMY*w$!DR*BPGPQN&acOFewz3=3$G=wZc4<+e=x)l7J7IB;;igR47 ztBLH}m8)}slaslg=AFz8gUY+(4HtT{t4tYVSX5hy{PXsmPcl$Up=&IsKMS}Tn45Rg zqVZ-D=IKRg>QR1myq%$o65?Uuy~TSmSa2p<*45P;WPKqSlat1dmNyt@f@n)tm*FT+ zDi!JJAh;@&R2e%w`nbV#6p+2(Q&G7gum8@_L=0XS+pApTlA!GIZqOmgVBQhxtjM zimfk7Is8UttJbi*ImfjX#irtMawwzz__&y*x5kTe2@ASh$gWA(aw5HR%}%dc zQOV#)U{;QotucwhZ@z)JQa3wmyVCl}Y@%G2%VL$dsdu-MWjd`yLtktjfEw0HP$tC5 zQ}Eeo%+qUlK5?dORY%#^#AQieWi?iki3TkwkWBoN$b?&M!-f#rEEwuY;jHselZDJm zWKaT(0+hB~HzF&8Nn7q)x!M0?AC}$Zt-u!Klha^|_sRG5vL7o{Us#21rZ8hmmuj^WnVtUi*7)iqrzt!3IlCtW1;@!yh zane<>1Jxo+S+Z1KYtH;=cTEb{Z_Ggic9A{-I5w|thBUEwS3SrN{CZV5wk-!)su-97(~)TgGHvG8Ie+{ zdllQJp)(kh*E9^?r&J(*th?k$_)9K#S+%v6{{3R2XtZ4!>lZCMZjk*aYg3Y;GMX%I zaxoCkO`^of&|bnliS48MT*Tf{sq>Xw8>&SdC~HmEWoJ2?r_DTS@t-U_&wF}H&o~Jp zuTPenS|3mBNS=(d(G;EWGRpIYxK&Yd=V7J&T^AKk;*5zk>S9oeMK}xB_rvp&x2t^| z-dk4cr;DB>UZt}n8zX4C@pty6HJ${9=~-aMv4X04?j-c;NZN5ofGPMEvR?NKzRSN8 z`872d%fDm5$y9!iK$fq;p*~f?n#lDD^uR%zyo&Aq>1iBG%t{(fUMl5qR8m%p?Wimx2La_)?o0hA z=2X1?%BCEn?NzY^WEd%}n%wGWVX`Lk{iZWAq7adO-zcRJx&=|lPEwh1ip`QqXWY1x z4P>5h7pI5J0J){|da5I1DZQWz(@R_Zvjrrxk@4m{VZR)^^I)Qp34xjOZMV8f@5$mS zk#pu}d6B^Ea$>9Ti!DqeyUnTSh#hah&NXJ$d2rBKx4Bd+`&+dj_q9BXY!ZVsE8yZB zQQ4ZP4bqJ>maA%u=WH>l++(vh6LfIJZz`12f_mGWL?&qx!%#lBEK~V@mbKwCFQQCw zn5K*VP?Cl+i&c|yqomX#4P!wC@{4VsD^#341DXoiHZpI+kv{!oq~D=nsT(rHV@Ne> z9kqNBM&ImE@A zxEge{q}Zjbcx;1@Yr$o{rU%IFtg(_*}_C= zOm}O|Hwdu3mw3Y?uD?OJ#;t~Ac?`5qN|#%~3JK28Mkb^KoI>kRMQZ;UziTY(Uu-0f z+0;v|t6~?fPH`Vl3!PQ&me^y%z1NlR*MmW(nR;eDr`xw04rz*&>y=qCdm|QD_IWK>m$v6J$q6 z422k*+~$?YAfTNqVCu<|V`~HW&&bC%xMIa<9hv&bL)NmBX2&OTGYT@LR;?%%TwLy% z%*kJ52AqnVW0{NsMnDOWAQMf7SPG({NXw#-#$@>6F}kA@*b$bHsTVLVOL7-2Kl2rV zSj#Vqw!E^nnYN0JAyQp~?JpvJNq&nS;#)?fvXQmyInD?n;otTS$rW}1?-Da~yJ8Oz zQ!MS}YU)a_Ig7Ww(EfT|-7 zr3hNLLvjiL#k+UAT+%39iKwV_ep4$gY2AfA)iEFX6C5lk>LhH0+IYuh@l7n97%&-+ zpgP$>L5m07rk8GgvsOoFr2g~?mu(8N;-$gVh$gZ&&6Q^)Lp2aG4;ezddXY6eo!5j4 z^d_SgJw!ILo1xeT)!UL?HRBR#8KV(fv}{xT>#{Vb-K{%RMiWC2gwjhktp-@hZMo5*p{wVhNGP zN={UqOBJ?X)-A{~ThJc#*=kz`AMH`7Y-Wrh8?{?`nsM6<+G5aD?QOO!&t)XrmN~XQ z$ZQnta#LnYA;wEb&32ONb?Q!hg0$2YQM#*+Ca2tBQt&$wufl8;jaPOXf*Pg|r(y<# zm?QPJ6O^Q{t$)*A4^HHRB(lF_Cm$S?!}(0R)X{bUdk-x4Kb7-F+&&j((s|L2TG4ig zE^SZEt3%0>Rt&xdG_NQmLIs@X>^Mg2o=vYo^%D#5c|LC&!2=1mhE$dBnw`P*;ZF8= zJH}R0n*6odqq3r*@jg(7Xx8%@4&iv3l)7NVCV13?K|}fvCQsNm?H)z=kQd&_7FL+1 zwqV(9rOqN~EF*VLk)%irG^g+~RI4Kxu-QHS=#7j*C|}W1HsH0TigZA2d%Mq(=~Rnf zn!CV#TJj5)fG<0onHaZlD0RDaTa_Cdw7RJ;7YByvZJz?sfeAIOiv#6Ow#izFu*UGB zG<%!y@;hLmeAI7&-IUJKcF>3?G5wrgGMDM_Mca$?OW++Xl*BaG7Z!EPv-4Jm#$x^k zM3q`=YUspvs_RhyLEdktLuiW2YHx0CMiIJ9QvSRBsLw~d5!IMlF3j> zf}13peba3R`gC|9H6pOoYFiOi=M97hZyVCSKP*A=H=ape%&JyRH_K3ukRQpgY2I4E zTpr^NKABYX_K*jy2`dS39SFlH*=vG6VG4jz?{b@9GOrnes94_+lgSd|gVAbQo7{+Z zmI1k9CgfnW3g4aP;CF}yiMs8v;5T*@2iU5JiaO(tCQ||svHn4vJU zMx*qz%pN9*O|QmNCL2=2nk|#1+{r+J{xg1Cj%e9PB)DvWZ?tqoRB3B-JeAV6cNyIz zDcvzgR8K}au{PWzK03+-iFdlyyOfRBsYmEMo8~cV)SUop^G~cc(rR=Q4{>@>o;GYn=Gf*w26OjNDTZotR zc2X%a zdNeXF`1!YJ_akIL6$`#>3)7+h-sy=c(OTz4FC;}g`WrE~B9*)l;+q?REqHgtX%vs` zW^x*1q$QkR3GY({?uw0AVh5vQy235e6CtKijVz9L>^Ehpn{JIfrX<=$hpZYWr+6Yu(A9Jv<NzcK_P4Zidcj616! z6%1e@d^I**vVr&%KZ#Gv-U%mnF9xFiQ=fg0Q8E1k3FLbB%k2!=AbIhMy{ z8F_AI(}l@y^;pv*d`QB?r$&XwNW!a_X?e51Rhw-yOkf6I(>z;~S2``kHmyj-JwU08 zhpAz`=?0+z>X(biJC{Jaf?ztNyn0K`gQcTj9xtSpihA)N;}z8FjFT>?GdwL?v{(AD z|A6%75EE^}yBNjbw{}Egd+}}#3d{&(GuRS~l=Z4DiZuvCOBU_sI#8hiIdA~!gYx^-eT z<#i^+%XTO6j`^aBB&iW$;w&YBh<$9jZp`Lk=z4C1N@Y<-6j2Rlh7+RjM-my4DI6zX zD6;3ENy6dU)tQ6leVkN1nN~4!QKf}vBDh4JL|E4H-{dPIQb<4%Xp)8@i9M z&PmQUpa+pD->I%e3>FAYh9m(VvP=G+>;4ey-#@rea~W4$YCXS5Hno+c_FPq8WA zlXDn!z%5}sEyCB%&-BnX2axduVv}{C2}?*)VTfxtLpY++*AtC&e$kzVAXujDXX#Q2 zGo}{Md5|5ENQz^QiGRA!*H?c#- zk~#S_NNv3u1@s+5^B9ruD9Ua1NKokf1e2M5(L08#P5?lHxLqQt#_j$eZN$k`Oedfk zml~GRu<JA3?+Bi9KP|GjpVK!&JZGMrN}BMVofOW9S;arCm7=?vQxdPHw&dVu>P~ zc(cyT)Iw%11FZ_Ai(fhcD!~)`%2K&DujANA=QL!safA)!TkZK^AxG`YiQGyyDpb!* zvuWew#S2=2idLvHax987a@)+9aCHr+^_)f7#T zt3@RZh_@rE0S|7&jA*(`XLi`>RTXpHk>Q}ON7LSsT#iGzP6(##2MIJH``W<+!n3U@ z{r0LtLL>2VkdO)ITev@4Iu*nvQ++mmzfT$~UfobX+&&(8XmLK|`!FM2 zH+Mx#0q3b7Rq0rm54 z#7X^0DUwuLB|*I+B^UTs|5Aph7nvenkh2^6%Bg`2WQ70HLPVWkkuIqoMZA)!4T(-5 zB(0Fz1_3szlzR-q!a+9I-T@G^CAXJ0i4w|evCR`qKk=lSk#|}^?R#UEh#g~-@M89> z$ga|yF@YW1Wp8bc3$X)R1Sh(|44G{i>gkw(16|d&rWiefUUZ@nF;NDSgr{tNAfEgt z;%=(akm@pmObFq!6r!yk8YO#8os`-Uc|x4F-GT$I2J~m*}>yJu!n1!+V0wW8_+KnH*!-E5@09G zKVEDU*|+Iq9pOiYO4zt0c9L34&A6GDEQ4OEiGMXE!DKUrnxRlj3B=w7jT z=EU<%rA8++E$)PP(-azr$q2gERYEMvTVKq9g;T@ok!d%C!zLDaQdG6y%VgNUJm{4Q zdC}Ms(mba->5G`~^kuNL95o5b#D(t8Y4e`_hCe~u&P2VQE6lF@leO;y{ta**0;#3IC7)_OFd!KUk-~n+ME$WQLhayoE zFU*06%>IXVy$!;ly+*`3rN#sp?U<}cdsMOPPhcy%LF{3@Z9%2q-N+0% zEl!FDZ(@x3wOPi-kp-0SUTSD|+6=2W842pNGS9*rbyB0L&7WaR!aR1)XoZ>}!Y|FF zJT{x((?~nX09ZLq$f?Ny)B9dWd8s5~NBp3uH1muv7WplaFUQP)Lc!dQ&XUH`h;~2o zW{(bvjm%6-i;#4;6L>I{5Tes6%ot^EqR>TWJf!RaMI-!~+))A-@yl4iBV&PtJ6&;h zE{nY~*5xyHj%-F5yS&*o!kNtQw-+S(`=?Gulo#)(U7ac@xBKp=$Yhzqp)$|_g)}EH zQ%Fn*va@8cC}rm;E3mfmkZP)+MCl}E0l~eK>hBL&R zinAEEImnSt6;q*5omnCrC9AG0^sJ0fH)om5tEOO*qH#4Dht%jZ!^XOmHj^qR3xL>% z65%+2J;Ua9Y|m`AM?~DIiej@0%L7naT4j1ZRt>q|j;=(%5%nQtxhXD-cd$+g*eF>` zGE1?5RFiHcySj{liPX|b?-Mm{nTqBqI0IK%1v-}1ZNhI1f~>djl;2^o3vjT2OP1U2 zjBbQgYZ0ZQj=CdBbm$3TC3h02@w8HMFa}a?UTk5cmNTb-Er&B+;D{`a)^dY&e-qOR?!+z7IkDj=tEFDGX;7Kw2qC5}ek!4ib$wm=aVy;zn1}7|No!SzP zR_=E6R44l-6_mhxgclJK!duF_G`l`>Kq}mfC^yGK8BtPFTsw2K&bLu#BB$Rv<$GBh zP8G;RE?p!A4k{8s5uLf5%a-Sdd_7@?SgcGkIecEOxV0HjnV-&3i*{-gxweo4S&OE= z;L1qwPq72))H36Y;v`5tdk^tPuD)ebm@ggKW3tPAF1gv6AIq#MA9I z!4(Tt8PIf0TyN_oN<@614U3OBoi20R&J$G6Lv37I6d)Ky90GR{LVDvI zPa0zb*?8YVCquoim1ltkh19B7CNPNX z0`D&R3~`y{6~}px8$WtXIC`(qBlnojR`6^UKW6;M(Nn7@>@jJy0-FQalB4Uy@qg*c z5?6;hHK19EVV!3{#-Swr@lI25_TiC+aHLBWH72&m4kypHSz@mJijw%V{<-NT)PwQ# znB7M2wd)=e$4?6P9g(kVCu|h<8>a&nw%lLIa^hoKlORg51qYevDW^y*l`KOZF=uhW zftWgZww;t6M*Ikl(j=>qc-M;j>L&1t$NV{7Cbz`tx^3)E1M@u=5!R9safj(pEK(6O03KXXH*1lk=b}VocivW*EU1cvt?<2s@p$Vj{oc&Io^u*AP(a7OYu|*lTD-B zOGr^#L`TP&y@J3#tRty!?jKGgs(MJaL?R?XHRpmL!o?NFctZzlhVsO^j}okrT;kle z4pJs%E7_cw3-gKNkuzF~T-J<0bV#qkr^W(-dcuVrlf$CDQREeg5i1X3wib(xHQIq0 zR52?`My6(HjI=~f48qnBiUb-lHPDudGmK(w8bS$#K`M=ksc1%tW-Zg)$0eiD4I+;i z|GJ*@cEadfx@q;z#Ukx+?lI@!lw^9k(?A`Q0n%x1dzaw~1E>-0*+NuA*=`zO-8=A(Z~;YauS^xIADpF}z~EWk zU{T;actVU79yfKl&5uV&TH2gt+)R?iU}1LE;hq+;8|k{^3~P0848!zMCLkEJ&EfMwf1tv$$k* z&Y~1rSrGL^_7{`$wr#)dH9@kK4uI2)ET#iix2j4GLWGrcVsgTEW@awV(GWV;^=7{-)a9T7yAes{u56z;I3OxJ11El%E8)@`U6ks=t{KpPDLEK&JGh_j$Pr3qpY zt-6&nkFH~=39oeOl*v@}Jc+ybe%4#&l!<;bbu~-txUeCkJrEi8CvM`{wq zvyC=1!vJh7Ccy-|!i^0?M^dR4$Tw$dGm4CI<4l;VGf|+RQ(t2`0OB&=;^WZ)X$maD zknWR5UvEZ!+)kzm6Aqlm(C^eh!tz!@9%)_35@ z$UAcVkY6kjq>h+*Bym{a&@*|Zaod>H?aUWp*m#(`I8^KvlSLBMD5>h^l00tX$sr#U zO@}}joJFu`(~RUUkrs>kLN}?9Pb#MFfxEqRkv5 znd6O$MIi%3%HNIFTMMmzKxuQ|o9f2-(b29%!D4BY#GX@PDvCOrE=r8&B?O$k zEeXa*L;%=2QW*h8K#71C;wLtfB6jhyUw&de+a3`d)k6HLv(o9rekobNt9I_Y@1T-k zqL~pVfdNw94lLnGLCm-)o}Du{)gms4Xp>V>ScIP*sAg40NMI0PD$dUK$8p9%5h2Fq z(nRiz2!Ji2f_h4UQlzv}PNkeixr%Z%W!UmT&_HRVoIyE@@+jqT%E~JQ!77whDbp!? zP}W&72-c-+Oxc8T5#?gaFZu+*uPODbP#@(&%0-lyDSxGWv{n$j`}7}fy5Knen;re9 z@Ac6YeLwDkMQoC`*;>u7tZ`y6xc3i7PFN?HJRt~nr_7{e_}wyY`5tA;R%_Z*?%DK% z`}O`|=V$vZwZ>wa@HHxfOud3qF!X;05>l722dT0c~K zNciuJcj5e(5#F=lSa?5^BD_CF5#Bw{h2KpnmxEW~_ZG^Om4H8GV{p3FYC+JSa^UJg zFlvn;7)|;0nnCbo8jJt=@$UnO;NBw$ni|9~!3M&`wea0_l=*AJ`;^-#v)2!TIg}gv z2El$C1i}84`5OhnU6i{iJ--95ZyW@BQi4r_po;RyrpN`#X`2PX>6BkmuA!{Ac@V5m z8B7^M`477PeK1I~S^Pc0e_zSmzfpwu-%>`e7X)J{^Ec!gal8_EU74~5WlhT4kN@uRU)X;qKmN8p56{ooCGLR#QoCmJb}MfcEKw>-dLyb# z)*_XEx&AqelaA>p(FjXFAY4Ffc7gk+(xCmCXMCG~JQz#UeD)x6w1e z>CWa~ECZa@6t32xtV{8HI*9M$({m~3QGUEt5d4JldJUqZHVDE2K`?-_;x_O#<$K!( z!ETgG2L-{+l%2NYH|3_GLGT3S?H!;S%Cdt?da4)A^_WnKr|ryf9XYlKL7LM z-v7&;t2h5w$U>;cd1Nf8gWQam3nHwqm}4Nauwxj z${#5AQ7*^k{sra4-GbmGO8pdUeaeq0M^M(-{ogm#Pc&Blw~Rk3NU`FbWxP}I*nj^I zKYTt7>r#p-{P&fN?FC+i-(P{(8z>&fZ}9z1%EsVz6Ut7M&Un9(Yrm)5OA!rRISG28 z{CyAP$=*S5K4s5+f?zMo$NL4rrHZNV{TV^>>@oZXPEFz{5Y%YHMCFPB|ki{YR=Z7NK!MVr(yWdAIP}Tzf zqJuNRx$u7un=9i68frV zBVEx+|D-KDKceW#CDiAij3FwGv4on{ez1yoaSZqru7%^DP)?!<*TVBRly%O)HlWm; z3BOaGq6|C>dyq2s>>%i%^j&~&pmHw$ALYFB@f|6LLmy95L@$4%taIT%fuKK0Q&q)} z57Kx3^8;uYuP0L9tiFW*`-*>sm$ku*aI-PxM9N8&1(X{of4YR25asMk(fgEzl;AR~ zF3LHS8!0zYc0siar%bzoTmZ_2S24d&DPN6Vpj=P+73BuX$=4!tD8Y4TWz5UaE=9H?GX?YQLtm5s=IQGXQWxwN z&34BjS~i~k2PMxExHaPbrO1;MPwUBVCx4bwxAFf#;d~RyrWB9&8~J_{<-&`=ALSd$ zLdp*=hMy_tKnn{fNBlepj--4^`HIp4T@)z&p@kZXXk!7z(}!qd1m#O$AOHR5$3F&; z3bD6%AjWWxBtgReCKLJ!AD#Ji=WF0)%3bj1-IUEDp4^SkEag~=`13SMcX(5Lx&dW7 zigbJHpp2E=Qwmb5*_C>HyK z(~@HX%IO_DI{}DI%d|a;PjIw_a?n=15Tj!0mk1@^wm8}EyK>i;Xe|ra7p*E6wI<|H zG+VSpnr(b`fzG*MhXtOojh@Jmgc|6FCI9=aR5~SdE7jF4tBCR`$(JP!8mPDxuS(sF z79T{599(iH#O>BfH)}U%P6g1qLFKX9b}A`CC%M=bdXYJt+VWIAqdqOOnL+luRvCxv zzEUdcAf-}?J}_G4c581zc4^QqSkR@$@Av4W2KMN5Od6qpHSsKh*go05Sl~@9(|}py zg=M71lb$O0khM$K6Zp8pyEr3(m;KsYR*xllt>qoU%AE+f$0@y9bEbD(vbQqoqkR!M zWI)&BbYQJXi0L%ju_&oGy+U9Icm9#vaUP(kZns^ZRe%tRki**Pb`FXXsO-oNwgF(tg|gvy zuqV?=(-|`A1wE*Q4&`luVzl?5OVnjeA8Sfoer~idhFoFWTihQ$0ndQqggIR2E#sV} zhxIJ)(z=V(v1TmOj56$bl|^r@S{hJCJE9zog46Y)Q{-J)iaiqk?oI)TQ}vn>3b;yvwBMZXxKfaFgxs-B^p@^nQzby|`INN^OROWxJ4)tVR9Wl ztrVSF{7}?sevUa=KRwXagn2#68HS}|j6f|^E!St*`pSdQEtiKNOaj>c0!gNKe^z$0 z(M)u5gjPM+x*j%*V_Aasy77tqKCPW~3an0s=>S8rS)L80o5=gMKQsbHh6Znj0Yti#|;pBgP(fe4XOI(pI+IDoa) zi&}?MfJRH~v!QN)Cif*SR_M(9?U#0zkFQ#*gdqb3Hm`qDt8EO=XekadgURhuJ! z9p43o`4zhUJQBF36MwqZk?G?J8zg`bXs|)t<7C05V|bQl)`ojWI|a)KiT1>C`|d%- zAl9#95Wq}fm~@m@i5J~yG#Y&=%f6!qEQAbutaYWgXc3>=7?;&MTIc6hNZGnT$U7$6 z=-?0Ay~4x-X^x9Vh+HEv6HO_y@|)9x6$m{KXR zMd@~}OV%nthGsBo`4V7kp@)E@m9q~q0_it+i8jGZ6pM#S!tqPsI7UU!y$Djb1Vr{P zK~Q)d3G>!v?VLeIEjY(JcZ*1LE{ZcZD>Q<-w&VpyCez&sm44d>TP^ICoI2WPbj3EU zj$)r7>;foSE4>*wq)AWMz0g4)0?FBil3Jwe7B{(d$dC)57u`f#xukaH5LreeP8RBz z6wy9RMr$6uY{UX%*)EMbo3WqbLN;#HB3LsMp&c1xi{3`#+Zy%TRP$G*f2z}t z?|=Vy#m@eWKmH(P)~n>=Qd%fQN-O1HN{K>@|F#Q{EfsG2@9*+5_n?=Hmj$(P_Ux|T zt(ap-2ijYksdu3T#dto7oiE$-+jT!^uii|NF6OOHX%|UDMCx4z+A>7ymVK6jT2CK_gwO|Qz#{UA5LoGopZNUvqc2btrvKx|>S=^Y?!X0!;4(qk@KLP#(b|F6Ql4 znAQE7?jw6dHy8V{a?s<03EaJ|#|j@H2ZJiT0WEGDtoXrdd_6oEUNyWbpwfj4tN53- ziNVGn_TkR&x(D-udAszqo53m{L`}`R6Ut6{MOF6adiC=S-so-hMOPR1pt6o9dgpI-{+&(l-;I} zUbt}KCL4ukeckh9u2i*6oir^N{@PQG`ce12v7>^cdu}j}AIrCn+nb!amF`xlI&G_! z*5~~njvqB*dh-w8J$r`}HXXgnPp%l3yMM%l-TJR^;`h$4F5JH6(0kT9y8o}nwXV3< z!6)Cj&+7RrXMX3%BOdN{#LS2H9dXYU8=m#aAI`dS!6}VLUH<34f3)hVhmRREZI9PC z9QyRa9d_;0%iX=xt-Czie&i7c9+c~T=kmkDtq=Na z$2Wu9*MH-)9djE^xqjuF@9p0AHwXXr^<%%9_mi5r-5xr2<#)gMXy@RAwZB|*!|LAG zegDMeE<649OIG!xBnBlzNdHF=BV8Cv75rXRo!^3di32om}%l`}GbEJ7-Xj>Z^C%z54Ubt9rB_@$)|OKHny{ z&STYQUwFjtUpi^Xpew%Ic=!>YUHsA;V_P16`i&3YI-`14dBuL+e)ZHAn+$vQ(QD4w z=(u_FHt4_p2`8-c={Bb>Kj7l(duyJ4;N(8TS2*GAdAIZ)zQVbK@?*!ovtqFO9dBR! zo#Re;YR%xnAN^*~8drb%@T7&SuCnHi8{GG4+jgVZtJ?jJM^Daw@BH4YO#5}8hfdt6 z=G?7kR6Trb%Uk#T<@1MEyR}!?^QiX8S3f$vrty=w1L){C-V4K~~cwy&9 z-x@r8$ET;AIQToWR)71J>fx_lyVeTdx%TDl!+pX}Hkp6M$B(>r`nG!v|M;uNsvrAB z`$50|WZh9KUcBM6&;RQCb-!=l>h9bnk6eDo8`}=vtNSX0KiRALo*~nY7#s|n_}!nK z{p6AT&m4J1_dj%dbDy45Uf-^1uP?URC!DtPS(o4c{$U$k64Pt>DxbCc zia}|YN16*KzW3X1y>I%{ek=4IJ7Z4O-5odHS2uW_m4CWic+vhB_S^iBZF;|U*{aJ%%5;-;s4e&$^pyKl|xL>z;7`7Tu11;QXWdPMLCh zCK!BZVZEQPJo@^rE*r7x@IC(AH1EdqkJ~)h@Y22W>r~x&*vh*+)$6h~`d58i*!@S( zJTrSg_3|`oB-h`9?(ssdv2X)_e-U^on=RaBX>-Baxty^Z3 zmo}SMxG{g>6D!<&`XS}j5B%P_Kis3f*OV7tT6e#5F2C&7HP;%j!Qr>|_}*J{d#%08 zKBZ~r9C%8h*He4{A^1h_hwi_B(t+E&xO2?~XH|`R`|<`{I%h}8K-ge%fj(hHjvsNg*_Vuvm|M2&=Oz&65=Kj3pyeq!gYpd15^?P3UR`H~} z_Id97nO9slcKAb2?s(?-pnGum@Cg_0e&thFet*WQRYNZO)eU{VxaSW~ZL!ZW?@jx| z`sds`X!>?Nhn_HV{Uf$sIdlGI9iR4l{;1Q+-F`7=`+n;dzPs6n#an-W#;yI2KK|lI zc6s~RkNaG+_t9syX8k6-K+K+wfaxaUax1% zhi84VQPp<)SM758E1%tc+@5_G{QboThwl8s^oec#DkxH_^b~%{NR9@ zGk@Fb=<4SuP5bJIi>6$izqO|L>et2VUfXQ=pL+jv&M$M5pFOucXzOV&zrMwr57n;s z(@h?Dq53=BKKQKPPwx8DfR7J5{++FVI{4^gXZ+yPw~pO9d+>r+9^T@PULyy7*7uP6 zs!prgr)Qr#dabzL{rB}aectze{6cNjz$ZSu=ZGV6pFQ>ERYTZVTV3*u zdG8!>!xzIp*>L4&%D-FTrT4}Je>vob-`(%f7oMo9S##z!efz9=?~uRjzs5s<8+PrX z#cmJmwBV_;zRCT4bn#~gjN9j=17@BPZ1KXSTMl0%cjfDUyPz~>@|E{(w#o}9H$7dQ z?Z5k1Z=d-|zFXbv@Aq5trR(nvo_PJ~NiVD#o_lchY3CkTzWt?5IyOG^g%umyPYjOU z`j6**det9~2nxs6Tyeyak9>2;t0T5O;G(s@dMh(;t#{|OA2ML4!`HdJY2igrt&{L%hP(BL2SJ>ehH;N81uaOv(vX>cyz zE)D)@FKO_LPJH{muiiWI`*#m5E%@}5FCJMK{F3X^;0vVmBMp8j*Sb8p2o3%oZ=7Np z{MVCyg984qYw*6220!b!C%iLgjd}I`Th`lj+SJVU&%b>3b}z0u_qct-zHKMJSQC7> z@ddYR_Sp3Dk5{Q4-J|FAbwidrZ=*v``D??y=UlSi_jdTrISU@#<@E>eJ@@KEb6dZA z$=ByS@U!!N+`Z3(=N~%n&2{GnH}BYexp`j_v(8$zqC{BjvL;y$(P6N^3HY_51I2=vCq@bZTS0|VOI`&YxYi0 zzcb*yr|VBRq-EX#AI#YC=&^e~v-^JAj2=38{Na~_P85fyz!YyU*`XC`rOIu|9YSLKOa2t%{%Y7^6t`4TJG%r+*a3y z-+AoR?{0GIw7F|s|5?q@+t=T0t>3@%{kw)_GEdY!eZtjM@4s~6-N!!p`A>HG^Bu1| zQMdVTMl|2P({Tr_an9g%*Z=gh-Xr(=>6(}RwEFSU$F^*?=k$lCJbU1zpR_zT=*2VV zpLXWfleT;Q?rD>TOz6MHrRx`7-g1k5-~DLX58CJ7v*60H_nn>JvSsR|CoXE()dxq@znVno&UrY$K6x@)hAoNbI}Tu_xa^JcNAWH zYuod$J}kGyG>2sj2H-yzU`4j9dQZ)9>2h7d4k%^z)zndj3yF zjh%T>kB;l-)Vx09A;`ldnm&RuPV`pZ5%=Zwvdyy&4T7X0ku z%&pIybN06T-#7E>JHMWIUj2f5-k5RFt~=Ha{_KvKYp?d!tiI=6ReRX%)B2rr{{Aly zz3B0W|M16$7sM%|TDy@$Op}7B@O$`faO?o4fs!Uq60Y(^q4Uz2@%sj~#UG zl~*r!%-3%fe*Bvet+&3h{?$jl^;X-=vo9Wb&t3hFczA=?Ke?{vozs7Q;emVpY{BDi zp72rrm!B8@IC!i5cKq>}^S*q0vv;rl>h+f6Hb3wF0qcGJ%CYZ$`nMDIf4O7wCVd}# z<>11Yf{JXXVy9Y#kKo>RP}YQE6$yF@U?#)+w=8d7aZ}- zg1=n0^EZ9|++67Y#wLdxfAuQYPJH^j9giA%#TKpS{$RN^ZqCoXzJ1@FMt6+s{^}}Q z?0Eai^L}4@&0oH}>YQ)3T=@^D{Q8ugrX6+6xYO?_uXNJ(Z(p|4iiItAE-#$^+`a3r z{ntMn-u(6Y9ScYF8Z~YIUl!ijZo#7?_n9(o*TeR`E&S@_*LJ-Bk(b_oJG=eM_bpuY z_>aq(U1pv-V8LG-ZaeI>nKQTj!OLf!SG~gMlRqEy=#S3JzV}#Z-JR=BysvQms~dg3 z?u4&y`ReoehrPS?-)i3Pb`Vl_a^mzE!_HmlhV%A%?w3cN@!fle+9@smSNJ$tp+`)vQGyH5Pw z311Y?eW2%|(0P6Z_os?DH2@jlFRD-fQpMy5r%!Zk>3@$2-(4_tM~D zFZ}7@pT54r9b^Ca)rsddT~@dzKjZIj{AK)~=biVr8)t5`=@}1v^x32zm2cc~&da|V zz2hMVG(A)mZ1~VmKYH_m{XW0t^2fG1wED$;`)|^`(S36_e{aLhF28o8-L9Sg+va1o z8#Md0N8f($%TMl}*81rVXN~);;klWA-QtDech5e1&PGrF_4i{A*tzFtC*3rDt8@Nz z#icJ^{pBft|N7DwU;F&CyBAiivEQ0c4L-Ag+m|R;eg7x@)%934SPfmcV%5qDCt>;N zuZMZVQjRMvrReE@<)7OBcmA0{@GTnrw$H0-z4MQ}_bs~hzwXg(u)fxz*SAA}4^dvE zd>~@P=39jlQU*|lQ>IW3q_k4zQBI;P?mgAp4>R#8%)K`#ATg~=cYvWUdI309-xUd_aeb&%#{q+ha1;wBg zv;>)eWu^hu1pT#KVb||gO`gz${o8u5e_PL}&OTPB&71_~aeaFDnpIQsH!2u$;71ED zAadBJr@y)uzp_Cit+dllTM!0Q_+Fwk*}ttpGuOt@mjZY7H#Nuwe_MDxpGhr!=zAup zqlPR`SN6Pbu=b}A>Yyij1yw6_&$}-@xsuW4Zo!Jw*)NzCe!TDwK7+Vt%UL~Pup8}_ zt?h1sVxr_?2fGcg;>}HiK0Q_mEKf7&!8kHJmF0f7U}gTD5PY-pN5oSn@Yc%FQ_IIs zg~3QhrjbJPi-2njP)y)C<$K+GtN~6WmA(_a`TWYiTgbP*AZ2wv_Z_JXcnfU@Oz&vT zmiMon+mgTX2Z~QT5Prc;O*IJu)yKbiwPAYA5(#4N_IkemTgJ*9( z@9TLhJ?Qx|M=@IKB>KUt79&BVDCGpf3fa0Z_LaNet7U@&xaqac-(4tUDM~7 z10HM&*R6T&cRQSW%sbCMv3LH~znpO035N}t`KL*DEL`KjPj-1@^+*47_`Zh&k%bGp z2bJ);D%$L_k3SiK677aOkz{dRSAz145mcdoe4`9rPE2HUJC>t?g87}XZTQ;c=4 z>-=^-@QA$fZpAUnpTAw>`njU?eRcV-hArocOu2hmSfocKIqZ#i)X; zamxy?Zym6w_qkrSVh7hbmvy5bm9F>Up++RcY-Pc95RIDCWEeQ((e$MT-3_u`hUw)rJ^Z`ta^wHNiz zZr$4`R9Eqldg@PD#$L=90r*-QD5p+?v0;w3}M zt~$o=w(ySIbfRMS8+2Qs?QvxB`9;^S-2Y{?sX{SFgyzR|ymaF+RSWcb2<)0PaP89n|L}2FiPMZ7GtA@~WA>Mqj zwnF}-svqaK@1=7%W4wOq#MxE7mv%kxTdZ^Kml0BjcEyfwQI$SEHfm(csudp`uDYb@ zo!zj}Cuqjc;r(ZHs+zRk&9vG3Uq0088?0G(<=GKcy=F$1f!F$f$~o1|^u^GwGdDiH zssF}i{m>q57s$?eF=oqN%jvhaPI-HK_oOR*z2Zj26dPa3zFu1Hcjdd;%heBs_kUpN z8!|-YGt;OiSGv8Wlasu2+}xJFSo2(w?>^@NDmyzjw;H>ngut;*4Pj zlH(TpHcuXVP+lQ_N?GvLL}|Ua%Wp;m9+)=n-oBR_hk_1zU0*kM(e^Fb`AQp-OXoyx z+_t46v*hZoG>@!}X$6zALTuN+)mh&zO0HNYW}yC+-(K(9JIvz@Ha;J{GIX~6sqVwq z-#V5$yX%|mg@dOq~dpB;a# znQ}U5`|ihg)Q;W_`?cm%yY-jGl{zk-aPD4All6Mno+n>aIXY+aQ@?lG2d)g%DjGK` z#bT-d=GL#g+E3cr`t~nN)uEOUeol5xs$XT*c#CIu3rsC8tJb(2T%pzZ-ie(?r&N3g zoDJE!S3Ou&%Wm1*$M4^6Sm^G3M17&2`@2W)st^65;2!CDdTsiGG57o0?Em!S%n^fS z?h8v^y*$_IQb9yz?H`BC_ka92w4=uPq#K-xmY38pAJ>u|w_fMxRLNZQN-&J-jKi+D9dqvrY^!8Wh zZ!GM4|KyvAo_iICZ0a&(r{crw1HRv0V|vx3OygD5#oc#5RyY;bzQ4Q2Vv)^0(=%&r zHB)YuR&~F=<>rf@DhhjQ>8!Riaa^9d$Lxu#hk^WSm)yIiKU-Q&xzi`v-Zm?1$$=!b zX8nr2`Z`R=QtnlF^MaS>-04ls{C18xv{b8N`T7@U-?b~enD)5ag!Q`3)pcES6OgPfkkbeB#a^4qc-?JHGUJu=p+9+BX7e%P50t1}jqA346j zI8t3l^^ZFRlP>w)h@AICC#!Sm%;QhARjTgaDr|0ZziF3O&3bp9JJrh4+}!_cpX-A< zem7tLW%ji zj9F5nJ8KPpRyf;ZS#L+@`$f5JBYu2)P50fZ&Ia>OE-sH6->ciq>-#l+Oi@qTy*4^? z_OFGR5lvm~25r_J8j8*5L(d*R|GA^L)32d}+Ff2ydE!(*r<%KaDs96Zyew}R8GTZC z6NFgo>X0%+TNjK!JC9hKb>`QKic}poHGgc zZ6b>D)OGjD-BxYW)3(Z8s;UiMij*1!pIPydP2Fv}{`FJ>z97J&x`^+v9D1@!}WrrHXzw-5aM- zcnMmwd(W%g{K-jsVzP}v%jnO2JaVs&m9tn{dGe0Q{Ixx0k4Np=b@=u_PF+g6J^s48 z%EP{Lf6{sF?f=gSeA|Ef65E#Y{HiziZNzW;Lti3lv7`7^zo@Q{^p*I(P3hat$(NKa z|5-|suFAJ*d|L^=q_K%MKwp>UKd2JD{pHw45^9PZqIve~CB_$B+}SlU6#q%bufAN3 z?W}E$`4vEXW&&+PU5)#ObZ_ru%rCTPwHeF5he&ia<{yz8ySu3=cZqe0Ps`~Qn`OuZ zGICvFU5!)n^0HiPY;yURMCq})*8D&rgZpTIN$XZ_<|NxBO0fHyx;IW@ zTin65wW<=`xNiMRXx&=fQXC-0$M3Wd2M-m7Rrw+>Rw24Sd%n2>#1r>8ciuvKh98qGP7%^9f zm@hzlGc3Lv6}E%IHZ+paqDX%-fW(q`B6QUx!sr-C1`(lShX&Kmlw=ZdE;9#|*Unl% zowmk_dpR~xBSsX|c>1jSkRhyy5`^(=SLnacpkF7CT8tPm0&h7;L?u|dW)F|lfTF|< zNkkMvR)1h&7SnRRVE_>XGoT7>-RI@Uk#xc*tCYpN={yse+Ji^)t6J8 zn>5QXnr2qEBD&qAsUO6JgdZtL`XtQ#YZic*B$PFXLC$?s+@Z?HcPG&}Kle=UgpTf(?3bKYAcczSp zs|%|q@g&_zbr}EHfSd^DBnsp%`IVgG9e9mABX5aX3~w}|M~uljvYxz&WA%?`{AqO) z?TC-*7ZYdRG_Is8QJ^ON--j&oR*>AHEGaLgB8j1->JDCZPE+a2sSwF$qVC7qM3$3l_Q%+b73s|G$d{8M&~}A$Zw@wUm6+VT(cTNAbBrL>U{( z)rI8~ZL$oz5Z|I833HRF>kcYX;`fPgt_+*W6oYvW@8f-|Wg>;OeBa_dKnf-7U06|> zkd2kbngAKBD3F0`o-7jm<=_z~hw0|>*x6Ga-USMX308!Ht`Zzvl`z{w3I3@{SUgY( z&5D%Z;;f8JS7jXNql^c|%Ft@20w=P~Pz4(-Rd6I$1?mYZP#dIzxG+^H_fti5iYhh~ zs$z08HGFTRhBg$#ln^yEOI3q(-zLZlR>$oGb*#%%$Kxyw?C#POqjj1=%efgG1~tQD z)#li$(H!>9%{iTTb3_+4$9^qMBsgm#EwKgWdA39{AHPnzTA0>R3sP=c$Qh&sYyJnt zvut9ngTt;m=%J(wZB<=di`B&#N{V2r@##;CP1MyD>ukc~3NOa~L> zgqz?_u?f2Cnc}5~DXP1f;)A>y9_gE5cAyzb3(PRzsSTV1+Q6uP8{CpJ$022N7&kXZ zgsnNc`k7;NdkfqPwZNq?3;vakB^Ie#BFoPbMg1({nP`cGftJWGw8U>{i`BYqG2F2& zDxBLwd=K=%ydB2bwZrM;c6gQ64lnGia6jA%eIu+ed$<*z2DC^2q3xl_|6*S+>{~YKN6g?Ga~VkAMJs9O!2chgf^)rP*UnLd(zuCO$Av$6(d2Sg+L;+q!t5 zCe#DEDIU=4=!ut|Jn%p|ZEu|F>5YN_Z?p;W#^+3LEY9^t z-{IcaEZ-fU47%fI)9$E@?2dJ^KG-PlgM0mbP-4&nW72!TH_jKb{ruo!;t2$K4|X{gb8jz2n!FwI{9FXbPLAk zZo#RNcRfC@9`n{kQV~AmZ6BW48`%bp}5sQ6u-rUVrXV4Dw>3$ zzgZaeTZds#?=V+bD#(MqyfT6n+Ye!VgmYpd=rS9m>%tZXS&{;nAql?+>@4{z%OnfQlgl5TX== zTlq0~Po}hr<^39qO&PKH&?*iFMsc`d8HY1Aafs;^hvI}dTsMnHx_LY{M#V!fJsx@4 z@o-R2fSq9iE@mabvRfkhcTIv(aT4Ykred&ZDn52gg_?IN5<^o_k(!FBIjLCPV<0wU z4#aDPK^Uc<23`L&L?)-YVnxqPbnKT2_54hDw#vd~ z+bs0xk_BDAELaT4V%wU9VanMk^2p}2*x5+U%7%AdHl{1&AW1I=37$ESEzH5`Cb_ua zkqfWXT%LO#1~$z@m_;6>J@Rmpa~@}!=Hq*_d{{ZYFS7*6I>XUEXgJ1a4ac&UBaq}c0*2`$;M{s7REtNVOluV6x{ZQ* z&?pRyABCfw?{$Cc(eP_C8le%RA?DGqY%&H@4aUHB=okdH9*dI^W1&(!7J!Q zdiLY7)N4ExY3%>I|9E7j)98Qjczm*(05!)6coaPWZM7!iM%#&q>@pFn-6vvK(nP$- znTY9nlQ1rG5;kgl6*mRdNmEd)G!=UsrlM4O8qUa1gP0C0N@p5w2~4J8WM~=Ix1NrbU8f^EWjZEs zKGUG0=@=J11DyxWz~wLI5j_*S$uluWy&P&<<;XQCM^HpLTw=?i z;6DrdB4!~xV;1b(zr$|%Iat(m4(yWV;8xxo94(oH!3uNn#9%I7o6bdU=eY>;n+uJo zxftGmE`Erei)#sUkuISFgBZGO6?LH6U+tjVP^YPAUK1vejv-`0Cg{I$QS<&~X zE&d+8WEUb%c_H!z$_?s}Lcx8b!TUV?p3*ROqaM z9J@?ABG=$;yR{M%20hbth_PFT<@xJyCiVyHl3$N!+Uud}ydKd?6-FM+*_g&Bm-i1P`-TWKG-O#q# z4Qc<~xYuVl7HIB4=T>_#*TrsEq*L%$J&o;_r_oOO463Ei!rtU863Niiv+S>& zgOcYt6vUoG+l+HK*ZVwLNL@gH$_1Rzzkq`_7x2{K0(!Vyz#X>>=-T-rb_}?PI|DCb zq5LJBcfN!{9+#lxdkN<}E@PYLWi0A;1()Kkz$W(!?n_l6$hHbzPF1Lmt%A$IDr`2r zipmbx;1F;PmFd@^t#AW3THfG&dIJY7Zs57k4P^DbfmQK0(B0xDW_P%Wi%oCgUi({+ zRlW_S=C^Uv_cj(r-^QZ2+i)0o8%tvDz&QI3uB%mJg=sZ5xK*R+z-r9MtcGK|yExbJ zE>=d}g<14nOzeLb(?Wj1u$W(P*WeyTSlz=An|pY`@2XF$KEQB?2bih)E84XA71_4G zB1!Whem8uGpBx@?1n40W2R}rB*CX@_c?8#tM_9_y-3cuor8}`BDGzmMo38}juhiv!iiDB zhV=$t`eEHZ$hcGC>dIk_Zp4dE4ZWu(Uw4S1A+Nr*T zt*97@J|MVeM3I;r;=TF-ZCt! zjJ%AD%yVfh_BRwVu5*j(&$}DrWbmx>n7gnD6s6$VigH7gn_`n?xvfzh6@vqo^|2+N zHFI5938vIbiSJ12@|2ZhBzYOelE$4{Q+U=#!k0W_B{HfzXG8R2DtVH(CR9q1tvI1I zYQ(qqYb0fCJ-XSEGh><^5vj;xB$pmq9C+hkoH|4$wUPFmQt-CXJ(aZONDH`jh zE25qG=BuKW4dD*a$cz0Gh=^H6IED$1`HSiWaT|!Lv4e;Q!(pOGE)wyaxkp4TsUgZl zgNdoq*QL*qR#?#INGlxZtJCj7U*zdUzd8M$^hLf~nW;YghKl>`y2!Ifm`8vQ{Xg3m zAZ!l!SQ7ihv7D1D$Bxyq;aG8ti}lu|S1M=j%gyA3c7bAgu0+GI%$x*C zvfksU`fHWb;-Sqkb>Csus;4F2ii-0PG7_z_@I`wq{6^O(fkp{5N}y2!jS^^-K%)d2 zCD15=MhP@Zpiu&i68JwMf&WPVm%eoB(gJH8jhWw3|F?QyVao!^Quh|RIz7nEkNbn$Lp=>0;M7ka*U_bv2!O~OydB|5#(`^9^6zV3!L(IL7-j|jcm zfEW@ZVoXekDKR5$h&iz!!osR8X-BL`dtyy&h%FITB=)2O5%23el1{{tI1y*!LOPQ! z#Fe-an#-Uo@gSb08}TCEq&pEd13ic@@gx4EC+S53NFeD=`j8+JOhO2a2_<6_{4NyX zB!UQ2z$ns>M3eqx0Er>7B#y+B1d>RSNHR$wsbnA-MAAq)$sm~|i)51=l1uVPKKV=o zpds`N$WStj6p|uROvL`-^hc19WE2@q#*ndO92rk0kcngxDJ7H16f%`eBV}YdnL%cf zax#m|CL)hH^yiX!WIkCyz9$Qb*uR+m60(#mBg@GOvXY4XpXym#zb(Q9jqblr0>Y+K zSVPYOKk^sl_&cc#76)n69cd@A*{qw{@$ba__LwHjUy6b9rx7% z^!YiF#8x$4Vyl`cxej%E|L03><}V~JNB(a9B30|hVkzPUOL7(SaEfd1%iNPBWfCF6 z{#Dq+{fcCHVi>x)iUzjB?%m^KIL0 z$hz^x?ok*#8ag|+=bTI(481br^Tj{RO8SPqg2g@tNp32!Zr!lo+6liqZxWr9M)!ZE G1pWs*xzl0* literal 0 HcmV?d00001 diff --git a/Data/eng/Health Management Industry/Baxter CEO msg_2012-2013.docx b/Data/eng/Health Management Industry/Baxter CEO msg_2012-2013.docx new file mode 100644 index 0000000000000000000000000000000000000000..2a6e2947b9df7737f2f20d71de3cebfec33164e7 GIT binary patch literal 15737 zcmeHuWmKHY((d5y?iwIKaJS&@?gV!U?ykYz-Q6{~y9Rd&7ThJko$Pb=-Dl_Qb=Up> zeebOGcCVSKXX@>#?s~eaT3!ka9321&fCc~nBmfxl5Pv@q03Zqi06+skgK7!c+Bh29 zIO-|8*%>?N(79S$5$Az}Qsn?Zf#3h%>woYFG$hE#1@I#WpHsX-)v1B4x-$$W+~wSs z$W&am(+MpPdmEWP-<}glN|ognYIekQGo3$=!!ZZUNG8vK@=#kUF37plf|6Mmjnf)e z&ka2!iC_ng2%94mSRo9H_Kk)2IGzH?%GgrsNWoo(I7dMny8F2p9OJaAMRK%0?#d1$ zF@kxo|5&#(mjR&d$eY(}Z-Lk|(hITZ&g`c33x(0PRqIu>D^g_8B%=F?KlU1JYVTAE z2_~ky)W{=NLkC={h8*wJ^faBN=3P<;n2~zAqNXuC%sxe!s!p=r#^5KLZ#TGAk+a+; zrd_Lok{VZy6>!c7rV_jfAj1DZy*Phwv5t1SsZ2HKh8V}^>_UjUTXs~?v{ZiT9Dqz! zpd{V->i=2outnueSiSdotV`h}%*B6?1y|`(w-+YtjUhs`4UKfV9c)wk+0?@-PWVP}GU)$sua0C;-?1IYhv z<`Tx@HeUnHQ5HBc;eaz&&)(R|fu8Qy{eNfd|KMr*ACDdpw<-xH03Un~v8g}o#l8wl zI=j3fp6f#T11vE01jGe#ykMoXBcHfUepPq>=3q>2Aw3}d8+S1eWVOD=e9lt(C$UXS zSL^0*D0z)xtu%jA1hL5)a~sGMu(Z^o6%7P)({ujDA$2yr1wCO0nKJ35eh$nY4Cn@lgRxkhn9{>&FVry?i|F4N+WNYYT4RmzBJlvm? z1_bElfZzU~eO1KE$OSU|Ynh+@ims{?xm<_Ex?Em$x%NTHEHKG&5b3o8qaJoN4~kC4 zB&~C5PU5R(*SyLNC}Cv1f8pm|(wfolgP8ujRJs0yKSz}XY8ss2*653I>q)^D(z}w)$J6@K#~F=yeGD)T7&nWD+h>1# zAKqk*Htb`{T^Z?bS)65A!{WaMExc`l%~VM53%=^Ivo-S2(!1j;Xr174$TBcG|1#67o&lV&u%nC2|xP?4vxKZRVwQOucUd0oc z33Jz?9@BwxEb4oju*|4TM_OCjONDmY4X*n&2m0H-Xxnh@@r3dQ*5dqtj!SVWv}N`5 z8^@b_J-stNoUpPailkQ7W5)*h`NN_5uGjA&j}lh-Me;?M*uBb>*Gyal#!fm}C+BJk zMX(yD7+m&EbrKy|%LbbiVNu^+*V^vFnvL#K)R8(3vf>@X}B3HJ*{K#Kc#L=dy zt%`AKG}UR-6KA&`)rrs@)s%Cr`T;RW`0*^bwm5$K^^*n5AvOl8d+VRCueKgmZj+il<4rHtMmPxv zEV?cGtWzR5GL-l92_HPw{sio8hi4b1ywq_K7D>kDF5XhR+wN{{5|RQri8 z&($W`zRzYTzSYjqO*nF5V(ovR#rt?iQ|)6pUkTaLGm3bzfMDo&+(`irSb zSwXFteLv{h`B}iX`m*cO9>BF0(p+1g74Q7&_;dYI=}p~+S1aSA^#w;l#jz=d$xXoZ z{p(k^Y(Fr{mf|CfgDdOG41Reo{H1{*IXp<+=d0!2WU&J&C<5#?8HXv$)xH-7m!mv9 zYaK0VqIxIS7CrsbB5rmfxT^GazeJZ^(5Xbnow6jQ#AP1Hm*vL?2O`-?dN3O9IgcqX z*N2YD?+X~JzHbVyu$FK4o3Cmx8i^|qh#^ygU!+IcCrOVIF3{&_!9Ol?O&oiY00KuR zPNi`e7o8}qc7^AC=`6{>urLbe7LGK_E#!U%>fk4bVBlsf;^xvQXeo@Oq7pB!FOx1Z ztDJ^%HU(Q^wN5gLm?DyejtC0NZb#X9B6jb;jf!gS zbLTuVpH`3r3@x{}e5t6-2?zD7QE1_gUFNh7txRFbIovw(Sakxux^kku_6U+LGNx2{ zPsZ?dwp6k;6*sfdZ_a1eKb3>V@S!3eP9KdH7p%A(uOLAkgwkIE_a}l_@49<9+>u}} z`7~~-+GaSq)TrAOycnV<;>?mpdb?c&)@@!OuS)3^zS-Gvx9AyjT!Ov6juRQ2UdqGk z=`-OEY<0!H;qxHs(KWh+UNJsDuIm<6mO-+F6jNBU`lhV`%Wf45KNOJi7yu|)qAyZ{ zYr8ur@y%f@Idz#I7a=x;4(Ku;iqt+Qy~_JoCWu~U2u7&70cLYo@CtEXVLJpUJ83R@ za{{Aq4(a5k&^gjc%lt#KjuIX9!1+)CHvjmQk*)wd)f=^2OvH2Sy9hz5csL@P+C)Mc zGHSV-={J_RQ3a&9yY|&`a09e0YD3RSp`VGpECb-npcT`DOE?S&9%CkPKg_T$3Gps4 zJ{fIIee)Ntpw3KFc_0MfGt@b=L8+=rt21XZ-!NGzp=;3vFQ~6n!VzypaDxTnGn_}?!Y>!(8Ie|5WbgM>w_S0-U#l6{4wllvVXFP86aiVlv3K$Iy1#tqhreA_= z5*$cze?GkxjOk3BL+qp*vY>VJokrD{ca8PNFwqoS^iADu5DSEf&rqaw_xPd)V6RBp zM*aa#NIY6nmf|NYS0-JADAVt+L;5ME!A7?{b{650@sUMUF7{f&LRrRrVw7ZJUdb00 ze5D`QR7FY2+IUm)e6!Mr9JE3BkS1eHw4o|kKW!@`l!$fLv87t@f2dKWSjjsCOha81 zjZXqX7#GCEoLGjbT0)ysJ$yv%DHr`E=yYJ40%>8gg;SSTCTS6cRFyxJX<}p~VKeuB zjW;>&69WxkQZJiGxKIA^{&ZnJss+6c*%&b&?1_8edq^fYD8|m02&PJtr71T*@LQ^y z4{OK{Rp{xj!C%FG=2cKja*Lh#-SV`t8>Ube_Jg)TQt-EV*0KxVd~Bt#L%Sv-7ULr0 zB&wKb+;W9V<6vD6IxJBTPzb<>Oz|6N^ev}&Y(vT9VVfR56I}*-yq3yGqs<9N?pDl$ zRh5xF3bxGhw8Ma}brBQBvEj$5@Ik`i6@U;c$MzMC5DqpX4*x_;L1&#CP6oRWlgo(uBGUu;PI4nc)^Pdl3|BZ3Uf-@W+FB#Bw%@Xs<8MN zum)Hh9kBf7zWZftLPy~#`tn^jKSfkEsq=_A!Q_Nwhfv~*_PLHxnJjH;U~P^>Pq$rk zVV1Fv`6d=HU78DL(=n7cv6?#5@{Z2Vo~7GEhH>|6;xYM^qag=9MVnukq)skpdd7rU z5JBowv4e4RR+sWq`gpy=8q?3#ep)INx@>Ey-F(y}eooLlva|2pZ(TcV@*%uFU&L@P z`yox1dK``V6VTUs9!<139kb(a)+{VJ*mO49N{ZW`kLN&;8Us9_mzLNKB7a z5DPKN^X6_mWz2%WnsBBL?KMW$K~s(4bLMEyKU4!DSx=ki{tm$Y)mbh($#*-+X4&ML z@bdFIF1#nf`WXeVA}okWLb;Zs}XIy6s!sx|EngMv_d1f1o z(%bdcC0oW?`>hGHk&a@D6P2=`KH)PL;}tB|eFPEVVTYU# zg_U*|7oANJYde~74IO3n-#8BMbe1QjA}(}I6(BEBqT`_X0yu{`idY2u@NPQ33D{~o zBthXJv+sfn!8)3%2K^K&Yz9DQq?CzNpH7BksVH^Jl##BQp)qaSQb!v<@6vzDfi)gx zXHq#po+#$iFUd{MlZ4WfA!EP5lJM~#Qv4*Lhbvc>@s1IqhFhbfcv?>9V1U!Nn@xcRJxjV>X$i^P2FPh8L2^B(p z#GpsLY?YnS_RP-^E}nt9-+Nq7JkQGn$i*XpH-J49S zR0`U)U!XE|*6J_kH1^ZjNkcZv@3dyT1^N9r&x+w`nBeVPwq0K7BRKrdXzqI^YtvsV z-sHE&Cwc<|h3eLT5LD51Y6|_M>;25}kOGHM3}@}@^7gkzoLgNS4*=Xtk`8pA@Dm|iy`f5E6AqE2^n}V5=HkqPc?v-1O>f%-roGZcE zF_rN8hnMEJCz<3tflUTZUt44oP~nRE0sybu31(9%X)Q7R#fyUV6gghDClPVM;B?o) zGWb(<+u5--I<&%8gf>!jYYbb`w9`!XLS^llwI+V;qsof@=g)?*CS*-I_&jZ{{@LB; zQQ=?MWmj1`1vq06ECk$ zuauxy)7bQ`$%mcq!ey#S!;_cq?$$N*d*cVyO^3vryPZn%VXNYN%IKf1Czl6{#d1iT z$}3wkCa<$%E%+NJejL*x_q%;!`pn+ihlz8vrw3FPoik40G|`05@fQ!hRvDko1NAU_ zLeB0(Cts2NY46vU4<{Z82>|He0RR|(?)@CijIE97|F|>$iY}aJ$k^hEV0V&T5{Y`) z8d5sriaC`n)xtEG=P!LY{@l*Jk!j*=%E~NzjAs!P2rejy-tQ;5=FZPwsJf%*Et3Nc zd#tyWnYw-}+papxmWS~zq@Vk_eUs>V@?ocNl~D*vSbQ|TN$sQFHL`>!;WW9G$70Bf zgC$`cEG38u4~ey{WPywM?z#)zjuS>~3UQ9y9+!%dDUbCX*8sF9FR?mgNDawH}^x?ydD=}&9M&WjL5N6rC6R6kZJ6n z#o^hOsx1REM(NNF0rgE#{-E9*vn9J0+#N36w9SjP4l}{&-Zwwh@YLZT$&du zShYRF-bOPfD`ku4tc=^#iy)1<*!C|h8|Mf2>jKz`!)+(G@iHfDT;_Z5Vg{-wx1X^z z%Mq|_`BCymUhy@d8aAg|uwocZR}(K-eXHl09^fIC<&Bat8TZ396D%1!2SkVfxWhGh zFp6^t5w%F>KTmqFeAeHfUmg#?n%;NL8eDMo6y7_JBs)lHlE!uBlv;QY6=1^}4&FY- z6J>pL3yeDB;cL6To>~7Y=Hgu!fnR2w5olZns}r?rjPte{o&EYWmOLMk8)|aQ^YXNP z9!U|BK5<) z@?K80EMp%=3*u*9S0R41QqWHJ*6&n2q5Z-$uu;kROCV=jSlm)$Q=?Prk>$#msDldh#EPmj+Gw9_-ybG3-c*j(oY$D2kOt*FtMF8R znj9Pc(773Dm!YZ;#S%8UbpM^NfJ*eMwn~pnix$Zf&W>+<&~~Rl7}{C<*B&QaF6s$X z;jUC@0x7d4S)wTOtF$zxhMwZhjq2fQ_C^9*SWOM2)uFTt(zVNl)$gP^w%!Npz41oL z{B={dA8ql@R|kK*9N?Yjx${|n&2&;X>vZ?52dl$L-VK_&N?~G?R}!rfXJ(LE`ryw; zYr*B9Og?b*K61-)VVyvmswP*!zZ|Lb3nYrH{!*1kngkW|Lay-pWV>PJvBY*(LP%%h z=ujCi*P0i8gT_9vukCrs*UW-FgD0H1oT2;vsw@F>uv)D#j1cvDqUt&{P8Q})`Dx}( zQ4PIDq1)}|HR`TtgUH~0aIS6`h(9!0@Z}iD{O-Q4`(4+hP-Pg08U=#I4T!Ju66LqS zC}z>@s{-tcNkyN!UHlg%XEoDKX~el@Vn%mx;rhSNcqCGN$KeT&t6DYuJ{)KNxelD5 zsYBJF^@xP1*xDBUKto3j!@*yi*E!xLG>gBOb+9%c|e;6#U2kM_`2nr$u* zRU}@8ks2UFgqZbH7$6BfIFs`8fGmUF*InSo!P+EE_y{20_-HvKg}k@qxGUwwB^A*Bs2EFZgtZbk z(utNbU*9oSXM{r*ukg;v*kYbA7OXe84XWz6V_gWPpzVl41COC)_wj(w6oUo!Hb$w6 zy*LEjqq@@1$K$GY0A94!YYCpE^$iY###u$mcKEuZ*(%hV5w9NCO~tonR&{!G^!1&J zYft5Za|LI3a(b&h@_<{oel2#WV#}?-6Vi!~@O1LqKARcKj{7jg5H&ACeHr) zkMZ#XmARlHlDvnXvr^- z_9WODO6b|sD!ZS$&6S*!;`xUM`7*fV((;i~fy1L?Rkp+Hk;X+2W~093WZoWC6eJa# z3R7#UNHo&ewmAy}rV)&`M1}}A%S>^&o)4$3Qour7Dh_fWODUC!g0XdGlxR_jyf3FB ztE6I8BIc)~GIlbMr_$1pAXHZMB<9Hz8usH`jQ!@Q{rHM3{9NIrpb3IKUisM zo{xBMrrPm%u*%H9C4cDQoA03q#1$Dd9?kT>iR7b~6B<3|lQ;R_J6of^4cAFEtF(Du zKBQh`2vw^14ax_ABOSqhx`Loc?F4gwe~Xgnj=n+2No6l*;IkrT^T7QEwvMQyU8@~{ zXk7$irw~fou`XUna=@Z&%@j#zme)!14$@jPpRPor{*X3GR5nWqnI#YIHl$7?ztO_T zEr7ocX;;D+V5i_`i z3-dJyWhNzurFE)_P8xGRdX|R3Cyn~6v?lXKkM_nlxJKiFp@rR;D&43EC=efeIce9^)MNxmeOM(~`x5J%~uQ z*5N`&+A~$mx{V%jM$cS3acw(Gw75BPclVK8HzUY`>y$>uJ|ja0(Sq-WGnIVoa)czi zy#C?-sK;f0f%DyA4(u}ZE)M-QdBYDFZXemSgugljj@l=?$~Ug z9he-c&K^wZT}`yiMRr8l$R5zkw-}AIadQONk(Zy5BRS7?oU|kpoEuYi zMDTT4Yo3O>h2dwLl|JRiS7RKM4O|srP3F1e$%88iM1Hdv%50FMzV(lip7@l$!#u;4 zG(Ow)B`py&>qt%vpDnMRLiZiDtKpBBjL$EkTvR=ZNT{0~?33QdZ)j5KN$Lz~(^iyM zyrzUf-JHy9eQAgD)H3fq@*XD0&fgBTf5QC}{mrwQi+upn-fZCFg8nD{bul(j`i~VP zV!B7Np8*+i>+2SG!dkPrG0J;uEMZKZa-^7|IkuFMz|;ySFZbOl*d1eA9Hwi=>*lX6 zHv@Pz9I%;XW0Dxiw2^enYNR72TmstKWfU-^n=`Sy>=dOlY$rJqm$zz{D0fcxi2 zIXJpm89S(%JDQ1@m>3&6{;}dVq+2Vkav%?FZjO6FMQ;ib=Io8KoXVS3k2ms4etOcZ z#mMVx^7JOQ%YIdjtHkDxaxuKe=x@5~D%W{g06$s}Ibg8Ma*czVlh6}J za=3pzyPhGciZ`LX(jX?|bJ24>_I7=HwmoM%Fuy~+_yz)|;NBV5(fW0=?!l8qvV#># z!yO-%KDJcbcqj{A%)SwokjUC-C%R~NMEwnua(34o)*_kK-Jnz}1ulKTXq;?XbA;ST z!<{xhL}55?h=&jK2jf`3A~>lB$m(wWY(&OaH`GilL;{VFZ!r$L@|XGeu`GE@xt5~3 z67)!J3FZR|y_ zhKwFe%Bgk4vcz;)gz32c5h6}uh2txhK2n-bJ?n*3a#83q zphk;Sr|czd6Sre{De?9|n@{V+c0hX@*a8;ln<($wLyx6Et=-b6k)~7NuVU*>T~+#Q zdHdeuM2 z!)h%jbC}=*I;kj3tkEU$5Y5+$K>V&Wz(awjgyDYAF&MK|;%5L#j5H2H;OK=Tq%t#+ zjRR{B?Nq_#0}+yqnNKomjecOGf?WQj)(!Ia6V2*^URLm32PYzUO4DZ%{IxNVRZ^y7Q@y ziQ+o{z@mbp0yga|(V2C_{&{7yKmC=$QQ$s3T*HTc3!>OoRN7j(3^n_kw0qG**|pu3 zv)o7-N+k6${tQ*xBuXUi5wH^m?7$x4&xpGogo=7|i?PhMx&#ifv>dBA=9z*u)|?At z^1q!BuNP1rf4SRTs|n;Kr`6>y+g@1TfEp9&9Ji~o$RI=<6G;-k#a&?}Q>uqYG`T8f z(5+YQUUg5FpDOKAsurHi4)a}HK`do2dcb8oYEI1ja6<8kP;adJAk1MXTSgRSw@b=Y ze}jiB^GE7J^^Sff=S5SArcLpZ##lk~RAB9!N`X7#o%3~ll6+f4zP;;$V)E%=*Jr&w zeNNWU=2+%F2f;K;)Rlo3CC4(wZ`%Et3MJs51Q|~K3H_U*FE&}Q+Po4CBi@QI2+WAK zyUewrRu*q-KXw_-YWFODK(uh17`D7ugk;kAF3<|eb;&?h{fWj8&aXYR(hHs3WDnyf zZ1!Z(L64qI3fH>>gE0kvSWW^_5qdUH+P#8rHS8q9!m{!*mXg!QLz@1`IBm^8B}(W+ zN+zPaC|WX-9uhu$10u)+*f*eDn^~a^^yzLdP*}JDtIb1737LGQS8^M zFHr)YocR6ayHv%IElQ*BTnJauE=ga~$ppe9j8_L7mvcvW$l{k_XEeL{z0fXS=j+^8 zEpwOIQKFd4Fa#__kh0PirBk%B4QYB%&tg)91-pK$^W*9C+p%K7r z1E+s=ZbMv}hwUyz&0?27rD_JT3yOafd{o+mRoRY2Cav$8u6md(Iq_H-ef?+y<;xBP z&!K1s{?bW94_6zf^;^;XeOn?@FdT3}exYmn%3ai%@d+4kK3tIFMt&H-PZyLb-+E>8Rg;nhO7a zLX+0(Q?}n4{QQ0)S`vfyE%2AlnYi*F4v;nXz~>uif!eg`y7%Fc6cBMLhob%(jlZD3 z5pArK_5mMF#3aDj0%HT3go&_1{*M;VxmT+?Ru9oO5SCLw=9kvXr6BV_HUCie&oO9Y z@c0)rzj!sNWLmHvJ87Q&RwVK<(z#9S_EzLHa7>vRVQmAEagbC?ezmCx7TF(8utaR- zG8@oAoU;X5%RxSHSWBR))<9n*Rl9-~Be>n4#boZ9eIU3CXPD2$3hHP=2D6!K3i z8sI>eHam75>To3nKvUN9Qo@|Qb~<*ZfH6dVZY$6|Z}*!Mn%@fKes2P&`kcN?~w)8h`+&c40xE}90$q)(YQ54H=ob5p&<&gI$bS8m{BJ34d*FFIA_z7aT-I^%piYh|BM6;ly`s*zpb5;GT+ z2TxlRJl2WQ9dl|Ij=h$KQ=P}PcLWVl9XOR4MEKqqWU7T%qw60ID#1M}6Lq(N_oa5% zLw@{SPi{a3*S;;yq9Wk98_g$oN7KunjI8 zGKxQUZ$BkIUkesTWJo^6!!T#=MlJi_?`-jLabl+zNu-%$k?qM{KJOnD;;|;Rtz$qb z8~H2Q_&u&*>OWahtwv;d3h>X%tBL8;pM7e7i} z0!x_wyMV5;CFTbckhijM0RX@V_`iyq{>58=Ss;+CI;8(eR)g?S~@6wL? z3Z0nlaRaOzLHbErCC=uu8$g5n8Nd2Y0 z6GXYR`g&t)%ZLB6?V$*vflf|pDD@UA@phWN>Eq$$LosjITTqN(bVZAh>|LSk&6YaM zU}8?J7n))Gv@MEmo^xYdn^_?6xp^#FFm~T>$1=%5ZdMa z82U{%I_(Um2!&zR*ysxH;7SKoUOO^Lydn~pOhpIFRw^?yw+)V@n>zG+w&Nhe@qTv} z#v;f2Wpuv6u=B$0<#{$Vks8^Xz4fW67k2l3QWV`fnHs4CmgE5^1>GdIi-UmSgqyP| zP#k;j{9OP=_(MLBii`PMywm+j}PEH}dR;Maj;r zAN`GvrcOURZU$ZUZcv}U6KJYDt35e%R=GDh+6>E=+nlIuWNW_(*fDdmiIDkJGQYVJ zEmq+;mpXylZk#6J1HA=&oM&riuZ52vIdyi<&K{Og%IM~m#Hdw*sWKUYf>2Keiom1; z+k$IrI_jgFp)HH@_I_95-uUF5Zej|A39tLsn*a&+txe7JT0{vSphoJ-iE*v}(hiM2 zBz@WpmkX=7PsR)u>9%)Y^aIVMfC_2Dh}u-xKsnfZOZSGll4da)b9avh`vPF+9k9cc z1MF;d@M>P3p3cA?^bqO;wk%9$Kuv(G&$dM}<;Vw_zuvEeCfwhJ0KKOP`f7>UxaR1N zM7_${GROhL?#WZVN|~h2`aEL%l*yGXezVvOU%YD5+`Y(~&+gcEocqhYX-~dxX)@cR zrlG$}Xvez~E*L?~aB_nnmp(!(VVIXLSldLX+$#T$Nd)*Grk#*k z@Dm{KOaf72!M;tWp)~~8CJ_q5F3fc6FgTRBZioz0v$Dw>ni^_b7)?;efVNW ze45m7S%p!Yn8&0hK{?xIqrXrMgm-`ORm5M!b$gwjiSQ4a%2BlN zFPaK7{|5oqr*GGf{P_n-1+nM@lGG?!uo6VzAlUojY9cy8SAGVPJO6%scp#HwaSKMS zAeBt{3mkvr1;}{+V3URx1b?u}4EaA=ym3CQ4n6b^UZ;gv@Fg$E`6|eUt#&eT^&WfQ z&E;T>Cvo&2n*>bqHMk@KwPd_CLY|cUnIWr79f#t`4d{B5+TBTKVoQZe+@UobymoP0 z`_*vg`MiL+W2pDH*OPc&gC*YD!}u2d4i+nNw<$l!xZN7-*VO04!p7fMTtOqVw9f+b zha8uNQ4fb~c2}i5hhT4YA0W2t`Pi{ktc&K7vBHmx-Dm}~&6#%I0_S%dXG}pn62`puO1FJtcUVB`R%_=eW(0Tk5 zBIfvC^-5Fb^|xS=yTY{<_B3ys@kYB4C{uScPpR6t4t`X>AvR8 zjxK}W(P)XQ=B>0gi7Sm+(3KJ#CDA~uu81FREmkN=OuQ8F8f!Lv3oA4WTrI>I#42fK z9BMf%Lyg$9Xo}Ttt@+5>4kA`*^+A)n#c8O;X{AClAEz1fj5hs{vQ*v!FYY6AoIj4W z(|1w3R2Gv2cbX+xyOa^gcX1fD3zB$kR=zr7_AEbo-s$9)fL~s&4rS}{k$>#;@%nkg z8K_m(@Eu&$%3O&wV;j#iYU6RajKi;PxpSQA5`QGSx;ofueP~oOtN)5a6j0MCwd_vhD-V zHxt>ZgRt(9d$Qs-@y+d08|D)8Amlim0P+KlkgT4Qb8+Hy{$n|EiihCtSYchEjpf@N zm{?A#T?xW7$ZvPT7dIb;eZ_7-M8!~3m0AOvx%hk0LdkhzPawp%PTq&Db(wdndB;O1 z0;~|{A!AY?^WKPOu);E5fJFblZ3N^UABsQFMy7zDBLC+$K;O>pe|G`EN%QY3BW^;r zj{!OGT)bT}witPw=T8H+Tud@!{S$PY3WSX{9s2nY^NmG3q<9yfAjP8z5rgR@~O1)X-p`aJF0e~Q1cs>t3w z?npIWqo)W3WwMi!_?+yfq}rE)v6acUl1mqI?_F~q8A46v^$g4TAwaaZ<&e@RA9M$! zE>uDbQV0%Xjn#p(p=_;qHw)ZLLp|uOE?!OCZP9~(P~*t z%A>{X4*pUHF$2E6I-Km)T^kUI4!J1oyVxrX?u`8Dl#Bi(N@?0l#M}1s4;q&_vZvN7 zt&EDtGNrGVf{H2iR~ggzm{}2@gtX;nAU*m504_Hg{zsdVF4h4SKKti6Vh>C|vpv1p zXbvAunikD2FNe1Efd9b1>=p#{127Tr&u2^j{Ga}8|KX&mywu+T{(i*mPr+Yp8*s<` z9|zuk7ySFVpZ^rx09Nb#zfJ-Dj`aKKj=!)3fr0-2I_vSf`0oWme~I&9{agI^a-rWL ze$UbV1@TJo=Z5S*@-4rM|DL1yOPrVV-{QYzY<@@hJ$LaJf+^Xb3j9+h<9D3D$20yy z0RYlz0D%9BZu~C(`&RTX03y1-sqt%3{9X8WNBftsH|xKJ|K@gom;d`B{FgKUkjMTX cy8nAgmY0G6ni&894}8G@Emae^dj-+zlC)c&Q zll9b{TD7XX?(V97WW<3%kO05{AOHXW@Btu+g8h5}0RW;v0RRvIAb`~Qt*smktsJx! zTx|^PHECQdE%0(dfXK1|fIjd4-|K&{1?m$drTux}f-Xqj!E2R)SKR0Z67I9_iY3dh z+G+TghP(`nU+ylj#l%Z<3e-AcellFVj6pN{Pm3i_194KA%PmN|Q2`NJ7LHLFR?QAR zCJCYi3=5ck&A0eEB-A?^-tBM(Kv>F>QcD2hJjgZzRR6P&oz5Xny-F}!oqI=W2$mk$ zYwcvs##9mjaa+c;dTSHVj-HmENo#s1t&cyHs=tPkwUUVGE-~#! z35dY3ax|Z9nlBamgBRw@3Bu(Cx!D@x*@gnyfGbQKmy$xqwQ~%V?MEX{fW`E)$0Ql~xaA=m%YdP%9$AR6Fp7#*4ANg+Y|+jDbYE zqsU9|NAB60Uva5E1{*jRnTe9XN(ggQz5B#DZ0T7N@51&t>x#o8Bmlt22QYxl-$pJ@ zEJoAKr#ni04ov9Jk*jTIXkkxF^ZWIGN9_OLVft?$JtA&J44C&z&;{s*?vN+z3KYT2 z(z-~FGr#UaQQC*8c6msPsa*fBGCp5hqxcuIhaDV!Dp-hPjJn zQ#iPc>X3SxpYd1WiE2|T>jhfQ*n}L;2>P$1)WT)eucpQqJPm^?EZPe&nyeUJP(~MvqoK${;JVgJGrpNP02D;x7?$1F3 z_!;It@BW{CmB&j;2hjc3G(XdZq@)?SREx^IR91PlN-b{^kmN7```&?E2Q`ulP9tfQ z);T#V+NRbuuXqcD6Ith1VB14bJ+e1|;`iOcTAD^RfXI@D(wMgzC8nZoCvP5GA+86X zO446eq=rmIbWX!Isx&}N?-Zk2SC~Uv9IAlUg>XKe%7-@2VAzw}-_U=|Bp!O7^@%*Z z(GqdU+nA#w($Bo;hj}%V-zJ2>mJu350j&?niu3m7@MCk&why0Wg7YC$|H%An{5x+4 znpOm11M+5G&b5%a%-rC|YTC63tV=}16K>w&PzSHW9g-It>5m?0Uu!qzYb(hjtce4M zsfih-^U@!K%I0F*7E+e|0kB*e_b~s-#|{=J`k7Dx0Ct=J0N_7e=MNwI zckepQoU~gRNE&#MXTI=}Q#3Lhj-&nvJy>qS;<$HQOAn*4BN;6rnIeMs2cQ86Gg5L5 zUK%SukldHOCc1f%0>;CarQhpgP*g&Rg#?Ne+IfANaGo%I->bSXR(04fW2e3@au)^< zc8{IhArQS8p6$Th=v?-0N1cxxMNCF+@osIpy<6ALdOPWQHM}As-+mf9knDqVeKU|9 zkbWqXl;>)3Z;C4N+CTPJ#ZVU1j7axyPFbTK*kQVNMioq4?QnK+F!`V;Be-`Qf75Dy z9h-MQv#ATuLoS$X`PE!(R9ONWW@hKSU+R2gmo+W^D?g7(Je^n{m+Lf${Kxrt*{di= z&YKrs>#k^u%u7*QZtEoy<~e4i$5N%w+LhHF0HTRb_fw_p{`)+$_uKubSLRNH& zpMorPc6mJR&+FwcmvUbh=XSa&Z*h4ZUdG3K%Ad(9eY+_gN>Ag}z%HV?gJ#84ESasI zJ#g)C+O4cC_1+3+O#Z&s=4>5J=)B_lsNM+dgorVAJ=wLhEqY_|LGfW)DVb6;UYK5# zbdV1IfWz%&NV_?5lA9=IkFws@>Z(=e)YT?ue$#0o#L-|keKOWTD`jlT_~xFp&(%Y? zhB>Bjp+(6Kx1>CY+u8adNt@{}e5~XpX|OVDnIcV|g?Zp6c&CP#B(=|-NaLBX>=D4z z`FQ_wD7pT4Om!DdHhwbDMno|X+xZByxJB~bd+{1}viQS`aQ*3W+Dh{H0(0HBcoUyJ zu#35&(JEcy_^mt5QonGa{J?lVUl|sM)6KA-O}S5zrN14Xi9G|lvs0#_9xiS|OEO8Nt*pC)=_jGFMhu&%Z^1TVdqf*~3{ z%4nSx1YK6Muf!US3OA69qwygso0|1MtAq>6(lQp6lBGR*BjcF{ey#W#9p}xU65E>@)YRw;LO1%Hjj!u#%sIDhnFa)iwgz$t~z z$9jze?{q=ru*23D@+}6hFK!dB6n$IuE>~@rB!vcLHU}}x6&ap@^dPDK9nWU6(Eh%8l1n0~wQ8Hy7f#>9fVJ1~8KYnO6|D6zdGdF$3i~*s~gGN5>fc z*0WM4CIrU??jg2nS98r7w(bx5H|#W`a?{THt_-Y`TXd>W^`evU``nCx@*Td$c%0>7 zdastmbc9MWv*W7q`$aE$NkVF>s%dz zA{FS?M^>VXCSh}%Ks()!%Qz6ymsd_8)^Qr)DBEf?W%ua1-OAhyCHFM-K^$c%uq10r}c`CY7laS8@a)KO}YtkpR+9d096|^=B}VC zT6Nf2*Y&FA_-4bUq!qOw!AFZ-M{t$eiB!zoh9aRj1R{b2Jc5iQRjmSuHdHz$SBt~I zI@Ag;1EzZS^_T-3N?Uc)X(!T>P#svjSzW~yT;n#q0nTJUPUp&|!zPizI0$c+bD&-K zE2agGR40LXQ$n+-kKQhMB)$3db7ff3w8(Wb>NjRK;Y|6-@!iyl_!BIVl_=MS1J!$! zYp$}Uv|X5%dNjDb8Bw1P!by&~Yx5Rh2=eYDMu6q^nqTuhl&SHTt#?&+TqAOJVP}Dm z@O9nA@5H~xIaRMq_qzQq2-404a(Z>~Yu_i}v;F(O7*`bfg2svDyYdA9R&Q4V0^l>r z#-=-#CdU*p#`WspjTazRu(Vgca@VMSU8oJWZFE!4f+T5aA4*2k$+BP`#f~dRIXyMj zX! z17gn``UHnW0u6RAnQP?m@y>f7vGD_+K!+rZ1k4!LCNT*4X&M7YVbaZLiU=d%EvT?z ztwG%bmqWZ}i=@D>MobXJM0VtOWkN-No0wV59k+_`KTL>WC?EheM=#ICk%-5yq|PI% zfOu>kt$k=o{_guEliT?dvRgk+5egOZhCIbaaz{5zU^+X%DE?|94P~-d7KOLy`GI{L z=VNg82Iooo3n8zDvgFzO{fT!LW1{!A2Uj1PH4K_GkTFV!949QXtyi}b1)VWN{K&Xb zufvYvH}haDDV^s6d=sz;XaT5O{ja?~UoRg~6|7-~tpKGj1sydChy&c6Z^P|zI8I-j zdh;AYv2O@2eDSOOzS|_+UFeognA9-^OaT3$W}YkbcL)fOPQntPJxJubTgt;w_G=?h z1${{-eIW!Y{JG4}d>%eG*cuE1kL-@G??4fx4YS+NG>%|V7y4bslt@WTd(%4wk7R|) z=~T>EF}O$8@^+poER#iWPSWq?_@_(;<8iv>K1?cMpYCxT0`OcX89asVkt=T<)2P5g z-`R@4ifVFdEg1-|P5TX2#F!(*?2Rob*yHtMhdQC*ou5*t2fbwNL^si5`@N)7yd`*Jd?BdM&uytsdhXd5Uc)$ardjyC^{0Bwi1ASE{$ith_F|-$$Ao^7g#p@`5J66P^LMn9)na<7mVL?Hcx(iD z(9;F4vd1)Y2=?9in)TiQb}+df2kIkV5epsWN-_e8hae~johgcy3PdHnDbFwF=53G) zlIvX4icNM|$3U6XNxiNRVUcLBFGg2xH^Cs4q>naBTciL2k1_u3Nnne8U&t_Hf3{b1 z>?Nw*Gjy%HIqIN#gitKDIx5Fa9UESn)O>Wa7uWDff}1Z|K}X`t_Z^u!+%%$K|^=7BN?U&{9l zna+*v{0O5P3pn?b;#YHYU~lCpc|{2@)=5%WO$V3=DXm!FuuF@@9G7Br&v* zvyeg{R;Jj+BXZNg-P7%-poJ<5+FI-cZ>+nx1qSZBm}7N+>5e|NAo%p2~Pvp6HkN` zNFtP25I2Lion*XH^gfy%&l; zmAqwT?{J9Av?z-}!1pHkv)oWHv5junE&;CS}fUxwdxZ!&;s0LBb>kbSD-tBHvGDt-oU1;&7NqAk_RLmy@A z0m+E3tQMp1nmfTOo`Knmzs>$4M|g;p{~>K6w#WSd=P%ph(gZ!{Avv(33v;Gl?v+Lv z*^0UKU+~NJQa!asgBxuW0+?bOS8?@+nac#H$(j*j!gL{d>dcGg&tuJ0Ehn*^DxKGoo7{t6y})0Dz1$}{9}2X!O?F-ig&uagF)TrB4g{R21zyV2 zZXf&oleN1RPnPL`I^54UmoSVp!l4Hn{3dMK~)GfoCV2~Pi)w)4UtI} zh6xtDHKCLi&NL9_1(+i!la>N+^YRPa-`n&`2gm8;FeZ^KTFB1qNRxl zK~x{Zkg}g)t_z`^Kw39LR>vw8Y zxpch-ljcp0)+h{ZgqB{3O@5Jm=##17C6X$pEZp@UFjPmx(|vn@lcbt!9O{ziwK50t zQkM2;NI1%}3cvPXy$?dahOqNG71gOx%%dP>tXf+wni8~|rf zfDI`qLF#$+OC%EPMco{y5mps5_pAFxTd$C9*-?b5agKF!*NFo!p)(SEp=WVAZMkNQ zrw6rR>&m`vP3{s9gM6%kGm$CC+r(k$yW$nVwI}9s27*#VkPHid3cc zNA{4SGGnADU)_S1dCU!b(FOfQiv2OGV;42a#=-GTvx_w3X`eMIF1)Wik%J1h`7hQ_ z4nD5H^oC>K=sap#JCIUlqGJ@^fE-LoYla%wZ^q61JsjN?hdg0+DGVZWKVCNSUV=Ss zHJ6dugl|OxJ1p%I{BaZ@s#pXsW~S089LW-tvb6+uUz)RL6c>Fx61it-q&%#@YtBt{ zYiF#)mdsYcbd*+G1+TfTfOL$1aULoP4!h$#zBhqi170<+`|fG%qErl;;W6wX5l5=< zwL}|V$v2oFwA0mB;6MkGrL}Q%-u7|4K_~#z*v+1<4@LzsW3I+k2X(p;`FW~huU-GA zsM}+h5ltiNAtt@3lKKpP(AJ70!-iH3F+$sA; z7IHraavnZ;4u+E?=Hu zmnpn<@r=VTtJC-~h{BX@ev( zYF?)t-o3h>RX!fy7H*^k7_3g|6c6V>IuA`uMiVxu&$(72LbzHpob`=qQS9f{TVhA5{?+iQ_^wGSP?H8j5TpLsOoR>Jybnx@9ry>aJYm?6+Tj zg~eCOYhqaD8O|pKpsFC-m>LHq&<8^b?8m60XNYwmzLp{1=JSk^-<*ljgR%{kV2IPn ziSSj+*SeOM}uYl|(H_ISmJw+6UgHm_;w|Ek+_N zo*)a}%>{CQBVN}&pvvwg7?>-&R1D*MHq}O;W|?xQ1NH!*q(SPjGm_AIg-WqluapM2 zvEfF*0}_n_sCX}oc%yWZW72GIFAs?VAKUU9F&=Ody+w?^XNcYU@}@KYL_dxx2)lyf zAjTw{47OT|9^wpbibo6t^t(D4xxnpj6OP4pC?&tERHAaU2jBgO8az3zlab`T; z&(j0G3^LA`tGbM8u9GT`gyK|pra<6$tfC@RmWSb#(&QaYy&po!k1~c#k)S^53qM7J zJJ!;CBkCLSk<4!aX+T=gG-YM`3bagD#Ri*)fHCIlR!O`F z`sKS9!4;Ex#~iQwYV?;v{Pr+CXEvR-;N`F;!_@*q%dUrv_x<=`S-^x?w>Y4od@Ge0 z$ZR->oNyToU!lK}Wsd&REN)Rn59q8ELh(g&U$>US2;wsd2jd5C+Pro5Ta7H^yBup+ zBwQ2{YXDZBQAe&89*DA<`-P?+yARTw(#}yK+(bnCO%{}-lxB=e{J{7^vKZ4zws;dZ*s`dlQh9rb1!n-*#Y7J|+L$RGw zfT*gzKeSOjk6+yqntGBT^y1k)#s;hUvbCBtMZKP|GWiGda=#=TzuZ)a4Zf|pIVMVo zpfv1UZQE^pWk1{cSE$10y0l@cvJ+<<`zTtuFt% zBa?!=w_kf!Jb-D{KU&HdpR0?OUMWeElK^3*yObXCHh8GkAs^Jw5cZNx`QFOutR}2O zIM-e#fAzBh6jWn-JJXmBzDtk|N+lv)W$++XdWqXU8epE}NVkX}x1Df{v9it6;?g`G z{mQGlD=RtuGTepB)%o#lEHA?&cznC)YgpV)Gz>5as(J6=j($29EvBCH9ox-LgEgf3 z&vfa}&B|(X!_m8|ld6j&E5xyEE}Wp1{y;UZwzHI|i|-J@_|)3UB}#nm@LBniV^kO1 z_2DXU)fkQJTh1hG3vcXabswMm=>H*&)0+n^5(x$Xpos|pfc)ncyMu|Lr6KJfuk^o@ zIH#(T)|i55orG7oLhjc3q)r&Zj-`t=koBf{i`2)q?HucwMoz}ej8ey#W`O}9e0)fK zzGACxJUj(T+j3r#*$`02+MAiFYj;xZN;53E$aBGc953w~xHl7z+XXB1{NMs2Bk_&O z+}byAq8>O?L>BJ9g5T`TapIsz0gX8EEv?1!olSSvoN2Zlkz-TvvZZ&~t=wbfj-F@Y zZgtT|Z#an|+cE9o^+BTvG@wAZKsxEw)hg$elJz7IVTr$iHU1jVKSsQL7|iOlgQ#%e3_g=MkIJRoC)2JsM}t`Xc1$m<(XQ(`b$5|mbbN7|E%I3{ZH zrJGRS9MCd?=7tADYXsh+HVcE`H;RCTm&k>{3coHuI_Bt;JGV8hj!k2L#fNUWGVxU7 zye_4ST~2Yl7snsYO$+7B8Xln^BN-DFQbn^ChOH`vU}{;YW6))QNp znd4T@^WB&+{Z$iNFQ{r|Us0`j;PZyxvDCopHzu1=W9W@n5-*v3s^%FUzkn{u7$l?6 z?}w@-nA3Om3*rJ`3{~es%FQN3)WDj)o_3>puYEwgJsq|gKXlIMU9xu+7L!({r~ zijnGzYSUAKz}y!_&MKXW(IM*2jYyjeC0%f)(2>Q5J+6E*p*9W0Zs%ro{AcuSpZLJ7 zPTo+&^Z2%IM+|m~aRh;`R0wQwlSL`qDAVh-G=}=_qK);cp(@q}Y-=brRoIomv`d23 ztA&+4f^2KAgSDP`gJhoCNo#Iv%!`$QleYuRi(EG@%eG8M6_ZXkk2>I5^yHnu+3OSr z78!Y=N)bjn@kMGsE-Ev2dj+EYBl5^i^My5R4YKMSUcWNfk}xoMDc!|N_cT#5#)TXK z@?@JK#?i!fW*jgl!{`u6PnYU99=(QM;I{VMLf`wgHQ$@+6tWD% z5Q6~VxPFn9@3?ubka9mL_mu$biU@?Be>(g95}Q#=JEIigkc=7G#(?hIn|4nm+e7CJ zkE>kK-y4dvv#kZeZtPI9Z#lxpEwZ%!a-jZ*Q3U5$LdreH*Gzn!SZ(U9N1slSC0Lh; zxsSq&T}f5Gaqz|InTH~Oxrd>)L|4m@{3inS@Nw5FNYjr*K$cl;zVJk5k)U6NppVmE zsnMfDt46wMDoi$(2Fnw#LkaZYK!Z*CNc3R&A012mz5^!O@anSrdHHZKpIP3FSWc); zCtBBjnW)rH68dJ|)GBZz)@UO?7zndpl8>{fRMJL&-Y-c{>@8H7F#G6j6t*tC*{MT3 z1%J6ErL2>G(r{**Lja>m7FoQ3O7|^g9dHTgq4p9Z4$3NN+?yBX)?3{^DVW^++kMG* z3<6$VZn;=I1JvcX;ZDSq`MQqLS_5>#cv)gcL$i6DSm2(ZR`AN>jx~Px{MI89RZP0( zou>mXV`L_%yBPUO)}mk}_o@nCZ};n({x3o;o{L|YT0WqWDV-F>t%q(pnk+)R=rQXs zTorw)XOyN!M&5}PUAik4oXXk4lha%5;QC#|b!*T<=6_M@kxa;vE1Pc~W_tn}_lU>XMLqJ{jD zckpu#5UDHCM1=MIKb9d}!*lWxf&c*MeHQZke<@;nLk9;_D`WfLu`5Gq#cqWK&htXz zgSYo!gvhZ5IchJ0ShWVTZ9K*4rJYEbz)a&C0GZm;GY!N{m_A$laQx4@He*zG{|Rm` zXs*Q^7Kve3xGaHg0K-ZslBS!@E8XuIpuqaPC_fYXT&slrP&KY9045TFP9*SE#y6`-A;laU*5Rc!*AAUHI5-VMH`T+dYaDyiIne~oC9;hbvi za;r2^%_m-2bgyR`uAo8sm>*bY2>mtGSkMuhpt^pArlGyoqcz_+e}`Y>)iO0t1Yrgr z?F79eg?vb%Y<^z|y>X^zJf%c$HH*bEjL%m84z*Le3-d6?-eHAAtvqeka=+v-<8Ocv zx#Qw0VaI}=HNLGMw`AA)Y%^y>k3DWA{ML@!J-=&#L>u*_DqUn;6rUG2I(zrnJbq0T zW;79GH)|+BWL4ogje782Ul@f6ku^vhBEg8Z+R`tqL@<0i>o=_R1E1RKRVi*kl@<%8 z<0r(Xhot5j^l~VCXnHlWm71CtxSRXt8Plz70@%YODovB1jCZc5tgCfo(6JB-$iw;e zaQ=>d9EQSeb4gu&Q(S#}C;asFlY0@iu8W9tyo%e6$R?&Fa z4yTGycH(K$Yj5fN_V2Kh*oZu z+D|A`KFkIXXErfr^e|j?dULK}67^-vgOPk7;5c1E#QkPGP^dC3)+jccxUzR096$Yf z>m5b&4*s7QajwN|?BgdB&ib5hkp5)E&W3vO|2C;aOm&O((ZPXjwrz4GtTve%!joH~ z3ZQV7!NwHMvZM?Lq?S8+y6sd#Z5vvnGu+VMG_^V3_G4CmgUT!&6+?!jiliCKbaP#| zK3BjW4w!aI9_{ffcTOrOyuTX(~HDc7JdJ(~k= zHEE}@8mP)c#XF+;$A2u7MQU?ON_WT@}($0S^z zZYjU=4Q_B_W6TpgdV?P)dv}ECOva>Ytl_(u&a+w#a&B*kF0x(|d%=IY3}px6aUxmbQu7M-L{k4rW+YH!LXH*b)uH!5?3Q?HUkpa4ikC zqYHP2RX$KiXLd}X%#x|x^h(rIpwkx&#t5g>hKUSR-KgS&WryMhIk|vN=tukHKnUCc zS9a=VA~M=s5i(I>uvLTSV(fQhuJW*AnQ|9%%!RZ>X<=OxO#5YffG>H4j@0^A=wKSa z@GHfWf82v!A%X4Lr@PoKPu1b;+u0;mf6do3uhz91GQ6cEJ9*|?jxK&T#`pI;|W`QS>W8SOa)u3;3;7hx2=CA`teAWN9D+J zKy??;3>@H-DC5&jiz-W@(cG(=rkU@jXzfK&S@L3jr*l_`eN>>@zbU*0?VK-w>x$6* zlN4oat)wO4-MOTlE;-B`FdS#ZoRhs(TcIPhE&BSfO5M>EGU$LtJPHMMWKkqo?Y%qz zt1AuQG2cT}f4}<}n9(B9763j*0{v^i$fX0A0wb=KJ##nJWd7A7F07S_cQQh?Za{;q zO*RE6u6Zhe5nwk;(5_8#Rj1fR>`V9;t1-?R>N*XQQvHmp2?wHFJ!*_pXYGV!xnfQiN9oo^lfH{Bg@_yS&kt z{!Ze+`;Z>4>P@=|T4XIGVX07xkToaaR`^(YV{`2!JzNSONpXxdO_nwRABl1F*$MsZ zKpkRDi?|$w2zhY`GtIO(2MjVbA1gZK8Ur^}UkIS^e4OH~<&z$V-S4bc2Ye@@(&8xH zT3A~L9~JBzv#B)8z=0VROcJ@nSf(eGuloXHbX`QJRj2TC#VuK8vZPDCN?;-@)aTbS zObKh@BL@9ZQ(`9dDTxk__UO-pQ2W6wNg>FcE^%Ysbx!uolhlQ(ZQV?^%f@0gtD;5K z(fp>#fSM1*d^ebTr<=MYnbwFrJC_ByXhB*o2m!PKAe)4!CUcJxPx~-V!EV05DqxT?#>b1-1^D`rWw;c5WK7xfC*qUD8Qa3uNUJ z;pTgi-+)rwii9Jm>z=B7oG3nZ|J>>0wgUHI{RGb@Y5)9Br}f>KIR&^m3Vf2IxiC4* zU)tgMdVgZ#GySdewzWphfYlDKX27CSsPr3gr~41&nP{2CYQ%N7`42l6LWLnnvmVSG zz6q(X#rMR>If9>t9R2*mCp;2=PCwdzV7RF^F>kzje;U zkfA<+Q`-fZuc!Ldrd7+W7ZX1pmrWrA;kPyZf}X=&UnA)K{Ahwk{)T4A>k#-1IOQ^b zw3tpk>Q%AYFxCN3Y`l`cwO%R#oc~nw4|V^vK`Wj6e?jwzR1t`!1^KcP>2i9J&rQ*%SRCNbA0nLY}{O zI&`K0(?#00=4)NF`_A&u@9;ej#j$?_@iL;N$65*<&D#)8m$ z?u%yM2A(`*6z}K7eWP9Blljof2wR5GwxZE3awG7!8(IV@h zYFK}IKaOG}DVQ`h6;97_H4hp0msfq^!(`PnU$U>-S;2WE^CZ7tx89f>rglW865{%HPUK^%TC4VXa%fg_iO#m2SoIXIBB+r^0--!+wHWEc|wDNYUqQG=Q|) zwaa@MNo-chSYo$$ZSqq&wS@!yq*09#)Oei%y)jz)w$k3xD;Y3lyp(Z24=UF)Ess;< zI)AZuUFl#JTi%jove5vSV^qCsWMk&x^Hjxu*l%=j+kck)WLB=9M=Rhz%f>&ed1dUZ zZR~0Ft?dkduh%{gSp09T_$Qf)h?5oXr9%qb0R7+}c29ShwG3zkPW;XWS1#cJJ-miu zF%#40`0`MAro?f}dnkU+_H^FDI-Vq~CdN7C^)JAOmg7sUPB0s?Lus6tr~TkO`4)@cgG*MQ}JQeo&}-=Wmj7uRC`-i7z*NMG+Zd&+(9q znLANSeh=H5T4laf2%P6|wIgUZX1x}ud zWL3R|O$dFxrZ#U%YITAB78}JX1}+|7JX>p?jqq~e67Kai6UJ|^N;Gox_-0;G0<5*- z*fJ-`@o_DS%U&!mJF_RI-}yBX0;bxQn6H4yTKj%+i(h^HPd@nM?bgls$y=G&0RUkC z&Rc(bV14?AeFn=XS>>4h@ZDN#(XL!`u^ay8wCa+UFE#Ol>x9R-7)*c{b>;1ZvVw=i z2CFTIa|zs}t8IDSm`&a7=A1sXHB?E*Qh06*Mt zB>5eY_SMmoNoPx}Yfr*^iZvd~Nocu~vNi`3B^0;5XVehDZ7WHau*5)Ep6s})L1=Gm zmCGCi>fEK{j+pOz8Q_#}I1u{t&41}c&AB8My8Urbg7cW!FYawci~OO9MtfRttu{7e z=@?lg>|EB$D*mB`^Y%2Zp=RDIp0y`jX0LAnl%vFLj&E!QbSfYDG@Ux{s zWneSen>fRo)Jdb-?BeVh51o1vr}kW>os6o?36Cp?W+%Tk?{7-P_wL*`+vXQM`KwEd zwl1eJ+MQjlYW_5z+k8CB~16694OR}3L;~t z#)ndYjMTeB-w*IWyyG>UoR-jH9DqgQr&ctpZI|ZIjiB@?6AX6LqFzZ8DA>E61)&Ox zD^W#;>VD;_(Ebx(VsoMT(qdd!G z#Ly~@KPuxBf1F@B+;e83@$mt0(fdMso{RS`!D-_2IEpqUiA(U}N{^Ku%B9Ev{$z*x zy9uKh+J~T9Sp;Y+^gTN(T}4(Oi`+VeU(yPt(+vI58l&!+Hv;HbcXz+T47^yDtpbcR z`*H2cqcKjHrkv#0ZOh%h>x`KFAdqGkm#`?wu;uV(R;YLY35Z6`DSm(#h!0EqoE28K zfk$igY3MV;*QUsm!2297n1f`AH1Rj&S$^s&`RnD5n3^%xwq`Zp4wrAlRXU`9u)fSs z)+aSg`3UaecEFq6)uMZxkP&Vig`hBWR83L6cv%w@Kl5`v0uG*y_iF_kuQ{4IB%i^d z*Um=Z6EsQ#IzYi%o6&`xmcy8j6>qWgVHHQo^G41A_E>MJM$z*mG3bMhS$I@pup;Hj z@I41#R4_A_-&8e>2pq-&6eJ(^-SpeUjvIlNfr~wnNo>t&D_R0}+E|eR0|&kuG+K!@ z!Fm_FlC?8+{U3ZU+i63fIHqp)(6G{)pkC-C9ik$taym1QU7nmb_QgnZr~?v@00Vp- zBFFZViu}>px;#fkhh2xDX28UfKl$W=-Gm8M&r-#o^yZV1BsuMEM3i=dE5UfTU<0m0 zAlvyZ|E5!Qv!K=iD4cvH0YORp*nH+#E`$LCzN~yEf9nMGwrLx1x)9b6S=dNae9|F- z0e{5O&lco2>qA|yKK5q+%^^V=wjyQljf(&k9^%5L2uO=__C5)cpDjz5hOyYyRKA+LX^3;t<@&##?2m_1(X3D^7 zHtVrO~4~g~ylj2GQ_uSNOEWmrMoE#6FXPiCi-@Cou9s$dnWJ164_B*~; zD;-*$!Rh(_h6u7k0~UKvFT=^byIsGhKe+CCdGoX>v?tXP{Qe|4%JtAIC3RvMoIG-h z%DuZ)zL%3J2KS$9QK`={_?&z)m(QE^;O||sBoQ1vmNxT1>w@KN z6a!COcP^~oDSLlz0d-cRD@H0iobT=d(>B;0?+NBGaWb(OO%ighC*nMucCa__Q0bO= zk!sck*+}@ZsOoiJ_FUoe!u=UN|NGIvgiWxd+fR;H^0_aM@MnBA`aJxupsQ!`2gz%X z>$Y0KLmRw^e}+MM7}#u;)SE9^c8GOa(mlrUfy2tfsP^d_x2&Qw<&avogspB;dw_cZ z;5eBx94!$+d;Qp)9E`rWKIUZ^PQs+Dr+`P-O|a>|6)ScOUEiRVA|ln@qotagxgAir!h%|jquFt=*>SmCEf2j3<(w-0khDa` z9W#!bG0qR&(s577CY8x3!HsfJ$|hwPj5rS2dO-}c)xt+p*pBI>n^-fa806||WiU&d zi-^0^+w=97EkM1reh);+!c?9hV++$GYEtKR+}l3E4OdBCzXcOTN+f}jLa+`~p+tGL z7|k?L{|;_Zj?hDk-k=`?2(zt^I4#J&5|xYs#4cq$YVf9CvdSPkK&V!W4HM}LC`c+O zt_p*%lw1GH?RZw|0F)cpu9S#Xd{evlx~b?qAQ5^e0MWs>;2+(m7b1A+Jjc>RB#%Kq zV+FMM*O%_LA!FIdc0_T`!RGD-E^oO7e1vZSg@h4OY7I$&~BKyzxy6+at7to z8yV>CP*}@dD@O<}=}>M53?z{xLRW~)1*Nr=&LCK4cvw%9uuz79_D%*U<*?uQ>#lQX zdFFqlQINKITotUkLyhJ1EnvpRa68$K3AD@sVJeVmA{5S1Uq5Bs=J*@S>hI>?fws41 z6J$*kLF;&aO&0>eN2K3PM(t;-js^I&j!7*@(EiFhx|v%hcYphp;N*)>g`4WE46P8BX=XCM#W0`d!m+Ln$B(qCg5*Jmf=0{O)K6m>6+cDdJivP1{=r8dC zynl)RvxMlM5dX~E{sm!3`Y(uo&*J`5{GUmhzr>p;|0Vv9l+8a8{+Yb^3t@}uPX+!{ zD&wCxf8Wsf3+1z%iWvalzin^)Q~aN6(Z2vvS^uWS?@95W!v74ke+fTv{Y&_7VfUZ% nf1iZ^k_G_4=KVL_|1~Ach=YE*834eS&mYK7Po3xg{oDTmS&e1B literal 0 HcmV?d00001 diff --git a/Data/eng/Health Management Industry/Glaxosmithkline CEO msg.doc b/Data/eng/Health Management Industry/Glaxosmithkline CEO msg.doc new file mode 100644 index 0000000000000000000000000000000000000000..02a26e2aa569019f42e8f47409fcf21ee15ca8f4 GIT binary patch literal 84992 zcmeEv34o2&|Mx>eGWMiwS5cN3`<6&!-$x7*;?B&SnQLb59rw-{lTb;8EUBcDvPH6` zM3#^urEFzwK@nM!iX?eIpYJ*6xz8P=)UW>U|M$L49d~=4vwZjMoM-En;`^t+cH;pn z$KM^+Rn~78ud(twzR!#I)6M5%mNgUa^Pv59@!~~({UX{+X!!W=-+u`Nj?Z3a4PARp zKFj*K#2VlZf50sM3R+hBR?8}4#SM%bc;DCeeJ$UH{c}ye(pL0#%PKQIkF){Lh5dZV zhl>}B+TUI7y}4kSym{(s^_j0HOQ`q1_gc!_j#napAM=(}U*`52i=TSp_XNjvchk@zWD{<=>UOR>pOw>tKA`IIF&8-HFdjaer&P z=KM2oFyrR@y%Od{gqYuRzOrBEpXtxMn)RA%`1u;(;TPOj8eeAJq<+cy%5h>rPdWR^ z`I+!>{+WK9-(AUjv#vkt@2~cMxjC5r44e$TEnYOSS);-qQ!vV(`Mzic;1+l__nF^^ z0uCgxVxT+xZ;}4^XRiAibiltnl`N|rdY#o!eKxBx+4;BQ|4XeQ>moUeu+&Fdfa(;oAx`9~Mw_nhOH&j!xs^W|R65C)GqU;pU$oY((d zpA8*cZr+#s-pu#UzFw|B%4Sz#%X*`@Wiw3sWz~iBtZmh^BJf|vMwj*Ds{QlJt=szEQ%hX< zwI!~0og-=kvSPR*bcE&E~gUR;%~kUvmF4m-X>mcjDgpYad_s^&9LZ4Sfgk zpW8~pyZdqF{p;U&@2L$n(dTVDKYPbz&0Uf4*83Qv$Ic7T3OzJCqBa;2)dHpL6_SVpXzZ3Tmero-R}!}K@|np61O+?wIQJ;mZtncF^Vb zxiSLo_!L(besH-H5-?2A>q~NZe1p9Kzc0<>%ZPL(d)%q~865`Qi5?6e@At)H$Y4!Z zcW;uAcY8PjqFt z14*6?Pl78w;7(3Sgd;nvI#JE9BzZ43AHB=xW`ryDL2vy>M#m#<9YTWH%6ixh8v3(>W=uMzAl} z0IPy)-s8?ljvFigtH1VMOxZbe=-BO z)q030J~IPLb;TqC`JO;TPWtksrKkF{JwOvDmF@;v`F-vTz%$OD393!@V1O)tAjK>O zABl*7Hx3;oQ6=fp8&O| zieD1Fz665Po^?$Zr&hOi?RufPknX)n$*E|RBN@p7e`Zp$A~cAh^vt+ah$zw(NSn8F z7GMcbG6%-(0%_rMH+u1*6G2s6CNM+pQ8!>cMk)=;#Dx%roVABc-~|%0Yl5|b;Y5Et z_zx0;q@f5W1Cj%zMJjb#l2B5=*lbnRu zjBJ2Xf%a?Ly(8dAxfB4z1Tb;HQlgid(N7@^a>08y?!_vFvHXG51c)!Psn$*zK|si# z1#KCK6m0tZB061JQ1aB_eu#&tDDVcT547kRk`B{>C?cM{q#r-DGLfLI2j~{?6o!Mi zP0tJjGrgj@L^B4V&f6z~6tkhbeMylrt3=)|R7lxpvjgZw3G(Djsx@sPP~kv{X1Fk8 zpQ3ND3#=4c2hs@?svjs7Vd9qo$hRJF0Q8S9fdUL@Zs`x;E?#6$T$w!>mLM1?EaMvJ zkE0Rb3VKqpY}yY>PXK;^eO)u}I?dWH)qXya!4o9&#u|Y>Kj6lw1%I_z4og&AUSi)C~&^69rkO zc@iKqi5q>JHVP>zp#8`SwCp@X+^{47-jF?srNd0XmoP_@y<$a*C?|oY2Rw-$${h@! znjHlg#N)D-{yP^{@j2j#ZPR8V*S^O^8u|AR{?Lox}gQ0ePFbcCFb>pe91q|w55}<=+ zAp;>sWKvivPnkY1#7u5NM$x@LL!nPDq+l2f zMignTsemfWHM3sb#;!DPYAUp+t7_$jwQHMC)u@U=BigJ75-^Pfnt8kwcyHLqT98{Ao&nCnLx#N>b)v3z#jC zQouH;g3P4#CTIdA17vwzko+JiWt_Nz@c}TDFPl~a89T%uoQ!4;PXfjQlF$jeO>+lQ z=r{onWGInOz(;&C=^EBBsWDAtC4{)xGhPs7Qoz_PFts3!;ZKN7PVBkUK~t0-m?PE> zD2D{NG81dMAWSm+ej4tMA2FwNCy&z3CGb++nLcy}Vqo_zp-)9h3iFyG9=X7McC__QnVE`p8z}mFzvi+GvEI5WUL_b=YP>D(h&S3yN zkkKCi(C8R)sgi!Mp@q0HmXb*#y7*%-GbstQ3(ldA&*@;cr7-;u|E{^_npOd)foR)n z|6#}W?HIv+pTiaYXROiOjL`;Sj0(Wb0%4a!v4H}Wt_Sm^(^zo|1H@|lsp5Emn?N;b zuxK*Dnh^2Ie2b@`5k{o14)PT$&Z(9a`N1@?%`XaGrM_svh%KazR&8!c@Fh%I*d8$l z0!5N@l`$6Ldm{ijB@-1Qq1u|7G({qlD1t~ga$PUl4z6}8WEB%gf*pLH;z5i9%M(@y z^?fH>)41B$s>W5dQ=4ic{9zR&h*J%gVz2Pgj*wAK zW{>oO)nHyQ(2YRr)P`ct;lwBjjM<9Q4?ix09zWJ+uir68LMPE1fYq7qO@}%MF<^Q= zPnIhqGtLu;&rJ10iH9aH_Fnzk64ijB1qi6nsMmSVVBlYjLir(N`WVYL%`Iku*aX@P z$V&E7Uy18MOJOkFY-K29_*K}BQ`8m#rlu?|NTADl89+R(F>%1Diiva;8kPCN;c-K^ z>ZplWAuv^-DiZ^6sY#Kx;ZNHhk{1}%aVdv8OYL-7&7^H4Wm4JQDW^Os8!?i2cP5py zc#0X~^buknUowMP>b8I2#3@Wg9OFMN}k z3UR^?lo3Y;2-%;wHitQ>W8T0ZJAog;pk6SNkz5W$V!%xhcHj_UF?%eI!Arty4_a zA?&=6Sx8&h0Y%%v5!#}ZvKOo;wWlUuSNZNm7Bf9%GF)8swFSTxDZFp&PI&{z&q#SQdZzvRyh{9~p z<4JK1_Ik3QVJN)ZkP84K>|F>rkcQKel$inK2t$LQgzVr^JB&I+rQmu4IEeLY+c{)n z+OsA6oMtA7#O?BBra@N-1w-Z=`eneIz6Rs{32~C9(#S@P+XMQCKICb+en(XT=!tM+-EtdZRS>W$>Phg1sX_^$17FEr8YF@k2yv)> zkwHPkl@~TMvxS_Kw3cLadGr~paYKKph5?Q>hP!1c@k&WsW9AO^taYE&}a^u z*Y=mm75_v;IVv|Rz9GPB(t>1qmD6!p@o|78>@>yk?yw1~I6f4XZxSM>@bCdI(XDn| zQR0nYI%abKG&}1CImehf0#GXT3Peb>4G>B9r$g|G&P>gWPhmETSrh_1B=B|8L1I_w z2&mGe6l2e})oQw;ZQnhly+J6UxFC8YZ48DSgal<5lvPIZ*=B|@cVK5rDws5->^K{L z^hQLxOAao`tS7sXuT(S|F)pkXAP6!;1JO$>UIz@sbD+=y-eWK!n0<~Any48+3`Kv?!hga}c8$Y^jOU;v{(J=;YX z@+z)3APU{&+FTxlaUhqKy~i;DUfhoG4+5NsyD2S_%4m=w1Vq_|I5Hrw6{iC-kjUb3 z)^wS;G9nW2Mu8SEI*m_J*E$rIi|4@}28x*rbcoeSVh9Hq5pVksoQ@6@2Kff}GZ6uL zgAu_HPhujvV!-@*MGmEz zBbjd%2G=(k{~Nl@3#maE1M3h621Eb=a=LVmG|iGH&D;SDm}QJDAfXL3^|XCt5+691 zEQ)kG{7ga|lQMw`0Hjd^r?_W8k8G~l1l|yn%uug@1~U%KUl7G8A#%a`amFtUagy@9 zl3Spc1@Rq^1dSUWlvr)-+`&+yT8wxU0Krv5Oj?EMgDzs3Nm7VV7;-9oNgSJ~F_nZ` zt;iQBv%xCoL@!q=i-7h<96*6oh)A(EmIawAVJxmXL=u#%tgPZxMTk+pD|d*(D7O`8 z%N9Qo;%JFv574Z~N05h;62eRHiNP4aTRe!GMn$ZV<31QKei+(>qTmibo0qE@v=JhgCv@(w(Q`$6#?@=87Qakq?9uin%#! zHkcqmjzS195f}wRB;1{7YzUQ~6@>^)D%un|qGAb&&hv+Gd0 z1(e0^-9eS1$8Urn4GW}<~rXv5A=>#h6Cs&?*aWH6p97#`);?i60`tCEDHiw zu@oEpkt)u|F?g{yPFPl>99!i2kna;=$~kDR)4;IpK6J`o9RUlaYnfLyE&u`x&=DL1 z+DQ18_67$|a}NYAlT!V0u#8hk+@@LtY9*!tFl8 zx+Z7|t2+sWBvK3oT;di{{66RmTHWzp1f|o+rigLfF2szXY(7?uuAN9t3KEob(gPH1 z27C~`SWbWht7>7meqi)}%#Umo5z$GNLW-V%8>yTb?G{30g(vpO!NyDxZ<=nLKQU2- zgt-o*eN`AAC{Q&`DuhQXM+;b38mT!XtY$lCUkx+~v+lhGiZP zBM>q>JH-=-Q+78AJr3)n2dYe-P!foB-na<@i&seyj4M`FkFtRg6;}Rq3NMTo)P##zN_7M0CCmNxNStfWTPHUVc zCpPS27r37&HAe+S3xgP_4Aqj{Ll`b<2bxsHc^a2FFnl?fgf?i0}a3!GpD8Erb?1@9U9l=CnOTb|;s)f5L3nG=bRk}4A zwKgP5cHLUn@i-H!j=UO7W%0e`9oDR|11BnllV;ghS|@B@9M@1bIGI zh1;c6$f2{~k6Oe|&B}NxAb+W^DNA;BYGXT?w3t}K563zY{sWhlm??IfuHqFZT_ia{ zt;(C!Bo&7ydXrSbf-ntvk=kzrR4!#HharWTYmYLoTROTU0gP*LO%$^%D{|(U2B$3lNz?-^u6)DY8(;*P0z#hseM}kl#W}gI~CzV z(5L~h64pAxKqePbm$)wmL>7et%9d8D9*a`xWkAUUp_MlT1UjpEH8==uQ!z!Dm;ygIvW&6O zL4^)em4#%tY~*X|f_B~5!a?^q7OPdFI~$Y7#85)5Xgnkl7|28=89)coPp98uMu5L{ z$^g5ipaQTfM@Hr9oxySAV9+npXonMk$wLPEkWmT-nfXxh0ZbZo2*}+-lyX)`JcF|7 z8)AV%<8V;)9v7XyQb7#2H;tFbiUp|VDg-2modj0i>U{&G2O2+uCOWFHD03v>^hO|R zcJUttq?icsnV48JqP-LmlU#IlvnDZ4Aw+?QvA`q7RiJgT;=)S&dAC6t)PNmv{{*i$unN3`Lga94&bh227{~I1QH_99La`;e0fWxzQlwT;gXz8dm zFu5tBy~~{zid#smpZ&>pIcQKwXl1jZY!kK9)TKF7XaqPoPiM64fQBK$@K7E=sSRG` zTGBSKgCzV>ZvzXneWjR6Ma-pG4+GK-22qhXxMY#~a1>J0@d?SOIzT#}rLoNz9lT1|-w$hsmZJheTegpbYm7$QdoNbiTR_d-A+ zLi{1+rS7CsF$K&KqMgYZI;5csPbhd)-U1%BP;MAu63YZN?QXqe#<_=56rn4EtOfFc z`6pzBDtFrax?d4My39Z-47BtC75=Trvc1LJGKGyJB05tz0sgjOKsPU1loeD)0=6c= zm{Wz9pf6=!wY2v%bTie?Y8Qnru28H@RR+M41n3PY?*@!cNV0+kA`r$bAn7b!3e`+B zRxuQlQG+^EGMEt%;Va+>{mOnx=82%Sm|QX2(xhjyn`k|XO(f1hM5Yc|69a=hrUnfz zyR9wE2w+M22^kR8dJqZdNl%!%Qwf;-l$~=31sAwvJCr3eGqfCuVd<3Pj|I>3Od_$o}lbFIlhAy}iztotjWJsu_wrzAz$P-MZN0;_3 zTerDPHU;t0Yyl(4s!r`Frx~o(aA=k~wgA~=`yL=Smb{T5>6S1UqEhd&GYp;E2@AcA zM*MVDrUSsCA4IVAu3DJTL5M(9hBEg@XgU}^62F97f}&YDu<{YK5TYL8t#(A85YS!( zwI&3LvV!cIzxERA1urpD&&n(8UII7!(~z^2olkn76nNg=)ga{S^`&4+*m?!_M)6ff z6sk#J6@)AhJIf(?2+2{)jbK~G736YGkEw5nEzq&d5AcO4&PDjM;6R$WfM`@s1<+IB zX{FpXnl1_aXoFPkRO2=;2yjp>FcwRv0Xu{R5KbJy2m&}6?a^T)q6khb^RR}slKdon ztOHns>+efqCXw_H6(>7`+OQNi(p-*UW~yJx+fX_{6`7do86sN-jDTfdw9?@J!03j1 zh=l@(;8Mwah`9?t< z#U*iz`Jr4eg(jfs8q$E?Rl39nJSf0{z0HzAyONbwkMtLl1g>h{V(gHC}6iS2qlqbRj6+Cpnf?fel6m$ya0a0+y zF6P0o|11d=sU#sig0K_%0=ncftjn&1(F7uwqg&bDMfIfKXD~_Foy3;FqE@KiI<9E2 zekxs^+lWmuNwwc0%&DXoL9J#7P=qkRg+r({K&?+sc_u(H0#C@#1;}BsQlyEh0P%(p ze_=k0iVhT5*Wq!86Ff#0$%%D9nnG5J#4#m+zc=yBfIt$U1I#6uMamYb1W_gom_vOa zb_w|^bWb@(p%031==PAPHhbX3>2XL7z$ML_fYd+~XqwR+b5Nu>Vvq{3J*c#B ztGY*-r~0G>(iinUHXP6Z712jpVVDP#BlR&Jflm-%Ff60uvZMG)j|snPz_r{q48od(<*U8>!nSr%REW%Sk^n}smq^*ek`Ypvp(u$aGKTE5u!Klu zV;G4j0Tg7%cXN?*S_X)bO{dw_9pwNB?e>B(pkwrsHWok4F^tGIY&DY_x5-M0na!S< zUMS=W-6%n3Zuo>4(?vKYY#NF zY{AR~8M-s9A!Kn~ZNd0K>_ZLZs}Uo{q`GxOzYWhYLTwlQEugPj24gWQuD79X<>1F>RosW_+N7+@o`vb&snYsuXt7Za7? zLZRw(;E$At9z)I_FqjyCS*wCDf>7KMMn@90SD`t;T>7WbQ2Pxe4n+}YI296(<`$@( zF=9jsZ^sY>J#A@$AS+0P`33x{>_0yD!Ggy2q-6o%+dH*Av7UTVnT&`CV%2M2z{?od{8i-7w+ zxO9-v&R~q$r%gmNDul#|lvEMKw&6-DXVI-l9#4F-+Lp=WC(F~tpOFZBTqZISW_H?u z2R--F8i~demV)DZ01L=3r^Dlzvu(Q}1~3GM7GbAh1f~vw2!(|rI0Q~2IdP$35|-Bk zH*z=#-Arug&X7}kn9=1Hab?)rwkIY<2}{=#gHTh3!d_f90`54)f_PNksNZLHWU8HT z?ra|3z@*#Fldl=hizJfE(MPfAw;~?|EdUwAVy%UB9!8*GhhZ_ zLP8lGMCpoJAQ5Y{mAH*AincJ>#~D7xw=hvdPPi>-O-YHVNTEw^j&uOQh(|2vkw7G< z%^Scj44lS-a|V2LA{RW2V~6AzBMu%apWwy|bLv1S2&Yq$G?f%zB*0ad(qgPo2RoGY zn@O1iX+gvpsYAjL5JD_4cOelF*nW7WC7A@6VB;Gx1x3#^m`Ky~~_NPbs|^6T}6KYnT#O!r*I91&7H2PQ~DsH%_NON7+?@~Pzl{C zpo7%Fh?Nc+W4+Nn%QcGcn=Kjt%xrO;|yG)pmtP0K+tpoa?@XZnF6DQ%a z;l6I_ptvgz_b~#i0(?B(;5LdKP^242Xo#jI9q1{6QbN+0RaC(!RqSW0BauBMXgdqS z=pStw8kIyY&1@7~>3}m41B?K5swk0HC}auail8vD#z3ZG2@^AKrFyhoeG|4|!4}z=Q4!R?dPphcBfv$tQ^Igkejq17 z30I?1)(l91IA^VCRf#3+}P!ELI4>5tGF6{bFDqXH9PEypcrc`8!<_|}4cwM2DfJpH> zDmTRlmDzD4r5sfi3cQ27SV}MXOJ1XRU7uhOf<3MY4_IJS`9?V=ke`ZVVA(rMwm_{= zHG)eugsp2J_N9&szd?N&gF6JSkV56GY^93OuWYJS5Y^5OloLWuCOtup_?=)!Bue5! zHIJ7lM-i;_{E_t(Lc!>^@FuKnO3~qX0igUKxCsG;--Wb~s*2P$AaI+LU24K35+qQX zDw7uGgNp2c?g1sZBm{-#e55{g(w^hw$n5KkIpq|^F4uuRC|lXJK8=L;VIo8hj|)-9 z6k^LH#xNTUaFcNfF|8n7r|4V^9rgtMiaXU=d#q^_L;82nAcSFpm?31_h!%exppYY@ zxBz865xJb9(KkZ=q5OvgXG9rGHHlLLagBEJLnN1q->9UN1Wd?b?ELZ}9I?YdKa^>$8}IJD-abK5i}-XxbP z2oV&EV`xKA*2t@*Xv{dTyfD|mHr+xkopNM7ZP#3Mp!JxO2Z3MG_~*GR9KA=p$2b`{9LXf{RHsjWpQ ztF1+kxmk`g2qn@Xsi!MVI9MqDk~1=+3=Vs!kiUn8Ito|lyc@f)D?&BD6R1(vt3+vT zxonI^7}Qi6+JZDJOCtp!#up~vt2{U6r6)r>Y53*a)*scv2jT zgb)(dv0;wk*rv%E6B|6jEl^1en&8C*PkCMoX`%zRcCju6Wq`F|aD)nB6c=bm+&QHD z5YOx%;&w!lL{2F)sq^W&sgSoa5cEVKn01U<$DA-U#VX|=Xcw9Ru0g0qjgl(|!lBl2 zt;kE<;7F43E1f2kKq9+yu#|{65M8XP;OFmdoG;5kwdXD*Z3`N)%b=iG`g-{sgR!)sI|0dnC;=y?hUoxwiVQrXf_4H;0H(|3WQL6Bhmp4Uin6&` zI;8u5X{Lpfq2(0?##dadt?D?O#g(8o?F3>vTq@X+96O6avkR3RECHaj z;h^E6z8qO*t*K>CCXO}`wE;|qDgP0rdfdjPUBy*xkO2HG00_5yU0)0dw zact-ZOG7j~gXsfJgp6WHXqsgNIuRw=Y}_WHNHY-jI~x`!3_xW<_u5glt51X~^>8#P z&_5{@f>oEZsm&UMYfhYlb2(S}8nt#t7zl<46c8avB^J|gwM06}kDWYVo0ixW2a5@j zCzh9kiqW;1skZpi;#A!64_U(%tz$YotBrFo9dXHG-8)Lqg`2|b6&Q_j@S7cOgR8=b zE3GtL!hoCgS>W{WK=D{QHcuGE3*xkOKNsyFvJm~^VkXUO5|d-_=mi83;bZ}iuI**~ zh5ZAc)IxHAxs%9w@{H7Uks~v4RwH9u&IG=rXiO9c2vG-?@k$p{!Y7bZGaHx?GNlZo zuNa5n8F6gsN95w8;7lAqM)J!c2Y`zvc8$3zOq5F+hS!Cp6|XXZSC$zWBUI$H(!)Yt zyv}LAEB&IgzexDnj)0&|!n3L#Q3YucvPZB{K*90D;!9%u!pVU7r;cUTY%R16a+0EV zfQsQZ-VF0zMTCuU0$SkrEzS4cVYFns%mIEPO=ug!f|3*7$ud4T#dnvxR4Yk~uVHY2G(!SHbf!oMwP##{cGOAiBFB2{0nJ*VWZ|ch zAmu~=lpR19z}r?vrU!ySRY8Dj2V&94A}IY}@TMgrhtkI^Fj^&bE#g#5QUk(JpC!PJ z1>hX?4kG~er7COS-OL2y7c&Y{Z2%Z$p9yg|u_RNJ=z^f%KpLq6iOT@8&I&Gw8zB%0 zIHUSN9a(80L`X=jt-|~7;#Ql3#;kYf15p6ZK{b&$t01rip8##I&0Rnf zq#B@%bo5Q|pyWzyHIrpkA>aLNVgYJ`dr4tU9z#?HplaLRdwvdnxZ#R0=IOu8c}mA|=|9 zrOoE7mxpHKSzbtd@E1rmZmrO70Xr}1vj7;l-Ke2bc`+rrSssWJU={XF-okOl|73_c z(~S^3r|Ad^^CQm8$D#CM%aRN!0VKvpa~1R;#tC?fH0OvB10yB7w~OxD+U4q7-PO5u zx3;a@#B}Q%9b2kkp6j@QgF25(2ZD3Pz{sj(6LUH`20_9UWNu1^aSvx^gHZI0umy@N zarTZ95|9wIVKY1tlbn4SQX{zVV^a1c%v8dCtA|e49!4Y=V<48G%nQ@^ueMnRYLC}uYhK8a} zJ3zt?FNv!HODxp`;iy_Up&{+S(nf&DRy)7xp4yY7B;yzC(%>(o0mabbJhgDpe893r zZpOoul~-@fD6>kXfRZwi>&StXCJ}g!Tln9WDttPU`mZIPDU_z49K>-0eN0h z&`Ou*4SDeFq^NBJ|NFaO2@zP=)r|&7Wwg=3wL|)E*(!J^5nQT z8sBB1?`%9}$%W?`c`yS%MhW76j-7#TLeD))#xtCf=*2 zQKpO>FTEw;6K51Y?-tTGSC)ahxi&NBcw8UEH+;TQgjLe&Znd+bt*&@t6k*lZs*Zm< z<5M?0m#VeZ#)`qa&bT5L&+;p1<*}~AUC|gZ9(@F5WeT2Y(x(^StLIh)rT<>|_68SW z=fW=`EO2EB_)gu+JL0h>59S+``;+jS8{g#|#jO3((VQ5ORWrwoG+BVW$DA-6eOR^* zTUefVBi@3zXF0=)?P*ydSY&i)qOP@5$3}nxxo=&c@Mnh!O=vL9j}zR)DAFgn2`l98 z%usH@u9dWkw!O`f4`!PwBnFNZbVjwhz`oVh36LkWzaUi9xl>A_q0;0h>Cy+2Y+s7t^f>Vsm&?gS!8Bs^7Wb?;M6`W_>DTD7A%xa>&s$dtV6+V7# zpnxgq4CaKDcvChtuL*^sWRYRQ6^4{P>77YMOj4g*r-P9|K1>v|TzQZd$XL+;BYr}? zvKNDH8{B4Hyv1A`pznybz(K+da@L4rK6Y8n48k7@zsFZLojm$IDW^9>vH)pZ+K)Q6#d{fOOOZ)yu(*0W+brmd!b|U6=B0z z4=g)-?-B5-R*v|QTbxSc7YM2l+m#2Wz|H6u+dZtV>8(5F7XoI*`h8bjubZwH83ZZs7!bA+Qkuf~mVM5g=j2E8i z01+^IFUj63$#h_WBGE#*9DrL?ws4A>q}s=Y2!fP;Xw~IBfX)aL0uOVLgH&jG2IG^l z{~=19UT_IU?NgE&8$z&+RkC1;G>OTCe**=|9r`NJgN~J`A<%Li0<(udg-DnVulr>G zH|r{)RvZ$8XTY(Nn+G)^-G%rSzA$~m>x{>7f?~WQxJC7?91rKp0V0!*(@@eE{pqtQ z#L!TVlYu+vQaTk?rXG!gGEr=PlV{7AO>}CznhFJR{_4~W`ngcI*ou{_0Q!9~*ZOy! z$tZG8WmN3qZNTPI2~Li8ocI9f!I(k_OSHG_h*Xta3?0jZH-YyU$U1p2AB8j%6(DDi zY%z571TsOw1jwP#;JC_tf<58|h9wUXaN`71C~0*jjG{_%2AKkg<}**=0VA(X+r}M; z6EU0#7Zh0tW;h$v7T;Qj-XLQUr8L!f0IY3ra0WhgKuVoDRY;GBnjuV&qdpKogYxkp zb*|34gaLpoEE4Mtl?Z@2mWth*ET)nZqJ(CFd7c=;3UbI_bp#vWqaXR>NHkzcD%eiF zPh9{TQ!Pi(@0>kI-dXRVk21!@vj`w+d42drorYCFEoPQT-QdZHFjD{`0=aG#a1`s_ z9jjM(`+Zu9u}ve<1LSpi@Q=_Di!^Amgd!uN71d)JVzN_+yG>FQh=R*A9p zL)Z{%#T1EXxcBHT&}P;_=mlnL6etE743M)=Xs14MjDUOX7;qBO>hOhhLK0$-C+xwp z1$uakKHd%(4>zzvF>Gboy^Sy|v7HK=1h8=t8AI-wadspJl-gDOFd0z9td~q~RE13JnOiP#PNZxd6k`iN zBbSMh+&~N*Z{*qoZw{Qzv z>XL51NHCsOrGzwaqUva&CvhN)o$gYkraUk1 z-ExCjb^gBsFgZ%i4zx4w1=g_JS#SY$rDj9Kb)m4 zr=x%fp!1MLSDSb-1)b|=FpwKGplHd; zVPp+a35Z{*TLNqp)9439VJOg@a(%Qa$48uEi)sj(f(W>wOIW1X)+QX2?(<}(`QxF1 zVZYe5H>Mt3{p!ORUqm8i1Cb%OVjM!|(mGs?ENED4n1Yjw(o;w#ebjmuL>x+6Fhzz< zv^rIZHCQc}5cA6dG8`nx@QElHn~@;7lq&^{;c7F2+|YJo|%U1SF*vMpOc^;rU7e&&26; z?vlk6Imo$6V3#7RooJ`fP~C7%kzXur+N^VTb)J+l?8qcGpF@zNZ|mwv%Z0s z+F?xm7TUN6Ar{&J!gER_M^A0V*o)|9L=6;c+x8160=76#3FIO{lq3?^g;*REJ_N3k z1Kf55bpE}_`orFwYQ&tl%bk?)D1ajYsMDtAN`Xjd7s_72hq!onfS2Cc135?@hg?_o zB-dP3e`9*(=igX%P&;T}`b4KojilykQork#dO@UYl}X;O;qi-5YNaEj(Rum~V^mQV!K zCw5hz0TC|~GX-vq6tzlN9!IJHfuJcN90qt$scv8<{6u-5fJa=x-4H()^Rh*NBQX}T zoP>H!xS!p|A@fV?P#r*R0`}UR4Ur1QQI$KHkik3vB}$pPx;!Ejg;v{pX{!(-HebjR z$P#936EndPo`FEJUmXJuafAI@Ea8^3S+H^fM$W;CM&wkW7}iNfgxfZj$QHa@_RHga zD359^D7_B|46fp^V$#~_3hhn_iz5s|TMS8M(Dovxs7}zm8uLrC%&mL()nsag=Eh5k-MlmKs#18IzWXRpG!i>vb|S-I`m3I`Z91oFzoTGESVj2O%U%icJ^gd5h&f_dl+%{v~J zI=5xyPaf2(#Fu*hj}&v{7M_t`R;CIk3`nA12__p4;*#JO^>og3gz|L$WHy2ag*XBv zKpY9ANB3wRYfUJTteid)n9TU8f>@qbz%okAhhW0|?Np7BkRnbA-AN{mNVGj9^yFjM zhyuno*Le`2y_3pmQfj*g+{WuEu<4Y^TTVKsNiF0;-Zc@@y}7CXOJpB383E8PIej546O#<0rO;L$?sFihfB} zoUk(?3aM$xLX#Q|F*&S(+dk-l0X8%cLL1-Z;ia}2MDH4M*pdFk8B14|{}jZSgbkB2 zc={rWM&+4_q-u|PjHiuYeXs*;69@tqb3aNE%?xK!MTf?oi4-Jv6UtKnL=zNu0H zZhVMca0xAA>biI?yVB;O1)%{OOROrC+HD}uLe_T~Y0-s*gf2w$s$(H3`t_5GMdGrG zNw|W~&cv*7HRftSXIHLM-EyxPkpfI|rMWwY*hCHR!pu_|Q$(LwgE_)?8aIXlBGm~i z2Is0yk`hAp%aM`o&2wONwG~KwNfTY;j10X?g21jG6QM|x2WU%R#kBy0U@+xEOz5Zp zG<&hvEb(W_k{dG#rK%twb%Ze_qJ2t}%n$Q|eG%{EK?DyVdw2plKn!ZK<9#Ykk!y5< z2R;%E4lFpP6xJh@2z`rReuXp#vU-hkN-c$=2jxVdw62_6{}5 zCx3XNcy-V_BuY#rmAa-uBsMTGC&|#pwOwk4_9BEAlYWAYw)d}ya4)@0Jo&Sq;m-&DKa;Ht%wi95E4Mc!`}=?go-ni{Nu%X&yMzhMdnK1 z&{4#a7 zvGJB{ET%N?a(IqP5!g`;lB^x)SCl)HHW35r``IR?SS=*MPij)CG0Y8II@ zi^j3dm}F;iy=osBbh?hpNB>{Q8vbs8K33Qf(~ok)p@VCqJTG?=imN~xG#5l;z-!9Q zv}AmrAfY2k5;Uhmh}$WyJ({dTh?=E&!bI6 zdjahYv`p+G8H`q^sAbhf>s`#U?m@euxMkglRu-)qT6MG11EI2dxGLA8gs7j1|+tvhG5=7tM{&Y3;7b=dYS4h!?BQb#kSB zeZ%lu`W1Z8c^7Y~k>ifbjlgTGI|{ek-dXoGVVC{;;rD38MGn@^!VjYfPCSKY3&tUhQ>%34-4w5ez_(UzgTg;u1TWmQ7E8EsQ}%lZIqQ5DNN zfL8Su@IKlow25d>piM%167Bw5Eo&IsaI{a*zCk;Jb`)c>9J4o z5-)F7&o!@3@^HTYPdM;zmKwQopHmJQ>GeHAhRTXj#c<<6M?C9xdu7yhj_4 zmQ)$Pq5a}S-@hOJ=Kw;uhxordaj_75Oa49R;9tYDhF{5}-=gKKYFSsKWmba?fVQAI z?nfIEX<6B56>D0S3vGKX%i4kVOl{~CwD0R!)@iiVdX|-j_Ako+FTo%O{wa6QYrHnB zZ&{7e9!495_9WUgw3pD{YhYO$(8@KmtXgPw&|0F6M4N%OzA@+r?Ug2$^*&ns?Ur?X z*ScM=PI`6Nt9TjqYEn!S`A;mo8?4Bj7G5sW$%2gJm8Iq1E3l!;5H68X)fL zqP0L18UWr00_W9$^X5%0>+xpb_d6^r@=n+Z(Ux@*?K`wz(9ZLfG-&?*H-GraOp>qv zogW-45UEf0aLE61SVAlg2(&(QAch40YDqa8x~8SOmU zu^sk*t9Q&0|q9S1eQh6yINo zR15ilq4njE5xLDAvh9!OOkmtXevH#NTZz|_z?mP7_?wGX68Iwih`UB;i_u;~Tix2S z-bTBn4fwnrY&^6t+FRC_Xied(H$ywy5x7LVrwix@ZAT33ezd=r<*$%0|K36WYkDJh z=)Zin*C+2tAXYizV`ewYnuT^_EMhlkpP+q;Hnt~ZIU0HMel+su1hik!$e+dThOLKI z32iLe6KIprX7#qL*=WuCSk|3rMfzD*QM9|!dZYa>1K$7B1Z0qp*Ie;WJQfAch|7v- z#3ymp3+?$t`2J{plPs$r+P!E4(QZwJJV&dB)(CA{8f*l#m(b>;EkJu0?LD*&XytsC zRTHfaT3x?o)kABC)*kKXwxg@I9o_aa{^P%@;opfvCvNM%t-oXXxxH<4)j)pjl>RxS zV~>J)auJYMZu|XH5?xE^-_cc$IKiKi{eMOmS{2EUetNAhQ9v{h(N4nk}Y?K`wnXiWm}`O!|JRSrV;qxD6580`_X(t|DQ zdbF#vEGs|S5wxRdXNQ26&`M^*cSNg=7B`4zMGEK7Se87DvG}1#=v~FmzXg$&HM!N@%_&c^xCFFiTDREhHS6=7204juKv^7;Lk`*_ykufjsK$U{#SKc{Y!PB zQ@iA@2rCc|#nDQjJv0=uAMMLwmbD-4C$uwYXVHE}JBL=|0oeO!(P%BuTB5Z=YmIjL z5yTSEzS_9x*+m-{Z5$qlfAG=Hjhk^40Xa~{00FH_OU(l`}Zdql}Mx#{+eu?`wX#LR!pp|$CG94}EVaN!y zF{9uIpnU`y_!w=UriUN#+W%49gBC#hSKMDQ3@)$bFaJvzc&*T%Nc~X$Px*i3*ABo* zU$lGC433hO9|tX<9sT6!s+Y$H#=ktiZ(ICV zYkXfj$Mwe?BjLy^j$8aGE(CX+{3~+hPe-4fy1^-XbMZiI$mCM%kjv$lsfx($%0J_= zSS84hLA0#LpxeBqX+RJEj(B42> zigprhz|iXr#hV+{a@xSwCv(*{zyCLOmu`tbaVLhIWNxL zn|EGid}-A5gse9whdM77No4cq6-ur@!*zDwSIGPSpv6&`{Md4$Wi3H_>K+E?GVuNTq(MC)`92l)Wth)wi@1s?H9&sVGxEGKIK+E?M zV*F^Iqx}l{Ast;r`zy5k?>&D5+{mS335fnLPh60vi=$OTtB&>*+S6$Mt%wVuT_N26 ziWCdGhg19a?;nFeZuVb6;=UM~!F@K~KZ5os+9b3m(F{E-!~5lEyU=!{S+meUAN|no zMKknrbjRCspTvJd<9ED`|J-OD|Jaq+3ZCtswbX10oJ;??*;N0GU7CBZ z&h;6+6&9iR18o>~ty9P4wy;v_I1HA7+gn4h`A6?m$7TWNpYLDRp7_$$mC>p!Mo3`s*1ToV3Qydcw^ceq4*&lBcSC>y(^h!K zfcnd;Uln4HRxV{7x$4MO`pe6{6t(i5>VRLDrv!V9< zIcAkFn*HU^LteUwx8w*#*;iu*aaMs-jWLV-`G1|ZtaF)KTPA#W(?jEz?!T$YMXMCP z=e>1><328B`6`?$jPEYFa&*@&Z6gZZ$oWUKZ`Z0DZtIO!I1g`(9ntGEyyWlNDYi9U zr$0UV(1Z_L;$5DMZe6-tcOKrI$PaNH+qSYEySjWke7GjPU2o)QioDB~=jj?n$|8yP zVEb0lvB?jf*xPyh?1se(q!+uk*06lO5`kI0Kc3N`%?CH_y6J;FhYMC3d%X8eS09Ld zYu@7#KaZ^Z`O$XYMZG*UarlM8XI?zL@z~3+jCi)dnNj_J9(8fikSWIor95-r{Nwjb zIDhNz-3xA9b|%lsX#+0gI~#LqKxVUsE9Y$-d}3am!h@TgJpM_K2`?>~xqtd&OVdil z*DL+~$=9L|4o@ld&7Lk*n$910%V(3n+!OiG%0f*WUFbXZK#Ln{JioZYSEEkvh`7*g z?d~(R-}0X?^jX0QlZqFgzyCzx13$K`S!QI+`l+upsIaK+=6(UI*~#KNuI{n_>b-Ls zPWt@#_tumZ^B1jseSgN5QBx{LKRJAPzLph(Ro;(1T5RRA)DwN*-MVq_fliGcU7mH~ z)r9AoZMfs*#!2_pd}rZ>N;he`NLJjW*qN^&?&O zCwJP0x2~@N=&lziIMoy_g>H5x;$W+q`wF&Q*K( z7y=Q?B!xF_Z7lHY#+c>mL$@7H$UQFHdg_cc8@t9QZj?%hvx>oITr%9Sfy94VN! z`=i<^z1+*173hm!#(nI*FW>3Es=|i6zk<_=?vd6d7sD5N@>r;&;EIU)W#*xN*maZwkd%^3q$~G-C z>F}6dkFNaTgL34EAs->H3LdH1la+QIk6_SrBXsejLLx2Ap{ znHtmr>;Ny zO;O*L#C~~39(yKg)WJ4!k3ZAs;LSxluWj6+$Agc))9k}QkLHCMJ~n8^sL1!{k9xGp zskEUZ4-~rSs#0S_a)CyPC#uxk@OhDCMLT@td*{8V{)K*6uy)uxvsXUdtm%`Do;gta z;_Jtvt1rE9-^exY770^-+Ub6?=eJMvS#@?&!qWH$gJUD7%xLyoiMXgi>)RYZKKYa7 z+lu|#ikf&$AQsn?ybG~>2F%ceAs_wjcJo=%sO+!9a;VIH#+?IbXS${(;xjN-xI2QI8mKRV8qY){A*7zS!!*zPs0)`euDh+r=5PN`Ljvx?PX%e{0Cy*RKwK|4i9C z@?Srq(pMwXk7h--=-Xt#uLYL>m~v;OnlH3z=pHuwfoBeG^E~`|#WStTy!_^^jn8j8 zd0os;%QKc&I2d*Qw)DqWF5uf{=Wjc8&H0(*n)Lnn?f&`pemMQ!($55cT(=fcO3&{q4_U0N+{ zG2o$U&<7!VEnI_LbKU8PhItw)b;g@6^OsYD6}Uu$QFrC0!7#XJuot1q^5;*PFk#cc zbt_iwn4dl-HtWE}i`Gzl&*6VWz!y0{(O^M*cgdBxXs{&QaZ)tcmv6@o#0R6nHmq4b zdB)x!@y(ypVEK+{4Yp^^_^<1ivC_*f+WFoKw?wrIZmQAsw4nbsuS0izxlCS?tk%xgsJZiPW2Y3^b#f6g(|5CHf>vOhVe^-;+rXL>s(ag9X?&wf_rng3mf!oV}lUDwvS}VWW z$cg^xZjhX%shX(Z^|vJR!sQZd+!T( zE?U#@jlQ3(nOE`sw_F!C-nFCkg%%qhS(`H9bs#Yv^jeJtPgiKoVp{r<;VA)U6DGy{tvrfI9z@G4_%TL zRDWm24_!Wtt~V|!bNZ4UyGP#M?~M~>CoXvHj+rILt?qPeM%tOio^5YFH*jal<`eg> zZ??AI#7>QWoc+Phay!c1dZ@;6?!;qFDTZPErU?oedN#(|&g-IDRSH}%& z&GvRXuyxV*KSr%AF!+;%mq%^iQ-0dSp$Bv>HHHLeyPxO#kPB@OuT=*H`DdmDzWWn6qs7M^Dx4+I{QR zi4(fk+IoHIe%m)}T~@pAYh4!Q%^1_9^$UCI*ZC=;%$dnwH~6~aft|B=HeT@4iZ_n< zpL)c7v`xyr-+%Z1hS|;Mp6s~q_Tu;!5@A9V5c{qyrbXdYL&hk_1lbFimYA| zx9@P0zfnI6oVI5ed)D4@3eXL z-T8Y)joDx8|M$;?&A)$_Kp-w(QL6-W_O*G6TBILwJ*|A=wbFAf@(1mb4*%vaIR5|S zAJ_b6{{HOs?3?%emHRF?ui7xn{@efRVhv@mh_xWVt!VqvPLUX4n-)WJq18sa6Rj)S z0JLUG6^iTNUQ)ZkVM<&|J9ouk`c(`+bc8ySveTMk@$-mO<-@Hk|K)rmh{X zvii5nlaJ@K_}Z1o$0CXhypk@lm1w~C7xUt^a4CM~Uw*3#o^u<(vwq!p{x9l|(PT?- zi|Tn|I^@HdFZpoh%hkHi!qR7YGVctwD{S}7&!N9oR`h_=7pKENDh!`P{guWi51vBo z#`Anr<>|g%@jigYCkDImMB-%2h3EJ3iNhIkOE)}O_lJwGTiqPJ6vo`$RvdcZ6MDmE zUe3Dy3<$OU&iq!MLRY1#H&^2uH^0tnU5j3;S}Cp{FRsI@rDs+OQu0vP7 zxw!n@%}yRVH>L8yiEpfE-muI34lN6ge0}YtPma$$*Je}c7BxS3>(-xY&Z;qb`bWLr zi9L72;v@HZ8fcdHL5LY}x$7qQNrkOTm!I2t0ZX}bp()vu zOOM0?$Dox%!$D|io?4E7JG*^2hBrV8DZIIJq4lm}cODovJ!|5gM)51FwvJo!;lh)6jNbUt_80feJ^tM)Z!HS|DPK=cAgBEjx98BLbBmVWNqxwOWomA;Go{NA@J4{SEJZLcFc&Q?3v z`dE!y3gvB_`{ZkX-m=lb>A16Bt{k(gN2|Dp1`NAt*Pwl4pX#vdnaQ(?uD|=< z!`0dk@NI7W_;stsq*p8UbHO7UQoV2W?9*>doz6|4+F$1VFK(RhO3c=-PyX02aIjha zMWZL(w>By6rS>J0My<jXqZoyK2C|3cHT|v|{yr(Oay= z-;I2^=j6H{wHdMCi%s6icb*wEZSb<4^BeTNfAnu3Ox?Vo%bXplo+WqB$e&QLZ1Cr$ zdk4k`_pB>B@x4ahoErCW;S+O0GJiNVt1jzE`{*Htc@1>dAvc zDp%cE_*9d1vv0Wl>kr?m^wG8L`)`e1y1Hoh!Z*~JdG_0LXBSOt-g;xvY2};$eDvo7 z>%S_{{GJvc&r6&7@Sz^H)?7HgWn;ye&8H3j;qCKftzvfH=2GoSh8p^kU-JW{iD`A#)D*PV6qtgz)bWHx?v`+Z}}t!Vdtq0QAFu2|yml<%8Nt6Hwt6Xgz0c{*bFRj6+w6Pe^Y7nTIJDCZW#?AAxzQ}|sw&5uMOV!KQ^^W^v#BpOC{(x2yshPugKcU&x3>4Q3;J$)>>=Nx_45~wYEp06isB!YYW--R z=}Q{EcH2`UH(mSbfW?b%so$XBJ(U)pu0Hi#gOtX{2eiqXmUV3AXHgrjz5eJ;Hyn5% z;g0S1Z8<;JH}$EFA56XJo}y(7|FVC`m`^)=cF%Li%ckEx_Q?;9-+1lrLthLnS?f^o zrazSEdi%5EBdgtdYsam3?MrF!%<~ma588WXLwc7-Ha5O`QOD2Q#+81@^W>t3BhGh! za!h?9&Z#h(}-P3_G7q`T2JAch*cg)YX_o_SkMqK-N#>;Oss~P+5^g^?X|8zd@ zjRm^j?z(6H@atc$G#i4<-InB?^2Q@AXYHL+sYIzWH(z&6i!(1pK6~W$ zQFk}nw=%N*eDExBmo%6a|#lfN12?_IoEos`#a z%fovkwePOqs@i9jDqSdWrg`=I6W0tr z5|R1-+39cI^z)GEqoa4<8QXu!xB}a+-d<$E z_O1V?z4HL8;%N8y{~US~6dOqIC|y)Qx*!UQ3P=a(MUbwdfMVC!YwQ|(iD+UpMorXQ zLyR>>jU~nw^|MP7ONfcw|C|HS@M*4J?#=hy+!h#dr!K9>KOH+r<{X81?64WDwpd&ahuu`>$0-EWgUJIt=Hja7u5lk38g z7Pg^tmwx$HRDE@g$Lg8U*DY4B3pljr%U(~1R;~PgiKOx~tB=$4D$c-QLI1@K+kf>i zoRaNq+BWI=fPm8T6IAS0)gHZKxnxrx<--ZPcOSg`Thb*`N4&nd%F|vluV}pX5Bq%p z&D(D;e7jJdFSX{Hdu-kwdg0N44aJw*Me;V%OX6=HQuD^ii;%v4RYO(XH)XYtWt9}8C}7YnX;oL(qCP3mJY zFsi4chehKm?_9<;)5l^&W~qgrua2g7s#kh`N#E2WGX_vl>XqtakyBPySK{#=4xS9R?e-AJZ`0B zy9qZp;l{0uJZ_2a$rP0FjK+;77ao_p{B};~CYR1l=eReyxHq|UX>#e( z#q20CLqd#_6(gZJ(n4snh#?$tfkeVd^GG3SB!grV5vEvKPpqycR#+0NtcaC1#B6&p z<66wR6Eknb=zB2&TZA1+Zv#m*i6!wQfzS(*Nh(PvnIwz2@vj#NBja*`MPwsg=s#@G&!r zAztu@$@hA+DM#^->gsAdrSPB&Y2AK$(u2BeP?+$@HCySfRF^EXmFuVuv+Gf#P6W{0 zNFg6g#=9ibnZ--X<2tfs)%+oYo)_y$wOK(P+U3gfiXp zfQV@{$Dm2Dk15c@e#y0K*Kkmz21g`jRHGUs?b)F*SxLC;Q!;}YW0ay!mb^O*RfYGK zg7C+7dfJZaNDgH);kmPvgqJz8|4og)>CkL&o9qBu)`_bXkv312kkH>RRpO#Kh2XWR zY8trp_qtcIMEyakng)LTy;3F1>VJ@`rojMzuT-%_{!;rVn96Z6oTMGJmlr z%NJsU=J!WrvXvibc0^X2z4C~xMtJ2B;V2#$86=O0Zq!OrMaGb^WIUNbCX*>-DiO~! z&fda8vYf0WYsosYfovo-WGmT0_L7gu0rDyNnNm}xzeqtUlQCo#xzF1B35j5@XFRz|ZW9&WCtc#hvBQ3(2MHxD^f?`k=uy;$ zq=<|pSI8}LpZrLAw&9ZDt$9W1%bExAChkt{2QMJAIuWEt5& zR$0rJMt#o)*h4DpDNphZxk1`>0!)aJBd5lbv*a>a>qOa+2BPB3YjEXqsHC1q-6$*K zOEz`k1B7UGW$qzA@OfKLo_ldvCmSNUK5QhAx5zxQ)tC2z%nsm#p7aRfvK{0uc|vvu z^ElD($uyF}FfQ3gZiI6{4sjdEPEj&2mW>s%BazEFlN)JV;)NJxG99EYhts=>PA+9m zIuQqwO9qn`C7dow)L9zziCF3*nRr$4?KAmqJeU3?TPJY35LrB#-FzfsDjPPW#ayPB z1d&iuJfE^9lgKRc9eGI7*ho=h&!!rmxo?iqZ)Xdi|5q`7McSH6>CdE{#amXF9HuSG zw^)zkF{vl%N^E?RDP%E8ROUWu$?|PNf>@S&k-hq?CrBpCq9~t^EQ8J@-JCCPh`KfN z54lDjkc5uRSL7$6(TVx73-3SK0O9w{s4ly@?sjP)kD%e?!DL{+n)PO8ZyvY6~8_r`E2 zHrYOoOIndjHHVcJa_(;as4Y{gC>t0CD+I@CDx3@T$O4P>7dSBL^_eJ zB&-!{Z{}`45=ZQf`P3kz_++_F?hs{DE}+Dmyqv6cU~VC9d@=-*hpgd6E&q(9Gk0%b zj@D;wUm4B?7D;k4uZOH;j{c0)5?AJGH`1GkTrAYRbmmx*bK{vKhm#TH5V2v7TtmcN zZ7%b_a-X7uWGtU>M4j<#khNqGuR~mm5;e3JbXSsVY!oPN2(L6=ber3OZM0OD`!v=O zmJ)2@d*|Rm5{#nG<-l$nNz@E|+Qw6N7)3!kTIK{rDS zI(b@1i_wN=qBfFpw6V298`E0pV41lNY`kD%bu0tyrc(#IjUMt+u*2fM#eYkn*b7@t5BvtBTpFwM6c(z7RC5_V6$= zz|1ZNkoX#)B+md&!G?HHOl&*gAiu-VOT!3;+D5pLYJ?Rg#`xaP7#p*VVKUSh-6SUP zQZs?Qp$Rg>P59c_6z$wiVG&`9iLs_gDmI0GJ9A`pFh`25Id*!PV|a-|IoCBg}yD~Tx{VVYKw7>cDNpGhchvDEIsyEp>2<%P@9rpwTCa_GJWAy(<5-_y zl!phyCL$Qm3xlz;G#CR%2V=WxPyA}y6Q5c2L~VReY*r4zHq{VZPY%H-(_R=qq!)Up z^@eg{D7?(W_!*BdWcY-^C@2h`L&7kSjmw*=eK0M(4~&NN!CvEVboB^FPLFWxE)U1y z*8O1Q*$-8L{gB+hANF_Z4~_Kx@KhRrPt^vXZO8!l^&WtY5d+{6KLF-M1K{W$fyurR zh>4BBX4OcH@r~p%(vdh78i`w(k%&^`AQGo2EO3v4v~Lt1rAOgeSrl~IMkC%n8izYZ z<5F@o?xsXzL}4^)TErmPItKfkVvyHA26lxpxYjlno_4Xwa*c&mek_ia#$r_GI4I}F z;hZ!cdTQ|q)r`j}r+8RvCZMZJ0-}8qFf%d%pT;EMT}dJ|RFkkvGYM7tNqE9_ZO@q` z!?!XSxm-)LX80gPX{6xN&=k~@>FrWkUQ_XYK`NfLOM|I-8ZO$W;e>M1caM#U%t62t47iGY{M<$Z}vtVA8g~evM7-p4=UwY(1CpZ_G z(YdJMV_`-~E;jTUjID)(@mMVnV@>j56qb+p?0nqT8-gX41&9kSKvHf2mPiXRE~F4^ zx$a+=#6su}Ekt0uB7E&qgkIi7FbXY#-Jl}Ytwk8AS&YhnVm!z$Ms86tg4uAItyY38 z;}T>9mO#0p1jk#H;#5E>f^til_A(4^S%w(9GDri;aCBf93ay4>ne|XOcnn3*prN>5 zF%C65vWZa ziA^~p(IBmWjaCKT3#h=MkP6hrSHL@=0$&fRz=50!JgcmLvt=bVI#eR2q!OtnRoH1; zg)ic&prkVjA8~!N54pbC^$w$;V>JpniKFmI;V5Kx7!AjW(U?>;8mrq@Bdc3A%!X9M zv;7!|`O(@{V=&8LEL3`og>J-H3{D@5Lqo=5U;A+g<>NOxZX9Y`jK>Vq@$BdwkACeZ z;Aq?gXjM%>zwC+dDV+#ow@FwPGzscld+SlyBoqyqgbQpa{^~jzI&2``PMVC422*gc z;}pbuPr(MiDcGGg1>cuU!EEEVFtPA0Y->Fg0ajCSgpI=b;Hh}rb1GbQrr}`gY5WAs zG6_T=WZ@iz7*MVU#@=3w7r~ z$6y{xP3IvZZXUc+=RqxOK0b+?kJy6w_|f=nxca?~J*o?_qUA!kW-Y{}vV}M_Y9WTH zEy6w1MR;tr2<@AtrPY^b!_fbn+s+o4N=WG8Unr>vh=SyAEwC*KxVTb*w|yV^in#@N!=di_Ge zknDkl)*cu-?}0RI53Uc`gQczaqIu zKY_Z&KFqV*hg7G1T%T|s0t)uw=kk4+>aib3hV6%D)qb=ay&s{{gIL!3AnrOGM8DXB zIICHU;X1W=r&BE!JJ(`WRV}VMevUHTL+ECB2v-XZp|8OgSm5&o0!MxUKDFVgdKmNl z4kIk~Fct+LfkVa-7#19Xnc-2K?R6C8RY$SK`55MRKE^iDF@$L!$A|XE(Mfs&SEXOV z&GJiRk`cLIvVC$A8i6NKo_Z1;3r^x>|F6(Sath&Er*OpN6b?9_!hQEs=;d_^SA0*w zzx!$I8gv?02A{@q)ie0Y^9=F=&OoF08JrCG8ao5O#)=+iaVG67oJ-H*hU6R~T+SiL z;~cK0o`cumbJ%Wm9<`k>z&-o|m)iaYhH4javF$~c&5Jl-cM%UmE~04QMXXQ1h@N)e zVnOF`vDp7xoNjpu*BviGS@SY9^e^Mv-j}gF=`vQNU55MM%XlZ{3M`7R;2WK*SZj5a zeNR`>a`08mDZGkqovz_zmupy;a1GW;*Dxjd8fHd)hmk4Y;hO1nR6AV9aOdl|X?_F8 zwQpjy`%TQ%{s(Mq{()kbe;}*%Ej%*2g-_jY;c3z>WDdK9@Sxl18+98#1-G#ZcQCol z9n>4&fpYd8oVUG;Q7(6JCgCmy=-tCSzk8T0y^olR``F(80ctxwz@W+p_(As}*4aM9 zIM;{JcYBDW?hjGcq7ElU{RrDOk1(7(u6hJZ{l_r!dyGNKPw=Dm6U>r6MS=EHShsiz z2bZU8b3a9f?@wqL^b_LE>XG4CkFBxw7@trN_vD}1K6r*4jc1sf_YC`oJj2$}&+t*u zFEH-&3wCJyiunG&V#J_dVWjgMA-c~Ip86bZhCb(eody`&H(-Ht13YqNFO+02;)Hf2 zjD$4!D^*L7Oc#MLqCdK6yUCXNizC9&PhAe7LRhzm3M)Nrqy8lh(QXZYnO)Mjf2(nS zrG)NWi-FE+>_RS}0$jimu*3N;TxH&c7aI9l!WOUI8sGB0w9S4WgqX}?P*SO?l8Um5 zR7ts^Bd+u)$9@f22=pr=qKQH-$NOe-w5u3Ho5}dh_(rvmZmEo!ohA%N3KbQJRHCLT zRS`i8qbIjy|JC9@5+mp*jXv|a=jX)ORi#?0%2Huo8+!o9`{ptx;pgRTPv2RRF-r7L zX$rGdifzv-&*r*_sAyI+%HzoP{k80rVXS2wOFV=}eB|j?;y8l}W5m&d8B zLQkqn^d-fW1}g+Mdcuo1Q)M!er`ZgB8A=($VK+P#@nZGK?NN77$_{(kHQJAB^?Az) ztv(l_C?k~rn(g=|n(BKC-YMaxq}QHj{@zu%2ve*C*(=<}UAd#;{|zOuQe~ye2lxPE z#<;ov-b*W%X2E~Q@D?{3jn3m*iug}VOT?1 zwlZ0|UHN;J5#4*DyjGGiWIUNnrV{plf)%IiMc6yE*OCpShU_H=$bS%dB`v{u4vY}e z6O|JCt7s&+O*e7bFT2&h;yewWAnwP@=NWKEg!8hS{VUG%q?-`t%jfmxPV;Mtqg(Uv za_QDQ-Vv`jZ^|pqTST|!@ouD>xP!EQlfg&aX?`tVyu$4~-CmZJxGu9Z*S^oyIMs4` z9rWUD7wt&dyJlx^HSRx@@ADLe`HLj*oX>Jq>5E#TDH?GvuS{6+Lw&y-z0I@L(aCoE zc^A4x@c?h3>|Tp9Bz(>yBF`-)BCm+@Bku7oA|B!gi8?t=M4R9`5hc2gXc9e!sZHC6 zwhnDO+AV0i(`GS(H*FDT5N-CjqYrHnujr;Xp)KMRrunvrvsX+&c*tvxg^N*cYz_#2 z;@qM9*1RjLkfv}%bu6~qlfJp)d+LQ*WoG@dvU1Zi&0-2mGU)D4_>qKYkq+7RgMEch zwT??<+so%!cGEsC5wa2K5w>`O3R^r|g{?3O2`D6>kbpu03JEAAppbw<0tyKzB%qLh zLIMg2{5vG@NBY0?%&{{|ojT~veVh8fLw$`4FG!iXx6svT$$FE8eqKa`zAyUMM8D8@ z(vnOgRCh6ti2gj$KOpq@HALv~?~=CU10wW((cdP*K2Bbx-wSkbpu03JEAAppbw<0tyNI%_Jc7T%i*S9a?C@LXQ`kuy}7T-ieF%_2S*O(BFk_ zF7$NqE?emRLYEhMzIc}}^!e7L4G}uM(EG)Ea|2>XIIoM7aXEpT2)){rm=SYgK`e(78m=ShL>!1CaU#ydg@_S9V(d|8BHq_`Azeu~;z2x#7wJyCi4XB59NGkb z5;eMny-`X2g`{$v1&Adw`B3?$JchQyLM5>FCHB1t02 zWDrRqsU(f0lMIqcvPd?`A-Uu^2VdpU&L=}i0VyO!q?nWtaZVZSp=1~tPRhv$GLlq~ zN>W8ekc$WpS5EGOdluZ^r~+!t;Fh57eMK#ac?BU;Uv^TpWI5?PMn4S7S;7Algat5u>O zRSl`k=YF|=QIuYo(%C*@Jj@!pR5!W?$;PFMQt;=DCZxZ`FRtTFLK)1HZtKao2^TR|S&UtNy|Mcf@}DV!Ym~prKc)O%yB-h5 zugu^?+J$-jmA*Lgw%BZpU&5MSj6g49jh+UPGyXNxice2@%<}&?^)2e`|0(ll;%|yu zV>Xb?$Ac0XRAk z&(-5qYZFNT(w2-##pVW(EgcO%qt@hhau0tHWmCC!NsAmwDn%T!kH|xp{<_9iDL-Fa zic^IQY&oRgg;K!LPDN+kX;StDxt}qCyE9@k?fukasFBhb(@i9Hg2`r$OBoU4O5*>En~BwrHF8!zmKW5n~b&!($LKi3t=`dnb6xg4EvF}I5jbL$q0e>(cXljX`w zw7vS;C?7N^o(iaRJq@?Zo&-7h?l5A?Uubnf1-;RR3N;}SOtgTkYdjg*nd^tEPU%au zIEXxTzh(bi_5D$#hsg%PMP{rdupGz~UgI`)3RmdjkQ;{KIo` zqcH2Q-lwC~yJNz(G^{?0e_1OQxZu+-d4~33eoRsjW5VQ)OBTh-rriMR+187gu#z74b~G(}>ILdi!& zjbPn`7B{u^Un_$oC*?1xel#&U;g+nCm@;{kxC2b0n}4yuZ^30svqGAc35$Z1rjW%Te^L^c*bS1KqC(_oveU zy@$E?Pyf%pN@66X{b~PenV)J#R?-YxtU_a2EH1lPp^`WDkGJoGdu>Ijh91g>pq4aD zZX2H#ZB}caRlEkq4XgIev*{wJ7~1Va_5EUQB~7jBPh>$&VZ>X38d+MsoimH05Z#4O zDd{IGQc0#FI-_9|UgWQ)dxBY^Bg~;K4xLBiOgI}u=}i-@Kj^{jXW%zt90Rk*^6)vN z&H`z`%ZQ^i%-5_S-K>JqcLP#j(-56LkH#Bx*=cKI@V=pI%bU+4*6Dz;cWCxG=9RY< zT`QEZ7G)zR>r%)}W~TpbCHYbW&N(#n0WarZpq1DD2HBI1G`$PP$I4at(o(Vjdu-o+ zVr)w3v?#q_*-UK9Tq;O;VfD>5u60k#AC61o7WO~Qv3vcm<$MSLK#dXr@ZJFam}7sR zT_>r_wksmG-_LM1oqilZu2;Gs229b$uS5<+Ibx?*@+H^O;LP$kut)&F&;W9&#U2pa z4>z}>&jzU8TorBtqYa{i(bNJ}SY-N&2ConMS?2}ZUSzg*+k9ycm+tm8Uaa(G67I=y z)mM|+UM^oe>F6EwhG+KL?Dumxlp|i&*9e~3ie0Jii$z<+w+6h-u zdcW`Yag;ZqOpxM&CJ_439J?q{jhtF<)*AB_ee(F&95p6lisDXNIc-XS)-g# zsaK+(uUTWE5{9v$xM)BuuJ@LeML65vtH&HV3VcV`cMgOs9zP-eY_0^`{oIzPs-;1> z6>)HvvaxImUoiB#V9Xsq->ssXnDJ?GvrujAa^^@Hb0ht*En|5oOd=}vg_XjiA_hCi zGD0fUc;^7PBJuuO%2R3Y_Ctl}dRhc5T!a)Hjh8di5w~l|Ar5YvtLO9c{muDiT*?x& z)v5NY;~^o=gGD4>*3-pOg5>BxofLii;}mL4q$-BvYgI`C7h7cWk@mw@-`;-C_BKKW zwmry2^%3|A+3wp5lGS)}$VJ)P;Bzvocp5J^i|Q0wLP2>O_l)GzPHpV$s2KC`Vv~z% z^;&yl(~CxZP<1vuhpMR!vyp=V(seC#nd4?(nEuOXvIHPG;}ss5!TglGtc)UI{|pN& znN|2f2*vG=Py6|#`(s(YXJjaM>|u_0gNy1%skg=85nZjSa*7}4kGqG*MsUL4PHk}v z6W}Xk=a?#j-MlW3b{;kdNkG+GH4sXkjQ6*4(uy&cL>rN+n;LAH(OdYe?J^3ePdwb0 zmFM?XgE4NRY1sT`hw&UfoYL9)OWbn3r1}EEol~f{kwbmRGRuzShv{wHfF`g#a?eCB>G@m46t%tFc zn*`209SURAn6a=jk~W&+;;V%jhB4IaadoE3z{0t*Q%4okcp;yzM4;3Caw%A$xOenL zNWxi(R^Hgl!g+}DUi~!gQxB6ZP}e5e6!WGMK~yCi1`uL|wEOD0_Tb6o7rSF;K1Azi zcg5uue5(3*sl6bLF_l&|U>Z*o{!b*$45$3`^}8b&@qM#T#neYI%0o07&%(8ZA=-P1 zQmZ6E>OQl?`2GVwkvGg5n1tf%V8g~MyeZom!jw7q#_I=beUF-LzGMo8sOCB45nnTX zK97D9LqbuhvjTC%HH38o#iJi|J4vc{E&@heU{=+&qkM2o_W`vt6q)0P=RL=#n08$5 zactj^Y;;r9`<>9ZH_{e#64C)Z(!`ZgJ$nrMy+RQPb zt z6V{7Am>@A0JVz1_=p~UnlNOaKwA?RCiAahf(AhD;LMO5>8=2`^`Ecu}2X0_%)2Ay> zbaO6$uOYXRUQM*p150OKIVvuZTH;RYC7WODM5b>5c0?_K#WCK6`02oc zPpCJN>U)~r4U#%PUC+e!?$qlO?RStc16L;ImX12U`AJ{>@p$@lT0j@dGJk2%|}&9viHJImVnW-Upa zQW&!DgN_ebt7n2+gaxSjoP55hbpo}-aE(De{sH$g;?K4inQMX4?eeqok;zv({#~dx z`O|XBaWvd%_suODLH>x$R2nd8GA8&R&2$GrYOCW+JegDBbWpg_=BQQRU5ILcB;%Z= zq*!`Utjs+AbkGxI3&pf*L&TQ2*q|Mh;2|aeLysLBy3Av#vOQE>I`t5UPAIaSkshvU z$u8~fC=Fsa&_bESte9?*fTZ}hn|xD#$puoSoNi+m6;)E;!We|@Lphpremauej`oq$ z#{n_yB!yU`Sl=xfe!0ByR_g=}K|UfY`F!f(ST5C$X10i0L^Uh`jm3}YWEr)xJs$3MG^(o!&@vdQ>j9a`px-cCHK>C;#Cgi zu`vY%1WXdkn{-rf-RcWz5(BKT?xLBqEv}G=)()GN>7NvFcA|^xRkJn`Vf9ipnziq! zPNh;Eco(y0QQ;WyDVXANV?l$zm<288eI_`N;rB5xz|>|fe(vh^(vWiplLQs^Z{)pc zu@;aE^c3O^du}=`Qti6bZNmWvQ+91M!XwH@wuU={#BtQHf zs|y{=lWV^~s<}*CDXn^ckg0FYEpwj|YHAvgjN*cIgoRTowddZA8(3b&z%sWd=o`;i zj9-~+1*&Xg4+^Y5{GbpVCtY{o&*#65B)n)REq7-kgj+zeD!_DWQY=|Gml7qGQ%S1+ zNqhl==%*DhajC5kHYx8)=|pIO<|nFtC};%>{y@$cft)I6n||U9Dcc#^z9Bbg6j&b* zgw-}4VM|iy7!|>XzSef7)0dpsMi~>)t46rd$dtevdJ*Jr>X0m99rIh{GNr^q)Fz1T z5RA%D4XE|>!0dk1O^9_OUxf*T?B!v4E58S%0O2%CeQeAuIAV$@E{H}V-8E96pQ1tD z7{N)E6HHl7N$VswSdl)dT9MdS3R;XtTK&@Af{y8RWUgcw3!6I)HUz^JxvMw@A0so_ z@5okFR{wo8Z-*9ir|V=FxK0uJ7Wu&>d(Z=o?L%CU&31oNFNxLS$XI~``KFlYN^VFf z7J+ec*hv+whCoamZfT8~?N2O3k5UmvB7;d)g^v?KtET*9V(#Mss^*x7OCvvWas<^H zje$$CHWV00agy)LW=n^$jKQ+`VtTR3awh|5YY@M}8@uva81iuQcB@=(1a+?JOC7%< z?vrp$pz>9Xj{JD~CPxNrN;y+|#4*O`p#hz$Bd58~ONjwZB|$Zd)F}viMSCxC5HC@J z3?E;{*?LyUI*uwKFP0uBw{%gV!h7CUJ)vdwZAX}=WdV|6l25%8Ey$TjRzn#>y$iFS zR@4<^SK5S$;D(PQFufJJaEAr^qv#K))enlW`o2o)cS&x%6rvHd=ZvgIOJeNu4L;LK zZqLxkY~;E;hAElEU7bsj+2{vE5|Wsx97@dx0DM~U8a-1Dm5VBvB<$ClcxWMLX^J4y znUG84vX~N&mSR7(Mp!`s)xy~9|@{$@5<3H=yG$l5LCue{2x-dQQmwZDCi}pBNF+1^gD4wHP zlfT`JBOQq5PB*V(vp>QSB$F+wH=dzjyir3+8tqj?9YFfJ_O$1q1br3~)&1$l+NbV( zR$o=t%WUn2jhpvdab91CPInS#EPN($Q$S)*9@2dY9eyRVxv?E|L%FqJ4^%aN?Ohm| zd#S)CnzTlWGPrWhXsBa)neVLOjm8l?a=E_(rDC4V{qoMzmqbmG1U+-Q*w;s7;SEdo zGL#Fhv23E~Er0MX6s)AcH^yj?Y12c8U^cKRyjp4cl#n2$^O#e{ibpc2`--n&A3D3x zFGbZtFt0<2@-~3*{R}Y)FoKi55KAF2>_#^@eh=>ax(c0t$}ebBu{cES*gBko;|Khp z7AH1L*!9?@q=Tn(d}vr&81$3ZuI}?jS;B`K!jGj?R!w(|0t+~>6j4ye3?vS7tRvDjnvR$@*%uqxd506q#aeBi z4H30oR?R|_`lC-YuFAF1MB3!$mTPR|B0`H-a`$b5f7ghoMFdO8J;nn$&>O_yvxVwe z`>kIBr+L249y!Q4YdnEwI)5t}GqCfN;SaEnbh!sai>@PBQf-Z6<+Bda5y#8vK-;^o zW{{5rxxEs^o8RRm>mQ@io>)X1vnwD;WGpFW?m+@vvG5~=$ED`2^$*^ja%??Z@vn4m z1Q8?Dt7AR+G7)-5{6FwQl6{vr1dj&Gl?Q^4WQyI=R}YQrr%e8-s=O)Q(lXM5 z8!kI|%U`-v3z17rR!oK^m#6aivp8bTrTvzOBs(szPq64`p>T8jXs(9xPuI|-oBfZ2 zpdZokmHjEUH&MXupEQ472|r2CuMNUCnRj-8~-x&yk{(-&cKirmmydIj%5{K08#V$ z!04%lw(8gESf;EXrdy=Dkk2NlVwN5-aj~jQx0BKFJrhf-t7#0!>P@}ZpIdCRO3Rs+ z5I9by?;ty>%Mf!12d8Bg{Ah-K&lf*G<;ifTSZNKWD zY3?D%2vezAHipaDNqHFe2DY6u&;5Fea8OTSdJ~?>CWanifUY@6uNl!!;aEQ{L@Puq zw=BA2q(+vU8Ut%2i$^O?RW|&=5NtZm!75H}1B_WmOVoIcj_v2?)IbOr3&_Y7(7%c*`M~ukfu0!G*3= zb90)3768t%Wqkd@GMG19&Xdxbpp3D0Nj;x)w#)S6I{4!05N0f#Y)`2=!#J6^;{qjv zo0~IQ+!yrh*~K;+o$Eq!JEV8LF@@R#MmCe&jmz~SZH?n5-OqnN=d7JOKFg5mo1IIP zo;$W8N_NgGiW_PFdT)e_(@9DP+tqS)DxsoPH3{#KQGqK`ACB@iAG2#VP54g2t3x%~ z8^y1UxPRZ&>&}4@2?GZJG_e2xls`9I?2Qd93~2s%rTev|ccLn3g(ZmIMtFfIWC@qP_$49Rb!H~Ky_r(!m*ZS=xD^mAa#Ug`pqAdj}N)WM{LEFhbK>IOU_d=6B7DJ zdm}Ar^+u{iX^J@;WhS79q1?Mi1moZ_FJ9MYZY=Sr9~ z+=JeRQpZZA3Z~5snpE<^_1l^E&dq9P`}V5*SU!bVjcsD3jaoX*c49^LmXB>dp{W&r zM6=>S$QgXaR)eTnA8$a5q%&HMJ7@APpQXS50JbQjpMXlY7o-+zM%UIWhzGzNsK|zr zn~n{wgfn?Q=|uBdeS>^?IA}JyYn#$NXYb6ra~w>t6IUaMZp$n*b;HX=ht})6d5FPF z=XUWAKjq|Vy1JTNZ5DR&tO~_0vPkteD1z1u-!{N_TaL(heH>1h4b2KPJmP$L+&qiG z<9gY<;%;kK23kjUR`?EQB0+t0^Ux-E%doZ6i7YrAbs4 zVp=TW!{NYSKE@<-7(VqhIT-$0xRs-2CajU7l2sH48kC}s>bFb&E^L;z08;3FMalqH zLxTYAPVyo-TUr!PjQJR70vyCXS(;CBN|PE$U#&hLB+y-#4pp30n4A!N%YIViEdM$- zJV4d99%h}YqyxbiG_-KH%auze)U2V{>C~W(|A?{W9rJCojW-DCG^V-J0h6746j7i( z2@*%#ctHv;+~hJjnZBm8V12E8pq!-^#|m0a6>hmd`J7ukC2_+=mKEZddKqB+e$#kkGYy&9wnBVqg7^kpJFvy8k@nFs@|_yUzL7o{n? zodQws;peaov$<6q4YGEfw`5T=hPf<(&k5E848w6POt|2V1`&ah z9?lgnJi4{rAk8h=30Dk!oqZ>4S!{uOzDkUK)6nXTk#u0y+CnOt6b_~)4mrst4&gOj z`hlA*CKW2qNPY02-7wBBD6q$BjM&n&gg&>;t3Fp1iDan;f%^U+(Y+$eU+{98pybji z_LKm&1q4Em9ZtUUVpD3#KPf~wBqN8mFkyOjC*9)6b}=|ZqRW=`b_b$uZK^ROfT z8V~XD3M{NX?5p2n7Qj0cl5&smH4tCMRhW3`(xs4R2v)~o?VY}eI)X_5d+<{0nc+|cETAv;V#5}Fd7ZS%L@_jxZ?0)hi6-Go*`A{cysqy+^e@WbB z5P>c{Sb%X4i7p)fy+e`j7oa$6ULAH{Pj3#UpB7g`7GtWDaaL6y#>({Kg;>q%n*^@J z>a6AazrpSm=Hf0W6*kkI_Da$bdkN*oPTzYO2CqqPw0$L>Kseu&QvRBIT>H}|ivU)W zEbPZR8ZB$$8qgx}UDY{eG_+;>s24BnwU@eGe86Wj*4x4_m;}5!+;UN$^wE~02iuSm zXRBL>tMoAlV`PaP3`}Qnqd>a8H$jvgwXX6b7wXeF{LyyH1tZW=-gR4 z=UBoPl91A93*YM!qEm?;DA#bq`v`a9rEnjb$T){}6nVyLC3v3WX9#WrqUtdQiz~t+ z(#-1HIY_;vKUGp?`hrtP8ir3*xQ>}8rl7dU8zbI^4rYtuWL!K0ioP1JyNzlu8=H5_z+)= zt!Qg9=5I-qCPRdy^=#YQCFYnD8g*CHrDt8TGLoZ|5OImI>=8fQzA`q!>r0_xRRW zR&-Kw_p6%8t)?i9dtMgt98GeZGNa_v+Lp?j)l59fnOOvXgPez%z7E!Us~jVoVA! zPLBa`b5YbdLNEl$3uCF_^N?6!wh z)=O+LRaqEV5gEigae~h)*HD*@hXGH=VCiJA$_b z2T5Q3kc1n|x>3eVAa-gfm^*aXW=-lHE*2cfkMR_s*OH1JTvTVC?!9JAZzEn}fo4gMU-wzVb>{f^LL!!P+YghF;x?mg z+;x1eR-DxqMcnyfH)y|fK_^N@?7G6}GN&%8#=;$Ftod9!9d2zeBAuf4C^jhq4>Mq) ztsL9kKXL=@Tbb~^lhakMyZmk}S?&Arh{wt~>`}5|!1bjCeMH0YQBRU;Q`~jbRf0Rm zslFafPD;!J3^KLK)G4eKKDKBv2X=*Mgd{9_>3Js0m#-PFC(}SFH|QSv%QZ{Wo_Q$u z0y)!oIBl}2#i+x_xT(VBnUSFKykQEa_4p>H3P(Pc2Fab&y+&$lD)i!SIHpR_&iU=A z7tVVl92QIIjOW5lQhTw-g!VGNd6-0PuEKo^l4@rCZ8auAU^%d(w*=hgeK8xXMtz1V z(}=ZV@&leY&wEL5UPjcf?-}cVN8fDo>8Sg6krmARtwPt zgvBD`?~DhbOAZl_V}5MM-ReUWidorc5f}E5SFAru*%U`kCNbLdIRV1Yoo+EaSIzwt z5^|YSnqW+Efu2MexZ^gF@r9B4nf~S$&wq>_O0saI|KLjKF=S}l!NE048Ek3K2DZoW zoUOBVt%$2%n2yaJuY$DANDWNouJjej?Cn2R$8b4=$Uj2>0R3M80L(u}%Ff=!+`vxR z#NJrY(9l57{*TqRCdER2nH9c&eSO3OB4V8%H*;r*@u!S&`AF>-v9FJ6l_=TWb?%;@ ztTSGfqD#>^!kzT)PRPp>BN z%3=&DFI7Jgaye-`A9*^zJz1SG@0;8rp3eY*$hx)#wKg`7Ro%NYinTJqsk&lA(?k_& z81$!q5VoyF#Kp7F--^iJ9#nZlC7s$ffi_K`bk!|XPlQRC(;p$6P#YxDS9PU~36LF# z?&stJKBgP)kpm@g16tm$o(fHEc0o)-gT+w|n2EI8mbu8mj$+JS$TAbs5~YE2i8bk! z?E*RH6*^SwS*C@p1;;NFPe{K7yFdotwM%ifU7D!I*R!>btN56!YgVCS*{^?ZD1)Bp zBJ;3nSZirRzlJ6eg<#P2=xwuEYj`L+AfP{r&CE1A`0Zw*pzTdUA6MN;cXE8m;o8`u z&_MLu+&y1ei>W47KeN&v%?#CU9;)@~I6#EN9K%~UWw0=Ze98mv$9bMpuQDZEm4b(a zW%QQbh3MNoWe%kS^FHN`e*=iWcbtrOCk>h`xkf{`YO-doucDPFd0F9;+0ECRe4N8P z)!q%^O&F(K0X!GP&JI%4k=4S+*jJ~*7TSbhGoTRMAu~?)CT)e*q~?grgK~8T6R7X| z)Z*c&XhRDk0cx)${@Crwfcso`QN6v+BM=7jI2!;$qy)xC|Dkhxa0LcDOFO1c%JJNb zdptNxW3L3n3LXDiS?f%4Fg&v)fFV#P>h~S%gz`4Av#6(#50)dErEq9xgT=O=N70bUFjp}ArH;-iwQ+uq{ne1 zP`EnndldHCi-9_r6BB~N9m&wttwz2j7q#76eP*Mpu8}twO)_-|zx67Q3}-*1VpK#> z1etIYZA-squ~}O0NqHr)=elpZWX2qQnj zo+L{iLkPn>eD4Ikcc2fjCq%&* z1>bJ3RQP`(qSWFj+MHWmgBTWU8?i1kO~r*B7K|6U!Cayvl&}5(Yj{~et5vPgvFw^4 zGhWy(UoJ3~5#&9;1Y5|Ge~(FbSRa>0bwctLS9`c)Kgg~>LsAH8yItH!XN{9R?Ko+! zd`l;d?Y!=Xnq|R)>TquTxPRrFVy-Lft>aa7yi8MQj;-^YT*A-3b{p*-9X6)G`Y48O zJHBKy#HHRBdHW){8I7Ja*&m=^`DlOo;`-J_oUb#YHF?D8g}&vZ;27g=wwq``EY06k za<}VGX>`t0!J4{^4w&7^fzzw*@-~9AU(gbkf2Ht&@o5Px^*|;v+(CJU&KUc)->Gex z$WFYkJ1px9&4wc+NW<(-xsy9n!GbR!ASEMdCN^=@ujUJn(NzB|`hzB*aFj=Wsm;uh zdOs!}!yDD#HQ+UBxa0}Pb*YQ9WXJ(jJ0W+avoNiugtJ6VRyuzj!FHwm0>S^$fyY;- zT}cGqv@qh<33nOkg5V{EkT)dMV7b?RF>8>MFlG^YQmuo>1L@**w#s$cENhVkfqVy) z>4}8zTWXpbO|=J77L&@lfN`yT*e$kVk{DF*3QIBHtt0?plJ;B(@*{|q|HQA(O@LGV zfc3eMan$11B(-lWd?MU@5Ay5Kiko5Z1l64rW%px0PTZD;Ub!tHyjk9rXOgtMf73}# zCstM-UX}u%0@$oyG(At{J6@0JSuf2t;^)*)@V z(S6=M7y1#2G~@rv<}^$hs(pC19njet%6Ds;v|PKf@N@Cl6ao={jmBT9XYkfm3A*2J zP0-NKz!YT-5}zKoMCOkc%dtznJW3nZ${(7ISMrzDi-kb5?`HmC?w@1OMC+sX>uiL#?G9mL z!^`cr1{3l;mK-o)L+U>EM6hpxj2|$F_wwSs&@A)GylJHdFF|TsQtK4B68PB;EP&>P zzr6UTozxB=eT`k394Y6jU3+*v3TGq98#gf#PRVjH3mo;6SAF8cV$n5Qv@73U#=R%= z_Thg0J+ccFVtX@43=-hz3&P9KkBSiOB{ed_MLnD#%=Rn#^zyu>?M zxx81@BD_}%z87)H*jicJ(db#(8vLsg{(nmZ-(e~=T2{Q97Wvyc*c<<#TZ+A%8sD?af9#?KRDZv1qP?hwI^M6CAk zEMbZx0XeI>-S?!+!08CKAt=ryiAD_|eTGEYNOI>0CT-@cAfWv+e!xF*q+*cYoWH2- zzP3zIAQeQv8h1$)G|1O&_^~#@Nrm^-S;RQ5^+P_$Keu_h9twx$ojUdc#Wilks()>( zG+5v@PTLkORM*BCI<7bj1GVwO)@+X(GuNSMW+6voOULEU@GQx~2qXi|>sB$^wRk;O zDV1R(JR~65Y%UfNlIMeZIN;Mr+&5yT@7ed5)rws?I@!1d)8U$O;{GC@OM-0M>J#ElY0u&4UxRD0`#^<}`B zD2l#pWMC-Oi!jMcy_M(N&zqMdg$SsabmqvxYDSI6O1b9hNs;e#;vf%vCo1_?mICSE zVqPQlIgA5mx6Ls!xy?KmOwtXm*pmI*joOKWbV@yj-Tb#&{!g(6(0viM@x~zpF?8#L zQ%hg^mRbjLG^zPW@?hB|OIjH>k{B4+EYQVV5@9|wAAN&0)c=BsA@6#x|DioE=qzt@ zah4g$r9$d@XH{D2g~fG`0HMt&p|zPpp|b z-Z;acherUIT$(tpf|VBP{K(4!r%LOg(04h-4{h5Bcfvx~;k!w=_k<$xuQOWFZ<^>d zCwW_Hi2BQyn8Q+*%8FL;uW76g*Q*+8X5Hf41JX+SeG8C$R9;GaYmHD9(zAQQMoRlG z2E&r$xXbRSn>Zm#V(Ti8P5PT#KW81r1k1!t58GW8H8d(?y>?`KBpedp4Cx{k*6D^V zi9^!Myq*AgYAPRkx#V3j_h1H8337%5B7aImnY2>UKHQsvA21&G%1imypU*~QYMU#IM6~~Nf^I9 zx$2nZ$i>~~k|Qi_70>mY%tl2s5n?LNuw~0KrV(N?O}%#z-#aK1Y}rxg@A&uZ7;c<< zbr47ku%0b82Cw!}TVT;39tq`!&J>lNL6PiihQ0in0@1v{U{P^;OQ%wHYxd0!#rn}* zrA&dk%3?oM;wQZ`a}3S2Cbme~x(R!}=aSu#)d)xMozYm1RAEBhJM?vO^mL*+rh(#z z2qIRlH0!`I=lEY}f2&^t%R2Q<8@rJ>Hfjrts}IiFbqpR=Cu#K{DR~*!=)%UO5?AXL?acZLt%KNDFOo16`HsB`ii-KY%7AF0jul^EU}|RaTx{lSL@g*jy?uK% z-pVsr$kGSzsZ-5rJGOB(L!SCiGaT3Ttum`;6Vs@BI*MiVFZ+mtoT*DC2D>`5!LC&= z;gQ>(VG*BZ%0UqQA8Yx1WyC#d+OHbY1JMrGv7yxTDVwRm4FX86d?gG?1xv%f!H#^0&WT#+2PE2OIUIN|70wf^t4>Hh}GztJ!2pY;3Z5T8`fJ_$}P%ac+GdaoMEoSO2$NU2Brqfi1r zk14?C7{VW~(QOM@(N(@y>kb8*yCl$Q?m=c0Iz}Afy?= zeq878$OrE^zrUA#nRMYykEgBCR^55PASv{mQPI+hO3qwg6JRa<2HKe)qEq7W0cAL% zk=62kp~?yO*`2*Xwn_dZ%gc4TYW$@pX4-XmE06x^J=e=>;%sa*>6f@n-~ydCtk|Ao`NtXslE= zqRG=ewqt}JX~2hrROPfvJW2SUy^%ksnTA8c&Ma=&ztGM)BAJWdR#rdnC_kjQUva-j z&wr1vu^Zs=*YAi|_`d&+_-A}Id_VH2prdR42jjIwcUmrgLhnC|d4xs1>)U9O)SWF{ zvX63H)H%ZShR4pqtnls`wJ4`G;gDLgfUBriyMuoMa2(GV3>S)^Kfi5^_eY#v9`P~{ z#$!>`kRxE|#9H@Wi~Vp2T3e@*A|^^`K@fV5D?4J(?PA=($i!eLj)I*HLR)|FyG z$~tinoH!cAYEBHR$=q90*p~6QlUOtB2k6Dca({+47ZG=xm&fxpo4L!+Z`1sfBQ7^k#S3D(oy+$llDUnzTa=~gWg+k?(ALu6E^lso6VtL#-;olr zjHz!CUo#P%1tP*|0}$=A2BdeMoQZr&;W?5fBDw$G5hb9-zqWX@1r^0cwk?W#3O;iy zaDL4#;4OR&BqWTOB;V*?&(70@6iCDwbpj@`aq>B6rQM`W*)s+*4qy&D3m%yWp8fV| z5-lk0cj5p37@%Wq{l8BE?@sftD>Zsps+$&G@J{5JKi1>8 zW>>bTkYWb9aznNdXfFPXC?)oC)yHhFasLU#p70XG(*+hMDd6IWIsG&AY)8i=={~{q ztT-tXb(*V!OGC!->O_CVF4mA?_Xs-ei)o|<@O?U>FgijQtOS>sXl+_l1HaNhJxujv z1?n0CSuE4NA~Eq5)`z)lNpm%1v=7{fYTrzEBEGwvH8@MZF)2zpK5W@F-XSOQ2bHoA z;CmfxC05!Nf;lQ=*^4I1)eq2!axqt+FbQ#i&7qxd`3AdlWdI$EtFRD2CIx=trZKd4 z`_xf;CnO#PN!>nA|L$zDUp#dN*g?K_6Y>~4lCAqnxoH8g>Z}W>1ldvm#}q@T0yzFw z1R0U+#yX_mI++kQ;%E_kULY$ROVJ$1KObfhbkE=Kh}R#&duTsU!QQ%07B0Hre;$2M zv|(CtruD_~;T5F7{@?}LkT;Gfai^4RV5Shj;01xxz5n{Q6H{%&JC0W4ClrF`h5h>9 z8{R;`RPSkk|9q7D&%e^2?SDAfEhGL<1^+xz`lsNpw(0$O`ETb-e;54cF}uGDuD#dk z{J##}{jTZv!&HCi;(NdAe>+*U@)-;|4(v654 zk+<_k+;H58%F044fgKXlJuLwOgur5F353KFyhZ}V5(x<;FA-}N$iwgVf8O_;b0f35 zJpxN!IMrPdaql_rdEe*z`~1)U(_j4G|Fi$(;IR`*;4kLM@o(-@kC{)?YgO&0GJ{t;3%k{_OjI`29buFX#XL?ce$x zo45YzzxNyY|G)8{gYY-}+iRcw>7V|~;o2xBtPdTmLnGAO0)1Zv7R$|Bj#j`=Ouz z;IG#AH-G-UU);JSJpN05`tKj-=U?Z#+y4>I=f?l_KfZPAU*qrpf%})>=jOkD?*81H z-~XrV>tE%={{79Lt~>wN;o5)p^Y&}}`)~XvoDF=0%fI#S);BkQ`kX&_Q21JNNnfY$ zxBo4C=KuOS^UwZqe(&e{b?f!@{|I`x^N+LeueqkL*U!`G?JxX4fB)g%{PX{#f-(R4 z=l|j#-MaO^{N4n&{{6oX9R4zYdBZrUtj;P{U`PJ|MqX+y7i1z```Wh`u6|( zfBU+9rH(J3^Os@a4(I-}KfnLofA;%-=x4v~=Fd)#{pSze-#@>{zCQ1N{EDA9pVR;D zaPEKq(9gbf$K%bPzwY~+*Z=?ZcgNQc?fZv5@B96;{`{f!l+DARzjf=s`HQ!1eFS~} zxm&-(e}DV8e&-D`>(Bbke|G&pX$b89ll?b*x%qZ+d9~UO_wU|)XK(M(a&b94eZII{ zKHsd5mzN*y?L8hAXTxx@UM{xFT+{_IvieaSLe&^cDPtxo@_49 z7UxIHVRb%it}ln-e06^He7fWntKS)hm(N#6&xc`oe$0X|S6uOGc{MD~H&@S>mn?s@ zxjg2__ImB7$HUp;@&y-c-PUlrSeLV7k*gK3QCX(bM1>PzE0X&%xX8 z4J`fMTR(zc&d;H#DD%k=6~J8_u9tU)&E@Ih ze04O`!S4(UNc?hheC>@VY*y+$0!ypy6$Ym5N26O5W^Z+42Q4! z#un%MY|pjx%*EyL3Yc$?uGg^d$tC!IzS=H<^Tme!AA7pv%{2$#KVF@#u7*p#4QYiP z?i3U5u-Wpv3zn9wPS=~m#d`hfU>FMC+v}qv7~W$n!6E=(tl_^x)^PNki^^7d9K8YNY+)F_{@q8c@a=LNbZmXpz58zsiZF@x9awtgiznh6Qkk)}M2NgnQVHbY zc=_#ey}8H^Z?pD~24I8?TV1i&0hqrK&>?j80}*Aj&sV1qsRUGiug;Gl!^_b48g}>= zxwUCh>Gr)34nBZ83mwql)q3$N+~I!Tp7HSksDP+v$77T0_2wm8kk?pJNXEH8ts;o;)!@N#v03WI&|-~b83)tgHsJxeN*E;zDEB3B=-HtWslt0Lj&%QGG% zTrL*ur0IpWgA*7P{ewQ*K3`qH6sQUoK3~HSEO)g!S#ih7_4)Ba^dQ7N(cJGOsttD!TSU^){t!qh52W)u!}emi3@e~ShKtq3a*c@QPPEGD z^NZ`N#>A5@9Uh-=ub>NAJv-#TAFnoFuu3${*PXI%fBE?1uYV+lkl@!Lg_4$RYXwCv zPdr|v7qao_O4$X?3O58mEq1lIJY9;SzJD417zRgQ4{#nN8669TPod>&cudV%TRG=s zp781ti37(%I3SQ;5O>RUU8Z`6zAskCz?%!Y6o&{m!vaYIV*m~5adY@HL@z`grj+d= zQ3U9Ab@IwpBUbyNSZcYxK3W|k5(^JtaHLXzegs~RhUeGFfZ=rME|8c&D%ggb#obTx z?Ptq#Ro_>a8=rqL{Pg(>KyfOl{u;RhMI5fLmlqrjNC8vt1w6HC_IbX6Ru|tcRku3-XB)q1Fv6<&-HWwcrhU5A!2BCd3m*XAxwV>BLL^a<*N-8 zAWT5p;=Bj~+6U&4v5c=M9kA9;*|#Lm-v`5kBh4*7+#l9(pR)A%0)z^sQz>clJ^1r> z?pZgvfh2)ynuKu^?_en)fL5}3qqi>ULYVguC!xZ{5o~<6S|Go_>YS9tBUy&y%WKRF zs77M)Soto80(2!h|9IPMPvq*}n*{fcs2=&1C9`6e%!i8Q;*9sPkh%=uT<@Y7xT=|{ zjfy#6H>~EGK=FozIaPSY=s`_BiPo=8Ux=?0<)Fqdi;o63b_v=Ig5>|ec?DrAM-=825MY6m4{c zRQ7QW8oGG4LAX6zo)1mocXharol$mf!6-z-8KDQ&@~UhO1uBwC^z(H29s~Rmy$;s) zkJgwzGYCr&2=QiUUrBbu`-SNUh^`OJ`W^)X*uQ7nMVo$N& zV#q&7Lxxm8`~0i@dk_@<23I_O{Fp6XDp3YxriS(9Pi`u$%TJe=aqXZ-4=h0evM3_+1k-DDB3OYB(e42DV0gN@ z(>E{u=aiARk+wo*((f2(`?2+liLO*n8-(oy(tt7~JA#j+y#2Rlkoxr5-+BK&37CcGuQxT)AeY*@bJS+^$Y&4;##KjqV4MR zT)hgtvX$JT~?Qk`3Coi#Ydz zS$VDub>E?eEinX+iz}ipcd|DT{ev&QymzjaVHnB6753rIBN@6vG7N;kI;5ktO&@$O> z!vnFWjDNLV;gsrW^4QG@CnP|#x-z6AT?Cv%?hjT~M~5+duUv1WkvqdO7F&SBR)_WK zWVw%xEaez9fbg!a7iC*-Ic%JRk;I#<1ow@MvEHtMZgwx_#(16klX{Jima0Z0c8>kY zi$Rl|Rn&%^E;lj{;^p)lf!jQcM!3+=wOcP=sOU(k%qI3x-`U0qFqW#178i@7)m6#r z2kY-K)d}Tbm0;L}KJNGs6aoAku8UBc{PS)A@+^=GbqB_}T;Qr6iz@>LJ}v}2pSHd z6Toqwxf-~PClI~AbMQS+o^xMfY;fW^L<5hbLNBqX@7@39y?4tnEab$Aa;@ceSMcM@s4^32z zQ2!#=Uu-U7pGy3v3KO_%_~snaJ|4ad0=L6g(>0G;1d|=>7&Q6L(ZA%c=feXeCOEt^ z5Hl7$Hy`oR=X%Ovcn@^Mck;SW607LY91I^<44`my|L%PVoWphjz@kVJ^Ag%!-Z?uL zJbVA$w|-y5esZlGXzmftFjRG+R7J3LC#k7n0y5vKALBz|q6mU+(;r9UB_>Fm=KKiS z#xO~!UqbS+z|jp?ztdQgZoW25pi5IL6H3du@9#-H3?OX9H6i$ zc{Ib%$YY?fS(m}#dx)l|*xF@qDliq-$e&r*8fl>)tyQozCpwEwgFz{jV|;pztXvWd zxP}<&3%jo>(CwUgJ$)* zrMJ~iaPv(CV_3RHrGsCLs&_P(;FK!k5Y--JgywjVuE{Fe%!WThOabNMMT{8jHzn%D z#fF^$I6`h7Lztdj5F`y#$s@-^o+`_k&;^iA7Jj`T8$y^C9#V~-FHegp#Utzi3`$ar zMir!+e3#5X!GXBS=6kvcIed7H67>s3Op?xRD=>Rc76B$L=*oH{7YT8)Ec+}A-n(Jq zqyz`^fqBNv9q2hbEi@fOZ>Wn(W|Qz_pBI=im@Kd(LIL8ZtaZLcqBchsOy=8>Bu76Dqik{Xcdu8tY2Nmfz{PjNPbmKJFVOsO zalSZS1Okt)FR3vA%Y6K3c`mLG_8weK>4=9sb5_>Ul>L)u5AO^Q&PkfBTfGa};g)~= z@|uA5ND7b3CLDfu_;|s-MrxC7z_!tnYZ#@GD2L`urb!#sSvQi}54WD<_BslD!v=j= zr82Bwc`CyZzYj4ak?5DhC+Ij!7>+OlA7!7y7m}*4ua*n)*YXITmbG0zqOyIvyo8o4 zLISE7tQsGqwe(XGdtYc_4^Ihuns|SFesq9os;au!fGzgj$yE=ItjSFn$S{|SP?aah zMf*K(3V;nxX~n3RU><2TIM=n`zCs?I`myIdDdVDv2-Ndeql_~gz_ZnuJ=rVHbs6`b zZH^aMNWh#}6Kt?}F;GiT)-t-Pd{#lxd|U+qb{Ps^3oqH)Ty!uDKV?hT2nZljt{OCZ zw7ekZo>AKxOW#mFNSc&4F)chgBWjgdWwpa=P+UihvJmlzw*sw(m{OW;WV) z+)atY=oX$TlT-DwtL!4p_pxo|4W3(q;`{um4L1f##N-jaHs&40MN5s>+V`TVIrgd! z>>dqeDhXIcY{3(T#irvylq4B6f()6Ll&K=05sXzBR1)pyjZk>TsIz~et~|YLJYuSv zdOgC12ywQG*jYi3IO!ZEruh`+ZLz#HY5L7p5`)I5XVT6mY)M#$RAWne{Gdsbhm=jz z+*qKMAdsXHdnhNLjDfKf3!q*?i!ut)UA&)ji%t4z4v-I)1)4PJdM2eLDhMeNUC>mQ z!PpifE~n+;hG#F&IEK%zcnemO0@35GCj*f91!P|V2oyGOt-_0DGbS!JSsMzCHPL&h z&fD5@`_@(JPH`aQj}<=f+B3-hOAOo8dVaba;e3i{BL*83KQd-iRZgQVXl#&NQnU=j zasOQ+00hi2kuSHVG?8B+@fbeJ1A-80@@v2zP0XnLgm5{m`sq zvO-N}!J;r`uVFJ(ktw~K8KP!0dF4c?dy$z~AK`>i1|1^=eOkh^?@vjc=4??FQv&u^ zvM_A$%!nZW3ps=x%s=n}ng>q7+mLx-yIc^;P)k^W*u+(*rCx+6sh0u^-sHE#ewxh0KVl|Dx#!*-t zr4A@tHq4FvIMyb!U=__E0-l;m;C>FrJ}@1ibK;S4IjI#{>24bKN)k|+tER+KJw(PR z$Dxm_Yw;lSl10{pfu69x_$DQ2bxUW?=mG7BRwEW0wOlo`PUYirOIJxPl6Etc#;zVW z1~x1Py;B>35Y|Yje5KlY5u>XT%CHfEGPmDs5cUW`*GJ|hg#z)h!f955c9B^x;Hk%~ zMc9*C9q0g4#|=^imf(iAZ)^&-Uo~K{SP1{gJF$o==tKPHYI(s5EE#&TH1o1nG1}O| zXCXTZ|F8{!x6G29Yy3R~Kq`JPsk=%qS7>kVc)7d)2ct_=z9_iTB5YXO&B}~&3we-` zG9lZf-A2y4$(%>|HJ4gmC?*^;={M!{asmqc@FXu~iFODnA&4SP}w`gkf zB(}=oB~49YZ8O_Rf`V_JBJviOhYLy>_Md#W29FPn8z4-YxuTk_T}|g-D&~x~45!yb zn@nk#S3I>YiGA?Q7Fm&Z6R2<-H^3Pi2kFYKs1#t*Km$Wy2o@5miAIjC3RCcmxzZO6 zX}CYV5%3@9#f9V^gYKBKc&Mo*(o_<)Ir@|#=dz}Uo4$)Wo8ne2sh`C$FNjF;{KF*x zS#2(%DRk8tnb<1!y<>8cAhxG~`8mcM@|7SM6#!XNW$i~M zqmDLy$0;715OZ4)#+V@iMyXH_di3hKcx;K$xkx+OR9_Lk5I&b0Kh%Z0YN<#$taf zNjA)zg`TD8ddsoA0xCGm8qJKgHK+$5J2vH!SMn|KJ z8X+Mq0Na}V7Dz}WH}S2|6?8rI=*_zEre?fgtu^COT|IW=QFvP2c%T=X>kZv_Hj=&l zRyI~8AhUivgkLr9ynTP(z4IrQ&dpkP5R$brY-s_n%F%{8mfmUgo2|^gDk{$r`B*|5 z-hC(AXf?Y~M;6_?{d?_;R-&@I%ER3lC{|hDOB^E>rXeg_@xLtk+94+p4aI~_@xZuC zZXV0f1;(Bp(R&9Ujs+_K?=D?EVH6JYXd6Uc%b>2r-`6sm_@zw%$N@0WP|y*A&d8 zUvTj}DJ5TJQ+Msu1e;5p#m@p2iFqr)y2EPh_6Ge|Z%K#c;fh)c%OreA%z&AF+*ux5 zf36=ZHn_LfIz!_nwQfTB$+JD&?K><;KY`}b*2Q))RM6*XM0DSA^oo|eJ!SR#BPuHI zvmGAU$_V0aM=e5l9F-7)*5NQ!t8C7HR3N*N3B9e1cl9Yu2C#d)@MZ?|M`Y@V?_lOu zuA=7)@T8!~YQ1b2#Rx(R!cpoU2+fQ{le6Jx=WA~xvk|Z?kfe{k2=;eLv+t5!yr~sfKi+%$VEEc5JH(n*y&#&XOUusi3n+#YT0l3*O9>9P z$GKL?V@&R{1i!wfW}c5aV=213*<9{g)(VuQ%IY-c8X(<*Jrk0^@?##X8E-1%pNs^G5aVAy$cOLj2)AZBXG%51;Tib{4F55raPt= zmdwU1`Y%=X5c3#yD_I9Oidgt!9aLF_ z!rptupaEdbbg#gAHx055GXn%TumVolUHdQf-zP?LK_#vj?2MBgqSaX!=dfywzZAd@1hLNuys6HI~mq@Yu2*)kjg zDwmyG={^>s;Lj0pvZW~nm*czwQSHowDt@0*b^|(%r`AR(PGHN5yRNJnM%6nNvotMY zQ9N586^?-n<#&(qv77`#f1zuo@1(NJeRhJ?TO}9Q$#xfILqWS*Ve~;E?mhh`Erw>i zBHF7QUP^}ct9>ZLNyCxph0QPHt_KD#Sxx|QmPH1x_#JogTP$*6g?cT ztT_sM#jx)>sEaoEloD0f=AHH3knwAIlQ7i%RH&08x zRoNNh>zBo}O06lkKaydw191DL(XMFQ$<6PEQt!G3nLgb#CIFw*5)~E7iEer4BB^aM z7JFL+a%eiR$CoYvP4^OCOx{-+#<8miM3ypEm-H%dLfkT5KRrTf(qsZ*S*+Np-6=i zv138xUoGng(0e8(SnYIc8<>KCvz4^>fPFOr3WW0YU6mN*`0xR9C0=RhRiY8;Nzl)< z(ZrhUQ|yj%ay)4liD|sWKp`f=mV0V0K|mF70*9gF?E>ClDd0#|0l(#;tnZE~3MAPK zvP}?w69n`Jc+U-j@}r%`A?gx)ob3y1(?@ zRiJ5Q*iFLIE8)!THilT6g}yD96biHW5Cio5?}J^WP?SyDZChX+pRg;ph{zeBk`N2T zVLMx8pk@J~vQaERL3|5&&NR!YS90P>mv|BnGI@f=MX_34=%ULfuV7s(tmE7Rnki2= z^-WG&E}`u-q1xxx-i=gY6Tcv^QZfp}QKS|}$r)LUp4!{{X>z5A9-H7R9tVwgM}b{& z(mFN2b6GNarG*qN2^q$rmVY!=_Rng33R0Gu2l$RqF{FsR_EaMz5YbrK=j08a@v%Cg zz}%5vL(rhtJl7%%ES|p9Ul9)4g?cxHj7LWagIv-o6V8otAT6wv!-iusNCc5k*_9 zXz5!=mP%xV87kxX+2Tjsq&RzEOqj_gS>P*tTDy9i4X)w+q?FS)Um zc&uZLL5fZpoz~(97l>XRI&KUs_$dYBXu~R1SEP#^{;QjmAc7Jykm-AW9XSC0*@(>< z)11JT7>$M;x+9h<5%w6n%g6gbfp7DS7uFv|7+`CfS@Iqv8Pj{pL6o1FyKms7IR9%3 zKG)0dp~D*Q12`$|BMXHMMuF+hqufVPq1<=1nqrk&MQv)63M?~z5QZ3VYDR)tTGOsjCi|j9hN>1K&W=?>GD_11q(&vbKQSupW0xGnld3t$1=I< z;AdlEBxX#E%!DgKKQk4U#ErqAV`DW4L1Kkz@5iQSmah%Ja(rvCgy;?};g2^VJ5IDz zK|9S38(leTAHIXMrvO2D7AZH9TTKgMOf0ZPO|jqD;;?3NB-D89%n$nI%ngp`5#)|6 ztTmx2=TsQk8E$CR95bn3WFCUEMP73gM4hZ{4#QYVfUnO10*5}Kh6AY@olOS@VsDLJ zr1+W71hOxklg?b2sK*Kes*E}9z5DyADS@bs;5ZGZnGS6FC%u%~r+c7Qg^b9IiGnV*EHd;jBJPSFae2tBc_*OtskfoBajFrLUcS1z2A-VlmjpN0>%Bb~ z!p0vcOJZO`K-|_6BF$RoyB=<;;?|fnt>8%(aa}8|B$zj;_E3S@R|LA*IKhFA2%Re9 z32Sp8W%sC-^|7hcqz>TyV^z?bWN$OPLGfjK^yVq;7DkM}ukY$Y8^{OD6^3-!>W$heun zffjGFfVl5U686W!@OmO8R^phW(fB4(t;OvaBdeT$iXosGQr-|pqDtDsRdxp>&X%F7 zJvBjq864qS)z9c4=YDcEq}uD%%4|h|)lkr8dm9MA*+2%6Wom_MT*BgG<(e~cwlG@~ z5nbr?#M5~&5P=al-q<8d5llX$=v(ncjKC9TFFm5&gllpqrC)Yy*d4JtD})2i4QCOf z5M$EqL|g5r)3RoLz&M4~U{1)2Xk2qwASi6nD}mOl#TPFDaD017K1a4vqCgB4B+BDo z+%tUhCI9(?$p4bK#5Hve^XTqpn>bJj>Y8_um4FQy1Psc>EYEVLSE15f z^hf5fg;tUkDNiUT;SDZ!BEi1=1yorE!{69c)b-dI$7U+gL%a#e(0qUp;T$Fb3jaw5 z0v2{AN;JSA8<^99lvWTZRxGAujt_swS42{me~$IxK88b5;$@+=HVw^T_G>_s99om? zDYzIGX3-}YXk&HO3Lv9u@I}WIP3%kxUXvz_&`({}hwq6I+{{2Y;?-&D9ZTbyhs3E# zE8^TEkwEz~$U3uKX`D(lJ3IiJAmw@qkRo34@AZ$OwR3P0oZpUwu(!weV{6=-8{-O1 zJtcm#)`fjNLG?3rgq6}Cglv~U*708s46Qh69QkIKjM%>J%))u3v2)E*RJ4Z+sQ26rD z(4$1cm@tNOz`~KVz_0f&1~Y!W=9nBl&)pGhWjGo%XIucMbR$|0yH&hmW~a%tAx8Kc z-Uk!CfHdLXz;z6vIR>eXZa~5Tm3pWz zhpWRXaA|d#S%pw6d#L(%gO$e-20s7Z+wWxReh=tZEmjMd@%;j~fMdz$_uubg)S|Pn zvYkKDSG@{?!X86J>oWI@C2oI|(NQh5S_i5bG_i$;5AO~2bel5Pn^()Kcd2k4a)NLc zBFcxqeZN0^%x;x(KOWEhT4ubgzHys zEHlmC;!4RqU>BnNy#tfJ5FiDn^C?(3%+-8WON=Lqq=Uo@I$%$=ob|^@yx7GXSTR5e zMFRZvCW+@(X2)w^i!if~66q`^MMN>Z^B((`zDvLt9LcIt+?Is0)?xRzdw5i9(eRnk zQw3jnII8%)4;d+yz)5h%l*kyFDA7?PcypbL`Hyun5>VKrAuqxy}SFxM-_NwUlvQFbS%K}jL1AbZXk`2 zS5ZKPc?3HOskF`LSaNQwPBnDot{1Yn&cW5P*1MRCDrTpT8&-h z@~2<-AzAG3-u(mT%~{A+!)T<4^c@#LJpJPFa2sger-+>^$gvn%p#Ulep-7~g62liy zA3mPaF{VI}Kd6*rW}MUt6y{Fz0s8`|H=-@`Qf!GU-JBv_kvCUde5X`ligl(=Fo$0Z zFn5a|XnByu4M8e24p+odM_6Ezkb43rSpa9c)sDlYo${g+CU=dAAv@dRM(xX34`11b zL~-R7p8d&keMVMmc)EH{(CyCfhfdxZdsdXAVDn?f5&&)fdX&+e!E|jC0GaJK67o4p zb-Y08%#e(T$K)`mk`_ywCd(7Y>ns>1>8I>IprXYZHBTW)YBJeb zk_SCBo5k{vENV~ z#1MG@1bYhc@dq2M8)7Zj$7{?P$;+LETqk-B=q8Gt6Kpuu_mja+Y2$+E%Wm!*)L|Ka ztkIqgjS#6zwtju$eW{<<8NiC#uACY(##vyb7>np~ZFwmbDit^A#tL8qm!fpk{PZTP z6dZ-TW`R>7Z*Ho;m&mP@m(fD*#AI27QlsIO6BkA9ypWG)no=mu;X`|SZ#JedDaq}+ zy;h)AAtZR+D2_Q7g(e`$$@MoQQ-o_&9B8ubn z=B6%Yg2b7iNrX|_!pdU)h><)y)jTZWdiU6K1surG(HNSh(`fk}2&$ftKhz3_tPwzMtDW6~EoKss9Ri{4s-$VlCtM#Epx zX$VYlrP1R)s+tY4|9Q(BO9mig1LCh}JN%8kM-RSy{K@CTA3k{c$>*OxU|`lion43T z?fv?;LkcTQ&cPVT;y{%WEuj%BD(mflMD7yCEUOoUBm6Yul?OfbCp#9=5zF4~KICN< zpC#2j^%SP(E$`v`Jzw!BFTB=h2kEtL!qIxBv~+laMF1;>>mYgPr@#2+9!2qW%ijEj zfZQ|dwoA+5z4!Z-!~3&W2Xf^nz1NPXv_`wzpM3T7M-|{CWpeMmx7(W`5#=7n^ zYVN;t@OJkZdpjMrl5x1oq_Q%^2P0Ysw%b;x)zNAg#xZDJwh)4lKxaep81(PF^2vz< z9pyHUf(0pv#8$UWV&#TR+3BG3s@@cr#{uCkQdmXGn8ZnBtan&$Mf?~8P9sIm^1>#~ ziE^;*ZW#5>xw6Q(`7GD-i-D1DbSc4qb#zJoSE*S1gE3KJhQG;Agf@uG5w&+hoCW>u zYGI22hycOul!o&3na>9qSKAYVOnT+oovGZ;wPxjsDpiY4*-R_)am|`P4Rchna?^Oy zxGsV5EWR0Ag#yLqHFCGIEm(j6G!rK4pI;G-)$-&%+DNA3n0#06S zd8L(kie2gkV}(f{fD5w5B%~{jVMQ=jryj$9J@1jr+Nc-Ie*!T+E8xp>3p9PWOr?cp z$L$Vv2-a*~>%hHFG)7`4bO5Oo79Dq?&0P*Tyy&wFi`KtAy~424KJsI%xx87i7_Dh< zKCMJ5u#K?;3~NBBbvE4)kYD=|n(aeq2A>|rF!(hMdF)oEoz<;Kj6^tRcGz3O+sk`UYqFcaT_Ob6aJGz4cHwo`?{975aA&rQWjB5 zdLotD0A`Oq=T3ki4)okQgWfRU3~B#532KLx~Q$CQL!_}*roCf%53DIvOkJFei#qnK;iMU0+%L_~@6KqwAwqX~CJM_WS z4|*1`|9UzEUYWlnwbRVJMX*y2;%9vg&^lR(CZjg7CvR5#N4kz}IFb#w&E8gVGaufy zEmSuVyQDv6FQ#E13AiOSf%&eaEF7D=Io?7&nbpg-Xdhmk=| z6lC)U(YEy1<~dU%7ZTlgL6jw(Yf-Nf5PA6ubSkN*A-*DEhHcmzdWJ}h9>7*pi`lqf z=?Wbv3LY7PNR+z~6^Cd#4VoCf9vz|I-AM{(ER{YGhJ5!DloBsYmquTLN_`9Hy}e&H zFE{jw-JYD7(Zn?HkE(%f+UVul5*;k+C%6MpxYKwi_#I!aF1Brh z^|EhF%%+4REl~tBr5BwC#44E1;Rn%gIf1xxadtAfz5g3e;)W4rn-6fs~wi)tj?<$35Vu%>c010Kx)mh^hf)*)aWZP~t zKrNov8EpH+jUyj;Pde)CYZP@b)e~h4? zxeUBn0J|M+709J!jV;qljjY!@*DAYBwa$E(8Jg`bNdf5 z|I(Kt89ka>j%sj4=TEX})=o;jT(psNOp;>sp=zNA!bAf?p(#$$6x|yM=)bR^v;1A zA@CksF7*P1QA^8hZbC@SDN)#0EC}G3yKNqndkMRKxSI!_;yoH9XfBoo-^uE}^X^+d zBAtY<56D6MO5Qi@@;?8CkU}a|y39F2FCi0<;I(InDKE3vDJDQL3MEyS%UWe~)8LFU zp?ITD$Eo@}@^;xYfG`uq0*TuYihY_k&xW}Mt8bn*GOsywf~9X|nln$oBqJ<*T#W*$ z$Wlup;pX32Q=xW-fQq+Q6km9X6u1{;rOQw12Df%Ubs43aHZdb1 zY|l0v1KS=A8(Q=Bjvg}}=-qKrag36&ZPaC^Ce)Tf``(w0M}zsb)^AS!f_- z)!>ZaGM1+KbR5;}&xk;3nWjgN=NU(ZRW5hFTQmJsyAhI9M#;~`2PP!PRyVh5jlg?w z#FxUNdy13frbUul+_t!Q`rvCg*BW}WWA@8e-J}D$sS-#hxYtoC=5$rIO!0s*N~t3e zqNec>Zc$W57*L-x(bK`#f;#S8G&K~K`W`78Vr^-9^B*eQ>XV&67(bz(BCcDRTc<}r{CGj1>a~OMR1M=22DXGSuL|; zgrMg z-46_^tSX@R!n6R8nBI-k#XU^oR9>_uc~VOpBEJ&ngH@0hXc#$tu+C%+zS~@Sg~4m9 zvNH=+;+3Y0s1{1{w_UxMG^%uHm?#)T9LjXmg+v8Gu}|V@}SNYV1a~gCs5oLsqu}#hp|HlqZi-@jj2j zeeD5ZCgv7gJWTIPnCafhJs~FcZ25vhm-EGsd*3a+h_h~AhtJrv%hIiBH%p7sQO)uU z@~N+I{u1A}l}G@zmg(C&P3(My&Ny1`A7ds$B58}Btt382OQ1QHtUTO@z<945W%Gs% zwHzA+kZ$&-5~y;P{Wx%0gY}6m*$)XP1@VsA>>eViS}4I_`I~% zz;_8|lmgQFVb9H@c}5Y`DG`L*=d1N*4|%;hw5b&d9?3StchBnW;5}j!KRWLh;Tzh= zps=2XyV;dQR0uMUQw^4bm4yS&y(=o0edF%*Q6Ju}Mok>yo{eB!PX#ZK zN74eHo!to)3j5e=->8qn2R>GtTIc5>fiAqEkp}ao6 zVoplr47whjiiLYk%#IhADPNg^Pz~#$l&>E=x_kGY)cWl2ypJlojSY5+?%~}$0Tcbc z^|B$$`k^ZA$I*?7IGD=^zH=~2k?;+{P|f8+vzj+|TI&@wqaH&R1NJnsmlDOjKx`xF z(UzfNhK`O+d6NK2O{HxGjR_hmfDn9Wg0tYPi5L8V7sV5V-q}&YFbdiDS$h<#I;G~2 z^bXkTg{&BajlGE2Vvo?YU(M!i9)i9`v;HA=;-FB?s6mwXWyz^OCNk&gzOg!>8i5!t zi!Gk8vBE2%e=1V6e^InRHm1Srh5;h(sUu|=C0#`Za3~Us@u)8%P>};4LIOn#=w-7B z(!jN)^?*b{fUP6>;=7xHd&QG^RQXgA1lo;yCOxus{%o_sCd z(~VfT#>3X18C}mJshULDD{{n753F*w2Ul}n6J4fTxL;yK5qOOAj0x3_SLq3C$TIeE z^;7gV4%g7JqPji#hh6CROl(^Htz{_nHm4tM#$T{Y2o0uH)qvsIqqXFo7UC7@4h^Wt z8q#*M-NIu=hP$z&g*gr*Ae^|g>+8lG0wD1iKWCyilZec~`yvZX`?X2GL&mHD!q?x`}4p4D_s10$sINaacv%kulvW*%E36!)- z=;<%uM(;m0?aB*H6sDjtK4jaif?@OyVAno3K;Q=T&W6xt>=`RVxjmBJq-lhxZ)p3u z^*$sZ;Pzj%-IkYH>OAmagFG^|5aY||4Sf-*sJ4H0Xlf?s8Ye~T*U(1W^FtE?N7f;X_6<;_FwD=$3$>|I$f z&&W7hQ%ZxH1klUo`JmM?dn;&1Fiqr~$`Z-2{Qq2HHX`p3pPHD;wA*#~1xi&$g1Y%M zLgdfqqCtivj1B(snrW^I;e7MAjCsCRj?#J5!20#GB^Da%H}@F@IjI_s_{-soS4RdX z4i!v2cn)#*=s8E`?g#kC<3&@veRi3{W1*`ai$a;24w?y%u;DH?uzET&iZy$g>CW?8 z-v#(-?{3TMlmz!UxF|zTpoH#=mNG`#z$g@JwNfo?s2b{C&_k~8)Hv|aRtl3NTfrg3 zEA#*rRrQKQiTZ_r3q2mmKkI6KrR|S<13zCQ=v{U291tw z%yHw%U@o+2g*OTmTP!L9?0CcLLRmZli^QG+;QqU%lo0}{7s(;#wY)Ie=0#JPM9y)r z>#e4(Q?g4k4aY{eY!_?B3UbG7Oh&^5Am%P1<8Szc0os?#3R`SQEbuIXwu18Edh@*# z7JmFWjVA+^ds7*0a^Z8``RCST7;rZrA@cRZ7XLMn|@ zRF&s75(I>JiI)r{vGk<{&%O0Vx_y`J6K3j)0Gaa`5f1YmT}i&^JcB$8wbbduL^9S0 zIcvfC=sgr5)0|_+;@)so<4Uzg}qAkItM~gUX#O z5BABYx`~M8+;)SJ4b64wDrLun;zErjq1d}$6$qigf;RaH-zw7a(G4rPI@L=;olCIo z@=(=F8l?DmTSKR!qSNgp z)~4zc>ze6}q;^BYW5M3ohBC`q>eFw{;DNDfg9l?%b!uyjRpR-?n-!U_6=ZgjuiRNz zgWxw7#@M(Pj+(JM0LnW_fULrhfQ6;8JB+L7PQ_tO@T}M>;`JDGy|$coaahXocF6r< z8`6&)Bq;Me51-xWtnBY%hZZp~7BnpJx;A5Cn2^mt0=Cbf zixFg_FJGp_Gc-}O#iQQ01Cu^wn|ZB$+?N|=DXkxR=J4|LRz8jFHkMD7R($&SC|AC; zp3sG1)iRYR>>giiZ_h_-7z&Lj!|{iyv%wJYb?42d46h08AZ2E7ityH6Cswh1&Elkr zrlROFY6>J_%(7F$DAYRTMZ2@$Ue&ZfHO&~QTy>IIBXzoEExU5=N?;YH| z3+>a=OxLcMNqN@C=R$c#h_mZ9u-40*=oRp5?@E-6ZMATh2!r~pa=x+3U!BU)a@ zPtyb-iJ=y!Xi0PCqcKFe2OJ_I`H3daa0JKn>n|lN9XiTYc9^Dc0XpkG;A%a7-k)f1O&khpo zf=l$J**m-A*mCsY%g>$=sCBB|G+LvvY|O}d=uB0V7zZYP=e?LG%g|LFk5{n;aBP=ZQ#Bqq=v|z(~Couw$Xn`V1_AmWYS706ls!|NS3pz_hBgvcR_;K(;${u z?YLz1>bmF@bwKL-!fbJ0;d00~vs>)>_$U;Hkx`zbnKN6uPuVM-zSl{%O%)Bo6^j$6 zpx0`RF>qW_{fOjsQ(L8|0YYW`b}x5U?37SKpVSr`Apy>@ls5tB1|{_&d(^eUvVpAV zViE20hsJWOgouK-2&z-NU#dbO*im4{566ib6-?MrbDvNL)!!VGJ{}CmZDcY zCyz;H8GHaSD+YQJkaxyHzA^YlPBLy{5fSvre-$omBrzA$Jye=Nyin13!7h0r*XHst zj5&r}8!9pA1wsm=xsq%y$Hd02>N?2NVdT|VOke};)b}MX1OrwuREnh}pdiXC!KeiW z!g(8*&?6bKPusw`^4J$8)YJ>0Y|E1K9@RYo^Z3f52uX+)rrMnQHVro|^;jEHGS2~g z`&)R4Y7OF{C1(;ka5yX!UU7V2=)OY6Fqw*eE&W zEKb%mv)(t8<|QK~0VA3vM_v8en*gkVx{8D9)l%F+Fj9*&V9qhB3jARLW2bXL(Yg0< zYL;W?xtMDhxruQjzGt=#N;FVTX34Y?=3$U0K}Ofj5(kRlyaHBn$4XJB#yv-W0HT;u zNzkDP!T?6g1HgyWui4t``t=PTjh5BJnWsj1sbz7EI3j&4&qaoOYHahnh53v-(_`cR zNqQI|tW81+Q&&QvlKgb}i|&Le?_dpL6-e$g=22e+ZR45R2oymS?<;Cczj7*+O(L)C zG`Z3`Yst9|)(vD1J-Ug_;B1ClV4Yx|+t4gBMA5TI6#s^`jIn`2;iMIWO*8_Y*duTN z_LvHQ*QN*jpV319O0O!q)!ES0k40XW)iRwGSrJgp9DTLJsRnk&Zj#z}bRGCAepIYe= zr<$mF(yw3&l7qGqeEx&QIe=yA#~r)Ss1Sv&9#P3gwFK_z@HU_8>HB_&-ozuQ%I%(k z865KH#1dg5^0Qzl4|iF`~n^iCy*;HV11)=M{*c42A4 z^cHHNKr6VQ&@j?;sr-n?#%wTb#;XGg!Bd0?vL@N6TTJCT{OR^yv~ zt%1iq(#X39@wT0P!@J<<&fy(y353E;znq|u1IHI7La4@u*9b_o?s3qMeW_@CUEL}6 z+brR*<(a%vQ9W#Khh8+>2X=b|T)tosT%30Ttr`cWv?Z_xW~=8M(V;xvqI7xx5;m34 z7lt)1kUyrmYy3gy4lSF&w+sIm`Q>@phb)ycDv(}}N|?m4a!PDqx7JwMmPtzkjWYm^(YHyk%>(li(wuG(v zfD_eDE%Q~=)Y$>%D?|dO8AuJFxwzTYi<(3$6r+p&2HP$KG($mJ2|draoSSzOl@TRz zL_sAl1o4C^ux2CChCVu#`~JzZMxFyL7_X^rs)J$QaWIvt*CkWa>M%HfW4wCArK~?f zAXPv;1-lebl$)W#IOZ+|V>>(l%OJLzsD_T(c+VIvc;)%Q(E)`*cq3Q5{c*``j!Nmn zD`3X`)N-f<|7cb1v6Fn?LHqdT9L+XHGstg*kJNr&NC|W)q}NwQP-QFa@sKPEHhES` zzqRzmg-WFoE3*Wz2zFQT=%I*lyAfPTM$b6&!Dm^ibIb7HGpMbPK#S$j_f(C{wX;rT zMPvFE+W1jF=IF5u=4yI0{-dRI^xX9E$fEAJv34cP7g+9|R{ua=MxGNBg8-q$Dm?S_ z5e;}aos_Ei)9Yhuq~Cb-u|m`ty}!5j#i$8#K%R~jQDibxmgsh&F8Ip3*F@P-dgYPM zG&rF9jlC#70)VgXAb914H7)X3NNak2|0x~5`2G*hUUZTsylc=ep10zH&XMRO4qg(3 z(E@ARphqLLmFhqij+~2*E3F=AmRwO!_KCcRuqFI zT0Dk?nF&QP!@0s2(kIaa-u;qO%JC%$E11yF$VG@BU6^^(pHOK*MCq`4`%3+B_Ag%R z?~^U)eZ?r0Ck1{>_SuApu1P2^Lnsxj@4feyfHk9Y?>+&g$_XKlVncDclYrQ_k52mp z9W&phXb!}~mEQO+Ln-^6KxyjUX`5}p>M9Jg!&_MqdC}=bM{<^P(ZQ`C6o#K~SM!d9 zeZNZ)4?xP6r^m{tb2MZ8Bt+Z#9wIED5W~c*+!}2hiv%6>Y@&-AUaG3GQYzjYz=><2 z1%{8!C3CSh1^2K}bfpYiDzf6rQ~77K%z>{M7-Qt936M&zjE3Vjqe?RTvpPi!j_qRi zGF^%kRM_6T_ZHLm!JuUID<+bDz-;q|S;z0aK9uy=KZ- zf`m-B-YKz!qKPohVxv%ri`)==2>!O; zE-;Y4^xSbZF#u8mIfKPlP=NRM*&4mrT;6=sxC&wAOVPu7H6j4P@(|=?6cMlSYdzS( z(#!*&Y7XG@uHq-vuYetkziu36l;YAK&>+Ot>K?<*m1%^@VdR}CHP!|?p2Ha~HR*FI z2pW)as-0hjv-YHRwIxb7v^p_2=u$&e2gkNfYH z32dAQt}my~0d9<6>1;nsXtUnUUN5xS^$X^B)F2hlV((FFV9-s(tJ5^;&$PoovtoV; z^w8Y=AE4>+y0giF5LT>4C#OHAI!@wK3y}A?u<4iz*sF5{dSisIx?bFa5iLlA=hGCY zf;zlPEgV_ymqtrVfewGPTw9#SpX{J~0#V}0u%c`1QyZcYO=OfN?oqQ*V9Mld)9^@z z4JOI8uc<`4F3;JZVEudpQ1OC3C+EgHRqqVXs7}Q6Y7xIr7iZtDP+1(ZVn{q3GUr~s zP)V{EC2@{%^!_+J#PBV_sT?Wr;1&XeFo?fM6#jc%d%r#DkpezCorF?^43F=eqt)kW zba+yk;EGe2%rUrppx@1`f%Q%4HVK3gQv{`XvwTVN?7EAHY`EDx+Iv9)2cTf>=;xy!2hURHhNk@mi<>LP zzUW3vI~?@ZHZ@60g;?h9TUo|-QYlCUL4>tDZ4$i>tx3LUwn1SZ)vjH8NY@sLc) zY8`{DgW+IWyJCTpCDrYy5ic_a$GnIsGdBbQfh^X#5*%)G``p)!DP}1Mh)X^StNse4 zo#B8zR)grjBBo066c{%~N_Z&joSZe@AO0*d(Y(2?tZ-Xd^>RrAJiWPKGHNROI6n%um3}YHjSz85FU6>}m%tA(H()&58VxlNq(OUh zOFs(IKLW6nfQ<)GYxODbp|j~&x?Jj5GPyA7=mem~g!IHpJ#bLrkWbSMERpjJ-bCp} zSjby`%^L(ty}&?b(t?MRy}j;DWN&XA`#&L)H1=~|SQO=Z!^hCWn9t22aGZ$q<(7}B zafKFFgnF$e2b>8K!P(fIR85g>qW4-t{h%z@_GSU;M(pl=a2JNA7@zEh@^)={0fO)&Cd`(-B-l!fhO_y%N7W0V`Y_FiRZGqIHkS%7_ufn^>?U< z_C2N1@nKw^7q+c;KuURtKv+aLLPAB{u+}=Dh4wR(9`*ykTOU#tvGZ4G)P(ObGY(Qgsc|rD`$}yh3 zw|i8hRRjK)mK1vzY|jo>t`Wv^Kz6?C0&*}I2rD*SPEB}~ z%TZHy4vSKsvGcBrowq@tAbt7wXcEfhQv2EJ_*fNCCcGQ(C5hF&QnlIi=V%qq)OH^7=^{umRwXX$?mHnj3w42Gj%D%bWY$SG%`tH z{m2?YkN4m!8xo6e&~C~bGq8oS;e$$BOS=}79n(Yuhw(XElGQlMgSCB&&M%0bPT*kX z2&qn#6_^c1IZ!LDN=&8ESYh7uGlQ3q)s^iwAZWzpX|E6Fgkx+Eg3nxo(ixANVXcB~ zZE)z|G$DPIDz6NWXHV92rpynhDB<^8SAa{Eyl zpQfW&E>y-e2TG5oeObO-S(6m=wCjk)Y20=_mBXb{9QtcP{x)DL>IUo(w5IUo+T;L= z-k88svu07S%}I4u;e~ht$un}9&$+ufw4J9a025|T2r-js1R9^!5rMh0klZEcz2`<54kKY|LPf(gUYb6eu(vu3ej)FqewQ3X0~BtduK zS}}APH9kucJ1JVl^`cOygbN-Zb^5lv7Br=TZ{9e!&nHJ9*UY}|xf9sJ$nR%28dkP% ztWaC12<4|u*ofx_CHjdp%Ef$c%HFGlWMDtE&bN1K9mU2QO!`ES!m z5DM*}=;cyfCB0ssqdkz-3_?R4U^X&q)!V94atsdF7#ONQ?ILpBadCEiX0e`@;DABxkbpwy{m56#^V;daGF>+0XKeD#u~tZ&7Qw_ z{)%ch$5uybvv$q$~xj|oi9 z75STR24Cykwd4$oA&P+9OayWV;8)GN&{!EiW&GtW8K!w*!9aVPT`-YthRIVBi9lT( z>#@q?7YvBJZs3F5Mqik(T67`B^;N?%RxpDgZp1>4DTY~`A@J?Z3Sg^6S@_A7LIQ^c z6uHSNsmv3N7g3Kx2l+K5ouJ2*%6D@K{xouM|L}gvI3QWm>K!MKoGp{${5>_bV z#W>s(z8y8IaV*i%+C6wukH*iUMI0l;wpDs2L<;oZ;(0uYvyk4rA%+aZZQTk}D85H> z`sC?|#6%HwT*pRdT`N^rFw%}V20es-R^N>$WYIB|z*&%&+P|L0M2>6%4A1*^^W)*!tM8XD7=ZbFsSr%E;^X#$)|v`a02GvLyWGD~rJzTs zd21#0cY4-n#C%c~YHjEH=s>LySLI_*%YwWeuEKAvs zW=@w@3$gk*ZAiwhB1G#XDAXAE))Y;fmfkiJbE#=Gv!X;|M^0oEA!S7rP#0PCF^vA* zM76&NpA}lp3Al~rcy7(EGVY$@wX6vjw9x@drqXL%+6%qzy>mDANR6#_@3^_7JCl&w zfeE8rQ~-by0t5_nprqajYuUfBYgDvYikWdaUo?7mG>1dA%1sgYNkOtN5`b6JL@ zcH}O05c143>>>lP~VS4d`w^yw0FJ&CbH2 zFWaJock!Zmj$k7iq(VLbjd6uG#o1=_9OK+g8M!F8;;;(Kh^{WG z=!j^l8TRM-5h6|aRgy#rLY*gd4%Tm-EUX#9J|Y^c1xNoA7KvO8gY}nWjmm9Yy0Lh( z&ED|h4i@Ke@5wvLg1GVEEa};{@;)>PA$Kp7T^LZnZ>%{=P3pOK3K?#`(t|TU0Mjvm zPdL)C_0E7kaRvmsP5QZSzh^QDzs*lwffvl|*qLScGaf^09-8U1#k3=8BV%DCGqUau zcbVic$ypBD6iZ%sSQ33o@kfwNgasxs%Q#oZS$l$|4UzAGSj;W%oZhL^QrR@j9qH%r z8kSKg7p=EttFK44?UZ<7nN*`XapOv!x00I zr?pU1TD`HMtLH;!HIa6{@)PWTHY#z>qG_I!{ZKTBPBl~kqKv6j!BB>mwxEeec06af z1yC7!38H+o`+jEj+PhDH(iB>g*``@`%IYiJVc@1zOKh^}9vaR$kfu?JunXYF;Y{?R zHFpO5KWFM{#s~9~824r0u8=CGhm84v8R`>I$mmkE${C|kxe_L;1!6Y{WW@k1etjWq zvENg}3*%%kO0%4qJki2Cj`q>fmKl&Um09ehmOXlyrk=LR}5!J48Mnx5Uk^A0oA1b#rRSy;ynnlk0}h|=U$ zB#f9y*bX(VB=2-li6}RG5E_O)W4EW2>z&Nw*P|pG1r%pLOoXUYjFg)ePiSRqMPh9n zOF5#PU4s>8?S)`kD43TRNgS91x((B*2_lTbn=(JF7+mAZcY^ab&e=pr9I_JFhY^$@ zdgU5zEUdC7H*Qjrba9^>#t;-P@$tpfzFdTXqJFwO<@p`Bw_gp#Feb73vN4%!I1 z@Q_sGupiPws`b2?=wso%s%d11Dg`vN1f!?&dqBhDal#@xunQ2Du@I$^G|Xq6>Fw%LqJj$R zdh!uQSVB!@{NM_kFBl`a-jcDuoB=##ya3!@tO4&lNac8Czq>~oiY7IJv`MpG4k)#s zFA0ZfU5^?02xn(T5amN=(*DeIl)u8W{IiKh9n;IrIoK>4#hqjQK_@3dfAvZMV9E6; zI%?5#Cs*VD8NDq*7cqx+0)rKNCfR$4I=aCfPY~kBaGxC?{+iS;xuU81C6s9}dz6Uq z!R3o3o=&hmN_JV-WnRzSQR;z>AqNB(W0KGCaeMZ14TzjQ`OtAT^w;afxY|r^jk4X( z+YNGQ`hqb%z`w&(4kOPhNy{V0?ym{nu<|TZPg{aw3!mF4cu7}WD?LHkm0_JEu`BPQ z-WK3;AsnBf3R*DyYw=-!RfIKcqRJgB!oRLHUW>~aR4750^O`^iioDfvS~Xw{O9ai7 z(Fap^?kv5)Gfi|Pf5-7U9-<0!S+*(BI~>X_Hvs#vQCD_g_5sfHOTS{83dm+jGT#id zp&CI3z}lQ%EQoN!f@p?Qt7R{h2X@=@IzHk2R=<6cE+M?=6d%aB+cFekoRD?F(6m*UzBt?Ig&udpXNcknu1#O7bW8m`!GSe za}c28&}TNF6T-t(c@^Xf0YHdnH5GvODN0Xa6!vtDv4j@j6p0Z)q?x|eYP4or)C@&R z97>bh`!0v;Tfp~GhrG{K2zJ|9aSioH0?&OtW@PcsGEeHAh+l2f(Et^(lS~NL=CYYb z=ZwgNFG><11lbJoiGkccKgmAmr!4vLJq6@;D}GnV(uQpIk^G0U!fHJMYAF3mwDZ|2 zv+tmSlwj$C`bbS;eMdZ1huR(tZE!uXNMR>$9s5%3jC~QQ;!tk2Q5|K2f^C4@GE4aULl0?mdjW6n{3F0xx*h>TAq5{3kndXG*Q-WkZ^6fp{BEEmcu+GoBX=^ zISZ>5y$68|EAPyOgjYDb=bLELBW3#t*sd@_zV?6c%dW+bt%XR7Ezkwi84q-c9xe6_ z&(?{pz8CmadxDfHt9(Qcdk~{}(#`T1cGv4;DnhNj)0Ms=D0LGaqI?;_?74c1j}4eA zCf{7Dgk#OPnI}8Jg%5o=grGspLKrK}0+b-9Ex1koYMFKJ?ih^J+X1n4FM&Pys?rI? zWHVXHX0dAHvTlk*nK?4ebanKFC#qWIH~~cRF_ak>#clyD#0XfiF_x5hYx_igVR7mt zWxFFJ2-&iIr!>Z;q_$lVsD>|J6fp=GpooMx7_@ZfaI^r(p^tiyM+Lf^k0VRS@gEjD{;uMRID9 zX&3T`<&?l|FE1WdyjmGhJ+2{%G3oCi+t5{ReAB3CERq@!{T|bzN44I$zvAQO)hwA)X~KN?_WRQk;$bv&qRbLt*yBBGZ^b(4&4XhDMz6|(=%{q`mZ|d{ z+&mtstiw~5MDnE^Nd^aQJ^2QmoiBOOXH^O}0}Sq%+0SSL(!ADd(-MiVZX{_o;5mde zTB>A+lgs%tw$`ZyNxobP!oGf2rqto4MpRa7J0Pt5ri&4&&q7By<#VxHLW^c!8 zym88Q6mi@w$b|3u_?hS#PBTryO5ChL&~r}Wb8dvOE2ngPWc@vC4+?9R)V+gQ3u-xP zWA?u}NH|rgAhvVaa@i1Y*?b)ZC7Q`qsBL>Rel+#*l}Xkx&XM=TUo0>{xtuz9B1cp? zG&`SnNi$QQR zLORVmtT2y4wQ+6EDpMmzTE$G-K_IM{C_A!dMGBF1t+fD z$M?1emSRISV_Qp&vW zpeRaWmME%4s^qS_jRQeQ05%JUl&Ht3OzR!}40+@4n}5u;)&{|>ZV%htHC(Ec0PMA6 zMa-Coe;#56S>(^2JbXmvxi+XWL2NfXQk6TN^sdXa^sOxdjjI{UikoEkqdG0GIq6Nw zQQb|-N{6|!9f8?^ig=EIk37si&++u|$=((6?~;h!_R%gkqRKx~B^S$&`scOASYI%V zlaKM9(zbJ&nUOI@vPGR_N5GVh!ocUm(_x-E6XkRoS;g*`ctbOBlhAJ&LKL%$F5+I% zz0jWM^`Zq|@sb4LJZcfK3D3t8BX?M~Ta(F)j19M}WuuNk(FVE@x?#avrS8-=_WlFa z&RJ=ffNn}8l+E+^BF#8LgA~Ys)ohV2k;buyc2eRE(h0yT@?S@a>gjD}U(~&n@~slo zXkaKj@(f6RrULr5BqHi&pc`{+Fl0$&$?AwzFAP{EyB5?A^74|H^7DfA>djO6Gt!Xg ze+sgzuE2hOV=8R&VfjJT5W*Po{3?mv>CJl5SfIC<~6^0Y#vA?=~ z~Vacp1GN2>L4N5KBzA~dv@#&asHfX6;cn8ao>YBx$Dhx5EFX~}& z)98o>Ed!WLZPcS@_ZI}?6+Wv8rl+oeKa{D1Ujd?}Vn)er?XX{%aV+7KLr%Y91z(=f zL%9~OUYO-ewby~DDbGmN4ZeXrC$^J8ngl4rB>lg6XHheCS~;c+p}zk~<61!M6%Esk#gF+x=;(J7`br9aNMS=^kymfHr4Hi&5%yn=J3x7i?{mtHO#sZp zK%$Ba!)24_o88o-x%lG~sOM?YQbTi{8p;S&!8YnFv(rOqqf!zq^NncHZ7sr!nZFh0 zx*y)|T2T)S4mZXTKlff22$ht7tx5tg%b`p7_QYlg2u+o*jju!JVMRyrtDgaR|6DY= z#>-F0e*Y}AEwi1An~i~&Sui>zDyet^ZV}Zv^#KdY88bL&-z4sIycw;dsvZ_J^~*Vj zU%G|dZ1#_7&Ayz7!pJP$c}9{GE9EeA7PJ-t5z~ahv|2UMnTQ}#Y|nX7c5Fhidj4cn zD_=_x3f}FILis;>+1Ki&eLeHCgCgQ7iATfIq6onYEdiq_kfu z(3c%=?1OAzWCmWz;y~V!!yi{l8YwG+@JSW3m&sSP?cOToHq_n1xx@PqBZZH`Jo~%1 zOpG#H&ioVuhQB(F1+SddK{%^-&7aLmQfh>yyse2aMCVv>#C5>5Z$teleNzRC>4VDe z)^S^=fw;v56=Isvtq_AZZQE|OZ0VGfz|XGhW|XLfUa3P*-=yOPahJo_ySPqp7wz{j zhKeEQL({RKxMoVD6noDg2-A}m(% z;ncdLggE>AFpbZ4OJ--k9;QRDK!(45o}SHrlQ=cI0W7K%poVvW2J7nhmJTlBMFptK zbH`aCV3h*ZD!rc;jP0!zLz>J-Usq|#4oLJ{zG@QAL?v`6Qll}JKDFbK$hh_;8T>f+ z@~{q0@tY0+%E&`1<+lQxUQLH)pdB;)X}$7&elb!u)GPXC&5_xQ%Udelu38xox`yR%webx^jf0#b~5!nKw~AKcB#Zd65L zLN{Y4Mh@!kD7#=d%)Urj$1b4<^h|Q=gr?Q#Z0Y2!5suK$@Sv33yFMlGC0J8z&X3UE zeJz5!RJ!Hh@THG9Z#Rm;)iAKtqudu$7N;NripHu79W`tmI&TpVsycxm=q4Ulu&%|^ zv-y(F-xUF&j3ZhZclzbpoD3;gUuFS_QtGiL%o_jgt8v*uSs|^J&tH&lz3d_-u zwF1Tbv4$C%{Soi1hJ^ePiJY3OK*3vOAr}pSb4h_N@O)9hh!hbxnXS^0&^lbqYvkDo zA6f9{xMA@JCL4nor#JefTa2VZ%M|>&Vgw!LgYfW04&<=NbX^-A{h`XOPwu8e=3>gw zv+Pf4gD4tcJx&Mn%Bcr}P9B%vBIcMb2q}>Z>b$HLVp51qjUK@@JZnm0+Y9o?#P=N)*Vq6ze#(it6G^1N=OadszgRS{ z>9~5$5Z2wMP0dt0I3sy1IYub@?==QlKt;g+C_!?>!K0vb&}IdJzQynWMH0 zbW^SnM#ftYD)%$i#x%>0jf~+nDzeQKp^P{k9t{^(iY#H$;-X3 z|8DY;^QKH3s!eu?$WbSSBVb(M#3r!>t(zrp5CgTFCS?pf@45>qiJGl#iTV>*|LS~? z7+YGnS8*^Blro8OBWs!zW752w>{8{O;8FAo=307S#nXUS@mQQzRTy0T zH(R=P*?N4-0Uu9)_k3_>%UTG=%d1#h>d)t6CQz`2IAw4>p9F^>%8MKws_*LBjHfZ^ zYuqdJW!rRS+rEQ~FGY5;KC0Vo$Cr3^^jP&ZeKap8^WYswkpmbNJFPypp*DZ!*zv9F z#DI4TjU-kDIawdxwKi%H1isSaTW$zTdbCD8+JD=lj)c}uWehXb8mEz^X4`MMe-xfP z11XMMuo90|CZf1YCk?QsG+DGLNMRufixTT&)6Jm3teTb*rx`A#1%ncS$)oOVx=zQI zLU|AM9TZRh7)C^CPL_Xx!ddP(o($Y8fDa$1-@Iw13`9^7)dY@BIdY__7_%aNrDR5Y z0U3!q5TcgII>B4F9$Ob(z_(%uxO}x>pI9gjx3{~pV!KI2+vI)-fA>E3F<0wT@3j?~4BlMWm9dQtQL6(h!_LEYS@#acpSdv8_b+Cdm)vXv)aaKG1BIY_u zQpGVaHQlOki2Upf^trvN^ec-G%cA-L3+=vaNoyo z{s+GDV`q0~we$7PX6G+E>z(tR%bnw$3;uF{=Y9V9c;^=Xe75s==i$z`{Pp?Hm-W+Q z{`+j_tNP^IdgckAu6IuP_v@XLokM=U;NJ)Qe!26C-!A#-fWKVu`7ys8j!*pW5#QMC z?D5nIzy0R#XZ&=wv(Iz+%RcjRR+*XaIjfN~wj-?Sjpuy-P5tJxM?B?9R*e0Uf3Nx9 zPyFmt2mEwg^YQa@zP(>_^Lrb<=Uz_z-)AcN-OP5)$glYM z5c=kud7JadIR1XIbH%JK$9(sggH-b!$2FUaqJ+=QtKUG$Lq?IdK6Nyn-sjt=eA4Td z+J4W!pN(g)rf=-=W>%2n&chA|pgg^Fq z!neEYXUy-oc=((V&T8eZ@-Ck~=KIp9IVs$6H0I-2Z)$WY=ia&s*W`cQH|KCtV>g|% z{+o8=m^Z&>4CSafIvVFuJT&mE(b_2*Pgv~H|AB!H_C?wqU?GZl==9-hHsJY#gci*nDBF}!Z^3~ z0vSg{)y0Wu>LHf8M9Et?=pjGNY>C}orwx#4#F*$>lp(CgU zZs|X*ECrIp1D~F}6ZG!{}jqFh}%uq zv$|xb{sDWC2F=oH00^uTUZtJEAcq!XyBCg?pw+@fq=W~jPtr3tL&56&Qo`Mn3vUqd z#+zUU#j=0c>dH`VnMnJyj3Tlf>o7z8 z)9M2*d(qNWDc{}qZ;dLYeCca*rCD_@p}Eg{`{|Fl31~chOF~IU8Vq;rNRTpuM-1V< z9v25rHUHoL;S0!tH-` zQ2`#?YDqwf2Pl`NUP3fAXmS4|>cx6}g?s?0!+o^4n+4@enem~DTCg8FSL3|V2uhT5 z!zVdi-#lKW46{&C&{DxUhJq#Q)`4ezX9pMF67h$X#zh?PmbcW6nFx%NnuKKo`~}p5 z0+V|O%T8gzTlelQ-ptgb<9GPkyyH3T08MdBy#V-oCDPnq0G)M2gOO7qRifQj-pE4t z?|#xmlae#dd67OqHM{AiJVor0^yTeiO-xo!rvKnW+&)V2S+?Clq)lzEdq98| zHEL@SKF|@XEWQ_}p`KVDdPOk0t2@Ik9w4j?;iTu*L%!tWkLRk}t(VM$qHk+dNGPQB zo=yj1INnp?eGBQ?sg3}YFuXB)$Q_p|?6vkr>lBP2Dhl#gW33OdeOg7Wi-_$23ldAE z{neIeQ?%titCeXqq9qQJcronhYUiK%hBkG!M>CGo&iTeO?4yW5yLFTOi(THvQwLZ; z5#won%Nc3mH`vCkq!EPk6Eoaoy|=MZRw@?Q@VqM)_4&=9%HzTy&ff7dzENP zK`t|Ae*_fb_N9?-qbtK0);@{Fliipy;sra;>b6jV8o2T4|&7i^+Z}NL9 zaQkXUr244-z1sPn-MzQ-!OjEz);sZEc7D6~EhB%*Uv3)JF+b&b#}w_0u3eiLKEDUW zI-AhQ-F5!1#reLy8u86jK6R8JamNj2k`ga#rs36|^BX=F`-tL1d(u`9B#2i|m2da> zi;%AMww`tjLa87>v(?PkcPKns|Fx)}sB8Q1_ox51|oPT`wlDUZ1 z#AVJe>pHE^uJ3a=<-DGM!xKuIl>Ui#NFTp1XP(s)@@5dbXz?$MEMj+U{{1EYWEWQa zByVKhatgk@F&mD1SILx``hpr+%-qNWM7woEn(LuhblhZfgRtyf+!nN;17?)e3<_z2 zA>1xL%;>P9f4KWmn*(xTXfQ4iDTP+YAknlxqxXrB6D}rl^hKhxn%6>py5@v}dBcP^ zD=A=>Y7U0PrnjLlh>BJu2w^qEuqneRYa?kxak2W={s-$jT=u&D#Ve9j(vMOnP(MG$ zB6zU3&9<=&H7}uDO58{POIXV}%&{*i? z*H*(T{o~va2?WwTm6oh4ayZJvQS_5*cSv?ro3~!OztNf_WH_Fb$|AZ9rMOEakt20o zO1v~DLk9Kq`lm&QMb3{V0wg)HSXe%XC76!W&#)LI?o~oZ;*YWpwPalNWMyGRCMJ zi`$oR>u5Lim|jPaUFIyhb3KWwDs9o69fyq6WD97UeuZ*g^yVpBOZcC{UWjplO}qSKDkXYKjEI@UO=-|C2XbnwlwU)O2uQVKev zyOHPJe}5ByU)CIA4U86F*Yd4d)xK*+bcNFO7>g2Kl1Jpp>mHt%zvIvDvEOWcoq0Hm zGv;<$Gszqpe@kzRKk(ZdXE178 zO23-rDh*qxW?isYWi&^4>s06{$DrJ0Tq7aYor~uI!O7O6xD0SQf;wz~#%skKRc%E4 z(6HJ1V6>{~OKBJw3&O1Gh+Qc@bKXL5Jcw6lGvX&ll=LOOb9Le2zM2a~Xh1qu;$mvG ztb%HPCAY{lN!-1m_aLy2a*vD6Zr2l|7pdN&z`#J)-_ZKUba(A2OQq}ivavnvl2b7! zc`-1sZL|{Q6+(jkS=weVaqvOcPE|WSFJ?{Oc*DV*1l(Qye+ePqmU6jLt$9$Kt=uY& z(Gzl#+^1B_u`T7woW6N*nXw!tEPO5RM^mXCjYs(HZB2c%UXxds5h?Y*2vn38trp7> z-_|kAfJ7fJBT=n2d?K@6zR%~CAhk|(hB7KbyRK1{+-Nd&Qgp3P&KUTnOscxsh=G|@ zwWN6aif>0lsFz}M;-hEwj;bASihov9kDvm4rYk<@Y*#IU zb9hFLos7j5bH#n*-9TXQ@#iSYsgJ_6l$w=Q3~So$zURuoY3RL&C#aJss1XhiD)uv* zgVIf^s?5+6tm5p#`flA(pfAls)Dc8C)*ckBNOG;H3ga$jGK%M}*TP98_HhlC?4$gz zI7g;B?pd*0->drk`nUmtabDKhLTaq9rB?`mh{n0&#dcYg@3GeJo)fuQHad>FC3G;+ zCEF!o>OJQMpJ5&NWA)98fBESBdrl{DjukONU{`aL|({)@t^l7fWAc1ob^L<$3kCudhh@3PAnxaF^qE7EM*`f^OQJtmHy* zp6ib3oX%LBtgVF2wBf7guRTk7LLFx4yL$MA#2U14V%`|6Z8L0#D9w(n!6NTmVuR>Rd(Mjw zR}UVPd?GD8%A0V|I6*i#rP`gbg?%Xjg|}2#W2&b(;d~ne37FC50i&M`@DE=9F{sTf zw|e}iB@r`WmhR&?gv9#J|6qHs^aBQo7`1!nUrfvl8Qu%8%c#6xJ>*FD0}KsQ^de zqTq;KLc)H3mN;b>S0BBPf?RxOc}Hav@b0Qo(%+qNmY72ri%S<{bQU#dZ~(EqajW3O zC($>aI;ns*awPdUW^4C@`7Mu7`vee_QqT9nHj6tTr;8qkDe250YRCyy&y2&Lt?1=m zl}hA6TpEiQKAxxa>+&$sidGX_pH=K|obZ7Q_!RBL5KL&?)JWHdG3{#{)T^LB&A5M& zN0a-Mr#ODj9raAiG$5Mb|DfqU;(=LjP&o-iTPd8p6hT;;#z-C zHZyoB`Iv2wJ@jyvqS{@)WsIV|$(ag?KN^b@tLcFzE7~5j?-S_-uZjTm@Xg+strXRD zlv14Rr&22(q@#&dd#p7-Idc)TBOLMX>t1l?ZLGo-8=VkEcC6uT5By!8e8vf?bzZKo zsWDR`+1>wTc5c0n7MXd`;fU(|4S6G)lamqCoTQbw~Pd(&1j+WLggOQkuM#_#jxYv8`K?-@|{aO zW)8g83$4f@0%}4JLy7sHM!REE%QaA~(n9%)co@W}M(ZE~)?<&*!lm{71Xka1zN-u1 zk2ci{cS=e*QVtYYwnRlf7KNKxxvCvCzd?c5*;A?`zyL8edIOX@SF3U-XT6v9u|R19 zlc3Bp)P>R)dDVC&1>jNZteUWfNk%5J1yu_;C0U3qe_Wwt;sP^$@VV#_KMvL9e2mDU z!u0~Y-NTpvE%5{W|CU`jXy!}#Tt1!oT3HLkB^X7eJ+&H8fGj^o8R;lf$T8A%n zkeXJ_pj@aqjZUdOPAg`%+G#m(^i*VYb%gVdUmQIVo%8R@b7G0h7=v2ZZ%31g0sX+yXfVnoKJc6uQt1$-a zjOUU4R_K_RWM|u2BaQy=6J{zHlt#zD)}cnkL9W#!Er|N+ilhV1N`W_Ix$?ynYo5~s zOGd1|U>>ywYt8cRC-YGaoCjOQ@sQu3}b}aTRNU+(U#oE{ehyO34LGvo6;NuMKe3#}C>~ zxrWas@YS$v25L5BLGSu%?=!MMa7pVVcpAIeAI{YC)Vvxn_kt<$et>qJjHxtKrHxRw zI9%%lP7eQZIPu>@Q7zwcc_X~oNzq)(2Q6@0>^KC)#obeK~7&NTZc~<}dP% zU0tqzsl}EW%r_?Txuix*x{+1qJLh}U3hEr^Bl--=a~4X!E6NI_n>bIZYu^(?wAx(F z<)@*FxL}?^(`{L+hxXyx4Xa(sr=K#H^3OPpX-I82>nZ?cKdd=U>DC!hS+N5Pn)5Q= zBW{4dL2c1=R;FzwJQ_b79v&C^dK$XW!ENQRBpY4BOs3iwMB4roBM8M1SG19~Vw>9& zyD|f)Kp2gt4-o@yfWcV0iqTF>r}%Ks9_eMfOLi#W7)8RBwVpZ)S7Sp(pIO@j>&ST5 z`hcJ8{96Sy9Ue`0{hR}@T2Q5#ndWBRiquqzIey|LO-8^oX}%hv_b@S;3$$Qz&9zJh zpuXs|)GDCD*H0?QWOS5gsm>87Kq<@$)Mr5hb>SZfVt)Eg&1UrNg`?#xWh)*}5M#^4 zd}1ci_r{;W;^Khtn$OFR^7IiS$;THvf8@7+g_HeFK5n@ar5XvBCzH)>`z8jSD?!8c zOG)(|N?=>zSkjyPPv5Ei7D+1!OPfApc%M=i_{2GDQQqTWw7ksEs=53uavJ~UZT;z3 zW=rBZ#`hHCYwJS;bw_k(*5{g}(s5DH-H30Ol{zo~A~JJMtuY)wxxAb#>G`T7I*Yvh z-bP7V7>{h0Ce!XuBMs)QQ^u*h3S|lc0s^p{UWjvg$T5B+h?*|U8Qo4ikqJMS@x)du zZzut~k8$9^3%a=4y)J%FZ3(76MO#!vj}Qujq9x$)vf)S#;ch^=!eQ?_bpc{XXcq|~ zvNBcEw+_khN;#cKPUyRy>5$)J*p%I+b5%8V;JBV`eeS40SbhmxkEHCQE~-a*eWkw9 zIXaeASSOd`4BWA7h082io@l027pVg}LwYt7Wa3|o*eDOH4r_VN7!|kZ1YubV0V&r! z%PjW(QC;8UA!d$Rm8PyF5kkIW8KgWxC-@)^G)6^(VbZ)`6` z`o(LzDMIE`?t!aGEy9b6F8Hm+816%!`H`RIz3CWT&rSTIMiY0m_FhuY=cJ=rwY9Hw zS!&Ooz0aw$qe$6}h#q|sbI7=0M7a!sMDd^Ovcj(~{>MRcw(t69#{m8(&mnN(To z>0Xuby2ez^dDi|YAFfZk>F)o;-}GALKT<_;*UQfbAhF@4aDDHaq3eUX#9y!6;1XUdJ zp623kn;am{*p}cPC!E;SoVg$z5V;6VLpQ1Iy4*u|yD8M1+FGffa}KFeDpbT-E`4m^ z@DrL_Tdt$0Pu~YES=kG$Zex2aa{2VhM#Y+YglSQ^%^^8%NH{4&L+0i1U~^h&m$^WQ z=D?KgU<2tYBc@$==oE?SjN3eoVr#)K&OfQ%8m%G=SUy8><*%F3;C|OM_Ao{uQXf4h z1S6E~klV(LPI#hBqc`YaU0<3Qs_B&pt*D(AdN?SBMk@E(E$~L^q~@6(MB@b~0HK^# z<8|O|t{`zu#N)^iO32Om2?w(3FjjZwso0>Pt8UULo9z^HD^jHv1qGE6JSW}C%D@d2 z84)pcOQ4>;`06!~12-R0GF(JV7}tw+ zkqWkefvq372ApY}^91l`S4KdOYwPRY*5uEasf<+@fYwN~c1ZwsE`;!?CeNgw=~i>V z2|+sVu z<}Rk~nqE^daPAB`o>le7lHX73EF;&tze!Xj`a~NL)bnl&qFz<6-Fy;G-O{H7W(%$! zRYQp*)m4qw+E)7w-`rZVD>c<+ZCh{3j#xDxAL$h{>imycIFV@3>(b8ngqXo9P_3yt z*w4Fa*0lvS-1MB33ALQ3v(?h6L&biX|7?97Hy)@K!>3~{LW5qd&->{|^xAl@kkRsd zm$uA#W_7c@bS7`m;nF8|(Ra8f*|&KeS~T&GGoP!xx7N`SN?bC61gZ&yknm4QuOf;P z`|$nuun#ZFwV6COBwHWN99>P-g3{FL$0Z^ z4>sD*rI#GLnl=qamg*wI5i=s+o`VTR!qHc!gqn00T5+y8=(g%Egz_E^HgI-{2H=#7 z-MkVl9K~p_k6)|s4MC$%Xgh-;<^^?y9fh#etF1Y}R~Di7Li(Vu*g<^Zj*zbw@hMLv zLz?1T5wsXqzU&;0m{}Q-Z}h9g?bfviH!5#4rj3N_4TwPG_GQLV8CLESzYM0G@vPdU zGnOayRNg2*i-m&Po|K#fKSc`VYUlKndFUywc0R9}zGAMCs+Q(P;^Jrhr=^aI42!aY zse_XfRgCk3c6Gn*l5ZRL>o(<_z&v#zdadVPkUcaIOA%31SY`=8H>F@{iI7-}Rv-1Pr(`U(yBk@*7xRSQg*#kXBpK3ogdSPCH^o-3- zcO5lN^H-$(MR8zTRo^8YuIhWv(6L*mv;=MQN_JA|mMY;CzxS}}hNOMu$iLklvk`4L zSF6mk!+sil=={3B)VGZCS@p-d$N6_>{De11CpoV7Knl!UzFq4goqy!XgPNIoX36KX z|LFX)C!IBN_c~sYPr}9WqT__-Ey39jCB}Wq^Vg)hY7^T`XvytKo|0Kx@CbCzaMzXZJG8>Ch1et0Z#*=k6Zq_4 zUDgW*@HKU6+T2K^1KM?B+Z#lG{^Gy<;XbWh*R<}T&8N2o*XtL7YvveV0_eTE;5!9Klz_>l5rgBJc?e)cHu|)eQW~M&hYz|`e zKjX9?cStQ0Rq<{PD7w+H5I#JlP{jO2OM^NsoD<30mOHuU3*^K2tlDmW=lAt{Q0G3M zs(tD{`7nuJ=2l-&vOZDI-REt+y~nyb7ageOBz&R;Ra?t|_kL*i zqEWPr&ct{4-JV@X`u)@~VvRlX?21K!M!4FFMc>a>%u&p~C9Wt<=94?K2jsVnX3k!o zr|a~`;u)&z=Db*2h;7?@(^|zFMsj0|UBPCYzH!9RR0{Rlq;x6>)t`-2UCoSQX3E6R zJc0(|w6-Ja-X$l*KDRz@8|51Ee%~q8Qb+j>-}Pjb@Ai{rq|tdcI$c_|mI!UBHm>n< zDAd@vk5_#Y6ek=d@9Xdhi{at{k!p7*OyS>4AWdc-&OY}Hq(s-O_6%l> zw8TfQ!x85wb^I;4FUZ&@I=-7Mdp{A1ioWKW**q&siVRDm_y_rYmR8>?R~TuCHZb$E zT|YR}Cmxj8_j(55`Ws?R-0S7Lu4}EkeEtI3I-Z`NC`+o!CqaUqx^9dbo3xB-xliG6 zIa6u&TakfCd~A(7aSErp+R$wtUr$dedmee#$%Et7fcO-;`)HkyaK4w7I*pOdnVd<+10^4K`Xc1@>RfA8ah@i#QE@v%^9h* zslI5=AnAX=p1phw?Ep1tNx@G!_m|5qC}JM$g1LKm z41ahgJZ114ww&%I%7hnJ*MM|`D#$mS#&18LvHv43V*xkAtxn?)6M@|Hg`#`G&ctVN(Ew>nN#S%FH z3La1Iycwlmth`>8U>P6ZOXO;fqZP&Fk*VqP9MF3(E-rq3xB=foh_AXJlI>=9tF~jb zNP_&1l9P!*?u)r0=@W{^EGAFX?~7b2`DHGDx&8G&fAJ+9_|^o^&i-3!tN$ZB8;#W# zOpUd)MQTCyqWD0}cZg1E%k{i;uxM4>_=HbIByZ|BwbzVY8(Bp2Htz5lHMl5o_Wv6( z={;=sxoc$lwwLWJmoWv$^KW80EmEJi=qQ?%7te;(h^;d!H(Tc*#+&?k*RD=i--iy; zL@X0D=G?R@y^6LSu`TN3^x%j!OO$QyD3P&6Gs%Z+`|@HJ?Ow-$+&NdNEm>C6I5#b% zXtF6E3N_`w=Ced@*jZ0@?@ zy1g>U(K)d-+o5&Ko^aLEu))K675FFbK`|J|I=gOEO>s=W*O3p%+jajr_d#_j)tk9O zQ)5+HKDZ&UXQpztsoXRctENxe_WJxzw8$5Xt2VMm{t=_93$5FF#$SA=y2tn$4gR+ zNH_IbKQYt9nYgO$*}rT4(Qr$extq-~`hMLR?SP*$^M7V;+m@iw_Giq;J(indrP4Jv znbwE=T~Eh3yQT{$q?S%!llGDHE~U%G;9^(u2*3H+^nN{JX_T3s@b?+-8xPa(i1z=I zXXMGA`9JFJo+#5z_Rk!T`w=ZJ#o|X~9shU6Tv{7@w$2q>ti~v6T-K}b%StOrMwuP3MxmC_*C=L=kCx$vb!X(FQrrZCjrTy~0 zl&bSMrX<*qHF%HoXr(^&NM^za1dh?9rhGYBw^4Z-iQ{?mOkYRGqt>At)72t3Mx7 zFg4iYj-he7BQaO@lcJcHtH<8Pq__5Tef}c{GIX^Z`&tW;CD*uDJYoC49;KV~e}?;Z zuzLI&myB_|rt1~&VHx!_eu(AEqivGaFATG&A}eBb*$d9vDXh4Eh0{W8e!g%(8@`N& z7t?N=`vv=sPU|ag`}tn)1$Z=3qv_d>^Xk)0IjYd*Gg`0|QlLbR;hL?-X)o)*sZ+zV zwa{z2^O~}#PzGQ8VQzH%0$^g3#;06N4w*@t_zWaG%^!03F7I8wHWfsbq=A{tsWA9w z+(_7q_>_zfcZ?q9?U6WNe!~*r0>4Q+T)#pA1O3JiXkbN|mQJ(B_239rsVE?yDbV`! z<`oS1<>oad92d5br(}Zz1hTG+X9?pPw)rc*|M~jlN9wVLTL#r1y8Vl5dH!qf-Rx4e zC4)dAJ?}dEdqz>*GaLS(II5$C0_zQ~%a^%6+p64wuWb!4r_-;?MS3P;>h4k%Aj8w9 zfd}Lm<%C|Q=yGQt{q-?N6F9)j*F8?*A>^uGV}InM;(+S`6$vw?jgm7O$FSHBeyaP; zc}qPv-~QxyKOTDFR@&xLc9N2t%PZsZ$--*WuZAtu#%WQl%doN{h-$9KZwt5GeX%Q? zMPFKVzbDobR|T(~^Rt*`U4KoznW!;1sw2$70c)Ohl($c{&GYheV|CimSbFhG<}Tjp zxPCBB$MAy=MQlMXFA5I@3yKGVr5fcfW8Xn8-D}XbG%W#YzFD)mT|dtp z=B#@#rl0v-@@4aAZ=>{O9si6+q@*JUEBJ4bb7o;hgCo0l3(QB-(iW(ZMH-GE3CrWP zb0A37p*h2vMRsTujv&(w$^$T&Ywh^UWI29<^@I zJ{EB}tZe&0#z!4?mU%q{P{l|TZN4)3lAEk0ZngJtn$OcM8U03Ty+ow?nE`vN-_#x=pCBh>x(@7-6YQwT|PfD*-~b2p!8J!&Fd z5>`^y6@7-{qPwkQ7I=Pz&fdA%O1N)=1aQtIaPkZvs0V$+jUTfi46{7%& zq&kDkapugduRe9+8hO(3+NSgjVu9Qj-{}bYn3-As)i?O_E`N__uiaGhcU5p=26H`B z>It9JJ)|S16%|w$*H^bUS~dU~r`uu*Z!QliQUVMpwN(8tl=CAiRj%H;5(O~8>1t>s z+7M1sm&$zQFef%N51f{`IyoTBPvb;Ykp_nd{z(ZK_=xIvlxLsWi`$=5I0oS~#^fiC@~= z)zj|cVdYC)X*^Ns-qgRNKg7f7f~z*@HO%MGl)&X#v}B<>d(qTMlt0qjJ$08l$hpm< zCyMCE+mS?Ra9V#2zBX3m+%sb}s84hyO#T|pok(at_f5WUyQUyB==qw>X>A|hKltW&ZQ)9za74Pa%Ndm}$3miCmN4|&d6 zSY=|)<~RJ$tdleKNwL5ACO`X(?`c2$Tke{Y7V<>$Q%@P=vl_?frwBQ=#I-l)F5{w) znWg$uP2U=H85i}PyZ@p8S>@JOTFe5ENV|SQqtM3>zg<25^5M6SzkK%9XOF*CB^&4H z43J7P^_S)Ei_#~UE)en_?N4Z60iGBB&48U>z(g-;T0z4Av?tfdm9icF?Nn%x17s@x zOTBOJCsrqmF|iM#sO#~h3A>IDV%CF%32V@)bB?YsBv>kb>of_MkaZ%6 z*_eNEPer3w0qgnU4_BO7jH@s##-g+EuOSB?jKgF$G{08 z%?X@ouFLw*ep#;`u5N#M@9TTNg${%<>`#ejnOC#(&ZMsE;JW&Wg(z5DKEj)A-Q+&JzqLqJ_Rc92FF{sfA@#_fU?;Gnr(99&u?XKZ{GXxLoRikZ@Bz* zaVsX#9CM6#eLvO6;~V$hzx)2yH=M_KmI`Kqtp}?Q-|O)|o^Rc}b8B&N$e@NTsG0b< zZSsw`xC1|soR>JHOx`U^9~enk-KA@H+z3v?>d=qRVLI1y@8eIVii;e(ny}PCxujfo za(MA4Ti|qT3l5oDZ0~Z5HLy#;!aX}aIy+_;>|eow&|Lyp92y%DPTlme>LUMqjVA=! zCh6zaHdBT3YW0#Dm2o6AtXnZPC7^is;LX{(*r6RpX8{i&u5$J|ZGD7lF7=bUAND@1 zxc~J2hwuG%u+KXc#}uHe_B<{jdh4E7p5DMYj?2RQ=my@ozu4TNSjNPw+6Fyy`IGlu zDHic>2`SRKw%lH~wsap*I?;MUft>ncaXud>oMXeg4(Y=%qh77s=X`vqZusWmthr5v|OL&NTuuU9> z=1ukC%j1`*79Quc^2QyUQyWZ=nM0Z4#k$suaLmi&!xIkbz3W2S1RNmDykTuv#z8=L zpj*1Ec|F{E?|qat!h{c*i#rN|SZcW0v-*Q^&kv7CDNzGLfbKOf#*){oNKsu?a?Kac zr{CwP!G^*l$-OO@YI9$jGqL#29G~&b=jtJf|Cl#5xzvo7?NAj%LjVg4k*4a2upXBb zIt)$mk^V{q@+&6z&FYDTdv;BD!RM>lw%1k}t(voA{1OnsBy;cw-QU+Df57F^%>BAe zMKOMWX5^Eb6yvO!qa5s@8UVr@G^(xB)#D%h;eMN}yUrGwx)v7pKoQG1vdhuvT<)p^ zH83Rb%*p0;x$*7jP%*P;}r+Lh`e675sP}TIiBM~ z-S9GOC+Ph&C!0vImGDAy#ZdUF!2QfkIin5ky?Y-`6s`-Ejk&`glTT24g88J023yzm zX2!`_JPUkT3DNicsuxpx4JKN$Of!nlmX0M5lvoj(Zf1#oY!cbr&Ai%w103`?TlYL9 zZZ4kpLIW)}MqVo;k4~wT-auHFy?aXA`$HP8zzfq3m*Qa-m^|*S*mry<#jhj|KpZ2p z5JYK?7Cua?#f27|)Y#AuBiK#Ox;4SLnRPfy=!5bq>QLXw8_n&&5x14#KP*7*>YW$S zv(m~;j!?fmHq}fl{jJGpxh=Cs%GY-Ji?+UNuHl^~$O?3U>35rC5?8E?8zP<4d-=?%TvUP#uyj*`%+S9BAxj3(sU{&{+Cu zT>HAa(xR}<#&@@`hWzgNkcvmw9P!CazOCTv#>ZYB zpJP|ZND*>=SpY#u126EQy;)P=F^S>;@nD#eLGUNta{jnjS9z!p7G}ErNnM3f*|PhC zyC1`LDaMCch)^I9vtgFO$~40+-f6*o%U&QNa}=|F@LmmdE0RN9e>=_7-MQXJ`RNq~ z#M&rt^rnr|$jcO&6@b3UO@J4|~GRQ>7jkX-tFA&$WlOk?V@qV4Xk7MH7b zcnX?TDi+cVZL7va@~7$!xR^!vy9yt0pqoTzgra_^p0Ts1xWLXjJ~)(N)Nur34i{mb zir>bop~7_xh}O*AsUuKTK2I^D?Xj43O?M#}QQ=4z;Ci+!NjC>4hq+4^Pxxnep=H@B z=``HsWlp#8H2+289hS21WK$g*I>qbO=}b!%_79t$G=Art8hoi(!44$E%hvyz+<$4K zl3(=G;x-zPJ#1)k8Tv92KIhUMa0>q3S+w!5a=PN+@@y8nET;P9md_2A>GTy!rmg_oR6`qwLJ zJED(*#zydR zbUncP9Gqk>d}E3Z6Tqy4Ia`gqcmm>%mb1o^szeK40;OX#1%FCc`0!^7&QPsY7vV?M zUo2r;@KPwRCs}1GrRRo?!dfo82{bX2FP^JY{DbjkH{Q;2JTb8qOm#*%Bkc|n^_i~x ztq_4TS+Y)@{6FBdfqku^WAO&nbg13hOB#iF3kBO8FUr>SRR>{Yg##DM`iZ$jm32kE zgDuB#2U_%_5Gqb!{3!6lrVbF`8OpQ*QWW$M&acxSgD+T?QASCFF-j$$;lN@%$bzj# zHA?m%+tM@!eae5e1hUY8y4ps65C_oV<2nCV$R0J|zWdh+d?^xGNjRLp>!;WhPv)*4 z*u5zZreg>{6Yp~WH((SG3u4w5i*owg^%xb?tVJAb(D2r09uWs8%t@SbadW}gXGGlA z!SyV9R01FbQAcrA36pyKrBTz>(wkLH!53_*&D|Dxh9n1*b zvXF$c{dW0h60C!DsLMmc4^U$cEqLV%;#Cjq7L+e%unL8ai9}J- zU)PaVFT7@I#`*_Wt$uG?*kbcS20}U;_pmP@DZ3v{v3BOq%rD+hdw-;6f(ByAo33uU zv&h6v(|}p~Trnf*(|d^&3m?{%Y$i$ZyQ?pdt{6PkwY*)?-%_9W5|iR)GyHJtl1$65 z)LNU@udqLKAxh52scY)jO2)M$8k{;ElUC2wHr9n&-lkgiW)7BV#3a_FY9}Xj#Dj`| z<*MSaD(x>6%At@?AAkRNr0oCgA{ku5U2o>GW?M4Sy{zy$yFyxgCaC$$Lri!zJ|vLeViS#!&;fUatMPK^qG1_@=z&%-H3Y8v2k#}K`@5rt&k(^2|g(F z`_Kt@)MBgx?t-*4)AAyFcqR0y#m8Qb;Ae%xup9MC%+0#Q>jac@aarvf@Mm6{Cax#K z$wBzKJwG8FZ{koh>XC6y2U-~$KRKpm!q9Y$AX`RTjjMxELq7W5^FM+54%PryIh%=1 zK88DhPObM}ZfY_QFOJvv+0rmx*mSM4P_>+zgvpnbO|Y!ce`&bUylfJ(U@E4rii~j8 zb8Oq_ZZ;{AS66%T3t$jF`N=y@ZC_v)R%hR*g-XK)ebh$GX-$S_A6@q%>$J3h;>^g! z^v=3v7M^ntp5r7Qy;>iKlJ`D(U&K5>%e~e6@4t_#2!}C0UsFfI=d{-F!(}T!9i^N` z?kS@FfC7|C8I8?;*U1$kg>dE;RLXo9l1j}Hw#LWApi&E(Oh3I|N3_W)&w)XME`OMd zF(QnqD=iZ-_L?bW1M3=$Dq>HF4F~4@V0Xlzt{=8xxx2)xF?@A(uuCS@*V(;9|xbtd+Is8|F@1?FnCNJN-9*#}Y4(n8NY&$)$PfnGL zN1b#T86Yh|Ls*6D}!c|$L zy`ArmVVWDZnXH+&+vUa=p9b-sM{$;ehpt;oH1rlCX7^y0S9f9);Pd${Hyo42j9(96 zh>Q=}aH4^GC^r6<<7T_Jif^)(iX`bBL3$AC=!I@``B9j_evp4OBFO+_bB0LrYgQUy z3Rd?=`k| zcv0J-YVM?LZCjnZWzsC*OeY8m4hHD%)W89EtzK)LI` zuniUOAyS5_$mP~G&KmhA_Qi-Ll?NQx(1LmNg)hN6!)-|s7BDTtiwJ5|Y9n^7nA82A zFqQH?A10GbJ!8Pfx8ZY$J`<_!SeBYpEwoT(c{+rl8ZXA~~8;T76fMdZYlM znN+}mQJ&f6^iwXZ`c=cCg!h|_cPmIg@B^{}2_&ot5=QuN*`{Z8ak}}D!j@_wsaUD> z5J48{Zv(bVWMd(CI+x6uL3r`Fz?w2r>oJ10@`lPk@Rru%kn;@6=se{%ME7{%>i3B7 z6z3+rqH5~33A7v{fH%O!j)h}>t%wmCL@(R9l`m-RUa>fHBbb{r%duiAhOQxsW?QI* zk(c5TbQ{iZxi3R@2QR`lgAJPtJtNSJGTo#F6(3J&Lq#J|?u5k<1U*QGDiyvMPeRuX z82FBLNeA%W+s3eVlU_u+fBi+tF3TcKsASTTIv2Yscf?&dh)=*I|u^o!c1V6^GQij^|ZxHGiN0?r6wa=2vF>0nE0&oCwiYiB`5VdK}= ziEjsGMxaxK{$cWk7a-&c3KnIC6t-g2b`*AiQsfW+ShqfC7LP^l=Afo3q}3XF+Zndh zz{I-96Dq#Gp!PER_{O&LO4rb!irgAF%%`dfXy^GDykG)xFuc@X9a$7{CYIM`atP8t zO6B2;UY=J4Kv_P+GK>}e9Cy3MvX@#w0KVBOp_6;d&|VQ0xuxwKBc#f8Z0CaA$8Bazs-|_U@7!=(?v;%200-TIo3mVJ$Yifo=KdN_Y$;V9f5c?KC}1>C0m>% z=V5rKvQKbaUBw3rJ;N(&80hOfZ{=EmAQ;O!-3ToTGnHnk$Q(9e+`Oq%H#fGsvGk=Z z(4u5&@>1mrSfAR9=(sYyQ;rMcVp7qE`l4Osq!nVJQjLCH3tEy@IMA%Sr4V2$O&To` zAh&}o*%|iGce7w-J42430oC*+$SH)OOCtGurTTawHXuz3jJOse?g#|9fO4Ty7y3l* z`h@nQhRb-J5{gX0mBgDolA+Jup?SXV*k{v%1ha`7!z5v*X?LR@+t$esqY0Pk?g|~v ziiNku@R!M)tz{cQSP`Z$yihNB^@a#%#Z-CixKB8NX#^w=`|0t)fe-<{^VM}vAWmo% zfI=Ft)KD6R$yUnRW^3}S$?n;SCDyHp8!o`HUB!aHxY3atR1H;8X0W|z2Qj=rhXIO$ z+nvcZ*Ky!VdpR2Zs)S0lqi{+s^w?250Pn9@~`xB8E6(%UKdA!TjABWYEeaCMQJvLHbtcW)US*ebrPE*z+l2?yuw!CYe2YsBalN-E`Bcsd? zK7T2E=mntE3K=b+N=AEyX6+gDu0($*g3W{y0xh=XO!>QL?21?a116(+YGS z!W`DaaiCLsW#jnZz{`@PHv$C5Ng$)!duUef7WJ1q)^PxO;9m+r6I*b z^GR5~bLVadK1l@%{MiB$atsE)&}FyEuP~ng$BYE%)cJjG{ElX3k|RCRCCXtrcu4J4 zro)wk2aNDtq92fBPRmxT;}lu zI4EqpD3yYE0Kn>Y>Rz$Ua~ul(?%M*wg9D*cZZmoq6@ndw=*7JHPRPad*4x+u?C;_EZ)ZZ+ydHn| zr%@Tcy8Ym7yLi1{mVx$ z>MLU_R<{LNOJl^4L)Iv>TYWo2+HLkwaOSugY~a;z^6ERUYe44uwua?p4R77mz+@G( zzJ)?|i`px|+yI{%$hvK!c6c(_3ijJnss%e{e1w6T@R2OuMQ=aW?PAdeRV?5nnbqFntXMDcJ6o1hRc%8~{Vp;IM&=47YF4E{hh=5niQW@+4cBIsK$M|25l z2v8IYT&_zX6l5|?C5OAV8;6x1Q4EOmA6MVg%Z(90-0oC@heaHlyzv1pc-0}%?WxLm z|2Ood(JjaS$LZ?zNx5Y*0aDbHxwgnkU?wj@7>TlLtduj9ax;B8&KRs|Y>x;Kr7>KB zZOiKNmgA)hF-cw$Zmo*m6h6+8=-Yw*l1#(AqCj%IY^pf@ExK15Zs?7M$;RctFD#%U z_57LGf~4wdF}cL*@E99`16~a*;0l^EwRp0_!i@67gy+lLTnFw0w!4?ZpY^R%(JnlC zy&c0LcMzgPsWB?l;skKE0LfT4di0_0(P}cwHC5GSLN-{=s#IqC(&Ln4xv0~!YE^R% z98W5zX5|j@K#Z0+#a$B)2XrvhZXH7n5x*Hc@QD#Ax9p-ah)NNNu})0M+ze3-W%QL$ zctr6ot~hS#F$|Pa`F|n_%oC39zr7W@s|gC_Npzqqsz3FgZr$Sbl~TQ=t(G^#fS2Kg5&Mj>Cv;MiCTHLCVZO3yAYyc_o(wDY+ubrb50CQdB66>>D{ zh6Xs)Mp%o7ELs{YO({?{UM#mcUh{~bPHm+0OgfHQ-Fdba%Tx)8Oa*aZ}Klfq4< z99@{F3*6c(y)|h-`38 zuKT*KbHb2z65=U(&6ZPVP-b?2GwQq5LKPX13g3H8Z67Xw2I;DOa}2=h_V-^t!$$jD z)o`n=z7AolXbOsPyypzm^0{H5+uwctk9+3g)@_{u8AV8+ePSnRto?~@&0n?3a@|2 zahwz^t5N}1$r-XMHzhEHtgoZCl`WBj= zIj9__z|o+Yt#m7Vi>AhGSFl4au28^~LXcb&QY&mW3UeS@B>|zsO>nKbPzGhS9m1Bp zEHdhUdM(5pRcU45LEO}s-T_vu>jrD4fXX{s6XqEO$u}(M8uDOTx+}Z1eXb+{#5^YU zWJu#lWw;)c?u_S4GBd>xIrLPgfILZU3_y`_1^@Jhvpg0LTymn3TvLP$9-rztaX$+v zcgqo}Rf&Vrfu$W*kDlEp_r*+9i_t<0uZl@RnQ^vvaZ6tsPOH%lNJvi3!5=xFDR|dW zWS;_Tl!g)0GSKhCg<+X|!$&*!(in4bQ192$1yiZfOTSTe4*d-YAjsmFu1OL9M$`gm z1(_L*Q@KH0n8b3Is%*#@4RU`2>cec6EN%65h4AT>d;G7X0#NuNc9-;yL+8V_Ij!D?Z);BUa$Ezxk;jcEn9jYMp9@K6@ zzf!+Q{v}^E>`qT{j>3_kpFPm7D1gU`Yq0f1U<7SYX>8DR$_L)5*na{CBLub-dG=a{ z(8E%bFw5RTRwOK*iU6$WsR!mwT^4c9K7IU?l8qr5^)=Ev%6{vC`r8oeq|PwUUUI0$CjrsSP^;-9gm)xCE56qmO;vQ z7971?C6%|JMFyL4qU4LAZ@u8<$@Zv z(&H=(f;!WJ*W=hQGWJ)rjZxfkV)V}bRxl-LWNHy7Jch-YTLQWi`wNyOkYu{`K;crs zo-bq)@=@B;&KqJPaj;j}vZCfNZbDZ0!?b7)5iV|;axJ_v;#YGc23XZ-KUlzHO?dq^ zc%Avwl0+x#6F?G;yQlMs<)%e_YTG~j=shGAQBwb6mhQ+cm%F1U7vHsN<<8Q>tU3Gi zIL)5G^f)3)(SB}?0j}~UQ|x zYKI#RMSYxIbVgMuuDA3no;J|ZpXK0G2E3x~HQ(y}g) zQYjfbdjUxqkl-%zR@m<@P3%UygXihe7Mn8g55!R{2rf$zSPz)0ShC{cuCZ5@J_1FEA^-pG${x)1w>$)q1 z4-NM=XIQ0SP}va_1K6|5@yhwo{f|y5Jusqvr|ar7uOVXbg^&ou6UQ0Dd2kMeheAQ0 zR4EEVUIVzeeyAV>CxMNAa{e0xUV$%4W+CSCEFkj)qQAmkBNqH$dGZWET$~9=whVoTI3;fWjEIFkFe=0O`zKsLA;?ezoJl) zztn;X@Q%@?nCi*)Mc;cWZ_19SF)M5WcO%`TY}D*DDtcozqReNa*n%_=ioc4~&}w1~ zo^RvEw{!To@BdrY(M#{ud;tJe^q^U@M9@l2(mcvUok9ivOa~rvpojTM)rU7;TafJp z;wOQ$jr`>gn8}muaAaAmzktpZ6}k73X*$Aq6_kGd25;wdNZ8~ky^!(hJ7fRiK%8*N zGQJt)Mn(wMctywD#Vl2Y65R#d@D^}Hit2QC-PMc{4IE_)M}crkz zXPGc$umS(@lA^=g{2Fd@ph@WZm?0;MQJKteYLr`?H`0kJ_QHD}HE8`=jvBlD5@i=` zqjIh}n+t_mp#eIlaQo+cR1Vv)Y+Es*hOw&HrEPf{~#f~Bo02W=U*;@IA( zG%+jGeX6i2`h<^o4>R5-N@-yqdrRYBTfM7@8)=qZ@8kFCOgq*D)K{M$?wwcC_8y+7 zT`WMaCOg>b3lr@V0VaghBD_B?^irQ<6Qtlt;GIDiGPOVa8Q2PZr(Sii_2B{ZlD z=UpXE^cvb%?@$Pdy4@#oz%V{pnfXJybD==1)me`@v9@FQbVWj+t`PlDKAjsR3@)={E#0&`n(P4zE$u5TvLXm>D1P4P<@<}7{66XZe<>1 zZb-PaX$wv;h{RMm<$ipixZ3HDqZ%wyy~qCul38AFd((Aky*f>rrZVtj30$!)dy=#A z_&jkI9buAN=#Qpm`%o0_@Kn)K6nCHAI;NK+o4TsTJd~kP&Soahgwr#|>a9l~jI-DU z1rqXH98PCba4=|S84Esf{hTg}?e};ZnHKDZY2a~$s=)BTEiM2(S%I>O%q>$Ad2d99gs*iYGNfdO&V3nBy{3R7c$k8(ZNqxOSI9>NU4Bb*} z1zw&ZmoDFI6@w6Xo{r@EX-xzy4_j277Iv>20%N=Pe{>;3WY0HT+fi(rlg6z73G!Rq zCWVEIES%NVZfil+|KoBJZZ+e|3)F_ekg~njDHTk@_{G2=kgfOvv#)^!ePCXqS)JUE zU_2_-sCz0e1APpwD-ydZH@9wsOJI#$51%=YUF|yu?d7T3RzFC6#BhpAwVRcd<7mi9 zdbo-NhfOJQVlkMI@mkhf9u-St#Zf%tx!3pTA?G)#9uu;bc3cyJ^*@G8GM$__NwYpb9*P_{b z`?8u#7BcZo!&Rvb9OwQM+bZxp?9~=v(N<|Jx@aTjsqypn zHa74?lN-8l+>(X`6Bpg%COca>e2yKA8UK;l=sS$+!nU?$wSl2gu;S1#22T@G%LZ*N zjXX;o3}uI5LU=i(7}cOi$BR-4nd_Jnk^woV@Jb!Fie6_y{oflvCxar}!wBs9==>NR^IY$84dNm zZF#X`QKJkTc}V=YuvIv4>$W2}dDN7u0Zm-hW^*_0;hNsG`&JZI4{k_Z$bLW*PIov% zzeF3YYYJN-eu!OO{nPpSO3i>wEi`BH0Q07L)HCoI-~&^P`dOVID1bEtu^u#db|DjC zFB|NZ&u+484KU$HOO_RoE$$nF<(_GU+j01xlZTBBq=J_Yz4l2Y=L)XR;aLzjDW~6q7ZQ81m=t)pN-9k{nVgI5 zsdjCc{Idnkki!UjRsD&6q`GBL`S(3jm%6=CcS{E30HLG>YRkt&bkuHNA!^dVcu2 z!f)QhNyF^r6s0Tm?DPkMw=eMPdGd;YG1HMu?(-LxvD991X3ff05i=CF#IqC*#D7X< zwzKuX4dqRBAt48~`0GRqMt|x}WVJyZ=V5hE>VSXn<)R8N*EAdu#gXfeTl2%*0ADw=R+;Xzo5PL zMHKKgTGL}z^}KXoa^*|GP{}{s89RD7#jh-}%MkJ))2u4WazO!Sz}mW#6%EtZwoaQa z6$8~vqb@yt#iHxUuojuJO37I&T*ljrH}#;Pm#2UvY?Oz@4}*|xtoFb4r4JsAl??)V zy1~BjL#l@hQ}^hO8iu)qp|0K?-@B=XvbaVTEAX!WN)pAGp=z?~AI$F5{K=-d6rJ=` zMjft?DyutNb`>V;9y+Ap6dRC*!v49zrvgeV8J$i>i(= z1h?56;>^|&F2}YY{bS3QiNv8S3aPxsJI^5TXo)_*LzU&xgXEPZO0iJMf8g1K>83-y zwGeuOLz*1nHNn?)gTriW-G-{RsVFFgOhH&pME}fcNo_Vo`7VVd9Oe?$+Tx<`3|tRoa7Y(OZ3?(8)W zkVF?gvNwH39R>k@u3s7j+Te|qdLxT!vPL&((QR(=-dN2XJz!i_EUC(=tk^BkYfoP} z&T*Nqp?LWar-&}luE2zaMyLW>%;$RR&RVq$-v?=R&F~b;2n^mTtAislqC#vV8*TG; zh>Q(kl21jgb9O)3kL&(wgAn~8Tf4ljn|>_kRU5`)U_lb}9`W#S;OIhBLgdjE!%fav z(Gp@^zk~4(%Ad1I96$%oCYrsK zki~Iv&^g{gkUsQ{rS;=bLSUzRB@=Vfu`d-%wrivRv55W33I}(JoSHXZuVOIE{n(i57 zdjoXBHe8E4Kq@@PYG>^$bZP5w{k9%seadIN>A^^Ky+@Jy@Qq~xc50vrA=F>*>7BA{ z4Eop?JdKp?*J9L@XjdGBMa_oQ2?8_Yv#oEE|gtJp#AWMqu z>D|xn(spTN7uSTb8om{6;XyPG{seVjxqrAF0CR4#EL>>(;p zfSV&^oHhpL>|G&cmYwvmWX1xn5)jh?^ibAPSXPKr2$DKI{S#ZbT8%exKWgk5{OhTT zlifWE_8DKXngCAeRrsH7rbDGtCCd@QiYQ4pn8`}I@hjVI7}^RToX7%+(rN@8aLLn7K@6rakzsHL&e!CY)y;)W;Y zj7z#Wz|ZjP8r;qd>#%P1_Gk+iu=yCYR)H6U?$0?pZWV3%PFR}tZEGA<)M zFo!y&V0>j@(Hw^zieRl_{qpQ5W?_DHz{xeH45=-~B^(Y+V7h#poBDFBG#T-YI)^tqPO!$74-t>2PM(vkMAfK#r zG7d&Y)ov|H;-t0)m+%*&=@s&s;l}VTRu8X^s$o@Vvyd(4%MlK1$2mI{Uik^Hw9ZBF z=1N&nvV69GHwbemfW!@*_6#dtNLIrH7EV_1N4cq3~jP%`mh98GO9>dVD+34;Ny3b(8cPQ<)qZca0=P zT)#wL<{Ta0(4tjAtc6sCpLB6paXbWp0p_`)|1E_?tGLx;Bv~NlqVp%Ea8t9>d0%T{ zsB{AK%X(Qm-hRd21OL4gh|(#}2G+B!^GCE}a!pHA-HL0MH4=a1KE)5;(~Q=C*gz%2 z5HqqpR5s#{g=INu9W@t4GLIWBX`F6=eDI#ba{G#WF^ziDp!e?0x7O64U$Z>z3=905gT(@0S!rMl2Zpy z?_ax9aqwta%n8SZj#wK)lEHVL!Eech(PRMa7EU-TLDPY1E^ zv(JBU{{s&TnM2;30U=daEJ6eE7Hv_G8f(Ay@q_ymosbgaTaf$(YkjA8S{E68@cztb z0)XFr#Ofp6VJ6;OIN=I#tW8?Mr4!>@V&HKH%D+ws`o}|3Y}E!MhBt09?66lEENZ^5iv0X`ST z&6=xV*6N-MFW#_eSH+)()h!L%eaa{0sH9d%q6d{w0*saeM>G0ZgG$j#ifj1*Rm1^| zk#Dvkh#$=^$Sj)oxQOUfnQIGi9* zk&VxZH|vB?4(jY6Y84=g#;6T=`rIwDW1xVM>g>_I(U_6U&npCD%y)hnGL36pHo$49 zrzml)zA7pPfS4Xfb*t_>J+sLq-nB#4slQCccLm?9X z+zHe^H66G&8XgLfN4|)^Z$V=076Yjjh(k#{>Uc+BT$pfo^%bkfpB0y=hU)&uz(y5u zfMd7&P(n>wF+152f}Z19_zTn+MJH5?LFB~V-o9+Imys|XFboc+!P3!LwQ&Ci>rWu! zga(zw-=Wnh-6pFoQGzgHvu;5_6rG*(9_Hyr%-i3*`rYc$)34y5%4%>6-pkeANtMUz zIFMBteM^e1!{v}hSjGbEl;VFMe@B?y2DG&W&p`>lP!{ZV1o*R&NtiME_4RP)y|<{Z zxHtZoo6wKAMSZh#!QJNv{Oud=O8?!?qn)QaU-4URVSmBj4*9KbynoHl=X}@iE6|T$S3n1>z{4C#kvR9^{qh(5Z^O4%^-b@IzhG7;W0c%E|J}}W?sCta z^PlkFJ-&0oKmE3-zirQKv-6U__|$*;`xW0i+xdlWdCR@C`EutTx2@l+@mD*qYYqoIb;>vP zd1A%d*Zj20Pczl-@Y_#N+h<=qa*w~x&&{jf ztDRgIEv5UW)^N^ukLnxSE0Bke_@C4a^-k+;q3&kv-G*`Y$J>DYhQ zDh)!3P&iNYSk7f0XZv}%EE2UUPH_Ic!@l{d#_k>6<1hO~7iBb5$-Lz?zE@X7qJFIY zB^`<)T^j`$CPYocp$asC9NdA5`d#G!^1?@0NAW}H)yHIdu|S}g(SBZ+i%i)$!>68M3HE*4h>+x7 z;o7CuOgc@e6!ZS$oP@w%3`;Rf4a`F6+K zJD^axXJ_@@b4^YKys88Y@4ozm&a;5T5^CeAcnCkwpp&>w-H3g7w)q+JL-ra6t|*(} z?Hm>B@2tiI5|b8GWIY%_U>z+xz4)p+4HcEKVHbq3*1v3QhLN(|6axwLQ}EJU2##Gw zv;rfDD_g90zS2bo^3$8e%RhQ0zGSiXcu3$XLn%1-UnHARNkd_!Njke!R~!+x9QQ_& z91=Yb98C-kr|BbF|3Ho#yiFqGPC-LlaBFtdMJP<0f)Q||aYac<9GS_3QiT#Jb^tjE z@pHX1tevR9h=8QyKD$-Uz=xABAb}aqz=o(vrndZiLe#{n;${>NR~?QhPJbjV{P>Xt zEtZ^E%EgA+&`?wt8GM3>k=T!_c!UFw&vV{=MLuhN;o@i|VdjlYX3$qcPy9aCp|ev_ z-s1iaqIgXJEey*mf_d=iZ{wBROz7WA&$vYQCo;fAMgGLvbc@f*=i$gw?t8ssHw@GXg&JF~dOr(W=r9%%7R{WGH-dIk-;$ znWq~OTsV-8NJR(KC`Rt9M;6TuC}6HYpie0Fp3SBPqEdwpyd7(1ik)ykpQ`i8f0U2R zQm1MIRYTcP3$>V9H}7H^IE{v0a4^lWa9)=;=-W46^MX<=lfJPM7`P{gg@IYeP6WsT>TT?=a zA;;i8u7jSMK;stlfX2>bJ1P-U?|{3g-Ko=&Y+vpU%+_i(7@XtC6(s9?lpS?Oi`#lP z#q)i&8-mbRsWHXDho$7;#xolQGamgsi%*i9Es~BkVqHe5>D24I-aKf?&lqOR5aHe2 zHpdcOy>9s;)_`Gx1CzI930-SpPub5QLo--R;~acaUbG=_^GM{(F(S!lLZyo}d@p1h z3`w55Ski2iqB_wBA}}afw=#^2`sMWHr}n@o5=>cQdB}f8Kr5DkRkU$Xct+y_v<6ih zAa1_o2H$kIm{B8SKGg_q3gvUubia(UqrRjhcT-k56siQt6s8qfVV{Y&n9PMop(}VN z*PuC3S2PGPJG9wb5y%+q7WM=HFxt|z;Rn1jo zaYu-j)@Bjg7{Mh4qbn!agzl6Bql}oChBaO6AQ4Xk4MM`R(Ve)oRI4K)T@Ey)oA|WN zh|^TYHxDT%H0E>Ey`BFb{h$8w;m&XVZZyESguZip=!+5Wd02lx=X0N#qaU+Jz2=G6 z@$nL?cEwP1?U%^$vxz8byHmer*ijK|;Ma6AS39NNs;N@UB7D|}s= zddR#>!s91(p$bAL@gdEn_U%kE!X2m)h%hDHhaO*sSqtJb>8iS$X5?hQ!VEIyhd4ag z-7=F8xd>(V8$j>>xC-Srf8QT5zC@sulnp%6F(xCik)}xV96vQ0xq-uG?u^7aLSk@o zX~&@=-O9@@e>>uv|0u>4Szq&{GWL=Ycj0U~Ka$}aI_6bTta>K#)7Bu-Ps))}({Zs2 zeoM4i9iw*0_tihHP(6{DqjP_-^FIHq>fip?*rpLq_1TL5MGI|5OP?^e1K!~~=eZcW zOmwm%+`d_vbfjp{eSTK&%`02$vJ*F?dcg}PL&*g7?_Q{`Tbs5U%dY**x-zCwyuL}|7)nll<;PYn^)kRZ3y1*+;CQHz^KEO8E}Osyew$M=NcHAJ*~A( z$*K|Lx}v$Ds@rv*0O38btrIXct9$3yyq7@ow)`c7Z)B{5K1H|q3@gPq5kdO)}0 z|6=bv0PL!&y}$2Fqz4d?UM{_5#uQ2bpD-Z_p(c`qfE2wmbElA*x#N^111g;-NE0O} zAWB!7;P(_CDn2VkR1`t6J&J{3R69i%J#z-5ZIX!VWlRy=_QO}Q1CvZGdgN=VjUL_r>!K+^ z&3Q6Q4&+cjcMxJHA{%9%GAq6cg3D*H3@)2dMH!f~Y>7CAdp*d|);+*pa}Q@0NXR&h z+)+7r3<9$QTB1&bl>DKbRhj4|N`Xvd{=4`(yQ4`A+LePqGbC)sZCc9u`TtrxPMjK&R zoPX_FaL1CCp&wsvV3u*BK${(NA5U)6Mp^A0u#?m+B$A?8@k~IkrDCKI&yX^gOMW8{ zSB9E`Eeyp2Q{vt<^Wp*+(vNe*Qlt?N)LZ6hbc2&jiE*kF-Sh1?=2^yLJ;BG=vB)Dx z5WFywc$A-5jWK$2PERKK(^eFuG&4uGA<{ib>WKd6r;F@q1g=KwfD?@&=TCjaG$KCa z@>-@}(VHhaqK6xI#S=nIf^kdKjV2=$4}=&j{jCLgV~k`8AJ7C@U?>PJl8{N-DRv?6K@)hW>x3nB6L_(rZ{kFqn*>g@Vwd(Dc~MP;p;I?U z&uP*?bOT&e$k0`S7o)SNwr0VKpz!oQ>tMte9I%+}O8u;gWa0BDjzNDW9brE!gG`ea z@QY>5bl#H}r$`#wNpxB{Qziu}kH{!cAc6!r<-L|CW{W($@xT#gkmN!gOIup2(lBE{UVStkiJ@Aif{qZHl)!Oe4qvkY!_G*C z?pbU08kbH@ehjx6TpW$2(;e9^!%;JItr#VCa`cBqil+azv}g<}rR{83DFi=>sg&a=S3zDKBVdJ?INd=<1 zMDxROi6$2*c;6QLwy0wd2ih<~%ak))o5hoq@5GP}w6wvPf-M&Cg&TFtws&}HV?upF z@)z-CaZvW#aDPnwlB$jCTG;^NUMl$-3=vt8Pq8+*L$EBkao}Z~0}q#)M070&Qc;=M zm)a9moENwieVzGfacMp+5axScq=~VMV%j0dCmXOWk$GHqa#;%HVKTG8)#?fXeIU_m zh6(|aBys4GJ|4XyJI*)Iu_X}IqbPekUQfg3@JrJy^2_pAEfQPHyk_w;JTS{A7*$rt z7Az5IcZTN{4#rDlqNl4pbO+W$I+(byRL8_2ixfR)1idv`<0ol)Wn(B)y>MhytXW!- z(WU%MtwAf+uFG{+@4o826>QOv{e-QAS`tz@!8NV==if&Q#}@3en`C9N_~wQV4`UI? z4mN<4ll92-$3|*|s(9xnhiOYcYDTg>*-yrZv1%(b0r#*L0II>LX(ouuDFnr9VR0{# zlR7VB1v3?M!b%>(#OA!mRbJUpEF;KTw(+a%uUU5W7LLBmTtiJSJJs|wQ^j%n4AcT@ z$jxldH%JuRYFkDzgh1VPW4@S!9B^Z}k8#^lCr*;vN_sLSy2bON1!*IpEY27?^;kq~ z^)o6-s{yj7mF5sn?bl`(GfR0cbdqKmy32i46U0W$83F3ab=t{oO&J2lun1Y4#&oi? zIwi42c+pKDU84`Jt|*cN`R%d?RLVXT>!brTSvQgpvG*KrHwtl1t{Jh$a>N<588oYc_%8o;NA0+2nA=cYi~1$-ecC z1NFtDbHx~Sx|NmEo^4G}6l>{hLc|{&>&A_pbIT>hIt+g7Sb49*y;9ZiH+Dr!JZTY? zV+t(B6C_z!DI-+?vK9*B@|S3i4^sEaBkV%d{@|iQQyPd>Te58i*k@L5h`vJaRyGio zj_xpT#7Dpo{G6ji9Pwk@1p@vg@6&{_NMx2Lg=$tgGq?a_UgFcY7!;;7>ea$26Lt&2z%6+Romys7s|gbw zX^shFA>w?mx_8*Dtzs$&NKL0?YJpbcS1!3wufQMTRYtJ2%#|MO14$C2XhjhTV~ffB zGO-XrMk*#hqw|vdHdh(-@(e^p=hxf^oefA{z9@7`EGI2C&b#700a4L~lDxCTh&HKS z`h)b$tFIuLbsnbtrmUzp#Epv9>9$%nHtpuqj8&u7n=&0n3TV%WrY6Haq#A z4mje;r{cgS+&1yE>TBq#3?odbWj!%t+)?pL1#%Lkwmf*LVaHs}0jz7^8ffOWl(J5D z-(SaH3{-VJt}ZmDaQP6rRRUAHJol1OyAYW_hWP)~rqsh`}itB=(`^Q7d+m%65^$x~vflh5c9+@O1%S_wnCa z{T$$1tz~FULGL^V-d7u|+*4syLF*a=y!Q2DU;R;gTJz}V?g3UEn|VJi=2wrf8llw} z&&*Ei&x5?z%12tC(EYwroUb`+E3H~F@r-?~-}>sOuR0aiRJ6*Y=a?z^;}<1)+$qlE7F>_=0=(6nlT@}k4r0e?es`}&hzby z*Q!0oT!kw%ieVcEYeI0$gz-B{iYONw+V}Hz3ZhM{2A8*Fi9X0754_xsKpYMX6M8&ijTXy{FXe?Rs4Z%p-_p}bVhhj@$*Te`5iZnoA6H(8s(il zQhCr4a}}w=xbfWFXQ?&k3i?{Hat9K=+1WOXq25=r8`RZ_M}J=aEZtRLIH1uNT9?gjEHn_HRJ*T zV~pHbB1f{+RsSUEOr8}tS||A}dEzXen^uR%Wi~UT2emDm^lVlpP^k==owf?m=$Xop zLO%`KUbHwLOrOSGu!mgOySm_U%vDlpS!m4S&2oriz&UQ$QbT5EQfDtF{LJz#ZYsoQ ziAV@o%Y3sza6QI3*#yy4>E>HyD`_1C<5$ha=#Qv$Gz@m99Q{0S;n$pMp7iPls~Sb4}d%31az1W8EJQZum?pajo0a}p{Z8x~!91??m0 zFqCvImkf!TcuZ(SL%O1M;=$K2A`m{|&>k;M#83NVs z=(U1iTOhHRgwMVouFHdse^YI`R(Z!A102lhJ&Lp>TS#on**!3V^R*pHQ*dL-vlYCz zlt9sIZvo3iLrf7;BJRjGSq#QCev+ThHhcp&)}IYUOC&!sJcYk8d58@o`!HoBVK9u~ zYnSqvIKxC7e4SJgz;RF%BjFyi7Dvs7RTZ+-LbHZgg)kw?p-33R;wX6m2#XrC0-kGD+s8BX5@mBj1?H+7!M~ZGs~C?&i6M4^i%Bd%&^wvkSB7}srpd^ zpn-IMezG@BIqhpshX?l`{k@)*Ta){j4@N`dh}akvBGKTuQ+ftxz=J4a^E7DXiz|ef zLm95iaNdJCq|jL1ad%6n!t6wG z&%_{Qytgd>TSYwZMAa;@e18||Hk#T#7*9ySJ%zcvim;f3kcqKz;edqvVHS38)?$;4 zIq$Qr)QlRf*dTH&Ly5t9ux)FOzTE~lk3gARwtjOw)j3*;>e<(Vv&2J8FC0|Xp6PLJ zb`d9)bTLCBr!VH%#wuL+7h|0r|)^0}NRT3OC%U{F< z)nodQgm3%FwCA!7TSuV?b9GH`NEjlLrS(9JCcxt0lnPZe29EPm7B|4D%@5W806uraN z-9m5K>d06M-zC~ZSXyzPCUW1*(AYIHhp)-0vmCZ7Y2=Gf!m^xq2+ovD9+NPShTSnJ zD>qDS`skQ;euyQ_&l)w(rm`xxd$o&!VHc(rgOZh@yblaS9as`=lVnqvTu|6g+fayr z>0BnHgku)GqWmcxh@7=7kLY$tQD*{$mQ3SvAs=><(p=`Ci5>GUsdPP3+js!l}l$Bm-()4^^0A*hPaJ`H<;oMc*6kWK~C(gU-UMv-uyOh$8Q zSroxQbYIU+J!YMAQs4(U1~&4jW9Sm;Q6^$jN74Uo-Qr$xlL8B}u%q>hrH#^uqA@tq z(mKo|qk%PWo#ILrJmtShmKIYCB8y;-V#76;O{cykBLpzdOF;~>Ag4TtD2{l~#idk_lCFZyVDZW6{lPbYDDcGq!dpTQ5 zCNSh7Z7uhw#zTNaGY8hlm1CvC$Z`c8Tqr@pHFIZkpgt*s2Vq%Y*r{Vvl;2Z-kd&%d zE9H?c=3J}W=jnhS4!cF^GXi_^ROYg$)^Ccn+@j*MklRf9okV>vq1q5vNfWb|p|qmLse zhXFfX=DJN+(XxoL-87(@7j9%#<6VI>jhI0y^aVBLkK$cC@*5R_2W`z}N88tR6SC7j z5iwzHtj;7C>eH#@yy13MxQrcba&db+T2e5Sbff@*63kLVPNrzIHCFzj(1ibP-HpAi z>ulCn+X8CQ(mWzztPrOmIvDb*wd`(4G4D}ivMh(%-RW04quh8|Q83L&!A(qVi)r2# zi5a6=J9UwmaUNCo_;v@ertH`*=n0==~4=V${(?abi zwm)PoYOjNKlvMcZ`;l}Cj$-ur`8`$cRVyAn_Z>}YTXAx&8YuFvSBh&7(gR-uNISlK z1;U?N;X6h22f3rd6Z-hw%3W2vU+=YFMc?`km7(~I{M;RXW**J=wE!P!iu!9jzJlQA z=xBG9+SMvR*-iw~+Qcx=PAdlLoyY&RLq;d-)U0=%e6HBMBL8Y7t%+zZ)%QM&@ca6J zuU!n->V@Xkd+K;`oN1+^!X0|5`lD5lnY6E&*SzpOnpcO7ieexNf;8|gDjl1&xCeZw zhD9OoDR&Mr`8@{|X2n+U^d#dK*<)xOZF}%`O#mmRLMc=@byMVS(E_xYati8{d*;#7 z9y~}WHXV*X%IXoHxZQwwnvR@jG8KOcqc)qF3%sJ@=l!6@uqE%Jqyl(Fb zL&yZL>3&-PB&w`~%D@o5f-e_pnBA6wk6ghAR@_?5PwRDDFV9Mo%qE<8e~0qW{} zK6bI%eI_35u*O|&L!2R?c<>1}jgKJPDi`H4^FMxXB;)ir>r5O$2umokfSA%jc%XVR zYST1xt535yK};>RaF|E$d1%}`!YkiRfbt|>>I*>aP$346IlTpq16`yu?qpvGp(tH5 zR}w|wXxr+nj$oA;05vN-8I>SJl?~S&S`15eNuxD=MqPUIhCmwT3JHl!^QeR5)NCq5 zK+G; zb>E>=X>gS?5Z@c!Iovj9%vq3eSTyTYw_^LH-%-rRDXWVG>C|bSfuPUr7cJ z!_18AFauBC;0d;Q3{=~Z{j7C#>IhD^!Hf{Fe+d)GMq|8jS9+1z4Qc6!1lf2_Go-%Y z=9ro_XTf|!jl*{z$o9~kDIYe=tK*V9Xb36d;jljz+c@5kL>Qbadg5YR1~OYl4MsX` zVotRWL@SmvHPz9vpnE28aq&pINdg@_nAk5`Vvrn#Z6&s%Y3MOJC@ncdV9ioVlzA;w zx!YJcq#yfVh-IyqRIYKj&`;{0Sa(vtp1%BZ`Zt_Cqh;2#a{0L3%7;%o@}OzcXC8TY z%bbnYD7|SV4)Bix&+50mwkP&aSk{64^Aw{*R^s-=%H5^5>F*t7H7c;4%Pst_-_uI||P;a?rHa zJ=7Kj^G#BfA(j{!qbUl4BbsO(b^~b=DAf^8YTAOa8l^2M_*7}qkQx0FaQ1jVgMg>i z2;5|m1edg?txfVWHZAL!SX3l|<8EDX(qjeV_MDs_=o}@fPE-dIZqB*Qsw?+tuG>`7 z-8VLxmj#DjVqSVMSpg>GgeWt`B!X-&G{c?4Fk?8?w6=*|lkJYx!YcM4R$g8;Hfhkb zo5Pm{L)qigvMmeOSXpCO~j@IC5PPGvirol?vflqf-mmcUH+nsc>qp$CZsYJq4S& zNCgLq2eU+-hgO5%RA6g99LZJ-szr$ac>sAews#FlrMPvm#sU#WdaP>OHg#!Fa&7`a zX_e&ACnso>50p@c#bq5eNdl94f&me1G?HyYNcY7WQ=rLm_wDE{*(l_QD??mmy0c6K z4FSx_rgqJ379y+11MnleD_9GScA%t9MpROO?kY)HDl({wSPO7S%IPr{mdm^|MG|mMDtx8+m}krxEjf3+(j-nCZz1gZkQebG+kp@H>-3*Y@Poa~DTL45 z?-BLcE;kFKI-Me*wD6Ga1CO+7bnPC8dMaUHA!M`FVC!^LTg(BHb%B-7gmhy*aRZi2 z+CIcr>>-DuZEp;p+D>im;Fwcix8ikyzbnH-weDU@e>$Pn`Z)*z@zi7M!KqR3nu#NE zVIB1mGJ-ZJk|F^RGk^T*L>4e>R(DQ>QZ ztzZ*WWO7A`^K(Q(X<2$r4o(Vo03CAs5$Ykiql&8n(y-+BMiA4+&lFZb~=1&h- z28qJcek4K^ZSD%{>+Ixp;i+)&dXyVRY?-haBpm5`6rfFXyYnrnKbUc^>>oM8gx2Qrq zRt8d+3dU4%13D}9PkkjO!i zSP1~MyTrb`UlvSPdI^FeXDKmR+FF`UEzb@uXWSUr2gyThgPY=py6glW6*I3W;f_2$ zJIO7bIq#D|2eRihmk;q}MxJMq1|JMn%Bj6gvZb(!?j%i9 zYd7g`a%M=-FghhLtSV;A4jts=p&p#@tPF*@i83%e=Aw0Twcg4(t$mha!@S^s*#^Np z?4wRZ|DOyT+$OU-asgBxtCf$g5%eQL4hwwPA|9(RBnrmUi$SQ{FG!AA#2i=}wD5vu z9;g#@XS?s{$Gm8I>F7j1qExg^Wf+sRHaW+zq zRGTb|n5JE;EoS1F^g&G9p)M`K&!Ojj7A2#w^;{*DV29hfJ%a0{WvG@YHL?4M>?8 zbq=NPj+Vazol1$2G_L%=7>Ux^TN3&xG!Us>s95p13mE%aty1?aFE2YbQz<%e71M(S z*thtY;I4KOE4#&qq%o2LVf9&yRKbW4GI`Yv?nmlmRyItB_$^PE2y69`p6jR=SGCos zhTOv|<;i9zU`tQMj8%2P6<{2#X2o7Au$Ory76>!3YRLl18!42hp)O!sJSaz03AbDI z2_BCz$Gdn4dvrviAL4F^sfWYk$!G{=Z^*4ZY$t>$vklVAhzA;LDKqW^fq6|6C_rr@ zt9*<$_$*=zG!cNsuDeIwS)Rfzh!7|n(Sft8^}EcR;w$D&=T|IjtqtHRShZ8_I8+^9 z&0n<8WDY`&5)e@=p}yxRh(y!Zo21+F9Da|Gn8LwJ zwWfM&m9^hydzz^V#voeGxxow$PczWt`If2T0qF!ITeO4frzitSx5~8hWCXMCZThI} z$eMG?`AVeDWQz=?&axo1#HbnpDV&^7H&nKlBq`E$^z3XJxJYqJi>20Chbhpje4%+J z4!9J(8nYRQZA7i0<=?_rrpu5h+N2Kqv=l-hI6cEU5Y!EJb#EzUg7G;xpD-y>-AB|{ z?PU0v6Um5TV0M0(JS8bG+_bdzfic!pU1YHz)sc~aMV%oU>kbHsR<5p&?(Rsv|_V2haY)2VQkr?4l^v|Z%7ZN$ zAnEkLY?(><5V8xfE0}u)PQfyCt}#K5xzAV3$DsT1Au~s}RWKL^%tBBo3-{R*%QP_b_HOGe=Z8e{OI-Cv51!uH&SyAqfoAZr2&l~ z=WAQ)k`5Hwks9<#`}BEZ=uGq0gxv}oXg+d@rpIA{(jG`3*64kwh`fI>bqj+Knd{&R zXfxkD*`&38E!^5JEG1TRCDQ}5$*RbVMP-W?gA5ErroXYPc`sO}zT3nWFR}~*ZOxct z+wUDEvTAH}#vT@&Xk)R)GV%4?w0Al_4Z?y%2DOj88PqJzrg3@I$i}sRnm0KY*IGef zI!Zu~j`A4B)tP9_nC-OJq&Uagl9qXG!ai#uG4Q2uaF%Ezr6qDDqM{dK7xr#)Y6O`_ zPCC|LCRdD-Qd^?kzUnX(VCVbM6R=|0*$}(q$k?6BtmQaAYEcg&Pe);JV=6A0g5yS{ zZmLhdE~s15ix||Q5NewRlSCRcCwhU+^NHdT&j&~8fkInBQcS4DgSeO-$TZ~#i}_(z z#1xz$_O%|Xy*irIP;)hfC=)wzFWLmViJ5ERm{X&-*%udH69p#d8@#epZrEeaw|69>d8CH9JXxzKH51u6Tyx%W;;?6&mid zl_ObcHhY$vYni!56p}6CH^PHXhPKH<0Ykz-CU>J8q5j9Guhe)8S z!l-Zc#F(Ks!?t^tXBI?)J7#-K9-k+Rwj+6=I%heDGd>hHRDQ0fkZJKGh582OzSQw;%HdT!*eto zjb=Z#OE|%x(J9T@T6|7gdVHM2aTexB3@CAf3Z~Qnswp;1MIePasgcx&U!k};!V=sJ@m+@ju-CqGc9aiV3{pWyi=u+f2V4kEy0Fsl zg%*v>uxZjS$t=T(uY(z0eFK)VVC=L9;{*Dg&mpuVCj-p`XEHzwyNLEPNhY~~B=Jo! zU_6nEL`0u0)o5OdRFaWNjJDUU7tk8RHU}tL%}`8=efW@l6_lQ; z+u1^BJey(!zQ$I-+i$|eume4F!;i^leOAL+NUhEkl~FLsl}2Hv%;K+hLP7`T@;^JT z2-@^f5m<}s$tEE)?=*%7z1g_tWI#v`fC0kc}v%S@1h1tOiLdqI+I z+hn2@6811&+2VLYkZ7u~I;JOLg5(A~cNZ*;g3$*tWQ#*_49Sp8lLYPi3A9lI#D#lV zTDh$t-kZm0taDJK>}K0A$@o(SqlW9cSR+WLKAw-(K2>%VUQ>-ToCaO$Q8Qa)lf<&% zSdv$IxO=mXmV()8=MkXog&zxC*cB#}(AU(RY|I zj9jsK9M<=Mq)%WyH1zTK*MOWa5YB)5%9R{mAm@0MNvNYi&1j~ReW-@lI4}@4Kg)5q!Rs202~&`eu7zI6^rH}*d6-Xl&3N)oFZ8%)7C=R1vfEDVc6jcA_CY z(OvItUlb_zXl`K-M=lnbj2NuJ53Y}nLM@6ci7!n+NC0I~O?rnZW6~TF!J5FP7_z!n zrcY(nCGznc8PSi;vb=B^7=?#POFK>FWez2*(`H9wB#Y15>WK;VM1sl6g+H@Ri*dqC zF3R4D7-u@;LJXW?2#iOf3oT$uAxP%RQrV15wKbth`*hS{Xk7i|TSyj8I@XmRS9RD8uNPpl$UWX&qQi2Ob8RHwKA4kztciXIFgL@*;LZit7-h5 z84j~=j|B>*aJ)u}8h_U1X7A-vqTbb&%umKNw{GEq!uTciXJL731L@8mtPa;?)vrMNM52r%-YmQP1;df_qK z#|g)RW=O zK(N&T>7)FVHM)T+@aXaV_Uda^ zFh+FbJ99)8s`#y4E6y3InzB9@?dY5=ohl{jUud+eZ=8pE_^VU2(k>lwo6#57iPCkh zmH0@zSp2*&eJ`3Gpj~|;4oTE54$&SMagR<9^RvX7_^UI<`mBGtLVcb=o2ufZXZWrg zuR!HHaa09K`+Zy%eON)DObdRc7Nm8T}v?NE=cjq#l z=apLYy+1xX+9jpCG`DFV(vY>}oayyhwC6};PF1XQdRRVI-&Lh26lZFXmW9CzV{|NO z-<4)fW72GEmWAPA`>R>g{R{a_vOtD*G8B5NT0SuK=_Uq>IV#Me6<~ zl6AhZ3Cn@leCsfqs2L&6yk`9RkA6_;rKNY3B`(yde*;EI+I1$nAHCzuWk%9xNk@to z-o?G5Nl~8PS$_nvmwNpsHNuUZw4=t^5^skcyRZUI3NV^Ct@J`xw=q-zn)B`;;Rm975C!ggK#3hCEUX#sQ z#o8AScG@#tI;kfvFP1)ya3Oth?oN9YQ>`b-+y(Sl60D46)QoMUosiDOY3HP$z?fI? zOH!Vh9xve2JOVEQ_Z687S&ndZ05lo8(uRW{lPX#>5=%FrOJ0EZ?yv z&8y7Hxr1bO@727wk|*Lh3*}uFPudaQC8R>Hl>RGmhM6Oe92WLkEDGXO2dT2;DKu&s zA)_PEma%qYU6l=L4gw%t5^3?L!@ubqtY&^~-Cnr(AU#O~&bFX>nAb2nVZ38jnLOjldoG1nA|PlFk)G%K#SKjaRWQL7 zeN zAsDUC71P@^cWvEMS_s#gtIU#w(yYoh*2&IyKGemqN)ZF~HIMT30$rr2N<7iRB#Y@| z&8VU+md%b+5=)BvcvBi7-N}=##z_b3HW?w&m{!hFAvRqoT+dd*j7~@t@M>03&M-wr zb!tr33fz_szcFk7zi}zYzsWSn{YdG-Hq+bg8K<4$R<(x?y=j*emSF zD{1+>RoVE`^ZKM{L%FZ8t9c7a*LT?!y0+D3aZ8Wp!(X4XBSMyNlVod5_d!>tw0Vq!JRhLBOjrpKoAN191EhVCJL3!Hql9NV z2t#tzSq?_cd;<6%>wgl864%_K`*1PagE%ppg>^!17KzK;{A^uL49XH1C%3a2N)n`t z+va^z-sHG)E`nTel0Bc-UDK{um>luJ0v+3eBuj~15OfvOr-7O7L@TsYUN)wP+eDNP zAvcErfwqE8%ET2bRwUP?e18@Nb&PRSJcXV0@@_&aql?X^w8fNO$vn&?f*6HPzD0~K z&?&hdT5&V4#g^SI{J|F-%9!U&q(k7+@o&CYv$=c_PK_xvoh^d~V5GLGH>?ptFVF|n zfK!1_uNA^pYlpDe*bp`cwg3(XjsQA<>o*AD2H?lQHXDX8ZKDvT1C=+0&<-5EaR|o( zr*9I%S-^#xhHx=(_+}x@0)7lE0e0S;Yk{|K#r43G+k`N_9K!uOh46b|lU=w5=mu)~ z+Z@7)zcMaoS#MoOa+Ln}(T(gzz@t_%%*Dfj<>K>YcIXm_cBd?Aqdm z#j9$&lyqU(z1Vi~;^UTXweDK_QM|m^wi+&P+;#eKv%@P~#nS^hrP0Zsuv2z(#d1iIK1mzWx0cAsh$K{tBKI-%copaQ1c~tg$^j3Ga%Bp9c2cHH53i<$U`A z_;zG`2rm}VzUs|uHzAt$oF29kE>4&PuJ#DwV|%(ReUZN#P7YxsVC=r&>n-p-vULy` z0!{%=1ug}?03^9P?tl>X2Mz$P2W|i!0KNEbNp{9 ze0&P{6HuN4zXEN*g}@cSeZY5t?*Thah4+C|fzyD?r*jSPN8nGui3f%76mZ%Ms(&mTiuZx7*S;4{GQfM0P+(HFv=KyxjGw*cP*9tWNTo(A63AHvqavkS2)faigA z7NLuPB@ZsSlb;8dTo+&YyE}QWSNg`k^>=qJIhRi~H~ib9k%!ZKy+v5G#OAJ18f}b) zS8orlyscSh6&5@4cUq8PPx0bM!0Bax@cVn<@*^1h%n&{VTmn3IWC%CS0nb3`s1O=} z)#st>fyL0lrNBGEdj%K^p4SC>fj;0{z>DBKfaenMj(2b^@S4pBT zqM+hz*z46td3S5u`*qKJIvfw=USH1tn@d+FJb#AQ!rfKCMrR?vfvx`){sqRqFN9ry z&z>8?mw_4YhrfaQ&ci+g);}K_0Nx9n1)Kw12;2;O9XRG9*2aPMumt_#mk5i?YP_sOo}D_v-JB4<3AI`muCb2 zslTU%u>I-qIq=;xu(yB>p#jmt_RzpO;9qp`IpE)cXMkscS?53pKr?i439uOW8gLNw zAv(D!(!tT-Uv%)7i&t^4`1M6&+W70WdZWkX{J)iO@mFA9_;5eq2Y`6;Dfsc%KtH_r zF5q_`3E^J&?mpl&c<#6G-0y&eSHh#fNgszFfnQ%8!f$~6uEk~tcDX);U4eUU;C|rj zPlWKVz-u+!RnHkU*Q4++*|`sJATS#cE>8i3%QJwj!P(BhfxuyaaCb4V|4qblfg^!q zfa8F6pbHoQ{^e#|L!kFo+60cfJ%j;Z$^XN51IGLt{vJ@eGlcbkd0!0Se4zg;v=4j` z_!;nX;7OqK-VlEIz#R`<#m_JK@!$T+KReI9yXw5FMy`55gM6ibQ6jIvi+c6m+{(!A zmDeA2t-nGXKWUM=*12|+f?9@l3cCrPZvjujR}Xj+zK#V?!q*+2M%DwX2~VHF?*n>1 z$2C9zXTsg}pC`@-90l%#!}IlNsj6&0bnQaw=?h+@V76x+Yh)G+}#Ik3+{x&tA)d#au4t+ z@OT?g`cHHQa6NDxIK3WN3!MHN@LJLTs^^TF>%hO9|F;q@J_DQ!kG&t53!fbYJOTV1 zI00V!Bz$%w@B+N{B5?i^Y{REQI1||VH`sN+An@a-L-+|W@<;pu;H*Dk?*n6=MIQjC zK8KzFe)9aNKCMF1Yd0aI@Gtqf-jj~MJHX)qzr}9{+J1-r22KXf06q#_3)~Al0=)6} z=yRYKcsKB6;2xk0{PzR*0gnKW{sEs57y~`51MCbm1CxRMf#ZO7py3(52RfmX8t^Fa zD?s!z2737^u;2w~5?c8c@cEa}3&3xHr-9A?OwJN;4R8Z+`5Q`Mv(-vrx3x>*T;Lku zM&O~brSMbWem%=ZBBR4B)&FH~9m+_;|{l~x6>l?Bkf2VJjJoxIOJ%6WG zS%Dr{84VPsh!-`t>oSMy0iR;-ZUcV(GII+&)>sOU1MOoh z3}B=2$N^xJNvrr?M2|U?|HIbG|NY%>@}{DdFE(0E{?``5$)>=Kz)ip-z}oQbI>6q* z0YD4T3tR$R58MF!X3tXiEwI^MrEtRJQg|n@^;=3|8{mNbu>}q&g?oS#r$94Pkt4vF zGfLqspy$w4bRa~%E^1E?9;5sZql~R2qrVMovo|^bI1ji4I1zka34CRrQg{GZcRy?d z;85`UHsGz`cz>Xy1)C5Me$Si6wKGfMG2rLGp|ij@@NHnhk)^N@xB|EmxEg4jT?+pN z^v@}UsYjK<1;FQzr|lC;;o^Z(_#kloU@3eGczRJOj2S6~Kc5V3zPl8ffy00w0lx$0 zyr&cffalIa&YTUcod^8^dz{bbz>Ob5u3Z8hf0$R?Yc@9 z{Sx$+zw_5c4?&;!4_7MxOH;ZW>74Wn_J5srTXCFzW%Oa)wJVbUE#k#K;K;*DVKxws zD1{Qx1pbcvI|1SHI~8aGxUq_S z0p8tN3hxD87usL-P;q}9{|grv_LRbxfd2r-_m#pewNkhh_z?Ve6})#faMW-q91HIq z2ki8oQh4gU=m6l%Q%d9y!2hT59q@)T;WOZF`0yU!0eJDdz_aheR{+MJi+=#DLdAa% z`7d0YexA$ANgqUB0-r=yN?!ILCnYaG|B+Jo0&w3I*nq(Mk(rX4&wm^|0ykcbzX;q0 zd;_=#_ye%-HOL2GookT`z}CPjyuWI^*O`fRZ(i9#kkFh{C$!$!&lmfSZ7uf$Ofv?gH)yz6HDhYzOYQ2j)aNIE}x<(7^)W z=fE$3j+^iYfoE<(-UHX(S_*IaG`=6O`)5jF95C&(|AS-z@#y^D|I9ae|J~{rqxmb7 z3|oqiHwHEZwgI*Ub_R9@#shl;(}5YlF~9=gJ;2q#?ZCC*`DWm^z#oA>1Dk>O5#S`? z_S;M04qzNKFbNnB4IBU*2pvoX{vG%_@D%VIaPH@zH(=6N;1yujy<7vVaepZc0e3wJ zeF0zkK`9*c!&3P4Bc<^FfO$W{&jcO?eg!N6o(BF1ya4;~Y(CrV*Hu-z}96W|{^s8y}KYHAvVf62ag0G+^mUgmT%RuLEh!Oo38S*r~ z2G9#!1RU@jbO+oGEO}t5AK$}w9Xt7KFW*IXF1mA3LCr1yC2Ik7GO}oSEn_oXlIqL3 zEJ^i$j{IMFnZ7c1a@bkCxHUKuuKxX3_-Wv2UEmwQw%}+xU_L&9VR3sT#%q;<0;x zKLO7G<>$dWupQ6|p1LB=KDK5<_%m?x+6`gmIt}4*;7Q<^u??XI7+kj@3;|oN*AQ+8 zZd|`1d=FUo#)hy6xD2=pSn}N^-~EDqU4Icj3;AiaR|j2x5k12@n!S#^qgUk7WqC)h zp7Z`rZd#5Mkbk%`oVV;gFG~Wgti;-VnRe)?mXpxhLcBN-z#njZV?($B7#`CQ7631- z)(~C}o`vsEf@k4-0r(ZZM}RYdvjE}!OTd2s%^Ng?Hv|7z zf?n0ys1?P!P?2fF)t8n3Yxduk;z{8~c!dAeKwrmKG0b%Qgumg<0PY381FW@IL)a8}c{2Ulhwp)tfD3_3flc4i z5UvA0{x7uuR{FbtLpT;#^1~%xU2@Bk4;6m&?iTy(mZiS)>-6m{wpXxDCau`Fs*?sQ zkQ~dF2FuD#SaG&P-E)`YjY?vLeTDb&KnpMh_#p5hpljoX&<*UrX+t;w7y(WK?gs7w zw%iOF0nP)?2krpw1?~f0-W-~NeilG03xV;_#6(~mw9o`Rz0)cgAijKEB$pms@c)F1 z{{rU0pGO0iME>lEd|95@5ViyMfDiWq?umT3$z=Epc-y`W;Yi@R{m>u4Ch(p3?_=rHJ4`v7N8 zhc*ss2+tf0UmwyCeh&N^coAqg6diF`LpbN~hVXUZ0bt=#4dLCui$|kRjzPD)9T@d;S2^S;ak8F{m=uj^}8CvHo(5X zG+;V#EU*gy|2^<8+4*(gen5DeR0BW2Nx;c~a90NQ1oi^<1||dh0K#KGFaSIX5UIO! z$qg4TS-5232?s9Z^+Z=UE4Eqj`}f~yrTzX1>71_IGB4WM%Lo`Fdyh&$o0UC zk%n+EFzqCG8aVqs4dGvbCxC`i8bTv**r^TSaNx?*um^!DXDpBJ>)h5?&T#mj`3*a) z@_+xtH_^5`dkZq`&B__- zd>i-y@Ej1p_t$~@fyaQyfhWNA5@5&EiTMCO0Ph=|*$_T_4s-xK_Wp*j-+2w8ay~vL zaNb4Od%!6lXb7hQrvbU47VSBr{ueIb=baI*yYRXTnNoO3gWcGEub7weYhTs+XkF_o z;3e!ywZ5FIl9Yg_g_g{!d{wc8{Eiijl0N6xE~huf|2v8&4+I_tgs0}S;CJAreda1ZeON3a8~M9u?u0$%{O`51f- zRIb4e0N!|QL)Z+M2QafC*U}6e>`vm_!Mr1$06V>@OL(_FSt8D;_z?b{W|NQ?#gp43F>G7=8)7X)iwCr!iaxTnl^_=sBP<{0!)8X$%8Em;%gb z3=3v8hDE^XZ==oGjp4&UI0`trF>DHK4!ra2+zEk^w~9hcY*)WmnZW!8e!P!8vY8jcMn`GC!kh$Bna3y@F1e^}!*l;G?QCUhzk@dQvUVL9SJ0$ud`|j*hB&s$PvM z>I{TbWzVbnse;e~pvNlGsgACy`+2n-?~CfxsAA>E^-4&(Cym(eRGlPM6UygW zbE{tK6V1CuShl}DV+j}Ph47|1PL)Ev;_yJAUUgq*6D4qaDR<>HFsVahrKZbA)D}<) zlM;DQt_-@_F|n>AxkB5_(-KV=>vt%y8B|$PpcW!TrOLA&@OsG`8(>QwU@1c zjcSBZk)1bQUMQA3tCXo{)=R0J9*TuxI@tv26^5mx#sx<|c1Z@4gb{S?3RO1?HHu_j(GBhhHQyRib2suxj=M^_K3 z3Y(Rmvm(OTe7953M}?VHrKeD8iRN)Isf*(|+vH}%Ln&@?^ z#i{qIeLZB=zEl;oW*j&(-q{KN)wtjJRrk8|P`xVg{%C%4E^xk3tu3$QtG>3I)DWdt ztOA&L)1`{|YQV14s3dn%pN8QK)ywkgTwc3WW1LT~Mz}Wdp}14Ec2!-=CD;hn%r-2m zf2wut-)am=ifCT)`k$)7JHRMaO*Bb7JylZ4D}olQl4=fA3#{8_qZ}Gus)j|p^D1Os zS5-2)0!SVvdE}g}F}3qqj@LAbBo%bMs)u?@k{~r}O?UP4E`1^?xR7`C^XK)`+U;(y zKANhd9?X*+6UA>+Yr0RpRi8(=QWfAN|1<-lEZwV`&8{^>Up{{tsc2Al>t4~J+E-0f zT_f$|)FX`RDPE!7t4pW)sQS*Ip;v=;N1A(8rb~2}YpopnE}b3kMXjZtd0$*d3PX9V zWyg?fu6mwGeR6tHb!?5SNZGB-ie{+vlIE+!M&HY;9D}2&T`i>QdCrpu*iDT${s=U3hYb00rR0Z#(Lf)XN`k_Wg&{tIB>#RxB*7&Rm)lYp;FO`YL z=|zpB!6{m*61!LveNw)vt;(IK%ZduDb`PQYrCIs3TJ=M11p2|QOqhYAK zsjR2dx$?AOij-59JXTYk+lQvbpup@Hl4YU-##RwLRUoYmP~*__E9x{ou)n*%+SA=f z?L99nIMjm~V&!)yOqyICWpT8tTym|yi6Xj`9j1vBDL6}`DxTg)`Eb|jy;L*Qm%Y?i z?dw!erR%%<+OdcRMo{N-YM4~Xpis^7o@%At%o3{LGPx=b&0bqu2bt{sZ>3liq#WM;}@;&#QU$LKgG#zxh^#7 z_g+dP%hnL*iUVYeNNVc6xT(){cD)qLc}DtBnr?tQB-@>*)K8ZzZoTMJw_S=HROMbt zg{9}nwZEi%e!Xi`+4#fa#m^laHt;#^fybv=}LRlQOhMV?iwE_1vNx#mkF((H(z z+qhaDjLTQGE16Ud^LXVmrSIJDD7LF7dxcww7h)Xjf+Z=K+1=R%OEk;urXFT>XncmZOA9xkP#W?5Byv0`gf!=y8LdfKU-3IAl~H3ob) zEZL6z-#6UbssiNj;QZ=H6eCS4JgVngk!j{ZFU5>l-s;SRiDIh0p|14QSv;t>(pDX& z9I0;2N_->U=w>QWUY;-k4n7e#XQ0}NXd0>wF!7n_qKhpuoF zk;3W+Qese5liP;Wai6`+dn?ZaD|j{LiJ5r77o(a)qoo2-kZkdYD-5(gR z>b2quSqrN2E16Zav~=x&abwM7gdz!p@QC4r&%dX7lvY4eS^`o|33hKAFtRx!sl|RFvCR;M~gSR@xV+f;&WwYcC4w?vv9mZ6xhx zE;+p1-VN=w$qFc|V7w@@LVaDdW^1)vN)`3EG7Q zO=HrcNL#uQ%}G)3p^<(Jg|TBJAsh93=S0q8fXuLf{HaXeRPJs=8N2cyP}jx&ebr7( z0CgcfPnCbG<=*Zd#D_GmxU;oNuheGZL$TEC?#{k$@dx7_Qs9GP$iqE|9P2OkLPVX_rdE59#JAf}XdX>^Su$D8=e}pxSRCL0W#- zFb)8BGP8y^^*Ev>1{FKxE*P!#R6u4|b9u@zT-62#m<>z+DHa~1VHo)ItkTm|9+8wV zMP=>wOO5fI4$Ne_x6eL%)7zTqX`BRaIZlgw0DGQHlwlixoJc~3O$-BxqgPu7P`m@l%e+Zk`4br!Z!ccQV;T%I~CeDE2w;$19wEVWkAEwiIr%*c01 z<5q@^WG-YeJcRXSE|MXotKv66Keaxnq6-U3me7EB1ql@$5qVYe4W>!9(tNB+@{i^SzKU2h8PaNQy&e+yM zbfIDqx=JnSDf#+JX+z} zUVY7HWmz6eFZ1PCcD(C}T4C^+@1XB(HV)ZJnx`~&wI$m~ksCc%Q8U>{Ls(+EXFl)r zY`;g>$PSYQ;y81R>dubBr@m$+E6nM!=pCsgQ9@b`(iLjUtr<%9&I&D3unoz7oL}n zhigWBE+tiTeHxqF=Zf1VIii^vrWf)_guTR<`d*U2sn4lJv?yHn(@*D&B+axAs|bPU zx0~->iX@Km9(&trQ@kLmtkq%OXVKRe6<_x`)>t(bwc#ETScvvla~XwW1 zR9_Far54ACC8{fE+n#DC8nss{v#(mE4^o_2z@Un~Si=;k#*U5(7g%7lt*0{BrQ2%# z3bLW(y&>sNIpwWYJb`vMncDFydV9?TlEWYiOg_(m2jDses_z=6yK<#4#LRve9x$(m zQRq_UhTvZtgR?Fx9Kw_^>)6|M#;V&Lvh3RlLh1>X&H={PR37fP$*2x2FneC!N)0oM zZmR3Lk4MoOJ{E5Qr>D8x!fNjbK?n;im_J)KMEY6WSxZ*syesn5?J*%MUMbpeB3T zCMq*HW7wzc3%ER_hCw=1!^zaLr)=_SUuUILZmYRt^p_Q9qE_t?Sgmu|zQEe#V#ot` z1k&jM8N~(gS`Q%{?C@p_tAMbFnsm2WD$GC*Yj@tROZlP=;Z~XJSJ!l@S3Y{JlS>kN>wbT_Vrg5!SKfW?E9pC*hg{2PHWdLL zHd{;mO6~bK{=B4Xg_|LMiuRhWcf1uXykZ1Nk!G!vyUi?J-N_xYGLj|c)S$U@>rqy_ zzSkTG!xg(*Hr6;kEymKM?_Fo*wtKQjG!|)ctum?=$DQz^z6e+Knmf0s)GxP3y#=SV zWDROnwf@dTm1(`gdnrq0VMZ_NspC|Zk&j3-;JHAlud-6|`~q1fZiVG^<5(Y^bLF$5 z(aL*p`cqr=D~`+ZtK7Em5xRAh<3%m`XHFU3zSb1*P6jIr%y(71N=_oOuiSzgtH6r% z9?@u|^FV*iJWu(S=ol1!cMqPY;sFGEB(+j_P{Mlw(zSlwX~OvNd_eG7+Pc45BT^HC zf9N5JdPK4XTP%!c(%b`Y)}=Bld&4L#bd)V-*&3Z(^ohx7cNNx(+8R5ld9NMS^P!rS zECwqC`*4t_R26~30$@C-V#OC&6zr)gls;mC0)@XAj4w#~7*Lbw%vREo%*v3Wsq{{!<@zAyb-1RKCebYUlQfQU*pqe6 z@%(jeSC6%Z;l7Nn^I0usA*T5~kgL>3UF9=boSUV;ooc;uze;nEq>to>dnvAIG>0C; zk+jo{B^j6bq+r^Gqf& z!CyHPoxZZ(RO@Jhf0`s#x@9C`l}i>3kr-%cfmmWZPG%NM3%tgBH!G;S)l4$$4~_%| zo`%1P=aByNp*C|NUskU-!{{t}GWv|8kF=`{|Ug&6cReB@HA(y0iv!p%xB zWH5{tToC&9wZXVh0e*7?o0pT)4iJ1YZY`yw+)-(h4lr?86kHi?=vlZ9_%0T~okQA% z1=FXd)gNY(#b%6llnWQhgttNGPe<^#`O40y#t!PKwIbc4bflp{R)H(ya7rsZiiaMI zP2JuelOmAn@+qr}aI`#O!n8nbps9c0?+~5;D{ie3;ga-E_N!ZLOUH*?(ksKjPP=MRg_r^=fHJuP3_gm#d&L3E^#G2l_@BBs@7aHmBXQYuAGmG z$$dr36pd8ms5eG(^<2eKy&sbE(h%iv1lKAylC)Yba}P3WSZ%n>oWpz99-0~1a*6<| z4VUg70hc{5OR<=Pot~>JH6oYs(u0!BihpVLJ808qbcAoD3DmmJd75w6r+Vh{<~+qb zv-nPIWm)=akAk+!HI=lAuRr%QPW99AHYrTvwKSY`oaR}0^Z1~8>sQHdlKtNkKM@^h z78NI+!)wuou6FFXW|gPqxv_pyzYqnueIUFgPtWn^ zYYJ{j=;=;Rq6cN>2z!pDWJ6TA#&x{<;JxrX)TKQ&QM>F0&5LMKw574SR@SF_tJwYGZyfNGb+_*(!xCvxxS0bH`Z?-yEc$HuTe@Qs}tSMC2qd%P~Y(4@6&XSnVE+Df>% z8F>Duhg?7adi6Bv)NPgm{{4ehzyGh!fV}zK z%PxA@t~sRjWH-4DrmJ0N%kFX8N$bqg@mdemO1A_ro%9fF(Bdx0Il8%!t zG;Ch1BFTEPe12I4@>7!~r1e18{pxWqKW=@cl{mK_b$4o4>-?UHkhEwqnp#{Dm0hYV zI*miUlXmVjJz31zRom*h=j|#QEW1fp7wxVd-qmYiSpm92b0Le+?T8b3rP0Y|@D|Ux$X78AJSTx!7#uei;Y)U=GD zn4XqN%*QuhH?CZ@@vWA^@Z7pt%Ob_SqU@y+0%@!Sx}%(}YiUV?RGfjT@>Lco>ZjEn zOFhG_Z09>Iy}19{J;>7uMy3okJkR05n8g#f0F=o(>Ta9Qa*;WXt!&I=1+45zU&?*6 zWL!K-#6q;Rq^A(VOm8jo z&;y{BrD+k^3TaMcR%QX(p;~)ogf+K9(wXIpjkDG|Nh4$uwMHns`9=Xnbkbs@dvx+B z-0F0z@|Abi=9HeeTGqazeaYr_389q;|IE4Bt!uwW{N=p4-y{t*HLwEVw(P$4$5w~So?A{|Ei#WcXn~RpZ z`v~>E@JRHMW;2#zHj17muiJfOmlkSWo{Z*E9;5zBI!G>h&raf<%gQu*Nh`@N`4=v) z&4+*iS){gQbQXW1L4swZ=G)q{(-ceZ3ZK9}BvmTy-rm6)B%E4$ZR9{t5ZVCqgf<8!XU0pq1zR=>*gXui3h)rMlA-QW!n8fc?4Jbfh2|#M{nV zF3m#F-2;{who~AHV!^qu+Cf%=a^$*eFr|ggwZhxoq13q%RszzZu2!K3s@mLJWo=q9 z_qf`t)nZamiCne8q1?uJc^1(mOO7UsxkA5@1q3c7uLv+II_K%kF$p?0p#=*V+PIk4 z1gU&(xjiODH|IkxM9|0u@P_*SIZM8ErjAE{oG+!36MZCIvuquty_?cL9;;3qqicJh zRHsGfJ^wAb)b%NEeI}eG%_mDiJf^E8KSbBk>e65GmQxfyaiCih(zxQ;9^xj6%X~kO zo*`-Aaf{S1$(wvtGDTXPJN0Bq5#1?mtRCp;S_RQ_G$)CJ+~&zM&6bV;q$e)hGFUn` zpy-m%kSr_lrQ#!+7nj5Bj3(Jxl5pysRuxioOz+c`RmSadHT6O(rm_GO33I$k?)aMS z=$MJ;5qj*yS0P2vM0k=8Qwq=uJLlt}&3oGI5&ttY$4ZA)M0REsGVr};^_hMGgQo!=+Dq`t|f z(`*V4iuGw#%qhXM289)$X>o>nuGtW+$1o#U|c4Mm?p70hc^=%3#%-|8p~t zQ&w7ya2as0(YNHKOYS7AT~h0JI(0*o>9KX~3w9nAk4Of1K6TDRE>*-E9u1fMAj`I9 zR;*-@eDcKQ;%Ltx7WGPMi9aMkohOPsrt3UQK-$qQ32~*O1nNi9fRX{l%%fzpxV7vW zR?@<=3AAfj(#=O8{UkY(q@UY4%Fj_wt?OdlshO0V%H>1SJL;o)rJQ)_k3191<>j(k zbQ?$g^p+(7UfD)*t3_=qhhMYo{VKMybY69RR3zCCN#^+OM$K^j?7KcpS9vZ|vJDaz zry8~t@#(W@$~+r~X2vO?UMp&hKGz;4NvkmcU|vRgs4FC0Td-1t1Exk<9dDNFKIbLkdQqCSm8pY+&T zjLz9R;5gQDfV(+U?;hYm;QN5i*n1fWt&O1sGysjj7~l=S>cASnn!wt?I>1<9Jz#y{ zf5DQ=e-({_Ul!l|toY`k;+wk5?kRrr%B|T|V?$W?%zIznp#7sShp_h!Ve$@P#tz|l zKB8*$2JK}qvBgg1&UQP!nR6W{?2um-)~bK+SJ{0Rm5TS}>pz>21VrXxS9d?bANE`f zlqc>Pk9)DyL<{!DW7ZVRn6P*J)}t9Uvc~e9to#^~Zcn3B9Mp2El=e;(MSD@(Eg5K_ z+Emr%Y)b*NP)>PD%>twZR;P9o;$_b)fz@udD3(bUwVk}QKp>i@RLkY51LUb5^6Wro z`AGIQkV)092ydlKq;o`Prm<19iCnKX0xyNgXmt^1!dMK+M%S*b3$|aFYYA?pgje5S zL3E0^Q16J+G8G|af3QE%^2peoO(=>Bj;QrDP0QLPsjHjZHugIBsV+XMicPI;{bi23 zd)eaPJ6YR(=V;vIFl(UJ!EREXGq=Z%fH>D6#KaM@j zWQtaM$ekKw9|lQLz0Fgb#~!$>j*azyCH^EB3k9zF_kU&vB;Wr8{1r&@J<0afkl&K) zYXM2FFM05bpZMb9lUk>@Hm`7wnzKrTQ+DGN=C#7iLns&poB&jK-%Ejm{w~^i*$yM# zyYa+xwhEk!9_#4XU7K=O;I0rx)pN*i9QB<1j$#3|{PMta9-`XBN}gcTVd+@J!dN-F;4c>+;UNwkcm*x_VvUjlc%LhQJfwy!$gNMDD5!R&oYj4fU+H zahI?b{sxL}FaHe`9mdE;E8_mS;;5b}zInR%X4UKeDKn7UdYFK!1X5=)HjWDuF6t_6 zbKB|7<=ei|vh8i>ykR?F`-{$b!w$fXw}r6DZC`8H6j~9s(=5xX5c@;=~Utx z{tpMj{)tpVxO?rj$Na4EXSf{8|F>Qk^YmU^^64>aJ-r5hOVFHrkx60gr#Il`m=?9S zT1n(Xx#6H|)_++;`D(S*J~?aCmW%)Lj-7UYc--Q}#~y#n%V7ea>)xq$ z>GPY0zOA3$mCu&C@|;;m95i;V&DH<02hW&#B!BM(rj^wBADuMo7yMam)?ss|z5Mda z+ikN=^D$E{=abUVkw?r92mJDf9eUGx=s{D%``)nC4Bo8SKjWA|T(PeSN|)@u?iO5d z<-t>1=1e~S7vKN#AzwXU{nZ{_v$1czZBM>s(~IZrvS|F2J?DLF%689(H?=e_-s$US z-0|XSZ~f*;pZwJA+x^=e8$5a4zfSqd4u^mK@&()d>8Vo=eQU?3_xpTPxMaU0AHDMW z-7kClAErLobojm7oVmw@%O)Sb?%~acAAi~DXUw_&pn1~{`oQF~Z~o8@Jy*T><)2>j z+ecqIdFaUfzjku_?|1q5E|Z?>8@hO{Z+*YB_25HqxVm!NW~;CDp|MXrcJ`4EUt7BA zeWgvtp1bJqzi$1)r+%^9R%^^Y|J?K6_w?Ae>@xlNs~+2u;$DPi<;no*FdQ15m-Dj-7^LsvAS#7h+kN(jH58ZdsBc=O4ciF{l*NngM z!){pIG~ zd*zyY-~aGYS8lw?W5+%@RC@HA+xEQumS@hs>cxdKP9A^r31=R8%?BogyZ-X_tMAz5 zgEzfz>@A0#e%k>f7ael*346VH@FRW4?6}_Bo@r{?@RCzzG!dUegC0feEhg=fAYdES6uqNTVL30?*+T9wfe%XE?Dr}^*^!Jb;s|!=uhu_e7D6{ z9KG&i$8}x0SMBzuQ{MZwE3fQ1^*w(+=(LN!{r}0k6L2cm{%`o#GG(3<88Q}SijtxX zQRXO=q#`n8o}z>d70OsLHAzSrLMkFdl8{g`4@IWR)L<&_cWLi?-}m18{=fhG`M>XT z9MAErj*qomUBh{u*Y6yz(^}`^Jf4v@PnGid^_W4o#iq(^wkJybA5)j{3;g7`xVU`n zmOaLMd{y-8CpTrPW-BE(Cq!0$V2?1}^zO<<(QIc&!z>mrme>=0{-bJ#_YC#Vz3y_; zzqG@(D>ZrBN*;%-fvR=`hginEbVmB*V%{z5FTT9-B-O4d^~cu{<5lV>%$-8G8~4Bd zC`#k%Ff41L!Wt}EpMGlZgR}0B1o~xqv+QlPPGk$LdN>n&Bk{%>fyb&m@%~-uUvel4 zowv+ZogLq2Rq?R&xLNL9hw|X0mo9z}>8RM&U)#4KO>^VCten(^92p)R-RohTdy;qf z((W?;(RlC1?HbqOkp9qwA+AB)^ilS2!?E0R&n{?t(nTE-dwWf4?u&WC>2q6CqBc~Q zCCA7wyPDyu#Gya;(JMhn=oD*Q60>}+>#Mil^Zcxvc749_bcH*G@X#B=@{5D}P@gZU zMO9&B=W$8xEISFW>MIHPerlQfV}fJu7e-XDWgME}e95u(vo@{u>C11bGliPY^Lso| zoV^`yk=sB?GJdM{Hca7YU{B~al?D^H(G^PiNr^8SmY0Q}wq<2~vo1}?a=i4qWI>XE z4)?mC0+Vp72zBGEO!vNff#U1O3+*(`JB?$uOd2)MByZg}F1zjv!{K#wok3oXr+mHr z>Au~II<*it$sjO&r}sGH>=(r0KT6|;{~t;t}&ntzqXw^;U}9ojrj=Iv zBP3-@3fr5|YgVgU1w}oz-fUcx=B?)WsqwJ2dJZ$GD$LyFVTBeg*O~J?sUaJ@I}}a4 z)PktzxYoSf`_|XroA@@lidyHyo~~=LKRNQ|_GGBsKfaar!HLH|Uw3OpomiOJW%zS% z=CHoe_QCEAO`lv0PjA_!aJy-F=vOJOD-KVUB(%4@X-hTUsLvFe{@!_1_3-YopL4ra z?s>)gDSmpT&p(?qD(UN57B{MP;I4RZSK7BTksEI5DjqQM?7VSytnQwJ`rPdv+VuxL zGkdfd`}A5W?#=~si(0PUT4>^HEWKyz!r$PL^#{bZqNa@oY%*-8wJZEOtRUgRwyerSVAI z4l~-QI}5w=(&f+g`;vkg?$tBCV0iFC*GH8hb%a-GbrYvRnU1szl-Y2r zMuXZ%)QulpOIe-fzIY`F3vFc;(eG9p9pIXq69`{MQ(6=yRu(P7%9E=kxuZ8SNAhvK zCEs&}A66`4i6(^?*SK7c%^V}D(fYa*GKwp1d2D=?k`Ne;Q;^=B7R_ zuzx(VYJO(T`xP|)S#bxiyfYyO_U}z2zL@#nHjUKu`zYk7#i_~b|5uMcH;q((DU9R= ze^(e$2A2wBBT5_%%_L>P@hv*XSw?rVp8Lq%&Amw6!E$n8+_uyu{Z$xmV!>b5{A*z( z?qECdrKYijB0-XzfZuw4cxh7E;*Y2QtZ5{1lMADG%#p+8H2dVa2mTY-ms+P>r%-a(3SP$$wefsoH zn$?a^iH&>uNR+`LOnUq1R!h!k1gQy9N=hln zDd<*7$`pEeEs)+k@Z&|E*<}I@l_5Xg>|-BPW1eVZ9eSuo$9G=Uwr8T>?dW<^zKefb z|J@@6B+>fD^1RxeQ?i{Rf+wqNm{b_Tcm*vjY0lV)eS1{jp!$t+TQEHhjrY0s^U{(M z@eJH7va$k!A#;n%4qLK(qhw^^9_8icy?$?UF@W-w7_}aE45j;Z3d+^d&xFtLK4&qp zBrZ{GxSFfTDTXZlM__%#P3FJrbKRCGrc))UlCSK4`S^2SQU4{d$g%l%frS;90?P`i zprI+_^U%Dj&Y&oGwS9Dd^~<0|VjGr|4}Y1FoPb|}rGRCBS@W-fMNxw-(w72@ktMGL zzx+=Fi{=hFuYjJQs8_h!AhH4{y1H7a-%7^ z*RL>l99j3=wO_6yO*WX;s%)pj&*;<*&Ce)1&(TUM-xLa%o|%~`-5JR<|9Stn`%FIS zB`FQ-e8qAHEFq75=u^C01*u5jog? z$~ms@)caK*qL&FL-5;v;imh*q-u%3sc5||5#5um>?~YD<@~G|aw-jtFd{q6MbYxen zHYu9TO#Ykhgs=QCM_jd}+`wkfjkRaCY|ru6Kb2J}8>~DXsF!ba-k4suR?bI#O^3UN z7R!M3*F7OO1sB%(sOMW|tfP*}xg(q(e(fUXORtrQpR#=uMbF+;nC!}BlUY;_J86s%f>y|I$U2fTW3ek#RwS=%#Sie=RU8j z|nz-RNkvYDe+v_oNVpU#L=&olc++A+NOd0&JzLb>U7A3u}Ak+^D= z$NO5#-ZRT%*|}@!w9k|uQt}qx5`B&O!LG`f*+9Q+@e8bp>iqdJiSh&Mgjej$zkF8f zwNT@yGtWn}S+tCKAM+?V^FMzTGPP}WO(hG%h*`|M)E9|umSdbY?T^!58S)>j%+xv-Oyh3p|`cv|YP%k4lsr1@r1@q(7UC}|xwqhT6BZeb49T2&l#k*>U)boU#1>IfIcPdSl zbe7NT88AwciKsQnEF9KmmjYyW?np8mFtSuyt#Z~{S~J9zQFi>pfV%CuR7!0-L;eS17oRT`61`HpSj$9s7>v;>*baTM!M+C z+sf^;Cx*AB9Nl9)#WhgmC_ybzTJ`xo%N3uE2Bwu-dhxN3(+jl6p4<3Xzf20M-6XYe z?6`(>7XLTe2RpjbUl{G`(Te63Ue{oL`Rj5y9iJ1=9qwLsx~H`Nns{FQa;jXm@!evD zYg}xY>Bc$}%4zNN)w#a1{i`z2VD=G4Q%1>%*$&;o_F=MXDgjh z9HRC$>!P6I89rD4X@q7ltZ%qhO0c#3Vq;Nvo?M2pb*iqVwzc0)OX)U)J1P4tBdsO1 z8Fc#|MX~bs4E~T1%4|>LFlp8^mX)^PH{ZOWBW@Mb0SC88lkd;Xif+mAU$XQ`yy^Gi zw67;M*Xmd+yFwA$D9*!T2FcYILf15u$uhMbxWJcpn=X0c?3y@s6Q-cJ$^xUr@f8;j zRlk<;xpg7S$3=e8kRd;(qHK=NI{Vwfl}t@7ICX z%mxZ0oBR)nlpe2Y(HxA}>MM}&bus(Kn)&4%drYez1Pyguz1#RbWl>~~&bL)>#X`QP z`c?TB>L-hQwFUlH?p)I-Q#G$$YA6;dXWc)Y{PIla;IH488V((U=tXL32h}ULt0aI^E}VH1|q}3qL$oae-ll^wTG5ZiDI-mjoYX9#hM#-hIjH zR`@tqNEtiFu`%6K*@ZXa^yEBjKbT#7w5xeEcfa|MuN5*OqVjQ%hEnEBdp%xW5m#fS z@>>?3D&DK~{ZRE{cuiD!k&~yz3M6Ptc-pler9}LJY2Xp zSWxhC-3|MdXDqLazsM3kHE0YOH^qQZ^pf zI5hZ(`lqDAKFbx#N=gx|LDq7$=$g6DOx0;+v}pD+M3iG94cn7Kj-3bDPNp`AKROVp zC0hBuChB%}w#`^;cK&L!5zals1@9H>U%u2)4{`dwFt(jaO;sUTYRi+%`;qVailx<9 z^Nu#GM7jzJ;%aMa2PcLu8=0D-(eXZGXkx-HazJQZw`Pcio?PO})CQ&0m(9wf2lfhsnxxA^HK_j`*-XTuS-gA zdj0xK_v5c6LLt#oX{qA0LU~T+9hVIndrp&%olB`W zNB5C}K8MiLMNLhCoJjSN)(uQ88=AcMRddeIzHMN6wwuksU+e0zw>e17(`OfW!>X+` zcP}bwy_?_0!NGB$%rEikRRLroE%HY^Jm|e*T8ljb;Ed&S3I*CAYLB_?npxxXasi~L zR_k}{*deR$VWYf2XP2~^;fdjDhN#jLU&D>pQrBmvL~qC|JTYM2xVy5PUWl8QS0qud zxvNW0Q6l$9-Mt4}!F!Y9~&d7#!*CaGN2?)d05gXrlbrs-Q3B@%slmVZ0}~vNuS5!VhfTVR@}bfK&@8(<;#Zc+qV}M z78;tFg|Sj-8YLtpz5CSpKu=$P`5ULu?^DXTT0IQo^VzMQ{uMlP(?5Tl{M=o#)69&g zCX&CZ$O+{~ja61jsjjb2Fk{!X4=6?-yGt%3+RX|Q(jN(~R?&#gn_0=vKUjX6a>IrV zuim`TR2I1W*1EuKL@S{;o+0%63v0R9gb~kTEo%CcGmZ*%iSo7+%29D^c2O)A72lwc z3>CaOw0!xMM+XeDo?cqFx2^Q#CKD5re6JLw^j&oX-)8ra&!3%di&`r28F+8G@+@DH zuSSjb^m|3c$UPbov1(d;9AROcrlzho%SI zHzUK+?PIk>xw*Nor>CFs8f!)A^qCr~P~d>$fdxd>+{-Sr;3iEXPPG6yi9!bH|S1PoHcMfw-d2 zIfr}&Zr;4v_1KrAF5k}1?)v@vmtMTkIh>|VFph%~ zuyNzY$9}W1&CRbB|$f(A8n49K|rPdq2FT-qJUS5v9WmmA%*jmx3RVvSl zoD>|}RF557m%Pa(9d+opZ{9eyoG}!2RL3X-yLPc;7+gs$Exi&JM(5XCBg?4QV(s7% zju?|uRz5Ir?BVz6{;Flp-Nm6pzI-bFDT#?Z+fL1e;O5W&M^b@pW31ll&7Q-o7cN{V zynlbWQxd87qs}5pA$z()$GH6vTI+v|nsojb!*M@J+7wFEM*nf2h4wFf7IZWIw$Fn8 z$Wouh2&tfZY0&g+w`$dg}w!>CUkBjfwpv9Vur_Aju!5sSo6lrTlQxa$Apm z&q-m5z_RhM;qQA7_>743Y-pIDn)K-!|Nih|=cjM(k64@RHt57^(6Xt!zLdDd%Em?t zJeT6py8oC{yv=$6bwOd_(fNbNn24e2S??14)f~5s<89dD_?XY;OGeeaAMu>(X*^o+ z^~Ba|jiul1lRo%v^Ob0v-k?8UwyVYXm<4AwifXv}vFwW!fel9s4oJUmYTYkk6Dvvt zz8$+1^}e(?r!N0)mcy1STZYcB|D^kjdx%fi+v07}r%$(voJw-cvrXrJ_&?~>mdL(; zVATpHf?Iu}hxZ7fdQ9rp08^w!z`L}uEq>ax6(WSO$^CtjJ)PS%TK6k(9Fg~}+_5uv zG0R6}w77NuCjIv*5v`%D{zvW4$L!XTV2c^&wjC{v@^UQ;sGQi_bS86X`u4?lJ)%NX zIs8NjtHx809{c0(b1m03;kK&GjhQ_+$*&4}%>km42 zhEavYsLw4D&#;^v+L?m*@mqJi49otq=HG;NIJV$i>W=RoyR{d;{P#keap_O3mU4Q~8Q*N>bUNSZmeeYm-QrHKXp2nZo?UMWJYoM>ZvE4Uo;zWy z&v0K@y;g(s60Ptn3X0vg?iq_qv#;!MjtKR?mtCSXzp=nWy1w2_ah0owf%^#`=ed|d z`SIz1o}p7c0qcf~ooRyt1!>WL71gFtee30@z?+orHqoaRR3RuOC3Sb-y&yyJr;j{_ zW`=J@Jv{Ms?Y3)C=&`5U7e07UaBAKgEmlRN%3{5_OKE7gbIm93n^|iM3JNY>ym&op zZC2Lqef!Q?axZlq&!wId568jM?Frf-Rb_#p?&G~;ob*jyUG>{pwmz*0UN*Zh-N?hw zf9vMW;Jt@VEq~IxOPtfHx9n8P)|2r?MG74q9j=OeqU?0dBO9bIGX#2WxsYz3ne`%7 zGeVY;lBkl+Yj>phZmGtu*)&&qw15=AX6LVh19W!k9yuaXU0qFXl3kwsh#wiT7u8P9 z&c0w%7wn0jlK02* zv9D+%ANouRpJnDxy>o{_jrF0|7?6c)=*O;?ae(%?r|(kRIwn74EOKHJ&|3~nN;z3@s0ZO)TcW??P%E`s$D6| zsA2R})?``+t<|ItpIQ87-zm{$ECK`Vw%5c2qR@~CD7f_0-;CP!0zI5V{OdX8`LI78Omk z9f>jf6t4}VV08+m!ro?Dm##ly9T+s30s1`3+Ov=ni1ap(~1=<2qk zw@7Y0A3j89Zl(GSR=mmF*x1;0`hz}_XJm3|`&s7oDk{6ss|oZ{EzXhOy0u}&AwM-m zzGq`!*)QyP4YOa*fG(W6ItdU_K-=f?|<)G*_c78YJ?Z8b%IceDEd zEj2YY_Wr7^O$*(Jio?-IY9iT~&)U1V*q%6%v~F+C1g^n*S4CFM7~{2?a*0om76@s_ zYCg;v6OGfhHY+=JT#TL0+H8jrCoU{{$rt0}g~NrHG4ox|&yPhvl8<@Wy?u;PHROIU zHxJK^%uHI;epDp0_}NbndKFK65obOdjH2`UHD{Pc5ITs>O-*X(pH>`ZJzJ$_U=TSt zcRL}RoTEX2J_x<@(ph}K%i;!=f& zha;7ihY#aEdu>N&C;H#kets!aQ|`E7bAFKg@uOpLNy*6gxGip^;*)X3M76D~tb%Y& z+!kisuKLf}6S%c{hPw`)RjX_f11QSf&TH7iCVEbeyY*L6(=#xzX|kEc-zMMPWzp-m zD0+Y77Kl2F9uN%;%{dL>hX8jR{Ot=znkb!f=9oIdZIxd5&%3*@Eh}3+aNh@4r1eu0#MOPOeuY%)YJG*l@Idoq4 z?Ai0>`}ZRcI`MsU=_Mt}lap@5i@G|qB1ayB3=R{Md!3(fNV-7Wb>}|$`C@ojye?kq z2nwrD>A|D6wg}_%7cShhu4PBDI^R3~VCMUYQUrB+diuE?H#cnBL@qasRo8QJBBzHM z-%t8X_$d3$jbu2s<(+CXgSDc|)eA9*t;ot5F>goGQL0Sq_p14Wcch*{=8n;2TXR8$XnD_7Bzwf@oa+EBTA7^K2 z|0k<5TEaxN2L=a?3=LIfxd#xIxNX1yKv~&U{bU8Bg9jrUjvlEFUmhQgdk}GH>7pbx zBTj3xqk}IlksFM$E!(cKXveX4himZ-V~!1B4u8LDpd!abP*Ae*KgjKrQxEo(NfttI$D1neKTDA zGFD9Y`OB9_t*t{)W78~KcKgnq_qA)TrDbHCy?t8(cR0Qyw=RpXTlcz@0P76bj7agEGz!cu|^dY{VKG8XP+c>5#sv{&MFBH^u1* z+`v)=tEu0JUY^=u#1T<#XmUwQR2?N>EGb}_8Y@P9kf2VNCk+DwqG)>@JBu!$_HuW3 zze^Ki!-Lk(#AJD@_--Sk(~@;)G4=JCqEvn=-oJm}M_GVV({iNwRy;?-ksa|i)@G~M ztz$qs(7^0co}@y%Juon^FGs3Q4tInIa4xC+*41=IoGx|O(pwVE&^bjc;?AplXu9A1 z5r#{wy}jcrD%4POvNewsS{BoymOzwj(0~6tMg&c4d3oR^$}?xrZbr4Hudnav=@}gt z7i`I0-`Hr*B|uAc*VP=CJRm^j$>L9?+{aV&s2{e+isl@8@{*E8S=H2(tG&G)eGKII z>`2Bnv@puk_41s{mp5T7Y46?@xVyuMQ&LiroxQz~ipn+PwKi;ri-X%oVzj8#SW)>g zGBV}`Ec(BjRP-+4zt*_Z((=Zj!BG#~z42?uK4+X+WIP&uB_$;d_iU(d4*E@MZc$Q_ zShudgJ(4G3&uz|pNscg$yv|RVSq_6MGFmXBSt6;EGcEB>YEz~dSCuSMgwdIg-X&h% zsp6^jE1Az$t&BRVaM6ax;;ptQJF2caZ4(nsR;sZsCk5W(9P{xnL)QZ2FpziMKFQLV zinzD0{=_Q`Xh^JGOYX85o0?L%qTWPAwU?bLv9TQS?4UnOpqBFc`ev`+w{~0PM(bU( z?T9SYbJZiB`$f6WSW;`n=~=v$sz|(YYIe$odDS+(g9io7A2?SJy5A5FUrs-+{8TTt z{&>WWn~W?h^2*BfXa~@kS~)v2SII`(@ECFW{`mT~wxOZ)j$!@%AIUCdmTz+`a1T87 zA=zcWsf#oD|u2wG8lEy^8#U;lR=R#YqmJMMoN zNG#+J2N1vhT0^z;9&Pd+74!d#|IRV~C+m=p|G)D=KIi}B@t>|w-Zy!h|CR0jlXU%` zwyqrhrp1j!mm>gQK_5(zgAw=ntRM)opbCa?7+fI`qT%0dN8YbEh5*`di$4s4SoeQr zKmWIHr-;1U2Qxq(%i{)9@F%~hr` z5g)t!^`OD*`{da+$TNsJVi9(O`I+!BNcFX(T{=|wz$X#M;KT@`ADF*}zJsgib!vlF;3_Iars7p!3Nzg3S5kkaB56ctG1wim2i#YIX zz8&8pgb5oD8I!*z-9p;O$?tLAsDh2TLcos@i4TCtI!n#h_|zw+maqFl9Y z`57kj-}Rb})iVXT93|W3zh6~)?_RoU+5M`7lnkBRDfM-tW4t>pZuM^3)t+q{c6ueZ zvgIw7gfGQqkHt5g4b%=x+I{Qf2UlCY{H>AE?yI8Hn&%WL>Na|>4*U_w+~8%@#XS}l zqximd``bavqCEb6TR#uZCWyX^E-Y42Fu1F;oi@0jJofd+%-J2aTiq*vHORGsnl>k@=B+3J2>A zDi%2pe^nXgXsHh{4?vDAE@H0wf61>~trq&^+`ZbZD?AC7_GUF>zSJ;JMSNQY}j;DxnVu;Ev+KiOYAJ?+IKzP zouh8uRLk0|quIH^N;DuN#_iDCRS8#l`V{n9zH;q;yXkOFRA%jBL6vO%)m;?e&xi-N=-Azo#@h(ZRQ`IR$9&_tf^mZ6K}bHpTn$b(GXL~b ze`#t4cXEU<*6Y((39_p8pSp28x_#4;5^+td{JNZyZ^ZVLm1;HDo3C}g9ef|W>18kH zn`B)kGs%=?OyM>S(&rvb_(^8)W_D=tRZBYd*DU`q;=^5Ac!8r=`?-hFDUmnPq1pGl z1zYd0dm}V1*?sVlsKeHXoqLB{zDvB*99y@Vo!SlY-Fi5^+wy>gjXc-y^XDSh6j&SwSe!{XZvQ&pR_Pw{rV4u|&9b3KcV5~x0c=k3?_SyIIivp`|-+BAFhLN9LNMcvV z!5{7o+eIgRRpatLbqjox$@bM+n?jW^8B$m(5z}-3!uQ^i@V6!!RzZhP3BPsgjJT-t z_Huk0OVz%EA0)I7JJ)NTU;a4URf2VfcKDg2{UcLzi}3aO$`|{%pZBbcy1na_VcZu5 z_jg-qa>HUzl-pWe*XFPdt)N-vbs>6ByA1`uRqMCFUFA_{2Fj*bt9Dmtblyq4_Mp(s zi!RqTB4K}CQDKgYe|xc`nroh;Pq?eGZ1#8F>~-eUrzj6Q2)rHpT3mWUt&zwZ4^B6Y zmuuJ&klj;jAFuk&?W*^K*1H=I_=Wv^ky4*+kkR63lfN&O#(EX6$ISf>ha(>C6}-{a zn}#MXygd4#WVDaz`MbSC6F=5vzc~}J>H4{*fy2z%{2k-AuNj^v6nxT|Sy}$pfyeJm zkezs{ZUOhShE(`{?%wyQECiGFz9y>M_Bzkn&WeA2=OZfK$~dv5;ueq6K;0vu1_tdz zuZ-`Pvg~2xS%35U=Xj`Vj8$>TERwU_C|F{~?_oYGNXyS3c&0C({@8c&8-lX?A z<=)8V!x|Qrx;*80Y8&aZ`^zl{jQ3maoL-ygtEgS+@WE>Lvrk9-_EnceaMV00)u#87 zXVKj`>8!!G{yVn;C$qLXXS2sbU^M-w&$~z4ye`iL>25O}me%CgTcEI}crXFd^D563seo{<`GdLXP6e#o2d{#jnYfi8f}*a@uuAwC(6D?4GR5IjP6P zn<*i(Db4<|*vGAEt7yJ%@pva%Eg^ZK&&XCz*46b!`B5hJ1E(}hHk@;%*FV|aqM@D` z!z`xrD5NTtCnqg?^3}|`ldl~|x1Y=AW4~h|(AK|vYs$5a^m040Uh&y^>{ypnZkCvR zp!Qslb8gk$oX{=u4~p3uI5p3j-^f?ExA|glEyJ6`d3mchY^2>UlsC0DWp?8+#gB(~ zP&geQyV)i6jA6xyFi(G=^|s~{jq{n#DHm&AqzLb4;bolb^9g^W)3rb8Bd@DcMBIyy zD;e4bdror546-Rtvl}WUMoLPoS)=>PsPovy%gF*$ZXMsAxf-0QQKZh*?cQm{RcRBK z8^ScdC$8Okwmv!g!1_&eqpn{qKW)p%+p}!9&>OD!7$zq9OQD4BhBfOJ-8t${7||OW z-z?C+mrqkMk*iJe_O#G_cI4fi`~qE(4)1Rp*WL0KY!NsU8-US zjwgg)Kh)=JVBV?ssCu(*@zjNcigvg9W?I`p(+s<-wOr2hyM=;%*M%)BHhJNEQR&Ir z)q^rxm)yA*8;zUh>AJSvrRt#Ec7TcDyk~mhR%zp>H|TG%eVwORxonS;;Ql`U73o5m zeL)=yD+UY~A8fX@PbfUIJ*^`{h@JDB$Z|UMZ`UOghm}J2ZS5?P)Q)G9V>4mjn{N7% zZL_Fj=CQu4p3beDYMIFnv6o1}N<0CdPsXd=G~Bd#(9dJ7*}d-_d@~tJtCH)lUo=0f zzdf$=3F|#OmZK$E7B2BaCtb|gwyr-`u+rC*C}=i)^`iObMoq;b(_`yeQ=Zi|98jEi z_xPFYz6}}@T|z=XmVHxM>v!~t_b`*!^Y1r`glBwigsHWu8XwBPu&kN7nK|;hTYj)Y z!UlV_J)4I5{6tl*x?mqV_`!!|Az(yto z6;Y#)pO|taX{FCvmL=MkT)tAvaYU|Xy$Ds9)65e-OXhX)~;lohmXFx zZ2Gj^Hbz%mf3@gtaq0C5?#yd+;!<9P8_x#jDBg@R9T2{muJ*j-mDYE!Q`aYxNq*I$ zrBd2#X6-hZ4ri9(9_ z_uW;j_D_$$>AV{1{_76@+<*IHYgy#yKlSGRyy2hwLw{_@gO1`q^^1P>k^U+B|GcL^ zcTWD;Q|sUDX{oF7=Y9M+2>#edKHa~j=D!FDLtSe0k;pd<)Px1jK6~lCtja3r8j)wZ zB7eugR^j#1vclx4u3X69U9eTy#CV64qVTV|w(!N*&Nf?xeQi91RkktFD_d?k;^?k# z=_-gFID2fd+$wD6>FK&fM#kd^I**nf()bo`XZ+uzGTDiOE&(#WaIBk6n-Pud23VwDx?}zQ&BEmWAunb4+og=ZEhVq_` z1@cG_`B*H!7UAcwBO;RU_cxPU9Tfd_bjH~7E_@Pktj0D%w$A#et6 zKq}-yAvkQKAOay6$nh3;=;Gp~Xhg$=A~^sEnhEmw2@^tv91-N<0c^B{JQJHLAu!2` z=U;KMNCXB35}2ch72!lN(St2m3EHJeH^>{31CoWHobbbP^844tmv%%qLEgci9~8u| z$vOyZL*ACWoyKq51>$!S@vqzMMQZT9Z%E{??Z|JyAWAF_5F1VCyf8@;{X`=W`n#eKm=QL6N zf0QQjd0jyMkn@TE-=+zZf8yGyW8L4c-O_|G7|Gv*Ye$ZVUstDYDW_4wQHxMfqERGN zaBav7|2WgrzZIILw|n7#$dBJ6(NlHlSN!0`ISar`XaZ;aCBp-}z!z$v1vpS$@cTeD>38x_#A|MjiCLV6Xeb|LkZ3?k)10+%K)`L83 zf=)Jqcn9xc1YWRXb^&ODRtUiOUJ!&pIM`vh)DgO&58lHN&|}1e8Q5Ssgg`i)hiE8; zDzHb*;slH9HBaOU*ji3Uy>v1e_2X7GD zKoDzTuL7!eh=dr3gJd|j3Hya9WgH)9x8mGE2*g1GWS|BefjW>-$5d-@NCU@$WtvzY zn1LN)v~YcaQky)j5aJBY+bR%(HE;)V;T{x{?LrJe1yqBsAqI0{07ik<2(=Q-z)zst zjktolkPn~XD{S3^rW9^NE|fqGjKe%I8RNP`9^8i)&L5pV%7 zxMxEU#b9w1O)pr14P3M%h%0a%QbEifWd*i_9vHwLka0jPz&6kT`eTS=-~ev;3|}D4 zksz|57Y5)1e1aHff=GbdE=UU$!b5oHigkeA19=H|ARjh+A@0B&ticu>VH&={U2m)h zh427cp&NSP9atR4c|tbi1BDNocc2AEFg$_!98BQ=^uh-ihB44SiR%X^!5{8IA zZ7_sAun%6qE1(HQo&h7U04uBjZV&)}2!Sw&f|u|bTA>5v&fxDP(0vZ|8N7pG&<;bl z7S@ELJi=bE0zU|bPzZ-z5l9nwpGWr#o?IY^XHW|-VGf8$<$| zMKtmX*1!vBfp;(hYB5L;2*e^!U=2vade{O!;17Xt9@?M>*2du+K_0e%3TVPnZ~#Ye z1CNX7MuHy%!f7}I>n>q?kcZ8%9dtk!c7rh-1P5>hckqT(NQc09PGe1b_3OhU|n7)ZcFD1&mS2HIrgC3M4kU`Rn72^(NDD8qJWfF^hiZ(;2f zkXqY0dqiHLq5Z5*bchj4JRNSZiDG{oHwZ4M7;<*K_7O*J~#kJzz$r& z4SZlI1Lp|iFb&IYBkjNhY;YwDc?W557e?+NT_AlI*BazO0c^klMqnJK;2WICK^#CJ zoQ0}9f_M%upb^aTk#0B)M<5g;-~vR!0F1yGOu+R5qy;kIF0?=wq!l6`pcKl1<37q9 zus_5fPkFJbU%*gZ!Z1Ff|L(GH!^15q!~Uc+U$0{t)u-(UeQ)uA2)`g-IcaDxEQ zHQ+pe1(rhu#K1FXfbmAO+2GlPx*3i)BY)rpG(r=+fgeC>L0k12bs9{<94r9E8~8OGnD{eo{W56*4Kdnjxth(}NY<iP6`sC3w6*4hp9-!5qLvQBD!D>e!_Jc5|IJ&%SeP09DqZ>MN1<1;X4p?B;o;- z!Uq_E3VIUp44y+hP%)7RM(Bn2FbHGtj+sOZ!3cZ=Emjht2O?}FLIT!-6u7`~@Pz<) z4h_%<%`gWP>?DE@gg^wu;4a*QcIW~s3`@}hJ+OiW9040}fRigoL?9${lZb0@1JdCu zEPw@u=B&VMCGrfczz%HrNQ5)Ef+y_c$9aGO>;^Fb60sJ1R$>3JUl7}a4LE`mc!0PN z&KHgeV_)D7$6<{q@&Ym-8}gt4T*OF(Hym1n^8g!gg!2#sagYc(;@Ac%pb8u$kX|U4 zBoR%pN{U3R262!91K0y5Z~)H3Md+8t^@0(Y24)!&!490j4`<;5#KC14fFT%$&)_Xf zB2EFbJc;0ebhrooFbqr^Ndy~k01sSKAQ8791MWiWCKAyBN{S>x9n9bmghB*dfJ+dw z8OMhNNQO>$2Lmt$hqmCFfde>0nG*5^=9Cf7Td@yFfVJB&YzYqF1cmSb9zrRUK{YU| zpiF?cI*E`3X^;b_CW_sz!iMpBm_V+bie{o z7~nV{4FM1gJ%%_p_yD6|XN2^^D2zk)9;6+Lpac#YBUa#z35jTf4(J9cQ`8<&1VAXH!5z5bfY(5M499_U5Cy~V2}B(c2OtfKpak1sixY`Z zgCJ*Y1K|(}L+}w;U6Eek27U;G7|4P=&~+mbMz9CWz!hWp-r(tlXE+Z2Py-Fn2rcl$ z8}SX*PzSez!_Y@1E%0BBxR#~ z!F9L=(=ZDQK$U|uf;g-NS;&SW*qe)X0q(&=D257n3NPRlv_LELzdT^#L#g2k<^Y zdO--*LQpxbFI=fa-vVwz7WBX%e1K6ftU~<+`@jNR;RM`zhO!II&<&$71z%wf7JyWP zGE#@@4R-Z-4Nl+%PhTNEpbnbAr-?-Pfj^u9iDtwR$ifE5f?UXhLMU!Q*#*8gI42N+ zweS$i;czSJ4yc40AiYIgg9J!{3@Cys?0`E^2tn=07dQtOU<5wH9FRJYuRsf8AO%LS z7mk55xPUu&gD;!}f4ByzkOoM0n9Z!iN3;L(k|f%zV+2cG@dC!B&n zD1b+>_8rm#(jX5TK^ZK;8Xmx7D1)ak2A^RZzJkX9>TK|ZK$w9A_z6^lxb`2g9}pQr zIfOzehR09|A7BJVVFK8PQJ=te*a3&Z7V4oHW?&vvMo?G6EG)qKQCt_W0((e=G$6*1 z4xj;g-~oPc10RU~NFrik628JuAU>f@_>35V5%>spaaRDCS4NcGn8>dmWK@awTDVTv9 zc)@kZfZLDd5Ddd-F#Ll44!DCa^uY(X^cD3Ctp0{L0T=KFAMl3|I0vub zEo}LY_<>M33%B4l+<{z}glTv?gFYK{!aEp%VK^|0`~e%V0~a_6S0N4V!$W9+R(K2V zfO!tr7Tm!LnxGZlLKl$cQLn)sFac9Ahj!=${RJ$CdUy%EKM*Id9}dDHu!d0>hY6U0 zpFsT+^*Bg_9k{?tcmrySh-26Zx=;?4&<{hfj-bF7KvLifASsAVpaxoS3W6XQ&OkT* zkUaoW6coe;7=bbP43jVgU*Q`i-hu#JR1^e12!jM9!F9L+cc2;Gz+3175;Z;s0H$yN zEWj3Wpb&UyC0TUes z!3nys3!)$i3ZMw8payj4DF{6<0u$K5fa?WkARHb*ISj%_U}mHs*g+XoKn-?6IGl%A zxC}{<3T#Xi#0ubnRWQs2ma0bGm5Q?A#Dq#X1IW7#HFj)`2|aLIHHaJD7%9 zpk0A$0r#O89zz9e!>5EaAOTX~Dx`rb-jKHg9KZ>j!5xC(0?4dH9)l+61063u8UrFA z2}ZCF@}U??p%SKngwM$cz#2FXC*c!(0Xu%Y1qYnL6S4&;h&(8S5@=tAxCJRe3SvD> zz&tn$VSUJg9LR-wXn-ylfpM6GZ?FJ_Fa>c5t^%V7;uPdyBWwj#FaRUi4SOLJ&Os`q z!7a#ydvG5fz++e=ifaOq@c*=TA7E8vYodmKq9k(!MNmOR5fD)U5dpI(Dk4Ed$%2X? zqGAAZ#+-A`iaE!&%{k|sbKB<3dnQ+vl~Y+Pl)KwN|C|S53xL z%)~uBgO@Gojvh$IVI0E=oWmDnV{t`YS%Fnp1A9Bx9l>aim-rQL@d-bmS4mg&VT7`% z02@?-Cw#FSYmkKvC~wd5A`l^HiwHPXCOr_3B=pA+48<61#10(5aa_c8Jis$N$4gYL zLjFW^w892#$78&}cZh?oOu#hEz-;Wr0erw$e1lF^UD1UJ8p03F(F$|16w9#&=8n|a zutG)nqcy%moJdc&U^BMirZeRlckvh>t1(affT0WZHR6$gM5Ll0GBFn8Fcr6i&;H|jrl zz!Tlk3wLl2pFmuge1(oX-yPF3XP9-jr>uugAQx4ZF~z zKHC9nu?a_T3Kww)r5fmpHJnfbHQ|QB4cYIZILu)WXY@q|24FZ!G}09d%)?SVzze*> zdwgrmI>4?8^%APX1Ab_U00dzOM!~!(>j+;oMK*N(NH>&#Q*)LBE&Ul6jxE@(2tW{$ z(F>UvhiRAthnD;fXK@}yTQNOkVhW}O=*le2##}7I670f$Shgme5RWbxgb`Sc4G0co zyP+@Ak%1vthfUaleeh_*z5$KlhvsO5j_86!q~IJbVSf;HAdcW9?&B%m;3Lw4b)^qZ z;Q}t<8bU)j2E$rx!RofuNq84V{nw6pAPvv)5ia3uf7F5(wqp-W+LQLE4i5~)2)xDz ze8LYj?m$_9KLU}2Zg`59c#9u!j36Jt1vL?e?ih+uSb|l^!Uk-@cI=7dSPKVn1W)lR z-ryT1Mo}g(1G7;mnqv$&q6XYh2Q3kR)@X~PIE&da)E_X8Wn4VKGla!a4iSxbB%m`q z;yGr6PA6T-htBARH=W7%_=+E}?LwV}s;Guk^uiJ>M;6w@Ba!JL4AIEI5bVK09LIT> zbY=Na1SQZPgRlgv5tPJwAsPwjjIPMSRuoAlFJlxYU>R2837*3$g?%18;e$Q+83%C^ zx9|{?x|80RiTOB;$MRDm;``jF?a z4ZGmcm+gm{Sb)%Urj1C%z%YZfK@{RqWB_#=B9Vap7y-k99Mhv9is9lQ>UP}3eMAo? zPvRL~!G8$*PedUWozWG0aS(@b4CRJVr^A0FzenmQnth}4Xtq5DVK~m>B4%ciZa6!J z`QR5AkEOoAM%5ihxrNDimKB9j3KG%>&vzpv?n+%{*ZF|M58HpPlwUJDxTV{x$QU zcDwyGw%fl-x%^jI&%aW+``@xn^w{4jf2Fk7F6)2)_WHB=|Brt6N5lVq+y2?#{r!0V z)B69ntjGVfbj@3yzhXV6PraKSc0{n(V@@~FXu6^*4%{P z=9shx7wdT^IMHfM?mgz{6U77@10pI>%8*EWtj2aSep|ui>r8oiWc1X$7oDJ(b7a?;V@34rX^8X zQ18*Ygs`$i{b3l!;2U(Th>*uTh&2IJxP;sAE=Lq5w&DP6%d@^Xj+=0*Ktv#R;wT(! zh|0ts9Kt+XBFiwfBHIT0>_ko=q!Q73m}XBD9MUTjfr$%MetU95YX{Pi)1EvAP7P)}|Mc4Ik^g&tejIw}-cmtyrMCD^L=3-?_A|a97ifsz@ zxc+uT$>M z-(w!u;RU{M(_lRk(5W&!jDnpztN-*W}-qS>x;cOiH2hsAD70G zcK8H?ag+}}Z?(P1si zjP=-x0qe*QD7t~PML&$jz>U-u$a_-29{xUw;LSuyV?Fkx{1zg>aRQgoax3YE{Wu4` zZPeFTgbjF#PZ+(O`T;d|kVnxIgHdxQ%ZXICrMY>oub~wAzVfE(?siIKTae34D}L@;UXHJWj-i)p7MxexQx^bEDt7P z4i;iHEH0AAa33GxcZu?ab=Zctkjq4zqX33r0@h(03SMEIu@viIbd}>0v_l+Bu2ENF zGxlKgb@DR$++d%J2Y8M4H!1fRi+Naii(@DR-zF{b1^Rc$Gq{PQyVSWDgK?;Kk7ErC z!*o=-PnpGO+(g+2lsj}sKWxR%FnvfGU?j%k0Y1a;5zB;MAG7XHczO*w!t^P>M_2Sl z!Dno5jKmD+Kc_B4(o3ES0JB%52lQW)e(3ot`4a1}11@jKR|rQ(9L7x)ct@R$T{s1u z_skn1h=Pj3H~v6g{KUH82MT^BFJUGEzOej={l>DO*>{Ga><^B)Fd6fqqU%kOg`G&z zA#w`tx(gO3a0v^Sf1{Pu| ze2cR_7>C)of!o+pf(R0HElI=@mSQc&mttDjWKM)G3R@5XggzLI_xO$trHRIaRT(0t zkcAykk@8_UiL-DhOJpGItXO~S!wHyL6XArZSPrLhI#Lrh<%w8BKV(8h$*TzYA1Gi; zI@%H8gvHp37x)58dm>M;3hQwdCY%_Vp%iMt3qELsL?mMhmf#fbU|dYVBsE-6!qJyvthf$^mQD!)eYY3@HenC1$Vy!z- zJxKFl-7yPG5a3DF4UXU{yy_68gmF-j?bcqok?pw1|PQ;-z_TxD2coXS_ z!9Gj_=X{Ak#EE)D2|=$u5nI^afapzhY{)Vp6AMthF_Ex1grn%*gylt{rmQ2DV-ptm zu`MvK84-I3Z%$r=ig*P7*n1Dr7p zi?Aw?hZd7c`FtkK_48vp$2qS&)2=CCT9Z^+K z5$-zSY&VRAigH&G?xQdjWjnB)@dIWNxhk{Orcm5<6{$!A}*SA!e!jU zEBwII7^23I5=)*#P#kp+mS8&`;tc{jQokTQo`^o&!fU7q_(m}7#J0i%yhi`dtS3^s z@Z<#?!g(}Iq^?4hu9QbKL~E2v(h+N@=yny^zNs7O4xbdF@bDa8u{4!(h$lTrKP2@e zf(8sNIayVH!6&x&cG%dgvDs`9)@Bnj53M(goFzs@Cm*2Rc(yfEq`NJ?!e}DVlbC|SlbAow<31uLvn=qKLOwvbsgxgF!fgzi z#`?i&I{ObKpckIv3ueurOykK+o_vA0S=66+3;o%Y8%#l=IjkE}F$kG+i9$u=dDH>O zi-=ENK-47m;RHe#vh8pRm(h9=^&@WLF#;D;58&hy@-9?ld|6b7ij3D;Nm)bJRn$pn zvWC2Y>RCi$VkkzUD)QV3jS&i+OY9TS6B&rVOkP5!Q>{tL9JWVSx}MTy0^*GFucRQ6t!{h9_fbm_gMzCd_WzJ;h2dk4@np3 zJ|f?t%45nF-Xa^ePpDUL1<#Q5l=6h{FnGo?q8xVN5E?w^xDT)J1EpTFUCqaY&Q(S1n6dS?2M1d#ycHaz3UQLg`aQ*4=_iMXa{_U zp+2p=F#+)gL`XnI+it^DLt2lcKt5V?Ie zTH9kacH%X@LPZD~RHPL;24N$9LIXQ~4;As}07H9Pm17HjLP%v=|D#D2=8J>4ggFi@ z6RzPNqN|cF_=xWq;z(37f}Ch!j&rz+Bxj<5@Bu%NR*mOt<2r6*sSA-GaH>w)z|fUe z@yNtXT*ZAv)F9#jnV1VJH`W1june`_Nek5WAboKV=a5jF`C%c}qPb^oWZ7G~-_+lA z$Xi%|C9v`$tr1X{^}spY!4_{Km*D0@WC8Bt89MtCU4{${hD$xt82fP%bLtayf~WX` z3Jr22%+}N0gK`atB)}0|Ls%oCl3>x8NDyQ+A#dUu?qYUR@(S`I!W{jGRKj`O#Pa6k z8>q;za2#k!bU0#Ku`S>fKokkqLq&9{$gQ1-4;S7*w%0lCMpek zZ~_ZMSRRZGWnFO+R}maWlmTX78H%=Jop1&>@B_x-lo!mw8~lKZoC?Kx+(n-V(iOMx z90j6?v_~tn#kd$E*RU^^4NO#r&O%RCpkW{t@*2B05`4;^#9;ApkAaLNvz z;uCa6QpPX}Q*dY$+XP!jQ~pselQhI5e1gSzqPMUKTX1j!>w-cP$)D&tiD(xr#U>P* z!Z`3p1a{*DT1{nHa2KzUZ#wle9^wr$XApgeJ9vqyGjk(rJZ6#KFc}MwIEVTK2j`Jb zadAF*1GN@VKVu8_BQIjcW+8bQM{pTc7yT9q^IPOgb?%~SY12TP2ef%Wn+LRcK${1& zc|e;7w0S_A2ef%Wn+LRc;J+gesF(`%NkkF`!Lv9mPT}At;*Bmoe23@!-~;j})A9q= zu@LG#HR}B|qkf`A1J2C`{l=w{Ugap)OaWP?9S#RpE%)n1i)w&e?Z3)N?5E&b|#e_x`Vvm!=bw zc~%adaAoHmlDUGTq@V{X_2;UQW?9vv-+?<9!c|vuo+}c`)n9)-S(2tFbyD>u*3UqEq6~PZzoBezW+)BP z@<~K%Bgt3BSX}EE%Tym@@k=n4`JIfVNIzroa5s^pIwrEOl?hjhOvJp1skmW_wW+MN zH!=-7b+?)?nNc3UQr3}S5)?z7n2zG zVzkmME;D^gNJpbm;#S67#?>$v9WQf9>1-~J4J_nUH`tYy19eJEW8*SnVOB=2MV66y zWi92`x|Xt{qotJXVJWqA%8Ez6vSM#hR$~3jN;$ETlCD-#KEO(bg;+^=H!JZjSx(|g zmy-y)ay(zGob*a5C-pNJCgo}IQeLv1%1cep@}eJBUM9I#kd%-LawollG_0@3tJhTW-GIJ`JKCeMJd<5qTDjDlb=oOqu3}(PLt5z9lttBQ$`W3<7ZFvHZCjJ~8`Khy*0toXRriqIVIDG|cx@?Ym)yK0G}cSpJ9&vmvX^A`@{*{EbtO8cuAJytm%I9PrKg#<-L#QTV44PSXv(^nov`ihZ%JtaFAT9GZkYI}jafQ_>EA#$8a9;gRt@E#O+z`r2g$AWL0tI`lHN%{l2ssB+S>-pUdLeR+%i}yB?a>w&k%916e4leLgZw%W^F6y9ovenNto1h4wIldVKT0DnCuS@lhr!y z#Mm%gwwZ)WdeLzC5E3p|%C;A;e(iaFRtL%I)jFaLB_k=jk+Pv{q67T1C?Qq4L>E+of@eZ5#| z?;R)Q(&J>Nb%OM?Nsw>#5+r|v1c?nwkgS9R8Jm(I%Nuu+wMm`ieZI~zsB9N0DuV3Heea&N4+}d{acfZ;G5M&|S{^beH-G-C6fk z=~OsXf-9wpu1~6*Xp_o&G<(P#+aBzTdr18bJ>+HI9`YIAtb2;7Lr>}9+*5|T^yHa> zJ*8S$PsujyB`=!x;_hA=cS+JDI5|y>3iXx?(Y@tRWFJ`>-$$}_`$|RAzOvq@uN-OA zS6;X6E1qF}f@>6_Y`P#295hDF$g+o6HPU$C+Wz%JgUAi0%O&7iV8M3`(hHNdB zArDGtNPe3PiEo!7dy+DwW9j}^N(_*=S_8y7ae%m&8YpJz17*DVATg*n zND2lFl1|Zstkn>nNj5}U(A4}y=uk0DA1cw-!=y#W zVN$32FtKzQE(_}q7o(=b<(=PfNlqLt*Ln_@@6|>~{#ql53>YDm%}2_O$|HHM<49Rv zcckoy8!5l0jFbtMqhwgpC|Or*wD{PJmg9D#<#U74^1k6{sg^%e4iw9jj#im+ux6%= zZI>yweq-cIt1*=AF=8GyM()Oqk#ys+w5l5`qjks0X~S_6R(hP=QYws-fkESCO{od8 z)O&(-i=QAPQYUb?Wr7R~pD49EPn3=QCrb5_lVpnJBx&I{Nsfn4;@u&WWO~8LlHYu? zbhnx;0ilz{BXTnDb(tc2LZ?Vb*C|AnOp~34(`8=a=~69jy4*^gE=Mw^OV4~WDBA-UN_xkIvMgnxj4!rGs+lj6x)zJXv&kZ9)Mb%alvynAEf@35 z$;DDSWU*XnzgQ0TT`b{FOJuU)Qn_1UsU+AgmCasDrFg%k@;QAe^~W+Z@KhqzFcOvST0$mSBQb<3fb0ng?y~CQY>v&Nkp|(vbe`8IUTuL`gL9{I}F#z zD~mN^=DtS4jk9ENu`CHHl_jC&v!qRhEUDTkO9m!o$;WP4w2oXW&3xBNx9)4@rmPct z+jVl*d7T)vTPI=d*U2(mwq7qK8m^ZzjvHjM?*{Q|wL#v-ZHN2bJH)*84qm0cQ_7p}6bq-FqU*O)9<YyX8aQ-8}1gkC=w+k)fUTh>`JLnOteFL^|#znrg53blodo()RLRqkX)yWuKU& z?~{`K_eoRT12U)B0eS9lKw5+xkjo~Aq*wk!vY^T#ndx*$7N#GPyHyVp9d|@(SsanO zU5`j}^P@7g&QbC0b5z)qi@V`5nNs(d_=Oyk84Zq$L(Flp=z3hNEl$Yg#wR2#{e-M> zIw@1CpX3AooxvP7I=NzArSoBUf!!gTQG4?$xX_058a@VswJM^3s z=Ouamrsw5&+4J&~(|LL6dR`iPoR>RZ=f%7B1=-f&g52qJLFO7>lymMErL)gPF>Z2E z&iY)EExwmzUcJk5G3v57b-yeRb*@N&^A)M@c17++UJ;K@S7_OLRSs3ZCa(V1@5#va_hek)eeOWtmwQ$ZWPrm1>E-l59+i72r_3Hnf7eGc$?UOItoT^EIX{-T zVo&6q^%L3e`b0j4KjB%APsG3eQ)wRfRO-+?exW>*5yhX$XUk`z-|?ATwR(eFJ)t?S8}NGE9ubhmAonVi!8PKMFv;_%3Dg|Byxne~5qN5AJx=WZop3R@T`v)hS!t5@<5dN1fkAKz%qflx%Ok0kj8V zh>|-rw_p98H%vD|olB_?r=ntqN^pcT4XrpWZRv`d;B@MNJ3QcvdZ436|7McwZN&bUmOi*IwGDM=QKR9?@R**PC?t!$e?X^aN6nD6EqU= zOG9t;1&spyXaL~HDXHI3a8uuJI7ZN@h8y-DxJmzE42=!OfgAKYxe32>GPvo!lN;?j zxw*b`1_{s2^U&Gg=6UE`%mX*hL%CVrg^hBAxI^(K&@VT|RhLxH>5tLP9Zss}^rvb1 zy*2$qH2rLWobShL`q=_G{nIu5ftr4{LeB7Yn&E9V{o6GCY>}Mr_i6gsGCBQ6H2rL$ zoc=4CezsCh{{u}wTPvrZt(4P!ry1T))1RT~8tHlGd_O|dUrf`Vsp+@Y^iS3FJ8Sx9 zYx+Gk{qr^b3pL%wn&IStoavX>bQ|mE&d){DAFt^rm*o5|S<~NA)4y2LPmam?{(`2T zEt=EsYLGiUwrWnlr>38+n$urj)4yEPAE@asq%JJ6eQgYL$1kSoFQMs{(sW%l-9*5!_o?wz<3mEzq>Xfy&PbA8{I7-@F+A^+`z!Tp!ku#d z|J%Rw@xw-C$1^EiT|+$seFI%R{p`wer(T-uGuBKbXGZ)TC<$D|i&V;z_kF?mYDk7|BqNv1lojZ6m&#k$yMN$ec9FU1w`)&QwyF z4nb*LsHVpfb?PMh1 zXoma;AEU-0>Kn7y*#&isbm|iJ$TrT-&hGz5)IlcMLtOsh1j}i1$nU=_R7T~oyiXc` zD0!dx2DyKkY6cJi%KVGueXZ#l@baTz@u3!J#I$-)wqhyW)%d6V{HvzG5B5-oy1(W3 zymU}`{m#&NZ$7t(FSKfckyNqUcvaQy>L4ty)*3;-8go3Ib?a@6pr5c4H@3%EI)@o67>0X;_Y8DY>zVWShD=)KCIx1~cC8fG*523nhFQK~H zk2VFgDWFXOZ3<{pK$`;E6ws!CHU+dPpiKd73TRW{zajOsVSw>O6ii)Oq}Bl)xsa z^Zs2>(>?`tUE%M~@74LTx_YX*>iVkcsw;iD=g|dn=E0yp?3QKbYPxFKbN@4A2ouaX z<5x=_n2^d7Bh~cOZ`5@F&CrzJhB8q5(WZbl1+*!kO#y8RXj4F&0@@VNrhqmDv?-uX z0c{HW#Zo|>=c;pJbfBtNr>lGO>bzf_%d7Kz zbuV9?&ldyHr8(#H>bzgwH#dg`h-l;mU%bQu>b%+t)+mSar~n(-q9W{2394OJWmJI! zs=^UYaE5BTqFT{Zhq}kET4AaC_O;*!cX*&SJW&T;pplMv!w0^ohx%xMhEQz=8lwrC z!Vk^R9R6s5mS}|lv_>G>APB(-K`7cH4DAq(_UM2JL?Q~&h(Rpk&=K)SKqquY7bK!9 zl8}sUNI`d`q6d1S7t+uheb5*Ekd6%W#{dk(APmM348<@E#|VtXD2zrX#$YVQVLT>a zA|_!nreG?jVLE1DCT3wa=3p-7VLldMAr@gVmS8ECVL4V{C01cI)*uUOu@3980UNOi zo3RC3u?^d?13R$`yRip*u@66CKYqpm9K<0U#t|IFF&xJUoWv=d#u=Q&Ih@A@T*M_@ z#uZ$}HC)FH+{7*1#vR16wJj5eB#uGfnGd#x&yu>T~g4g&JZ}1lH@E#xV5uflG zU+@**@Et#p4Rw)AHJ8+d9@Mox0~jJ7j9?5Cn8FPCQ2+&@+U*oZ5fnu+6h{e^L@AiV z0;Qqa_gJDVtYD3DD31!T0ny}t(|q5a{>rEV2ULY>((eRkRD%m>-k;N6s0Q7ds0G#F z+#NLYm)cP6i0Z%#b>R&k_@W-_qX8O%FaT)`LIHAKfaOP5wL2mlK>R^SfV4y_5E>w@ zq1r~Zfoh;0j1Z{nl&XO`;R4bQ;ZP0KJ0Jp)h(a`C5DV2ny(8k00740*GrAxVU6F)j z5MIDb1}OhXMGy2uFQ^9Wz0n7K(GTfR4cPl*00v?Z24e_@Vi<;F1V&;MMk5nrFc#x5 z9uqJTlQ0=mFcs4<9WyW!voITTFc4({R}?&AR-;t?L>37+B^p5p~x;uU_uYy65gc#C&< zj}Q2WPxy>4_=<1%jvvT|+VRtLTvYQvLQsSd6fpo{C_)&D7{M4OFohZNqW}t`5DKFR zilP{bqXbH#6nI*JSfDh@K&4+Nn`-*h!Pzm;^j4E(|`u_VrP+jw# z`d-m~{#**ENCMS1-_au*b-olOCfOstm(tU(WwIhf=wJ@qf$d zYwM}@kTv+p0L{?)qFUHT{-59cXa6u^@0B-y)%`Q$Zz1nrsha!CY8ry7=Qe!^iQO}rCQ)ZxzjZGcWeHiTOK#& zug|2^x~tD0FX?aJ*#2(*yz+oGOypR)1-YQpZ$J8ze-)t;&7E`Z|9^6{oMZMs``iEM zcmK@%^QNituC~7XeG2|-{mp9uvh_@I%g^7}-PYud-`c&a2JhDHwW_)}J6E@^pA_9A oF}7=J&b5K&t<`r7$|=<9Z^yjv9o^)e`-X0LxlP;spOymu2J&l;(EtDd literal 0 HcmV?d00001 diff --git a/Data/eng/Health Management Industry/Roche CEO msg.doc b/Data/eng/Health Management Industry/Roche CEO msg.doc new file mode 100644 index 0000000000000000000000000000000000000000..68d1a8dd1bd48502af175507a816301d3cd69080 GIT binary patch literal 229376 zcmeFaO^l^kn%@-zV?-kd;4!jBV9>jutSn7LOlDTrR}V0b%B+vs~0EaxuI z=->Y{|LB0vpW@HI_>1wI?LYOse*+rYUT6E?f=~OOvQGQ6pXTr7eBZX-?|1#%_E6R< za4Pin*?;`+-+Awk|NY7e<>!ABKlg19@%!!Xlz$gEmw(^(XZb|Ihb&;DM&@K2xr!-v4XyLYsAZ|`0I-=p99 z5C8Vv|FPS9xc6-D>E8eOxBlU8{^{S|`^|3e&;O-A`#b;1-}}|Sa`jibz5B?hyL%7z z9{pCgxBPoQ```XYzxj9g>F@sKzxq4f-oN&@9{t@v{oB9sTYv8F{_6kq=l{}Q*!zv& z`3rl$yw~mR^M8l`Klr~6sLb|G_b&EEoT@-Vr~4V7@pJ!tus8RgS9=rw9PBOl-yzR0 zdAHlU@^AICDL?7>*@~ZZe(IEeP5taMe!AfIgS|078SI_#=Y;<*_pW*NDQ{o#?A$B- z$xf?G*_U=T*gMa+I=|cT^V!~|SI|mJeyXRty;olEqFY{!y0h_gFg@%}$Ad{XA6?Dn z%dQ(Ny1}&T#?$5Kd_Gu?hFy0x&@X0ZonPvXr_&WLJdGCy(_wcuo9BA-#j;zDFGpH# zK3a^X%klKwzk78tn~b`rvs1qN;e58bI_O@Fm$8rW^mMXXjAv7QWVV`jmxC{6^YQY! zmM^n}vonCY&t7SL(l6Uotzw+eyLw>p#Pe+S|w>6zj54Dri z`S@z7FI<5T^f=LgH~73W>>k#4w}mqo5egZWYSTmTxJavnc7>IU;sceOe>>?Y&I zg`Pc`vHyS@K+}VxZZY8ShQM;PSdP!e`q0dW8jeO+-RW%la(t?t9K^yGY~Xx8d&Svb zj^^FHyLUT%f04gltQN}wXgV2B1dr3fbUIshCwyoGS^__3^VwxL;_d6<;JQD)U^QNJ zdj1Pm=>~vx{$dmunaw6giH*gGJ?dd?WiWX)xCSJn(X<;c7o*8pcQqgL;&^gx+TfqF zv+?q<13^N=kRx4Q4W|5-C6*U_@zr=T@n=sj2GjGAK*>)>9DQ~;ID z%d#xcxd5WTiZ3t5!_l108digDGMkne;P(5o4gZ(@Hr9=$s1-e*@nSpc{j zU0zLQ*P{^(!c&lHJwB-MgX1ZP9(I=kIUiom$B-#BG28gg>3rl3>r5{Pla&_~m|!LC z8e$tH;P~NmbP7Qa=GXe{Y|c?k+`&z(%oztK?4G~sljAAt=^x|iOQ=vU35Y|WJDFWw zf;N423@N>26GFsnvJ&`$XD;B&(VW-2)s)|W61Fs$Km5B-ypti4F3t5r3U=vN1@}yQ4#ng-C(_S!R24 zmQe*#5TnlPvuzwWz;m>}|D01_&IIyHiPM2->E)QCf}F+p+yYLJS*%WlQ5{no9-Xl< zU}uzxG#21;KA0{z)o6MeXy-YBL|9@IEz#ix7&BSXL{!Kq<@_Y44saKoZ>{}FoP1# zFA)8MOGKkUQURGl<^YnmT9Z&3A#&%lspwvWGMWSI%fa-tNT$IhgcZ;~h3*mBr?F^A z3(g?44@Xxc{zn)!v0cL+D4O#|o}pww#dyFLQ3u^CNR7Qiq!r*rR=yIvULlhZb^{pj zMDjL?;%qe$fn1>GM$M#TW#jnx@0Se2B7obumUzE=B?)`#XVZFQjfP zry!s=VU8!P)-6t@HUwiy&dc%A;z(cci{d}jUkcskFgoXS^r}drUSb*6?Dcdq14h?q z=jn?e_agQ!8ms!5j~6d=HXVCD(y`*4TWniJx2TKVRT!IGQ!z+WgJ#fWIlJ+}GYcyK zhLvSzyF~VMVs-2fkx_qy{`Aw;MC{3G-xzZfhL zkYPrAF*_-W>-+)=_;t)vSzg0JY^WtsC?s|X*-E`@Pp`(%F_IAW6Um-R2+Xe~#9PU$ z(?VP0DMCS3a#APEz;YtUg-k+m0s>vyyEiZ!d&>OX>jbGhD{r%?j|c6%gr`NhX>VFE zAbUn|t-d{6Nf*v!gUSN+rrFPG(ktD%&&3j(SmHu!33`$e=pV~AzG8|N8S+;#LfN$U z^J+A~DVSl%>Q{@^l|2K&Naux`k^S@QLy50S#9B}rJ_wmPMN!Da#movc=6;}RR-cHv zwO+G*xP(IqXZa`+UzUzVK2S&je29R9ceF87HY70NXmC^>L*@kwUv`6+gYl%;MEaDW zcA6@>QNK3g^}uHr1GK^^iwfEyA0CYdhu!%Ug+7Ll9$}8iOKHGb-5mB=+?nxQcG7Tl z3SPWX#Nr&IA9RS8WE}OBkTyA=n@nb}SOwk(lqPe|bTY%mxqt8guRyRjrJJ1(`5fS9 zK}!IHH1EO`z(1Wa%QIO;s2HezgD5=d@|>e ztuM4OEgH6;sSK=(V#{arTYR2T25^z>Z6 zI-g1E&4`lVOj`y{u8+DW(h%K%*bCBJ3q738Q3u+|mJ9IE*4z@;7))LR2?_1q3z{qZ zW7yju2x#9V_2Sr}8Nx^8ElD((11RV%^TKezKBwo>>UecYeH^Gd%CT9{Uv}G_ufP*f zty=Nw3h}VKurDDoTQT0s3w`@^h9bhsN$khhBJRT;j=E}y9au;=AL4CXfJ?Msm>ifP zLf(8dvAiXWbQNl2^d*kN6lEr^I%FAqLt%Y7nscf<(!p$2_!>`NmuI0v3%_#C!zmhd z?|(TuMSEe-^tb@xPfnM!Vw9!+tI!SK3k&OPG@1Ybxh>~2Ky)&?o{2o!ZO`c8kcUTa zaA5}!%u}&j}TPQmB|TxL*#`xky%DeXdh6|D+Z-#BGz)RCJn?J+Grtr%8@;|X$E7-8L}+| z_%Kw$_<__=LZOUpPfTVq{VFK{IEh=u*u=xr!4R#3y$d_qgyUK1ON*ToQ#J@K8m5T1 z?-HWm8KE2H_~5RU@H1H8qB}n0Jj5Lk+*qUMLR2?j$;yh)2IWPtNirGQBXmMMu7=$IzIK*jcMw*)RD%)@Ff7i zl$2x|bkH_2%)w-|OhszXMxj6n5mNv}*IN?F@D{_6HG3HrJX_{lhQaAlBhXE}__Vl) zAJpf;jyzulvWiPmysEeFm*bSvu~c{vijt$=KNmM6)9wBiR!*xDh)Y5*u0|#!cq=I{ z%_y;OrErT3*+ZDCXmEnbC>R4YZQY~pv-!+lm82l-9R}iaR#_>s@(CzjU5YQ?BS4Ac z6^v_9U99pH)`|)Mhr?sS84@Ux=U2pM<|J~6bp0BcoKSEMGYEPCJS(n6I9b?0ax}#? zI^=LJ&Bn)J6xr+&x_t~G^!=9IRDg^$ha^!%tEt><{b)ZnWe%F)&ytcb4=3k zj~0Wo(GrD|L3b;r%@F2%M*hp%wc57;9y?u0AT-eeiheozF4p`wfyoZ!-%3OhuqfdQ zDUx)@b%xbtp@;Lm_LQqY-R`?D@@m#I~|36T=XoO|HynuisWn^(Lj9F$mJfT=V zG)HW|q^6W*5*OOY$;=ZFlbpaK;APUC%4dO*r=xSB2N)>wAxdM9)iDd3NmyB3Ngn9e z%BHZ!Wl{jqTPWq#=mb|4@|FKjOjPMY{d}tYkhhC>38tiN<|E~sw2+>VzW|Pw_zb_k z0=hk##3~lcCD)=Kpy`p}7|DtZou)^yWu8BcbZu%GIJ>&R`1U$XYKK07xwu-PE!lz; zrUJmYa)k_7<{Sz^JUweUW(!6_7of-(kUlab;2P0TR)Dxdpo_bT&P)L^Al885Zc-$f zcoQf>7Fs=ebAUijqcDM2M%YIViX1h-x$jt?p!s5?Y%*XX-MYG3bUzYtg=-~jAAkd) zeL0h4?3I5=7O}^2PE1EaC|;63rjO_=#+t44F&6txVZ)@oUd_bYyee8dp_zB_nGQK#%|@{EY~oj?R@QGc)sof4yMEpV|KaM)|6H@2LAovHAUnxM0d2CCIw> zW(39bk4H{l7IZv(|H=OT{^39I|D@hTM!v~j_kT^Nm9CZ4OM%PrB=4Pr&~q|UYvwo9 zZVCSe0wKa0^Td9?l6fgZ3a3fZ2D{ZkbO#0O`pw5mSzx#;aVZijJ`AK4!lk!$`GFS+ zD^y69^92s&Buncko{eoQ|0XrnQo=lH7lPV4g(G6GgDR5x@V2wBa*eGQL;|rNJ^)wX ztYicX?<2f^Rg}m@_+%8-5nz)9M^Dw-@D4ni)L2o54bA`nkO2?75yzL4CaZJ*{+q9f z$?hM$dAEB;$^jJ*L1B%vr#y`~^j1zG2J;x(HGO?a7Nn}bEak<<49Ksk5rBh;zD$AJ z&5cOHF607ThYt#6Kf?~j&kuA283az|I?la!Uz2zYR|u9x7^_f-H?&)Eq`rMNt_43b zmYkt|E4kO*lyoQCkr$wZIf7mBny{{r`+_N; zR`vm!&GirLjh@MJ$L3O*4oT zgMwtgkp%LvXbvF>M35vo{G+5vWM}!{ySJbMx_|5F?VZ0=3=0OrP$ph+s%j=DR<%6V z4fYmXB-9g-dug^8&>_DtU=Psni!0eYxdNNGfAq%AFXd(h;ml$$GDI$oWJy=Y!9~Z|&##V=6<(DdMViOWStd+@Uj^cWm zOoNE-d1mw_vemLwWR_Z1W&jabLdu^@ZUsJh5@CRM3Ih54#@e~G1=MmzS%Sj75teaO z=FOwsTm<(`R}@VkR~<^UNi3_@tYR~0G6WlDpYp{+8H^l#A=@RC1B`ssJ?cx|rl@#y zvsh)4Q7X)=kTb@@x9~0JsIDMV#vH^r#~`qu@x1AR`yaM=JF~~ zB$Lh3p}SC4hnx=m88!&YWmnAx@kfJ4L<91AseHkm)%fH^wVS zCj0&~S=(q@%znQ%xHn@7QJ_uoEx@EVl!MB<#)=8BPkN~QM{OPMe6 zI>wZtB+a}ST}LcRrKR8HO29IMeK?c?(i4lxOiR>>CHNaSa)*kzfdut9U2R~`+=aU&ywwxf1Dc2EIKu00W z95;}Ys|tp_0=UNRvZyt$8eYLIY0Yt%2lp*CrJkyDBmGmfm-URK^A6Phs5^d%AO}JQ zJDA6gQmtT~PIB!zcERW+?gogNC@7u3`;p6Q1``ba;dR8{wzE1A*Qe|x;L$_M7Hs(0 z0|Jw-eTn?@A=)a_WI@*=?!lEyQz8)qs@RhQ4)$``Yq$uk=Pl~!3cg1rBRohjNA=I- zOlldB&Af0_IJ#s_sgk#RHU|S)0S%oZ_@I;Lt8)~=$I^R7Mx5%D92$0xikA?_gx4Kn zb!a3lH=DGQW=fsF5!!#yV??bo0YgC%CMWhTwgI2hF=|m0!8X@Ki`gJ|%Knic{7eQm z1><_&-0{%}R4G3!96@!&tu~J>qn!+@#C7Egl)&Wr5Jy?X14?1oHWQl+&K>F!f1U_h zG6F>Op%3fsh=ciHQS2O>cLmD5H=JO5#lcV#CP;SL^}Cb>qyUv`DGd~mE%)7}*Mg{P z7THSD9Mox#jQv}N2=KuaWsx8lREZJ~__+X^lS;A3mu96;1}D!&RKM6g#X|iOI0Zj; zlk3Z?i`gYLt3{IFjU)Q;xWTF|rLwp`sqKjd_xmw3&5;2J0R74T7+pM2Yuje2iOPn|$knDQm+ph{i#Bx1)M;zX7g*e(u2aAfF4 zrK=Ick}S!R6yPdMs^AuP6S4ThE&`kltyvB_LA$?yY#Tv>U4_Q3we3?9I669XZ`GTi zTeE(sG`fP$=G4B^0rTQY&iG=6VCPSKNUg*Mi<2)@$sh=o-E%QIbKoGSVIIzjsZ>PT z%VM*rXey+6B>GssaT9F)wYdTDcuMKwHEd)y5n-PLd!fd%y%i$pYcq%x6@QNe5}!|C z00U(jL>lra*0jlXjFhiE=fs7Or-KnF(oQv zGPsP;yGYfN#f%+p5M>iKLpEN*O^tA_s}!@fN%iqcxjn>ab5uUq#WKcJgFOmT5aHrd z0_I^$x0YUm2P;JdO{Ro%E59YXVJ%7q3H@SWQj)TJt*}bjj>UpSk%URt04t%j9J5#R z_CRM-xK|MaJ)N)*UfP2PyP7vkHNX&`f-C+GMQ2h@_C zP`3lQ%X${jL*;~XYA!-rsJV%rv8X+=Id6GT2#D1N(C|}N71?{|Oxl@zHzQK{VJZTo zxR6z6lNDRVXT}G`(vj`gu#d$Ahk@+z1EdhLj!HgK>`stXst^n)xQOv2f=WQaVp-gT z6ojMXctWtn87Q1s9AKrM!JtHf4I%+eM86tMzY6IA**~Xtf*&FH`f?*_mC===sfyP? zX0pC{72V3dA!4NbrQ9jdL=c|1+TrTTO1sdL^BX94ymf;20Lru^A#ar=tPh6NjKyN5 z7$z%5jV%!Y^1XTisIaAw?_i&x$|)%}fwg(YVm$SU&a6<25kTfSOdd{RPL%gcU{|hB zSk8!MZI+!z;X}eh@D-jvcY_K_*L_Ug6IX3~l?fb6VRSBX$bKlf9=X)iP+U>AZs@at zk|7&ikw{VFkha?rO+zpO3}06Cyn{eQ=~Qf!V6yqsuf1_(``5)@HPYg!k(V^+LnWAr z$@IyB2}zplZ*+YV5Y4Azt!%7>7!GM{A?89NbOPk8(;=$aSAaJh6vt@9c%Y1u&O~T6 ztl^f7?GRjx=uXMIkJYlFEFZ-NaNh@DG`OP;xmJgK5C-Mh?9`R|=VVfqxgLLoum6ZBX>7k zbCoZxrZa?L6Bx3;5YG;_E*(sR<0Hh3D7!+`&=P4S8`xJmpEQ~;LHapzqXaM z5x3pDC1_ocaU)KCz=xZlH4^yH&AD!0N=Dg;WE1zv=nQnN^1dctB;lZQ2p17z55cVS zVWqh%q7Q)MayS8id<(%YJm}FI2LqQxI?!&UiS8b~i68qc(qUDeqA)O|M{F6xXiUi*){lR=#+041XuzM;Ps>HgT=2|R=kpfM^}vZp2!Rm2%7kYi0b(CbahBs(u)FI)NCNOM397UHWwlWit3vaLXvRC zlM!Wrjlk+l$HBTp90jN{_LTl%yEaKh5bie)j!UZ`iZ{~>LI@*tNFfD5Br@M$k#rpK zJ)!*j&w5mH8Y$>w49YPjSXbS{U;FF~+>b~#be7IYZc^F94pUmetaFj>tL!~Z3{wnpvgB3nC9|!RWX6&ZYfxtH| zM+i^iYpB=a(S`q_bP56bV440^;SN(O7!&cTSRSupV%P1aH1tRkt_jZk#gaZ%fbS!6YQ%DCNw^w zEl>jVQD-2wtl8Uw;Wj^rRR?8Bcu3#8aqw2#1vDuU7&4Bki`P-KVq_ZVBUH(^$U9YT zXX^J^hpL4_X<)ek*GAt3zLN~w?HJGo$Y5)Za{AZ)XQnCRM?jY?q-_> zM=BIyJY^EHi9VmKhIl0Fc{i=LJs+uxSkbC^j7mzowljgvx8G> zz~IgVe`HW$6Bz`M2!DdHV)uiazL+P=$^AeA8lUPo>NMOia|Uyj;A7PEu@T!DFbguY z^t%hSjuN_C3|esgUDJmijaFM7=zu_n5+{A|{Mq{tKEws>9^-|4X_eN;Y%$8!W}G=H zme(tr`7}NsMu7-_bndLub48-82^5R-WC+0`2%~~7N({4V3AnK%#YJI6fc2P;5~d2c z(i3efG3i9C*q7g^9YBsIF$Mq5nzW>LvlCFN1}Vgw5qz~uM!FeZwl6;*@3A7UtWS5( zRDXSn2WEdH9^zfH>Tzxu90`sIk`|TIYK`+i@QYxB%V=r$;5Q3h#Q2jte6jQv-#pQ zCOVZN^Qa6duk=KXI|8u!O~wUvY(gi{f(xNcjv+b4?&{N2DXCn3=^4*EkWa-iBKSj9 zj?*93`DBR0wk!c*ct$yKOAb5MephITraZZTIF@8veLm=tiaIXt)#SQ+J zJa9G4Bj#j~5ddhQ8YM3Lj9sf7D>7!@L8I6l9D`^?B95Lnj47Z;TuEk;i7aO3IF=Uc z6=hL37z-Ai|5$aADEsOa7dIzm6vT+3R-J3;k)2?u!E|L(1DLpQeHofG2%Vp(&`6p` zbs=QrFlEtaG5Z6hgwsD$HSRg|jNP>v!e~tmNaPd_Qz8}d%UV`A@L`mJp`u1 zv(`?f4=v|XR3gu6VgW14EG_y(oYvD=OX6cfCK2!Dn2MYL3k6JU)Na>+D30ATA88vT zZgfBLQFcs*7Pk24@eh9S`0=A>fj?Ya5w>>G#JM(C3PGYyG*MuqsuUSuhoXZT^d3bX zPs&o9GFK^75f?Bto^yXD(XGQlaiqs^c$#67NJ(4R&~KTSN$-&@0}kE~gchBq;7)NS zv$YCNB7lpPqKO{RIY{VBP=sa&0=GV^Oh;epBZWBsz5BxMWvtq)V1rxoAB>oEGF(tdK;Uwq7W>&EVDn;RtKUBnEC z(PY;K{y%GXAsfWaaGq(v}vMG4i^jS5iZ+WVRD$L=Jpcxnidcf`5*1EyN&AQF*2kPUfKyWo>bggpsPqdz+<}t;6~9 zPEm<>ZY#fiy^?^lk@vSq?+|iuL7E_N@3x@jCMDkz6>L6~6^s!leEaBK;)LlJ)t(*u zDB=A|b16Q}5iOPzhKsL}Ay@#_6cGH2X0f$$HNMI=dHu>JL7{hG=#o|-gtQM7D#^v# zuH@7U(stkzd0z6XLZfiMyArf71O=O)DiPL~aq93Y2XX$*JE7%@Ow~r_(Q2qxK!_Q| zbcztDUNcu{%ca?3)=R&8O9VXY4@==;QUlyCJ09uWcIlEW7MR~}NH3ZP7>(p#eD>`1 zsMfy!mdeaTu;128V9Q2;l#X#*T@=Mzu;L^2_&{*H@z!f1vp0?&{5~5Dx;p?hYT|A* zDL_4fD5Kb(tvt3-pQ0(3sEIogfHG1@TRo0y!4Gd~r8soP37I14fQ&623|i{`UFDx3 z8Z`%5lIYwUofH7>c!7V5aj%jlh&xy_tgBm#Jxk4=vk#GW;6)ehY0tgj$WBiT)%18c zxK56+e2m>1g12vR*j>;reO_@Rs=t44w@PAhXI>>OWr+epL@VTl`v5nB(5f9B>#+8e zxBzfWU{ohqApx_-E`5S6iIWi7id4B-PaUys0lq{st1Yh(dRUumgY-LF^4L5jk|P@` zyT}%n;KzA26J;|OU7cu2g8&?$cu(W4UJibdKlvl#sGWQ>x@TZcS28@wqDzn}FIMw? z=z(;c-)cfr{9KeNW2g_e>Lj84@RY&{?h8#IZ0ZRBoSdZ}$bhWDGTG++2E)P5&~60? z_AizhVo=o1m{CX%&5?!L_jcFlhgqjurfg|3z^M=*INvL@2sxwDB4C@g1)KZ;3sAuA z3wB!~moZ)@RFzB>i`>v28>%ZjXT?m_JMub?X7=jbySp<37$=Y+aAV!bRfRy?ki%>e zA%w0gLasG0%1&i+i+L+qymL!Jj~#Sxig_I6v=-a8p2PSOq_z@xF;YV5H^pR>Bg02` z&rn(y3II%CHtmE>*FGH^?}q(OhP*Y=J(SFd6`!SEY zn5ol@)UlXXloCWf#9O8ZgE-faOyp)AzT07cq}UD_5M^B*rzVLuSD3zEr z64a^S4-OInvNu?@hp^b(TF)t=M+BZ)RuzU(9o;#>8_>eK6pNla43>Q#HZk_)EKuBBs9h4 zj4-Jx{wfs{r>ud`DhVLF#y;e$ZstkX-r;F)9W{pHe~&N|wW%#TYZ`m-RwJZgfVc;2^(Z$ZJ zPCoy6$x2#E*w5(hy`#CIuIt+DGQln(?xbv>g3I#-t>vj(!B?Fx4yrz`siLQ}DLrDp zeNSF8)~&{4j0G0Wzz_G{MziS~)+7;=K5^Jhn%c8Fqygo2-29RlUnsM^8M>1t9fNWN z;jNwWCE4sP)v!2s5y)-gvpc%{`W`q!0V{JSsnL2Uud~R1si_7H3nFI(0+^Pc!7Fe+pVY8DiqX=QDx z#ZpqmnP2TMCx?rCvBdI4V@(!nu2UK=`wyE5sF|v zSW9!Km2hbT{5d}-mRimbxk6ltyYntmo$SZhwx5bTvczLwFksoX#-r3Xf^&CV2)lky zoXQ^Dn;=D_N((5mlnSKw32l~cZ-Fqt4)a&VmliHr zWFni)lXdNE%bf3n{sPZNNeuuFIlQZ&ruZwiyD(s}{~x$)hoe~1zx`l$p^b10Dx{xF z?u%1GMY7~Ipe%}RM4Ze~H9fEqBQJJi)q)|`@2V&rgc^cns0ke$Qm?4Bh~%!>-07OM z6^id4ieVU+JJ2)aVf(^NDRY-(3e0$Dt4IRO#B^X%EO7J)8-P(YRr_i)(U|}bZAAMC z-zAX&qf#ai(zgzr30qFIjdiRXUsf8OsRRLTH3+2Huovxf6(TmPWjzm67HujzN#uaF zP_;yQap13W^+gnjh*pbN&bJ^xisA})MJW=?Fx3zhvoWzw zUK*JyI@UWyRfEkUQ~5v!&*k_Y`kH?6>RWMxE9J$=g5@X_QDMh{uVy3&9g5qJ^||0*suLYg4r+j<2`RA4wM9UvxV|qLLQ`w3hlUh==P-L zX0Fq)%Go=k=jgtO+q$PX-Ux7{nwB0`kO7^zVa!=@xpbQg%q zbwvrZD2Eo)dlV|TI_fn^?)?Y5-HEigY!ge3bUULO@`f|!CLHD_N^~+ZF;+i4gd*Xo znlsdHrSdjtNyzdBJ#WUPf?={VppCgBvLW?}J)Pw%&+R3UBE5p4DxhWc`Bj-@Q9l$| z2;KCkk1AA#0!<2mI2NQ(XO$b93nwxaS_Zd(g#SnC&+%URMG*=LRWvq#@M^+R=;@=3 zh*sz-BEe;oPfKb!0TCny@kuwT*u@bfPsxA;wVseu)9XznmXHANw9~IzIRo9_$dKCD zDboi{gUA|%h&B6?sVcOhA3A-X^dFf0J>{^R%aN?GG`x|)dh<2Ojt56?{ed%BH?v^* z)wh0%6qbkJd`liHhuaAT7;7bqRiH*t5z5@mWtA}+B985xR7Z45u7Y+kJYAXA4`ZJ zV#O4-MF>x1JHRiY+9_f;HmYd8Wq+;o7Xd2T&5;>#D$iV&t>)43`eq%E!;@-URZNoC z+VO1R(OY{!lEtTj_~W^Vq};!6>bdt|chv?$vM5(PL5_j*=p<3D0S9W#NG+;RMwOLt zhm>kTKwwHC8xR%jfHNw`!MqTV`~)+hDd3kt_n`M0l-;W3$I?BqvZ_uQ!9@@Tn<(!7!LTg+aU)W%a6_+=NK8;ki3iAT zJ!FWvKy=vH0F-&S741&cX^km@jc9XdMPxb9T(;3 zF5%((7Ot`a!?x*@`@(404c?e4DPbbR%D&EKuDO`0NG!z%7*$gCcQac`cXTzFJ-i$INEv%Ck zCs_r5F8Aa0OAUc8vt^adu~5L&RGL8w3xe4knqY>lHmqBodkeNn*&1c4yzLXM-fMPd z$)5M@p=x&^cMR#>6rbvMG5#|3>SYQbovtUZ-9=wQc9GF(qq?Wwz}^UPmI$ZO8yV+> zrET4WcRj=Q=5L#s6dxB+{NP4@IvN_o%tjwSq*a#zeHj84-m>exWE;Sm3TimELLyS% zQXrmPRS5OwsJEa-D>OGp;wo%AjO74vL0j_`ze^6fSx2M>2Q92$mD2PqmQ}eKw0j6b&}Sw98Tw zu$|b4uVBH#fn_+{Xo`N6xusWkIN!Zsh^BKkVo6zp-0}=Lj>wQ_3Hy;)`fd#pBUVcd zg92?iwnFoUOL~XMAPsR`yQn*t>Q8<0@<=fqrJNLqWV*mh`QnRf!i<-BF`d2-Nur%9;$T8xqolua#T&ojr$y&zy?YqFA@q=5NZD(1dnjV(MIRdO!=R@jVdI$FNNz(hEIT6*1j$0(>Kw8k&j?!Iu@}M2>fl(a7G)?>hX&2N8cas0Pv%Ss&q>=; z13~kOr5O~%kYb3?fn~xeylTwr1ab*8vu;0}quuCi)puFX(MN@9uoawWsvXFg03& z&NNFnhJX=;J(eAgU6eep@*0ASctGP;U~)`hjon&dVDLc+1G|fGO>9NJq-d11t#NF} zO94^$A3AGnRKjiV=pM5jxk~K>8{3_zFsZ<(X&+L`u>JjD3)ZXR@sl|FsNE6*kpu zp|qNA!%~RPwtkwM3bcX}NBN<0(1anzR?U~N_c&&~#MY~hClB$b2AjNki8RgeQs0_E! z2pLoo-khgf1jIx|-+y)(tIgJMI>M|XICu0-8IPJoo*itbQYH&c9s>2>VQy7K(G5K=pV`3F9& zsKNB_QM&qXS*0>>qtqzactL3LfbVJn zC|bGcmbUF<*ZE>bPg^ZvM_D_U=JomM%J#e<3Zb6>zu}ltRMKGm?JiNdr2qn^bD8UI zhv{ux%5bOez56cJ%*T}fAQM4I&DDY)b+5`?b!NNfy|OitlQz4?;w(pED?u|pnZ%+j zeX_bGrEM3~%2f13!oph;80;-a&$(W5K9bsR(~T;~DJ0XxCA-`G(0ox+94~z}2NSTMG1*2>8UtpS2DnAY`x*qs2bC^5BD^=6$g{?zG@8 zGE}$)mgWTr{@R7gdiD2O*#qN*e*%Oc6NW@^&8TyPER#2Agxg6>3MEHi2?n7y1S^hp z=s3T4B|gBFDzPJUKQqeNLmPh<(5evN1(7vjRyyDb91*Gld&KYPi~x)HBTQ)38{h@^ ztPcaJ-u%>!hDasCM4$SqAP{I!luhNHqGrKi5k3br5Kt~b;+yheiH*t`0Er5E%3x6v z_`r8ofZUR%Y=Wpw+CYe`lJPL_Xd_m2j?R;*iS!dm0&>7>mQ=>j(VX}qimL*I zYFdJQqFcLLqhtSj|2Kw4B49ki@Q#3xZ+58Y>9He{U`^wwjg=gAxsV=>bp-g}c$0Dq ztE8e{?=@vHf{0#qwSumDn{y2dR?UQi^xfY&Xl#NdViw||vkV4naU*RR{a^nkTUivx! zM7kUD=8xkhjT)l7I*&4M995VP_eOZtn=+IK?s>W=87SN}{PkQ&OWG-`QG_mSL$#U&&%u+cRCpj}?75#^S4*%=L$jmku>{2--x!_fed*MV)H4(mG`)chei()d z&+G8yA2bdKdlx~8s;q)#fC+LHU` z)HA;+m&N%KsNw#VL164wE_?3Ec4U!W&olnqEanJdc@Tr+8+~8Ob)=I)POjWfodw0 zEc6vKJZQAIReh+j5Cd~W$i>T2;u@$dsKAGHwoQV=kPX`-V+%q+6p~Tr^)2NSahxLN zi;qlfH&QZfpOsGEYXF7O=(|GJV2jDDR^@C2H_NCJ8=<^a#$+CG0|Uyq@^-$`SA0nb zpoeUV8Pj2ml?gF2bI~#kf-uJ-LgY2)<)Y0~c)jMsL>Xg?^8QTO=q#-TzO}!4o63zc||aKHUoGVSHSWzv7s#jPXu;oA`*m0(OLXq-EGh!6;8+-PDJiVdzbo##jjL4v8p(RlD~Ah$5f_#r~YL)Q+A} z@*cL4QXaQAz(p~jL^X?-L|)GIx2FUtMtwlfKXH(6XgTMElF$VG)SKhb51A2|lCDpi zg5;vLVVROxA?6tiyQVCq^g24g36KlZ^e$c@(BT~BA zC)4n@DhZMLJqaK!xNQz1;!2i3a0SrKDx&=8+rPgGp#57e1r!MI!HSJy6%SF|zt1s+ zg3`*KspSfSa_k8BI^M=>WI#?xLkMeCJWkwhTq=#7#?EqMVJ_SOK^S%d;Tx@X$qLCV z?mG=^$dk80#FaIXv_W`2scO~r* zk!*HMY*$HuCVCBbNN3qJavA_&iW%RyMFeY+4@M{RngZ#^5g3X^{acrqA3`cYO%`TF zFLG5Y87j_HtNizGNl>);8O;pKBvx>B$=Rir*^!?pWdm#sXSj~atyB!TZ&0lc9{>fO z;S`8p9LI4#jsyn?m`BvIgqGPr!_XuXlxow6(wfpMj^QQ)H8)0J9CN(}Q0VSFJ$@Zc zNNjDz#Ty#zEtI*rG$?!EdCFK%iZ|T9SF@U>fvEIpMp~NSCml~^Bcyv=t?`R^aHVjg z25+3jS6hg{AkL|9l6HK0EcAbms|MJbL;(-fImh28a5BZS8Ejoz6G@ojm2WZX7WL?M z3s}P4f%+65tZV=hWYdxKA8?&evO;h8b>%hgvzw@#q2Zh1`);(dt& z_`c^@sQG7DwZA6{O_Ih0T1KiVq~5Y(8+fl5FOHywumifU7## zxo%G>bd&`U5RrgIu}Od+bervwO)Z~AO@7o5VQ)0GO}Why7KXgc`C7Oy3Q&H3i!}??>FR~IV#pTVUn?OM~1ItINF{#j@~CfFjV&-yrD@hCTfc= ze#S?f$g{oSqt-dGX~ot%(CTM1+beUp)gIcjGXcn39oJG%nja0+saQv`KF zZ*C~=v3E1}fa{XjQSd-u+ZXo23<6B@k)Y`)K2A3dMWdbRIdr+fT&%(R1W-{{p5PDo z&{)Ql9Vp{+4;2bUX`(7Jcl2Jx+VLrHOlxN_W^oSETNv&)yZ{&1?Rl866D^oTW>%N= z1e4+@eckswO5KK;>W>nI4h7-yiFE>1cF;kbJ9-$3>e&@hepmy_iu7<6M;^&FrlZ52 z+cSh~VB<>Vc^j6ugWL}13pu(6TJ#(RO2WzRfHM{8@ny@W5E#3pOz)~|^^%T-vcR}Y z`SbQ6T;iJS#bU;UCf@GT>_g)UGH@bxQycI@f+`%=^dh?u9xR5Np$+;><~ck^@pXw* zi?@~Tr+eU+w6ZVqQd>j|9>9<-{1PgOP*^Ocl@zbVzKv59ATr|dNokJShJ;o8yG)u8 zX7RA7$q=Y>=!B$nnT4ud>)5ivJfs=3vRvWgOP@-&wZeddzToBO?4yE&5Tb|ncOEqOiprCBKPyo-JLlfbH2T>G`S#Q3}t*l zw{Z8F8>0`lYm+pjw zRh#vu3b*NB(u$b3&@UoQ8Hd=k_STx?5k7KMHL7K#>^UcdPAX?>JaZ|AksKF#ZIU?U zvsrese@l7K{vYam=XZCef?Co^g@6qBX_7w&W>iPsX)9FIL6dJb1VtM*JCC|&E^LDh zet$ge%+1ag;$YvJu0gHZR0<;YD34q6Hln%*?;hROlqB~Lg_+Yi)e?XREWwHrGFj}i zh$A7@)(JTh(ToFij9?woEutPls2|rF3;(dx8|n_tp(g{14I`JZJv6MqE@`Zv*I71E zW_CJ7^2RMwarve02asrr(p@#`wc%v*AdwFIJ;}%=H%&Z2IAh(w%B^g=kYI9SrEx+V!?#dc`);g*_; zI5&jn!M7P5NHL16Bt_5lhRp4pkgn0*tP*w>Z1+-z)jlajckfz{>MhsoT3%A$99CiC ztZ^*D-P6T-r7%KUQcHusoOPVGlrj&i)Jv{oBSsB6ypxr?C4w^S9d{`}324=WI2)Eq zO{Z(!!)i=+*oCE35=`T+>rs1cnosnCHWZ2u(0V=xA!iF=eS&@T<;19PTj>88B{ zlxG0v1NLSwOjZbLy63v57?-ur>3z2hKSJg(ea+|y9JYX=8!f^W2ndCb`nzQm+0r#1 zk8!E%Z6!TZ=_GP|u)T!aq$ipKMDWD8^}{4yP%iPK;YM+Xb6V8e5)qB~p&Ue=I3%Id zY^9?0T%H}_tPOF@;-SC%nX(AGK~gM#XTp*XDTm^X8Si!a z@osgenveT;8Fn9~A$}S1OWy%tysmIZ}aaCXKzI7*QFvHBh>L>uBVXRYO$tafU|h7u$fC2~=oEBRhMH zKn+sGoX_g87LkC#H*Y%!bpt%VaSkKv{?QvdkwqVBb12W94mgMP46({H0RJw`h!eFN zQPaFRMcUbZmCm9}iozo?j|4Q*)vs;5bIa@p?;`7AS|EErUHOQCQ_Azt5@{tDw#C5CJQZx^C5+Z^+gTR zWI4D*2Xje0II0AsxF*oUrJiyX!DC9yVh}<0ZgG|-sO72&UGD{5D>Ids2g1Y=zG-IA zYEcf(>Y>vkauD-0yzR6(ZHO5y1@x{*b!HRGo7h_32P!BQc*}MnySC^)lc7V!KP#33 zgoyI?&t`<0?d&>822>LRxv|24w8#l3%1!}n| zHVyG%ikIMout8MJgt5J8J!MwF2D3R7u z_-v)qKf{XQ(;vH&G0MZ}Bx_v6S6WAg zZEqjP$vBxR_ii~RMW3Ca?hMh$ztb{!Eg&^UQ zmFu*b*UzqRmiQpVw&O{;`$aYiup8~~w&@~RuKKl6f@pU%8V9+Ibf|Qe6%*S*6~sZ7 zm&BCxQcz!=AumiYh37DlW6}a!dh=a#M%JS+yis)!_N+ihEp<_)D(FN|6GnndusCHv zxY$s2tjb%W+#CO@`*9ixP=|c?`3rLnmaxhR6=@z)qT<~NN2N=}5>#-Q)V!Q#FesnO z3?gAhfDnoyIy9J!SZ^R|ikc0y6*zs@L62Mci4s7Yr8YwDR(%cRyJKQW-n`1^A!w&> z@;c4fNDnz*fa=RxU!tq76?bZR(;x`UL=g1P}9j|HMI zKM-{#Eeg^hM8;!L=u#Mb*}^asLPE|%X1mG{QrPh<^ayt_b(LLU<=ya z=KT$H%qW}@S#^)fW?~O+aIK1qt9#iJQXJM?#^uerQ53+77(wi@6KGmooqF54NQAjF zizN=wOOSEQD%U@BGmWZ73!l%3RB3t%<4e%g@H3RJVd89AVdNw~^LYf!uo5$AO%W8o zHZ8JnUI)jz0)FcK%GbxIr>nz<7o!&htgz5|%9qF-mOErPp{|e#VlSnJF;g?@#{`D( zn=+bd=jL;ona0>cpXh?qxq{;lyZ5nP@^srtzem~5ad4wOb?e1l@C-xbd$M*_fc+~+ z50AQEabT0rN;f;m+L{(J*%WR%zE=h~ zsP8xwFH}ALL{(hvwO`U%z+s1TUwG&nsUzb4n-vG8n&7gSMz}hh_&RIz!3x=9raf7! z$$y{{18SUIQ@-wcgdkUaUs^`!B#4T+j~=#p8IvV&+^Jh}T73G&>>Bdi2!8My-))Vu zqA2^we*~j;oP9H}!N7YWS)!t3?ft^qrh{YZm?iGG*@Z~Z)RWjB<~#w>U~kIa{F41Q zo$%(bcr}aLKBCT6U;lWCME=G&4cu_Q=5S~$+TZ^S%A)ohDYopM<9aTLtiJHJKSP(! zyZ5N;9x-RYZlQwwYLZZ-0m8DWVH^;b@WmTeO0fgts&{X>V6o;=f>RX-mVukd1S=K$ zm6BQ5(n6p}4vdmdRCYwvg3FVLIM`2Bp8m0p&X9gnNduBhkPHmN6WN37G!cg}-xLGaBt`UPz??zg&WnEc zjAhrNb*fqY=_@Y&hzc$!L%SksCL3G&>al8|s7@C9!+ENUl053sCF+$&0~`e~3-JAL znQfIu!toLzNlBb4VgEp+? zXsxETwHmGt)~Y1uAA-<2hx;F`AMz<@A_I3pVamBeuH^BPuF?*M!e8lD&!Ojaf_CH{V&T z86~pTAWtvMY8&Rv!J3fxWR#04khI3_6~UFSQVhOk6R;cGV<%Ax#*a?WEQ|GQ>W!8= z{QRZG(fUbj8DB=%aZwJjR{VnWrB8y!9-l(Sl3+qS}~|~$gBW; zY~g@!X)Y)<=_ECqa{>f1@JEz4(_%h*<6y6`Z2&v>tLVuHj0)~OwXdW6MhvK8#A9@h zR$PqMh17`suFYp_#FYSZ&i$9`szwrEz~LjDOB69+9<7xcSf61AczY!)S!gCSioQU) zVX=Pv^~=%v3x<-hRo#$yf{7(kQ%KnF3ojq&t2)jj;rDoWsfqBKyJbo@G- z(S!pwiC-u%6F86Gi%)d^y!vzl1!@NqLO94J6^2a;05nQIAhIEN}Zpe zxIta(3`2XvHFuyBNAzM{T=cbk=(QAB!6GaNQ~Ft@ zl#KeXVXeHG`e^+zG|Lyfwnc?L^1-8H*2o;lTD+*#DY5|C=0wUhLTRto^@eL5Ap1kL z7@(kVCP1o(!QqH{7f0f*y-yba9?H*MZ$KeN`(o)q!t0OlQ=i^HEcxpKqKFn8tv@%P z4(fK`6vGR1aUC6cYmr2aQ?Om<8FYkZvpSylmQaB#;tQOl41j~U$IG?TIfy05m$b>X zaEVe~*C>v65+IkUi70ZR`Z{|DkHG0@&HZ2owkQ$NGz9vRbqQ@3G^{)LjYmsw-})2X z&jhR%>th_v)9dw}_q$J^W5hLpL@t!`fLf1VD;Ra4W$i#Ue3KEfJYFjz8J~mzH>yg) zeiPaOS>2YPkK%l+K-_F?JH3$@W`_o$&e$KV74%+9lIGx|b%rt|ZW=naTn}Mxxf?e# z@uH%H23mwZ*PoGlz+eLfxQ}jSk~GPxdo#5JqA-*d@<@&nZSnr2I8RWjzCP;edf_vz zt?SoOBSA>)fLEC5Sqiz9t!hAO^2Gew;;b0Qq7@euo79ELaPK+704zW-8eM%IS5BE( zhuc~s%(fUIU6!PFwiWB1H4mou=#P$gvBa`3|?d~Mm7YbA@-a@%XLSAH)){>;! z*W@4+7u*R7Tz<5s8}Ym@L9#J zGgFL8`usu!40|z~d$kZHm2Nuy^ipbrSmazNzl5*jEZ_+tJDwt#kZu54-Idoz>(3B$ zF-=#xKLS*SUPG*+528d^5AeEK-?CT0UpJA+ zMhVS@S<$nrtwdT<*Y^QqgcMCugSEw(R$a%c&|nJ+*Ko5d?4;EMG(s#3NwT8J>zD+n zv9TS#N1wyOzhqpunV7m1#je99RP{d4u^{nH=mXPT{>CQ#SOm0G+bkMG%O=Ek%(9tkbsxZomt%fv2jTQW(yE$y zHpn#t6w&4>LsjyN)DG76Jz;ytf7V7@4EgCoGUrNu zU9V#ZM0@10Y-C#n`qdAgKu9*~*fN02Y1%R)z`fFEoDX5HIWDIIj{eO{4^raTg+TEbwsrnZoOp-nfT zyuS0mKX0L+n#0Falnf$~uLLZ_cGnnHp`WiMcrVtf(KKB}Urg;AD&LHpx7J7uD)9^^y2erxeiP~@gfAa(x%KR4oYx{pMKs!VR48i41$J!?l2wGlz^md`@9_Y|jq^#B!) z*yA+F)mx}{rEx^tww+g32u;DJxR3l|H+m4EMEZg42XjbG66y2V)@(iJ(pE???c=_cXnlrsLwbg) z!G0rk74AvnzgkB3`Lu$tjCZcj9j`SAONM9dysROQfQoVNYc`aSO}Od?CA?{qVnvby zL?L458WIpT%cy+h(g7=b4DX}TNAqdAOa8nT={^|`iK!q~(D*uy#^a)JS__Qkz~_LIw6v+aDag@b%MsE(4)A7ynY5^e_Q~x96RKJ}Tr*Th70WC=9N9WU0}der zS;@%yV`;$ZW>43TsI$7HWawc1*#JZ8z18Ft(!Rq4VbsE6Ir&HHXGh0Ju-^XqA+u^I z47|F4YzNb?)_0(DTtT#?C|GYiqUMG4%4q%ZiZ)%%&{!XT__}}XT+90D(fS7nBp83a zf5$mt$cn5NRJDZ3o?#tevrkT64?PT%o7QzYNs*F)ks=I-L|eBCtvCd*$2NX%W9p*h zZ5kH|Y4xu)K?)Ay57Ez4M~&w= z;aua*n-WS+0*7MH-h4Uk#vXCL)}&{ADye_TeC!h%7RuL)#A)PLV{a1K*isFe6u@%G z6KedG-1mLqCK#oMw*f^fD)lIeFNo0fT9deya;q{hmSDSOM;Z)+(~CpqSksZ1OEV&O z*#*KZIycdAOjX1BBVCoOMg2ZV3Tmj};f+9BcLQ&TlYRwT9Gb`-U=G(h7^uLo$6!x} zbaNC8@+DB&8LJ`DssK)gI&4=y*g2^lJ70imh{Hr9F0*lfO>yPc>=-W*^OvI=sd4@cVWlii3y?a1Dz}2oj!o6r#ArfFg3pPDs z?Yapa`;v+$LiZ(>=Cib~ovJwJkc27zg2PxiEyhkAVzDMM;@Ls6CR8XfvTbr`VII** zsVKSTOf2F6B~T-OPRL5u3F<1Cg9kOpRspf~Leq9!gK9AwHK+mh8rmvR-w3*viW7w= zB>b|`Px!1^Llaz4=Dnr|K{AfZHnH|k8NkN%bGrJ&hY$1>Kxerpjt-|oke37K%)$sn zqUs4wsk{TCkUeC)SqUDpSPJwS7kX3(7Fo!QP>#C68{QF$Kx>w77b-=5w#y@eNCXp+ zoX?s7LZHpDgO>Kei>B0o-1+j1K-V=x-)?dtAR>r@LY-RFqPgT3B?5o z^Y#A2Vl#mQ9nR|h4>y;4Z)Yy|xeF6yGD0d*qM)oPrGy|d(gH3HVbdLh|Ip^$Gjb+w zz^G$Vv)xbiUAl%&rDc>}skpOV%2X$*hUrdtf_vD=gj42HO28t?QA!(%$4x0Cg}ZQq zYdYnRskEeI8`YoUOs!t)GraUaE5oZO2u<>@MjEo~3#xoq8jtp}uI!lt2UR$-9F(Az zS1~5m>4-^xmq>JiMydmKktG!)XETDo0vU_hWV6&^E_L*2X8gy1h`mJd+H68=&2dw& z-|v~a#nxr$;eQY{O6*G))KfYj;V;*df})bbR>P+f4Bk>Zyi^%&DvL1CwbRY4{DOjO z)M2*d^>W9PyO4W_phm_JpljN*e+*F7;jL&*8JEnClr2{yD-TnuWy^))RzpaWoZxi* zy@9(zTB-ryMH#jvdUYn%CYQ#qMYdvaEbT!t*HY=i#}NKepeoXIoHZxXL>*DdE_L)S z#)jlmY!71Y?qEJA05aX~PFsxK& z1Gov|cW{`X5k0o=-qtTkm`In2n1+4$)ce3GtKq)2qeVCW#B6Ks#Sw1kP!YUr0jT9p zHb8c@h~j$u^i3@`pG#j$DgY8!)YUcWx_J}i+XkvtX9&lwhQmM?{VC`b(TZZKY|iIu z7qtx_p&E%SGasU*S^zi4SXthi?LdgsKBuZ`UsDcU+2k?{YO&FbC?9uxMDs2pjKR6M z(k_rKCjo(OF;>aD#~GLbqA;53D<$S&FN$}A3d)266@Gc%Z)Rvz_Fwu~fVGW_QxX3M zyz3TZ{7LR_qzD{f6exP26*39=pzbJ0xN$%%rhBAizAw)2)ZZb(3*U~xe2tW{@RB@m zo-dj+c#c7u6a}as54sjwa7`HW`ovvD*o%x_bx73Cc_6FO27`{n+}M&a-b$ZKpxGda z12F<76|Rtk<$U@(#;ZCJ5G3kTplj;K^dLZJ$`W|Ym?Wg=G*eKlSSKRSUQ= z2{$CMYx!KL%D7r$BmO32Of-+WxaeUSpvGXu%ycBTwCKvyYs-KFlieASgtGkf$SLzQl|3QS>oci5007Y_IrT{8F^k25(36nh3C;NJ@Gj z2j>7=V^t#XDn?{$f4aF(?58|+?flX7jMG!f8}B11-o+f|-pK2Czm--Lu2y+%^%lnMQseb)T?B$z1mkaPEj?LX#vB zvF5ZP?H}U~?@|ggq?G!QdUu*7<7V@s(t8f!ydpVP-U3S=83lLCI;=>{wqSl% z?V*CGRG~X073x|U387ZbC%I%=FYt;X^m2DOZaXai{V=VbuETfX_CV*U6n$5-8&QEF zlfzE{W^DnlR|Xgun7Wu5kj6*)bYuA1C@-7#qm6Di;<`S@A&NvN$@UH_$1X0U3QlzW zGK^+*%n_gdnMbZ6kJF{+YU2g=QI1mfG&ZCJJwO`LSErz}X@pc|x#JrsW%-jx%9a5i zk(3H7kg!ZMGVXIgE)Ql{Tt1+{lb(m$Q|^+191yR?o-&Wzws< z$I-#US1mgiwaHi0Fj=an`5!2vXHq#a7(p=ut8P&A^!WvX{1SHEaJyQSWi=%jg^tm2 zBSi4a3>c%w1};E-gr;;OVVFZiTkH0KGgWumph5%a!D@SzErxxOwH6`$I796u#$7aj z*Dl|a@i|4RH@bY&$+-7G?Z4YhEO7?J!#%If5)?+@hBKpwq%Of=8$xCS1Sy@IoI5pR z-#8@PrPk1Qu!^$!9j(mO1HD=@F-PGD?z(y>?g?|0qo6f+U-~11^j2PwF|=4=ddc-6 zN5C+1V09^G(8{VbF3pOEo{Q*nPRLQ5y-Gn?JH3@P{AAI0t< zELcvKo~N4zN!kPu)0Au1Z`<-scb-aKNE6`(eY{d7m>}Y2k05 zER&K2bT*;1D&~xe_;)sz>lf3}iUJT142L6+m-~W3y(G=YG;3B?5+G8-R5H~&<_R>3 zTm#_6iFs0NtFILJcr<)3Q_~lcB_?JI&Ilo}NzcV^C~-u6A;OeR&_N&4PRgJIqzEFz zfkta5-FYuFv-%eq&Jphc+?cjrq=Y5PHjC&Bjh^$-5FKjBkid3kSl{fs-jn{rc}WSO zUS#YRrtHI4CC3+>B|ohD4B9LK)@FhP#0^yt=4Bw*bB@`j1&X+=Gi-1S1d8uJYr1^@ zz0pLYtK|T&5^gi#Qrm=|R2WY+dq~YsWDY9q+eLjZ60Pd*8TSjz@UgJq99t}HvE1}_ z2ZytfYSf68*qK|oeX*Z*BbsWJS{X7R_eQo3ZivLh7*@sBOddm= zU>jrRq=CD#b;++53%`*~gpVkNEzpHsKmgo!uVWz6WUIM~Gob>N3rg?Gr$G8 zbcJv(y92=YYH%&RX+EMYlg8qnJG6l?GlEmHszL%O@A=VY+~O&L?nTpcNzcq@AkA+k z(pGfmV+pPhfP}KZR)SZj+k}qgFDF*~%lQ#gSy~UWmP_s;sGWqCih|X+jbIXNe79b! z9zswla^j?8X@BDV0uy!t>6aLu_S9Hmp@4$Mdv5dwo#>NL_cwhNS3nhurD=;I#+l=) ziSEpC+@O`mk_4ES(4PRB5CWqq%ivyVG&|rTnx5j*(F}&Fc<&89JzX1$Xoq7az-%fM z$xo8|QR)Gnh{NLg@p9<8?On`ZymjJ*FA|Yy)sJr$}1~r zOx03(Wp1=qr35Q{ebsSo422W>@yOk87!M{RP%w*1s4fez5ECxI5^=rNx7FU4IN>}Q zJE+#?{WrIUvqv2kjFb(4<*eXJ$z;y~;)Y&@V>vepP4Plxk=MCb0=87NZ& z`A}1qXy$!}xADE%#k6}&>om}Ok6;>GVvJ)H8HJ!Gv872d@`)wU5iQg6Rd~grgaS!f zDFp zonIjE4sW<96W&2EEHt1_;e>A-XT34mgMVZpGFMec1S#YFB4Zoe&@0;D#!aL_hS|^o z)uosU?@}8RM{XqB;({jsyaoc&n&+^JPESxEdNosaa+1<+wGn$Z!aCp9V<9#g@mw-h znAb6wv|52;uxR+%QZZ>VtuZ%Ft;pGr3WXgYxWwd$D39#%35rait7w%4Fm>*UEpwKj zyT$fGWN`Y^P#@;`Wxf{7@;*Fpxc`-uTWTv}JYqy7)P_1D@-4k=suN`SFfrMX2$`^? z^VWs(c8BVBO-6bn(m2Ml65K?(Hp718RunR_UCF?xm|yp?%JaHoo}{8!8#OiJ1j)#?cqbK35@eIL9$2%Ejs zU1y*!4R~&=ww{wmi?P<55CAe0RS2juBDDt4-5(({7xS3+1s1(tj9z{4Hdp{tdRU#Y z)M#kl%urRd&51m*tk1(I%+$aZbS_KT2F8X!QOR)sj0BcIpfP}6u($v^DD4g0Kudg-- zeKGBlz&+Px*?0LA+e6n!ev0ApJxoXfctA|s+T?uJa?&FgfvcJ6JnpBJ!AA~|hlp?h zU)7UL)+%Ik*=4pU&PrW&Q*VS3F z8#R8n)rwUq>Ql^P{e^q?ZmK`e1DY%*L#H=c{XJ3(!eB*xBBvcBc1j`ns?qdMEt6LF!LH>%=P_6=l^CtsAY>L%)d zqim)=8WM_KbvMDG=-XlqL+=@RWxdZ@Fn{DRx;i8?js|>#0k7eH--zz;-WObB6gPR^ z9IjV_8}a)x(hfdW%Fy!}0T;H`uB}T!IOu`A;=Cn!Xldum6iOYR?s^X}H^YRj&}K*mB3gr z;jD->t8z9Y2S=#C+GQ!4^exqmQyGpYg_B05F^iMZj07;PV#KmJgLa5c_lPi8I)D;E zks39>T5FcqT%@PmjF?tX*l{em@vubuy7;V^yQ1l`aT@Dsa+KgqAS(Ss^Q?`g$OfmS z5zs~Ji(-8`%j@Ax+L+A?BxTGRKS17X)BLuj;J6!#+;$CA0MEEL7{Yi~ie*tK8PQN! z3TO(3l0dGU5dKlQ47@yj`h%wv3Grwbik*95A`9Gs zt)Bv$deO9atN_+%cKRe_EJ^T5kK~4~W5X*`}?fth< zo_=?YoyG~uam8D#>dbzzwNP+GEj^|mvLu{B_LSJjK}J;Gqe*K<)Q1+IpvsSD!_lkp z7caW+9X&l_`R)gZlJ1VZ;*6LS-LnHNQCdKu{e#yduaVs(W*?4b^=FYnIdKiI@C$MF zj`d{D=*UwvIu=gs$Qg6hVP(q6Wvc zwo=Rtjl;st)y}EV15(WP;t`j7D+!KtdA|El$sHliDiC=0k)}-Jn}Eh=rx!%W@a$=? zD)0`W^C86$SNsA*Yj790Lc5QvJhTIdtQ@a?)KAk(VPLX~o}~r_TC0y=nn`r`27y=X z$gXd~>03AqD^&>rGwMQQO!gt$oWxO7k-w>SaES>Q=n45fkoB(wvX#Y*F(!m^+ko;; zCoJIYXrRE-Y`EERyX8X8l_?xQ(dRKr>3U%DX0o=u5>MmCVb{fr=&=YV$YKIr23~IZ zyB+tIbE6FA#*?of4N&sPI)VV;Qe9BZC0yAB)!ljcgqsBby1xCW?{u#LCO{{2m;RlO z=gZ@tZH(Dk)K~g3yWKsgiqWEKnX~nV2{KbnHP4bro+!pz_lV7gOB6ei^Zw({2B)6D zO*T~~VV*bWsoCoG4sRpR1}n7{sKtr4wFy2&@x!4+!vTfn?9KPWJ)nBa=ALguI;U#+0BSaDuAFQUx0*29b=$5KFjfpeX9U zn6Y11izjXjW>rl|Rz#K}Fs5TfXvuYEGPGh0jqN_iFreI8_1bWAbWE5vrI}Ls@L@xn zW!MOl8y)Iv5+)!fsOBbYvr^kwD{vvP1dIZ%Ko61(lUD@NSn)r$G7%6;!i*;i07%X? z8LfVTz1Bdz~04qKY~1e1+GQkanX zaiQzJY^JdMjsT&>p59WLW$3PBLb|n~l^xyiiqh+c-Xu6tzGZBpwQv#S855}vhrA8q zA?QDXuy{s9b*wo~j*A67+0{||d-0Txx-|NVn>Hx4b`$j~65bVx|2 zfOI#~A>Aq6AV`OjQqnCF0s<-mf+CHSqQ3X+v-_;izPtPE^S}Q8_kX?DwG5w`Gc)(x zC%(Tr_c>?gALFYCLq=3Q|F|XuEW%F(!Ox?-Kdd?MmtV>zZd}#h9Lod!11J7{=?=ZOE;V8f zSIBH0$npKr5`*=EK#O{hpnuciPu3drL4wfV3Sa~HMSCTny)r--Xs!qFAc7!Iz#=gO zQISFrHQ+ND1bqSckwcI_;4?LN4v3|Ppg2G*6LF+7f-Z4G5HbM$Dgoc{<~N8_(x0n`w0lqKW>m8 zrhii1iHP7w{izV~8lm$XfC*^G0=U8lv;trO{jdSJKtDVHnkdj7z#s+Q2O!IVt^mz| z7JwuO&r$$9WeCCt(A@&I1>gn<0Rl82C7yQ>$a~tE{Z=*5D3Wz!Urtjaj0{Q6Q zwE86C`b7NPSZU|DU4%uaSTXp^F~S1fh!oz!1P?2z(Z>d>evZ0Zg1A$Q0o30el#c07wLU1$+Zs z^8$7PsPjhDe#14xnLphEhF|YF=!gSj_}xF?gESB?@L9w?@T-6CgTQD0dpPLd9<2K>UicUL|4-rqSjRt!Ha}O0e_sC) z|DwAQ(ET>xOdo=V4IpR)kZuG)82}$(1HOPq#t`%vU~C3#0>EhrLGo5$UjgvN7J@DS zL=GVD19}`Gs26Yt*v$(UkY50#ZV*HU@B=pUx7YqJZ3Bca{_6kK2rUqP9S8^l{MNU> zgV%^Wfu?|EK!gv-3jim7P}>2j0wAaw;28w!fqS59fJqpL7XYdVP+$U5BO&NM;6oJ1 z1AzaE_Wu&p{`krMkD=!8C%Yi zKsz4n4+1_Vfw&K-$$+3*KsVqifIAcDp9N+D7z7LflyV^GCICGb>@NU@0K)*KeDFE| zs{quO0DFJ~U<@!0cv}QPtAL_n2r34A2S6nd#gHO(Tk*@A71$N zt$$4YXcYf44I=2D$4A6I_U}aQU$V{5d4$y;5$6%@ez*1S<&po{><6;cpDZf3`(`(Er!TAM{7WQc}Pv;0!D1P1G&ck zIHrS7>4H%BC-eHfOz@XuHT0kC|A6s|f0F@z8Wv~%Q5R95jWR$55C`-*1)JauAlw3U z11PouI{+9x0s9JoK%i9+K(-ScGXNko%LUAJ1B>hh`vd^pevn%LqywP#2h0xrnYI3L z^!@vtKikXy<0j@0UiR%0h55|0NPoQ{{fr;EzG^*$gCU^fMH2DX8)k!`>i03omkgsqSO7yt-+ z5d-{UGYEV6J8S$2hfO-JR3lO^j6!X9y0AmXvKP-X# z0H}Ed>;>TR27+7x58gshDL`WlyazZ0906{wgBk!}{tkjH06Uw%S?@m%UHdVHI>ZUi&|S^;ff&B*n({~7B2FO83kUU`j5)yO(5JW|S zt^*(}BnSy0g@Xi118f2R%p>h!sxs>X;^AL!h*ttX{J44k$~1_?*~y4VjMzM6Ki&W4 z_|EUuYyUn=ffk4!f7915btYoW0OXo~ndhHpGemX*@&8Zy{IPZgRpP(&{d?ozzn(yW z@W)+%?0X2x1MC3gz?PH;uy28!4p7<#ehe7e0pm9Sk3CT50}yt>0_;E*AO|P}Oao>B zzh@_Yz)t)Df5-m6ybb<1I{w9t_=6w(TJ`-jg)kC`3ZVxwmsM3E~0N0wf55zJOgK zBxny1NP+|f0aQtmAT@w5z~nL#WD4*mM}m9+gA_>65a0q}K!pSu0{(bu|K*)Ow*9}~ z`O7pUm^Z^kxHC0;~YP=>Chw9zfqzzG`eKKY9g=8r4#AN=lrck(w` zAK?Z+L;@0oUm~=m20H$tryZEK2b==V06{=sgvJmv0O)H0_)+fdl#o<$ z*W!O;g~8cQhykrX9SQ!YZ~VzIzaOIpGARE+rHDL ztox7Ze**A*3qM@h0nRP|^(#0K*D8RkFn|7bNW>*mKYi=PPv@Hd{2d@aU6>3mVgP5$ zgVW0q7x9Cu)WJ_v{>$Yb;L--%{|%G)d!Bz`3vfd4BpW2!`Vj6b^@Eah_0g#G0EVP! zR7L<(JvbAfzW)*ofRogJ=`VEnca#6GwgBRy3mNE_kd5{8vV%Ae{`&Brp#)zF{raByI3lwK(uxcegbYOVk|CGaL?ILk+`_3B;oLK2PdXI$YU71B9mI2o zx6l+WsSs$Z%&wboR5{5S6AO(?EM0tg!z(WS>b8lAiTUL>?qLLGaqxav$*IJ)7@ol0 z<~_03FKa7XTB^2ocHSH|E+uv!2fS|my41CAX#8bx()V#)XKLbiiMmAiV9V!=H&rf! zup^zl{!T3Wnua-w;9}O-Td&R&vEXt6d~*ASLE6r(ol|~6OHtiDG+%3++m9}~cQBoe z#J-iCUPPK!cfVSztYo*YX>vZsd_BP3HP17MVd_=4x5uTUtE(ID?sQtXYj(NaTN8s0 z` zdX7=3hpjHDeG3&e7nM-q5{8sa16HLH4o%KGuM>p}d7KwfcF}~$>>t*n3I_?bqbo6x z`U@8<`cS8pGz)Irh%0pYlDm5WS;)N(ac+*ic8|K`z)>8R>Glo!Tj`{F@=LN(u*YJ< zBJNF*b?he|hTD0gSq?A**+A!?Fa|yQXgHD9 zLVUq4l~xf>NKL0$biNFcU>F90B>fc>?U0bP^@}W+Le;$#F@@A;93g|Bu5MGr`(Zk> zi!~JUm&#luEw9JDP}j+KCH2`zBMm&qu5+nkw`s=0^Kh3~;PSRGi7a`H>L;3TVnL}r zpm3$6H!QgF5}p=@tu8@4?4^DUPGtn^rNLL>(g(DBD6!InA--BTa#Z~m__=Ul974J* zyc;P(QHpfs3NqR^aOF@VYx>j_&@6R>-y2I}(6#O@_!VPKG05~|6c;vOUyE@m5!zUu zgB+fH7zo+SX3s^o%=2ieQ8{oOu2=#O+b$UBO1N~a!PuE#KPfI(V}^iqK0 z6h{i9C*a}h)Zn7~%(#Xtp#)M_G87m>TWAa3W=QN4m~_<-4jfBdJx115dN<1YR8H3Q z@hV5gXR3U%4VD}+(WSR*v&*(!l6MI1!&h;}1?V;7ndPm;)li2b@v*9wRGbp1>uM5Pn|aqu2k16+TSVSa zx(7_TJ9$3E&hVo$hV8H4W2O~Pa(B6t&^AIvs>oe~As1Hu#%b^F!D)CrQ_XX82ScOR zQDQ-!v2`X(D=(S|zutLZg4yXhDvhb+bU!+x=-Nw*yJZ6nZOnTG&TghhVR|fzUao2@D%xr?RD$+MAxT7Oz@2cL9;vDgq+ zT)*K!X~?2F)1(!dWA&eo{{?||;+1<}ydJETOsa-TGhqZ{=@a4R23nw`&YUt&GUP zvoj~vao9uJBOS~z=oaK@13pa^d}#y!*N*8bax*ZbV~`sfW8ykf$?>0E%U_;f?Q+V= z>V;GFrR~74*2N3AiWw`h-l@bSqA^-JSZN%J{_e3H6nYy9Gxa z$i~L_4n9K;C8o`mtkvkL@btV&EXX|8$tuekTSb$1-fg-2`KqZ`$~R%RI|1XR#-^5f2kQ>0p|7ayXwc0x z^aa~!qu@~uZ#FHDqwIJq2la5sEgSC>QXxg6r*^)$b}rr*d$sGVIAArJCI9Sf==!$< zpaC5#{DxJJg3NMzM`q?@^bye*W}f=Hy_AHfYtH_RGT1?rfyOr&eJp zMh!M^#mH&X`Ul=Fj3UoiaW4xC=N%0D_k6qiY#PJZkoGyH4|naU{&HnKv$ZqJ!x;zc0h&=H%7G z?!dR&UA~^7$U7lx*r-`5xOs!E7HNBgxe@`NKjrB%2q`rZlGdBS?ch_U3e=D1SVhdk zlEn0C-U}k{bvefj;d|1J^;lJ>M_dnd3^zHSmJK{Q*EYUgi=nlC*I(Z2yK!Wyf)fcm zA$%l`R!n4MMxMpyWz-B|o0b;RUIka0&%M73&$R^2=d-n(h6!ec(%k zN-ukFYzSJCZpjHc=_+f;=S0F@uQKePN>@Z2ArBQ?MSWJ|qZ0{dk}hGnqIIg*{tmD0 zV?rPYVPr#%%v|s6Wt{E(6zY3oDD)zPkrauTNW=`qH}-==JaH;xteqX)%sFuelTG}; zkf1-L3yZ@-uVhPTBoOeNFfhOSMYjw0uCG=e3Zt)^J*F8ZmKjzDR%fM|FqKsG4J^5m zl${+3xofSrG@i>epqOXn5zz>X-aMKnvtNtB{%Gjne43e^UrkAr24lFpnd@IrkXzHW zxiuPP%md3v6^V^sDWTJo+<)3hoWD%kcAYR(0FObDUph{*TJd{~X>b%%41?k+Op8i~ zK~aa7<;zm8#aK7=$X+U8|~ZX>%&wLA4LRl5WMZ`CjYUlpGqJ#xdF_ zG$y)!EyZ%_6uq0=<(Utb2+b=i%jb%zeB0T$E9bs{-FWlrn-BIBWt_hLt1vwc;ZjS| z0U{O2*Vt*efVy=MK^9W;WlNIPo3s@3Oa$d?Ynf< zc7--{?LqbT=#p^LN1{cxPhoEKU$FY5kT%QrF{F8`1=jE1cxrzy5zU(T!&u~O_iVyn#2nulsgdM04v$}# zm19dEzY(W2>&H@n^!=6`3`l@iLqdj-a3O|-6Lw-PDP2kAO`a9pud*t&Q)rDSpXgz6Ly^J?(9F-AK- z7>bB`oX$BWNj=xfxX8e$Hqg36r#P#CA#vPjL9U<9q#ByJ^vFc@eiu`(^r$!<* z^AM)bdWEa@O`@LYLo+V^Uf#NlS4tfxu8SapSMA2_*8a!0p2O7XB~YYDl5ngYQm&QP z1jo=}dfM=c7JCLcrrgzfx>&v8$#^UnrMEdOeI*P|!P#S_Rfb77!oMt{z)o5<=Oe5+ zHb*g-cDQ(VAkB3Z&yyKzLsTT|0b^aVpW5QviR1j`J5lUTELOPL9#XRPgJrQX7;j37Fg59wyww>mNbkscN@D~8L;cO&P;;IPLGR7r99c30@D@!u{kX5JystdEe+ z%gt);vB7#AkKvn09xwFbo$teBeg!UqDHsODNSx)J#e?Q>L6g?zfq2P*E36;23pGj| z*E7C>oSNd<23OwU-It&WvbF-*i5g%G4;nud53ckHN@0G|%u{Sa>!xQW~%FaXc z=@xDDOI7xz5}gIu)0|(rao+yka82C7Y*<w}p*;43#^7Z4t)mxIF#2i zrNnQ7kwy1dy=zrA zrd?-6uS2%$lA>bA@l5IEF{gBx@Ms>YbR)g(qwvQjso>kqnoC#L?+gquNlCqM>BIN zI_MZWR-{#>Dl|;NMF^B7am(i_$Tr z^d4cAeu7l3=x&@Md`szs+zwfPXs?(@L!M0}i;*qJ`tExz#mix^DE9l=!USyx!hFo- zcc>^~g?BDV(yNnlkfTYH-ysPfzcKSla*ZUlq1@&83TIKOVHt%!FBz7k3VTh0*ww4f zZa!7$%;s+#Vng}jKT*p%CkjCW6rqHnDT7)VgbXXWOvN}iC&zR%&Q0>$2A#V_%aY=H zVT*7#`|^uHsO!^!z_&>MwC}4s?*1R|hwWKj(y)8`u>8Ykfg2dfU@xQT07J%Bh$_!2 zqH@K)hn?fvBkfbXU5#Uzr+SwXc(EjBsF*@!`)A)OFfw)?F>2V;ljo;v2_HmP5t7!3 zX}`ntQKf&xZbvnt8Va_Vk7wJu=BBgj=M9Pik@=0THs+y|b-h%B2I(EMVh#Ii3N@F? z%3=N}17)%LX_cHk!bWq-5R2jI#y8@isS9yPV_n1JSfYn(56zn zt5U33b%-k@^3({jGmBq1c9{Ne6kD7GV+Xo!t0BZG}bb_<4%S&iu~Oh(c}VMt5C z#;pJG^y$S`8@xN9s5t2@CS+W50rLvhs_tBz)agO4ViJpt5j#pPLGsF4QJ zMPIebn)G)l*6&MDmo2lm44o_TcF{b|^qrOKC*o0u>s2de!(L;D5&FfZ-=dCVOplx^ycuEPM*Q;_|VKk0p{C2atN>EO5 zRa53xfx)h}#!Oj*ZF2ifgq>&dkHVRC=VE57+$M11Y>mu2Th~S~>_+-$MkD#LoW{m0 z>dHGLz%-^zYeX{nG_vgW+uY4l7VC+zS6|Jx$Fn@K1 z#G|}yJ^d8vA>JmAKA#$LNXXEO%f!V=OoAnKoyZ(9iMP;7u}0#Xj>{u*qvGkfbms_} zUWr|k(WccPfmWlnQmk7qgw5N(cHqlNi>;93lj~oFxyS^y4W*QwI?`kw>8#x{ABi*9 zLwjcQ@!;^-Gm3QY<(s$N0iPkY>pW`thJlCE6yJ|7*X>7Mo@;Y)PtM2?^s+{1 zkFHXXmb#pt4JlR5N1mmT=#)cR9pp4N0!12h6fF+M2kYE}SG4+*q^KE4r}X3`UW(Xj zDC{Vds0cj3B3`wx3-Ropm>J**L*$L|xWPJgTNy>?er-_dy)wgIGj8yDrrN#Em zW?>*iA)c9cO}U7-L2bM-3OC*7whq42a9MAMV`(Ws?rRFYGtVnGs!XoTg50MuJ@W3? zw4Ruk`;AF0jNp<#5@VTkkGsW3gDfP=lCk@gN$G8&1bgIT2dz^66&YolAi1Nqh@)bYKhvgPz6 z7d56+q_5qMWbs+GiH)d&*+;Z8S0)&7WHX1$&cS3#^FNlDirXo5 zSZOI8(l_C`Rlx(r(9~l%OI|pX!SN_sRqjf=5Mf}oG^eFaCs#zOevHW5v1{G1~I=5ga-9 zCQbA3wT3)o?QQX$@d#J8QHo!s2YZ2}cv*It$xWAi zCd>CmqYX+9--D5G%SjfsxLR~!Gc1nEhJYM{L{@Hh`U@=C zSFfRHT83tnasR9c^R;LFfV+^6$YYUJd!d%IdnMGOT=Lvx@{AEA+)*k{W?LP~f%5gZ z&Gej3XvUpQJ-R0PZ?~q&;+NsC#=YM^W!!rbgfIUjeZ)cGKF$j=r5k3LJuHOAIShi4 zwdYoP|76-Wii+bcSx;U{!Cl7|batT~csh$4(Q{B6swoy= z5hJbwMUGL&Us1MEkn3YCQE$C3&2uUFM!64)j<~A4G8wtrGcRF@mn)wP1{POEW9?Jd z2XN*}=Qt};U8D@k13pF9awaq-Z+>dx`gWLx`)xlhC-?Tpk}mFMEHVG0o*}1`vzK1f z>yBR@uUFbpkfFp_p_Ym^a}){Px*ykT$bnLlgc+r9a;2WmsL>%V5@McRj!lX*2(6+r#F7K$(E1!KKuuoKh2y=b;<(RQ= zwr7Pla3+d9Ojk;H6*Jz%fT#8$Z351ThaT7AX7gkq;IRmGD)9@`D2q#GR1>|tFWuHv zS;rLk9ycl{xZaC=NPXScAD`CWhBk5c>ibrVhJHnh&g<*=#vP+|{>RLnqag+xkDmIe zjk}vx4q#udbGLJioe&7dpqqAR%5)MOhJ|{6UR)nnnanVGGB7r;>*KoQe&<@fXgP+Y z@SE;|?B1(gM?8LuA~Ujs5xQhT@(%IgI{8wAdb+C3W5efNci<#9(6$cDygePqzx!-a zXokNn=m^MfOK0l85gz=QD$9wNg)~EG=wc+z(fBp&2qcaIZ;Skgc#R7)N(QW6Il^}{ zdWj7++svOp@!>W;yPrk7zaO$|#GehY;2miu(yk60#g5R=iep9)Tw1amQP32!dW)l@ zvHBccm!)}H;f8#nR%y&AvfmO_j=h_&=eT_pGItIB%kKKM!G}tU>{ZN@L$Ie7%gZ?a zy8~4hZ|6)Tc7GA{2S5eZ!iCbq(dsxBOa<)|?P-zu=D&AZWbly*L zI%z=?kJG@`_~;U|0XvnsfQ8-e*@Iaa!@JhrFZ_~RV|=_BPIxjH%+`C#pn^^HKc5Sx zETQXm4~)nDc<-xb#d1fR`1+i0LCz9#8E+rUYuB&wX|4xnesy} zxn(IkxpsbmZ~a)%`H6nuXz6kuf>Uu_|Pp7Nrvvl`ChyX3`I`FpuKn6wMd*Nfl6q zqtZDjk&QdLMn?mvpTrBAqt+36jDNxNIDbEdn&0-Qhqn94v!)%o0x{3PVBd>n6XUrvotDhZUmKg(`3;1{LqV;q0P)uTq4cwTAcHXO~ZtNZz4pcH8{T~MTDQO&uCkY&`vm}ka`@A{IJZ?p8{@`n@1{aEo4HoVm` zRyh&TQiYdAL{bkJSa2Rw_pD2WYoIdeFjNz=&ll4c-M`^-jBCtPA!XE4U~GKn`O*dh zKCRh+1q#Chin|u>{HC5fR&R_l-VVEe>!k>~`;Fat&QI$lio7+8@M!QCGG=m{p3SQ@ z?mq34kLx&(X1{SC_FHv-+Wpka>}My?VkleawyIhN0eX zR&pHZH!ZlZ4Arm1iOdp8Ts-I86P{i17Fs(sUR*yPz}1n@AAKm(x$EukMd%g1oVK-k zZG4QtwEeo7t9gzj`Fqs~-WRr}v*s?D1`QMpQ7CZ~aabyF{>N0V+^JFYrAe(-jod&$K%_ zN~Bq5IQ8;*XO-CP?-T9*aj6=QBLqu+Nkvsvu)$1yk8M?O3rlA#r;<8r zSHD%@>6T8s+kxxq2%hI@MzlqToW6Nex-`rK55dRbD2*X=2t9Yo=;NaLh%~U_)p`7Fw`uUr?lpx6mF%o9 zT9sw!tQ%w)(`~2IT@~#T6gF@ou`>mj_zZXnNBI?BXJ;o-MKON6v|3Leoy(B?H80l* z$$Rqfb1*oViEeFJu4s-Ho(bz3Y!Hp}-yIaJt4(A*%q{2&N(lOv;6t-)f8O)O;Nnxs z%(C9=jk(Xkycn8XLw%9$+XW|jg#7CczGJkVt)o|icG%x6yqBC>w|?W35_G;B5LS3G zC8TrKRA;h&Q^@JjzR?KsE8=Z&-g^RMbqOOKg?ZOZ$Ca+vi{p&1BiD;q>|6_sc^&m& zElX)BLx}w|DJOmy?}KlJX2r5|w|L3b;fmy%ZqCh^d!0eqsYfb0U-FGnRj^aTi(a@W zH}Wpx%HJU^u`~;rvoocS-bS}I-u}imMC^Ah*Mw$&bxZL3m!lgx``^r|@w^y_CsI~! zc6e3a7YPcy6B~52&6RJs-N5taT~8JnU#F+4<0qdQ{(cP0eN!>NYt(~2sqruOQsDi$6TBL+3NVx7EgZtA#l zW?KeY*p-~MCvEk-4|HW|_Q)>Yk8qz(V$9*&P>f9}j!k{wrh9f}uuQ|S{3$-0NKy@7bH#kwvdyqB8x)EdipZ68Y5MUY{T|5j^0RT{usD=r=5Rq`4y=zN(_Ci<@?_q& zO+%xkle#)X%NNV25)F+R1wLl?kn?bk)2|vYuV2sY8sTg4b-)vozoruSfg1ZF)oa%h zX)<1Aa=>v?sm_eQHq*`kkK2P)+j}=WFuD4IX zxU;|Xc?q_m-lpC%g>?DC(r~70I`WXH|JzZDvCCp6U0ox41y4pVX8eS^SXg3dR--D! z);dqs=+5CMdHSnr+?=ife*MS!n{8Ew<3jFFcH*i+;W=sO?7Y+uKenZN5+w6$*;#kI zGn}3G@aiRoM@`tFE(MboX$vzOpk@)yeP%LDqsyjxNvHkdotF8^NJ;9rN=uZaF#m^! z)dRbalrzlf-ND&ZnyC@R6r$lJS(F3|)e2M)(by!xR=NYyF^=DoqN5>0Bnx(e2M#VV z`82b_-7i%78B!s^8WjUMc;N^AqwcPr!-qPUQ}^O;p-G&Nqh@zS$D3rRn$~C!9rGs(Z!>yXFDz&$9S1tq+9zyYkYXOo=o8h+V=>-4ugWD(Zyi3 zZtvJqj3sT0?^>~;J8{bbx9F`Rha;GLV=HB4Q%+F1+n#4Tm69rvU} zot;3Ocy2#ojrv>FA*|Hs?Mr*Z<@fU6Ud%h~*Qs8W=8JU0(MElTK`E{_>2a?1#x;{R z$RQ?R0*QNrN`Lre%kx65n^Do13Jhh9o*hJ^d+(nG&+8~fsN1Toi*>ZDoZWvU5ZuT0 zPFL-!`(4NWK_1+G<^*rE(SxZk8^R43Uv9Gx+G??}XtJaJD!TaLZS6EDoyc>Lq$ z`x>ItHjcN7)yUBXyfAe&zDeQd+?j5p1Fw_DmhvBl&}GQP5xH*j-)MFmn5vbIE5Trb zKgfJu6b91>l)7KY3>UJ09l=LvJ_8%R1EFx{-*RUlxMl9-rC0WRglA@lXG$T(+Ws_AZ1&xA zht$d3CnGGAuUD3R6=8BPMj;w|*Ba*QLEmY*k`!M%87hJ{Lvnw(gngx5guRv3+@&tPKr(UrU`wyv{7UT`wbzPd2HGm=&WKJZ1= zP+TUSVK8Nby*2p{wwl81Fj?9tcQ5Q(dX ziR0e9CbSI0X?^rWB}iEDwd&Uz&+TM`2PLv0bIUk4ne^@KW(bMI&3I+ZJGqDkZoP2a zPJSRn-oH|9*3@rr%yFb}D0+8T$Bb^y;g~-d)t(+TnXE$FWPnax9aoPt3uAThQ^_4M zRew~1eM@nTXZxcYnLz=c$-bXl5J6p3CG;0+57W;+wNY+I-$QTL^xsboAQ@oP%%h>S zU#fOUcR0Oy(wOblNb+6ib`+bHs)nZ;ZO$soWow@~hbtJ@Jsh%2W};si%ISJ>=48L6 zfM-9`PB|-?3nIN$WB8H!Nosczb)DLCoAQvMXtUeMw;1m?Hm)9=#|<*@HTDI6cX7?r z{hTez+Zfi-BcJ%}s6bqBO!~|HGHR)D9txYw=8Tu7ZfV0OUXB=5dh3`M(`r!2Kc=%F zB2T+_3$v$*)yT9C_u>-+SH6+()2b@cKG*dH<YNY-Il5k)ze@(6i+x z(LU(fxs9o&eB0_3T`DoMG1cjg?ZNQ<`bRq=Ul)1ns0%h6Wm9_}1fsx8X2)y~AINi{ zIWW9hXY`tQ8FvM*7h`V-*6`uR&{G$lGAivtrKK#Hqq*5w3T+I#D9?GTsd3gADr6($ z9al%km^IDku1Ii2{^sc?4H!N8p+mgYrd8wK?-qIAc)z3n+CyN5_iW!hl3Bz-EXdcs z-@a2pKgDJN<33a0fQsr1cl|CG`((bG^DgnWpVu%3)dwC7xCpT`zKLn9EFD|zS01?@ zWOt8Nm{(qIrRXc}#zRfb43$*~HpRbUc;{ipP*Pl#jU2)A@?(Q~O*0j7^0sJL&g*Dc zc`&Q~7V=0+Ya)U7zC!F;B+bTka+&n`p|HY6-o9-uRldtunyW_D)+_5;cJGe|l}XZd zcI)vP%Nj!^53RPsFIA^2;6&Hm3-?7+9>b_9yJKe3ll+odg0%*Rf}5Z+hTTf|`P-+p-6*WqM$b)v7xY8d$~aKSX?Py`b$o_YC17o@1BN%%#{`< z!8j4IoTKOdp_=peyA6ysb-P{{z7*|WI!)&{x~CMXEY7Wi(&V6<-lV>AI6?D$H=I=B z=uo@4*;hgEo^T}EyT=*LGa7f4vGnDZl$YRpuY|z5CGcLGf@nn^i>>fo&N#ow?y*RI zM0Jn6sM5PZrY&bSuRCEG<8;p+{3c=qsoEWXqBoj3{IYlZnNf-f8zrPGE@`%Wp;S51 z@bYNi5;S>x_tgT7Zt`eWpQ4D9VGe7`T9{>>`Bs0*SFVLO+;$?DLNUd0(v`B~N|K@< zR^*q#D0aj=2ZylWilc>Cv$Niz5m=zIi&Ns2gMYBpv%Zn7C5fRvT*IS{!e2HhI~>LB zgNcN!V{5mv^Tm+rqiEo&<88S#aPHs8J+?>`#nJW5*$eraM5$uj;67O2y*4uRjqLk0 zSXCt4)MZPWoX4Kz{KJ)BL}XU1>d zzwgZzMd$j_>+Zg@sEz6+X{<-f1RRP_VBXwLar(4zk~g2^g+%K_L@~pSre+Uo3Pr8h zA9q;qk(gw?T>Vso8@Sg?5%ab{qAil;v_~di#!bG*)u(3l<;|*#58gF8#p`%}E;N1i{S$@L>tx0!p z+Ei;kkA&4^nE9jq3h{3>_c=XOsCe#FoHFc;eY`yJ(f*l`k1V~d!3E{P;G6HbH`53e zsdLijyWLJAE_d8Xdi2rz7czgQx3xiMZ zJ>T!Fju?iw^K-HZ2!-c`mAk?&5kEV8pUi!__hw^znmx#~b5hzmL*%(5?{!;O4Z@Oh z=9uchSPuhUDjH`_W~^|OevC2mv5delx+ud}|+d1||!E%lM_ntt((F&|RNoyAmKWaKIe>mrG{QLKR~re#S&^qm3&315MP zj`4v`xz;#)c~Pt4VwvMKqiT-*&`D=o-%DitFW%)J`BA1nHg4~|Rg(95E+Q}bWw&Y0 z`RklUZ1McN3#A_SO|tVo!&tHDau-vFOnw!8gO6^z;B*2L$EhYFEeB4+5&TG6c zLmuXL@VXy;_3LT0+dQHrK_>DFPnh+bM88VXtIvBUi(Jur>p4MC5XWY(ThF9%drwiP zwAj~M@!5ADeB^*HnYT|66&=w@Ukz}P+iDN%?won67VD^kBPNk@u%FM~#2<#Ggz_Dg zDa0^SA;R@F-?d7gjZZk5O<}ZGjovk#IyWrpcDOjA26;A#p-VEOW{rx7WV`!5>Cqfw z_V)Nrz}JVFwH^AA$B&>(_g zleK>3c;Xob*j3hC=4j+q`cq6~#W3GZ$=*vd#qB_?3o+)CG@2*2q^ZjpEh_2zk8YLr{`Ta5u1T!{G?-iox?L< zT-!X5y@WgD>O+D{rE{f&Ibmi6MTu6W8T+xib%(tJl+_;X+mw}u3vb!1#g}o zX0g-VG2I&_ z0AIW+Sv7^FMWKmK*-5EBygxPlHA%6<3thb#OEo6TM`a3ZxA3O9wBr=k1D_h$H!XZ4 zd2RooH!YBuZV+cw%sTWa8T_VJ*(e_ii;ww)%Yjv7!S||>X}gR%Dw@?X`N2%sXp+)S zCW=Pw)1vp3Lwm+18}isH+$}f^`lDX7*(=fKXz`q3x#DYtmE$WJ`44m~6|4*2$d{2D zvtXnpwS@$bW>%t>R(uNHK`CWqld{M9*q{-z^Y*q&(KLN)Ds~>ae!3zdWA!9lpbH|` zDxD*J(0qeM!61!6*e?hUY`MN+{)KeB%Rm^2k#8i~K<(Olz zb-s9@$X(|h=y`&*nXx41)zx>t!LFNbkef}t`CK{lLqu`^)-wS$V8w1u-1!VPgU7JW5V zkldi^^^Mc=$Sb5LtsuFEVwpU=%R?Y*!^-D~%_dV}0#(ln+h>+P^xvCeE7P2GHa1*8 zouCP_B{TZ=(R1VV|6%Vfqw83bY~dp&ir{qz){boGEd(=5{aI+|%wtrOH6it_baypj zzqj7%>ZJ>Pj13MJQM}K#&C}f1k5q8$vjzy!I)|V6HmefS)gsKnDMjff)#}+wQT^++ zRij^gg!F9mY$4d~DZ6Oit`L%`4SFqu$8cv*1=%H$NS~}rs)Rv3R&c|yEHrZoT zLuo5H@z$-!t{o~lg7x7S<@lDGImT4dbpI%-4W7>S*9Yh8cJ zJ~-H)MCOQxa5+djCZU%wea<-!WH^0h$uUI;@S-UG>>Q|jhToS+wGiEnb>(Wr^d%4C zL#G;SMM&;_pGkNMLqMbQD4D?{KSOdh5D6AC{TzV<$?amU`9hmIfu{IlcwgVjdT!HD$oPBI@1dQ+&1V8d1}3gQ0zq?XIx&!jII#rRiKVTgxOEKMLs& zI|`kGoDZp&NgbVOQGX@cD&x-b<$l=fAZ*pogViKQf(e%K@b|8Yk+v`i)6pfE zsyJ}h+Q$od$=FJ@vqiGp0R}qlQ#&`bT9z(C5+jE&r-AE)161-;1X2P&$|~kG8kc8( zNRV9(c50aImZ{1CZxm%9)^F=(k}toHw2_PdFtr|Q^a7)EOBx#X&;iz41y*epl@%!y z((?_5`qxZf8}cN00T6-TRNMcw{YR!R=wFz=zd64DjOhzJ^&d>%Hy|Mw5|YCKo{9t2 z>4u*8mz~Oruhu(Y38?>lc?O=}4*bdVodW9qV)<95FQ^xA!~qBx@OO?ok}2>5QvS2D z===LSz^W+~_01os0kKzwm9a)3{lMo$~l(NO@`t*3{B<A>miSBIQ%CZ*~%Kin)m4BgC$2 zPE^eNGNJVH-uFfv61=mef(YsDn)aAP*DOT7XmDDOJX5ic@IMtJJdkk(M>4m4ITy6O z8*Oi46c9GP`+N+#79ueYDPbf#ls>r!v=~DLZjhiVN9diM`xa*^o}MoR5UB9qGeSkX zL8Zav4E=)tV!h52CEQO&h zeJ0KAp4g+<(Vz5_->#|ZSe%%yR5aQuW{Ot7#A^oNYP~=omk~_B5-zZKAcGBEnP4qg z_|`z_TJWp8Z#-B|37iOmxEq~aQUUB|^f_OiQ3N43%zL@ z3V?^8j^yX3L)rn>JFY;ZT<1Q3C2@BEsjC&tL@cxD1Pc%d!cjEgA`LV><@gN10?WDq z2LXt_bG-R#{zV7^AbN!A7zSqKvk!t<-P+_(Naqz$?))d%H)iXy7*i#3dg=GQsC>tHpJJx_s2wYcAEfNPH*{{*t#sC3vuJ<7g-hDOwyg*S&qgIbXGGF z`pT9G!z(dXvs3d93;{*$)J>(&1M7tp<*W-EIRm(hu6Z!v+>zgoAIUiaJ6obx!;;F$Y0kaOlT{VCu{K#ipXcj;r%cQB5+D+da4-^ZIadU*kxpaNI${(K4% zlCK}xaxi-eMIsbfr@vuQv~dn#W;;2^nA-;XN#Zcg6RFIq86t7)z;(b0nN`UqRCNxb z>NtAvoE-WxmsAKsw*#pA`TF_B{)Avg+HC;dr(D)b`a+Y3t7Qm`r|`4AC$A>dk=YbZD&(1K#8N+Y z^(O;?JkPHDVWckURJR?ziU}gIIIJEl`4h0p0jBRJ>mh`jrXAj#7^;3Btf~=b21~kb z=;r)XcsSOpS>KPw=v6l5_eQElf47ZL;p8&-S*k=sLNHUgrL%Mo54lpmi+BuH2fkz87L_Xcyw z3}=fJypB;w^QglS-dY}HcN;!31Vvf57jaNXCmU~41HunKnJtnZ6gCKQOz>)H8!&6^ z3j`2}hfD`adegqzrt-OvhBgokS_RFtwUJW&;2wudL8AuTLSC#3ywba*Y|ue zM2k;?igXQchB>X7&xsiKNhk1we|xO+biUI+Ahr~%{8~%f`J)Eb-{)a6V3CS{RdHhw zh6aoof*ArhFa4+OKhDEof0>7W&xZeO9tO_O-ipAA8_6&L00cy1P?&_FQ{sbmP;~CS zY}V5|z!9kbJrCCj|8~FuGgA!z!V;+ai{<;m`vw3>N=y=1$rS`x^AGp~cwYtx1HeE* ze+#gI0|f#a0s8q_T3@ipF7B&t!1tk?V4GSw9I|nD1u!yLbxP+vXlCsJdRW)^u zZw7|njf_o9?d%;Kot#}<{rm$0gMvdsV}HcOCnP5QOwP*A$<50zC@iX~uBol7Z)j}l z>h9_7>mL{#nwp-Oots}+T-w~)-r3#TKR7(Pyt=-*y}N&SeEJ<1uuk8fVf`br{}2~4 zFfLGVa4>MF-*JI}IsrQvGB^bBM@SSw1t@(RR1#(%Xf&aiUzMFOq@NTo(7)PF!eWrI zY?5F84(*S~{(FJ>{vSp5kHG$STuXotU?9Mo2Zjvb2fQj}H9W6}w4u~q65hd&2cOW_ z4g`93+t`!*cn6eg2LR9%ME_geHl67LG05HNs|AmE_M++CJ7BfR&%xO#%3j;*&TNXF zH3Q-(v8gQVu7Iw66S@8Mgr5^Rib83GW8fD3oR4lEvuh1|_BKJu?ha19?4?{gRFW{) z1u>k5duu(^3%rG6neNP8kasSvFd^t(zBA;DEO!PY*m3ABlbp(_?%A2MOTfu%)Fr3f z=Lfg#RqieEK#STmb}CL^VrywEl@We5;?owQ&nb9L>_-nXG9BYUg_$0?oo&|MpqwI=nUkI^zEZLMU#9N>jGI$L z)r;>bUPew9h0fU|&>w$Tis+!YY7lm`kT?`nWP5~W$5+e+!n;V^H&1-4o_72tckYX&Bd0H_>_hYN z>cJNMBcG?CJ73L8{Yxfx#c20+L)Vd5&O`aDIWIjktX$0UT6g377%)*?6poPgA8~HH zP~A;0^8H$Px9ElT71hUsFh~oQHQlH3lf4}I@n%{+-APipy^OsB0s?Lyn$`)=9$muP zQ9Nm#tv0_zvofOSz!{Tqe+>l~Bv^7I+)nG7K6ymM*N(0ZEeqNOZ-2rwXk((?rI+hT zcIvl^cn2Uj;HJoY8ScEtNVE~DAFi}2%LeHYG0GqEI?nsJRO4V3fg|1%we+bI=aVLH zdQ|R_Mrf}GCxOiAigl8=?yqlit&Asgr5Ww|{2nU?iFt;$>8q-fc`(EGnUv-yS+MAQF zFbJAkGu`-gyBX^|;6;_HTm9r~BKMXA?W{P4BwC@1<9!x>KM>@btAgaK+{}V|dr&`c z@IsfP)jnumf^D7Ky3H~Ll$w08SBcaTh0wJd zZ9{cu(hcG=TxHLE2;768EVRjRa`cnBZOctlm!1wusmvB0BT9m`MGn9*_{z60jQ%`9++ z)+4DVdGNEHO}Cyr7>1U5YiWPDI8KCP@7=Ptw@kLo;69TP$%hJ@>u6spZ3ISLO7`5d zy9P!Tc3aL37an5riM%P@M)3tb%@>v}IY||vr$LQME_AgKa0HkJB|nUB1O>I&T%3(} zI&JO2qx26jg*h!V5I?tUyaQ+s_&2p5yxz$9FR5$Z0U_)!es8)D_uGVwxeh!Ez5Euc z4Q{Z!QB*Cj$(}g6$CyoNnTR#34F{A*z7!|#A@ zMtA0`m#7C}bH~?|fn!R!GPAiWUaEncB9-IPyxv<=!s|0i&~^wOvNpWQ8j$SX*Pq!H z34JICMEa@7<2o|dO>!r>o6pi6tSOUQ_>c>$_}n7R)nNnmsHqkF*Yi;t_brGTOuQx~ z4$cQfSYAe(886K|T-SF(4;BtNM|0N3c`K%*3DO~6)?SB+JgP=c7xi*&57uk&&mOy_ zziOT_mrkSNnXvi<%kD?eTzqrq%kF>H&se_$2JCbZTd<+JGr$ktaO)e*Qnc9?1Sm2J z!RDGmsY+x!vO=i<|3(LUUz`P&Nc&egVhAk=@L$4zAFKJD&;0+Zvi(;4vm6naJN|*y zNCUlqgq*mpONQTnoBw*YRL6Q5zV{BG1nPe$P)jnulc+zj8bYA%FP8rVs{xjp2b}+b z)tEsXi~|q;fz{YFPHIMP0yY00Rs$9HH>_qwrfh`;4{+g6HxgPQY|bRE7lKsemQyB= zse;&cOz=L^?hKZ&o^S%5;PTf~5sL*?}n!$?{8&F!QPY+P~n{yTF!N8PvQ^9LD~ z)qK1VwAo+J0=LN-$8_rA`L6JEL~wT^LN|GG-II@o^Bt4qGL-u&6gQ3%UC7|>2u~vT zL>tLU*RmkaAMr(wd~ZGyh=U>yqE)o&WOx z$@sj(U(srub`oi!FXg47vwIb^k<){MfaRO0QSi-#szE8^iP54NC|_18()SW&)1B76Q5|A%x(Gck zwN)B1>-D)*VMQ~%^%XAqGX5+f_@(6kzOmizmrHgU-#rw&k*c(-3*?&Kv(r}W6FvD`> zlAcHtCfwaq4ya(`GPgZOEJ|D3oheR}MYY%EW@`2&TfK%cJ(#GS?6h`X`z1B8>Qa91 zIzok490k*qKZ@r-Q2cz|wj23l=6VMP7FSp|zXSRBo0Qkd)X%~&-AeO^&L&gCyDuT1 zwdHPl+Jh%mjv_BnuwR=~L7i+XGb7aqr<+*W7wwNP#aoka%C8Sn)%qv;*<7*b&9{*HOdanpLS;1??1Yh<$aY%2%pHO-csNG zFzQCj%*)`)4!>dK!?ihv5kl`uduueIe;e~ew-WEJXq|RNIXPT=++n&&|$Z@&g=vhkjE@r9bde<@xPoTn4rUUeBvpoJA zfr!FHY2;V}PP}C~?u+BJaRscXDUnAt!>5`nG+kGFbsL7(^@GwWT%tr#qo<=5zm%tN z;r?Tj7%r3uXZfdzAri{1prz7c2;ut3FWOKhr{3bZVOPlKF+Sen^JX0gX*b5#kPw@j z!#USda~#-AEj*J@>Swo?=?Un@2exc;LfOIuHlI{>rn>O&k4Y7^kM$c*+btn^`Y_8A;Wj)H7I4bwwX3o4tM7 zTk+oI=uA97tM;FjD0Ldnj@i3h*VujrrSRDmk>=6>a>#aQ} zi3O`7BWUuk*)rNxjH@Y!Z|dfR&e@Ntg-tPd`magi_2rr~)U<_ly9&ohankjO)#H@ z9Oi>%8|yujyB%hUV|EAd)eLMbF7^iN;qyDx*fX40>EiWP zFJn3Ncc->4z7&PaQWSE=^7?LTpAHe%g3>8d?T=g>qquMU^9Ac}dMbUc6);|Hy6z?} z>?=zPcV=89c|Fa{!gZL=9VTrV%bwGHb&K!oi`hjT?1#D9=T8d_>x;LmT%D#}I|7!%xjQ6Q|}{ zsqHozk}u~{$1ghdWFHIG%EqLRY*k$wF+zf}o-R}Tm?^;5+7%m^Suf1WD5VpW8NHMg z$pm{anR+R4UTRfCTsgHYs~8LFH`j~eV{Li!YV)n6x9$)5TE}k~S1L3%$&RTB+cT} z96vD-1wi^UsVV>R+vh)%npvRkFP48zYCsf#BY2>JX%pa})Ry>j!sh`**8*w<~+M%eyyAJ2#8lHw)W0^V>IbTi3Ij z*E1W}(;L@Q>sOO&R}-t3U$yr!A8w%@Ze06DN)1#|>l0^`pmiqsO(Q$2B8I)x$?s zLr0ZEhZTc|<%5T10|%u82PORn#eD}weFufT`vtxG`91r2-TS#+dpTWu*ZN)Wi{b<~ZZP)}#O#Nnb z-DXtXMr7?qM9oHc%|=+wMrieVNcDPf)p}6XdSK;RK;@c$#hPFFs&DzKPuZ$>*{WCR zif8GHN6CtN$%HtDQEh zl{TxHI;)X7qnd{09Jkir)ahum89B{#|_f0RIs0UcjH?)e8WM=bzF8@azG2{9W9;0YGv4 zQ@Q}I{~vMb0szIi6DZwt+P}9^_%Bym;kEyk!E3>2DXU---ibnpSnI;bd>)NJ6qOYD zGyrjJ$3CT{u_8}giN>ll{ecy|_Or0vd-`yfKh0^a@jlJzym3F(jnXF*1m3u#9XSHB^~^wNKCM8mB9v;p(Z$9gsOe1n zRq$F%-np()TKhhyt;3zNGC%l5TGv2j-lLGxxTy^=SzL~iBG&!|c+7b5^k_J9!)hY1 zG}Ck@<>Av?0t#Lq1>OU9T!Bd;YoWBYb=`0$2?-%FDxjQ)c@xg9Mym zzVpcdQwO#s80&qk;gA^jYZsL?TXR@kLZ9Wlg%R>CvhEGL4r=RHpBeqW>2mzM6z{C) zx|8@*Ij}*mpt#KUjJxNvRkC0YI9ZdSaQWT3 z^3uJML}k=g5&9kO!pvdh64v?9^DSYaix++LXl|F5U${s3hQth`k@I~hx}s?^u0ZFL zR`YhEy5U=H_DU-hKzq)yqOrAo@>{99j-c1#KdtHtq|Ss{Rp&K5^aocX>=wr(Vq|3! z3Uks8u82Z?>h6^&iKLy0WK&1Fn`4~1!GLu)9wPjB6+F5NS@fN4f3<|c>0=wpE)xAl zY5m@TYIyGl)|L|{)SYpVx=YoCe6+zaSMtwYM9<-QS_I_vKkV3rtKz+ioAl~p=wvRb zTwCu{j(sJ`6q}~v(zuT;zX*OcUOMv0z+%TejJF=_Fnn76iQlKjIlTvZhD(fRWeYLr z=qF{}n5MtD)D=vVTBWjS9#HYg%fqL`@)ZRndh}Na_QEec1loQVQaU2p`isn5BKg2` zQ{8%oq!J%{l0<#47;F zzq+%zQH_53He<9fxRuhM7*Q7&jLKL--hft6S-EJ5Mu_sygAx$aTPQIQu%(`jSMVHjybFz9vNU}RaS2M3#YiJj$7;vB*m-IODiIf-xF^Xm zr6r1^u#V8A*ldL#F)WEPRtnTjYL{WR(H$2h6H*5Rw57Vn> zq+;YD2b!UDw-=tIQoFdg!eNJtkHVwFh1URA@JR4`daTK1^Zu^|`vxgMT zmsw2ep#F|39CjLO)UOR!rq<+NjDJ+sY^T#R&7I`Pi=_jWA9=CG6V3bK>IjlfT zBBR2rVKp?)P$cOm8z*&6V|`R*HC&+~Jhn%5Eu#d#~|?38zrP zP0-uG8Iq=*{bN_qnB_t@8H+>|XIsGuw6R>?-wL9N3#Nbx^zvxz3slL@=6+BIcydxN z3omiMDB;gv_@Vs}PI>^$nPxqu7tVp$s|(&r87BK2@IM z=@H00C~slVo1_S&XT=ulL@l^|G4e(%di;8obzr~Yk(}fY+v^Bo1MzVVbZn^M0ESun zCq|dYbR>;cxG&X#Y+wSpG$voXyuuRuz-i8oOR%-PFcVf*E*a`0nT$Vv}+V#&QrcwzC^U*Gdmr@ z3!}7Dj4W_22&b%jsRVe`SuEmPbd&_ABqDf^8b#E77(3H`b~rs(lHh3LnO#499?=Rp zT6T%ENu7>Q2lSoyG`)MGqnCG81U>w$z=Eu{d|KkJjy`4DlFvF9D;p?S_MDMzPOwfZ z#KF@F$a5dY%GniOq)MnIc<`q^!;{vC^;cqS07&Ju z2|rfQjE)E(j*KPRlTJFY%~>ZUTp~TmM!Z`5A`QZZ6;a6UCIPuWP;q5jJ%||pUg{!( zjEgRu9~FnAcIO6TM=^>eAK1KuJZz%!l~}#XPiF3yzXQHf=?wMeay<0@?go!uj=9)ej2=?Z%h#|n-6YBc##S} zlKniSCc}t6yS`@ZmCjI#!?`pMxZ<2$upzcAU{?Eam>fy{VKzHXY64NUgE=*LWW(t^LDc{$0G`o2b}7Gz}OA$7wufMeX77yY%L?RVBs46t@PwokldG<_33&_5G?atV+b!hHhPW-x?6@L3#4H5bb3 zLtJg`3&13?D|nfEa33m^3N$X53PL1K-g)`(ta69us+x6S4)};Id#gxBUCfCfMi34j%#=?AQVp*&e1_$cTbFtsTMIXJej&2jLc2)Ea zy@Et;d%WDD0qsc|NMAW0A9$WDf=mmhpzamXbV_2wmGm{vL##hxCds{^I=h&G4wDJO zf0`Il2kkvUSqLICT_|yPhbFh~(zwu|sAIyb78Ei;k_1<}fI7veBOy+=BCoh2E0%|J zNprlfjM9-@a{4;D+jNEvi(#@f_JW6Ee>zFcBuUO4`|Tsj;_GVPU91U8<;v~I3^&?4Uu+n_0w#KN2XqMUhk(5||;Vr-*+8=t3Ap6uEU zIJ)2!=2^{6k6dbU?W>hDl9Yopz2XA2o=*)2k@t;GPiSLI)a|jV(NJ)onesPW`7E8t zgEm!7*O>=IEv5&>jEx42V(|*gG(Avt_;()Xov#e?ZJhyzb?UWtY3&+qCfGMOYBEBU zusQ+CAVTx2AU@|bOUCu2hbKh@SH*SPkhVLYRm7B_yuRn2riS_Z#Bo=Id_y3hq+U^N zCOp(nf5Xc9_N~9g4Z=BFW7Xmn%?N(%NzPh%I?F%rQCl-S}W3{tYGI3(|WM z`&y>Gj#LqdTMT-HqP=OFbA_rn&z6<5%dFNdLC}6e(#ZLZ z4i5yOyl9vSKM*L^&vS;I4oVe2Ajt{uk-6gY5D$$d&SLX(n@3Vd# zE6O3CU0FCv?q58a4rp{PyZnaSZ^n^xm0X7)#$#+El2qrwzOiuXVKjbGWJ$hNTTMk! zGR6Y8!mkyuNgNxggqiFYnk*{#j&efzu__Q3pSts&COpq;D<@g`+KnT>DPRqNbNxxy zEDlKqQJ~22$+Aqj>GNz(nEc+ine^9hlTy>W^RFkNB zZ5+6t(MW@oHlPOtvlJ3;pF&zYSm5_GGO0=^g_nauW3JfK$)5AGgXEX3AaN{yfGk#u z3-1SqLTOo*n4fYoFfVVs#nIlG-8Pu|h-vo7gbKNHTBpB*+(R07yf882c;0BIsL|2il^^rX(B6#ZvlrmV zo2i9tzjzJI0qC)iW-j|9C^@ z_qc!7{^L7Hkbi+vyMD18U`1NFZz z&t?4kx_?43?m*pNEdL1<6A2s<@dp%>$Z4VcKTyp7Kr#OV#r*f77$oq&K{07g0%+ox z9rp;V?Zoy3RTI>J43GSRz_cKSG>q(UaCIaw!U(vapa+iv|KSDD<1(RkCgW%kKEe{# z2ptL$ctoB87!+^dvJP|!!^CG;jteh&6Prc{h{w-WVij+jHRT4p9Eii%hsV7Q+2=$= zmDx+HYOtqkARW*=!*62bM9w1|Aq9%N+`Nk%Ntj4zd?0{H%K}(_p`?e1ijx6wKN9%R zLPvqo5d$4S>pTZsOTu-M_7V~3@t6?LguvQWe)X4%QXcjjgB9wh8#ox*i?W5+9t&4G z_`E~`!c(KzPQ`Ph25sF+VM6Ro2Hge7x{;9XB<(!F>EM|Xs_;u!N8Q&+Uk@idpR7yg zGtpP>Il}G`nG#~^Yudl57+9vpCdwl^9qZ+kk%Y^IwQQ8%=xe~RwY=vl4GiqjaY4As z;VgcihcLHtx&Rx{I~h0Brg5#o!*b?3^xHXVcY8bPth^Nj`O!Ci`9|SjdzsIk z1DUkg@0*|(Ah=xHUCPZ}HE?tZe#!CnXAO0W%pzXR%X69I7YF#FpL28N^8+5;UK4)b zwO8bWCIGL3V8z0{d18;dC?xKa7E@>K)v)Br0}ZVn-|PGKY;(;a=f7NNTYgIiRJ1(= zZ{xy$)@*9}01eCgthhw6))VB$xoGo!ZZs8P;Koy016l*?Nk?ud!C|H`YRm7Lg@is1 z+K11~=@QHP^>;k zZm(6+^suty-2Ggf>CN%R3&RQ+ASMfUM31(^&j$}f)#@Vs+djhirKzG2cHE$0gSl8c z!dNjWte)S2Oq9I=grjXUZ6eg-5{nt|mWW3^-e21)3Uxcuq6_9L`>b z8aVLQaZsT3vG*b$VLDbuoteuo5JRxge!j_Tew(_0=omMRm#U_NYEXh}y&H!b$iWX) zTg`HFl4E@Ld!8FjXLDQZY>lB!v{c7=GkYkz@QV>AAxUIVZ(-*8{{C}4lHkMZ=0M16 zvAet9-Wwx}f$4y+%UZYC!;@UnM!liCZ2_HHt563VgnY_-X5dnkZ*ZX^Y@>FZfd zVOR_1Xvz-1-O|nZcRCF`v<63ygT7KX5`-Qd4o{-1fq3pBex_xRRX9^bp8A$Rhqc_>W(Eb7SVw=7vZS`OppnE@@$nN|k!EvQfRBsCHV&)l zTy0%lRjt`XjVNyao#ol;veOZZHOZD4X4GXmSkR5_*;Kw$hGm3it%~{mzwB2%IYTxsACl&dLiTnj;vV6>>0HzD$#K-XUcHIO*gktD z!-rc5BLC8k=;N3CLJ(#E3#^HwpZf{K5=(wrUS*R-{G4@PjP6^nY?Yvlfq|doYr}R? zQh&&Kq{E5z2kkbx7+W1C7B$TYy3nd;#0?o-M+4_lK8wv_YeA_=;6pm|$C880hRG`5)x`E^!xFCt#4#!Iz=GUms}8diwo9tu z@C69X2QF?M)c{(-gBcce12Z=p@jsf7Ig`@XVze&hf%!8R70Pg-HM$3IWs9Cjl`hua$|he$nNRh_dcIWOTPt3uR`#wD z*CjojJ?pr@2J60YW?85e6cUaZ#E+h_$wUNLsq}5JKD`2w4#rVLf27!0E1{Nvf5yeHX*kpytm1GoKshINK7-^LbNW2uCMe zK2b@wLA8Yji&uRUO)11(Nl1a4bT9LJsA#Nlgno^EA&pjEq*_ikMVP!CVhH#5aJaUp zwNz!kYBYLqpV;*mv*4^*O7c1ythDY~<5Pt9GS01I>#W8Dd2?1i-bnS8{3sYv^)=L6 zdfm+^)2HnEk9P?f%O2C_Pb{Xv30j*?V`VY02n` zcmor1EU2{#Cj^&}&hu)w?}1qr$NOcuD<^^{+gd$*c+Q~_jx;u z@mN9)G83G-fCSYp-Y`&SLV2{ZnQnEkM8CIRpM8Ud8*LZF=0I$Xxxt0YdQO71v6l)+PLVB({X2~m`? zU90srm!@36dZIzNlQTS1Xcb->Kj9*u!c9j5T6IEAf=YUvw(7^WT2t7if2ysA$HG#%+d6Cx7<%yzOSU=? z8936K5VuYre1c5BOslUm%yJXFLCqBx<(>SwvJG!MZxATHM?gMa)8z>z0eyYBNJx43 z%(s$6yWSiZw8v8-yI3WY2UcBCVVLE>jTbML#~Y%(GK;2(@=FD7SP?lA!;AKW-=tbG z?_xU_f4lXv@xv3g+UO-@ihk9%ZM_wiv4&7QK3@dnsZNQjR0gS}FQXQp`%zoZbD`iW za=?Z#O!%f&XDto{_Q%J^adJbu1(b6=LzQu#Wu&~mdU9RcoIpRZvUbvI?G0i31yL~e z4?dl*rJPBzPv!SE*p%y@UxE;cxavKFj$RvE!ct4VdSL~2M1eX7;ObSZco*6o|G9jSq_$`Ic-w9X6T3USt;(-vA`Y3~^ z5i){$tdJ)nZVGYzc?<2A(0D=A!3H}gd*y`V)*w%%kWK*Spo$pQpBjA3vN3?4$kHh8_cTXa6Up@%zm{ zje4)k7*D%+NM!gQqWYY89W?4(ndsWbX&D)t$6RteBn&wGWqInygZ&wxJdZ+tSu{O2 z3_Hwgrhffksxv!ostC=>i$tfhcd&hHT{inYA$cGK*RI+h)HexQCJRBKInPjwpGrO-5oggx4Y)Z4E2mDrbCS*F7 z)J=SOFIX5BQ;@7Uan3bST%EG`hF}}qudbv$A#O@YkoF^65|B?;Am_CTv16nMZu&K# z+3f&JJAKYg@tjDQoB$#@Dgj6+$E`!{jnG-Luv1#^*_~6X(i8wEUW)M#0e%FcMg|jV zs{VQa^)1XRM{`uKULT3K{Z(~=gL7+N&X#RF!8qsu?iZVntf(RRc1y_|=`u$=ROr_N zkgv27_|1~ioe&oY5z9CGT}PbD6#iWz#g zpIYik<7YZTSwJGmqv!|hB11jCoYCN~wEt!~Pss&Y}XmVUC3wgf#Q z7%>x@pzTi^3dv>xx(0$tvNoUH0?j~loXDxbIFEQa)%HG9b&&gBEA~f0FytqFf1dnO zl;)~CM->j~JSapVta1sGgey+7O>IJfHfZ7b#!PtiL_<@I?GCcGBcvbTRz*u1Io`E9 z# z_2Ct?<6gEHE<0F9l_){_hB8Ezwpu)sG4rsBbz`_dX&6+2`w0xf?rG>^cHm~ck)&1n zoT*GSGK9+~-FsmOfSM#)s`Sv*%1>Tvse<5aZ-mO9<`n2 zX$Zr|AieQo+ir_SNxUJ*qnh_XPsqqWL{T!!kW+4OpxefOz}|oiRF&pME|`_}w$r$G z50vW3q;pnEC0Zwf+)!flow_IiI1>+^W(N^&yG08xZxs>UsRJN_E~@)WE`P9}72Yo@ zNag6wtI4c1wyFPMGhWs&(aNSO6U*#IK`HhC^nCVztOk9 zvlbcg{&U3e|74$VsJ|eFz!C-j6fp!MiGQ#bbAcOlLqJ^BVaNA=iKQ3OZ_93Ao@ICk z_yG045kqtL-#-7zT66*G{$lxm18Xq?B=Ub)i+`{&|6gD&{(Ibyzw<;uydBZn_M%)n zFB8Lnq#Q73BZc`}Ri*_sf$Om&b|%rAe5@hc-N<_8xNPWaX_1H(d4Vx;jlC9-Z8OB+ zHKeH*(LAz2{Q}{Ak$RZgyPL-#)@g@v7Aa=`RD+T^9~iM5<;^13Uo#4#r1Jj;Gv)8z z{maihrGre+P^v#Vq!)5|{5xPHlaI7zstxPlNxLQroU82D?#iQAKMKWb{u?-ihr)|` zc^uH_7mi`TcvmUT)3-FCbtN^6HqVsV`j__J9*5JNmW(B3&gXPUuhG{;-T38IUb{P! zx@Z0lT~NkXp)ITNjANZl4#-BUKn)>degyYV`9w?fEX&UP=SefFD(mRGTSlj}V;(z; zhx)`P2TDQ4Ib1+i4#LEL5jRL$0nw8x{-u)EC1&6YYT=O%`jnF9+=eLI9fK@6cc3`l z&8Yi)){E$C{)>YX8Acnyv^#UsJ3!YXzecM4{xZ3hjsaAypegk-RCkn?K#Y+&5F^LL zjdQSlH)6bE;8D)zP|GTWkMV)Fv$wBytCdzR#w9@vI&<9MHe)zu z-GOUoR-ni$Pvtuxa*j3Q0CS z74Lw}Mwa1>HIsEj9&Ingm)pouoBE4yI=!2~C+r)@#Sr4jIMgA=YW-`x`a9q}Z?LRs z`EyN0lwoZS644v!`QS9xga8HvV8Sa-APIx7FuCGi4_EKZ@N+lAy@thBTwPU*4spV{=HiXKAh#iAq*>e^EJ~PZ2jXEX z@^PvovgtGImI7&j@L)C!CC6E_)>Kv~Em#3nRw&><>v}x4CLkOHyo8%Mb2u4v+azk zldc(JRcCy)m-$@}Wi9&8P7nQ>QK%XwABVwX-vQRa3FsP6*%Fs~0b7J{?ZG#tvg-;{ zC>SZHZ0D`8MLXBJAK$vZTt8&!K16Ic`#bzlZWD>(Km9cD4tPRQtxoK-XKEOl`ck9p z@OJ$U@OJ(g_e&SuFB{Wsa9Hjv`-F=stIht&`(J!N!S)H4tnL!#Jt0h=Sj*Bj7izh= z2Xxe}7z_*rI=!#v342FfA`{;M5O@NTGw!g;8QXO;b}w7yRSp(7!`d}&ykb*u$41YS z+G172Ple@4?dHe22rnNWKJo_oWgRZD_O-j9*JS9`L^6I<+Be_yS}ZRb+V}2x<{{T& zXB9gg9ho0_7+J!O#9Z1o`Pyib>#3vsCa$odyKJ;M9(HDNa?VITVU_O@nmAbzTzR^8 zx~wZ8N)>}XTTg4Rubbh8&O^B|4)y|i;T6DNLC@GmWqP4GRBncGoWrpE=J>q8-BPRT z`YgUNA5i{+eo^1Ggi&m>e}us%`Qh|vef5R!d{gav106lALXUn~IYq38;QGJDl0PEQ3| zj-ZVlU2$3W4N!+B0P;EvmfjUIz|~wVNVY{p@0;}fn=pk`1S*6%G)&?1?F^1)Gnn18 zF%Zb|h?0^|&_@ogoa;3;Y%9(TG?_rolj7jDqp5XMNYWa~9nS&O^oeq%Xq@x?yfh8E`9q@>O-_d+F{LIyE=@2|NNT+(Il{amh=qxAEHr<_1j1qc ziv%$jI|oIUa07##-M&CVW!7?k?qnaD_IVsQ&li!b4{K@+oj{7>iFLylu=Ovgu-$F7 z^2SdvPO2R>QWRL&4}uMbSvldRTXfyXW%6T-MzNA_)^SzHx)(vXt`*My00EO9`LF&U z$rG+y5!|km0IOUzC9Ti8&a*8OLzUG>sTQV=d+|A_kb5)*cf>MP)X`-%#sK=Fd&46N zz!0P-|B&?_6)v;B77fNdIpGX(_q54O=||1(zuGvr1;79e*Ct(OLe^h*jQSxN-nnhn zU{2p%8IfEz`vtHtA@xMOSdM3lVAJ*^3bMv~7juaE?=C{Pg+_26(U7NAV%;+w2PHqx z_R2y~mdp}xLp_CEx&nX)NL0gAIwLu!8w4+^-fgb+ay{z}N+{azVruNnyt7yvw(F~_ z>2ohTIdK4FbWOlDp#HtI*ieV?s*O(RIRjE1?5fB{OR3^{kqkFSF(7}lsT@zwK)|1& z=~QQ?$qCvL&N-4Sn-VpiGy~D{<{b(V|KEQ?6kuw-c?3{Vm_tz*{RAyqTcRabi|UV# zOcz_ft-R+Pdtbqxp2sY$ty9v}E_1hBZKEwVJ8}%jN#i6d13TCSuNUNz&01{rQf`NZ zETR&OcrtkbPmXt)UK}IfqK_!ezTl?-SDq*^t~8;k(^%QsybEc;{QUjYk2AWj$Elvf zr5(J12KYzt%`KJLoZL3O7M^7{ei9x$^ZiPEGhC8aDBSxq+eh%RJSjyLashDp4RN> zS(x5A-8;_RGvdXpL$DxRT}?G~t7@(Y@CYY~u8gAJme9GN_rWDh4XrTW+*fIKQ$U=U z7hpcqTbkjy4XGp!2YItHach+XDjlssk;W<93pzWe0pkXGRUVxEniIf|kz8x=*c&n& z`ekxyqqSl7zG5I(MV4?^<#hR^K-Zu`(I<(+|1MW3d)~U`#ClCIZ%r5_@~Y zFz)W8SG+pt{H1j_y9SU4l4RBkf+F*SH}LU$@d_MY6_gzW<_(VNv2!L1&)VIs^;*8^ z9bd@hF}k7S>jRvz1OI>pB(C_Nd*L9JO%a$y(Ix<{Ed8=wpfesOXlX}-&3$^AfLIAF zeuKjHh;nI!TzuYl0S`k6K&dS;=yf)mJEE7fF_~QhwtF@dPp=v}+`|$EK@1)T;&*dO zFXXNpVbqh?Q;qgTv6f}FnNco_>FPY3p#wnHjtY^(EAZF)KD;twHuQoqA6jAfr;W8J zzZVwpIOFDtK61TOLt9W-(7D#V|?d@a5=PFrhhn66}2_JPZ6OV6$O5~^4{5P zXbFp&xl{Hz^WnHUaMe*DdDV?HLD6%=e$z4}A@wiXy?wdZU6$Jf@NT?=?9%0i=n4gH zCj=xvkmhT9MA0c^S*T9EJ0H#$0Q^L1WJRN|O0oxxXK}fS|%14hOoF zZ%(Rr?6lxm(IfnG5NlrJ9N)Hg(9V|Q>wJ~CQQlVa3L6&J%q*Fo;O7f2yhE2ZJs_VZte(| z$aXezOIFWLpZi?_l#yx3?8UtUZ=n8e$X$bNr|*YK=#nxtM7T79BVKh3H;DXH zNML2h&$j!KN`o)Bcm-R@g}7w}cTc6|5rr05uZFfa+okvb5~RwdL%hh37Wblaod9OA z(0;E?mVx~_TpMBzajZuK49kSLg{-|$dWb{5rJ0I&QXJ<#_!bY~xzhE7F|@!uBQM4r ze(x?KW+lp#?zju0&a3lq0|=8i+w6beiVkT?P8@I%>!{Zv4frP=p>4oCq{&6Mz@rYI z*u)U}^IopdWx`adL(=bVb{kpE%yCruIP`fd$85OhCCN-gzhSq*)ikp+web&T9Csf3 z=p;d{e59F>zo4fIXNOd}h_KZJWT}^Tp80XL)2+vo%3RNx+@i$8)P9M5Z`sg`?Kc>h zNjH-Rz9Khc#vx%=!lyMZN`gm0dwXSwFS0{L`fi=3e^l?@$?JTh5fpLU<4_>`Zji;| z!*-gE!kb#;D1CC4c~30#wu{sWi+MhO3A;@Od{@B{3zxWaFbR;^7?0U-mL#Zl3989; z$(X>ViBEOE10VA|oSOikI-&0NllN2`@SMQ2l@Y&*pa_k)+dAM6Nxm|GE!;uhJ^6kwF+rvVMSSxteM`SXuTCbj>NAtQJg1n0 z<6p9pvu-!{DQ0k{Ur{ijt3R>%_=xF#qOi z68mlKk!YJMomk8Z%mKOI;kcN*s$2y3(h+MEswxRLEUOUVUpvZmAZ~&6KCM0~Ie4O# zJ-e-=ggYfVNae*b6WV8UmP0GCTBTumlaX=T_APkv8NhcBX(SC+t$8-Wg-k`7+atKS zO3mx#_@5hD%9ghBVBSB0;)e@W<(eu(yK-FtOnELE+Z=*2myo24jq`bc#n5 zuLYS55STHNoO1;0h8G^e4p=iv3#GICRspRV%mfgC_=U28cx!NHyX4Qpiy0FFgNqtf z*FO8^b=Ndb21`>V6rw`sm&_C@!|Wq<7rsTTZxlUFTMt+Zi>LoH-~FG*Y;jmm4TNwN zmsIPs4$cCO-L1{fGz5Q$5t;KvWGM~~#=1~?8+3n7aLnwjNi ztuBB;MN|u6=}nZwEu{$$E3p@e~jZ$xgRwyCbkz(tK2SVw#tx0y} zWu-gEW@N`48_M_AP^JD^&5tXbc?W!mW#eRkK2TFv!dEDB(>Ku*?;v?p#&>qI3Te7G zPRLf3nFv`=lv*%kwiJl#9b`EshV@I+=l9VyTt#w+J*18}R3DVD@tgw#pT*wDATZaw zB<^`(OqwzisYVZTTg1Ut2kUFRKsk}9`caO-yRnD8Zz%>>H}06oNDNPh>|d^2>dIdh z$N&1Fn4UF?em|mx?IfNE3_+OZpr^3mPEXQqJy)Q?mXZ#SjQvE>qiuD`oV@Z#X1a+j&K{m4NhX)+}s;V>h%fX$ptLU zPCcS{NEfg^&6&$YOyo&@+JJPQ61wQg+{$N+IlF+@vJ@7JE+HEh-$BnHPrHQSk0_Pk z!AF#&JQ}!8>FA!)WZ9iz4J;STs{w)BVIn7aCzoUcJ|#RI0+n0MEF|@e%^<_Nk%^J< zUjsJYAyxcQaRf3H0|7p$FRCw2vs_xL^)`03C(iaqR84Fi#h!yPtkS3!nP6(BB%w zb|na2IiGyn-FoLWsO?+4xKP@nRb=7Vr-xVz8t>RhI;tk>o&?74tzdz;r{s~mYf^+< z9oY|ymw*MCb@S8SP|EYZE@pn21flai3yQV?;yP&y04VG{cn-9*Pbxg8Yu@jOYNQ)_ zlfqlGrYj~C5Ymh4Wf952Tl{A@k}$T6BE;leWXU4#*Lm$Xcc-~TMk@0eulB@PHh*`n z1?2nMg5tvZzX+ZFSE1E^9!Gy%I7NbQ|2qOJFH%8_*ry-{|hb@L$>{gGymTJ7sfvU{Qq#_ z|F_{nx!=E^PMDo0f^2P(PJWMgOLP<0BZ|#b^oZ)mL`QX7N5T zrWB7LyqGif7SOv!Ts zosJR=o=#-Q^Y$gaPo<*1)-lEHQHYgahf&-!sSp3xGY-A9=I(l`+= zDhkZx1USkh(lUU)Ny@>zZ+k{_QXM%`?yn5&u=|5V&A8ZM-c=^NEx{|dZv{sBHxD*; z$aM?YGm&KotK4o=O<=E5H@5LB5B!2`L=-`-${+8IW6#!z5OZr-A>1@{{k#W6tdA%L zrHa?6ch7ZNE^8zdA3jUsqduaz!0@W7;e|)JqjQ-KLM-6rULVAzgi7Yd=|`}W6vswp zR2c1_T@|;nnennZyR3yCfx?twl^cDZ4)|;*rLkF;rYd2s5%E&JwxQ|42@-!Eu8teE zDcmF1)pcP%9$PsstiM;zzgmbg_3pxh`)mSz){VWnD^nJtTDc2^G)hRI?Ct zuV7+elFlBIJLwJ_IE6WuM3xxFo4HKy9WAOLD8n$2#`TWGe>sAa6N&TRs3~hc5qxqc zbNqd5Q!5$?et_r*ziF(N>8Gb$wq10RXbw1Yb8!`C@iYv> zswA2AY+vxVT?u)2z5R0(8tZTLMuAwDTt_+ZdDVzNDnF;U2DP_{yaP&>2$A1%gMwbD z=7inZ*z}V@Z99}HD#Q9W=N3yzKR(?%FI*9&n5$hF5L7OZFU+1jPf%3DR7APm{hBqK z|MDeIbypBq+-GShqV-pv8D?3jJ3doJ)(TNHxJxei@Yw=%R9EEY>DLAULjc= zK+$^+nCV&$e=cxpP9DSulyTTCT%B9!8oRg*qMpw>>+M}+72|GR;og6LA+_JNe`_?j z_T2Xo1+Mmp;+`LUdr{x$Ug+7Z+?F9;pnh3CAhsK?Aa!1%^_g(*kygm`PQau zFa2v{&FPBmvcBErQh!*)$0|Ag5?xPp(yif?gemu~L;IPNF!!XQ=;1@%@IehWABmwA zW|Gjn0Ts^d<&oar9#M7WOvB$F3#B|%nKgGd#PAc%smQL2S?jaUIu2msj0Q2c{ zyB5Fd5L~n4_a+nutf~sEWYY(+%B%u2qzT_10LUcYl!QpdjV5W#G=Y!J6{a#4%iq|9 zegRuT-yVk>p zvjBS^es(o&k_~c7!UK`~xdxX)B&iS|Bznw~zkyI(JGe3g@ATXQMsK_T>-m=WB&rFP zeZiP_g}a=9Kb1vh*;P=ykdkB3Z>yz|1rfcSXI1*1oodMMc|wp*~q5co3eOB{o31yt|g?Hwe0I zo=X77BT7CtQjG{~gW>+b$lRyk_@--!<)vA^Wrr>u@(X-kE(eeX#H77@J`lMcM`A{q{R7V>mb`sqGpLSA;LPx)B68D?2)+Y=Qm z-dN&yyb{+y!@}6J!?}u>@`Ks*?Q6%nsNTt*Nqwh*2~+w~@Umx#_!lUyl`q{Z#1b89 zh{*f(2h&X^u2_DL1}>|Cln=sc}%XrOSB6$07o9uV^P-T(|l_$8ZQJEoDmt}PXO1KeeylL z3phTtox-1gkDFcG^rgWr-YQ*cPBQi`MEX^_dY)iib?f4e$I&Sh)w2c*jU^w@Loq^31uD{QXwsDXnKJkIcyX~8^(;-@of|U9@+8=ZV%;;* zk}|}erfJy{<9KVTMB$5>*@4ZpxG;wOD!(FL5ao@?rtr6|W3~QO68M`<*Hj;$;?;*Z ztz6_>)HiF(lj$hU7wEK z>*|q-DxtQnXC$#>u=jRl?D`wSZMq3JU6cM=73+Y;q~o`)P^$!dje2vn{ua_h@j;d` zPq!b+&t)-~pvpRPv#k*918`$a-G&4m<@})q?MyZI@$3l~=5bHQfZ{vePkHle`9Von zgAdvFa$DwMkb%_~jdvbJB<=md&K|PMVv3{QW!KT@cyO?B&LkS(;yBrQrAr5u5#B#%6J$h2q-MS)J= zyYL+v!`v?~oUS1e`Aw&vLR?Fh`ZuxvNHTBoi7a>sj$E-dYkQs5k#|eCcCVjXoa4ku zI>Bmvttj4VzM+W*j?++GQNYVKsRBm?67s*f&3zl@l~rE8 z2~Ej#NY5X?<@tFRe<9S5%#zr`{}e_hl@(BA(L8C_AsQ*>PiiHeLQF{PZ~K8m@8>Od z(Z(9azKKIal?u=$<2R>2WqdhFnb%D8@xCSLy% zV&}B}d3~Md*U9U{#GtvTkKH;o2h%{Al_?{4kIVX|yL`E?TZh&&l)f+ThHHkTGBW*J zY)?jlzn*NwI+;o8vic?m;$Zw@Jis+BXN<9yPax)W{ZLtig7*_E4`eP*d(hd0j5mFZ zAl9Xg{J?i_|I9o<#ymn9m-+J_Y~P`TD4`pFC|O^IC0>XMe!LJ6Z53XmUT;CF~g7Yx&fL^716}ebsz-6ZiLeEIZ|#W5@2JCquVJds@9( zNtDQyMYI7?-LzDbSqJBRMs9VgcvmsBe5Aj&C`Jg@q+Bm(X-W(O#9{GbMJyzpjdR%s zmGyJB=N2s0isZ|ZWzuios2q>gKu-s6wU9v)EMs_*T>8#bP507nfs$@< zq#;c-LwnX4{sLeleXqw8SRxILcpXU{8(r89=WNTCunI44t82kDat|MkvmQ zC`cLznWTa&7KLsih;@uo)$teWp7IahS zlR2zunhwM%I6@{R`+-sqo=T2PN|{@{+_J1!%zmDICkdB)9a|XenET7j(;<0Cs0WHqUGDj}}U@0T=;1F)6y`HlA{AyLy`sqCAS^FMNHRkB{Ch^fT9 zYA)Tds3maXDda#JKC_?*cVAPN?GU|j08eK-H>eB*$PhvnA86lp|#ImVLZXLI_F`s``O zzet2G_K3`gML9oBq{G{W*Fk&Dpdd0ed#`|Ko7_3?s^Zu!#^32rYeE>IEcYCAQQ~9~ zV{1$K8ZBp8+uSQh#&z^|TPdzhh3(RHdh?t@4}GVe5~gQjq@*c*p$@ALZJs;92uEfw z=u~g!szfs^VLTmoFxq|nj#I=lgYUbIA~BSlFwD*IdHW*kj}o!*hIkA;!K|1i7P4Me)_FW>8^lV^PYbu?RgwqcQ$3MZZhSq+Bt2<`uC*LZ3_^vcg;$QNmX3x_2<6~&Q!E9*IKX-F6*nL=HcyYLXh7L;(?iUc3+wpN&B?60U+x zri9j=eCi3u+&y0@(vpJ*t4{s=+1M0|18DyUC~?(^ALkQ|5>+TK1GB3ls$GV=?Y^4v ze=Z4ZJsw?ZDGcIi)l5r#7av+NZ4@3#umgU91di#Vz=Ye*m-%>0al0r~OOoAuxAp5H z_ZXBnQ~h)ekiNBr#Z3*L4MlMI!L8;a3cop{Q}Q&RiGbOj{DfGfOz7&EdkO_L&6 z_-5n2ekM#JBng`=)!IvIk$Fh3xTv`65#^W`DC`n9Qy@#H>+M9#Bs{RyI@_^c za~bU)IvoCh7V28yJh>mFk&rW&dO&2_m)yBBL~GZFL+a+wk~LM>2K(9{>nxjNO)|-G z9^6ob_Ax+y`Czy>??mg&ln0p%L9$0%{-2~n{LfU0c>dyGqkLBjq4qZTC)@QEEXfrn zH9(aM>NA>zu8lfzt06X=r+M`9rH;O1biNu>M+-tl3!>&Vk`0hJ%Z{SifV5lHLI*4W&3qUYW%j6~7i zeE%0u?@8+Bm>C?<(>`8KTvu10wdX`J-p3UmMsjn$@!)WJl?I=J7EWI4XSimYqUG!4 zMk;5Cm9{3!B8%eq6(+ei-LjRxm8&o|TQn>C<|(N`9IYwB@f71eA%LvgbAd=1E&`)H z?I#Ud8N0X8TUvOlL74QCI{xIH_ujK-9|x;LxeXF}t^OFMT~v9#Uut(*i#cl>KqpE7 z%JR;pKRg5rp2F!~vwu($;vzO0qtp8<&j9D&`~3gaJ{#3ZehC-xlkK%8b}gQxo2_K` zRGzC~YCOE(BOTDCtR*-R0Ivk<*)2l4ABe)13K5 z#ZxeFVEa9Luk?D>jpvmWJTf1^zQowQqvZt8^D&Y3KdtW7T<_Aud4g<}S@s;ToH9FFoUZwb326ciaE`xC@kWrQ}8E0u3 z#M~lT6z4o-;}k8~D{RH~+@SZDbaC|7J!NOrRV;kS5$d=xa|zF5p5rcZ5*+c91XT|l z;SF7bar|rat_0!MJfFH~=m-u*I0BOTCPUi~Oq1^>D3}Jy4ln^#vv6_{DP^g&no$6f z@*1HAbCkAbPU_bi*{W~c`_n~o4hWYHH(1iuQ3%<;{3nq0e{%a&WJN|522P}F5Q*p# z!#Dwc&a!ADbW752)HW;sQ~#{D{6HefqmB$b==KhF+)5zar^$t$nYQ0{V_pmmGG?UDf0{+FU_@BDuzj^G*4wauLbm_4 zIxx2J-{3wJ4_as^vh6>d`7ijyejqQ2$M}oMjGibLS(+8)`QOEZA5oA$-#g1vkuCqK zf-pVGzY!@Nbq1zU&%H0ZS-ECl5U8pb=8OnsiB7Llj;`ucDCQg@r-0YM9 zfPOt?inEGi{(?$Cr$rL`_O*eXgZ#4p>D|g&`p!ru&nf$#lamv~2CxGuhnGP{{{Gis zc>9Ataz8iaZ+YuINaMc@JMjnKt;ie%Pkelajt5#q*Vp|^&WipV92^8yoPIMpf35nr zjLTEh{@V^_JMyNM2f_9~+1Zd1xT5V~%>0+^p*mt27gpZ7(5kEaB}3n$w?xO!B_B5i zM{uf&k+S{1U(NpQKQAGs6&TcxKV1ysW-@Z;}}`Go(YDTgSHx%(eYnZvb(Mt83* z-1SLNUuzSi$#>I#|BQc^MQii-A94nLe3pSe@J2!>K}CRtm^?=1 za}bJxB*))TR&AR6NZqt_DdlWo2p+Ig1Y-w(*u(4MpHCPFBWsuGN%8;xnj_MdSjph zP0L0;zdi2b557TGXREgH-vZ5we-!4ZfvnZSQDW$N)kw?|Mokh2X_i}jz5qbM=vpV) zh1OQ?NoS`r-i)4a-Dckj^#`BvY zZ)P+7EK$4S3pC%!%N!GUHS<2GbOzCmW3@->`3I*;fo1$>H|ECpgP!C&dV9O}=Q@&TX-%X27EDDNCV^ zOOCyRX|8(~3$xM2F_a45B=Ke`$FQ-Gvd@ejjpo+G*R}sCel6PaEJK!64E5t@ag-#J z-n_c!{vP@3aZC8;7ZWZht7r zA)IR~!Ql`Yzch0>je5mTTyf%oQ<2yU;>+tXD_in`pDcq1Uxgvsn_jZA(HE3jd==CQ zGEYkz#Zz#`5@g=^{dKRKY;fMo>2sUPc=cg$>s1fJXoDQBFC^(9omTKoV z&Zw>+-e`|_&-drqK{t8ra~K8QymZnMX6GEv<1Yf8~e>W1Q34`JLf|_lN=h>ZLnOJ zsaep7OGrpmH_eLeX#(z-F^pHYW^DTzq-_HhVe20;X=Nl81TNhyIF~_fRH;}=CscNJ zF0o^3wyRBb!<80jr*c9QSYOxQJ&AbYv4q-!gPe&x3C)=S$5?2Bo!-9u_J^wkh?60L zyoJuFjneglk#`#3pHt1&lu93Bt2>5?5Ec+_phQ_|M4J!nOvi7|_ z?47R({QiNb-cfL;(B2?y&z%gK`2JkkH(nXdO@uv`M_;{6&AKGska>^qI7se~z3;{| zx&cb7o-9ooC-iT!ZuCYw+Rvmr+|#ty&N=T&ZPh2Es)FKOCsk6_$e5N}>ylWrBU`1b zY~!IH-XN(q#%yw(NjOyt*UjU4ry{kayu#7(n#=v)`#hAkah|fGk?k?8AZ5?)r!KKP zxjWX{ict5OR8U&=AeHa?%X;U22E~E&K?`!LxpgKo;NhOg8YrB~@S3n-9w$27XIG7sq@8>*oxPqKl|Y)GZZ;X7->&WvBa2%@A3t|8n`(@qyeRZK8M=o#nSW- zNqUsKhw5(c>iiqP>h&b&`vTD;~o#e&%BHyo?%fd+Z1wVHt30 z#q;R&tM+qcQ5(8l%s z1v?=vLq)1j3S&a_qwgF+*BLyFf6cBpJVISHfl=={Ol(A4imuIpc@FqPkD2kDuWob_ zqJTd!H4RZGWfHu&Z3SgwE)(P;r6iv|_9*)f0#nkJ4BaFJ1TC^`Q^s%C}Y-I;0}`6iZs+3H;wEe@7F}uiZ8mIim86F>ZDi_9`T)ZES7?0C z`->>+e@>XeXQ$-u_sLGJ^GBcT8LzN_u7^oDPa30x`WERw@rdmOtUTu={vi&!o^~M+ zG<9O$wVQ%1MB$zLudQK+W`ALIs25WdmQ+#Dg6bi|PDa4DJx$nLPKn*47mlL90Q|ZH z<>5+8l_3h4GKRM3>txmf=13i$BT>;Y&(MA6$ZMJca6??2aP^Km$1Qo5)7el*ewj%% z)aS4x;PHLcLTjxi16z4FCFUEsCf3e;Hn%_wFa;1v3HDon?Q;fk)E7o$Vgh^FbWf?y z?9eba?gKk(-+26*Q(IenCgJWlD}4ejZOIJhS+V}ZW+seq2(FjiOO5Ui4J22ZB_W=3 ztQXaVDaGnSxbo+<9`X5Yc2DR!{KPW3YRPS1NEXrx5i`I3#HRzN)A~Y$v?TA99gcpC>*&|dwWTt3XHC4Niz2{kOY`=M2$pTdcdz4> zga+dZBHpbfzCj!ydL^Y7w78_Y(Yeh=BN1OaT8{0me~GSKYOb~gzC1O}tu6KVa`i>= zZYxtT2fzB2B2F^FbiQ}dON=MUoN|o4Dmah#zs~Q+LLm*VmCwimS3$Ks5+awil@biz z6wzp|I>aPwzz3f%bM8N%z9auJ!l#o?_G*3Yex-Lgn6KZ}?+IbCOB3G{GoZp~bT5*2A- zZI1ZoWd5g{zhOB+%$vK}+@<0G+DBLoS)jwHt4 zy&W|hw4OcLd;Q%WM~gOZ_Yk6W-V;E^geet&-i$la7UYa?p2aX;ko>{q2OoxRJoUF7 zSL3tFGjVQASu`yVPR5^(v@)YtI{n$?MA$;M^V8X0ckLz1pwd*a_n(XuqF-d{#Yw*1 zASK5pM;rP!vAtUpkzli!@CEuwSm2#Wj46pcEHF`?G+#p9jv%m&G6Xrr$=yZ9$*@Id zUJy?c6uhA?h&+ypx>-&|htFCJp2XmlrjVLuKx`oeZ@O;(VB6si?r<2LQ^|B@na=r6 zR=xSN{r<`aNGv;BRsf(_^Lr4q;;Q%zGGJRn&o>CB&lZCPG7uNCoWhq`eXmK~khh+8k*14K| z+p?l;M6YQK2tvGsDOnYBNM(%ag$;6q-(jIXVlQeQm$D{AV<4;7xYz5z2TOm1W`dru zE^{o-+F|uO1zU1%aVnK^`geVWMI7Ve#Z#TBs#Et<)4EUS#|aQ*ayKn^NpDtiL(G8X zdZ0RTiH>*3#Ii*tOyW7)uXxhTJ=gv;yPhWtL%m9jubQ$|ebT5ze9yZQIQ9oW2I+I^ z{?JELn1LKY(sPhCwLX-Tb=c~Des+1>7(x9hNXzasHJxT9XTQk{FC3=a`|FODb1g`Y z-4_LN4PzOeEkI{!em>Zj&qpHlTdK$IcXv3`F%RUO=AtBPByU+RC}J-@NE&o*2Yq*r0kze`b&Q^#U)6!*W5mZ;wuqYb--R^ z;QiSQN1L_1NbbRl%k8gve&jMw;slb{Rf{kzaN79Pi-)iM==LC|EB&*d*z|N*E}6F6 z5ASY_L@a;ahW(ZtRGQgznW2{l8gdv@L`@+GcZonaeYIS!|Mr)?s}nKgp0s!pbZa4R47t0~=8xR~a6iMScUcoQ%MJ90a!4_vyybC()3 zm-45{*8!Z0IJ3`h%JFpl&x}P|%a2Fav=p_1sS)(5QdHZUfh58_ z_2e28zc!b$@TE$41#My}0+24)oM;tAh7W}oAtT{d6Yr?tg!*#5iJgH zS!&eHL37bjjuT(<)#khDsnn4B=8>C-5mJ7hvqsGZm!Oj3e%asOjd9141-jM3v$II! zeH<)HW5YDBKf4j9VHA6-uu zKE-?{v2?04#32`VM!rq112RU|Sg(*H3PDUfgaFo9?_P2B@fl?5`RkcA`$^NahfsKe zYcs`!n7z0_^R?@>k!Bxljv#KmA6XS{xRu^TV`*AF2E;+6#d>HYs2Yj;N_?j_tJPdV zk10DB6FuL^9c>(zpZ2axgnhr&^&a;!d}c`9Zx=|e@|~eSj6j|+>psUM$2bd1u80Ev zlp4vCK({kt%atfZlvRxfA~jetE~v=@+Xn-hr@Tg({9^Z;A>=MC9le1_I_Gx{fkL?dZB67%IBZ7Cw^0v(aPgg z5_D;Iq5{!0Rcg_4B8i%)DJ8H4N7Ln~g`f8GFTRs(4*o3BeB$^^KZfw-3?3)u$nN_y zFzDv#YS*4$^>$T~`mUELqu;IF!@>Ub|}GNpT%Hc$ILTUWQi(ERZLW zlR7hN2$H4?-gC*gVv640;orp_e#?zX$>1vIwiI~Xbo9+( zsY~Zdt4!VW&H3}MpOv#gdnsYkh~_3U~!l%t|#ip6_c)cEtyyFBIaqN1q>XfpVuLJJ()e_r>wcsN7@@N3b5E?9#`0E;Xv+r!Hg9cTwsW zV+?IZ#ARYG5zl+_HoRz8MTS2Gmj(D)Wjz$-310s=5mnJwF>d~z6sTBNS!VcUNB4v| z*``WWofZEr!H@9rlr7#amGH@T8Me4PP^aPKp|oU&aTx5ml4dD29Z~(P;3T!Zf#+yK z=8x@LvGaWrTt7+RWok&%?D=L8IOoy&)@a zetUpxtlZYHZPcr_y$F>&Dst<}iSIy(jVx?3@2y2FGOlkUi*4_BnPp{TmE+$;kGJO; z!|cij)b|L274@XA=cQ@qB~%3to@-RJz9QqQ_CCB7ySOEt#c0D4PE@n~AVPl`)aen= zw;H?_cEsXG87ma92a|5C;h^=jebsl?^ILFjEi4DW1RE9t;rIrWvr=ga`RejF%(UB;I4a{dZU+-jy5P^g1S*^I^WoGL5yF9eHBIuY0HJ zN!g|3n^kKx=tT`(Cye)*j|$QQXGdNNoX4sQC%6jNsi0|8s^8)z#yd#*xMfvG4J@<+ zqKl>|2&v43HO$jS$hd8+AE^yT-~POf5SksWnsUV)N2`1R_Gsq~+bn-t^GD|PCDlvI z3yr|04b%S6g@Wj>^maPRW{GxO(Ol_FApjG`NK-a{nWlUhK)~0nF|X&Pl*;@`%Z4g0 ziI*$GgFuVkQW8ud9h-dHGaSC~@n{r?$Lna~AoKCYxBw5yom0B`5i;7fUX1tAu6@<) zo)%MMJS#y@stzK5X?@hv#lf!}Fq-BaTXY?X5z*Vf4`m&Je0`31dtke$5}c{}MzereEr{Ovo3 z-{@(LPF=V`@Nh_j87TLgjh?nX?BE5*yh#EniC^w$Yw#&?e%LlDI{Nc>+_qkx5o(5z zz0DHy3k5DxeaTGDqoR%mRYyX-7_LpZDD4q_-ZMp!Wh35&_zlN|sx?&XbI!Evvldn%D9ofrr$j_)asZSE|Y?NZRx4J0s z80Z!UjH^sozA7>LLzU7%T00$O@RcNqUA&6sFrJTchdu07KXwS*flUdF9!dbxFV7bG!Xe13%Q z?>~;KMQmIUbKB(`NNQ$wUSuK|BRCUAd`DJ@jR#Vi#5{Gh#h>4Ogs<-y!*|bT%c>e5 zy{v;<)-7P`!4@y>IZo1=W_AA@*37REX^vM*t`bb2G%Ewv%b{QhE+Hw2Dh!1XA&fC`XvZx*v{WjrdEG9Yao}-9uw-THO8;Ala)ndy^h>Paes3^s$ z2kVRB8fwwVFx*gv8p`&AgKXb-l-*M`o*NwENVCb*c#GypgVn1yP+PK$=bzsW-P24? zP0^h-x$%O5bZ7%5CAS?RSf1t@(|*-Md3=^*?$7k}1-?Eo&KK|7!O`KI zWlI-e;)JQ88n<7+o)2Hw&zfE#Qit;f;yBD8&U2#JhQ%snCFG694+}4TVgak-8YJ0C z#%>R~ zvmK@{2=Yk9|fK8BVm6!7;}}dq&uHY?`h6j&pE$ zf^k=;B_3KSYvy)y!I~9pzVHIZ(-tS6A7XH#PT$-bx2{>sFRWj|Rm(c5Xo@q6l?qNy z+ow{8AVnvW;E8^s?}+ND?#2w*GdRg#-}f9(Z$HZXIsGi3-^ISeLtJ^`a(@0T7qYqE z5=-dilo|guuyKTlVC9Xwzj;1$)&iEZHBzaO_?)X(D3>hmX2G)gSoI_*x%ccHYx4IG z@8Rh~IY}krvOde(m-SN76xC>!_o$+eKTD~`2K6be-1EX@${+sIHXc0OB1$~huIS|7 z|I~V}T@2$c=UY1(eBr6Xw7lazSFPsiwR6L&wk;qidV^kW53K|ckIyAcb}%tUayBff zaNBhoX+6A;!JW@AdSp5D_COrkAKJ2O>&@BSA~^?$(y8!;iSQDU#|fE2!wEwtrZ_m6 zGB7d0^MlhIni8JdbA)44DGh}=ee+p_W1gmb^rq{%Xni`7uO;;29bznYn+-Yl60~!HT=$3 zcd&i;33}?CT(W)zhmMZ0*f#j!n^$q+Tua5YTY!JKf&ctk*qm>iwUVGJG*#)WMl4v+ z11<~B$$5ra!{}7Xy}PG)`sf4_SGaNQ0)FlK`P6g@AtA@kt|MIpV+@Ie36A3~=7ouz z-~Y?+^7u%Ei95MzS(88d(9NvXNu0*)8n5t)hjueCbb^~VF5v@LE@5fi;Ib^t_7Nen zMKi3aobUJ3mqi4k*pe5)-nSa`R=Rlq)r;ush`Iaj!*sSz;C z>mgU1tugB0`JpNHjy5?oF6=ru$iw@_8JTJ^G2LQrPZvvT5g)#C370LdvZB}0(Gk&S z3=6xvur14I}E6~SVPjH-AW+MV0& zMcXW&pEEHQVN9VO_kd|KJ_UC?b)2ULQtCbZT(PtR-tl2jA6tn24bKD?1dky6u`NoTl!puw}p$C*=s|M}Y0 ztn1B@R*H!`g5yH&ur`zh9dC4%+AI+PFSHFwynsXz;-^`W)Oi0DbGhxx_tUA+DH*CM zzA!-!`&Q-n7H<-=BxVxB{RhVQ+dJ;(iTx)@Yx5xL;F7sDE}GXxz1G8qC4Fq3-@!$T zdYRW@Fp)=$BX&8Xtp@+;yZiXmGdW{^1J}-L^6%c>!}TlssYVg)();PQMbT-WXOJKH za+X zmd-EET80&80CS@N03ZNKL_t)xc|5)_*Q^K#DNSlTd!ordZavDb!6x&14ZnWPI&N6q ziH$s>RT`0{(|MT1hynrBrKqtqG5r1AFYwHGA6oCE#!=pL#d4NaKpdR#hHpQAgnM>Q zlD8&#_myk7Zb^lj$-NZL*DQEHH04w-4P_6pWSK#Fx!^x24bw0MK!jiriTTSTdtdXb^Nf<@1gh7Q( ziFoKpllz|?Ve;50>*jXz;Tt!zY0+HbS&jgiE#fn1Hc68R6IJ-L2M_Uydq$W@>-^r; zYiYJ}zV_5nE?qH~+uuB&6huk9X1e9T)H#Qgf(xA5+DHDagiZzx|oJjK8J%3h`?Gj6_c5x;cJa^_V4f}dI& zF{dCh;tb67%L#AFl;b{t&z5)`}tjTjU)$hdP%r=K}^r} z7trtt5?2r_EUrU$Bt*HxsN(R!q1-E04LOE8o*Ci)eds7V_BXkxJL3PiZ4+XD?uhkVn0w8B`<1_!bSH@%&NGL(dJ8R_5^Y8zVmY=4Eu%05Mn(i6Pv?sGsJX z{-g2gplAlxLh5T~f=bTr3E}_x_QQPjiE$F~4Z0?9@$w@Nl<-xrZ{Fl!^ zNyArJ+voVrw{K#@;xKEgbY!0;A{bkg1l5yzMT{k~m0&029W(i=mk_Lc;V3fW7kK^> zrdoT9X4J&6ZhkFf6@=c#>0pC_@rn@##*u57X_c$tj;+V}i-!)eb)do8#S8e4?_I^M z7g}N+1K-JOUDWp0(#(Y^7xR_p4zY9ZVKy)5@Z_N>rm}?Jy=gVKUQnlE!}Cfs zMPp76_fi-dmsyS+5+KS#KC)5D5*ac`+Kqnqt69J6Hih4qqtH z&hwW(mlzK?r$nYu>#2fwAdpBXp%NEXW4Xf+)3TNqh9>#kju9R|GKs_)H(j!dixzc~ zFhR?;5GusPuj!J^d0}|E#{YBQGu-ji5LvZ@4I7t}t7mZJ1n=B5kLy>}>9P(_=mQql z#E6oc4pibYV4Y{2y$p+RzsU^5-XjXn?Hb{c7Z1^jg_|#0LVtfBNt}e)JYEY6rGPR2 zBdhD;;w^?ySb=5+tvKS_PweN*_aEWtSkBzuD!*|3DmJWAY}`O}AzP2Zzy1179)9Kk zD;MCc!~q^-V;XtPwj)jc@u3&_{@xRqM0oq=e%`gQ&fHoHCB{ZIvP{4` z67$;iD@B^I{m=;a@5wkm8Piv6*RY6TC-;uRQ#F10s znWGIp_4sl2jv7`i?&J20d-$bGt1PNDnKV6ocemk>zqW%XjydM{_3_bb7W08C=CGh< zXkp1QMB2cJ<$T{qnKf;9t@7^jV`DVOXnVd>F?CrbOfEo?BJI$^xG6O;+m22058pq) zH+PI;V#}}Iu!Ik9S;3kPL(K|lZqVG5#9EZz&mtOzwW@&87HEc#DrCfHnsLX@asIt4b^xBTdKW9zVu+ zc1_ca6W+CDDVHy{R7?&UVG3mv1j`p`J5*S6#v7eeQ^=nU#yFgM#+>E5&mQ8L5ko6Z zdDlgY`N-uxtmsOybaBstnE&$NF18Jyq+aXbh70<5$L6^#?r0$zk=rU>1eXh#V%*QG z#c6ZJwfHQB%ud@I%!RSOXmF0ll!4%liUeEq!hBXi!=9BC*{U;PYOr;Hi5Q%A+_&o} zcfW9qBds~ybio{MTi3(JjtJ45)EkU7R57Saf&8rcF@~_Jg<6;}8!yX{NZ2{lZvUB%r8yJ8vrjBZ`=K7 z#r2@Uzc2Ix2IE^r7@WxY+OxxaaoZ%v8!>NLrTp$&=WyA=I*~O%(Z5t=De@`^E<7GJ zK1{Gvi#HKQJ^P0m{O!H_`06vqafwBe8m);5mY4>&u3N#DB^Bz<1%qi*dHG*da^7%O z1C}#};XL8llT}X8LtmHY?H6=&L1#iNiV=Itk+1kdAY4^1r?@Eop79x09Vb%DSDqf? zlMf%`#lehai|V}p;zew(D$nd4H6#8;mmV=|i0?LW1ce|vR5o4OhZ(`3>?7Ik3p z#6Cw*#D)=pUP09%8qN$86jg^S7F<@8ku>5PdsDu=XM)MjJ|fK+9y-ZFJI>E+ z>f@#rox}>>J0fWjW`mdfC|>KXgx7+zS`r-1Gd}m|aXx$haYiSnc<&{>eC+DQT+mlX z#o|(RnEJBbyhR1=l31pj;)6{*qqN5Yx?-$RlQuks1u_O zRRjK1LLr1{ra=M~9?1xOIgteNDEb!I7ms+;Kr6S2fLCU=6WP>m?|mtLAkE!Gv~ zI}^%*&MJAa9bqz03aS50 zwy#);NHH9oQoi&237#5AsaET3Szh6m)g8=>!nW6Id*lXH!K!Cs+VQ2QkMTDTA7anY z6xBIBOplGx-#ec_eD8WbxUPcu6x5Owkt&ZmUmx~os_5xuekcZ5DzlM)wAImJ6%zLN zM8iEV%z*=c+C?sHD@P+FNnEHV&#xOmS65e;h=>+h!H*ZP)ZtJZ!HCkL*kXKn%fX#{ zYutCNizT&_yl3NLE?-^;nkbcEs;T@yx4N|VuL>eE6h~&-QdYY`P5?rJbTbrkSX+TSWomqy&b|s_ zAocF-59m}49+swpD*{EV3fe>k)Fv43P^S=Af^Y;7LjNbCnAyC(0^X)U{HX1UjVbmj zE$WrrT2OErf}~f7C3tiOzq9izU_l64(WO8D0UdRD8!c^)xHtjj#goOsy_Em{hu>v{ZiWS$;w6b^j zBnQVb4h&8aJI9vQbGYh)xl~`pnOvC*q7i`Dgub`1GA!o~olV5p;2hi@ag%h?l$d>E z8Fy|Q;4klgk;XLq^hK-rjjI=M>EbHZ8d?ToNoRLMoi!fu4F+9>&pb82)5j+9)jmvX znhgu)^M@b0nCrSBc0wzvQ17jv>d9=3nuwT;v+2g6KvM*hXGD1eu@Nd2oUP0>w^xmZ ziOYEt8`;9n%FZa1XR}-k``T^KOoI=Go56aDFyT3JO)$1-u@Q_d{5ek-r=5pc)+-8F zNZ3b-kQs$_3OsUfjQ{(aFLKX|Cs?znm!EypVzw;pBKF`V#)wC8sGJ&K@S_;jm^)t_ z;!BS`$CkB=_~k3-(5pGAcv`u#`@|IAcyXG&qapf4GEJ{E*|KU8KX=s{Zd_BLKWPP# zf(WhRcSR;VQKOzS`H>k7HbEjnZmJy3EO+i4<{!SXl~(R}|8*PrgPT_U;7iiZtW?RI zGTwleR~o>;*fh@`Ji@^E6a!<^>=~Tmo5ApREjxZf{ zBMqqe2EX#QYk1qjIyG}@Ar#b$wvbr}XWKeTM96$XhslByi-~C&LrQ2&u8?upU_@`t zQELeo%t@%^O{@)KC+|b4a5nM6YGq~*OH5E!hU>C0L})dTIEG@fbm+4wW#OZ!n_EsxUjcpBxJE(N#n43Gb%x*;T6Tu zbjq;_&$B}*dyfn(->s2`0g`cz+=m6U6*zbz<-R9(@_XN#V*K!nT)U#ipZ)fG z*xXmeW@#t~ip;v=8k)YtqSz2bXCO$HhwT7cL&OH}eV5N{Ehr|m-N^aZl7G7J;>TPr zOR=BhQRiqH%f7Km9(evJ6AfiaZs7^#v7fzho|J`{z@M1kF9u%@*4yl)ry`kbk&uJ89GhwSKT+ zdQjCiS+Q^~Rw+(g2`=)*Yw1i|SJXD16|5?erg-&Crk-8HO`be_k|z(RJTY8l;Lu)N zl+)i^VZ(~~d~n4=R`%AYWI0hiVSaZN$-sIb&zLwli1AJ4yiA5#GD}3Tk;SV=e1_PF z=Z{YE$vd9nzGsKIc;n^VJb#K0T)vnZ6y;fi5s#=TRE95Ib{8Pkpf|-U*7&ebrW7|q z^Dk7e{{nT0wRnVCjqurr_H%5y6Dt{=GR{YDx|E+=*};mMCx0De3GKWv z5+yP%goxdvhEG2+%4Z)pOtzrXS*N$B1MeJOeb_e=L*~NVzuANgH7U6d9*~G3^@77N zHXV`X!l*H%t(=wf41G}&RD*>b-T8X$z2bnSgz~z@;ZzxzhP$4hX4kPPs(Hp0D|&g) zo0bsckf=%|F-{#Gi$TK+e}>;tnK9Nb;16 z`o{S6YZr0NicS)Rh!|CiiqfHzm>jS%Vv-;kwQ;e3rKeUaGoK-wQRbx_YYCr!^dO&k z;y5R$(^qNoTW?*$Z(g;6T4RDnt&T~df}#mb<({pFrnqCzD4)3JFcZELe1&U{ zw453qano2^K}_fw%Q2)fvrZ;brIH2f9;co$VzwTg;?wuP$oF0tWUyiIl`4y>!sdlN z{M6=UT(hEwweu@<*lA2QjWH0}wyZJ1YYYn()0`fsS_Z7y({2_o@|`e_#fHuY^<+fE zF2@KQX+?beE6?%hks9;n_VByc^>EwzMbsi6W&;=Rg{qkeR4;cct@sQz5iJkigyvo` zL1Adywkl_$XoSxc5>Z5yR1J?GI>}#ucNhD|E2Oz&@w}K1T(Xj1ytJQXm1!zTPNGG6 z@*2i0!9w1^M#70q_{LKQ`OHHH**ft5v-jRXc3t`QN(>^ANDw3e zA`n2M0dxR5hnMcX=lu4Ma~q@r0oq*Iv^3`r7OIQg@4fr(J-^@i{=Ok$Ce87_tqr{C zn%A(tuSkCZB1u7M9G>lK$+CDbH)>DF23$BpBn3hTC9Is!BUVS7*gt@dE#u9Pyg^Z6-vB$dozFVwvF^Ep_W1} zYQRVpWmBwa^e=W9&Ojm1Z0XChsI8Z_c1`2a3C`m5Gy-eMidt=BJ-wQhHH~ix@XfQ)7{t@fZ?IgII1{y@Zv`3KiEN@cB_9 zf^!OtBFK8i0E@;UGDnhxoOMO+ADH7S`$jo9P^MZBxn}(;R=3TweMJ{58uM)EEYY4f zL?I+nLJEyIpn~{-MG<1_$c369Dv@IUr)>FUE^*dx`Xb(P$!Kbc_aq8TK%P1(fXO(= zcLx%VoSmX46yCO>gPp6JDdaW53;c_Ik^pr1H(>nX+~ZMbA-ku%v;Jk<5%E%symEw+ zkR}N;CgMwvo#Fc@V(Pk)0^_`9O&{;u*3XJY1uCMh6p?c%lg(rPm6mA5tPObNnGwG7 z#5wj1#f(hMv$`eZ-@R!auUi(;RSGf2;;aRoC5}5w7^*A+=AZC-FSK7%fQ!)1ktlfh z)GS{)aE?P~CK#HDNmGY41%m1nU2Uh>wsItwK}yrF};xApVw zW3znd&=C{?*DmkiH?I!Zwe<>gASmYu)q-{^$d2mz$2*{(_-^ZHa>^o3lc<2mIU=cX zaysDepBUxSkDq09ra)_RJO9fq{k(T$3(Ywp)-Y>hx@?{KNHJa2{Mpy`@Tp^Ers+i4 zh$U?yw{PyG&y=`fc{`gHHBkyv0+aewSf|O65>sT*75K{^o?NZ+3AHhTyh@6L2v{Govph25@Tbn>rCge~}@#(!6_}oJ$sS>fOy`5{j z6W(>xGOlQ@(AAV95J#jPalMX}Jb^K&RFOoIg=2z25gFsX9-a02Ab$B+O8>vEEM3_t zPn19_bl@3au|Pqk)G2V!(=+_v_YE*x5#D`cC%<#sIu^O%W5|P=3IFnGIQVfN?2`6tOWCU1ay*98U~Ynb(aJndXffI(gsbKCWmHlyM*t zAsY9y%=-U@*Z#pW_Z}VRdxyq3JZcFGIo`5sIUm^G!Ilm~F;EwY4o+)CsqEY-gwA5M zVz!!6O)QOth(;4&QUPU21C3~}pG=*`S;!edON>(ni=plm=O-#WHD2a3`-get)C{&( zr?r%)Ou*b+N_Sg{-i~HMZ6HlOGds|TkLvyC1pAZ z`J3+?=W_>V2y&WR*U$3K^#R25s6re;({#7=$8U$V2sz1Rg;u_6oA$Y%tUXbeEPrz{_=DJx|7AlJXbc=*|njKUt7~k6bj8v zIr0%C&U?fOn%Eigsb>EqeDq6Cb8yGgTS3{BW zo26DHN<*Z*(+FP6Y^-O1#<8G7d>XKVG=(613HDh(^NW1}v+S4cY5R$#6eP}pF=D*+LRlC2;fXRI|G{xi4o|S6r&$`Yc1p~&F{c~xf(s zqMSmx2&EPC)hY)D%Y5n3B=?@4U~FcZ)tzl@>FK4h81RF0^URo8?%cA3+qd@9*BoM$ z1B~|~)ymKDf63M*Awg?}z$kB-gvywG!UFCdD94P8`1)X(*;z|#_Z+|frdtU^jRY+( z^H%iCHdU!01;wBIV3=peYJ`owyzkm(Zdq)wMhF0B1=0RDBpVz%QCW7-i~Mz^h-`&A zO*G^~j5wZ~sPWhPC-~}t1rUKBdYQ>Mh@L-3zIeIHMr znx}W^GWxpfylYK6Z{4(*#*(HnEkl&|^94~D2~dghSK284^Vg5?#ivF&m6m9bSzf!M z!0){4CjRVm5AyIpj80*FPmYhieiPR$%~P;3Nup845M~dh1)n&JLxlmUhA~k*a%_UX zc;q~%<{}CvW?f&7+tzgRhBbM5@?O$ubq=KjC1BD7r4>p$5)4VCDcCY7MHFg3-w?0C z3L{61@_vxcGpiKhy%u#wpGSj>y&aXanK3|sWSSCxRO8Y^{a=Em76j^&VpNPu>$t>0 zu8AY_5&!VaBqQ}at)&X@x_%iw4SB@mvC3rv{GTpXFLgyaA$7vMGfX9UPMl9UJ~YbN z^V4+qF5=A_+F9E4;=eC8K`BeBBaY3a{J#&L;E{nEO}UV_ZEoWo*L1PGF~m5*x`04A zoJz395fHr~KIEUbyco>Ntvq!VI(U4b;oL1DdBf%17?jIGac<{so|KnTF@aV9n(%8Zk zZOy!Y%OYNVWgicnnCAY&6Rc~Exb=z_*0x6!Z55OtChsZk|8g?SSJZmZ6P8knzzEh_ zj4>IzPY4V+>)p*$LjIrcJ;UKCA#8B`-EZ8;Qll`{8gao}tNc@L$psw~+3$t*D$>}+ z<7X!L9vo$= zDwsl!ySHuR-PiTAp*JE@2|91lO7nxG)BMqQ&$0jX7_kj#>}=(?ZduI-Ha5^%OtIP$ z)fLrT-n&Gg!zbtX!l^Q+(~w|hls8?yk~^+j!Gi~8*f;E$&b70$slr`5 zmaw%iq(Bv`bEIf;#-LpSIsoMmQc!|bh8Z;9e`cIN|MK@ZQt6aVf^wgKR;49d;+s_2}%i)Yvk}~g^zvvN$xv3gG7e+-n^1u zyS|SljR7`Iv09VU3iC2{u6kPL%y^lDW11%>0`?xCLy;hw!{^ULQZ=jyb|qm?^KpBEtifDdTC4l)ISvvX74K%jS`2k zDOMC`=Y>ayCivW*K^{9f#j4I6@3^|3o7XO4b58?pMhFmGph&brNgbOyQu1h{3DX(| z;Y>B)Gy6vP#Qsr6Yavm-naTMI_db1^=PC)i`-;4KWg|B%Zp3OxF$7wBJze5>bU5MD zhig1qZ9+9WcJvwEcx4;cEebd}Jjk~mAHr5*ZoGO4Tf0j%=@cavl=e+{=AEs6Nrl4; z|Nf~HmJ*9n+Rv&4Z_1h`q}CEd1qLgc@1LHdTC*(gO4(7&(WopcC{kZ=cYGNaGz?&* zBK(JY$CxR{Eb40Ezr0~7>w6l&Xp~C<@hWlADB}ml;+(fHxy);)I*&@KOx6{D^Vk_a zcVL{ERMDVntnO;#J=d({s_qC|FGDV(W{RAxXg~7B*hHl#hLLH>c+eTAH|`Ddg90 z+QM6}ZlOJA(TU)+5C#IyYcdiPhS(P%D-6UDfAFo-+_(1>6S)l-Im+Fy+QtXB_p>CI z5{S#9O#=KjX}tlx4m>{ZK)Zy%cwx28Yc!fdB1Fcabc_m8BvF*o2m(PCqV55dL7^^2 znu{`6fh6@s&1g>v)*8gRU&;sW$CkcmZ3-xq7*d_%Op@cvhlY4~po(${x30|b=Jky% zZG@b}%-6lHN#&x8oBj)pm*K@vTatO>C05vTzQEt_zQBFYj4(292oYAb8eY4um)EY$ z(UFf4t1o`9*cg-}(S}$B1Vq$o2|pT~B5xpSPz)M=P z>B7ri;<8h^_VBV3n;A-ja?Yn2Scg`QvBdE8LlgY%?qQyrs#D12xP4tOzp-N}9nBGW zllb|N(rBg0Wj>%b@Nxl_I#SV$Rvh0vGR-|lYE0KOH($}p=H3z`BNupdc$y=p&ogpX zbNW~#cU`@V*KTT|s{|2_c_-ZS)Or5mfs-7XvvhRixOr)T_guY*8<%(R#K~bkzV9@% zrpWtVy^K58x6@S&FfK-Eg~gCcR`fF|%`e;Ya~YPPptbh!53rCR=yb@m)qL^EF-9h; z=%B(!Z@Si({WKybB{C^W=Xp7IW?drw{98|O@I(!#4R@`ISks~iq(X&8atJ!pn=J5n z9S#wjeVE{quRoVshGyz~>-Yp;KQYIYmbLzzm(G9E+PH z8kGPME{MSCED={SF}S)o1Xh{znoAv88}i}vo$$hJQJMeAFkKLu59G`-verfb9r~FUmV%q- zz&oyA&MoWvDFrTzEBHBHzZcAK9TrguD$^f|c$tSYA#vTX_w+pX9-3irQdrs9#2eQ& z^0xIIEG6PN!67O(<*i%#c=y$9Y+BsL zg~>J!o-gyj$!Q)sHqGPb6;FTX1mAc(;Ul~H*tw>Qf7pA5KYn!zq8X;rxNVZw(>`Nxi%Iwc#BSIxkI6OGPfBpV5e19lqCf5!KO9I1N zu3EF` zsm16DN+KjEanI8ueEdhlJUeg>n~V79t}VRlx;|F51vE*5atdcO5-e!7yc_)U^EDwz zYbfQY>pXi-&hV*+&+)@!qa^il{*QO<hjaVsO(IYre4bvM3Bico;)|tHxEv5YEoEVxWKzs zFXF16WWOLQb3Npu25wr}!0lJG z(G$w^My@~4rG3G&&LWa{XgZ_igC=k=R;%;9=VtiZ-6K3bIL($Nt-SZzUS7YdnXU#+ zth65~V^G5%r6gn0J|irC#u?Igk`5 zA(JUQd~BREqqDRYHNUd5i|#z=)KU(FyckT_^sd$Nks28AXRhbBd7M^)uG zJQMPT!)3m6D&a!hOjlz_Vj?dt#rxYCmwKwNHd$Zdy%z;o*g5KeMUlf02A=+mB#@=% z%FDVtUinKzkTe7Rf{axu8EHv;=9xd0CR7mio|)y7yU+5>&;*Oya=i1#ExhiUKALkG z3p6uhU8sGRyL$e4NKqujCg6c%6a4YFjNCQIJc(Zo1H zQp7ui<3|EUdoxzCHD-b$-x+p%<8;KlZYR(YSM>zEaeXVRTJ*(Jw=bzb&m)$9zIArO zS3qio#0e@0m`-B8{p=ur^6lq1F`Z|1Tf}>}w(+Z1w^DG<8%=8u#TuK>IUw`*eZ* zUpU3c^fY->=Y~~neB{;ZxVo>A<1+~l96!$&pEyfrgW>I4`dQPN_r8MSP}XKNc29JR zl)<1uMWh0W2t_PTpl$-6njtaHfds#J1?w`9pr_4xOxU80rjBCZe2v4y^HfA}?UH_$ zw-;zu0jW;OsT5I`n2=EPrF9^9tXXGJ7h=KHh;@#yAD&|GxfB-!T+=5k(~d&oNJ;&s zDEaI!SacR~@;qI`Q$Ljkwi#Cg7TY=(zUmN_*Mv$ECj8@sOL&h=d^YKSm$>5A;|uv@G(N6*di#mCRF zeO77;NY}>8ztt;v-hHOZ+TBJCx2- zRUrp1lo^}~u?DoU>{`*q+U^FFt1nEH5EX%FLb5Z{ zR!YPuTlbrb(Jze|bBXmz*ZGV14OMCF=Pa3<%0ljp)rM3ofsHvbGRMas9N^x=b9A>g z@LRVm=UrQSXfX<0ib#se7`y&Ne0iq`Ck`hTrwu2j6<<4AVgHz*@{O$PDe}(k-Mss% zW?D<0cw<$7s1SuEatUMwE3_8t6iJxl&}fCfdGKkzajeW(HAgxa2A*8;6(YN6(}K8DQ!_q zYeSy0>wqNXd{Sk6ZiG@=h!*X z8BA|=inWeVhlENphj$R2q9ma}h;uOk3X^4NISFtgezyHH^sfJw*CkI_qD}VH2{=ot z3>8uAK0d|L{6bl*rt~m4dQ@Ll@?m zn4e=wTLagvUru*tGdd6=LYz|Bqc1q;5T!G=6*%!?VWky;OVD^bl_cNFkPZ0T`%dr= zKRV5HVtD)Z<@9%S@STHW)F#KcsjtLMiyBFjm~WoEz^C>Pv*(;;rUEOw+qnCNKHj{c ziADL;_l+vzQXQmZDV5HJ>>nE9@v$;hQEcsLXG?z@O$AuLw1wYpzKZsiJpBbBN(ChK zxmcM)2hMvTYRNvc4oC&&CFH?V=lRUO0S0D$PFK#>DNrL9r4VGnk7R|<`AtOO3m|~A zDX5e*Fg$so%I6PU;K7qK%&H=bdNl9d*2Uf1`soj|0XG(0iZuaF2mXDLpvB@;K#XBv zs?K*FJH|cxM;ME9Or?gtt~OSe0`h_Q%|$6s$(O8n0*Uf9ED-UpqsTUQe_B`=R$3=m z1xD*vbR>`{@lAxv(y75WSK!eHf5TFfh(n`}-KQ-&Y~q^UJhv}xqthm6G2R1H`C{dR z{?zjUjhFcRf%4zZh1oLyxOa$q9v#L?13Oma`QXlO?%3Eto1}Uk`;D z$w)pZlxWHc{OIryfAx*MJTu?Lj^(|4=vAxOxx9()f-j@a2u39su|N)G1+6Sj3sn_@ zO4xsLlDB_tf@HkLja~4OS1;lXoBIe|igm_&e7+z7L0SK7o}Q}m$?qLv@O%Y_Mi<)& z>Sg-+y7~QgUd74=2T8)g;R@e7aF*4r!iQh8j%$|YkktD|DrY?+Vl-MbRup1YW-I3q zNihm4i7;Q&v^0icdryooT`jX|LmOB3 zH_{jxRA!{99H2DD1ed*8^$R*MKj0M{5y#J`>>I2xJ~qOZ_5ED4sDZYk!nqXf6k2Oi zpJL{*ay-Lr0f12A5Ep|>Kr}TK@U^GM`Rj*Ac>MG4Vm2;m#wkr}sX%9zf~;Z>mk|}SC(u6(3kMM=kf@M3(F{%}JalxFuReX6 zr^ai{YfY1_va7$9_5H2XjD@5|PI81{fL1zlgkC6m%0os<5Ye2TjQQqMBRq6+o;lTo zF$vq3wDR_CE9h^kA=V z8MK$Cn%!qBeEGl>)3uOm7U%f29eu3ohV$+H_1Nf0$Oq@Kv8Glr6Z)OG+4A1o zw($1tU94+e_#Oi9H!2Q?!6F38qE*Uhy}*|bTkb!VGA{~UOmTB_C}&xhJI{&+As1T? zj$6L<%rGehZr|3&&czW8X&p}&vtGj()sZgt9dhnwhHR{=<_zbFR#q#XaoUu#)alk(}~IklC>S zE1JuoWq`lo7V>la=w35x6^|Yr;_&HdItvjymlwFQqd-7{(+*`7Dpg3RaVP?%(8}w9 z5Km!6IYc|pW|WWvlbU;;t+D^)Bt0d?d$#v*=ZXf(GZn^X9Cc?{+TKo>Yv6~+$NAjj zLp(mDsg)I1brpHb)k}H(l?|*eSquSXXQ%@W!KFW;IGC)$y+CycknE`pPOc|8d3?0pk~>+tdIZg zwhe4t8emmQOBkTD+je0?&>6K{E)D=3F>rFK!sCN8T(F8Dtg)%t@b;B0Y;3V839-76 zMRxmTz%vg;sJW2wYRa>tlYIA?IqrQfVPHN0quAVGc~%4$g{Yu==Dh%3?>A)jCp2QxGt~k4pM%iDRUxz9to7wls%^|@K--P z#gB#+{hfI}{DzfW->Xr&Mui+j>pa22V~gI7=_T$%N-2yA2#lhk)JhnQA?F9kS2dCA z#SwU?6Y=_Pl{Ga=1dS!Oj;BXz+;d=sfh)NGl%Zd%LIWsUsp*J4ta=c+aBtnAOB zL@*6GQW1<;v}nX+l9=Z&1`E|!v2beiCozzVA;Ug&Bb(t~0@CtH^$w>XvM`^@g=c+WJR^S|gEdvRu7;MnWgiH8uUwxFn zdMYNa)!1{miO>Ars|oQob;0x1{}*aq@`UBG8_bsm$Ibhf zjCEOY%JSXGZoT|4K)=oJP+S^e2C9Ke2l^II=8Lv;6L24mg|=_5-50bu1=+rkd*5*F7D>| zl;Y5-GweAtjgdS%`wRT)4gK75We5FvOQgVBL$DBAav6+RTR3%Yiu;aVU~o>@+26vO zH!fjSJARgl2A~BCP17QYWq381!bwFmZyele16{uj~<_7wi=@XFuFj& z=2+4e(c7yjsWOsUROpR{6)%))`1wiZcj{*%4z!Cv6>xElMICwGyK_0WZFIe3lqA9O zK0G`2jxt&M**M2{?Hx(a)1Jt8*Sz|Jt<@%3%GFJ$WPizm zsori@+EIi;V@fd(i&4TxBye!C4bKcfp1-ZTj60s6PC-c^x#I~T=Ya4rAtdJ=>flR$ z8diYS#fj!Kk%0>nV4bmp8rvjalOHyNN2J;3g?On(!t5^oWBE4 z6xHKt=FvQmaYCY&wD{SwB+;H50<<%T7D?Zi?`Y;U>hBqaZH^hgqFwJEFup%S)nucR zO=GaG*Jj7tomg+h_^=G!iiTJ`CqLfL*T_Tq&3;CsqK24c*pq{(`HbEZ$A(8%d|Oje zW#~Se1S(X8etQf{E;VshfEEaZjD9ha z=8=Y}3i$&YqVCy&7Wu{-zHIsI11y=z%X!<{(@#y9S}H>4O(R5i{dRN~%Wscs6BNpn zC=-tW-tq@5OY|pKd@5**6!j_plMLiW0znf>d1Yz`QM;iRsISCZl8+ zQ2ZV#>ay6xrPD*L!o6h$QN}^Vu68zI8CJR?ioTCLkp;e^B|A|ap|yFCBffWlIE&%E ze#jN@sr6xs$jV+0AKcH`6*nubDNyMAyuuWaTB(URKbGmNi^#4!T5C)PLR$|ahA9Xp zWd{=%Z1ud7hWz%@P-!}hgt%k`Bq=!(?AVj>_e$D*R@rwBToQw$C+{Ya9kXz7{}%n} zEdeIoju4MbQW&{hU$*%~on*!cE>~vI3xM_*Gdl~Av~V@*nEEsxyKuEit0!W(XU$DZ za5b7kN*HoIU%X_7h?SFeLSy*CGVSC)@;syk1I??m;(bpAE)G03n@}vCy8Seu(5p>v zZ*scNHE%y*rTBeQG?9pTHi%{uGrt1;L!Ut@F0Wt94tYCzlD8RA7*$3w zn=a?NU9NKf23Luq3{2Zo$Z3z|b$jTO_6MUlH5wUwNNlvxVFru%fyM97J^z43S&AGX z>3NdDKGg6KDZ7h)L_dfD?4)Uk*@HtuN~)}cW@Ja2p}jM5v*s!|f$A~jy=w-13bLLF z?a@OkBZz^$hyJu_l=S3|A9xycWe%L-Voxs&RAVQR_$%;riz^Pt@oxzn2Os3XKYo?V zP|(RqXdmUYYCaC54h(*XVri658C5r}WJRgvOD&dKFnDdX(TOOX=_U`A5?7AKXk8Ohn?SD$6urHZb$;>nolNzXGEG2>=A~nHud*O$Mnhb#Y0mLU`?z}^~2E78?v?UNz3 z+E^ESp2UnqNyk0uVvJihiYqMwzMxaqL3LT$Je6l7olG;WRYC-JX`!RD7rCq@aKdbg zqE9jya(lI_if0@-yoOkVF;uY!0aEW_yA73#pwTurDAD9 z!Uz>Nz>cin0HVP6KF`~YLbiiK(RU*~QT%iAu9e3aGovEbKCDn`jX}Q0gr^XDd2~4G zv6G;>wJtKNBq|J9b0uONmXGdHI}*u`)>m~l*S;YLPI`(W3#Y{Pdp96z34BVaocnIU z7Ct-uP>^TmBG7aI1IzBmrE7m?dBBxOrZ5eThxs*qa4_lV^+Ly0nRXIO5xGWxNFgP` zPh8C1Yv=6UP`%-qh<+s9#ypm>T76qz8L712e{2sjY<3=)#e$4phRq_)n=6Y81rS3) z(sLXj#}E$g>E2egp`?Bw!O)_Zspk(Mh3$U??2kwPyr1zgSUyAB>a=J0#VH7^PdpJz z`5Q2C1E(_(B_ltJ&5M|6F5vg}*Lx65^&|>YHpV%>4_h@$Ee@u_&P0EL{{tA(VNas{ znHugbw)aR)k0>h(X$nfv!8a?j_BkF&8pb=TMd}_5Ggu0-7G5-|S9HJ7smZrI2Z25M zQB-R?%v8ssE^OQaTg!fF_$~WX6H0*Bz+wI7!U(nrJ9Gf zLwO7lOE`cf*h8`6VwZ;#l!cw;YMr59&eTU|q`4Hw+xdSdKmwl|VGvj!lU`2Fm+UZm0`jb!E-WDa2T{8o?WuX@H{G>^@=1v?XmB>H3`d?VBH(Tu~uw5fO%Kc^Sh_)vLZ z$Kur5zSC5!pFC{i-z$7_mUezJGEwJM7lp0Onb$aJ#HBEBtv<`ur^i#1o78kz4bbBD zuKFmkXbI)M6kR9o%aE>=syH@=Iz-i5b)nOIZhoEpP~D$}#x`*ZDh!JEXqM2RgTSuw zH6EtFR36!Co2U*l%Zb!~g+~++KxC)yubfb;JUQBIuHgbJ=96+{rKcRPmQrTBSOi>S zX9Vc84UPbslhiP9q1hT@IWDDHTLQIDnDxu*$i5YL8?aMEh$syLm#;tV7kWI5w2?Q- zKqwJjXC0zjH=W5|nb0x*_1Q$AYnQD>+~#yv?kL4phZn%MhE85wfevX>Oi4b~xBO#X z=uEpN!LI}y=M{6SsVsEO()@KE0^(&1dHD72t9WH?&fhWWwv|#gU@(*9s-rCYT&1bT z(3HyjEj?60M0PU9tVXZL*Zz1$&!>EWVhNPYk1-W_3OJYWJl?CLSJ6jI{DbTs&gyq* z&K=kcfgYrxAp9x#iQVk$dm0#!#(J8s?)1k$rVb&xAP8Ej}_-ktvFbKioF@5$?EL zy{+n8RBP`o=IfGS0=}mlcqDbLo#Hb6WIs804DvVJ?fmd?vyCWOOEUahIjpod`?EVOIaHcJ3lzwd!Lvb5jteQ3)pFc1 z!$llGC37vqB+5$Y!xo?sVxC<_%aw`Q%<-G$!!^l4NFyANq*8Bj5@GVK zjI*zg@qtMTT`ctNmNJA7g&Z7-q4ZBmFzXCkK`BIE8G=@jLINevhl-%j=ETLLx=$pV zw%eYCft@O7CAnQeu zrQs3!9GzDM?3a;Gr1UZN1Rs^jH8~neAxe4-=}1(@E2bd?k_i`<$V2cM3AfQv8r}Fw z(|{f*xHXeO+M*=TDVz6;ofq|X`DY};auH@VoBdzF#Ic^j-qy$Lv{*>)K1f-F*Wuks z{TB!tdO#l9ZwB#^vL#@xNH8Z_N8-i=OP(MgXNJ8WVyq?JhRs2e6mv5>z(Tf7VV2OY zC#@2^o`A?9b`ua*YU7qvzfKasmNWzG!+ygMdRe`9Fs$)ew?ZNz5%P>fSf3TwH%Ifm zd?CZaMlo?~l39(~9s-=xSg34xh)`*~r=6IGaW5nrc@r;^?>9P=iZig{!@^7?_DAr8 zkT=HA#!Dap%!3xdP(%gJI=-xSdr079h$ZD^!Op3DSr4cWGKn6_o}_5YKQSGqR|zPY z()RYyuC`i}f@=Kc3M&K_S0Z9f5`qcOp{J&L$l#Y;Eo`!WPustz(Xu`!kOywrP2}0o z5-jXV$SLHD!^evz4Bo8FU}t;SW!xVoP_;ATtu#hlhTCy}Y=9lbQI4PrF8#|Z?_+Yyx5lV+S)DCpv1z& z+|qb`ZO|lDELdg-pDw9mE(H9Tndvd+cnHqh)g}bu>8An(Rh7o-6oj?*L}fWNvwAj9 zJf+PPQx11PClC}hx7-hQv5-D;e{o389&kj4Zx3^cLX^tD5Ef4yZubvr7Sq2KqzPEm zYfBU<*y@XbP2mf`T@ByNIxF63{fZRI%!L{HmtnkCr{b@XD%E<9LSr5>3|yQ7t`F2S zg+^AIvja(8+^rFQMHR)b5QGb340=Lej36o^TBr;KC`uDFTCPc(jakU|_Bn)U7Rd5a z{8N}|(wS86cLA~;4*b-6*!TMU3Spf3t_-9qnMVU0ldtMNl|#fYKgp zRvROW;cRs!EDzcsZ?DzDvG*K?;7v49D+~30l5t<&mzioYn#-=+-rF3{TU+i=aPP4E z`UK*>IpQ|)jR3cmqmTuhnxchQbMXtIH6T071DM-t)HcbTz@JICE z0wirh?>Ums8^*^3Mu0efXvWiBk=spK9Dd^qF zLlzf~G11{1?EJc>XXfs`Y(Y+H+TDOx> zh)E_MQ;ZL$lrbZCI}qynwL>QMav00m9Fg#PiWh#Y;MW=5X}9wg97n$ z`fhC%tI{dl`}MN@b?yLRaHKqyeVyMba2PeV(lQsGN{AOEEIiHftpHU)ddsoa z5Ls;g+>xtN;1spE8o~z^{DE9C?z0hCnMgTf%#8R|8h1AsFL=wMYqQPk$`~*y0W-!GV0Q$q= zrust2u&8ZRQ$BiBg<(}d#PBh#&>-+&Qs|(NJv0#3qw8zj11>IzQB$ccW_eD{tIPo` z%`#!aJxEpjS=0&_0w3!O+}%*N>HE*Z0Pox3X+j;GgI&*c49pXv>PG92rl`TffGA~? z%$YjDO%ZJF*}cI0`V2L{dl{j5N~|~RYwU7cBPRq7Oa_-d6vag}oi**lESXP>>L3ej zikRtlN!`P_b2`fh3zDSlPP>TaZI0efcjp@oot43(Sw>2$!Z>Rz0}mGal7N-o-Bx(- zw+rTNcc-*Cje~Otr@KrLjTNR0B08B0W{=tMN7Opb2m2HH9qAtPdpLkyzxDmXY|5tr zNtgS!XqVkOMt-coI(IwU(F#{b4;NWr>mXXZ!TyIopuU?TMiS-w&X6+Uc17Y)9HwiQ zm&I0BFR!Y>Xl>4^hYiA5B-Uv7+eyuAkt+cm52ttzRVwguD)0R{AcqM0 zeUxcAI{F2jomjw{el)fNe}$0NF%WMrTb(+8IH6?Hh)9@GdH*_D+D4Zr5LL~>RgR;u z46qkN{YW#pHdjKWZ&}sFn?fS!Vxp5B zH~~SiAmL?sT83@N6A?;IKdJ!|IkmBdZlu)z1u77fpU?M;E6jUDY)e7s#QLRA4`Hap(n>Bp( z>WNgRitN>*2iLe-+X6jR&dZO7;SBJ2RY4l;6$a7Yr~5OdA_Gns6zq1YR~zz%1vwNg z7>Nz@`WM(Z<{?Tp^8IwDHGJlk+ahbs0n}XxqCMq2C01SqY_k%<#1pnAUHyt;#jypw zLW;^)TdD;)nad_Wf!owm#*MW*CT1QLYGeW+<4rVG`H2aPIS)|yVFi9@^2b2m0gr2E zf+V0oW%jA*v@VaJyVzX+@p5`e#x|w+Iv7;UfO=c07h%GNx)e=+B^lqH51(j4vDM5^ zQa#elayHh;$f}&TgO3HB*Un2ciHPKfIPeGG!?w<1pB@*J`(3H@I<^G7?dbyX&ibf` zn0@b*M?d8*%~TK5;q(D}UzvhqfJ%BtkZYeKL=T^jDz6(Wi}Opk!$J0C{#fqbUq{A3 zXwZ7g5oVjCCNk5XPiXa!v&<+C~85I7I*^%aBXNQ??YGOBzySvFCpu5&R zrB=|#DU4+Fb}5zA_$V5BuiH&DjJsT~>u{ znWZVU`qc*Wkg+w+Ue6MxvkduGij1lq$KDih_I7tU<+B zT}ImeAd`$XyHk|Gbt6YJM!ZR+BO;UI@Tsv;3I_vVam(b_voxG`b-}UNl%4oYvh)ts z2@1xcOS@G{w9wT$_r#YxWE>hTxetq`n#ZZ6i<~G0q<_fhF48-x-N)XFeAjn|VNOSI zTxf2baog$3Z8(|B$Lsz?MuxFX!HAG^Ft`{;zzHW1G{d?YN57TOF!)vG9+3v8Nk!Kq#Ay+~(JQgP?+$qQxkA&YdKM z^!MfvXm%S~-va#ezQcwqnfji+^2ZK_dT*3-aDizEH$CexHu0|mAd35%xw2@kS zazet~l68}0GCWgahAw=vk@r?jNYWW?3x8Ch?=OLXO{A-5_lD#|k~74Fxrw1PzPCf> zV`Jl1Z;jM$=WTdV7}sx4NuNeDS4e__$;ua7#4YD8r-rc~dxms~I!7HD7IK|NzNjiz zhV_I#B-hH+#6x;eP_5?oK+zYN$70>w6EMY;+~3~Q2&1rz89RIMmQ)MtQ7J%|N#x1* zC}AXa&~NX09c8WN!=g@B7`m#*r{T1o5!6SrflXxrZV+=H`T;BS%_ zrDiq^e_&+r%CjR2hXcI!&1?(w{*x)48Wmr&reKdl7T?}%V-P7Q< zn}1qG6&0M7V3d9_#pv*%mIUo!h3~8%f@Q;bVM3d`w%=kU8?VL1!nSy+LRuXl1RZ98u8fSO>IilV<$JZ%nfK!;7!+74cjleRI zi0-rnQGUe=mVWUh-eDIOSYQvdCghA1&QA&K>rK{5;Fp)XPGTp>x{FhtxD@K>aX5+~ zM&(fo_M+1L59Gj@GGIfb-(4Qt<#hA&40P8d<~302)XH#)es_6Ia?et4GGwS$V$|J~F2-j(Ro3O2GYE zNQ4P>mL@2#xj%og3HJ;AIZUcLeWr;574sv8;sE0+NBn+}YQ8^rZ@TMTMt5~J$`bXA z(w9Y44m*Hx4SVHorPrm$tG5K$BYKB+W#rKX_+m$>*gYHvj=bf@NHzm)GkfZuYhQ7I zeBa(KyX?)t@_Bv|KUPy^{~G>2}txJP7ybg4Jf>=5Ha3liIQIZ~nMpBo!e7^wB#Y|PeUb8^U0P})pa z{=)c$cTjmRqwW68lf~UOA_w1`YRUR?VTo*ksr2!Xh-IB=R`1dl$+Hd)h?{vJG&rL> z5j4w~Uhc}vqj|Jz337o6RT2PC1~nBJGRmM{Nw2^m6~M1w4Ive>=xbebRr_v1LVUu14pg3Fx;qJ2QGedku)rg?**+p1VxAR%WS1@r z@+z!*q}oLoaQcm;fbbIe-fYi{b;QT#nvpHzY!gl+jU@j&4MzyI>+Oa;daKb_qb$t} zF3gKgVh;&e71u&nBp$hAN_XroUzzLvFfYu;@3C6XWQ7F$eV)j&r(>phhNd6{om4@lp@eAy`JFACu>F|u$IhVX6fJvKhclD= zP`J_uO+(ROo{C!O4|x3Fs{0`sdQu#^_gB2U?d8#fOWzePYu=oVfBE;tBuWe;P=BmMty(dVt%1+nQ zP%TQ5k_qUJGU}yGsePr`TG7fJ)j)Qg$Itzu6%tZ)^LB3LpC|^iUbl5P39`hv!BYAa0n|u$ojRFEt;yQ($>DB|CB+HE`+%+h5gvb6A!b9{(h`Wn z5`q^qPX%RU`_~(DB zyOSXp)Kr3J%EDAKAKHaVwu;ksh@Y;VDK*GoKv73utVR^}><1sa+}?1k$%IcSL)tTZ zdPZps2fr+sBu;N~j(x##4BZ7G@Ff!1a#(ESVv)m3Czv#fF~G27ad-sPSNb%g38HyD zVF}FrRoun}7i+MlusQ0JTSBg|#CC#@hkONcvdTVi?rMmA7c~gV145;w_mZ}U47rPU ztA^l{-~u)Os2ay&O=1T8u!O!_g8^UCGem^vCZw<_F- zAs4}PAZUD>#RTliwlVTv zd;j?T)^-=p1|De_WYxogB0v#NbTG=6{9@hBDMC~G@ic{qyQW%H#;N-2eUJ|h;^|5G z!cm}7s#u%Kqa>1fxk%6^?eG-%R27?yR3`G&pk8)GHPxk`ymSt2#HBE66YhXcSrz1EJ*T8-hkbLUL6+0p9uDNRV-og z;aY(8JIFc}H@({5?;-(FDX%P4eN0+%>kB9!z+7olouJxu#PHhI5GPim#W81u?b%wt zpnD{!WUy5oq7d~EUw2yAcY3qSA7?SvEBOcM*hJxr|;+DQ}eDlgUt;&O?bBvd8R+vW&7+scx46Riuk6H_i4cW*SOuKK_WE z)TV*5k1KNqjZ<1MY2`w+uMOz3;iv)>xAPzw zGl`#S{4Pf)m|L8#S?<=D`@NSS5y!o%k@GLL6s$jh-CCu`3&WEO%r01O38V`>3VIOT z6fZ3}X@}8iISM=e7-7l(o-zjsb14NPAjT;RUja=l(A(}&Id-ilJwO<`PZOq)PP;s> z0`a3yMR$Ub$ue_v*()(Td4*>>K7QSyMo0)obt5Ef8!6`NgXb?&=ee0RDX zTpvm;qr^LtJnU4$O1jjR_Hu8y^TdD=#m;Stcn0&>jbfNu!op71(mx-d&vzZROb1_S zHb}XR%TI|iIxTuiz79J4D43Sw^0u$Jt4e17mNcjk46P}|zKL89a^eMW_E_zYta(#~zxpHQYkHf1;Y)ecpUakGWQ{#|y79?~g z&XwW(chc8Nh^9J6d|hh01I@ioya#0(=RBM|q#8Iv5O=XLkLNClsbzHw9Gn6qVkMX$ z$u585rC&V_d-d*e?*Z#&kr{D@EV+kac~U#Vv7lc~V+IspINMPMuzM)7z|tr&x(rA; z4Wg|;mMpC+Z0v;|>{>A|PT z#+*P~Rrj$c;w3~-5y!9b>HUXC`~HMew&%CN{mm1lHLXQXYR1uK|25-pw5yfIP>^^c zZnt$(_y~X&_izqc@egbC6epfrH!M6KriOV5Wq+59VFXn?QDSu8dGXsw=+Edq3qat9 z>}D05hjEC-finDK%#|Ax9i#zvOsDG0HFBMJJcIiVD zE*(_6S%B1_8GlTHZJY1Y8F^2bgZ%AmjvsAd?DC^t{8S8!^3U$z8SehlsYVbb_`b5< zoD@PPPzOZ0)Mpt}Pe4YhWRN_uoP6CHQWK&wWy%!pSgsp54!r&Hxx*I+_7@POE%k@C z-Rt+EMNI+Y3sluIf-G@F;Nt61q5y22nSssBOrWOl7L-&`O~(AQpz- zh;((=>SEl>GQS}P^k>&0<}C1Suf^~7yhy4TMI%}E;1Bq~tP=wVAuzITBFP^(Y{99+ z-29qYwL^;XLvD>{gU7V*?wXpKneFZEZr<49s^bG7kBX(x{-Rf05>sV0bwg701eRy+ zIOreF*@8wXys|G-rWJ8k%z;HL9U4p*nb^9-;*gdhvt7^BNcGg1#5_7Sv+s~G%}|P9 zDPvFv)aq^v6wj1vbhN%IT^pNtk zRzerNJ8dksk;fv`y!@1uD^^}+BR($UMX7PmF3ej^ zn?Vxtv>XWx&GGG=0I3J?n0$AelIRc*nWPSIShj zP!`8W5MvdHV?N02w)$Y~vG*GoF{r`A55GwoZH(LL_;RD({+Cygr%@U&HMU@dT}VOM z#VHbYEB6nE85(nOp_{$%3D4Z*?^DB0%^wbaIZ%nRJZ8bN>of^>vjmA%QnIIqWykoF zs0MfmF_?v#m=hMr-xe}=6MC;7_Rz%Vg+LfHk1KNIslFfzCxC?CAt zemY06i>L7$YVqw4|Kc;v%>f2RM;_!L214A&sqkrF96GLO^NReIPaAHtI1i~Qsyz0) ziNZG*`a*Z1=~QpAsjs&Jry|-f8iu5_BUW|L#h?>`O~N1WYZ!rD3J!)mP{JyVh0L>( z)AhQfZ#NvTWzEi5jZ2R=YgC`S>&C>y!?*?E15?)zttDsZsvN=Ekl_saFzTc7eqBiw zw`N;2-oOAff`myGz>0!M3@MS3O_m)}WMF_0t`G(frUM!i8*AG?BIt*Sxg3HjuofhU zvO^qvVwEM_p?)!`9+en7o3B*9Xl7Ky$XFFSLNP$TJ&6ga-+|w+ z?PJRk;C~yf_CsyslI8^u*Z~t~=Pv`<# zR`JUgdw3b(Isc_))`WTK-Gz}?^FQL=`kpv&W|p&%mX9a4=hnSR2C7vqnl=98u)_Vv zaSN5RY1PapF8)sxIhA8W&P-YN&SQ!*-%DF_`z_}+kCT6EF;9lNa2gmWMrSMbA8BOW{qX>zA zl``^H{ROAmFDfY4coJ|o_;YBG^gUkaFb?Q0w{SpHJpOw82C?V3KFXh=86O!rp#jKf zE78_wxUBz|_K)6>Op!)XZ0xMYU+{ASQI+Nk%07eZd(F1d@2ma6!9lqOD>c9?U>%ED zf!l*&V5L+-J^!zmmllA$=EM?l2W}A)W^!cl38Viyj4_+szfryU!Yxv!e$}E1@HheF z5qIM1zi8FG&PJ&8r`)j3@Za0Q#)KEv3m6-fRDr!!LpKX%jc)%DBsTU(IqV;R9B%R7 zfPTjvw*9|sTcOwQ7`~C+EUR}_AOJ~-$O=~p>iWr{009XD{r#5(An5-lKtKMIHo_}| z^?;0l{9oq(Z}Jle^oA91wGI^e1`?1$gZ?`K0Wkr=+#mryf(raA7yJh>;QS3J`X3L% z%|9k6ARr%oAc&hmWWaUsi0b;36#Zyd>;7XRt2t&Z7E^l8iZeP!DUeB&yPp@81u3nBWUyd%G z4=P+CGP(}ZI}g%24^lh!Q#$sO+xL^&_7mIo5?l8YTKD2x_TpN0W1Dwl0I_eH zcB2}1A{%!i8g{}PcEaknL+iIg>b8UHwu5T70&BMdYPS4qw*0C$eXBQpsy4l=HoYo0 zJu5dnDmL6JHr&cLT+7#8%GRCB)}2ZLSaU2{b0}G}FJ7}NUbQV+wJBP)E?l)LT(K-z zu_#zE&tEaiUop*FHpyEy&RsUjT{g^F`kS+4kiDdzy`-DHq?5I%owcZyxu}`BsFAUt zp0S{ozMz`Eppw4uCv9FSZC){TULkc}K4tEA%A8#CoJ{hZbn={3(yV0Cta#$ASmLZ` z!i;djj8OcHVEhb!{0v{*G!GzBZ|pQ@>@-L06kE&`OUx8=^b}+C6n*q0ZPX-n)Ffr( zBzfc{Y2*ZP!~{Xa1YY5_4& z3FDx&*!smJF~Ws_kB)?Enh>nJIIbvgZlIQ1LbIrDO}VGMj@6-Bt`er4tUhR#+|abJ z_D3>2kH+lWtPr(!&)>~a%fm-k5oDH>e=BvgW7;5lc>8;s2{~v&`iNN8NPb6$nB#Z? z5OQUE>)ZYM#|5Nb(&!bNRonY62A-@gpD$0i1MoZ4h3r+Z!3Xk6wBkko;wz8=e8i|A z-JTh{$!sG>z;kA_`-7f}e1A_|#?n4QJ5GU)H>Tpss7w^oMUfwQ7f3!g>zWDN*QY=P zfUkM>Mh8;)$KMO6%P7-}hJ`X`g)Iq69bDrTiNQzwgKR?LC(vBJqS|v(be{hb^}W6HAx{dxVS-Nn9iS>1Ite>wPFE=}_6i z7E!SWi*hVh+$8$T%A!=#R6`M@*b%W57YZloqEXQK4v(vYR`d?Lxp>yj(QE_J)bkT* z6GVacd#LQ;5xC#uRTKAa&fQ(PR#)i0gVd(o8op~2(%qvLWA0_-xs;4HK-go`T0BxZO@D=5C_KutP#?fi zdSP&uy)VMDpm{zasind?fbYo5seCDnk0R5ZsW5DUH-a_5S9i=-`>S&GK7gQSgIDG- zhklF+B@%Mx&mBGYhJw+9Bv`Wk??M`pR9_XO0Rv31Og%)6c_ zs~gW7W3`o)v?Y{Q=|0ue(|f_llC5sL-Z#GI!6X2wi|3-Gc@DVGMq5VIBYzH~nW&bC z6`_y6}W(gLm_k>3U(kWuHXb580_3M2JP z(t-Px5pn~I@zH99$5G=kY?Mw;5td0Z2oFW1&t;kMV|vzNSZxxw6UX1FsYY?Usn#`J zrUQMadt0ioOOLUOplMJ{7M`bOF($}XAKzBZj2;`>Wm5~say`rS4ks&(+(}32*)mMG zhJ&se_2-&+kpeIBfen~v7R^Oc6db)i8*U2pcnu$`M4tU|k^3J_PUE=&MdQUJxe8nz z4!6H*r!5jJ`%-t%V@1+gHglNw$635|lJiDc4DWo#9z|{wC$S`8tw16%?vD`i$k5_T zu_V0@>fD*u{UJktP49CIletmAyB|N_wYLY8;+F_=^04d_^1oWCis8DGf8xc?JrjF% zc~Kt-U>+nTw&II&cplib+J)XphTFZmS{>|faKEy#c@HT0XmE;a5j**d2;buXLL1zI zP8fBk>KcI4v{SwfN)h2(Yf?mD+dnqr@#5pT&pi^++ZgDfHbu~N4X01cv4DAN0w2<< zcAd>`cfTwzZ-127>dX&+TUeP!%?0Ciyn9!7H5^7yTW&q11LAS&&u4!<^kwU8v{`Bx z?0-dnuiD+jSf3XKsp{wstw1*Y_Q>~Odrs#@hYDj=z4#kUE}lwJ+zw3czKmXu+nmjC2#b)J41`){7(S=lmSR z=Ry@#fa4(F4k)MI0KtkmV^Ou0wwu6azLcHhSXs`QD=gUDlTgJ1+NViy`2m?la72LH zrT_lUWWouoXMV%wYEH>QznLhyA3KYIdiqzh%{xy^v z3U&yqJ64*B)woAQ<%X9O_H}w^zyE87PW6Y zU0}W^vV$mpZD+NsT#6IcCX|Jbd{1|Q)9smT?QNM2dH1tL`u0%kxWHpgKDd&!^aB{V-BbcMMMg(~jY7s48V{J_LFmozcahuD|CNCFgQSv+%?4gxGLS%HP+w<_P&-&I-Y&=g);wNe^yLu`MRfZfW@+JMQ+m?)*^pNxRqWi^Ex|T$}E{a_9JRxBctm0OhZONgiJSPxs1+ zuJk@OhE%Co=GYMvPjz=-$Dl2y^q;?5GDXUrD55ffuHIKeTcb8#*Ai$ouF(9wZE`bP ztc2cPkC|OQ8=3i~cP^gJ{TU6P>sZ=x-8XUSBdhu@88>ZMcHSJ27O6c`L+3ePaH?l~ za7W!i*8Gp6c;?&iK5L20G)dlANp^~=+N%bHjCa#e$pxaz%&%=aDgLrSb{!zv=l$|S) z&=-P%C4}L`hXw6)H4aJVzmE94q3kyIl9y(cTjTHULYrD<_C`T)@*CD*NJZzKwz<2h z#L3(Y&p9O-r`rciWx_A*coy=8qAV#g`UtlVdHwrZ$CZ`4?=dMkLnYa~G z>1`|?t(eoq5SXjGfI=r&8AZN)8ENeNl+M^+OXF+|8YVZV;i--7()0Yx`)(N=nyM4H z_&}4#Co}pM$t2a2GDGxpvrI2V%jkyJXZ*R?sHEdVANIj!YM@>kRlYf;b| zuuBk)8rB8I7Z%Eoh_-#ax!z#ZTF2Xp#!3oTC1|PY7<3%IvYF!<{XUteO5*^)EZJ}OUod<5Jnj)d5CB8(rJ;0+djI6S?0PpEJlLn$sg<&)Z}UQQyt^W%+OU= z1k)&H1eu20mV3F4`F8eq_N1GO)W0->MnIj4QGOAHYzL7Lex@QEqm(wcP?(XjH?hxD^!khfgt$VB9IrshXX1b zgzejjsSIoUAswf9Hd}SIxGQVR5g@wXSd!n$Y8dtO<>m=S_3$IrTl;h00OT-@i%7QB z4=>;2tqtm*l4B~R+9i=Hfxn0%-i8j9d&k0#$rs1L7s5N@VkmV^I7 z&AZk1A6$WNm8D;R$q-&9;LV~jWYqmCj**rR8Jl~s5>AO<7or7K*uW0XwQs+>t6`XT zaFX_XAauLJZ~Q1|%bR>X?N_E@^DxZ=lR7U-r~KWpfH3ig7>4gSansO9N`0(>LuTL0 z6G7GGc)m7{f;pu?DvGOu(wZu-g90ti?+v{i(*Od)M@h%Wx;M;dEvdWB&vToxRn$at z%Y7`fcT=?ONnM|=<&et_)VX$F#fRuz8ZSz_iJ{6jh&Kg@C%v#cI3Bp43~}4OsR|gi zr9diWvLGk71C&rxoCwC2-{U(Hm^ijHKgqTK`6=M2?~0N>BdU$9FHZUQpG`K`eS!vBU7 z6Zrq{a3T*X$LG=iA8;bVe}fYdz&-v?a3UD~`wyH52Oh=e&wwjkcQh``Y2hHq6{)I> zrw@pIzW;&~rIr2e6McQ!-Ym3AWIBvKd_%EDf-^e1$Xm?v*L{vANRb5qG zHx}-j@_n?c7Vg2NWFx444^xl?k$;6FeT0;te3Yhiy!UohUAl}dJ*m7nmY|F?L_4{6 z1I+QyX&)8q4+vPmTa;SxU6Rg;gliXya)TCH5r&jx6C` z;YK=?$te;TMra~wZY9!M3?MpMM8K_F;`5I3T+7~xjnG!-fm3$o7j#M>VZ^W6gvlgv zW8;Jt4Hk(*qgj|Vw?<(yM$mYQIL0Udo+Um&T7vA1AAeu)_dz>lFr%0wrjXsqqex%G2ZYouH!xEk;T}pyJl_ZWi)_+4`Fu)S7kQSsx zfqse&q)W>bFNCLLPGhoHkf$D%BvT|y0?~e;sZTVFBn@LIvCM2_3JXytq(~%<_DizR zsLPK4(uN*vr*balxGBPpB-t-z3|RD`hB1vOlK45&`W?WXVwM`ArC`n)2j>Z2$o!96Y}EU;88)+livW52kDRCQFBo$tRy6ilwgI;Oi18X zfV`Cbq7RK{DUzh~f3ZkpN$+xN>3Zxq<-~+bgoT+icW}pzCMPPXI9juja+H9ibW|in zmZWZ2t^=fNsnO|2zr_#3$JhQ~$sV{Rrc6uaY6%-F8elWe1BHVxe`vuD64sgE#2rZ< zP9E)tX9-V`ZZ8yd*!_3rr+7Nre?NuCr+*p&0yP9RC=3ip9F4K3hnJ=#hV2_Eh@=_S z@Fhzd;DV&3+s)%k*;Bvb`JSBxYcbFsmrJu~mKM$y-)d-h>r@ubo_a{o=~95i<-y0r zqj6Ejz{g{-x;<=9VqyyLkcXAXYXf;0(Z`~6Q$XJ=^7IY0fu#_^vo)?}y+PrMG5gpI zJ*Tzsc4*q%9Sp_t@ms`Kzy=%^g3_eW#O_Ei0h?oji zzo2jlf4ArXK>GT>~RpR#N4l_Jt_7l6pGm z3pxmYq`k)gUW2k_5D-!7Nf|M(Gz}NfL#9yLHRthqBPgnYpRnhk2q10SBDSB+G{y` zVmXm(Ns}wol>FTHWC#R-hlM6d^IsaZRQMtKj5N{BebCAE<8*{Cja&~Pp#9SzseHMc z(oQEWe=yJ@4#Drkv#cQ(tLM58sRC?t&ZL6INL zKHpwrj8=FP4{DDg2~^@Q`PYU}9!1JN!3kw?$ykr{yD=%juCJr-6RWzg`bNM;s=QZw zlJrfvM1B9J>wIuhk!NVtWYGQv>Jqu_`4OBHbg;>#>)ToN;!ZA=_QMTHK_e70(w0R{ zIsyt#4|O3!g<%h=+0Au%;vBn?xnp7EZyp`?)J@%iUW6^*))4ypb*l%rG|Hs#Co}Y9 ze+Zj1J;TH2?kZI{;u?e@nRLH z9T#!0*Jqz>zD&6<((=V`L2gm(!P2Y z+*G7csWUwOFz2F!26$J{=m@bY&mQde@=f@F2qjkG!bSbC*{hr`GF%%?OZO0aGMwmi zGG=PiyZV(&lUrJ|LJ}%Zvw^S8zlVkDABPPPR85R zjD2^e}2f{MSqyuP!L`1BhsKJ?|hwBaI!; z2&wKKTJy*BQGsb#SvD9j7hXn!IXa$hXI6?iO%7}~ z%&>zifszUPTzksj=LjJ&dLgNrrmS|Yk2oE5VpHOVMiVJv6R58iz#AkdRs2MxxNX?0 zMHMa(5oqj#!3xLc_40a~MK*D5c5~~4>srP)rcUSX6qZ3xdT7P+lk1iMq;sEO1970g zPv_f4U`>CJz;$rl!9AcAcV- zu(T!rE~IkVpwdr>-0CJ9nj#CXb5$%V`W(=moku6Q!Zf_sM|021o;=MpUE#rBYVs7r zxecz1JZYNjTB}!@GVuy}n|dL?6Rk6uI6VDcq(?$oMe>z9&9hE?Aq?Nl2pSG*tdEGn z{PwEzSH-xQ<8>r<%vDyj*fPdQ>8E@LMI=fN939#P{{n<$iWLGxQ`#u3Fgi=TxXmdjB8uICuJ3aL03;z^$X(qzNX(e?wbkn*X$<{!f0tMN%{lsi%I43QvxP_`xB7>3D4=IHLqs`RHoW^a`R38aranS$3?sl0UEXB^R2@mwMTAqcW_4bQy<+z+(J1 z<^6`gV3KX8F8we)t=!^i;&v)ZLiRdkN{@*?*vgizb!bhWABg97f1Kf%EDfvI?q1>W zPkd*4=`)O1`|4E7w4JM@5{K!=oo%Sg=4pcNom>W0F^|pCJt+!VPo9k0uONWPY#@a14 z>Mst|8qxzc24*+tg);RFg`CHOp@5Z_S2xKpGWF0_{R$#3$i`}AOV%gJr6M4#lQ}Kv zs7UZ)%&9h90^`dwp%%K6!$CPo-w0X8t784D)t!;?-+Jdn-HTY%8Pg1wQYLj8dG6Jp zg@5@8oUZd6)0-dGzxIVgF`mWLIi;htloO~D9^yi7IDCaUgw}3%jEEg8f`x0LCy2px zduxEp(Q@|NbP}SEpAP>c&FDWJKJblMaC<+nE7=$B^AP>zMFu7V?h^>jZL_~xb> z^eO2#&O%r=L)_^l?M1SUJ6^ri-oC1O+gGf%^7U4L^su4vWjvzqI$JM_2YE;%<*GfF zOxdv;Dk~c31Hc)1`$Dk3c(6CBE|k57zK0#U+g>*@rmM9)x|v7kYKw283n<{{Q`%_S zeVU0o;X+HD+ds@w^rHK7SADFP5b7eDy4%1^v9H(H19){b-HD=rtA8c*(ld$EOlh3O z9=R^ShIO;!k^u;07pWYUjV6Z`N%2+N zt5N(CUzN*P-1ZvEtow`Grd>BrrN^HpHQM|yf;7zYpO5E_f=EMEN5Yc3Y8S^qBg z;u$=u_kP7Kv+f|2TI?eHbWtS4VjNsn3>zoxRwGyvVl(B0Lku`~E=7C~hk_M#;9J7q zyN<6av`VF@^c#fkZYhp0lf8efz&kBXikb_EcR=4Y_K8!W`=CjA-%lCB;{iw;| zRHVX6F!4Y)hbLF0|AdX2P>gpf9U0PjNrb%FT!%MDYkm~`A3DPyO&A_|TM8k+8>l5< zEj2axF}-$LTDks(yr?xS)&%nX@ApK(A*JYoHL{zg$W=8Tpr05=?3JExf{|4~e;(%3 z$tQ|4*Q-tjVp68^_6Orm6> z;ir7J{=ta}w(9toS>Dth6Vw&Xgo70CaEp_kYk);M*S7@w1y7zY{qqp3R`n#?xf8ZW zp_a(E{br&R6!Ls7^GIwTx)7mBQtd9A9yaKq1@0Fbu0d3xb99z2x0~)0PB7W0_n*LFcZ=ky6D@R}4VAzJ@dGM^3HLlR(C-(5Q2415=O_|XTK(x631 zljv#4x+QGA$s)AY&vp-=C#;U8?5DEjLk!gEL!s-1DF%}>ahxzG3^Z^Zt`97WckRXB zwoFm3Gdj8WiFk>1=SK%v-}o9>M}LN*l_IDzl;e3O&zVrq7w8tW{Q0rn71rG`oeC(c;jKyRjwga_m2GccovvE zekZSj;f0K_<$Yb9E?k0e;4yocnuYg4NOj^Fo`r<zxD9M!Q8icB;qvR@3Z3!`((T3RaYb?uz$m%p4L+=KAJ`ZPe?- zz%p}!1>MPF{Vw5=$>|pBUu|2as;S+Vqq{9xfa7xWhUn{}i1+(eh9#X!RXA{ZaGzB~ zUmX<5sKpH<|Me*)^znMkd*J0jUM(q|;;x0_yqu2{`g`5dV2-PZdo!a>Mh@G| zIj5Bt*Q6TtlFY0r$e0hZ@V54FG^?H=xzwD0fzrM&fYJk&m2Vom3b`nKWx|d%3aJI~ z#VE~gdVn*5%otiLSr4t7 z7)$qbd!}Q~{rR?@y~eQUaAP@0@qL_719l&$8fy#)o==mSMRQoy*S;596MG)<<*1ke zrA?`ctzE1FX~%{=-##E}gH^#DW)u6==bo{1q@EI)b7SmGolMuR`qb1*aDUI*&?o zz4?|BMhC{1HlcYQwa)}m@P0G75!4*!yXMFAMLC(iN&bh0gx zzsd;Ew!yNjcjdr#CFWUaGsa?_@PG-sIF(VoaK&qkIhi+I5dmijpoZ#2z|@ zGB+GaLV+Z(kd>UNh+FWDMB=!e=T*=Igz+2U^BtEUr@9YI)H_a^U>rv}$)5;R< zbG~0&v~8q&IuaDx&zt2n5{l$>N3HQ|4s}0?pY-o@qe^k%s$wrNyuirVTr{^vF7W1i zoj2$^!$iPG<*hid6Mnx$%iXA7Gi|yWImp70GCp+nOr1T`>+1w;`83An+{dVpa}N4z ze|$e(YfxuH`YC^U~_~*O%WZdq72$5b~|W zzvtWBjoze%0#Afp(XW8t#OUAAnmee5&!se1oB@4|F0r-b>A1W#1ebqd1``q=e6p7Y z#F885z&E$FgXp`;F*-M6m6V8g{^&M~I{2~ol=fo#1K{`zp81Q{U+x1Wenf{B4-f_% zjJDTduM0Br!P91XA5)Re#M9SOL6t@icgh6$FF#dm7w_u=!Jf{pgE(IUMekf&ftRCg zlvg{0{p=sI#ihlO6CP*5E(7?H%<&=JGu2nV)1V|qf06vLBZzJ)c&B9wn@rR~-ap&q zQ-n&U7SZ#`!5iyr{KH5`>@_>z6MWsCuWESx7EiTQ!Uu$~v4b+lt?hT5#rx|hJjCkC ziAI=|zN!A4HARvj94KWIh=VG(y1t5!Tt$U>Ixfny*!#|;wmjsneM0UdO4DP0P$#vj zCP3w_@Qxrg+-ws(u(@+gOn445I#qf4nu=eY1ja_tme z#aEj{d=^_4-RU$THZ{30aSh(yF?6EW)Fiao3m6yu3UU(`|1rPW7>Kc@ zuN{DG874WH@?gJ1j=lv(h>>j1W+&JQ^ zkl5yRBf~Z510Y7#B8^Oj2a2(S+}H9=pdpFej8ofOqFKI<5&p6=4R|GZOgLd{j{(kuk&D^ zhXY9f=C4)EZnBa!>QP%OmFz^EA&c2bN8t28F{4#6tg|o`%Rt&R`@_==l+o7k<<0!MRUhw znO$psABL<8Q-Jb*lV*s!0h=PBnCKr+qQGXuxsuN5p77UHVkd_ocm2v#bijU%L0y;{ z1?1Lb*x)ZvP9j7CI~M2wnxG!wpk0^Il)2Quwf{R~f{P732V6|dg} zRjq-1^p+f#JyO#WP8FA_Rl+8-#|g5g+|Ic;NAr-a#>>U;y^p)I+8eK42-@tulmg|7O=nZ552zq>8Z}2NmP(@ z4EIW?wYI-omC`VC)^NQa1Bdb;s$N`WY*HU`0&5g~=wO2Qn-jXMpFT^cG97<^fZyJy zQI*__Tt7Bk?fCb*HuazUF*3Ax%onF~*`*W2C3h20hHU26Xp{=Jt3YkeXn=(1kGXL+tU3^?GMlCkpoDo%ha`?Epz?*N}MBC&p2U!*rw=eZq?FTASEZ7sKJdo zWgLqhMiM?nc{r5n<5T!ADZYBnqSo(8U5faqCB(X`+ijJ7L!OhC`kub&#I|@wp_>+} zvngIIYNAO-obzGnhd=0TAFoS{2{V_@cS;CRFE#{vS;@_*OTyDXn3~eo7|f~S>95OD zV4p`W;9wKDo$YWUSlXa~o9yJn%C`Ygl#zEsH6DZM+1=T2IO!g)C-B9&ei$^ z8Ysp*Q|eg~sjtTFz02`{s-8br=uiHhfY_n|03z!}0g(J-To@FsCZCogFf6cu+vk1t z_bNRE9zen31DB1aLtn3LODIKoceXksO$JD`f&Pn8#r3?tW)E28Q`J0z(kaa=Ys^KTHD6|f#nA^uwE zUB>fvbwF2Y*CQ$F7H(DJ$Sg0VdhVowtjt6=TCkLNIgBtAS-U19lVd*E^0Z;SZChV| zJ_;-+l2G+zUb<}ZDKSC14Fn3bRww$T! zeDcX=A6}4i9X{ITC)5$}l7J0> z*z)vA^+Xw*cbtK(?vyOcZctMS5YroukeZ*S=OKvOe@APJv3U7T=x4{6lpz=_e%S!W?}$_9`fnVetoRej z;^}M5N>e_}KW2s@AP98-lMArMrg9lY+Tjp%pGHP1zukBYS(%1zz?6N|gde(+GhWv| z2Chj7Kp~8(qfaOyTEk@tNf0TZy&~mjk7uWq$i`<0NIx}k9QJTA3TTnI3fdpy7)0$ts8;IQGrKTl@PhrZM( z^E$eU9?cO7_*Y*7ze#6(@KTp(_rR$0ThOR;VdZZGMlKkkbIXlCMA0dhj;p5QtB#jn zT3UP}a=>Ox%}^J+WVWT zpJ@x7jxmS@SNQr{#Y57a{L>XuB2Iq{G-L>4DJ!Uy_U{X1!+bgU{2Jf~(wwr?2dMAM z!q%Ty`j-mi{~^;el=>3cKN<&8*Qc5~i>cvJ|7}fDg%E!KRiqUPXam>AUA6Jkmo0XJ zEMatnZx&w!sdLZ3YHwT|>m+ozR?@DaU|9d-o;uq8z;LfYAd88wJuf%X z)%Dfws259TGiBSi5plsK&kFE_Uug*5uBWO9=6Nh~)$QIcov~|qs3>oK`4T>Wr?Z#H zCLMPl?A7xD!?(%__cN-HS-(y#9KNx&N~61*HRK}5p>`LmiBx8x8ytNP5ws#Mu|70i zFFK6yG1E`2%nkHhM82B)Yh zX#FYcUX0>Qsxf^b)M6+1Bk4Zz`MD`c5n+HK$quRWRekwvmyjRwu(5TSCyp|m{u(kT zx{rAw-~Ho`#8$8?EhaZ>s4=RPQ`0s6j?y{FP|3ee&Yuuvk$zJ4Yvw=fnbvLy~I*y#}D-A-2Z!FRj8)*VA z8GGp7$|&46N7R<5;HNr|sP;lI#k(0q}QMWlRZ1toZ(} zWhU3tMKONL{G1TcU#o18F6XKJ>tY8Dn#UT=QA7KTX!JKjDnN-Cg5Q9{1{hPCqP2d} zqmQ}5UVhB^5(uDO=qa$K-FLJDPfbG%Cwffs+m%RSZca?WOU8y8wSLras`L)1<2!VGt-?n}E&n#jMNHhSEYi3inJnUMfkyzs)Hth80D6T_68komKQ8N|dwT!)9xHe&#i0WKt!&7)>8b%nU%`53cw1W{i%d2(#?2F(#D|tR087=vz(o(DFCR`-5e{_-torG%dXoLa zwk6;%e!U~jGUV$%?-_V|3PapQHRw&|)I9J4VeA#{O~r0F_C z_4Ba|PJVR?X%p8+&pbyH4;f)5BEUF8xes42P9G|1kDXCt_88O zEz!EAQCd&*{Rrbq-R1EP+q6N`9KP<>9!@R0yFt=$Xn?9hOc0`=B19}}eIq}h%| z)d7nL%ne1b67X=b1ky)N#qJB#xk|ico0k^LL~P$ThsWDbe9erbjhW*qrZ8~L^kXipN2wTC?_W=dRJ0>!+w_*{@t)zftFL5JTxxx}$~2@}c(8#Pe>?&h1U${Df)&7s z^~F(IpS^QbV#DpcGf`Q;X>vVl)mmTEUnf6TI*XlYvzX!n^-2WK)VYgYY(^A^%gxWU zkd~OxO;cvO){Ys?7jKjRiR~EO^L^F(WTz6L#4EN|rvRwLthO`BTd8R&mxYVCdWQO zmy>m*k*(#c-v`9<(yHvB>K}|llw^)aegbdwh~W=IPqaCEuvfPvLz+!k@{O)i&^tIy>YWg-auK#xLx^X~qq&b4ax>mWr}UqV7V1zdY#0DxH!J9Q}P73bl&wt5?w5bm#~D>o-nV_dA;T{Fyx?bi^<+! zcW>eltFMdczzm3O;;Iu9i{l$$Xh z>tO7R`DV{D8$PyHtYSE2Rh!=a!i3jff@BVwjxr_)K`Wf~;|JO}?4fELFcdLSP`RJTBrI zQQD>kD(D$j`8jN~(M-T#%*Dc|^%g^%Hi+1XF9|fmUf00_%5+O&Z9ZNBa?#nx@f>>8 z*?YHTDAyw}`jh64*Kd~09-(zs+zE%j#FGhIdClskEt04cF%Iinp4-xLxDwkA7w z=pM@n^*rf@I@_gn$zUnc3j0RIa#qK*HA9E-WbPEd>;+mTHQxpR!M>fKI;U2H0o8i8 zT40{{cw`_=$P&@v2EUI-05bBxO*ygj?Xnr(jYGpA;&*wl4VICu107iFsGyukWcI3| z)rJM}yJQCVsiK)RO1jaJakoeps+sgvi{5ZZWDy{&?o)kfH?^k?C3jcuE6s^BV&A$X zX0$pA37&XcBYwPj?QG6#FVv!NDeFf`k=-d8py#VK5At2(6VCwDg59zRZXt%u3)A~b z>VL*s#;8%8&eq=1I3*SVoKJATB11$QSOfJMTIY4NfO?-wQDZS-j@nwiC0~+uE^~+! z$w#n7&x6Y4V=(Kb5(~F9g;dkZS+w{f&GsxyOs!#ipb`qxq@B;1T-Cr(j@IP#+yVv( z4_%sZff&yj*vQI^$um`#)-v-{W9!#YY<;)r+GqIg+ zMv}C-tjXTv`FvmRAU{h=QebWuGa`L;(m3s1Kw5`3B>A4P&?v&bQ6zB z_zz?D{S#T%<;Blh!(1#O|A$b<@yN`>3Wedf1_xf}-M&!g-$ipTD|>u?Uh;L$1k#*Q z^oP~7%lh4hu;vOf)&OMiV+~-Swf4cchQ#NPFyd0*-ZqQTwI)(&(>O5%k~fd_68#`T z=+YD{{7h+ub?;#|lF0g#VRQ5NSMf*>@e)cILsxQ(4(`}0hppMI19+M(a}j=iycY`- zX02!URP!YnDR;s446XID-+*{U<8BaZSrY{TSQe}g8bvDTvQLap^Dt!3qIPSfw7BM` z1O@9=vznt?^s(a81YosY5XLk%q!GC7G(>ckbEYGXSP8PyEZFzZgDnCMgxM(H_2Y$; z-N0K+s`#|>=CeEq!>VVU_>w68gEeOv7z>`!5=f>G>+ST5Q^rioDi=6a2zRqLJeV-O;T#+Zx4L!tjn&O=HRObx?yW)=5>J zQ2F0&80)h?QjS}lsmZ*Ce~Ja<=VO`qt8*jgJ-VJ>rpyG1iKMR|HtfL`o4I&nfWCm6 zC76W}5+9++twsa7_L)T`@;fCXYXTkEtvtgW2h#=64ZyQTG2>;vah8Zo_Cj0As4;_u z^BiaT(NPTRd_?ONF-jPPu-WUl&2zGwbE`wi0i|>`N@>8 za*uEDDAvrTR6dhkr6I@W4_=hL{Fk=iHP3)$aP-UPCAakT7$jaG0u%F@9QF8hPCpal zZt5gwMi*Q1Z7NyF2?js(N5cG>vA za!Gb?QAA$_sc0onmQ5wxoD{Zi1PaD`m(GlaLI`__qXo{>y1kZhWXiK(p%NBOIYpt* zS;huzlijUesbi5$|2e+=DbCDYV?P1PMz48n*wVK(xod$NWD1FxIx9JPj=m8a@pKsm z+>HQ-(#R6(J7nXuxt&7<+SX^aTFeX)BS}yot~C%E+Jy*s+y4MpMF5NkjcM_c4YRJH!i^t=77P8=FM5}`!L*7M5~OadIyM&K;c z8!fs}O^kUjY7tV0dSG7q1zNbVJ4^Q7q%v$v^PFZ~th*1@kxMg8A_jp6KwVx9oQ=bZ z?K%yPu!9Y#-BzBkH4<_98Vct7j4h`5gGS3<1n{qc`afsFF26g4NU+(uA*K7L%7W0vdq~oh=PJ|JWzaVQ z!ASTh_hHwl!lxI};D>WG*xTCGfPOAs(X||QUh9Wm6gXjy+`-v5 zRMMD(P?DMUtk)J*9rwX*?Ck5(BnmSI<4xeg`?_G9)ih!y5FH(Q)DHj;-NB*%p(px$ zJ{IWZd&0`uCH_&QU1nZAUy|#RY*L86iy}jsBR-n$w54@4io-Eun-kCXjF3OyG^)HzJ5CF7wJoh4#Poa^ZR7$X+8hRi#rs zMb0W=YMmYQlM-R1zun_6cyqJum+Q%WuaM^nwAUQm7v;ZQYqoxOGz|Ogk69?jm*=r@ zIwvv6E7&pJs-F@nYWThnF02=6PIm4*G%(_D3@i|ty%MSttemr6F;7J-RKiAG<4)Cg zW$|^1OF$KUl%PVJPOiruY|Qu9P;HZcj_lkJ#j1{vi&|2sTC+<0rClVclVr62@|xQg z^tnSp6H&;yXO(OGNL3QTE?WGTxh; z{o2D#xD!SG6Jos zwVWX*gS+Lk5BufR=LEse7Se^&!ea{3sa#m25u`H;V>p#l%slwhVSp3fP$0nIg_0y= zPpE>{G)M0g1cJZ)oV7CTgs_n`(|{yWqCPPg6kd?0@|G=L#|7e&CcsQ5GAq}e9}}76 zP@U|T_*pTqpNfbD3a^72G@Cb~X5z3H%^N(<0mCcklrg~`9sTpN(gai%VdlN(&N8V? z`n!Pqkks{uIwlJPFingVxnZ{nObrCLJN?k)YUJpd9XDjr@9n?t{f7Fmd>sxYAklA% z`eg;+#qlLpx&N|yyGG)P08Jnirs`*JS;PE88y$Et>5~G}^t0C_DTq`$awI66lZuVy zi#U{zL_fXqNWUri^(y_-8JbTqOp{D$T=*2t&WukhA(~AnOqmEqh+iJMn;X0IJ_kJ| zn0m%&g$4FE+VdqTeImuXDR*ilq0i8C+JdGkH2~mFQ)B?!3iRmYX>QtBfa`wHNO=D; zG{~@Fi5)!VpdF;E%Uiu>7XsXEessTAISS-;&F`IL#pmp-;m|4`qDq)@`ZNA5JPQ|84a&!1q0 z$owi!rl0ev>32f7s=^2$_aN<$(XQ*f1*J!CI*^*E7`&)r8R_rG4Xyd7CLIFv@e#XsnSH+jbCLfyBO3+f|IWz9#)5_OgYx@Vm+}Ae_5UvL zi1^LrFWemBm?Tpd_KHvjhz2z_w-zwS5V{|_Tu z9o+Wc&io%3+5bq`;r}V{_?N3WAAB9_e+3>zV=BaBDkNenC1We4;;Llgs(^7-vhh`N z|D;+zzFHxnS}~zU8C0VJs!>g>RZFZ@|0i`CNp+e@by~^)L_4`&C#7CDrCu+!K|i&@ zAhp3TthdZAOSd;zio1P^yM2H6 z`2FtjFX;&==?yIXCqZB->kBUH3n}jpt>_P{7znQ%h^QQhtOCnmRMlW~^|6<7-C}>i!9+ZX~gOB&lIE87z&XDUD;PP2*`z_j~R==X1~f6a7wxHItQOC6laYWn~8ct8VYCy1nb{ zo#L~1cAu-q|2^mHORDegtG>Jc!o33*?;X5&|4_~SLzfy#FEy0m|K*1A%MBG*9vr^< z@W|DNmDd`NUTZv7+jyM$-*n=7)5#l6r*Agn|Cw9ORdtWg-hO-z|L?S%ztd8E=gEco zCl~KNskzsB>0axV`)&At?Lm9(!>89DKE2WS^k&nuTTRdF9zDPP==q)I7xj-{+--Sz zkNMwm?@7n~){chOjt6b89=5$|Y=7PK^!1}>ZFeq3>+SpY?c4Y7{rx|F^y8~UTdJ{ zz_v9RVs?^OiJ&$i{ZVAr#eCAYB zUQ?d&bpH?vV=3O!n4-R_p-&-U>HDp9Np3kw3;QeEDV7LlwoE$9-pZ+Vj{SHvX`A+~brmVar|n!`Q37 z>Rhf9ja5zBzVh!rP2Fvl#%ZM%tH*T+ z&ewC=lFYSo)4NsACrk?-Yx~8+*R12->$A=l1_69Z0?XRYe)dazKXKyujD|}x_w=t@ z-Q6`|wZz+~z~~D9jul!rDIum4EO~?uc)GnLk=8y0^NFJF@;+|0vvQ zJnGO{Rih3$jyub&O{+KFmy*%hc0SLkeACr=Q@1|X+oPrQo~zNR^a4vm-^{GouN$he z)84cU#9XX6nzl@oN4BA_z@WJ!v1qs3GK04plvQRdJHye?H*Wdsjcz>!Q+_UW5|f&L z^T4feowaTbBl0VvLT#TmcOIARV5vJTAkq-AXAb4=`&qfFvBL9vRQ%;qOB2%{ zOg2dj^lW)Ff5DT8qV0z^6l{%1Gs>H~@Zekr2Wg)z1$%GWyWZN6|NN5S=ml>YN*|1ebcCXqv%|E+mHKo znum-$3g*-wP5b#Sbn{)q@Vy7pU&$XH#dAPZ(0;?0FE5wrf4Xs`swA=5>(k*g*V_(g z2s>?XFYIC4+dOXnJB{(79@Q%=DQevHxD$EyXTlOY+cUQ&uBiOHZshZCZdZc51a*W| zeT|E>K8@u2>^*x$k+0p{5eXLBMn>lL(;HPCTE!aPf7>tlc0gQdd;ZESr75-Rmh6*u zjT4j!i=4G-*}G41nkO}PY-=m2JZ^O8;*1qpc}HyIJX_7Ub6Du`Wn=JMq zZd=Xwtl)rJ%ggp2+K+?NQ`M@+u!kii^V!SlR?m&@6Z|Y(9XI;v3HQ^}bqj-=-bUVN z4x+89&qEFcBz3EMMygEC700{Nt`A#( zuFW^uEgEyir>ycaf1B7jFuy9u;GOV+chV0J9bXc+!Z}c`%Am6$_UiN)_d)g?uABH`A zbJWIG&EwE!A5lE^87FUSbw(7@zRD9f7r2oBgp~$MeBPS)aU2QlK zQ#r}xV%06>V3Ubu!3#!obagJQ5V}%zW~^pHaZJfu;jvd!R_liBx)YmVHgiw&-U1Da zd#!7>eeYd+Orb?EN?IGCSE_0bWr+{@8wUz ze1(F7-|i>W_uDq~t*(~5%~m)V@_B~ggb$Y9qi!ZoGKp~7m4DOlgXaS; zbe8MZ%dH7K_fmWDE^RfXe5X;HLs=9%y6r4#1ou7od|^lJ&AN_R&MDiXyJD}kulVMY z-FJoOcG#B}H!Qqg<(RMU&+8E4JTE-bK&9iL`qd)gZ7#mHF>_r;2M(m2oiy`MeA&xK zk?qD~4rxD|=0b*A2NQ41ZPk6mUgyPW*nfAvuZDGrZ}<*f_2ed^(|v(?LI zI$rPXkr~w+`(UA@(v-#5_uk(2-YtCb)O`K)qVy+Ue{%Jo4Q{bbxx2li=$XnxX|Jv0 z<=!7Tdu|zLO>Ii$`neotdvz+ByTn>IoKA3#%XcXlHUHFr;u=5Uo9$v@%QNmDC(D3i z?LT^*T4yY2OIV>F|9M`(#q3cg^q}{lUO4}U3Vcf-tuWmE<>MQ>`?c?WoVuDI{jz*S zlBSPQL&vQv0owhKQ||}fdEZ?p+qX_KkGFel{^_`$lO}<8{GM7qM(}^H@WGZLj>yf}>XR-Uk}C_VjWk9g=7L+~W7+utLnz>Pdbd&xSs? zx;^bgx&uePo|fLL_8rbk7rfeb!o6?axd5(%ns&~bOHGsy>2JHXTrs$9enZBdC!I-s z*W%8-|6a9zgyps#=?xYd0s|vdj(Dk0TG)G4rHePi$2~5Nr?$@_b4!fk8IG!q&JoKL zFJ^O}UOFU-lusC~R zxo)Gl@YIgT_`J=B$xoo-cFmVds_|x#AJ+UB-LSgIFXUOBUDD!BBes9;4*J^3nYs1O z;#5DO-Tv+aBc`>zerG?5M3g>1na?(7)f?vr9+TtEO13UFocF-brpHn<{OsCYlg=y5 z4-|F$;k5hJ_QpMCa}*a&%8^s*Xcghled$i4HVCIEPakFQO_GT~C`Q&V4WW;O3)5*3^^=9tQIVNWErz^Oo7n*B&E;uON zw)3q-y`z{|M}f_R+N2F-_eIjD7mnI;Ab@^m3Rk)E-0t%~dBbIKyOYnmDnXscO&a;f zJx6t>RDba`($40*VU-h_SIlyvZrvB(=wmzPG>xeLppFDc{5_KQ0 zdEe0=8QhoVYh<3&Y(8srxA5FA@(mr8^LnPQ>m0{9oqvJO8Bb&BHkZ}ad-zv<9yqG? z?NXyua9_V~w@7PrYeHXvdaEZ>jW|0xIAv6uyPmsWx75?0exu}roX&;i9zLm* zvo=Ums$vy~&TN}@N9`A7FGgwZx^t~2Zu@{9x1P_e<@rtFLCI>_i-V1Pjm-nSD-}-P z(6QsLa=142UN5VYpSHiy!HmxQ4{tvzF4(j0{o8#bKUA8Y*>!|9?2B63#uW)O7A{>W zUEq4DZl>@=XPbAEMjrm`+Ao(Ryz2Jc`Nl!0q5rpr!vcRh97dS@x5DAh9mC=9a5y|1 z4iAUJ!{P97I6NE<4~N6U;qY)cJRA-Whr`3+@NhW%|6(|tRHnM)Fv~^Tyi13gmaS^j z{-6Gv3C)Lx|NSN4&n`$J_^C!d7D3{|>J0s6B>Uh`Ju*M{h)eqassHX0VCMfnIWX(| z?+pL$`{ya4>~Xzrh_lUKqlnC zznYH8R}~#q8qqHI3gq$L|4Kgpr%z{uvU7)C;6`~$fEz4io?|mjcVHtQdlvRcdmi>E zdlB|{j1w?s_Cr@}u8#w(81v&tYlj9-a-wL8qe$|j2qYmJ(ja~AMV9I;&JOJ40&^WW ze#?`8Fwd9}X4-gr{(t1m{Qdi2O%}eN26p0SarrrZrHbRPAex7{Bw{`ZBu~@vJPv{f zA7dy4X|`CFD7?xHGbofk4^(3OdoKJ~c0ck*4ncVLKQFlqjrximRqp{OvGB4*3_amM ziXW5AO3ZIws8YE6mw^iy(?6DsYcL;qnu__w56+vFnBG_@OGh?#G2$FNMkvthCxYh( zkSc>B!Y}BOmsNCBLQqtKk84UyP`tNRa%9Az^*5YqbcAer?E9Cz&~zv~GMQWX_2R2* zukK2#zLuvXUfX!2WY+hdsdrs1_sNS#Xf#de**@`E+*vuUV>P*jB@X4EEXOImmA3QV z(`xA4RO*(sNJ?Uo-yXr-FQ?B{sT!`xoRXD4V^8YKnBb{LOxNbb$>r?6`^|{;hJMo6 z%paK}ZY8=rmUx@B-soAa)x#HT$17yrP2a!h%T;=sbM&;ifzu%eEAAzg)f?`=+t+7X zD{iTE{gg_#*6wjxJ8yYhbnTO@cr`ajzg~ae6Zubkt3_%m__KU&2g^%pzC1s1d)B+= z2ObesEo+agO*5E#)9J#1m~XfFE75y5GrTfTA_D{XdEkF4uRRY+I;v4l1}rpK_C9ez z5%Jnu%;VB^x5H|5_*Z;bc6Ld9y35@f3FRd1Jvmm|#p%?pnh~NX-7NjK+4(9b?-}l; zyFc{oH~m?b-PgXULtZ@p0B6lpEAty6?MbHRGZxn_+g+l}?Ufv}yg0S_m`~O8`r=8q zbfx#$AJ^F|BDk{2xoSq4Wng`+&|L?cW<7tUjFR=SJ`d$`w@bDeOug4FKI5UGZ`rzi zwF8wkIybjFU&tuecwxgHWw>c-=yU&_`?R0UJe#vG=)nEacaELxd+-CR@*h_;JY|dc z60GPdkb#7dpvWNYKRizJi}DK&ievT={+rWyYvhF{x2Nx%pVMR*a7NX}|HzH9GhfN7 zP|D)!j=M$84_`c6VpxZc5Cx6`9vX#Q0;_^&;_NyabzD|~? zJ-SA;b;`APm-I0WIm=3qwa7m>Hm*V8gGS5TQ%Yf`*>Z6gF)k}QZpry zzGvSDM$7F#`0)KzepwL(HRnfjf5hFgQu>%Od1FOq%jmD#r78C6h3vT>mmWQT#0LPW;O+}%KAU} zn(17gJs|^QKMU+SAz`T|dT^HZ0FJ+_AF$ zx$lTl*+(CO@AF;Dt?YE@m8yOiCYiQ;afs?J$4ZIM)|#u1NwhxOB}f8+?)B{ZLmjR( zu26mdG+9aY0e_dtg*}oJpWis8aEot>&mGreX9Z{SOX?Q)yy@#H-)?SmRdBnkdGG7q z_L^s0=AM>y2OQu9SLKS$w=ewsseV*Lvd5KyZ#63C`}i_z#HoM&H$B#31BfF+8vJ2|XxnjMm;5m2aX9=+hZn4TLV`9&Ztl_@*Y1J*IO-2{; z9XWn%UnTS9mfF0$`7*{PmyWf`vb-qfO-_%yEu1Wrm9=YR;rv~VEbrs$Oy;8?xrdW#IjqlIQ;q81s z<4t4Y)^Cd)&D>sT*~m^EH*NgxF)I1py+L!F)w>exCG5^-+It*(xrNdlomwwU zKdjzz?#AB3*YeLc1h7V`p)+zKB}>YJL}+ zllbZHBb3*kaW3aP5&CMS9-olu1mThAs+>-Wo?oIS9pLXEAeLC-c2%$M%*9)(u2DDI zpYj@Rx<1Osye#K?q-Ik=Me3{l@WYYXo+^?E_ww>rwY8sOx^x5nFnWz0_ zMyUgRPpedmw9hHsKAo!)V&_aoj| ztt^!hIp{sQv3;azVUa%Xc-sSaWJ2O?$K_XhP7B`>vsvM_ z^N7J=<4sFy`5JsHD#q&Rb9*XOd{Qs$(+@X#=WELvIsa|(W6djkqh2dYwr2*K-Cc0| z`@X2cO;@iMDtZb^^M7kgUe)06*fal~bj-x;jo05v@io49k}9hGLU__=k?9lj)@rD! zs5stnX%5%lS}^)k?4z$&Vw{#=HR33DY_anfzZkT!e5t_qnH!q|`)(GL&e1jGc@xv^ z*J)N#F_UYCLWB60^#TGDHZLPbJ(Y0-aiTXDxbV8V7FSL=e1!8tSNRl{qy%rrD*;ar z9;tL3^C;=7{ZK3Re9nO=L=giMtwZo?^%E_yF>Z!}dj;BAZ z$-U4Nd-E=L@C&z+knOeNQM@x0mZXf!;yOL+deo+g=her)(6-+kCoyo_wf;NLW3xl- zkJ!xS2=J{=*n8Ae%k|Pu-aW$I-&v)&W=@p%Y+E>Lufo2z#gF<&J)b^s!ZS^=NC%qC#ywqTG~P8nTC1t2pZqm&)x|qT=GP>y=H3o`q3w~D zASiQ|qm_T`)G4AYhtu8Kr$Ctox7G^3 zb9td>wr;Bx4H*AKH{^g6x5?|xvH2GwPrh3_d4{-CR@2153g5+RqYXPp2CsKioiyw~E|nLGA9iRn8&7Oo;V&w$ z(;fdggFn~bexF(g<@tx&+@B}>bA9Od2_;cc{6oEHsE+i9;{S6_f3BSTp3{TB%4x8w z^5;DMyc7JM#}S@?UYh@8mzeIzfjSZsG;okN*1i-!lt(nl991Lvq@cL?(C8>rMO`f& zMfsqpfat)`s9;mYS+2I4MvC(B34T$5ei6}8L8gi+LGg;_W&*sE{7eEO;->k<$RmTO zcoRQU#gK%A7!z&n_yANM{o=KvV}hda+PvtvNWTR985gV_80R-18AnEFkJr&L(2n#A zjZ&2N57sqRj7ZQ`lut;;v%qjX^A8@+q>X3N@GLMK&-?-c5USuEzdiYtg4c&q{_&m( zzfvardXL_(6un<5`oB{2f2A1wN-YSx_}xL~hXS`iE)>9a z*a5{*0{el&88z&JLn9-0j2U?TMFy;08;~SK++A4yp$U%<|Cy9=VB~4Ic?IXJZ+hw{RCT!QjgnGy6aD zssIQB6Y0pp7*K+-z#L??fH@p;$^rQh=FdnYJbqEx_rhuo+IlS$Gehp&R-@Z5+x195t|~K%^#)l8^*x@ED$h5O&E?FdmHIzAn*2 zV3~mZ1o%J%LLma8ARd(Tu?-*&7QuSh3gu7*K?axxVj%?pH!aBet6CxY%1Rtn@ z8{jmNXco){Z>XI_bPI07J>h@`Y4b1pJeUM#2;50A&jzUC4rsz-Nh15(tAh z#8{y`APLf7uQkyDI0TgtV}sXWpB>RbD1}OhwI`YnDX;|EpaUwV5FLf%a2l!{(1;2` zQ;DQN8Pwq?a7{xwfCgy6c*utJun}_Mxf9WA=ySnEgc)e@gJ1}liR}O-u2?Q8g~RaF zjpzk*Kqth`#{LZp-LVhCQdk9*a0<@AC3p?*p$opk4^JF*yoe^iB&dcM5H~@!XM>0+mV3I;)2Ki6~OBbMAVOc6Zldu*x!5OFl`83P}Ho_J- z0q4La9mg}^T8MoUI^aEgfX~nky%3*)GKK?i0;=H(#4N(T3(1fMd*L9ILM5zSjQN4k zQXHRQ>oS~TL1Q_#EgXeY@C05!2fP7=71$PF0HzQMaWG~j(!m@o!5SREEDO)U7N)|f zwOBvcy$;(Ngtp-L0@08J6SkrZVP-DT9B|LW=O6qa435J&sD`Vck&o>ITA&TH!3X>x z1ZEZBZ%BYl*b9f@+%}vyfOi*~d11*uY)>eL12FOc&V3*Y3b5@E_9w6_#jzTCp&xz% zdl`;*hq3-}7n&gM80HCF$8m0i@)P*n!wcvFyDFk-FzGzX3wSQzTnI9t1hKFHxG&eu!Z?CQK^AO=qi_;VLp4OAA{GY;kPNlZ04yU|h#TZV6>J2to-i9c!5_jP16Dyc zY=U!83r~btr~|$MCn|a~VGbOCGN^zPU@F2wlR;0Eg^a)i%pe;!LLuw`u8}On1H2#% zlf_xc8XBPm=8s~bMKDT&g+@a*tcS&t2oYc%Y=kXREK~rY2s5})AO34HNFO#_2E+Tn zfB!xpi_aQkxUB#GRR)A%Je+4kBnG_fIKzV$7{McW3C}o)K7t=7YNsH=unN`#AEJ9Ha1ln74y>YxI6)2c;5Iw}Co!}FfcQw% zs)0=cH5>4NAXqJlnm1TVp=JuJWe_dETRGIoz-SC!g9u0i2PH)05C(@JQ5lg4tR0J* zGB6Q0uPSQ3YFIz$S4U(t4z&*rObe2ls6~MVEQT)V2U{)FsvrX5;RAewjoPR=fwwN^ z2|OrlA(#n)uw?=w3itruKt&I=aConejbebB57rgK)TGf?7Qk zPC{)E6itUBW>quPlHe3vhf;IY2H^|zL(gQ?bS+Ru;0Q}C(G>`ktWXPwWNV@ou*eqC zDyZ3^r3IMCxC)NgW8VS2DTo|^iGnXewkslW}m1OCpaS%Us_tRJYm zV0GaZJOSRB*gs$^?1442uzi5j4f`G}f>qEBG#lyesAm0S$hrdBS3U^qPXg>?q!7(_g<0=7VOEXov0pb|dDA^HaKcp^FAO2GaNiy#Xc;4#Q0Vc&p6*bL3^ z8jO;$eW49r!`u{(v9e4t5+i{G6O+|P=SnWWh4hlQ5&p~D}S_9z9UMwrDK7jQA-U=LR;NdY$4-bwb zk^q4dIOf2$bBNx+`67-ZAX$@Kq;Jr-Oc!%Kx!+tCv1aq;B7pM2GNVkUqmp0h*ILg z6j6!;d;tzbCQKy4gGj>{QA9j2kwO8iLu8N(Ok@xQ9f$&YKnt~fV^}H1g4R|#6NU|!!SFutZ|wtwAy^UT1ZZ|bE4njUnsAQt zg^X|<520c$&c{#+|+ydVJg*@k=>fipPR_TWeeU41ws0%MCcV4i4r>+bE5im>=2={c+?RgLV%iw4wO0&_Z1N)4&C9 zc0X3y@5F{SU^X&MV5cBQ4zlp)p!F)8bZROm*(7t3?@VsulHtMi2_D*F!9$LrJhUT> zheXnN$i$eJqD^_J+J%>1rt^}d2p<{2ad|!}SL36retaYt$VUR0p8&MTrQ}n;0QFGf9}1NQ;mp zE{y4gi_jZ>Q933hO5=@1DcVYukhmi7nB(&$84GGrM|CS0RQ zO=>g+IgKU-lA}?2a-=vzj+VR2k$0>dO&+B{^Q0BXS4Dx2n<&uyI0dp^h%{0pXHi8O z&{iaaNs7eorAQm~#!#I57-~x&L$aytCP0Tt^S(4N@_Te_@dOIJK?=^(ouRdCwT z^SO4kP|lu~M%vR9|0%>i$AL@~9BIQ?M+!7`BpGW*GLCelSt*Y6l5;Ap4wyU^*GIxzI%}7ZSH~A@eCN zw10*R8F{*pLW~P(>dl~)W;1BE`wTkBIg=Kd&7_}JGwGhgOnMbGllZkrP4$?sO~Oofb~;AofrXYGm~!AudmH;Ps??TArlL>qQ1SUgT!#MeAmI(Z$(b zbckgR@o;+6NnUSC7xl)qJ8xdXnf%eXwSfA3n2wbR^1; zzK`-JIR$@utmaR*wf)I=nm?rn`ct!V07a?LN>U1?eydOtunDCgw@@kz4W+elp|sCFjLM_KsGBRC7LSe~8OI3n z4341JLXlK3CW<_4qR2ZmiV9exX^CAl?U@=)`g5X5Ffp1eN5#+sofxv86hkr&F{J7f zgX3%rE#Qr%G>cez9~?`eF|lNm5KHU1;&A+rqd?0zVo!~ux)Jeo&mx|zL*udT2^5C# zX|`$tv05b1%~=T)t&~XHloLtAD3Ppv5~(vak@}!tK8g4=k|5_@CS}Jp^vz`r z&GKGDlKyL`ecl>M=UGctdTS}0bsgR2Tt{Bg>*xt%%sNE&IaDgKp7u^&Pq88EX=TEC znvu4imV0lYiQyZlGGhZx7`2f$%WfoR$BlHudn3sNZ=_toO(Y<>iQ?rp(F~7GWa77p zxEwdrIgicc9<`Zt&9~AS&Ri-I&L!P>xw!V5OV<|WQW94ly_3tMZlyempO{Cp9r8%X zD~~ef=FuTspnMdVM^VE0^iU?BUd!bZyKO!llPREHqXJqORDiIskc!i`(Lnk(n#R7J z{CT(23Cr!I6}_Ftj3^>g!6HgGE26cIMI_9>gLE8rP;SHy3fJ68OAL3?!N{G|th$R% zx$Z)1!!9a`+eJBI#iT1)Oy*L>G-*mP*+mqSl+14GmfcNDr|c$a_ubSucQ;*5-A&%w zduS8qUTPn+mqL~I(lN8WG%{^3^`-B{aioL}Oei4}y%JIkDj^THeUvtB9~C<9qcZ9J z#4%|w3LtkOa9)jdeN6A#jDze9AIvy|RTl@h;kDS7jh(QdIaa+4?{55+Q? zHKvR-?aF9TbQ$%;meEzca++#cPOj-VKJVItJN9c1%C544olJ3Gvk~KL>$6Sumt2sx>%J(RZQ94FzRFBau*5fo${x}_& zbew`_9jE!GC#ZMo3EC}wl2)sqq^}E3(v*>>NksEBiJ70Ke%sR|IrB87vYa7BzB44H zeTG;a&(L$1GgK&6MH5F=(Q3IW+LTa5+U#eEH{>jRO+8C9Mb8nR`#D+`c8<7t&eJB< z^W>*>p2T#{lSR~d`j&j2vW=?gMp8BLrdQLbjB0XVy@Y;7m*}m=C31GZL=Snd(0qX_ zv~%1Q%GbU^yV9>vyXI9&5WGf)QrDKaXxtfeicwPd-VmT>kaW6tZe+59>=x?iU} zn;WDNc!Q*(ZjijxO?qg5lakYKQmOVW+C1SF>PNT8k-v^ksMXOp*4xz1dWXi3xkEva z5_$*qm3rc_tfypL*j10Jr@Z;~R6qSLjbyn;PJH+1#^`%=LHizc>fIxIlY7)=c8?}c zyiX^6?o(UXecI01KzEHBDBPlfc&0Q^y~P7MZux+UtR7N>|3lJ_e@HJ_8fk`3BUu|Y zQoCOxnS?b`rBV}Jned48oF37Y$Yzq_dQ6YSALBFnm@cS3rVnh+(}UazOXUs# z?7?rSN#!jq)Okw{UT?`o=pAh`e@81>J85=mCsj(krz`63$tUeSeG>dYdsRNr65S6Z zI{pLtGJT+g5nXh9;b&4A`Gw{~cls9^Bic|Q0q@mM; z`gacnn)TwB%6iFDzK;Sm`>5Q#kCuA%k>1>Is3&}<5T5U}G5kAKM}DXBjPG>Hx}Rim z5&Rg>5AvM;gHn8ckc_}jvJ?DCPJTaWWa3W*U;`wpHb7gn2goRNU@#71x^gnH6f-c7 z1Cv=YafSM~2yG~J=x^pZlg^lkwLg8kh#+^2=kN2y@=6B^TV9c?2LR^iGzcMm4%Cwm4nHe8H9#LgO8ca z<4j7yH2#<}0)LrnVeXu)e4Om8%vLU_JNglILb3+JTw$B1&qN8 z(?kv43CXNy!r)S1ZJFgJX1P&p>{xCsYWMP`YPF$>(1CPla_0Wbkl#uPOFlGDb`DI$ z$%d&|sck@sEPtDbexIk`U>Oaqvph{hE(yp77atyUpcmr6yZAx8dIu&OzZuNX}K#{a2);T_emg)IoSPiT2-X|F+XM+ z`G%(-LwW8AujwKoPnEo5zE!)APvOGfABO(MTZV^!l)z7%u{c?O-~WHTz?5p+vZ7CY z&LKhv*K^Z2mC7a^q`Be+W(zQ{uLNew9ALJ3AuxNvK47-|Nnp0vCE$kpz?|)#1GATP z0n@B1gv|IcW&S@>ufMu`p#b3Yal-ZeYgDS%Vo555pxeTmr)- zFkAw|B`{n9!zD0W0>dRRTmr)-FkAw|CGbB{0{>b3&)RUSp-@X&XyaDI{~CQ|I#?j| z&m4@^F&bXX0h1HI*4N?XAq1Y55z9qel$R14;jKJQ_1+@@1BN=z$+8OzQy?@iR;A8k!Ih zG?*Xro!hKJ!27%qX~5*RLl;Sv}wf#DJuE`i|^7%qX~5*RLl;S%^?Rsu|% z%f!S?49!HsOdQWd!pwDh=9)Njy`H&7&&2OcY|g~#%(ZzY?q_0oCeCNBooa zrf1@Q=DN8gNCECv8thdfi!l>d%Yi&7fFg_mB~S*Y$B7E40@Ke6m&|D#Xn-a#y-~D5 z2XMK5uvZQG*N`6Qg8>)>?bumLv0CfE#HU@PQ89^^v-6v8&x4n?p7cET8E!38&yRoPjDh3+LcGRKo?h2sLmCF2fbL3fG_(uEPzu3AdmQ zZo?g@hr4hO?n47SfQQfsP4Ebs;W4zp6KI7tXosip44%UacnKZw3SPq-cnj~K6W+rI z=z@>%2|mLY=!UP*1HI4(-{3p+!w>ig1HiO_G2JKety07WOxqsryB_=sO)iYN0ryxF z?y(;HN=@8jJ@~bnxW}3Vf$6t{`>F}|R1@x}CNaQ$)P#Ge3Ez}NxQCi>-!$Pq%)#$M zX8QLqy>&-}9LR$LD8d*}0%aHrD!}vuQUi4u2O6LWTA&R&pbO(+0xI>9h=&A7gd~^`$&dmI zAQjRe9Tq|cWWpj?3`<}sFrTsI7_WepkOiwC8&<;_SPSbQ2iC&|*a(|oGi-sakPCT` z4+T&N+h98s!4B97yPz0$!yecR%yR6*ct0F~gK!8+p$wSUD=p3ruUcctgjQ`HWhwvsNX6M16i?jBxU-lVH z_%|O$VE#-_obY$&zYG(6vK*SxY?MB32psG&A28TsK4@?|{N2Tn!u**M=lD0~&*ZJe z9HcOCpytB#(`W83V7C1f%zfVAGBGJkFMOs~{=Xhn{|n_`!pvG|C{K?6u;%~X@)%+M z?8xfZKJc%X^!HcF|1f`isUg-d5_KtO)WgDlf79Q5CW6}YuX+F7?ayQ#_c!zZJ8%21 z%>P%uOi>IU3;$Sx|7ShN7l;n9@eX}{{(S6~$G-71m n*?%xLoHmnr4M~F^YUa7tuh;R-*+qP}nwrykg-fi2qZM%2dy#361&z+fP&b|M@d)5zGS)ZzJ zRApqu3ap5fmjVVs0RRJl0000W1lW8}VK)T?03ZMb06+$S0MZh&vvoGHb=Fh%us3ni zp>wyfCMW~}qR0mT`u_g^UjG+!ph0=uwvPd!L+y-TxJxynAgrtm0_T;ZN&F|i{spZ1 zgVf{g>zgf*unM#Q)gcn4#?{2d#X!*PTBbE5qs5iv61^u4FnQ;kt!iD|sFd$?U2q?z zK}S%c4MFYf^{XYrDu_6yOS^I%r=j}}&nTyQ0u+9a!q3}TsN!XgeSr}*xGs#JfX3Uj0zDHt0O(IAi%pWW6}E@Xscx;0O*VJ9TUB7Gww(y=(QuGDTdPm+jK8GO3a-?n?&gBxCw_&$51KU@^t z@WpZME}M7Jza{JI3m8ED-_#Q?0jv4$`xDu3?SuYSPd!HyYbScTzsCPn%m0gY@n4o6 zowzOuEC3UF1-fl8;={fUMKrg%C0^i0bPgPxaRKNCH&MLS)mcQ)CcmzGbbmZ9x0Dr> zwZQ$02dvsaV=;dvOJ8i;%H5_p3S3@eL@P7U3|4Ha#=_QaiJm7Rxqv5{vAl4vK2(5& zkI0m{rbs(vq)WLi9!COFDK23G`ysl#t!wyR4LCESWK9Fs!tCltD9`31nLO5f!!*dA(genkYkJ`Kx1st^9a%E2S9twq2qQ2601f~Ipqrhe zG5vojim{!Mi_Nz+`^${|x6%N9+p=#u|94*%iIbN73<$wjAzeW$UbNgF1;Hb&$v>(p z-vA;zKMU$e8nT*v-=KsP!@!>QqVz@0kCGa){-) zfgMxH#WDs( zW{zkes1B+~1u5W1Avc2~)ItdWN9MnKhhaHueH|t}=ZuB;Y>HEiwPG8-t|1ZnLxcXR zPljW54njx|#{2a@%FZm?a{xav0Dwg~0082*Nc=-~{#9x&a@K9v)l);Sz|-9bU|42i zYIB@a5>MUZB}o_YoZA9PV*0cdkw|N$6RZ>K3fs!u(p%F3O?9hsjl2B*bW%pD;tbPr zx~|0tlGlZ;G*`w(2QnQMFlz-g(21Ns>)2GSp>9XGrZ`13+nEw3)7To73 zY@2-FJ(tzY@2=#IxcxRu(ogv_PEBNML7THG%;MGhN`wbn*`mTrChyqgnB48Y@)h0J z0n2Rq@p5~6pWN*|U$-_sT_uk$|M=4W?<4s2ZI zrtiahmKuCl`?beQ+`0*!AIC@0OhUHC>bM%bF0c2Bmc~^Wu7u`Sj6~wsY$|#bMhL9) z+-B>f2??upsO;GrNmZfSe2Zj>2wPvD-z&g!-rJwG#6GU>0XCfjX}2yqHvP;a^-Pkg ztYg-pJ)%(kC~(hgv3iqahbIcDOtR9#lJL|)p2+i)K^9qux)I;(sIr_ZVXaLb1GUY_*f-7;69)pcxcU)Arzaz>e=17QB zIV8g@rVIfwW+`IGIhV!56p|Lyk164YCL=-d53^|aU*yk{+B7%qZzM=~60TuFF2@=l ztoYP_CGmh#4|w#C&0&5fk{)^|lA_lS;E_p@&y!INZJxWZ8Ew1nwG&mf>~p;GRVErJ zDZ3;uAui9;YV_E3f10&hJ$2iZSPSWr_qYD(Rpk0DSF`I|jr8Z3f>%aNf{*LnI;R8A z&=)bJgKfzuO?2rLvXH>xkw}A-HN2RuG=85aIva1%A+#8r5u*~9*DBfS#X8HcN}&%L zLYcpE+#Q00T0>nihs;Y%;cKh6r8;NzC)z@7grng0J6#`;1Zg-S7G{n`wp`-xNCgMV zvwk}`e6e7_jO3?HqRQ1~s;MxS`!_$2YwlCYr!YT;5789r3qi3QlT$Q>n0o5^L*L-p zHoq^ow)al2FnE5~7q7T!-LE@TN1O3JzDsQ>?sXa+6z{f038jLglMj~ORfA%+ElMoJ zxIN5+tplDZH=Z{I#k5fdk)hNh;GtVHPNYzN%(1Jn>akix0TTBE4><8534*jokGt7P zpsVPQ>aRse+Gg5$rqS$fqmUaI@KENoZkH0^YVwF>_&INuLbu1vQFef!poPQlilgrN)#ShWh7_X?&$}dtDYT5U*`z#mCOwU=&Pe zp)g`V=0qO}VWgdi6~pZURI@4tqjF=zA_3-yKR9}Zu$YiZQ`}`AeUPv8mG}&RN{kHO zfoZqV17I`kb_FGTxLjD1BeU6>t5+5+%wzb(6(t#Cs)(5Ov`!e>8{2YCeb#<_km_2N zyH~}5qb~ROu@6${ema2MTO_0BUvvcZ zn?xokU<^jor=iv8w+}#$Ra}Y%an=AX;Fz(R>mJVr+$%awJj*I?5NIkBr{!XMUoB#Bc=Qr!uM z)=m-AyEH5$zvc^1i86NJCL3K2Qk0nvIx~%Wi508^8OB{t+S_x1ChiK+j6IhBk?yo+ zWVSZ}R>ea(W=N$lI-xk!SlYy zARAzUx)B{DB1O0`SrtCXX7QJt6J}IbE-l?NQhz30+$L|X?d}$8b)R>itOwvFV()~( zns49Fb9ad;Y*T+6s&HXCy2}-Y#N$vC;*6fVuiT^8QAezHaJ__^LVXbsIbaFF)HMij zWvFM1069`<8%Ami;!fyG_FL1OBs1H)#$5~E^~i`L!S#r z*&^L-Ad)!$h@v?&;aj^&WV`AFG9rpe7Z+;3w9x!D@vLMB&!+NjO)B;Z0iwJJHJbHiv<}saYpy@Oe2BeN^ zUas*Vz*FM1888f3BZ%h9FOui8sSoKBugR%57SiomK|gc&4DSy8Eag)zhCg1z>Mbk$ zqx*n27aKU9y!dd)$#G5uGnxq|`aZbE1YFr?fuCWcw7)xV@?Gm2eeo&gaWJWmfQtwv z*!rBry&MW`vhl_4cs|x~(0ZubmF$HT(qVebo^xiwUeQ;@`$6mrh&y`430I2k;dVG) zTYE-hM+P1EXKLE3I)-pMU~Xk0YeEkclRFk{rhNNeQu82Ru|}pvE)({8ZkpcHc}P{w zv?rYE<@eoFsf2cjxcXWQdt+p9GoOWvRVJNAqpSF4>ZOe#?mrLfLCEGTV1yPWkDxU_{?yPM2Q{5AKOpq6fg1)A(^)?=D&#P|zy@%kW^ z%kv3y<%`fVcuyi;4w0(P6=oHXeDr7v{lKRdX1S5rHfUT$Vw9z#Uo#u)4f7^dbD#w3 zN37Isz-&SipML^@wGC7;pDws8%uaiQoF9kFZvZ$XB-oyB^$^hr+Lsp-oMGpJNUEFa zfg)uf8JTC7)9m)iyTW2wqeCB(?K{JWH(Ej#B>Xm1dWjm(#hyy23S#gwYr!nmk;s=% z5G@!gmR&k86CZjs5(2K(oA4ep*)20GC8ZHLfI*@uWn&IdB3lE!8XXrXO7{P7-ubE= z!&|>g=`R98BL6Lv)VP@9bzF;@Bgi6`_!;6hh=cR8*P?ajcQ@IspGwGEubkTAP=hMB zo%TygA@F?2uYPvW6;=-Jj7SQwY1`nrCMZ7!DU-OD;Ay#*xwUFmQJ>{n=cWEoY3|^Q z)|-Wvr^R<&Zw#&JV5BUB@s{({gz8ffh9m_s9wcm54{EjGQ^xJvBZB{h!fjv@;-2B5 zBwr7Yz1N9Ok*5lL;%NvOCE-|T1Pu#TJiZ?(KiChMAq9-)9nA#yAV*<3HB5D8rQK89 ziB`lPkeqUdM1ZN(Vqx8soi%Yh4qu>n9g=ZEM#wR}+x`~nQm@pCB=#gL=COI2;MRXi zG^NEf77}o9#X$kDFty|miB->oXM)@cS~=52*_w{w4Z^Cpyw7=vq(jCrN=@3}(lk}~ zd~(0!wc&nMyQ+`Vj^M~aOJUvQ<|*| zuY(VE&s(%3>Ix{eK|%^M4s=&fwbrztLanGuL)CA1Lq~ERv42A1e5jcTM7t64=n`wBg7ND>h#YE5%mH zrQNK`UWRZ(6t(HWN-lf7ukxdy%PCCb=VaZNcJ9Oup9{b0Eehd5)k2>}cRkx;hH?jL zgf${v4K;7v7bx#4G!wUrQu4?9$q}hfZTKJ5(fO?s8`7#*kp{B>4MGMrT#i^cU;nd; zcLKn$d%IR@V^`r=R9BV;r4iFimW(?*6tgmzCP1mv9fl=&)fc=$lO0adwiO_&?A9`| z?FzG+zFrtFr`IGH7dwTlkb6ml9oRW+#F@miX6B@5 z6g~0jM1V+~gbLBa3JpiZG|SzljX1(-qhX>praTcTY6?tLCFm8^B~6O8XzO;Tr=W-# zufiZj*>-|YI$GM=%aEjVR$dNHGd&`zZK}5TQ|`z5B|?eXfXQifcA?L2|s~{ z@8K$OuT0u2xZ;dO>J~s@XD{@W``siL^TrGM^J5Von7g6r4iB-J%b{L>o8f$c8A$F&(O$=Zc6oXn^1Zq$a5XzCBK*I zN;XaL;2c|uw>O*H@xUtb{(5)*JtdU;C%r5?^8WXJ5x}vkN>xYH+X;NN4ru{tgsKl= z>K2h%Qi8S5*{cr9R-1eef--)8ez-h!z3?EP4d_Rxy#RdS@TJeK4O3Qg!)jD2*4+m+ ztvhi}Y@ErPcUL!AB<$v8)wv~4b&K~;KJ=OD!vh^-#Sv_?h^TRmo*$HSvdU)@fsM;K zq%GPg@HpUhCQ+sjjG)Kk;rtc)0XiP{FL)-C3?NoFq!;&A+aeqCn9yC)v^vMH z5S!oRTKj^;tkjW|LxbrFF^>r;9?t*%_uHS17@Za!^scI(T1L zh(d5sm{RH7PJ}j1 zp$RP>dJ#MW^F`87gIc64MTaU9-Y&PV+5Wdq52;RkR}za4b~1@iF)iH-Ot?;`tm)j& zSp{m5khJvXhR+S(Eyb%aJ;N+ENi92_DXx3pXHvBGab_RB5+rrFa1ZD$CCF)O7!MRZ zP{sDGD-^JmcT(_Z$!C5OAlAlFLB4Wi!ljx~xaS|`9>i1m@@>))l%eGoQdA5Wy<7+p zV+l)^d&jA_RaL@yS!D*Cq~tO)Ez!DDkZ?LH%!U^r2~<%4ze>;7CJQs<&BEkjSPc`F z;4D92$|!HXqYjHU2LG?4*L{XWh&>@g1r?(f=}#uL z&n%;oztD(=1VX?r*B-4P-BKsy5;d@hSMQ=9FV${@dDCVyK zh=+(%r5vc1%$3CN3N%W^QaN0+TtxCUoJ~30O<{1)PaXK<$<3%!;wecgt$TiX%$QST z;WBtm)>3!fxO8i^&RrfHTkSs}T*s8H)MGCj{nUC8IHu~3ANr1Tudp~a&NjV%ABj29 zi#sqruQr4AMJpWHj>*VDe=xcl!P_WQl#0Ix)A9EOA!we zBT>&KN(Hd@PPcMFSSy|(mjRr%{*@(Wek~?!Mzv$`Yj##Ex-o04XbM7nwxs!N;DJch z!>TN_aC(cOOOBQOn2DW=!uhJH{8I2ip`E#jyNrss$OQ9PSDF>8O6V^xvhEzvqwLgs z|4Yb{Ai$~L&Bc;#ho=+O(xzk>NK7^OXv8H-r-JpZf)I-mB>X;L3qiL4&yxXFJxY1$ zIW6`lsD#AlrmcpNFcQpui`43r@51C7XQ+vPX7Gd~(Fas@+oh^CAqdzqFo#y{Bw5to z(X)D5a?76vQP1yIkH@}ONL40wIUyDz^ccy%&|U-{iJfh@7;xh8 zy3znLDRW%%T9;C-PJm_&Z4Hh-SS4KOG%7E#_t6<=e#~WMK!{!vhuNsr7?_pTswyKT zA*KR(i7Q&yf~7!l#5hKrleCp@v~!tea#(YTPgko+q+hnKT(uQWK*x`W?$g<4WUMvD zd0lJXl$6X#0KPc1&wlOpva5Z)WP$S}G6}$t;E)4udP|O>S#D+@%`Cyh~ zix_COyI|RNJr$Ml*prMD_JohDDdP}0ZywOn+EqG)p@b?UeV8VgE93evHrkbVl;{w{ zJxa@Az{qGy<1DU==wg}*dHAUFtpZwo!xZNm(dnd!SMzs0F^Z@=HSkNEDnM5r&T+Hr zrM@{98f&q+fETQ$c9W^uN`S2zf;%N8t?yW7DV!q7XI7&p^y$fUgf|Bu_FH;R*Y8Wp(1^ zo)g_HJ*c0mdi<2DMNu1zZrbM?0eY^02!H^kENWvWhPcWsM>(fHX6zO;Xotx6!aFKz zAYRztWg(rak1UQaaZn}^)yW{p3KL0{XaT1uU~k9L*jE^DWj68W8WT8=DwltoP)^&a z>!fBx>w^8j9bGL+IJ*bV(97yloP^co1mNm7dog#NXTiA69$btH_D_2TRW28)oD5to zCMoy$(AWC38V*`NVX(=Bwte8#yXlZ9f`Ph8&!qs9w=5$89)8BuDu&2fY*6XyI`H6C zpuD15ZpU)iLqsA8(Ha1F;#tCB%DT1V3#m5|#R{A00{lVPIqrIvn&iQSM1(4&wMIiV z{-FVi^C@rlX>oJP_AAf^eiG+nQ>nM9Idzf)Q%{y@Y3ytp9YmZ@Q7{u_&c2KbVxF7W z2+a4ysz)20Quraxf4UYONf#d4?fiMV%j-|1QehV8Tt&#}+C#tr7Kae-Kn%gMs!NAU zJ%~cVsH&4Oq2e|3vn;!4fs{tv!)@g{k3;j$ZK$d|UKr0PqX=ibaEpYM%(d+6R#AKK zjOBC$;fcdR-3?g4!G#&j9)n(2*;nd%BNf?L>jUCX#0x1roQ$?JQu+f#Iq&Uw@~;rG zonwfeMcsiJfE6}IJwfuB_Nue6b!u=4hSRMsVq;SV0X_=$9)S*z&_53|#b)Gm%bxG0 z;pX+VXULrGh24CDQ3v-|NO|8GaWo|e0lWm?liVMJIr6m&A8>XKAEznfzTtev<;_E)1L zQ+8_?p;;eg?U|PyNDszin(rG(k-$AfFNltOZLa78BW>@9H=8x{tk@fJu(vHct(3pe zVaTDx>!}W!p;L+%YGL;iSCf}QZgCf*G#!@{>j*i?FOz41IPWYs%*R2Q!I5HmvVlWb zL|5WP=*gGMvyZS~;u`NADYUFwg+1_pZi<}xGH?@}qlV*`>-FJ`s<-aKE4wsR`_D=e zI(a}r@3qE8deWd4CgSlDeo6;Hg%9VzLP;Q03KelXu%{mNm^d&#We8~B7^8X(fu^^L z5tdnMK8GEWsvUat;)i;!&;2Y;F*2X;N5?#JHWDH>1F34uZ0{%039!WdV3A=S5N=ac zrR)T3pkFCZBYmmbfP{QtMV_m!5-m+!MRgPJlJ0#}>qsdmT~QFpXDVQfU_X^;grSHV z;C-H!+#j%Al@?*dtFrFf61F0cEH9ceEO?VT0#r4W{(W0_2H!y+xfeM;pUvL4hkYdU z)${`mjmv!94cF0+>4wzu*OPZ^v}*XP8Y%VJ6LCN|t^8oLD2mjg#+X}&@I?Mv_}pTo zJCKRvL)j}>_3DnqhDjlK@!*szPlHZOF%>@mq|HiabUK`W!d)98XRC2R)mnn3!`g8@ zfz0`w5#?FJhoTSuqRprPBVSJsP7Q@Q>Kk@AT=)t&70#x zNz>8%;3jNMP5gJlmakgs;7ye(i2^7qZKVvhV0+W zVSfawE!DDxGX|3|Sv?%z&Oj1$!eh6^=3joC-Z1#C9YkX@MHRe|mNGR-YFsgMXCy2( z@no!e@WC7BiC(pom|DWld#V!{+UChv>&#`}*})5S58j#E`R-eYuX0yF&zTZa?u9?;gvq|-7pbPc zK3`vwih+0^YW%VaI&G%v!)*a*Y~>7e8-?U_X7_Gku31XLh7-0VKuh5O=?Tw(!hKNO z;YWp@yjSV$R3IAC2o~(P6sMKCidV3xXP|=>7MaVQ*-!}?`^+PeW^F9{P%I+xHb727 zOZmO`Rs^&$c|6d6EyoiQiM(!hUBC~Zc4R$ntOi*X$MZbqBf?2Bz5XOBCJB6P>A+il;kk1_8(cenU+BtJ-PjlNb5+k7%B}tAImixg`|+W3ADz*V!#lAHd}`Xuhf#*k^E; zmh(E)z&Inp`8{C(``+I)5kNms<4t%|&wP&-at0xn_C}knep{}ix!j;cE%TU_!8^t0 z-4aEac^RAazH}J1SbJhQF5HU^_@-Q3%)ZoD_{>sV_VvY_Ovh;KgO_`F#T^JPf%k>a z*cT z#}$y{z*SJM%-E66vQ;aM7uNkl0|WCov#n$QwDGic4Wm!EbHH%d6c%x3ji6nNV>9E- z(J3i959<#ZTo3G#KYu*Fl1l_WHz}s&FYoX(&4?XYAdW36)0kz)0yc?p8M7#6y&EJ^ zBFlg$eByn3vGAI#S|75^ckd)G=<2o~uiDrY-8K6S5n#w*Lvlz3O4W(LPfNPl<(M4( zD@pqG*%wSL_*&xKR+HGKmaOCn=CG~vlYKHm_}Tk;$hT#zX`!lwPLBIZVa|35gFouopV(V5BP8<*yB3 z`^_Z`h#=YH7HO3$cOFxt7{oHyTQY*nlxQwOa5t@2pr5`+WTP)_H2ZO#SON0&6fHziaTreCHmtpkqAHA-fa@p85wtt|J2Pe@Od?kqu<>u*$?{xQf~_ zwK^Jpn~JYSi%#p49!1d%k95w#iq;0Gtw9Q=bq4jKr3WdU7;=zhc)0n3VUDRV@q4LLp!X2wK06Uf z6+D0;G`A2vkPF_*;(}G91LDTsW@8~n^8#-1`Gi~n;gQTMHfwYX#W-kd21hL!um%be z))C`RJm7qd%9eH==2m4ZK@o5^86_N*6HmK+ri}P4q`TUe{Sw8Bie9y4r4QwNWKA=r zr0mnkcbYjAQxdnw>cd0=l$1zRjdst zkJ_#?Abg|*Oo;ACr>%2=_JUE@n>584-b}ohbyT z%?=Uj6v5lXD>_8R`OON7@ezms5twN9lUIH|9=dXImjsdrtO3;B#>rW+@FFU#J*(eF zeQcBV>KV-2L&tlog(h;J1#`M&|M$4{Yar|DPOIdL_BoBG{KJw3szb4+#+Q=tdc4SQ zZ*`BV*3;vA?2yB!>g~_X`*RKZipfel0cM(~Vr@X>KH}=z zA5*}2O4mh80-3Rh{*@V z(%kYMKON#&8X#dU&+>3s{%F<#DV9>@6d!*ts*an*1rJAZzmu z-Imi>A(3X!<5=G}?^lv?_SnTGA7uve@7?D&j??t{_DDC$l6m!1EvSIA=Eh#f_)7Vk zW>W>Ob5E&4g7HB^n$GrAT*B@QUu{{@PinI?+2MLVZTZjH(?DiXt&Nj-H4T;wHyN5v zycpRKEh^bf=;nsKvP1aqTAKf?)aoyS7LNe~0MNk(06_ikY8z*B6B`rye~gTO)oER5 z$k<_vV001R;EQ_M8IikUiMf=m)Iv5`6s^#nIdpJu<(Rsfu`ehDQ*}?#S0*0<>P&AZCu8$LwnKG}tq^q~Y=HZ%V;lc&>Ur6QU7l9FaB@2p>onqn2jXqH3CJtdx*&FfD7&d$?3_tk zx5ZxU_`&L_-8Xd2a#(b`ABaVxpE#P}4cpT#=<$qZ>nYc){?&_2&oH2?^2TXsj7Jfg z$ySVAgCh6#h8|v$@N@Y+f@3dv_}cF7W;ff#+Ge{TDLOKs`eH68K@s614JptQD5}nCBkS8yo}@9}SB}+O z)mU5*g%rN2@KozhjgQcFZO7PWs~Ui_M2xLG9r6`Zh_-91^t!cZ5x!#X`6q?!b_qlv zUnaHpx?pipO(F?*XF%XenXky=$6DNGW->MO{@UKE9;s$;#I=Lc)PP?f&b%htxLI01 zB+9q*J>Kj~GEVzZH*Lpnhkdm^bpCOSeO2hmXVaeJqHf;h>0J+8hncn?GJl)S#3rvK zS|!fRAhkjp$VX$z<)ln9cuEt$&p3Ry!=gsr9eD@=q#xSd0~PLElLbePfjHo?eKX*$CY>VNB-}U{ zIB`&Xofp5T4N@_e`bZVP@fVTkYmZytvgDj*<{xTtZkhP8JuK*f!&$EsibG7EsKlyu zqr;IzM~6BP+@?-dr`A(K{9iV9FvnWYSicZlO3C>r1Y1aNQ)(>y3>mYi@)uk|t2l^W=pQ1&3vj-GXIfHdc(0J6>N2}Y%`iia+jfIiQ{(qhI% zRFC!2RhnEp2DK9F$=s^%E^go`3c;jogyk>Cz{iLA>6T zRnsp%Z~Ws>Km?~l5%YT+oq;2L3vdH-cQRZHH^}V&KQ$8NrBYG#BvcY0k|);4ZP~Cb5jVhxb2io1Dl~`|K*s^ z43!1yAzrD9{Z|-@S9N88pVw{eAdG0M&k77n>lZXCwX2Gh-N;>Mvvs&HBX&KOhl+pA zoa)Tj*e9uqdvE2EYXxUiT2`wg!k|Z#K`lnOV#|ZTEBu9@@^f@L%M$ik{FQ*6$aPVW zDVPPYhR+lno;bUBJ4ayeDBYUzTt$Ud{j7u+?RLeq`yA~7o>SA(1UVcoD4O6t&yz!1pLdzZ>5Xk?tNKz{R1m0w>n%P2@UJtR!ganAxE zN_UF6IQ!@SSS@;+r;tom*C+j}4(~6TXZ^S#CekEx zN48in3TPFkR+++I!_MxAuob`>Kx#-yC;n`neh=sLX)@NcoQn0ph4E~v63W<^>xF`V zt`zD9$tu|FG|AzMru|SC{0epkiN76Xhl>>KoJ&|F4c94%dsdlEnu?|zOCvS&or_N0 zJ1{U0c18@e7;S*Fp1ZB@l~KhX`JoNz-Dj-G_VX+rciG00w`sQaa@l7@QO#*hRIll@ z0j0sP#<%QV(%~ z4ERxgNw(@r>z2zL^$)`&FlvH!kxDK`o=H2>HTaRPy^2e+ab?JQ;V1FwG&OA?#*D7toLI_+vMK3X2Fg&MfMM#Ag}w^ru~d zwsgszM&7SEb<}1HO!EX`7TkfnbG~d723v z`}OUw%rYy4v$Hl~lLT^!|DbtOj-K&Ag!RkngWBgRB7*?NIFaAbwhqWhO2z@QU;WP22Labnb`o2>h#$M+(K8jdLZe?#%m%;m9!?9? zbgk}^{~(HOE;i1D!`r2hT@E(h4nQ{Rmrn=T1Qere*`06BrMv<3F;o}i6FuF)U27cs z8JC#?l$&JEmD_A`-e}=5+mUnPNmgAUHzNQUYsp|y?q<00_~F*Y;t&B^gf|IC#7|dJ zKjko0F)lw3=QJii@<;Zg(uD7`uKM%4z3o5!(OJqv>&9BZg)bzUnPT9cF z+T<^V?nso9{jQS_eG=awyv5r~|A9{=B7c$y8VKA{If2D%7W__;H*U{d^4n>X5MM5=(pI#bg;8g+>3@_KQ~NC|}rJ&cTBO|U&( zp$%C}!6D2{h|-E6N2@+k%jlw_i3}Y;y`n5IZ%;8vK}}}?hE+}d;jaH-d{gEA-u=tl z>AatH8B9136I$0Kn91`;^C{Za`l7B9QZt{&C@n;@^aZ&9T}$HPp`wZ@Sp{5zW?P3g z7}|y;U!^caK(^5iP6-P!u;0{YFbHWc7Fby4mb>E&B@Aje(h{YXRES|(4bxQ+rO$@M zuLizN%jsyLtS$h~6v-dXG?^y@6nNo2B7G-tM5`r~wxM#{#J!e0rPJaSPY(g85jX~$ z)_%7EBN!>V{10ED3tQncz4*fMV%Gwq)JT|4tb@8A3^=p_KMG0vJ_A5Z@Fj|EU!fyx#r5x@{-;frT!~C<|K41X?~O+J?@e|yF;x1O`*!qH?{_-{ z%+QUO!4-nDUd{u9q_`qQ5&g^qpthI=Osz4A&DP^Rt99C@CraM)%@w?!g$h zolSuN6pu(7ti1<6?^S`q9m`7!B>1yvNdI%gsg&BcD_{Rw`u*gT8&jWgJjV$OOD2p2Y4UIcwh|7I2%xn}o!vy~)QVu)J9_Uupu%Pt!w~nnno??zg7U-0L|hKIG8a z$f{u^zq=tP6uO9m(bZ>ToZI(O{!^kMJrH37zZbgj-7kjl-3#;G${_D(XYWLBU~m7I zJbyQh{cr!vH|Mew$N$o6ktgwYp=4ecB;B8xSOr7_foTgrmQ#5pzUvn2U<>`GgJ+Ni zVk=B9IoRD~VbbtBN4FS-|6DN9n~CHWq{v#V)7>4v9+~HwF+!FHJD{b#pc(m&!o%-S za>Nl@L}O~Kv`n-ozX#S*a9@aI&#ufBI~1Tttj#bjvuN%$CfV_>4U`pf7(FMBVi>U*JDrUjR}#C3EK_-ywknKRxZ z>l*=Lqbnb%c<2IRTdBJcL1csz(wFbQP}W2Mscm7?iV$_Z>yGafS}8t0ix6Ss_{+or z%xV;QLvz`909vp0AAld(vTdF$RCdM-Whc#B@@;xB1+mr&h)7-F_<^+i^h2Jw*4Q)A zQf_DV0|y>VyGcaa*ASRSZ^{wPy0U}+`o7oxr`&$+iDpZD%dN+^+#>#~+#1TMwcl5CqMlSg1IpkwXt&U)SC;cUr{sFTSS}8PEXuZ^V>4(LKZ(O;SEoe#BAgGx zYoeE|@6$$BYE+PQBCk4mLz#RoVzR$sCUj%v%(-XAl)@g5N;aFOKuGM)Okr0SRR(2x z)AhGWJO^zdiBG0ZFP)k4QqsRzfg^Fzu>Vb9+mNylR?}lYZS9V2Xi-K)@sHj%Ju&7hbiEpWbi-?Vv&*?e}sM95+Oz6c5$l18YGCRMr;6&eL%3gI0to zv=`#`?=H%lXN*^8qlZar4~!1_ z5v2w{ddw@66OsP5^+va##Q819Nirur~RJU*C`= z3=Y$t6ec55)YEI1_%nhe?Q!$Rtt*iv08W3IvU0Dz31>nvq0{ zuwoXV(;>CmbKVTU&hk9vL~7gwL*58l>kAM3Qvjgsm~tMh3aM7fz~B#_(I4HT8@e<^wK4a0nVe2qWR2&c7WDBG-t8KnvXqZ> zy~DxbJ>>V6_zczF4@#v3gykUz=E2Gl&rarVXh8F^R}($*D!QL zY4|mAG>nMTEnn)H4s-MXmdl&?$e_r`sL_?`J-zQFMBR9FE$;L&Gdui;vc}7`N3>6d zO`gwGW?S~OZWIO>n<lMeZwk93(mrG+-m=v1*$s-T?1Z&#mFtl3m1&97yce_6JGm0;T!o3FxWrfzOPqv> z#l9zsh2In4?+MTrXCdPD6k?1$9xfsyLX{`lq&}-W_M7HO^7@S!sQH}IS!5xCc5U|N zk#!nK6U@>kA6aVohvvRED5p=CdX+O>{rVJYMw`vGwajPDCaE;!-RErW{d}&J-{cY{ z{O5?sMug{SVl^YVdl-j$UzH--jc^I$bdc5O4v{3rmk3xnZj?0Yg>#jeI)B8vFnBqL zq%FDiR^7=T>fH-JB&emG6VuFQ>7U~qRH1jN9oFoh8N-I%v}s^BY)o#RvJg(NfOL3z zh3IU;lQJ8e(AWSIDB7+0a)1}a?{0%3w%bD(``y$c(+zRg+o)A$YhmvkczShn9cC{& z{%g9>w_Chvr4#IL4I98Yw>1P;`f)un0UZ&YKFQ)VBizs6FECSuBi>H^2b7#>a$J)6 z@%_6LHLKT7gy28Pypa2%M*z!eOF&flD@pxF3g2S<&>yFT7YqTY{%o^yH{Vs5fJ#FO zb_)4zN^O3?@!HJt&>S)``_U=z^vs&la>Gke-;OSF3r4@8@&WzU110f)O%Vk8P0GKv z?cpsmAoPkZ1{6gz-W4gZR*>Q$plS+VnBpIBMz;4+Zt~Q0ELd+#L~#JXdQKK77%N+u z`qCDm539&<<^S=@hJ#|a63wsEfr#ShpSc&4A77+|tX%B`fyViRHTC=V zpl^RRf3I%lu$5pe`kN60e+~a%+|a<|`TZAHG_c_!*)J0E=>A&$51AWL`H|UD$g*#8 zQ8@Wn<5IYRtkK^@k|=rU82C3WF`aS^Z!9{!cdllkf$nmXj`u50A@SBFKsp z*kLIci~SlB2~AD<4tv*bYpdHpyIj~kNGdZ4g4P@`_n@2N7HCV*W_>D%K+ymfDpIU7 ze;;Mem`L#I-iS=#dG}OM+$E5-5l-DZqbS_x4cqOY- z%E(q9RTY51u#^*FcyA28*WmDdK$hHhBK$ec1~7Pg^01-hf*G$ny*pbQWtnIqhYb3Q zoC?4Cr);E_{Pl!8R8L8if}wXb%XC~Thwbxn^JaxpXa>ehcCydMdn)P z!ehrXBRn}Q{3aEc{oF=K$7xz?D`>7W=TV%tfL*8Tre~HO9WyqPlN|hK=TRXZKZDs4 z5C5^nYleVx!$zZ<%!_FIuO!Cgu}n&2dD`Yb`%WAZaJe{4`l?N5(QoGDvt0+PzU@aI z4iH_mZoj}&H*v#V5FfFp-QikebZ*GI$F>);{@E)H2t@lGH2u$q#r(q``Iq5;I66jN z>fZ_c`*9Zkf(6L?POJUP;TC@f{(F!AzXJQet@i(4$N%3c{k`M+pR~TdPsI6;{_nrT z|NaQ;pKu$R{{#Q~1FgT4_>j5`rlpse?^D!{0sWO9sj?>|L&>%lK?pX ee{=8u_1om7K)=P~ucK3-0eZhf3u@87-u*vi#zS8K literal 0 HcmV?d00001 diff --git a/Data/eng/Health Management Industry/merged.txt b/Data/eng/Health Management Industry/merged.txt new file mode 100644 index 0000000..19ff21d --- /dev/null +++ b/Data/eng/Health Management Industry/merged.txt @@ -0,0 +1,3140 @@ +---------------------------------------------------------------------------------------------- Astrazeneca 2003 + +Chief Executives message + +Our reputation is built on the trust and confidence of all our stakeholders and is one of AstraZenecas most valuable assets. Along with our commitment to competitiveness and performance, we will continue to be led by our core values to achieve sustainable success. +Stakeholder expectations are constantly evolving and we continuously monitor our internal and external environment for issues relating to our business that affect or concern society today. We use a formal risk assessment process to identify both the opportunities and the challenges that these issues present, and to plan the actions needed to ensure our response is appropriate and consistent. Our current Priority Action Plan is shown on page 4. Corporate responsibility (CR) is not an optional extra ? it must be integral to all that we do. Our strategy to include considerations of corporate responsibility across all our activities is beginning to take effect. In particular, relevant aspects are being increasingly integrated into our risk assessments, scenario planning, training, purchasing practices and market access strategy. In 2003, we made some good progress, but recognise that there is more work to do to ensure that a sense of corporate responsibility is consistently embedded throughout the Group and actively interpreted and managed at a local level. +Because corporate responsibility spans a wide range of issues, they cannot all be covered in this brief introduction. However, I will highlight under each of our core values some areas of progress and some where further work is needed. More information is available in this Summary Report and on our website, astrazeneca.com. + +Respect for the individual and diversity +We value the different backgrounds and skills that our global workforce brings to our business and are committed to ensuring that diversity is appropriately supported in the workplace ? at all levels. At the end of 2003, we had around 28 diversity programmes in place within the Group and a number of awareness +raising initiatives took place during the year, mainly within R&D and our US business. Further work is needed to ensure that the benefits of diversity are fully recognised across the Group. + +Openness, honesty, trust and support for each other +Our Code of Conduct has been revised and re-published during the year and a formal, confidential helpline procedure is now in place for employees wishing to raise concerns on integrity issues or +report inappropriate behaviour. We also concentrated on reviewing and refining our corporate governance controls and reporting procedures to ensure that we are meeting new laws and regulatory requirements. This includes the ability +to meet the appropriate executive certification requirements of the Sarbanes-Oxley legislation in the US and the changes introduced in 2003 by the revised Combined Code on Corporate Governance of the UK Financial Reporting Council. + +Integrity and high ethical standards +During the year, we added sales and marketing practices to the Priority Action Plan to ensure they continue to get the appropriate high level of attention and that we develop ways of improving our global reporting in this area. The settlement of the Zoladex investigation +in the US (see page 13) strengthened our commitment to deliver high standards of ethical behaviour in the marketing of our medicines worldwide. + +Leadership by example at all levels +Good corporate responsibility depends on the right level of commitment from +all employees, led by the AstraZeneca Board, who approve the strategic direction, and our Senior Executive Team and management, who are accountable for the development and implementation all employees, led by the AstraZeneca Board, who approve the strategic direction, and our Senior Executive Team and management, who are accountable for the development and implementation of appropriate programmes in their areas of responsibility. An important step in 2003 was the inclusion in our annual compliance report by senior management to the AstraZeneca Board (the letter of assurance) of a requirement to develop local CR implementation plans. + +Our business is focused on the discovery and development of life-saving and +life-enhancing medicines. Historically, the markets for these therapies have been in developed countries but as the economies of developing countries grow, new markets for our prescription medicines emerge. Our strategy for expansion in these emerging markets is designed to ensure that through timely investment, we are well placed to meet the needs of patients in these countries. As part of this, we are committed to playing a role in targeting improved treatment of the highest priority diseases. In June 2003, we opened +our new state of the art laboratories in Bangalore, India. Work there is dedicated to finding the first new treatment in 40 years for tuberculosis, one of the worlds greatest causes of death from infectious disease. AstraZeneca will make any treatment invented in these laboratories available for clinical development and supply to the worlds poorest countries at low prices in partnership with governments, healthcare systems, international agencies and others ? all of whom have a part to play in bringing essential medicines to the patients who need them. + +Good corporate responsibility enhances the benefits of our medicines, the quality of our financial performance and the significance of our contributions to our local communities. I am committed to the high standards necessary for our continued business success and for maintaining the value of our contribution +to society. + +Sir Tom McKillop +Chief Executive + + +---------------------------------------------------------------------------------------------- Astrazeneca 2004 + +Chief Executives message + +At AstraZeneca, we consider the value of our products to patients and to society to +be at the core of our corporate responsibility (CR) effort. We make our unique contribution through successful research and development of new medicines. Innovation drives progress +in society and in the case of pharmaceuticals, innovative research not only brings benefits for patients, improving health and quality +of life, it also creates wealth and contributes to the economic development of the communities we serve. + +We see our core values as central to achieving sustainable success through innovation. +We know that we must act appropriately and consistently, wherever we operate. Our reputation and continued success depend on it. + +Adding value through innovation +The path to a new medicine is long, complex and costly. It may take over ten years of development and only one in ten projects entering development will make it to market. Typically, about $1 billion is invested in research and development before the first dollar of sales is realised. The pharmaceutical industry is responsible for the vast majority +of new medicines ? no one else has the combination of skills, experience and resources to do all that is needed to deliver real pharmaceutical advances. + +Each of AstraZenecas R&D projects has clear targets and must demonstrate benefit to patients, otherwise it is stopped. Sometimes the benefits are incremental +and sometimes they can be described as breakthroughs. Clearly, fundamental breakthroughs are exciting, but they are exceedingly rare. Incremental innovation is important too because the first product in a class is almost never the best. Refinement brings quality, reliability and additional benefits. Also, choice is good for patients, who respond differently to different medicines, and for competition, +helping to add value for healthcare systems. Very often, the full benefit of a medicine only becomes apparent after long usage and extensive clinical trials ? for example our +own product, Nolvadex, launched to treat breast cancer is now used to help prevent the disease. + +The inequality of access to healthcare remains one of the biggest challenges +the world faces today. The pharmaceutical industry has a significant role to play, but responsibility also rests with governments and other organisations to provide appropriate infrastructures that support good public +health and the reliable provision of medicines +and other aspects of healthcare to those +in need. AstraZeneca is committed to playing its part (and you can read more about this +on page 18), but I believe that real progress will depend on the acceptance of a shared responsibility and commitment. + +Delivering our core values +In practice, walking the talk of our core values means ensuring that CR is consistently embedded throughout the organisation and actively interpreted and managed at a local level. For a company of AstraZenecas size, this is a significant task. We are making progress but there is still work to do. An important step forward has been the creation of National CR Committees in the US, the UK and Sweden, where more than 60% of our employees are located. National CR action plans, including local priorities and objectives, are now in place in these three cornerstones +of our global presence. + +Another significant move was our decision in 2004 to formally integrate CR into the personal targets and performance reviews of all employees, including AstraZenecas Senior Executive Team and senior management. This will further support the integration of CR considerations into business strategy development and day-to-day decision-making, actions and behaviours. + +We have also begun to integrate CR into our leadership development programmes and during the year, we launched an intranet site dedicated to providing managers with the tools and guidance they need to put CR into practice at a local level. + +I was pleased to see that 80% of our people took time to respond to our third two-yearly global employee survey, which took place +in 2004 and the results of which helped +us to identify areas for further improvement. We are working to develop improvement plans that address the areas highlighted +for attention by the survey, which included organisational efficiency, strengthening leadership capabilities and clarity around performance expectations. + +Our biggest employee safety issue is driving-related accidents ? a particular problem with so many sales representatives driving extensively on business. Despite our increased focus in this area, we are currently showing little improvement in our driver safety record. I am committed to doing better. Alongside the other work being done in this area and to further promote best practice, during 2004 I gave a special Chief Executives award to AstraZeneca in the Czech Republic for the most effective driver safety initiative implemented in the previous year. Examples of best practice such as theirs continue to be shared within the Company to help stimulate further improvement in performance. + +Following the devastating tsunami in December 2004, our first priority was to account for our employees working in the region and those visiting on holiday. I am sad to report that, to date, three of our employees are still missing. Our deepest sympathies and condolences +go to their families and friends and to all those affected by this tragic event. AstraZeneca responded immediately to the disaster with cash donations totalling $600,000 and medicines. For the longer term, we have established a fund of a further $1.5 million to provide ongoing support to help those stricken by the disaster rebuild their lives and their communities. + +CR is an evolving landscape. We use stakeholder dialogue, external benchmarking and internal risk assessment to make sure we are staying in tune with the issues relating to our business that affect or concern society. During the year, we added clinical trials and pharmaceuticals in the environment to our Global CR Priority Action Plan, and we introduced new key performance indicators for marketing and sales practices and animal welfare, which provide the platform for further strengthening of our global monitoring systems in these areas. + +We are committed to transparent, balanced reporting of our CR performance and this year, we have taken a further step with the introduction of a pilot scheme to provide independent assurance of this CR Summary Report and the processes that underpin it. You can read the results of this on page 20. + +The pharmaceutical industry faces many challenges to its reputation ? some justified, some less so. I am convinced that the effective implementation of corporate responsibility +and a wider appreciation of the health and economic benefits we bring to patients and society will enable AstraZeneca to promote and safeguard its reputation in an increasingly +critical climate of public opinion. + +Sir Tom McKillop +Chief Executive + + +----------------------------------------------------------------------------------- Supplementary Information + +We are committed to ensuring that our actions reflect our core values. Our reputation and our continued success depend on it. + + +AstraZeneca Core Values +> Integrity and high ethical standards +> Respect for the individual and diversity +> Openness, honesty, trust and support +for each other +> Leadership by example at all levels + +AstraZeneca Group CR Policy +Through the innovation of new medicines, +AstraZeneca improves human health and +enhances peoples lives. Our activities impact +not just on the patients we serve and our +investors, but also on our employees and +on society as a whole. +Our reputation and continued long term +success depend on our ability to integrate +successfully our financial obligations with +our social and environmental responsibilities. +In so doing, we will maintain the trust and +confidence of our stakeholders and continue +to be a company that is welcomed by society +and for which our employees are proud to work. +AstraZeneca aims to set, promote and maintain +high standards of corporate responsibility +worldwide, in line with our core values and +consistent with our publicly declared code +of conduct, which will ensure that: +> Patient benefit and safety continue to be +the core priority +> Safety, health and environmental issues +remain a fundamental company +consideration +> The individuality, diverse talent and creative +potential that every employee brings to the +business are fully valued and respected +> We maintain high ethical standards in our +research and development of new medicines +> We maintain high ethical standards of +marketing and sales practices in all countries +of operation +> We make a positive contribution to the +communities in which we operate +> As a minimum, we meet national and +international regulations +> Our CR commitments are expanded +by encouraging suppliers to embrace +standards similar to our own +> New and emerging issues relating to CR +are dealt with appropriately and effectively +We will be transparent in our communications +about the work we are doing to meet these +commitments and drive continuous +improvement in our CR performance. +Revised and approved by the AstraZeneca +Board in January 2005. + + +---------------------------------------------------------------------------------------------- Astrazeneca 2005 + +Making a difference in the lives of patients is +the glue that holds us together wherever we are located. And it is through the successful introduction of medicines which help in the fight against disease that we reward our shareholders, pension funds and other institutional investors as well as supporting the economic development +of the communities around us. + +We believe that what we do is important. We also believe that how we do it is just as important. Only by working responsibly can we earn the trust and confidence that makes such a vital contribution to our corporate reputation and +our licence to do business from stakeholders and wider society. + +AstraZeneca operates in an increasingly challenging business environment, and ours +is a high performance culture that requires all of us in the Company to make our best contribution to business success. We are determined that our corporate responsibility is consistently given appropriate consideration and that we continue to live up to our core values through thick +and thin. Key to this is ensuring that everyone understands what is expected of them and +that they are accountable for their own actions. We are making progress in building that understanding and driving the integration of +CR considerations into everyday thinking, at all levels. As part of this, all employees are now required to have, as a minimum, a performance objective that reflects the need to ensure compliance with relevant AstraZeneca +CR-related policies as part of their core role. + +Each quarter we ask a random sample of employees for their views on a range of business practices including our approach to corporate responsibility. During 2005, the results of these pulse surveys, which are discussed at the regular meetings of our Global CR Committee, showed a consistently good understanding +of CR among employees and strong familiarity with the Companys Code of Conduct. They also provided constructive suggestions for improving leadership roles in the continued delivery of our CR agenda. + +Effective leadership is critical to delivery of our CR objectives and we continue to support our leaders with learning opportunities and tools for communicating with their teams to build awareness and understanding of what CR means in practice. During 2005, some 245 of our top managers were involved in leadership +development programmes that included CR. + +We have national CR committees and +management frameworks in place in the US, the UK and Sweden, where more than 60% of our employees are located. Elsewhere in the world, CR continues to be integrated into leadership team agendas and interpreted at +a local level. + +We have more work to do to improve how we gather information about our CR-related activities across the organisation and during the year, we began the process of developing +a common platform for formally capturing local information at a global level. + +In todays demanding world, it is important to me that we continue to provide a healthy, safe and energising work environment for our people and I am pleased to report that we are +widely recognised as a good employer with high standards of employment practice. + +The Board, in its annual review of safety, health and environmental issues, specifically reviewed progress on targets set in previous years as well as agreeing challenging new targets for the next five years. Success in exceeding our health and wellbeing targets, and achieving most of our environmental targets set in 2002, was tempered by the disappointment of our failure to meet +our targeted reduction in the rate of accidents with serious injury. However, we did achieve +a substantial reduction of 26% and we are now building on our existing safety programmes to support future improvement in this area. + +We know that establishing targets is in itself not sufficient to deliver sustained performance improvements. Only through the continued identification of appropriate actions and the clear allocation of management responsibilities for their delivery can such improvements +be achieved. This Report describes our performance against targets set in earlier years; introduces new targets and details +the key performance indicators against which we measure our progress. + +Approximately one third of AstraZenecas employees worldwide are engaged in the promotion and detailing of information on our medicines to doctors and specialists. Their work is governed by our own Code of Sales and Marketing Practice as well as relevant external national and international codes. +We are committed to driving high standards +in these activities, and have introduced a new key performance indicator by which to measure our progress ? namely, the number of confirmed cases where AstraZeneca has been ruled to have breached external regulations or codes of sales and marketing practice. Any breach is treated seriously and appropriate actions are taken by management to prevent repetition. By publishing +the number of confirmed breaches, we have made +public a global benchmark against which we can be judged over time on our commitment +to responsible sales and marketing practice. + +Sales and marketing practice is one of the areas in which the pharmaceutical industry is increasingly under public scrutiny. Other +aspects of our business that affect or concern society today include the safety of medicines, access to healthcare and pre-clinical and +clinical research practices. In this years Report, we have set out to communicate more information about our approach in these areas, in line with our commitment to transparency and openness, and with a view to building a better understanding of what is required to get life changing medicines to patients that also add value for shareholders and wider society. + +For the second year running, we have sought independent assurance of the information contained in the Report. This year, the process was extended to include visits to our operations in the US and India, to enable the external assurance team to assess the validity of +our corporate statements about a global commitment to CR. You can read their assurance statement on page 36. + +AstraZeneca is once again listed in the 2006 +Dow Jones Sustainability World Index and +we continue to receive widespread recognition in the communities in which we operate for our responsible approach to business. What perhaps is not so well recognised is the benefits that our medicines and our presence bring to patients and wider society. I am determined that they should be, so that the full value of AstraZenecas contribution is better understood by our +stakeholders and those who influence them ? + +DAVID R BRENNAN +Chief Executive Officer +February 2006 + +----------------------------------------------------------------------------------- Supplementary Information + +Only by working responsibly can we earn +the trust and confidence that makes such +a vital contribution to our corporate +reputation and our licence to do business +from stakeholders and wider society. + +OUR CORE VALUES: +>INTEGRITY AND HIGH ETHICAL STANDARDS +>RESPECT FOR THE INDIVIDUAL AND DIVERSITY +>OPENNESS,HONESTY,TRUST AND SUPPORT FOR EACH OTHER +>LEADERSHIP BY EXAMPLE AT ALL LEVELS + +The 65,000 employees of +AstraZeneca are dedicated to +providing medicines that improve +health and quality of life worldwide. +OUR CORE + +GROUP CR POLICY +Through the innovation of new medicines, AstraZeneca improves human health and enhances peoples lives. Our activities affect not just the patients we serve and our investors, but also our employees and society as a whole. + +Our reputation and continued long term success depend on our ability to integrate successfully our financial obligations with our social and environmental responsibilities. In so doing, we will maintain the trust and confidence of our stakeholders and continue to be a company that is welcomed by society and for which our employees are proud to work. + +AstraZeneca aims to set, promote and maintain high standards of corporate responsibility worldwide, in line with our +core values and consistent with our publicly declared codes of conduct, which will ensure that: + +> Patient benefit and safety continue to be the core priority. + +> Safety, health and environmental issues remain a fundamental Company consideration. + +> The individuality, diverse talent and creative potential that every employee brings to the business are fully valued and respected. + +> We maintain high ethical standards in our research and development of new medicines. + +> We maintain high ethical standards of sales and marketing practices in all countries of operation. + +> We make a positive contribution to the communities in which we operate. + +> As a minimum, we meet national and international regulations. + +> Our CR commitments are expanded +by encouraging our suppliers to embrace standards similar to our own. + +> New and emerging issues relating to CR +are dealt with appropriately and effectively. + +We will be transparent in our communications about the work we are doing to meet these commitments and drive continuous improvement in our CR performance. + + +---------------------------------------------------------------------------------------------- Astrazeneca 2006 + +MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER + +AstraZenecas business strategy centres on building our capabilities in the new science and technologies that will help us develop better, safer medicines; on maximising the therapeutic and economic value of all our medicines to deliver their full benefit for patients and society, and on working closely with all our stakeholders to gain the insight +we need to continue to make a valued contribution to patients and healthcare. Throughout all of these activities, maintaining our fundamental commitment to corporate responsibility (CR) remains a top priority. + +As Chief Executive Officer, I am accountable, together with senior leaders in the organisation, for leading the delivery of our business goals, and for maintaining the trust of our stakeholders and wider society that +is so vital to our continued success. + +Our Business Performance Management (BPM) framework sets financial and non- financial targets, including CR, in line with our strategic objectives in four core areas: +Patients, Products, People and Performance. Progress in each of these four areas is reviewed quarterly by the AstraZeneca Board and Senior Executive Team (SET). + +TAKING OWNERSHIP +We know that targets alone cannot deliver improved performance. Actions must be identified and accountability assigned to people who can ensure that these actions are implemented. Led by the SET, each AstraZeneca function and location is responsible for setting its own CR targets, based on the global framework but relevant to their local issues and priorities. And we continue to work to ensure that +all of our people are clear about our CR commitment; that they fully understand what it means for them and that they are empowered to integrate CR considerations +into their everyday business decision-making. + +GAINING INSIGHT +Understanding the needs of our stakeholders is essential for effective leadership of our business. We have increased our emphasis on stakeholder dialogue and are making it a more permanent feature of how we operate +in AstraZeneca. Stakeholder engagement is also important in identifying our CR priorities and, during 2006, we published internally a new guideline on how to engage stakeholders +in CR-specific dialogues as an important step +in local CR priority action planning. You can read more about this on page 26. + +LISTENING TO OUR PEOPLE +The views of our employees are very important to us and the results of this years global employee survey helped us track employee engagement and identify areas +of concern. Conducted every two years, this was our fourth such survey, and I was heartened to see that it achieved the highest response rate to date (86%), which reflects peoples continuing confidence in it as a trusted feedback mechanism. This years scores improved across all categories compared to the last survey, with positive feedback in areas such as health, safety, information sharing and communication. +The survey also highlighted areas for further improvement, including some aspects of leadership and performance management. +I take this feedback very seriously, and am determined to address these areas for improvement. Initiatives that have already begun include increased clarity on accountabilities being integrated into the BPM framework described above. + +BROADENING OUR BASE FOR INNOVATION During the year, we continued to recognise the importance of accessing new science and technologies that will boost our own innovation and provide a broader base for researching the next generation of medicines that offer better results for patients. To that end, we completed a number of acquisitions designed to add strength to our pipeline +of new medicines. This strategy brings +with it a duty to ensure that our CR policies and principles are understood and applied consistently by the new members of the AstraZeneca family of companies. For that reason we have included this in our CR Priority Action Plan this year. + +IN THE DEVELOPING WORLD +We continue to explore ways in which AstraZeneca can help more patients around the world to get the healthcare they need. +As part of this, we are piloting a project in Ethiopia which centres around building local capability in breast cancer care and management. We have also entered a new +partnership with Voluntary Service Overseas, in which our employees will be able to lend their skills and experience to help the charity +in its goal to improve key infrastructures +in developing countries. Our expanded support for the Red Cross and African Medical and Research Foundation in their community-focused efforts to combat TB continues to be consistent with our own research effort in Bangalore to find a new treatment for this devastating disease. You can read more about this on page 8. + +OUR CLIMATE CHANGE CHALLENGE +In common with most businesses, our potential impact on climate change arises from the global warming emissions from energy use at our facilities, from other +in-house activities and from the various means of transport we use. However, we also face an additional challenge since +some of our asthma therapies use propellant gases in their delivery mechanisms, +which potentially contribute to global warming. As we grow our business and more patients benefit from such therapies, the associated increase in emissions means we will not be able to continue to reduce our emissions of global warming gases year-on-year. We are working hard, +however, to ensure that our emissions from all sources, including products, will in 2010 be no greater than they were in 2000. +You can read more about this on page 30. + +EVERY INTERACTION COUNTS +We are making progress but in the ever- changing world in which we live, we will continue to face challenges as well as opportunities for our CR. We know that as we continue to drive our business forward, we must not lose sight of our fundamental responsibility to do business the right way. Our reputation with our stakeholders and wider society depends on it. Wherever people are located within the Company, and whatever their role, everyone has a +part to play. Every interaction counts towards ensuring that AstraZeneca continues to be welcomed as a valued and trusted member +of society. + +DAVID R BRENNAN +CHIEF EXECUTIVE OFFICER + +----------------------------------------------------------------------------------- Supplementary Information + +I WANT ASTRAZENECA TO +BE VALUED AS A SOURCE OF INNOVATIVE MEDICINES THAT HELP IN THE FIGHT AGAINST HUMAN DISEASE, AND TO BE TRUSTED FOR THE WAY IN WHICH WE DO THAT. + +---------------------------------------------------------------------------------------------- Astrazeneca 2007 + +Q.2007ʹ ANNUAL REPORT AND +FORM 20-F INFORMATION 2007̷ µ, CSR ȣϰ ϴ Ƽ, Ȯ Ź. + +CHAIRMANS STATEMENT + +istent with the values of the Company. + +During 2007, the Board has reviewed key aspects of the Companys strategy and operations including its financial policies, human resources planning, and externalisation projects. In January 2008, the Board concluded its yearly review of its own processes to ensure that it is functioning well and properly representing the interests of shareholders. + +At the end of July, I announced the resignation of Jon Symonds as Chief Financial Officer +to pursue his career outside AstraZeneca. +Group sales increased by 7% in 2007 to a total +of $29.6 billion. The inclusion of MedImmune for seven months of the year increased sales by 3%. Operating profit was $8.1 billion, reduced by restructuring and synergy costs of $966 million and by a $178 million loss from the inclusion of MedImmune. Excluding restructuring and synergy costs, operating profit for 2007 was up by 8% and R&D investment increased to over $5 billion for +the full year. + +Reported earnings per share for the full year were $3.74, compared with $3.86 in 2006. Earnings per share excluding restructuring and synergy costs were $4.20, compared with our guidance of $3.98 to $4.13 on the same basis. The Board has recommended a +10% increase in the second interim dividend to $1.35 (67.7 pence, SEK 8.61) per Ordinary Share. This brings the dividend for the full year to $1.87 (93.0 pence, SEK +12.10), an increase of 9%. In 2007, cash distributions to shareholders, through a combination of dividends and share +re-purchases totalled $6.8 billion. Share +re-purchases for the full year amounted to +$4.2 billion. The Board expects to undertake share re-purchases in the region of $1 billion in 2008, subject to business needs. + +With the debt that we issued following the acquisition of MedImmune, we have now established a balanced portfolio of short-term funding, which we intend to pay down over the next three or four years, as well as medium- to long-term funding, while still maintaining a strong credit rating. + +Our drive to strengthen the pipeline has been led by the review conducted in 2006 to determine the areas of disease where we could derive the most value for patients and shareholders. This resulted in a strategy reflecting both our inherent strength in certain fields of research and the areas of greatest unmet medical need. As a result, we are focusing on six disease areas and ensuring that we have access to leading research in each area. Some of this research resides in our own laboratories and some has been sourced from third party researchers. + +We have continued our investment in both areas and you can read a review of the progress made in this report. + +The acquisition of MedImmune was a major decision, which the Board sees as transformational for the Company. The addition of MedImmune builds on the earlier investment in Cambridge Antibody Technology in the field of biologics and takes AstraZeneca into vaccine technology for the first time. MedImmune brings not only first class biologics and vaccines assets to the Group but also around 3,000 skilled professionals with expertise ranging from discovery through to commercialisation. In developing areas of medical science, these are skills that are scarce and valuable. I am confident that the combined strength of our existing small molecule expertise and the newly acquired expertise in large molecules and vaccines will generate benefits for the Company and its shareholders. + +Our key products have continued to deliver benefits to millions of patients every day around the world. We have met our sales targets despite depressed pricing in our traditional heartlands of Europe and the US and challenges to our intellectual property. In the emerging markets, we have continued to build our businesses for the benefit of patients today as well as pursuing opportunities to broaden access to our medicines in the future. + +2007 has not been an easy year for the pharmaceutical sector. With pressure on pricing and increased demand for investment, companies have been forced to drive efficiencies right across the business in order to maintain shareholder returns. The Board has been fully supportive of the programme that David Brennan has put in place to improve productivity in every area of the Company. There is no question that this sort of activity poses challenges for a management team and the Board believes that this high level of change has been handled responsibly and in a way that is consistent with the values of the Company. + +During 2007, the Board has reviewed key aspects of the Companys strategy and operations including its financial policies, human resources planning, and externalisation projects. In January 2008, the Board concluded its yearly review of its own processes to ensure that it is functioning well and properly representing the interests of shareholders. + +At the end of July, I announced the resignation of Jon Symonds as Chief Financial Officer to pursue his career outside AstraZeneca. Jon had completed 10 years of distinguished +service in the Group and his experience +and management skills were greatly valued. I am delighted that Simon Lowth joined the Company in November as an Executive Director and the Chief Financial Officer. Simon brings with him a successful track +record of business transformation in previous strategic and financial roles at Scottish Power. He has proved to be a valuable addition to David Brennans leadership team. + +There were a number of changes to the composition of the Board during the year. +At our AGM in April, we said a warm farewell and thank you to Peter Bonfield and Erna M?ller when they stepped down as Non- Executive Directors following 12 years of service. Their individual contributions to the Company over those years were significant and both served on various Board committees. In addition, Peter ably took on the role of AstraZenecas senior, independent Non- Executive Director for many years. Also in April, Joe Jimenez resigned as a Non-Executive Director following his appointment to an executive position at Novartis and we wish him well. + +I was pleased on behalf of the Board to be able to welcome Bo Angelin as a new Non- Executive Director in July. Bo is a distinguished medical scientist and I am sure that he will provide a valuable contribution to the Boards work. It also gives me pleasure to report that Michele Hooper, who has been a member of the Board for over four years now, has agreed to become our new senior, independent Non-Executive Director, in succession to Peter Bonfield. + +In 2008, our strategy remains unchanged: we shall continue to meet the needs of patients today, while investing for the benefit of patients of the future. By doing this successfully and responsibly, we will deliver the greatest rewards to shareholders and society as a whole. The business environment will continue to present challenges and the Board will work with +David Brennan and his leadership team to ensure that our business continues to adapt as needed, taking advantage of opportunities and investing for sustainable growth. + +LOUIS SCHWEITZER +Chairman + + +CHIEF EXECUTIVE OFFICERS REVIEW + +2007 was a transformational year for +AstraZeneca and I am very proud of the way that my Senior Executive Team and all our employees are adapting to a challenging external environment and addressing the needs of our business. + +Strengthening our pipeline continues to be our highest priority and we have made substantial progress over the past twelve months. We have also successfully delivered against our sales targets, whilst continuing to challenge all aspects of our cost base and drive productivity throughout the organisation. + +The acquisition of MedImmune in June gave us a leading position in biologics technology and took us into vaccines for the first time. This was a very significant move for the Group. Increased investment in these approaches to fighting disease was key to our strategy of strengthening our ability to deliver the next generation of valued medicines. MedImmune is a leader in both biologics and vaccines and brings expertise and capabilities that span the pipeline from discovery through commercialisation. It is also a vertically- integrated company that has invested for future growth and gives us significant biologics and vaccines manufacturing capability and capacity. By combining our own biologics projects and those of Cambridge Antibody Technology under MedImmunes leadership, +I believe we have created a powerful engine to drive future development. + +Our key strategic priorities are: + +> Strengthening our pipeline of new medicines from our own research laboratories and by gaining access to scientific innovation outside AstraZeneca. + +> Delivering the full potential of all our marketed medicines through rigorous life cycle management and excellent +customer support. + +> Challenging our cost structure to make +room for further investment in R&D and externalisation, whilst increasing access to our medicines. + +Promoting a culture of responsibility and accountability is a fourth priority that underpins the other three. + +As the industry changes and our business evolves, it is important that we have a workforce and style of leadership that can leverage opportunities and adapt quickly to changing circumstances. I believe that a lean infrastructure, combined with an agile mindset and a responsible approach to business, will be a critical success factor in determining our future. + +STRENGTHENING THE PIPELINE +I am pleased to report very significant progress during the year. The number of phase III projects in the pipeline has doubled to 10 from five and it was a record year for our phase I development pipeline with 24 new molecules entering first tests in man, compared with 12 in 2006. Importantly, we are also improving the quality of our early phase pipeline by researching the use of biomarkers, to give +us an indication early in the discovery process of any toxicity or other signals that might impede progression of a molecule at a +later stage. + +It is just as important to gain access to leading science from outside AstraZeneca and our externalisation programme has delivered over 20 major deals in the +last two years, as well as the acquisitions of Cambridge Antibody Technology and MedImmune. + +We also continue to partner with external organisations that share our commitment +to finding novel solutions for important areas of healthcare. During 2007 we formed +a number of important new collaborations, including one with Bristol-Myers Squibb Company to co-develop and co-commercialise saxagliptin and dapagliflozin, two products +in development for the treatment of +Type 2 diabetes. + +VALUED MEDICINES +At AstraZeneca, we take great pride in our track record of pharmaceutical innovation which spans seven decades and includes the introduction of many world-leading medicines. The key products in our range continue to make a difference for millions +of patients around the world every day. +We remain focused on leveraging the full +potential of our range and delivered a growth in sales during 2007 despite pricing challenges in key markets in Europe and the US, where payers and healthcare providers have been wrestling with the dual challenge of a growing demand for healthcare as a result of the ageing population and continued public demand for the benefits that modern medicines provide. + +Highlights in 2007 included: + +> Seroquel XR, the sustained release form +of our schizophrenia therapy, was launched in the US. It was also approved for sale in Canada and The Netherlands and the EU mutual recognition process has been completed, paving the way for launches in other European markets in the coming months. Regulatory submissions for Seroquel XR for the treatment of major depressive disorder and generalised anxiety disorder are planned for 2008. + +> The atherosclerosis label for our statin, Crestor, has been approved in the US, reflecting its efficacy in slowing the progression of atherosclerosis in adult patients with elevated cholesterol as an adjunct to diet. + +> We launched our asthma therapy, Symbicort, in the US and our innovative Symbicort Maintenance and Reliever Therapy (Symbicort SMART) is proving popular with patients in many European countries because, by combining both maintenance and rapid relief therapies +in a single inhaler, it puts them more in control of their variable disease. + +> Nexium continues to be the strongest performing branded proton pump inhibitor in the US, although the highly competitive market and the challenge of generic omeprazole are both significant. In the emerging markets, Nexium continues to show very strong growth. + +> Arimidex remains the product of choice for post-menopausal breast cancer patients and its sales are firmly in line with market growth. + +In the emerging markets of Asia, Eastern Europe and Russia, we have continued to build our business focusing on maximising our sales today whilst investing to broaden access to our medicines in future. During the year, we opened a new Process R&D facility in Bangalore, India, to add to the existing R&D facility and we are investing in a new centre for translational medicine in Shanghai, which will focus on researching medicines +especially designed to help patients in China. + +In Japan, the worlds second largest pharmaceutical market, we are working with the authorities to increase the range of medicines available to Japanese patients. Mutual recognition of research data generated in other Asian countries means that we are able to progress more quickly with dedicated studies for these markets. + +Inevitably, as a successful, research-based pharmaceutical company, this year we have received further challenges to some of our patents, the details of which are set out elsewhere in this report. We will maximise the value of our intellectual property and will vigorously defend our patents in order to protect the many years of research, and the considerable investment, which have delivered the medicines to which those patents relate. + +BECOMING LEAN AND AGILE +In 2007, we accelerated our focus on productivity, recognising the pressure on +the industry to deliver more with less. In the first quarter we made the first significant announcement of role reductions associated with the implementation of our asset strategy review. As a result of this review, we have changed the manufacturing pattern across our operations and have addressed excess manufacturing capacity in some areas. +Our drive is to maximise the efficiency of our supply chain whilst maintaining the highest possible standards of quality and security of supply at every stage. + +At the half-year, we announced further job reductions resulting from productivity improvements in other areas of the business. The full implementation of these reductions will take until 2009. However, they reflect important efficiency improvements including: the centralisation of clinical data +management to a single approach managed at two locations; re-shaping the sales force in several European countries to be able to better respond to changes in the respective national healthcare systems; the establishment of a single, global contract with IBM for information technology services and support; and the globalisation of functions such as Human Resources and +Regulatory Affairs. + +Implementing changes that involve the loss +of loyal employees is one of the hardest tasks for a Chief Executive Officer and 2007 has been particularly challenging in this respect. Throughout, we have consulted fully with +staff representatives and acted in line with local labour laws. We have also provided appropriate support to help individuals to pursue their careers beyond AstraZeneca and have engaged with the communities around our affected sites to mitigate the local impact. + +DOING BUSINESS THE RIGHT WAY +As we drive the business forward, maintaining our fundamental commitment to corporate responsibility (CR) remains a top priority. +We continuously work to ensure that our +high level values are translated into consistent actions and behaviours worldwide that are aligned with, and support the achievement +of our strategic business objectives. + +In 2007, we further strengthened our CR leadership and governance to make sure that we have appropriate systems in place for identifying the risks and opportunities +associated with our CR, together with effective frameworks for managing them and driving compliance with all relevant policies and standards. As part of this, we reviewed and expanded our Code of Conduct to provide clear direction and guidance for all our staff on what is required of them. The new Code +is being translated into over 40 languages and will be distributed to all our employees in early 2008. In addition, since the acquisition in June, we are working closely with MedImmune, which has its own long-standing commitment to working responsibly, to make sure that our policies and standards are aligned. + +CR targets and measures are included in our business performance management framework and related objectives are being included in personal targets at all levels to support the integration of CR management across the +full range of our business activities. + +You can read about key aspects of our commitment to doing business the right way, and our performance, throughout this report and further details are provided on +our website, astrazeneca.com/responsibility. We are making progress, but in the ever- changing world in which we live, there will always be work to do to ensure that AstraZeneca is not only valued as a source of great medicines, but also trusted for the +way in which we do business worldwide. + +SENIOR EXECUTIVE TEAM CHANGES +There were several important changes to my Senior Executive Team during 2007. Following the departure of Jon Symonds at the end of July after a decade of outstanding service, we welcomed Simon Lowth as our new +Chief Financial Officer at the beginning of November. During the year, Lynn Tetrault also joined the team as Executive Vice-President, Human Resources and Corporate Affairs, following the retirement of Tony Bloxham. +The responsibilities of Tony Zook, President and Chief Executive Officer, North America were extended to include Global Marketing following the departure of Martin Nicklasson to pursue his career outside AstraZeneca. David Mott, President and Chief Executive Officer of MedImmune, also joined the team following the completion of the acquisition of MedImmune in June. + +LOOKING AHEAD +We will continue our drive to broaden access to our existing medicines, improving adherence by refining the dosage and delivery mechanisms and providing support to physicians and carers. While building our business in mature markets, we will also develop the promising foundations we have in emerging markets. Driving productivity and cost reduction will continue to be a priority whilst still maintaining the levels of +strategic investment in R&D needed to push the boundaries of medical science for the benefit of patients around the world. + +Whilst we cannot predict with precision what the next decade will look like for our business, we do know that the environment in which we operate will continue to present new challenges and opportunities. I am confident that AstraZeneca has the strategy, skills and resources that will enable us to anticipate, and adapt quickly and effectively to the changes that our business faces. Above all, our single-minded determination to succeed will ensure that we will continue to stay focused on our mission to deliver great medicines and a business performance that creates enduring value for our shareholders. + +DAVID R BRENNAN +Chief Executive Officer + + +---------------------------------------------------------------------------------------------- Astrazeneca 2008 +CHAIRMANs STATEMENT + +During 2008, AstraZeneca maintained its strong focus on delivering benefit to patients and value to shareholders and society through industry-leading R&D productivity, commercial excellence and operational efficiency. + +Group sales increased by 3% in 2008 to a total of $31.6 billion. Operating profit was +$9.1 billion, up 4%. Reported earnings per share for the full year were $4.20 ($3.74 in +2007). The Board has recommended an 11% increase in the second interim dividend to +$1.50 (104.8 pence, SEK 12.02) per Ordinary Share. This brings the dividend for the full year to $2.05 (132.6 pence, SEK 15.36), an increase of 10%. In 2008, cash distributions to shareholders, through a combination of dividends and share re-purchases totaled $3,349 million. Share re-purchases for the full year amounted to $610 million. Shareholders also benefited in 2008 from an improvement in the Company share price. The London- listed share price increased by 30% during the course of 2008, as compared to a decline of 31% for the FTSE 100 index. + +During the year, we continued to invest in enhancing our R&D capabilities alongside accessing high quality opportunities externally. This investment is guided by our disease +area strategy, which reflects both our inherent strengths and the areas of greatest unmet medical need. We now have a strong development portfolio of small molecule and biological products targeted at bringing new therapeutic approaches to important areas of healthcare as quickly and safely as possible. +In particular, the improvements we have made to our cycle times mean that we should +deliver new medicines to patients even faster. +We continued to drive sales growth despite +continuing pricing and intellectual property challenges in our Established Markets. Managing the impact of challenges from generic manufacturers is now a key feature of our business. The Board was pleased to support the Senior Executive Team strategy of settling legal challenges concerning Nexium and Pulmicort Respules, rather than +managing the continued cost and uncertainty associated with a sustained legal defence. Protecting our intellectual property ensures that we can re-invest in the discovery and development of the medicines of the future and we must manage this important asset actively and effectively over the long term. + +We continued our investment in fast-growing economies to strengthen our platform +for growth in key Emerging Markets, and, alongside the rest of the pharmaceutical industry, we continued to drive efficiencies across our organisation to support sustained shareholder returns. + +In conjunction with the Senior Executive Team, during 2008 the Board reviewed the Groups strategy. This review reinforced our commitment to delivering differentiated medicines that make a meaningful difference to patients lives and to doing so in an efficient, focused, cost-effective and responsible manner. More information about the work and operation of the Board and its Committees is set out in the Business Organisation and Corporate Governance section of this Report. + +In February and September 2008 we announced the appointments of Jean-Philippe Courtois and Rudy Markham respectively. Jean-Philippes considerable experience with Microsoft in global sales and marketing, including Emerging Markets, will be of great benefit to the work of the Board. Rudys considerable experience of over 35 years at Unilever, latterly in finance, will also be invaluable to the work of the Board and to the Audit Committee. + +In November 2008, we announced the retirement of John Patterson who will leave the Company after 34 years of service and will retire from the Board on 31 March 2009. +John has made an important and highly valued contribution to the business over the course of his career with AstraZeneca and over the last five years as a member of the Board. +At the end of 2008, Graeme Musker stepped +down from his position as Group Secretary and Solicitor, and will retire in early 2009. The Board appointed Adrian Kemp to the position of Company Secretary with effect +from 1 January 2009. On behalf of the Board, I would like to thank Graeme for his 30 years of invaluable service, advice and guidance to the Board and the Company. + +The Board continues to be confident in the strong leadership of David Brennan and his Senior Executive Team and would like to thank them and all AstraZenecas employees for their hard work and dedication, which underpins the Companys success. + +The fundamentals of the world pharmaceutical market remain robust. Although industry growth is slowing, mainly due to ever-greater pressure on costs and increased generic competition, the continued demand for healthcare that underpins the industrys future growth prospects remains strong. +The pharmaceutical industry is also arguably less exposed than other sectors to the current global economic downturn, although some impact may result from increased constraints on payers, suppliers and distributors. + +Nevertheless, our rapidly changing business environment will continue to be a challenging one. The companies that will be most successful will be those that are able to manage the risks and maximise the opportunities effectively, through timely and efficient investment, appropriate use of intellectual property and constructive stakeholder engagement. I am confident that AstraZeneca is such a company and that, with our clear strategy, strong leadership and intense focus on execution, we will continue to deliver sustainable success, to the benefit of +patients, shareholders and society. + +Louis SCHWEITZER +Chairman + + +CHIEF EXECUTIVE OFFICERs REVIEW + +We are committed to delivering on our strategy and to changing the way we work so we are prepared for the future. 2008 was a year of both opportunity and challenge for the Company. I am proud to report that we delivered some significant successes against a tough background of slowing growth rates +in Established Markets, ever-greater pressure on costs and increasing challenge from generic manufacturers. + +Our strategy is clear. At its simplest, it is to create enduring value for shareholders by delivering medicines that make a meaningful difference to patient health. + +Our vision is to be an innovation-driven, research-based pharmaceutical company focused on human health and capable of delivering a consistent flow of innovative and differentiated products to patients in markets around the world. To achieve this we will make sustained investment in an industry-leading, externally networked R&D organisation with expertise in both small molecule and large molecule technologies. We will commercialise our products rapidly and globally at affordable prices through a world class sales and marketing organisation operating in both primary and specialty care markets. + +Underpinning our research and commercial operations will be a supply chain and +operating infrastructure, through which we are aiming to achieve industry-leading efficiency. + +Above all, we will seek to apply an investment discipline to all of our activities that attaches equal weight to delivering patient health and creating shareholder wealth. We will only invest shareholders funds where we see attractive returns and the opportunity to +create enduring shareholder value. +To help the organisation maintain our focus +on execution, our strategy targets four main priorities: + +STRENGTHENING ouR pIpElINE +We are discovering and developing effective medicines faster than ever before and the considerable progress we have made in reducing development cycle times and costs has been achieved without compromising on safety and quality. + +During 2008, we made eight significant regulatory submissions across several jurisdictions to broaden the use of our marketed products Seroquel, Symbicort, Iressa and FluMist, as well as two new product submissions for motavizumab, an improved anti-respiratory syncytial virus monoclonal antibody, and Onglyza, for treating Type 2 diabetes. We have strengthened our mid-stage pipeline and now have 10 projects in Phase +III development. 32 projects entered the pipeline during the year and 44 projects were progressed to their next phase of development. We now have a total of 144 projects within +a balanced pipeline of small molecule and biological products. This compares with 137 projects in 2007. + +We also continue to pursue high quality external opportunities to enhance further our in-house capabilities and have completed over 40 major deals in the last two years. These deals have increased the quality and size of our pipeline and improved the prospects +of consistently launching more new medicines each year as the pipeline matures. + +GROWING THE BUSINESS +Backed by our 70 year track record of innovation, we have a range of medicines on the market that continue to make a difference in important areas of healthcare ? and our commitment to delivering the full benefit of these medicines to patients and maximising their commercial potential remains undiminished. + +Highlights of the year included the conclusion of a major study of our statin, Crestor, in the primary prevention area, which demonstrated significant reduction in major cardiovascular events ? 44% compared to placebo in men and women with elevated hsCRP and other risk factors but low/normal cholesterol levels, a level of cardiovascular risk reduction not previously seen in a large placebo controlled statin outcome trial. +Seroquel XR has had approvals for acute bipolar depression, acute bipolar mania and as an adjunct therapy to lithium or divalproex for bipolar maintenance treatment in a number of major jurisdictions. These approvals for new indications put Seroquel XR on track to deliver its full therapeutic potential. + +In addition, our expertise in regulatory, sales and marketing is also helping to bring to markets outside the US the biological products that MedImmune brought to our range, specifically motavizumab and FluMist. + +Despite the challenging market conditions, we have continued to drive high performance and market share gains in our Established Markets and increased sales across North America, Europe and Japan. I believe our sales forces are among the best and we continue +to evolve our commercial model to ensure that we stay at the forefront of best practice in meeting the needs of our customers. + +We continue to deliver strong, profitable growth in our Emerging Markets, while continuing +our strategic investment in these markets aimed at ensuring that we are appropriately resourced to deliver the full potential of the business opportunities in these developing economies. One in seven dollars of our sales now comes from Emerging Markets and as our presence in these countries matures, and as their economies strengthen, I am confident that we will be able to increase further business efficiency and deliver improved profitability in the future. + +We received further challenges to some of our patents during the year, the details of which are set out elsewhere in this Report. We will continue to vigorously defend our patents +to protect the many years of research and the considerable investment which have delivered the medicines to which those patents relate. + +BECOMING LEAN AND AGIL +We have to be relentless in our pursuit of opportunities to drive further efficiencies across the value chain. As well as the progress delivered in R&D, we have reshaped our manufacturing and packing activities to improve productivity whilst maintaining high standards of quality and security; we have established agreements with third parties who offer specialist outsourced expertise in areas ranging from data management to catering; and put even greater focus on leveraging efficiencies within our global procurement activity. +Our continuing drive to improve efficiency and effectiveness resulted in further planned reductions of our workforce in some areas of our business during 2008 and our work on these initiatives continues. My management teams and I, take these changes very seriously and remain +committed to ensuring that we manage these changes in line with our core values. Throughout, we have consulted with staff representatives and acted in line with local labour laws. We have also provided appropriate support to help individuals pursue their careers beyond AstraZeneca and have engaged with communities around the affected sites to mitigate the local impact. + +DOIN BUSINSS THE RIGHT WAY +I want AstraZeneca to be valued as a source of great medicines, but also to be trusted for the way in which we do business. Therefore, our strategic focus includes a fourth priority, which underpins and supports achievement of the first three. We must continue to nurture a culture of responsibility and accountability across all aspects of our business activity to ensure that AstraZeneca continues to be welcomed as a trusted member of society. + +Our core values are the cornerstone of this culture and in 2007, we reviewed and expanded our Code of Conduct to provide clear direction as to how these high level values are to be translated into consistent actions across all areas of our business. +The new Code went into effect in 2008, and it was followed by mandatory training during the year for everyone in the Company. + +During the year, 86% of our employees participated in our global employee opinion survey. Results showed that employee engagement scores ? defined as the extent to which people are committed to the future success of the Company ? were very strong, and we continue to outperform other pharmaceutical companies in this area. +The results also indicated that people were seeing increased levels of co-operation between senior leaders, leading to more effective global and cross-functional working. The survey also identified some key areas +that continue to require attention, including change management, personal development and leadership communication. I take this feedback very seriously and new targets that address these issues have been included in the Senior Executive Teams performance +goals for 2009. + +SENIOR EXECUTIV TEAM (SET) CHANGES +I am delighted that we have further strengthened the SET through the appointments of Anders Ekblom and Jeff Pott. Anders was appointed to the role of Executive Vice-President, Development with effect from 1 January 2009. Jeff has already taken up his new role as the Groups General Counsel, having spent a number of years as legal counsel within AstraZenecas US business, most recently with responsibility +for managing intellectual property litigation within the US. + +During 2008 we announced that, after a long and distinguished career within the Company, John Patterson, Executive Director, Development, will retire at the end of March +2009. John has made an important and lasting contribution to the business over the course of his career with AstraZeneca. Under his leadership, the productivity and efficiency of our product development has improved significantly, and we now have the largest pipeline in our history. Also in 2008, David Mott, formerly President of MedImmune left the Company to pursue other opportunities. The role of President of MedImmune has been taken on by Tony Zook, who has also retained his responsibilities as Chief Executive Officer, North America and Executive Vice-President, Global Marketing. + +LOOKING AHEAD +Despite the very significant and economic challenges being experienced around the world, I am confident the progress that we continue to make in our four priority areas means AstraZeneca is well placed to manage the challenges and opportunities of a rapidly changing business environment. I believe that we have the strategy, the engines for growth and the levels of commitment it takes to continue making a meaningful difference in patient health through great medicines, and creating enduring value for our shareholders and society. + +DAVID R BRENNAN +Chief Executive Officer + +---------------------------------------------------------------------------------------------- Astrazeneca 2009 + +Chairmans Statement + +Group sales increased by 7% in 2009 to a total of $32,804 million. Reported operating profit was $11,543 million, up 24%. Reported earnings per share for the full year were +$5.19 (2008: $4.20). The Board has recommended a second interim dividend of $1.71, a 14% increase over the second interim dividend awarded in 2008. This brings the dividend for the full year to $2.30 (141.4 pence, SEK 16.84), an increase of 12% from 2008. In 2009, cash distributions to shareholders through dividends totalled $2,977 million. + +Meeting patient need lies at the heart of what we do. In 2009, immediate need was met when our people and technology enabled us to develop and be the first to market an H1N1 influenza (swine flu) vaccine in the US. Equally, when generic producers proved unable to supply the market for Toprol-XL, we successfully rebuilt our supply chain to fill the void. + +2009 was also a year in which AstraZeneca science was at the forefront of the industry, ensuring that we are able to meet patient need in the longer term. Two of the biggest landmark clinical trials to report in recent years, the Crestor JUPITER and the Brilinta PLATO trials, engaged academic and clinical communities across the globe. We have made regulatory submissions based on the results of these trials. + +Our strategic focus is on innovation-driven medicines that are valued by patients and payers alike. We continue to invest in new medicines and we work to protect our investments by rigorously defending our patent rights and thereby optimising our intellectual property. To this end, AstraZeneca will vigorously defend the challenge to the Crestor US substance patent brought by a number of generic drug manufacturers when the case goes to trial in February 2010. + +Worldwide, pharmaceutical industry revenue growth, while positive, is slowing. This is due to pressure on healthcare costs, exacerbated by the current economic downturn, as well +as increased competition from generic medicines. We believe pressures on costs are likely to continue, especially in the US. + +Nevertheless, the demand for healthcare that will drive the industrys future growth remains strong, especially from economic and demographic growth in Emerging Markets and the growing number of patients there who can afford our medicines. In response to these developments we have continued to drive change in the business. We are reshaping our presence in Established Markets to +ensure we remain competitive and investing in Emerging Markets around the world so that we can benefit from their growth. + +We used our assessment of the future for the pharmaceutical sector as the basis for the annual strategy review with David Brennan and his executive team. +We confirmed our commitment to being an integrated, global and innovation-driven prescription-based biopharmaceutical business. While there has already been much change in the business, the review also highlighted the need to redouble our efforts +if we are to stay at the forefront of the sector. Our plans for the business are outlined in more detail in Davids Review and the Strategy and Performance section. + +In recognition of the Groups strong balance sheet, sustainable significant cash flow and the Boards confidence in the strategic direction and long-term prospects for the business, we have adopted a progressive dividend policy, intending to maintain or grow the dividend each year. In order to ensure that long-term management incentives and shareholder interests remain aligned, we are tabling proposals for a new share-based long-term incentive plan for shareholder approval. This has been developed as part of an overall review of executive remuneration. Further information about this plan and the review can be found in the Directors Remuneration Report from page 101 and in the Notice of AGM. + +During 2009, H?kan Mogren retired from the Board, having been a Director of the Company since its formation in 1999. Before then, he had served as Chief Executive Officer and a Director of Astra AB for more than 10 years. He brought a wealth of experience and sound judgement to the work of the Board which we valued highly. As announced last year, John Patterson +also retired in 2009. On behalf of their fellow Directors, I would like to reiterate my thanks to both of them for their service to the Company. + +Once again, the Board would like to place on record its appreciation of the leadership shown by David Brennan and his team. +On behalf of the Board I would also like to thank AstraZeneca employees around the world for their contribution to what has been a very successful year. Their contribution, which has been the foundation of our past success, is also needed more than ever as we address the challenges to come. I am confident that AstraZeneca has the skills +and capabilities to continue that success by harnessing both its own efforts and the efforts of those with whom we work. + +Louis Schweitzer +Chairman + +----------------------------------------------------------------------------------- Supplementary Information + +Despite the difficult world economic conditions, 2009 was a successful year for AstraZeneca. Our strong performance and considerable achievement in making a real difference to patient health around the world meant that our shareholders were also able to benefit. + + + +CEOs Review + +Operational highlights of the year include four significant regulatory filings for new medicines and two product launches. We agreed four late-stage project collaborations and have 89 projects in clinical development. In addition, sales of Toprol-XL and H1N1 influenza +(swine flu) vaccine in the US accounted for three percentage points of the global revenue growth at CER, while growth in Emerging Markets was up 12%, accounting for 13% of total revenue. 2009 was also the year in which we reached an agreement in principle with the US Attorneys Office to settle claims relating to Seroquel sales and marketing practices and to make a payment of $524 million (including interest). + +If we are to bring benefits to patients and create value for shareholders, we need +a constant flow of new and innovative medicines. Of the four regulatory filings made in 2009, Brilinta is a treatment for acute coronary syndromes, Certriad is for the treatment of lipid abnormalities and Vimovo is for arthritic pain. The fourth submission was for a fixed-dose combination of Onglyza and metformin for treating diabetes. 2009 saw Onglyza launched in the US and in the EU for the treatment of Type 2 diabetes. Iressa, our anti-cancer medicine, was launched in the EU. Of course, in the process of developing new medicines, we experience setbacks as well as successes. The decision we made during the year to withdraw the regulatory submissions we had made for our anti-cancer medicine, Zactima, came as a disappointment. + +As projects leave the development pipeline, we replenish it with new projects that will yield regulatory submissions in future years. We now have 11 projects in Phase III development. Twenty-nine projects entered the pipeline during the year and 53 projects were progressed to their next phase of development. We seek to provide each +of these projects with a business case underpinned by a clear scientific rationale and sound financial case. + +In strengthening our pipeline we look beyond our own laboratories to access the best science and external sources of innovation. As a result, a significant number of our projects come from our programme of collaboration. These include two of our regulatory filings: Certriad was submitted with Abbott and Vimovo was submitted by our partner Pozen Inc. In addition, Onglyza was the first product of our diabetes collaboration with BMS. + +Other collaborations agreed in 2009 included the in-licence from Forest of ceftaroline, a next generation anti-infective. We enhanced the value of this programme in December with +an agreement to acquire Novexel, a private infection research company. We also agreed in-licensing deals with Nektar and Targacept. + +A further focus in 2009 was the continued reshaping of the business to give us the organisational flexibility we need to take advantage of opportunities. Initiatives include outsourcing some of our R&D activities, other business processes and support services, such as HR. To meet evolving customer needs we are adapting our methods of sales and marketing and altering our supply chains. + +Our drive to improve efficiency and effectiveness across AstraZeneca has resulted in further reductions in our workforce. The executive team and I remain committed to ensuring that we manage these changes in the right way. This means that, in meeting the needs of the business, we deal responsibly and sympathetically with affected individuals and the communities in which they live. + +We continue to integrate responsible business considerations into everyday decision-making across all our activities, reinforcing personal accountability for compliance with our Code of Conduct through training and monitoring of business practices. We were pleased to have our efforts recognised externally with improved scores in the 2009 Dow Jones Index. Looking ahead, we have identified areas for improvement and will take action +to strengthen further our governance and management processes, building on our progress to date and driving continuous improvement throughout the business. + +2009 also saw some changes to the executive team. Jan Lundberg, Executive Vice-President, Discovery Research left AstraZeneca in November. We thank him for his significant contribution to the business. Christer K?hler has taken over the role on an interim basis. Bruno Angelici, Executive Vice-President, International Sales and Marketing Organisation, will be leaving AstraZeneca later in 2010. He has made an enormous contribution and we thank him for his sound judgement and strong leadership. + +Finally, the achievements of the year would not have been possible without the dedication and hard work of all our employees, to whom I offer my thanks. For many of our employees 2009 was a year of change. The pace of change is not going to let up in 2010. Indeed, it is going to accelerate. I am confident that our staff will respond with the commitment they have shown in the past. + +The Strategy and Performance section from page 14 outlines our plans and priorities for 2010 and beyond, which we need to implement to ensure we prosper in the years ahead. In doing so, we will improve the health of patients around the world and thereby create value for our shareholders. + +David R Brennan +Chief Executive Officer + +----------------------------------------------------------------------------------- Supplementary Information + +2009 was a year of considerable achievement in which I believe we laid firm foundations for the future success of the business. Underpinning all this is excellent execution of our plans, improved organisational flexibility and a committed workforce. + + +--------------------------------------------------------------------------------------------- Astrazeneca 2010 + +Q. 2010 Ȯϰ CEO Chairman message ׿䡦 Ȯ Ź. + +--------------------------------------------------------------------------------------------- Astrazeneca 2011 + +Q. 2011 Դϴ. + +--------------------------------------------------------------------------------------------------- AstraZeneca 2010 + +At AstraZeneca, we are dedicated to the research, development and marketing of medicines that make a difference in healthcare. For us, this is at the core of our responsibility to our stakeholders and society. Successful pharmaceutical innovation, delivered responsibly, brings benefit for patients, creates value for shareholders and contributes to the economic development of the communities we serve. + +Today, new medicines are needed more than ever. People are living longer, populations are increasing and new markets such as China are fast emerging. And despite significant medical advances in recent decades, there are still many diseases which are not well treated or there is not yet an effective medicine. But while demand continues to grow, the coming years represent an unprecedented challenge for the pharmaceutical industry and for AstraZeneca. We face patent expiries on major medicines, ever higher hurdles for R&D productivity and increasing pressure on pricing as healthcare budgets around the world feel the strain. To succeed in this increasingly competitive environment, we need to get even better at what we do and build stronger relationships with our customers and other stakeholders. + +In early 2010, AstraZeneca announced a refreshed business strategy. Our overall direction remains the same but we have accelerated our effort in some key areas to make sure we are well positioned to manage the challenges ahead. We are transforming our R&D to leverage the best of what we have and building the capabilities that we need for worldclass performance. We will grow our business by further increasing our footprint in emerging markets - strengthening our sales and marketing capability alongside capital investment in new facilities. We are boosting our efforts to source innovation from outside AstraZenecas walls and working in partnerships throughout the value chain that broaden the base for success. Across all these areas, we continue to drive efficiency and effectiveness, including increased outsourcing to a diverse range of strategic suppliers. + +Our work to implement these changes is underpinned by our continued commitment to the sustainable development of our business which delivers value for our stakeholders and for us. To that end, our responsible business objectives must be closely aligned to, and support delivery of, our business strategy. In the light of our accelerated strategy, the insights gained from dialogue with our stakeholders (link to Stakeholder Engagement) and our internal risk assessment we reviewed and re-shaped our Corporate Responsibility priority action plan during the year. Our new Responsible Business Plan combines our CR and Compliance agendas and puts at the top those areas most impacted by our business changes and which are therefore key enablers of our business strategy. + +Alongside effectively managing the particular responsible business challenges associated with the changes to our strategy, we will be maintaining focus on other aspects of our responsibility: +? Patient safety +? Environment +? Employee safety, health and wellbeing +? Community investment + +During 2010, we continued to progress our CR agenda and this Responsibility section of our website provides further detailed information in each of our areas of focus. For a quick summary, please visit the our year in brief section. + +Looking ahead + +AstraZenecas continued success depends on us forging strong relationships with our stakeholders, understanding the challenges they face and working together towards a common goal: improved healthcare. The strongest relationships are built on trust and we will continue to drive our responsible business agenda to earn and maintain that trust. Our Responsible Business Plan maps that agenda and sets our direction for the next five years. And because this is a dynamic and rapidly evolving area, we will continue to engage with our stakeholders to stay in touch with the demands of a responsible business and work within the business to explore how we can further improve performance. + +--------------------------------------------------------------------------------------------------- AstraZeneca 2011 + +Dear Shareholder + +I write to you at the end of a year in which researchbased pharmaceutical companies faced a tough marketplace and operating environment. Against this challenging background, disciplined execution of our strategy delivered a good performance. Our strong cash flow supported a significant increase in cash distributions to shareholders and continued investment to drive future growth and value. These conditions also provided the backdrop to the annual review by your Board of our business strategy ? which remains to be a focused, integrated, innovation-driven, global, prescriptionbased biopharmaceutical business. + +I would like to take this opportunity to review AstraZenecas financial performance in 2011 and the decisions we took to ensure we continue to deliver sustainable value for you. + +Financial performance + +Group sales in 2011 were down 2% at CER to $33,591 million (2010: $33,269 million) and reported operating profit was up 10% at $12,795 million (2010: $11,494 million), which included the gain on the sale of Astra Tech. Performance for the year reflected strong double digit sales growth for Crestor, Seroquel XR and Symbicort. It was also impacted by government pricing interventions and generic competition, which combined to reduce revenue by some $3 billion. Revenue in the US was down 2%, as was revenue in markets outside the US: revenue was down 11% in Western Europe, up 4% in Established ROW and up 10% in Emerging Markets. + +Reported earnings per share for the full year were up 29% at $7.33 (2010: $5.60), which also included the non-taxable gain of $1.08 from the Astra Tech sale. Our effective tax rate also benefited from an adjustment in respect of prior periods following the announcement in March 2011 that HM Revenue & Customs in the UK and the US Internal Revenue Service had agreed the terms of an Advance Pricing Agreement regarding transfer pricing arrangements for AstraZenecas US business. + +A challenging marketplace + +The world pharmaceutical market grew by 4.5% in 2011 and the fundamentals of the industry remain strong. First, the world population continues to increase and age: it passed the seven billion mark in 2011, while the number of people over 65 in 2030 is estimated to be almost one billion, double the 2005 figure. Secondly, we are seeing the emergence of expanding numbers of patients in new markets who can access our medicines for the first time. Thirdly, there remains considerable unmet medical need. Chronic diseases are on the increase, not only in wealthy countries but also in middle income and, increasingly, lower income countries. For example, some 346 million people around the world have diabetes while 24 million are affected by Alzheimers Disease. Finally, advances in science and technology promise the continued delivery of new medicines that can make a real difference to patient health. + +Yet, while the fundamentals remain strong, the challenges facing the industry have been unprecedented in recent years. Patents on some of the worlds most successful innovative medicines are starting to expire and we face increasing competition from generic alternatives. Additionally, the need to improve R&D productivity and the number of product launches remains a critical challenge for the whole sector. + +Around the world, rising healthcare costs, coupled with the difficult economic climate and continued austerity measures being implemented by governments, have resulted in pressure on prices. This includes pricing interventions in many countries. The regulatory landscape is changing, becoming more global and more complex. It is no longer enough for new medicines to be safe and effective. Health authorities increasingly require additional information regarding a medicines comparative clinical and cost effectiveness. + +Our strategic response + +It was with these challenges in mind that your Board undertook its strategy review process in 2011. We are confident that long-term growth in demand for innovative biopharmaceuticals will remain strong. We believe there continue to be opportunities to create value for those who invest in pharmaceutical innovation, and that AstraZeneca has the skills and capabilities to take advantage of these opportunities and turn them into long-term value through the research, development and marketing of our medicines. We also recognise that the industry is going through a period of fundamental change as it seeks to overcome the serious challenges we face. + +For us, that means a continued focus on ensuring we drive: +> world class productivity in R&D +> increased external collaboration +> a global orientation, reflecting the growth in Emerging Markets +> stronger customer orientation, particularly towards payers +> operational efficiency with a flexible cost base. + +Our 2011 review highlighted the ongoing need for a substantial improvement in R&D productivity if we are to sustain acceptable returns to shareholders. We are therefore planning to accelerate our R&D strategy. We intend to take a new approach to Neuroscience, closing our existing research centres and creating a new virtual innovative medicines unit for our R&D in this challenging field. We also plan to reshape our other R&D global functions to better support a more focused portfolio and create a simpler organization with greater flexibility in all functional areas. + +In his Chief Executive Officers Review on the following pages, David Brennan outlines the steps we took in 2011 to secure our future business success. David also emphasises that how we do business is as important as what we do. We need to continue to work with integrity and to high ethical standards if we are to deliver on our promise of bringing benefits to patients, creating sustainable value for shareholders and contributing to economic and social welfare. In this regard, the Board has an important role to play in setting high standards and monitoring performance. + +Outlook + +We continue to plan on the basis that revenue will be in the range of $28-34 billion a year over the 2010-14 period, as revenue growth from key franchises that retain exclusivity and continued growth in Emerging Markets are pressured by the loss of market exclusivity on a number of products. However, based on the evolution of the base case assumptions since 2010, such as the downward pressure on revenue from government interventions, revenue for the remainder of the period is likely to be in the lower half of the range. + +Returns to shareholders + +In recognition of the Groups strong balance sheet and sustainable significant cash flow, and the Boards confidence in the strategic direction and long-term prospects for the business, we announced, in conjunction with the full year 2009 results, the adoption of a progressive dividend policy, intending to maintain or grow the dividend each year. After providing for business investment, funding the progressive dividend policy and meeting our debt service obligations, the Board will also keep under review the opportunity to return cash in excess of these requirements to shareholders through periodic share repurchases. + +The Board has recommended a second interim dividend of $1.95, a 5% increase over the second interim dividend awarded in 2010. This brings the dividend for the full year to $2.80 (175.5 pence, SEK 18.54), an increase of 10% from 2010. In 2011, cash distributions to shareholders through dividends totalled $3,764 million and net share repurchases totalled $5,606 million. + +Appreciation + +In the face of intensified pressures we delivered a good performance in 2011 and took difficult decisions to ensure the future success of AstraZeneca. None of this would have been possible without the leadership of David Brennan and the other members of his executive team. My thanks, and those of the whole Board, go to them and all our employees for their effort in working to deliver on our promise. + +---------------------------------------------------------------------------------------------- AstraZeneca PLC 2012 + +Dear Shareholder + +I am glad I was able to meet a number of you in April 2012 when AstraZeneca held its Annual General Meeting in London. At that meeting you elected me as a Director and it is my privilege to have served as your Chairman since June. + +Louis Schweitzer and David Brennan +The day of the AGM was, by any measure, an historic one for your Company. It was the day on which David Brennan announced his decision to retire from AstraZeneca as your Chief Executive Officer. It was also the day on which your previous Chairman, Louis Schweitzer, brought forward the date of his intended retirement to 1 June to coincide with that of David. + +Louis had been a Director since 2004 and your Chairman for seven years. During that time he worked tirelessly to ensure that the Board was effective in its task of setting our strategy and overseeing its implementation. We are grateful to him for his efforts on your behalf. + +As Chief Executive Officer, David led AstraZeneca with skill, integrity and courage during a period of enormous change for the industry and for the Company in particular. I would like to thank David for his selfless leadership during his six years at the helm. + +Non-Executive changes +Part of the strength of any board comes from refreshing and renewing the mix of people sitting around the boardroom table. When I joined the Board, I was pleased that both Graham Chipchase and Genevi?ve Berger also became Non-Executive Directors. They bring, respectively, in-depth financial and scientific expertise, as well as significant international business experience to our discussions. + +Also in April 2012, we said farewell to Michele Hooper who stood down from the Board. We are all grateful for her distinguished contribution to our work and her dedicated service as Chairman of the Audit Committee and senior independent Non-Executive Director. In her place, John Varley took over as senior independent Non-Executive Director and Rudy Markham became Chairman of the Audit Committee. + +A new Chief Executive Officer +Upon my election to the Board I was also appointed Chairman of the Nomination Committee. This enabled me to lead the important process of selecting David Brennans successor. This was a process that included both internal and external candidates and culminated in the appointment of Pascal Soriot to the Board as the Companys Chief Executive Officer on 1 October. + +Pascal joined us from Roche where he had been serving as Chief Operating Officer of the companys pharmaceuticals division. His was a key appointment at an important time for AstraZeneca. The Board is certain that Pascals leadership qualities, combined with his strategic thinking and extensive experience in the industry, make him the right person to drive AstraZeneca to success over the coming years. I am confident that Pascals approach and his track record of delivering results in innovation-driven businesses will be valued by shareholders and employees alike. + +Following Davids departure, Simon Lowth acted as Interim Chief Executive Officer. The Board and I would like to record our appreciation for his impressive leadership in this period. Supported by a highly capable and committed executive team, Simon maintained the organisations focus on key business priorities during a period of significant change. + +Sound governance +All the changes I have outlined took place at the same time as AstraZeneca completed a record number of business development deals. We also undertook our annual strategic review, in which Pascal has been fully involved, as well as our regular programme of meetings and business activity. That we have been able to do all this is a tribute both to the sound corporate governance processes we have in place and to the dedication and hard work of my fellow Directors. I am grateful to all of them for the contribution they made in 2012. + +Challenging times +We will need to harness all our skills, capabilities and experience if we are to successfully navigate the current harsh climate for the pharmaceutical sector. The world pharmaceutical market is still growing and underlying demographic trends remain favourable to long-term industry growth. However, many of the drivers of demand and supply in the industry are under pressure. + +On the demand side, we face increased competition from generic medicines as some of the worlds most successful drugs come off patent. In addition, securing recognition (through reimbursement approval) and reward (through favourable pricing and sales) for innovation is becoming more difficult in the face of intensifying pricing pressures, particularly in Established Markets facing rising healthcare costs. On the supply side, the industry faces an ongoing R&D productivity challenge. R&D costs have risen significantly over the past decade, while industry-wide probability of success continues to decline. + +Strategic focus +It is for the reasons outlined above that the outcome of our current strategic review is so important. Our strategy is rooted in our heritage as a company focused on innovative science to deliver great medicines to patients. I firmly believe that it is the path we need to take if we are to remain competitive and return to growth. That path must also include a commitment to the responsible and sustainable development of our business. That is why I was so pleased that we were once again listed in the Dow Jones Sustainability World Index in 2012 and retained our listing on the European Index for the fifth year running. + +Financial performance +We cannot hope to secure our long-term success if we do not meet our financial targets and deliver acceptable levels of return to our owners. Group sales in 2012 were down 15% to $27,973 million (2011: $33,591 million) and Reported operating profit was down 34% at $8,148 million (2011: $12,795 million). Revenue in the US was down 21% while revenue outside the US was down 11%. + +More than 13 percentage points of the revenue decline, approximately $4.5 billion, was related to loss of exclusivity on several brands in the portfolio. Seroquel IR alone declined by more than $3 billion, while regional losses of exclusivity for Atacand, Nexium and Crestor accounted for more than $1 billion. Additionally, the disposals of Astra Tech and Aptium accounted for around 1.7 percentage points of the decline. On the other hand, taken together, Symbicort, Faslodex, Onglyza, Iressa, Brilinta/Brilique and Seroquel XR accounted for more than $600 million of revenue growth. Additionally, our diabetes alliance with BMS is strengthened by the inclusion of the Amylin portfolio and the approval of Forxiga in Europe. + +Reported earnings per share were down 29% to $4.99. The decline reflects the $1.08 per share benefit in 2011 from the sale of Astra Tech and higher restructuring costs in 2012. + +Returns to shareholders +Consistent with our progressive dividend policy, the Board has recommended a second interim dividend of $1.90. This brings the dividend for the full year to $2.80 (178.6 pence, SEK 18.34). In 2012, cash distributions to shareholders through dividends totalled $3,665 million and net share repurchases totalled $2,206 million. In October, we announced the suspension of our share repurchase programme for 2012 and the Board has decided that no share repurchases will take place in 2013 in order to maintain the flexibility to invest in the business. + +Outlook +We believe challenging market conditions will persist in 2013, including continued government interventions in price. The revenue impact from the loss of exclusivity will also continue to affect our performance. In the context of the ongoing update to our strategy, we have withdrawn the planning assumptions for revenue and margin evolution for the period 2010 to 2014 we outlined in January 2010. We plan to hold a Capital Markets Day in March 2013 to provide a more detailed exposition of our strategic priorities. + +---------------------------------------------------------------------------------------------- AstraZeneca PLC 2013 + +Dear shareholder +One of the key responsibilities of a board of directors is to set a companys strategy. As the CEO outlines in his Review on the following pages, and as we seek to demonstrate throughout this Annual Report, your Board has chosen a very clear strategic route to follow. It is rooted in our heritage as a company focused on innovative science to deliver great medicines and sets out our ambition to lead in science and return to growth. + +Good governance +As your Directors review our strategy and carry out their other duties, it is my role as Chairman to lead the Board effectively. To my mind, good governance is at the heart of that. So that you can easily see how we are governed, we have provided a corporate governance overview on page 26 of this Annual Report. We also briefly describe how our governance structure supports the delivery of our business strategy. You can find more detail in my full Corporate Governance Report from page 88. On page 24, we have also provided an overview of the risks that might prevent us from achieving the full potential of our strategy. + +Transparent reporting +Hand in hand with good governance goes transparent reporting and this year we have made a number of other changes in the Annual Report intended to promote this. Some have been caused by changes in UK reporting regulations, others by changes to the Corporate Governance Code and some by ever-evolving reporting best practice. Significant changes include the introduction of a Strategic Report, which starts by explaining our business model and goes on to describe how each element helps deliver our strategic goals. The Strategic Report is introduced in more detail on page 1. + +This year, the Annual Report also includes a revised Directors Remuneration Report from page 102, which is introduced by the Chairman of the Remuneration Committee, John Varley. A separate Audit Committee Report is introduced by the Chairman of the Audit Committee, Rudy Markham. + +All the changes we have made are also intended to reflect our greater than ever efforts to make this Annual Report fair, balanced and understandable. + +Challenging environment +Any balanced review of AstraZeneca needs to reflect the environment in which we operate. The challenging conditions which I touched on last year continue. The world pharmaceutical market is still growing and underlying demographic trends remain favourable to long-term industry growth. However, many of the drivers of demand and supply in the industry are under pressure. + +On the demand side, we face increased competition from generic drugs as some of the worlds most successful medicines come off patent. In addition, securing recognition (through reimbursement approval) and reward for innovation (through favourable pricing and sales) is becoming more difficult in the face of intense pricing pressures, particularly in Established Markets facing rising healthcare costs. On the supply side, the industry faces an ongoing R&D productivity challenge. R&D costs have risen significantly over the past decade, while industry-wide probability of success of new medicines, though showing some recent signs of improvement, has not kept pace. + +Loss of exclusivity +Loss of exclusivity has had, and continues to have, a significant impact on AstraZeneca. In 2013, loss of exclusivity on brands such as Arimidex, Atacand, Crestor, Nexium and Seroquel IR in a number of markets accounted for a revenue decline of some $2.2 billion. Over the coming years, this trend will continue as medicines such as Crestor, Nexium and Seroquel XR continue to lose exclusivity in markets such as the US and Europe. + +Of course, loss of exclusivity is a normal part of an innovative medicines life-cycle. It comes at the end of the period when a new medicine is safeguarded from being copied so that we can generate returns on the investment we have made, both to reinvest in the business and provide an appropriate return to you, our owners. A well-functioning intellectual property system of this type, which rewards innovation, is the principal economic safeguard in our industry. It underpins our business model, which we explore in more detail in the Business model section from page 10. + +Our performance in 2013 +As expected, our financial performance in 2013 reflected the ongoing impact of the loss of exclusivity for several key brands, with revenue down 6% to $25,711 million (2012: $27,973 million). Core operating profit fell by 22% to $8,390 million (2012: $11,159 million). The decline in revenue was, in part, offset by our key growth platforms: Brilinta, our diabetes franchise, respiratory, Emerging Markets and Japan, which delivered an incremental $1.2 billion of revenue in 2013. + +Core EPS for 2013 were $5.05, down 23% on 2012. This decline was greater than the decline in revenue primarily due to our investment in our key growth platforms and strengthened pipeline. Reported EPS for the year was down 55% to $2.04. The impairment of Bydureon in the fourth quarter reduced Reported EPS by $1.10, resulting in a Reported loss per share for the quarter of $0.42. + +A responsible company +I firmly believe that our commitment to good financial performance needs to be matched by a continued focus on being a responsible company, by working with integrity and delivering sustainable business development. I therefore fully support the decision we have made to focus our responsible business activities on access to healthcare, diversity and reducing our environmental impact. It is where I believe we are able to implement standards that will accelerate our business strategy and deliver wider benefits to society. + +It is also gratifying to see our current efforts recognised by again being listed in the Dow Jones Sustainability World Index in 2013, with a record-equalling score, and retaining our listing on the European Index for the sixth year running. + +Return to shareholders +Consistent with our progressive dividend policy to maintain or grow the dividend each year, the Board has recommended a second interim dividend of $1.90. This brings the dividend for the full year to $2.80 (176.0 pence, SEK 18.33). + +The Board regularly reviews our distribution policy and overall financial strategy to continue to strike a balance between the interests of the business, our financial creditors and our shareholders. Having regard for business investment, funding the progressive dividend policy and meeting our debt service obligations, we currently believe it is appropriate to continue the suspension of the share repurchase programme which was announced in October 2012. We continue to target a strong, investment grade credit rating. + +Outlook +As we look to the future, we expect a low-to-mid single digit percentage decline in revenue at CER for 2014. In percentage terms, Core EPS for 2014 is expected to decline in the teens at CER. Following the acquisition of BMSs 50% interest in our joint diabetes business, and as the diabetes businesss pipeline of new products is progressively launched, we expect 2017 revenues will be broadly in line with 2013 revenues. This expectation involves a number of assumptions, including, among other things, Nexium US generic launch in May 2014. + +Appreciation +Before closing, and on behalf of the Board, I want to thank the employees of AstraZeneca whose efforts helped us achieve so much in 2013 as we lay the foundations for leading in science and returning to growth. In particular, I want to express my appreciation to Pascal and all the members of the SET for the leadership they have shown and the inspiration they have provided to the organisation. + +Finally, I would like to thank all my fellow Directors for the contribution they have made to our discussions throughout a busy 2013. We look forward to welcoming as many of you as possible to our Annual General Meeting in April. + +---------------------------------------------------------------------------------------------- AstraZeneca PLC 2014 + +Dear shareholder +As 2014 finished, it brought to a close an exceptional year for AstraZeneca. We ended it fully focused on the delivery of our strategy as an independent company. This means turning our attractive growth prospects and a rapidly progressing pipeline into life-changing medicines and value for shareholders. + +In his Review on the following pages, your Chief Executive Officer outlines the progress we made during the year in delivering our strategic priorities. I would like to concentrate on the context in which that progress was made and the implications for you, our owners. + +Clear decisions, responsibly made +When Pfizer approached AstraZeneca during 2014, our responsibilities as Directors were clear: to act in a way that promoted the success of the Company for the benefit of its shareholders. In addition to assessing the value and deliverability of Pfizers proposals, we had to have regard to the long-term consequences of our decisions, the interests of employees, relationships with customers, our impact on the wider community, including patients, and the reputation of the Company. At each stage of the process, it was my duty as Chairman to ensure we carried out our deliberations responsibly, with those duties in mind. After extensive review and discussions, your Board rejected Pfizers various proposals. We did so because + +> the proposals fell short of AstraZenecas value as an independent, science-led company + +> AstraZeneca had excellent momentum in the delivery of our clearly defined strategy, underpinning the Boards confidence in our long-term revenue targets and profitability + +> Pfizers proposals brought uncertainty and risks for AstraZeneca shareholders. + +In the wake of that decision, I believe we have taken full advantage of the opportunity to galvanise employees and build on our demonstrable progress as an independent company. + +A responsible business +Of course, acting responsibly is not restricted to the AstraZeneca boardroom. It applies to all our activities. External recognition is particularly helpful in providing independent validation of our performance. I was therefore pleased that we were once again listed in the Dow Jones Sustainability World Index in 2014. We also retained our listing on the European Index for the seventh year running. + +In the biennial Access to Medicines Index, we were disappointed to find ourselves in 15th position. We remain determined to find new ways to improve access to healthcare. I am confident that our Healthy Heart Africa programme, which aims to improve the lives of hypertensive patients across Africa through increased education, screening, diagnosis and treatment, will make an important contribution. + +Improved access matters because our innovative medicines can make a global contribution to better health. They help increase survival rates and improve quality of life for patients in important areas of medical need. + +Financial performance in 2014 +Revenue was up 3% to $26,095 million, which was in line with our upgraded guidance. On an actual basis, revenue was up 1% as a result of the negative impact of exchange rate movements. Core operating profit in 2014 was down 13% to $6,937 million while Core EPS were $4.28, down 8%. + +Our performance reflected the delayed launch of generic Nexium (esomeprazole) in the US as well as the accelerating performance of our growth platforms, which now contribute over half of our revenues. Taken together, they more than offset the impact of loss of exclusivity. Our strong performance in Emerging Markets was a particular highlight, with China becoming our second largest market. + +Loss of exclusivity +The loss of exclusivity referred to above, and its timing, has had, and continues to have, an impact on AstraZeneca. Over the coming years, this trend will continue as medicines such as Nexium and Crestor continue to lose exclusivity in key markets, including the US and Europe. + +Of course, loss of exclusivity is a normal part of an innovative medicines life-cycle. It comes at the end of the period when a new medicine is safeguarded from being copied so that we can generate returns on the investment we have made. A well-functioning intellectual property system of this type, which rewards innovation, is the principal economic safeguard in our industry. It is why we commit significant resources to establishing and defending our patent protections. + +The challenging environment continues +More generally, we continue to face challenging market conditions. While the world pharmaceutical market is growing and underlying demographic trends remain favourable to long-term growth, many of the drivers of demand and supply in the sector are under pressure. + +On the demand side, we face increased competition from generic drugs as some of the worlds most successful medicines come off patent. In addition, securing an appropriate level of reward for our medicines is becoming more difficult in the face of intense pricing pressures, particularly in Established Markets facing rising healthcare costs. On the supply side, the industry faces an ongoing R&D productivity challenge. Costs have risen significantly and, while in 2014 the FDA approved the highest number of new medicines for 18 years, there is still some way to go in improving the probability of success of our projects. + +Return to shareholders +Consistent with our progressive dividend policy to maintain or grow the dividend each year, the Board has recommended a second interim dividend of $1.90 per Ordinary Share. This brings the dividend for the full year to $2.80 per Ordinary Share. + +The Board regularly reviews its distribution policy and its overall financial strategy to strike a balance between the interests of the business, financial creditors and shareholders. We continue to target a strong, investment grade credit rating. + +Outlook +As we look to the future, we expect sales revenue to decline by mid single-digit percent at CER in 2015. Consistent with our business model, we will continue to seek externalisation revenue from collaborations and licensing select products and technologies. Core EPS is expected to increase by low single-digit percent at CER. This expectation involves a number of assumptions, including the imminent launch of a Nexium generic in the US market. + +Appreciation +Before closing, and on behalf of the Board, I want to thank the employees of AstraZeneca. Their outstanding efforts helped us achieve so much in 2014 towards leading in science and returning to growth. In particular, I want to express my appreciation to Pascal and all the members of the Senior Executive Team for showing such inspirational leadership throughout a challenging year. + +Finally, I would like to thank all my fellow Directors for the quality of their contributions and conscientiousness they brought to our discussions throughout an exceptionally busy 2014. +------------------------------------------------------------------------------------------------- Baxter 2004 + +A Message from the Chairman and CEO + +Dear Baxter Stakeholder, + +I have been in my role as Baxter chairman and CEO for just over a year and, in that time, I have focused on four key business priorities: +1. Rebuilding our senior leadership team; + +2. Restoring investor credibility in the company; + +3. Implementing the companywide restructuring program; and + +4. Re-engineering business and administrative processes. + +One could ask, quite legitimately, what these priorities have to do with sustainability. The answer is: everything. This focus is helping us considerably strengthen our business and places us in a much better position to make a positive impact socially and environmentally. + +Enlightened companies are increasingly realizing the intercon- nection between the business enterprise and society at large. In the coming years, one thing that will differentiate great from good companies is a companys participation in, and commitment to, broader societal issues ? in short, its success across the triple bottom line of economic, social and environmental performance. + +Making Progress +It all starts with people, which is why the first priority has been to rebuild our senior leadership team. Making sure we have the right skill sets to lead us prosperously into the future is critical to sustainability. But as important as experience, education and intellect are, it also is essential that our leaders set the right exam- ple and model the right behaviors for the rest of the organization. + +In addressing our second priority that focuses on restoring cred- ibility with investors, we are strengthening the quality of our earnings and our balance sheet, and driving greater discipline in capital allocation. We are focused on being realistic in our financial projections and then meeting those targets, quarter after quarter. We also are forthright and transparent when something goes awry. In July 2004, we announced plans to restate our financial results +for the years 2001 through 2003 and the first quarter of 2004 due to incorrect revenue recognition and inadequate provisions for bad debts in Brazil during that period. You can read more about this on our sustainability website as well. While the adjustments were not significant to our overall operations, we felt a restatement was the most appropriate action. We were transparent about the reasons and have taken remedial actions to ensure this type of situation does not occur again, in Brazil or elsewhere at Baxter. + +The third priority has been to implement the companywide restructuring program to help us reduce cost structure, change how work is done and drive improvements in financial perfor- mance. While there was a significant impact to our global work- force, which we discuss in this sustainability summary report, +the restructuring will result in a stronger company. This provides us with the financial strength and flexibility to pursue new prod- ucts, new innovations, new businesses and markets going forward, and ultimately job creation. + +We are making great progress on the fourth priority?re-engineering business processes. We have been very focused on improvements to our quality and regulatory systems for both new and existing products. In terms of new products, we are implementing a new product development process that will result in better product quality and products that better meet customer needs. +It includes an assessment called a Product Sustainability Review designed in part to minimize the environmental impact of our products throughout their entire lifecycle. We also are re-engineering processes in finance, R&D, and strategic planning. + +These ongoing efforts do not immediately translate into improved financial results or accelerated growth, but they do lay the ground- work for future success. We acknowledge room for continued improvement in all these areas. + +Making a Difference?Now and in the Future +Perhaps nowhere does our business come together more with our commitment to social responsibility than in the area of increasing access to healthcare. Given our business to provide high quality and effective healthcare options for individuals around the world, we can contribute to increasing access to care in ways that other companies cannot. For example, thousands of people around the world with end-stage renal disease currently go untreated due to inadequate healthcare resources, particularly in developing coun- tries. One possible answer for these patients is peritoneal dialysis (PD), an ambulatory therapy that, unlike more conventional hemodialysis, does not require an infrastructure of clinics, offering potential cost as well as quality-of-life benefits. Through efforts like our PD colleges in Asia, we are working to increase awareness and education about PD in these countries so patients can have access to this life-saving therapy. + +Additionally, our sustainability report and website feature our efforts in providing emergency relief to victims of the tsunami in southern Asia in December 2004 and other product donations to meet critical healthcare needs worldwide. Together, Baxter and The Baxter International Foundation contributed approximately +$15 million worldwide to communities in need in 2004, much of it focused on increasing access to healthcare for children, the uninsured, the indigent and the elderly. + +Increasing access to care is just one of the many ways we have a positive impact on our communities around the world. We are proud of the contributions we make and the recognition we have received for our efforts. For example, the U.S. Environmental Protection Agency recognized Baxter as a Corporate Leader in its Performance Track Program. Our health and safety program had another record-best year in 2004. We were named to Business Ethics magazines 100 Best Corporate Citizens list. In addition, we were named by Innovest Strategic Value Advisors to the Global +100 Most Sustainable Corporations in the World. + +While this recognition is rewarding, we will not become com- placent about other areas where we can do more. Except in the environment, health and safety area, where we set long-term goals and are currently in the process of finalizing 2010 goals, we need to do more in setting strategic priorities with measurable goals +for other areas of sustainability. We need to identify and focus on those areas where we can have the greatest impact and establish clear targets. We plan to address this over the next year, and I hope to report back next year with a strategic framework and specific priorities to guide our short- and long-term sustainability efforts. + +Sustainability by its very definition implies continuous improve- ment. Its about aspiring to be more and do more. This is the basis on which great companies are built. + +I am proud to be associated with a company in which people are committed to having a positive impact on society at large. Together, we are making a difference through our foundation work and other charitable giving, representation and support of civic and cultural organizations in the communities we serve, business practices, education, environment, diversity, safety, governance, work/life balance and, of course, the products we make that save lives every day. + +Our commitment to all stakeholders is to continue to make Baxter stronger and more competitive as a business while also doing all we can to make the world a better place for future generations. + +Robert L. Parkinson, Jr. + +--------------------------------------------------------------------------------------------- Baxter 2005 + +FROM THE CHAIRMAN AND CEO + +As the first manufacturer of commercially prepared intravenous (IV) solutions, Baxter revolutionized an industry. Today, as we celebrate our 75th anniversary, saving and sustaining lives remains our hallmark, and our mission. Breakthrough technologies in hemophilia treatment, kidney dialysis and other advances over the years have given rise to current research initiatives involving adult stem cell therapies, tissue- regeneration technologies, and vaccines for avian flu and other infectious diseases using our patented vero cell technology ? all aimed at providing better healthcare for people worldwide. + +Our ability to continue providing life-saving products and therapies for future generations requires a strong foundation to invest in new product development, acquisitions and alliances, and longer-term research and development (R&D) opportunities. Weve made substantial progress over the last few years in strengthen- ing our business and our financial position, giving us the resources to accelerate R&D spending and other investments in our future. I believe our success as a business and our ability to excel across all aspects of sustainability go hand in hand. The successful companies of the future will recognize that these elements do not operate independently, but rather, depend on each other, and must be integrated into the fabric of a companys culture. + +Clearly, innovation is key to our future success. In January 2006, we lost one of the great innovators in the history of healthcare when former Baxter Chairman and Chief Executive Officer William B. Graham passed away at the age of 94. Mr. Graham presided over Baxters most innovative period, during which the company introduced a steady stream of new products and therapies that changed the face of medi- cine. The reputation Baxter enjoys around the world to this day is largely due to Bill Grahams leadership from the 1950s to the early 1980s. We aspire to continue his legacy. + +Meeting Healthcare Challenges + +We are privileged to work in an industry where the products we make save lives. At the same time, the healthcare industry is complex, highly regulated and defined by constantly changing technologies. These dynamics create unique challenges for companies like Baxter, and for doctors, patients, payers and others in a varied array of healthcare systems around the world. Key challenges and how we address them are highlighted below. Youll have an opportunity to read more about these issues and Baxters response throughout this report. + +Patient Safety. As a company with a long history of products and therapies that improve patient safety, we are working with customers and industry groups to reduce medication errors and promote other safe medical practices. In December 2005, Baxter was one of the first healthcare companies to participate in the Institute for Healthcare Improvements 100,000 Lives Campaign ? an initiative to save 100,000 lives in U.S. hospitals over 18 months through adoption of best-safety practices. + +Access to Care. The rising cost of healthcare and limited reimbursement makes expanding access to care a major challenge, particularly in developing countries. We invest significant time and resources in educat- ing elected officials around the world on the costs of different therapies, and work with them to facilitate +reimbursement policies to fund needed healthcare in their countries. We also provide cost-effective products and therapies that make care more accessible in emerging markets like China, where our peritoneal dialysis (PD) products make home therapy possible for thousands of people with end-stage kidney disease who might otherwise go untreated. + +Product Quality. One of our greatest challenges in 2005 and 2006 has been working with the U.S. Food and Drug Administration (FDA) to resolve quality issues related to our COLLEAGUE and SYNDEO infusion pumps. In June 2006, we reached agreement on a consent decree with the FDA outlining steps we must take to resume sales of new pumps in the United States. Baxter has a long tradition of quality excellence, and we continue to make this the highest priority in the company. With todays healthcare technologies more complex than ever, we must continue to improve our quality systems to sustain the reputation we enjoy around the world, today and in the future. + +Public Health. We are partnering with governments around the world to help protect citizens from poten- tial pandemics and bio-terrorist threats. In the last few years, Baxter has been involved, directly or indirectly, in the development and/or production of vaccines targeted at smallpox, SARS, anthrax and avian flu, as well as therapeutic products for nerve gas exposure. + +Other Sustainability Highlights + +Weve made significant progress in our understanding of sustainability and its importance to our business. In part, this is reflected in a more robust report this year, with more in-depth reporting and several new sections, including content that covers Baxters broader economic impacts as well as efforts to influence our suppliers sustainability performance. + +I believe sustainability reporting is not just a way to be transparent with our stakeholders, but also helps motivate organizational improvement. In my letter last year, I mentioned the need to set sustainability priorities with measurable goals in areas where we can have the greatest impact. In the next section of this report, you can read about where we are in this process. + +Other highlights in the report include: + +? New EHS goals: We describe our performance against our 1996-2005 environmental, health and safety (EHS) goals and introduce a new set of long-term goals. Last year also marked our third straight year of record safety performance. However, with several serious work-related accidents, we must continue to improve in this area. +? Update on diversity: Although we recognize the need to improve our employee diversity programs, weve increased the diversity of our senior management significantly over the last few years. Of our 16 corporate officers, seven are women or minorities, none of whom were in their positions three years ago. This reflects our commitment to a diversified work force, which must start at the top. +? Addressing market needs: We launched a new line of IV solution containers made of non-PVC (non- polyvinyl chloride) film, containing no latex and offering a DEHP-free [di (2-ethylhexyl) phthalate-free] fluid pathway to patients. Coupled with our existing lines of non-PVC containers, we are now positioned to offer the broadest non-PVC, non-DEHP portfolio of any manufacturer. +? Community support: Total giving by Baxter and The Baxter International Foundation exceeded $35 million in 2005, including cash contributions, product donations and foundation grants. In a year marked by natural disasters, we donated more than $17 million worth of vital healthcare products to recipients in 51 countries, mostly through international disaster-relief and humanitarian-aid organization AmeriCares. + +As we reflect on our 75th anniversary, we will continue to develop products and therapies to save and sus- tain lives for another 75-plus years. At the same time, we will be equally focused on sustaining our world in a socially, environmentally and economically responsible manner. There is much to do on all these fronts. I look forward to reporting progress in the coming years. + +Robert L. Parkinson, Jr. + +------------------------------------------------------------------------------- Supplementary Information + +75 YEARS OF SA VING AND SUST AINING LIVES + +At Baxter, sustainability is part of our business, and our business success. Since our founding in 1931, we have provided the world with medical technologies and therapies that have saved and sustained countless lives. Today, as we celebrate our 75th anniversary, we are also focused on the social, environmental and economic impacts we have on our stakeholders as we work to meet the challenges of a complex and changing global healthcare environment. + +Today, as we celebrate our 75th anniversary, saving and sustaining lives remains our hallmark, and our mission. + +------------------------------------------------------------------------------------------------- Baxter 2006 + +FROM THE CHAIRMAN AND CEO + +Today, being a great company requires more than sustained ?nancial success and technological innovation. It also requires a commitment to address pressing social and environmental concerns. The interdependence of these elements will only become greater in the years ahead. The challenge, of course, is to effectively balance societys current and future needs with the goals of the business. The companies that succeed in the 21st century will be those that can make this happen. + +Making the business case for sustainability ? that sustainability is good business ? isnt a novel concept. For example, most companies have come to realize that eliminating waste or saving energy is good for their bottom line as well as the environment. Leadership in sustainability is also instrumental in attracting top talent in an increasingly competitive global marketplace. For Baxter, increasing access to healthcare around the world also expands the market for our products. + +As a healthcare company, we already address some of the worlds key sustainability challenges. Our products provide critical therapies for millions of people, saving and sustaining lives in more than 100 countries. Our work provides a heightened sense of purpose to what we do, which extends across the breadth of issues that de?ne sustainability. Whether by producing breakthrough innovations to improve patient safety, responding to the critical healthcare needs of disaster victims, or protecting the health of the planet through environmental stewardship, virtually all we do is about saving and sustaining lives ? a purpose that binds us as a company and as global citizens. + +SUSTAINABILIT Y HIGHLIGHTS + +Baxter had a number of accomplishments in the area of sustainability during the past year that you can read about in this report. These include: + +? Forming an executive-level Sustainability Steering Committee to embed sustainability more deeply into our business and guide our global sustainability efforts. In June 2007, the committee de?ned a set of sustainability priorities to help focus our resources where we +can have the greatest impact. These priorities appear on page 5. + +? Continuing to work with health authorities around the world in the development and production of a candidate H5N1 vaccine to protect citizens in the event of an avian ?u pandemic. Were also working with the World Health Organization on global pandemic planning, including donations of our candidate vaccine to an international stockpile for developing countries. + +? Making our corporate headquarters in Deer?eld, Illinois, a carbon-neutral facility. Our decision to offset 100 percent of the greenhouse gas emissions associated with electricity and natural gas use at our 105-acre complex with renewable, clean energy complements our +many other efforts to address climate change. These range from improving energy ef?ciency in our operations to advocating progressive public policy at the local, state and national level. + +? Making signi?cant progress against our long-term environment, health and safety goals, +including a 9 percent reduction in water usage and a 5 percent reduction in energy usage and greenhouse gas emissions per unit of sales. +? Earning a Green-e label ? the ?rst in the medical industry ? for our new AVIVA intravenous solution container, the ?rst product of its kind made with 100 percent certi?ed renewable electricity. + +? Exceeding $35 million in product donations, cash contributions and grants from Baxter and The Baxter International Foundation to increase access to healthcare, aid disaster victims and address other critical needs in communities worldwide. + +SUSTAINABILIT Y CHALLENGES + +Last year, I outlined some of the sustainability challenges we face in the healthcare industry. Ensuring patient safety, expanding access to care, improving product quality and supporting public health all remain areas of focus for Baxter globally. + +Two new areas of focus are primarily U.S.-based. One is increasing our support of the U.S. educational system, particularly in the area of math and science. We already support education worldwide through programs and grants from The Baxter International Foundation and volunteer efforts by our employees and facilities. But I believe we can play a larger role in supporting math and science education given our place in the scienti?c community. + +The other area of focus is U.S. healthcare reform. Baxter operates in more than 100 countries and has extensive exposure to the bene?ts and drawbacks associated with various healthcare systems around the world. As the United States looks to reform its healthcare system, we can provide a valuable perspective to policymakers as they search for a solution to the problem of an estimated +47 million people without health insurance in the worlds most prosperous country. + +Corporations today ? particularly global corporations ? have a greater role to play, and a greater responsibility, in ensuring a sustainable world. Sustainability and pro?tability are not mutually exclusive. On the contrary, they are closely intertwined and reinforcing. Im proud of the achievements we have made so far, and look forward to reporting on future efforts in the years to come. + + +July 2007 + +------------------------------------------------------------------------------- Supplementary Information + +Every great company is built on its ability to recognize and embrace challenges, and develop effective solutions. A companys approach to sustainability is no exception. + +Today, being a great company requires more than sustained ?nancial success and technological innovation. It also requires a commitment to address pressing social and environmental concerns. The interdependence of these elements will only become greater in the years ahead. The challenge, of course, is to effectively balance societys current and future needs with the goals of the business. The companies that succeed in the 21st century will be those that can make this happen. + +------------------------------------------------------------------------------------------------- Baxter 2007 + +From the Chairman and CEO + +As a recognized innovator and leader in healthcare, Baxter is responsible for many medical breakthroughs that society takes for granted today. The company has played a leading role +in the development of modern intravenous (iV) therapy, hemophilia treatment, kidney dialysis and other life-saving therapies. + +Baxters unique combination of expertise in medical devices, pharmaceuticals and biotechnology sets us apart from others in the healthcare industry. i believe the critical natur of our work extends naturally to sustainability, where the goal is sustaining all life on the planet + +A Critical Challenge +We are privileged to work in an industry where the work we do benefits so many. of course, what makes our business so rewarding also presents our greatest challenge: ensuring the safety and efficacy of our products, which are used millions of times a day by patients world- wide, each time to treat a critical, life-threatening condition. + +When youre in a business like ours, the stakes are high. Product quality is paramount. We are committed to the highest quality standards attainable to protect the health and safety +of patients wherever we do business. its a challenge and responsibility we accept as a global leader in healthcare. + +In the Product responsibility section of this report, you will read about a situation that unfolded during the first half of 2008 regarding heparin, a commonly used generic blood thinner that Baxter manufactures. The challenge for us is, how can we learn from this to prevent similar occurrences in the future? How can we provide better oversight of vendors, and of vendors to vendors, in a complex global supply chain? it is an opportunity for us +to improve our practices based on our learnings and to share those learnings with industry. + +Sustainability highlights +? In 2007, we established nine sustainability priorities to focus our efforts in areas where Baxter can have the greatest impact. To provide strategic direction and help us make progress in these areas, in 2008 we added long-term, measurable goals for each sustainability priority. We present these goals in this report and will continue to update you on our performance in the future. +? The pace of innovation is accelerating at Baxter. in this report, Baxter chief scientific officer norbert Riedel, ph.d., discusses several promising areas. These include adult stem cell therapies for coronary and peripheral artery disease, alternatives to iV infusion for critical fluids and drugs, and an automated home dialysis system designed specifically for developing markets. +? in 2007, we made progress toward our water usage, energy usage and greenhouse +gas emissions goals, although advancement toward our total waste reduction goal was slowed in part by production changes in our operations. our manufacturing facility in costa Rica became the countrys first to be recognized as carbon neutral, joining other Baxter sites, including our corporate headquarters. +? We extended our commitment to employee wellness by launching BeWell@Baxter, which offers an expansive array of programs and resources to help our 46,500 employees and their families worldwide stay well. We recognize that a healthy, productive workforce is vital to our business. +? Responding to stakeholder input, we have provided a more robust public policy section in this years report. it includes examples of how we are working with governments around the world to increase patient access to Baxters life-saving therapies, as well as data regarding political contributions and lobbying expenses. +? Finally, in the area of corporate giving, combined contributions by Baxter and The Baxter international Foundation ? the philanthropic arm of the company ? totaled nearly $55 million in 2007. This includes more than $31 million in product donations to organizations in 53 countries for disaster relief and humanitarian aid. + +Working toward Sustainable Future +No global corporation can afford not to act responsibly in todays marketplace. Baxters approach to sustainability reflects the quality of our management, our people and our company culture. it also reflects the responsibility and accountability we must demonstrate to remain a global leader in our industry. + +We also see sustainability as a way to attract and retain talent and make Baxter a rewarding place to work and develop. Ultimately, we believe our efforts in sustainability enhance shareholder value by making Baxter a more competitive company in an increasingly challenging business environment. + +Our efforts to bring life-saving therapies to countries where many people still go untreated for conditions such as hemophilia, kidney disease and others are not altruistic. its our business. But the goal is similar to other elements of sustainability ? to save and sustain lives. it is this higher purpose that binds everyone at Baxter together as a company and as global citizens. + + +May 2008 + +------------------------------------------------------------------------------- Supplementary Information + +Part of being a great company is being a responsible corporate citizen. At Baxter, we use the term sustainability to describe our long-term approach to balancing our business priorities with our social, economic and environmental responsibilities. These efforts align with and support the companys higher purpose of saving and sustaining lives. + +When youre in a business like ours, the stakes are high. Product quality is paramount. We are committed to the highest quality standards attainable to protect the health and safety of patients wherever we do business. Its a challenge and responsibility we accept as a global leader in healthcare. + +------------------------------------------------------------------------------------------------- Baxter 2008 + +From the Chairman and CEO + +Baxter plays a unique role in healthcare. Virtually every product we make is used to treat a critical, life-threatening condition. Our therapies are infused, injected or inhaled an estimated six million times a day, in more than 100 countries, to save and sustain the lives of people with hemophilia, immune disorders, end-stage kidney disease and other critical illnesses. + +The sustainability challenges we face as a society are no less critical. Poverty, hunger, climate change, resource depletion, and lack of access to quality healthcare and education are just some of the threats to the well-being of future generations. +At Baxter, we are committed to applying the same dedication and spirit of innovation to improving the health of the planet as we do in developing new and better therapies for patients. + +We define sustainability as a long-term approach to including our social, economic and environmental responsibilities among our business priorities. Baxters efforts in this area align with and support our mission of saving and sustaining lives. + +This is the 10th year that Baxter has published a sustainability report. In all of our sustainability-related activities, whether its corporate giving, expanding access to healthcare, strengthening education or other areas you can read about in this report, we strive to be leaders, setting the pace for others to follow. + +Establishing Sustainability as part of our culture +Since joining Baxter as chairman and chief executive officer in 2004, I have been highly supportive of accelerating Baxters sustainability efforts, and I am proud of the progress weve made in making sustainability part of our culture. + +Our formation in 2006 of an executive-level Sustainability Steering Committee to guide our global sustainability efforts was a significant step forward. It further institutionalized sustainability at Baxter and elevated accountability for sustainability across the company and to the highest levels of management. + +The creation of nine sustainability priorities in 2007 was the next step in this process. These priorities, which are the focus of our print report this year, define what we consider to be the most important sustainability areas as a company and help us channel our resources where we can maximize our impact. Since then, we have added long-term 2015 goals for each priority to further clarify our expected progress. Advancement toward these targets is measured quarterly and reported to management. + +Our sustainability priorities tie to larger societal goals. For Baxter, increasing access to healthcare, promoting diversity and inclusion, strengthening education and reducing our environmental impact are all areas where Baxters success contributes to a greater good while also benefiting us as a company. Acting with integrity, ensuring the health and safety of our employees, and developing partnerships with suppliers to foster a greener supply chain are equally important to industry leadership. + +In early 2009, we added to our product stewardship priority an animal welfare goal to identify additional opportunities + +to replace, reduce and refine (3Rs) the use of animal testing. While we have long-standing policies and practices designed to minimize animal testing, the addition of this goal reflects our continuing commitment to build on our history of conscientious action and innovation in this area. + +Looking ahead, moving forward +Despite these accomplishments, sustainability is not about yesterdays achievements. It is about creating a better world for tomorrow. We must continue to engage our customers, suppliers, employees, communities, other business sectors, and regional and national governments if we are truly to make the progress necessary to meet the challenges we face. + +We are in the midst of one of the most difficult economic crises in our lifetimes. While no company, including Baxter, is immune to the issues affecting the global economy, +we remain committed to making a positive impact on the health and well-being of our local and global communities. + +As a society, the biggest problem we face in tackling our most pressing sustainability challenges is simply the scope and enormity of the task. Successfully addressing these challenges requires the cooperative effort of governments, businesses, interest groups and individual citizens. + +I believe corporations can play a lead role in making a difference. I encourage all stakeholders to join us in appreciating todays sustainability challenges and contributing toward long-term solutions. Working together, we can create a better world for future generations. + +Robert L. Parkinson, JR +Chairman and Chief Executive Officer +June 2009 + +----------------------------------------------------------------------------------------------- Baxter 2009 + +From the Chairman and CEO + +These are challenging times for healthcare. While the need for healthcare continues to grow, resources are limited. In many developing countries, people with hemophilia, end-stage kidney disease and other critical diseases still go untreated. In the United States, as many as +50 million people lack health insurance, which in early 2010 precipitated the most significant national healthcare reform legislation since the introduction of Medicare. + +The new U.S. healthcare reform legislation will expand access to healthcare coverage for + +U.S. citizens without insurance and seeks to reduce long-term healthcare costs. Other changes in our industry, coupled with an ongoing global economic crisis, also are contributing to a challenging environment for Baxter, encouraging us to intensify our focus on ways to become even more innovative, productive and efficient. + +Sustainability, like any effective business strategy, requires a long-term view. Global climate change, natural resource depletion, political unrest, financial instability and insufficient access to quality healthcare and education are not problems that are solved overnight. Corporations have an important role to play, as do governments, non-governmental organizations and other groups, to help address these issues. + +Some of these challenges, such as increasing access to healthcare and education, are especially relevant to Baxter. As a global healthcare company, we provide life-saving and life-sustaining products and therapies to developing markets, where healthcare needs are greatest. Much of our community involvement focuses on increasing access to health services for the poor and underserved. Weve also taken a leadership role in supporting education, particularly in science, technology, engineering and math (STEM). + +In many ways, sustainability is an extension of our business and our culture. Each of our sustainability priorities represents an opportunity to engage employees, contribute to a more sustainable world and benefit our business. Reducing natural resource use, for example, conserves precious resources for the future and decreases operational costs. Promoting an inclusive and diverse workplace creates a culture that enables employees to work together more effectively and helps us retain good people. Supporting STEM education today helps ensure that more children are equipped to meet the scientific and technical challenges of tomorrow. + +While were proud of the progress we continue to make on our sustainability priorities and goals, we are never satisfied. Were working to accelerate our progress on a number of these challenges, as we clearly can do more. +I look forward to reporting further progress on our sustainability initiatives next year. + +Robert L. Parkinson, JR +CHAIRMAN AND CHIEF EXECUTIVE OFFICER +JUNE 2010 + +------------------------------------------------------------------------------- Supplementary Information + +Baxter 2009 Sustainability Highlights + +Received Carbon Reduction certification from the Carbon Trust for FLEXBUMIN [Albumin (Human)] ? the first and only albumin therapy in a flexible, plastic container, and the first and only medical product to receive this certification. + +Decreased water usage by 9% in absolute terms and 29% indexed to revenue compared to 2005. + +Decreased net greenhouse gas emissions from operations by 5% on an absolute basis and 26% indexed to revenue compared to 2005. + +Realized environmental benefits at Baxters European headquarters in Zurich, Switzerland, which uses nearly 80% less energy than a typical office building of its size due to green-building design elements such as natural lighting, roof-top solar panels and other innovative features. + +Delivered professional development to nearly 400 Chicago Public Schools teachers through Baxters Science@Work program, bringing biotechnology to more than 24,000 students and earning the company Outstanding Partner recognition. + +Launched Global Supplier Sustainability Program, incorporating 20 green criteria into Baxters purchasing procedures. + +Achieved a third straight year of improvement in reducing cases resulting in days lost due to workplace injuries. + +Provided more than $52 million in foundation grants and company cash contributions and product donations to address critical needs globally, with a focus on increasing access to healthcare. + +------------------------------------------------------------------------------------------------- Baxter 2010 + +From the Chairman and CEO + +At Baxter, sustainability is our approach to integrate our social, economic and environmental responsibilities among the company's business priorities. These efforts align with and support our mission of saving and sustaining lives. Each year, we reaffirm our commitment to sustainability through our annual sustainability report. And, each year, we strive to make our reporting more robust. + +As a global healthcare company, Baxter takes seriously the health of the planet. It is within this context that we look at our business and challenge ourselves as to how Baxter can utilize its assets, expertise and influence to best contribute to a more sustainable world. + +One thing we have done is align our business and sustainability strategies. Baxter's executive-level Sustainability Steering Committee, established in 2006, leads the company's efforts to integrate sustainability into our long-term strategic planning as well as our daily activities. Since its inception, this group has made significant progress in assessing our global sustainability challenges and opportunities, establishing and tracking progress against Baxter's sustainability priorities and goals, and elevating accountability for sustainability to the highest levels of management. + +Increasingly we are integrating sustainability considerations into our product development, from product planning throughout the product life cycle. We are implementing green principles into our manufacturing and other operations. We are using our global scope and industry leadership to help increase access to healthcare in developing countries, where people with life-threatening conditions are often untreated or undertreated. We adhere to the highest standards of ethics and compliance wherever we do business, embrace an inclusive culture and diverse workforce, and contribute in other ways to the health and welfare of people in need in communities worldwide. + +Baxter operates in an increasingly challenging business environment, which has motivated us to intensify our efforts to become more innovative, productive and efficient. Sustained financial strength is critical to our ability to achieve both our business and sustainability goals, and to fund innovation, which is the real key to creating solutions for today's and tomorrow's challenges. + +Baxter is in a unique position to make an impact due to the industry we are in, our strong global presence and reputation, the sustainability progress we have made and the experience we continue to gain. While we have made great strides in many areas of sustainability, we clearly need to improve in others. I look forward to reporting further progress +in next year's sustainability report. + +Robert L. Parkinson, Jr. +Chairman and Chief Executive Officer +June 2011 + +------------------------------------------------------------------------------------------------- Baxter 2011 + +Sustainability at Baxter +From the Chairman and CEO + +Dear Stakeholders +At Baxter, sustainability means creating lasting social, environmental and economic value by addressing the needs of our wide- ranging stakeholder base. Our goal is to realize todays priorities and commitments in a way that ensures that our company and the many who depend on us can continue to thrive for generations to come. + +We serve a broad array of constituencies in our mission to save and sustain lives: patients and healthcare professionals, who rely on todays products and tomorrows innovations; governments, insurers and other institutions and business partners that count on our ongoing collaboration; our employees, who seek a safe, inclusive workplace and professional growth opportunities; shareholders, who expect and deserve a return on their investment; and communities around the world, where we positively impact health while contributing to economic growth. We succeed as a business by operating responsibly in service of these diverse stakeholders ? which, in turn, ensures we can continue to advance our social, environmental and economic priorities well into the future. + +With the guidance of Baxters executive Sustainability Steering Committee and the commitment of employees worldwide, we made meaningful progress on our nine sustainability priorities in 2011. The global macroeconomic landscape continued to pose serious challenges, yet it also helped inspire new ways to strengthen existing practices and drive greater innovation. We implemented novel facility-based energy initiatives and continued to shift to less carbon-intensive modes of product transport. We completed five new green building projects, our most yet in a single year. We responded to natural disasters around the world with millions of dollars in product donations and cash. You can learn more about these efforts and many others throughout our comprehensive online sustainability report. + +Our annual assessment of progress also serves as a reminder of how much more we can accomplish. While the path forward for the healthcare industry remains challenging, there is immense potential to foster innovation through Baxters sustainability priorities as we advance the companys mission on behalf of our patients. We see great opportunities to increase access to healthcare worldwide, further reduce our carbon footprint, use natural resources more efficiently, help improve math and science education in the communities we serve, and much more. Employees at all levels of the company are taking action, motivated by a sense of responsibility and desire to make a difference. + +Through our balanced approach and broad-based employee involvement, we are confident that Baxter is well-positioned to make a positive impact for many years to come. + +Robert L. Parkinson, Jr. +Chairman and Chief Executive Officer +June 2012 + + + +---------------------------------------------------------------------------------------------------------- Baxter 2012 + +Dear Stakeholders, + +Baxters aspirations as a healthcare company are tightly interwoven with our sustainability priorities. Just as our mission is to save and sustain lives, we are committed to helping our many global stakeholders thrive by creating lasting social, environmental and economic value in how we do business. + +Baxter serves a broad array of constituencies: patients and healthcare professionals; governments and payors; investors; employees; and the communities where we do business. Our goal is to operate responsibly and effectively in service to all these groups as we advance the frontiers of patient health. + +One of Baxters most critical objectives is exploring new ways to expand access to quality healthcare. Our efforts have led to a number of innovative public-private partnerships designed to help governments control costs while increasing patient access and improving health outcomes. In 2012 Baxter initiated many such partnerships, including a collaboration in Brazil that will meaningfully increase the availability of recombinant therapy for hemophilia patients while also creating local economic opportunity. + +We also continue to integrate sustainability considerations across our operations. This includes reducing our carbon footprint at facilities worldwide through recent measures such as our use of biomass energy in India and the installation in Malta of Baxters largest solar photovoltaic system to date. Thanks to fresh thinking like this, I am pleased to report that we have achieved our 2015 goal of using 20% renewable power in our facilities three years early. + +Our sustainability efforts must continually reflect our business strategies in light of new opportunities, challenges and stakeholder needs. We are now in the process of establishing our sustainability goals for 2020, making sure our ongoing focus is in line with our ability to achieve the greatest impact. + +I want to thank the many Baxter employees worldwide whose leadership and ingenuity are fostering todays successes, and whose passion will spark continued progress. Thanks as well to the many stakeholders whose needs and priorities point the way to future innovation. + +----------------------------------------------------------------------------------------------------------- Baxter 2013 + +Dear Stakeholders, + +Baxters vitality as a healthcare enterprise, and our ability to deliver on our commitments to our stakeholders, depends on our embrace of the new. This includes not only the scientific innovations that define our service to patients and healthcare providers; it also encompasses new ways of doing business that advance our goals as a publicly traded company and global corporate citizen. + +In March 2014 we announced our intention to launch the BioScience portion of our business as a fully independent company. Charting a new course as two separate entities will place both organizations in an even stronger position to expand global patient access to current therapies, introduce new products addressing unmet needs and concentrate on other key priorities and objectives. + +I am confident that each company will build on our legacy of sustainable development grounded in responsible business practices to create lasting social, environmental and economic value. In fact, this year marks the 15th annual edition of Baxters sustainability report; and as you will see here, our commitment remains unwavering as we strive to benefit our broad stakeholder base. + +In 2013 Baxter decreased greenhouse gas emissions, energy use and water use. We increased patient access to market leading therapies in developing countries. We ensured our products are first on the scene in disaster-stricken communities. We helped advance STEM education to cultivate the future of scientific innovation. Yet for every milestone achieved, there are more opportunities to make a difference for the communities we serve. + +Our executive Sustainability Steering Committee is now assessing our strategy in light of our changing corporate structure and stakeholder expectations, and we are updating our goals to reflect our aspirations. + +As always, the needs of our stakeholders inspire us to ever greater levels of accomplishment. Every day our employees worldwide are focused on new opportunities to integrate our sustainability principles across our strategies and operations ? and I urge them to maintain the pace. Together we will continue making an impact for generations to come in pursuit of our mission to save and sustain lives. + +------------------------------------------------------------------------------------ Glaxosmithkline 2003 + + Chairman CEOӸ ƴ϶ message . Ȥ 𸣴 Ȯ ٶϴ. Ͽ Chaiman CEO ־ϴ. + +Chairman of the Board +The GlaxoSmithKline Board of Directors has a clear responsibility to report to external stakeholders and make sure GlaxoSmithKline stays on track with addressing environment, health and safety concerns. Significant achievements this year in safety include development of targeted programmes to improve the safety of our sales force. For the environment, our programmes have succeeded in producing continuous improvement and we are well on our way toward meeting most of our five-year targets. +As Chairman of the Board of Directors, I strongly support the ten-year EHS plan and the programmes that are helping us make progress on the path +to environmental sustainability. + +Sir Christopher Hogg + + +Chief Executive Officer +GlaxoSmithKline employees are passionate about their work and their contributions to helping people do more, feel better and live longer. Good environment, health and safety (EHS) performance and consistent progress in improving our programmes can be driven by encouraging people to contribute with passion and recognising their good work. +Every year I sponsor the CEOs EHS Excellence Awards recognising innovative, creative solutions to EHS issues and concerns. The awards motivate the winners as well as all employees to continue to work toward the goal of excellence in EHS and to be creative in finding solutions. The 2003 winners are highlighted throughout this publication. + +The goals of EHS are very well aligned with business goals to improve quality and efficiency. Both focus on driving out waste by having more robust and efficient processes that consume less natural resource, generate less waste and are good for the companys bottom line. + +This web site demonstrates GlaxoSmithKlines continuing commitment to clear and transparent reporting of our environment, health and safety programmes and performance. + +Dr. JP Garnier + +------------------------------------------------------------------------------------- Glaxosmithkline 2004 + +CEO/Chairman Statement + +Through our products GSK delivers clear benefits to patients around the world. Great products, however, are not the whole story -- society expects companies to act responsibly in their pursuit of success. If anything, the fact that our business is about human health makes it even more important that we operate to the highest standards. + +Corporate responsibility is not just a job for selected people at GSK, it defines the way we do business. Our ten corporate responsibility principles set the standard for everyone, since responsible business is only a reality if it is practised by all employees at all times. In this report we show our progress against each principle. + +We are reporting significant achievements in 2004. GSK is one of the leading pharmaceutical companies in the essential area of improving access to medicines in the developing world. For example, this year we tripled shipments of our preferentially-priced Combivir tablets to help alleviate HIV/AIDS in the developing world. Over 80% of these went to Africa, and we also granted five more voluntary licences to African companies to produce HIV treatments locally. + +We are proud of our commitment to communities around the world. Our total community investment in 2004 was ?328 million ($600 million). This includes our donation of 67 million tablets to support the elimination of lymphatic filariasis, a debilitating disease that threatens one billion people in the developing world. + +Responsible business practices are also the key to a good reputation. In +2004, the pharmaceutical industry and GSK continued to come under public scrutiny on how medicines are developed, tested and marketed. To meet this challenge we must act with integrity and be open about our approach to these important issues. We took an important step this year with the launch of our Clinical Trial Register, providing public access to our product information. + +We also want to make information on our corporate responsibility performance more widely available. The transition of the 2004 report to the internet, and the integration of our environmental, health and safety information, means this information is now accessible by more of our stakeholders. + +We invite you to read this report for more information on all our corporate responsibility principles, and we welcome your comments and suggestions. + +Sir Christopher Gent Dr JP Garnier +Chairman Chief Executive + +------------------------------------------------------------------------------------ Glaxosmithkline 2005 + +CEO and Chairmans letter + +We accept this challenge. Solving problems such as healthcare provision in the developing world is not a job for one company alone, however we do have an important contribution to make. Our access to medicine programmes for HIV/AIDS and our work with the World Health Organization to eradicate Lymphatic Filariasis (LF) are evidence of the efforts we are making. In 2005 we shipped 126 million preferentially priced Combivir and Epivir tablets to developing countries for treatment of HIV/AIDS and donated 136 million albendazole tablets for the prevention of LF. Through our public private partnerships we are developing the first pipeline of new tuberculosis treatments in 40 years and testing new vaccines and treatments against malaria, a disease which takes a devastating toll on the people of Africa. + +Corporate responsibility encompasses how we address and manage issues that arise from our business activities. Good performance on corporate responsibility supports our business strategy because it protects and enhances our relationships and reputation with doctors, governments and patients. + +GSKs core business ? the research and production of medicines ? makes a valuable contribution to society. For many people our medicines are, quite literally, life-saving. But our satisfaction in what we do does not mean we can ignore issues associated with the research, manufacture and sale of medicines ? from the publication of research results and marketing practices of pharmaceutical sales representatives, +to the use of animals in research and the environmental impacts of our manufacturing processes. + +We are confident we have the right policies and programmes in place so that we operate to the highest standards. This report provides an update on the progress we have made against our ten corporate responsibility principles during 2005. Particular highlights include our new policies on the authorship of research articles, consumer advertising and patient advocacy, and our Clinical Trial Register that now contains results from over 2,000 GSK sponsored clinical trials. + +We seek views from a wide range of stakeholders and respond to their suggestions where possible. This report contains new information in a number of areas in response to feedback we have received. We hope this report provides the information you are seeking about corporate responsibility at GSK and we welcome your feedback. + +Sir Christopher Gent JP Garnier +Chairman Chief Executive Officer + +----------------------------------------------------------------------------- Supplementary Information + +Corporate responsibility is fundamental to delivering our business goals. While the interests of shareholders remain paramount we also need to respond to stakeholder expectations by helping to address societys healthcare challenges. + +------------------------------------------------------------------------------------- Glaxosmithkline 2006 + +Chairman and CEOs letter + +We believe that a healthcare company isnt sustainable if it is only concerned about the 20 percent of the worlds population lucky enough to have the resources to pay for new treatments. Access to medicines is essential to our vision for GSK and our business strategy. Improving peoples health is what drives us and what makes talented scientists want to work here. + +Our commitment to the poorest countries is integral to this. These countries may not represent a viable commercial market for some new medicines but there is still a medical need for people to have medicines they cannot afford. Yet pure philanthropy is not the right solution either ? the needs are too great. + +We look for new ways to tackle these problems. GSK is involved in over ten public private partnership projects researching new medicines and vaccines for diseases disproportionately affecting developing countries, including HIV/AIDS, malaria and TB. We are also making key medicines and vaccines more accessible through discounted prices and have negotiated eight licences for third-party manufacturers to produce generic versions of our key HIV medicines. + +As this Review shows, our efforts are starting to bear fruit. Preferential pricing and voluntary licences are helping to increase the supply of HIV/AIDS medicines to sub-Saharan Africa. In 2006, seven countries completed their five-year programmes to eliminate lymphatic filariasis using our albendazole treatment. We will continue donating our tablets until this disabling and incurable disease is completely wiped out. + +Vaccines are another exciting area. In 2006, 75 percent of all the vaccine doses we produced were sold at preferential prices for immunisation campaigns in the developing world. These will save millions of lives. We expect to launch our vaccine for cervical cancer in 2007. This disease affects women in all countries but has the greatest impact in the developing world where there are few screening programmes to catch early cases. + +There is no room for complacency ? much more effort is needed from all stakeholders to resolve the healthcare problems of developing countries. But we are proud of the contribution we are making. + +We know that our efforts on access to medicines must be based on a solid foundation. Our industry is high profile and often the subject of criticism. Good medicines can make a big difference to quality and length of life for all of us and it is rightly expected that we should meet the highest standards of integrity in all aspects of our work. + +This Review gives a snapshot of our approach to embedding an ethical culture across GSK. This includes applying the highest standards of behaviour and transparency in our R&D and promotion of medicines, treating our people well, and minimising the impact of our business on the environment. We also need to play our part in tackling major global issues such as climate change. + +We value the input of our stakeholders and would welcome your views on this Review or any aspects of corporate responsibility at GSK. + +Sir Christopher Gent +Chairman + +JP Garnier +Chief Executive Officer + +---------------------------------------------------------------------------- Supplementary Information + +Every day we are involved in a race to find new medicines and vaccines to address unmet medical needs; to improve access to these new medicines for all patients regardless of their financial circumstances; and to meet the expectations of our many stakeholders. Its a race for the human race. + +------------------------------------------------------------------------------------- Glaxosmithkline 2007 + +Letter from CEO + +Our sustained investment in R&D continued to pay off with the launch of new products that will make a real difference to global health. Our vaccine Cervarix will help to protect women worldwide against cervical cancer. We have already submitted the new vaccine for World Health Organization pre-qualification ? meaning it can be used in mass vaccination programmes across the developing world where 85 per cent of cervical cancer deaths occur. Tykerb, our new breast cancer treatment holds out new hope for women affected by one of the most aggressive forms of this disease. +There was also exciting news from Phase II trials of our candidate malaria vaccine for African children. Our commitment to malaria is long-standing ? scientists in GSK and our legacy companies have been working on this vaccine for over 20 years. If results continue to be successful we may see the submission to regulatory authorities of the worlds first malaria vaccine for children as early as 2011. We will seek to ensure this vaccine is affordable and available to all who need it. +We are celebrating ten years of our involvement in the Global Alliance to Eliminate Lymphatic Filariasis and 15 years of GSKs Positive Action programme to help people living with HIV/AIDS. +Both these programmes have had an enormous beneficial impact on some of the worlds most disadvantaged communities. Several countries have now completed their five year LF elimination plans, freeing future generations from the threat of this disfiguring and disabling disease. +Our commitment to environmental issues was strengthened with the launch of a new climate change strategy. We have committed to reducing our climate change impact and energy use by 20 per cent per unit of sales by 2010 and by 45 per cent by 2015. A lot of work is already underway to make sure we meet these challenging new targets. +Concerns about Avandia proved to be one of the years big challenges. We have responded to these concerns by examining the data in their entirety, and working collaboratively with regulators and other stakeholders. We strongly defend our product because we believe it is important that Avandiais available to support effective treatment of type 2 diabetes. +The company restructuring programme announced in 2007 will help us remain a competitive and sustainable business. These changes are necessary but have inevitably required us to reduce employee numbers. We aim to treat our employees with dignity and respect and offer a wide range of support for all affected staff. +It is the way we respond to challenges like these that demonstrates the importance of the strong value system on which our business is based. Performance with integrity is integral to GSK and is the foundation of our past and future successes. +I am proud of what GSK has achieved in my time as Chief Executive and confident that our company will continue to make a major contribution to meeting global healthcare needs now and well into the future. + +JP Garnier + +---------------------------------------------------------------------------- Supplementary Information + +Despite advances in healthcare, society still faces huge unmet medical needs. R&D into +new vaccines and treatments is essential to benefit patients, families and communities +worldwide. This search is at the core of our business and the central responsibility issue +for GSK. I am pleased at the progress we made in 2007. + +------------------------------------------------------------------------------------- Glaxosmithkline 2008 + +Message from the CEO +A new mindset +Welcome to GSKs Corporate Responsibility report which provides information on our activity and performance during 2008. + +We want to be a company that is forward looking, innovative and willing to try new approaches and partnerships; a company that is constantly looking for new and sustainable ways to increase access to our medicines and vaccines, especially for those least able to pay. + +We have made significant progress in helping to address global healthcare challenges. For example, over +the past ten years we have donated over one billion tablets to the programme to eliminate lymphatic filariasis, a debilitating tropical disease and we are doubling manufacturing capacity to 600 million tablets a year. Our commitment to preferential pricing means we offer our AIDS and malaria medicines at not-for-profit prices in the worlds poorest countries. We also supply our vaccines to organisations such as GAVI and UNICEF at preferential prices, typically 10-20 per cent of the prices in developed countries. + +But for every success story, there are examples of where we could do more. As I review our performance, I believe it is time for a new mindset in our industry and a new contract with society. In these difficult economic times it is a challenge to think beyond short-term performance. But we must look to the long-term and not be distracted by our own economic problems when the needs of the developing world remain just as pressing. + +To begin with, there are four areas where we can show we are going to do things differently. + +First, we are exploring a more flexible approach to intellectual property rights to incentivise much needed research into medicines for 16 neglected tropical diseases where there is a severe lack of research. One option is a Least Developed Country (LDC) patent pool in to which we would put our relevant small molecule compounds, process patents or other knowledge, and which would allow others access to develop and produce new products. + +Secondly, on 1 April 2009 we will reduce our prices for patented medicines in the 50 poorest countries in the world, the LDCs, so they are no higher than 25 per cent of the developed world price. Where possible we will reduce our prices further while ensuring we cover our manufacturing costs so this offer is sustainable. We also recognise the challenge in middle-income countries where there is a wide disparity in incomes and ability to pay. Here our intention is to work on a case-by-case basis recognising that there is no one size fits all solution to improving access to medicines in these countries. + +Thirdly, we will seek out partnerships and open the doors of our developing world research centre in Spain. We already know what partnership can achieve ? for example, we successfully trialled a malaria vaccine candidate in partnership with the PATHs Malaria Vaccine Initiative and the Bill and Melinda Gates Foundation. If we extend this approach the benefits will be huge. + +Fourthly, working with partners such as NGOs, we will reinvest 20 per cent of the profit we make from selling medicines in LDCs to support the strengthening of healthcare infrastructure in these countries. Our sales in LDCs are relatively low so this profit is limited; initially this funding will amount to ?1 to ?2 million annually. But by our action we hope to send a signal to all multi-national companies operating in LDCs to join us and make a meaningful change in these countries. In all developing countries we must transform GSK into a local company addressing local healthcare needs. Our Brazilian business is leading the way ? supplying vaccines and sharing technical expertise to help build local capacity. + +We will not forget that significant healthcare challenges exist in developed countries too. We must work in partnership to create a virtuous circle, where industry gets rewarded for demonstrating genuine innovation, healthcare payers get value-for-money because our medicines save them from high-cost healthcare interventions, and more patients get the medicines they need. + +Of course, access to medicines is not the only issue that counts. We want GSK to be recognised around the world - by all stakeholders - as a company with the highest ethical standards. + +We made good progress in 2008. We committed to stopping all corporate political contributions from 2009. Our decision to report more fully on our funding for medical education, patient groups and payments to physicians, will increase transparency and provide reassurance to stakeholders. Reflecting our commitment to animal welfare, we took a voluntary decision to end research in great apes, the highest-order of animals next to humans. + +It is time for a new mindset in our industry and a new contract with society. With the support of other pharmaceutical companies and partners outside the industry, I believe significant improvements in human health can really be achieved. + +Andrew Witty, CEO + +------------------------------------------------------------------------------------- Glaxosmithkline 2009 + +Message from the CEO +GSK is changing + +Welcome to GSKs 2009 Corporate Responsibility Report which provides information on our activities during +2009. + +Our ambition for GSK is to create a values-based business that our employees, investors and wider society can be proud of and can rely on. We want to run our business to the highest ethical standards, adapting and changing so we are more responsive to the needs of society. + +Since I became CEO of GSK, we have been focusing on changing our business to improve our financial performance through diversifying our sales growth and improving returns from the investment we make in R&D. And we know that part of being a successful and sustainable business is fulfilling our social responsibilities, making our company more responsive, more flexible and more open to societys expectations. + +We are making progress on many areas such as improving access to our medicines, enhancing research opportunities for neglected tropical diseases, raising the ethical standards for conducting our research and business activities, and being more open and transparent in the way we run our business. Making the changes needed to reach our ambitious energy and climate change targets is proving to be a challenge and we are stepping up our efforts to achieve these. + +Access to medicines and encouraging R&D into neglected tropical diseases + +We believe access to medicines is the defining issue for our industry and during 2009 we took some significant steps forward. We reduced the price of our patented medicines in the worlds poorest countries to no more that 25 per cent of the UK price. The resulting increase in sales volumes suggests that more patients are now accessing these medicines. We are also reinvesting 20 per cent of the profits from selling medicines in these markets in projects that will strengthen healthcare infrastructure in Least Developed Countries. + +In middle income countries we are developing a more flexible approach to pricing that better reflects the +ability to pay. Pilot studies in 2009 showed promising improvements in access to our products, and our more flexible approach to pricing is being extended during 2010. + +We also have a unique opportunity with our candidate malaria vaccine which is being developed in collaboration with the PATH Malaria Vaccine Initiative, the Bill & Melinda Gates Foundation and African research organisations. The vaccine is still in development, however we are already thinking about access. We want to set a price which is sustainable but which is also as low as possible. So in January 2010 I announced that we will set a price that covers our costs and makes a small return which we will reinvest in R&D for the next generation of malaria vaccines, or for other vaccines for diseases of the developing world. + +Tackling the acute need for more medicines to treat neglected tropical diseases needs innovative approaches and partnerships. We have set out our open innovation agenda where we will launch more new collaborations to share our intellectual property and know-how, and create broad-based partnerships to give researchers access to our expertise, processes, facilities and infrastructure. For example, we are publishing information on more than 13,500 compounds which have shown activity against the malaria parasite. We will not seek any rights over these compounds if researchers discover a new treatment for malaria. + +Another important aspect to open innovation is the open lab we are creating at our Tres Cantos R&D Campus dedicated to research for combating diseases of the developing world. At the open lab researchers from across the world, especially from developing countries, will be able to work with GSK on their projects, accessing our expertise, know-how, processes and industrial scale. To help fund these external partnerships +GSK has set up a not-for-profit foundation with an initial investment of ?5 million. + +Transparency +Our social responsibilities go beyond enhancing our R&D efforts and improving access to our medicines and vaccines. I believe that being open and transparent about how we do business will help us to build trust with our stakeholders. + +We continue to publish the results of all our clinical studies on our Clinical Study Register and now include the names of the principal clinical investigators and the institutions where they work. We will also seek publication of the results of all clinical studies as full scientific papers in peer reviewed journals. We believe we are the only company to make this commitment. If, as is sometimes the case, a journal does not want to publish the paper, we will include additional information to help interpretation of the study results on our Clinical Study Register. + +We are also publishing more information on our payments to healthcare professionals. In 2009 we started publishing the speaking and consulting fees paid to US healthcare professionals and plans are in place to extend this to other countries. We have also set new standards for funding medical education in the US to ensure that we support programmes that bring the greatest improvements to patient health. + +Our commitment +At GSK, we have a real opportunity to make a difference to patients and to society. We know there is always more we can do and we are committed to making changes to our business to achieve this. I believe we have made good progress in 2009 and I am excited by the opportunities to evolve GSKs business. I look forward +to updating you on our future progress. + +Andrew Witty +Chief Executive Officer + +------------------------------------------------------------------------------------- Glaxosmithkline 2010 + +Message from our CEO + +We are transforming GSK into a more competitive and efficient company. A company built on strong values and a deep commitment to excellence ? a company that our employees, our customers and the societies we work in can be proud of. + + +Continuing to run our business in a responsible way is central to our transformation. We dont have a separate +responsible business strategy because our commitment to responsible, values-based business underlies everything we do. This means being led by our values and principles, being transparent about how we work, responding to the needs of our stakeholders especially by putting patients first in our decision-making, being thoughtful in how we communicate and not compromising our ethical standards. When we do this we generate real value for patients and for our business. + +We are building on our strong culture in which all our decisions are guided by our values: + + Commit to transparency + Show respect for people + Always demonstrate the highest integrity in our conduct + Be patient focused + + +Access to medicines + +Were committed to increasing access to our medicines for patients, irrespective of where they live and their ability to pay. In 2010 we have further embedded a range of flexible pricing models to deliver our medicines and vaccines to as many of the people who need them as possible. Not only is this the right thing to do, it will also contribute to our business success. For example, weve capped the price of our patented medicines in Least Developed Countries at no more than 25% of what we charge in developed countries, and were introducing more flexible pricing in developing countries. + +This is challenging and the work is at an early stage, however the results of some of our initiatives so far are promising, indicating that price reductions are extending access to more patients and providing a sustainable return to GSK. + +This year we also created a specific operating unit dedicated to increasing access to medicines in developing countries. Its success will be judged not on profits but on its contribution to increasing access to our medicines. + +I believe the approach we are taking will define GSK as a company that healthcare providers and patients can trust. Combined with our commitment to quality and ethical business practices, this will help us to stand out as a business that is truly committed to patients. + + +Neglected tropical diseases + +We continue with our significant commitment to work on neglected tropical diseases and our R&D partnerships in this area are progressing well. GSKs RTS,S malaria vaccine candidate is in phase III trials and, if all goes well, this will be the first ever vaccine against malaria, with the potential to save the lives of millions of children in Africa. We have committed to price RTS,S responsibly and will seek to ensure that price will not be a barrier to access. We will set a price which covers our costs and generates a small return of around 5% which we will reinvest in the development of +next generation malaria vaccines or for other products for diseases of the developing world. + +We also announced in 2010 that we will donate enough of our albendazole medicine to protect all school-aged children in Africa against intestinal worms. Intestinal worms cause more ill health in school-aged children than any other infection, so this will have a major positive health impact. When added to the albendazole we already donate to the Global Alliance to Eliminate Lymphatic Filariasis, it means we will be donating about one billion tablets a year for five years ? a very significant commitment. + + +Environmental sustainability + +We have strengthened our commitment to the environment too, setting new ambitious targets. Our goal is to reduce +the environmental impact of our value chain, from raw materials to product disposal, becoming carbon neutral by 2050. We have already achieved a reduction of nearly 11% in greenhouse gas emissions since 2006 which, although less than we had hoped, gives us a good foundation to build on in the coming years. We have also reduced the amount of water we use by 16% since 2006, exceeding our 2% annual reduction target. + + +Operating with integrity + +We are continuing to work towards resolving a number of long-standing legal matters. In light of these cases we have fundamentally changed our procedures for compliance, marketing and selling in the US. We now have far-reaching policies and procedures in place to guard against inappropriate promotion to healthcare professionals, and to seek to ensure that if breaches of regulations do occur they are reported to the US government. + +To truly embed our values we need to be willing to change how we work, to invest resources and to demonstrate leadership. The changes we are making this year to how we reward our US sales teams are just one example of how we are doing this. Historically, sales teams were rewarded according to the volume of prescriptions in their area, a practice common across the industry. Our new incentive system will assess sales representatives on their scientific and business knowledge, feedback from customers in their region, and the overall performance of their business unit. + +By focusing on providing the information and support our customers want, rather than generating the next prescription, we will be acting in the best interests of patients. The more we do this, the more healthcare practitioners will see us as a true partner in delivering the best possible care for their patients. + +In my view, it is strong values that differentiate great companies from mediocre ones. By living our values we will achieve results that are good for society and good for GSK. As this Report demonstrates, we continue to make important and exciting changes and I look forward to updating you on further progress next year. + +Andrew Witty +Chief Executive Officer + +------------------------------------------------------------------------------------- Glaxosmithkline 2011 + +From our Chairman + +This year we have made good progress. In my role as Chairman of both the Board and the Corporate Responsibility Committee, I am acutely aware of the pressures and challenges faced by the company and I receive regular reports of how these are being addressed. + +During the year I was particularly pleased to see further commitments made to improve global access to our medicines, including agreements to supply large quantities of our vaccines to protect against rotavirus gastroenteritis and pneumococcal diseases such as pneumonia and meningitis to the poorest countries of the world at fractions of western prices. The company has also made substantive progress in other areas such as environmental sustainability and in supporting the communities in +which we operate. + +Much of this progress is due to the leadership of +Sir Andrew and the executive team. The Board will continue to support and constructively challenge their thinking and the actions they take to operate a responsible values-based business. + + + +Sir Christopher Gent +Chairman + +------------------------------------------------------------------------------ Supplementary Information + +GSK has always believed that operating in a responsible and ethical way is essential for the success of its business. During 2011 we continued to examine our policies and operations to ensure that our approach to corporate responsibility supports the delivery of our business strategy and is consistent with our values. + +--------------------------------------------------------------------------------------------------------------- + +From our CEO + +Our record in 2011 demonstrates that we are succeeding, +through increased sales and returns to our shareholders and significant progress in our research and development. + +We remain committed to operating with transparency and responsibility. During the year we made multiple advances on our agenda to ensure that our behaviour and our actions meet or even exceed the expectations of society. Much of this is reflected in this report which +is structured around four areas: Health for all, Our people and communities, Our behaviour and Our planet. + +One of our key priorities is to continue to align our commercial success with forming new partnerships +to tackle the healthcare needs of people in developing countries. This is particularly pertinent for vaccines, +and tackling pneumococcal disease is a great example of how these partnerships make a difference. Early in 2011, GSK began supplying pneumococcal vaccines to Kenya through an innovative financing mechanism known +as the Advance Market Commitment. This is the largest fund ever designed for a single vaccine and has dramatically increased sustainable access to this vaccine for babies across Africa. + +This success was built upon mid-year when we announced a new pricing structure for our vaccine against diarrhoeal disease. We offered the GAVI Alliance our vaccine at +a fraction of the cost of developed western markets. Millions of children living in the worlds poorest countries are now set to receive it, which will save countless lives +in the future. Importantly, this offer is sustainable over the long term because we are recouping the cost of goods and manufacture. +2011 also demonstrated that we are making significant +progress to improve returns and productivity in R&D. We are seeing this productivity translate into real filings and approvals, with three medicines approved in 2011 and four more ready to file in 2012. These include our new MEK inhibitor for melanoma and a new four-valent flu vaccine. + +We are also on the cusp of creating the worlds first malaria vaccine. I have seen first-hand the devastating impact that this disease has on Africa, having lived there for several years in the 1990s. In October 2011, late-stage trials confirmed the promise we have seen so far, showing that the vaccine reduces the risk of malaria by half in African children aged 5-17 months. We also reiterated +our commitment to price the vaccine at a level that covers costs and generates a small return of around 5% that will be ploughed back into research for the next generation of malaria medicines and vaccines. + +During the year we also reached an agreement in principle with the US Government to resolve some long-standing legal issues around our sales and marketing practices for +a settlement of $3 billion. I know this was difficult, but is +a necessary step towards resolving multiple, long-standing matters which do not reflect the company that we are today. + +As part of an ongoing strategy, we continue to fundamentally change our procedures for compliance, marketing and selling, particularly in the USA. +This will ensure that we operate with high standards of integrity and that we conduct our business openly and transparently. We will continue to innovate and to respond to the expectations of our stakeholders, and our new compensation system that rewards sales representatives in the USA on quality of service rather than sales volumes is one example. + +We also made progress on implementing our environmental strategy which has been revised to set ambitious goals for our entire value chain ? from raw materials to product disposal. We need to work in ways that enable business growth while protecting the natural resources for the future. For example, almost 40% of our carbon footprint derives from propellants when patients use our inhalers, and eliminating CFC gases from our products has substantially reduced inhaler emissions ? from 24 million tonnes of CO2 equivalents in 1998 to less than 5,000 tonnes today. + +None of this would be possible without the efforts of all of our employees. Investing in our people and communities underpins the long-term sustainability of our business, creating the right internal and external conditions to support our strategy. As a company, we are mindful of the potential pressures our employees face given the current global, political and economic environment. Despite these challenges, we remain committed to offering all of our employees a range of learning opportunities and tailored development and volunteering programmes. The PULSE programme, for example, gives employees the chance to join a non-profit or non-governmental organisation for +a three- or six-month placement. There were 80 PULSE volunteers in 2011, up from 58 in 2010. I am delighted that nearly 200 employees from 26 countries have served as PULSE volunteers since the scheme began in 2009. + +These changes and others we have made right across our business are laying the foundations for our future success. We have come a long way but we have by no means achieved everything we aspire to. We will continue to review our plans and commitments across each of the four areas, looking to establish further long-term goals and targets which will support meaningful measurement and demonstrate our commitment to responsible, values-based business. We will continue to be restless, to challenge ourselves and to ask what more we can do. + + + +Sir Andrew Witty +Chief Executive Officer + +------------------------------------------------------------------------------ Supplementary Information + +Three-and-a-half years ago, we set out to fundamentally change GSK to create a different type of company, delivering sustainable financial performance and providing shared value to patients, consumers and governments. + +---------------------------------------------------------------------------------------------- GlaxoSmithKline 2012 + +CEO Interview instead of CEO Message + +---------------------------------------------------------------------------------------------- GlaxoSmithKline 2013 + +As a global healthcare company, GSK can play an important role in meeting societal challenges. In 2013, we continued to develop innovative life-saving drugs and work with partners to get medicines to the people that need them most. + +Over the past six years we have been making fundamental changes to deliver innovation and access to our products for patients and customers, and improved sustainable financial performance for our shareholders. + +2013 was the most productive period of R&D output in the companys history. Of the six major new medicine files we profiled at the start of 2013, five were approved and we are expecting regulatory decisions for the remaining asset in this group in the first half of 2014. In addition, we launched our new injectable quadrivalent flu vaccine in the USA. Together, these new drugs offer patients a range of new treatment options and represent substantial opportunities for business growth. + +We continue to take action to reform our business model to meet the expectations of society and deliver our mission, in line with our values. + +In 2013, we made new commitments to increase transparency of our clinical research by announcing our support for the AllTrials campaign and becoming the first pharmaceutical company to commit to publishing the detailed clinical study reports for all of our medicines. In May, we were the first in our industry to launch an online system enabling researchers to request access to anonymised patient-level data from our clinical trials. I am pleased that some other companies have now also adopted this approach. + +We also announced plans to evolve the way we sell and market products to healthcare professionals, to further align our activities with the interests of patients and remove even the perception of conflict of interest. Specifically, we plan to stop direct payments to healthcare professionals for speaking engagements and for attendance at medical conferences, and extend our US Patient First programme globally, to decouple sales team remuneration from scrip generation. + +We continue to expand access to our medicines to people living in the developing world. During 2013, we signed a ground-breaking five-year partnership with Save the Children, to combine the resources and capabilities of our two organisations to help save the lives of one million children living in the poorest countries in Africa. + +In 2013, we donated our four billionth tablet of albendazole to treat intestinal worms and lymphatic filariasis ? part of our long-term commitment to tackle neglected tropical diseases ? and delivered 862 million vaccine doses worldwide. We also strengthened our global initiatives to tackle non-communicable diseases such as cancer, diabetes, respiratory and heart disease. + +I am also delighted we achieved a significant milestone for our malaria vaccine candidate which demonstrated that it could potentially halve the number of malaria cases in young children. This vaccine has the potential to save hundreds of thousands of childrens lives and we plan to file for approval during 2014. We are committed to making it available at a not-for-profit price. + +There is no higher priority for me than the values-based conduct of our employees. In the past few years, we have focused on bringing to life our values and being thoughtful about what they really mean at a human level. + +It is because of my strong belief in our companys values that the allegations made in China about the behaviour of some individuals were so disappointing. The investigation into this matter by the authorities in China continues and we are cooperating fully. As a company, we are committed to learning the lessons and taking all necessary action in relation to the outcome of this investigation. + +Our continued commitment to transparency was also evident in our efforts to disclose and address our environmental impacts. We are the only healthcare company listed in both the CDPs Disclosure Leadership Index and its Performance Leadership Index in 2013, for our clear reporting and performance on climate impacts. + +My job as CEO is to deliver a healthy company, and that is only possible with healthy employees. Our ground breaking Partnership for Prevention initiative will give benefits-eligible employees and their families equal access to preventive and basic healthcare benefits wherever they are based. + +In 2014, we will continue to challenge our business model at every level, to ensure we are responding to the needs of patients and meeting the wider expectations of society. + +---------------------------------------------------------------------------------------------- GlaxoSmithKline 2014 + +In 2014, despite challenges resulting from our operating environment, we made sustained progress against both the companys strategic priorities and our commitment to operate responsibly. + +I was particularly proud of the progress on our commitments to improve access to medicines this year. We saw the worlds first malaria vaccine come another step closer when we submitted our RTS,S candidate for regulatory approval. We have committed that we will make the vaccine available at a not for profit price for those who need it. + +We also saw progress on addressing affordability barriers to access to healthcare. In 2014, we extended our tiered pricing approach to prescription medicines, asking countries to pay based on their national income. In early 2015, we also committed to freeze vaccine prices for GAVI graduating countries for ten years. + +In addition we committed to invest ?130 million in Africa over the next five years, aiming to provide a portfolio of relevant products, develop innovative pricing strategies, support African R&D expertise and increase local manufacturing capacity and capability. + +2014 saw a critical public health emergency with the outbreak of Ebola in West Africa, which demanded an urgent response. As well as providing humanitarian support to affected regions, we accelerated the development of our candidate vaccine for Ebola at an unprecedented rate, with trials now underway. + +We continue to look at ways to transform our commercial model. A new approach to compensation for sales representatives has now been rolled out worldwide. These changes build on the reforms we started in the USA more than two years ago and I was pleased to see our most recent Healthcare Practitioner customer satisfaction research showing that GSK now ranks first in the USA among our peer group for the value we bring to their work. Adding to this, by 2016, we will have fully implemented our commitment to stop paying doctors to speak on our behalf and instead deliver information to them through a new multi-channel system. + +We believe these changes are not only the right thing to do, but that they will also be a competitive advantage. They follow our initiatives on clinical trial data transparency. + +We expect all our people to put our values at the heart of their decisions and that their work meets or exceeds the expectations of society. Thats why the issues we saw in China last year have been wholly disappointing and we have taken significant steps to rectify the issues identified in our Chinese business, to apply appropriate lessons to our operations elsewhere and to strengthen our monitoring of ethical conduct. Given the complexity of our sector and the challenges of working in global healthcare, we will continue to face risks. However, we continue to believe that with robust systems in place our presence in these markets can improve access to medicine and broader healthcare. + +Looking at other priority areas, we made good progress on employee gender diversity ? slightly increasing the proportion of women in management ? from 41% to 42% ? and are on track with the roll-out of our preventative healthcare programme for our employees and their families, reaching 15 countries so far. + +We have also set ambitious targets on carbon, water and waste. We continue to face the challenge of reducing our carbon footprint across the value chain while sales of our propellant based inhalers, our product with the biggest carbon footprint, continue to grow. However, we have met our operational water use target a year early, cutting use by 20% since 2010. + +Finally, it is through the efforts of many that we look to fulfil our commitment to operate responsibly. Id like to thank all our employees and partners ? their continued support has helped us both address challenges and deliver substantial achievements this year. + +-------------------------------------------------------------------------------------------------------- Norvatis 2013 + +Dear Shareholder, + +Novartis achieved another strong operating result in 2013 and reinforced its leadership position as a diversified global healthcare company. With the launch of innovative therapies, a clear focus on growth markets, and productivity-oriented cost control, we increased sales and net income at constant currency exchange rates. + +This success was due primarily to the continued dynamic development of our largest division, Pharmaceuticals, which has one of the industrys most robust product portfolios. Our eye care division, Alcon, and our generics business, Sandoz, also contributed to the positive result. With the market launch of state-of-the-art eye surgery systems, Alcon strengthened its leading position in the fast-growing area of cataract operations, while Sandoz gained further market share amid accelerated demand for sophisticated biosimilars. + +The smaller businesses ? Vaccines and Diagnostics, and Consumer Health ? also improved their operations and created a solid basis for their activities following a series of difficult quarters. Our goal is to strengthen Novartis as a diversified healthcare company in its individual fields of business and as a whole. Given our continuous effort to optimize our businesses, we divested our blood transfusion diagnostics unit in January 2014 for USD 1.7 billion. + +As a science-based healthcare company dedicated to serving the interests of patients, Novartis strives for a broad and competitive product portfolio and strong positioning in long-term growth markets. To this end, we are continuing to pursue our long-standing and proven diversification strategy, which ? alongside our focus on innovation ? includes the development of affordable and nonpatented medicines. + +Research and development of innovative and highly effective drugs that fulfill unmet patient needs remains central to our strategy and fundamental to our future success. With more than 6 000 scientists in our global research organization, Novartis aims to provide measurable benefits for patients and for society. + +Due to the ongoing demographic change ? which affects developing and emerging countries and coincides with growing urbanization and high environmental pollution ? chronic and age-related disorders such as eye diseases, diabetes, cardiovascular conditions, and cancer are rising. This will continue to put a great strain on public health, the economy and the labor market. + +In this context, we are systematically working on innovative compounds that are aimed at enhancing treatment results and increasing patient satisfaction. In the past year, we have achieved significant progress to this end with the introduction of medicines in the areas of oncology and difficult-to-treat lung diseases that enabled Novartis to broaden its product portfolio. + +Novartis can only operate successfully if the company acts as a trustworthy, cooperative and transparent partner. With this in mind, we are continuously reviewing our corporate governance principles and compensation systems ? and adapting them regularly in consultation with investors and other stakeholder groups, while aspiring to the leading industry standards. We have simplified our corporate governance structure to free up resources, reduce bureaucratic hurdles, cut costs, and accelerate decision-making. We have empowered management to make decisions that were previously made by the Chairmans Committee, which has been disbanded. These changes have also led to adjustments to the compensation system of the Board of Directors. Finally, the Board of Directors has set up a Research and Development Committee that is designed to oversee our research and development strategy and organization. + +To help establish efficient healthcare systems amid rapidly evolving patient needs, Novartis also intends to assume greater social responsibility. We are seeking to enhance dialogue and collaboration with governments and health organizations to expedite the development of more comprehensive, integrated and cost-effective medical services. The creation and production of nonpatented therapies and generics remain essential to this goal, as millions of people in developing and emerging countries have no sustainable access to safe and effective medical care and rely ? more than ever ? on affordable, yet high-quality medicines. + +Moreover, we strive to accelerate specifically-designed social business programs in fast-growing regions of Asia, Africa and Latin America that enable us to benefit from economic growth, while helping to build a sustainable base for regional healthcare systems. We are also continuing our fight against malaria and we delivered more than 600 million Coartem and Coartem Dispersible treatments without profit since 2001. + +The strategic positioning of Novartis and the performance of our approximately 136,000 associates give us confidence about our medium- and long-term prospects. Following the strong results of the past year, we are poised in 2014 to consolidate our leading position as a science-based and patient-oriented healthcare company, and to sustainably increase shareholder value through the continuous management of our diversified product portfolio. Although economic and regulatory conditions remain generally challenging, and price and competitive pressures persist, Novartis stands on firm ground and is ready to address future challenges. We will continue to make every effort to fulfill our core tasks in the interest of all stakeholder groups: to cure diseases, ease suffering, and enhance the quality of life for patients around the world. + +I would like to thank you, our shareholders, for the trust you have placed in our company, and am pleased to propose a 7% dividend increase to CHF 2.45 at the next Annual General Meeting. + +----------------------------------------------------------------------------------------------- Novartis 2004 + +Dear Shareholder: + +I am pleased to report strong business performance in our ninth business year, which ended with yet another record result and market share gains. + +Let me summarize the key 2004 figures: +? Group net sales increased 14% (9% in local currencies) +to USD 28.2 billion +? Pharmaceuticals net sales rose 15% (10% in local currencies) +? Consumer Health net sales gained 10% (5% in local currencies) + +? Group operating income advanced to USD 6.5 billion +(+11%), + +? Net income growth of 15% to USD 5.8 billion + +? Earnings per share USD 2.36 (+16%) + +Innovation and a focus on patients, core elements of our strategy, resulted in another record performance These record results reflect our emphasis on sustainable, organic growth, a product of our consistent innovation strategy and the skills and commitment of over 81 000 associates worldwide. +The Pharmaceuticals division, again led by our can- cer and cardiovascular franchises, posted a double-digit rise in sales, with market share expanding globally. These successes were realized in a challenging health-care mar- ket characterized by cost-containment measures in many parts of the world. + +In 2004, we increased overall R&D investments by 12% to USD 4.2 billion +Our pharmaceutical research and development (R&D) expenditure ranked as one of the highest in the industry, relative to sales (18.8%), with outlays of USD 3.5 billion. This investment allowed us to complete construction of new laboratories, and hire more than 800 scientists at our new research headquarters in Cambridge, MA. New or enhanced platforms in biology and chemistry, paired with scientific leadership, not only fortified fundamental and applied research but also improved the compound selec- tion process, speeding up pipeline throughput. +The Novartis Institutes for BioMedical Research (NIBR) continue to focus their efforts on tractable biolog- ical targets and selected disease areas with high unmet medical needs, striving to bring novel medicines rapidly to patients. To achieve this objective, we are intensifying our efforts to elucidate the function of specific human genes identified by the Human Genome Project. While structur- al blueprints for these genes are now available, in most cases the genes primary role in the body and their poten- tial involvement in disease remain unknown. Functional- izing the genome is a vast undertaking ? one beyond the means and resources of any single company. According- ly, we have forged dozens of collaborations, completing 48 alliances with industry and 100 with academia. + +Pipeline of new drugs is one of the industrys strongest +Our pharmaceutical development pipeline is one of the best with 75 compounds, 52 of which are in advanced development or registration. Over the past few years, Novartis has maintained its leading position in R&D pro- ductivity. Novartis has received 13 US approvals since 2000, the highest figure of any Top Ten global pharma- ceutical company. Of particular importance are first- in-class compounds and, currently, 7 of our 10 highly innovative compounds in mid-to-late-stage development belong to this group. + +Among these are: +? LAF237, the first of a new class of incretin enhancers, oral antidiabetic agents that indirectly increase the blood glucose regulating hormone GLP-1. Phase III trial data for LAF237 are expected during the latter part of 2005. + +? SPP100 is the first in a new antihypertensive class called renin inhibitors. Elevated renin levels increase the risk of myocardial infarction and renal damage. So, SPP100 has the potential for improved end-organ pro- tection. Phase III data are expected in 3Q 2005. + +? FTY720, an immunomodulator with a novel mechanism of action, has recently completed Phase II studies as an oral treatment for multiple sclerosis, showing a reduc- tion of brain lesions and a significantly reduced relapse rate for MS patients treated. + +? PTK787 is an anticancer drug that inhibits all known angiogenesis factors involved in cancer. Submission for US regulatory approval is planned for the second half of +2005. + +? AMN107 is our new, most selective BCR-ABL inhibitor, a potentially more effective follow-up compound for our revolutionary medicine Gleevec/Glivec. Phase II studies will begin in the first half of 2005. + +Promising new compounds bring hope to patients As a physician, I often witnessed the hope that R&D brought to patients, especially in life-threatening situa- tions. New treatments that can reduce suffering and high health-care costs are needed for the more than 10 million people diagnosed with cancer annually, and for those suf- fering from incapacitating Alzheimers dementia, diabetes and cardiovascular disease, all on the rise. +It is a fact that a good profit outlook is a precondition for any industrial R&D activities. In turn intellectual prop- erty protection is the only way to ensure the open sharing of research findings without fear of copying, and to be cer- tain that there is a potential to earn an adequate return from successful projects. Therefore strong intellectual +property rights are a foundation for sustained innovation and allow us to continue to invest in R&D despite long lead times of 12?15 years. In this context I welcome the deci- sion by India to introduce patent protection in 2005, which, I believe will accelerate development of an innova- tive domestic Indian pharmaceutical industry and encour- age direct investment by international companies in local drug discovery and clinical research. Lets remember that overall the pharmaceutical industry invests nearly USD 50 billion a year in research and development, the single most important source of investment in health research. + +Drugs effectively fight disease and reduce overall health-care costs +On a macro level, it is clear that the need for novel medi- cines will rise as the population ages. The United Nations Population Division reports that in North America, 16% of the population was over 60 years of age in 2000. By the year 2025, it projects this percentage will rise to 25%; in Europe, the corresponding figure will be even higher. The increased life expectancy is primarily a consequence of the tremendous advances we have made in medical knowl- edge. For example: Over the last 40 years mortality as a consequence of hypertensive heart disease dropped by +67%, the death rate for GI ulcers declined by 61%, and for emphysema by 31%, and infant mortality dropped by a staggering 80%. +Of course, this is not just due to better drug therapies but, also, to better diagnostics, surgery and care. But there is no doubt, for example, that modern pharmacotherapy played a major role in the 60% drop in mortality over the past 25 years for children who suffer from cancer. Since I became a physician, I have witnessed how new medicines have revolutionized many medical fields, such as trans- plantation, ulcer therapy, cancer therapy, the treatment of ischemic heart disease and the therapy for schizophrenia, to name just a few. New treatments have also helped reduce chronic disability, which dropped by 25% over the past 20 years in people over 60. So people on average not only live longer, but also better. Furthermore, studies demonstrate that rational drug therapy shortens hospital stays, creating significant system savings. These savings by far exceed the incremental costs of modern drug therapy. + +A medicine-based business portfolio +As a company, we want to discover, develop and market medicines that are best suited for specific conditions. This includes innovative prescription medicines, which some- times are breakthroughs and have the power to change the way medicine is practiced. A recent example is Gleevec/Glivec for the treatment of chronic myeloid leukemia; another is Neoral, which revolutionized the field of organ transplantation. But our medicine-based business portfolio not only includes innovative medicines, but also provides generics and self-medication drugs. +Generics play an important role in times of rising healthcare costs, providing cost-effective treatment options. Our generics business unit, Sandoz, offers best- quality and attractively priced medicines. After a dynam- ic internal and external growth phase over the past few years, the 2004 performance of our Generics business in the US and German markets was disappointing. Price competition and delays of new product launches had a negative impact. As a consequence, we are focusing our efforts on building a cost-competitive structure on a global scale and investing to speed up our development efforts. Following our strategy we pursue organic growth comple- mented by external growth. In 2004, we participated in the ongoing consolidation of the generics industry by acquir- ing Sabex Holding in Canada and Durascan in Denmark. +At Novartis Consumer Health, the OTC, Animal Health, Medical Nutrition and Infant & Baby business units all out- performed their markets, reflecting the divisions strategic focus on Consumer and Customer Excellence. Dedicated customer teams formed last year to serve key accounts such as Wal-Mart Stores, Inc., are pooling efforts across business units and drawing on cross-functional capabili- ties to generate synergies and further growth. + +Providing access for patients in need +Today, many speak about the right to health as a basic human right. We support this concept as an aspirational objective, realizing that no single party will ever be able to cover the many needs of patients who do not have the financial means to buy healthcare services and drugs. All the various actors, primarily governments, but also inter- national organizations, companies and civil society, have a role to play. But thanks to our strong financial results in +2004, we were able to expand our access to medicines programs for uninsured and indigent patients suffering from leprosy, malaria, tuberculosis, chronic myeloid leukemia and other diseases, all part of our important worldwide corporate citizenship program. Currently we are also scaling up production capacity for Coartem, our novel antimalarial medicine, in response to rapid changes in treatment policies in malaria-endemic countries. The Novartis Foundation for Sustainable Development, which celebrated its 25th anniversary in 2004, is an outstanding example of how we actively shoulder our social responsi- bility to alleviate the immense poverty and associated human misery in the developing world. +The most innovative initiative, however, is our research center for tropical diseases, The Novartis Institute for Trop- ical Diseases (NITD), which we recently inaugurated in Singapore. NITD, managed on a not-for-profit basis, focus- es on finding new therapies for Dengue fever and Tuber- culosis, both neglected diseases that are gaining in impor- tance, especially in developing countries. +All told, in 2004, we donated USD 570 million through various corporate citizenship programs. This is the Novar- tis contribution to the most needy patients in the world. + +The solution to future health-care challenges is an undiminished commitment to innovation +At present, a number of parties are attacking the phar- maceutical industry. Some of this critique is valid. But often, the public unfortunately ignores or forgets the immense progress achieved in medical practice thanks to modern pharmacotherapy. In the past, money was often not a key factor when the health or even the life of a patient was at stake. It appears today that costs can be a primary concern for many people. Steps taken to lower costs, such as continuous, imposed price reductions, have had a + +deeply negative effect on the pharmaceutical research base in certain countries, especially in Europe. Proposals to break patents would have an even more devastating consequence, as this would destroy the foundation for R&D investment. Keeping the pharmaceutical industry profitable is a safeguard for our children and grandchil- dren, so that they will be able to continue to benefit from the advances of innovative medicines that treat the unavoidable burden of disease. +Let me finish my letter by emphasizing that we are determined to run our business not only according to all regulatory and legal requirements but, also, in an ethical way. We have therefore adapted our control environment, dedicating additional resources in order to comply with the US Sarbanes-Oxley Act. In 2004, we have not only enforced guidelines regarding internal conduct in our business activities but, also, started to report on cases of misconduct that we do discover, as transparency com- bined with adequate training is the most effective way to discourage misbehavior. +I am grateful to our associates, who have done an out- standing job during the past year, allowing Novartis to achieve excellent results and to improve the lives of many patients across the globe. Id particularly like to mention the efforts of our associates to aid emergency relief pro- grams following the recent earthquake and tsunamis that caused such immense destruction and suffering in South- east Asia and the eastern coast of Africa. During the com- ing months, we will continue to cooperate closely with gov- ernments and non-governmental organizations to insure that our medicines and donations reach people in need in the affected areas. +I also wish to thank you, our Novartis shareholders, for your continued confidence in us. + +Sincerely, + +Daniel Vasella, M.D. +Chairman and Chief Executive Officer + +----------------------------------------------------------------------------------------------- Novartis 2005 + +DEAR SHAREHOLDERS: + +It gives me particular pleasure in our tenth business year to report another set of record results. + +Let me summarize the key 2005 figures: + +? Group net sales increased 14% (+13% in local currencies) to USD 32.2 billion +? Pharmaceuticals sales grew by 10% (+9% in local currencies) +? Sandoz secured a 54% increase in sales +(+54% in local currencies) +? Consumer Health sales gained 8% (+8% in local currencies) +? Group operating income advanced to +USD 6.9 billion (+10%) +? Net income rose by 10% to USD 6.1 billion +? Earnings per share amounted to USD +2.63 (+11%) +? Free cash flow reached USD 4.7 billion +(+42%) + +This good performance reflects our clear and consistent strategy, which is based on innovation and achieving a leading position in the healthcare sector. Ultimately, however, the key factors in our success are the skills and commitment of our associates, and I would like to thank them for their contribution. + +Pharmaceuticals remains our biggest and most profitable business. Particularly strong + +growth was posted by the Cardiovascular and Oncology franchises, thanks to the class-leading products Diovan (used to con- trol hypertension) and Gleevec/Glivec (for the treatment of chronic myeloid leukemia). Overall, the division once again successfully increased its market share last year. With a total of 76 projects in clinical development, we have a full, innovative and promising pipeline. But in spite of ? or precisely because of ? our current success, we need to keep a sharp eye on the market evolution. + +Three fundamental trends are boosting de- mand for healthcare services and medicines: + +1. The aging of the worlds population, as the incidence and the prevalence of disease rise with increasing age; +2. Ongoing technological discoveries and developments, which lay the foundation for innovative pharmaceutical products; and +3. Rapid economic growth in countries such as China, India and Russia, leading to improvements in the provision of public healthcare. + +In line with changes in the populations standard of living and lifestyles, these countries are also experiencing increasing incidence of chronic cardiovascular disease, diabetes, cancer and respiratory illness. In +China alone, it is estimated that more than +160 million patients suffer from hypertension and more than 20 million have diabetes. In addition, the demand for effective treat- ments is outpacing economic growth: while the Chinese economy grew by 9.8% in +2005, sales of pharmaceuticals leapt by +22.5%. In India, some 35% of the population currently has access to essential drugs, and the proportion is expected to increase to +80% by 2020. + +Counteracting the effects of these growth drivers, however, are various negative trends, notably government price controls, with mandatory discounts, competitive pricing pressures, parallel imports from low-wage countries, and increasingly stringent re- gulatory requirements. Cost containment measures introduced by governments include the promotion of generics, which over the next few years will show double-digit expan- sion worldwide ? in contrast to market growth for patent-protected medicines, which will be in the mid to high single-digit range. + +In light of these developments, Novartis has +set its strategic direction as follows: +? First, consistent investment in R&D ? enabling us to bring to market innovative and differentiated products that offer patients clear therapeutic benefits +? Second, expansion of our generics business (to provide affordable treatment options following patent expiries) and, +? Development of promising new growth platforms such as vaccines (to reduce health- care costs through disease prevention). + +These, precisely, were the priorities that we pursued in 2005. The Pharmaceuticals Division further expanded its research operations, and this process will continue in the coming year. For our generics business, the acquisition of Hexal and Eon Labs re- presented not only a geographical expansion but a substantial reinforcement and rein- vigoration. In the US and Germany ? the most important generics markets ? we have secured a leading position, and gained access to a rich pipeline and new technologies. The incorporation of a dynamic entrepreneurial culture is also having beneficial effects. Sales are growing rapidly, integration is proceeding according to plan, and the team is highly motivated. Also pending is the out- right acquisition of Chiron, a company in which we have held a minority stake since +1995. While Chirons pharmaceutical oper- ations can be integrated into our own and its diagnostics unit has posted strong growth, its vaccines business suffered a seri- ous decline as a result of significant quality problems in production. Accordingly, we have decided to bring our quality assurance expertise to bear and are planning strategic expansion of the vaccines business through appropriate investments. + +Last year also saw the strengthening of our OTC Business Unit through the acquisition of the North American Consumer Medicines business of Bristol-Myers Squibb (BMS). This move has consolidated our position not only in a key market but also in the analgesics segment, where BMS was a major player with its Excedrin brand. + +Through organic growth and acquisitions in the course of 2005, we thus further expanded our operations in the healthcare sector, paving the way for additional sustained growth and at the same time spreading risks more widely. + +What is ultimately essential, of course, is not only strategic decision-making but progress on the operational front. The gains in market share achieved by Pharmaceuti- cals have already been mentioned above. There was a further rise in the proportion of sales generated by products that will con- tinue to enjoy patent protection for an extended period of time. + +The first approval worldwide was granted last year by the US FDA for Exjade, the breakthrough oral iron chelator. Iron over- load, mainly occurring as a result of frequent blood transfusions, previously required continuous infusion therapy, which was especially burdensome for children and adolescents. Exjade now sub- stantially facilitates treatment for this group of patients in particular. + +In Europe, the regulatory authorities granted marketing clearance for Xolair (for the treatment of severe allergic asthma) and Aclasta (for Pagets disease). + +Of the 76 projects currently in clinical de- velopment, 50 are already in late-stage trials. + +One product I mentioned in last years letter was Galvus (LAF237, vildagliptin) ? +the first of a new class of oral antidiabetic agents known as incretin enhancers. In the meantime, positive data have been reported from the most recent large-scale (Phase III) clinical trials. This new drug can be com- bined with several other antidiabetic agents, including insulin, or used alone. Another encouraging finding is that patients treated with Galvus showed no weight gain ? in contrast to most other oral antidiabetics. The first regulatory filing for this product is planned in the US for the first half of +2006. + +Also successful were the clinical trials for Rasilez (SPP100, aliskiren), the first in a new antihypertensive class called renin inhibitors. In these studies, Rasilez showed excellent tolerability and provided sus- tained 24-hour blood pressure control, thus also offering protection against dangerous early morning surges. + +Further observation of patients with multi- ple sclerosis who were treated with FTY720 +? a novel, experimental immunomodulator ? substantiated the positive Phase II data. During treatment with this agent, inflam- matory lesions in the brain resolved more rapidly, and relapse rates were significantly reduced over a 12-month follow-up period. However, these findings will need to be confirmed in additional studies before reg- istration can be envisaged. + +Unfortunately, the trial data for PTK787 ? an agent designed to block new blood vessel formation (angiogenesis) in tumors ? fell + +short of expectations. The course of disease was only improved in one subgroup of patients with colorectal cancer who received this treatment. Whether this compound can ever be registered remains to be seen. + +Clinical development of pitavastatin, a cholesterol-lowering compound licensed-in some years ago, has been terminated, as it proved less effective than had been hoped. We are thus reminded that while R&D is often fortunate enough to achieve break- throughs that decisively improve the lives of thousands of patients, it is never immune to costly setbacks. + +Access to medicine and drugs for needy patients, particularly in developing coun- tries, remains an important concern. There is little public awareness of the fact that, since the UN Millennium Development Goals were proclaimed in 2000, multi- national pharmaceutical companies have entered into more than 126 partnerships for the benefit of patients in developing nations. As a result of these initiatives, over +540 million treatments, worth in excess of USD 4.4 billion, have been provided to needy patients. These figures relate only to long-term programs and do not include assistance to patients in industrialized nations or disaster relief. Last year, taking all pro bono contributions into account, the total aid provided for patients in need by Novartis alone amounted to USD 696 mil- lion, with 6.5 million patients being treated. The main element of this commitment was the donation of medicines for the treatment + +of leprosy, malaria, tuberculosis and chronic myeloid leukemia. On top of humanitarian considerations, this aid produces substantial economic benefits, as it may enable patients to start work again and support themselves and their families. + +The pharmaceutical industrys commitment to patients in developing countries exceeds that of any other industry sector world- wide. But it cannot succeed single-handedly. There is a fundamental need for effective action by governments that are primarily concerned with the welfare of their citizens, as well as for partnerships with interna- tional organizations and civil society. + +The companys tenth year of operations provides me with the opportunity for a brief review. In 1995, Ciba and Sandoz with a combined headcount of 134 000 posted total sales of around USD 27 billion (using todays currency translation rates); in 2005, with just over 91 000 employees, sales reached USD 32 billion. In the initial post- merger years, spin-offs and disposals removed almost 50% of the 1995 total sales and a corresponding number of employees. This transformed the business portfolio dramatically. +While the healthcare sector accounted for only 46% of total sales a decade ago, this proportion has now risen to more than +90%. In just 10 years, Novartis has trans- formed itself from a widely diversified con- glomerate into a focused leading healthcare company. During this 10-year period, net income increased from USD 3.17 billion to +USD 6.1 billion (+92%), of course not tak- ing into account revenues or profits from divested companies. + +The Novartis brand has also been success- fully established worldwide, ranking among the 50 best global brands according to Business Week. The company also enjoys an excellent reputation: in 2005, Novartis was listed among the worlds 50 most respected companies by the Financial Times and Barrons, and it also featured in Fortune magazines list of the worlds 50 most admired companies. A key point of interest to investors is the total sharehold- er return (TSR). Taking spin-offs into account, the annual TSR averaged 12.7%, outperforming both the SMI (by 2.1 per- centage points) and the MSCI Pharmaceu- tical Index (by 2.6 percentage points). + +I would like to take this opportunity to thank everyone whose efforts and ideas have contributed to the success of Novartis. In particular, I would like to mention Pro- fessor Helmut Sihler, Vice Chairman of the Board of Directors and independent Lead Director, who has played a vital role in shaping our companys success since its creation. As a man of exceptional intelli- gence and experience, he has influenced our deliberations and decisions with keen business acumen and excellent judgment, without ever neglecting the importance of human relations. Professor Sihler will retire from the Board at the forthcoming Annual General Meeting. In his capacity as independent Lead Director, he will be succeeded by Professor Ulrich Lehner, who will additionally serve, together with Hans- Joerg Rudloff, as Vice Chairman of the Board of Directors. + +I am confident that Novartis will remain successful in the future despite any possible setbacks. Sound foundations are provided by our clear strategy ? with significant in- vestments in world-class research yielding innovative products and our determination to invest in growth segments of the health- care sector. The skills, integrity and com- mitment of our associates, management and Board of Directors can be trusted, giving us the ability to act rapidly, flexibly and with circumspection. Naturally, we also hope for a little luck, which occasionally is needed. + +I wish to thank you, our Novartis sharehol- ders, for your loyalty and your confidence in us. + +Sincerely, + +DANIEL VASELLA, M.D. +Chairman and Chief Executive Officer + +----------------------------------------------------------------------------------------------- Novartis 2006 + + +DEAR SHAREHOLDERS: + +It gives me great pleasure in our eleventh busi- ness year to report another set of record results. + +? Group net sales rose 15% (+14% in local currencies) to USD 37 billion +? Operating income advanced 18% to USD +8.2 billion +? Net income grew 17% to USD 7.2 billion +? Earnings per share (EPS) were up 16% +? Free cash flow reached USD 4.3 billion + +This outstanding performance reflects our continuous focus on innovation and building a broad portfolio around growth areas of the healthcare sector. Ultimately, the skills and commitment of our associates are the key fac- tors for our success, and I would like to thank them for their contributions. + +The pharmaceutical industry is confronted with conflicting trends. Demand is continu- ally rising for healthcare services, medicines, vaccines and diagnostics, which is generating higher costs that in many countries are increasingly the focal point of political and social debate. Studies have repeatedly proven that appropriate use of medicines generally reduces treatment costs and also that the majority of healthcare cost increases are gen- erated in hospitals. However, the pharmaceu- tical industry remains the primary target in the cost debate even though medicines account for only 10% to 20% of overall costs, depend- ing on the country. + +Still, the healthcare sector will remain a dynamic growth area in the future driven by the following trends: + +? The aging of the worlds population contin- ues unabated, generating steadily increas- ing demand for medicines due to the rising incidence of degenerative diseases and cancer as people grow older. The approach- ing wave of retirements in the post-war + +baby boomer generation will further stimu- late demand in our most important markets. +? The strong economic expansion in popu- lous countries such as China, India and Russia is translating into over-proportional growth in demand for healthcare services. Accompanying this economic growth has been the increasing adoption of lifestyles typical of affluent, industrial countries. That, in turn, has led to a higher incidence of obesity, chronic cardiovascular disease, diabetes, cancer and lung diseases. +? Finally, new technologies are enabling the discovery and development of innovative medicines for patients suffering from otherwise untreatable diseases. + +At the same time, our industry faces chal- lenges ranging from government price controls and intensified competition to increasingly stringent regulatory controls that are escalat- ing the costs of Research & Development. Product liability risks, which can be very cost- ly, are another important factor that is attract- ing a great deal of attention and fueling fun- damental distrust of the industry. + +The most far-reaching cost reduction meas- ures taken by various governments include promoting greater use of generic pharmaceu- ticals, sales of which are likely to experience double-digit growth in the coming years as opposed to the anticipated single-digit growth forecast for patent-protected medicines. + +In these industry conditions, business as usual is no longer a viable long-term option. Identifying and addressing the needs of patients remains at the forefront of all that we do. This includes taking a serious look at the economic and political realities in which patients live because this plays a major role in determining how products are made available to them. This is why our business portfolio sys- tematically reflects the dynamically changing healthcare market: growing demand for inno +vative medicines (Pharmaceuticals), the rising support for greater use of cheaper generics (Sandoz), the increasingly prominent role of vaccines (Vaccines and Diagnostics) and greater empowerment of patients (Consumer Health). + +We have the best portfolio to optimally lever- age growth opportunities in healthcare in the interest of both our customers and sharehold- ers while also reducing risks. + +Novartis has defined the following strategic ini- tiatives: + +? Invest vigorously in R&D to continue bringing new and innovative products to the market +? Strengthen the Sandoz generics business, which provides affordable treatment options following the expiry of patents +? Expand businesses with synergy potential, such as between Pharmaceuticals, OTC and Animal Health +? Further build our new growth platform in Vaccines and Diagnostics by focusing on preventive medicine + +We sharpened our focus on these priorities in +2006, which resulted in the healthcare busi- nesses now accounting for 96% of total net sales compared to just 45% in 1995. + +Pharmaceuticals is our most important division, again growing faster than the mar- ket. Strong demand for our top cardiovascular and oncology drugs led the performance. Sales growth in the US and in emerging mar- kets such as China and Russia were particu- larly dynamic, with the performance in Europe less robust. The extraordinary success of our antihypertensive medicine Diovan is poised to continue its dynamic growth. Our cancer ther- apy Gleevec/Glivec generated sales of over USD 2.5 billion in only its fifth year. Two other cancer medicines, Zometa and Femara, have also developed well. + +Vaccines and Diagnostics enjoyed impres- sive growth, with the integration of the newly acquired Chiron business proceeding smooth- ly and the successful resolution of quality problems in influenza vaccine production. Our new cell culture production technology for influenza vaccines could save lives in the event of a pandemic flu outbreak due to the shorter lead times. A new seasonal influenza vaccine based on this technology was submitted for European approval in 2006. New diseases, such as avian flu and SARS as well as resistant bacterial and fungal infections, will continue to generate strong demand in the future for new vaccines and medicines. + +Sandoz expanded its retail generics business, particularly in the US, Eastern and Southern Europe, Russia, Switzerland, Canada, and Aus- tralia. In Germany, the impact of severe price pressure was felt. Our recombinant growth hormone Omnitrope became the first follow- on version of an approved biotechnology drug to be granted US and European approvals. Given the large number of biotechnology drugs already without or set to lose patent pro- tection in the coming years, these so-called biosimilars are expected to play an increas- ingly important role by providing patients with affordable, safe and effective alternatives to the original treatments. + +The Consumer Health Division performed very well as the OTC and Animal Health busi- nesses each posted double-digit net sales growth. In line with our continued focus on healthcare, we signed a definitive agreement to divest the Medical Nutrition business. I am convinced this transaction is an ideal solution for Medical Nutrition, one that offers the man- agement and associates of this business the best future prospects. Proceeds from the transaction will further strengthen our financial position and provide greater strategic flexibility. + +Of course, the successes of our businesses depends not only on strategic objectives but also in executing them successfully, particu- larly in R&D. + +We are planning to launch several innova- tive medicines during the next two years and will keep investing vigorously in R&D. We will also further complement our own R&D programs through alliances and collaborations for development compounds and cutting-edge technologies. + +Novartis has 138 projects in clinical devel- opment. Among these are 50 new molecular entities (NMEs) and 88 life-cycle management projects with new indications or formulations. In 2006, over 20 new projects were added to the pipeline. Key areas of R&D are cardiovas- cular/metabolic diseases, cancer and neuro- logical conditions as well as respiratory and infectious diseases. + +Shortly before the end of 2006, we received approval from the US Food and Drug Admin- istration (FDA) for Exforge (valsartan and amlodipine), a single-tablet combination of the two most prescribed antihypertensives in their respective classes, and expect European approval to follow during the course of this year. We also anticipate regulatory decisions in +2007 for two other important medicines: Tekturna/Rasilez (aliskiren), a renin inhibitor for the treatment of hypertension, and Galvus (vildagliptin), a once-daily oral treatment for patients with type 2 diabetes. The US regula- tory agency extended its review after recently available data for both Tekturna/Rasilez and Galvus were submitted to clarify open ques- tions. Delays are unfortunately part of our industry and inherent in the R&D process. + +For two other development compounds, the submissions for US and European regulatory approvals were accelerated and completed earlier than planned in 2006. Tasigna (nilo +tinib) is a new treatment option for patients with certain forms of chronic myeloid leukemia who have resistance and/or intolerance to treatment with our Gleevec/Glivec, while Aclasta/Reclast (zoledronic acid) is a conven- ient once-yearly infusion lasting only 15 min- utes as a treatment for women with post- menopausal osteoporosis. + +Among the many innovative compounds in late-stage development at Novartis, I would like to particularly highlight FTY720 and RAD001. + +FTY720 (fingolimod) is seeking to become the first oral once-daily therapy for patients with relapsing multiple sclerosis, a condition esti- mated to affect more than 2.5 million patients worldwide and women at twice the rate as men. This compound is now in the final stage of development after an earlier Phase II trial showed positive results during two years of treatment in helping patients with this poten- tially debilitating neurological condition. Sub- mission is on track for 2009. + +RAD001 (everolimus) is a novel oral com- pound in development to inhibit a cell signal- ing pathway called mTOR considered to be an important therapeutic target in oncology. At effective and well-tolerated doses, RAD001 has demonstrated broad clinical activity in patients with various tumor types. This compound acts by directly inhibiting both the growth of tumor cells as well as the formation of new blood ves- sels (angiogenesis). If positive results are achieved in clinical trials with difficult-to-treat forms of cancer, the first regulatory submis- sions could be submitted as early as 2008. + +The Novartis Institutes for BioMedical Research (NIBR), created four years ago to strengthen the companys long tradition in drug discovery, is bolstering the pipeline through new discovery approaches and an increasing focus on biotech- nology compounds. We are expanding our exist- ing development activities in China by estab- + +lishing an integrated R&D institute in Shanghai that will focus on diseases particular to the region, such as liver cancer. This is not a typi- cal China investment focused on cost savings but one aimed at gaining access to the coun- trys vast talent pool and scientific promise. The choice of Shanghai reflects the vitality and eco- nomic potential of this city and the changing global economy; it is imperative to have a strong local presence in this fast-growing environment. + +Novartis has been rapidly advancing its pipeline by complementing internal efforts with collaborations and targeted acquisitions. Last year, we acquired the UK biopharmaceu- ticals company NeuTec and added two com- pounds ? Mycograb for fungal infections and Aurograb for bacterial infections ? that will fur- ther strengthen our presence in the fast-grow- ing hospital infections segment. + +Let me close by offering some perspectives on the challenges facing the pharmaceutical industry and how we are addressing the sig- nificant social and political changes underway: + +Innovation is our core activity. We must not allow the challenging political environment to distract us from our ultimate goal: discovering, developing and quickly bringing to the market new drugs with real therapeutic benefits to both individual patients and to society. The pharmaceutical industry is not without criticism, but thanks to the important contributions of medicines and vaccines, many infectious diseases can now be prevented or effectively treated. Survival rates for children suffering from cancer have doubled in the last 25 years, while the incidence of strokes and heart attacks have been significantly reduced. Novartis medicines ? from Gleevec/Glivec and Neoral to Coartem and Clozaril/Leponex ? have positively changed the lives of thousands, if not millions, of patients around the world. These patients have benefited enormously from the success of our industry and also Novartis. + +Intellectual property rights are central to the economy. Without them, many of the breath- taking technological developments since the Industrial Revolution would not have occurred. Protecting innovation is the best protection for patients, laying the foundation for the massive investments made by the pharmaceuticals industry in R&D that are vital to medical progress. Novartis will continue to resist the pressure to soften its position on the need to vigorously protect intellectual property in favor of short-term political gain. + +Reputation is valuable capital in the form of trust, but a resource that cannot be stockpiled. It must be earned daily. Novartis enjoys an excellent international reputation. However, we must better explain to the public the positive impact of our industry, how it functions, the benefits of our products for society and the relationship between risk, reward and innova- tion. Our industry has failed to communicate effectively on the substantial role medicines play in reducing overall healthcare costs. It would be a serious setback if the demand for innovative medicines continues but without an understanding that innovation requires enor- mous investments and risks ? in other words, that innovation has its price. + +Corporate citizenship is taken seriously at Novartis and is an integral component of our business strategy. Our access-to-medicine programs in 2006 reached over 33 million patients worldwide, with contributions totaling USD 755 million. This represented some 2% of our total Group net sales donated to disad- vantaged patients. + +The Novartis Institute for Tropical Diseases in Singapore has expanded its research activities to include malaria along with tuberculosis and dengue fever, diseases that are still troubling and common in developing countries. We decided in 2006 to sharply reduce the average treatment price of Coartem, the most effective +anti-malaria drug, to USD 1.00 ? a loss-mak- ing activity for us. More than 60 million treat- ments were delivered to endemic countries last year, a dramatic increase from only four million in 2004 due to our expanded produc- tion capacity. + +We are doing what we believe is right: helping patients in need while also strengthening our position as a reliable partner in the health sec- tor. At the same time, corporate citizenship also calls for a strong sense of reality, and this means rejecting overblown expectations of some stakeholders. We cannot assume the responsibilities of governments. Well-func- tioning access-to-medicine programs require governments to create the appropriate infra- structure and distribution networks, provide legal certainty and a safe environment ? all of which we cannot provide. This can only be achieved through the collaboration of all involved stakeholders. It is imperative that pharmaceutical companies, governments, international organizations and NGOs work together to ensure that patients in need receive proper care. + +We must overcome a culture of blaming each other; the precarious situation in many devel- oping countries is far too serious for symbolic posturing. We are seeking an open dialogue with all stakeholder groups, one based on mutual trust and tolerance with the aim of long-term success ? not only in access-to- medicine initiatives but also in day-to-day business activities. + +Strong values are critical during this time of rapid change. Now more than ever, strong val- ues are important to hold a company togeth- er: to concentrate energies, guide decisions and place greater focus on performance objec- tives. Our success during the last 10 years has been based on such values ? a consistent focus on performance and results, an open culture and acting responsibly for patients and soci- + +eties. The values of a company become par- ticularly evident during a takeover situation, where there is often a temptation to simply absorb the acquired company. I personally see acquisitions ? such as those during the last two years involving Hexal, Eon Labs and Chi- ron ? as learning opportunities and assurance that monotony, complacency and self-satis- faction have no chance of taking hold in our organization. + +Balancing global aspirations and local identities is a constant task. The process of globalization is not a one-way street; to think so would be a dangerous illusion. We must respect local and national customs, whether they involve languages, cultural aspects or the law. At the same time, we have established and are implementing standards throughout Novartis ? particularly our Code of Conduct and our Corporate Citizenship Policy and guidelines. For example, Novartis has initiated a living wage program to set minimum pay standards around the world for its associates. We expect similar conduct from our business partners. We have also set strict global envi- ronmental and safety standards, ones that are the same at our Basel headquarters as in developing countries. + +As a shareholder, you naturally have an inter- est in the performance of your company. Our innovative and risk-diversified portfolio has delivered strong returns when looking at share price gains, dividends and spin-offs. Indeed, the value of an investment in Novartis more than tripled from January 1, 1996, to Decem- ber 31, 2006, exceeding the total shareholder return of most of our competitors. I am confi- dent that Novartis will continue to be suc- cessful. Since the creation of Novartis in 1996, our company has been a leader of change and progress, not a passive observer. This remains the case today thanks to our forward-looking strategy, our considerable powers of innovation, operational excellence + +and solid basic values ? Novartis has what it takes to identify future opportunities and to translate them into commercial success. + +Dr. Marc Moret, a talented leader who served as Chairman of the Board of Directors of San- doz until the merger with Ciba-Geigy in 1996, passed away on March 17, 2006. One of his most impressive achievements was certainly the creation of Novartis. With a strategic fore- sight still admired today, he realized much ear- lier than others how such strong, global organ- izations could succeed in an increasingly competitive environment. + +The skills, dedication, and integrity of our asso- ciates have enabled us to secure our place among the world's most respected and suc- cessful pharmaceutical companies. When it comes to setting the strategic direction, appointing the best talent to key positions and ensuring effective control, our Board of Direc- tors plays a vital role. Dr. h.c. Birgit Breuel will leave the Board at the end of her term at the Annual General Meeting in March 2007. We would like to thank Dr. Breuel for her efficient and valuable contribution to the work of the Boards of both Ciba-Geigy AG and Novartis AG. + +I would also like to again thank our associates, whose excellent performance during 2006 enabled Novartis to achieve both another year of record results and improve the lives of countless patients worldwide. + +My thanks also to you, our shareholders, for the trust you continue to place in Novartis. + + +Sincerely, + +Daniel Vasella, M.D. +Chairman and Chief Executive Officer + +----------------------------------------------------------------------------------------------- Novartis 2007 + +DEAR SHAREHOLDERS: + +It gives me great pleasure in our twelfth business year, which has been the most exceptional in the history of Novartis, to report another set of record results despite a difficult environment for the Pharmaceuticals Division, which experienced disappoint- ments as well as successes. + +We took decisive steps in 2007 to focus Novartis solely on healthcare through the divestments of Medical Nutrition and Gerber, which led to net income advancing 66% to USD 12 billion. This includes the after-tax gain of USD 5.2 billion from the divest- ments. + +The sale of these businesses, along with one- time charges of approximately USD 1 billion for environmental provisions and restruc- turing measures, makes it challenging to compare this performance with the previ- ous year. Therefore I will focus on continu- ing operations: + +? Net sales from continuing operations rose 11% (+6% in local currencies) to USD 38.1 billion + +? Operating income from continuing operations rose 2% to USD 7.8 billion excluding these one-time factors + +? Earnings per share (EPS) rose 68% to +USD 5.15 for the Group, and were up +9% to USD 3.15 for continuing opera- tions when also excluding these one- time factors + +? Free cash flow from continuing opera- tions reached USD 3.8 billion + +All divisions contributed to another record level of net sales for the Group. However, the overall results were impacted by a weaker performance in the Pharmaceuticals + +Division, which stood in stark contrast to the dynamic growth of Vaccines and Diagnos- tics and Sandoz. Consumer Health also delivered substantially improved results. + +While the Pharmaceuticals Division faced a challenging year, it is important to note the overall good results, even if these were less likely to make headlines than the setbacks. Europe, Latin America and the priority emerging growth markets all posted dou- ble-digit expansion in net sales, while the Oncology and Neuroscience franchises delivered strong double-digit growth. Many of the top ten selling medicines ? above all Gleevec/Glivec for the treatment of chronic myeloid leukemia and the high blood pres- sure medicine Diovan ? maintained leading positions in their therapeutic areas. In the US, by contrast, net sales declined sharply following the withdrawal of Zelnorm in March and the entry of generic competition, which to some extent was unforeseen, for Lotrel, Lamisil, Trileptal and Famvir. In 2006, these five products together generated annual net sales of approximately USD 3 billion in the US, so these setbacks represent a loss of more than 10% of glob- al Pharmaceuticals Division net sales. Addi- tional challenges included the ongoing delay in gaining US regulatory approval for the new diabetes medicine Galvus and a regulatory decision in the US not to approve Prexige. + +At the same time, all of our other healthcare businesses delivered excellent results. + +The Vaccines and Diagnostics Division enjoyed dynamic growth in 2007. Strong deliveries of influenza vaccines to the US, as well as vaccines for tick-borne encephalitis and for pediatric immunization, were the most important growth drivers. The pipeline made significant progress, particularly the development of potentially first-in-class vaccines for meningococcal meningitis, and +supported by a new strategic alliance with Intercell that provides exclusive access to several promising projects. + +The generics Division Sandoz also reported dynamic growth, especially in the US. The successful launches of several new difficult- to-make generics, which provide Sandoz a competitive advantage, underpinned the strong expansion. Operating income improved much faster than net sales, ben- efiting from sustained increases in sales volumes and productivity initiatives. + +The Consumer Health Division delivered a good performance, as both OTC (non- prescription medicines) and Animal Health achieved attractive growth thanks to a com- mon focus on strategic brands and the launch of new products as well as expan- sion in Japan and emerging growth mar- kets. CIBA Vision improved its net sales, and in particular operating income, following the resumption of deliveries in 2007 after some recent product shortages. Operating income for the Division improved and sup- ported significant R&D investments and geographic expansion. + +The overall good performance in a diffi- cult environment confirms that we are on the right strategic path. The events of +2007 have made clear the advantages of our strategy centered on focused diversifi- cation. We are active in fast-growing areas of the healthcare market while reducing risks, such as over-dependence on govern- ment-regulated pricing for medicines or the actions of regulatory agencies. + +Despite the current industry challenges, the healthcare sectors future continues to promise robust growth. The growing need for medical services and medicines is driv- en above all by the following factors: + +? First and foremost is the aging of the worlds population. The incidence of + +chronic and degenerative diseases, such as arthritis, high blood pressure, cancer and, of course, dementia, rises with age. An estimated 80% of people over age +80 suffer from at least one disease, and more than 60% have two or more condi- tions. The entry of the baby boomer generation into retirement ? the first members reached the traditional retire- ment age in 2007 ? will further support this trend. + +? Younger generations are also being impacted by health-related changes in society. Changes in dietary habits and an increasingly sedentary lifestyle are having an impact. The number of over- weight people is not only rising in the US but also in Europe and many devel- oping countries. Negative health conse- quences linked to obesity are becoming +increasingly visible, especially cardiovas- cular disease and diabetes. At the same time, environmental pollution is causing more cases of cancer and pulmonary disease. + +? Strong economic growth in emerging markets with large populations, particu- larly China, India and Russia, has led to rapid expansion of the middle class and greater demands for better healthcare services. + +? Finally, new technological discoveries and trends are continuously enabling the development of innovative medicines to address a range of diseases that previ- ously could not be adequately treated. + +Although these developments reaffirm prospects for rising demand for healthcare and our products, a number of challenges exist: + +? Increased pressure on costs: Political resistance to high-price medicines is likely to grow throughout the world as +the overall cost of healthcare keeps ris- ing. Although doctors, pharmacies and hospitals will not be able to escape political pressures, the pharmaceuticals industry unduly suffers due to its status as the most visible and tangible partici- pant in the healthcare system. This makes us an easy scapegoat for rising costs. + +? Erosion of patent rights: Our industry has recently found itself confronted by aggressive behavior from certain gener- ics manufacturers. Some have launched copies of medicines before the expiry of patents because they consider these patents to be contestable, and in many instances courts have not yet stepped in to stop them. + +? Growing mistrust: The pharmaceuticals industry has faced for some time a con- servative attitude from the US Food and Drug Administration (FDA), which appears to be a reaction to public criti- cism. This conservatism is reflected in the agencys demands for growing vol- umes of data aimed at guaranteeing an unparalleled degree of safety. In the long term, this approach will be detrimental +to medical progress since it is simply not possible to provide medicines that are completely free of side effects in all patients. The benefits and risks of any treatment must in the end be weighed individually by the physician and patient. + +A strategy ignoring these trends, which to some extent overlap and are at times con- tradictory, will fail sooner rather than later. We are convinced that our diversified port- folio ? yet one focused on growth areas of healthcare ? ideally positions Novartis for the future and reduces risks. We have been steadfast in pursuing this strategy in recent years, for example, by purchasing Chiron in +2006 as well as by divesting the remaining non-core nutrition businesses in 2007. + +The most decisive factor remains our strength in innovation. Our overall per- formance in gaining new product approvals was positive. It goes without saying that the delays in approvals for Galvus have been particularly disappointing. It is important, nonetheless, to recognize the overall suc- cesses during the year. Novartis received six positive regulatory decisions in the US and nine in the EU (15 positive decisions out of a total of 17). These included approvals for Rasilez/Tekturna and Exforge (high blood pressure), Exelon Patch (Alzheimers dis- ease) and Aclasta/Reclast (osteoporosis) in the US and Europe. In addition, Lucentis (wet age-related macular degeneration, a leading cause of blindness) and Sebivo/ Tyzeka (hepatitis B) were both approved in Europe. In the third quarter, Galvus received European approval as a new oral treatment option for patients with type 2 diabetes. At the end of 2007, the US and EU both grant- ed approvals for Tasigna as a new medicine for patients with chronic myeloid leukemia no longer responding to Gleevec/ Glivec. + +Novartis is widely recognized as having one of the industrys most attractive develop- ment pipelines. Research and Development activities are focused in particular on car- diovascular and metabolic diseases, oncol- ogy and neurology as well as respiratory and infectious diseases. Our portfolio includes 140 projects in clinical develop- ment, more than ever before. Several late- stage projects are progressing on track toward regulatory submissions. These include FTY720 (multiple sclerosis), QAB149 (respiratory diseases), RAD001 (cancer), ACZ885 (Muckle-Wells syndrome) and SOM230 (Cushings disease). + +Breakthroughs have also been achieved in Sandoz and Vaccines and Diagnostics: Thanks to improvements in innovation and productivity, Sandoz has strengthened its leading position in bringing difficult-to- make generics to the market. European + +approval was granted in 2007 for epoetin alfa ? a further milestone following the US approval of the growth hormone Omnitrope in 2006 as the worlds first follow-on version of a previously approved biotechnology drug. As an affordable, high-quality bio- generic, epoetin alfa could be used to pro- vide benefits to approximately 250 000 patients in Europe. + +In 2007, Vaccines and Diagnostics gained European approval for the new pandemic flu vaccine Focetria. Novartis also gained a leading position in cell-culture flu vaccines with the European approval of Optaflu, which utilizes new technologies represen- ting the most important innovation in influenza vaccine manufacturing in more than 50 years. + +Innovation is our core competency ? this comprises the development of novel med- icines and the creation of new R&D strate- gies. Driven by the increasing number of therapeutic proteins discovered by our researchers, we established a new Biologics R&D unit in 2007 to unify our core capabil- ities in biologics within one group. + +It takes courage during uncertain times to follow your own path and be true to your convictions, rather than just keeping an anxious eye on competition. Novartis has steadfast positions and stands by them. Our points of view often do not win popularity contests. The tendency toward group think- ing has sometimes been confused with the practice of benchmarking. This approach can often lead to errors in judgment. In such a situation, one rarely has the courage to review a situation objectively, draw conclusions and also take responsibility. + +One of the fundamental aspects of the Novartis culture is being true to our values, ensuring that we remain committed ulti- mately to the needs of patients while engaging in social and political debates. It is critical to differentiate between legitimate discussions about healthcare costs and those that appear to address this issue but instead actually mask hostility toward innovation. + +Pressure on healthcare prices is simply a reality that must be accepted. Given the demographic trends, one can appreciate the cost reduction efforts. But there is a limit, and crossing it endangers incentives needed to drive innovation. Going beyond this limit would have dramatic conse- quences, massively weakening long-term investments that have led to historical advances in medicine. Progress is only pos- sible in an environment that values innova- tion. I personally feel the level of hostility toward innovation goes too far when indus- trialized countries take for granted that they have the healthiest populations in the his- tory of mankind but at the same time demand breakthrough medicines with no side effects and offered at minimal prices. + +Aging societies are precisely those that can neither support such ill-considered views toward innovation nor the political condi- tions that facilitate them. On the contrary, aging societies must embrace innovation. One of the most urgent challenges in many critical markets for Novartis is the cost of healthcare, coupled with overall care of the elderly. Concern for the healthcare needs of the elderly could be reasonably addressed through innovation, especially if one even- tually wants to avoid rationing. One inter- esting example is the link between Alzheimers disease and the rise in life expectancy. If an effective treatment is not found, the costs of treating and caring for these patients could quickly skyrocket to absolutely unaffordable levels. The annual costs of caring for the estimated five million people in the US with Alzheimers disease already represents about USD 150 billion of the nations healthcare budget. Consider + +the implications of estimates forecasting the number of patients will rise to an unimaginable 100 million in 2025. + +One would surmise that society would encourage research into these types of dis- eases, creating more attractive rewards for those who make significant R&D invest- ments. This might seem counter-intuitive at first, but from a long-term perspective it could be the only viable approach. + +Another development eroding the vital culture of innovation is the increasing aversion to any conceivable risk. This reflects several societal trends, and mani- fests itself mainly in relation to our prod- ucts. Let me be clear: No medicine exists today that is completely free of side effects in all patients. Of course, this poses a dilem- ma for those involved ? doctors and patients. During my time as a physician working in hospitals, I was confronted every day by this dilemma. I still firmly believe that one of the core capabilities of physi- cians is to take responsibility for decisions that involve their patients. When regulatory agencies take over these responsibilities, as is increasingly the case in the US, then healthcare policies will move toward a patronizing system where physicians and the pharmaceuticals industry are viewed with distrust instead of as important part- ners. These developments oppose the con- sistent demand for industry and individuals to take more responsibility for their actions, coupled with a corresponding reduction in the role of governments. Strict control sys- tems are appropriate and important ? and opinions should not differ on this point. But excessive anxiety will slow the pace of med- ical progress over the long term, and lead to suffering that will impact our entire society. + +A sustained commitment to social responsibility is a fundamental value of Novartis. Our actions in corporate citizenship are too critical to be linked to business +cycles. Last year, for example, our access- to-medicine programs reached 66 million patients worldwide, with contributions total- ing USD 937 million and representing about +2.5% of annual net sales from continuing operations. + +Important Novartis initiatives are focused on neglected diseases, especially malaria, leprosy, dengue fever and treatment-resist- ant tuberculosis. In 2007 in more than 40 +African countries, Novartis provided 66 mil- lion treatments of the anti-malaria medicine Coartem below costs, which saved an esti- mated 200 000 lives, a majority of which were children. Moreover, annual production capacity has been ramped up to deliver +100 million treatments of Coartem. + +I would also like to take an opportunity to provide an industry perspective as well: An impressive 1.3 billion health-related inter- ventions ? ranging from medicines to vac- cines and disease awareness campaigns ? worth billions of dollars were distributed between 2000 and 2006 in developing countries considered to be of little com- mercial interest. + +Attracting the best talent from around the world is critical for a global company like Novartis, ensuring that associates feel respected and are recognized for their contributions. Ensuring equal opportuni- ties, fairness and mutual respect are a sine qua non in a world that, in business terms, is growing ever closer together. Our Diversity +& Inclusion Advisory Council (DIAC), com- prised of nine external experts with differ- ent cultural, ethnic and social backgrounds, supports the objective of building teams that are both diverse and talented. The DIAC will further strengthen our competitiveness by reinforcing the importance of an inclu- sive environment ? not only among our associates but also in interaction with +patients and other interest groups. I have +been personally following the progress of the DIAC members, and I am deeply impressed by their engagement and contributions. + +Novartis has long been committed to the principles of sustainability, encompassing more than just environmental protection ? and long before this issue found its way to the forefront ? as one of the first signatories of the UN Global Compact. A key aspect of our corporate culture is ensuring appropri- ate use of energy and other resources. Three years ago, Novartis made a voluntary commitment to reduce its greenhouse-gas emissions to levels mandated by the Kyoto Protocol. The improvements in energy effi- ciency have already exceeded expectations. Sustainability is a prominent feature of the Novartis Campus at our headquarters in Basel. A key objective is to use renewable energy on the Campus and eliminate CO2 emissions in the medium term. The chang- ing composition of the worldwide vehicle fleet is also contributing to these objectives: A 10% reduction in CO2 emissions is expected by 2010 through the replacement of older vehicles with new ones utilizing hybrid technology or diesel motors with micro-particle filters. + +I am particularly pleased that our commit- ment to sustainability of all forms was acknowledged in 2007 with the selection of Novartis as a sustainability leader in the Dow Jones Sustainability Index, a worldwide rating of companies according to econom- ic, environmental and social factors. + +This engagement in corporate responsi- bility ? and actually the success story of Novartis ? would not have been possi- ble without a consistent focus on per- formance and results. As a global compa- ny, we have consistently considered challenging periods as opportunities to review how we work and to pursue improve- +ments. The initiatives announced in the sec- +ond half of 2007 involve innovation, effi- ciency and leadership. Beyond the creation of the new Biologics unit, two other initia- tives will help us more quickly achieve our objectives: + +? Project Step-up is designed to improve the effectiveness of drug development: We want to strengthen our project teams, integrate decision-making under +the leadership of experienced colleagues at the franchise level and simplify development processes. + +? A Group-wide initiative called Forward is underway to simplify our structures, accelerate and decentralize decision- making processes, and redesign the +way Novartis operates, while at the same time providing productivity gains. Although the results of internal surveys show Novartis performs in almost +all aspects better than comparable companies, they also show many associates feel the organization is too complex and could benefit from simplification. Given these perspectives, we have taken this opportunity both +to streamline our organization and to redefine the way we work. + +Coping with change is never easy, especially when jobs are affected. However, it would be fatal if we were to ignore significant indus- try changes taking place. Only by taking a proactive approach can we improve our competitiveness. + +Last year, some leadership changes were also made to broaden experience at the top management level and to provide fresh impetus to our business. Switching posi- tions, Joseph Jimenez became Head of the Pharmaceuticals Division and Thomas Ebeling took over as Head of the Consumer Health Division. + + +As a shareholder, you are naturally inter- ested in the performance of our company. Since its creation in 1996, Novartis has pro- vided on average a total annual return of +9.9% to shareholders, more than the returns of most large pharmaceutical companies. Our earnings per share have risen approxi- mately 80% during the last five years, while the annual dividend payout has risen on average 11% during the same period. Unfortunately, these improvements have not been reflected in the share price, and this is not something to gloss over. At the same time, our fundamentals remain strong and are reflected in the twelfth consecutive year of record results achieved in 2007 despite significant challenges. + +Indeed, the pharmaceuticals industry has suffered from a period of overall devalua- tion in market capitalization. The industrys price/earnings ratios only a few years ago ranged from between 25 to 30, but many have since collapsed to between 10 and 15. This broad devaluation indicates that finan- cial markets have viewed pharmaceutical stocks with suspicion for some time, based on reasons already discussed. However, I believe the emphasis is far too much on challenges than on opportunities. In turbu- lent times, investors have often turned to the pharmaceuticals sector; a downturn in the economy will offer pharmaceutical stocks an opportunity to again be seen as valuable investments. + +We are now preparing for a new growth cycle. The results in the first half of 2008 will be negatively impacted by a weak per- formance in the Pharmaceuticals Division, particularly in the US. This period will be used to further improve productivity and efficiency. + +Thanks to new product launches and the strength of our flagship products Diovan and Gleevec/Glivec, a new growth cycle in + +Pharmaceuticals is also expected to emerge in the second half of 2008. + +Cautious optimism seems appropriate for +2008: One must remember that the indus- try is facing a more volatile phase than experienced in the past. I am confident that I speak for all Novartis associates in saying we all are well aware that greater efforts will be needed for success as compared to the past. + +Even when considering the challenges and setbacks, we look to the future with confi- dence. My conviction that 2008 will be a successful year is based on our long-term strategy, well-acknowledged innovation capabilities, operational excellence and the courage to act independently. + +In times like these, marked by uncertain dynamics and fundamental changes, I would like to thank our associates, whose outstanding performances have once again helped Novartis achieve a record perform- ance in a very challenging environment. These particularly valuable efforts are anchored in our shared purpose of improv- ing the lives of patients. + +In closing, I would like to once again express my appreciation to you, our shareholders, for the trust you continue to place in Novartis. + +Sincerely, + + + +Daniel Vasella, M.D. +Chairman and Chief Executive Officer + +----------------------------------------------------------------------------------------------- Novartis 2008 + +DEAR SHAREHOLDER + +I am pleased that despite the global ?nancial crisis and the early signs of a worldwide recession that marked 2008, Novar tis achieved record results both in sales and operating income of its continuing business. + +Our diversi?ed healthcare portfolio strategy underpinned our success in a dif?cult envi- ronment. Especially gratifying are the accel- erated sales and improved ef?ciency of our Pharmaceuticals Division. Our newly launched medicines are transforming our portfolio and more than made up for the loss of a number of products in the previous year. Vaccines and Diagnostics continued to show dynamic grow th, whereas grow th slowed in our generics Division Sandoz. Consumer Health achieved its targets. + +On a comparable basis, excluding the sales and operating income of the nutrition busi- nesses we divested in 2007, the Group results were: + +? Net sales from continuing operations rose +9% (+5% in local currencies) to USD 41.5 billion. + +? Operating income grew 32% to USD 9.0 +billion. + +? Net income rose 25% to USD 8.2 billion +and basic earnings per share increased +28% to USD 3.59. + +The performance of the Pharmaceuticals Division exceeded the expectations of the market and increased net sales by 5% in local currencies to USD 26.3 billion. This growth was realized not only in new markets, but also in Europe, where key products ? most notably in Oncology ? posted double- digit growth rates. + +The successful market launches of more than +11 products in the United States, European Union, and around the world contributed USD 2.9 billion to net sales in 2008. In addition to sustained growth of our antihypertensives and cancer medicines, the most successful innovative new products include Aclasta/ Reclast (USD 254 million), the only osteo- porosis treatment given in a once-yearly dose, and Lucentis (USD 886 million), the only treatment proven to preserve and, in some cases, improve the eyesight of patients with age-related macular degeneration. + +The Vaccines and Diagnostics Division achieved dynamic growth in net sales and continued to make signi?cant investments in the development of the new meningitis vaccines Menveo (serogroups A , C, W-135 and Y) and MenB (serogroup B), as well as other innovative vaccines. Millions of infants and young people could bene?t from both Menveo and MenB, as tens of thousands currently die of meningitis every year, while many sur vivors suffer from severe long- term consequences. + +In the generic pharmaceuticals Division Sandoz, net sales grew by 1% in local cur- rencies to USD 7.6 billion. Sandoz presents a mixed picture. Growth was slower than in previous years. Outstanding sales increases in important growth markets such as Russia, Brazil, and Central and Eastern Europe, are in sharp contrast to declining sales in the United States and some West European countries. Delays in new launches and price erosion are the main reasons for stagnation in these markets. In Germany, Sandoz is the leading generics company and is gaining further market share. As a result of price cuts, however, the market has contracted and competition has become tougher. On the positive side, Sandoz is in a pole position in biosimilars. In the future, it will be crucial +that we are the ?rst to launch new products and that Sandoz further extends its leading position in biosimilars. + +With increased net sales of 4% in local cur- rencies to USD 5.8 billion, the Consumer Health Division met its targets and also gained market share in several segments. The most important driver of growth was CIBA Vision, which ? under new leadership +? launched a number of new products and resolved its prior supply and delivery chal- lenges. Animal Health also achieved good results, especially in the companion-animal business, but its farm-animal business was negatively affected by the recession. OTC is expanding rapidly in the emerging markets and in Japan. But, like other manufacturers of OTC brands, the business struggled with the economic downturn in the United States. + +We achieved our strong overall perfor- mance in 2008 against a background that remains dif?cult, despite fundamentally robust prospects for growth. Compared to many competitors, however, our strategy of focused diversi?cation in healthcare puts us in a better position to capitalize on growth opportunities in a number of mar- kets and, at the same time, to spread our risks. It is interesting to note that our port- folio strateg y now enjoys broad suppor t and that a growing number of major pharma- ceutical companies are also investing in generic pharmaceuticals. + +It is gradually becoming clear that, like all entrenched dogmas, the usual comparison of companies that are pure plays with so-called conglomerates fails to present the real streng ths and weaknesses. It is obvious that a strategy of unfocused diversi- ?cation is bad, because you are in unfamiliar territory up against competitors with a much stronger concentration on core competen- cies. However, I believe that Novartis has + +pursued a different path, one of focused diversi?cation that also allows us to develop our core business, which both differentiates us and adds value. + +Thanks to our strategy, in 2008, Novartis stayed on course and completed several targeted acquisitions and strategic invest- ments that both strengthened the portfolio and enhanced our internal growth drivers. For example, Novartis acquired a 25% stake in Alcon, the world leader in eye care. This transaction is part of an agreement that offers Novartis the opportunity to acquire a majority holding in Alcon. + +With the purchase of Protez Pharmaceuticals, a privately owned US biotechnology company, Novartis acquired the rights to PTZ601 in Europe and the United States. This ver y promising antibiotic in Phase II development has the potential to treat life-threatening nosocomial infections. + +Novartis also acquired Speedel Holding AG, a company in which we already had a minor- ity stake. This essentially allowed us to acquire all the rights to Tek turna/Rasilez. + +Despite cost pressures, the demand for medicines and treatments will neverthe- less continue to rise. This demand will be driven by the following factors: + +? An aging world population with an increased need for medical care. This continuing trend is important because, after age 55, there is an exponential rise in chronic disorders such as degenerative diseases of the joints, the cardiovascular system, and the central nervous system. The risk of cancer also increases with age. The impact of disease also heightens with advancing age due to co-morbidity. For example, over 80% of 80-year-olds suffer from at least one disease, and more than 60% suffer from two or more diseases. + +? Unhealthy lifestyles and environmental pollution increase the frequency of chronic diseases. Changes in eating habits and lifestyles that include very little exer- cise, as well as pollution ? especially air pollution ? are taking their toll in obesity, chronic cardiovascular diseases, diabetes, cancer and lung diseases. + +? Economic growth in emerging markets with improved access to medicines. Eco- nomic growth that ? despite the ?nancial crisis ? remains relatively robust in coun- tries with large populations such as China, creates disproportionately high growth in demand for better healthcare in these countries. + +? Scienti?c and technological advances allow new approaches in drug research that create the foundation for innovative medicines for hither to untreatable diseases. + +The cost increases associated with the growing demand for healthcare services, diagnostics and medicines lead to political activities aimed at reducing expenditures on medicines, via price reductions and generic substitution. Unfortunately, these efforts go even further and also encompass attempts to weaken patents and intellectual property. This increases the risk that long- term investment in research and development will decline. Effective medicines ultimately offer the most cost-ef?cient treatment for a patient and for lowering costs for the health- care system. The weakening of protection for innovation with potential curtailment of research and development, will not lower costs in the long run, but will instead lead to massive increases in costs ? not to mention the human suffering. In short, the best way of reducing the long-term costs of health- care is to provide incentives for sustainable investment in successful research and development. Without better prevention + +and innovative medicines, the costs of treat- ing patients with cardiovascular diseases, cancer, diabetes or dementia ? not to mention other diseases ? will skyrocket. + +The past year was marked by a severe ?nancial crisis and recession. The recession will likely intensify over the current year and leave deep scars on the economy and the sociopolitical climate. The healthcare sector will not be spared, although it is considered a defensive sector and generally much less affected by economic factors than other industries. The pressure on prices will con- tinue to increase because public funding (and in many countries also private bud- gets) will be constrained by dramatic levels of debt. This year we expect new policies from the incoming US administration, which wants not only to provide all its citizens access to medical care, but also to stem the rising costs of its healthcare system. + +To provide cost-effective healthcare, all sys- tems around the world must achieve three goals: quality assurance in diagnosis and treatment, access to all essential medical services and medicines, and ?nancial sus- tainability. This requires greater transpar- ency and comparability of treatment results with standardized treatment methods, mea- surement, databases and information tech- nology systems. There has been little mean- ingful progress to date in these areas not only because systemic analysis and plan- ning have been lacking, but also because politicians have been focused on short-term success. Moreover, there are many groups who are resistant to any fundamental change in healthcare. + +Criticism of markets and corporations will likely increase over the next few years, extending among some, to a questioning of the principles of a free-market economy and capitalism. One thing is certain: The state has positioned itself as the only actor capable + +of engendering trust amidst the current ?nancial crisis. There is a risk of a growing belief in state intervention, and the tempta- tion to extend the capacity and scope of state responsibility in naive and dangerous ways. This is also true in the ?eld of corpo- rate governance. We have witnessed a shift in power from management to the board of directors, and then from the board of direc- tors to shareholder activists. Lawmakers are increasingly in?uenced by activists who seek to restrict the actions of corporations, their owners and their representatives. I question whether these pressures reduce risks. They do, however, curtail the freedom of companies ? a disturbing development +? even if it stems from the best of intentions. + +Optimism for the future and faith in progress will erode if freedom and risk are increas- ingly associated with chaos and failure. In a fast-moving modern world, some believe that restrictions promise order and there- fore engender a feeling of securit y and protection. This is a fallacy. The erection of walls ? either intellectual or economic ones +? only further heightens the crisis. It is more important than ever before, that we endorse open markets, multilateralism and embrace a point of view that sees the opportunities of globalization and not only the threats. In a society in which control and order are val- ued most highly, a mentality of entitlement, coupled with hostility to reform and innova- tion will triumph. + +Society has every reason to believe in the power of innovation. Over the last 40 years, we have witnessed a signi?cant reduction in mor tality due to numerous diseases. Deaths resulting from rheumatic fever and rheumatic hear t disease have fallen by more than 60%, while deaths from hyper- tensive and ischemic hear t disease have fallen by more than 40%. There has been impressive progress in reducing the number of patients who die from cancer. The results +are especially striking in children, as over the last 25 years, mortality has more than halved. Moreover, medicines are responsible for 40% of the increased life expectancy and have helped to reduce chronic disability in seniors by 25% over the last 25 years. + +Our pipeline continues to make encourag- ing progress, and this success not only gives me cause for optimism, but is also in line with our corporate social mission. In research, Mark Fishman and his team have discovered many new biologic targets and +93 highly promising new molecular entities. For the ?rst time, promising new compounds for the treatment of motor disturbances associated with brain disease, cancers and bone metastases that are dif?cult to treat, metabolic disorders, and juvenile rheuma- toid arthritis have entered clinical trials. Our scientists are currently engaged in 152 projects in various stages of clinical devel- opment. These include our new cancer medicine A?nitor (everolimus, formerly RAD001). In patients with advanced kidney cancer who did not respond to any of the standard treatments, this product has shown a 70% decrease in the risk of pro- gression. Fur ther indications are under investigation. Also highly promising are the clinical results reported with FTY720, a tablet for the treatment of multiple sclerosis, as well as the results of QAB149 for the treatment of chronic obstructive pulmonary disease. + +In 2008, Novartis was the only pharmaceu- tical company with three medicines under priority review by the US Food and Drug Administration. In addition to A?nitor, these included Gleevec/Glivec as adjuvant therapy in gastrointestinal stromal tumors (GIST ) and Coar tem for malaria. In December +2008, the FDA approved Gleevec/Glivec for this additional indication. In this context, it is important to note that, for some time, US authorities have followed much more rigorous safety requirements, and it is impossible to + +predict timing or chances for regulator y approvals of new medicines. + +Payor in?uence over medical decisions in Europe and in the United States has been growing. These customers place greater emphasis on evidence that new treatments of fer bet ter results and improved cost / bene?t ratios. + +As investments in research and development increase and pressure on drug prices becomes more intense, ef?cient cost man- agement becomes even more important. To achieve our objectives, we need to further streamline our organization and processes so that decisions can be made more quickly and be more systematically implemented. + +In the context of the economic uncertainty and volatility of the global market, it is increasingly clear that we took the right step in launching the For ward initative. We exceeded our own savings targets and, in some cases, we also fostered renewed growth. Our aim is to save USD 1.6 billion by 2010. The initiative also enabled us to simplify our organizational structure and accelerate decision-making processes. + +Our business success allows us to continue our corporate social responsibility activities. With our unique malaria and leprosy programs, we have provided more than 200 million treatments since 2001 and helped to save the lives of more than 500 000 people. + +Last year, we also launched the Novar tis Vaccines Institute for Global Health (NVGH), a nonpro?t research institute in Siena, Italy, dedicated to the development of vaccines for patients in developing countries. + +Our commitment to patients is an integral part of our strategy. The same is true of the ethical principles anchored in the Novartis corporate culture. I am most pleased that + +The Dow Jones Sustainability Index recog- nized Novartis as healthcare super sector leader in 2008. The indispensibility of these principles has become even more clear over the last few months as we are all burdened by the irresponsibility of certain actors in the ?nancial sector which has deeply harmed the global economy. + +The promotion of talented leaders to key management positions is critical to the future success of the company. In November, Joerg Reinhardt assumed the new position of Group Chief Operating Of?cer reporting to me. Joerg Reinhardt is succeeded as Head of Vaccines and Diagnostics by Andrin Oswald, previously CEO of Speedel and Global Head of Pharmaceutical Development Franchises in Pharmaceutical Development. The Board also appointed George Gunn Head of the Consumer Health Division, in addition to his role as Head of Animal Health. He replaces Thomas Ebeling, who decided to pursue his career outside Novartis. During his tenure with Novartis, Thomas Ebeling made outstanding contributions, and I would like to take this opportunity to express my sincere thanks to him. Andreas Rummelt assumed the newly created position of Group Head of Quality Assurance and Tech- nical Operations and remains a member of the Novar tis E xecutive Commit tee. Jef f George, formerly Head of Emerging Markets in the Pharmaceuticals Division, is the new Head of Sandoz. David Epstein now heads a new unit focused on the development of innovative molecular diagnostics in addition to his responsibility as Head of Oncolog y. + +William George, member of the Board of Directors, has decided not to stand for re- election at the next Annual General Meeting. At this meeting, the Board of Directors will pro- pose that Dr. William Brody be elected to the Board of Directors. Dr. Brody served until recently as president of Johns Hopkins Univer- sity and is now president of the Salk Institute. + +As a shareholder, you are naturally inter- ested in the further development of our company. Our ten-year total shareholder return, including dividends, which we have continuously increased, and business spin- offs, surpasses that of the global market, the pharmaceutical industry index, and the performance of key competitors. The tumul- tuous stock market of 2008 also made it clear that we are seen as a defensive stock delivering strong per formance. This view has been suppor ted by the fact that we managed to weather the ?nancial crisis and remain intact both operationally and in our investment activities thanks to our conser- vative strategy focused on sustainability. + +In 2009 we anticipate another year of record results in net sales and earnings. All the elements for success are in place: products, resources, creative thinking, a determination to succeed through an even greater focus on our customers, as well as a competent management team that is distinguished by ambition and integrity. + +I expect Joe Jimenez and the management team of the Pharmaceuticals Division to take advantage of the strong performance in the years ahead by investing in research and development, growth products and strategic markets. This will help to ensure that the Pharmaceuticals Division is pre- pared for the challenging period after 2012, when we can expect generic competition for our top-selling product Diovan. Our focused diversi?cation strategy will also provide us with further growth opportunities beyond pharmaceuticals. + +There are many changes taking place at the moment, but one thing remains constant: Patients need the best and most cost- ef fective medicines. I am certain that if we never lose sight of this fundamental impera- tive, we will succeed in meeting the major challenges of the future. + +I would like to thank all our associates for their excellent work, their entrepreneurial mindset and their contributions to the achievement of our objectives. I am espe- cially grati?ed that our associates under- stand the need to reorient our organization to a dif?cult and challenging environment. + +Finally I would like to thank you, our share- holders, for the trust you place in our com- pany. I am pleased to be able to propose an increase in the dividend to CHF 2.00 (+25%) at the next Annual General Meeting. + + +Sincerely, + +Daniel Vasella, M.D. +Chairman and Chief Executive Of?cer + +----------------------------------------------------------------------------------------------- Novartis 2009 + +DEAR SHAREHOLDER + +I am pleased to report record results for +2009, both in sales and in profits, despite the global economic crisis that shaped the year. + +Our Pharmaceuticals Division delivered an outstanding performance during the past year. This achievement was possible through new product growth and rejuvenation of our portfolio ? both of which clearly bring value to patients and shareholders. Consumer Health and Sandoz, our generics division, showed solid growth, accelerating in the fourth quarter. The Vaccines and Diagnostics Division exceeded its targets thanks to the rapid rise in demand for influenza A (H1N1) pandemic vaccines. + +The specific results were as follows: + +? Net sales rose by 11% in local currencies +(+7% in US dollars) to USD 44.3 billion. + +? Operating income grew 11% to USD 10.0 billion. + +? Net income climbed 4% to USD 8.5 billion, +negatively influenced by currency effects, financing costs for Alcon and exceptional costs of USD 189 million from associated companies; excluding acquisition-related and significant one-off factors, net income rose 8% to USD 10.3 billion. + +? Free cash flow before dividends showed dynamic growth and reached a level of USD 9.4 billion (+24%). + +The Pharmaceuticals Division increased its net sales 12% in local currencies (+8% in US dollars) to USD 28.5 billion. This growth rate is twice the market, illustrating that we remain one of the strongest-growing com- panies in the industry. Oncology in particular posted outstanding growth rates: we have increased our global market share to 11% from 7.7% in 2001, and moved from fifth to second position in this competitive field. Operating income grew ahead of net sales despite increasing investments in research and development, and negative external factors, such as price-cutting measures and adverse exchange rates. + +I am also pleased that we successfully reju- venated our product portfolio. Two factors contributed to this accomplishment: the global launches of new products ? Lucentis, Exforge, Exjade, Exelon Patch, Reclast/Aclasta, Tekturna/Rasilez ? and our leukemia treatment Tasigna, which showed clear superiority to Gleevec/Glivec in comparative studies. New products accounted for 16% of total sales, a significant increase from 10% the previous year. We obtained regulatory approval for a number of important products in 2009 ? in particular for the cancer medicine Afinitor, which shows considerable potential, and the biological therapy Ilaris. + +The Vaccines and Diagnostics Division increased sales by 39% in local currencies (+38% in US dollars) to USD 2.4 billion, and operating income reached USD 372 million. +These record results are largely due to the rapid development of several innovative influenza vaccines, in particular for protection against the influenza A (H1N1) virus. To date, nearly 50 million people have been infected, requiring exceptional efforts on a global scale to contain the pandemic. All vaccine production sites have been operating at maximum capacit y since the summer, thanks to unprecedented suppor t from hundreds of Novartis associates from other divisions. By the end of the year, approxi- mately 116 million doses were delivered. To strengthen this division, we aim to discover and develop innovative vaccines to comple- ment our influenza vaccines, which serve a cyclical public health need. One such inno- vative product is Menveo, a vaccine for meningococcal meningitis that is currently pending regulatory approval. + +The generics division Sandoz achieved solid underlying growth (USD 7.5 billion, +5% in local currencies) in key markets thanks to new product launches and increased market- ing initiatives. Operating income remained nearly stable (-1%) at USD 1.1 billion. As in past years, the business experienced an annual price erosion of about 7% and was fur ther impacted by adverse exchange rates. Despite increases in efficiency and productivity, the impact of these factors could not be entirely neutralized. Falling sales had an impact in Eastern European countries against the backdrop of the global economic crisis. However, this was more than offset by new product launches and a significant increase in net sales from biosimi- lars, especially in the US. + +The Consumer Health Division felt the impact of the global recession particularly in the first half of 2009. Nevertheless, the division posted a solid result: net sales grew 5% in local currencies to USD 5.8 billion, while operating income fell slightly by 3% to +USD 1.0 billion. In the OTC Business Unit, we invested significantly in the largest-ever launch campaign for Prevacid24HR, our proton pump inhibitor. The Prevacid24HR launch was one of the biggest prescription- to-OTC switches in recent years, sales exceeded USD 100 million in the few weeks following its November launch. CIBA Vision achieved stronger growth than any competi- tor in the contact lens and lens care industry. New product expansion helped accelerate solid growth in local currencies. Animal Health also grew faster than the global market. + +We achieved strong 2009 results in a global market that will remain challenging for the foreseeable future. We must continue to focus all our efforts and engagement ? even more in this environment ? on adding value for patients, and, ultimately, for our company. This focus shields us from erratic, ill-consid- ered action on one hand and from clinging defensively to the status quo on the other ? both would weaken Novartis in the long term. Since Novartis was founded in 1996 we have experienced a rapid acceleration in economic globalization and information flow, increasing the complexity of managing multinational companies. + +In light of these developments, we will only remain successful if we continue to navigate the rapidly changing environment with dili- gence, foresight and reflection, and venture to seize strategic opportunities, which are always accompanied by risk. + +Our strategy, based on the concept of diver- sification within the healthcare sector, has again proven to be the right approach in the past year. The fact that more and more com- panies are starting to imitate our strategy of focused diversification does not guarantee long-term success ? but does indicate that we recognized the signs of the times at a very early stage. + +We have systematically transformed Novartis into a company focused clearly on growth areas of the healthcare market. Businesses in chemicals, nutrition and agribusiness, as well as beverages and medical nutrition, were spun off or sold. Other companies were added to our portfolio, including the generics manufacturers Hexal and Eon Labs, as well as the vaccines producer Chiron, where we successfully increased our holding to 100% in 2006 and have since nearly tripled sales. + +Our strong yet adaptable corporate culture enabled the successful integration of these and other companies. Since the founding of Novartis, we have shaped our culture by pro- actively facing inevitable change with confi- dence in the future, without ever giving up our fundamental beliefs. Intensive training and continuing education of our associates established a corporate culture based on per formance and results, integrit y and cultural openness. + +I firmly believe that our recently proposed merger with Alcon can result in a successful integration of the two companies. Ultimately, we aim not only to acquire the majority stake in Alcon from Nestl?, as agreed in April 2008, but also to integrate Alcon fully as a new and largely independent division via a direct merger into Novar tis. This would immediately make Novartis a world leader in eye care. With our complementary prod- uct portfolios and synergies in research and development, Alcon and Novartis constitute an excellent strategic fit. Given the growing medical needs of the aging world popula- tion, ophthalmology is an area of dynamic growth. + +Last year we also substantially strengthened our generics division Sandoz with the acqui- sition of EBEWE Pharmas specialty generics business, which specializes in injectable cancer medicines. +In addition, our Vaccines and Diagnostics Division announced plans to acquire an 85% stake in the Chinese vaccines manufacturer Zhejiang Tianyuan. This company is a leading privately owned producer of vaccines with a large range of competitive products in China and an interesting pipeline in the field of viral and bacterial diseases. + +As a global company, our strategic invest- ments are influenced by the fundamental eastward shift in the world economy. Twenty years ago, the equilibrium shifted from Europe to the US; today, we are experiencing a shift toward Asia. China, for example, has long been interesting not only as a highly dynamic market, but also as a promising research hub. That is why last fall we decided to increase our investment and the number of associates at our research center in Shanghai from 160 to nearly 1 000. + +China is the most important market of the future. By 2013, sales in the pharmaceutical industry could nearly triple from their current level of USD 25 billion to more than USD 70 billion. This would make China, in only a few years, the third-largest pharmaceutical mar- ket after the US and Japan. + +We are currently witnessing the dawn of a new era. Globalization no longer implies west- ernization. A company that acknowledges that Asia will shape our society and economy in the future has the potential to base its actions on the ramifications of this shift. Projects in China are typically approached systematically, strategically and with a long- term horizon ? in contrast to the West, where politics, economics and financial analysis are often short-term and characterized by a hasty response to risks and opportunities. +I hope that we in the West succeed in return- +ing to the values we once embraced, such as trust in the future and belief in progress. + +Robust growth drivers will remain a distin- guishing characteristic of the healthcare sector in the future. There are several contributing factors: + +? Demographic changes are increasing the demand for medical care. Co- and multi- morbidity are a feature of advanced age and, without effective medicines and ade- quate medical care, have a huge impact on quality of life. + +? Chronic diseases are more common not only because of aging societies, but also because of lifestyle changes. In China there are almost 400 million smokers. In the US alone, the direct and indirect cost of obesity amounts to almost USD 500 billion annually ? not including the cost of sec- ondary diseases such as diabetes. + +? The strong and stable growth of emerging markets, despite the financial crisis, is evident in the increased demand for medi- cines and treatments. Experience in 2009 again confirmed that demand for the best possible healthcare is outpacing economic growth in emerging markets. In the seven leading emerging markets acknowledged by IMS (Brazil, China, India, Mexico, Russia, South Korea and Turkey), the growth fore- cast for 2010 is between 12% and 14% and is likely to accelerate further in the years to come. + +? Scientific and technological advances are creating new ways to better develop novel medicines that fight diseases we cannot treat today. + +At the same time, there are several opposing forces: ever stricter regulatory authorities, financially restrictive payors increasingly aware of their power, and governments around the world trying to reduce health- care system costs. Price-cutting is often used +to reduce costs in the healthcare system; however, cutting prices across the board does not take into account the overall goal of improving productivity and quality in healthcare, which can only be achieved through transparency and the comparison of various treatment methods. + +Our company can meet these challenges with confidence, because our aim is to discover and develop more innovative vaccines and med- icines for patients. New and better medi- cines will continue to be appreciated by soci- ety and financially rewarded. Nevertheless, we should be aware that we must constantly adapt our business model to changing mar- ket demands to maintain our level of growth in the years to come. + +Without better prevention and treatment, the cost of the most prevalent diseases in society ? including diabetes, cancer and hypertension ? will triple by the middle of the next decade, totaling billions annually for each disease area in the US alone. + +Despite heated health policy controversies +? where the pharmaceutical sector some- times serves as the ideal scapegoat ? I remain optimistic. I firmly believe society recognizes the value of medical progress and that the majority understands and accepts that incentives and investments make innovation possible. + +Against the backdrop of cost pressure and inherent skepticism facing the pharmaceutical sector, innovation is more important than ever. Novartis is in a strong position. Our consistent investments in research and development, made regardless of business cycle pres- sures, are paying off: Novartis has one of the most competitive pipelines in the pharma- ceutical industry with 145 projects in devel- opment. Sixty of these are new molecular entities. Since the turn of the millennium we +have received more Food and Drug Admin- istration approvals than our competitors, outperforming them year after year. + +In 2009, our company received more than 30 positive decisions from regulatory author- ities in the US, EU and Japan, including a record number of six approvals in Japan for Rasilez, Tasigna, Xolair, Co-Dio, Lucentis and Clozaril. Furthermore, in January 2010, Equa (local brand name for Galvus), Exforge and Afinitor were approved in Japan, the worlds second-largest pharmaceutical market. Additional approvals include Afinitor (can- cer) in the US and EU; Ilaris (CAPS), Extavia (multiple sclerosis), and combination prod- ucts Valturna, Exforge HCT and Rasilez (all hypertension), in the US. Regulatory author- ities are currently reviewing QAB149 for the treatment of chronic obstructive pulmonary disease, the highly innovative medicine FTY720 for treatment of multiple sclerosis and the novel vaccine Menveo. + +Even in a difficult global economic environment we continue to extend our engagement in the area of corporate social responsibility. The current global economic situation is a litmus test for the social responsibility of companies: Who is taking action and who is merely talk- ing? Since the founding of Novartis, we have always viewed social responsibility as an integral part of our corporate strategy and acted accordingly. In 2009 we spent about USD 1.5 billion (which is again 3% of our net sales) on programs aimed at providing patients in need with access to our medicines, and on research to discover new vaccines and medicines for developing countries. + +I would like to emphasize that our primary purpose as a pharmaceutical company is to discover and develop effective medicines and successfully bring them to market. By doing this, we make an indispensable con- tribution to help alleviate suffering, improve patients quality of life and even save lives; + +we also make a major contribution toward lowering the direct and indirect cost of dis- ease. It is the responsibility of governments, on the other hand, to provide for the welfare of their citizens including a functioning healthcare system. For this reason, we remain convinced that any access solution can only have a sustainable impact when governments, international organizations, local aid groups and the private sector col- laborate ? managing the complexity would be overwhelming for any one stakeholder. + +Our engagement in malaria provides an example. We supply our malaria treatment Coartem to affected countries without profit, in cooperation with the World Health Orga- nization (WHO), the United Nations Chil- drens Fund (UNICEF), state health authori- ties and private aid organizations. To date, Novartis has supplied 300 million Coartem treatments, helping to save the lives of about 750 000 people suffering from malaria. + +Since 2000 we have also supplied leprosy patients worldwide with the medicines they need free of charge in partnership with the WHO. Through the end of 2009, these dona- tions, totaling USD 60 million, have cured more than 4.5 million patients. + +The successful campaign against leprosy is a public health milestone. In the last two decades, more than 14 million people have been cured, resulting in a 95% decrease in leprosy cases worldwide. Novar tis has played a crucial part in ensuring that this terrible disease, which has been the scourge of humankind for centuries, could be eradi- cated in the near future. Only three countries +? Brazil, Timor-Leste and Nepal ? have more than one in 10 000 people with leprosy. + +Our associates are gratified by our contribu- tions in the fight against leprosy and malaria, and of course, as our shareholders, you too can take pride in these achievements. These +successes are acknowledged by the WHO, as well as many nongovernmental organizations that do not always view us favorably. These stakeholders also recognize our commitment to researching new medicines and vaccines for diseases common in developing countries, which is the goal of our nonprofit research institutes in Siena, Italy, and Singapore. + +We also recognize our responsibility in envi- ronmental issues. In 2005 we were among the first signatories of the Kyoto Protocol, which established binding targets for reductions in CO2 emissions. In environmental protection, Novartis pursues a dual strategy: On one hand, we consistently strive to improve energy efficiency ? for example, five Novar tis sites have used solar energ y systems since last year ? on the other hand, we take advantage of voluntary CO offsetting +? for example, by planting more than three million trees in northeast Argentina. + +We regularly and critically assess our strategy, to ensure it remains relevant for the future. In the same manner, we must constantly review our organizational processes and improve their effectiveness and efficiency. Given the difficult market environment and rising research and development costs, it is essential that we continue to work as effi- ciently and productively as possible. This also means simplif ying processes and creating leaner and flatter structures, so that we can work more quickly, in less compli- cated ways. Avoiding unnecessar y costs enables us to invest more in research and to cope with pricing pressures. We initiated Project Forward two years ago with these objectives in mind. The programs goal was to implement productivity improvements and achieve savings of USD 1.6 billion within three years. After just two years, the project has already exceeded this target by 46%. + +In the new, post-crisis reality, governments and the public have rightly raised the ethical bar for good corporate governance. At Novartis +we have always been convinced that integrity and transparency are indispensable for a sustainable and successful business. Our Code of Conduct, which our associates must learn and apply in their daily work, builds on these values. We also decided last year to include long-term objectives in the employ- ment contracts of our associates, and sys- tematically implement clawback provi- sions for bonuses. In concrete terms, this means that action may be taken to reclaim bonuses if it later emerges that the bonuses were paid out based on false information or dishonest management. Set ting clear boundaries should prevent our financial incentive programs from abuse. + +Last year, the Board of Directors formed a new committee to ensure that risks in the company are properly analyzed and evaluated, and respective processes are followed. + +In addition, the Board of Directors has decided to propose at the upcoming Annual General Meeting that you, our shareholders, may consultatively vote on our Compensation System in the future. This vote should take place before every significant change to the Compensation System, but at least every three years. We continue to believe that a vote on individual compensation does not increase the likelihood of achieving business objectives. Decisions on compensation are a key strategic management tool of the Board of Directors, and are based on clearly defined objectives and performance criteria, which are confidential for competitive rea- sons. For many years, Novartis has voluntarily exceeded the legally required disclosure level in reporting individual compensation of the Executive Committee. + +Appointing outstanding leaders to positions of great responsibility is crucial to the sus- tainable success of our company. The timely planning of CEO succession was initiated in 2008 with the creation of a transitory COO position. Completing this process the Board of Directors accepted my request to hand over my CEO responsibilities and has decided to appoint Joe Jimenez as the new CEO effective February 1. I felt it was timely after 14 years that I concentrate on the duties of Chairman of the Board, and will henceforth focus on the strategic priorities of Novartis and the tasks which lie within the area of accountability of the Board. Joe Jimenez will be fully in charge of all aspects of the operational business. + +At Novartis, the question of whether the functions of CEO and Chairman should be separated or not, will continue to be answered in a flexible manner, according to the companys strategic requirements. This will be decided in the future in the best interest of shareholders and will not be rigidly prejudged for formalistic reasons. + +I felt that this was the right moment for a transition, as our full pipeline and the acqui- sition of Alcon marks a new growth phase. Our business portfolio has been transformed to exclusively focus on healthcare, our pipe- line is highly valued, and our research orga- nization is productive and greatly respect- ed. Our leadership team is competent and motivated. Due to all these factors, today, Novartis is one of the most admired compa- nies in the healthcare industry. + +Over the last several years, Joe Jimenez has led our Pharmaceuticals business, our most impor tant division, back to the road of success. In this process, he has distinguished himself as an excellent leader with a focus on clear objectives and impressive implementation skills. It is not just his energy, his self-discipline and his engage- ment that makes him an ideal appointment as CEO. At least as important is his poised composure, as well as his sense of humor, which is also a great asset in this job. + + +Furthermore, Joes international experience in several business sectors will allow him to move easily in different cultures and take on the responsibilities of a global leader imple- menting the Novartis strategy. + +Joe Jimenez embodies two of the most important values in our corporate culture: a consistent focus on per formance and a sense of responsibility towards patients and society. These two values have already shaped our predecessor companies Sandoz and Ciba-Geigy. Marc Moret never lost him- self in theoretical reflection, but instead pursued his goals with energ y and great determination, against all kinds of bureau- cratic resistance which lurk in all big orga- nizations. Alex Krauer was one of the first corporate leaders who understood that credibility and a holistic view are indispens- able requirements for success in business. I owe a lot to my predecessors. It is with this in mind that I wish Joe Jimenez all the best as he assumes the responsibilities of his new position! + +The Board appointed David Epstein as the new Head of our Pharmaceutical Division. Due to his great skills and sustained sense of continuity, David has led our oncology business to a thriving success. + +In these times of leadership change, our finance depar tment is not an exception. On February 1, 2010, Jon Symonds will take over as Chief Financial Of ficer (CFO) from Raymund Breu, who has reached the mandator y retirement age of 65. Since Sep- tember 1, Jon Symonds has ser ved as Dep- uty CFO of the Group and designated suc- cessor to Mr. Breu. Previously, Mr. Symonds was Managing Director, Investment Bank- ing, with Goldman Sachs. Mr. Symonds experience in the pharmaceutical industr y goes back many years. He was CFO with AstraZeneca for eight years and, prior to that, Finance Director at Zeneca. + +I extend my heartfelt thanks to Raymund Breu for his outstanding contributions as CFO and for his exceptional achievements in management during his 35 years in the service of our company. He played a crucial role in the founding of Novartis and has been an invaluable partner for me and my col- leagues. Novartis owes a great deal to his expertise and his sound judgment. I would also like to thank our COO, Joerg Reinhardt, who for many years successfully led our product development before he took over the responsibility for our vaccines and diagnostics business. He has now decided to leave our company to pursue new opportunities. + +As shareholders you are obviously interested in the development of the value of our company. Our total shareholder return since the found- ing of Novartis amounts to 9% annually, including continuously increasing dividends and business divestments. Our total share- holder return surpasses not only that of the global market, but also the pharmaceutical industry index and share price performance of important competitors. This shows that we remain in demand as a safe stock with attractive long-term performance. + +In 2010, we expect net sales to grow at a mid- single-digit percentage rate in local currencies and for further improvement in the Groups operating income margin. + +Most critically, the Pharmaceuticals Division is equipped to manage the period of increas- ing generic competition for our best-selling product, Diovan. It is gratifying to note that the rest of our cardiovascular portfolio ? including the innovative medicine Tek turna/ Rasilez and combination products ? is grow- ing dynamically, allowing us to most likely maintain our leading position in this thera- peutic area. In addition, our broad product por tfolio beyond pharmaceuticals offers further growth opportunities ? not least in the field of eye care. But above all, at the start of this new decade, Novartis has a pipe- line that is more promising than ever before in our corporate history. + +I would like to thank all our associates for their ongoing engagement, commitment to Novartis, and determination in this challenging envi- ronment. I am especially pleased that our associates, in ever-changing conditions, have remained fully engaged and unde- terred in contributing to a successful year. We should not take this for granted; it deserves our utmost respect. + +Finally, I thank you, our shareholders, for the trust you continue to place in our company. I am pleased to propose an increase in the dividend to CHF 2.10 (+5%) at the next Annual General Meeting. + + +Sincerely, + +Daniel Vasella, M.D. +Chairman and Chief Executive Officer + +----------------------------------------------------------------------------------------------- Novartis 2010 + + +DEAR SHAREHOLDER + +I am pleased to repor t record results for 2010, both in sales and in profits. + +The past year was shaped by repercussions from the global financial crisis and consid- erable currency turbulence. Despite these dif ficult conditions , Novar tis was ver y successful. Our well-balanced business por t folio and long-term strateg y focused on innovation once more have proved to be robust and appropriate for the future. The abilit y to repeatedly launch new and bet ter products, and thus establish market positions, is decisive for the sustainabilit y of our success. We demonstrated both of these core competencies last year. New and recently launched products were a key growth driver in 2010 and hold more prom- ise for the future. Joe Jimenez, our new CEO since Februar y 2010, has successfully continued this strateg y and launched new initiatives to improve productivit y. His nomination has proven to be right both in terms of timing and in terms of the divi- sion of labor bet ween the Chairman and the CEO. + +In addition, since August 2010, Novar tis has held majorit y ownership of Alcon, Inc., the global leader in eye care. This year we will propose to you a merger that will fully integrate Alcon into Novar tis. While this will result in an increase of the Novar tis share capital, the merger not only provides you with a new grow th plat form but also is expected to allow for the realization of substantial synergies bet ween the t wo organizations. + +Let me summarize the results achieved in the last year: + +? Net sales grew 14% (+14% in constant currencies) to USD 50.6 billion. + +? Operating income rose by 15% (+17% in constant currencies) to USD 11.5 billion. + +? Net income climbed 18% (+20% in con- stant currencies) to USD 10.0 billion, faster than operating income. + +? Free cash flow before dividends reached +USD 12.3 billion. + +? Alcon was fully consolidated from August 25 when we completed the pur- chase of an additional 52% stake in the eye care leader. From that date, Alcon net sales totaled USD 2.4 billion; oper- ating income amounted to USD 323 mil- lion; and core operating income was USD 852 million. + +The Pharmaceuticals Division (USD 30.6 billion, +6% in const ant currencie s) achieved strong volume grow th of eight percent age point s . Sales of recently launched products were USD 6.6 billion accounting for 21% of the divisions sales, a significant increase from 16% the pre- vious year. This enabled Novar tis to grow signific antly faster than the industr y average. One of the most impor tant regu- lator y approvals was for Gilenya, the first oral medication for first-line treatment of relapsing forms of multiple sclerosis (MS), the most common forms of the disease. Currently 2.1 million people worldwide suf fer from MS, a lifelong, progressive and disabling disease. Compared to the standard of care, Gilenya represents a major breakthrough by significantly reducing relapses and improving patients qualit y of life. + +Our oncolog y por t folio expanded fur ther during 2010. Longer-term studies demon- strated Tasigna continues to surpass the highly ef fective Gleevec/Glivec in patients with newly diagnosed Philadelphia chromo- some-positive chronic myeloid leukemia (Ph+ CML), a form of blood cancer. Tasigna was approved in the US, the EU, Japan and Switzerland for treatment of patients with newly diagnosed Ph+CML . + +The sharp rise in Vaccines and Diagnostics Division net sales to USD 2.9 billion (+25% in constant currencies) resulted mainly from sales of in?uenza A (H1N1) pandemic vac- cines, which totaled USD 1.3 billion during the ?rst half of the year. Among the newly developed vaccines, Phase III studies showed that Bexsero has the potential to be the ?rst broad coverage vaccine against meningo- coccal B (MenB) disease. Meningococcal disease is a leading cause of bacterial men- ingitis, an often deadly disease in infants. + +The generics division Sandoz achieved double-digit grow th (USD 8.5 billion, +15% in constant currencies), thanks to stronger grow th in the US, Canada, Italy and emer- ging markets compared to the previous year. The divisions grow th rate in Central and E astern Europe is four times faster than the market ? and three times faster in Turkey, the Middle East and Africa. Sandoz posted an excellent result due to the first- to-market launches in the US of dif ferenti- ated generic versions of complex products such as enoxaparin (the most successful product launch ever by Sandoz), tacroli- mus and lansoprazole. This underscores the divisions abilit y to expand its por t folio + +with complex and dif ferentiated products. Growth also was attributable to biosimilars, as sales rose 63% in constant currencies. With patents expected to expire over the nex t five years on biologics with global sales of USD 64 billion, the full strategic impor tance of our leading position in biosimilars will soon become apparent. + +The Consumer Health Division overcame the ef fects of the global recession and increased net sales by 7% (6% in constant currencies) to USD 6.2 billion. With this solid grow th, the Consumer Health Division excelled in its respective markets, and continues to grow thanks to the strong per formance of several key brands. With sales up 6.4% (in constant currencies) the CIBA Vision Business Unit recorded solid grow th, while Animal Health benefitted from some of its top brands. OTC sales grow th was driven by analgesics and Prevacid24HR for treatment of hear tburn. + +We achieved strong growth in 2010 despite a global politic al and economic situation shaped by considerable challenges and uncer tainties. Our strateg y, which focuses consistently on grow th areas of the health- care market while paying careful at tention to risks, has proved its value in this dynamic environment. Also in the future, based on this strateg y of focused diversification, we expect our company to develop in a more stable way than several of our impor tant competitors. Our acquisition of global eye care leader Alcon is expected to soon provide an additional grow th plat form with considerable synerg y potential. In view of our sustainable success, it is not sur- prising that our strateg y is imitated today. In the long-term, success is reser ved for those companies that can systematically focus on their core business, recognize the inevitable associated risks, and handle them rationally, with strategic vision. + +At the core of our corporate culture is the high significance we place on innovation. For several years Novar tis has received more approvals for new medicines than competi- tors. We are recognized as having one of the best pipelines in the industr y, and we continue to invest steadily in research and development. Cuts would increase profit in the short-term ? but only at a much higher long-term cost. This can already be ob - ser ved today at other companies that reduced their R&D investments in recent years. Through our ongoing commitment of people and other resources to innovation, we develop differentiated medicines, vaccines and other new products to bene?t patients. + +Apar t from the approvals for Gilenya and Tasigna mentioned above, we achieved other impressive breakthroughs during the past year. + +A clinical trial showed Onbrez Breezhaler a treatment for chronic obstructive pul- monar y disease (COPD), was superior to salmeterol, currently one of the mainstays of therapy for this condition. Onbrez Breezhaler is already approved in more than 40 countries, including the EU. + +Menveo, a groundbreaking vaccine to pre- vent meningococcal disease, was launched in the US, the EU, and cer tain countries in Latin America and Asia-Paci?c. Menveo is an impor tant tool for prevention of menin- gococcal disease, a life-threatening infec- tion that causes illness in more than 500 000 people each year. Indication extensions are proceeding according to plan and should help to fur ther streng then this brand. + +Biosimilars ? high- qualit y, cost- ef fective follow- on versions of biologic medicines that are dif ficult to develop and manu- facture ? continue their strong sales grow th. They are led by products such as Omnitrope, which is gaining ground against originator medicines to treat growth hor- mone deficiency, and by Binocrit (epoetin alfa) and Zar zio (filgrastim), which were introduced for oncolog y indications. This success is paving the way to fur ther extend the position of Sandoz as market leader in the field of biosimilars. + +Novar tis has several ver y promising medi- cines in the pipeline for patients with unmet medical need. For example, SOM230 is the first medical therapy to show ef fi- cacy in a Phase III trial in Cushings dis- ease, a debilitating hormonal disorder. There are currently no approved medicines to treat Cushings disease. + +These outstanding innovation milestones will play a key role in sustaining the grow th momentum of our company. + +Expanding our presence in emerging coun- tries and continuously increasing our pro- ductivity are decisive elements of our growth strateg y. Last year we were able to fur ther expand our circle of patients and cus- tomers in our six key emerging markets, and posted corporate grow th of appro - ximately 12% (in constant currencies) compared with the previous year. + +It is imperative to steadily increase produc- tivity, particularly in these times of restricted public spending. By consistently simplifying our processes, we can provide added value for patients. This ensures our ability to invest in the future, despite price reductions and + +margin pressures. These investments are critical to sustain growth in our industry. + +The demand for medicines and therapies will continue to rise in the future for the following reasons: + +? An aging world population with an increas- ing need for medical care. The impor tance of this trend is accentuated by the increasing incidence in the elderly of chronic conditions such as degenerative diseases of the joints, the cardiovascular system and the central ner vous system, as well as a heightened risk of cancer. + +? Unhealthy lifest yles and environmental pollution are causing chronic illnesses on a pandemic scale. Unhealthy eating hab- its, sedentar y lifest yles and environmen- tal pollution have serious consequences including obesit y, chronic cardiovascular disorders, diabetes, cancer and pulmo- nar y disease. + +? Rapid economic growth of emerging mar- kets, with better access to medical care. E xpanding populations and increasing prosperit y are creating a new middle class of about 2 billion people. The demand for bet ter healthcare is rising disproportionately in China, India, Russia and Brazil. The build up of sustainable healthcare systems also is playing a significant role, as in the case of China, where such expansion is being pursued with substantial political energ y. + +? Scientific and technologic al advances enable new approaches in pharmaceutical research, leading to innovative medicines against previously incurable diseases or those that lacked suf ficient treatment. + +Cost increases, which result from rising demand for healthcare ser vices, diagnos- tics and medicines, have led to a political backlash, aiming to reduce the price of pat- ented medicines and streng then generics. With financial problems of public health- care systems exacerbated by the conse- quences of the global recession, ever yone is required to use their resources as ef fi- ciently as possible. + +We are responding to these intensif ying challenges primarily by mobilizing our orga- nization around a common overarching goal: to make the right medicine available to the right patient at the right time. As our com- pany incorporates the rigorous demands of societ y, patients and payors into its pro- cesses, and strives to bring medicines with an optimal cost-benefit profile to market, we will continue to position ourselves as a driver of change. Novar tis, which is recog- nized as an innovative company, has no reason to fear these growing demands, for true innovation will always be valued by societ y. + +Novar tis also is responding to increasing pressure on prices by implementing inno- vative pricing models, in which payment is clearly linked to added value for patients. In Germany, for example, the payment for our osteoporosis medicine Aclast a is refunded if a patient suf fers a fracture at tributable to osteoporosis within one year of treatment. Similarly, in the United Kingdom, we have introduced innovative pricing models for our asthma medicine Xolair as well as for Lucentis, a treatment for age-related macular degeneration. + +Technological advances also help us to respond flexibly and creatively to changing + +circumstances. At Novar tis, we are com- mit ted to developing technolog y-based healthcare solutions . E xamples include applications to remind patients to take their medicines, redeem their prescrip - tions or check their vaccination status ? as well as telemonitoring of patients using mobile technolog y. + +Political debate all too often ignores the fact that medical problems have heav y costs for healthcare systems, but also have various socioeconomic cost implications. Far more politic al at tention should be paid to indirect cost saving s realized through preventing or treating disease with inno- vative therapies and procedures. Because the indirect cost of illness is not covered by government budgets, however, it rarely receives systemic cost-benefit analysis or is the subject of debate. Who calculates the economic benefits of a quicker recover y and faster reintegration into work? + +Moreover, too lit tle at tention is paid to the fact that patented innovations become less expensive with widespread use and the length of time they remain on the market; this is particularly true after patent expiry. Everyone bene?ts in the end from this price reduction process. Novartis makes a sub- stantial contribution in this respect through Sandoz, a global leader in generics. Medi- cines generally account for 10% to 15% of total healthcare costs. A rational assessment of drug prices should take into consideration the average price over the entire life cycle. + +Broad availabilit y of medical advances played a decisive role in the dramatic improvement of public health in the 20th centur y. Healthcare must not be allowed to fall victim to shor tsighted austerit y measures that ignore the fundamental connec- tions bet ween prevention and treatment. Medicine has seen enormous progress that has vastly improved the treatment and prevention of various illnesses, par ticularly during the last 50 years. People live longer today and they stay healthier longer. In the middle of the 20th centur y, cancer patients still had ver y lit tle chance of sur vival. Today, almost two-thirds of cancer patients sur vive at least five years af ter initial diag- nosis. During the last 25 years, deaths of children due to cancer have decreased by +60%. + +It is a dangerously shor t-term view to deny that research and development requires enormous investment to deliver innova- tion. In other words, innovation has ? and must have ? its price. Allowing austerit y to become the principal aim of healthcare policy not only risks lowering the qualit y of medical care, but also endangers the fun- damental impetus for medical progress. + +Progress requires tangible incentives. Cer- tainly, it is not always easy to make invest- ments that do not bear fruit for years, or even until the next generation. Such long- term investments, however, are a hallmark of sound policy. The pharmaceutical indus- tr y is accustomed to long cycles but, here again, it is not always easy to raise R&D expenditures amid the pressures of shor t- term expectations. + +The post- crisis sobriet y now reigning in many of the worlds prosperous nations may also have a positive side. Now is the time to ask and answer some fundamental ques- tions. How impor tant is health to us? How impor tant is innovation? Is societ y willing to continue investing in basic research, education and training ? or will budgets impor tant for the future be cut, and other politically sensitive areas spared instead? + +We should remember that our prosperit y is founded on innovation and that, espe- cially today, global economic competition is primarily a competition in innovation. Even in todays increasingly volatile and polarized politic al climate, innovation remains the rational core of societ y and must be upheld. I place my trust with the majorit y who see more oppor tunities than risks in progress, because our industr y in par ticular needs a societ y that suppor ts the idea of progress. Novar tis too can make social progress a realit y rather than merely an empt y phrase, namely by helping to solve significant social problems. That is the case in par ticular for health problems arising from extreme pover t y in develop- ing countries, precisely during these times of increasing protectionism and shrinking development aid budgets. + +Long-term engagement and a clear strate- gic direction are also essential for corpo- rate citizenship. In view of todays eco - nomic uncer tainties, both development aid and corporate citizenship face an uncer- tain future. Moreover, the term corporate citizenship (or corporate social responsi- bilit y) risks being devalued from overuse by many economic players. + +Today, for those who take corporate citi- zenship truly seriously, stringent require- ments must apply. It must be strategically embedded and it must be quantifiable through concrete indicators. And it must not lose sight of the fact that our success- ful core business constitutes our main con- tribution to public welfare: We discover and market new medicines to help patients worldwide. + +Last year Novartis contributed USD 1.5 bil- lion or 3% of net sales through access-to- medicine programs as well as investment in research targeting diseases that are prevalent in the developing world. We strive to eradicate ? in the mid-term ? diseases such as malaria that can be prevented and treated to alleviate future suf fering. In 2010 alone, Novar tis access-to -medicine pro - grams reached 85 million patients in need, of whom 81 million were malaria patients. + +The last few years have taught us that merely providing medicines is not enough. Here again, a holistic approach is indis- pensable for sustainable success. Training, logistics management and other forms of technical exper tise are necessar y to achieve ef fective solutions. I am pleased that the Novartis Malaria Initiative has been recognized repeatedly for its effectiveness, and as a role model. Last year our anti- malarial medicine Coartem and the Novartis Malaria Initiative won the US Prix Galien for Best Pharmaceutical Product, as well as the World Business and Development Award. + +Our contributions to corporate citizenship do not depend on the economy or business cycles, but solely on the long-term success of Novar tis. + +As shareholders you are obviously inter- ested in the development of the value of our company. Our total shareholder return since the founding of Novar tis amounts to +9% annually, including continuously increasing dividends and business divest- ments. Our total shareholder return sur- passes not only that of the global market, but also the pharmaceutical industr y index and share price per formance of impor tant competitors. Again for 2010, this confirms that Novar tis not only fulfills its primar y mission ef fectively, but also represents a sustainable investment, which, especially in times of severe ?uctuations and ongoing unease in financial markets, is at tractive. Our strateg y of focused diversification, together with the traditional streng th and consistency of our dividend payout, will ensure Novar tis remains an at tractive investment in the future. + +For 2011, we expect fur ther grow th of net sales in local currencies and further improve- ment in net operating income. Thanks to a number of recently launched products with rapid sales grow th, Novar tis is less af fected by patent expiries than most of its competitors. In the last year, 21% of net sales (excluding Alcon) was at tributable to products launched since 2007. Fur ther- more, we have one of the best pipelines in the industr y, with some ver y promising pro- ducts at advanced stages of development. + +Gilenya has impressive grow th potential, and strong successor products are already on the market to replace Gleevec/Glivec and Diovan. We are confident of our abilit y to compensate for lost sales due to expir y of Diovan patents. Our broad por t folio with varied business cycles should deliver sustainable development compared with the industr y. Therefore we have a good chance to more than compensate for the loss in sales, given of course a lit tle luck . + +I would like to thank all our associates for their ongoing eng agement and tireless commitment. Thanks to our associates we succeeded again last year in sustaining our leading position in innovation, accelerating our grow th, and increasing our produc- tivit y. Once again, we will work together to focus our company firmly on the needs of patients throughout the world. + +Finally, I thank you, our shareholders, for the trust you place in our company. I am pleased to be able to propose an increase in the dividend to CHF 2.20 (+5%) at the next Annual General Meeting. + + +Sincerely, + +Daniel Vasella, M.D. +Chairman of the Board + +----------------------------------------------------------------------------------------------- Novartis 2011 + +DEAR SHAREHOLDER + +What started with a banking crisis in 2008 grew into a debt crisis for a number of industrialized nations last year. So far there has been a distinct lack of credible propos- als for a short-term solution to tackling the budget deficits and reducing the debt, let alone any long-term solution. It now appears unlikely that all the institutions of social wel- fare that have been built up over the past decades can be maintained in the long term. Expansion of the money supply may paper over problems in the short term, but there can be no doubt that the consequences of debt and money supply policies will catch up with us one day. + +Despite the uncertainties that are shaping the current mood, Novartis again succeeded in posting record sales of USD 58.6 billion and a net income of USD 9. 2 billion in +2011, as well as gained market share in most divisions. + +The strategy of focusing on the healthcare sector, which we have pursued over the last 15 years, has proven successful. Our activities include preventive healthcare, diagnostics and above all drug therapy. This opens up multiple opportunities for expan- sion both geographically and also in terms of new products, and it allows knowledge and experience to be successfully leveraged over several business areas. Our focused diversification strateg y also reduces risks notably by diversifying the payor base. + +Innovation, qualit y and productivit y are a prerequisite for all divisions to remain com- petitive. Innovative streng th is especially crucial for Pharmaceuticals. We therefore invested over 20% of Pharmaceuticals sales in R&D last year, consistent with previous years. Our robust pipeline includes products for the treatment of cer tain cancers, res- pirator y diseases, metabolic disorders, infections, as well as autoimmune and oph- thalmic diseases. + +Novartis has successfully established itself in new therapeutic areas and expanded its product portfolio of highly specialized medi- cines. New discovery approaches could also enable us to tackle previously untreatable diseases of genetic origin. + +The launch of Gilenya, the first oral therapy for multiple sclerosis is a success. Afinitor/ Votubia has proven to be a new and valuable cancer therapy. In addition to previously approved indications, the results of clinical studies confirm that it also has consider- able potential in the treatment of estrogen receptor-positive, metastatic breast cancer n combination with the aromatase inhibitor exemestane. Tasigna is an even more effec- tive treatment for chronic myeloid leukemia than Glivec, which already set a very high standard in this treatment. Just before the end of the year, we received marketing authorization for Lucentis in China. In the key countries, Lucentis is approved not only for wet macular degeneration, but also for the treatment of diabetic macular edema and retinal vein occlusion. + +The year 2011 was also the beginning of pat- ent expiries for Diovan ? our most successful +antihypertensive ? in larger European markets. Patent expiry in the US will follow in 2012. Within two years we expect a corresponding decline in sales, which could amount to a drop of USD 4 billion dollars. We expect this will probably be offset by the dynamic growth of new products. + +Thanks to a diligent and highly professional approach, the integration of Alcon ? the worlds leading producer of eye-care products ? went smoothly. The synergy targets that were set were exceeded while sales increased by 7% n constant currencies. This new division is thus contributing significantly to the growth of the Group. + +The decision to systematically build up our generics business was initially questioned, but is now imitated by other companies. Sandoz, our generics division, shows dynamic grow th worldwide and, over the past 12 months, the anticoagulant enoxaparin has become our first generic to generate sales of more than USD 1 billion. + +The Vaccines and Diagnostics Division gained market share with Menveo, a vaccine for meningitis t ypes A , C, W-135 and Y. Bexsero ? for meningitis t ype B, an of ten fatal infection among newborns ? is under regulator y review in Europe. Thanks to its investment in the vaccines producer Zhejiang Tianyuan Bio-Pharmaceutical Co. in China, the division has access to this promising market. + +Both the self-medication and animal health businesses showed grow th in the single- digit range thanks to their good product por t folios. + +While there were many successes, there were also setbacks. A long-term study with the antihypertensive aliskiren showed negative results in high-risk patients with pre-existing renal or cardiovascular disease. For all the advances made in research and development, there were also delays in the regulator y approval of some products. + +Particular attention and fur ther ef for ts are needed regarding qualit y management in production. A s with many competitors, Sandoz received a warning let ter from the US Food and Drug Administration, which has tightened up it s requirement s . For qualit y assurance reasons we also tempo- rarily stopped production in our Lincoln, Nebraska, US, factor y for over-the-counter and animal health products. Remediation actions are now under way including lead- er ship change s and rigorous tr aining. Across our businesses, we decided to pro- ceed with qualit y-oriented investments at our manufacturing sites. + +As a result of government-imposed price cuts and patent expiries, productivit y ini- tiatives continue to gain impor tance. These factors led to some site closures and related product transfers. Research and develop- ment also reviewed their operations, which led to the outsourcing of some cyclical activities in development, as well as the reorganization of research activities in neuroscience ultimately resulting in the closure of the depar tment in Basel. Due to the Diovan patent expir y, restructuring of our US operations remains an imperative. At the same time, we are increasing our investments in grow th regions, such as Asia and South America. + +Restructuring is very stressful for associ- ates, especially in an environment of rising unemployment, and it is one of the most unpleasant responsibilities for manage- ment. However, a company that fails to make the necessary adjustments to market con- ditions because of the hardship associated with such decisions will sooner or later pay an even higher price for inaction. + +In 2011, Novartis continued its support for patients who are unable to afford treatment. This is especially the case for people in developing countries. For several years now, all the leprosy medicines needed world- wide have been provided free of charge by Novar tis in collaboration with the World Health Organization. The 480 million doses of our antimalarial drug Coartem that have been sold without profit since 2001 have helped save an estimated 1 million lives ? most of them children. This is the largest and most important program of its kind. + +Our researchers also recently succeeded in discovering a new and promising class of compounds for the treatment of malaria, known as imidazolopiperazines . Addition- ally, we are continuing our discovery efforts for new medicines and vaccines to treat neglec ted diseases mainly occurring in developing countries. + +Alcon also conducts pro bono programs in the field of ophthalmolog y. In India some years ago, Novartis began an innovative ini- tiative with doctors to improve healthcare in rural regions. There is significant demand for this program, which already encom- passes 33 000 villages. + +In the new year, we will continue to pursue our primar y objectives in the field of pre- ventive care and treatment by working to discover innovative medicines and vac- cines, as well as by offering low-cost, high- quality generics. + +In spite of the uncertain economy ? partic- ularly government debt and weak growth ? we will pursue our strategy. Continued inno- vation and expansion in grow th markets will remain key to gaining market share in the medium term. At the same time, pricing pressure must be of fset by productivit y gains, including restructuring activities in cer tain markets, which we will implement with social responsibilit y. We must con- tinue to ensure the highest qualit y stan- dards across the Group. We are building our research and development center in China and also production sites in Brazil and Russia. + +We will continue to invest in the training and education of our associates because their competence, motivation and integ- rit y are key to our success. The E xecutive Commit tee is commit ted to enforcing our Code of Conduct worldwide. It is essential that the trust of our stakeholders and the companys good reputation be preser ved also in the future. + +We are confident that thanks to our pipe- line, one of the richest and most promising in the industr y, we will be able to continu- ously contribute to the ef fective treatment of patient s worldwide and thereby grow and generate profits. + +I am grateful to all our as sociates and leaders worldwide for their excellent work during the past year and their continued engagement in the pursuit of our mission. + +We also extend our thanks to you, our share- holders, for your loyalt y, and are pleased to propose an increase in the dividend to CHF 2.25 for 2011. + +Sincerely, + +Daniel Vasella, M.D. +Chairman of the Board + +----------------------------------------------------------------------------------------------- Novartis 2012 + +DEAR SHAREHOLDER + +The economic and debt crisis has cast a shadow over europe and the united states for more than four years, and it signi?cantly affected 2012, as well. Despite major con- certed effor ts, the end of this troubling period is not yet in sight. + +Even the regions and markets that have so far escaped the crisis are now in danger of being affected by its socioeconomic side effects. Protectionist market interventions, monetary expansion and over-regulation ? all signs of reactive politics ? are increasing and can lead to a deepening of structural de?cits. Persistent weak growth is likely, despite low interest rates and monetary ex- pansion. High levels of public debt make the problem worse in many countries, and there is no certainty as to whether pension funds and social welfare institutions will be able to meet their promises in the medium term. + +Despite this ominous backdrop, Novartis once again posted strong results in 2012. This is all the more remarkable given that we were forced to deal with increased price pressure, the patent expiration for our successful heart drug Diovan, and persistent turbulence on ?nancial and currency markets. moreover, quality problems at sandoz and consumer Health led to production downtime, which also affected results. + +Despite these far-reaching events, Novartis was able to provide 1.2 billion patients world- wide with medical care in 2012 ? exceeding the record-setting level of previous years ? thanks to recently launched products and the further expansion in fast-growing markets. + +The Groups net sales reached UsD 56.7 bil- lion (?3%, unchanged in constant curren- cies), while net income increased by 4% (7% in constant currencies) to UsD 9.6 billion. + +The pharmaceuticals Division (UsD 32.2 bil- lion, 2% in constant currencies) rejuvenated its product portfolio with the help of recently launched products such as leukemia drug Tasigna and ophthalmic medicine Lucentis, which helped balance the Diovan patent loss. moreover, groundbreaking therapies such as Gilenya and Afinitor ? which in 2012 posted revenue growth in constant curren- cies of 147% and 85%, respectively ? are expected to generate sustainable growth in the future. + +Alcon (UsD 10.2 billion, 5% in constant cur- rencies) was able to assert itself and with- stand the growing price pressure and com- petition from generics, due to product launches and the successful integration of ciBA vision. sandoz (UsD 8.7 billion, ?4% in constant currencies) succeeded in com- pensating for the competition-driven price decline of enoxaparin, on the back of strong demand for biosimilars, growth in emerging markets, and the strategically signi?cant acquisition of Us dermatology drug maker Fougera. + +The performance of otc and animal health, which together make up consumer health (UsD 3.7 billion, ?16% in constant currencies), was hurt by quality issues at a Us production site in Lincoln, Nebraska, which required additional investment. Both divisions, how- ever, are expected to return to growth once again in 2013. + +Production bottlenecks also affected vaccines and diagnostics (UsD 1.9 billion, ?4% in con- stant currencies). On an encouraging note, the division received EU approval in January +2013 for the new, potentially life-saving menin- gococcal disease vaccine Bexsero. + +Our strategy of focused diversification is effective, especially during times of crisis. Geared toward the needs of patients, the strategy centers on the research and devel- opment of innovative and cost-effective med- ical treatments. This clearly de?ned approach enables us to respond to ever-changing demand and to focus on areas that have the potential for long-term success. + +Since Novartis was created in 1996, we have consistently focused on markets and tech- nologies with potential for sustainable growth. This has enabled the company to grow from a chemical and pharmaceutical group into a pure healthcare company. This forward-looking approach and long-term planning have helped maintain the growth and earnings prospects of Novartis despite the expiration of the patent for Diovan and other products. + +Our geographic diversi?cation is just as crit- ical as our broad product portfolio. Our global presence enables us to take advantage of market opportunities quickly and decisively +? especially during turbulent times, which require ?exibility, a stable foundation and the ability to adapt to new market conditions. + +In addition to cost synergies in purchasing, cros s- divisional cooperation in sales, + +research and development, distribution, and production allows us to bene?t from the advantages of our Group structure. + +Central to our strategy and the ful?llment of our primary task is our ability to consistently introduce new drugs that are more effective or more cost-ef?cient. Research and devel- opment remains our essential core compe- tency in achieving this mission. This is why Novartis began several years ago to over- haul and promote its internal research activities. These efforts have paid off: From +1996 through 2011, Novartis received more +product approvals for new molecular enti- ties in Europe and the United states than our competitors, and our product pipeline, currently with 138 pharmaceutical develop- ment projects, is one of the most promising in the industry. + +To maintain our leading position, Novartis invested more than UsD 9 billion in the research and development of new drugs in +2012. This is especially notewor thy be - cause many of our competitors are instead reducing their research spending to achieve short-term savings in this dif?cult economic climate. We believe this strategy is short- sighted. The detrimental effects of these activities often will not come to light until sometime in the future, which is not in the best long-term interests of patients, the company and shareholders. + +Novartis achieved a number of key approv- als in 2012. in the past 12 months, the Pharmaceuticals Division has reached 11 major regulatory approvals. + +And our rich pipeline also offers the pros- pect of future success. We are focusing on serious illnesses for which there are cur- rently no or only inadequate treatments. This applies to cancer, diabetes, and cardio- vascular and lung diseases, which are expected to increase due to global demo- graphic trends. + +As scienti?c understanding of genetics advances, we are increasingly able to dis- cover drugs that can be used in a targeted manner, even for diseases with different phenotypes. + +We are also advancing the research of med- icines for rare and neglected diseases. One milestone has been the approval of Signifor to treat adults with cushings disease, a rare and life-threatening disease caused by too much cortisol in the blood. + +A closer look reveals, however, that increas- ingly stringent public policies ? in particular, pressure on drug prices ? threaten to erode the culture of innovation in healthcare. This is made worse by the one-sided and biased public debate that ignores the built-in uncertainties that are part of a complex knowledge-based industry such as the healthcare sector. + +Despite major medical breakthroughs and therapeutic successes, the healthcare sec- tor remains an industry fraught with consid- erable risks. The costs involved in bringing a drug to market have risen substantially in recent years and have surpassed the UsD 1 billion mark , which is repeatedly quoted as the cost of a successful drug launch. But according to retrospective anal- yses for the period from 1997 to 2011, launching a new drug actually costs any- where from UsD 3.7 billion to UsD 11.8 bil- lion, depending on the company. During this period, Novartis obtained the most approv- als from Us authorities and had the second- highest rate of productivity. + +Even though research and development at Novartis is among the most productive in the world, deep ?nancial resources alone are no guarantee that drugs will receive marketing approval, even when they have advanced to late-stage development. The tremendous complexit y of modern drug research must therefore factor in the risk of + +setbacks in order to offer the long-term innovation and ongoing medical progress that society justi?ably demands. But this has its economic price. + +The tougher environment requires additional skills from business leaders. managers can no longer measure their performance based solely on ?nancial success. They must also be measured by their ability to deal with the growing number of interest groups that participate in the often emotionally charged healthcare debate. Business leaders must set clear priorities, as it is impossible to take all wishes and demands into consideration, especially when they are often mutually in- compatible. close attention should be paid to the legitimate needs of patients, employ- ees and shareholders. + +This clash of opposing needs is also behind the dilemmas that arise ever more frequently in the current tense economic climate, when private healthcare companies deliver agreed- upon services without being compensated accordingly, or at all. A way out of this situ- ation, which must always keep the patients well-being in mind, can only be found through a cooperative process in which interest groups work together and engage in a ratio- nal dialogue in order to identify long-term solutions. We should avoid imprudent mea- sures that often entail unforeseen risks. + +This goal cannot be achieved in an atmo- sphere of distrust, which is re?ected in the rising number of con?icts that are fought out in court. This tendency is re?ective of the anxious atmosphere that has struck vast portions of societ y since the outbreak of the economic crisis. This also includes the increased attacks that risk undermining legal and contractual certainty, which only will lead to further instability. + +Thanks to our pro?tability in 2012, we were once again able to support millions of patients who lack suf?cient ?nancial resources and access to life-saving treatments. As part of our corporate responsibility, we were able to provide more than 100 million people with access to medicines and treatments valued at more than UsD 2 billion, or about +3.6% of total sales. + +Besides our free anti-leprosy drugs ? we have provided combination therapies to more than 5 million people since 2000 ? Novartis continues to work with partners such as the World Health Organization and UNicEF to ?ght the spread of malaria and to stem the epidemics health and economic conse- quences. since 2001, the Novartis malaria initiative has distributed more than 500 mil- lion treatments of Coar tem and Coar tem Dispersible without pro?t. in order to help more patients and to save even more lives, Novartis is breaking new ground by using state-of-the-art information technology to improve the distribution and management of drugs in Africa and Asia. These new solu- tions will enable us to supply much-needed drugs to people in remote areas in the future. + +But the concept of corporate responsibility goes beyond charitable donations. To combat the health disparity resulting from neglected diseases and develop new therapies against widespread infectious diseases, Novartis also maintains research facilities such as the Novartis institute for Tropical Diseases in singapore and the Novartis vaccines institute for Global Health in siena, italy. + +In addition, we are extending our for-pro?t social business to improve access to medi- cines in economically underdeveloped regions of Kenya, vietnam, indonesia, Nigeria and Ghana. This builds on work we have done over the past five years to provide access to medical care to more than 40 million peo- ple in 33 000 villages in rural india. + +Times of structural change are marked by uncertainties. There is no question, however, that the macroeconomic challenges will remain signi?cant and the threat of over- regulation will grow. As a consequence we need a stronger dialogue between the private and public sector to ?nd common ground and keep the crisis from escalating. short- term political calculations can do major harm to the healthcare industry, which depends on long-term policies. This ultimately could risk prolonging the current crisis and irrep- arably weaken the economic structure. + +Excessive price reductions and discounts on drugs usually receive quick and broad- based political support, but they threaten the necessary funding for the research and development of new drugs. Hasty popular decisions also disregard the fact that in- patient and outpatient treatments generate a large part of todays healthcare costs, and gloss over the positive economic impact of effective medical therapies. studies show that spending UsD 1 on drugs can save about UsD 6 in the healthcare sector and thus provide signi?cant savings to the over- all economy. + +Society simply has not yet recognized the potential of prevention. At a time when health- care budgets are restricted and debates rage over how to allocate resources fairly, prevention measures offer a sensible alter- native due to their high cost-benefit ratio. Healthy lifest yles should be rewarded, as should diagnostic tests to advance early detection so diseases can be diagnosed and treated in a timely manner. measures such as these can bene?t the entire healthcare system and help rein in costs. + +Our business model has proven itself to be stable and attractive to investors despite the ongoing economic and political challenges. in a time of dangerous levels of debt and fundamental uncertainty over what an ef?- cient market economy should look like, together with ?uctuating share prices, we offer our shareholders a high degree of reli- ability, evidenced by continually increasing dividend payments and above -average creditworthiness. + +Thanks to our strategic positioning, focus on innovation, strong product por tfolio and healthy pipeline, we can therefore look to the future with con?dence and the certainty that we can build on the strong performance we have delivered in the past. + +I would like to take this opportunity to thank all employees for their dedication and tire- less commitment, which helped us in 2012 to generate results on par with our record- breaking results of the past despite the pit- falls of the ?nancial crisis and the expiration of the patent for Diovan. We will continue to do everything we can in 2013 to consistently focus our efforts on the needs of patients around the world, and i am con?dent that this will enable us to generate strong, sustainable results over the long term. + +Dear shareholders, i am pleased to propose an increase in the dividend to cHF 2.30 (2%) at the next Annual General meeting. And ?nally, i would like to thank you for the trust you have placed in our company and my leadership. After 25 years with the company and 17 years in a top management position, i have decided not to stand for re-election to the Board of Directors. i am pleased to propose Dr. J?rg Reinhardt, a very experi- enced healthcare executive with deep knowl- edge of our company, as my successor. J?rg will serve as Non-Executive chairman of the Board after an interim period during which Prof. Dr. Ulrich Lehner will lead the Board of Directors. + +Sincerely, + +Daniel vasella, m.D. +Chairman of the Board + + + + + + +Q.1999 CSR ִ 2004 ͵ ٿ ޾Ƽϳ??? + +-------------------------------------------------------------------------------------------------- Roche 2004 + + + +We are pleased to present our second Sustainability Report ? once again in combination with the finan- cial report as an integrated part of the Annual Report and for the first time representing the whole Roche Group, with the inclusion of our majority holdings Chugai and Genentech but excluding the OTC business for non-prescription medicines that was sold during the year. The fact that we are pub- lishing both reports at the same time testifies to our deep conviction, that has grown over 100 years, that sustainability cannot be separated from everyday business and is not just a marketing tool. Roche sees and has always seen itself primarily as a profit- oriented company and this will not change. This economic objective should not be achieved, how- ever, on the basis of short-term profit maximisation. It should rather be considered from a long- term, sustainable point of view. Each and every employee in our company can and indeed must contribute to sustainable creation of value in his or her area. This is necessary in order for Roche to be able to continue to invest in the development of innovative solutions for hitherto unsolved health problems and also, in the interests of all the parties involved, take responsibility for the direct field of activity that surrounds them. It is a central part of our long-term strategy, therefore, to unite entre- preneurial responsibility with innovation in the interests of health. + +The most important visible sign of the success of our efforts to increase transparency in our actions in sustainable terms was the fact of being selected to join two leading sustainability indexes in Septem- ber 2004: the Dow Jones Sustainability World Index (DJSI World) and the Dow Jones STOXX Sustain- ability Index (DJSI STOXX). This was preceded by thorough examination of our economic, social and environmental performance. This amounts to certification from an independent party using objective criteria that we, as a leading company worldwide, have been successful in orienting our- selves to the principles of sustainable development. We are proud of this visible success and at the same time it is our aim to maintain these high standards, which sets the benchmark for 2005. + +Our scientific commitment to the research and development of new health solutions that is closely linked to considerable economic risk is and remains our most important contribution to sustainability. Each year we invest considerable funds in finding more efficient solutions to the numerous as yet unresolved health problems. In 2004 we invested +5.1 billion francs worldwide in research and devel- opment. The opening of our research centre in Shanghai (China) on 1 November 2004 is a further milestone for our innovation-oriented company. In doing so we are also creating attractive jobs for highly qualified scientists, who might otherwise leave the country. + +Transparency in clinical research into new sub- stances or medicines has always been important for Roche. We are convinced that we have an ethical duty to publish the results of all clinical studies that are of significance to science and medicine. We wel- come and support the new industry-wide solution to have, from now on, ongoing studies as well as the results of finished studies recorded by an indepen- dent and neutral office and make them available to the public. + +The success of both the Pharmaceuticals and Dia- gnostics Divisions that are represented with their products and services in all important markets allowed us to create about 2,400 new jobs world- wide in 2004 aimed at, for the most part, highly qualified people. The orientation of our employ- ment policy towards sustainable creation of value has paid off. Clear objectives for more than 1,000 members of senior management, career and succes- sion planning that was introduced early on as well as a transparent and motivating performance culture creates the basis on which both the employ- ees and company can develop further. + +Our efforts to further spread sustainable thinking and action within the company and its employees have been successful. Sustainability is the duty of every employee and should be practised in every business area and activity. I would like to thank every employee in his or her place of work who contributes to sustainable value creation at Roche and urge them to continue doing so in future. The overwhelming success of the worldwide competi- tion for ecological ideas called ECOmpetition has shown us that we can depend on the creativity and willingness to participate of our employees. This basis allows us to approach the coming year with its challenging goals optimistically. Once again, the Corporate Sustainability Committee played an important role in furthering sustainable thinking. It is responsible for preparing and adapting, where and as necessary, the corporate guidelines that apply throughout the world as well as for coordina- tion and reporting. In 2004, new guidelines for, among others, our relationship with external busi- ness partners (supply chain) were approved by the Executive Committee in October 2004. + +The responsibility we feel that goes beyond our business activities in the strictest sense of the defi- nition is recognised fully in this report. Roche has put its commitment to the Least Developed coun- tries in the world, as defined by the UN, into prac- tice and has adapted and extended, where neces- sary, its patent and pricing policy that was introduced some years ago. Our well established cooperation with local partners in areas with inad- equate medical care has brought further success: more than 40,000 South Africans living in rural areas were able to benefit directly from the Phelophepa health train in 2004. After the tsunami disaster in Asia, Roche took action after a swift but careful assessment by the general managers on the spot together with the local authorities and in- ternational aid organisations. In addition to the immediate medical and financial aid provided by Roche country affiliates on the spot, we reserved all available stocks of antibiotics at the Group level and made them available to an international aid organ- isation. These were used to treat 80,000 individuals in the affected areas. + +In 2004 once again, many young scientists and scientific institutions were able to take advantage of a rich palette of opportunities within Roche and its partner foundations. In this way the Roche Research Foundation alone was able to support 72 scientists and their projects. We have also further developed our special tradition of working together with contemporary art and culture. Projects such as the Tinguely Museum in Basel or the commis- sion to the Chinese-American composer Chen Yi as part of the Roche Commissions illustrate our drive in promoting innovation, the willingness to support what is unconventional and challenging, striving for excellence in all our activities without consideration of the attractions of short-term pop- ularity. + +Our figures for safety, health and environmental protection continue to be very positive: emissions of harmful substances as well as consumption of resources were further reduced. There were no acci- dents or damaging events that had an important impact on people or the environment in 2004. This is a noteworthy achievement for an industrial com- pany and not one that should be taken for granted. + +Regular reporting on sustainability and updating of information on our web site serve both our need for a critical review of our own status quo as well as the interests of the broader public. This Sustainability Report provides transparency and at the same time spurs us on to make further progress. Striving for sustainability is an ongoing and demanding process and in addition to the awareness of our employees we also count on the working collaboration of +other stakeholder groups ? in particular, regulatory authorities, the constructive participation of our suppliers, the willingness of healthcare providers to enter into a dialogue, as well as the trust and loyalty of doctors and patients to our products and ser- vices. Our thanks go to all of them. I would also like to extend special thanks to our shareholders and holders of non-voting equity securities (Genuss- scheine) who make it possible for us to follow our long-term strategy. + +We will continue in our efforts to create value with- out neglecting our values. + + +Franz B. Humer +Chairman of the Board of Directors and CEO + + +-------------------------------------------------------------------------------------------------- Roche 2005 + + +Your company had an outstanding 2005. Innovative Roche medicines and diagnostics helped advance the fight against serious diseases. Operationally and financially the Group posted strong results, with substantial market share gains and a further significant improvement in operating profitability. At the General Meeting of Shareholders the Board of Directors will propose a dividend increase of +25% to 2.50 Swiss francs per share and non-voting equity security. If approved, this will be the Groups nineteenth dividend increase in as many years. + +Sales by the Roche Group rose 19% in local curren- cies and for the first time exceeded 35 billion Swiss francs. The Pharmaceuticals Division accounted for most of this increase. Its sales were up 25% for the year, four times the average market growth rate. + +The Diagnostics Division maintained its leadership position in a difficult market, but fell slightly short of its performance goals. + +Group operating profit before exceptional items rose by one-third to a record high of 9 billion Swiss francs. At 6.7 billion Swiss francs, net income came close to matching the previous years figure, despite income of 2.3 billion Swiss francs recorded in 2004 from the divested consumer health business. This strong earnings performance will enable us to con- tinue investing heavily in research and develop- ment and in expanding our production base. With Group expenditure on research and development totalling more than 5.5 billion Swiss francs annu- ally, ours is one of the worlds most research-inten- sive companies. During the next several years we will additionally be investing about 2 billion Swiss francs in new biotech manufacturing facilities to keep pace with rising demand for our products. + +Roche is in excellent financial health. In 2005 we further strengthened our balance sheet and significantly increased net cash. Over the last three years our ratio of equity to total assets has risen steadily from 40% to 60%. This increased financial strength gives us the strategic flexibility to selectively expand our core pharmaceuticals and diagnostics busi- nesses. In late 2005 Standard & Poors and Moodys awarded Roche credit ratings of AA+ and Aa1, respectively ? the second highest ratings assigned by these agencies. + +For the Pharmaceuticals Division 2005 was the best year in Roche history. Despite the expiry of the US patent on Rocephin, once Roches top-selling medicine, the division increased its sales by a truly impressive 5.5 billion Swiss francs to over 27 billion Swiss francs. For the first time ever, seven Roche medicines generated annual sales of more than +1 billion Swiss francs each ? in some cases signifi- cantly more. The divisions operating profit margin before exceptional items also showed another sig- nificant improvement, advancing from 25.0% to 27.4%. + +Our powerful oncology portfolio was the key driver behind these superb results. Roche is the only healthcare company with five medicines for cancer on the market that have been shown to increase patient survival. Within the space of just a few years, a new generation of more targeted, less toxic anticancer medicines have made Roche the global market leader in oncology. We reinforced this leadership last year with sales growth of 42%. The innovative new additions to our oncology portfolio ? Avastin for colorectal cancer and Tarceva for lung cancer ? are already very well established. + +New Roche medicines were also launched success- fully in other therapeutic areas, and supplemental approvals for new indications spurred a significant increase in prescriptions of some of our existing drugs. Last year Roche captured the attention of health professionals and the public with some exciting new clinical data. These include data show- ing that Herceptin can make a significant difference in the early-stage treatment of aggressive breast cancers. In clinical trials involving nearly 13,000 women, adding Herceptin to standard therapy halved the risk of cancer recurrence compared with standard therapy alone. And in a trial of MabThera/ Rituxan in lymphoma patients, maintenance therapy with the drug was shown to increase sur- vival so dramatically that the tide may now also be turning in the battle against certain forms of this disease. A claim like this would have been unthinkable a few years ago. + +As these examples illustrate, drug research and development does not and should not stop as soon as a drug is approved in its first indication. Taking the development of anticancer drugs to a new level is one of the core missions of our global research organisation. + +We also made significant progress on projects to develop novel biotherapeutics for rheumatoid arthri- tis, a common disease characterised by progressive inflammation, and in most cases progressive destruction, of the joints. Clinical trial data have confirmed that our top-selling anticancer medi- cine, MabThera/Rituxan, offers a completely new approach to treating rheumatoid arthritis. And a product being developed by our Chugai sub- division has also been shown in clinical trials to slow joint damage significantly and dramatically improve the diseases painful, disabling symptoms. The chances are good, I believe, that Roche will soon be a major player in this disease area. + +Responding to the threat of a potential flu pan- demic was one of the years greatest challenges. Roche has acted energetically and responsibly to meet increased global demand for its leading influenza drug, Tamiflu. Among other steps, we promptly initiated a massive scale-up of production capacity at our own risk and adopted a pricing policy that provides significant discounts on deliveries of the drug for pandemic use, and we have given over five million packs of Tamiflu to the World Health Organization as a rapid response stockpile for use at the epicentre of a potential pan- demic and to help establish regional stockpiles of the drug. In addition, we have granted our first sub- licences for production of the drug for pandemic use and are holding in-depth talks with a dozen companies that could provide additional manufac- turing support if necessary. + +For Roche Diagnostics 2005 was a year focused on launching new products, particularly for diabetes management. And it was also a year in which the division expanded into markets where it had never competed before ? notably DNA sequencing. While market conditions continue to be difficult, Roche Diagnostics maintained its leading market posi- tion, with sales advancing 4% in local currencies to 8.2 billion Swiss francs. The divisions immuno- diagnostics and molecular diagnostics portfolios were the main growth drivers. + +Roche Diagnostics posted an operating profit of 1.7 billion Swiss francs before exceptional items, matching the all-time high of the previous year. Divisional profitability remained high for the industry, despite a slight decrease in the operating profit margin, to 20.5%. Strong pricing pressures, production start-up costs and the costs related to the many new products launches during the year were the main reasons for this decline. + +As the global market leader, we feel we have an obli- gation to supply advanced diagnostics that make a significant contribution to effective, cost-efficient patient care. Our new generation of Accu-Chek products for improved diabetes management, which we began launching worldwide in 2005, is a perfect case in point. The response has also been very strong to the European and US launches of our AmpliChip CYP450 Test, a product that takes us another step closer to personalised medicine. Using this DNA microarray test, doctors can gauge a patients ability to metabolise certain drugs based on the patients genetic profile ? information which can then help guide drug selection and dosing deci- sions. Additional DNA microarray tests, for cancer screening, are currently in late-stage development. + +Reflecting the Groups strong performance, we created 3,600 new jobs last year, bringing the total number of Roche employees worldwide to over 68,000. I would like to take this opportunity to express my thanks to all our people for their dedi- cation and professionalism. The value they create every working day is vital if Roche is to continue to invest in developing innovative solutions for areas of unmet medical need. By helping to make patient care more effective, and hence more cost-efficient, our clinically differentiated medicines and diag- nostics will play an increasingly important role in easing the pressure on healthcare budgets. + +For decades Roche has been actively committed to socially and environmentally sustainable develop- ment, as well as to delivering long-term benefits to patients. At the end of last year not only were we reselected for inclusion in both Dow Jones Sustain- ability Indexes and the FTSE4Good Index, we were also ranked second in the pharmaceutical industry category. This is a tribute to our sustainability efforts, and something I am very pleased about. I am equally pleased that several highly respected publications, including Fortune and Science, have included us in their lists of the best companies to work for. + +Roche has always striven to be a responsible cor- porate citizen as well as a healthcare innovator. The action we are taking to ensure the availability of Tamiflu in the event of a pandemic is a recent example of how seriously we take our wider respon- sibilities as a company. We also set high standards with our policies and practices regarding trans- parency in clinical research. We disclose negative as well as positive results from our late-stage trials, and early last year we also began publishing data from all our clinical trials on the Internet. In addi- tion, Roche has established an independently hosted, publicly accessible online trial protocol registry that provides information in clear, simple language. + +Our commitment to corporate social responsibility also extends to the worlds least developed coun- tries. Ours is one of the few companies still doing research on HIV/AIDS, and it is also one of the few companies that supplies medicines at cost and does not enforce patent rights in the poorest developing countries. In addition, in early 2006 we announced that we would provide the technical expertise to manufacture the AIDS drug saquinavir to inter- ested manufacturers in Least Developed Countries at no cost. + +Clearly, the greatest contribution we can make to sustainability is to continue developing new and better solutions for unmet medical needs. But we also recognise that our continued viability and suc- cess as an innovative company depend on our doing business in a socially and environmentally respon- sible way. + +Our outlook remains very positive. Thanks to a portfolio of innovative products, we are well positioned to continue creating value. In 2006 we expect both divisions to achieve above-market sales growth in local currencies, and our target is for core earnings per share to rise in line with Group sales. + + + +Franz B. Humer + +-------------------------------------------------------------------------------------------------- Roche 2006 + + + +2006 was another year of strong growth and outstanding financial performance at Roche. The Groups sales rose 17% in local currencies to a record high of 42 billion Swiss francs. This 6.5 billion Swiss franc revenue increase over 2005 reflects organic growth. Top-line growth was driven primarily by the Pharmaceuticals Division, where sales advanced at more than three times the market growth rate in +2006. Roche Diagnostics maintained its leadership position in an increasingly competitive market, thanks to numerous new product launches and continued growth in all of the divisions business areas. + +The Groups earnings performance improved sig- nificantly again last year. Operating profit (before exceptional items) increased by 27% in local cur- rencies to 11.7 billion Swiss francs. The Groups operating profit margin increased further, to 27.9%. At the same time, we invested more in our divisions rich research and development pipelines and also increased spending on launch activities and the con- struction of new biotech manufacturing facilities. + +Net financial income was also up significantly compared with 2005. Total net income rose by one- third to 9.2 billion Swiss francs ? the highest profit ever recorded by Roche. Core Earnings per Share (Core EPS) rose 26%. + +The Board of Directors will propose that the divi- dend for 2006 be increased by 36% to 3.40 Swiss francs per share and non-voting equity security (up from 2.50 Swiss francs in 2005). Subject to your approval at the Annual General Meeting of Share- holders, this will be our 20th consecutive dividend increase. + +As I indicated before, the Pharmaceuticals Division was the main driver behind the Groups excellent results in 2006. Its sales exceeded 33 billion Swiss francs, an increase of 21% in local currencies in a market that averaged 6% growth last year. This robust increase was driven primarily by sus- tained strong demand for our cancer medicines, continued government stockpiling of the anti- influenza drug Tamiflu and sales of Bonviva/Boniva, for osteoporosis. Oncology, transplantation and virology are currently our three leading therapeutic franchises. Very importantly, sales of our cancer medicines surged approximately 40% to 15 billion Swiss francs, and now account for half of the divi- sions total revenues. For the first time, the Pharma- ceuticals Divisions operating profit (before excep- tional items) exceeded 10 billion Swiss francs, and its operating profit margin rose significantly, to 31.7%. + +The Diagnostics Division posted sales of 8.7 billion Swiss francs, a 5% increase in local currencies over the previous year. After a slow start, sales growth accelerated to slightly above the market growth rate in the second half of the year, helped by the roll- out of new products. Once again, the divisions Centralized Diagnostics business ? particularly the immunodiagnostics portfolio ? was the main con- tributor to growth. With the new portfolio of Accu-Chek blood glucose monitoring products now on the market, we expect Roche Diabetes Care to return to above-market growth as well. Divi- sional operating profit (before exceptional items) declined 21% in local currencies to approximately +1.4 billion Swiss francs. The decrease was primarily due to higher costs for new product launches and ongoing pricing pressure in the divisions markets. Operating profit was also impacted by impairment charges on intangible assets relating to the Dise- tronic acquisition in 2003. + +Roches strategy remains firmly focused on pre- scription medicines and modern diagnostics. With our increased financial strength, we have the resources for targeted business-building invest- ments in both of these core businesses. Developing healthcare innovations ? products and services rep- resenting real advances in the fight against serious diseases ? is the most important thing Roche does, and our mission is not about to change. Our research and development activities are aimed at extending patients lives and improving their health and quality of life. Worldwide, we spend 18 million Swiss francs every day in pursuit of these objectives. Last year R & D expenditure in the Pharmaceuticals Division amounted to 17.7% of sales. In absolute figures, total R & D expenditure for the Group rose to well over 6 billion Swiss francs in 2006, making Roche one of the most research-intensive compa- nies in the industry. + +We plan to intensify cooperation between our Pharmaceuticals and Diagnostics Divisions in major therapeutic areas, in order to deliver more products tailored to the needs of specific patient populations. The benefits of more precise diag- noses and better targeted treatments are already evident ? particularly in oncology. Tighter cross- divisional linkages between our research, develop- ment and marketing organisations will strengthen our ability to actively shape the future of therapeu- tics and diagnostics. + +Roche has been reselected for inclusion in the Dow Jones Sustainability Indexes and the FTSE4Good Index Series. This is recognition of our efforts to balance corporate responsibility with our business objectives and core mission to innovate healthcare. We believe that making sustainability an integral part of our business model and operations fosters innovation, minimises business risks and creates value for all stakeholders. + +In the final analysis, of course, it is Roches people who have made it the prosperous, innovative com- pany it is today. Thanks to their untiring dedication +and professionalism, Roche is able to bring prod- ucts and services to market that make a real differ- ence in patients lives. Our strong businesses con- tinued to create new jobs last year. In 2006 the total number of Roche employees worldwide increased by about 4,600 to over 74,000. I would like to take this additional opportunity to thank all of the Roche Groups employees for the tremendous job they have been doing, and continue to do, in a tough and challenging marketplace. The awards we received last year for being an outstanding com- pany to work for are a special source of pride to all of us at Roche. + +Without innovation, medical progress and access to quality healthcare are unsustainable. For that reason, it is vital to raise awareness of the role that pricing and patent protection play in the industrys ability to innovate. Roche will continue to actively engage with policymakers and the public on these issues. + +Tomorrows healthcare market will offer enormous opportunities and pose some enormous challenges. At Roche we can pursue those opportunities and tackle those challenges with confidence and from a position of strength. With our strategy of focused innovation and our portfolio of new products, we are well equipped for sustained growth. In 2007 we once again expect the Groups and the Pharmaceu- ticals Divisions sales to grow at double-digit rates in local currencies, and we expect to see continued above-market sales growth in both divisions. We are aiming for Core EPS to increase in line with Group sales. + + + +Franz B. Humer + +-------------------------------------------------------------------------------------------------- Roche 2007 + + +Dear Shareholders, + +Your company achieved outstanding results again in 2007, despite tougher market conditions. For the seventh straight year the Roche Groups sales increased by double-digits, advancing 10% to +46 billion Swiss francs. This more than 4 billion Swiss franc increase in sales revenues was all achieved organically. Once again, the Pharmaceu- ticals Division was the main growth driver. Its sales grew almost twice as fast as the global pharmaceu- ticals market. The Diagnostics Division maintained its position as the global market leader in in vitro diagnostics, with divisional sales increasing slightly ahead of the market. Revenue growth again out- paced costs, resulting in another significant im- provement in the Groups earnings performance. In view of Roches excellent full-year results, the Board of Directors will propose that the dividend for 2007 be increased by 35% to 4.60 Swiss francs per share and non-voting equity security (up from 3.40 Swiss francs for 2006). Subject to your approval at the next Annual General Meeting of Shareholders, this will be Roches 21st consecutive annual dividend increase. + +While research and development expenses in- creased 16% to 8.4 billion Swiss francs, and thus grew faster than sales, overall costs increased less than sales as a result of a variety of programmes to increase productivity. This had a very positive impact on profitability. The Groups operating profit rose 22% to 14.5 billion Swiss francs, and the corresponding profit margin advanced by 3.5 per- centage points to 31.4%. Our Groups strong operating performance, combined with a lower effective tax rate, boosted net income 25% to well over 11 billion Swiss francs. This record income includes no exceptional items. As a result, the Groups equity ratio and balance sheet were also strengthened further. + +Roches operating profit has more than tripled since 2001, while the operating profit margin has nearly doubled during the same period. This impressive growth is reflected in our Core Earnings per Share, which over the last 5 years has averaged 22% growth annually. In 2007 we achieved 20% Core EPS growth. + +Looking to the future, one very positive develop- ment is that the portfolio of products driving our business success is much broader now than it was even a few years ago. The Pharmaceuticals Division currently has nine medicines that generate annual revenues of over 1 billion Swiss francs, with six of them producing more than 2 billion Swiss francs in annual sales. And the Diagnostics Division has three product lines that generate revenues of over +1 billion Swiss francs annually. Very importantly, except for CellCept, none of our major products is facing patent expiry over the next several years. In this time we will continue to strengthen our portfolio by launching new medicines ? as we did in 2007 with Mircera and as we expect to do soon with Actemra ? and by gaining additional new indications for our leading cancer medicines. + +In 2007 we further enhanced our ability to innovate in our five main therapeutic areas of interest: oncology, virology, inflammatory diseases, meta- bolic diseases and diseases of the central nervous system. Each of these areas now encompasses all activities from drug discovery and clinical develop- ment to strategic marketing. By streamlining decision-making processes, we believe this funda- mentally new approach will enable us to translate research activities into marketed products more efficiently and effectively. During the year we also reinforced our presence in China by opening a clinical development centre for pharmaceuticals in Shanghai. Our pharmaceutical operations in this key emerging market now span the entire value chain from research and clinical development to manufacturing, marketing and distribution. + +Construction work on our new biotech manufac- turing facilities in Basel (Switzerland) and Penzberg (Germany) went very quickly, with both buildings being completed on schedule in 2007. These facili- ties, representing a total investment of 800 million Swiss francs, will help us to meet the steadily grow- ing demand for our cancer medicines Avastin and Herceptin, along with demand for future Roche medicines, over the medium to long term. + +In 2007 we continued to invest heavily in new tech- nologies. This included acquiring or entering into alliances with leading companies in pioneering new fields such as DNA sequencing, microarrays, therapeutic antibodies and RNAi therapeutics. Transactions like these open the way to developing new and better diagnostic tests and treatments for complex diseases. + +In January 2008 we signed a merger agreement with the US-based diagnostics company Ventana Medi- cal Systems, Inc. The acquisition will enable us to move into the fast-growing market for tissue-based diagnostics. Acquiring Ventana will contribute to our efforts to develop and commercialise person- alised healthcare solutions in oncology. + +Our strategy remains firmly focused on innovating healthcare. In the medium to long term, our global research network, strengths in biotechnology and leadership as a developer of diagnostic products will remain sources of competitive advantage in a rapidly changing healthcare market, just as they are today. At the same time, we remain committed to combining and balancing our pursuit of innova- tion with corporate social responsibility. In recog- nition of this, Roche was selected for inclusion in the Dow Jones STOXX and World Sustainability Indexes for the fourth consecutive year in 2007. And for progress related specifically to protecting the environment, we were honoured with an award for reducing our carbon dioxide emissions relative to sales by over 70% since 1996. Another indication of how integral sustainability and environmental protection are to the way we do business is the fact that over the last decade we have cut our energy use per Swiss franc of sales revenue in half. We believe that sustainable policies and practices not only minimise business risks but also create value and promote innovation. + +As previously announced, the Roche Board of Directors has voted to split the positions of Chair- man of the Board and Chief Executive Officer. At the Annual General Meeting on 4 March 2008 I will be stepping down as CEO after a decade in the post in order to concentrate on my duties as Chairman. In designating Severin Schwan as Roches next CEO, the Board has selected an individual who at age 40 already has an impressive track record. Not only will Severin Schwan bring broad inter- national experience to his new role, gained from a variety of divisional and corporate-level assign- ments, but he is also firmly committed to continu- ing our strategy of innovation. On 1 January 2008 +J?rgen Schwiezer succeeded Severin Schwan as CEO of Roche Diagnostics. J?rgen Schwiezer has decades of experience in the diagnostics business and has been instrumental in establishing Roche as the leader in Europes in vitro diagnostics market. In March Silvia Ayyoubi will join Roches Cor- porate Executive Committee as the Groups most senior human resources executive; she will be the first woman ever to serve on the CEC. I am pleased to say that we were able to fill all three of these key positions with people from within our organi- sation. For my own part, you can be assured that as Chairman I will continue to work closely and energetically with the Board and the Corporate Executive Committee to help achieve Roches ambitious goals as one of the worlds leading healthcare groups. + +I would like to take this opportunity to thank the roughly 79,000 Roche employees around the world for their contributions to the Group. Without their professionalism and dedication, Roche would not be the highly successful company it is today. + +Significant challenges and opportunities lie ahead for the healthcare industry, and Roche will be able to tackle them with confidence from a position of strength. For 2008 we expect to achieve a high single-digit increase in Group sales, with continued above-market sales growth in both Roche divisions. This excludes government and corporate stock- piling orders for Tamiflu for pandemic use. Most of these orders have been filled over the last several years, so that we anticipate a considerable decrease in pandemic Tamiflu sales in 2008. This year we will again be substantially increasing our investment in research and development, particularly in phase III development projects, in order to capture the full potential of our strong pipeline. At the same time we are aiming for Core EPS for 2008 to remain at least at the same high level as in 2007. + + + +Franz B. Humer + +-------------------------------------------------------------------------------------------------- Roche 2008 + +Dear Shareholders + +The past year was dominated by the global financial and economic crisis. Nevertheless, your com- pany continued to perform strongly, building on the achievements of previous years. Once again, the Pharmaceuticals and Diagnostics Divisions sales grew well ahead of their respective markets. Group sales rose 10% in local currencies, excluding pandemic Tamiflu sales, which, as expected, declined sharply. Including pandemic Tamiflu, sales increased 6% to 45.6 billion Swiss francs. +The Groups operating profit increased to almost 14 billion Swiss francs, even though we increased our research and development spending on promising projects in our strong development pipeline. Net income, at 10.8 billion Swiss francs, was down only slightly from the previous years record high, despite the marked appreciation of the Swiss franc against other major currencies and lower financial income. Core Earnings per Share (at constant exchange rates) were 2% higher than the year before. In view of these latest strong results, the Board of Directors will propose that the dividend for 2008 be increased by 9% to 5.00 Swiss francs per share and non-voting equity security (up from 4.60 Swiss francs for 2007). Subject to your approval at the next Annual General +Meeting of Shareholders, this will be Roches 22nd consecutive annual dividend increase. + +In todays turbulent economic climate, it is more vital than ever that we stay focused on developing products that significantly improve the treatment options available to patients. In recent years this strategy has yielded some major advances, notably in the diagnosis and treatment of cancer. We are particularly excited about the many large-scale clinical trials the Group is conducting with Avastin, the first targeted cancer medicine that halts the development of new blood vessels to tumours. While these trials require substantial investments of time and money, they hold out the promise of a longer, better life for countless patients suffering from a wide variety of cancers. + +Ventana, the U S-based leader in tissue diagnostics which we acquired for 3.8 billion Swiss francs in February 2008, continues to perform even more strongly than expected. Having access to +tissue-based diagnostic tests and technologies will help us in our efforts to develop further per- sonalised treatments, particularly for cancer. + +Roche has also made considerable progress in developing biological medicines for the treatment of rheumatoid arthritis (RA), an autoimmune disease that affects over 21 million people worldwide. Our novel medicine Actemra/ RoActemra has been approved for the treatment of RA in Japan and the European Union. MabThera/ Rituxan, our leading cancer medicine, continues to show benefit in RA patients as well. Data from a phase I I I clinical trial, for example, show that MabThera/ Rituxan can prevent structural damage to joints in patients with early RA. + +All told, twelve projects entered the final stage of clinical development at Roche in 2008, including three promising new molecules for the treatment of breast cancer (pertuzumab), type 2 diabetes (taspoglutide) and cardiovascular risk reduction (dalcetrapib). + +On 21 July last year Roche announced its intention to purchase all outstanding shares of Genentech, a company in which we have held a majority stake for nearly 20 years. We remain committed to completing this transaction. + +We believe that bringing Genentech entirely within the Roche Group will significantly enhance the Groups ability to remain innovative over the long term. We will take the necessary care to preserve Genentechs unique innovation culture. The Group will continue to encourage and promote a diver- sity of research approaches, because this helps create an ideal climate for medical progress. We will ensure that the existing research networks, technologies and expertise in our pharmaceuticals and diagnostics businesses can be shared across the Group. At the same time, we will leverage +the scale of our combined operations in the U S and improve operational efficiency. + +Roche is taking this step from a position of strength and in the conviction that the proposed +transaction is in the best interests of both companies employees, patients and you, our share- holders. Roches Board of Directors and the Corporate Executive Committee are confident that this transaction will bring us significantly closer to our goal of being the worlds leading health- care company. + +We remain committed to operating our businesses in a responsible, sustainable manner that +respects the needs of all our stakeholders. Our products are our greatest contribution to society; they provide significant benefits to patients, tangibly improving peoples health and increasing their quality and length of life. We recognise our responsibility to help expand global access to our products. We do this primarily through partnerships and in collaboration with various stakeholders. + +Last year we achieved all of our environmental goals for improving energy efficiency and reducing emissions of greenhouse gases. We firmly believe that sustainable policies and business practices create long-term corporate value and support innovation. In recognition of its efforts, Roche was selected for inclusion in the Dow Jones World Sustainability Index for the fifth consecutive year. + +Finally, we would like to take this additional opportunity to thank the 80,000 Roche employees worldwide for their tremendous dedication and professionalism. Without their efforts, Roche would not be one of the worlds most successful companies. Recruiting, retaining and developing talented people remain among our most important tasks. + +Barring unforeseen events, we expect the Group to continue to perform strongly in 2009. In both the Pharmaceuticals and the Diagnostics Division we expect full-year sales to grow ahead of the market, with increases in the mid-single-digit range in local currencies. We will continue to invest in the large-scale confirmatory clinical trials that are vital to Roches long-term success. Despite the higher research and development costs involved and an expected decrease in net financial income, we are aiming for Core Earnings per Share (Core E P S) at constant exchange rates to remain at the same high level as in 2008. We expect that the Genentech transaction will have a positive impact on Core E P S within the first year after closing. + + + +Franz B. Humer +Chairman of the Board + + + +Severin Schwan +Chief Executive Officer + +-------------------------------------------------------------------------------------------------- Roche 2009 + +Dear Shareholders + +Despite the sustained global financial and economic crisis, 2009 was a very successful year for Roche. Sales in both the Pharmaceuticals and the Diagnostics Division grew twice as fast as the market. Group s ales increased by 10% in local currencies to 49.1 billion Swiss francs, mainly driven by our leading medicines +to treat patients with cancer, viral infections, age-related blindness and other serious diseases. Sales of the influenza medicine Tamiflu, at 3.2 billion Swiss francs, also contributed significantly to revenue growth. Operating profit before exceptional items grew even more strongly than s ales, advancing 14% in local currencies to 15.0 billion Swiss francs. + +2009 will be remembered as one of the most important years in your companys long history. Following the merger agreement with Genentech in March 2009 and the rapid finalisation of the transaction, we were able to complete the integration by the end of the year. By combining Roche and Genentech we are not only increasing operational efficienc y but also promoting internal knowledge transfer. We are committed to strengthening the Roche Groups innovative power in the long term and to providing patients with inno- vative medicines through research of the highest quality. + +Excellent research is and will remain a basic requirement for the development of therapies that are decisive for patients health and quality of life. After concluding the Genentech integration we will continue to systematically pursue diverse research approaches for innovative healthcare solutions. This creates scope for creativity and increases the chances of devising sustainable medical and therapeutic progress. For this reason Genentech Research and Early Development will continue to function as an independent unit. + +In addition, combining the activities of the two companies in the areas of product development, production and s ales has already generated significant increases in productivity. Our aim is to achieve pre-tax annual s avings of approximately 1 billion Swiss francs by 2011. + +The operating free cash flow of the Group increased by 27% to 15.7 billion Swiss francs despite significant negative currenc y effects. Roches strong operating performance is also clearly reflected in Core Earnings per Share, which advanced 20% in local currencies (10% in Swiss francs). + +As a result of exceptional costs of 2.7 billion Swiss francs, which were primarily integration-related, the Groups operating profit in 2009 declined by 5% in local currencies (12% in Swiss francs) to 12.3 billion Swiss francs. Exceptional items also impacted net income, which declined by 22% compared with the previous-year period to 8.5 billion Swiss francs. Excluding exceptional items, net income attributable to Roche shareholders increased by 9%. + +In view of Roches strong full-year operating results, at the Annual General Meeting the Board of Directors will propose an increase of 20% in the dividend for 2009 to 6.00 Swiss francs per share and non-voting equity security (2008: 5.00 Swiss francs). Subject to your approval, this will be the 23 rd consecutive annual dividend increase. + +The rapid spread of the pandemic A (H1N1) influenza virus (swine flu), which began in April 2009, pre- sented a major challenge not only for governments worldwide, but also for Roche during the past year. We have been supporting the World Health Organization (W H O) and national governments in global efforts +to fight the new virus. In May Roche announced that an additional 5.65 million treatment courses of Tamiflu would be donated to replenish the W H Os regional and rapid-response stockpiles. We had previously granted sublicences to three manufacturers to produce generic oseltamivir for pandemic use in China, India and specified developing countries, to ensure that local populations in these areas have access to the medication. In addition, in July we initiated the Tamiflu Reserves Program to further improve Tamiflu access in developing countries. In response to the increased W H O pandemic threat level, our network of manufacturing partners scaled up production to approximately 33 million treatment courses per month, and we are now able to supply up to 400 million packs annually, if required. + +The Roche Group received significant recognition for achievements in several areas during the past year. The Dow Jones Sustainability Indexes named Roche the new Super Sector Leader in Healthcare, ranking us as the most sustainable healthcare company worldwide. Roche and Genentech were also again voted best employer in a number of countries. + +We would like to take this opportunity to thank the more than 80,000 Group employees worldwide for the outstanding dedication and professionalism during this eventful and challenging time. + +Scientific excellence and innovation in our core pharma and diagnostics businesses will continue to be the foundation of our success. Aside from oncology, we are developing new therapeutics for metabolic and autoimmune diseases, viral infections and disorders of the central nervous system. As the worlds largest biotech company we have one of the most promising R & D pipelines in the world. From a total of 59 new molecular entities in clinical testing, ten are already in late stage development ? which is remarkable by any standards in our industry. In the last year alone, six new compounds entered late phase development, including potential new therapies for breast cancer and type 2 diabetes. + +During the year we published exciting early phase clinical trial data on a targeted treatment and com- panion diagnostic in malignant melanoma patients whose cancer cells carry a specific genetic mutation; malignant melanoma is the deadliest form of skin cancer. The new compound effectively slowed tumor progression and increased patients quality of life. This is a beacon of hope in the fight against a cancer that until now has been regarded as virtually untreatable. + +Among the key achievements in our Diagnostics Division are the start of the rollout of the cobas 8000 modular analyser series for large medical laboratories and the launch of new products in the Accu-Chek line of blood-glucose monitors for people with diabetes. + +At the end of 2009 William M. Burns, C E O of the Pharmaceuticals Division, J?rgen Schwiezer, C E O of the Diagnostics Division, and Jonathan K.C. Knowles, Head of Roche Group Research, left the Corporate Executive Committee as planned. Each of them has made significant contributions to Roches success and helped write an important chapter in the companys history. Every generation of managers has the task of ensuring Roches healthy future as an independent company. Bill Burns, Jonathan Knowles and J?rgen Schwiezer have fulfilled this task in an exemplary manner driven by profound conviction. They have +significantly contributed to Roches strong market position and success. On behalf of the entire Board of Directors and the Corporate Executive Committee, we would like to thank them for their many years of invaluable service, loyalty to Roche and for the great working relationship we enjoyed. + +In view of their outstanding industry knowledge, the Board of Directors will propose appointing William +M. Burns and Arthur D. Levinson, Chairman of Genentech Board of Directors, to the Board of Directors of +Roche Holding Ltd at the Annual General Meeting on 2 March 2010. + +Prof. Horst Teltschik and Peter Brabeck have decided not to stand for re-election at the 2010 Annual General Meeting. We are very grateful for their valuable contributions to the company over a period of many years. + +Barring unforeseen events, we expect s ales in 2010 for the Pharmaceuticals Division and for the Group +to increase in the mid-single-digit range in local currencies 1. In the Diagnostics Division, we expect full-year sales to grow considerably ahead of the market. Furthermore, we are aiming to achieve double-digit +Core Earnings per Share growth at constant exchange rates in 2010. We anticipate that we will already have repaid 25% of the debt raised to finance the Genentech trans action by the end of 2010. Based on the Groups strong operating free cash flow, Roche expects to return to a net cash position by the end of 2015. We will simultaneously maintain our attractive dividend polic y. + + +Franz B. Humer +Chairman of the Board + + +Severin Schwan +Chief Executive Officer + +------------------------------------------------------------------------------- Supplementary Information + +Bringing Genentech fully into the Roche +Group is a major step on the road to creating a stronger, even more innovative organization. + +-------------------------------------------------------------------------------------------------- Roche 2010 + +Dear Shareholders + +2010 was a challenging yearforthepharmaceuticalindustry.Marketconditions,as +anticipatedforquitesometime,becameeventougher.Inthewakeofthefinancial +crisis,highgovernmentbudgetdeficitsaddedtopricingpressuresintheglobalhealth- caresector.InEuropemanygovernmentscutdrugpricessignificantly,whilehealthcare reformintheU Sresultedinhigherrebatesonprescriptiondrugs.Ontheregulatory front,thehurdlesforgainingapprovalofnewmedicineswereraisedevenhigher,dra- maticallyincreasingthecostofdrugdevelopmentanddelayingaccesstoinnovative treatments. + +Amidthesechallenges,Rochepostedgoodfull-yearresults.However,wealsofeltthe effectsofthemarketchangesIvejustdescribed.InJulytheU SFoodandDrugAdmin- istration(F DA)rejectedourapplicationforacceleratedapprovalofT?D M1,even thoughthisnovelcompoundisexpectedtosignificantlyimprovethetreatmentofbreast cancer.ThiswillincreasetheclinicaldevelopmentcostsforT?DM1anddelaythis +promisingdrugsapproval.LateintheyeartheFDAannounceditsintentiontowithdraw approvalofAvastinincombinationwithchemotherapyforfirst-linetreatmentofmeta- staticH E R2-negativebreastcancer.WhileawithdrawalwillnotaffectU Spatients accesstoAvastininitsotherapprovedcancerindications,itwouldadverselyimpact patientswiththisveryseriousdisease.ThedaytheF DAmadeitsannouncement, theEuropeanMedicinesAgency(E MA)confirmedAvastinsvalueinthefightagainst breastcancer.InEuropewomenwithadvancedbreastcancerwillthuscontinueto haveaccesstothistreatmentoption. + +Wearecloselymonitoringdevelopmentsinhealthcarepolicyaroundtheworld.Precisely becausewebelieveourhighlyinnovativeproductscontributeinimportantwaysto moreeffective,cost-efficienthealthcaredelivery,weconsideritvitalforthefuturethat policymakersandhealthofficialslooknotonlyatthecostsofnewmedicinesbutalso attheinnovationtheyembodyandthebenefitstheyofferpatients.Giventhemanydis- easesthatstillcannotbetreatedsatisfactorily,oratall,medicalprogressshouldbe viewedmoreasapublicgoodthatdeservesvigorouspoliticalsupport. + +Whenwediscussinnovationwemustbearinmindthatitisinherentlyrisky.Pioneering researchanddevelopmenteffortssometimesproducebreakthroughs,buttheyalsocan sometimesnotachievethedesiredendpoints.Taspoglutideisacaseinpoint.Wesus- pendedalate-stagedevelopmentprogrammeonthisnewtreatmentfortype2diabetes ataverylatestageofdevelopmentaftercarefulassessmentoftheavailablesafetyand efficacydata. + +Ourintenseresearchanddevelopmentactivitiesalsoyieldedsomeverystrongand promisingresultslastyear.Wecurrentlyhavetwelvenewmolecularentitiesinlate-stage development,halfofwhicharedesignedfortargeteduseinspecificpatientpopulations withthehelpofcompaniondiagnostictests.Wehavemadeenormousprogressin personalisedhealthcare,helpedbythecloseinterplaybetweenourPharmaceuticals andDiagnosticsDivisions.Thesedevelopmentsrepresentmajorstridesandmakeus confidentthatwewillremainanindustryleader. + +Rocheconvincinglymetitssalesandearningstargetsfor2010.Excludingsalesofour influenzamedicine,Tamiflu,whichasexpectedweredownsharplyfortheyear,Group s alesrose5%inlocalcurrencies.NetincomeattributabletoRocheshareholders showedastrongincrease,advancing11%to8.7billionSwissfrancsdespitethecosts associatedwiththeOperationalExcellenceprogrammeamountingtoaconsiderable +1.3billionSwissfrancs.CoreEarningsperShare,akeyindicatorofunderlyingbusiness +performance,increased10%inlocalcurrencies(4%inSwissfrancs). + +InviewofthecompanyshealthycashflowandpositiveoutlooktheBoardofDirectors +willproposeadividendincreasefor2010of10%to6.60Swissfrancspershareand +non-votingequitysecurity(upfrom6.00Swissfrancsfor2009).Subjecttoyour approvalattheAnnualGeneralMeeting(AG M),thiswillbeRoches24thconsecutive annualdividendincrease. + +LookingaheadtotheAnnualGeneralMeetingon1March2011,Iwouldliketomention theupcomingchangesontheBoardofDirectors.WalterFreyandWolfgangRuttens- torferhavedecidednottostandforre-election.OnbehalfoftheentireBoard,Iwould liketothankthembothfortheirdedicatedservicetoRoche.Duringhislongtenureon theBoardMrFrey,whorunsahighlysuccessfulfamilycompany,hasmadesignificant contributionstotheGroupsgrowthandsuccess.AmongthestrengthsMrRuttenstorfer broughttotheBoard,hisexpertiseonthegrowthmarketsinEasternEuropeandthe MiddleEasthasbeenparticularlyvaluable. + +WeintendtousethisopportunitytostrengthentheBoardfurtherbynominatingaddi- +tionalindependentdirectors.AsannouncedinDecember,PaulBulcke(CEONestl?S.A.), +ChristophFranz(chairmanandCEODeutscheLufthansaAG)andPeterR.Voser +(C E ORoyalDutchShellplc)willbestandingforelectionasnewmembersoftheBoard. + +AttheAnnualGeneralMeetingwewillalsoproposethatthetermofBoardmembers bereducedfromthreetotwoyears.Thiswillenableshareholderstoinfluencethecom- positionoftheBoardatshorterintervalsinfuture. + +AftertenyearsofexceptionalserviceontheCorporateExecutiveCommittee,Erich HunzikerhasdecidedtoretirefromRocheattheendofMarch2011.ErichHunzikerwas appointedChiefFinancialOfficerin2001,becomingDeputyHeadoftheCorporate ExecutiveCommitteein2005.DuringhislongcareeratRoche,ErichHunzikerwasone ofthekeyarchitectsoftheGroupssuccessfuldevelopment.Iwouldliketotakethis opportunitytothankErichHunzikersincerelyforhisoutstandingcontributiontothe Groupsoverallsuccess. + +TheBoardofDirectorshasappointedAlanHippetosucceedErichHunzikerasChief FinancialOfficer.AlanHippewilljoinRocheasamemberoftheCorporateExecutive CommitteeasofApril2011.AlanHippeservedasamemberoftheexecutiveboardof ContinentalAGfrom2002to2009.SinceApril2009hehasbeenCFOandamember oftheexecutiveboardofThyssenKruppAG. + +Ourcompanywashonouredlastyearforoutstandingachievementsinanumberof areas.IamparticularlypleasedthattheDowJonesSustainabilityIndexesnamedusthe SupersectorLeaderinhealthcareforthesecondyearinarow,rankingRocheasthe worldsmostsustainablehealthcarecompany.Wefirmlybelievethatsustainablecorpo- ratepoliciesandpracticesultimatelycreatelong-termvalueandpromoteinnovation. + +Oursuccessasacompanyisbuiltonscientificexcellencethatbenefitspatients.The successfulintegrationofGenentechhasfurtherstrengthenedourinnovativecapa- bilitiesastheworldslargestbiotechcompanyandtheleadingsupplierofcancermedi- cines.Weleadinpersonalisedhealthcare,aretheworldsnumberonesupplierof +in vitrodiagnosticsandhaveoutstandingproductportfoliosinboththePharmaceuticals +andtheDiagnosticsDivision. + +Ourabilitytocreatevalueforallstakeholdersiscrucialtoourfuturesuccessandwe +willcontinuetovigorouslypursuethisstrategy. + +FranzB.Humer +ChairmanoftheBoard + +-------------------------------------------------------------------------------------------------- Roche 2011 + +Dear Shareholders + +The deepening debt crises in Europe and the United States, turbulent currency markets and slower global economic growth all had a profound impact on the business landscape in 2011. Increasing pressure on government budgets also weighed heavily on healthcare markets. With resources stretched, many countries are focusing on short-term savings targets and budget controls. A number of governments, particularly in Europe, have sought to ease their deficits by imposing substantial price cuts on pharmaceuticals ? including innovative, patent-protected medicines ? along with other measures aimed at controlling or reducing healthcare expenditure. + +Amid these challenges Roche posted very strong results for the year. Group sales advanced 2% at constant exchange rates (excluding Tamiflu) to 42.2 billion Swiss francs. Earnings performance improved significantly faster, with net income rising 7% to 9.5 billion Swiss francs. + +I am also very pleased that the Dow Jones Sustainability Indexes once again named us the Super- sector Leader in healthcare, ranking Roche as the worlds most sustainable healthcare company for the third consecutive year. We are convinced that sustainable corporate policies and practices create long-term value and promote innovation. They therefore support our primary mission as a company, which is to prolong peoples lives or improve quality of life through excellence in science. + +For a research-based company like ours, recent developments in healthcare policy and policy- makers short-term focus on costs are a major cause for concern. Of course I understand that Roche as a leading pharmaceutical and diagnostics company ? and indeed, our industry as a whole ? must play its part in efforts to overcome the current financial and debt crises. We are pre- pared to do that. Through constructive dialogue we aim to contribute to finding a fair and sus- tainable balance between health policy and industrial policy ? a balance that encourages and rewards the type of innovation from which society as a whole will benefit. + +In my nearly four decades of working in the healthcare industry, I have rarely been as optimistic as I am now about the medium- to long-term outlook for research-based, innovation-driven companies. The fundamental trends point in the right direction: a growing, ageing global population; increas- ingly affluent emerging markets; rapid scientific and technological advances that are paving the way for more targeted, cost-effective treatments; and an undiminished need for medical progress, since many diseases are still not effectively treated. + +We must not forget the increasing economic significance of innovation and the fact that nations, regions and communities around the globe compete with each other for investment and jobs. We see countries increasingly taking targeted action to promote research and innovation within their borders. I am very impressed by the progress Shanghai, Beijing, Singapore and other cities in emerging markets have made as they strive to become global leaders in the life sciences, particularly in pharmaceuticals and diagnostics. Moreover, their positive attitude and openness towards new scientific discoveries and technologies are definite assets. + +These countries recognise that the research-based healthcare industrys high productivity can translate into significant economic growth, generating skilled jobs, further investment and exports. High expenditures on research and development lead ultimately to strong value creation. Much of Roches R&D activity continues to be located at our headquarters in Switzerland precisely because of the countrys competitive advantage. Switzerland will remain one of the best places in the world for investments in science if we can maintain and strengthen these innovation-pro- moting advantages. + +Why am I particularly optimistic about our companys future? For over a decade now Roche has maintained its strategic focus on innovative diagnostics and therapeutics. As the worlds biggest biotech company, with 14 biopharmaceuticals on the market, we are ideally equipped to transform our growing knowledge of disease biology into novel treatments and tests. In 2011 we spent 8 billion Swiss francs on research and development ? a sum that puts us among the top R&D spenders, regardless of the industry. Unlike some of our competitors, we intend to continue invest- ing heavily in research and development, particularly in those areas where we have competitive advantages: oncology, diabetes, inflammatory and autoimmune diseases, and neuroscience. At +the same time, we will maintain our strong focus on the optimal use of resources and continued productivity improvements. + +Roche remains the worlds leading supplier of cancer medicines and the number one in vitro diag- nostics company. With its combined strengths in pharmaceuticals and diagnostics and proven expertise in molecular biology, our company is uniquely positioned to make Personalised Healthcare a reality. The achievements of the past year ? the US launch of Zelboraf in record time, the Euro- pean Medicines Agencys positive opinion on this novel treatment for skin cancer and the progress of other projects in our development pipeline ? are all testimony to this. + +Cost-effective, targeted medicines and diagnostics have a key role to play in overcoming the health- care sectors current difficulties. As pricing pressures increase, payers will shift resources to products and services offering the greatest incremental benefit to patients. As a company focused on developing medicines and tests that create real value for patients and physicians, we are well equipped to compete successfully in an increasingly challenging healthcare market. The strengths that serve us well today will be even more important tomorrow. + +In view of the companys strong performance and positive outlook ? the difficult economic and financial environment notwithstanding ? the Board of Directors is proposing a dividend increase of 3% to 6.80 per share and non-voting equity security for 2011 (up from 6.60 Swiss francs in 2010). Subject to your approval at the Annual General Meeting on 6 March 2012, this will be Roches 25th consecutive annual dividend increase. + +Finally, I want to inform you that Andr? Hoffmann and Prof. Sir John Irving Bell, two highly experi- enced and distinguished Roche Board members, have agreed to stand for election for a further term at the forthcoming Annual General Meeting. I will be standing for re-election as Chairman and would be honoured by your continued confidence. + + +Franz B. Humer +Chairman of the Board + +-------------------------------------------------------------------------------------------------- Roche 2012 + +Letter to Shareholders from Franz B. Humer + +Dear Shareholders, + +Group sales increased 4%, at constant exchange rates, to 45.5 billion Swiss francs (+7% in Swiss francs), with both the Pharmaceuticals and Diagnostics Divisions growing faster than their respective markets. Roche delivered strong growth in the United States and the emerging markets, whilst in Europe we continued to feel pricing pressure from healthcare budget cuts. Our focus on highvalue medicines and diagnos tic tests, however, meant that, relative to the rest of the indus try, our sales in Europe held up well. + +In general, what we are seeing is an increasing shift from the established markets, especially in Europe, to the faster grow +ing emerging market nations in Asia and Latin America, where Roche already records a fifth of its sales. Cancer and cardio vascular disease are now among the leading causes of death in emerging economies and demand for our medicines is rising as a result. We are actively expanding our position in Asia and Latin America, thereby improving global access to our medi cines and diagnostics products. + +We have optimised our organisational structure over the past year, adapting our processes to this changing market environ ment. A notable move was the closure of the Roche site in Nutley, New Jersey in the United States as part of the consolidation of research and earlystage development activities. Closing the site was not an easy decision. Nutley has played a pivotal role in the companys success over the past 80 years. + +Core operating profit for 2012 again improved significantly, while net income was slightly higher at 9.8 billion Swiss francs, as the good operating performance was offset by costs associ ated with a number of major restructuring programmes and a higher tax rate. On a comparable basis, core net income was up 10% over the previousyear period at constant exchange rates (+11% in Swiss francs). + +Another highlight for the year was the Dow Jones Sustainability Indexes naming Roche Supersector Leader for the fourth con secutive year, ranking us as the worlds most sustainable healthcare company. + +Leading the way in personalised healthcare +As a leader in personalised healthcare, Roche is uniquely posi tioned to develop treatments that raise current standards of care and extend and improve the lives of patients. Some 60% of the projects in our pharmaceuticals pipeline are being devel oped in conjunction with companion diagnostic tests. In 2012 we further strengthened Personalised Healthcare, launching the cancer medicines Perjeta, for breast cancer and Zelboraf, for melanoma, alongside their companion diagnostics. + +Medical innovation not only benefits patients, but also our partners in the healthcare market, payers, the economy and society in general. Regrettably, in Europe in particular, there continues to be too much focus on costs and shortterm think ing, which harbours the risk of missing longerterm opportuni ties for our economy and society. This longerterm perspective tends to be neglected in the discussions about rising health care costs, as does the contribution that pharmaceuticals and diagnostics make to medical progress. + +Sustainable success ? and this applies not only to Roche but to business generally ? requires longterm thinking and for wardlooking investments. Innovation is, and will continue to be, the motor driving our longterm success. This success story must be continued through open dialogue between poli ticians and industry. + +Board to propose 7.35 Swiss francs dividend for 2012 +In view of these good results, the Board of Directors is propos ing an 8% dividend increase, to 7.35 Swiss francs per share and nonvoting equity security (2011: 6.80 Swiss francs). More than half of net income will be distributed to shareholders as dividends. Subject to your approval, this will be our 26th divi dend increase in as many years. + +As previously announced, Prof. Bruno Gehrig and Lodewijk J.R. de Vink (both members of the Board of Directors since 2004) have decided not to stand for reelection to the Board of Directors at our next Annual General Meeting. During their many years of service, both have made exceptionally valuable contributions to the growth of our company. We owe them a debt of gratitude. + +The Board of Directors proposes the election of Dr Severin Schwan, CEO of the Roche Group, as a new member of the Board of Directors of Roche Holding Ltd. This will enable the Board of Directors and Corporate Executive Committee to work together even more closely, which will help promote the growth of the company in todays challenging market environ ment. + +The two new Corporate Executive Committee members announced in the second half of 2012 were recruited from within the company: Daniel ODay, former Chief Operating Officer (COO) of the Diagnostics Division, was appointed COO of the Pharmaceuticals Division effective 1 September 2012. Roland Diggelmann, former Head of the Asia?Pacific region within Roche Diagnostics, was appointed as a new member of the Corporate Executive Committee and Daniel ODays successor as COO of the Diagnostics Division. + +In its newly constituted form, the Corporate Executive Com mittee will continue to progress the Groups current strategic course and sustainably drive Roches success as a global leader in healthcare. Clinical differentiation is the key to serving patients medical needs in a better, safer and more costeffec tive way, which is even more crucial in this increasingly cost sensitive environment. + +Roche will continue to advance its successful strategy of focus and innovation ? for the benefit of patients, physicians, employees and you, our shareholders. + + +Franz B. Humer +Chairman of the Board + +------------------------------------------------------------------------------- Supplementary Information + +High levels of public debt, especially in Europe and the United States, and the continued strength of the emerging economies were the two dominant influences on the healthcare sector in 2012, bringing both challenges and opportunities. Overall, it was a demanding year for the industry and one where cost pressure in many markets continued to increase. +Notwithstanding these challenges, Roche again posted very good results for the year, with a firm strategy of developing medically differentiated medicines and diagnostic products for diseases in areas of high unmet medical need. + + +----------------------------------------------------------------------------------------------------------- Roche 2013 + +Dear Shareholders + +In my last letter to you as Chairman, it gives me great pleasure to report an excellent performance for the Roche Group in 2013. In a challenging, increasingly cost-sensitive environment, our focus on targeted medicines and diagnostic tests has allowed us to expand our strong market position and to significantly improve net income. In light of our strong performance, the Board of Directors is proposing ? for the 27th consecutive year ? an increase in dividend. + +Roche posted strong results for 2013. Group sales increased 6% at constant exchange rates to 46.8 billion Swiss francs (+3% in Swiss francs) and overall net income grew sharply, up 22% to 11.4 billion Swiss francs (+18% in Swiss francs). + +There is increasing demand for our medicines and diagnostic tests, especially the five new cancer treatments we launched over the last two years; and our pipelines are amongst the strongest in the industry. The 2013 results reaffirm the Roche strategy of focusing on innovation in medicines and diagnostics ? and the resulting competitive advantage from developing medically differentiated products. Our strengths will become even more important in the future, as targeted, cost-effective treatments have a key role to play in overcoming todays healthcare challenges. Roche is developing medicines which not only improve and prolong the lives of patients, but can also save significant resources in other parts of the healthcare sector. To this end, diagnostic testing is increasingly playing a critical role in the detection of disease, the monitoring of treatment modalities and in the development of targeted treatments, all of which reduce overall costs to the healthcare system. + +One of Roches strengths is our significant biotech know-how. Our expertise in this area opens up a world of new possibilities to treat disease, bringing real medical breakthroughs to patients. Our leadership in biotech is also the result of targeted acquisitions. The Genentech merger in 2009 was the transaction that has had the biggest impact on our pharmaceuticals business and in diagnostics, we became the market leader when we acquired Boehringer Mannheim in 1997. Over the past 15 years, with our systematic focus on innovation and selective transactions, Roche has become the worlds leading company in oncology and the global number one in in vitro diagnostics. This focus on pharmaceuticals and diagnostics will enable us to succeed in an increasingly competitive marketplace. + +There is no doubt in my mind that Roche is a unique company and this is as true today as it was two decades ago when I joined. It is unique because of its culture and unique because of the majority ownership by the original founding family, which allows us to take a long-term view and to pursue our long-term strategy to develop innovative products. The Hoffmann and Oeri families have my sincere gratitude for all the support they have given me throughout my career at Roche. + +Our selection once again by the Dow Jones Sustainability Indices as the worlds most sustainable healthcare company, is just another indication that Roche is on the right track. Roche was singled out for this distinction for the fifth year in a row in 2013. This rating recognises our commitment to behaving ethically and responsibly and creating long-term value for all our stakeholders. + +The foundations of Roche are rock-solid. But as my predecessor used to say: the house of Roche is never finished. No company has an automatic right to prosperity. It needs to be earned again and again. I am very confident that the new generation of leaders in our Executive Committee under Severin Schwans leadership, and on the Board of Directors, will continue to build a successful business and enrich the Roche culture. + +I have chosen the Annual General Meeting (AGM) on 4 March 2014 as the moment to step down as Chairman of the Roche Group. I have worked in the pharmaceutical industry for 40 years, half of which have been with Roche, as head of the Pharmaceuticals Division, as CEO and as Chairman of the Board. + +At the forthcoming AGM, the Roche Board of Directors will propose that Christoph Franz, who has served as a non-executive Director on Roches board since 2011, be elected Chairman of the Board. With Christoph Franz, Roche will have a Chairman with outstanding personal qualities and an impressive record as head of a major global company. I am sure that his extensive experience and exceptional worldwide network will be great assets. + +In March 2013, a majority of Swiss citizens voted in a referendum in favour of a set of changes to the Swiss Constitution regarding governance regulations for listed companies. Roche has decided to comply with the new regulations earlier than required and will propose changes to the companys Articles of Incorporation at this years AGM. The most important ones include: from 2014, the Chairman of the Board, all members of the Board of Directors and the members of the Remuneration Committee will be elected annually by the shareholders; and furthermore, we propose to implement the binding votes on remuneration in 2014, ahead of the mandatory date of 2015. + +In light of our strong performance in 2013, the Board of Directors is proposing an 6% dividend increase to 7.80 Swiss francs per share and non-voting equity security (2012: 7.35 Swiss francs), making this the 27th dividend increase in as many years. If approved, more than half of our net income will be distributed to shareholders as dividends. + +I would like to thank you, Roche shareholders, for your trust in me over these past years. I have immensely enjoyed my work with the Board, the management and the employees of Roche and am very proud of what we have accomplished together. Roche is a truly great company. + +----------------------------------------------------------------------------------------------------------- Roche 2014 + +Dear Shareholders + +After my first year as Chairman of the Board of Directors, I am very pleased to present you with solid results. In 2014, despite challenging conditions in some of our markets, particularly Europe, we delivered strong sales growth across both divisions and reported a strong net income of 9.5 billion Swiss francs. + +We also had some notable successes in research and development. Thanks to some of our medicines, we helped to improve the treatment of leukemia, pulmonary diseases and skin disorders. We also introduced a test for the detection of the virus causing cervical cancer. Once again, millions of people were treated with our medicines in 2014, and thanks to our diagnostic tests, even more received a reliable diagnosis for the basis of targeted, successful treatment. + +Our main objective remains to offer patients a better quality of life and, where possible, to cure them or help them live longer. + +At last years Annual General Meeting, I made a commitment to continue the course Roche has set to ensure that the Group remains a driver of innovation in the healthcare sector. I am particularly impressed by the large number of projects in our pharmaceutical and diagnostic pipelines. We are tackling serious diseases with high unmet need, such as bladder cancer, a devastating disease with limited treatment options. Our main goal will always be to use cutting-edge science to offer patients a better quality of life and, where possible, to cure them or help them live longer. + +In 2014, Roche invested close to 9 billion Swiss francs in research and development. We are convinced of the enormous potential of modern biosciences and will continue to rigorously pursue our efforts and investments in this area. As the worlds largest biotech company, we are in the best possible position to use our knowledge of disease biology to develop new treatments and tests that are better tailored for specific patient groups, making them safer and more effective. But, of course, its always better to prevent than to treat ? and as a global leader in healthcare diagnostics ?Roche is playing a crucial role here. From early screening to personalised medicines, our products can help to overcome some of the major challenges healthcare systems are facing today. + +Innovation is at the heart of what we do. For us, this means being open to good ideas, including ones generated outside of Roche. In fact, about one third of our pharmaceutical products were born out of a partnership, usually with a smaller biotech firm or university. We maintain an impressive global partnership network spanning over 240 alliances, underpinned by the targeted acquisition of technologies, active ingredients and expertise. In 2014, we entered into a number of important strategic partnerships. The acquisition of the biotech company InterMune, for example, significantly strengthened our portfolio in the area of respiratory disorders with Esbriet, a treatment for a fatal lung disease. + +Sustainable success demands long-term thinking. + +Another important achievement for the Group in 2014 was certainly the selection by the Dow Jones Sustainability Indices as the worlds most sustainable company in the life sciences sector for the sixth year running. For me, its just another indicator that were on the right track. Sustainable success ? and this is not only true for Roche ? requires long-term thinking and commitment. When it comes to the implementation and development of our long-term strategy, Roche benefits from a tremendous advantage thanks to the guidance, support and trust provided by the Hoffmann and Oeri families. To me, this is one of the Groups biggest strengths. + +Roches decentralised management style is a strength that we want to continue to foster. + +In 2014, I visited many of our 150 sites around the world to meet our employees and also get to know the companys key stakeholder groups. What really stood out for me were the vast differences from one national healthcare system to the next, along with the unique challenges each system is facing. Our success hinges on giving our employees sufficient responsibility and latitude to adapt to their local situation. In this context, our decentralised management style is a core strength that we want to continue to foster. + +Nonetheless, providing access to our innovative tests and medicines in economically weaker countries is a major challenge, particularly in oncology, where treatments are complex and the demands made on facilities, expertise and resources are high. We need to work with local partners, who best understand local barriers, to find ways to help patients and also improve preventive screening. + +Whilst our primary focus is always on developing innovative treatments and tests, 2014 was also a year of site expansions. This is largely to provide more space for our growing workforce, additional research infrastructure, and increased production capacities. The biggest investment we announced was in our Basel headquarters, where we aim to invest 3 billion Swiss francs over the next decade, primarily in a new, modern research centre and in a second, state-of-the-art office building. In addition, we will spend 450 million Swiss francs on increasing our production capacity in China over a three-year period in order to meet the growing demand for our diagnostic tests. We are also investing in an IT hub at another site in Switzerland, in modern research laboratories in South San Francisco, and in expanding our research and production capacities in Germany. + +In light of our good performance, we propose a 3% dividend increase to 8.00 Swiss francs per share and non-voting equity security. + +Roche is a very successful company with excellent prospects. However, I know from personal experience that it requires just as much effort to keep a company at the top as it does to get it there. Roche is unique in that it is focused on science-driven innovation, cooperative despite a decentralised structure, rooted in Switzerland, but open to the world. We are deeply committed to sustaining this distinctive culture in the future. + +Whilst I look forward to addressing you in person at the 97th Annual General Meeting (AGM) of Roche Holding Ltd on 3 March 2015, I would like to highlight two important items on the agenda. + +We are proposing two prominent figures, with a wealth of experience in the pharmaceutical sector, as new Board members. + +In light of our strong performance and solid outlook, the Board of Directors is proposing a 3% dividend increase to 8.00 Swiss francs per share and non-voting equity security. Subject to your approval, this will be the 28th consecutive dividend increase. + +In addition to the re-election of existing members, the AGM will see some changes on the Board of Directors. Art Levinson decided to step down from the Roche Board of Directors to avoid potential conflicts of interest following his appointment as CEO of a research institution. Art has been a major contributor to Genentechs success over the years. Under his leadership, Genentech has become one of the most important biotech companies in the world. He joined the Board of Directors of Roche in 2010, following the integration of Genentech. On behalf of the Board, I would like to thank him sincerely for his invaluable contribution to the companys overall success. + +I am delighted to propose Bernard Poussot and Professor Richard Lifton as new members of the Board of Directors. These two prominent figures would bring a wealth of experience in the pharmaceutical sector and basic biomedical research respectively. Bernard comes from Wyeth where he spent 23 years leading the company in positions including President, CEO, and Chairman. Director of the Yale Center for Genome Analysis, Richard is an award-winning scientist who provided valuable insights as a member of advisory boards of various leading pharmaceutical companies. + +With its clear strategic focus on innovative medicines and diagnostics, Roche is well positioned to continue growing. The Board of Directors and Management are committed to ensuring that Roche remains one of the worlds most successful research-based healthcare companies. + +I would like to take this opportunity to extend sincere thanks ? as does the entire Board of Directors ? to our 88,509 employees, as well as to the Corporate Executive Committee, for their achievements. + +I also wish to thank you, valued shareholders, for your confidence in our company. + + + + + + + + + + + + + + diff --git a/Data/kor/minjoo2016.csv b/Data/kor/minjoo2016.csv new file mode 100644 index 0000000..fc770de --- /dev/null +++ b/Data/kor/minjoo2016.csv @@ -0,0 +1,200 @@ +http://theminjoo.kr/briefingDetail.do?bd_seq=59166,2016-11-25, 이재정 원내대변인 오후 현안 서면 브리핑 농민을 향한 경찰의 어깃장 더 이상 국민의 기본권을 침해하지 말라 오늘 오후 법원이 전국농민회총연맹의 농기계 상경 집회를 허용했다 이는 헌법에 명시된 집회 결사의 자유를 생각하면 당연한 결정이다 그러나 경찰이 트랙터의 서울 진입을 막고 재제를 가하려는 시도는 국민의 기본권을 무시한 처사다 트랙터 상경이 교통에 큰 방해가 된다는 경찰의 주장도 빈약하다 우리 국민은 번에 걸친 전국적 촛불집회에서 성숙한 집회문화를 보여주었다 경찰은 길을 열어 법원이 허용한 농민들의 트랙터 이동과 집회를 보장해야 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59164,2016-11-25, 금태섭 대변인 오후 현안 브리핑 일시 시 분 장소 국회 정론관 정진석 원내대표는 국민들을 속이려 들지 마라 새누리당 정진석 원내대표가 박근혜 대통령의 탄핵소추안이 발의도 되기 전에 변호사 역할에 나섰다 야 당의 탄핵안 발의 합의에 대해 민생예산론 을 들고 나오더니 이제는 질서 있는 탄핵론 이다 질서 있는 탄핵론 은 박근혜 대통령이 피의자로 입건되었다는 점을 교묘하게 이용하려 드는 궤변이다 피의자인 박근혜 대통령으로부터 특검과 국정조사 과정에서 소명을 듣고 탄핵소추안을 결정하자는 것이다 그러나 탄핵은 박근혜라는 개인에 대한 절차가 아니라 대통령의 헌법과 법률 위반을 근거로 파면 여부를 결정하는 절차다 개인에 대한 형사절차와는 전혀 다르다 정진석 원내대표의 주장은 재판을 마냥 미루려고 하는 악덕변호사의 수법 그대로이다 국민들의 요구가 탄핵이다 민생을 걱정하고 국민의 법적 권리를 주장하려면 조속히 대통령 탄핵절차에 동참하는 게 마땅하다 정진석 원내대표는 궤변을 그만두고 탄핵을 반대하려면 탄핵반대 라고 당당히 입장을 밝혀라 한일 군사정보보호협정 체결 하루 만에 혼란이 시작되었다 한일 군사정보보호협정 체결 하루 만에 일본의 속내가 드러났다 일본 언론들은 한반도에서 유사 사태 발생 시 한국 내 일본인의 퇴거 활동이 필요하다며 한일 군사정보보호협정에 따라 한국군의 배치나 사용 가능한 공항 항만 정보를 요구할 방침이라고 보도했다 정부는 그동안 북한 핵과 미사일 대응을 위해 필요한 협정이라고 주장했다 하지만 일본은 한국군 배치 정보를 원하고 있다 벌써부터 같은 협정을 두고 양국의 입장과 요구는 전혀 다르다 이 상황을 지켜보는 중국의 비판의 목소리도 크다 중국 외교부는 유관 국가들이 냉전 사고를 하고 군사 협력을 강화하고 있는데 이는 한반도 대립과 대치를 격화시키고 동북아 지역에 새로운 불안 요소를 증가시킬 수 있다 며 유감을 표명했다 한일 군사정보보호협정 체결 하루 만에 한중일은 혼란 속으로 내딛고 있다 국정농단 사태로 혼란스러운 상황 속에 놓여있는 우리 국민들을 위로하지는 못할망정 일본과의 군사정보보호협정을 밀실에서 이렇게 빨리 강행한 이유를 도무지 알 수가 없다 정부는 밀실협약을 통해 일본에 약속해 준 군사정보가 무엇인지 밝히고 국민과 국회의 반대를 무릅쓰고 신속강행 추진이 이유가 무엇인지 밝혀야 한다 사과만으로 끝날 일이 아니다 새누리당은 또다시 역사에 죄를 지어서는 안된다 야 당은 이르면 월 일 늦어도 월 일까지는 탄핵안을 공동 발의하기로 합의했다 그런데 새누리당은 오늘 의총에서 이를 받아들일 수가 없다고 선언했다 표면적으로는 예산국회와 국정조사에 집중 한다는 것이지만 사실은 대통령 지키기에 앞장 서는 것에 불과하다 예산국회와 국정조사에 집중해야 하는 것은 당연한 얘기이다 그러나 예산심의를 꼼꼼히 하고 국정조사에 철저히 임하면서도 탄핵소추는 충분히 가능하다 예산국회와 국정조사에 집중해야 한다고 탄핵소추를 거부하는 것은 새누리당이 무능하다는 것을 자인하는 꼴이다 국민들이 한목소리로 물러나라고 해도 버티고 있는 대통령을 하루라도 빨리 자리에서 내려오게 하려면 탄핵소추가 조속히 필요하다 새누리당은 무능한 사람을 대통령으로 만드는데 앞장섰고 여전히 대통령의 방패막이 역할을 하고 있다 새누리당은 또다시 역사에 죄를 지어서는 안 된다 새누리당은 야 당이 합의한 대로 탄핵소추안을 조속히 처리하는데 협조를 해야 한다 그것이 새누리당이 조금이라도 반성하고 있다는 모습을 보여줄 수 있는 방법이다 오락가락 국정교과서 당장 폐기하라 국정교과서 검토본 발표를 앞두고 정부의 오락가락한 태도가 국민들을 더욱 혼란스럽게 하고 있다 언론은 교육부 관계자가 일 현장 검토본은 예정대로 공개하되 국민 여론을 수렴해 향후 국정 역사교과서 추진 방향을 결정하겠다는 견해를 동시에 발표하는 방안도 고민 중 이라고 밝혔다고 보도했다 역사교과서 국정화를 사실상 철회하기로 내부 방침을 정했다는 것이다 그러나 교육부는 곧바로 현장검토본은 계획대로 일에 국민들에게 공개할 예정이며 국정화 철회나 국 검정체제를 혼용하는 방법 등에 대해서는 결정된 바 없다 고 발표했다 청와대는 큰 변화 없이 예정대로 간다 고 밝혔다 국정교과서를 강행하는 과정에서 국민들은 큰 상처를 입었다 국정교과서 홍보비로 억 원의 세금을 사용하였고 국정교과서 예비비 억원에 대한 정보공개 요구에 맞서 변호사를 명이나 선임했다 국민의 이상이 반대하고 있는 국정교과서를 강행하기 위해 국민 혈세를 펑펑 쓴 것이다 법원은 국정교과서의 집필 기준을 공개하지 않은 교육 당국의 처분은 위법하다고 판결했다 교육부는 역사교과서 국정화를 당장 폐기해야 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59151,2016-11-25, 이재정 원내대변인 오전 현안 추가 서면 브리핑 의원총회 결과 서면 브리핑 박근혜 대통령 탄핵소추안 발의 일정과 담길 내용에 관한 논의들이 있었다 우상호 원내대표가 밝힌 대로 이번 정기국회 내에 처리하는 것이 목표이다 박근혜 게이트로 엄중한 정국이지만 예산안과 법안 심사 역시 차질이 없도록 해야 한다는 논의도 있었다 더불어민주당은 민심에 따라는 대통령 탄핵안 준비는 물론이고 민생경제를 위한 예산 법안 논의에 최선을 다할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59149,2016-11-25, 제 차 의원총회 모두발언 일시 금 장소 국회 본청 호 추미애 대표 이 혼미한 상황에서 나라 걱정에 밤잠을 이루지 못하시는 의원님들 촛불을 들고 생업을 뒤로 한 채 또 나오는 우리 국민들의 마음은 같으리라 생각한다 이제 박근혜 대통령이 선택할 수 있는 것은 스스로 물러나는 것뿐이다 이제 검찰수사로 정권과 재벌간 정경유착의 베일이 풀려가고 있다 박근혜 대통령의 제 자 뇌물수수의 전모가 드러나 더 이상 퇴진은 피할 수 없는 상태가 됐다 대통령이 청와대에 숨어서 하루하루 버틸수록 국민의 분노만 더 커질 것이다 국민이 더 힘들어질 것이다 아마도 내일은 전국에서 만명이 집결하리라 예상이 된다 오는 일부터는 국정조사가 시작되고 내달 초부터 특검도 활동을 시작할 것이다 어느 것 하나도 피할 수가 없다 헌법재판소에 가서 길게 논쟁하지 말고 대통령 스스로 퇴진하는 것이 마지막으로 나라를 구할 수 있는 길이라는 것을 다시 한 번 말씀 드린다 대통령이 민심을 읽지 못하고 퇴진하지 않는다면 결국 탄핵밖에는 남는 것이 없다 더불어민주당은 좌고우면하지 않고 질서 있게 탄핵을 준비해나갈 것이다 국민의 가 탄핵에 찬성하고 있다 탄핵절차를 추진하는 동시에 우리는 또 민생예산 내년도 예산안도 꼼꼼히 살펴보고 처리해야 할 것이다 우리는 탄핵 국면에서 시민사회를 비롯한 국민의 목소리를 잘 새기고 받들겠다 당 차원의 탄핵추진실무준비단을 구성해서 주말도 없이 시간 소추안을 만들어나갈 것이다 또 서명운동본부와 국민과 함께하는 퇴진국민운동본부도 전국을 다니면서 끝까지 독려해나갈 것이다 한 분 한 분 합류해서 수고해주시는 의원님들께 특별히 건강에 유의해주시고 긴 장기전에 국민을 잘 격려하며 나아갈 것을 당부 드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59148,2016-11-25, 제 차 최고위원회의 모두발언 일시 금 장소 국회 당대표 회의실 추미애 대표 제가 문자 메시지를 하나 읽어드리겠다 추미애 청와대 빅딜 주범은 문재인 관련하여 걸렸다 는 제목이다 긴급속보라고 되어있다 부산 해운대 모래밭을 건축부지용도로 변경해준 주범은 당시 참여정부 민정수석이었던 문재인이었다 이영복이 검찰에서 모든 사실을 불었다 이를 정치검사 출신 청와대의 최재경이 받아서 수사에 들어갔다 문재인이 핵심 당사자로 걸려들면서 그 당시 총리를 했던 이해찬까지 걸려들었다 이를 연결고리로 삼아 한광옥으로부터 반협박 연락을 받은 추미애가 청와대에 들어가서 협상을 나섰다고 한다 문재인 뜻대로 청와대의 협박으로 청 들어가는 것이 결과는 박근혜의 의도대로 나올 것이다 문재인을 살리겠다면 그럴 수도 없고 다 죽는다 이런 내용이다 댓글 부대가 작동한 것인지 이런 유언비어를 유포하는 세력이 있다 국민들께서 법치질서와 헌정질서를 바로 세운다고 촛불을 들고 있는데 어둠의 세력들이 이런 일을 한다면 검찰은 엄정 단속해야 한다 법률위원장에게 지시를 하겠다 이런 혹세무민의 유언비어를 유포하는 자를 검찰에 고발해 주시기 바란다 다시 말씀드리지만 년 전 부산판 수서비리 사건 이라고 명명해서 이영복 회장의 다대 만덕지구의 특혜비리 사건을 파헤치고 그것이 나중에는 삼성의 자동차 사업 진출과도 연관이 있다는 것을 또 정경유착의 주체가 새누리당의 전신인 한나라당이었다는 것을 밝혀낸 것은 바로 저 추미애다 그 당시의 수법은 종합 금융사기로 를 불러온 단기금융거래로 의 한 단초를 제공했던 일이다 금융권에 로비를 하고 부산시에 로비하여 환경영향평가나 고도제한 같은 것을 풀고 또 거기서 만든 비자금을 가지고 한나라당에 정치 자금을 파이프 물 공급하듯이 대준 사람이 바로 이영복 회장이었다 그 정경유착의 뿌리는 깊고도 넓어서 년 동안 뽑아지지 않았다는 것이 드러난 것이다 그래서 이렇게 허무맹랑한 유언비어를 보고 저는 대단히 경악하고 있다 국정이 농단 당하고 있으니까 이런 부패공화국의 뿌리가 워낙 깊어서 이를 옹호하는 어둠의 세력이 활개치고 있다는 것이 느껴진다 소름이 끼친다 이 문자를 제가 아침에 받은 문자여서 소개드렸는데 오늘 하루를 그렇게 시작할 수는 없다 말씀을 다시 드리겠다 박근혜 대통령의 퇴진은 국민의 명령이다 대통령이 자진사퇴를 거부하면 대통령을 탄핵할 수밖에 없는 것이다 국민의 명령을 받드는 국회의 사명이 바로 탄핵제도다 지금 겪고 있는 사상초유의 국정농단을 심판해야 한다 탄핵 발의와 의결 심리의 전 과정은 헌법기관 각자가 역사적 사명감을 가지고 임해야 하는 일이다 탄핵 사유 발의에 있어 한 치 오차도 없이 완벽하게 해야 한다 법적 사유에 있어서도 국민의 요구를 담기 위해 만전을 기해야할 것이다 그러기 위해서 우리 민주당은 주축이 되어서 밖에 있는 전문가 널리 지혜를 모으겠다 이렇게 탄핵 의결은 헌법기관이 양심을 걸고 역사적 사명감으로 해야 하는 일이다 제정치 세력이나 개인은 어떤 조건이나 의도도 결부시키지 말아야 한다 오로지 헌법기관의 사명감으로 이 국가 중대사를 국민 뜻을 받든다는 입장에서 해야 하고 그런 의미에서 머뭇거리지 말고 개개인의 입장을 선명히 밝혀주시기를 바란다 또한 제대로 준비해서 지체 없이 추진하는 것이 헌법의 주인인 국민의 뜻을 받드는 것이다 우리가 회복해야 할 법치주의의 엄정함을 탄핵을 심판할 헌법재판소 재판관은 잘 아시리라고 생각한다 우상호 원내대표 어제 야 당 원내대표들이 모여서 향후 정치일정의 불확실성을 대부분 제거했다 또한 야권공조의 균열이 올만한 여러 이견 요소들도 대부분 해소했다 이제는 야 당이 하나로 뭉쳐서 탄핵을 관철하는 것이 최대의 목표가 되어 있다 앞으로 튼튼한 야권공조 속에서 박근혜 대통령의 조기퇴진을 이끌어낼 탄핵의 관철에 최선을 다하겠다 새누리당 의원들도 하루빨리 국정 공백을 최소화하고 국민들이 일상에 전념할 수 있도록 탄핵에 동참해야 한다는 점을 다시 한 번 강조한다 지금 박근혜 최순실 게이트 국정조사가 진행될 예정이지만 증인채택 과정에서 새누리당의 일부 의원들이 증인 채택을 최소화하려고 하는 움직임을 보이고 있다 이번 국정감사에서는 재벌을 중심으로 한 정경유착 최순실과 그 일파들에 의한 국정농단 세월호 시간 언론 장악 및 언론에서 제대로 최순실 게이트가 보도되지 않은 경위들이 하나하나 제대로 밝혀져야 한다 특히 삼성과 국민연금 문제 그리고 부영의 이중근 회장의 세무조사 무마 문제 등 구체적인 뇌물과 관련된 여러 가지 혐의들이 국정조사를 통해서 명명백백하게 밝혀져야 하고 이를 위한 증인 채택이 시급히 이뤄져야 한다 새누리당이 증인채택을 방해한다면 또 다시 최순실 게이트를 은폐하려는 집단으로 낙인찍히게 될 것이다 국정조사와 관련된 증인 채택이 원활하게 이뤄질 것을 다시 한 번 경고하고 만약 이 문제에 협조하지 않는다면 전면적으로 문제를 제기할 것을 경고한다 김영주 최고위원 김현웅 법무장관과 최재경 민정수석이 사의를 표명했으나 대통령은 결론을 내지 않고 있다 대통령이 범죄행위를 저질렀다면 일국의 법치 수호를 책임지는 법무부 장관이라면 마땅히 대통령에게 검찰의 수사를 받으라고 직언해야 한다 검찰에서 년 동안 근무했던 최재경 민정수석도 마찬가지다 그러나 김현웅 장관과 최재경 수석은 대통령의 자진사퇴를 건의하며 사표를 낸 게 아니었다 김현웅 장관은 검찰을 지휘 감독하면서 임명권자인 대통령을 보좌해야 하는데 잘못 모신 상황에 책임을 지는 것 이라고 말했다 최재경 수석도 임명권자인 대통령이 피의자가 되고 대통령이 검찰 수사를 부정하는 상황에 이른 데 책임지는 것이 공직자의 도리 라고 말했다고 한다 김 장관과 최 수석은 공직자의 도리 를 크게 잘못 알고 있다 두 사람은 검찰이 대통령을 철저하게 수사하지 못하게 하는 것이 공직자의 도리 를 다 하는 것이라고 생각하는 것인가 민주주의 국가에서 공직자의 도리 는 임명권자의 범법행위까지 보위하는 것이 아니다 공직자의 도리 는 주권자인 국민의 뜻을 받드는 것이다 헌법과 법률 공무원 복무규정 어디에도 공직자에게 임명권자의 범법행위까지 보위하라고 돼 있지 않다 공무원은 국민 전체의 봉사자로서 직무를 민주적이고 능률적으로 수행하기 위하여 창의와 성실로써 맡은 바 책임을 완수하여야 한다 고 대통령령인 공무원 복무규정 조에 명시돼 있다 결국 박 대통령과 김현웅 장관 최재경 수석의 사의표명 은 국민의 눈과 귀를 분산시키기 위한 쇼 에 불과하다 공직자의 기본자세도 갖추지 못한 것이 드러난 두 사람은 사의표명 쇼 를 당장 그만두고 즉시 물러나야 한다 한 말씀만 더 드리겠다 사의표명 쇼 를 두고 검찰총장의 사퇴를 압박하는 포석이라는 관측이 나오고 있다 우리는 이미 국가정보원 댓글공작 사건에서 수사를 방해하기 위해 이 정권이 검찰총장을 끌어내렸던 일을 생생히 기억하고 있다 그러나 이번 사의표명 을 통한 검찰총장 사퇴압력은 성공하지 못할 것이다 검찰총장은 좌고우면하지 말고 철저한 수사를 계속할 수 있도록 지휘해 주기 바란다 수사에 임하는 검사들도 검찰청에 걸려 있는 검사선서 대로 오로지 진실만을 따라 가는 공평한 검사 처음부터 끝까지 혼신의 힘을 다해 국민을 섬기고 국가에 봉사 해주기 바란다 김춘진 최고위원 고병원성 조류 인플레인자가 발생해서 국민들의 걱정 태산같이 많고 농심은 멍들어져 가고만 있다 진시황이 영생하기 위해 불로초를 구하려고 우리 대한민국에 사람을 보냈지 않았나 대통령께서 마치 줄기세포 치료 태반 주사 등을 이용해서 영생을 추구했던 것 같다 그러나 사람이 태어나서 죽는 것은 만고의 진리이다 역사적으로 심판 받는 것은 어떻게 대통령직을 수행했느냐에 따라서 영원히 살 수도 있고 바로 죽을 수도 있다 이제 남은 선택은 국민들을 괴롭히지 않게 하고 즉시 하야의 수순을 밟아서 혼란 없는 조기 대선 국면으로 가야된다고 본다 강력히 대통령에게 건의하는 바이다 우리가 고병원성 발생 신고현황을 보면 짧은 기간 내에 전국적으로 확산되어 가고 있다 지난 월에 환경부에서 철새 분변에서 바이러스가 검출됨에도 불구하고 예방을 제대로 하지 못한 결과라고 말씀 드릴 수 있다 차제에 매번 반복되는 이러한 현상은 근절되어야 한다 정부는 년 년 일 동안 발생 현황을 겪었다 바로 년 년 유행했을 때 일보다 배 이상 긴 기간 와 싸웠다 또 년 겨울철에 연이어서 발생한 바가 지금 창궐되고 있다 이런 것은 과거의 경험을 소중히 여기지 않은 까닭이라 본다 이미 중국에서 년 발생해서 현재까지도 고병원성 가 유행하고 있다 이런 문제에 대해 효율적으로 대처하지 못한 정부 측에 강력히 대응해줄 것을 권고한다 지금 국정 컨트롤타워를 잃어버린 것 같다 만일에 사람한테 옮겨간다 하고 사람 간에 전파가 된다고 하면 대재앙이다 혹시 만에 하나 있을 수 있는 것에 철저히 대비해야 한다 환경부 농림부 보건복부지부가 상호유기적 관계를 긴밀히 하면서 대책을 세워줄 것을 강력히 촉구한다 우리 국민은 지난 메르스로 인해 많은 고통을 겪었다 만사가 불여튼튼이라고 생각한다 이러한 경험을 토대로 신속한 대응으로 국민과 우리 경제를 안심시켜야 한다 또 매번 가 발생하면 국민들은 많은 피해를 입는다 특히 어려운 경제 상황에서 음식업에 종사 하는 분들에게는 엎친 데 덮친 격이다 농민 음식 자영업자에 대한 구제책을 신속히 마련해야 하고 개인위생 지침을 마련해서 홍보해주기를 당부한다 가금류에 대해서도 수급 안정대책을 신속히 마련해야 한다 년 당 대책위원장을 할 때 점검에서 나타난 바 있지만 바이러스에 대해 신속하게 공유해야 한다 농림부에서 검출한 바이러스도 어제 천안에서 발견한 것만 질병관리본부에 주었지 다른 농가에서 발생한 바이러스는 공유하지 않고 있다 대학연구소 민간 연구소 정부 간에 신속하게 바이러스를 공유해야 한다 매번 바이러스에 대한 부처 이기주의 국가이기주의가 있기에 여기에 대한 대책 마련해 줄 것을 당부한다 양향자 최고위원 호남의 대표 정치이신 박지원 대표님의 자랑스러운 후배 정치인이고 싶은 양향자가 한 말씀 드린다 박지원 대표님의 왼손은 야권과 잡고 있지만 오른손은 박근혜 정권의 부역자들과 잡고 싶은 것은 아닌지 의심된다 새누리당에 탄핵을 찬성한 의원들은 고해성사의 당사자이지 연대의 대상이 아님을 분명히 해야 한다 양손 모두 야권과 잡으라는 것이 호남 민심임을 명심하길 바란다 제가 그 유명한 박지원입니다 항상 듣던 인사말이다 이제 그 유명세를 박근혜 퇴진과 정권교체에 써야한다 우상호 원내대표가 탄핵일정을 밝혔다 제 야당 원내대표로써 국민의 위임을 받아 헌법과 법률에 따라 역사적 소임 맡은 우상호의 원내대표의 압박감과 책임감을 모두 이해하고 힘을 실어드려야 한다 저를 포함한 지도부는 말을 아끼고 행동으로 보여줘야 한다 국민의 요구는 두 가지다 박근혜 대통령의 퇴진과 정권교체다 둘 중 하나라도 실패한다면 우리는 역사의 대죄인이 된다 국민들께서는 우리를 믿고 힘을 모아주고 계신다 이제는 우리의 몫이다 추미애 대표와 우상호 원내대표의 지도에 따라 역사적 역할을 차질 없이 완수해야 한다 상대에 대해 분노하되 경멸하지 말자 비판하되 조롱하지 말자 야당의 공조가 그 어느 때보다 중요하다 국민당과 정의당에 대해서도 우리당이 예의를 갖춰 힘을 하나로 모아야 한다 박지원 국민의당 대표님은 나이로나 경험으로나 경륜이 있는 분이다 이 싸움을 승리로 이끄는데 가장 중요한 역할을 해야 할 분이다 우리 당의 원내대표가 선봉장으로 용장이라면 박지원 원내대표는 지장이자 덕장의 역할을 해줘야 한다 주권자의 국민의 힘을 믿고 당 지도부의 지도력 믿고 흐트러짐 없이 역사적 소임을 해 내야 할 것이다 김병관 최고위원 박근혜 대통령의 퇴진을 원하는 국민이 중 명이라는 한 일간지 결과가 나왔다 청년들의 지지율은 라고 한다 새누리당 의원마저 박근혜 대통령의 퇴진과 탄핵을 말하는데 대통령을 배신할 수 없다면서 버티기에 들어간 분이 계신다 바로 이정현 새누리당 대표다 어제 이정현 대표가 박근혜 대통령을 버릴 수 없다면서 예수를 팔아먹는 유다가 되라는 것이냐 라는 말이 다시 국민들의 분노를 사고 있다 독실한 기독교 신자로 알려진 이정현 대표가 설마 이런 말을 했을까 제 귀를 의심했다 누가 예수이고 누가 유다인가 박근혜 대통령은 헌법을 유린하고 국정을 농단한 혐의를 받고 있는 피의자다 검찰에 따르면 대통령 권력을 이용해서 사익을 챙긴 범죄자들과 공동정범이다 이런 박근혜 대통령을 힘없고 가난한 사람들과 함께 하다 권력에 의해 박해 받은 예수님과 비교하는지 묻지 않을 수 없다 많은 기독교인들이 심한 모욕감을 느끼고 있다 이정도면 이정현 대표는 기독교인이 아니라 박근혜교 맹신도가 아닌가 이정현 대표 말대로라면 박근혜 대통령 퇴진을 원하는 전국민의 광화문에 모인 백만이 넘는 촛불시민이 예수님을 버리고 못 박으려는 유대인이란 말인가 이정현 대표는 국민과 기독교인들에게 사과해야 한다 지금 대한민국이 이 지경까지 오게 된 데 이정현 대표의 책임이 적지 않다 이정현 대표의 맹목적 충성심이 지금의 이런 사태를 불러왔다 정치인의 충성심은 오로지 국민을 위한 것이어야 하는데 이정현 대표의 충성심은 권력자에 대한 맹목적 신앙으로 크게 잘못 나간 것 같다 어제 더불어민주당 청년위원회가 여러 청년단체와 공동주최로 박근혜 대통령 헌정유린에 대한 청년 발언대 라는 토론회를 열었다 이 자리에서 대학생 취준생 직장인 젊은 배우 의사까지 마이크를 잡고 울분을 토하는 것을 보고 저는 한편으로 이런 청년들이 있어 다행이라 생각하고 또 한편으로는 지금 대한민국의 상황이 얼마나 엄중하면 청년들이 나서게 됐나 부끄러운 생각도 들었다 청년은 우리 미래라고 한다 이들이 간절히 원하고 있다 취업 못한 청년들에게 중동으로 오지로 가라는 대통령 대한민국 대통령의 자격이 없는 대통령은 하루빨리 국정에서 손을 떼고 퇴진하시기 바란다 이것이 박근혜 대통령과 이정현 대표가 국가를 위해 대한민국 청년을 위해 할 수 있는 마지막 일이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59147,2016-11-25, 금태섭 대변인 오전 현안 브리핑 일시 장소 국회 정론관 대통령은 이래도 대면조사를 거부할 것인가 최순실과 안종범이 특정범죄가중처벌법상 뇌물 혐의로 추가 입건됐다 검찰이 어제 와 롯데그룹 사무실을 압수수색하면서 압수수색영장 죄명란에 특가법 뇌물을 적시했다 두 그룹은 면세점 사업자 선정을 대가로 미르재단 및 스포츠재단에 거액을 출연했다는 의혹을 받고 있다 대통령은 최태원 회장과 신동빈 롯데 회장을 비공개 면담했다 면담 이후에 기획재정부는 면세점 승인 요건을 완화하는 정책 방안을 발표했고 관세청은 월 서울 시내 면세점 곳에 신규 설치를 발표했다 대통령은 최순실을 위해서 기업에 뇌물을 요구했다 그럼에도 불구하고 대통령은 기업이 선의로 도움을 주었다 라고 포장하고 있다 그러나 모든 정황은 기업이 대가를 바라고 재단에 거액을 기부했다고 말하고 있다 피의자인 대통령은 더 이상 검찰 수사를 거부할 명분이 없다 대통령이 저지른 불법은 덮고 싶어도 덮어지지 않고 피하고 싶어도 피할 수 없다 대통령이 검찰 수사를 거부하는 것은 법치주의를 부정하는 것이고 대통령이라면 당연히 지녀야 할 품격조차 저버리는 것이다 대통령 주치의 출국 검찰은 언제까지 닭 쫓던 개 신세 소리를 들어야 하나 현직 장관이 청와대가 최순실 성형외과에 대한 지원을 요청했다는 사실을 밝혔다 최순실 성형외과가 올해 예정에 없던 억 원의 예산을 따냈고 청와대가 산업부에 직접 이러한 요청을 했다는 것이 주형환 산업부장관의 증언이다 안종범 전 수석 김진수 보건복지비서관 정만기 차관으로 이어지는 최순실 청탁의 고리이다 여기에 대통령 주치의인 서창석 서울대 병원장이 또 등장한다 대통령 주치의가 최순실 성형외과의 봉합실 개발에 공동참여자로 이름을 올렸다 청와대가 산업부를 시켜서 최순실의 단골 성형외과를 지원하고 대통령 주치의가 공동연구자로 참여하고 대통령 주치의는 본인이 원장으로 있는 서울대 병원에서 최순실 성형외과의 제품을 구입하고 또 최순실 성형외과 원장을 서울대 외래교수로 위촉했다 언론이 문제 삼은 청와대 의약품 구매도 서창석 주치의 시절인 것으로 드러났다 이렇듯 비선의료 문제가 연일 문제가 되고 있지만 검찰수사는 또다시 느린 걸음이다 아수라장의 핵심인물인 서원장이 해외출국을 했다 차움병원 관계자들도 해외로 나갔다고 한다 검찰은 지금이라도 비선의료 관계자들을 출국금지하고 도피성 출국자들을 수사해야 한다 국민들은 특검이 시작된 후에 검찰의 변명을 듣고 싶어하는 게 아니다 천만 국민의 마음 속 촛불은 그 무엇으로도 꺼뜨릴 수 없다 대통령은 대선 시절 대통령 후보 차 토론회에서 역대 정권마다 반복되어 온 권력형 비리 정말 부끄러운 일 이라며 하루하루 성실하게 살아가시는 국민들이 살맛 안 나시게 하고 또 국가적으로도 얼마나 망신인가 라고 말했다 지금 대한민국은 바로 그 말을 했던 대통령 때문에 지금 살맛이 안 나고 망신스럽다 국민들은 대통령이 공약을 지키게 하기 위해서 매주 촛불을 들고 있다 내일 역시 광화문에서 촛불 집회가 열릴 것이다 촛불은 바람이 불면 꺼진다는 말이 무색하게도 많은 국민들이 점점 더 많이 촛불집회에 힘을 모으고 있다 대통령 한 명 때문에 수백만의 시민들이 매주 주말도 반납하고 광장에 모이고 있다 대통령의 비정상적인 판단과 행동으로 점점 더 많은 촛불이 광장에서 타오르고 있다 불통과 비상식으로 점철된 대통령에 맞서 민주적이고 평화롭게 국민들은 목소리를 낼 것이다 박근혜 대통령은 내일 국민들의 목소리를 똑바로 듣기 바란다 결국은 민주주의가 이길 것이다 천만 국민의 마음 속 촛불은 그 무엇으로도 꺼뜨릴 수 없다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59146,2016-11-25, 이재정 원내대변인 오전 현안 브리핑 일시 시 분 장소 국회 정론관 검찰수사 직전 최순실의 증거은폐 우병우가 핵심이다 지난 일 법원은 최순실과 안종범에 대한 검찰의 접견금지 신청을 받아들였다고 한다 이에 따라 최순실 씨와 안종범 전 수석은 다음달 일까지 변호인 또는 변호인이 되려는 사람을 제외하면 구치소에서의 접견은 물론 물건을 받는 것도 금지된다 하지만 이미 대부분의 증거는 파기되고 인멸되었음이 밝혀지고 있다 검찰의 때늦은 뒷북수사가 한심하다 최순실은 독일에서 체류 중이었던 지난 월 일 측근들에게 더블루 에서 가져온 컴퓨터 대를 모두 파기하라고 지시했다고 한다 월 일 검찰의 압수수색 바로 하루 전의 일이다 텅 빈 압수수색 상자를 들고 나오던 검찰의 모습이 이제 서야 이해가 된다 누가 최순실에게 압수수색을 알려줬겠는가 민정수석이었던 우병우의 도움 없이는 불가능할 것으로 추측 된다 엄동설한의 추위 속에 더불어민주당 의원들은 연일 서울 중앙지검 앞에서 우병우를 구속수사를 촉구하는 농성을 이어가고 있다 검찰이 외면한 우병우 구속수사가 결국 이번 사건의 증거파기와 인멸을 방조한 것이다 검찰은 당장 우병우를 구속수사하라 국정 역사교과서 집필기준은 공개대상이라는 판결에 교육부에게 묻는다 당신들에게 역사란 무엇인가 어제 서울행정법원은 국정 역사교과서 집필기준은 공개대상이라는 판결을 선고했다 교육부는 집필기준 비공개에 대해 업무의 공정한 수행이나 연구 개발에 현저한 지장을 초래한다고 인정할 만한 이유 라고 강변했지만 법원은 받아들이지 않았다 이번 판결은 국정역사교과서의 절차적 위법성을 다시금 확인해준 판결로서 사필귀정이며 당연한 결과이다 아무도 모르게 추진된 역사교과서 국정화는 박근혜 대통령과 함께 정당성도 추동력을 상실했다 전국 개 교육감들은 어제 일제히 국정교과서 반대를 공식화했다 이제 대한민국에서 국정교과서를 원하는 사람은 오직 박근혜 대통령 뿐이다 하지만 교육부는 국정교과서 추진의 뜻을 굽히지 않고 있다 국가 혼란과 국민 고통은 아랑곳 않고 대통령만 바라보고 있는 교육부에게 묻는다 당신들의 역사는 무엇인가 왜곡된 역사를 가르치려 하는 이 순간 당신들 역시 정권을 비호하는 부역자로서 그 심판을 피할 수 없음을 경고한다 당장 역사교과서 국정화를 중단하라 위안부합의 파기만이 해답이다 박근혜 정부가 맺은 위안부 합의는 다분히 의도적이고 일방적인 양보로 인한 굴욕적 담합이다 이 굴욕적 담합에도 최순실이 개입했다는 의혹마저 나오고 있는 상황이다 그만큼 이해할 수 없는 합의다 취소와 파기도 모자랄 지경이다 그런데 정부는 오히려 피해 할머니들에게 원치 않는 현금지급을 강요하고 있다 누구를 위한 정부인가 대체 누구를 위한 합의인가 박근혜 정권에서 자행된 항일역사 부정과 친일행적 지우기가 반민족적인 상처를 남기고 있다 정당성을 상실한 정부가 국민의 반대를 무릅쓰고 강행한 합의다 이제 파기만이 해답이다 한일군사정보보호협정 하루 만에 말바꾸는 일본정부 대한민국 정부는 무슨 협정을 맺었는지 알고는 있는가 한일군사정보보호협정 체결 하루만인 어제 일본정부가 한반도 유사시 한국 내 일본인 대피계획을 세우기 위해 한국 군 배치상황 공항 및 항만 등 민감한 정보를 요구할 것이라는 일본 언론의 보도가 있었다 협상재개 일 만에 졸속으로 협정을 맺었을 때 그 때 전 국민은 한일군사정보보호협정이 문제를 일으킬 것을 예견했다 오직 박근혜정부만 몰랐던 것이다 국가의 최소한의 의무인 자주국방과 안보마저무능 무책임 무기력으로 일관하는 박근혜정부에 한탄을 금할 수 없다 국민의 마음속에서 탄핵당한 대통령과해임결의안 통과를 앞둔 국방부장관이 조급하게 처리한 이번 협정체결은 제 의 위안부 합의이다 퍼주기 식 협정으로 인한 피해는 오롯이 대한민국과 우리 국민의 몫이다 정부는 국익 누수 굴욕적 협정의 원천 무효를 위한 모든 조치를 즉각 착수하라 전 세계의 놀림거리 된 푸른지붕 아래 푸른알약 왜 부끄러움은 국민몫이 되어야 하나 푸른 집 속의 푸른 알약 청와대의 특정약품 대량구입에 대한 외신보도 제목이다 맥이 빠진 한국 대통령이 해당 약품 구입사실을 인정했다는 영국 가디언지 기사는 가장 많이 본 국제면 기사 위로 등극했다 케냐를 방문하기 위해 구입했다는 청와대의 해명에 대해 케냐 언론이 오히려 의문을 제기하고 있다 입에 담기 부끄러운 사실이 밝혀지면 질수록 부끄러움의 몫은 죄 없는 국민들에게 전가되고 있다 청와대가 이럴 줄을 몰랐다는 국민의 한탄이 한국인임이 부끄러워 얼굴을 들 수 없다는 해외 교민의 심경토로가 갈수록 거세지고 있다 그런데 청와대는 자신들이 무엇을 잘못했냐며 당당하기 이를 데 없다 청와대가 변호인을 내세워 강조한 대통령의 사생활은 관심없다 국민은 관심없다 이번 사건은 공적 기관의 자원과 기능을 사유화하고 대통령의 공적 책임을 망각했다는 것이 핵심이다 연일 계속되는 촛불시위는 그저 축제가 아니다 대통령을 부끄러워하는 국민의 아우성이다 제발 착각말고 이제 그만 내려와라 경찰은 국민의 목소리를 우리의 광장을 지켜달라 경찰이 교통혼잡과 안전사고 우려로 청와대 앞 집회에 제동을 걸었다 또한 서울로 상경중인 울분에 찬 농민들의 트랙터 행렬에 대해선 교통소통을 이유로 서울 진입 자체를 막을 계획인 것으로 알려졌다 촛불집회로 인한 교통혼잡이 사실이 아니라는 연구결과가 나오고 있는 상황이다 경찰이 내세우는 교통소통과 혼잡 안전사고에 대한 우려는 더 이상 집회를 막을 이유가 될 수 없다 심각하게 훼손된 대한민국 민주주의를 바로세우기 위한 준엄한 촛불의 행렬을 막을 이유가 되지 않는다 지난 한달 간의 촛불집회에서 우리 국민은 안전하고 질서 있는 집회가 무엇인지 몸소 자랑스럽게 보여주었다 경찰이 해야 할 일 지켜야 할 것은 청와대가 아니라 국민이고 국민의 목소리다 어떤 바람에도 꺼지지 않을 수 백 만개의 촛불이 환히 타오를 우리의 광장을 지켜달라 +http://theminjoo.kr/briefingDetail.do?bd_seq=59145,2016-11-25, 박근혜 대통령 퇴진 국민주권운동본부 차 회의 모두발언 일시 금 장소 국회 당대표 회의실 추미애 대표 박근혜 대통령 퇴진 국민주권운동본부 제 차 회의가 열리고 있다 추위가 닥치는데 전국의 민심을 받들고 국민주권회복을 위해서 현장에서 맹활약을 해주실 의원님들께 당대표로서 진심으로 감사의 말씀부터 드린다 박근혜 대통령 퇴진 운동이 전 국민 참여 캠페인으로 확산되고 있다 촛불 민심은 대동하야지도를 그리고 있다 오늘부터 전국 대학에서는 동맹 휴업에 들어간다 시민단체들과 지역사회의 시국선언이 끊이지 않고 있다 아파트 베란다마다 박근혜 대통령 퇴진 현수막을 내걸고 경제가 어려운 가운데 자영업자들도 손해를 무릅쓰고 대통령이 퇴진하는 그날까지 음료 등을 무료로 제공하겠다고 하는 등 시민과 함께하는 참여 대열이 늘어나고 있다 진정한 국민주권시대를 열어야 한다 박근혜 대통령 퇴진 운동에 피가 끓어오르고 있는 우리 당원들의 모습에 당대표로서 진심으로 존경과 감사의 말씀을 드리며 깊은 책임감을 가지고 이끌어가도록 하겠다 참여해주시는 의원님들께서는 건강에 유의하시면서 우리 시민들 잘 독려해주시기를 부탁드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59142,2016-11-24, 박지원 대표님 적당히 하십시오 박지원 국민의당 대표가 우리당 추미애 대표에 대해 똥볼 을 찰 것이라는 예측이 적중했다 고 하셨다 도대체 무엇을 말하고자 하시는지 알 수 없다 새누리당이 박근혜 대통령과 비선실세들의 국정농단 부역자 집단임은 국민 모두가 아는 주지의 사실이다 탄핵을 위해 양식있는 새누리당 의원들의 참여가 필요한 것은 분명하지만 그것이 이들의 과거를 덮어주는 묻지마 방식이어서는 곤란하다 새누리당 비주류 의원들은 국민의 뜻을 받드는 정치세력으로서 국민과 함께 할 것인지 국민의 퇴출 명령을 받은 대통령 곁에 남을 것인지 선택하는 것이 마땅하다 원내 당으로 그리고 이재명 성남시장에게도 지지도가 추월당한 대권후보만을 보유한 당의 어려움과 초조함을 모르지 않지만 그래도 명색이 정치 단이신 박대표가 국가적 혼란사태 속에서 야권의 우군인 민주당대표와 유력 대권후보를 향해서 날선 비난을 계속하는 모습은 김대중대통령의 정치적 계승자라고 자처하는 당신의 스타일과 뭔가 어울리지 않는다 아침에는 야권 공조를 강조하고 저녁엔 추대표와 문재인 전대표를 힐난한다 아침저녁으로 입장 바꾸셔야 하니 참 바쁘셔 보인다 박대표가 문재인 대통령 다 된 것처럼 행동한다 고 가르치시니 정진석 새누리당 원내대표가 따라 하기도 한다 그런 아리송한 행보 때문에 호남에서 국민의당과 안철수 전 대표의 지지도 떨어지고 있지 않는가 자꾸 그러면 더 떨어진다 이제 적당히 하시라고 말씀 드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59138,2016-11-24, 추미애 대표 박근혜 대통령 헌정유린에 대한 청년발언대 축사 일시 목 오후 시 장소 국회 의원회관 제 세미나실 추미애 대표 대한민국 청년 여러분 오늘 같은 시국 상황이 어른으로서 대단히 부끄럽다 나라가 어려울 때일수록 특히 우리 청년들이 나라를 구하기 위해 일어섰던 역사가 있다 조국을 일제에 빼앗겼을 때 운동의 주체는 청년이었다 이 땅의 민주주의가 부정선거로 얼룩지고 민주주의를 되찾기 위한 의거가 일어났을 때도 청년이 앞장섰다 유신 세력이 끝까지 민중을 폭압으로 다룰 때에도 부마항쟁의 주인공은 청년이었다 그리고 광주 에서도 시민혁명을 이끌었던 주인공은 젊은 청년들이었다 드디어 오늘 삼성과 주고받은 것을 단순히 직권남용과 강요가 아니라 뇌물로 판단한 것 같다 이제 드디어 수사가 본격 궤도에 진입한 것 같다 부정부패와 정경유착으로 얼룩진 대한민국에서 여러분이 아무리 실력으로 승부하고자 노력해도 안 되는 사회 구조의 본연에는 그 깊은 뿌리와 원인은 역시 정경유착이었다 커피숍 알바를 하면서 때로는 학교를 휴학하고 전전긍긍 주거비와 학비를 대면서 열심히 산 여러분이 대학 졸업장을 쥐어도 일자리가 없었던 것과 최저임금을 조금이라도 올리려고 안간힘을 썼지만 메아리가 없었던 것 모두가 우리 사회의 구조 때문이었다 그 배후는 검은 뒷거래와 정경유착이었다 이제 청년들은 요구한다 단순히 박근혜 퇴진이 아니라 우리 사회의 부정부패를 일소해서 일한만큼 대접받고 노력한 만큼 공정한 대가가 주어지는 보람된 사회를 만들자고 요구한다 꿈을 이룰 수 있고 보람을 내 것으로 성취할 수 있는 대한민국을 만드는 출발이 바로 이제부터라는 것이다 정치인들은 유불리를 계산하는 셈법에서 벗어나야 한다 벌써부터 마음이 콩밭에 가있는 정치인과 정치세력도 있다 벌써 우리 세력에게 유리한 개헌 논의를 해야 하겠다고 꿈꾸고 있는 정치세력도 있다 다 물리쳐야 한다 우리 사회를 근본부터 기초부터 주춧돌을 다시 놓는 새로운 틀을 다지는 기회가 되어야 한다 주인공은 바로 여러분이다 여러분이 원하는 나라를 제대로 설계해야 하기 때문에 이번만큼은 누구의 정치 셈법도 통하지 않도록 여러분이 설계자가 돼야한다 저는 오는 길에 잠깐 생각을 해봤다 하늘을 한번 봤다 흘러온 현대사를 생각해봤다 연해주에서 만주벌판에서 말발굽 달리면서 조국의 미래를 꿈꿨던 독립운동가들은 결코 이런 부정부패와 꿈을 꾸지 못하는 나라를 만들려고 독립운동을 하지 않았다 우리가 단순히 순국선열에 대한 묵념을 형식적으로 하는 것이 아니라면 조국 해방과 독립을 위해서 목숨조차 기꺼이 바쳤던 선조들의 삶을 우리가 조금이라도 생각한다면 이번만큼은 우리에게 주어진 새로운 대한민국을 위한 절호의 기회라는 것이다 그것은 여러분의 몫이다 여러분이 어떤 대한민국을 설계하고 만들 수 있을 것인가는 여러분의 의지에 달려있다 촛불은 간절함이고 소망이고 꿈이다 촛불은 어떤 폭력도 거부한다 그 간절한 소망이 전국에 닿아서 우리 국민 모두가 꿈을 꿀 수 있는 새로운 대한민국을 만드는 소중한 기회다 결코 어떤 정치세력에 의해서 힘없이 꺼지지 않도록 여러분이 가열차게 들어주시고 호소해주시기 바란다 대한민국을 위한 새로운 설계를 잘 부탁드리겠다 축하드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59136,2016-11-24, 금태섭 대변인 오후 현안 브리핑 일시 장소 국회 정론관 이정현 대표는 홍정길 원로 목사의 하야 호소문을 읽고 깊이 묵상하길 바란다 오늘 한 여론조사에서 박근혜 대통령이 임기를 끝까지 마쳐야 한다 고 생각하는 사람은 우리 국민의 로 나타났다 반면 하야나 탄핵에 찬성하는 비율은 를 훌쩍 넘었다 박 대통령이 자리에서 내려와야 한다는 데 대해선 우리 사회의 진보와 보수 그리고 중도까지 한 마음 한 뜻인 것이다 하지만 오늘 새누리당 이정현 대표는 예수를 팔아먹는 유다가 되라는 것이냐 베드로가 되라는 것이냐 면서 민심을 거역하고 대통령을 옹위했다 우리 당 추미애 대표를 향해선 보수세력을 집권여당을 어떻게 보고 감히 이렇게 이야기를 하느냐 고 목소리를 높였다 남경필 경기도지사가 이정현 대표를 향해 박근혜교 사이비신도 같다 고 말한 바 있지만 우리는 이 대표가 사이비가 아니라 박근혜교의 충실한 신도라고 생각한다 박근혜 대통령을 예수처럼 여기는 것은 이정현 대표의 종교적 자유다 하지만 종교적 자유에 충실한 이 대표가 집권여당을 보수 세력을 대변할 정치적 자격은 갖추지 못하고 있다고 생각한다 최근 여러 사람들에게 깊은 울림을 남긴 홍정길 원로 목사의 하야 호소문을 이 대표도 읽고 깊이 묵상하길 권고하고 싶다 여 년간 북한동포를 도우면서도 북한 체제를 비판해 온 홍 목사는 북측 인사에게 민주화가 뭐냐 는 질문을 받고 국가 최고 책임자라 할지라도 잘못했으면 감옥 가는 것입니다 라고 대답했던 일화를 전하며 이 나라를 농단하고 당신을 이용하여 사리사욕을 채운 모든 사악한 세력들과 함께 무너지십시오 이것이 대통령께서 짧은 시간에 실수를 회복하실 수 있는 최선의 길이라고 믿습니다 라고 호소했다 오늘 우리가 박 대통령의 탄핵을 요구하는 이유는 바로 홍 목사의 글 속에 담겨 있다 박 대통령의 퇴진이야 말로 피땀으로 일궈낸 민주화를 지키는 길이기 때문이다 이 민주화를 위한 도정 앞에는 진보와 중도 보수도 따로 없다 여야도 다르지 않다 본인변명에 급급한 왕실장 더 이상 국민을 우롱하지마라 김기춘 전 청와대 비서실장은 국정농단의 또 다른 주인공이다 최순실 국정개입 사건에 김 전 실장이 연루됐다는 진술과 정황이 잇따르고 있다 김 전 실장은 최 씨를 알지 못한다며 관련 의혹을 모두 부인하고 있다 김 전 실장은 이 와중에 또 거짓말을 하는 것으로 보인다 김종 전 문체부 차관은 김 전 실장을 통해 최순실 씨를 알게 됐다 고 증언했다 전 육영재단 관계자는 지난 년 육영재단 분규 당시 김 전 실장이 최태민을 만나기 위해 여러 차례 재단을 방문했다 고 밝히기도 했다 김 전 실장은 평검사 시절인 년엔 유신헌법 제정에 관여한 것으로 알려져 있다 이후 중앙정보부 대공수사국 국장을 지내며 지금의 검찰의 권력시녀화 문화를 만들어 냈다 년 대선 직전엔 복요리를 먹으며 우리가 남이가 라며 관권선거를 논의했다 여 년간 대한민국의 민주주의를 가로막고 대한민국의 갈등을 조장한 인물이다 김 전 실장의 악행은 최근까지 이어지고 있다 인사와 보도 이사회 등에 개입했고 정윤회 문건 특종을 한 세계일보와 기자에 대한 압박과 사찰을 하였으며 법원이 지나치게 강대하니 견제수단이 생길 때마다 길을 들이라 고 지시하였다 김 전 실장은 박근혜 게이트의 또 다른 조연이다 검찰은 김 전 실장을 즉각 수사하여 그의 년에 걸친 악행을 끝내야 한다 박근혜 대통령은 국정교과서를 논할 자격조차 없다 교육부가 국정 역사교과서의 현장검토본 공개를 강행하기로 했다 일 공개하는 국정교과서는 박정희 정권의 경제발전에 대한 긍정적인 서술이 늘고 유신 독재에 대한 민주주의 파괴 부분은 축소될 것이라는 전망이 지배적이다 우리 아이들을 국정교과서를 통해 보수화 시키겠다는 의도이다 우리 아이들은 이미 현장에서 민주주의를 배우고 있다 자발적으로 집회에 참여하여 목소리를 내고 있는 우리 아이들을 정부의 일방적인 주입식 보수화 교육으로 길들일 수 없다 박근혜 대통령은 한국사 교과서 국정화 추진으로 국론분열을 꾀하고 분열을 통해 어려움을 타개하겠다는 계획이 아니라면 지금 당장 국정교과서 공개를 중단해야 한다 가까운 미래에 박근혜 게이트가 역사 교과서에 어떻게 기록될지 국민들은 이미 알고 있다 정부는 더 이상 국정교과서 논란으로 국론이 분열되지 않도록 국정화를 중단해야 한다 자리에서 물러나야 할 대통령은 국정교과서 추진은 고사하고 논할 자격조차 없다 청와대 의무실장의 해명 번짓수가 틀렸다 이선우 청와대 의무실장이 오늘 청와대가 구입한 의약품에 대해 해명을 하였다 의무실은 청와대 모든 직원을 대상으로 하고 있으며 의약품 구입도 직원에게 필요한 의료 지원 차원에서 이뤄졌다는 것이다 특정 의약품 구입에 대한 국민의 비난과 조롱을 고산병 핑계로 해명하려는 것은 문제의 본질을 하나도 파악하지 못한 것이다 국민들은 청와대 의무실이 직원들을 상대로 진료하고 약을 처방하는 것을 비난하는 것이 아니다 태반주사 백옥주사 감초주사 마늘주사 같은 주사제를 왜 대량으로 구매했냐고 질문하는 것이다 질병치료가 아닌 피부비용이나 건강증진을 위한 주사를 왜 세금으로 구입했는지 누가 이 주사들을 맞았는지 질문하는 것이다 더구나 대통령이 태반주사를 먼저 요구했다는 초대 주치의의 증언은 국민들의 의심과 분노를 더욱 크게 만들고 있다 비선의료 에 문제를 제기하는 것이다 언론과 국민들의 의심이 근거없는 것이라면 주사제 구입에 대해 정확히 해명을 하면 될 것이다 감출 것은 다 감춘 채 의학지식으로 진실을 호도하지 마라 +http://theminjoo.kr/briefingDetail.do?bd_seq=59135,2016-11-24, 이정현 대표 어디까지 망가질 것인가 이정현 대표가 점점 망가지고 있다 말도 안되는 소리를 쏟아내며 자신의 바닥을 드러내고 있다 우리당 추미애 대표가 탄핵표 구걸하지 않겠다고 한 발언은 이대표가 착각하듯이 새누리당이 우리의 하수인이 되어 달라는 요구가 아니다 물론 박근혜의 하수인은 더더욱 아닌 국민의 하수인이 되라는 말이다 어이없는 것은 박대통령을 감히 예수님에게 비유하는 것이다 대단히 불쾌하다 어디 감히 박대통령을 예수님에게 비유하고 은연중에 자기 자신을 열두제자 중 한명으로 비유하는가 오히려 박대통령은 이스라엘 백성을 탄압하고 착취한 본디오 빌라도에 가깝다 성경의 어떤 구절을 봤길래 이대표가 그런 비유를 하는지 놀라울 따름이다 이대표는 전남 순천곡성 주민들의 머슴이 되겠다고 하고 국회의원이 되었지만 대통령을 탄핵하라는 지역구 주민의 뜻을 외면한 채 지역민들의 머슴이 아닌 박대통령의 머슴 노릇만 하고 있는 것 아닌가 이대표가 스스로 부역자는 국가 반역을 도모하거나 동조한 사람 이라고 했는데 일면 맞는 말이다 그런데 나라의 헌법을 무시하며 최순실과 공모하여 국정농단 및 부정부패를 저지르고 국가 외교 안보상 주요 기밀을 최순실에게 누설하고 국민의 의사와 배치되는 한일군사정보 보호협정을 밀실에서 체결하고 검찰 수사에 불복하며 사법체계를 무력화 시키려는 그러한 박대통령에게 동조하는 이대표를 비롯한 새누리당 소위 친박의 무리들이 부역자 집단이 아니면 무엇인가 새누리당 이대표 본인이 바로 부역자들의 우두머리인 것이다 이대표는 더 이상 부역자 우두머리 노릇 그만하고 전남 순천곡성 주민의 머슴이 되겠다는 약속을 위반한 책임을 지고 정계를 떠나라 +http://theminjoo.kr/briefingDetail.do?bd_seq=59133,2016-11-24, 이재정 원내대변인 오후 현안 서면 브리핑 탄핵 여론 박근혜 대통령은 민심에 따르라 오늘 발표된 여론조사에 따르면 국민 명 중 명은 박근혜 대통령 탄핵에 찬성하는 것으로 나타났다 이미 국민은 박근혜 대통령을 탄핵했다 탄핵 여론은 지역과 연령을 가리지 않고 들불처럼 번진 상황이다 그러나 박근혜 대통령은 청와대를 농성장 삼아 검찰수사마저 거부하고 있다 자기만 살겠다며 국민을 내팽개치고 민생을 외면하는 대통령은 그 자격이 없다 박근혜 대통령은 민심에 따라야 한다 더불어민주당 등 야 당은 엄중한 각오로 탄핵안을 준비할 것이다 박근혜 정권을 향한 국민의 실망과 분노를 온전히 담아내겠다 인체감염 막기 위한 과감하고 선제적 조치가 있어야 한다 고병원성 조류인플루엔자가 전남 충북을 시작으로 수도권 확산이 우려되고 있다 특히 고병원성 는 우리나라에서 첫 발생이고 인체감염 우려도 큰 상황이다 따라서 보건당국은 정확한 정보를 신속히 국민에게 제공하여 불안감을 불식시켜야 할 것이다 초기 미온적 대처로 조류인플루엔자가 전국으로 확산된 아픈 경험을 갖고 있다 중앙정부와 보건기관은 물론 지자체와의 긴밀한 협조는 필수이다 보건당국은 과감하고 선제적인 조치를 통해 전국적 확산을 막는 총력전에 나설 것을 당부한다 철도공사의 징계위원회 연기 사태 해결의 시발점이 되기를 바란다 철도파업 노동자에 대한 철도공사의 징계 연기 결정을 환영한다 국토부와 철도공사의 성과연봉제 강행으로 비롯된 장기 파업이 지속되는 가운데 내려진 이번 결정이 사태 해결의 첫걸음이 되길 바란다 조직과 개인의 가치 및 인권을 존중함으로써 신뢰를 확보한다 고용 및 업무에 차별을 없애고 동료와 화합하는 조직문화에 앞장선다 철도공사 홈페이지에 올라와 있는 윤리헌장이다 금과옥조와 같은 윤리헌장이 있어도 지키지 않으면 소용없다 철도 노동자는 철도공사의 톱니바퀴도 아니고 종이에 적힌 숫자도 아니다 철도현장 최전선에서 철도서비스와 안전을 책임지는 주역이다 국토부와 철도공사는 성과연봉제 강행을 즉각 중단하고 노동자의 시선에서 협상을 시작하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59130,2016-11-24, 금태섭 대변인 오전 현안 브리핑 일시 시 분 장소 국회 정론관 문형표 전 장관에 대한 철저한 수사가 필요하다 문형표 전 보건복지부 장관이 오늘 검찰의 소환조사를 받고 있다 어제 국민연금공단에 대한 압수수색에 이은 조치이다 의결권 자문기구의 반대권고가 있었지만 국민연금기금운용본부는 삼성물산의 합병 찬성을 결정했다 합병으로 인하여 발생한 국민연금 손해액은 억원에 달한다 문형표 국민연금 이사장은 합병찬성 당시 국민연금의 상급기관인 보건복지부의 장관이었다 청와대와 국민연금 사이의 연결고리인 것이다 년 한국개발연구원 선임연구위원을 장관으로 임명하는 것에 대해서도 박근혜 정부의 기초연금 공약을 수행하기 위한 것이라는 지적이 많았다 년 월 메르스사태에 대한 책임을 지고 물러났지만 불과 개월만에 국민연금공단 이사장으로 복귀했다 장관이 사임 직후 소속기관장으로 가게 된 인사도 이례적이라는 말도 있었지만 박근혜 대통령의 복지분야 지시사항의 수행자였으므로 너무도 당연한 일이었다 하지만 문형표 전 장관은 의결권행사전문위원들에게 전화를 걸었다는 의혹에 대해 아는 분에게 전문가로서의 의견을 물어본 것 뿐 이고 어떤 의도를 갖고 전화를 드린 것은 하나도 없다 는 변명으로 책임을 면하려고 하고 있다 문형표 전 장관은 국민연금기금운용위원회의 위원장이었고 의결권행사전문위원회는 직속 산하 위원회이다 국민의 미래를 위해 연금개혁을 하겠다던 박근혜 정부가 왜 이재용의 경영권 승계를 위해 연금의 손실을 감수했는지 국민들은 묻고 있다 검찰은 문형표 전 장관이 청와대와 삼성과의 거래에 관해 어떠한 역할을 했는지 철저히 밝혀야 한다 박근혜게이트가 국민의 미래까지 훔친 것인지 검찰은 명명백백히 밝혀야 한다 앞으로 일주일이 검찰에게 주어진 골든타임이다 검찰이 피의자 박근혜 대통령에게 일까지 대면조사를 요청했다 하지만 박근혜 대통령은 검찰 수사가 공정하지 않다고 하며 이미 조사 거부를 한 바 있다 피의자로 입건된 상황에서 검찰 수사를 상상과 추측을 거듭해서 지은 사상누각 부당한 정치공세 인격살인 이라는 말들로 비난했다 중립적 특검에 대비하겠다는 유영하 변호사의 입장은 특검수사도 얼마든 거부할 수 있을 것 같은 태도이다 앞으로 일주일이면 검찰의 역할이 끝날 지도 모른다 특검이 시작되면 그동안의 검찰조사가 얼마나 충실했는지 낱낱이 드러날 것이다 박근혜 게이트의 철저한 수사는 검찰도 살고 나라도 사는 길이다 국민들이 납득할 만한 수사결과로 마무리하지 못한다면 특검과 국정조사를 통해 검찰의 책임런이 제기될 것이다 어제 국회 국정조사위원회가 증인으로 채택한 정유라 최순득에 대한 소환 조사와 박근혜 대통령에 대한 대면 조사는 특검 이전에 반드시 이루어져야 한다 대통령은 품위 있게 물러날 기회를 잃었다 국민과 야당은 그동안 대통령에게 품위 있게 물러날 기회를 여러 차례나 주었다 그럼에도 불통의 아이콘인 대통령은 검찰 수사도 거부하며 버티기에 들어갔다 국민들은 박근혜 대통령이 더 이상 대통령이 아니라고 하고 있다 대통령의 권한을 회수할 수 있는 탄핵만 남은 상황이다 오늘 보도된 탄핵에 대한 국민여론은 찬성이 에 달한다 이에 더불어민주당은 박근혜 대통령 퇴진 국민주권운동본부 산하에 탄핵추진실무준비단을 설치하고 어제부터 본격적인 활동에 들어갔다 우리 당은 다음 주 초까지 대통령 탄핵소추안의 초안을 마련하기로 했다 법률전문가들과 국민들의 의견을 담아 탄핵소추안을 완성하고 빠른 시일 내에 제출할 계획이다 정부와 새누리당이 국민적 요구에는 귀를 막고 있는 동안 우리 당은 국민들과 소통하기 위한 노력을 끊임없이 해왔다 앞으로도 우리 더불어민주당은 오직 국민들만 보고 국민들과 함께 할 것이다 청와대의 언론통제 진상규명을 위한 활동을 지지한다 지난 일 전국언론노동조합 등 개 언론단체는 박근혜 대통령 김기춘 전 비서실장 김성우 전 홍보수석 최성준 방통위원장을 직권 남용 혐의로 검찰에 고발했다 년 세계일보의 정윤회 문건 보도 이후 청와대의 부당한 사장교체 압력과 김영한 비망록 을 통해 드러난 인사와 보도개입에 대한 의혹을 밝히고 책임자를 처벌해 달라는 것이다 이미 세월호 보도통제와 관련하여 길환영 전 사장 이정현 당시 청와대 홍보수석에 대한 고발 파업에 국정원 개입의혹에 대한 원세훈 전 국정원장에 대한 고소가 있었다 더불어민주당은 그동안 여러 차례 청와대의 언론통제에 대해 문제제기를 해왔다 진실을 밝히고자 하는 우리당과 언론인 진실을 숨기고 언론을 통제하려는 청와대이다 검찰은 둘 중에 어느 편에 설 것인지 입장을 분명히 해야 한다 더불어민주당은 청와대의 언론통재 진상규명을 위한 언론단체의 활동을 지지한다 검찰의 조속하고 철저한 수사를 촉구한다 이정현 대표는 차라리 청와대 대변인으로 나서라 자기 당 내에서 사퇴압력을 받고 있는 새누리당 이정현 대표가 더 이상 새누리당을 대표하는 것을 포기한 것처럼 보인다 오늘 이정현 대표는 최고위 발언을 통해 우리당 추미애 대표를 비난하며 탄핵에 대한 입장을 밝혔다 탄핵에 찬성하면 더불어민주당의 하수인 이 되는 것이고 배신자 변절자 가 돼달라고 요구하는 것이라며 유영하 변호사 다음의 제 의 변호사 역할을 맡았다 이정현 대표는 청와대 방패 역할을 하면서 특검 취소요구까지 나아갔다 탄핵을 추진하려면 특검을 취소하라는 것이다 이정현 대표는 얼마 남지 않은 기간 동안 여당의 대표역할을 할 것인지 아니면 청와대 대변인이자 박근혜 대통령 변호인 역할을 하려는 것인지 입장을 분명히 하라 특검을 취소하고 싶으면 특검법 폐지 법안을 당당히 발의하고 탄핵을 막고 싶으면 탄핵반대 당론을 분명히 하라 국민의 가 찬성하는 탄핵을 박 대통령의 편에 서서 거부한다면 새누리당과 그 당대표를 역사는 영원히 기억할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59128,2016-11-24, 제 차 정책조정회의 모두발언 일시 목 장소 국회 원내대표 회의실 우상호 원내대표 제가 원내대표 당선이 되고 원내대표실에 있는 배경 현수막을 한 번도 안 바꿨는데 오늘 바꿨다 만 촛불민심을 반영해서 구호로 바꿨다 광장에 나온 우리 국민들이 바라는 것은 단순히 박근혜 대통령 한명 물러가라는 구호가 아니다 바로 특권과 반칙으로 일관된 대한민국 정의롭지 못한 대한민국을 바꾸자 세상을 바꾸자는 외침이라고 더불어민주당은 해석했다 그래서 세상을 바꾸자 는 국민들의 외침을 자막 배경 현수막으로 걸었다 이번 정기국회에서 우리당의 과제는 최순실 게이트에서 드러났지만 재벌 개혁 서민경제 민주회복이라는 세 가지의 구체적인 목표를 더불어민주당이 안아서 실천해 보겠다는 의지를 담아서 배경 현수막을 바꿨다 저 마음으로 국민과 하께 하겠다 반면에 만 촛불 민심을 거역하는 한 장의 사진을 소개하려고 한다 국민일보 면에 나왔다 제가 대변인을 오래 했고 정치면을 오래봤다 하지만 사진기자들이 카메라를 내려놓은 사진은 처음 봤다 밀실에서 진행되고 있는 한일군사정보보호협정에 대해 항의하는 상징적인 사진이라고 보여서 여러분에게 보여드린다 사진 공동 취재단이 오죽했으면 이런 항의의 모습을 보였겠나 이것이 바로 수천만 국민이 분노하고 있는데도 일방적으로 밀어붙이고 있는 협정에 대한 또 국정운영 방식에 대한 언론인들의 항의의 상징적인 모습이다 감동받았다 그동안 탄핵 정국을 둘러싸고 많은 국민들이 답답해하셨다 언제 어느 때쯤 어떤 방식으로 진행되는 것인가에 대한 국민들의 관심이 고조되고 있어서 오늘 제가 전체적인 탄핵 일정에 대해서 밝히겠다 박근혜 대통령 탄핵일정은 정기국회 내에 하겠다 빠르면 월 일 늦어도 월 일 국회 본회의장에서 탄핵안이 표결되도록 하겠다 모든 불확실성 줄이고 앞으로 앞으로의 정치 일정이 국민들께 예측 가능하게 만들겠다 탄핵에 집중하기 위해서 여러 혼란스럽던 사안들 정리하겠다 첫 번째 국회추천 총리문제는 더 이상 검토 하지 않겠다 탄핵에 집중하겠다 경제부총리 문제는 현재 혼선이 있는데 야 당과 상의해 보겠다 어떤 방식으로 경제부총리 문제를 정리하는 것이 바람직한지 현재 유일호 부총리 체제로 가는 것이 탄핵 정국에서 맞는지 비록 박근혜 대통령이 김병준씨가 상의했다고는 하는데 임종룡씨로 가는 것이 나은지에 대해서는 야 당 간의 협의를 시작하겠다 불확실성을 줄이고 앞으로 모든 사안들이 예측가능하게 해서 국민들이 불안하지 않도록 하나씩 하나씩 만들어나가도록 하겠다 지금 검찰청에서 우병우의 구속수사를 위해서 농성이 진행되고 있다 박근혜 최순실 게이트 국정조사 또 탄핵에 집중하기 위해서 이번 주에 내에 검찰청 농성을 해제해 달라고 요청 드린다 그동안 많은 의원들이 고생하셨는데 이제는 국회 내로 들어와서 국회 내의 일정에 집중할 때라고 부탁드린다 이번 국정조사에서 상대적으로 국민의 관심이 덜 하지만 어제 언론노조 관계자를 면담했다 많은 국민들은 결국 재벌 언론 검찰 청와대가 바뀌어야 한다고 이야기하고 있다 이곳들이 최순실 게이트을 묻었거나 비호한 세력이라고 이야기한다 이번 국정조사에 언론 특히 공영방송이 대통령과 청와대에 장악되어 제대로 된 진실을 파헤치지 못하고 최순실 게이트를 결과적으로 은폐하는데 협조했다는 측면에 대해서 분명히 밝혀야 한다 이 부분을 주요 과제로 다루도록 요청 드리겠다 국정공백을 최소화하고 국민들이 향후 일정을 예측할 수 있도록 만들고 더불어민주당이 이 문제에 대한 무거운 책임감으로 한 가지 한 가지씩 정리해나가겠다는 말씀을 드린다 한편으로 지금 다루고 있는 예산과 법안에 있어서 한 치의 소홀함도 없이 국민들의 민생을 챙기는 일에도 전력을 다하겠는 말씀을 드린다 윤호중 정책위의장 요즘 우리 국민들이 정말 분노하지 않는 순간이 없다 이른바 부유층과 특권층들의 피부 관리 각종 의약품 주사제 등이 보도되는 것을 보면서 이것이 과연 우리 사회 지도층의 모습인가 하는데 자괴감을 느끼고 있다 박근혜 대통령은 그동안 국정은 최순실에게 맡기고 매일 거울보고 거울아 거울아 내가 몇 살로 보이니 이런 물음을 묻는 것으로 하루하루를 보냈다는 것을 알게 되었다 그동안 왜 복지부 공무원들이 안티에이징 산업 육성을 그렇게 합창하듯 노래를 불렀는지 또 차 의료원이 왜 미용 의료 사업에 목을 매달았는지 이 모든 것들이 하나 하나 다 드러났다 대통령께서 또는 청와대에서 금 의약품을 어디에 썼는지는 굳이 묻고 싶지 않다 오죽하면 대통령의 장관과 수석들이 고개를 들지 못하고 있겠는가 국민들은 지금 정말 낯부끄러운 대통령에 대해서 탄핵도 사치다 당장 하야하라 이렇게 이야기하고 있다는 것을 대통령께서 다시 한 번 곰곰이 생각해보셔야 한다 이제 국회의 탄핵 절차 그리고 헌법재판소의 탄핵 심판을 그야말로 겸허한 자세로 기다려야 할 것이다 만약 그것이 두렵다면 지금이라도 당장 그 자리에서 물러나시는 것이 도리라고 생각한다 원내대표께서 탄핵절차 일정을 말씀하셨다 그러나 우리가 해야 할 일이 있다 오늘은 예결위원회 예산 처리 시한의 이다 이제 일밖에 남지 않았다 남아있는 일 동안 우리 당은 내년 예산이 차질 없이 편성 심의 확정되도록 모든 노력을 기울이겠다 먼저 지난 년간 보육현장의 대란을 몰고 온 누리과정 예산 해결 문제를 깔끔하게 해결하도록 노력하겠다 앞으로 수년간은 재론의 여지가 없도록 해결책을 간구하겠다는 말씀을 드린다 두 번째로 예산안이 편성되어 국회에 제출된 이후에 발생한 신규 재정 수요를 충족시키는 예산을 편성하겠다 특히 쌀값하락이 심각하다 산지 쌀값이 만 원대로 추락하면서 변동 직불금 수요가 증가했다 그리고 최근의 잇따른 지진대책 주요 시설에 대한 내진보강 등 지진대책 예산도 확보하겠다 아울러 내년부터 경제활동인구가 줄어드는 등 저출산 문제가 심각하다 청년일자리 창출을 위한 예산도 최대한 확보하기위해 노력하겠다 더불어 노인 장애인 복지예산 등을 통해서 어려움 속에 있는 국민들을 위로하는 예산도 최대한 노력하겠다 가능하다면 지난 보수정권 년이 나은 실정을 치유하는 예산도 만들어보도록 하겠다 개성공단 피해기업에 대한 지원예산 녹차라떼 를 만든 대강 수중보 해체 예산도 가능하면 확보하도록 노력하겠다 이와 같은 예산의 재원을 마련하기 위해서 우리당이 그동안 주장해온 법인세와 소득세의 최고세율 구간 신설을 통한 재원 마련에도 마지막 한순간까지 최선을 다하겠다는 말씀을 드린다 한 가지만 더 말씀드린다 검찰이 롯데그룹과 최경환 전 경제부총리 사이에 있었던 시내면세점 특허면허와 관련된 커넥션 관련 수사에 착수했다는 소식이 있다 롯데그룹은 시내면세점 사업을 따내기 위해서 미르재단에 억을 작년 월에 기부했고 또 올 초에도 억을 더 기부했다가 돌려받은바 있다 이 과정에 최경환 전 부총리가 관련이 되었다면 이것은 관세청의 시내면세점 입찰과 관련된 비리와 뇌물이 오고갔다는 것을 의미한다 지난 월에 추가로 시내 면세점 두 곳에 대한 입찰 절차를 공고하고 현재 그 입찰이 진행 중에 있다 관세청에 요구한다 롯데그룹과 최경환 전 부총리 사이에 불미스러운 의혹에 대한 검찰 수사가 끝날 때까지 시내면세점 입찰 절차를 중지할 것을 촉구한다 박정 부대표 전기요금체계 개편방안에 대해서 말씀드리겠다 오늘 오전 시 산업통상자원위원회에서 전기요금누진제개편안 업무보고가 예정되어 있다 단계 배에서 단계 배 또는 배로 발표할 것 같은데 이는 우리당이 그동안 제시한 단계 배 안과 비슷한 것이다 전기요금 체제에 대해서는 년부터 개편에 대한 요구가 있었고 정부 역시 개편의 필요성에 동의해왔었다 그러나 결과적으로 국민의 분노가 극에 달하는 상황에서야 개편에 나섰다 정부의 진심 어린 반성이 필요하다 여기에 올해 국감에서 전기요금 총괄 원가를 공개한다고 했으나 여전히 공개하지 않는 등 투명성은 여전히 부족하다 날씨가 추워지고 있다 가장 먼저 우리 아이들이 생각난다 따뜻하고 쾌적한 환경에서 공부할 수 있도록 만들어주는 것이 우리의 의무라고 생각한다 년 기준 전국 초중등학교 학교운영비는 전년 대비 억 원이 감소한 반면 전기요금은 억 원이 증가하는 등 교육기관의 전기요금 부담이 커지고 있다 이런 상황에서 정부의 교육용 전기 인하방안은 환영한다 다만 태양광 설치 학교에 대한 연간 만 원 수준의 임대료 지원방원에 추가로 학교에서 생산되는 전력 일부를 해당학교가 사용할 수 있도록 할 필요가 있다 이를 통해 기본요금을 결정하는 피크치를 낮출 수 있고 실질적인 전기요금 인하 효과를 낼 수 있다 교육은 수익성을 따질 분야가 아닌 미래세대를 위한 투자로 보고 지원과 배려를 아끼자 않아야 할 분야이다 극적인 정부의 검토가 필요하다 탄핵정국에서도 더불어민주당은 서민경제를 앞으로 더욱 꼼꼼히 챙기겠다 홍익표 수석부의장 박근혜 대통령의 탄핵이 원내대표께서 말씀하신 것처럼 가시화되는 것 같다 대한민국이 이런 상황에까지 온 것에 대해서 매우 불행하고 유감스럽게 생각한다 왜 이런 일이 일어났을까 제가 짤막하게 몇 개만 지적하겠다 첫 번째 이미 오래전부터 지적된 것처럼 독선적인 권력에 대해서 여당 내에 견제와 비판이 전혀 없다는 것이다 여당의 무능과 여당이 대통령만 바라본 것이 이번 사태를 초래한 근본적인 원인 중에 하나다 두 번째 저희 야당도 반성한다 보다 용기 있게 싸우고 그 잘못을 지적했다면 이런 사태를 조금이라도 막았을 텐데 우리 정치권 자체가 제대로 견제하지 못한 측면도 있다 세 번째 견제하지 않은 언론이다 사실상 언론이 어떤 의미에서는 권력과 독재자의 홍보역할을 한 것이 아닌지 생각한다 견제하지 언론이 결국 정권의 무능과 방만한 운영 그리고 국정농단을 자초한 것이 아닌가 생각한다 마지막은 관료시스템의 붕괴다 민주주의 국가에서 관료제는 국가운영을 지키는 최소한의 버팀목이다 비록 개혁적이지는 않지만 국가운영의 버팀목이 관료체제에 기초한 정부운영 시스템인데 전문 관료 시스템이 완전히 붕괴되었다 인사에서부터 정책 모든 결정을 특정 비선세력이 농단하면서 관료시스템이 매우 취약한 기반이 한국사회에서 드러난 것이다 이 모든 것들이 총체적으로 오늘의 박근혜 최순실 게이트를 만들어낸 요인이 아닌가 생각한다 그런 측면에서 대한민국에서 이제는 세상을 바꾸기 위한 정치개혁 그 다음에 정당개혁 언론을 포함한 사회전반의 사회개혁에 대한 논의가 바로 시작되어야 한다고 생각한다 그것이 세상을 바꾸고 새로운 시대를 여는 시작이 아닐까 생각한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59126,2016-11-24, 이재정 원내대변인 오전 현안 브리핑 일시 목 오전 시 분 장소 국회 정론관 변죽만 울리는 검찰수사 우병우를 구속 수사하라 그동안 박근혜 정부를 비호하기 위해 최선을 다한 법무부장관과 민정수석마저 박근혜 게이트의 실체가 밝혀지자 고개를 돌리고 사임했다 박근혜 게이트를 가장 먼저 막아냈어야 할 민정수석인 우병우는 오히려 그 힘을 등에 업고 각종 비리를 주도했다 우병우에 대한 각종 비리가 드러났을 때 즉시 실시되었어야 할 압수수색이다 하지만 이제 와서 늑장수사 보여주기식 압수수색이라는 비난을 피하기 위해 청와대 민정수석실을 압수수색했다며 부산을 떠는 검찰을 바라보는 국민의 시선을 차갑기 그지없다 다시 한 번 강조하지만 늦어도 너무 늦었다 증거인멸 입맞추기를 하기에 너무 많은 시간이 주어졌다 얼마나 더 많은 시간을 우병우에게 줄 것인가 검찰은 괜한 변죽만 울리지 말고 비리의 핵심인 우병우를 구속 수사할 것을 촉구한다 증거인멸 앞에 속수무책 검찰은 바라만 볼 것인가 각종 보도를 통해 최순실을 진료한 차움의원 측이 최순실 자매와 관련된 각종 의료기록을 파기하고 있다는 내부증언이 나오고 있다 뿐만 아니라 삼성물산과 제일모직 합병을 위해 최순실의 딸 정유라에 대한 대규모 지원을 이행했다는 의혹을 받고 있는 삼성물산측은 정보보호라는 명목 하에 대규모 자료파기를 단행하고 있다 현직 대통령이 국가권력을 사유화한 사건이다 대통령의 건강이 병원도 아닌 의원에게 맡겨졌으며 재벌은 자신들의 이익을 위해 스스럼없이 뇌물을 바친 사건이다 검찰은 바라만 볼 것인가 증거가 모두 파기된 뒤에야 진한 아쉬움을 표할 것인가 검찰의 무능한 수사야 말로 박근혜 게이트의 공범과 다름 아니다 차움의원과 삼성물산은 증거인멸을 중단하라 만약 단 하나의 증거라도 인멸된 것으로 나타난다면 국민이 절대 용서하지 않을 것이다 쌀값 폭락과 국정파탄에 분노한 농민들의 농기계 행렬 보국안민 년 전의 동학농민운동 정신을 외치며 장엄한 농기계 행렬이 서울로 향하고 있다 박근혜 정부의 쌀값 폭락과 국정파탄에 분노한 농민들이 일부터 땅끝 해남과 진주에서 농기계 상경투쟁에 나선 것이다 박근혜 정부는 대통령 후보 시절 쌀값을 만원대에서 만원대로 인상하겠다고 공약했다 하지만 절대 지켜지지 않을 공약 중 하나로 전락했다 년 만에 쌀값이 가장 낮다고 한다 작년 겨울 백남기 농민이 광화문으로 향한 이유 역시 쌀값 이었다 박근혜 정부가 존재하는 한 농업은 방치될 것이고 국민과 농민의 불행이 계속될 것임은 자명하다 나라의 근간마저 저버린 박근혜 정부는 하루 빨리 퇴진하는 것만이 국가의 경제발전을 도모하는 유일한 지름길이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59120,2016-11-23, 이재정 원내대변인 오후 현안 추가 서면 브리핑 늦어도 너무 늦은 검찰의 청와대 압수수색 만시지탄이다 오늘 검찰은 청와대 민정수석비서관실 특별감찰반에 대한압수수색을 단행했다 법무부장관과 민정수석의 동시다발적인 사의표명 후 실시되는 검찰의 압수수색이 잘 짜여진 각본을 보는 듯 하다 검찰은 호기롭게 압수수색 들어가서 텅 빈 상자만 들고 나오기에는 국민 보기 부끄럽지 않은가 늦어도 너무 늦었다 국민들은 검찰의 늑장대응에 만시지탄이라 입을 모으고 있다 검찰은 그간 보여주기식 수사 늑장수사 봐주기 수사로 신뢰를 잃을 대로 잃었다 이제라도 반성하고 제대로 된 수사의지를 보이는 것이라면 그 시작은 바로 우병우 구속수사이다 그것만이 추락한 검찰의 위신을 조금이나마 되세우는 일이 될 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59119,2016-11-23, 추미애 대표 광주 전남 박근혜 대통령 퇴진 국민주권운동본부 공동 출정식 인사말 일시 수 오후 시 장소 광주 충장로 우체국 앞 추미애 대표 이 추위에 나라를 지키기 위해서 이곳에 오신 당원 동지 여러분과 광주 시민 여러분께 미안하고 죄송하다 제대로 국정을 감시하지 못해 부끄러울 뿐이다 며칠 전 검찰이 이 나라 대통령이 직권남용과 강요죄를 저지른 공범이고 국가의 주요기밀문서를 누출한 혐의자라고 밝혔다 헌정사상 초유의 일이고 정말 부끄러운 일이다 이제 우리 아이들에게 자랑스러운 대한민국을 말할 수 없게 되었다 그래서 우리가 촛불을 들었다 이 땅의 재벌들은 골목상권마다 서민경제를 죽이는 침투행위를 해대고 싹쓸이를 해왔다 그런 재벌들이 대통령의 말 한마디에는 제대로 항변도 못하고 수십 수백억을 갖다 바쳤다 정규직을 비정규직으로 만들고 왼쪽 바퀴 가는 사람과 오른쪽 바퀴 가는 사람을 임금으로 차별하고 최저임금 한 푼 올려달라는데도 국민을 핍박하고 벌벌 떨던 재벌들이다 국민에게 큰소리쳤던 재벌들이 대통령의 말 한마디에는 꼼짝 못하고 돈을 바쳤다 대통령은 입만 열면 국회와 언론을 향해서 야당이 경제의 발목을 잡아서 나라 경제가 안돌아간다 고 압박을 했다 이랬던 재벌과 대통령이 검은 뒷거래를 했다 아쉽게도 검찰의 공소장에는 재벌이 바친 돈의 본질이 뇌물임에도 불구하고 직권남용과 강요죄라는 죄명으로 슬그머니 꼬리를 감췄다 대통령은 지금도 변호사를 앞세워서 이렇게 말할 것이다 제가 언제 협박을 했는가 나라가 어려우니 대사를 앞두고 웃으면서 돈 좀 내시라고 말했을 뿐이다 이것이 박근혜식 화법이다 우리는 속지 말아야 한다 재벌이 준 돈은 명백히 뇌물이다 재벌로부터 돈을 받은 것은 협박해서 받은 것이 아니라 검은 뒷거래이다 뇌물 공범이라는 것을 밝혀야 한다 이 땅의 대한민국 재벌도 단단히 발목이 잡혔다 최순실의 딸의 학교 친구의 아버지가 경영하는 회사에 현대자동차가 일감을 줄 수 없느냐고 대통령이 한마디 하니까 검사도 거치지 않고 그 회사가 협력업체로 낙찰이 됐다고 한다 세계 자동차시장에서는 대한민국 재벌이 만든 현대자동차도 못 믿겠다고 한다 언제든지 권력에 무릎 꿇고 소비자의 안전은 뒷전일 것 아니냐고 말한다고 한다 정말 절단이 났다 이대로 국정에서 손을 떼지 않는다면 대한민국 경제를 망치는 것이 대통령 장본인이 될 것이다 나라를 바로 잡아야 한다 경제를 바로 잡아야 한다 그런데 새누리당은 어떤가 박근혜 대통령 당선의 등 공신이라고 한 부역자 집단의 당대표를 지낸 분이 탄핵에 앞장서겠다고 한다 우리는 지켜볼 것이다 대통령이 이 지경이 되도록 막기는커녕 비호해온 부역자 정당이다 석고대죄부터 하는 것이 순서가 아니겠는가 국민이 촛불을 들고 국민의 가 대통령은 물러나라고 하는데 새누리당은 이제 와서 탄핵 발의에 앞장서겠다고 한다 새판 짜기를 하겠다고 하는데 믿지 못하겠다 그 말을 안 믿겠다는 것이 아니라 그것만으로는 안 된다는 것이다 새누리당의 석고대죄가 먼저다 새누리당의 해체선언이 먼저 있어야 한다는 국민의 요구를 받들라는 것이다 우리는 탄핵 표를 구걸하지 않겠다 새누리당의 표가 있어야만 탄핵이 된다고 해서 새누리당 국회의원들에게 구걸하는 것이 아니다 탄핵은 국민의 명령이다 제 발로 물러나지 않으면 탄핵을 받들라는 것은 국민의 뜻이고 명령이다 이것을 촉구하는 것이다 대통령이 얼마나 뻔뻔한지 보시라 대통령이 탄핵 한 번 해봐라 어디 할 테면 해보라 며 국민을 상대로 조롱을 하고 있다 청와대에서 장기 농성전에 들어갔다 이렇게 하다가는 박원순 시장이 살수차에 물을 끊는 것이 아니라 청와대에 식수를 끊겠다고 할지도 모르겠다 장기 농성전에 들어간 대통령이다 금방 끝나지 않을 것 같다 이리저리 변명하고 회피할 방법을 찾을 것 같다 그래서 우리가 수구 꼴통보수의 실력을 가볍게 봐서는 안 되는 것이다 교활한 그들이 어떻게 정치권의 새판을 짜서 민주공화국 주권회복운동에 찬물을 끼얹을지 우리는 예의주시해야한다 탄핵 소추도 새누리당에 구걸해서 표가 적당히 모아졌다고 해서 덜커덕 하면 안 된다 정확하고 엄밀하게 실수가 없도록 제대로 탄핵소추안을 만들어야 한다 그것이 민심을 받드는 길이다 여기서 실수가 있으면 안 된다 그래서 더불어민주당은 제 야당답게 차분히 진행할 것이다 절대로 여러분이 서두르라고 재촉하거나 강박하시면 안 된다 이번만큼은 실수가 없어야하지 않겠는가 더불어민주당은 탄핵추진실무준비단을 구성했다 대통령직을 유지하는 것이 더 이상 우리나라의 헌정 질서를 수호할 수 없다는 것을 명명백백하도록 만들어낼 것이다 국민의 신임을 어떻게 배반했는지 대통령직을 유지하는 것이 국익을 해치는 것이라는 것을 낱낱이 조목조목 밝혀낼 것이다 스스로 물러나지 않는다면 길게 끌면서 농성전으로 나라를 망치는 대통령을 어떻게 신속하게 끌어내릴 수 있을 것인지 우리는 길을 찾고 방법을 찾을 것이다 대통령이 재벌과 결탁해서 뇌물을 주고받고 뒷거래를 하고 부정부패를 한 행위를 특검을 통해서 낱낱이 밝혀내야한다 어떻게 국익을 해쳐왔는지를 제대로 밝혀내야한다 그래서 절대로 길을 재촉하거나 서두르면 안 된다 한 단계 한 단계 국민과 걸어가겠다 국정농단의 도가 너무 지나쳤다 재작년 송파의 세 모녀가 이제 더 이상 살지 못하겠다 다 큰 딸자식은 일자리가 없고 더 이상 기댈 곳이 없다 는 비관적인 유서와 만원 돈을 남기고 목숨을 끊었다 그때 대통령이 국회에 나타나서 송파 세 모녀법을 만들어 달라 고 간절한 눈빛으로 호소했다 우리 국민은 그 눈빛을 믿었다 그런데 그 순간에도 오늘 드러난 사실에는 미용을 위해서 국민혈세를 천만원 이상을 썼다는 것이다 도대체 대통령이 어디까지 갈 것인가 국민은 일자리를 잃고 희망을 잃고 눈물로 밤을 지새우게 생겼는데 대통령은 피부건강과 미용을 위해서 온갖 주사를 맞고 온갖 영양주사로 국민 혈세를 썼다니 얼마나 통탄할 일인가 야권공조에 대해서 한 말씀 드리지 않을 수 없다 어떤 분이 지난 몇 년 동안 적어도 나라를 위해서는 몸 바쳐 일한다고 믿었던 대통령이 최순실에게 결재를 받고 국무위원과 총리를 임명하고 국가외교문서를 누출하고 통일대박이라는 말도 최순실의 머리에서 나온 것이라고 한다 나라가 귀신에 씐 것인가 라며 통탄했다 여성 대통령의 마음을 읽을 수 있는 여성 대표이니 한번 만나서 설득해볼 수 없겠느냐 고 호소했다 나라가 어디까지 흔들려야 하는가 어린아이와 노약자 할 것 없이 이렇게 날마다 길가에서 밤을 새야 하는 것인가 야당의 정치력은 어디갔는가 하는 절절한 호소를 들었다 담판을 지어야겠다고 마음을 먹었다 야당 대표가 그냥 있을 수가 없었다 정치가 작동하는 것이 순리고 상식이 아니었겠는가 그런데 왜 야당 대표 혼자 나서느냐고 한다 협력할 때는 협력하는 것이고 담판 지을 때는 담판지어서 정치력을 발휘하는 것이 총선 민의 아닌가 저는 야당끼리 경쟁하는 것은 바람직하지 않다고 생각한다 서로 경쟁 심리로 이 엄중한 국면에서 실기하면 안 된다 대통령이 스스로 퇴진하는 것이 헌법재판소에 가서 길게 논쟁하지 않고 국민을 지치지 않게 하는 것이 가장 정확한 해법이다 대통령 스스로 물러나게 하도록 정치력을 발휘해야한다고 이 순간에도 생각한다 그러나 대통령이 민심을 못 읽고 스스로 퇴진하지 않는다면 결국 우리가 대통령을 쫓아낼 수밖에 없다 그것이 바로 탄핵이다 그래서 탄핵도 국민 뜻대로 해야 한다는 것이다 우리가 총리 하나 바꾸자고 촛불을 들지 않았다 총리도 국민 뜻대로 해야 하는 것이다 어떤 총리를 어떻게 뽑아야 할지 선정방식도 국민 뜻대로 해야 하는 것이다 이 자리에서 밝힌다 물러나야 할 대통령 앞에 머리를 조아리면서 야당끼리 경쟁하면서 정치 주판알 튕겨가면서 총리를 누구로 해야 하느냐 는 경쟁을 해서는 절대로 안 된다 국민추천 총리로 가야한다는 것을 이 자리에서 밝히는 바이다 진정한 국민주권시대를 열어가자 순서 있게 질서 있게 열어가자 그것이 진정한 민주정부로 가는 길이고 광주가 원하는 바가 아니겠는가 광주는 한 번도 틀린 길을 가는 정치 세력을 용서해본 적이 없다 광주는 한 번도 분열을 용납해본 적이 없다 지금은 국민주권을 되찾고 제대로 된 헌정질서와 민주정부를 세우는 그 길로 가는 것이 국민의 뜻이고 광주가 명령하는 바이다 우리 함께 똘똘 뭉쳐서 가자 어느 누구든 정치 셈법을 우선한다면 그들 먼저 퇴장시켜야 한다 그래서 다시는 교활한 정권 교활한 수구에게 길을 터주는 헛발질을 하지 않도록 우리 스스로 단속하자 하나로 똘똘 뭉쳐 민주정부로 나아가자 +http://theminjoo.kr/briefingDetail.do?bd_seq=59116,2016-11-23, 박경미 대변인 오후 현안 브리핑 일시 시 분 장소 국회 정론관 김현웅 장관과 최재경 수석의 사의 표명은 검찰 수사 수용하라는 압박 김현웅 법무부 장관과 최재경 청와대 민정수석이 사의를 표명했다 김 장관과 최 수석은 대통령이 형사 사건 피의자로 입건되고 검찰 수사를 거부하는 사상 초유의 사태에 책임을 지고 사직서를 제출한 것으로 전해졌다 법무부 장관과 민정수석이 옷을 벗겠다는 것은 대통령의 검찰 수사 수용을 압박한 것이라고 볼 수 있다 대통령이 피의자가 되어 검찰과 다투는 참상 앞에서 법무부 장관이 어떻게 법치를 바로 세울 것이며 민정수석이 어떻게 검찰을 지휘할 수 있겠는가 결국 박근혜 대통령은 국정과 안보에 이어 법치마저 진공상태로 밀어 넣고 있는 것이다 국정이 붕괴되고 안보가 흔들리고 법치마저 무너지고 있다 이 모든 책임이 박근혜 대통령에게 있음에도 불구하고 청와대는 오히려 적반하장격으로 검찰 수사에 대해 상상과 추측을 거듭해 지은 사상누각 이라고 평했다 이러한 청와대의 입장이 오죽 황당하면 오늘 한 현직 평검사는 박 대통령을 체포하여 강제수사하라는 글을 검찰 내부 게시판에 올렸겠는가 박 장관과 최 수석의 사표 수리 여부는 우리 국민의 관심사가 아니다 우리 국민들은 대통령이 사법당국의 조사 요구에 응하는지에 관심이 있을 뿐이다 박 대통령이 나라와 국민에 대한 일말의 책임감이라도 있다면 대통령의 신분에서 벗어나 검찰 조사를 받을 것을 다시 한 번 촉구한다 청와대 교육문화수석실은 최순실의 서포터즈인가 최순실 씨가 차은택 씨의 외삼촌인 김상률 전 청와대 교육문화수석을 전방위로 활용했음이 검찰의 수사로 드러났다 언론보도에 따르면 교문수석실이 주도하여 최 씨 소유의 하남시 부동산 매매와 연계된 보고서를 작성했고 년 월에는 정유라를 염두에 둔 체육특기생 입시 개선 방안을 만들어 최씨에게 넘겼다고 한다 그 덕에 정유라는 이화여대에 무난히 합격한 것이다 이 뿐만이 아니다 교문수석실은 최 씨 소유의 더블루 가 추진하는 스포츠클럽 사업을 지원하는 문건도 만들었고 대통령의 멕시코 순방과 아프리카 개국 순방에 대한 정보를 제공함으로써 최 씨 소유의 광고회사 플레이그라운드 가 대통령 순방 행사의 담당업체가 되도록 도와줬다고 한다 이로 인해 최씨가 거액을 챙겼음은 자명하다 최 씨가 박 대통령에게 청탁해 경제 정책조정 교육문화 민정 등 청와대의 여러 수석실을 사유화하고 자신의 이익을 위해 이용했다니 어떻게 대명천지에 이런 일이 일어날 수 있는가 검찰은 박근혜 최순실 게이트 의 부역자들을 철저히 찾아내 엄단함으로써 우리 사회에 법과 원칙이 살아 있음을 확인시켜 주기 바란다 감사를 받아야 할 문체부와 교육부가 감사를 하는 것은 주객전도이다 문화체육관광부는 대한체육회와 합동으로 대한승마협회에 대해 감사를 실시한다고 밝혔다 대한승마협회의 회장사인 삼성은 최순실씨 소유의 독일회사에 억 원을 지원한 데 이어 도쿄올림픽을 핑계로 정유라에게 억 원을 추가 지원하려 했다는 의혹을 받고 있는 상태이다 그런데 대한승마협회의 특혜의혹은 문체부와의 사전 협의 없이는 불가능하다 얼마 전 교육부도 정유라 특혜입학 의혹이 불거진 이화여대를 특별감사를 했다 이화여대는 교육부의 재정지원사업을 싹쓸이하다시피 하고 관련 교수들이 거액의 연구비를 수주하는 반대급부가 있었기에 정유라에게 특혜를 주지 않았겠는가 문체부 감사는 교육부 감사의 데자뷰를 보는 듯 하다 문체부와 교육부가 책임의 주체인데 대체 누가 누구를 감사한다는 말인가 책임을 모면하려는 방법도 가지가지다 이처럼 비열하게 산하기관에 책임을 떠넘기는 문체부와 교육부의 면피용 감사 꼬리자르기식 감사는 절대 용납할 수 없다 감사원은 교육부 감사에 착수했다고 한다 감사원 감사와 검찰 수사를 통해 양 부처의 게이트 부역 행위를 철저히 밝혀내고 엄벌에 처하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59115,2016-11-23, 박근혜 대통령 누구에게 묻고 군사 외교적 판단을 내리는가 외신에 따르면 박 대통령이 박근혜 최순실게이트로 힘을 잃은 것은 미국의 입장에서 손해라는 분석을 내놓았다 미국이 구슬린 대로 일본의 우익 총리와 위안부 합의도 한 박근혜 대통령이기 때문이라는 것이다 이에 발 맞추어 최근 언론 보도에서 위안부 합의 관련 주무 장관인 윤병세 외교부 장관이 개선된 합의를 이끌어내겠다며 석 달 추가 협상을 요청했으나 박근혜 대통령의 강행으로 받아들여지지 않았다고 한다 한일군사정보보호협정 체결 과정 역시 위안부 합의와 많이 닮아 있다 한민구 국방장관이 국민 동의를 얻는 과정을 거치자고 건의 했음에도 불구하고 박근혜 대통령은 조기 타결을 강행하였다 주무부처 장관조차 부족하다고 판단한 군사 외교적 사안들을 박 대통령이 일방적으로 밀어 붙인 데는 그럴 수 밖에 없었던 이유가 있을 것이다 보이는 손 최순실에 의해 꼭두각시 놀음을 당했듯 보이지 않는 손으로부터 조정을 당하고 있는 것은 아닌지 의구심이 든다 어려운 국내 현실 속에 장관들의 진언도 들리지 않을 만큼 현재 본인의 처지에서도 일단 서명은 하고 봐야 할 만큼 그리고 국민과 국가 안위는 나 몰라라 해야 할 만큼 절실하고 긴박했던 것 인가 위안부 합의도 한일군사정보보호협정도 박 대통령에게는 그저 이용 수단 정도로 밖에 안 보이나 싶다 잔인한 일제식민지배의 상처가 여전히 남아 있는 우리 국민들에게 한일 간의 문제는 군사적 외교적 차원을 넘어선 몸과 마음이 아프고 민감한 사안들이다 재차 강조하지만 위안부 합의는 철회되고 한일군사정보보호협정은 무효화 되어야 한다 또한 대통령의 이러한 일방적인 결정은 오히려 탄핵사유가 하나 더 추가될 뿐임을 명심하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59114,2016-11-23, 이재정 원내대변인 오후 현안 브리핑 일시 수 오후 시 분 장소 국회 정론관 김현웅 법무부 장관 최재경 청와대 민정수석의 사의표명 관련 오늘 오전 김현웅 법무부 장관과 최재경 청와대 민정수석이 지금 상황에서는 사직하는 것이 도리 라며 사의를 표명했다 형사사건의 피의자로 입건된 대통령이 검찰수사를 거부하는 사상초유의 사태에 대한 책임을 진다는 것이다 그런데 과연 이들이 도리 를 논할 수 있는지 의문이다 최재경 수석은 입성 당시 박근혜 최순실 게이트의 핵심 중 하나인 김기춘 비서실장의 라인으로 통했다 김현웅 장관 역시 년 이른바 정윤회 문건 수사에서 비선실세 의혹을 근거 없는 것으로 단정하며 박근혜 최순실 게이트를 비호했던 자이다 국민에 대한 진정한 도리 는 박근혜 대통령을 엄정히 수사하는 것이다 최재경 민정수석의 사임을 통해 청와대가 강경입장을 고수할 것이라는 우려가 높아지는 상황에서 대통령을 체포하라며 강제수사 를 촉구하는 한 현직검사의 글은 우리에게 많은 메시지를 주고 있다 검찰 내부 게시판에 게시된 글에 따르면 검찰수사 불응은 우리 사회의 근간인 헌법과 법치주의를 부정한 것으로 그 자체로 탄핵사유에 해당하고 또한 일국의 대통령이라면 지녀야 할 최소한의 품격조차 내팽개친 처사라며 현직검사로서의 참담함을 토로하고 있다 청와대와 대통령에 의해 법과 원칙이 송두리째 흔들리고 있다 검찰에게도 대통령에게도 더 이상은 선택할 권리가 없다 대한민국의 주권자인 국민의 명령이다 박근혜 피의자와 그 부역자들에 대한 타협 없는 수사 그것만이 정답이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59110,2016-11-23, 박원순시장의 국무위원들에 대한 질책 박근혜 대통령이 국무회의 출석해도 계속될 것이다 박원순 서울시장이 어제 국무회의에서 대통령퇴진과 국무위원 총사퇴를 주장했고 현 시국에 대해 그 어떤 국무위원도 책임지지 않는것에 대해 따끔하게 질책했다 주말마다 백만의 촛불이 타오르는 서울시 행정의 책임자이자 천만 서울시민의 대표자로써 제대로 된 민심의 전달이었다 지금 대한민국 국무회의에서 가장 심도있게 다루어져야 할 안건이 대통령퇴진임은 분명하다 그럼에도 이에 대해 아무런 역할도 수행하지 못하는 허수아비 국무위원들과 새누리당이 되레 박시장에게 역정을 내고 대선운동의 일환으로 비판하는것은 결코 온당치 못하다 어제 박시장의 국무회의 발언은 이번주말 만 촛불을 준비하는 온국민들의 마음을 대변한 신선한 청량제였다 국민들은 박시장이 앞으로도 국무회의에서 지속적으로 민의를 제대로 대변해줄것이라 기대한다 특히 박대통령이 검찰수사 거부하며 아무일 없었다는 듯이 뻔뻔하게 국무회의에 참석할 경우 결정타를 날려 줄 것이라 확신한다 박시장이 지키는 국무회의 박대통령의 참석 상당히 고민되겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59108,2016-11-23, 제 차 최고위원회의 모두발언 일시 수 오전 시 장소 국회 본청 당대표 회의실 추미애 대표 시국이 대통령 때문에 혼미한 가운데 조류인플루엔자 확산 방지를 위한 방역당국의 총력을 당부해야 할 때이다 지금 확산되고 있다는 조류인플루엔자는 전염력이 매우 강하다고 한다 축산농가가 피해를 입지 않도록 당국의 철저한 방역활동을 당부 드린다 헌정파괴 국정농단도 모자라 군사주권까지 팔아먹는 매국 정권의 매국 국무회의가 벌어졌다 어제 부총리를 필두로 한 국무회의에서 한일군사정보보호협정을 통과시켰다 만 시민들의 퇴진 요구를 받고 있고 중대 범죄혐의의 피의자인 국민의 신뢰를 잃은 대통령의 국무회의가 할 일은 아니다 우리 당은 국민을 배신한 굴욕적 한일군사정보보호협정을 결코 용납할 수 없다 협정을 주도하고 동조한 모든 책임자들에게 응당한 책임을 물을 것을 미리 경고한다 어제 국무회의에서 박원순 서울시장은 한일군사정보보호협정의 일사천리에 대해서 그런 일을 해서는 안 된다 이런 일을 할 거면 국무위원들은 전원 사퇴하라 고 했다 이런 천부당만부당한 국민의 신뢰를 배신하고 국익을 해치는 일에 대해서 충고한데 대한 반격과 반발이 너무 지나치다 이것이 국내 정치적으로 대할 사안이겠는가 정파적으로 볼 사안이겠는가 이것만으로도 국익을 배신한 죄로써 헌법재판소가 판단할 감이다 미국에 혈세를 퍼주겠다는 장명진 방사청장이 나라를 망신시키고 있다 트럼프 행정부가 출범도 안했고 그쪽에서 아직 어떤 언급조차 없는 상황이다 그런데도 방사청장이 트럼프 행정부가 방위비 증액을 요청할 시에 수용하겠다 고 말했다 잘못 들은 것인지 제 귀를 의심할 수밖에 없다 방사청장은 다른 나라의 대신인지 우리나라의 관리인지 입장을 밝혀야 할 것이다 이 정권은 국민주권 군사주권 외교주권까지 모두 엿 바꿔먹을 셈인가 굴욕적 한일외교에 이은 대미 조공외교를 즉각 중단하기 바란다 엘시티 비리가 친박 정권 차원의 비리 게이트로 속속 드러나고 있다 박근혜 대통령의 핵심측근인 현기환 전 청와대 정무수석 서병수 부산시장의 최측근이 엘시티 게이트에 연루된 사실이 확인되었다 야당과 비박계를 겨냥한 공안정국 조장을 위한 엘시티 비리 엄단 지시가 박근혜 대통령에게 거꾸로 자승자박이 된 것이다 검찰은 속히 사건의 실체를 밝혀내야 할 것이다 최순실에 이은 또 한 명의 박근혜 대통령의 선생님 사부 김기춘 전 비서실장을 구속수사 해야 할 것이다 박근혜 최순실 게이트의 또 하나의 고리라는 정황들이 나오고 있다 김종 전 차관의 증언 최순실의 빌딩 층을 사무실로 사용한 점 우병우 전 민정수석을 통한 국정 개입과 막후 조종의 지휘 역할 박근혜 대통령의 세월호 시간도 청와대 수석들의 입을 막으며 진실은폐를 주도했다고 한다 검찰은 더 이상 무엇을 망설이는가 김기춘을 즉각 구속 수사하라 오늘부터 특검법이 발효된다 피의자가 특검에 대해서 중립성과 편향성을 운운하는 것은 가당치않다 민주당은 국정조사 등을 충실히 이행해 탄핵 절차를 밟는데 힘을 싣겠다 우상호 원내대표 지금 대한민국이 위기에 처해있다 국민들은 거리에 정부는 기능상실 청와대는 자기방어 대한민국이 움직이지 않고 있다 대한민국이 정지해있다 잘못하면 더 큰 위기가 올 수 있다 경제상황도 심상치 않다 미국의 금리인상 사드 배치에 따르는 중국의 경제보복도 가시화되고 있다 이 상황을 장기간 방치하는 것은 대한민국이라는 배를 침몰시킬 수 있다는 점에서 정치권 특히 국회의 노력이 매우 중요하다고 판단한다 새누리당에 호소한다 언제까지 국정공백을 장기화시킬 것인가 대통령은 퇴진할 생각이 전혀 없고 국정공백 장기화에 대해서도 대안을 제시하지 않고 있다 결국 탄핵밖에는 다른 방법이 없다고 야당이 결론을 내렸다 대통령은 내려올 생각이 없고 국민은 거리에서 싸우고 정부는 아무 일도 하지 않는 이 상황을 장기간 방치할 수 없다 탄핵을 통해서 정치일정을 예상 가능하게 만들고 거기에 따른 대응들을 해나가는 것이 대한민국의 기능을 다시 복원하는 가장 바람직한 길이라고 생각한다 새누리당 의원들께서 자기 당 소속의 대통령에 대한 탄핵에 대해서 이런저런 고민을 하지 않을 수 없다는 점은 이해한다 하지만 대한민국의 헌법기관으로써 대한민국의 미래를 위해 무엇이 가장 바람직한 해법인지 심사숙고해 주실 것을 말씀드리고 싶다 군사정보보호협정도 미스터리다 독립운동가의 후손인 한민구 장관은 이 협정이 조기에 타결되는 것을 주저했다 국방부도 이 협정을 조기에 타결하기보다 국민들의 동의를 얻는 과정을 거쳐서 하라고 건의했다 그런데도 대통령이 이 와중에 김관진 안보실장을 통해서 밀어붙였다 여기에는 정략적 의도가 숨어있다고 본다 탄핵 국면에서 안보를 이슈화함으로써 보수단체를 자극해서 탄핵의 찬성파와 반대파로 나누어서 남남갈등을 일으키겠다는 것이 군사정보보호협정을 밀어붙인 대통령의 숨은 의중이라고 생각한다 야당은 여기에 이용당할 생각이 없다 안보조차 정쟁도구화 하는 대통령과 청와대의 모습이 오히려 탄핵사유로 하나 더 추가될 뿐이다 보혁 대결 남남 갈등이 이루어지지 않게 현명하게 대처하면서 군사정보보호협정 자체가 사실상 오랜 생명력을 갖지 못하도록 만드는 일에 나서겠다 김기춘씨의 거짓말이 만천하에 폭로되고 있다 최순실을 알지도 못하고 통화한 적도 없다고 말했던 화면을 보면서 어떻게 대한민국 청와대의 비서실장까지 한 분이 저렇게 뻔뻔하게 거짓말을 할 수 있는지 어이가 없다 관련자들의 증언을 보면 최순실씨를 소개해주거나 최순실씨를 알선해주는데 김기춘씨가 직접 관여돼있었고 심지어 최순실씨의 아버지 최태민씨와는 년 전부터 교류가 있었다는 것이 밝혀지고 있다 결국 박근혜 최순실 게이트의 핵심에 김기춘이라는 사람도 암약을 했다고 결론을 내릴 수밖에 없다 검찰 수사를 통해서 명명백백하게 밝혀야 한다 김영주 최고위원 박근혜 대통령 선거캠프 본부장을 지냈던 김무성 전 대표가 박 대통령을 당선되게 한 데 대해 국민께 사죄했다 하태경 의원도 이렇게 저급한 사람을 대통령으로 만들어 죄송하다 고 했다 국가정보원과 군 사이버사령부의 인터넷 게시물 댓글 공작으로 당선된 박근혜 대통령은 대통령이 돼서는 안 될 사람이었다 박근혜 대통령은 국민이 위임한 권력을 사유화하고 국민의 세금을 최순실을 위해 쏟아 붓고 재벌들로부터 뇌물을 받아 정경유착의 구태를 저질렀다 어제 서울대 학생들이 박근혜 정권 퇴진을 위한 동맹휴업을 선포하면서 박근혜 대통령이 퇴진할 때까지 이 나라에 일상은 없다 고 했다 박근혜 대통령의 안하무인 버티기가 우리 국민의 일상을 빼앗고 있다 정치의 본령이 국태민안 즉 나라를 태평하게 하고 국민들이 일상을 편하게 즐길 수 있도록 만드는 것인데 박근혜 대통령이 망가뜨렸다 태어나지 말았어야 할 박근혜 정권이 빼앗아간 우리 국민의 일상을 되찾기 위해 하루속히 박근혜 대통령을 퇴진시켜야 한다 최재경 청와대 민정수석의 두 가지 몰래 변론 의혹에 대해 말씀드리겠다 박 대통령은 비서실장을 임명하기도 전에 최재경 민정수석부터 임명했는데 이제 그 저의가 밝혀졌다 언론 보도를 보면 박 대통령의 변호인인 유영하 변호사가 작성한 검찰 공소장에 대한 반박 입장문이 민정수석실의 검찰 출신 행정관의 컴퓨터에서 작성됐다는 사실이 밝혀졌다 이러려고 민정수석부터 황급히 임명한 것인가 박근혜 게이트 의 주범인 피의자 박근혜 대통령을 법적으로 변호하는 데 공적조직인 청와대 민정수석실이 관여한 것은 매우 중대한 위법행위이다 언론 보도가 나가자 최재경 민정수석은 처음에는 언론에 민정에서 변론 업무를 다 담당한다 하더라도 업무분장 상 어차피 대통령 법률보좌를 하는 것이니 문제가 없다 고 했다 그러나 민정수석실이 대통령 변론행위를 하는 것은 직권남용이라는 법조계의 지적이 있자 청와대는 어제 정연국 대변인을 통해 민정수석실이 주도적으로 한 것은 아니고 변호인이 필요한 것을 도와주고 자료를 제공한 것 이라고 말을 바꿨다 분명히 경고한다 최재경 민정수석은 대통령 변호에서 완전히 손을 떼기 바란다 정 대통령을 변호하려거든 국민 세금으로 월급을 받으면서 피의자를 몰래 변론 할 것이 아니라 민정수석 직에서 물러나 정식으로 선임계를 내고 변호해야 할 것이다 최재경 민정수석의 두 번째 몰래 변론 의혹에 대해 말씀 드리겠다 지난 일 국회 법제사법위원회에서 최재경 민정수석이 변호사 시절 효성그룹 형제의 난 사건을 몰래 변론했다는 폭로가 있었다 당시 우리 당 백혜련 의원은 년 월 이후 부터 민정수석이 되기 전까지 최재경 수석이 선임계를 내지 않고 몰래 변론을 해 수억 원을 받았다 고 발언했다 법사위 속기록을 보면 제보내용이 매우 구체적이고 액수까지 등장한다 그런데 최재경 민정수석은 한 언론에 지인을 통해 사건을 맡아달라는 연락을 받은 적은 있지만 사건을 맡거나 돈을 받지 않았다 고 해명하면서 전면 부인했다 최재경 수석에게 묻겠다 떳떳하다면 효성 사건을 맡아달라고 한 지인이 누군지 밝히시기 바란다 그리고 차제에 이 의혹을 말끔히 해소하기 위해 서울지방변호사회는 최재경 민정수석이 변호사 시절 수임한 사건 건수와 수임액수 보고의무를 제대로 지켰는지 살펴봐 주시기 바란다 이미 서울지방변호사회는 최근 우병우 전 민정수석의 사건수임 누락 관련 내용을 조사해 조사위원회에 회부한 것으로 알고 있는데 최재경 민정수석의 몰래 변론 의혹도 조사해 주시기 바란다 전해철 최고위원 대통령을 공범으로 적시한 검찰 수사는 일견 평가할만하다 하지만 박근혜 정부 들어 땅에 떨어졌던 검찰에 대한 신뢰를 되찾기에는 아직 부족하다 더욱 분발해야 할 것이다 특히 특검법 시행으로 검찰 수사가 마무리를 향해 가고 있는데 몇 가지 점에 대해서는 확실하게 수사에 임해야 할 것이다 자신의 말을 뒤집고 조사를 거부한 박근혜 대통령에 대해서는 더욱 적극적 조사를 진행해야 한다 중립적 특검이라는 모호한 의미의 단어로 향후 특검에도 협조하지 않겠다는 의중도 내비쳤다 출석요구서를 발송하는 등 대면조사를 위해 노력해야 하고 필요하다면 강제수사도 검토해야 한다 검찰의 정당한 수사 국가권력의 정당한 법 집행을 거부하는 대통령의 행위는 또 하나의 탄핵사유가 될 것이다 뇌물죄에 대해서 철저하게 수사해야한다 국민들은 이번 수사결과에서 뇌물죄가 빠진 부분에 대해 대통령의 퇴로를 열어주고 재벌에게 면죄부를 준 것이 아닌지 의심의 눈초리를 보내고 있다 김기춘 전 비서실장과 우병우 전 민정수석에 대한 엄정한 수사가 그 동안의 검찰수사를 평가하게 할 것이다 특히 우병우 전 수석은 특검의 주요한 수사대상이 되어있다 검찰은 마지막까지 우병우 전 수석 김기춘 전 비서실장의 청와대 기밀누출 재벌에 대한 압력 청와대 인사관리 등에 직접 연관이 있는 부분에 대한 엄정한 수사를 해야 할 것이다 국민의당 대표께서 더불어민주당 소속 인사에 대하여 도를 지나친 인신공격성 발언을 하고 있다 이미 수차례 반복되고 있다 적절하지도 않고 옳지 않다 그동안 야권 공조 때문에 인내하고 참고 있음에도 불구하고 정치적 현안에 대한 다양한 의견제시를 넘어서는 인신공격성 발언을 하는 것은 맞지 않다 여러 가지 정략적 목적에 의해서 이런 발언을 하고 있으리라 생각은 하지만 야권공조의 큰 틀에서 공조를 위한 협조를 위하여 앞으로 발언을 신중하게 하시고 자제했으면 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59107,2016-11-23, 이재정 원내대변인 오전 현안 브리핑 일시 수 오전 시 장소 국회 정론관 협상재개 일 만에 체결되는 한일군사정보보호협정 왜 그리 급하고 무엇을 숨기려고 하는가 오늘 오전 시 한민구 국방부 장관과 일본 나가미네 야스마사 주한 일본대사가 한일군사정보보호협정에 최종서명한다고 한다 국민적 지탄을 속에 협상이 재개된 지 일만의 일이다 안보의 척도인 군사정보를 일본과 공유하는 일이 한달도 안돼 속전속결로 이뤄졌다 박근혜 정부는 무엇이 그리 급하고 무엇을 숨기고 싶은가 외교안보 기밀자료를 최순실에 퍼준 대통령이 이제는 군사기밀마저 일본에 퍼주고 있다 반성과 사죄 없는 일본정부의 우경화와 군사대국 도약에 박근혜정부가 협조했다는 역사적 비판을 피할 수 없을 것이다 무엇보다 정당성을 잃은 박근혜 정부이다 당장 손을 떼라 정부 뒤에 숨어 협정체결을 방조한 새누리당 역시 역사의 죄인이 될 것임을 경고한다 방위비 인상 장명진 궤변 즉각 사과하고 취소해야 한다 장명진 방위사업청장은 누구를 위해 일하는지 모르겠다 트럼프 차기 미국 정부가 출범한 것도 아니다 트럼프 인수위에서 우리 정부에 요구한 것도 아니다 그런데도 미국의 방위비 인상 요구를 수용해야 한다는 장명진 청장의 발언은 월권이며 굴욕적 궤변이다 게다가 이같은 발언은 미국에게 잘못된 신호를 줄 수 있다 미국에만 충성하고 국민은 안중에 없는 장명진 청장은 즉각 사과하고 발언을 취소해야 한다 사과하지 않는다면 장명진 청장은 트럼프 대변인을 자인하는 꼴이다 세월호 시간을 알지 못하게 하라던 김기춘 전 대통령 비서실장 김기춘 전 비서실장은 수석비서관들에게 월 일 대통령의 동선과 위치는 경호 상 알지도 알려고도 하지 않는다는 지침을 내리고 국회의 자료요구에 대해서도 제출불가방침을 내렸다 국회에 출석해 뻔뻔한 답변으로 일관했던 그에 대해 모두가 무능하다고 손가락질 했지만 이는 철저한 공작으로 일관했음이 드러난 것이다 국가가 국민을 지키지 못한 참사에 대해 대통령 감싸기로 일관한 김기춘을 비롯한 청와대 부역자들이 국민의 촛불을 횃불로 만들기 위해 애써 노력하고 있다 특검과 국정조사로 반드시 대통령의 감춰진 시간에 대한 진상을 밝혀낼 것이다 검찰 포승줄에 묶여서도 비겁하게 모르쇠로 일관할 것인가 김기춘 비서실장은 이제 사실을 밝혀라 김기춘과 최순실은 한 몸이다 김기춘에 대한 수사를 촉구한다 박근혜 대통령의 정치적 동반자인 김기춘과 최순실과의 관계가 밝혀질수록 김기춘과 최순실이 한 몸임이 확실해지고 있다 박근혜 게이트의 중심에는 언제나 김기춘과 최순실이 함께했다 세월호 참사의 감춰진 시간부터 대통령이 연루된 각종 비리에는 항상 김기춘과 최순실의 이름이 빠지지 않는다 뻔뻔한 거짓말로 국민을 농락한 김기춘에 대한 수사야말로 이번 박근혜 게이트 수사의 핵심이다 검찰은 더 이상 김기춘에 대한 수사를 외면하지 말라 김기춘이 최순실이고 최순실이 곧 김기춘이다 들불처럼 번지는 대학 동맹휴업 박근혜 대통령의 퇴진을 요구하는 대학의 동맹휴업이 들불처럼 번지고 있다 전국의 많은 대학이 오는 일 동맹휴업과 총궐기에 나설 계획을 밝히고 있다 이는 일로 예정된 전국 대규모 촛불집회의 마중물이 될 것이다 우리 현대사를 돌이켜보면 행동하는 청년 지성은 항상 민주주의 위기 극복의 저력이 되었다 오늘날 진리는 강의실에 있는 것이 아니라 박근혜를 퇴진시키는 바로 그 거리에 있다 한 대학의 동맹휴업 선언 내용이다 다시 맞닥뜨린 민주주의의 위기 진리를 지키기 위해 거리로 나서는 청년들에게 고마움과 미안함을 함께 느끼는 참담한 현실이다 박근혜 대통령은 청년들의 목소리를 이 시대를 살아가는 청년 지성의 요구를 외면하지 말아야 할 것이다 되풀이되는 피해 언제까지 반복할 것인가 정부 방역체계의 민낯이 또다시 드러났다 중국에서 벌써 명의 목숨을 앗아간 의 국내 확산속도가 심상찮다 연례행사가 된 발생에 농민들은 벙어리 냉가슴 앓듯 답답한 심정이지만 정부는 살처분 외에 뚜렷한 대책을 내놓지 못하고 있다 땜질처방만 반복하는 정부의 무사안일주의가 확산의 주범이다 도대체 언제까지 철새 핑계만 댈 것인가 상시적인 방역체계 확립을 통한 근본적 대책마련이 이루어져야 할 것이다 식물정부 박근혜 대통령이 시급히 물러나야 할 이유가 여기에도 있다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59106,2016-11-23, 박경미 대변인 오전 현안 브리핑 일시 시 분 장소 국회 정론관 현기환 전 정무수석은 엘시티의 뒤를 봐줬나 박근혜 대통령이 퇴진 압력 속에 반전 카드로 꺼낸 엘시티 수사가 자폭으로 귀결될 것 같다 해운대 엘시티 비리 의혹에 대한 검찰 수사가 현기환 전 청와대 정무수석을 정조준했기 때문이다 검찰은 현기환 전 수석에 대해 압수수색을 하고 출국을 금지시켰다 현 전 수석은 현직에 있을 때 엘시티 비리 의혹 수사와 관련해 검찰 간부에게 수차례 전화를 해 수사 무마를 시도한 것으로 의심되고 있다 또 현 전 수석은 엘시티 이영복 회장과 가명까지 써가며 여 차례 골프를 쳤고 이 회장과는 호형호제하는 관계로 알려져 있다 박 대통령은 엘시티 수사로 국면 전환을 기대했는지 모르겠지만 결국 끔찍한 자충수가 되고 있다 검찰은 철저한 수사로 엘시티와 관련된 비리를 철저히 색출해 엄단할 것을 촉구한다 한일 군사정보보호협정은 천부당만부당하다 박근혜 정부가 군사작전 하듯 밀어붙인 한일 군사정보보호협정이 재추진 결정 일 만인 어제 국무회의에서 의결되어 대통령 재가를 받았다 오늘 양국이 정식으로 서명한 후 통보를 하면 즉시 발효된다 전쟁할 수 있는 국가를 추구하는 일본에게 한일 군사정보보호협정은 얻을게 많은 협정이다 자위대의 한반도 진출 빌미를 제공해 일본의 군사대국화를 촉진하는 디딤돌로 삼을 수 있기 때문이다 그에 반해 우리가 얻을 것은 별로 없다 한일 군사정보보호협정은 중국을 자극해 동북아시아 안보구조를 악화시킬 가능성만 높여준다 실제 미국은 중국을 견제하기 위해 한 미 일 미사일방어 체계를 구축해 왔고 이를 위해 한일 군사정보보호협정의 체결을 압박해온 것으로 보인다 이 협정이 체결되면 한 미 일 대 북 중 러 의 신냉전 구도가 더욱 강화되어 북한 핵의 문제 해결을 보다 어렵게 만들 것이다 탄핵위기에 몰린 박근혜 대통령이 일본에게 우리의 군사기밀을 고스란히 넘겨주는 매국적 망동을 하는 이유는 대체 무엇인가 자신의 건재를 과시하려는 마지막 오기이자 예민한 사안에 대한 논란을 촉발시켜 잠시 시선을 돌리려는 책략이라고 볼 수밖에 없다 박 대통령과 그 부역자들은 엄중한 외교 사안을 추진할 자격이 없다 박 대통령은 천부당만부당한 한일 군사정보보호협정의 체결을 즉각 멈춰라 졸속 매국협정을 강행한다면 이를 주도한 자들을 우리 국민들이 똑똑히 기억하고 반드시 역사의 준엄한 심판을 받도록 할 것이다 게이트 동전 앞면은 박근혜 최순실의 욕망 뒷면은 삼성의 야망이다 어제 검찰은 제일모직 삼성물산 합병 과정에서 찬성 의결권을 행사한 국민연금공단의 불법행위와 외압 의혹에 대해 강제수사를 착수한다고 밝혔다 양사의 지분을 모두 들고 있는 국민연금공단은 삼성물산의 합병 비율이 적정하지 않아 투자 손실이 예상되는데도 합병에 찬성하는 비상식적인 선택을 했다 그 결과 국민의 혈세로 운용되는 국민연금은 최소 억 원의 손실을 입은 반면 이재용 부회장은 삼성전자에 대한 지배를 더욱 강화하고 수천억 원대의 부당 이득까지 본 것으로 추산된다 한 언론이 공개한 국민연금공단의 내부 법률보고서에 따르면 외부 전문가의 의견 수렴을 생략한 채 내부 인력만의 투자위원회에서 합병 찬성이 결정되어 절차상 문제가 크다고 지적했다 그동안 합병 찬성에 문제는 없었다는 해명이 새빨간 거짓으로 드러난 것이다 게다가 청와대와 보건복지부장관이 합병 찬성을 종용했다는 증언까지 나왔다 한편 삼성은 미르 스포츠재단에 억 원을 출연한 것과 별도로 최순실 씨가 세운 독일회사에 억 원을 직접 전달하고 정유라 씨에게 말과 승마 경기장을 지원하는 등 최 씨 모녀에게 유난히 많은 정성을 기울여왔다 삼성이 아무런 대가도 없이 최순실 모녀에게 수백억 원을 지원했겠는가 삼성과 한화 사이에 진행된 화학 방산계열사 빅딜 당시 대한승마협회 회장사가 한화에서 삼성으로 바뀌는 과정에서 최 씨가 개입한 것 아니냐는 의혹까지 겹치면서 박근혜 최순실 게이트는 삼성의 기업적 야심과 떼려야 뗄 수 없는 관계라는 것이 점차 선명해지고 있다 삼성이 경영권과 부의 세습을 공고히 하기 위해 비선실세에 결탁하고 뇌물까지 주었다는 의혹이 사실로 드러난다면 국민들은 결코 좌시하지 않을 것이다 검찰은 철저히 조사해 국민적 의구심을 해소시키기 바란다 청와대는 불법 피부미용 시술소인가 청와대가 최근 년여 동안 태반주사 개 감초주사 개 마늘주사 개 등 만 원이 넘는 약품을 나랏돈으로 사들인 것으로 확인됐다 이들 약품은 잔주름 개선 피부미백 노화방지 등에 효능이 있다고 하니 박근혜 대통령이 국민의 피 같은 세금을 얼굴에 퍼부은 것 아니냐는 의심이 생길 수밖에 없다 이렇게 많은 분량의 주사제라면 청와대에 불법 피부미용 시술소 를 차려도 될 정도이다 뿐만 아니라 청와대의 구입 목록에는 입에 담기 민망한 남성 치료제까지 포함되어 있다니 이 막장드라마의 끝은 도대체 어디까지인가 청와대는 경호실을 비롯한 근무자들의 건강관리를 위해 정상적으로 구매했다 는 구차한 변명이나 늘어놓고 있으니 가관이다 대통령에 대한 의혹을 직원들에게 돌리다니 참으로 후안무치하다 그런데 주사제를 공급한 녹십자의 자회사인 녹십자아이메드의 원장이 바로 최순실 자매에게 대리 처방을 해줬고 청와대에 매주 들어가 대통령을 진료한 의혹을 받고 있는 차움병원 출신의 김상만 의사라는 점에서 궁금증은 더욱 깊어질 수밖에 없다 이에 더하여 박 대통령이 취임 이후인 년 월과 월에도 차움병원에서 길라임 이라는 이름으로 안티에이징 노화방지 진료를 받은 정황이 확인됐다는 언론보도까지 나오고 있어 국민들은 절망과 분노의 탄식을 쏟아내고 있다 국정은 도외시 한 채 얼굴 미용에만 신경을 쓰는 박 대통령을 우리 국민은 털끝만큼도 용서할 수 없다 검찰과 사법부는 국정을 저잣거리 투전판으로 전락시킨 박 대통령의 죄상을 낱낱이 밝히고 그 대가를 반드시 치르게 해주기를 바란다 검찰에 이어 국정원마저 하수인으로 삼은 우병우 전 수석 우병우 전 민정수석과 문고리 인방이 국정원 간부 인사에 무리하게 개입한 사실이 언론보도를 통해 드러났다 이들은 자신들에게 최순실씨 관련 정보를 직보한 혐의를 받고 있는 추모 국장의 승진을 위해 압력을 행사했고 문제를 삼았던 인사는 찍어냈다고 한다 우 전 수석이 검찰 조직을 권력의 주구로 만든 것도 모자라 국정원마저 국정농단의 하수인으로 전락하게 한 것이 아닌지 의심스럽다 검찰은 우 전 수석에 대한 미온적인 수사 태도를 버리고 즉각 국정농단의 주범으로 구속 수사해야 한다 또 문고리 인방이 모두 박근혜 최순실 게이트의 공범이거나 종범으로 보이는 만큼 이재만 안봉근 두 사람 역시 당장 소환해 엄정 수사할 것을 촉구한다 아울러 검찰은 조직 내부에 여전히 잔존하는 우병우 사단을 모조리 거둬내 검찰의 수사의지에 대한 국민의 우려를 씻어낼 것을 엄중히 촉구한다 검찰은 김기춘 전 비서실장을 즉각 수사하라 어제 김기춘 전 비서실장은 최순실 씨가 국정에 개입하고 있다는 사실을 까맣게 몰랐다 고 말했다 단언해서 말씀드린다 새빨간 거짓말이다 김기춘 전 비서실장과 최순실 씨와의 연결고리는 매일같이 밝혀지고 있다 김종 전 문체부차관은 김기춘 전 비서실장의 소개로 최순실 씨를 알게 됐다 고 진술했다 년 박 대통령이 저도에서 휴가를 보낼 당시 김기춘 전 실장과 최순실 씨도 함께 있었다는 증언도 나왔다 김기춘 전 비서실장이 최순실 씨가 소유한 건물의 사무실을 사용했다는 의혹도 제기됐다 김기춘 전 비서실장이 최순실씨와 함께 국정농단의 주범이라는 정황도 계속 포착되고 있다 세월호 당시 박 대통령의 시간 행적에 대해 보도한 일본 산케이신문 지국장이 명예훼손으로 고발됐던 사건도 김기춘 전 비서실장이 막후 지휘했다는 증거도 나왔다 김종덕 전 문체부 장관 김종 전 문체부 차관 김상률 전 청와대 교육문화수석 송성각 전 한국콘텐츠진흥원 원장은 김기춘 비서실장의 개입으로 그 자리에 있을 수 있었다고 한다 지금까지 드러난 비선실세 국정농단의 실상은 빙산의 일각에 불과하다 김기춘 전 비서실장이라는 판도라의 상자는 아직 열리지 않았다 검찰은 김기춘 전 비서실장을 즉각 구속수사 하여 비선실세 국정농단의 전모를 밝히고 모든 죗값을 치르게 해야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59101,2016-11-22, 박경미 대변인 추가 현안 브리핑 일시 시 분 장소 국회 정론관 정진석 원내대표는 당원 동원 주장의 근거를 제시하라 새누리당 정진석 원내대표가 오늘 대규모 군중 동원의 한 주체가 더불어민주당이라는 것은 누구나 다 아는 사실 이라며 전세버스 및 당원 동원을 중단해 달라 고 주장했다 더불어민주당과 당원들에 대한 모욕이다 정진석 원내대표는 무슨 근거로 그러한 주장을 했는지 근거를 밝힐 것을 요구한다 우리당 당원들은 동원의 대상이 아니며 자발적 참여의 주체이다 우리당이 그동안 깨끗한 정치를 실현하기 위해 지속적으로 노력해왔음을 국민들께서 잘 알고 계신다 새누리당은 어떤지 모르겠지만 우리당에 대해 아무런 근거도 없는 비방을 하는 것은 참기 어렵다 지난 토요일 보수단체 집회에서 돈 봉투 사건이 터지자 이를 물타기 하려는 모양인데 참으로 후안무치하다 정진석 원내대표는 더불어민주당과 당원들에 대해서 정식으로 사과할 것을 엄중히 촉구한다 국민의당은 대통령 탄핵을 바라는 국민의 기대를 흔들지 말라 국민의당 최경환 원내기획부대표가 탄핵과 관련한 우리당의 태도가 너무도 느긋하다고 비난했다 박근혜 대통령의 퇴진을 바라는 국민들의 기대가 야권에 모아지고 있는 때에 국민의당이 야권 공조를 해치려는 듯한 발언을 쏟아내고 있어 매우 유감스럽다 탄핵이 하루아침에 될 일인 것처럼 말해서는 안 된다 속도보다 중요한 것은 실질적으로 성사되도록 해야 한다는 점이다 더불어민주당은 박근혜 대통령에 대한 탄핵이 관철될 수 있도록 제반 여건을 충분히 고려하며 철저한 준비를 하고 있다는 점을 밝힌다 한편 국민의당은 청와대가 이미 철회할 뜻을 내비치는 총리 문제에 대해서 왜 이렇게 집착하는 듯한 태도를 보이는지 모르겠다 지나치게 당리당략적인 모습은 아닌지 자성하기 바란다 국민들은 야 당이 힘을 하나로 모아 박근혜 대통령을 퇴진시키고 혼돈에 빠진 국정을 정상화해줄 것을 요구하고 있다 국민의당은 백가쟁명 식 논란으로 국민을 실망시키지 말고 무거운 책임감으로 야권 공조에 임해주길 호소한다 아울러 지금 국민의당이 압박해야 할 대상은 더불어민주당이 아니라 청와대와 새누리당이라는 점을 분명히 지적한다 민주화에 앞장섰던 고 김영삼 대통령을 기린다 오늘 고 김영삼 전 대통령의 주기 추모식이 현충원에서 엄수됐다 우리 당 추미애 대표는 나라가 혼미하고 국민 주권을 되찾자는 함성이 깊어질수록 김 전 대통령이 더욱 많이 생각난다 이 시대를 이끌 정치인으로서 무거운 책무감을 느낀다 고 소감을 밝혔다 또한 새누리당에 대해 헌법기관으로 자기 이름 석 자가 어떤 의미를 갖는지 스스로 깨닫기를 바란다 며 대통령 퇴진 및 탄핵 동참을 촉구했다 고 김영삼 대통령은 박정희 전두환으로 이어지는 서슬 퍼런 군부독재 시절에 고 김대중 대통령과 함께 야당의 강력한 지도자로서 민주주의의 부활을 위해 정치인생을 바친 큰 정치인이다 특히 년 월 민주항쟁의 맨 앞에서 투쟁하여 민주헌법과 투명사회를 여는 역사적 족적을 남겼고 대통령이 되어서는 문민통치의 기틀을 세웠고 더 나아가 역사 바로 세우기 금융실명제 실시 하나회 척결 쿠데타 심판 등의 업적을 남긴 존경받을 만한 지도자이다 대통령이 주범이 되어 국정을 농단하고 국기를 뒤흔드는 작금의 상황에 김영삼 대통령의 민주화에 대한 신념을 되새겨 본다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59098,2016-11-22, 금태섭 대변인 오후 현안 추가 브리핑 일시 시 분 장소 국회 정론관 국민의당은 야권공조를 흔드는 이유를 분명히 하라 오늘 국민의당 이용호 원내대변인의 발언은 그동안의 야권공조를 흔드는 심각한 분열행위이다 이 대변인은 오늘 우리당 문재인 전 대표에 대해서 혼선이 빚어진다 청와대 근처까지 가서 집권의 문턱까지 갔다고 생각하는 착각 마치 대통령이 다 된 것처럼 행동하고 있다 라고 심한 비난을 퍼부었다 더불어민주당과 문재인 전 대표를 비난하는 것을 국민의당의 전략적인 목표로 삼은 것 같다 국민의당 주장대로 엄중한 국가비상상황 에서 협력의 대상을 비난하는 것이 혼선을 만들고 야권공조의 진정성을 의심하게 만든다는 너무나 당연한 상식을 거스르는 행동이다 국민의당 박지원 비대위원장은 오늘 국민의당 원내대책회의의 발언들이 국민의당의 공식입장인지 분명히 해야 한다 야권공조를 흔드는 목적이 무엇인지 새누리당에서 나오는 근거 없는 이야기 까지 동원해서 상대당을 흠집내는 이유가 무엇인지 분명히 밝히기 바란다 야권공조를 흔드는 것은 촛불을 들고 광화문 광장에 나오는 만 시민들의 마음을 저버리는 행위라는 것을 명심하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59096,2016-11-22, 박경미 대변인 오후 현안 브리핑 일시 시 분 장소 국회 정론관 청와대는 대통령의 사적 업무를 도와주는 곳이 아니다 청와대는 민정수석실이 박근혜 대통령을 변호하는 유영하 변호사를 도왔다는 보도에 대해 법률과 관련한 것을 보조한 것은 민정수석실 업무 라고 해명했다 민정수석실이 주도한 것은 아니고 도와준 정도라고 밝혔지만 보도가 사실임을 시인한 셈이다 그러나 청와대는 대통령의 공무를 보좌하는 곳이지 사적 업무를 도와주는 곳이 아니다 특히 민정수석실은 대통령 친인척의 동향과 비위 공직자 인사를 검증하는 것을 주요 업무로 한다 그런 민정수석실이 직무를 유기하여 결국 전대미문의 국정농단 게이트가 벌어졌는데 이제는 피의자로 전락한 대통령의 변론을 보조하고 있으니 참으로 개탄스럽다 이러니 청와대가 비선실세들의 놀이터가 되고 국정농단과 국기문란의 복마전으로 전락한 것이다 최재경 민정수석이 임명되었을 때 기대를 한 국민도 별로 없었지만 혹시나 했는데 역시나이다 최재경 민정수석은 우병우 전 수석의 전철을 밝으려는 것이 아니라면 이번 사안에 대해 국민들 앞에 분명하게 해명할 것을 촉구한다 순실증 을 앓고 있는 국민들 역사 속에서나 존재하는 단어일 줄 알았던 하야 가 온 국민의 입으로 터져 나온 지 벌써 몇 주가 지났다 박근혜 최순실 게이트가 촉발한 분노 우울 자괴감 무기력증 등의 복합적 증상을 일컫는 이른바 순실증 을 호소하는 국민들이 늘고 있다고 한다 특히 년 민주화 이후 출생한 청년세대들이 느끼는 충격은 상상 이상이라고 한다 돈도 실력 이라는 정유라의 망언은 능력과 실력으로 승부할 수 있다는 믿음으로 년을 살아가고 있는 청년들의 가슴에 절망의 대못을 박았다 청와대가 측근들과 권력을 사유화하고 부를 축적하는 동안 우리 국민들은 무한경쟁 시대의 경주마처럼 오로지 앞만 보며 달려왔다 국민의 힘으로 독재정권을 물리고 민주정부를 세웠고 국민의 정부와 참여정부를 지나왔기에 누가 대통령이 된다한들 우리 정치가 지금과 같이 뿌리까지 흔들릴 것이라 상상도 하지 못했다 주말마다 펼쳐진 만 촛불 민심의 도도한 물결을 청와대는 보았는가 공자는 임금은 배와 같고 백성은 물과 같으니 물은 배를 띄울 수도 있지만 배를 뒤집을 수도 있다 군자주야 서인수야 수즉재주 수즉복주 고 했다 성난 민심의 파도는 배를 뒤집을 때까지 계속 휘몰아칠 것이다 문화예술인 블랙리스트도 부족해 체육계도 쥐락펴락하려고 했나 대한민국을 자랑스럽게 했던 운동선수들이 대통령의 비선실세들에게 찍혀 핍박 받았다고 한다 박태환 선수는 리우 올림픽에 불참하도록 김종 전 문체부차관으로부터 압력을 받았고 김연아 선수는 늘품체조 시연에 참석하지 않았다는 사소한 이유로 최순실의 조카 장시호에게 찍혀 불이익을 받았다고 한다 문화 예술계 인사들을 블랙리스트를 만들어 검열했던 이들이니 체육계인들 마수를 뻗고 싶지 않았겠는가 문화 예술과 체육을 진흥해야 할 문화체육관광부가 오히려 억압의 주체가 되었던 점은 공분을 자아낸다 검찰은 대통령의 힘을 이용해 대한민국을 제멋대로 농간한 비선실세들의 여죄를 모두 찾아내 엄단할 것을 강력히 촉구한다 세월호는 침몰했지만 진실은 결코 침몰하지 않는다 세월호 참사로 희생된 단원고 학생들과 교사들이 사용하던 교실과 교무실을 재현한 단원고 기억교실 이 어제 공개됐다 세월호가 침몰하는 그 긴박한 순간에 박 대통령은 시 분까지 구조하라 는 하나마나한 이야기만 남기고 잠적했다가 시간 후에야 나타나서는 상황을 전혀 파악 하지 못한 황당한 질문을 던졌다 이러니 시간 동안 대통령 행적에 대해 여러 가지 추측이 난무할 수밖에 없다 박 대통령이 한나라당 대표 시절부터 불법적인 줄기세포 치료를 받아왔다는 며칠 전 방송 내용은 충격적이었다 거기에 더해 오늘은 청와대가 최근 년여 동안 태반주사 감초주사 마늘주사 등 만 원어치의 약품을 사들였다는 보도가 있었고 청와대도 이를 시인했다 지난 년 반 동안 사라진 시간에 대해 침묵하던 청와대가 차 촛불집회 가 열린 날에야 홈페이지에 그날의 행적이라며 때늦은 변명을 올렸다 그러나 이는 그 긴박한 시간에 박 대통령이 왜 아무것도 안 했느냐 에 대한 답은 되지 않는다 박 대통령과 그 부역자들에게 세월호 희생자를 추모하는 노래의 가사를 들려준다 거짓은 참을 이길 수 없다 진실은 침몰하지 않는다 세월호 시간의 행적은 도도한 역사의 물결 속에서 그 실체를 드러낼 수밖에 없을 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59094,2016-11-22, 박경미 대변인 오전 현안 브리핑 일시 시 분 장소 국회 정론관 군사정보를 팔아먹는 한일 군사정보보호협정 체결을 즉각 중단하라 오늘 국무회의에서 한일 군사정보보호협정이 의결됐다 이제 대통령 재가와 최종 서명절차만 남았다 양국의 군사비밀정보를 공유하는 중대한 사안임에도 불구하고 협의를 시작한 지 불과 주 만에 졸속으로 체결한 박 대통령의 독선에 분노를 금할 길이 없다 한 언론 보도에 따르면 한일 위안부 합의 역시 윤병세 외교부장관이 석 달 추가 협상 을 요청했으나 박 대통령이 연내 타결을 강행했다고 한다 외교부 의견을 무시한 채 이병기 당시 비서실장과 일본 국가안전보장국장의 비밀 협상 에서 사실상 타결했다는 것이다 박근혜 대통령에게 묻는다 국민의 퇴출 명령까지 받는 마당에 국민들이 반대하는 외교 정책들을 마구잡이로 밀어붙이는 만용은 어디에서 나오는가 오늘 국무회의는 경질을 앞둔 유일호 경제부총리가 주재했다 청와대는 검찰 조사 결과에 부담을 느끼기 때문이라고 했는데 자신에게 쏟아질 비판을 의식해 뒤로 슬쩍 숨은 것에 불과하다는 것을 국민들은 잘 알고 있다 박 대통령은 전대미문의 국정농단 게이트로 국정을 마비시킨 것도 모자라 급기야 외교와 안보까지 파탄을 내고 있다 박 대통령은 국가안보를 담보로 한 위험한 불장난을 당장 중단하라 그렇지 않으면 박 대통령은 일본에 우리의 군사정보를 팔아먹고 굴욕적인 협상을 진행한 매국 대통령으로 역사에 기록될 것임을 국민의 이름으로 엄중하게 경고한다 대통령 역사 교과서 발언 그때는 맞고 지금은 틀리다 논어 안연편 에 나오는 민무신불립 백성의 신뢰가 없으면 나라가 설 수 없다는 말이다 신뢰는 정직을 바탕으로 장시간 일관성 있게 행동할 때 쌓인다 그러나 삼척동자도 알다시피 박근혜 대통령의 행보는 그렇지 못하다 역사교과서 국정화가 그 대표적인 예이다 박 대통령은 한나라당 대표 시절인 년 신년회견에서 어떤 경우든 정권이 역사를 재단하려 해선 안 된다 고 강조한 바 있다 년이 지난 년 국회 연설에서는 역사를 바로잡는 것은 정쟁의 대상이 될 수 없다 역사교육을 정상화하는 것은 당연한 과제이자 사명 이라고 역설했다 입장을 도 바꾼 것이다 교육부는 이제 국정 역사교과서를 대한민국 역사교과서 로 명명하고 예정대로 오는 일 현장검토본 그리고 편찬기준과 집필진 명 명단을 공개하겠다고 밝혔다 청와대는 정국 주도권을 놓지 않겠다고 시위하듯 국정 역사교과서를 강행하고 있는 것이다 년을 대한민국 수립일 로 삼아 임시정부의 법통을 부정한 교과서에 어찌 감히 대한민국 이라는 이름을 붙여 국민들의 자존심에 쇠말뚝을 박으려하는 것인가 국민은 국정 역사교과서의 본질이 최순실 박근혜 교과서 임을 명백히 알고 있다 내일 국회 교문위 법안소위에서는 최순실 박근혜 교과서 를 폐기하기 위한 법안들을 심사한다 국정 역사교과서 추진을 중단하라는 국민의 명을 받들어 야당은 이 법안을 반드시 통과시킬 것이다 자신의 이익을 위해 역사교육이라는 엄중한 정책을 손바닥 뒤집듯이 한 박 대통령은 이제라도 한민족 년 역사에 더 이상의 죄를 짓지 말고 국정 역사교과서를 폐기하기 바란다 유체이탈 화법의 종결자 박근혜 대통령 박근혜 대통령이 명예로운 퇴진 을 조언하는 원로 인사에게 내가 뭘 잘못했는데요 라고 반문했다는 증언은 대단히 충격적이다 청와대는 황급히 사실무근이라고 손사래를 쳤지만 자신의 잘못을 인정하지 않고 눈 감고 귀 막은 불통 대통령에 국민들은 기가 막힐 뿐이다 이 증언이 사실이라면 지금까지 의문이었던 퍼즐의 조각들이 맞춰진다 번번이 국민 앞에 진실을 말하고 용서를 구할 기회를 놓친 이유 만 촛불과 지지율에도 아무 일 없다는 듯이 버티는 이유 이제 와서 검찰조사에 응할 수 없다고 말을 바꾸며 몽니를 부리는 이유가 설명된다 검찰이 박 대통령을 강제로라도 소환해야 할 이유가 분명해졌다 박 대통령은 자신의 정치적 도의적 책임을 전혀 인지하지 못하는 수준이므로 검찰은 즉각 강제 조사하여 하나부터 열까지 박 대통령의 범죄 혐의를 조목조목 가르쳐주고 모든 죗값을 치르게 하는 일만 남았다 다시 한 번 강조한다 이런 대통령에게 분 초도 국정 운영을 맡겨둘 수 없다는 게 국민들의 결론이다 대한민국은 당신들의 놀이터 가 아니다 검찰 중간수사 발표에 최순실 씨가 만들고 차은택 씨가 운영에 관여한 광고회사 플레이그라운드 가 등장했다 플레이그라운드 의 사전적 의미는 놀이터 이다 박근혜 최순실 일당은 세상을 자신들의 놀이터로 삼아 국정을 농단하겠다는 어처구니없는 야망을 회사명에 담았던 것은 아닐까 이번 게이트의 전반을 들여다보면 청와대는 최순실의 놀이터 이화여대는 정유라의 놀이터 문화계는 차은택의 놀이터 체육계는 김종의 놀이터 의료계는 차움 병원의 놀이터 동계올림픽은 장시호의 놀이터 베트남은 장승호 놀이터였다 공사를 구분하지 못하고 비선실세의 돈벌이를 위해 대기업의 팔을 비튼 부박 한 대통령이 이 나라 현직 대통령이라니 우리 국민들은 부끄러워 얼굴을 들 수 없다 최근 네 차례의 집회에서 참가자들은 시종일관 평화를 유지하며 집회 후 휴지 한 조각 남기지 않고 깨끗이 청소하는 수준 높은 행동을 보여주었다 대통령 퇴진을 촉구하는 정치적인 집회마저 문화행사로 승화시킨 높은 수준의 국민과 온갖 일탈을 일삼은 범법자 대통령은 어울리지 않는다 이 시점에서 알베르 카뮈의 말을 되뇌어 본다 어제의 죄악을 벌하지 않는 것은 내일의 죄악에게 용기를 주는 것이다 민주공화국은 관용으로 건설되지 않는다 대한민국은 민주공화국이라는 헌법 조 항을 재확립하고 국민들의 자존감을 회복하기 위해서라도 대통령의 죗값을 반드시 치르게 해야 한다 더불어민주당은 김경재 자유총연맹 회장을 고발할 것이다 자유총연맹 김경재 회장은 지난 토요일 서울역 보수단체 집회에서 고인이 되신 노무현 대통령에 대해 근거 없는 비방을 늘어놓았다 또한 김경재 회장은 우리당 소속의 이해찬 의원에 대해서도 허위사실을 적시해 명예를 훼손했다 전대미문의 국정농단을 저지른 현직 대통령을 감싸기 위해 관제데모를 주도하고 고 노무현 대통령과 이해찬 의원에 대해 근거 없는 비방을 늘어놓은 것이 헌정 수호라는 말인가 더불어민주당은 진실을 왜곡하고 국민을 기만한 김경재 회장을 고발할 예정이라는 점을 밝힌다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59093,2016-11-22, 제 차 원내대책회의 모두발언 일시 화 오전 시 장소 국회 본청 원내대표 회의실 우상호 원내대표 더불어민주당은 어제 의원총회를 열어서 박근혜 대통령 탄핵을 당론으로 결정했다 이제 당내에 추진을 위한 실무기구를 설치해서 빠르게 탄핵소추안 작성 및 탄핵 정족수 확보를 위한 작업에 들어갈 예정이다 더불어민주당은 탄핵 정족수가 확보되면 지체 없이 탄핵소추안을 발의해서 탄핵안이 통과되도록 노력할 계획이다 정족수 확보가 야당 의석수만으로 될 수 있는 것이 아니기 때문에 정족수 확보를 어떤 방식으로 할지 다각적으로 모색하겠다 다시 말씀드리지만 탄핵 정족수가 확보되면 내일이라도 발의한다 오늘 국무회의에서 특검법이 통과됐다고 한다 야당 간의 협의를 통해서 제대로 된 수사지휘를 할 수 있는 특검 선정 작업부터 들어가도록 하겠다 검찰조사에서 미진한 부분들과 더 확대해서 수사해야 될 부분에 대해서 성역 없이 수사할 수 있는 분을 특검으로 선정하도록 노력하겠다 박근혜 최순실 게이트의 핵심 분야는 정경유착이다 대통령이 재벌에게 강요해 모금을 지시하고 재벌들은 자기 회사의 이해관계와 관련된 부탁을 하거나 혜택을 받을 것을 고려하여 금품을 제공한 전형적인 비리사건이다 이 문제에 대해서 성역 없이 수사해서 다시는 이런 식의 정경유착이 재발하지 않도록 해야 한다고 강조한다 특히 삼성 같은 경우는 피해자 코스프레를 할 수 없다 대통령이 부탁한 금품 이상의 별도의 금품을 비선실세인 최순실씨 가족에게 제공하고 지속적으로 편의를 제공한 적극적 협조의 혐의가 있기 때문에 빠져나갈 수 없다 이 문제들이 검찰의 차 수사발표에 포함되지 않은 것에 대해서 차 결과에 반드시 들어갈 것으로 기대하지만 혹시라도 망설이고 계시다면 검찰의 수사 의지에 대해서 국민들이 분노하게 될 것이라는 점을 경고한다 최순실 게이트 과정에서 국민감정을 건드린 것 중의 하나는 김종 문체부 차관이 박태환 선수에게 압력을 가했다는 것이다 박태환 선수는 심리적 압박이 너무 커서 올림픽에서 제대로 된 성적을 내지 못했다 스포츠분야를 담당하는 차관이 이런 짓을 해서 국민적 영웅에게 제대로 된 실력 발휘를 할 수 없게 만들었다는 것 이런 관료들이 이 정권에 있었다는 것이 한심스럽다 김연아 선수가 늘품체조 시연장에 참석하지 않아서 불이익을 줬다는 보도도 믿을 수 없다 얼마나 졸렬하고 봉건적인 체육정책들이 있었는지에 대해서 낱낱이 밝혀져야 할 대목이다 국정조사에서도 이 문제를 다루도록 하겠다 지금 정기국회 중인데 박근혜 최순실 게이트 탄핵 등 워낙 큰 현안들 때문에 법안과 예산 심의에 대한 관심이 상대적으로 소홀한 측면이 있다 이런 정국에서도 국민들의 삶과 관련된 문제들이 소홀히 되어서는 안 된다 오늘 시에 더불어민주당이 역점적으로 추진할 법안들과 관련해서 상임위 간사단 회의를 소집했다 꼼꼼하게 이번 정기국회에서 통과시켜야할 더불어민주당의 핵심법안들에 대해서 국민여러분께 보고 드리고 해당 상임위 간사들이 그 법안의 통과를 위해 최선을 다하도록 독려하도록 하겠다 윤호중 정책위의장 박근혜 대통령의 변호인을 맡고 있는 유영하 변호사가 대통령은 법정에서 항변할 기회가 없다 고 하면서 검찰 수사에 응할 수 없다는 이야기를 했다 중립적인 특검이 아니면 조사에 응하지 않겠다 고 이야기하고 있다 법정에서 항변할 기회가 없다는 것은 대통령이 제도의 피해자 검찰수사의 약자인 것처럼 코스프레를 하는 것이다 형사소추 되지 않을 권리는 대통령에게만 허용되는 특권이다 천만 국민 중에 어느 누구에게 형사소추 되지 않을 권리가 있는가 이 특권을 가지고 피해자 약자인 것처럼 뒤집어서 국민의 눈을 속이려고 하는 것이다 정말 가소롭다 그 특권이 무거우시다면 당장 내려놓으시면 된다 대통령직에서 물러나시면 형사소추 될 권리도 회복될 것이고 법정에서 항변할 기회를 무제한으로 드릴 수 있다 방금 전 국무회의에서 한일군사정보보호협정이 가결됐다고 한다 최순실 등 범죄자들과 공모한 사실이 명백히 드러나고 있고 검찰에 의해서 피의자 신분으로 전락한 현직 대통령이 과연 한일군사정보보호협정과 같은 국가안보와 국민안전에 지대한 영향을 미치는 정책을 추진할 자격과 권한이 있는지 묻지 않을 수 없다 국정농단 범죄의 몸통 내지는 주범으로 낙인찍힌 대통령은 이러한 중대 사안에 대해서 마음대로 좌지우지할 권리가 없다 국무회의 의결이 되면 대통령의 재가를 거쳐서 내일쯤 정식 협정 체결 사인을 하는 절차를 거치게 될 것으로 보인다 다음 주 월요일에는 교육부가 국정 역사교과서 현장검토본을 공개하겠다고 하고 있다 국정에 관여하는 모든 행위를 즉각 중단하고 피의자답게 국정에서 손을 떼고 즉각 퇴진하는 것이 대통령이 하실 일이다 정부 역시 한일군사정보보호협정 국정역사교과서 공개를 즉각 중단하기 바란다 트럼프 미국 대통령의 당선과 더불어 미국의 정책금리가 월에 인상될 것으로 확정되어가고 있다 본격적인 금리 상승기가 도래하는 것이 아닌지 우려된다 이미 시중금리가 올라가기 시작했다 한국은행 역시 국고채 금리가 올라가는 것을 막기 위해서 지난 일에 조 억원 규모의 국고채를 매입했다 금융시장 안정용이라고 이야기하고 있지만 조 억 규모는 지난 위기와 년 국제금융위기 이후 최대 규모의 국고채 매입이다 심각하게 금리인상에 대해서 우려를 하고 있는 것이 한국은행에 의해서도 확인되고 있다 한국은행이 지금 신경써야할 것은 금융안정만이 아니다 트럼프 행정부가 조 달러 규모에 이르는 신규 인프라 투자를 하겠다고 정책을 발표하고 있다 그래서 이미 미국에서부터 물가인상 트럼플레이션 의 우려가 나오고 있다 우리나라도 금리인상 못지않게 물가인상에 대해서 심각하게 감시해야 할 시기다 이미 월부터 우리 물가는 전년 대비 이상의 상승을 하고 있다 대 물가상승률을 벗어나고 있다 한국은행과 금융위원회 등 금융당국에 다시 한 번 촉구한다 가계부채와 기업부채에 직접적인 부담이 될 금리인상과 물가인상 등 모든 문제를 집중 감시해서 금융시장 안정과 물가안정에 만전을 기해주기 바란다 홍익표 정책위 수석부의장 이번 박근혜 최순실 게이트에서 드러난 바와 같이 재벌 대기업은 자신들의 세 경영승계 재벌 오너들의 사면복권 각종 이권사업에 대한 규제완화 자신들이 원하는 법률 통과와 관련한 민원처리를 하는 과정에서 적극적으로 권력에게 돈을 제공한 것이다 전형적인 정경유착이다 아쉽게도 검찰이 중간수사 발표과정에서 뇌물죄가 아니라 강요죄를 적용한 것은 재벌기업들에 대한 봐주기 수사로 비쳐진다 매우 잘못된 것이다 그 중심에 전경련이 있다 전경련은 그 태생부터 정경유착의 산물이다 년 쿠데타 당시 구속된 부패기업인을 구제하는 조건으로 정부에 협조하는 차원에서 만들어진 것이 전경련의 전신이다 이제 전경련 자신이 해체에 준하는 개혁을 하지 않는다면 국민들이 매우 엄격하게 전경련에 대한 심판을 하실 것이다 정경유착이 갖는 해악은 매우 심각하다 첫 번째 정경유착은 자유롭고 공정한 시장경제를 교란하고 위협한다 두 번째 정경유착은 재벌대기업의 독과점에 따른 상생의 경제생태계를 파괴하고 중산층과 서민의 삶을 위협한다 세 번째 정경유착은 정치학 고전에서 가장 나쁘다고 표현되는 금권정치를 가능하게 하는 토대가 된다 정경유착은 민주주의 시장경제 중산층과 서민의 삶을 위협하는 중대한 범죄행위이자 헌법에 도전하는 행위다 검찰은 재벌오너에 대한 예외 없는 수사와 엄정한 수사를 통해서 우리 사회에서 돈으로 사고 팔 수 없는 것이 있다는 것을 우리 미래 세대들에게 보여줘야 한다 그것이 무너진 헌법질서를 회복하고 사회정의를 회복하는 것이다 다시 한 번 검찰의 엄정한 수사를 촉구하면서 국회 차원에서도 재벌대기업에 의한 각종 폐해와 시장교란행위를 막을 수 있는 적극적인 관련 법 제도를 만드는데 최선을 다하겠다 전경련에 대해서 해당 상임위에서도 좌시하지 않겠다 김한정 부대표 탄핵소추 표결과 관련된 현행 국회법은 무기명 투표로 하게 되어있어서 표결 결과에 불확실성이 있다 그래서 국민들이 불안해하고 있다 민의가 제대로 반영될 것인가 걱정이 있다 이러한 중대한 국가적 결정에 대해서 무기명 투표는 적절하지 않다고 본다 국민의 알 권리가 보장되어야 한다고 생각한다 오늘 우리 더불어민주당을 비롯한 야당 의원들은 관련 국회법 개정안 발의에 나선다 특히 미국 영국 일본 등 선진국과 최근 대통령 탄핵을 추진한 브라질도 대통령 국가지도자에 대한 탄핵소추 표결을 기명 투표로 하고 있다 선진국의 관례이다 우리만 안하고 있다 현재 재적 과반수가 아니라 재적 가 필요한 탄핵 소추 결의인 만큼 기명으로 바꿔서 우리 국민들이 어떤 국회의원들이 우리의 민의를 대변하고 있고 어떤 국회의원이 어떤 투표를 했는지 알권리를 보장해주는 국회법 개정안 발의에 여당도 협력과 호응을 해주기를 바란다 박완주 원내수석부대표 김한정 부대표님의 말씀은 당론으로 추진됐다는 말씀은 아니고 탄핵과 관련해 의원님들의 의견이 있다는 말씀을 드린다 정권은 짧고 돈은 영원하다 지난 일요일 검찰이 선언한 박근혜 최순실 게이트의 중간 수사발표 결과이다 검찰은 죽어가는 정치권력에는 칼날을 들이대고 살아있는 경제 권력에는 면죄부를 부여하는 듯하다 대통령을 피의자로 입건하는 헌정 사상 초유의 사태에도 피해자 코스프레에 나선 재벌을 비호하는 모순만 보였다 수백억이 오고간 권력형 비리게이트를 수사하면서 돈을 요구한 자만 지고 있고 돈을 건넨 자는 죄가 없다고 강변하는 듯하다 엄정한 수사를 요구하는 만 촛불의 외침은 검찰도 엄중하고 무겁게 받아들여야 할 것이다 누차 강조하지만 재벌은 박근혜 최순실 게이트의 공범이다 삼성의 최순실 일가에 대한 금품 헌납 국민연금을 이용한 경영권 승계 특별사면 롯데 억 수사 면제 특별사면 등 많은 의혹을 가지고 있다 이번 사태를 둘러싼 모든 의혹의 끝은 결국 재벌을 향하고 있다 특검이 시작되기 전까지 시간이 남아있다 검찰에 최후의 일각까지 철저한 수사를 다시 한 번 촉구한다 돈과 권력이 맞물려 발생하는 악순환의 고리를 이제는 과감히 끊어내야 한다 변화가 없다면 제 의 최순실은 언제든 또 다시 등장할 수밖에 없다 개혁이 없다면 또다시 대한민국호 는 언제든지 파산 될 수밖에 없다 특검과 국정조사를 앞두고 있다 이번 국정조사에서는 삼성 현대 롯데 한화 한진 에 이르는 대 재벌기업 총수들이 청문회 증인으로 채택되었다 또한 이번 기업의 모금 창구 역할을 맡았던 전경련도 증인으로 채택되었다 청문회에 출석하지 않을 이유가 없다 이번 국정조사에서 박근혜 최순실 게이트의 정경유착을 반드시 밝히고 특검에서 반드시 처벌해야 한다 이 길만이 또 다른 최순실의 등장을 막는 근본적 해결책 마련에 첫 걸음이 될 것이다 더불어민주당은 최선을 다하겠다 우상호 원내대표 오늘 원내대표 수석부대표 정책위의장 수석부의장이 일관되게 정경유착을 끊어야 한다고 강조했다 역시 재벌 개혁이라고 하는 화두를 이번 정기국회 최대의 화두로 상정하겠다는 의지의 표현으로 이해해주시기를 바란다 시에 발표하겠지만 김종인 의원께서 대표발의하신 상법 공정거래위원회의 전속고발권 폐지와 관련된 개의 법안은 경제민주화를 위해 피할 수 없는 법안이다 이 법안들이 이번 정기국회에서 통과되어 새누리당도 정경유착의 고리를 끊고 재벌개혁에 동참하겠다는 의사표현으로 강조할 것이다 이를 거절한다면 저는 어두운 정경유착의 역사를 계속 가져가겠다는 의사로 판단할 수밖에 없다 새누리당도 남은 정기국회 기간 중에 적어도 상법과 전속고발권폐지와 관련된 법안을 통과시키는데 협조해달라고 강조한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59092,2016-11-22, 기동민 원내대변인 오전 현안 브리핑 일시 화 장소 정론관 국민의 이름으로 대통령을 탄핵한다 돌아올 수 없는 강을 건넜다 국민의 명령을 거부한 대통령에게 남은 것은 역사 속으로의 강제퇴장 뿐이다 국민이 물러나라면 대통령도 물러나는 것이 우리나라의 헌법 정신이다 박근혜 대통령은 국민이 위임하고 헌법이 보장한 권력의 정당성을 상실했다 일신의 안위를 위한 야욕과 집착만 남아있을 뿐이다 물러날 때를 모르는 권력자는 국민의 이름으로 탄핵해야 한다 누구를 원망할 일도 아니고 동정과 연민의 대상은 더더욱 아니다 스스로 자초한 일이다 우리당은 국민의 이름으로 대통령의 탄핵을 결정했다 대통령이라는 직책 이 뭔지도 몰랐던 권력자 에게 유린당한 국민의 권리를 되찾아올 것이다 더 이상 불행한 역사가 반복되지 않기 위한 결단이다 우리당은 대통령의 권력 연장 야욕에 반대하는 야당과 새누리당 내 양심 세력 시민사회 학생 노동자 농민 자영업자 등 뜻을 같이하는 모든 이들과 연대하여 반드시 탄핵을 관철할 것이다 백만 촛불로 타오른 국민의 명령을 겸허히 받들고 박근혜 정권이 남긴 오욕의 흔적을 씻어나갈 것이다 한일 군사정보보호협정 국무회의 졸속 통과는 용납할 수 없다 모든 권력은 국민으로부터 나오고 공무원은 국민 전체에 대한 봉사자다 우리 헌법 정신이다 국민의 녹을 먹는 모든 공직자들은 대통령 명령 이전에 국민의 명령을 따라야 한다 그것이 공직수행의 올바른 자세다 더군다나 국민이 이미 탄핵한 박근혜 정권이라면 더더욱 그렇다 그런데도 대통령과 현 국무위원들은 국민을 배신하고 한일 군사정보보호협정을 졸속으로 통과시켰다 한일 군사정보보호협정은 국민이 인정하지 않는 굴욕적 매국협상이다 우리당은 밀실 졸속 굴욕 한일 군사정보보호협정 체결은 용납할 수 없고 이 협정을 주도하고 동조한 모든 책임자들에게 그에 따른 응당한 책임을 물을 것임을 다시 한 번 강조한다 국조 포비아 를 외치는 재벌 자신들의 과오부터 반성하라 박근혜 최순실 부역자들이 국민의 피같은 노후자금을 재벌 대기업에 갖다 바쳤다 수천 억원의 국민 노후자금 손실을 외면하고 삼성 말을 따랐다 절차와 관행도 무시됐다 시너지 운운했지만 이는 삼성의 발표를 앵무새처럼 옮긴 것에 불과하다 박근혜 대통령과 친박 실세 최경환 전 경제부총리 문형표 전 보건복지부 장관 홍완선 전 기금운용본부장 등은 선량한 관리자로서의 의무 를 내팽개쳤다 국민의 미래를 재벌에 갖다 바친 배임 죄인들 이다 삼성도 공범이다 비선실세에 자금을 헌납하고 세 경영권을 공고히 했다 권력과 재벌의 추악한 부패의 카르텔만 남았을 뿐이다 국정조사를 앞둔 재벌들이 면박주기 망신주기 보여주기 정치쇼 라며 반발하고 있다 적반하장이다 면박 받을 일을 했고 망신당할 죄를 졌다 국민 몰래 밀실에서 권력과 짬짜미한 죄과를 치러야 한다 이재용 정몽구 최태원 구본무 신동빈 김승연 조양호 손경식 허창수 등 명의 재벌 증인들은 국민들 앞에 과오를 낱낱이 고하고 응당한 처벌을 받아야 한다 이번 국정조사를 계기로 한국사회 이면에 도사리고 있는 권력과 재벌의 어두운 고리를 깔끔하게 도려내고 경제민주화의 초석을 만들어야 한다 검찰 역시 재벌들의 부당한 거래에 대해 철저히 수사하고 책임을 물어야 한다 뇌물을 받은 자 못지않게 뇌물을 건넨 자 역시 중죄인이다 이를 외면한다면 재벌검찰 이란 오명까지 뒤집어쓰게 될 것이다 남의 일 말하듯 하는 국정농단 사태에서 자유로울 수 없다 어떻게 이렇게 부끄럽고 부끄러운 일이 일어날 수 있는가 작금의 사태를 마치 남의 일인양 언급한 이명박 전 대통령의 말이다 박근혜 최순실 게이트의 책임은 이명박 정부에게도 있다 권력과 재벌의 부패한 짬짜미는 이명박 정부에서 절정에 달했다 해외자원개발 대강 사업 등 수십조 혈세를 날렸고 누군가가 이 과정에서 사익을 봤다 한일군사정보보호협정 역사 국정교과서도 정부에서 잉태된 일이다 년 경선과정에서 이미 파악했을 것으로 추정되는 최순실의 실상을 묵인 방조했다는 책임으로부터도 결코 자유로울 수 없다 전직 대통령 의 예우라도 받고자 한다면 조용히 반성하고 그 입 다무시길 바란다 노동자에게 가혹한 검찰 형평성을 잃었다 검찰이 한상균 민주노총위원장의 심 재판에서도 징역 년의 중형을 구형했다 징역 년을 선고한 심 판결이 가볍다고 했다 왜 이 정부와 검찰은 유독 노동자들에게만 가혹한가 평화적 촛불집회를 핑계로 폭력과 불법을 불러일으킨 경찰의 살수차와 차벽에는 왜 눈을 감는가 노동개악 대기업 고용주들과의 유착 비정규직 차별 열악한 최저임금과 노동시간 등 최고수준의 열악한 노동 환경을 외면하고 노동자들만 엄단하겠다는 건가 이명박 정부 년 박근혜 정부 년 반 동안 묵살하고 억압하고 누르기만 했을 뿐이다 대화와 타협의 장으로 이끌어야 할 정부가 노동자들을 거리로 내몬 원인 제공자다 한상균 위원장에 대한 년 구형 가혹한 처사다 재판부의 현명한 판단과 선처를 기대한다 사라진 세월호 시간 대통령이 직접 해명하라 세월호 참사 당일 대통령은 관저에서 전화지시만 했다 상황의 시급성을 몰랐던 건지 알아도 못나올 이유가 있었는지는 그 누구도 알 수 없다 구속된 문고리권력 정호성 비서관이 세월호와 관련한 대면보고를 막았다는 의혹이 나왔다 대통령에게 대리처방한 것으로 의심받는 김상만 원장 외에 또 다른 대리 처방의사까지 등장했다 전 국민이 기억하는 월 일 무엇을 했는가라는 질문에 이들은 기억이 나지 않는다 고 말했다 기억을 못하는 건지 기억해서는 안 되는 건지 의구심만 증폭될 뿐이다 대통령이 직접 해명해야 한다 국민의 의문에 답해야 한다 대통령이 침묵할수록 의구심만 증폭된다 다른 날도 아니고 우리 국민 분이 억울하게 수장당한 날이기 때문이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59089,2016-11-21, 추미애 대표 대전시당 세종시당 박근혜 대통령 퇴진 국민주권운동본부 공동출정식 인사말 일시 월 오후 시 장소 대전 서구 삼성디지털프라자 둔산중앙점 앞 추미애 대표 존경하는 대전 시민 여러분 사랑하는 애당동지 여러분 더불어민주당 당대표 추미애 인사드린다 요즘 불면의 밤이 계속되고 있다 나라 걱정이 태산이실 것이다 늘어나는 가계부채 공부를 열심히 해도 일자리를 못 찾는 우리 아이들의 미래를 생각하니 나라가 이 꼴인데 잠이 올 리가 있겠는가 나라를 이 지경으로 만들어놓고도 검찰 조사를 못 받겠다며 변호사를 선임하며 대통령이 나라를 더욱더 어둡게 만들고 있는 지경이다 우리 보통 사람들도 죄를 지으면 가슴이 콩콩거리고 낯을 들 수가 없을 지경인데 대통령은 검찰수사도 못 받겠다고 하다가 이제는 특별검사도 마음에 안 들면 조사 안 받을 수 있다고 큰소리를 치고 있다 대통령이 더 이상 큰소리치지 못하도록 하야하라 물러나라 고 외쳐주시라 오늘 우리는 박근혜 대통령이 무너뜨린 헌정질서를 바로잡고 국민이 대통령에게 준 권한을 회수하기 위해서 모였다 오늘은 국민주권을 수호하기 위해서 대전에서 국민운동본부가 출발하는 날이다 대통령의 특권은 우리 국민이 준 것이다 대통령은 헌법상 특권을 주장하면서 내란죄나 외환죄를 빼놓고는 재직 중에 형사상의 소추를 받지 않는다고 주장하고 있다 그것은 대통령으로서 올바르고 제대로 국격을 유지하고 대통령 업무를 수행했을 때 준 권한인 것이지 대통령 권한을 최순실에게 상납한 개인과 가족의 비리의 공범 주범한테 준 것이 아니다 그래서 대통령은 헌법상의 특권을 주장할 자격조차 없다 오늘 보니까 대통령이 다음 국무총리와 국정원장을 뽑는데도 모두 다 최순실 선생한테 물어보라 고 했다고 한다 국가의 직책을 맡을 국무총리도 최 선생한테 물어보라 고 결재 받으라 고 했던 대통령이다 무자격자에게 국무총리를 물어서 결재를 받아 오라고 한 한심한 대통령이었다 어제 공소장에는 대통령이 단순한 국정농단의 피해자 중의 한사람이 아니라 주범으로 적시됐다 공범도 아닌 주범이었던 것이다 이런 대통령이 미르 스포츠 재단을 만들어서 공익으로 포장하고 마치 곶감 빼먹듯이 재벌의 팔목을 비틀어서 헌납을 강요하고 그 돈을 가지고 사익을 챙기려고 희한한 구조의 재단법인을 만들었다고 공소장에는 적시되어있다 뿐만 아니다 문화융성 창조경제 같은 화려한 말로 국민을 속이기까지 했다 국정을 철저하게 유린하고 농단한 대통령이 우리 아이들에게 부끄럽다 우리 아이들에게 올바로 된 대한민국을 물려주기 위해서 우리 아이들의 꿈을 제대로 만들어주기 위해서 우리가 지켜야한다 그래서 대통령이 스스로 물러나지 않겠다고 버티기를 선언한 이상 우리는 대통령을 끌어내려야 하는 것이다 대통령이 끝까지 버티기를 한다면 우리는 국회의원으로서 헌법절차에 따라 탄핵을 할 수 밖에 없다 국민의 이상이 대통령의 자격이 없다고 하는 마당에 공범자집단 부역자집단인 새누리당이 대통령을 엄호한다면 국민 여러분이 먼저 새누리당을 심판해 달라 만약 탄핵절차에 돌입할 때 헌법기관으로서 헌법을 사수하는데 새누리당 의원들이 묵묵부답하고 눈치 보기를 한다면 여러분이 새누리당 국회의원의 집 앞마다 삼삼오오 대열을 지어서 그 국회의원의 손을 붙잡아 국회로 보내주시기 바란다 무릇 주권은 국민으로부터 나오고 모든 헌법기관은 국민의 뜻을 준엄하게 받들 수밖에 없다는 것을 이번 기회에 보여주시기 바란다 새누리당은 대통령과 공범으로써 해체되어야 할 집단이다 그런데 이 순간에도 새누리당 대표는 대통령을 감싸고 있다 대통령은 얼른 나를 탄핵하라 헌법재판소 재판관들은 내가 임명했던 사람들인데 그들이 배신할 리가 없지 않느냐 고 떵떵거리고 있다 우리가 보여주자 전국 방방곡곡에서 대통령 탄핵 서명운동으로 국민의 의사를 제대로 보여줘서 헌법재판관 개개인도 출세한 자리가 아니라 국민을 대신해서 있는 자리라는 것을 확실하게 보여주시라 그래서 도도한 정의의 물결을 어느 누구도 거스를 수가 없다는 것을 선포하는 자리가 돼야한다 존경하는 대전시 애국시민 여러분 이제 우리는 역사를 만드는 대장정을 시작했다 헝클어지고 짓밟힌 역사는 다시 고쳐 쓸 수는 없지만 새로운 역사는 얼마든지 만들 수 있다 이제는 국민이 주권자로서 정의롭고 당당한 새로운 대한민국을 써내려가는 데 여러분 한 분 한 분 동참해주실 것을 이 자리에서 약속해주시라 +http://theminjoo.kr/briefingDetail.do?bd_seq=59086,2016-11-21, 윤관석 수석대변인 추가 현안 서면 브리핑 는 길환영 전 사장의 해임은 정당하다는 대법원의 판결을 공영성 회복의 기회로 삼기 바란다 오늘 세월호 참사 보도개입 의혹을 받은 길환영 전 사장의 해임은 정당하다는 대법원의 최종 판단이 나왔다 대법원이 보도 내용으로 세월호 유가족이 피해를 입고 국민 신뢰에 타격을 줬다면 원고의 책임으로 귀결될 수밖에 없다 는 심의 판결을 다시금 확인한 것이다 청와대 하수인 역할에 골몰했던 길 전 사장의 해임은 정당하다는 대법원의 판결을 존중하며 가 공영방송으로서 공정성을 회복하는 계기로 삼길 바란다 는 세월호 참사 발생 당시 전원구조 라는 오보를 내고 정부의 구조작업을 과장해서 보도하는 등 스스로 공영방송으로서의 신뢰도에 깊은 의문을 자아냈다 길환영 사장은 이후 보도 통제 논란으로 대내외적 반발이 거세지자 해임됐지만 박근혜 정권의 언론 장악과 방송 통제는 계속됐다 이정현 전 청와대 홍보수석의 보도 개입은 물론이고 김기춘 전 비서실장도 사장 선임과 이사장 선출 보도 및 시사 프로그램에 개입했다는 폭로가 제기됐다 의 공정성을 짓밟고 국민의 알권리를 침해하며 민주주의 후퇴에 앞장선 이정현 새누리당 대표와 김기춘 전 비서실장도 법의 준엄한 심판대에 서야 한다 고대영 사장 또한 오늘의 판결로부터 자유롭지 못하다는 점에서 자신과 지금의 에 대한 비판을 깊게 되새기길 경고한다 는 이번 대법원의 판결을 무겁게 받아들여 공영방송으로서의 공정성과 독립성 객관성과 공익성 회복을 위해 나설 것을 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59084,2016-11-21, 기동민 원내대변인 의원총회 결과 브리핑 일시 월 오후 시 분 장소 국회 정론관 의원총회 결과 오늘 더불어민주당은 백만 촛불 민심과 오천만 국민의 뜻을 받들어 박근혜 대통령 탄핵 추진 을 만장일치로 결정했다 이를 위해 당내에 탄핵추진기구를 구성하기로 했다 이 기구는 법리적 검토 등 탄핵과 관련된 다양한 실무적 준비를 할 예정이다 온 국민의 마음을 모아 탄핵을 추진하기 위해서 야 당 공조는 물론이고 시민사회 새누리당 비박계 등 탄핵에 동의하는 모든 세력과 함께하기 위한 다양한 방안을 강구하기로 했다 의총에서는 광장의 힘과 국회의 힘을 모아가는 탄핵추진범국민운동본부 구성 국회 차원의 대통령사퇴촉구결의안 국민의 다양한 여론을 반영할 수 있는 시민미디어플랫폼 설립 등 다양한 의견이 제시됐고 지도부는 이를 진지하게 논의해 추후 의총을 통해 결정하기로 했다 국회 추천 총리의 추진 여부는 그 실효성과 의미 현실가능성 등을 종합적으로 고려해 빠른 시일 내에 결정하기로 뜻을 모았다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59083,2016-11-21, 윤관석 수석대변인 오후 현안 서면 브리핑 한일 군사정보보호협정 강행은 들불처럼 번지는 민심을 폭발시킬 것 국방부가 국정 마비의 혼란한 정국을 틈타 속전속결로 처리한 한일 군사정보보호협정이 일 국무회의에 상정한다고 밝혔다 한일 군사정보보호협정은 우리나라의 군사정보를 군사적 팽창을 모색하는 일본에 고스란히 넘겨주게 된다는 점에서 매국적 협정이다 박근혜 대통령이 한일 군사정보보호협정을 통해 외국에 자신의 건재함을 과시하려는 것이라면 국가안보를 위기에 빠뜨리는 불장난임을 분명히 지적한다 더욱이 박근혜 대통령은 내일 국무회의에 참석하지 않고 유일호 경제부총리가 회의를 주재한다고 한다 대통령이 국가안보와 직결된 중대한 협정을 처리하면서 숨어서 서명하겠다니 협정 강행에 따른 국민의 분노를 조금이라도 피해보려는 비겁한 꼼수가 아닐 수 없다 국민 모두가 반대하는 잘못된 협정을 강행하면서 그 비판은 자신이 임명한 국무위원들에게 떠넘기겠다니 무책임을 넘어 파렴치하다 어떤 식이 되었건 박근혜 대통령이 협정의 최종 서명을 강행한다면 국정을 무너뜨린 것도 부족해 국가 안보를 팔아먹은 대통령이 될 것이다 한일 군사정보보호협정의 강행은 들불처럼 번진 민심을 활화산처럼 폭발시킬 것임을 경고하며 즉각 중단할 것을 엄중하게 촉구한다 도대체 누가 이렇게 친일 독재미화 교과서를 밀어붙이는가 교육부가 거센 반대 여론에 보류 기류를 내비치던 국정 역사교과서 현장검토본을 결국 예정대로 일 공개하기로 방침을 확정했다 야당은 물론이고 진보와 보수를 가릴 것 없이 교육계 전체가 반대하는 국정 역사교과서를 도대체 누가 이렇게 밀어붙이고 있는 것인가 이 같은 방침이 누구의 의지이고 지시인지 분명하게 밝힐 것을 이준식 교육부장관에게 엄중하게 요구한다 박근혜 대통령이 검찰의 피의자 입건에 격분해 국민들에게 복수의 폭탄을 연달아 던지려는 모양이다 아니면 언제 물러날지 모르는 상황에서 아버지의 부끄러운 역사를 우리 국민의 역사교과서에서 도려내겠다는 의도가 아닐 수 없다 친일과 독재의 역사는 아무리 미화하려 해도 미화할 수 없고 지우려 해도 지울 수 없다는 점을 엄중히 경고하며 괜한 헛수고를 중단할 것을 엄중히 촉구한다 청와대가 대통령 권력은 자신에게 있음을 과시하기 위해서 국민이 반대하는 일을 마구잡이로 밀어붙이고 있는 모양인데 국민이 용서하지 않을 것이다 역사교과서가 공개되고 국민의 의견이 수렴되는 기간 국민의 분노는 활화산처럼 폭발할 것임을 분명하게 경고한다 문고리 인방 중 막내만 솎아내고 그친다면 검찰은 손에 쥔 칼자루 내려놔야 검찰의 중간 수사결과 발표가 나오면서 검찰 수사에 대한 비판이 쏟아져나오고 있다 문고리 인방 중 막내인 정호성 전 비서관의 기소와는 달리 공소장에 이재만 안봉근 두 전직 비서관의 이름이 빠진 이유를 납득하기 어렵다 청와대의 권력구조를 안다면 정호성 전 비서관에 비해 이들의 죄가 더욱 클 수밖에 없는데 검찰은 이들을 한차례 소환 조사한 뒤 별다른 조치 없이 돌려보냈다 이재만 안봉근 두 사람은 박근혜 정부 국정농단의 한 책임자로 지목되어왔다는 점에서 검찰이 여전히 청와대와 국민 사이에서 갈피를 못 잡는 것 같다 이들은 각각 경제 산업 분야와 사정기관 인사 및 정책을 나누어 자신의 측근들을 챙기고 각종 대형 국가정책에 손댔다는 소문이 무성했다 이들에게 줄을 대려는 정부 고위직들로 사무실이 문전성시를 이뤘다는 말도 무성한데 각종 파일을 캐비넷에 쌓아두고 있는 검찰이 이를 모를 리 만무하다 없는 죄도 만들어낸다는 검찰이 수사의지가 있었다면 이들의 신병부터 확보하고 파들어갔을 것이다 검찰수사가 언론이 노력해서 파헤친 증거들을 얼기설기 모아 기소하는 수준에 그친다면 검찰은 손에 쥔 칼자루를 내려놔야 한다 검찰은 박근혜 정부의 국정농단과 국기문란의 전모를 파헤치라는 국민의 명령을 받들어 이재만 안봉근 두 사람을 즉각 소환해 엄정 수사할 것을 촉구한다 철도파업 장기화 정부와 철도공사는 무엇을 하고 있는가 오늘로 철도파업 일째이다 사상 최장기 파업으로 인한 경제적 손실은 최소 억원으로 추산되며 파업기간 동안 열차 고장과 사고가 잇따라 발생하고 있어 시민들의 불안이 계속되고 있다 최장기간 철도파업으로 국민의 안전과 민생경제가 벼랑 끝에 내몰렸고 이제는 파국으로 치닫고 있다 철도파업의 주 책임자인 국토교통부 강호인 장관과 코레일 홍순만 사장은 그 동안 무엇을 한 것인가 파업을 불법으로 단정 짓고 노조간부 고소고발하며 노조원들을 징계하는 등 강경대응 일변도였다 어렵게 진행된 일간의 집중교섭은 단 한걸음도 양보하지 않으며 결렬시켰고 파업 일째이던 일 담화에서는 해결할 의지가 없다는 것을 다시 한 번 천명했다 또한 지난 주 국회 조정식 국토교통위원장과 홍영표 환경노동위원장의 파업해결 위한 중재안에 대해서도 정부와 철도공사는 받아들일 수 없다며 거부의사를 밝혔다 지금 대한민국을 살아가고 있는 우리 국민들은 초유의 국정농단 국기문란 사태로 정부에 대한 신뢰가 무너졌다 이런 상황에서 정부와 공공기관장은 국민 신뢰 회복을 위해 노력해야 하지만 강호인 장관은 무능한 장관 홍순만 사장은 불통사장 역할만 하고 있다 이는 장관으로서 사장으로서 자격이 없는 것이다 이제 선택은 두 가지이다 하나는 이 사태에 대한 책임을 지고 사태 해결을 위해 성과연봉제 도입 한시적 유보 및 사회적 논의기구 구성에 적극 동참하는 것이다 다른 하나는 이 사태를 해결할 의지도 능력도 없다는 것을 인정하고 강호인 장관 홍순만 사장 모두 자리에서 물러나는 것이다 철도파업 일째 더 이상 기다릴 수 없다 조속한 결단을 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59080,2016-11-21, 제 차 의원총회 모두발언 일시 월 오후 시 장소 국회 본청 호 추미애 대표 오늘 이 자리를 전 국민이 주시하고 있다 심지어 외국 언론도 주목을 하고 있는 자리가 된 것 같다 나라의 대통령이 중대한 범죄의 혐의자로 검찰의 공소장에 기재됐다 대통령이 건국 대통령 이라고 추앙했던 교과서 국정화를 통해서 이른바 건국절 이라고 바꾸려고 했던 그 대통령도 이 정도 사안이 되니까 나라를 위해서 일개 시민으로 돌아가겠다고 자진 사퇴를 선언했다 박근혜 대통령이 이 정도 되면 분 초를 아끼지 말고 국정 혼란을 수습하고 헌정 중단을 막기 위해서 스스로 물러나겠다고 했어야 되는 날이다 국민이 결자해지하도록 시간을 드리고 있고 전 세계가 지켜보고 있다는 것을 대통령은 구중궁궐에 숨지만 말고 제대로 직시해야 할 것이다 검찰의 어제 공소장을 보면 점 만점에 점 정도 되는 것 같다 대통령은 빵점이었다 검찰에 점밖에 주지 못하는 이유는 사안의 핵심인 뇌물죄가 빠졌기 때문이다 재벌과 정경유착으로 결탁하고 재벌의 뒤를 봐주고 국회에까지 재벌을 위한 법을 만들어달라고 집권당을 통해서 또 국회에 와서 직접 강박을 했던 대통령이다 그런 대통령에게 뇌물죄를 먼저 주도면밀하게 수사하지 않은 것은 규탄 받아 마땅하다 뇌물죄를 처음부터 놓치고자 했던 것인지 증거인멸의 시간을 주려고 했던 것인가 뇌물죄를 빼버린다면 몰수도 할 수 없고 추징도 할 수 없다 잘못하면 큰 요란함 뒤에 별로 건질 것이 없는 태산명동 서일필 로 귀결될 수도 있다 우리 국민은 부패 없는 대한민국 정경유착이 다시는 일어나지 않는 새로운 대한민국을 바라고 있지만 그 기회가 사라질 수도 있는 것이다 그래서 대통령은 빵점이고 검찰은 점이라고 하는 것이다 나머지는 국회가 일에 통과시킨 특검으로 해결해야 하는데 그마저도 대통령은 중립적이니 아니니 하면서 국민 특검을 부정하려고 먼저 말을 요리조리 꾸미고 있는 중이다 헌법 제 조 항에 따르면 법은 만민에게 평등하게 적용되어야 한다 대통령의 특권을 이용해서 검찰 수사를 피하고 특검도 거부한다면 대통령은 더 이상 용서가 될 수 없을 것이다 검찰 스스로 약속한대로 또 대통령이 직접 두 차례 사과를 통해서 약속했던 대로 제대로 수사를 받아야 할 것이다 김기춘 전 비서실장과 우병우 전 민정수석에 대해서도 구속 수사를 착수해야 할 것이다 오늘 아침 우리 당 최고위원회에서는 탄핵 시기와 추진방안에 대해서 검토하기로 하고 탄핵추진검토기구를 설치하기로 했다는 것을 보고 드린다 국회의 탄핵 의결은 대한민국을 생각하는 새누리당 비박 의원들의 양심에 달려있다 말로는 탄핵쇼를 한다고 하고 진심은 보이지 않고 행동으로 책임지지 않는다면 국민이 새누리당 의원도 탄핵에 나설 것이다 탄핵은 최장 개월의 긴 시간이 걸리는 만큼 엄청난 국력소모가 예상된다 국민들은 지금도 대통령이 스스로 물러나 검찰 수사를 받고 국정 수습은 국민과 국회에 맡기라고 하고 있다 대통령이 앉아있는 일촌일각이 국민을 괴롭히는 것뿐이다 국정혼란을 최소화할 방안을 의견을 많이 피력해주시기 바란다 우상호 원내대표 오늘은 아마 대한민국 야당사 헌정사에 기록될 날일 것이다 오늘 더불어민주당 최고위원회는 어제 검찰의 수사결과 발표를 토대로 박근혜 대통령의 탄핵을 추진하기로 의견을 모았다 의원총회에서 최고위원회의 방침을 보고하고 여러분의 의견을 듣는 날이다 좋은 지혜를 빌려주시기 바란다 대한민국이 대통령이 퇴진하느냐 안하느냐의 문제로 장기적이고 소모적인 논란을 벌이는 것보다는 헌법이 정한 절차를 밟아나가는 것이 국정 공백을 최소화하고 국론 분열을 최소화하는 방책이라는 고민 속에 최고위원회에서 의견을 모았다는 점을 말씀드린다 새누리당 의원들도 대한민국 국가를 생각한다면 친박과 비박이라는 계파를 넘어서 하루빨리 대한민국의 혼란을 정리해야 하겠다는 마음으로 동참해주실 것을 부탁드린다 앞으로 당내에 만들어질 검토기구에서 이와 관련한 세부적 논의들을 진행해나가겠다 무엇보다 더불어민주당 의원 한 명 한 명이 대한민국을 책임진다는 무거운 책임감으로 이 문제에 대응해달라고 부탁드린다 각 상임위별로 법안과 예산심의가 계속해서 진행되고 있다 탄핵여부와 무관하게 국민의 민생을 챙기는 일에 더불어민주당이 모든 것을 책임진다는 자세로 임해주실 것도 당부 드린다 너무 큰 사안에 집중하다보면 혹시라도 상임위에서 꼼꼼히 챙겨봐야 할 것들을 놓치는 경우가 있다 더불어민주당이 수권정당으로 국민의 신뢰를 받으려면 큰 국가적 현안에도 집중을 해야 되겠지만 지금 우리가 다루고 있는 법안과 예산에서 혹시라도 소홀함이 없는지 항상 챙기는 자세도 필요하다 월 초까지 여러 가지 복잡한 일들이 많이 있지만 우리가 인 역을 한다는 마음으로 충실하게 민생도 챙기고 국가 혼란도 최소화하는 자세로 임해주실 것을 당부 드린다 비공개 회의 때 여러분들의 고견을 경청해서 당론을 정하도록 하겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59079,2016-11-21, 박근혜 대통령은 정상 출근한 날이 며칠이나 되는지 밝혀라 청와대가 세월호 시간 에 대해 박근혜 대통령이 관저 집무실 에 있었다고 해명했다 세월호 참사 이후 년 개월 만에 대통령이 있었던 장소를 공개한 것이다 그러나 관저는 퇴근해서 쉬는 곳 이다 국가적 재난 상황에 정상 출근하지 않은 채 관저에서 상황 보고를 받고 있었다는 뜻이다 대통령은 뒤늦게 중앙재난대책본부에 나타나 학생들이 구명조끼를 입었다는데 발견하기 힘든가 라고 말했다 보고사항조차도 제대로 이해하지 못한 것이 아닌가 시중에서는 박 대통령은 공개행사가 있는 날 정도에만 본관 집무실에 출근한다는 의혹까지 제기되고 있다 박근혜 대통령의 범죄 혐의는 최순실과 안종범과 공모한 범행 가지만이 아니다 국민 명의 생명이 스러져 가는 상황을 관저에서 보고만 받고 있었던 직무유기는 더 큰 범죄이다 청와대는 관저에서 있었던 시간 동안의 대통령의 행적은 물론이고 정상 출근한 날이 며칠이나 되는지 밝힐 것을 요구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59078,2016-11-21, 삼성물산과 제일모직간의 합병도 박근혜 최순실 게이트 인가 검찰은 국민노후자금을 손실시킨 국민연금공단의 삼성물산과 제일모직간 합병찬성 과정의 의혹을 철저히 수사하라 삼성물산과 제일모직간의 합병과정에서 국민연금관리공단은 관례에 따른 절차를 무시하고 찬성표를 던져서 삼성물산 합병성사에 결정적인 역할을 했다 그러나 이는 억원이라는 엄청난 금액의 국민노후자금 손실로 이어졌다 국민연금공단은 이러한 중차대한 결정을 하는 과정에서 기금운용전문위원회의 심의를 생략했다 그리고 청와대와 복지부 장관이 국민연금공단에 압력성 전화를 한 사실이 밝혀지고 있다 반면 삼성은 정유라에게 억원을 지급하는등 박근혜 최순실게이트에 적극 협조해왔다 이상의 상황을 종합해볼때 국민연금의 삼성물산 합병 찬성 과정이 박근혜최순실게이트의 일환이 아닌가하는 의심을 떨치기 어렵다 절차를 무시하면서 까지 삼성을 밀어주어 국민노후자금의 막대한 손실을 초래하고 자본시장 질서를 교란시킨 국민연금공단 기금운용을 둘러싼 의혹이 박근혜게이트와 어떤 연관이 있는지를 검찰은 철저히 조사해야할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59060,2016-11-21, 제 차 최고위원회의 모두발언 일시 월 오전 시 장소 국회 본청 당대표 회의실 추미애 당대표 어제 검찰 수사 결과를 보면 검찰은 점 대통령은 빵점이다 검찰은 대통령을 공범이자 사실상 주범으로 지목했다 직접 기업에서 돈을 뜯고 청탁을 하고 압력을 행사한 정경유착의 몸통임이 밝혀졌다 일선 검사들은 나름 애를 썼다고 할 것이다 그러나 검찰은 늑장수사를 통해서 증거인멸과 말맞추기 시간을 줬다 우병우를 봐주고 뇌물죄를 제외해서 대통령을 봐주고 대기업도 봐줬다 검찰은 지금이라도 대통령을 강제수사하고 뇌물죄를 적용하고 우병우를 구속 수사해야 할 것이다 검찰 수뇌부가 국민의 분노 앞에 적당히 면피하며 이 정도에서 끝내려하면 안 된다 뇌물죄 의료법 위반 등 박근혜의 판도라 상자는 아직도 많이 남아있다 판도라의 상자가 다 열려야 세월호 시간 의 비밀도 밝혀질 것이다 빵점짜리 대통령은 이제 대통령직을 백 으로 자신을 방어하는 행보를 하고 있다 검찰 조사에 협조하겠다 던 대국민담화의 약속을 주 만에 뒤집고 특검도 거부할 작전을 짜고 있다 국민의 뜨거운 맛을 더 봐야할 모양이다 국회의 탄핵 의결이 이루어질 경우 현재 드러난 범죄혐의만 헌재에서 정상적으로 판단하면 탄핵은 이루어질 것이다 따라서 탄핵의 시기와 추진 방안에 대해 즉각적인 검토에 들어가고 탄핵추진검토기구도 설치할 것이다 탄핵추진은 최대한 완벽한 준비가 필요하다 첫째 새누리당의 비박이 민심을 제대로 판단해야 하고 둘째 헌재가 국민의 의사와 법적 상식을 거스르는 판단을 하지 않아야하며 셋째 탄핵이 최장 개월이나 걸릴 수 있다는 점도 감안해야한다 이렇게 지난한 길을 생각할 때 아직도 최선의 방책은 박근혜 대통령이 스스로 사임을 결심하고 후속조치를 국회와 국민에게 맡기는 것이다 그것이 나라를 구하는 대통령으로서의 마지막 해야 할 일이다 그러나 대통령은 국민과 장기전을 벌이면서 헌재에서 판을 뒤집을 의도로 차라리 탄핵해달라 고 버티고 있다 보수적 사고를 가지고 있는 헌재를 홈그라운드로 보고 홈그라운드에서 한판 붙겠다는 것이다 게다가 내년 초에 명의 헌법재판관의 사임으로 지연작전과 뒤집기에 더 유리해졌다고 주판알을 튕기는 모양이다 참으로 후안무치한 작태이다 그러나 이미 국민에게 버림받은 대통령에게 홈그라운드는 어디에도 없다 지난 대선에서 박 대통령을 지지했던 국민도 지역도 세대도 모두 나가라 하고 있다 헌재 또한 민심을 거역할 수는 없을 것이다 지금은 첫째도 퇴진 둘째도 퇴진 셋째도 퇴진이다 그 기조 아래에서 탄핵을 검토하고 적절한 시기에 과두내각 문제도 검토되어야 할 것이다 다시 한 번 대통령에게 요구한다 물러나시라 김종필 전 총리의 이야기처럼 온 국민이 촛불을 든다 해도 안 물러날 생각이라면 더 나쁜 비극적 결말만 기다리고 있을 뿐이다 단 한 번 단 한순간이라도 애처로운 국민을 생각해주시라 우상호 원내대표 어제 검찰 수사의 중간발표를 들으신 국민들은 참담했다 설마 최순실이라는 기이한 사람이 대통령과의 친분을 이용해서 호가호위한 것이겠지 라고 믿고 싶었던 국민들은 대통령이 직접 모든 것을 지시하고 특정 이권사업에까지 개입해서 기업을 압박했다는 발표에 절망했다 이 사건은 결국 권력을 활용해서 비선실세들이 좌지우지했던 국정농단사건을 넘어서 대통령과 관련 피의자들이 공모한 공동범죄인 것으로 검찰이 각종 증거를 토대로 의 확신을 가지고 발표한 것이다 이런 발표에 대해서 청와대가 검찰이 중립적이지 않다 상상에 의거해서 공소장을 썼다 고 발표했다 대한민국 청와대가 자신들이 임명한 검사들의 수사결과를 상상 속의 소설 이라고 말할 수 있는지 어안이 벙벙했다 그들만의 섬에 갇혀서 객관적인 발표와 조사를 다 부정하는 모습으로 전락했구나 청와대가 특정범죄의 피의자를 변호하는 집단으로 전락했구나 하는 절망이 또 몰려왔다 이런 상태를 그대로 방치할 수 없다 하야할 생각도 없고 오로지 다가올 처벌을 막기 위하여 청와대 전체가 대통령 변호집단으로 전락한 이 상황을 장기적으로 방치할 수 없다 더불어민주당은 여러 가지 고민 끝에 탄핵을 포함한 대통령의 조기퇴진 방안들을 검토할 생각이다 오늘 의총에서 의원들의 의견을 수렴해서 이 상황이 장기화되지 않도록 국정혼란을 최소화하는 방향으로 헌법이 부여한 국회의 권능을 활용할 방법을 찾아보도록 하겠다 특검이 검찰보다 중립적이라고 판단해서 수사를 받겠다는 이야기가 의아하다 언제부터 야당을 중립적이라고 믿으셨는가 혹시 특검의 중립성을 문제 삼아서 수사를 거부하겠다는 의사는 아닌지 이제는 모든 것이 의심스럽다 검찰조사를 받겠다고 했다가 안 받겠다고 하셨다 특검 앞에 붙은 중립적이라는 말이 걸린다 본인이 판단할 때 특검이 중립적이라고 판단이 안 되면 그 수사도 거부하겠다는 소리인지 명백하게 입장을 밝혀주시기 바란다 이 와중에 한일군사정보보호협정을 내일 국무회의에서 의결하겠다고 이야기한다 본인이 직접 국무회의를 주재한다는 이야기도 들었다 경고한다 한일군사정보보호협정은 검찰에서 수사 발표한 피의자 신분으로 국무회의에서 통과시켜야할 정책이 아니다 국민들을 납득시킬 수도 없고 그 절차 자체도 너무 신속하게 진행해서 국민의 대다수가 반대하고 있는 협정이다 내일 국무회의에서 이 협정의 통과를 하지 마실 것을 정식으로 경고한다 만약 국민의 반대에도 불구하고 이 협정을 국무회의에서 통과시키면 엄청난 국민적 저항에 부딪치게 될 것이다 야 당 원내대표는 오늘 철도파업을 풀기위한 새로운 제안을 내놓기로 했다 야 당이 제안한 내용에 따라서 정부는 성과연봉제 실시 시기를 유보하고 노조는 파업을 철회해 줄 것을 당부 드리고자한다 오늘 야 당이 공식으로 제안하는 철도파업을 풀기 위한 제안을 정부와 노조에서 전향적으로 받아주실 것을 당부 드린다 김영주 최고위원 대한민국 검찰이 어제 박근혜 최순실 게이트의 몸통이자 사실상의 주범이 박근혜 대통령임을 확인했다 박근혜 최순실 게이트가 아니라 박근혜 게이트 인 셈이다 비록 미진하지만 대통령 스스로 임명한 대한민국 검사들이 작성한 공소장에 피의자 박근혜 대통령과 최순실 안종범 정호성 등의 범죄혐의가 낱낱이 적시됐다 검찰에 따르면 공소장에 기재된 내용은 는 입증 가능한 부분만 적시했다 고 한다 우리 당은 그동안 제 야당으로서 대통령 스스로 국민 앞에 사죄하고 책임을 질 기회를 여러 차례 주었다 그러나 이제 검찰의 공소장에 대통령의 법률 위반 사실이 적시된 만큼 헌법과 법률을 위반한 대통령에 대해서 국회는 헌법 조에 따라 탄핵 절차에 착수해야한다 대통령을 수사할 특검법에 대해 한 말씀 드리겠다 지난 일 국회는 박근혜 게이트 수사를 위한 특검법을 통과시켰다 특검법은 내일 국무회의에 상정될 예정인 것으로 알려져 있다 그런데 어제 대통령의 변호인은 앞으로 검찰의 직접 조사 협조 요청에는 일체 응하지 않고 중립적인 특검의 수사에 대비하겠다 는 입장을 밝혔다 특검 앞에 중립적 이라는 단서를 달아놓은 것이다 이를 두고 박근혜 대통령이 검찰의 조사를 거부한 데 이어 중립적 인 특검까지 운운하면서 여야가 합의한 특검법에 거부권을 행사하는 것 아니냐는 우려가 나오고 있다 이미 특검법 통과 과정에서 청와대와 친박 의원들은 야당이 특별검사 후보 명을 추천하기로 한 조항이 특별검사의 정치적 중립성 이라는 원칙을 훼손할 수 있다 는 어불성설을 내놓은 바 있다 박근혜 대통령이 시간을 벌기 위해 특검법에 거부권을 행사한다면 제 의 닉슨 이 되는 길로 가게 될 것이다 닉슨 대통령은 자신을 수사하기 위한 특별검사를 해임시킨 이른바 토요일 밤의 학살 로 사실상 대통령 자리에서 쫓겨난 바 있다 박근혜 대통령이 특검법을 거부하더라도 국회는 반드시 압도적 다수로 특검법을 재의결할 것이다 혹여 특검의 중립성 운운이 재의결 된 특검의 수사마저 받지 않겠다는 꼼수라면 미리 경고해 두겠다 피의자는 변호인을 선임할 수는 있지만 검사를 선임할 수 없다 피의자가 수사에 협조하지 않을 경우 특검은 강제수사에 착수할 수밖에 없다 모든 국민은 법 앞에 평등하고 대통령도 예외가 아니다 전해철 최고위원 검찰 공소장에 대통령의 위법행위가 적시되었다 검찰은 박 대통령에 대해 최씨와 안 수석 정 비서관과의 공모관계를 적시하고 공동정범에 해당한다고 공소장에 분명히 적시했다 박 대통령은 대국민사과에서 개인적 인연을 믿고 제대로 살피지 못한 나머지 주변사람들에게 엄격하지 못한 결과가 되었다며 주변인에게 책임을 전가를 했지만 국정농단사태 주범은 오히려 박 대통령 자신이었다는 점이 밝혀진 것이다 대통령은 향후 검찰조사에 일절 응하지 않겠다고 했다 하지만 피의자로 신분이 전환된 만큼 검찰은 향후 특검이 시작될 때까지 소환조사를 포함해 철저히 수사해야 하고 뇌물죄를 적용해야 한다 특히 이번 사태의 여전한 핵심 의혹이 계속 제기되고 있는 김기춘 우병우에 대한 수사 역시 엄정하게 해야 한다 이제 탄핵소추를 위한 법률적 요건은 모두 갖춰졌다 그 동안 국정농단을 최소화위해 대통령에게 자진사퇴를 요구했으나 대통령은 명백하게 이를 거부했고 이제는 할 테면 해보라며 오히려 탄핵절차로 가기를 바라는 태도를 보이고 있다 검찰의 수사를 거부하겠다는 의사를 변호인을 통해 명백히 한 것이다 이런 상황에서 국회가 유불리를 계산해 탄핵소추 절차를 미루는 것은 옳지 않다 탄핵 결정을 이루기 위한 모든 노력을 다 해야 한다 탄핵을 준비하는 당 내 기구에서 충분히 잘 논의해 탄핵결정을 반드시 이뤄내도록 하겠다 매주 백만명 이상의 국민이 촛불을 들고 대통령의 퇴진을 요구하고 있다 박 대통령은 더 이상 대한민국의 헌법 수호를 감당할 수도 없고 통치의 정당성의 기반이 되는 국민적 신뢰역시 상실했다 지난 년간 추진해온 정책은 정당성을 의심받고 있으며 남은 년 개월의 임기도 제대로 된 국정을 수행할 수 없을 것이 명백하다 국민들이 요구하는 자진사퇴가 가장 합당한 해결책이다 하지만 대통령이 거부한다면 남는 방법은 탄핵밖에 없음을 분명히 말씀 드린다 최인호 최고위원 스스로 하야하는 최소한의 명예도 포기한 대통령에게 국민들은 탄핵을 요구하고 있다 대통령 탄핵 추진은 국민의 준엄한 명령이 되었다 민주주의와 정의를 바로 세우기 위해 탄핵을 추진할 수밖에 없다 검찰은 어제 공소장에서 박대통령이 최순실과 공범임을 분명히 했다 사실상 주범이다 헌정 사상 처음으로 현직 대통령이 피의자가 되었다 그런데도 대통령은 국민들에게 지금까지 거짓말로 진실을 은폐하고 있다 검찰의 공소내용은 지난 두 차례 대통령의 담화가 모두 거짓말임을 밝히고 있다 검찰조사에 성실히 임하겠다는 대통령이 검찰조사를 거부했다 대통령이 이제는 사법체계까지 유린하고 있다 검찰의 수사결과를 상상과 추측에 거듭해 지은 사상누각 이라고 비난 한 것은 대통령이 반성하지 않고 진실을 감추려는 평범한 범죄자의 길을 가겠다고 선언한 것에 다름없다 국민에 대한 명백한 선전포고다 대통령이 거듭해서 국민을 속이는 것도 용납할 수 없는 탄핵 사유다 대통령의 범죄는 단순한 강요 직권남용 기밀누설이 아니다 단순한 뇌물사건도 아니다 대통령은 대통령이라는 헌법적 지위와 권한을 범법행위에 이용했다 박근혜 대통령은 최순실 일가와 공모하여 해방 이후 국민이 피를 흘리며 만들어낸 헌법과 민주주의를 유린하고 파괴하는 범죄를 저질렀다 국민은 국민의 생명과 권리를 돌보라고 대통령에게 권한을 주었다 그러나 세월호 참사 당일 대통 집무실로 출근하지 않았던 반면 자신과 최순실의 이권을 보장하기 위해서는 그 바쁜 와중에도 재벌들을 일일이 장시간 독대했다 대통령의 권한을 앞세워 특권과 반칙이 난무하고 누구에게나 주어져야 할 공정한 기회가 박탈되었다 대통령이 최순실 등과 공모한 범죄로 대한민국의 정의가 무너졌다 국민은 대통령에게 즉각 퇴진하라고 명령하고 있다 스스로 하야하는 명예로운 퇴진을 거부한 대통령에게 국민의 마지막 명령은 탄핵추진일 수밖에 없다 양향자 최고위원 이제는 박근혜 대통령도 아니다 박근혜씨도 아니다 이제 더 이상 박근혜에게 요구하지 맙시다 수사를 받든 말든 퇴진을 하든 말든 선 후퇴를 하든 말든 이제는 아무것도 요구하지 말고 우리가 할 일을 합시다 박근혜는 입에 담기도 부끄러운 류 사기범죄 주범이며 요즘 자주 거론되는 부정청탁 금지를 주요 골자로 하는 소위 김영란법을 위반한 자질도 없는 저질 공무원으로 판명되었다 제 제 의 박근혜 출현을 방지하기 위해 향후 헌법 개정 시 사기 등 모든 형사사건에도 대통령을 소추할 수 있다고 해야 할 형편이다 누구도 민심 거슬러서는 안 된다 누구도 시간을 지체해서는 안 된다 더 이상 국민을 아프게 해서는 안 된다 바로 이 순간부터 탄핵을 추진해야 한다고 주장한다 김병관 최고위원 주 연속 경찰이 청와대 인근에서의 집회를 막아섰다 법원에 의해서 기각되는 상황이 발생하고 있다 촛불집회에서 시민들이 이성적으로 협조해준 것에 감사하다던 경찰이 말 따로 행동 따로 의 행태를 이어가고 있다 경찰이 진정 지키고자 하는 것이 무엇인가 청와대인가 시민인가 일 촛불집회를 지켜보겠다 경찰이 국민의 목소리를 외면한 채 다시 청와대 지키기에 나선다면 경찰이 시민과의 대결에 정면으로 나선 것으로 간주하겠다 경찰에 엄중히 경고하겠다 국정농단의 주범인 박근혜 대통령에 대한 시민의 준엄한 명령에 맞서지 마시기 바란다 어제 최순실 등의 공소장은 사실상 박근혜 대통령에 대한 공소장으로 보입니다 대통령 당신이 이러려고 대통령이 되었나 자괴감 든다고 하셨는데 공소장을 읽어보는 내내 국민으로써 국회의원으로써 한없는 자괴감이 들었다 자랑스러운 국민들 더 이상 부끄럽게 하지 마시고 대통령 스스로 물러나시라 우리 국민들과 국회 더불어민주당은 퇴진 추진과 함께 탄핵 추진을 계속해 나가겠다는 것을 다시 한 번 말씀드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59059,2016-11-21, 기동민 원내대변인 오전 현안 브리핑 일시 월 오전 시 분 장소 국회 정론관 불법 대통령 의 어처구니없는 합법 절차 요구 대통령이 주범이었다 조폭 수준의 불법 모금 과 민간기업 채용과 인사 까지 앞장서 챙겼다 심지어 청와대를 총동원해 사전 말맞추기 와 증거 인멸 의 의혹까지 받고 있다 이것이 우리가 뽑은 대통령의 진짜 모습이었다 부끄럽고 한탄스러울 뿐이다 참 나쁜 대통령 파렴치한 대통령 이란 시민의 분노와 절규가 하늘을 찌르는데 대통령은 오리발이다 국민 앞에 약속한 성실한 검찰 조사 를 언제 그랬냐는 듯 뒤집어 버렸다 명백히 드러난 범죄사실을 인격 살인 사상누각 상상과 추측으로 만든 환상 일 뿐이라며 헌법 절차 대로 하자는 대통령의 적반하장에 기가 막힐 뿐이다 국민 다수가 선택했던 대통령의 마무리가 정말 탄핵이여야만 하는가 국민이 뽑은 대통령을 국민이 끌어내리는 역사적 불행을 감수하란 말인가 참 잔인한 대통령이다 본인이 약속한 검찰 수사를 안 받겠다고 하고 야당 추천총리도 불수용하겠다는 불법 대통령 은 스스로 물러나라 그것이 국민에 대한 최소한의 예의다 우리당은 대통령의 즉각적인 퇴진을 재차 촉구한다 탄핵을 포함한 대통령의 조기퇴진 방안 역시 고민하고 철저히 준비할 것이다 검찰은 박대통령을 강제 소환 조사하고 뇌물죄 로 기소하라 특검까지 주 남았다 검찰이 할 일은 대통령을 즉각 소환 조사하여 뇌물죄 로 추가 기소하는 것이다 망설일 이유가 없다 지금 당장 대통령 소환 절차에 돌입하라 필요하다면 청와대를 재압수 수색하고 체포영장을 발부해서라도 대통령을 조사하라 삼성 비선실세 금품 헌납 국민연금을 동원한 경영권 거래 롯데 억원 수사면제 특별사면 부영 세무조사 무마 등 모든 정황이 대가성 을 가리키고 있다 그리고 그 몸통은 명백히 박근혜 대통령이다 검찰의 모든 역량을 총동원하여 수사하고 혐의를 입증해야 한다 그것이 권력에 부역한 불명예를 그나마 씻는 유일한 길이다 정치 검찰 도 모자라 재벌 검찰 이 되겠다는 것인가 검찰은 재벌 대기업의 박근혜 최순실 게이트 연루 부분을 의례적인 수사를 방패삼아 공란으로 남겨뒀다 대기업과 그들의 모금창구 역할을 한 전경련은 피해자 가 됐다 비리의 공모자 들이 피해자 가 된 것이다 재벌에 대한 면죄부 수사다 삼성은 검은 돈을 이용해 경영권을 공고히 하고 대통령과 비선실세들은 수 천 억원의 국민노후자금 손해를 감수하며 삼성을 비호했다 롯데 부영은 물론 대통령과 비선실세들에게 돈을 갖다 바친 기업들 모두가 공범이고 부역자들이다 이들에 대한 수사와 처벌이야말로 정의이고 경제민주화의 첫걸음이다 검찰은 정치 검찰 도 모자라 재벌 검찰 이 돼는 오욕의 길을 걷지 마라 철저한 재수사로 부정한 거래의 진상을 파헤쳐야 한다 우리당은 특검과 국정조사를 통해 진상을 밝혀낼 것이다 검찰 역시 결코 자유롭지 않다는 걸 알아야 한다 재벌 대기업에게도 촉구한다 특검은 물론 국정조사까지 시작되면 경영활동이 올스톱 될 것 이라는 언론 플레이는 그만 두기 바란다 잘못이 있다면 철저히 조사받고 책임지는 모습을 보여라 당신들이 그토록 강조해온 글로벌기업으로 성장하는 첫걸음이다 이 사태를 기점으로 정경유착의 어두운 굴레를 뿌리 뽑아야 한다 정치가 기업에 손 벌리고 기업은 돈으로 특권을 얻는 비정상 을 끝내야 한다 모두에게 인정받는 국민 기업으로 재탄생하길 간절히 바란다 김기춘 우병우 구속수사로 검찰 불명예를 씻어라 헌정사 처음으로 현직대통령의 비리와 불법이 밝혀지는 오명을 남겼다 하지만 끝이 아니다 대통령과 최순실의 국정 농단과 국기 문란에 방조하고 동조했던 핵심 부역자들에 대한 단죄가 이어져야 한다 김기춘 전 실장과 우병우 전 수석이 대표적이다 김기춘 전 실장은 왕실장 기춘대원군 으로 불리며 막강한 권력을 휘두르고 국정농단을 주도했다 심지어 지금도 그림자 실세 라는 의심을 받고 있다 우병우 전 수석도 다르지 않다 김 전 실장의 뒤를 이어 검찰 조직을 권력의 주구로 만들었고 인사 전횡을 휘두르며 군림해온 사실상의 주역이다 검찰은 김기춘 전 실장과 우병우 전 수석을 국정농단의 주범으로 구속 수사해야 한다 이들에 대한 단죄 없이 정의도 없고 검찰 쇄신도 불가능하다 강도 높은 수사와 엄정한 단죄로 이런 불행한 역사가 다시는 반복되지 않도록 본보기를 만들어야 한다 사라진 세월호 시간 대통령은 누구와 함께 무엇을 했나 청와대의 오만한 오보 괴담 바로잡기 를 인정하기도 싫지만 인정한다 해도 도대체 납득하기 어렵다 사고 발생 시간 분 후 최초 보고와 최초 지시가 이뤄지고 처음 모습을 드러낸 오후 시 분까지 전화 보고와 서면 보고를 받았다지만 그 외 시간에 대통령은 누구와 있었고 무엇을 한 것인가 청와대가 떳떳하다면 세부 일정과 근거를 제대로 밝혀라 청와대 해명을 좋게 인정해 재택근무 와 유연근무 했다 쳐도 왜 하필 아이들이 죽어가고 있는 그 시간 이었는지를 밝혀라 대통령 혼자 명상과 고민이라도 했단 말인가 말 못할 비밀은 도대체 뭔가 보고를 제대로 받았다는 대통령의 첫마디가 뚱딴지같은 구명조끼 발언이었다 누가 납득할 수 있겠나 국민들은 진실을 원한다 얼토당토않은 짜깁기 로 국민을 현혹하지 마라 우리당은 특검과 국정조사를 통해 세월호 시간 의 진실을 반드시 밝혀낼 것이다 세월호 시간 의 진실을 규명하는 것이 우리 헌정사의 비극이자 불행인 세월호 참사 의 해법을 찾고 유가족의 한을 푸는 첫걸음이기 때문이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59057,2016-11-21, 윤관석 수석대변인 오전 현안 브리핑 일시 오전 시 분 장소 국회 정론관 박근혜 대통령은 이성을 찾고 자신의 약속대로 검찰 조사에 즉각 응해야 박근혜 대통령은 헌정사상 첫 피의자 대통령이다 비선실세 국정농단 박근혜 최순실 게이트의 몸통이자 주범은 박근혜 대통령이었다 민족시인 신동엽 시인의 외침처럼 대통령과 청와대 이제 껍데기는 가라 국민의 명령이다 정연국 청와대 대변인은 어제 차라리 헌법상 법률상 대통령의 책임 유무를 명확히 가릴 수 있는 합법적 절차에 따라 하루 빨리 논란이 매듭지어 지기를 바란다 고 말했다 헌법상 법률상 대통령의 책임 유무를 명확히 가릴 수 있는 합법적 절차가 무엇인가 결국 탄핵을 의미한다 청와대가 탄핵을 먼저 요구하라고 하다니 정말 이성을 상실한 것이 아닌지 묻고 싶다 국정을 담보로 법적 책임을 면하고 자리를 지킬 시간을 벌겠다는 꼼수라는 점에서 무책임의 극치이다 버티면서 자리를 지키겠다는 것이 청와대의 방침인가 국정이 마비되건 나라가 극심한 혼란에 빠지건 법적 책임을 면하고 대통령의 자리를 지키는 것에만 골몰하는 행태가 참으로 후안무치하다 차라리 국민이 부끄럽고 참담하다 정연국 대변인은 오늘은 상황이 조금 변화했다 며 국회 추천 총리의 임명을 철회할 가능성마저 시사했다 대통령이 자신이 한 말을 깡그리 뒤집으려고 하는 것인지 통탄할 노릇이다 국정농단을 넘어 비상시국에 중차대한 국정을 가지고 말장난을 하는 것인가 아니면 황교안 총리체제로 아무일 없었다는 듯이 그대로 가겠다는 또 다른 꼼수인가 국회 농단 야당 농단 국민 농단이다 박 대통령이 스스로 임명한 검찰의 중간수사결과를 부정하고 검찰 조사에 불응하는 것 또한 자신의 약속을 완전히 뒤집는 것이다 박 대통령은 지난 차 대국민사과에서 어떻게 말했는가 검찰에 어떠한 것에도 구애받지 말고 명명백백하게 진실을 밝히라 고 요청했다 이제와서 불리한 수사결과라고 해서 부정하는 것은 참으로 용렬하다 대통령은 분명히 필요하다면 저 역시 검찰의 조사에 성실하게 임할 각오이며 특별검사에 의한 수사까지도 수용하겠다 라고 약속했다 며칠이 지났는가 약속을 지켜 지금이라도 즉시 검찰 조사에 응해야 한다 어느 누구라도 이번 수사를 통해 잘못이 드러나면 그에 상응하는 책임을 져야 할 것이며 저역시도 모든 책임을 질 각오가 돼있다 는 말은 누가 했는가 박근혜 대통령이 한 말이다 결국 국민을 속이기 위한 빈말이었는가 대통령은 지난 대통령 취임식에서 헌법을 준수하고 대통령으로서의 직책을 성실히 수행하겠다 고 선서한 바 있음을 상기시켜드린다 대통령 스스로 말했듯 대통령 임기는 유한하지만 대한민국은 영원히 계속되어야만 한다 박근혜 대통령은 더 큰 국정혼란과 국정공백을 막기 위해 하루 속히 대통령직에서 물러날 것을 다시 한 번 절규하듯 엄중히 촉구한다 검찰은 박 대통령에 대한 뇌물죄 적용으로 즉각적인 강제수사에 나서야 한다 박근혜 대통령의 검찰조사 거부로 온 나라가 들끓고 있다 박 대통령이 당초 입장을 번복하고 배째라 는 식으로 버티기에 들어간 것이다 그 이유는 첫째 검찰의 중간수사 발표가 대단히 미진했기 때문이고 둘째 국민을 안중에도 없기 때문이다 이번 검찰의 중간수사 발표는 진실의 문을 열지 못하고 문앞에서 문고리만 잡고 있는 반의 반쪽짜리도 되지 않는 매우 미흡한 부실수사였다 먼저 박 대통령이 롯데그룹 신동빈 회장에게 억 원의 추가 출연금을 직접 요청한 일은 뇌물죄가 되어야 마땅하다 미르 스포츠 재단의 억 강제모금과정 또한 제 자 뇌물죄의 죄목이 적용되고도 남을 일이다 삼성과 등 부정한 청탁을 한 재벌들에 대해서도 아무런 혐의 내용이 포함되지 않았다 물론 검찰이 중간 수사발표를 통해 박근혜 대통령을 피의자 신분으로 전환한 것은 유의미한 성과이다 그러나 향후에 있을 수사발표에서는 박 대통령의 공모와 뇌물죄 적용 등 보다 진전되고 구체적인 혐의 내용이 반드시 적시되어야 할 것이다 만약 최종수사 발표에서조차 검찰이 스스로의 역할을 다하지 못한 채 권력 앞에 무릎을 꿇는다면 이후에는 특검을 통해 박근혜 최순실 게이트의 죄목을 낱낱이 규명할 수밖에 없다 그때 검찰의 직무유기도 특검의 대상이 될 것이라는 점을 명확히 경고한다 박근혜 대통령이 검찰조사도 한번 제대로 받지 않고 인격살인을 운운하는 것은 어불성설이다 대한민국의 모든 국민은 법 앞에 평등하며 결코 대통령도 예외가 될 순 없다 검찰은 대통령을 피의자로 입건 한다는 공소장에 따라 즉각적인 강제수사에 나설 것을 촉구한다 노려보면 기소도 못하는 검찰인가 어제 검찰이 박근혜 최순실 게이트의 중간 수사 결과를 발표했다 최순실 안종범 정호성 등 주요 관계자에 대한 기소 사실을 밝혔으며 박근혜 대통령은 이 모든 범죄행위의 공동정범으로 결론을 냈다 사실상 대통령도 기소대상이나 헌법 조 불소추 특권을 이유로 기소하지 못함을 밝힌 것이다 하지만 우병우 전 수석에 대한 기소 내용은 밝히지 않았다 검찰은 아직도 수사 중이라는 원론적 입장만을 앵무새처럼 반복하고 있다 이석수 전 특별감찰관이 우병우에 대해 직권남용과 횡령 혐의로 검찰에 수사를 의뢰한 것이 지난 월 일이다 특별감찰관도 찾은 사실을 검찰은 석 달 동안 못 찾았다는 것인가 아니면 찾지 않는 것인가 기자의 질문에 노려보기로 응답하고 검찰의 소환에 황제조사란 이런 것이다 를 보여준 갑중의 갑 우병우에 대한 검찰의 소극적 태도를 보며 국민들은 또다시 분노하고 있다 민정수석의 위치에서 시정잡배 수준의 국정농단을 스스로 몰랐다면 무능이고 알았다면 공범이다 그럼에도 검찰이 우병우에 대한 소극적 수사 태도를 보이는 것은 검찰이 우병우 전 수석을 특별히 배려해야 할 이유가 있다고 밖에 생각할 수 없다 검찰이 이런 식이라면 우병우에 대한 수사도 특검에서 밝히는 수밖에 없다 특검이 그의 범죄사실을 낱낱이 밝히고 나서 검찰은 무어라 변명할 수 있겠는가 검찰이 우병우를 감싸는 만큼 국민의 분노 백만 첫불은 더욱 커지고 있다는 사실을 깨달아야 한다 껍데기만 남은 대통령 붙잡고 있는 새누리당 국민께 석고대죄해야 새누리당 지도부이 대통령 공모 혐의 판단은 대통령이 직접 수사를 받지 않아 단정하기 어려운 사안 이라며 시간을 갖고 지켜보다는 입장을 되풀이했다 새누리당에게 묻겠다 지난 년 박근혜 대통령과 함께 박근혜 최순실 게이트 의 부역자 역할을 해온 새누리당은 아직도 현실을 직시하지 못한다는 말인가 끝까지 대통령의 친위부대로 남겠다는 것인가 대한민국 국민들은 그 동안 대기업에 대한 미르 스포츠재단 출연금 강요 청와대 대외비 문서 유출 최순실 정유라 모녀 학사농단 등 갖갖이 의혹을 지켜보며 이게 나라냐 고 절규하고 있다 대한민국 헌정과 가치를 무너뜨린 박 대통령은 즉시 하야하고 부역자인 새누리당은 해체하라고 백만 촛불은 외치고 있다 또한 검찰은 박근혜 대통령이 최순실과 안종범 전 수석 정호성 전 비서관 등의 범죄 사실과 관련해 상당부분 공모관계가 있다는 것으로 판단했다 지금까지 국민의 분노를 산 의혹들이 단순히 의혹이 아니라 범죄였으며 박 대통령은 범죄 혐의가 있는 피의자 신분임을 명확히 한 것이다 이같은 상황에서 새누리당은 현실을 바로 보지 못하고 있다 뼈저리게 반성하고 국민께 석고대죄를 해도 부족하다 껍데기만 남은 대통령을 붙잡고 있는 까닭은 무엇인가 혹여 새누리당 한 의원의 실언처럼 바람 불어 촛불 꺼질 때만 기다리고 있는 것인가 이는 오판이다 이미 바싹 말라버린 국민들 마음속에서 작고 희미한 촛불 하나가 바람에 쓰러진다면 촛불이 꺼지는 것이 아니라 활활 타오르는 들불이 될 것이라는 점을 명심하길 바란다 최고위원회의 결과 최고위원회는 오늘 박근혜 대통령 퇴진 국민주권운동본부 의 구성을 마쳤다 부본부장에 원혜영 강창일 양승조 의원을 임명하고 원내대책위원장은 우상호 원내대표가 맡기로 했다 또 운영지원단장에 안규백 사무총장 의원홍보단장에 송영길 의원 서명운동단장에 김상희 의원을 임명했다 더불어민주당은 국민주권운동본부의 구성을 마친 만큼 박근혜 대통령의 퇴진을 위해 전국적으로 거당적 활동에 더욱 박차를 가할 계획이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59052,2016-11-20, 윤관석 수석대변인 추가 현안 브리핑 일시 오후 시 분 장소 국회 정론관 또 말 바꾼 박근혜 대통령 검찰수사 거부는 결국 대한민국과 국민을 부정하겠단 것인가 박근혜 대통령은 결국 역사와 국민에 정면도전을 선택했다 또다시 말 바꾼 박근혜 대통령의 검찰수사 거부는 결국 대한민국과 국민을 부정하겠다는 것이다 박근혜 대통령의 변호인이 환상의 집 사상누각 등의 표현까지 써가며 검찰 수사결과에 전혀 승복할 수 없고 향후 검찰 조사에 일절 응하지 않겠다고 입장을 밝혔다 대통령이 자신이 임명한 사법기관의 수사를 스스로 부정한 것은 국가의 공적 시스템을 부정하는 행태로 경악을 금할 수 없다 유영하 변호사는 검찰 수사결과 발표가 증거를 엄밀히 따져 보지도 않고 상상과 추측을 거듭한 뒤 그에 근거하여 자신들이 바라는 환상의 집을 지었다 고 규정했다 이미 알려진 바와 같이 무수히 많은 증거와 증언이 나왔다 심지어 오늘 나온 검찰 공소장은 박근혜 대통령의 공소장이나 다름없다는 평도 있는데 환상의 집 이라니 아연실색할 따름이다 자신은 결백하다는 자기 최면에 빠져 검찰 수사 결과가 신기루로 보이는 것 아닌지 묻고 싶다 변호인의 주장에 박근혜 정부가 얼마나 사상누각 같은 정부였는지 재삼 확인하며 국민들은 참담함을 금할 수 없다 오늘로 박근혜 정부의 공적 시스템은 완전히 붕괴됐다 중립적인 특검의 엄격한 수사에 대비하겠다니 기가 막힐 노릇이다 또다시 시간을 끌면서 특검에 자신을 옹호해줄 사람을 임명할 수 있다고 착각이라도 하는 모양이다 검찰 조사에 성실하게 응하겠다고 했다가 며칠 만에 입장을 바꿨듯 특검 수사에 응하겠다는 말도 믿을 수 없다 국민은 대통령이라는 신분을 망각하고 죄를 면하기 위해 자신이 임명한 검찰과 싸우는 피의자 대통령의 국정 수행을 더 이상 용납하지 않을 것이다 박근혜 대통령은 더 이상 헌법을 유린해 국민의 마음을 참담하게 하지 말고 즉각 대통령직에서 물러나 검찰 수사에 성실히 응할 것을 엄중히 촉구한다 검찰은 박근혜 대통령을 피의자 신분으로 즉각 소환조사해야 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59051,2016-11-20, 최고위원 국민조사위원회 연석회의 모두발언 일시 오후 시 장소 국회 당대표회의실 추미애 대표 국민 여러분 나라가 위기에 빠졌다 그런 가운데 어제 서울에서 제주까지 전국 여 곳에서 또 다시 만개의 촛불이 타올랐다 분노한 민심이다 박근혜 대통령이 검찰 조사에 응하기는커녕 오히려 국정 전반에 다시 등장하고 국민과 전면전을 전개한 것에 대해 분노한 시민들의 마음이 모인 것이다 국민들의 요구는 하나 박근혜 대통령은 즉각 퇴진하라는 것이다 이제 위대한 국민들이 주권과 민주주의를 되찾기 위해 시민혁명 명예혁명을 만들고 있다 오늘 박근혜 대통령은 피의자로 입건됐다 검찰은 거의 모든 혐의에 대해 기소된 최순실 안종범 정호성이 대통령과 공모관계라고 밝혔다 현직 대통령의 범죄 혐의를 공소장에 적은 것은 헌정사상 처음이라고 할 것이다 대통령의 범죄혐의가 도저히 덮을 수 없을 만큼 범죄행위가 중대하고 심각함이 드러난 것이다 검찰 수사로 통에 대한 탄핵소추의 법적여건이 형성됐다고 할 것이다 그러나 미르 스포츠재단 설립에 뇌물죄를 적용하지 않은 것은 검찰이 칼을 절반만 넣었다 뺀 것이라고 할 것이다 검찰은 뇌물죄 등에 대해 추가 수사를 한다고 하는데 몸통인 대통령에 대한 조사를 하지 못하면 부실 수사가 될 것이다 최순실 안종범 등 수많은 인사 개입 관련 직권남용 강요 입학비리에 대해서도 공소사실에 포함시키지 않았다 대통령 수사를 포함해 철저하고 엄중한 검찰 수사를 다시 한 번 촉구한다 대통령이 버티면 버틸수록 퇴진하라는 국민적 요구가 거세질 것이다 박근혜 대통령은 다시 한 번 즉각 퇴진하고 진솔하게 수사를 받는 것만이 마지막으로 나라를 살리는 길이라는 것을 명심하기 바란다 이석현 국민조사위 공동위원장 오늘 검찰의 피고인 인에 대한 공소장은 사실상 박근혜 공소장이다 공소장 면 중 면에 걸쳐서 박 대통령의 공모 범행 관련 피의사실이 적시돼 있다고 한다 공소장에 기재된 박 대통령의 기업관련 범행은 여섯 가지이다 미르와 스포츠 강제모금 관련 현대차 롯데그룹 포스코 그리고 그랜드코리아레저와 관련한 집권남용 혐의이다 아울러 국가기밀 누설과 관련한 정호성과의 공모범행이 적시됐다 검찰 공소장은 준사법기관인 검찰의 수사결과가 기재된 것으로 언론에서 제기한 지금까지의 의혹들이 사실이었음이 정부기관에 의해 처음 입증된 것이다 이제 박 대통령은 더 이상 대통령의 자리에 머물 명분이 사라졌다 더이상 나라에 혼란이 없도록 마지막 애국심으로 모든 것을 내려놓고 사퇴해야 한다 검찰은 더이상 청와대와 전화로만 상의하지 말고 정식으로 피의자 소환장을 발부할 것과 이에 불응하면 법원에서 체포영장을 받아서 긴급 체포해 강제수사할 것을 강력히 촉구한다 어제도 만 집회가 있었지만 집회가 끝난 자리가 쓰레기 휴지조각 하나 없이 깨끗했다 세계적으로 유례없이 높은 수준의 국민들이다 그 국민에 걸맞지 않는 세계적으로 유례없는 대통령이 자리 떠날 수밖에 없다 국민이 자리를 떠날 수는 없는 것이다 전해철 국민조사위 공동위원장 오늘 수사발표는 박근혜 대통령이 즉시 즉각 사퇴해야 할 충분한 근거를 보여주고 있다고 판단된다 오늘 검찰 특별수사본부가 박 대통령의 최측근인 최순실씨 등을 공소하면서 공소장에 남긴 사실은 박근혜 대통령이 이들과 공모관계에 있다고 적시하며 공범임을 명확히 하고 피의자로 정식 입건했다 공소장을 보면 아주 구체적이고 상세하다 미르 스포츠 재단 설립 현대차 납품업체와 광고업체 특혜선정 홍보담당 이사 임원채용에 대해서 최순실과 안종범의 직권남용 강요 정호성 비서관의 공무상 비밀누설 행위도 모두 대통령의 지시로 밝혀져 있다 특히 최순실의 지인이 운영하는 업체에 현대차 납품업체에 대한 납품 특혜를 위해 대통령이 직접 지시하고 회장에 있는 자리에서 안종범 수석으로 하여금 발언을 하도록 한 사실과 용의 순수어로 신비롭고 영향력이 있다는 뜻을 가진 미르 라고 하라고 하며 명칭은 물론 이사장 사무총장 사무실 위치까지 지시한 것은 경악을 금할 수 없다 나라를 잘 이끌어 달라고 국민이 뽑은 대한민국의 대통령이 직권남용 등의 죄를 저지른 범죄 집단의 중심에서 사실상 이를 지휘했다는 기막힌 현실 앞에 우리 국민은 망연자실할 수밖에 없다 이제 현직 대통령이 현직 검찰에 의해서 구속 사유가 충분한 범죄사실이 확인된 만큼 대통령은 통치의 정당성 신뢰성을 모두 상실함과 동시에 국민들의 엄청난 분노에 직면할 것임을 거듭 강조한다 특히 대통령은 헌법과 법률을 위배했음을 명백히 말씀드린다 오늘 수사 발표를 통해 대통령을 공범으로 적시한 것은 검찰이 이제야 국민의 분노와 뜻을 두려워하는 모습을 작게나마 보여주는 것이라고 생각한다 하지만 오늘 수사 내용이 최종적인 것이 아니라고 감안하더라도 여전히 많은 부분이 미진하다 많은 의혹이 제기됐음에도 검찰은 늦장 수사로 초기수사에 실패하고 결국 대통령에 대한 조사도 하지 못한 채 포괄적 뇌물죄에 대해 기소하지 못했다 즉각 박근혜 대통령을 소환조사해 뇌물죄에 대해 엄정수사해야 한다 덧붙여 검찰 길들이기의 주역으로 검찰을 쥐락펴락한 김기춘 우병우도 박근혜 대통령과 최순실 국정농단에 적극 가담했다는 의혹을 받고 있다 검찰이 이번에 김기춘 전 실장에 제대로 수사하지 않으면 특검에서 반드시 수사대상이 될 것임을 경고한다 우병우 수석도 즉각 소환조사하고 필요한 경우 구속수사를 통해 검찰의 명운을 걸고 최선을 다해야 한다 안민석 국민조사위 공동위원장 일 동안 진행된 이화여대에 대한 교육부 특별감사는 두 가지 의문에 대한 규명을 하는 것이었다 첫째 누가 입시 부정을 주도했는가 둘째는 누가 학칙개정을 주도했는가 하는 것이었다 그런데 두 가지 모두 주모자를 찾아내지 못하고 꼬리 자르기 감사에 머물렀다 특히 입시부정과 관련해서는 당사자인 정유라를 조사하지 않은 채 감사가 진행됐다 부정행위를 했으면 당사자를 불러서 조사해야 하는데 정유라를 조사하지 않은 부실감사에 대해 참으로 개탄하지 않을 수 없다 문제는 도대체 이 두 가지 원인규명을 하지 못했을까 이대 내에 또 다른 최순실이 있는 것 같다 지난 금요일 이름을 밝힐 수 없는 이대 교수들 몇 분이 저의 의원실에서 이대 내부의 사정을 얘기하면서 최경희를 움직일 수 있는 실세가 이대에 있다고 했다 입시부정과 학칙개정은 최경희 혼자 독단으로 할 수 없는 행위이며 나머지 교수들이 일사분란하게 가담한 것은 최경희를 움직이고 이대를 움직이는 이대 비선실세가 있다고 말했다 이후에 특검과 국정조사에서 이대와 최경희를 움직이는 비선실세의 실체를 확인해야 할 것 같다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59050,2016-11-20, 기동민 원내대변인 추가 현안 서면 브리핑 대통령의 후안무치한 검찰조사 거부를 규탄한다 대통령이 검찰수사를 일체 받지 않고 특검에 대비하겠다고 한다 대통령의 후안무치에 기가 막힌다 검찰 수사를 성실히 받겠다며 국민 앞에 약속하고 사과한 것이 얼마 전이다 국민을 무시하고 법질서를 우롱하는 초법적 대통령의 횡포에 분노할 따름이다 대통령은 검찰수사를 받지 않고 특검에 대비하겠다고 하지만 검찰 조사마저 무시하는 대통령이 특검 조사 제대로 받을지 의문이다 검찰을 권력유지의 도구로 활용하더니 이제와서 토사구팽한 것이나 다름없다 국민의 분노를 무시하고 사법질서마저 깡그리 무시하는 박근혜대통령은 이미 자격을 상실했다 대통령은 검찰을 토사구팽했지만 검찰은 팽 당해선 안 된다 철저한 진상조사로 국민의 검찰이 돼야한다 국민을 배신한 피의자 박근혜 대통령을 강제로라도 즉각 소환하여 진실을 밝혀야 한다 뇌물죄 등 여죄를 추궁해 사법정의를 세우는 데 조직의 명운을 걸어야 한다 박근혜 대통령은 특검 운운하지 마라 검찰조사를 통과하는 것이 먼저다 상황을 파국으로 몰아가는 대통령은 그 자리에 있을 자격이 없다 물러나 법의 심판을 받아야 한다 국민의 단죄를 받아야 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59048,2016-11-20, 윤관석 수석대변인 오후 현안 서면 브리핑 유언비어 유포해 국민의 분노 물타기하려는 책동을 좌시하지 않을 것이다 더불어민주당은 최근 엘시티 사건과 관련해 야당 인사가 연루됐다는 유언비어들이 유포되고 있어 유언비어 신고센터를 개설하고 법적 대응을 천명한 바 있다 그런데 김경재 자유총연맹 회장이 보수단체의 집회에서 노무현 전 대통령이 임기말 기업에서 억원을 걷었다고 주장했다 근거 없는 비방이다 항변조차 할 수 없는 돌아가신 분을 논란에 끌어드리는 행태에 분노를 금할 수 없다 더불어민주당은 야당을 흠집 내서 박근혜 최순실 게이트에 대한 국민의 분노를 왜곡하려는 보수세력의 책동에 단호하게 대응할 것임을 거듭 천명한다 구태를 벗지 못하고 또다시 관제데모로 국정을 파탄에 빠뜨린 대통령을 감싸는 김경재 회장과 자유총연맹에 대해서도 반드시 책임을 물을 것임을 엄중히 경고한다 보수단체 집회 돈 살포 의혹 검찰의 즉각 수사를 촉구한다 어제 서울역사 앞에서 열린 보수단체 집회 주변에서 시위 참가자들에게 돈을 나눠주는 장면이 언론에 포착됐다 보도에 따르면 한 무리의 사람들이 노인들에게 돈을 주었고 돈을 받은 이들은 보수단체 맞불 집회에 참석했다고 한다 어제 보수단체의 집회가 금품에 의한 불법 동원된 관제데모를 의심하며 사법기관의 즉각적인 수사를 촉구한다 전경련으로부터 불법 자금을 지원받아 알바를 동원했다는 혐의로 수사를 받고 있는 어버이연합이 요즘 다시 활개를 치고 있다 어버이연합을 비롯한 보수단체들의 활동 뒤에 누가 있기에 보수단체들이 검찰 수사마저 의식하지 않고 활개를 치고 있는 것인지 의문을 제기한다 민주국가에서 민의를 왜곡하는 세력은 사법당국이 단호하게 대처해야 한다 그렇지 못하다면 그 배후가 검찰이 눈치 볼 수밖에 없는 권력이라고 의심할 수밖에 없다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59046,2016-11-20, 윤관석 수석대변인 오전 현안 브리핑 일시 오전 시 분 장소 국회 정론관 피의자 입건된 대통령이 국정을 이끌겠다는 것은 어불성설이다 오늘 박근혜 대통령은 피의자로 입건됐다 검찰 발표에 따르면 앞으로 대통령에 대한 수사는 피의자 신분으로 전환된다 검찰이 박근혜 최순실 게이트 중간수사결과를 발표하고 박근혜 대통령을 피의자로 입건했다 검찰이 박근혜 대통령에 대해 최순실씨 등과 상당부분 공모관계가 있는 것으로 판단하고 입건한 것은 그 의미가 크다 박근혜 대통령이 즉각 검찰 조사에 응해야 함은 물론이고 검찰 또한 즉각 박 대통령을 소환 조사해야 한다 법 앞에 만인이 공평하다 박근혜 대통령이 피의자가 된 만큼 검찰은 즉각 박 대통령을 검찰에 소환해 조사해야 한다 박근혜 대통령은 당장 대통령직에서 물러나야 한다 검찰이 현직 대통령을 국정농단 국기문란 사건의 피의자로 입건했다 피의자 신분의 대통령이 대한민국을 이끌 수는 없다 공직자들이 피의자 신분의 대통령이 내린 지시를 받드는 것도 어불성설이고 그런 대통령이 외국 정상들과 외교를 하겠다는 것도 국가적 망신이다 박 대통령은 기소중지상태가 될 것으로 보인다 헌법에 명시된 대통령의 불소추 조항은 대통령 스스로 결단하라는 것이다 이제 대통령에 대한 탄핵 소추의 법적 여건이 형성됐다 박 대통령이 버틴다면 탄핵하라는 국민들의 요구가 커질 것이다 박 대통령은 최악의 선택으로 나라를 더 큰 혼란에 빠뜨리지 말고 스스로 물러나는 결단을 통해 마지막이나 국민의 뜻을 따를 것을 촉구한다 다만 이번 수사는 중간 결과이다 지금까지 밝혀진 것에 국한한 발표이다 그런 점에서 아직 많은 부분에 대한 수사가 반드시 뒤따라야 한다 특히 검찰은 뇌물죄에 대해 기소하지 않았는데 이미 증거를 확보하고도 기소하지 않은 것은 아닌지 의문스럽다 최종 수사결과 발표에는 꼭 뇌물 관련 부분을 엄정히 수사해야 한다 특검 수사가 기다리고 있는 만큼 검찰은 남은 기간 더욱 철저한 수사의지를 보여줄 것을 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59047,2016-11-20, 기동민 원내대변인 추가 현안 브리핑 일시 오전 시 분 장소 국회 정론관 변죽만 울린 면죄부 중간 수사 발표일 뿐이다 몸통은 건드리지도 못하고 곁가지 변죽만 울린 면죄부 중간 수사 발표다 최순실 안종범에게 뇌물죄 제 자 뇌물공여죄를 적용하지 않은 것은 국정 논란 헌정 질서 파괴범 을 잡범으로 취급한 것이다 이들에게 뇌물죄를 적용하지 않았다는 것은 대통령에게도 뇌물죄를 적용하지 않겠다는 것과 다름없다 몸통은 피하고 곁가지만 건드리며 변죽만 울렸을 뿐이다 국민의 검찰이 아니라 대통령의 검찰 일 뿐이라는 의구심을 지울 수 없다 실질적으로 범죄를 지시하고 주도한 당사자인 대통령을 피의자로 신분으로 수사진행하겠다고 했지만 직권남용 기록물 유출 등에 국한될 가능성이 크다 사실상 대통령에게 면죄부를 준 것이다 하지만 그것만으로도 대통령직에서 물러나야 할 사유는 충분하다 박근혜 대통령은 현직 대통령으로 수사 받는 역사적 불행을 기록하지 말고 민간인 신분으로 수사 받아야 한다 대통령은 롯데수사 관련 최태원 회장 사면 부영 세무조사 면죄 시도 삼성물산과 제일모직 인수합병 과정에서의 국민연금 동원 등을 사실상 주도한 당사자라는 의혹을 받고 있다 기업의 편의를 봐주고 사익을 취한 것은 명백한 뇌물죄 적용대상이다 최순실 안종범 정호성 등은 대통령의 지시를 받아 이를 실행한 종범일 뿐이다 그런데도 이들에게 뇌물죄를 적용하지 않은 것은 그 불똥이 대통령에게 튀는 것을 막아보겠다는 면죄부 수사일 따름이다 우리당은 마지막까지 눈 부릅뜨고 검찰 수사를 지켜볼 것이다 검찰은 대통령을 강제로 소환해서라도 모든 의혹을 철저하게 수사해야 한다 특검과 국정조사가 기다리고 있다는 것을 명심해야 한다 마지막까지 검찰이 진실에 접근하기를 거부한다면 우리당은 특검과 국정조사를 통해 박근혜 최순실 게이트 의 진실을 파헤치기 위해 모든 노력을 다할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59045,2016-11-20, 기동민 원내대변인 오전 현안 브리핑 일시 오전 시 분 장소 국회 정론관 촛불은 꺼지지 않는다 박근혜 대통령은 퇴진하라 전국 만 촛불이 다시 타올랐다 대한민국의 심장 광화문 항쟁의 고장 광주 박근혜 대통령의 심장부 대구는 물론 부산에서도 만의 촛불이 타올랐다 전국 방방 곳곳이 대통령의 망상 과 반민주적 죄악 을 불태우기 위한 횃불이 되었다 바람이 불어 촛불이 꺼지기는커녕 더욱 훨훨 타올라 들불처럼 번지고 있다 성숙한 시민의식 평화적 항의와 질서 의식은 꽃처럼 빛났고 영롱한 빛이 되어 대한민국을 살아있게 만들었다 더불어민주당은 이제까지와 마찬가지로 앞으로도 그 뜻을 더욱 겸허하게 따를 것이다 국민은 피의자 박근혜 대통령의 퇴진을 명하고 있다 더 이상 국민들을 힘들게 하지 말라 자제하고 인내하며 끝까지 평화를 호소하는 국민들을 더 이상 괴롭히지 말라 거짓과 위선 집착으로 점철된 가면을 벗고 법의 심판대에 서야 한다 국민에 대한 최소한의 도리이고 양심이다 순방부터 모금 인사 건강까지 최 선생님 뜻대로 이뤄진 최순실 공화국 의 진상을 밝혀라 최순실 일파를 위해 미르 재단을 만들고 재벌과의 부당한 거래와 특권 보장 시장 질서를 망가뜨린 죄를 달게 받아야 한다 나쁜 사람 이란 낙인을 찍고 우병우 전 수석을 앞세운 인사전횡으로 국정을 농단한 책임을 져야 한다 세월호 시간 동안 대한민국의 국가원수가 관저에 앉아 한 일은 무엇인지 낱낱이 고해야 한다 더 이상 대한민국 얼굴에 먹칠하지 마라 민주주의를 따르는 대통령을 원한다 는 초등학생 앞에서 더 이상 자리를 탐하지 마라 모든 것을 내려놓고 물러나라 박근혜 대통령은 홈피 해명 같은 허튼 행위 하지 말고 검찰청 포토라인에서 진실을 밝혀라 청와대가 오보 괴담 바로잡기 코너를 만들고 국민의 물음을 괴담으로 전락시켰다 이것이 국민과 소통하는 방식인가 생업과 일상을 뒤로하고 거리로 나온 국민에 대한 예의인가 국민을 무시하는 오만한 정권의 불손한 태도에 분노할 따름이다 박근혜 대통령이 조금이라도 성의가 있다면 유폐된 청와대 담장을 나와 검찰청 포토라인에서 서야 할 것이다 사법 심판대에서 진상을 고백하고 심판받는 것이 대통령 이 할 수 있는 마지막 선택이다 국정 농단 에 대한 죄를 청하라고 했더니 국정 농성 으로 국민에게 화답하는 것이 대통령이 할 일인가 구중궁궐 청와대 담장 속에서 홈페이지에 허튼 소리나 나열하며 국민을 우롱하지 마라 국민이 용서치 않을 것이다 아울러 청와대 담장과 그림자 속에 숨어 대통령의 망상과 집착을 부채질하는 측근들에게도 경고한다 저열한 정략과 꼼수로 국민을 모독하지 마라 모두가 공범이고 역사의 죄인일 뿐이다 검찰은 국정농단의 배후 김기춘 을 당장 소환하라 검찰은 전직 왕실장 김기춘 을 법의 심판대에 세워라 진실은 숨겨지지 않다 그림자 속에 숨어 국민을 모독하고 권력 연장의 집착을 부채질하는 김기춘 전 실장은 스스로 죄를 고백하고 법의 심판을 받아야 한다 최순실과 김 전 실장의 어두운 커넥션이 드러났다 정윤회 문건 조응천 공직기강비서관 경질 김종 김종덕의 임명과 전횡 을 비롯한 최순실의 국정농단 을 법적 행정적으로 뒷받침해준 공식적 실세는 김 전 실장이라고 추정된다 청와대에선 공식적인 왕실장 이었고 지금은 그림자 배후 로 모든 공작정치를 주도하며 국민 모독 행위의 핵심으로 지목되고 있다 검찰은 망설일 이유가 없다 김기춘 전 실장을 즉각 소환하여 법의 심판대에 세워야 한다 불의가 용납될 수 없음을 보여야 한다 가장 큰 죄는 국민의 뜻을 배반하고 헌정질서를 문란하게 만든 죄다 엄정한 단죄를 촉구한다 우리당은 앞으로 진행될 국정조사와 특검에서 김기춘 전 실장의 죄상을 국민 앞에 낱낱이 밝혀낼 것을 약속드린다 나홀로 대통령 의 반민족적 한 일 군사정보보호협정 체결을 용납할 수 없다 국민 뜻에 반한 한 일 군사정보보호협정 은 용납할 수 없다 박근혜 대통령이 조금이라도 민심을 두려워한다면 역사의 죄를 짓는 어리석은 집착을 버려야 할 것이다 박근혜 대통령이 주재하는 국무회의 그 안에서 결정된 굴욕적 매국협정 에 동의할 사람은 없다 국민이 반대하고 역사가 용서치 않는 한 일 군사정보보호협정 의 날림 통과 는 꿈도 꾸지 말아야 할 것이다 매국 협정 을 이용해 국정에 복귀하겠다는 얕은 수는 통하지 않는다 군 내부에서는 벌써부터 한 일 군수지원협정 체결을 준비한다는 말이 나오고 있다 결코 용납할 수 없는 일이다 국민의 동의없는 일본과의 정보 군수 등 모든 협정은 제 의 을사조약 으로 역사에 기록될 것이다 어리석은 집착과 오판으로 나라의 운명을 내동댕이치는 우를 범하지 마라 또 하나의 죄만 더할 뿐이다 즉각 중단하라 정유라 특혜 눈감고 부실감사로 면피하려는 교육부는 각성하라 비선 실세 최순실과 그 딸 정유라의 특혜 입학을 방조한 책임은 교육부에 있다 돈과 권력에 오염된 한국사회의 민낯을 적나라하게 드러냈고 교육의 근간을 뿌리째 훼손했다 돈도 실력이야 능력 없으면 부모를 원망해 라며 대한민국 모든 학부모들과 아이들의 자존심을 짓밟은 죄악을 방조하고 조장한 공범 중 하나다 교육부의 감사결과 발표는 그야말로 면피 에 불과했다 시중에 나돌던 의혹만 확인했을 뿐 윗선 개입 과 이를 통한 대가성 의혹은 손도 대지 못했다 그 누구도 납득할 수 없는 면피 감사 였을 뿐이다 교육부는 감사할 의지도 진상규명의 의지도 없다는 것이 확인됐다 오히려 국민들의 화만 돋웠을 뿐이다 정유라 특혜의 공범 교육부의 각성을 촉구한다 아이들의 꿈과 희망을 짓밟은 죄 결코 용납할 수 없는 범죄 행위이다 우리당은 필요하다면 정유라 특혜 를 방조하고 조장한 교육부에 대한 감사원 감사를 청구할 것이다 또한 아이들과 부모들의 마음에 상처를 준 교육부 장관에 대해서도 그 책임을 엄중하게 물을 것이다 박 대통령 경호당 새누리당은 역사 속으로 퇴장하라 새누리당 이정현 대표의 독선과 집착이 도를 넘고 있다 인민재판 여론 선동 등 공당의 대표로서 입에 담지 못할 막말을 서슴지 않는 것도 모자라 집권여당을 대통령 경호당 으로 전락시키고 있다 이정현 대표가 고집 부릴수록 새누리당은 우스워지고 국회가 부끄러워질 뿐이다 이정현 대표가 있는 한 여 야 소통도 없고 합의도 어렵다 이제 그만 정신 차리고 스스로 물러나시길 권한다 정진석 원내대표에게도 한 말씀 드린다 난데없는 개헌론 으로 국민의 질타를 피해보겠다는 꼼수는 포기하시라 전 국민이 거리로 나와 대통령 퇴진과 처벌을 외치고 있는 상황이다 한가로운 개헌론으로 국민을 우롱하고 화살을 피하겠다는 정략은 먹히지도 않고 도리도 아니다 새누리당이 할 일은 국민의 뜻을 받들어 대통령에게 퇴진을 권하고 법의 심판을 받게 하는 것뿐이다 새누리당은 박근혜 대통령과 함께 국정농단 국기문란 헌법유린 의 책임을 지고 역사 속으로 퇴장하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59041,2016-11-19, 추미애 대표 더불어민주당 박근혜대통령 퇴진 결의대회 인사말 일시 월 일 토 장소 서울 청계광장 소라상 앞 추미애 대표 우리 국민은 생업도 포기한 채 대한민국을 구하기 위해서 하루하루 힘들게 살면서도 이 자리에 모였다 그런데 대한민국 대통령은 오직 자기 자신만 살겠다고 버티기를 하고 있다 만 촛불 만 국민의 뜻은 너무나 분명하다 대통령을 하루도 아니 단 분 초도 인정할 수 없으니 즉각 하야하라는 것이 국민의 뜻이다 박근혜 대통령은 우리 국민과 전면전을 선포했다 만 촛불의 준엄한 명령을 수용하긴 커녕 오히려 적반하장으로 반격의 총공세를 펼치고 있다 국민이 퇴진을 요구하니까 국정공백 중단은 안 된다며 버티기를 하고 있다 검찰 수사를 받으라고 하니까 막가파식 버티기에 돌입했다 대통령이 오히려 국정을 망치고 있다 무면허 선장으로 대한민국을 급변침해서 침몰시키려고 한다 지금 이 순간 한일 군사정보보호협정은 서둘러서 할 필요도 할 이유도 없는데 우리나라를 위험에 빠뜨리고 있다 지지율도 안 되는 대통령이 한일 군사정보보호협정을 서둘러서 일사처리로 해결하겠다고 하려하니 역사의 주인공이 되려고 하는 것인가 대통령은 즉각 중단해야 한다 사드는 논의조차 안하겠다는 대통령이 갑자기 사드만이 핵을 막을 수 있다 나라를 지킬 수 있다 며 누구의 말도 듣지 않고 마음대로 해치웠다 직권남용뿐만이 아니라 공무상 국가기밀 누설 제 자 뇌물수수 혐의 등 지금까지 거론된 혐의만 해도 입에 담기조차 어려울 정도로 무지막지하다 외치를 손에 놓지 않겠다는 대통령 외치를 할수록 나라를 망신시킬 뿐이다 엊그제 미국 일간지 워싱턴포스트가 박근혜 스캔들은 워터게이트보다 심각하다고 보도했다 외치를 망치고 내치는 재벌과 검은 뒷거래를 해온 대통령 더 이상 나라 망신시키지 말고 즉각 하야하라고 외쳐 달라 대통령은 하야하라 당원 동지 여러분 헌정 사상 초유의 국정 유린과 부정비리 부패를 우리 국민이 절대로 용서할 수 없다 우리 아이들에게 부끄러울 뿐이다 청년들은 알바를 뛰면서 공부를 해도 일자리가 없고 꿈을 이룰 수 없는 청년이 열심히 일했지만 스크린도어에 끼어 죽는 참사가 있었다 이런 대한민국 청년에게는 아무런 희망이 없고 대답 없는 대통령이 오직 최순실 딸 정유라에게는 온갖 특혜와 관심과 걱정을 줬다 우리 아이들의 꿈을 뺏어버린 대통령에게 이제 우리는 나라의 미래를 맡길 수 없다 대통령은 하야하라 즉각 내려오라 거꾸로 국민이 나라 걱정을 하고 있다 나라 빚 걱정 가계부채 등 온통 국민이 걱정하고 있는데 대통령은 한가하게 최순실 일가의 이권만 챙기고 있다 청와대가 문고리 인방이 권력을 농단하고 엄호하고 있는 사이 최순실의 부정부패는 눈덩이처럼 불어나고 있다 유신망령을 보는듯한 문화계 블랙리스트는 또 무슨 말인가 대한민국을 쑥대밭으로 만든 거대한 게이트의 몸통은 박근혜 대통령이다 새누리당은 용납할 수 없는 반국가적인 박근혜 정권의 공범이자 홍위병이다 새누리당 국회의원 공천까지 당 내부에도 최순실 입김이 뻗치지 않은 곳 없다고 한다 최순실이 공천한 국회의원 오로지 이 순간에도 당 대표가 대통령의 홍위병을 자처하는 새누리당 더 이상 헌법기관으로 인정 할 수 없다 년 전부터 부정부패의 온상으로 지목됐던 엘시티 이영복 회장을 감싼 것도 새누리당이다 최순실의 부역자 부정부패를 감싸고 국정감사를 방해한 최후의 보루도 새누리당이다 국가가 망가지든 말든 국민이 분열하든 말든 자신의 집단만 살고보자는 먹튀 정권 먹튀 대통령을 더 이상은 용서할 수 없다 대통령은 하야하라 나라를 뺏겼을 때는 국권을 회복하고 자주독립을 찾기 위해 전국 방방곳곳 모든 애국시민이 대한독립만세를 외쳤다 이 땅의 민주주의가 짓밟혔을 때 자랑스러운 우리 민주당은 민주주의의 새역사를 쓰기 위해서 부정선거를 규탄하고 대한민국 민주질서를 바로 세웠다 저 또한 신군부가 국권을 찬탈했을 때 광주 민중들은 김밥 싸들고 거리로 나와 대한민국 국권회복을 위해 목숨을 바쳤다 시대마다 최선을 다해온 자랑스러운 우리 민주당원 여러분 이제 우리는 박근혜 대통령 박근혜 부역집단이 짓밟은 민주주의와 국권 회복을 위해 주권회복국민운동본부를 출범했다 이제 촛불이 횃불이 되고 횃불이 들불처럼 일어나 다함께 대한민국을 정의로운 대한민국으로 함께 일으키자 헌법 질서를 바로 잡고 국권을 회복해서 나라의 주인이 국민이라는 것을 천만 국민이 똘똘 뭉쳐 함성으로 외치자 내일도 모레도 우리 민주당원 동지 여러분들과 함께 천만 삼천 오천만 결의서명을 받아 대한민국 주권을 회복하는데 분 초를 다 쓰겠다 피땀 흘려 나라를 바로 세우겠다 감사하다 당원동지 여러분 +http://theminjoo.kr/briefingDetail.do?bd_seq=59040,2016-11-19, 추미애 대표 한국노총 전국노동자대회 연대사 일시 월 일 토 장소 서울시청 광장 추미애 대표 노동동지 여러분 반갑다 김동만 위원장을 비롯해 전국에서 모이신 한국노총 백만 조합원 여러분과 함께 박근혜 정권 퇴진을 함성을 드높이 외치겠다 박근혜는 하야하라 이 자리에 계신 노동자 여러분 저와 민주당이 함께한 이유는 똑같다 민주공화국과 국민주권을 먼저 배신한 박근혜 대통령은 즉각 퇴진하라는 것이 우리의 결의이다 지금까지 오로지 노동자에만 책임을 떠넘긴 최순실표 노동개악은 하늘이 두쪽 나도 함께 막아낼 것이다 백만 촛불 민심은 단 하루 아니 단 일분일초도 박근혜 대통령의 국민으로 살고 싶지 않다는 것이다 전대미문의 국정농단 국기문란에 국민은 허탈감에 빠졌다 일이 손에 잡히지 않는다 이게 나라냐 이게 내가 믿은 대통령이냐 찍은 사람들도 손가락이 원망스럽다 최순실 정유라 모녀는 동등한 대한민국 열심히 일하면 꿈을 이룰 수 있다는 대한민국을 처참히 짓밟았다 아무리 땀 흘려 열심히 노력하고 일을 해도 이제 우리는 어쩔 수 없다 대한민국을 바꾸지 않으면 열심히 일해도 아무 소용이 없다 이런 대한민국의 슬픔을 누가 해결할 수 있겠는가 존경하는 한국노총 동지 여러분 박근혜 정권 노동개악의 실체가 이제 얼굴을 드러냈다 재벌 대기업과 박근혜 정권 최순실의 검은 뒷거래가 노동개악의 실체였다는 것이다 재벌 대기업과 박근혜 대통령 최순실은 우리 사회를 짓밟은 노동개악의 공범이란 것을 선언한다 대통령이 필요할 때마다 시정연설과 대국민 담화를 통해서 원샷법을 통과해 달라 국회가 발목잡지 말라 노동개혁법을 통과시켜 달라 경제가 망가진다 는 소리 할 때마다 뒤에서 웃는 재벌들이 있었다 권력과 재벌의 결탁 뒤에 국기문란과 국정농단이 고스란히 국민과 노동자 피해로 돌아왔다 거창한 정경유착을 전대미문의 국정농단을 계획한 장본인은 바로 대통령 본인이었다 검찰은 박근혜 정권의 대기업과의 검은 뒷거래를 철저히 밝혀내고 관련자를 엄중 처벌해야 한다 이 사태의 공범인 전경련은 즉각 해체돼야 한다 입만 열면 떠들던 저성과자 퇴출해야 한다 성과연봉제 도입해야 한다 취업규칙 변경해야 한다와 같은 엉터리 노동개악은 반드시 철폐돼야 한다 대통령이 국민을 상대로 전면전을 선포하고 있는 나라 달랑 지지로 한일 군사정보보호협정을 서둘러서 이완용보다 더하다는 매국노 소리 들을 대통령은 즉각 하야하라고 다시 외쳐 달라 박근혜는 하야하라 매국행위 중단하라 노동자를 짓밟지 마라 존경하는 노동동지 여러분 우리는 힘을 합쳐서 노동개악을 반드시 저지하고 땀 흘려 일하는 서민 근로자와 우리 자녀들이 이 대한민국 민주공화국 아래서 국민주권이 이뤄지고 법치질서가 이뤄지는 자랑스러운 대한민국 아래에서 우리 힘으로 꿈과 기회를 이룰 수 있도록 길을 열자 희망을 만들어내자 함께 해달라 +http://theminjoo.kr/briefingDetail.do?bd_seq=59039,2016-11-19, 윤관석 수석대변인 오후 현안 서면 브리핑 모든 범죄는 박근혜 대통령으로부터 시작되었다 비선실세 국정농단의 주역 최순실씨의 검찰기소를 앞두고 피의자 박근혜 대통령의 윤곽이 선명해지고 있다 박근혜 최순실 게이트의 주범이 박근혜 대통령이라는 것을 모든 국민은 다 아는데 검찰만 모른다고 할 수는 없을 것이다 박 대통령이 헌정파괴의 주범임에도 국민에게 번의 거짓사과를 한 후에 언제 그랬냐는 듯이 환한 얼굴로 국정복귀를 선언했다 이번 주 하겠다던 검찰수사도 국민 약속을 걷어차고 버티기에 들어갔다 버티면 산다 이 또한 지나가리라고 믿는 것인가 국민의 내려오라 하야하라 는 외침에 주째 한줌도 안 되는 국정지지를 움켜쥐고 나홀로 청와대를 근거지로 국민 없는 대통령이 신비선실세들과 반격에 나선 것이다 이제 국민을 위한 대통령은 없다 대통령을 위한 국민도 당연히 없다 박근혜 대통령은 참고인 이 아닌 피의자 로 국민 앞에 서야 한다 헌정파괴와 온갖 불법행위 이권개입의 출발점은 박근혜 대통령이기 때문이다 그 권력에서 최순실이 나왔고 안종범 차은택이 종범역할을 했다 정유라 장시호도 박근혜 대통령이 있었기에 가능했다 주범 박근혜 대통령과 수많은 종범들이 함께 한 국정농단을 일일이 열거할 수도 없다 대통령 연설문과 국가 기밀문서가 아무렇게나 취급되었다 대통령이 미르재단과 케이스포츠재단을 설립부터 지원까지 주도했고 온갖 특혜를 주었다 대통령이 대기업 총수와 독대하면 안종범과 최순실이 나서서 수금했다 한 국가를 개인 소유물 취급하여 인사권을 휘두르고 눈 밖에 난 인사들을 찍어냈다 대통령 주치의도 모르는 비선 의사의 의료행위에 관한 온갖 소문들은 창피할 지경이다 검찰은 우리 사회의 법과 질서를 바로 세우고 국민의 안녕과 인권을 지키는 국가 최고 법집행기관 이다 국민의 거센 퇴진 요구를 받고 있는 대통령은 검찰조사에 당당히 응해야 한다 검찰은 모든 사건의 출발점인 박근혜 대통령을 피의자로 수사해야 한다 박근혜 대통령의 공모혐의를 입증할 증거와 진술이 충분한 만큼 최순실 안종범 정호성의 공소장에 구체적으로 적시해야 한다 오늘 저녁 또 다시 밝혀지는 국민의 촛불은 평화적으로 그러나 더욱 커지며 대통령의 결단과 검찰수사를 눈 부릅뜨고 지켜볼 것이다 내일이 검찰 년 역사상 가장 치욕적인 날로 기억되지 않길 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59038,2016-11-19, 지지율 대통령 국민에 맞서지 말라 한국갤럽의 여론조사에서 박근혜 대통령의 지지율은 주 연속 로 나타났다 부정평가는 여전히 인데도 박대통령은 옷깃을 여미며 국정에 복귀했다 신임 민정수석에게 임명장을 주는 그 환한 모습이 만 촛불의 민심을 비웃고 있다 한 언론이 박 대통령 퇴진 여론조사를 했더니 국민 명 중 명이 퇴진을 요구했다 국민들은 대통령 자리에서 내려오라는데 검찰조사도 무시한 채 버티기 에 들어갔다 국민들과 결사항전이라도 벌이겠다는 태세다 오늘 차 촛불집회가 전국 방방곡곡에서 열린다 청와대와 새누리당은 대통령 퇴진을 요구하는 국민들이 광장에 나온 만 명뿐이라고 착각하지 말라 나서지 못한 만명도 같은 마음이라는 것을 애써 외면해서는 안 된다 박근혜 대통령은 세계 위권의 경제대국 대한민국을 세상의 조롱거리로 만들었다 더 이상 국민들은 대통령을 인정하지 않는다 이 나라는 한 사람의 나라가 아니고 우리 국민들은 왕에게 절대 복종해야 하는 신민이 아니다 오늘 국민들은 민주공화국인 대한민국을 지키기 위한 평화적 집회를 해 나갈 것이다 역사의 흐름을 되돌리기 위해 꺼지기는커녕 더 활활 타오르는 민심의 촛불 에 맞서 한줌도 안 되는 어리석은 바람 을 일으키지 말아야 한다 지지율 의 대통령이 의 국민을 이길 수 없다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59035,2016-11-18, 박근혜 퇴진을 위한 국민주권운동본부 출정식 인사말 일시 금 오후 시 장소 세종문화회관 계단 추미애 대표 우리는 지금 할 말을 잃었다 국민이 뽑은 대통령인데 대통령은 최태민의 기운으로 대통령이 되었다고 믿고 있다 국민이 준 권력인데 우주의 기운으로 권력을 받았다고 생각하는 어처구니없는 대통령 앞에서 온 국민은 그저 슬플 뿐이다 우리 국민을 철저히 속인 대통령이다 저는 결혼하지 않았습니다 오직 대한민국 국민과 결혼했습니다 저는 대한민국 국민의 어머니가 되겠습니다 이렇게 말 한 것을 우리는 잘 기억하고 있다 그 말씀대로 해주시라 자식이 울고 있다 자식이 대한민국 살려달라 하고 있다 자식 이기는 부모가 없다고 하지 않는가 이제 자식이 내려오라 한다 대한민국 국민을 자식으로 여긴다면 국민을 이기려 하지 말고 즉각 내려오시기 바란다 역사 속에서 국민을 이기는 제왕은 없었다 국민을 이기는 권력도 없었다 오늘 참 우스운 분석을 봤다 박근혜 대통령이 월 말까지 버티기를 한다고 한다 사정 정국을 조성하고 정치 불신을 심화시키고 보수지지층을 결집시키고 새누리당 전당대회를 열어서 민심을 반전시켜서 끝까지 대통령을 한다고 한다 그래서 나온 것이 고작 엘시티 이영복 회장의 사건에 우리 당 대선주자도 연루됐다는 의혹이 있으니 철저하게 수사하라는 어처구니없는 말을 지어내고 있다 년 전 바로 저 추다르크 추미애가 부산판 수서비리 사건 이라고 해서 새누리당의 전신인 신한국당과 부산지역 정치인 부산시 공무원 등이 결탁해서 개발특혜를 주고 고도제한을 풀고 환경파괴를 해서 엄청난 비자금을 조성한 것을 파헤쳤다 그런데 그것을 어물쩍 덮어버리고 봐준 정권이 바로 부패의 공범집단 새누리당이다 부패한 정권이 어떻게 부패를 수사할 수 있나 년 후 다시 부활한 이영복 회장과 부패의 뿌리가 철저하게 새누리당 집단과 함께 박혀있다 그런데 부패집단 부역집단이 뒤집어씌우기를 하고 있다 용서하지 않을 것이다 한 번 제대로 파헤쳐보시라 지난번에 이영복 회장이 비자금을 어디에 썼는지 검찰이 제대로 밝혀내지 못했다 그래서 기소권을 독점하고 있는 검찰이 제대로 기소도 하지 않고 증거도 찾지 않고 어물쩍 봐주는 바람에 뇌물죄 등은 다 무죄를 받고 겨우 집행유예 판결을 받은 것이었다 그 부패사범을 다시 큰 능구렁이로 키워낸 것이 바로 새누리당 부역자들이다 그런데 이제 와서 가증스럽게 다시 한 번 각본대로 보수지지층의 결집을 위해서 사정정국을 조성한다고 하니 지나가는 소가 웃을 일이 아니겠는가 다시 한 번 외쳐주시라 부패권력이 부패를 수사하라 지시하기 전에 내려오라 박근혜 하야하라 고 외쳐주시기 바란다 대한민국 국민인 것이 이렇게 부끄러운 적이 없었다 대통령은 방산비리에 대해서 큰 소리를 친 분이다 방산비리의 주범은 반역자와 똑같다고 하신 분이 박근혜 대통령이다 이제 보니 사드 배치결정을 왜 그렇게 졸속으로 청와대가 서둘렀는지 알 것 같다 해당부처 장차관도 모르고 외교부장관은 그 순간에 바지를 사러 백화점에 갔다고 하는 어처구니없는 일이 왜 벌어졌나 그 사업을 추진한 록히드마틴사는 무려 수천억원의 이득을 보았다고 하는 것이다 이렇게 졸속으로 처리된 모든 배후에는 청와대가 있고 그 한가운데 박근혜 대통령이 있었던 것이다 이권을 챙기기 위해서 나라를 몽땅 갖다 바친 대통령이다 세월호만 하더라도 그렇다 우리 국민은 그래도 대통령인데 뭔가 있겠지 그렇게 국민과 애국을 말씀하신 대통령이니까 뭔가 있겠지 하고 기대를 하고 있었다 그런데 이제 와서 겨우 변호사를 내세워서 대통령도 여성이고 사생활이 있다 라고 말씀하신다 너무 억울하다 아무런 조치도 취하지 못했다 제대로 해군만 지휘할 수 있는 멀쩡한 대통령이었어도 단 몇 명이라도 꽃다운 생명을 구할 수 있지 않았겠는가 그것을 우리는 하지 못했다 그저 순실일가 재산 챙기고 순실일가 이권 챙기고 순실일가 학벌 챙기고 순실아버지 은혜받고 우주의 기운 받는데만 몰두한 대통령은 이제 그만 지칠 때도 되지 않았나 이제 그만 내려오시라 국정이 벅차지 않은가 드라마 보시기 바쁜데 국정이 방해되지 않는가 국민을 걱정하느라 주름살 하나 더 생기시면 어떤가 그것이 더 아름다운 여성 대통령 아닌가 굳이 주름살 가리려고 우리 국민은 모르는 백옥주사니 무슨 주사니 다 맞는 것이 무슨 대수겠는가 그냥 주사가 더 좋으시고 그것 때문에 안타까운 생명이 쓰러져가도 아무 일도 못하시겠거든 정신이 몽롱해서 아무 지휘도 못하시겠거든 그냥 내려오시라 건강에 무리가 되시면 그냥 내려오시라 우리가 그냥 고이 보내드리겠다 우리 청년들이 재벌대기업 갈취한 돈으로 일자리를 달라고 한 적이 없다 그런데 청년에게 꿈을 주시는 척 청년희망펀드라고 하며 뒤로는 재벌을 갈취했다 어떻게 우리 청년들에게 정직하게 살라고 호소할 수 있겠는가 세월호 아이들이 아무리 절규를 해도 어느 누구 구제의 손길이 없었는데 대통령은 그 다음날 오로지 최순실의 딸을 위해서 대학에 명령을 내렸다 오로지 최순실 딸의 학력이 더 소중한 대통령은 가정으로 돌아가시라 국정이 벅차시다면 드라마가 더 재미있으시다면 우리는 굳이 그런 대통령을 원하지 않는다 자연의 이치다 대통령이 국정에 노심초사해서 늙어가신다면 우리는 그 대통령을 더 오래오래 기억할 것 같다 그런데 대통령께서 그런 게 싫으시다면 나랏일을 걱정해서 고뇌의 주름살이 깊어지는 것이 걱정되신다면 굳이 이 엄중한 시국을 맡길 국민이 어디 있겠는가 물러날 때 물러날 줄 아는 것도 지혜다 낙엽이 떨어지고 있는데 아직도 형형색색의 단풍이라고 자랑하는 것이 더 무서운 것이다 대통령 순방 비용이 억이라고 한다 그런데 대통령이 순방할 때마다 갈아입는 그 옷들 대통령이 세일즈외교라고 자랑하실 때마다 우리 중소기업의 수행한 분들은 힘들었다고 한다 그냥 관광만 하는 대통령을 따라서 아무런 성과도 없이 인터뷰를 해야 하는 기업들은 힘들었다고 한다 대기업을 불러 모아서 금품을 모금하고 평창올림픽에 개입하고 수상한 의료행위 하고 해외순방 다니면서 생선 발라먹듯이 다 발라먹으시면 이 나라는 어떻게 되는가 대통령 일이 벅차시면 우리 국민은 대통령께 외쳐드리겠다 내려오셔서 드라마를 편히 감상하시기 바란다 국민주권운동본부의 첫 시작이다 민주공화국 대한민국을 회복하기 위한 국민대장정이 시작됐다 야권공조를 제대로 해서 박근혜 대통령 엄정수사하고 국권을 수호하고 확립해서 대한민국 헌정질서를 회복할 것을 약속드린다 우상호 원내대표 전두환을 쓰러뜨렸던 년 전의 기개로 반드시 박근혜를 퇴진시키겠다고 여러분께 열렬하게 인사드린다 대통령 한사람 때문에 국민들이 생고생을 한다 이 추운 겨울날 거리에 앉아있다 생업에 종사할 시간도 부족하고 먹고살기도 힘들다 그런데 나라 한번 바로잡아보려고 민주주의 바로 세우려고 사회정의 바로잡아보려고 이렇게 나오신 것이다 대한민국의 거대 야당이 정면으로 대통령 퇴진을 당론으로 정하고 투쟁한 것은 처음 있는 일이다 그만큼 엄중한 일이기 때문이다 우리는 당 체제를 박근혜 퇴진 운동체제로 전면적으로 운동본부 형태로 개편했다 가볍게 볼 일이 아니다 전 당원이 국민과 함께 박근혜 대통령을 퇴진시키기 위해서 끝까지 싸우겠다는 결의를 한 것이다 오늘은 그 결의를 국민들께 보고하는 자리다 그 결의를 담아서 국민들을 향해서 외쳐보겠다 박근혜 퇴진하라 이다 오늘은 대통령이 조사를 받는 마감시한이다 눈물을 글썽글썽하면서 검찰수사에 응하겠다 특검수사에도 응하겠다 라고 이야기했기 때문에 조사는 받겠구나 조사에 나와서 무슨 말을 할까 궁금했다 그런데 며칠 전부터 변호사가 대신해서 조사 받을 수 없다 대한민국 대통령이기 때문에 서면조사를 신청하든가 안 받겠다 고 며칠사이에 말을 뒤엎었다 조사를 받지 않겠다는 것 자체가 바로 본인의 범죄 연루 혐의를 인정한 것이다 겁이 나서 못 받는 것이다 자백을 하면 감옥에 가야되고 탄핵될 수 있기 때문에 잔머리를 굴리는 것이다 변호사를 앞세워서 검찰조사를 회피한다고 진실이 묻혀지는가 이미 더불어민주당이 국정감사를 통해서 낱낱이 진실을 파헤쳤고 수많은 언론이 많은 제보와 증거를 들이밀고 있는데 피한다고 피해질 수 있겠는가 도망간다고 도망갈 수 있겠는가 헛된 대응을 하고 있는 것이다 재벌 돈 좀 뜯어와라 압박하라 라고 시켜서 하수인처럼 움직인 안종범이 구속됐다 대한민국 경제수석이 재벌 돈 뜯는 위치로 전락했다 그렇게 만들어진 재단에서 최순실이 자신의 수족 같은 고영태 같은 사람들을 앞세워서 국가예산을 빨아먹고 재벌을 뜯어먹고 사리사욕을 채웠다 그 재단에 돈을 준 사람은 차은택을 보고 줬겠나 최순실을 보고 줬겠나 박근혜 대통령이 내놓으라고 하니까 내놓은 것이다 안종범이 대통령이 돈을 뜯으라고 하니까 재벌들에게 전화를 했지 개인적으로 돈을 뜯으려고 전화를 했겠나 안종범에게 시킨 사람이 누구인가 사리사욕을 채운 사람들은 다 감옥에 갔는데 정작 그것을 지시한 주범은 조사도 받지 않겠다니 이것이 대한민국인가 이래서는 안 된다 법은 만인에게 평등해야 한다 대통령이라고 해서 잘못된 범죄가 있는데 조사를 회피할 수는 없다 우리는 박근혜 대통령을 현직 대통령 재임 중에는 어쩔 수 없겠지만 반드시 역사의 법정에 세우겠다고 약속한다 쿠데타로 난다 긴다 하며 군부독재했던 전두환 노태우도 모두 감옥에 갔다 이런 식의 범죄행위를 저지르고 무사할 것이라고 생각한다면 오산이다 우리는 개인적인 감정으로 보복하려는 것이 아니다 대한민국 민주주의를 후퇴시키고 역사를 유린하고 세계 속의 자랑스러운 대한민국의 국격을 추락시킨 이 역사를 바로잡으려는 것이다 오늘 여기에 나오신 여러분들의 하루하루의 투쟁은 한국 현대사에 기록될 것이다 혁명이 역사에 기록되고 월항쟁이 역사에 기록되고 광주항쟁이 역사에 기록됐던 것처럼 년 월 오늘 더불어민주당의 투쟁은 현대사의 한 페이지에 기록될 것이다 반드시 박근혜 대통령은 그 자리에서 물러나서 자신의 잘못에 대한 벌을 받게 될 것이다 그 날까지 더불어민주당은 추미애 대표를 중심으로 똘똘 뭉쳐서 국민과 함께 승리할 때까지 투쟁하자 진격하자 승리하자 +http://theminjoo.kr/briefingDetail.do?bd_seq=59033,2016-11-18, 윤관석 수석대변인 추가 현안 서면 브리핑 헌정을 붕괴상태에 빠뜨린 청와대가 답할 것은 대통령의 퇴진뿐 추미애 대표의 우려 어린 질책에 대해서 청와대와 새누리당이 거꾸로 발끈하고 역공을 펼치고 있으니 적반하장도 유분수이다 헌정을 무너뜨린 대통령과 새누리당이 야당을 정치선동 유언비어 유포 라며 매도하고 있으니 무책임과 후안무치의 극치이다 비선실세들의 국정농단으로 헌정을 사실상 붕괴상태에 빠뜨린 장본인들이 지금 야당과 말다툼을 벌이겠다니 제 정신인지 묻고 싶다 국민의 민심은 하루 빨리 대통령이 자리에서 물러나라는 것이다 그러나 대통령은 오히려 국정운영으로 복귀할 움직임을 보이고 있다 대통령이 자신을 수사하는 검찰에 엘시티 수사를 지시하는가 하면 새누리당 이정현 대표는 민의를 인민재판 에 비유하고 김진태 의원은 촛불은 바람 불면 꺼진다 며 반격에 나섰다 집권세력이 이러한 상식적으로 납득할 수 없는 적반하장을 벌이고 있으니 계엄령에 대한 우려까지 나오는 것이다 청와대와 여당은 작금의 사태가 지극히 정상적이라고 주장하고 싶은 것인가 전대미문의 대참사 앞에도 현실을 호도하며 국민을 우롱하는 새누리당의 불통에 분노를 금할 수 없다 대통령과 새누리당은 거울에 비친 자신들의 자화상을 보고 이성을 찾기 바란다 지금 집권세력이 답할 것은 대통령의 퇴진뿐이다 대통령과 새누리당은 국민을 호도하려 하지 말고 물러나라는 민심의 거센 요구를 하루 빨리 받들 것을 거듭 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59032,2016-11-18, 금태섭 대변인 오후 현안 서면 브리핑 교육부 이화여대 감사 비리주범은 왜 제외하나 교육부가 오늘 이화여대 입시부정과 학사관리에 대한 감사결과를 발표하였다 정유라의 입학을 취소하고 특혜를 준 교수들을 중징계 검찰고발하겠다는 것이다 하지만 새롭게 밝혀진 사실은 하나도 없다 감사 이전부터 언론보도와 이화여대 구성원들의 진술을 통해 이미 다 알려진 사실들을 확인하는 데 그쳤다 오히려 이번 감사에서 정작 조사해야할 비리주범 최순실 정유라는 빠져있다 일간 명의 조사관이 투입되어 명에 대한 조사를 하면서도 비리주범인 격인 정유라와 최순실에 대해서는 대면조사는 고사하고 서면조사조차 하지 않았다 교육부장관이 직접 나서서 체육특기자 입시비리 근절의 계기로 삼겠다고 하는 대목은 최순실 정유라를 빼주고 이화여대에만 책임을 미루려는 것으로 밖에 보이지 않는다 금번 입시부정과 학사부정은 권력을 뒤에 업은 최순실 정유라의 부정비리행위이다 부정한 권력에 굴복하여 협력한 대학교수들을 방패삼아 빠져나갈 수 없다 교육부 감사로 끝낼 수 없다 이제는 검찰이 정유라의 신병을 확보하고 조사할 차례이다 외신도 아는 사태의 심각성을 대통령만 모르고 있다 외신들은 앞다투어 대한민국의 현 시국을 보도하고 있다 뉴욕타임즈는 한국 대통령의 조언자가 체포됐다 며 최순실의 조종을 받는 대통령을 로봇으로 표현한 만평을 실었다 워싱턴 포스트는 부패와 뇌물 횡령 권력 남용이라는 한국병이 다시 도졌다 며 워터게이트보다 더 심각한 사건이라고 보도했다 로이터통신은 박 대통령이 길라임을 가명으로 썼다는 보도가 나온 이후 길라임이 패러디 대상이 됐다 며 인터넷에서 쏟아진 다양한 패러디를 소개했다 이렇게 외신의 조롱을 받고 있는데도 정작 대통령 본인만 사태의 심각성을 모르고 있는 것 같다 부끄러움은 오로지 국민들만의 몫이 되고 있다 성실하고 부지런한 국민들이 왜 대통령 때문에 한국병 이라며 싸잡아 비난받아야 하나 한강의 기적과 민주화를 이루어낸 현명하고 위대한 국민들이 왜 대통령 때문에 고개를 들 수 없어야 하나 박 대통령은 즉각 퇴진하는 것만이 국민들을 조금이라도 덜 부끄럽게 하는 일임을 깨닫기 바란다 차움의원은 대통령 감싸기를 그만두라 이동모 차움의원 원장이 비선진료 에 대해 변호에 나섰다 대통령의 길라임 이라는 가명진료에 대해서는 직원이 혼자 알아서 한 것이다 최순실의 불법적인 주사제 반출은 대리처방이 아니라 대리수령 이다 최순실의 포장 목록에 프로포폴은 없다 라는 식으로 대통령을 적극 변호했다 동시에 의료법을 이유로 대통령의 무료시술 태반주사 신데렐라 주사 여부는 말할 수 없다고 한다 특혜 제공도 물론 강하게 부정하였다 이 원장의 이런 행태는 의료법을 제멋대로 해석해서 환자의 비밀을 지켜준다는 구실로 실제로는 대통령을 감싸려는 의도가 있는 것이다 이 원장은 보건사회부에서 보건국장까지 지내고 한나라당 전문의원 경력자이다 차의과대학 부총장을 지내면서 보건복지부 산하의 한국보건산업진흥원 선임이사를 하였다 보건산업진흥원은 수천억의 보건의료 연구개발을 집행하는 기관이다 지금 차움의원의 역할은 비선진료 수사에 적극 협조하고 언론에서 제기된 특혜의혹에 대한 해명이다 의사 자격증과 자의적인 법해석을 앞세워 대통령을 변호할 일이 아니다 트럼프 아베의 만남 대통령의 퇴진결단을 다시한번 촉구한다 아베 신조 일본 총리가 세계 정상 중 가장 먼저 미국 대통령 당선자 도널드 트럼프를 만났다 대한민국이 국정농단 사태로 내부 혼란을 경험하며 다가올 트럼프 체제에 대비하지 못하고 있는 지금 일본은 발 빠르게 미 일 동맹 체제를 강화하고 있다 신고립주의와 보호무역을 외쳐온 트럼프 당선인의 당선 이후 트럼프 체제가 불러 올 불확실성에 대한 우려가 이만저만이 아니다 우리나라도 예외가 아니다 트럼프는 불과 한 달 전까지도 한미 방위비 분담금 재협상의 필요성을 주장해왔다 우리는 지금 대통령이 트럼프 당선인을 상대할 수 없는 상황이다 변화하는 세계정세에 빠르게 대처하지 못하는 이유도 다 대통령 때문이다 박근혜 최순실 게이트는 국내문제를 넘어 국제문제에서 대한민국이 나갈 방향까지 잃게 만들었다 대한민국을 위해 박 대통령의 결단을 다시 한번 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59031,2016-11-18, 이재정 원내대변인 오후 현안 브리핑 일시 금 오후 시 분 장소 국회 정론관 세월호 참사 앞에서 공영방송을 손아귀에 넣고 주무른 청와대 어제 전국언론노조 본부가 공개한 김영한 전 청와대 민정수석의 비망록에 따르면 세월호 참사 후 청와대에서 의 보도와 인사에 지속적으로 개입한 흔적이 발견됐다 길환영 전 사장의 해임 직후에는 상황 파악과 플랜 작성이 같은 해 월 일에는 이사의 정치성향을 파악하라는 메모가 있었으며 이 외에도 대통령 행적보도 천안함 관련 판결 등 보도프로그램 관련 내용까지 적시되어 있었다 또한 새누리당은 국회 미방위 전체회의 등을 통해 세월호 참사 직후 보도본부장에게 보도지침을 내린 이정현 전 청와대 홍보수석의 통화에 대해 잘못된 것을 바로잡으려는 시도였고 청와대 홍보수석의 통상적인 임무라며 비호했다 이제 그 모든 전모가 밝혀졌다 청와대가 노골적으로 공영방송인 를 잠식하고 자신들의 입맛에 맞는 인사를 심고 보도지침을 내린 것이다 그 어떤 수사로 변명을 이어간다 해도 알량한 정치권력으로 기자의 펜대를 꺾어버린 청와대와 새누리당을 국민은 절대 용서하지 않을 것이다 유가족의 울분 외면한 채 대통령 심기경호에만 앞장선 국정원의 세월호 보고서 경기 침체의 주요인 정부에 대한 부당한 압박 맞대응 집회와 지탄여론 조성 교황방문 흠집내기 국정교과서 당위성 확보 필요 대한민국 국가정보원이 여객선 사고로 격하시킨 세월호 참사에 대해 작성한 보고서의 주요내용이다 이후 지금까지 자식을 보낸 부모와 부모를 보낸 자식 남편을 보낸 부인과 부인을 보낸 남편 형제와 자매를 보낸 이들 모두는 눈물로 밤을 지새우며 오늘도 혹여나 대통령이 자신들의 이야기를 들어줄까 하는 마음으로 거리로 나서고 있다 하지만 박근혜 정부에게 이 모든 것은 정부 흠집내기 불법시위이자 대통령의 심기를 거스르는 항명에 불과했다 국정원이 대통령의 눈과 귀를 막은 것인가 대통령이 국정원을 통해 눈과 귀를 호사롭게 해달라고 원한 것인가 최소한 인간이라면 그리고 한 나라의 대통령이라면 이런 보고를 받을 수도 받아서도 안 되는 것이다 이번에도 보수 세력 준동과 허위사실 유포 국민을 우롱하며 피해가려 하는 박근혜 정부와 새누리당에게 엄중히 경고한다 당신들에게 최소한의 양심적 가책은 있는가 없다면 인간이 아닌 것이다 당장 사과하고 책임져라 시간이 아니라 단 분 초도 용서할 수 없다 세월호 참사 발생 이후 대통령이 안전행정부 상황실에 당도할 때까지 대통령을 직접 목격한 이를 찾을 수 없다 명의 국민이 살려달라며 애원하는 그 순간 대한민국 대통령은 어디에도 없었다 성형수술설 청와대 굿판설 등 대통령의 시간은 설만 난무할 뿐이다 집무실도 아닌 관저에서 유선보고와 서면보고만 받았다는 대통령 시간 후 상황실을 찾아 구명조끼 입었는데 왜 발견이 힘드냐 고 묻던 대통령 진도체육관에서 유가족 누구든 전화하라더니 정작 유가족이 한번만 만나서 목소리를 들어달라고 하니 매몰차게 외면한 대통령 검찰수사의 칼 끝이 자신을 향하자 비겁하게 변호인을 보내 수사를 방해하고 여성사생활 운운하는 대통령 우리가 분노하는 것은 게이트가 아니라 박근혜 대통령 그 자체에 있다 시간이 아니라 단 분 초라도 절대 용서할 수 없다 눈 가리고 아웅 하는 식으로 외면만하는 대통령을 이제 국민이 외면하고 있다 이제 남은 것은 대통령직에서 내려오는 일 뿐이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59028,2016-11-18, 대통령과 새누리당 조금의 애국심이라도 남아있다면 막말을 멈추고 퇴진해야 대통령이 민심을 도발하고 새누리당이 민심을 도발하고 있다 수사받아야 할 대통령이 다른 사건을 고강도 수사하라니 적반하장이다 민심은 하야하라고 하는데 차관을 임명하고 국무회의도 하겠다고 한다 반성 없는 민심도발만 보인다 새누리당도 마찬가지이다 김진태의원은 촛불은 바람이 불면 꺼진다 고 대통령 하야를 외치는 국민들의 촛불을 무시하고 막말을 하며 민심을 도발하고 있다 이정현 대표는 하야 민심에 퇴진론은 인민재판 이라며 버티고 있다 국정농단의 책임을 조금이라도 생각한다면 대통령과 새누리당은 국민을 모욕하는 막말을 당장 멈추어야 한다 촛불에 바람이 불면 민심의 큰 불 이 된다는 사실을 잊지 말아야 할 것이다 대통령과 새누리당에 경고한다 조금의 애국심이라도 남아있다면 막말을 멈추고 퇴진을 준비하라 +http://theminjoo.kr/briefingDetail.do?bd_seq=59027,2016-11-18, 정진석은 허위사실 유포 말라 정진석 새누리당 원내대표가 오늘 문재인 전 더불어민주당 대표는 노무현 전 대통령에게 전해진 거액의 불법자금 때문에 비극적 선택한 것을 가장 가까이서 지켜본 사람이 아니냐 문재인 안철수 두 분이 그렇게 원하는 조기 대선을 하기 위해서라도 개헌을 해야 한다 두 야당 정치지도자는 박근혜 대통령을 당장 끌어내리고 일 내에 대선을 치르자고 한다 는 사실과 다른 발언을 했다 고 노무현 전 대통령에게 거액의 불법자금이 전달되었다는 것이 도대체 무슨 소리인가 명백한 허위사실 유포이다 고인을 욕되게 하지 말라 정대표는 허위사실 유포 중단하고 재벌들로부터 뜯어낸 자금이 최순실을 거쳐 박대통령에게 전달되었을 것이라는 의혹이나 파헤치길 바란다 그리고 문재인 전 대표는 일 이내의 조기 대선을 말한 적이 없다 사실 관계 잘 파악하라 하기야 너무 무서우면 정작 그 사람이 하지 않았음에도 세상 모든 말들이 그 사람의 말로 들리는 환청현상이 생길 수도 있겠다 너무 두려움에 떨지 말라 사실 정대표의 발언은 현 정국에서 그 어떤 흐름도 대변 못하는 자신만의 독백이다 남들이 들어주지 않는다고 고인의 명예를 함부로 훼손하며 허위사실 유포를 일삼으면 크게 화를 당할 수 있으니 조심하라 경고한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59026,2016-11-18, 제 차 최고위원회의 모두발언 일시 금 장소 국회 당대표 회의실 추미애 대표 대통령이 국민과 싸우기로 작정을 한 모양이다 국민이 조사를 받으라고 명하는데 청와대에 앉아서 인사권을 행사하고 검찰 조사를 거부하고 수사를 지시하고 친박 지도부를 버티게 하고 하수인을 시켜서 촛불민심을 인민재판이라고 하느니 마녀 사냥이라고 하느니 공격을 하고 있다 박사모를 시켜서 물리적 충돌을 준비하게 하고 시간을 끌며 지지층 결집시키기를 시도하고 사정기관에 흔들지 말라는 신호를 보내고 있다 이렇게 한 다음에 최종적으로는 계엄령까지도 준비하고 있다는 정보도 돌고 있다 참으로 무지막지한 대통령이다 하야하라 하야하지 않으면 우리는 헌법상 대통령에게 부여된 권한을 정지시키는 조치에 착착 들어갈 것이다 이 순간에도 드라마를 보며 쿨쿨 주무시고 반격을 결심하고 있는 대통령 우리 민주당은 당 공조아래 정치적 법적 퇴진을 준비할 것이다 천만 명이 촛불을 들 때까지 아니 천만 명이 촛불을 들고 나올 때까지 촛불을 들 것이다 준법 투쟁을 고수할 것이다 우리는 평화집회를 통해서 준법 투쟁을 통해서 정권의 불법과 맞서 싸울 것이다 선으로 악을 물리치겠다 경찰에도 경고한다 공연히 폭력을 준비하고 있는 박사모를 즉각 수사하라 특정인에게 폭력을 가하겠다는 테러를 하겠다는 이 집단의 폭력 예비 음모에 대해서 즉각 수사하라 우리당은 평화집회에 대한 보장을 요구한다 만약 경찰이 평화집회 보장 요구를 묵살하고 불법을 방치한다면 경찰총장마저 직무 유기로 탄핵 당할 것임을 경고한다 어제 당 대표자 회담이 있었다 국민의당 대표가 자 영수회담을 하자고 하였으나 적절치 않다고 말했다 제가 대통령을 만나고자 했던 유일한 이유는 퇴진하라는 민심을 전달하고 대통령의 자진 사퇴를 요구하기 위한 것이었다 그런데 물러나기를 거부하고 있는 대통령에게 총리 선임을 의논하겠다고 하는 것은 더군다나 부역자 당 대표와 함께 총리 선출을 논의하자고 하는 것은 어불성설이라고 말씀드렸다 대통령의 사임 거부는 확실하다 우리는 일 집회 이후에 후속 법적 조치도 계획하고 있다는 것을 미리 예고 드린다 년 전 특혜 비리 비자금 조성 의혹을 받고 있는 이영복 회장 이른바 부산 판 수서비리 사건 이라고 제가 명명했었다 그 당시 부산의 다대 만덕지구 택지 전환과 용도 변경 과정에서 막대한 특혜를 얻고 비자금을 조성해서 당시 새누리당을 둘러싼 정치권에 로비자금을 뿌렸던 핵심인물 이영복을 수사하게 한 것은 바로 저 추미애였다 박근혜 정부를 이번 사건을 반대세력을 겁박하고 본인이 몸통인 박근혜 최순실 게이트를 물타기 하기 위한 국면전환용으로 이용하려고 하고 있다 스스로 퇴진해야할 분이 되려 정치공작을 하고 있는 어처구니없는 현실에 대해 국민의 한 사람으로서 깊은 분노를 느낀다 놀라운 것은 범죄의 수법이 년 전이나 지금이나 크게 다르지 않다는 점이다 당시 다대 만덕지구는 자연 녹지였는데 일반주거용지로 용도변경 되어 막대한 시세차익을 얻는 과정에서 정관계 로비 의혹이 제기되었던 것이다 환경영향평가를 거치지 않고 고도 제한을 풀어주는 등 각종 특혜에 관한 의혹을 제가 제기했었다 이번 사업도 환경영향평가나 교통영향평가없이 사업 계획이 승인된 것이다 또한 여권을 중심으로한 로비설이 증폭되고 있다 그 당시 년 전 저의 끊임없는 지적에도 불구하고 제대로 된 수사가 이뤄지지 않았고 이영복은 년간 잠적했다가 자수하고 심에서 징역 년을 선고받았지만 항소심에서는 정관계 로비 관련 상당수의 혐의를 검찰의 부실수사로 인해 무죄를 받고 징역 년에 집행유예 년을 받아 풀려난 일이 있다 이씨가 이런 솜방망이 처벌을 받은 이유는 당시 김무성 총재 비서실장의 발언을 기억해보시면 알 수 있다 김무성 실장은 당시 이렇게 말했다 부산지검에 철저한 수사를 하라고 했더니 일선 검사들은 우리 회사의 어른이 있는 한 안 된다 했다고 한다 검찰은 부패를 가려주는 방조범인가 또 정치권 부산에 알박기 를 하고 있는 부역당 새누리당은 부패의 공범인가 그리고 지라시를 통해서 우리당 대선주자가 연루되어 있다는 등 허위사실 유포에 대해서는 오늘 이 자리를 통해 법률위원장에게 형사고발을 하라고 지시하겠다 부패한 권력이 부패를 제대로 수사할 수 있겠나 부패한 권력이 하야를 하고 제대로 된 수사권이 확보되어야 수사를 할 수 있을 것이다 도대체 부패한 권력의 최 정점에 있는 대통령은 무슨 자격으로 이런 사건을 수사하라고 지시할 수 있는가 부패한 당과의 정경유착 부패한 권력은 더 이상 권력이라고 할 수 없는 죽은 권력 이라는 것을 차제에 확실히 보여드리도록 하겠다 공작정치 지라시 정치로 적당히 물타기하려는 것은 이번에는 용서되지 않을 것이다 우상호 원내대표 최근 대통령과 청와대 그리고 새누리당의 친박 세력을 보면 죄의식도 없고 죄송한 마음도 없이 뻣뻣하게 버티고 있는 모습만 보인다 충격적이다 사람이 어디까지 망가질 수 있나 사람이 얼마나 뻔뻔할 수 있나 를 전 국민들에게 보여주는 것 같다 정말 심정적으로는 국회의원직을 사퇴하고 거리에 나가서 싸우고 싶다 대통령이 진실을 은폐하고 오로지 자신의 안위만 걱정하고 있는 상황에서 역시 국회가 진실을 밝힐 수밖에 없다고 생각한다 어제 통과된 국정조사와 특검을 통해 제대로 된 사실이 규명될 수 있도록 최대한 노력하겠다 검찰도 대통령에 대한 조사가 무산됐다고 해서 그것을 핑계로 이런저런 변명을 늘어놓을 수 없다고 생각한다 최순실의 공소장에 박근혜 대통령의 범죄사실을 분명하게 적시해줄 것을 요청 드린다 시킨 대로 한사람은 재판을 받는데 정작 시킨 주범의 죄상이 적시되지 않는다면 이 수사가 제대로 된 수사라고 할 수 있는가 그런데 왜 이런 식으로 나오는가 이것을 단적으로 보여주는 한 문장이 오늘 보도가 되었다 새누리당의 모 의원이 촛불은 바람이 불면 다 꺼진다 고 이야기했다고 한다 바로 이것이 박근혜 대통령과 청와대 새누리당 친박 세력의 인식이 아닌가 생각한다 시간이 지나면 다 꺼진다 이 또한 지나가리라 이런 인식인 것 같다 이런 분들에게 제가 김수영 시인의 풀 이라는 시 한 구절을 읽어드리겠다 풀이 눕는다 바람보다 더 빨리 눕는다 바람보다 더 빨리 울고 바람보다 먼저 일어난다 민초라고 한다 이들은 바람이 두려워서 먼저 쓰러지기도 하지만 바람에 굴하지 않고 바람보다 먼저 일어나는 그런 뛰어난 능력을 갖추고 있다 가 그랬고 항쟁이 그랬고 년의 촛불이 그렇다 보잘 것 없는 민초들이지만 이 풀과 풀이 서로 얽혀서 강하게 연대하면 어떤 권력의 발도 쓰러뜨릴 수 있다 어떤 권력자도 거기에 걸려 넘어지게 되어있다 민초들을 우습게보지 마시라 점점 더 강하게 뭉치고 점점 더 강하게 일어나는 우리 국민들을 보게 될 것이다 권력자들이 후회하게 될 것이다 더불어민주당은 어제 통과된 특검법에 의거해서 특검 후보들에 대한 논의를 시작했다 가능한 뛰어난 수사 지휘능력을 가지고 있으면서 또 작은 구설도 없는 분을 찾고자 한다 정의당의 의견도 듣고 시민사회 쪽 의견도 수렴하겠다 빠른 시간 내에 후보를 선정하겠지만 가능한 많은 국민들이 믿고 저분이면 제대로 수사하겠구나 할 수 있는 분을 선정하기 위해 노력하겠다 청와대의 방송장악 음모가 확인되었다 그동안 시민사회와 야당은 청와대가 공영방송의 이사진부터 사장단 선임에 이르기까지 끊임없이 개입했고 또 그들을 선임한 이후에 끊임없이 뒤에서 배후조종하고 압력을 넣었다고 끊임없이 주장해왔지만 이번에 여러 가지 문건을 통해서 최종적으로 확인되었다 민주주의 후퇴는 결국 권력의 언론장악으로부터 시작된다 이 문제에 대해서는 민주주의의 후퇴라고 하는 관점에서 언론자유의 쟁취라고 하는 측면에서 반드시 문제를 파헤치고 이 문제에 직 간접적으로 연루된 사람들을 반드시 증언대에 세우도록 하겠다 먼저 방송이 스스로 이러한 굴종의 역사를 극복하기위한 노력을 해주셔야 한다 진실을 밝히고 제대로 된 보도를 위해서 노력해주시라 그것이 국민들의 뜻에 따르는 것이다 김춘진 최고위원 박근혜 최순실 게이트가 어디까지 미치고 있는지 참담하다 정부의 중요한 정책과 우리 세대의 미래 먹거리 창조를 위해 노력하는 분들이 허탈감에 싸여있다 차움병원 건강검진센터를 대통령을 비롯한 청와대 실세 김기춘 비서실장 등 많은 분들이 이용을 했다는 보도가 나오고 있다 이 병원에서 건강검진을 받으려면 돈을 얼마나 내고 회원권을 사야하는가 억 천만 원 이상이라고 한다 서민들로서는 감히 엄두도 낼 수 없다 이것은 의료계 특혜 의혹을 입증하는 사례라고 본다 차병원은 비영리법인인 성광의료재단과 학교법인 성광학원을 중심으로 각종 영리기업을 두고 있는 사실상의 의산복합체 성격을 띠고 있다 박근혜 정부의 급격한 의료 영리화 정책이 차병원 그룹의 이해관계와 직결된다는 점에서 박근혜 최순실 게이트와의 연관성이 제기된 만큼 철저한 수사가 필요하다 특히 억 규모의 펀드 운영 특혜 줄기세포 관련 규제 완화 특혜 병원 부대사업 확대 등 의료 영리화로 지적된 대부분의 사업들이 차병원 그룹과 연관돼있다는 점에서 문제의 심각성이 크다 제가 대 국회에서 보건복지위원장을 맡을 당시 우리당은 영리 자법인 설립과 부대사업 범위를 확대하려던 의료법 개정안에 대해 복지위 상정조차 거부하고 폐기시켰다 그러나 정부는 법 개정에 실패하자 시행규칙 개정이라는 꼼수를 통해서 사실상 자법인 설립을 통한 부대 사업 확대를 추진했다 이것은 심각한 입법권 침해라는 논란을 넘어서 특정의료법인의 영리화 사업을 위해 입법체계를 무력화시키고 특혜적 조치를 시행했다는 점에서 전면적인 수사가 필요하다 고령친화대학원 설립 등 많은 특혜가 있었다 또 펀드조성사업이 천억 원에 달하는데 그 천억 원에 대해서 우리 당은 삭감을 주장했다 이렇게 펀드를 조성해서 최대 특혜를 받은 법인이 바로 대통령을 비롯한 청와대 실세들이 이용한 병원 그룹이라는 면에서 심각한 우려가 있다 우리 서민들은 금수저들이 이런 특혜를 누리고 있다는 점에서 허탈감을 금할 수 없다 철저한 수사를 촉구한다 심기준 최고위원 지금 국민의 손에 들린 촛불은 가슴속에 불타는 커다란 분노의 횃불이며 국가가 처한 위기 상황을 알리는 봉화이다 이제 박근혜 최순실의 국정농단과 이에 부화뇌동한 새누리당에 대한 국민의 분노는 그 무엇으로도 돌이킬 수 없다 국민은 탄핵 과정도 아깝다며 대통령의 퇴진과 새누리당의 해체를 명령하고 있다 탱크로 권력을 잡았던 전두환 정권도 국민이 이정도로 거부하면 무릎을 꿇었다 국민의 준엄한 명령을 무겁게 받아들여야 할 새누리당이 보이는 안하무인 행태는 그 대통령에 그 여당 이라는 생각을 하게 한다 어제 친박을 자처하는 김진태 의원은 촛불은 촛불일 뿐 결국 바람이 불면 꺼진다 민심은 언제든 변한다 며 촛불로 대변된 민심을 폄훼하고 깎아내렸다 이 발언은 국회의원이라는 지위와 권한을 부여한 주권자가 국민이 아닌 박근혜 최순실이라는 평소 인식에 대한 자기고백이며 대한민국의 민주주의와 헌정을 회복하기위해 촛불을 밝히고 있는 국민에 대한 선전포고다 부끄럽게도 그는 강원도 춘천이 지역구이고 새누리당 강원도당위원장이라는 직책을 맡고 있다 도민의 한 사람으로서 정말 부끄럽고 참담한 심정이다 김진태 의원은 지난 총선에서 선거법 위반 혐의로 고발됐지만 불기소됐다 우리당과 선관위에서는 재정신청을 한 상황이다 사법정의가 살아있다면 김진태 의원은 박근혜 대통령과 함께 정치를 떠나는 원내 순장조 순위가 될 것임을 확신한다 조선후기 국권을 팔아넘긴 을사오적이 있었다 년 월에는 박근혜 최순실의 국정농단에 부화뇌동하고 여전히 그들의 호위무사 역할을 하고 있는 친박오적 이 있다 그들은 여전히 국민들께 사과 한마디가 없고 조기 전대를 운운하며 후안무치한 행동을 하고 있다 주권자의 의사를 무시하고 여전히 박심 과 최심 만을 바라보는 정계퇴출 오적이다 이정현 서청원 조원진 최경환 김진태 의원이 바로 이들이다 정치권에서는 이들을 친박 이라고 표현하지만 성숙한 국민의 눈에는 천박하게 보일 뿐이다 앞으로 천박오적 이라고 불려야한다 비박을 비롯한 나머지 새누리당 의원들도 마찬가지다 자기들은 아무런 책임이 없는 것처럼 탄핵을 운운하고 있지만 스스로가 탄핵 대상인데 누가 누구를 탄핵하라고 운운하는가 그들 역시 국민의 탄핵을 기다려야 할 것이다 새누리당의 역사는 쿠데타와 초래 차떼기와 비선의 국정농단으로 요약된다 박근혜 대통령의 퇴진과 함께 새누리당은 반드시 해체돼야 한다 김진태 의원에게 충고한다 박근혜 최순실 게이트로 인해 분노와 자괴감에 빠져있는 춘천시민이 당신의 천박한 발언으로 인해 이제 부끄러움까지 감당하고 있음을 명심하고 교조적 맹신주의에서 벗어나기 바란다 최근 샤머니즘 게이트 라며 전 세계 외신의 조롱거리로 전락했던 대한민국이 촛불로 표현된 성숙한 국민의식으로 인해 조롱이 경의로 바뀌었다는 것을 알기 바란다 김진태 의원의 말처럼 촛불은 바람에 꺼질 수도 있다 그러나 당신들의 그 저급하고 천박한 바람으로는 숭고한 주권의식으로 피워 올린 단 한 개의 촛불도 끌 수 없음을 국민들이 가르쳐 줄 것이다 더 이상 당신의 여의도 오욕의 역사 를 듣고 싶지도 보고 싶지도 않다는 것을 꼭 명심하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59025,2016-11-18, 금태섭 대변인 오전 현안 브리핑 일시 시 분 장소 국회 정론관 검찰조사 거부는 국민을 등지는 것이다 대통령이 결국 검찰의 조사를 거부했다 검찰은 오늘까지 대통령을 대면조사하겠다는 계획이었으나 대통령이 다음 주에 조사를 받겠다고 일방적으로 선언했다 대통령은 검찰조사에 성실히 협조하겠다는 국민과의 약속을 손바닥 뒤집듯이 뒤집어 버렸다 대놓고 거짓말을 하는 대통령을 지켜봐야하는 국민의 분노는 하늘을 찌를 듯하다 대통령이 조사를 다음 주로 고집하는 것은 최순실 등의 공소장을 보고 검찰 조사에 대비하겠다는 의도로 보인다 정답을 보고 수능시험을 치르겠다는 것이다 대통령이 다음주에 수사를 받겠다는 말도 이제는 아무도 믿지 못한다 실제로 조사받겠다는 약속을 지키겠다는 것인지 서면조사만 받겠다는 것인지 아무것도 분명하지 않다 분명한 것은 검찰 조사에 적극적으로 협조하겠다 는 국민과의 약속은 이미 잊었다는 것이다 오늘이 마지막 날이다 대통령의 검찰조사 거부는 그동안의 사과와 약속이 다 거짓이었다는 선언이다 박근혜 최순실 게이트가 멈추지 않고 대한민국을 무너뜨리고 있다 아이들에게 이런 나라를 물려주어서는 안된다 어제 수학능력시험이 있었다 우리 아이들은 이날 단 하루를 위해 십년 이상을 공부에 매달려다 그런 수험생들을 힘 빠지게 하는 뉴스가 있다 바로 장시호의 연세대 입학 특혜 이다 장시호는 고등학교 시절 년 내내 최하위 성적을 기록했고 경기 실적도 국내 대회 입상이 전부였다 그런데도 장시호는 성적장학금을 받고 연세대학교에 입학했다 십 수년을 공부하고도 대학 입시에 실패하는 학생들이 많고 대학에 입학했어도 등록금이 없어 입학을 포기하는 학생들이 수없이 많다 장시호의 특혜 의혹은 이런 학생들의 마음에 큰 상처를 주었다 수능을 마치고 촛불 집회에 참석한 한 고 학생은 어른들의 투표로 이런 사달이 났는데 그 피해를 보는 것은 잘못이 없는 우리 청소년 이라고 말했다 미안하고 또 미안하다 우리 아이들에게 이런 나라를 물려주어서는 안된다 교육부는 특혜 의혹에 대해 철저히 조사하고 관련자는 마땅히 책임을 져야 한다 공작정치 막말정치로 덮을 수 있는 시국이 아니다 촛불 정국이 한 달 째 이어지고 있다 박근혜 최순실 게이트로 대한민국을 망가뜨린 세력들이 그새를 못참고 못된 버릇을 다시 드러내고 있다 대통령은 엘시티 엄정 수사 지시를 하고 차관 인사를 발표하는 등 권력을 놓지 못하고 있다 새누리당 이정현 대표는 선동을 통해 끌어내리겠다는 것은 딱 인민재판식 이라며 자발적 집회 참여자를 선동에 의한 참여로 매도했다 김진태 의원은 특검을 반대하며 촛불은 촛불일 뿐 바람이 불면 꺼진다 며 국민들의 진정성을 폄훼했다 민심과 동떨어져도 한 참 동떨어져 진 발언이다 시대가 변했고 국민이 변했다 과거와 같이 공작정치와 막말정치로 시국을 덮고 국민들의 시선을 돌릴 수 없다 내일 있을 촛불 집회에라도 참석하여 민심을 똑바로 쳐다보길 바란다 약촌오거리 재심 무죄 잘못을 바로잡는 계기가 되어야 한다 어제 익산 약촌오거리 살인사건의 피고인이 재심 끝에 무죄 선고를 받았다 무려 년만이다 참으로 다행한 일이다 경찰과 검찰의 무리한 수사와 이를 받아들인 재판부 모두 살인 누명이 씌워진 채 어른이 되어 버린 미성년 피고인과 가족들에게 응당 고개를 숙여야 한다 첫 번째 잘못과 거짓의 결과가 검찰에 대한 신뢰를 떨어뜨리고 사법부에 대한 불신을 키운 것이다 약촌 오거리 재심사건이 우리에게 주는 교훈은 지금 바로잡지 못하면 훨씬 큰 댓가를 치룰 것이다 는 것이다 박근혜 최순실 게이트를 수사하는 검찰이 깊이 새겨야 할 것이다 박근혜 대통령 퇴진 국민주권운동본부 출범 및 활동계획 관련 더불어민주당은 오늘부로 전당 차원의 체계적인 조직을 갖추어 본격적인 박근혜 대통령 퇴진 운동에 돌입한다 우리당은 오늘 오후 시 광화문 세종문화회관 앞에서 박근혜 대통령 퇴진 국민주권운동본부 출정식을 갖는다 박근혜대통령 퇴진 국민주권운동본부는 국민조사위원회 국민행동위원회 부문주권위원회 원내대책위원회 운영지원단 서명운동단 의원홍보단을 비롯해 개 시도당 별 국민주권운동본부 등 전당 차원의 체계적인 조직을 갖추고 박근혜 대통령 퇴진 운동을 전개해 나갈 것이다 출정식 이후에는 일 토 서울 청계광장에서 박근혜 대통령 퇴진 국민주권회복 규탄대회를 개최할 예정이며 일 월 에는 범국민서명운동발대식을 갖고 전국적인 서명운동에 돌입하고자 한다 지역별로는 일 월 대전 일 수 광주전남 일 금 부산 등 각 시 도당 별 국민주권운동본부 출정식을 가진 뒤 일 토 에는 시 도당 및 전국지역위원회가 서울로 총집결하여 대대적인 촛불집회를 열 계획이다 이 싸움은 박근혜 대통령 퇴진과 관련자 엄벌이 이뤄져야 끝나는 싸움이다 만 명이 거리로 나오는 상황 대통령 지지도가 에 불과한 상황에서도 박근혜 대통령은 검찰 조사를 거부한 채 버티기로 일관하고 있다 우리당은 국민이 승리하는 그날까지 국민과 함께 촛불을 들고 박근혜 대통령 퇴진과 진상규명 책임자 처벌을 위해 모든 당력을 집중해나갈 것이다 최고위원회의 결과 오늘 최고위원회의에서는 지난 전국대의원대회에서 선출하지 못한 노동과 민생부문 최고위원을 선출하지 않고 미선출 중앙당 전국위원장은 최고위원회와 협의해 당대표가 임명하기로 의결하였다 지난 월 일 중앙위원회는 선출이 불가능한 부문 최고위원 및 중앙당 전국위원장을 최고위원회 의결로 달리 정하기로 결정한 바 있다 또한 최고위원회의는 년 중앙당 예산 안 을 의결했다 년 중앙당 예산안은 깨끗하고 투명한 자금 운용으로 국민과 당원이 신뢰할 수 있는 재정 운용을 목표로 했다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59023,2016-11-18, 이재정 원내대변인 오전 현안 브리핑 일시 금 오전 시 분 장소 국회 정론관 법불아귀 강조한 검찰총장 박근혜 대통령 앞에서는 좌불안석 법불아귀 법은 신분이 귀한 사람에게 아부를 하지 않는다 김수남 검찰총장이 늘 강조하는 말이다 하지만 국민이 바라보는 검찰의 박근혜 대통령 수사는 법불아귀가 아닌 좌불안석에 불과하다 박근혜 대통령은 오히려 앞장서서 수사의 가이드라인을 제시하고 대통령의 변호인은 거침없이 검찰수사를 농락하고 있다 검찰이 가진 힘은 국민이 부여한 힘이다 만약 대통령 앞에서 그 힘을 발휘하지 못한다면 검찰에게 주어진 과도한 권력은 이양되어야 마땅하다 검찰은 국민이 무서운가 아니면 박근혜 대통령이 무서운가 준엄한 민의의 파도가 검찰로 향할 날이 멀지 않았다 대국민 담화 약속 저버리고 꼼수부리는 대통령 검찰 조사에 성실히 응하겠다던 반성의 담화도 또 거짓말이었다 박근혜 대통령이 변론 준비에 시간이 필요하다는 이유로 검찰 조사를 거부하고 있다 변론 준비는 핑계일 뿐이다 박 대통령의 버티기는 최순실 공소내용을 파악하고 대응하기 위한 꼼수다 돌이켜보면 모든 것이 거짓말이고 꼼수였다 상황모면과 국면전환에만 몰두하며 자기 권력 지키기에만 급급한 대통령에게 더 이상 속을 국민은 없다 박근혜 대통령은 약속을 지켜라 책임회피하는 박근혜 대통령 명백한 공범이다 최순실 차은택 안종범에 대한 검찰 기소가 목전으로 다가왔다 검찰은 이르면 일에 최순실 안종범 정호성 등 박근혜 게이트와 연루된 자들에 대한 기소를 예고했다 이제 남은 것은 박근혜 대통령의 공범적시 여부다 모든 국민이 지켜보고 있다 안종범과 최순실은 그동안 모든 사안에 대해 박근혜 대통령의 지시 하에 이행했다고 증언했다 또한 검찰 수사과정에서 재벌기업들이 대통령과 독대한 후 재단에 기금을 납입했음이 드러났다 지시한 자도 기금각출을 강제한 자도 모두 대통령이다 박근혜 대통령은 참고인이 아닌 공범이다 검찰은 좌고우면 하지 말고 당장 수사에 착수하라 한중일 정상회담 참석하겠다는 박근혜 대통령 국민은 안중에도 없나 청와대는 오늘 다음 달로 예정된 한중일 정상회담에 박근혜 대통령이 참석할 것임을 예고했다 지난 차례의 대국민 사과 이후 만 촛불 민심을 똑똑하게 목도했음에도 불구하고 문체부 차관임명부터 국무회의 주재 그리고 정상회담 참석까지 박근혜 대통령에게 더 이상 국민은 안중에도 없다 국민이 속아서 뽑은 대통령이다 불통과 밀어붙이기식 국정운영은 더 이상 통하지 않는다 성난 민심을 외면하고 자기 갈 길을 가겠다는 뻔뻔한 대통령 행보의 끝이 어디로 향할지는 우리 모두가 알고 있다 더욱이 이번 사태가 워터게이트보다 심하다 는 워싱턴 포스트 보도를 비롯하여 박 대통령의 퇴진가능성이 에 이른다는 유라시아 그룹의 보고서 등 해외의 우려와 평가가 최악이다 대통령이 나라에 먹칠하는 동안 국격을 지키는 것은 시민들의 촛불이었다 제발 자중자애하고 국민의 목소리를 들어라 상황인식 결여된 청와대와 여당 인민재판 운운하며 시간벌기에 나서 청와대를 비롯한 일부 여당 의원들의 발언과 태도가 성난 민심에 기름을 붓고 있다 어제 이정현 새누리당 대표는 물러나라는 당 내외의 목소리를 무시한 채 대통령을 물러나라고 하는 것은 인민재판 이상도 이하도 아니라며 청와대 비호에 앞장섰다 조원진 최고위원은 또다시 좌파세력을 들먹이며 색깔론을 동원했고 정홍원 전 총리는 마녀사냥이라며 대통령 감싸기에 일관했다 한심하다 상황인식이 결여된 이들의 발언을 바라보는 국민의 한마디다 국가권력을 사유화하고 사인에게 조종당한 이가 바로 대통령이다 재벌들에게 말 한마디로 수백억을 빼앗은 것도 대통령이다 국가 안보와 외교 기밀문서를 빼돌린 것도 대통령이다 드라마 주인공 이름으로 대통령의 건강을 위협한 이 역시 대통령이다 대한민국과 국민의 얼굴에 먹칠한 그 죄가를 치러도 모자란 상황에서 국민의 심판을 외면하기에 급급한 이 역시 대통령이다 대통령을 위한다면 감언이설로 눈과 귀를 막을 것이 아니라 국민이 대통령을 어떻게 바라보는지 맑은 거울을 하나 선물하라 그것이 국민에 대한 최소한의 예의이자 공직자로서의 본분이다 다시 청와대 지키기에 나선 경찰 촛불집회에서 시민들이 이성적으로 협조해 준 것에 감사하다던 경찰이 사흘 만에 입장을 뒤집었다 내일로 예정된 집회에 또다시 제동을 건 것이다 경찰은 청와대로 향하는 길목인 내자교차로에서 일부 시민이 집회시간을 넘기고 장시간 차로를 점거했다며 소수 시민이 경찰과 대치하며 불법시위를 했다는 이유를 들었다 불법시위라고 한다 국가의 주인인 국민이 권력을 위임한 대통령에게 목소리를 전하고자 나서는 일이 어찌 불법이 될 수 있는가 국정 농단의 주범인 박근혜 대통령에 대한 만 시민의 준엄한 명령은 외면한 채 경찰이 진정 지키고자 하는 것이 무엇인가 경찰이 지켜야 할 것은 청와대가 아니라 국민이고 국민의 목소리다 월 일 더불어민주당 의원총회 개최 관련 박근혜 게이트에 분노한 국민들의 촛불집회가 끝없이 이어지고 있으며 더불어민주당은 전국 지역별 당원대회 등을 실시할 예정이다 정국이 비상한 상황이다 제 야당인 더불어민주당은 국민과 소통하고 상시적인 비상체계를 구축해 대응방안을 논의하기 위해 월 일 월요일 오전 의원총회를 실시한다 더불어민주당은 국민을 최우선으로 하여 앞으로도 지속적인 대응방안을 논의하며 국민을 위한 길을 찾기 위해 최선을 다할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59020,2016-11-17, 기동민 원내대변인 오후 현안 추가 서면 브리핑 박근혜 최순실 게이트 국정조사계획서 와 특별검사법 통과를 환영한다 오늘 본회의에서 박근혜 정부의 최순실 등 민간인에 의한 국정농단 의혹사건 진상규명을 위한 국정조사계획서 와 박근혜 정부의 최순실 등 민간인에 의한 국정농단 의혹 사건 규명을 위한 특별검사의 임명 등에 관한 법률안 이 통과됐다 이번 국정조사와 특검을 통해 박근혜 대통령과 최순실 및 비선실세들의 국정농단 행위를 낱낱이 밝혀내고 심판할 수 있는 계기를 마련될 수 있을 것으로 기대한다 특히 이번 국정조사에서는 조사 범위를 가지 세부사항으로 나눴고 호에는 위원회가 의결한 안건 조항을 삽입하여 필요하다면 어떤 부분일지라도 성역 없는 조사가 가능하도록 했다 또한 조사 대상기관에 검찰청을 포함했고 세월호 시간 에 대한 조사가 가능하도록 했다는 점에서 큰 의미가 있다고 평가한다 우리 당은 이번 국정조사와 특검을 통해 박근혜 최순실 게이트 의 진상을 낱낱이 밝혀내고 국민적 의혹을 해소하는 계기를 만들 수 있을 것으로 기대한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59019,2016-11-17, 추미애 대표 야 당 대표 회동 인사말 일시 목 오후 시 장소 국회 사랑재 추미애 대표 오늘 당이 다시 만났다 고 수험생들이 이제 시험을 막 마칠 무렵이다 고생 많으셨다 우리 아이들이 꿈을 키울 수 있는 대한민국을 만들어야 한다는 역사적 사명감 아래에 야 당 대표들이 다시 만났다 야 당의 공조를 위해서 우리 스스로 절제하고 마음을 비워야 할 때이다 서로 지록위마 가 안 되도록 조심하고 경계했으면 좋겠다 저도 통 크게 마음을 풀겠다 이제 대한민국 국민과 야 당은 민주공화국 대한민국의 주권회복운동에 함께 할 것이다 대통령은 퇴진이 정답이다 그런데 자꾸 정답을 두고 오답만 지시하고 있다 만 촛불의 민심을 받들어서 야 당 모두 박근혜 대통령 퇴진 이라는 깃발 아래 다시 힘을 합치겠다 위정자가 민심을 따르면 정치가 일어나고 민심을 거스르면 정치가 황폐해진다 고 했다 모든 권력은 국민으로부터 나온다 가을이 깊어갈수록 낙엽이 많이 떨어지는데 권력도 그와 같다 대통령은 이미 낙엽이 된 권력을 부여잡고 아직도 본인이 울긋불긋 아름다운 단풍인 것 마냥 착각하고 계신듯하다 드라마에 심취하신 대통령이 국민의 눈물은 헤아리지 못하고 오로지 권력은 내 것 이라고만 주장한다면 우리는 민심에 따라서 과감히 행동하겠다 다시 한 번 야 당이 한마음 한뜻으로 공조해서 국민의 민심을 보호하고 받들고 존중하겠다 권능을 상실한 대통령의 부역자 집단인 새누리당은 여당으로써의 기능을 잃고 마비되어있다 오로지 야당이 국정현안의 실타래를 풀어야 한다 함께 힘을 모아 박근혜 대통령이 물러나고 헌정질서를 바로잡고 민주공화국으로 가는 길을 단일대오로 나아가겠다 두 분께서 함께해주셔서 감사하다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59013,2016-11-17, 기동민 원내대변인 오후 서면 브리핑 의원총회 논의사항 우리당은 이번 주말에도 총력을 다해 박근혜 퇴진 투쟁 에 당력을 집중하기로 했다 일 금 오후 시에는 광화문 세종문화회관 앞에서 박근혜대통령 퇴진 국민주권운동본부 발대식 에 적극 참여하기로 했다 일 토 오후 시에는 각 시 도당별로 박근혜 대통령 퇴진 당원 집회 개최할 예정이다 또한 일 토 촛불집회에 모든 당력을 집중하기로 결정했음을 알려드린다 이정현 대표와 신 인회 는 나라망치는 책동을 그만두라 사죄하겠다고 머리를 조아리던 대통령이 변한 이유가 다 있었다 이정현 대표와 신 인회 가 배후였다 나라가 두 동강날 지경인데도 아랑곳하지 않고 대통령 지키기 에만 혈안이다 민심도 외면하고 분당 마저 감수한 채 청와대에 유폐된 대통령만을 살려보겠다고 혈안이다 이들이 공당의 중진의원이 맞는지 의문이다 이정현 대표와 신 인회 에게 경고한다 더 이상 국민을 우롱하고 헌정 질서를 어지럽히지 마라 인민 재판 년대식 거리정치 여론 선동 등의 막말로 야당과 국회를 조롱하고 국민을 모독하지 마라 보수 세력조차 이정현 최경환 서청원 홍문종 조원진 의원을 친박 오적 으로 규정하고 정계은퇴를 요구하고 있는 엄중한 현실을 직시하기 바란다 소위 친박 핵심 들이 해야 할 일은 대통령이 검찰조사에 순순히 응하고 법에 따라 엄정하게 처벌받도록 설득하여 국민에 대한 최소한의 도리를 다하는 것이다 더 이상의 음모와 농간은 국민이 용서치 않을 것이다 박근혜 정부 전 현직 총리의 망발 각성을 촉구한다 박근혜 정부 전 현직 총리들의 망발이 도를 넘었다 정홍원 전총리는 국민의 분노를 마녀사냥 으로 치부하고 시한부 총리로 전락한 황교안 총리는 정상적 국정과제도 근거없는 의혹으로 평가절하되고 있다 며 불만을 토로했다고 한다 어처구니없다 박근혜 최순실 게이트 가 마녀사냥인가 대통령 스스로 자백했고 몸통임이 서서히 드러나고 있다 문화 체육 복지 의료 재벌 문제까지 최순실이 손대지 않은 것이 있는지 찾기조차 힘든 상황이다 국정을 총괄했던 전 현직 총리라면 죄송하다 고 사죄하는 것이 먼저다 박근혜 최순실 게이트 를 방치하고 동조한 자신들의 책임을 반성하고 자숙해야 마땅하다 더 이상 남의 나라 일처럼 유체 이탈 화법으로 국민을 모독하지 말라 최순실과 재벌들의 수상한 거래 법으로 단죄해야 한다 박근혜 대통령과 최순실 재벌들의 수상한 거래가 사실로 나타나고 있다 재벌은 민원을 내고 대통령의 독대가 끝나면 최순실은 수금을 했다 삼성 롯데 등 예외가 없다 박근혜 대통령과 최순실은 권력을 이용해 재벌과 암거래를 했고 재벌은 피해자가 아닌 게이트의 주범이었다는 게 명확해지고 있다 심지어 삼성물산 인수합병 과정에서 대통령의 뜻 이라며 국민연금의 찬성을 종용했다는 내부자 증언까지 나왔다 검찰은 망설일 이유가 없다 박근혜 최순실 게이트 에 부역하고 공조한 재벌들을 공범으로 처벌해야 한다 뒷돈 거래로 불법과 편법을 일삼은 특권층의 일탈을 단죄해야 한다 그것이 정의이고 공정한 사회로 가는 첫걸음이다 엄정한 검찰 수사를 재차 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59012,2016-11-17, 금태섭 대변인 오후 현안 추가 서면 브리핑 김현 전 의원에 대한 무죄판결을 환영한다 세월호 유가족들과 함께 대리기사를 폭행했다는 혐의로 기소되었던 우리당 김현 전 의원이 항소심에서도 무죄를 선고받았다 세월호 참사를 정쟁화시키려던 박근혜 정권과 권력의 입맛대로 움직였던 검찰의 무리한 기소가 낳은 당연한 결과이다 김현 전 의원에 대한 검찰의 무리한 기소 이외에도 정권 차원에서 세월호 참사를 국민 갈등의 소재로 삼으려 했다는 정황들이 속속 밝혀지고 있다 국정원과 민정수석실이 올린 대통령 보고서에서는 참사를 여객선 사고 로 지칭하며 보수단체를 활용해 적극 맞대응 집회를 열어야 한다고 조언했다 실제 새누리당 의원들은 세월호 참사는 교통사고 라고 부르고 어버이연합은 세월호 유가족들의 천막을 찾아다니며 행패를 부렸다 대통령은 세월호 사건을 버렸다 이제는 국민들이 대통령을 심판 할 것이다 유동훈 문체부 차관 임명 박근혜 대통령은 언제까지 국민들의 외침을 무시할텐가 오늘 박근혜 대통령은 김종 문체부 차관 후임으로 유동훈 국민소통실장을 임명했다 박근혜 대통령은 최순실을 비롯한 측근과 함께 국가적 과업을 사적 이득을 위해 활용한 헌정 이래 최대의 국정농단으로 국민적 저항에 부딪혀 있다 퇴진 과 하야 를 외치는 국민들을 무시하고 차관 임명권을 행사한 대통령은 권력을 손에서 놓지 못하겠다는 의지의 표명으로 밖에 해석할 수 없다 박근혜 대통령은 국정 안정화를 위해 노력하겠다고 말은 했지만 결국 최순실 국정농단 사건의 핵심이었던 문체부 제 차관 자리를 국민과 국회 그 어떠한 협의도 없이 임명권을 행사했다 이는 사태를 무마하기 위한 기만술이었다는 것을 반증한 것이다 더불어 민주당은 우리나라 문화융성을 문화망국으로 전락시킨 대통령이 또 다시 문체부 인사권을 행사한 것에 대해 온 국민과 규탄한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59011,2016-11-17, 금태섭 대변인 오후 현안 브리핑 일시 오후 시 분 장소 국회 정론관 박근혜 게이트 특검법안은 신속히 통과 되어야 한다 법사위 소위에서 오전에 박근혜 게이트 특검법에 대한 논의가 있었다 야당이 특검을 추천하기로 한 것은 누구도 자기의 사건에 대해 심판관이 될 수 없다 는 국민의 요구에 기댄 것이다 특검법을 미루는 것은 박근혜 게이트를 비호하는 일이다 새누리당은 특검법에 대해서 분명한 입장을 밝혀야 한다 청와대의 편에 설 것인지 국민의 편에 설 것인지 새누리당 의원들은 입장을 분명히 하길 바란다 차움의원이 청와대 의무실인가 차움의원 청와대 의무실 놀음 이 사실로 드러났다 비선진료 가 청와대 주치의나 청와대 의무실 모르게 이루어졌고 대통령의 건강문제가 사생활 로 숨어버렸다 비선실세 에 이어 드러난 비선의료 는 국가의 질서를 무너뜨린 비선공화국 비선청와대 의 산 증거이다 하지만 보건복지부는 대통령 감싸기에 나서고 있다 보건복지부는 차움의원 김상만 원장에 대해 진료기록부 허위작성을 이유로 행정처분한다고 한다 대통령의 비선진료가 의사 한명의 불법행위로 둔갑한 것이다 강남구 보건소에 조사책임을 미룬 당연한 결과이다 보건복지부는 전면적인 조사에 나서야한다 의료법 위반행위가 확인된 만큼 보건복지부는 차움의원과 김영재의원에 대해 실사를 시작해야 한다 건강보험공단과 건강보험심사평가원도 법에서 정한 조사를 실시해야 한다 모든 국민과 의료기관에게 적용되는 건강보험 당연지정제를 비웃고 법위에 군림한 차움의원의 비호세력이 박근혜 게이트의 주범이다 대한의사협회는 윤리위원회를 즉각 개최하라 국민의 생명과 건강을 지키기 위해 항상 노력을 아끼지 않는 의료인들에게 항상 감사한 마음을 갖고 있다 백남기 사망진단서 문제에 이어 박근혜 게이트로 인해 지금 일선 의료인들의 허탈과 당혹은 이루 말할 수 없는 지경이다 사망진단서 논란 책임으로 서울대 백선하 교수가 보직해임된다고 한다 비선진료 차움의원 김원장은 복지부 행정처분이 예정되어 있다 국민들은 대한의사협회가 의료사안에 대해 해답을 주기를 기대한다 의사협회는 윤리위원회를 열어 각종 추문에 연루된 의사들을 조사하여야 한다 어떠한 윤리적 문제가 있었는지 어떠한 불법행위가 있었는지 밝히고 관련자에 대한 징계를 서둘러야 한다 국민 편에 선 의사를 기대한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59010,2016-11-17, 제 차 의원총회 모두발언 일시 목 장소 국회 본청 호 우상호 원내대표 지금이 비상정국이다 저희의 예상대로 박근혜 대통령과 청와대 그리고 집권당의 친박 세력들이 정면 돌파를 결심한 듯하다 주일 정도 잠시 반성하는 척 고개를 숙인 척하다가 며칠 전부터 머리를 꼿꼿이 세우고 뭘 잘못했냐는 듯이 오히려 큰소리를 치는 형국이다 이런 때일수록 제 야당 더불어민주당 의원님들이 똘똘 뭉쳐서 견결하게 싸워할 때라고 생각한다 각오를 더 새롭게 해야 할 것 같다 저들의 반격이 어디까지 올지 지켜봐야겠지만 심상치가 않다 우리가 이런 때일수록 더 열심히 싸워야 한다 사실 의원 여러분들은 지금 많이 지쳐있다 월 국회 개원부터 하루도 안 쉬고 국회에서 열심히 일하시고 노력하시는 가운데 최순실 게이트 같은 전국적인 이슈도 발굴해내고 정권을 흔들 정도의 사안들을 만들어내는 과정에서 많은 분들이 감기몸살 등으로 건강이 많이 상해있다 박완주 수석도 몸이 안 좋아서 병원에 가있고 대표님도 몸이 매우 안 좋다 더불어민주당 의원들이 한 일이 뭐있냐는 여론도 있다고 들었지만 정말 열심히 일하다가 건강을 해치고 있다 이런 때일수록 자기 몸 관리를 잘하셔서 앞으로 남은 몇 주일 간의 투쟁 전선에서 더 잘 싸울 수 있도록 몸 관리를 잘해주시라는 부탁을 드린다 오늘 특검법 통과가 여야 간에 합의가 돼서 원만하게 처리가 될 것으로 예상을 했지만 법사위에서 제동이 걸려있다 국회의장님께서는 여야 당 원내대표가 합의하면 직권상정을 하겠다고 약속해주셨기 때문에 법사위가 정상적으로 진행이 안 되면 오후엔 직권상정의 수순을 밟아나갈 것으로 보인다 여러분들께서 자리를 잘 지키셔서 역사적인 특검법이 통과될 때까지 다 함께해주기를 바란다 이번 주말까지의 투쟁 계획은 비공개 회의 때 안규백 총장께서 보고하실 예정이지만 사실 우리 의원님들이 낮에는 국회에서 법안심의와 예산심의를 하느라고 정신이 없고 저녁에는 지역구에서 촛불집회에 참석하셔야 하고 주말이면 또 도심에서 주요 집회와 촛불 시위에 참석해야 해서 사실 휴일도 없고 쉴 시간도 없이 인 역 인 역 하시느라 고생이 많으시다 우리가 열심히 일하다보면 국민들이 어느 순간에는 수고했다고 말해주시는 날이 올 것이라고 생각한다 더 용기를 내시고 힘을 내셔서 함께 해주십사 부탁을 드린다 오늘 처리할 안건이 건이 넘는다 특검법과 국정조사 계획서 의결 건이 있기 때문에 아마 오후 내내 국회에서 본회의가 진행될 것이다 진행되는 중간에도 계속 원내대표 회동 등 여러 일정들이 진행될 예정이다 중간 중간에 보고할 일이 있으면 여러분들에게 계속해서 보고해드리겠다 지금까지 국회에서 열심히 일하시고 거리에서 투쟁하시느라고 고생하시는 여러분들의 노고에 감사드리면서 향후의 계획도 차질 없이 국민과 함께 할 수 있도록 논의하도록 하겠다 오늘 의총에서 좋은 고견을 부탁드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59007,2016-11-17, 금태섭 대변인 오전 현안 브리핑 일시 오전 시 분 장소 국회 정론관 우리 모두가 수험생 여러분을 응원한다 올해 수험생들은 그 어느 때보다도 고생하였다 정당한 노력을 비웃는 어른들 때문에 고생하고 무능한 대통령 때문에 고생했다 정유라가 각종 특혜와 편법으로 대학에 들어간 사실을 접하고 누구보다 허탈했을 것이다 그럼에도 오늘까지 열심히 공부한 수험생들이 정말 자랑스럽다 그동안의 노력이 오늘 수학능력시험에서 빛을 발할 것으로 믿는다 우리 모두는 수험생 여러분을 응원하고 있다 대부분의 어른들은 여러분 모두의 노력이 정당한 결과를 얻을 수 있는 대한민국을 위해 만 촛불을 들었다는 것이 여러분에게 위로가 되길 바란다 검찰은 대통령을 공개 소환하라 불과 주 전이다 지난 일 차 대국민담화를 통해 박근혜 대통령은 검찰 조사에 성실히 임하겠다고 국민과 약속을 하였다 하지만 대통령은 검찰조사를 거부하고 있다 청와대와 유영하 변호사는 검찰과 협의해서 조사시점을 정한다고 한다 그리고 검찰은 어제 예정되어 있던 대면조사를 일로 연기했다 대통령의 소환조사는 협의대상이 아니다 대통령은 현재 구속된 최순실 안종범과 떼려야 뗄 수 없는 관계이다 대통령의 소환은 통보 대상이고 공개 대상이다 검찰은 대통령을 공개 소환해야 한다 안봉근을 재수사하라 대통령과 최순실 사이의 문고리 인방 의 국정농단이 계속 드러나고 있다 오늘은 안봉근 전 비서관이 경찰 고위직 인사를 독점하고 흔들었다는 진술이 나왔다 검찰이 안봉근과 이재만을 혐의 없다고 돌려보낸 지 불과 이틀만이다 대통령과 문고리 인방이 박근혜 최순실 게이트의 주연이다 검찰은 안봉근을 즉각 재소환해서 수사해야 한다 박근혜 게이트 특검법은 오늘 반드시 처리되어야 한다 여야간의 합의로 만들어진 특검법의 처리가 오늘로 미루어졌다 권선동 법사위원장이 국회법을 이유로 시간 끌기에 나선 결과이다 새누리당 의원들도 갖은 핑계로 논의를 더하자고 한다 박 대통령의 검찰수사 미루기와 똑같이 닮아있다 대통령의 검찰조사도 새누리당의 특검법 미루기도 국민들을 민심을 되돌릴 수는 없다 오늘 본회의에서 반드시 특검법이 통과되어야 한다 청와대와 새누리당은 더 이상 국민들을 우롱하지 말기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59006,2016-11-17, 제 차 정책조정회의 모두발언 일시 목 오전 시 장소 국회 본청 원내대표 회의실 우상호 원내대표 박근혜 대통령과 새누리당은 국민의 민심을 제대로 읽어야한다 지금은 민심에 역행하고 있다 본인이 약속했던 검찰조사도 받지 않겠다고 정면으로 거역하는 행태를 보이고 있다 새누리당 이정현 대표도 연일 당내의 비박계를 향해서 당을 떠나라고 압박하고 있다 나갈 사람 다 내보내고 자기편끼리 똘똘 뭉쳐서 정국을 돌파하겠다는 태도다 전가의 보도처럼 보수단체를 동원해서 집회를 하겠다고 한다 민민갈등을 유발하려는 전형적인 정치공작이다 이런 식으로는 돌파할 수 없다 대통령이 개헌을 추진하겠다는 엄청난 발표를 해도 최순실 게이트가 덮여지지 않는다 국민의 민심이 가라앉지 않는다 정면 돌파하겠다는 것은 오로지 자신들만 국민 속에 고립되겠다는 이야기다 지금 대통령은 사실상 청와대에 유폐돼있는 상황이다 청와대 바깥으로 나오지 못한다 대통령 주최 행사에 국민이 가지도 않는다 이런 나라를 계속 장기적으로 끌고 가겠다는 것인가 대통령과 새누리당은 국가를 생각하기는 하는가 자기 집단의 안위와 정권 유지에만 혈안이 되어 있는 것이 아닌가 바로 퇴진해야 한다 국가와 민생을 위해서 그렇다 지금 그들이 무엇 하나 국민의 삶과 관련된 정책 하나 돌볼 수 있는가 아무것도 할 수 없는 정권이 그저 청와대만 지키겠다고 농성투쟁을 하는 것이 말이 되는가 이제 결단하시기 바란다 국민을 자극하는 일련의 도발적인 언사들이 이번 주말에 더 많은 국민들을 거리로 나오게 하는 것이다 국가적 불행이 예고되고 있다 결단하시기 바란다 진실을 규명하기 위해서 여야가 오랜 협의 끝에 국정조사와 특검법에 대한 합의를 했다 오늘 본회의에서 통과시켜야 한다 그런데 법사위 소속 새누리당 의원들의 행태는 참으로 한심하다 더 이상 꼬투리 잡지 말고 오늘 오전 중에 이 법안을 통과시켜주시기 바란다 법사위에서 계속해서 몽니를 부리면 할 수 없이 직권상정을 추진해야겠지만 가능한 법사위에서 통과시켜주는 것이 국민의 민심을 거스르지 않는 순리다 정세균 국회의장께서는 여야 원내대표가 합의하고 법사위에서 정상적으로 통과되지 않으면 오늘 본회의 통과를 위해서 직권상정하겠다고 약속했다 약간 삐걱거렸던 야당 공조가 오늘부터 정상화된다 야 당 대표 회동이 있고 이번 주말에도 박근혜 대통령의 퇴진을 위한 각 당의 공동 노력이 있을 것이다 이번 주를 경과한 시점에 노회찬 의원께서 제안하신 야 당 합동 의원총회를 하는 것도 좋은 방법이라고 생각한다 각 당의 당론이 퇴진으로 모아졌기 때문에 야 당 의원들이 같이 모여서 공동 요구를 국민들에게 호소하는 모습도 필요하다 윤호중 정책위의장 검찰 조사를 받아야 할 대통령이 검찰 조사를 못 받겠다는 것을 넘어서 검찰에 사건 수사를 지시하고 나섰다 국민의 퇴진 요구가 이미 지난 일 봇물처럼 터져서 만의 함성이 되었고 이제 천만의 한 뜻이 되었음에도 불구하고 박근혜 대통령 혼자만 귀 가리고 눈 가린 채 모르쇠로 일관하고 있다 외교부 차관 등 인사권을 행사하고 한일군사정보보호협정 가서명 등 협정 체결을 추진하고 있다 국민의 민심에 완전히 역행하는 대통령의 행태를 보면서 대통령의 생각이 도대체 무엇인지 국민은 의문스럽다 검찰 조사에는 당연히 대통령으로서 당당하게 응해야 한다 검찰조사에 불응하는 것은 범죄자들이나 할 일이다 대통령으로서의 권위와 명예를 완전히 상실한 박근혜 대통령은 이제 작은 일에까지 상황판단능력을 완전히 상실한 것 아닌가하는 생각이 든다 박근혜 대통령에게 요구한다 더 이상 국민을 피곤하고 고통스럽게 하지 말고 당장 퇴진하라 절대로 추진되어서는 안 되었던 국정 역사교과서를 강행하겠다고 교육부가 나섰다 오는 월 일에 국정 역사교과서 현장 검토본을 공개하겠다는 것이다 그런데 현장 검토본은 공개하면서 역사교과서의 교사용 지도서는 공개검증 대상에서 제외했다고 한다 집필진도 깜깜이고 집필기준도 깜깜이고 교사용 지도서도 깜깜이인 상태에서 국정교과서를 계속 추진하겠다는 것이다 지금까지 교육부는 국정화 추진 과정에서 수차례 행정예고절차를 위반하고 불법 를 운영하다 적발되는 등 위법행위를 반복해왔다 국민의 반대를 무릅쓰고 진행되고 있는 국정 역사교과서를 불법적으로 계속 추진하고 있는 것은 아직도 우리 국정에 최순실의 그림자가 지워지지 않고 있다는 것을 의미한다 박근혜 대통령은 최순실의 지침에 따라서 혼이 비정상이 될 우려가 있으니 교과서를 새로 만들어야겠다고 이야기했던 분이다 과연 최순실의 혼이 비정상인가 천만 국민의 혼이 비정상인가 박근혜 대통령은 당장 최순실의 영향력에서 벗어나서 국정교과서 추진을 중단하기 바란다 박완주 원내수석부대표 수험생 여러분을 응원한다 오늘은 년도 대입수능시험이 있는 날이다 오랜 기간 동안 열심히 준비해온 우리 수험생들에게 좋은 결과가 있기를 응원한다 자식들 위해 물심양면으로 뒷바라지해 오신 우리 부모님들께도 진심으로 고생하셨다는 말씀을 드린다 그러나 마음이 참 무거운 수능 날이다 대학입학제도는 그나마 대한민국이 공평한 기회가 있는 나라라는 것을 보여주는 제도라고 생각한다 누구나 실력만 있다면 원하는 대학에 갈수 있기 때문이다 그러나 최순실 정유라 모녀는 공평한 대한민국 균등한 기회가 존재하는 대한민국의 가치를 처참히 깨버렸다 지난 주말에 열린 집회에서 많은 학생들을 만났다 대학생은 물론이고 고등학생과 중학생 심지어 초등학생의 입에서도 대통령은 퇴진하라 는 외침이 들렸다 대통령을 등에 업은 최순실 모녀가 국정농단을 넘어 교육농단까지 자행했다는 사실에 분노한 학생들은 펜을 내려놓고 거리로 나섰던 것이다 보도에 따르면 최순실씨는 수업중인 선생님에게 폭언과 협박을 일삼았고 금품까지 전달했다는 사실이 드러났다 이화여대 부정입학을 위해 지난 년도 입시에서 정유라의 합격을 위해 상위권 학생 두 명에게 낙제점을 주었다는 충격적인 사실도 밝혀졌다 온갖 특혜와 편법으로 얼룩진 박근혜 최순실 정권이 정정당당하게 공부하며 꿈을 키워가는 학생들에게 엄청난 악영향을 미친 것은 아닌지 매우 걱정스러운 지경에 이르렀다 정정당당함이 곧 실력인 사회를 위해 국회가 더 노력하겠다 박근혜 최순실 게이트의 명명백백한 진상규명은 비단 책임자 처벌만을 위한 것이 아니다 이제 특검과 국정조사를 앞두고 있다 국회는 우리 아이들에게 공정한 대한민국 나아가 정의로운 대한민국의 모습을 보여야 하는 중대한 기로에 놓여있다 우리 아이들이 대한민국의 미래이다 특검과 국정조사를 통해 온갖 의혹들에 대한 진실이 밝혀질 때까지 국회가 모든 역량을 집중하고 초당적으로 협력해야 한다는 점을 다시 한 번 강조한다 이정현 대표는 지지율 발언을 대통령에게도 해보시기 바란다 박근혜 대통령은 지지율 에 불과한 식물 대통령 그 이상도 이하도 아니다 국민의 지지를 잃은 지도자가 중대한 국사를 결정한다는 것은 어불성설이다 국정운영이 불가능한 지도자가 국정장악에만 몰두하는 것은 결국 국민 불행으로 이어질 수밖에 없다 사드배치 한일 군사정보보호협정 국정교과서 문제까지 민의를 무시한 대통령의 마이웨이 선언으로 이미 국민들은 현 정권에 지칠 대로 지쳐버렸다 다시 한 번 경고한다 박근혜 대통령이 진정 국가와 국민을 위한다면 즉각 퇴진해야 한다 그것이 바로 민의이다 이미 이정현 대표조차 본인의 당 대선주자를 향해 지지율 를 넘기 전에는 어디서 대권주자라는 말을 꺼내지도 말고 사퇴하라 고 한바 있다 새누리당 대표의 의견이 그렇다면 지지율 에 불과한 박 대통령도 예외일 수 없다 이정현 대표의 말을 대통령은 유념해야 할 것이다 박정 부대표 재벌 대기업은 박근혜 최순실 게이트의 피해자가 아니라 공동정범이었다 검찰이 박근혜 대통령과 독대를 한 재벌 대기업 총수들을 비공개로 불러서 조사했다 마치 재벌 대기업은 박근혜 최순실 게이트의 피해자인 것 같았다 하지만 박근혜 최순실 게이트는 박근혜 대통령과 최순실을 중심으로 이 정권의 경제 컨트롤 타워였던 장 차관 청와대 수석 그리고 재벌 대기업 총수들이 얽히고설킨 거대한 국정농단의 한 단면이었다 대통령까지 직접 나서서 기획한 거대한 정경유착의 범죄행위였다 억 원을 강취한 것이 아니라 자발적으로 내놓은 삼성은 이건희 회장에서 이재용 부회장으로의 경영승계에 정부의 지원이 절실했다 제가 긴급현안질의에서 한 삼성물산과 제일모직의 합병에 청와대가 개입했다는 의혹과 관련해 오늘자 언론에선 국민연금 압박을 통해 관여했다는 증언도 나왔다 삼성 경영승계에 절대적 도움을 주는데 청와대가 개입했다는 증거인 것이다 명백한 뇌물수수이고 대가성 범죄에 해당하는 것이다 미르재단과 스포츠재단에 억 천만 원을 출연한 현대자동차는 골치 아픈 불법 파견 사내 하청 문제를 해결하기 위해 정부여당이 추진 중인 파견법 개정을 애타게 기다리고 있다 정부의 법인세 개정으로 삼성동 한전 부지를 사들이며 부지 매입 및 개발비용 총 조원 가운데 이상을 투자로 인정받아 천억 원 가량의 세금감면 혜택도 보았다 롯데는 신동빈 회장 등 총수 일가에 대한 수사가 목을 죄고 있던 상황이었고 면세점 사업을 되찾기 위해 정부에 잘 보여야 했다 와 는 총수를 감옥에서 빼내기 위해 무엇이든 해야 하는 상황이었다 박근혜 대통령은 대기업 재벌로부터 최순실에게 상납이 이루어지면 그 보답으로 필요할 때마다 시정연설과 대국민담화를 통해 원샷법 노동개혁법 등 재벌을 돕기 위한 법률안 통과를 지원했다 권력과 재벌의 뒷거래 속에서 국기문란과 국정농단의 피해는 고스란히 국민들이 짊어지고 있다 박근혜정부와 재벌은 서민들의 피땀에는 아무런 관심이 없다 재벌 대기업은 피해자가 아니다 검찰은 박근혜 최순실 게이트의 깊숙한 이면에 숨어있는 정권과 대기업의 공생관계에 대해서 철저히 밝혀내고 관련자들을 엄벌에 처해야 할 것이다 아울러 경제계를 주물렀던 또 다른 비선실세들의 대한민국 경제농단 문제도 반드시 밝혀내야 할 것이다 김경협 정책위 제 정조위원장 외통위 간사 어제 보도에 의하면 세월호 참사 직후에 국정원이 작성해서 청와대 민정수석실을 통해 청와대에 보고된 자료는 가히 충격적이다 세월호 유족들을 어떻게 분열시켜서 대응할 것인가 그리고 보수단체들을 내세워서 여론전을 펼쳐야 한다는 것이다 국정원이 이것을 만들었다 그리고 청와대에 보고했고 이대로 상당정도가 시행됐다고 하는 점이 가히 충격적이다 문제는 박근혜 대통령의 퇴진정국에서 또다시 이것이 재연되고 있다는 것이다 보수단체를 동원해 관제데모 맞불집회를 놓겠다 그리고 국민들 간의 싸움으로 몰아가겠다는 의도가 곳곳에서 드러나고 있다 세월호 참사 직후에 코너에 몰린 청와대가 이렇게 상황을 돌파하려 했듯이 이번에도 다시 재연되고 있는 것이다 현재 카톡과 같은 등에 떠돌아다니고 있는 우리당과 우리당의 유력한 대선후보들에 대해서 조직적인 마타도어가 유포되고 있다 청와대로 쏟아지는 화살의 타깃을 민주당과 우리당의 대선후보들로 돌리고자 하는 작전으로 보인다 작성자는 물론이고 유포자와 배후세력을 철저하게 색출해서 법적으로 책임을 물어야 한다 그리고 세월호참사보고서에 대한 국정원에 대한 조사도 다시 한 번 철저하게 이뤄져야 한다 청와대과 새누리당의 친박들이 공동보조를 취하면서 헌정질서를 지키기 위해서 대통령의 하야와 퇴진은 안 된다 며 퇴진을 거부하고 있다 헌정유린 국정농단 법치파괴를 한 사람은 지위고하를 막론하고 책임지고 처벌을 받는 것이 헌정질서이고 법치이다 국민들은 최순실에게 맡겼던 권력을 이제 국민들에게 반납할 것을 요구하고 있다 국민의 마음속에 이미 박근혜 대통령은 대통령이 아니다 박근혜 대통령은 이미 대통령으로서의 권위와 신뢰를 다 잃었다 국정농단 헌정유린 집권남용 기밀누설 뇌물수수 의 주범이고 범죄 피의자이다 어제 엘시티 수사 지시를 보고 범죄 피의자가 수사를 지휘하는 것을 보며 참으로 부끄러워 할 줄 모른다는 생각이었다 즉시 검찰의 수사를 받아야한다 하야 퇴진 탄핵 권한대행체제 전부 헌정질서 내에서 이루어지는 것이다 헌정을 유린하고 법치를 파괴한 사람이 책임지고 물러나는 것이 헌정질서이다 더 이상 추한 모습을 보이면 안 된다 집착과 미련을 버려야 한다 국회 추천 총리를 대통령 권한대행으로 위임하고 물러나는 것이 순리이다 이것이 헌정질서라는 점을 다시 한 번 강조한다 홍익표 정책위 수석부의장 우리당은 두 달 전에 가정용 전기요금과 관련해서 단계를 단계로 줄이고 배를 배로 줄이는 누진세 조정안을 발표한 바 있다 그런데 아직 확정적으로 발표하지 않았지만 며칠 전 정부여당이 우리 당의 안을 상당 부분 수렴해서 가져온 것으로 알려지고 있다 대략 단계 배수 안 정도로 알려져 있다 해당 상임위에 곧 보고를 할 예정이다 우리당은 국민들이 부담을 갖는 문제에 대해서 소홀히 하지 않겠다 전기세 요금을 반드시 관철해서 동절기 서민들의 부담을 줄여 다시는 전기요금 대란이 오지 않도록 하겠다 특히 이와 더불어서 스티글리츠 교수가 불평등의 대가 에서 말씀한 바와 같이 경제가 공평하지 않다면 경제는 회복된 것이 아니라고 했다 이는 경제를 공평하게 하는 것이 경제를 회복하는 지름길이라는 이야기다 국민 가계에 부담을 주고 있는 전기세를 포함해서 유류세 그리고 통신요금을 비롯한 와 관련하여 여러 가지 부담이 있다 각종 세금 및 공과금에 대해서 우리당은 대폭적으로 낮출 수 있는 방안을 적극적으로 모색해 나가겠다 서민의 부담을 줄이고 경제를 공평하게 하는 것이 경제를 살리는 지름길이라고 생각한다 대통령이 조롱과 웃음거리를 넘어서 이제 범죄의 핵심 몸통으로 인식되고 있다 빨리 스스로 거취를 결정해주시라 청와대를 가든 이라는 말이 요즘 유행하고 있다 첫 번째 는 짝퉁 길라임씨가 사는 흔히 근라임씨라고 하는 시크릿가든 의 두 번째 는 무속과 각종 사이비 종교의 그늘이 드리워져 있는 샤먼가든 의 그리고 이를 총괄하고 있는 순실이가든 의 그래서 가든이라는 말이 떠돌고 있다 청와대가 더 이상 국민적 국제적 조롱거리가 되지 않았으면 좋겠다 대통령께서 또 다시 국민에게 정면으로 도전하고 있다 몇 년 전에 제가 박근혜 정권이 할 수 있는 정치의 방향이 공 정치라고 말씀드렸다 즉 공작 정치 공포 정치 공안 정치에 능하다보면 반드시 공멸의 정치로 갈 것이라고 경고한 바 있다 박근혜 대통령께서 본인의 공작 공포 공안정치를 통해서 또다시 대한민국이 공멸에 이르지 않게 해주시라 대통령 박근혜씨에게 경고 드린다 우상호 원내대표 여러분의 이해를 돕기 위해서 두 가지만 말씀드리겠다 더불어민주당은 지금 정국에 관한 대책을 주간 단위 계획을 잡아서 옮겨가고 있다 첫 번째 주는 이전에 국정감사에서 최순실 게이트를 정면으로 제기해서 국가적 이슈로 만드는 과정이 끝난 이후에 단계적 퇴진론을 당론으로 정해서 일주일을 끌어왔다 이번 주는 월요일 퇴진을 당론으로 정하고 당론을 관철하기 위한 퇴진운동을 주간 단위로 진행할 것이다 우리당의 여러 가지 입장 전환을 물어보는 분이 많이 계신데 주간 단위로 계획을 짜서 하고 있고 이번 주는 계속 퇴진운동에 집중할 것임을 유념해주시기 바란다 다음 주 월요일 즈음에 그 주의 테마를 무엇을 잡을 것인가를 단계적으로 원내외 전술을 병행하면서 해나가고 있다는 점을 말씀드린다 최근 국민들의 관심이 집중되면서 정치권 내부의 속사정이나 여러 가지 흐름 등에 대해서 카더라 통신이 많이 유포되고 있다 국민들 판단을 흐리게 하는데 기여하고 있다고 본다 더불어민주당의 원내소식을 국민에게 직접 전달하는 직접 소통을 시작하려고 한다 그래서 페이스북을 개설해서 더불어민주당의 원내소식란을 만들어서 저희가 직접 뒷사정이나 앞으로 전개되는 과정들을 국민들과 소통하려고 한다 언론인 여러분들도 해당 페이스북을 개설하면 충분히 습득하지 못한 정보를 그쪽을 통해서 들을 수 있다는 것을 공지해드리겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59005,2016-11-17, 기동민 원내대변인 오전 현안 브리핑 일시 목 오전 시 분 장소 국회 정론관 만 수험생 여러분의 건투를 기원한다 박근혜 대통령과 최순실의 국정 농단과 헌정질서 파괴로 나라가 어수선하다 하지만 오늘 만큼은 모든 것은 내일로 미루고 시험에 집중하길 당부한다 돈도 실력이야 니네 부모 원망해 라는 말이 다시 나오지 않는 공정하고 투명한 사회를 만드는 건 어른들과 기성세대가 감당해야 할 몫이다 비선 실세의 딸을 위해 입시요강을 바꾸고 면접까지 조작하는 대학이 밉더라도 여러분과 가족들을 위해 최선을 다하길 바란다 만 수험생 모두가 준비한 만큼 소기의 성과가 있길 기대하고 응원한다 검찰은 박근혜 대통령을 피의자 로 소환하라 철면피도 이런 철면피가 따로 없다 대통령만 아니면 당장 구속 수사해도 모자랄 판인데 국민과 한판 대결이라도 불사할 태도이다 천만이 시위해도 절대 물러나지 않을 사람 이라는 노 정객의 말이 결코 헛말이 아니었다 입이 닳도록 외쳐온 법치주의 는 어디로 갔는지 국민도 없고 법치도 없고 염치도 없는 대통령의 행태에 어이가 없을 뿐이다 이 나라는 박근혜의 나라 가 아니다 국민이 없으면 대통령도 없다 박근혜 대통령에게 주어진 지위는 국민이 만들어 준 것이다 이제 국민이 그 자리를 내려오라고 명령하고 있다 국민의 명령에 복종하고 물러나는 것이 대통령의 도리다 명심해야 할 것이다 검찰은 더 이상 눈치 보지 말고 대통령을 범죄 피의자로 소환하여 조사해야 한다 박근혜 최순실 게이트 의 몸통으로 수사해야 한다 무엇보다 헌정 질서를 파괴한 반민주적 독재자로 역사의 처벌을 받도록 법의 엄정함을 보여야 할 것이다 유폐 대통령 과 친박 일족 은 저열한 정치놀음을 중단하라 유폐 대통령 이 명령하고 친박 일족 이 주도하는 한 일 군사정보보호협정 과 국정교과서 강행 은 결코 용납할 수 없다 국민의 분노를 저열한 정치놀음으로 희석시키려는 반민주적 폭거에 불과하다 나라의 중대사를 놀음판 화투패 던지듯 하는 대통령과 친박 세력은 역사의 죄인일 뿐이다 오로지 정략과 권력에 대한 망상일 뿐 눈곱만큼의 애국도 애민도 없다 국민들의 분노에 불을 지필뿐이다 당장 그만두기 바란다 지금 대통령은 길라임 이란 가명에 나라보다 자신의 진돗개가 우선이고 여성으로서의 사생활 이 중요한 유폐 대통령 일 뿐이다 혹여 국정 복귀의 미련이 있다면 남김없이 비우기 바란다 결코 국민이 용납하지 않는다 엘시티 사건 의 엄정한 법집행을 촉구한다 국정농단의 몸통 박근혜 대통령이 엘시티 사건 의 철저한 수사를 지시한 것은 어불성설이다 대통령은 검찰을 지휘할 권한도 도덕성도 상실했다 법 앞에 죄인으로 엄정하게 조사받고 처벌을 기다리는 것이 본인이 할 일이다 모든 것은 법에 따라 처리할 문제다 검찰은 엄정하게 수사해서 낱낱이 진상을 밝혀야 한다 문제가 있다면 지위 고하를 막론하고 법에 따라 처리하면 그만이다 불법은 처단할 문제지 흥정이 대상이 아니다 그게 법치주의의 기본 이다 대통령과 친박들에게도 경고한다 청와대가 직접 엘시티 사건 에 대한 수사보고를 받고 이 사건을 이용해 국면을 전환하려 한다는 의혹이 시중에 파다하게 퍼져있다 엘시티 사건 으로 자신들의 죄를 감추고 정국을 혼돈으로 몰아가겠다는 꼼수에 불과하다 꿈도 꾸지 마시라 국민이 용납하지 않는다 중립 을 외치는 권성동 법사위원장 대통령 지시라도 받았나 여야 합의로 진행된 박근혜 최순실 게이트 특검법 이 친박 권성동 법사위원장 때문에 차질을 빚고 있다 여야 원내대표가 합의한 사항이고 전례가 있었음에도 안하무인이다 대통령 지시라도 받은 것인가 특검을 야당이 추천하면 야당에 편향적인 정치검찰 이라고 비난받을 수 있다는 이유는 더 기가 막힌다 정치검찰을 만들고 권력의 주구로 활용한 당사자가 대통령과 친박들 아니었나 적반하장도 유분수다 권성동 위원장은 정신 차리고 국민 목소리에 귀 기울이기 바란다 불법과 헌정 파괴 국정농단 앞에서 중립 이란 그 자체로 민주주의에 반하는 행위이다 지금 당장 특검법을 처리하고 국회가 해야 할 일을 제대로 하기 바란다 주사제 대리처방의 대가가 낙하산이었나 대통령의 주사제 대리처방 의혹이 커지고 있다 대통령 건강에 무슨 문제가 생겼기에 대리처방까지 받아야 했는지 의문이다 게다가 대통령 혈액은 기밀사항이라 외부에 맡겼다 청와대에 영양제가 없어 밖에서 들고 갔다 는 말도 안 되는 변명은 더 가관이다 차움병원이 국정원이라도 되는 건가 청와대에도 맡기지 못 할 국가기밀사항이 차움병원에서는 지켜진다는 말인가 차의과대학에 최원영 문병우 문창진 엄영진 이신호 등 청와대 복지부 식약청 출신의 낙하산 고위간부들이 포진된 것으로 알려졌다 청와대 복지부 차병원의 어두운 연결고리가 의심되는 상황이다 대통령의 대리처방 의혹 법에 따라 엄정히 수사해야 한다 도대체 대통령의 피를 가지고 무슨 짓을 했는지 대통령이 불법으로 처방받은 약은 무엇이었는지 대통령과 복지부 차병원간에 이뤄진 특혜와 대가성은 무엇이었는지 낱낱이 밝혀야 한다 공적 존재인 대통령이 여성으로서의 사생활 까지 들먹이며 이해를 구해야 하는 내용은 무엇인지 한 점 의혹없이 밝혀져야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=59000,2016-11-16, 박근혜 대통령 엄정수사 촉구 촛불집회 인사말 일시 수 장소 서울중앙지방검찰청 앞 추미애 당대표 어제 갑자기 길라임은 하야하라고 해서 깜짝 놀랐다 대통령이 드라마에 심취한 나머지 우주의 기운도 역시 길라임처럼 받으셨구나 그래서 가명도 길라임을 쓰셨구나 밤새 우울한 날을 한방에 날려버리고 웃을 수 있게 해준 대통령이 감사하다고 해야 하나 웃기다고 해야 되나 그런 막장 드라마도 없었다 박근혜 최순실 게이트의 몸통인 박근혜 대통령의 조사 없이 수사 없이 앙꼬 없는 찐빵처럼 빈껍데기 각본에 따른 수사를 들고서 대한민국 헌정 질서를 무너트린 대통령을 향해서 우리가 무엇을 더 할 수 있겠나 한번 외쳐보자 대통령은 하야하라 지난번 국정원 댓글녀가 스스로 셀프 감금 되어 놓고 우리당 국회의원들이 감금시켰다고 윽박지르고 기소했던 검찰이었다 이번에 국민이 촛불을 들고 나오니까 대통령 스스로 감금됐다 이대로 가다가는 대통령이 나중에 온 국민을 기소하면서 자기 자신을 감금시켰다고 할 지경이다 대통령의 변호를 자처한 최순실의 대역 유영하 변호사가 나타나서 대통령도 여성이고 사생활이 있다고 이야기하는 걸 보니 촛불 들고 나와 분노로 들끓는 광화문광장의 국민은 외면한 채 드라마를 보다가 느닷없이 내가 청와대 밖으로 외출하고 싶었는데 촛불시민이 나를 감금했다 기소하라고 최재경 민정수석에게 명령하지 않을까 많이 걱정된다 대통령이 외치를 하겠다고 한다 이렇게 국제적 조롱거리를 만들어 놓고 대한민국 국민인 것이 낯부끄러워서 끊었던 배행기표도 취소할 지경이다 어떻게 대통령이 외치를 한다고 말할 자격이 있나 대통령은 이제 시끄러워서 나라를 이렇게 망신시켜놓고 신문도 안 본다는 말인가 샤머니즘으로 통치해온 나라로 대한민국 국민의 수준을 떨어뜨리고 국격을 떨어뜨려 수치스럽게 만든 대통령이 이제 와서 외치를 하겠다고 한다니 말이 되나 집나간 부인이 집에 마실 물 걱정한다는 자체가 우습다고 그러더라 대통령이 걱정을 내려놓고 하야해주면 대한민국이 편하지 않겠나 우병우를 제발 구속해라 우병우가 망친 것이다 정윤회 문건 사건 때 제대로 수사했었더라면 우병우가 민정수석으로 제대로 제 역할을 했었더라면 이렇게까지 사태가 커지지 않았을 것이다 감시자 역할을 해야 할 사람이 감시역할은 커녕 오히려 더 키우고 조장하고 대통령을 비호하며 국정농단을 하도록 했던 본인을 구속하지 않고 빈껍데기 수사로 국민을 속이려고 하나 대한민국 검찰은 누가 준 권력인가 바로 국민이 만들어준 권력이 아닌가 대한민국 국민 위에 검찰이 있지 않다 민심을 받들고 수사명령을 제대로 해야 할 대한민국 검찰이 아닌가 우병우의 하수인이 될 것인가 아니면 국민의 검찰이 되겠나 우병우를 즉각 구속하라 최순실이 떠나간 자리 최태민을 잘 알고 있고 최순실을 더 잘 알고 있는 가족과 같은 대리인 변호사를 내세워서 국민의 억장을 더 무너지게 할 게 아니라 대통령이 먼저 변호사를 집어 치우고 국민께 진솔한 사죄부터 하는게 우선이다 그런 다음 미련 없이 국정에서 손 떼라 국민 앞에 무릎 꿇어라 성난 촛불 앞에 대통령이 무릎을 꿇어라 그날이 늦으면 안된다 대민민국이 더 망가진다 대통령이 무너뜨리는 것이다 대통령이 드라마를 보고 웃고 있는 사이 대한민국 국민의 눈물은 깊은 강물이 되고 한숨이 되어 흘러가고 있다 제발 나라를 조금이라도 생각한다면 마지막 남은 눈곱 만큼의 애국심이 있다면 대통령은 하루 빨리 국정을 내려놓고 나와야 하는 것이다 대통령에게 필요한 것은 그저 대통령을 가려줄 꼭두각시나 변명해줄 제 의 최순실이 필요한 것이 아니다 대통령의 진심이 필요하다 그 진심을 촛불 민심 앞에 와서 드러내라 그래야만 우리 국민이 조금이라도 위로를 받을 것이다 지난 년 동안 망가트린 대한민국을 앞으로 년 더 망가트릴 것인가 아니면 대한민국을 살려 놓을 것인가 대통령은 대답하라 오늘 더불어민주당은 대통령을 미리 법정에 세우는 국민 법정을 만들었다 대통령은 나이 드신 노구의 김대중 대통령 보다 일정이 적었다 토론을 즐겼던 노무현 대통령 보다 몇십분의 일도 안 되는 일정을 소화했다 그렇게 외유 순방을 좋아하는 대통령이 문만 열고나오면 성난 촛불 민심을 마주할 수 있다 그것이 두려우면 청와대 뒷산만 올라가도 국민이 무엇을 원하는지 눈으로 확인할 수 있을 것이다 대통령이 국정을 중단시키고 있는데 국정을 중단시킬 수가 없다고 거꾸로 버티는 대통령이 과연 이 나라를 조금이라도 생각한다는 말인가 대통령이 일신을 걱정할 때가 아니다 꿈이 꺾여버려 좌절한 우리 아이들을 생각해야 하는 것이다 바로 코앞이 시험인데도 촛불을 들고 아버지 손잡고 나와야 하는 우리 아들딸들을 생각해야 하는 대통령이다 생업을 접고 월세를 못 내면서 한숨 쉬면서 주말마다 촛불 들고 나와야 되는 대 이 땅의 아버지 어머니들을 생각해야 되는 대통령인 것이다 세월호 아이들이 죽어갈 때도 그 이튿날 조카딸 정유라만 챙긴 대통령 멀쩡한 사학에 개입해서 학칙까지 바꿔 놓도록 한 그 어마 무시한 권력을 휘두른 족벌주의 그리고 끝내 권력이 일 년 남았을 즈음 해외로 재산을 빼돌리고 그들의 안위만 생각했던 최순실 가족과 몸통 박근혜 대통령의 부역자들 을 이제 어떻게 하실 것인가 대한민국을 더 이상 도탄에 빠트리지 말고 즉각 하야하라 수사 받기 싫어서 이 핑계 저핑계 대고 있는 대통령 헌법을 스스로 짓밟고 이제 와서 내란외환의 죄를 빼고는 형사상의 소추 당하지 않는다고 헌법상 권리가 있으니 헌법상 권리를 보장하라는 엉터리 같은 대통령 국민은 그 조항 빼놓고 모든 권리를 박탈당해왔다 인간으로서 존중받을 권리를 박탈당했다 대통령이 거주하는 코앞에서 물대포를 맞으며 죽어가는 농민도 있었다 겨우 쌀값 보장하라는 주장을 했다는 이유만으로 누명을 쓰고 죽어가는 한 농민이 있었다 그 뿐 만 아니다 내 아들딸이 왜 죽었는지 모르겠다 시간을 밝혀내다오 대통령이 국정을 지휘하지 않아 제때 목숨을 못 구했다 절규하는 세월호 유족들이 년 넘게 광화문에 있었지만 눈길 한번 주지 않았던 잔인했던 대통령이다 이렇게 국민을 철저하게 무시하는 대통령이 오로지 헌법에 있는 한 조항에만 기대 철저하게 대한민국을 유린한 죄 값을 받기는 커녕 수사를 적당히 얼버무리려 하고 있다 그래서 국민이 참을 수 없는 것이다 우리는 대통령이 결단하지 않는다면 국민이 주권을 회수하는 운동에 들어가기로 했다 지난 일 촛불민심은 그것이었다 대통령에게 준 헌법상의 권리를 회수하겠다는 것이 촛불의 민심이었다 대통령이 방패 뒤에 숨고 우병우를 끝내 제대로 수사 않고 있다면 대통령을 용서하지 말자 오늘 부산의 엘시티 비리 의혹 주범을 철저히 수사하라고 큰 소리쳤다 대한민국 국민은 대통령보다 더 똑똑하다 가장 큰 죄를 저지른 국사범 헌법을 파괴한 대통령이 사건 하나 건수 하나 생겼다고 국민 의 가장 큰 지탄을 받고 있는 피의자가 사건 하나 물었다고 큰 소리 치는구나 눈치 챘을 것이다 부패와 비리는 뿌리 뽑아야 한다 이영복 회장의 부산판 수사 비리 사건을 파헤친 것은 저 추미애가 초선 시절이었다 부패 비리 정권을 엄호한 세력은 최순실 부역 집단 바로 새누리당이었다 부산판 수사 비리 주인공 이영복 회장이 다시 한번 해운대 분양비리로 불법 비자금을 조성해서 돈을 뿌렸다면 최순실 부역자당이 전적으로 연루가 되어 있을 것이다 부패는 부패를 낳고 그 뿌리를 더 키우는 것이다 박근혜 정권을 탄생시킨 공동정범이 바로 새누리당 아닌가 일부 언론이 엉터리처럼 그게 부산이니까 야당도 적당이 연루되어 있을 것기라는 언론공작 정치공작에 선동될 국민이 아니다 제가 여러분께 약속드린다 우리당 그 누구도 그런 부패 사건에 연루된 사람이 없다는 것을 그래서 정치공작 언론 공작에 흔들리지 말고 청와대에서 버티기하고 셀프 감금하면서 촛불 민심은 무서워 나와 보지도 못하는 박근혜 대통령이 건수 하나 물었다고 큰소리 치는데 피의자가 떵떵 거리다니 여러분 큰 함성으로 야유 한번 보내 달라 우병우는 구속하라 박근혜는 하야하라고 외쳐주시기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58999,2016-11-16, 박경미 대변인 오후 현안 브리핑 일시 시 분 장소 국회 정론관 엘시티 엄정수사를 지시한 박근혜 대통령 누가 누구를 엄단한다는 말인가 박근혜 대통령은 오늘 여야 정치인 등이 연루됐다는 엘시티 비리의혹 사건과 관련해 철저한 수사와 함께 관련자 엄단을 지시했다고 청와대가 밝혔다 엘시티 비리의혹 사건은 인허가 과정에서 많은 특혜와 뇌물 공여 의혹을 받고 있다 당연히 철저한 수사가 이루어져야 하며 여기에 연루된 인사가 있다면 지위고하를 막론하고 엄정한 법의 심판을 받아야 한다 그러나 국민의 퇴진 요구가 거센 상황에서 박근혜 대통령이 갑작스럽게 긴급 브리핑을 통해 철저한 수사와 연루자 엄단을 지시한 것은 어불성설이다 마치 정상적으로 국정을 수행하는 대통령처럼 법무부장관에게 지시를 내린 것은 가당찮다 전대미문의 국정농단 국기문란 사태로 검찰 조사에 응해야할 대통령이 누구를 엄단하라고 말할 자격이 있다는 말인가 또 당장 긴급 기자회견을 통해 자리에서 물러나겠다고 밝혀도 부족할 대통령이 누구에게 지시를 내린다는 말인가 박 대통령의 정치적 저의가 매우 의심스럽다 이런 정략적인 방식으로 정치권을 겁박하며 국정에 복귀하려는 것이라면 대단한 오판임을 분명히 지적한다 박 대통령은 엘시티 사건을 사정당국에 맡겨두고 검찰조사에 응해 자신에게 제기된 의혹에 대해서나 성실하게 답할 것을 엄중하게 촉구한다 박근혜 대통령은 추잡한 법정극 시청을 온 국민에게 강제하겠다는 것인가 청와대가 거세지는 국민의 퇴진 요구에 맞서 버티기를 장기화하려는 것 같다 청와대의 한 관계자가 어떻게 의혹만 갖고 대통령에게 내려오라고 할 수 있느냐 며 대통령은 헌법이 부여한 지켜야 할 책임이 있는 것이고 박 대통령은 목숨을 내놓고라도 지키겠다는 입장 이라고 주장했다고 한다 이를 뒷받침하듯 박근혜 대통령은 오늘 기습 작전하듯 긴급 브리핑을 통해 엘시티 비리의혹 사건과 관련해 철저한 수사와 함께 연루자 엄단을 지시했다 박근혜 최순실 게이트로 상상을 초월한 미증유의 막장을 보여준 것도 부족해서 후안무치의 끝판왕을 연출하려는 것인지 그저 기가 막힐 따름이다 청와대 전체가 주 연속 지지율과 만 촛불 민심 을 모르는 척 하자고 결의라도 한 것인지 궁금하다 관계자의 말처럼 의혹만 있는 것이라면 도대체 두 차례의 대국민 사과는 왜 했는가 검찰 수사에 성실하게 임하겠다던 약속은 어디 갔는가 게이트 관련 인물들의 구속수사 등은 왜 하고 있는가 검찰 고위 관계자마저 대통령이 자신의 범죄 혐의에 대한 심각성을 전혀 인지하지 못한 채 버티기를 하고 있다 고 안이한 상황 인식을 질타하고 있다 검찰은 박 대통령의 범죄 혐의가 이미 상당 부분 확인된 만큼 대통령이 계속 대면조사에 응하지 않는다면 검찰이 조사한 박 대통령의 연루 혐의를 모두 공개하는 방안을 검토 중이라고 한다 국민은 이미 박근혜 대통령에 대한 심판을 끝냈다 국민의 마음 속에 박 대통령은 더 이상 없다 그런데도 검찰과 진실 공방을 벌이며 추잡한 법정극을 온 국민이 억지로 시청하게 만들겠다는 말인가 단군 이래 최악의 국정농단 국기문란 사건의 몸통 박근혜 대통령은 더 이상 버틸 생각을 버리고 순순히 자리에서 물러나시기 바란다 화해치유재단은 위안부 피해자들에 대한 억 엔 현금 지급을 즉각 중단하라 화해치유재단이 일본정부로부터 받은 억 엔을 위안부 피해 할머니들에게 지급을 강행하고 있는 것으로 드러났다 박근혜 대통령에 대한 퇴진 요구가 빗발치는 상황에서도 한일 위안부 합의에 종지부를 찍겠다며 현금 지급으로 쐐기를 박고 있는 것이다 돈을 앞세워 피해 할머니들을 우롱하고 가슴에 대못을 박고 있다 졸속적이고 굴욕적인 한일 합의는 원천무효다 일본 정부의 공식 사과와 법적 배상이 이뤄져야 피해 할머니들의 명예 회복도 가능하고 철저한 진상규명과 책임자 처벌도 뒤따를 수 있다 그러나 문제의 핵심은 모두 빗겨간 채 억 엔에 일제의 반인륜적 범죄에 대한 모든 책임을 면해주겠다고 하니 어느 국민이 동의하겠는가 위안부 피해 할머니들이야말로 이러려고 년동안 수요 집회를 열었나 자괴감이 든다 고 가슴을 칠 일이다 박 대통령은 여성으로서의 사생활은 지켜달라고 말하면서 왜 같은 여성으로서 충분히 공감해야 할 위안부 피해자들의 고통은 철저히 외면하는가 반성도 하지 않는 일본에 면책을 주고 싶어 안달이 난 박근혜 정부는 대체 어느 나라 정부인가 화해치유재단은 일본정부의 끄나풀 노릇을 중단하고 일본으로부터 받은 억 엔의 현금 지급을 즉각 취소해야 한다 이미 박 대통령의 국정운영 동력 상실로 한일 합의의 기반과 실효성 자체가 흔들리고 있다 더 이상 일본군 위안부 피해자들의 눈에서 피눈물이 나게 하지 말라 대통령은 재벌 민원 들어주고 부당한 자금출연을 시켰나 지난해 월 말 박근혜 대통령이 개 그룹 총수들과 독대하기에 앞서 안종범 전 청와대 수석이 대기업들에게 각 그룹의 당면 현안을 정리한 자료 를 내도록 해서 받은 것으로 알려졌다 결국 기업들에게 민원을 들어주는 대가로 재단에 돈을 내게 했다는 것이다 이게 박근혜 정부 경제정책의 민낯이다 지난 년 동안 경제를 회생시켜야 한다며 펼쳤던 대기업 편중 정책의 이면에서 어떤 일이 벌어지고 있는지를 확인하며 참담함을 금할 수가 없다 노동개혁 이란 미명하에 노동자들에게 쉬운 해고와 저임금의 질 낮은 일자리를 그토록 가혹하게 강요하던 박근혜 정부가 밀실에서는 대기업들과 거래를 했다는 것 아닌가 검찰은 엄정하게 수사하여 대기업들이 미르 스포츠재단에 억 원의 출연금을 내고 과연 무엇과 맞바꾸었는지 낱낱이 밝혀내야 한다 대통령과 재벌 간에 이루어진 부당거래의 결과들을 제 자리로 돌려놓고 관련자들을 법의 심판대에 세워 응분의 죗값을 치르게 할 것을 엄중히 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58998,2016-11-16, 추미애 대표 박근혜 대통령 국민법정에 세우다 긴급 토론회 축사 일시 수 장소 의원회관 대회의실 추미애 대표 대통령이 국민의 법정에 서기 전에 먼저 하야 결단을 내려야한다 국민의 민심과 마음은 이미 대통령을 떠났다 대통령이 국민을 배신했기 때문에 국민도 대통령을 버릴 수밖에 없다 그래서 먼저 한번 씩씩하게 외쳐보자 국민의 명령이다 대통령은 하야하라 하야하지 않는다면 우리는 대통령을 법정에 세울 것이다 국민들은 이미 정치적으로는 대통령에게 탄핵이라는 최종 판결을 내린 것이나 진배가 없다 만 촛불은 오직 하나 박근혜 대통령은 즉각 하야하라 는 것이다 대통령이 국정을 빌미로 외치를 핑계로 국정 마비를 불러오니 내려오지 못하겠다 고 하야는 꿈도 꾸지 말라 고 하는 것이다 그리고 당신은 일찌감치 년 새누리당 대선 후보경선에서 최태민 게이트로 번질 뻔 했던 당시에 이미 한 역할을 했던 변호사를 선정하고 최종 단계에서 조사를 받겠다는 둥 서면 조사를 받겠다는 둥의 이야기를 하고 있다 최순실이 없는 자리에 변호사를 세워서 변호사가 시키는 대로 각본대로 한다면 국민의 울분을 잠재울 수 있겠는가 가장 먼저 대통령이 해야 할 일은 진상에 대한 대국민 사과이고 진실함과 진정성을 보이는 것이다 만약 그렇게 하지 않고 변호사를 세워서 얼버무리려고 하고 각본대로 조사에 응하는 척만 한다면 오늘 일 촛불의 민심은 전국적으로 들불처럼 번져 나갈 수밖에 없다 일을 더 키우는 대통령 혼란을 자초하는 대통령 국정을 농단하고 그 책임조차 지지 않는 대통령이 앞으로 더 은폐하지 못하도록 이미 드러난 사실만으로도 하야 사유 탄핵 사유가 충분하다는 것을 오늘 우리는 조목조목 밝힐 것이다 검찰은 어떻게 하든지 포괄적 뇌물죄만은 피하자고 하지만 포괄적 뇌물죄의 전례는 있었다 전두환 대통령에 대한 대법원의 확정 판결이 그랬다 오히려 그것보다 더 하면 더 했지 조금도 덜함이 없다 오늘 대통령의 간단한 범죄 혐의들에 대해 적용가능 한 실정법이 무엇인지 오늘 들어보면 이 엄청난 사실들을 여러분이 아시게 될 것이다 오늘 국민 법정에서 박근혜 대통령에 대해 엄정한 판결을 내려주실 것을 부탁드리며 민심이 이를 계기로 하여 순리대로 결자해지해서 평화롭고 순조로운 국정 정상화의 결단을 촉구하는 길을 열어주실 것이라고 기대한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58996,2016-11-16, 이재정 원내대변인 오후 현안 브리핑 일시 수 오후 시 분 장소 국회 정론관 박근혜 게이트 국정조사 특위 구성 관련 더불어민주당은 박근혜 정부의 최순실 등 민간인에 의한 국정농단 의혹 사건 규명을 위한 국정조사 특별위원회의 구성을 아래와 같이 결정했다 국정조사 특위 간사는 박범계 의원으로 하며 특위 위원으로는 도종환 손혜원 안민석 박영선 김한정 의원을 선정했다 특히 박영선 의원을 중심으로 재벌과의 정경유착관계를 김한정 의원을 중심으로 청와대 시스템과 관련한 진상규명을 집중적으로 실시할 것이다 이번 국정조사 특별위원회 위원들은 사안의 전문성과 연속성을 최우선을 했다 기존 당내의 박근혜 최순실 게이트 국민조사위원회 위원들을 중심으로 선정했다 더불어민주당은 향후 있을 국정조사를 통해 박근혜 게이트의 진상을 낱낱이 밝혀낼 것이다 권성동 법제사법위원장은 추호라도 청와대를 비호할 생각마라 오늘 국회 법제사법위원회 전체회의에서 박근혜 대통령 특검법의 상정이 예정되어 있다 여야가 합의한 특검법안이다 국민이 명령한 특검이다 권성동 법사위원장은 추호라도 청와대를 비호할 생각마라 오늘 특검법안이 국회 법사위에 상정되고 논의되어 내일 본회의까지 차질없이 통과된 후 즉시 시행되어야 한다 연일 계속되는 박근혜 게이트의 진상규명이야 말로 과거로 회귀하는 대한민국을 정상화 시킬 유일한 대안이라는 것을 권성동 위원장은 명심하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58993,2016-11-16, 박경미 대변인 오전 현안 브리핑 일시 시 분 장소 국회 정론관 길라임 대통령님 검찰조사 못 받겠다고 버티는 게 최선입니까 박근혜 대통령이 년부터 차움병원을 이용하며 드라마 시크릿가든 의 여주인공인 길라임 이라는 가명을 사용했고 병원의 시설을 맘대로 이용하면서 돈을 내지도 않은 채 융성한 식사대접까지 받았다고 한다 뿐만 아니라 최순실씨 자매가 박 대통령을 위해 대리처방으로 주사제를 받아갔고 대통령은 최씨의 이름을 빌려 혈액검사까지 한 정황이 포착되었다 뇌물죄 의료법 위반 등 죄목이 한두 가지가 아니다 더욱이 차병원은 지난 월 복지부로부터 체세포 복제배아 연구에 대해 조건부 승인을 받는 등 정부로부터 특혜를 받았다는 의혹을 사고 있다 이게 유영하 변호사가 말하던 여성으로서의 사생활이라는 말인가 막장도 이런 막장이 없다 박근혜 최순실 게이트는 여성이기에 앞서 국가원수로서 대통령직을 수행하며 일어난 사건이다 변명의 여지가 없다 이로써 검찰이 박근혜 대통령을 직접 조사해야 할 이유가 하나 더 추가되었다 시크릿가든 청와대와 길라임 대통령에 대해 성역 없는 수사를 촉구한다 허수아비 박근혜 대통령은 로데오 경기를 하고 있다 검찰이 정호성 전 비서관의 휴대전화에서 박근혜 대통령이 최순실씨를 최 선생님 으로 부르며 문건을 최씨에게 컨펌 받았는지 묻고 컨펌을 독촉한 문자메시지를 확보한 것으로 알려졌다 충격을 금할 수 없다 이것은 자문 정도가 아니라 아예 결재를 받은 것이다 대통령이 국정을 일개 민간인에게 결재 받아 운영했다니 그저 기가 막힐 뿐이다 결국 박근혜 대통령은 허수아비였음이 명명백백해졌다 무슨 말이 더 필요한가 이러고서도 국정을 계속 운영하겠다는 뜻을 굽히지 않으니 이제 국민들은 분노할 힘도 없다 대통령은 지금 로데오 경기를 하고 있는 셈이다 로데오 경기에서 소는 사람을 떨어트리려 하는데 사람은 떨어지지 않으려고 한다 그러나 종국에는 떨어질 수밖에 없다 여기서 중요한 것은 어떤 타이밍에 어떻게 떨어지느냐이다 박근혜 대통령은 더 이상 국민을 부끄럽게 하지 말고 즉각 자리에서 물러나야 한다 대통령이 국민에 대해 일말의 책임감이라도 느낀다면 언제 어떻게 떨어질 것인지 속히 결단해야 한다 대통령은 호위무사를 내세워 궤변으로 검찰조사를 피하려 하는가 박근혜 대통령의 변호인에 선임된 원조친박 호위무사 유영하 변호사가 국민의 분노에 기름을 부었다 유 변호사는 대통령이 임기 중에 수사나 재판을 받으면 국정이 마비되고 국론이 분열된다고 주장하는 한편 아직은 대통령을 조사할 때가 아니며 설령 조사를 하더라도 서면조사 가 바람직하다고 발언했다 서면조사는 당사자의 일방적인 해명문 이 될 수도 있으므로 헌법유린과 국정농단으로 점철된 이번 사건의 조사 방식으로는 부적절하다 유 변호사는 선의 주변사람 관리 못했다 등 박 대통령의 발언을 거론했는데 범죄 혐의를 부인하고 수사의 가이드라인을 제시하는 것으로밖에 볼 수 없다 지금까지 드러난 박 대통령의 혐의는 하나 둘이 아니며 혐의 자체도 헌정 사상 유례를 찾을 수 없는 황당한 것들이다 오만불손하고 당당한 유 변호사를 내세워 해괴한 궤변을 늘어놓으며 검찰수사를 피하려 하는 모습을 보니 박 대통령은 이번 사태의 무게와 헌정사적 의미 그리고 국민들의 깊은 분노를 전혀 인지하지 못하는 것 같다 주 연속 지지율과 만 촛불 민심 에서 보듯 국론은 한 곳으로 모여 있다 유영하 변호사와 같은 극소수의 친박을 끌어 모아 국민과 일전을 벌이려는 대통령의 불가사의한 행태를 국민들은 더 이상 좌시하지 않을 것이다 안봉근 이재만 혐의 없다는 검찰 벌써 꼬리 내리나 최순실 게이트를 수사 중인 검찰이 안봉근 이재만 전 비서관의 공무상 비밀누설 혐의에 대해 수사했지만 뚜렷한 혐의점을 찾지 못했다고 밝혔다 대통령의 수족처럼 움직여온 두 사람이 전대미문의 국정농단 사태에서 고작 문서 유출만 관여했을 것으로 판단하고 수사를 하고 있다는 것인지 개탄스럽다 검찰이 지금까지의 관성을 벗어버리지 못하고 슬그머니 권력의 서슬에 꼬리를 내리고 부실수사를 한다면 민심의 역풍을 맞을 것이다 증거인멸 지침까지 짜맞춘 대응 시나리오대로 대통령이 움직이고 있는 상황에서 검찰은 늑장 수사를 하고도 모자라 그 의지를 의심받을 만큼 수사에 미온적이다 검찰은 똑바로 수사하라 국민들이 두 눈 뜨고 지켜보고 계시고 또한 특검이 기다리고 있다 검찰은 허술한 수사로 인해 국정농단 사태의 공범으로 전락하지 말고 국민의 뜻을 받들어 엄정하게 수사할 것을 다시 한 번 촉구한다 정진석 원내대표는 자신이 야당 원내대표라고 생각하는가 정진석 새누리당 원내대표가 어제 우리당 문재인 전 대표의 대국민 기자회견에 대해 질서 있는 국정 수습은 걷어차 버리고 나라의 혼란만 부추겨 대한민국을 아노미 상태로 빠트릴 작정이냐 면서 지금 대통령이 다된 줄 착각하고 있다 고 맹비난했다 지금 누가 누구를 비난하는 것인가 현 사태에 대해 새누리당이 무슨 할 말이 있단 말인가 온 국민이 대통령에게 물러나라고 외치고 있는데 새누리당이 야권의 유력 대선주자를 공격하며 상황을 호도하고 있으니 적반하장도 이런 적반하장이 없다 새누리당은 질서 있는 국정 수습 을 말할 자격이 없다 당 대표가 단식을 하고 최순실 게이트 연루자들의 국회 증인 채택을 방해하며 국회의 진상조사를 가로막지 않았는가 대한민국을 아노미 상태로 빠뜨리고 있는 것은 박근혜 대통령과 새누리당이다 새누리당은 전대미문의 국정농단을 방조함으로써 공범이 되었고 그 진상규명까지 방탄했다 이 엄청난 반역사적 반헌법적 범죄에 대해 사죄하고 또 사죄해도 부족할 판이다 새누리당은 더 이상 사태의 본질을 호도하지 말고 막말을 일삼는 당대표와 원내대표부터 물러나게 하는 것이 국민에 대한 최소한의 예의를 갖추는 것임을 충고한다 최고위원회의 결과 더불어민주당은 박근혜 대통령의 퇴진을 요구하는 민심을 준엄하게 받들어 거당적 차원의 퇴진운동을 벌이기 위해 박근혜 대통령 퇴진 국민주권운동본부 를 설치했다 위원장은 추미애 대표가 맡기로 했으며 활동시한은 박근혜 대통령 퇴진 시까지로 했다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58985,2016-11-16, 추미애 대표 박근혜 대통령 퇴진 국민주권운동본부 현판식 인사말 일시 수 오전 시 분 장소 국회 당대표 회의실 앞 추미애 대표 오늘 박근혜 대통령의 퇴진을 촉구하는 국민주권운동본부를 출발한다 앞으로 전국 각지에서 시 도당이 중심이 되어 박근혜 대통령 퇴진 운동을 전개해 나갈 것이다 사상 초유로 대통령이 몸통이 돼서 직접 헌정질서를 파괴시켰다 국민이 대통령에게 부여한 헌법상의 권한을 회수하기 위한 국민주권확립운동의 출발이 될 것이다 평화롭고 순조로운 국권회수운동을 통해서 국정정상화의 길을 열고 민주정부 민주공화국을 수립하는 기틀을 잡아나가겠다 공정하고 정의로운 우리 국민이 바라는 세상을 열겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58984,2016-11-16, 제 차 최고위원회의 모두발언 일시 수 장소 국회 당대표 회의실 추미애 대표 오늘은 원래 박근혜 대통령에 대한 검찰 조사가 예정된 날이었다 그런데 어제 대통령의 변호인이 수사 정리 시점에 가서 조사를 받겠다고 입장을 표명했다 주객이 전도된 상황이다 헌정 최대 게이트의 몸통이 된 대통령이 수사를 받지 않았는데 어떻게 수사가 정리가 될 수가 있는가 날마다 새로운 의혹이 터져 나오는 상황에서 어떻게 서면조사로 조사를 하고 또 최소화하라는 주장을 할 수 있는가 대통령의 상황인식이 너무도 참담한 수준이다 이미 국민들은 대통령이 증거인멸 지침까지 짜 맞춘 대응 시나리오대로 움직이고 있다는 것을 다 알고 있다 대통령만큼이나 검찰의 문제도 심각하다 사건의 곁가지 파악을 통한 증거 수집은 어느 정도 진행이 되지 않았겠는가 왜 아직 우병우를 구속수사하지 않는가 대통령 눈치를 보고 있는가 우리당 의원들이 벌써 열흘이 넘도록 검찰청 앞에서 우병우 구속수사하라 고 촉구하는 농성을 진행하고 있다 지나가는 시민들이 격려로 음료수도 주시고 간식도 주셨다 국민들이 마음으로 함께하고 있는 것을 어제 제가 가서 봤다 국민들의 울분이 쌓이고 폭발할 때까지 뜸을 들일 것인가 조속히 우병우를 구속하라 내일은 국회 본회의에서 박근혜 최순실 국정농단 특검을 통과시킬 것이다 더 이상 권력의 눈치를 보는 검찰에게 이 엄중한 수사를 맡길 수 없다는 것이 국민의 준엄한 요구이다 당내에는 박근혜 퇴진 국민주권운동본부를 설치하여 긴밀한 대응 체계를 갖춰 나가겠다 더불어민주당은 만 촛불과 만 민심과 한 배를 타고 난국을 헤쳐 나가겠다 우상호 원내대표 어제 대통령 변호인의 말씀은 대통령이 검찰조사를 안 받겠다는 소리다 어려운 이야기가 아니다 어차피 나중에 특검 조사를 받을 건데 검찰조사는 안 받겠다는 소리다 이정현 대표가 자기당내 비박계 대선주자들이 도 지지율이 안 되는데 왜 떠드느냐고 독설을 퍼부었다 이것은 분당하자는 통첩으로 보인다 대통령과 대통령 변호인의 태도 그리고 이를 대변하는 이정현 새누리당 대표의 독설에는 유사성이 있다 촛불을 정면으로 거역하고 싸워보겠다는 것이다 검찰 조사를 받겠다는 자신의 말도 번복하면서 또 잠시 몸을 낮추듯 도망 다니던 이정현 대표까지 정면으로 국민과 맞서 싸우겠다는 의사 표현으로 보인다 이런 식으로 나오신다면 국민과의 일대 결전이 불가피해 보인다 상황 판단에 큰 오판을 한 것이라고 생각한다 이제 검찰이 결단해야 한다 국민과 맞서서 정면 돌파를 하려고 하는 이 정권에 굴종할 것인가 아니면 제대로 된 진상규명을 위해서 할 일을 하라고 하는 국민의 목소리에 귀를 기울일 것인가 이 두 가지 사이에 절충은 불가하다 저는 오늘내일 중에 이 문제에 대한 검찰 태도가 결정된다고 본다 내일까지 조사를 안 하면 사실상 대통령과 관련된 혐의가 기소장에 들어갈 수 없다 시간을 끌 문제가 아니다 대통령과 이정현 새누리당 대표에게 경고한다 이 나라를 얼마나 혼란스럽게 끌고 가려고 이렇게 말도 안 되는 오기 아집 정면 돌파의 태도를 보일 수 있는가 뭘 잘했다고 이런 식의 방향을 잡을 수 있단 말인가 야당은 결코 이 문제를 좌시하지 않을 것이다 이런 식으로 나가면 박근혜 대통령의 퇴임 후 안전도 보장할 수 없다고 경고한다 특검에 대해서 여야가 합의한지 하루 밖에 안 지났는데 새누리당 소속 법사위원들이 이 법안을 통과시키지 않으려고 하는 기류가 나타났다 이건 또 뭔가 경고한다 평상시가 아니다 민심을 거역하면 거대한 심판을 받게 되어있다 두려워할 줄 알아야 한다 오늘 하루 새누리당 소속 법사위원들의 태도를 지켜보겠다 어제오늘 사이에 여권 전체의 기류가 변화한 것은 아닌지 진심으로 걱정된다 이 문제에 대해서 오늘은 경고하는 수준에서 말씀드리지만 만약 이것이 기정사실화된다면 더불어민주당은 대응수위를 더욱 높여 나가겠다 국가를 생각한다면 이런 식으로 나와서는 안 된다 양향자 최고위원 학년도 대입 수능시험이 내일이다 대한민국 모든 수험생들을 더불어민주당이 응원한다 지난 주말에 서울 도심에서 열린 집회에는 수능을 앞둔 수험생들도 많이 참여했다고 한다 어떤 수험생은 방송 인터뷰에서 고 이지만 수능시험보다 나라가 더 걱정이다 이렇게 불공평한 나라에서 공부를 열심히 해서 뭐하냐는 생각이 든다 고 말했다 우리 역사 속에서 독재자에게 항거하는 혁명이 격렬해질 때 항상 청소년들이 있었다 그 옛날 혁명의 현장에도 청소년들이 나섰고 광주민주화운동의 금남로 거리에도 어린 학생들이 있었다 그런데 최순실 게이트에 분노한 요즘 청소년들의 외침은 과거 그것과는 또 다른 차원의 깊고 뜨거운 분노이다 최순실의 국정농단과 이권개입 그리고 그 딸인 정유라의 학사부정 입시부정은 우리 청소년들에게도 좌절감을 불러일으켰고 이렇게 불공평한 사회라면 열심히 공부할 필요가 없다는 허무감까지 갖게 만들었다 어제는 또 년도 입시에서 정유라를 합격시키기 위해 상위권 응시생 명에게 낙제점을 주어 탈락시켰다는 보도가 나왔다 저들이 누린 특권과 반칙 그 뻔뻔함에 경악을 금할 수 없다 박근혜 최순실 게이트가 이제 막 꿈을 키울 학생들에게까지 영향을 미치고 있다는 사실에 분노하며 정치인으로서 학부모로서 또 선배로서 너무도 미안하다 우리 청소년들에게 꼭 약속드리고 싶다 지금까지 더불어민주당 의원들이 박근혜 최순실의 비리의혹을 꾸준히 밝혀왔던 것처럼 국민의 뜻과 더불어 이 무리한 정권을 기필코 퇴진시키겠다고 약속드린다 정권교체를 넘어 시대교체와 세력교체 근본적인 사회대개조를 이루겠다 단지 정권을 바꾸는 것을 넘어 이 사회의 주류를 정의로운 이들로 교체해서 특권 편법 반칙이 통하지 않고 열심히 공부하면 꿈을 이룰 수 있는 사회 신분이나 재력으로 차별받지 않는 사회 정정당당한 사람들이 성공하는 사회로 다시 만들겠다 광화문 거리에서 만난 청소년들의 함성을 기억하며 박근혜 대통령이 역사의 심판을 받을 그날까지 우리당이 앞장설 것이다 김병관 최고위원 지난 주말 서울 도심을 촛불로 밝힌 백만의 목소리는 박근혜 대통령의 퇴진이었다 박근혜 대통령은 이제 물러나셔야 한다 민심의 바다 그 중심에 청년들이 있었다 그동안 청년을 버려둔 박근혜 정부에 대해서 분노를 표출할 시간도 없이 쫓기는 삶을 살았던 청년들이 집단적으로 목소리를 내고 행동하기 시작했다 주말에 친구들과 놀고 싶은 중학생들 수능을 일주일도 남기지 않은 고등학생들 스펙 쌓기 아르바이트 내몰리고 있는 대학생들 하루라도 쉬고 싶은 젊은 직장인들이 거리로 나선 이유는 단 하나이다 박근혜 정부의 국정농단으로 나라의 미래 청년의 미래가 없다고 판단했기 때문이다 노력하면 된다는 단순한 희망조차 비선실세 자녀에 대한 각종 특혜 제공과 그것을 당연하게 여겼던 그 딸의 조롱 섞인 말에 의해서 산산이 부서졌기 때문이다 그런 청년들에게 박근혜 대통령은 중동으로 가라고 했다 이것도 최순실의 작품이 아닌지 의심이 된다 청년들은 중동으로 가는 대신 거리로 나왔다 최소한의 희망도 가지지 못하는 청년들이 거리에서 스스로 희망의 촛불을 밝혔다 거리로 나선 학생과 청년들의 명쾌한 발언과 노래 춤 등 다양한 퍼포먼슬 통해서 더욱 생동감 넘치는 집회가 이뤄졌다 집회가 평화롭게 이어지는데도 기여했다 분노하고 절망하는 국민들이 청년들의 참여를 보면서 희망을 찾고 있다 청년에게 희망을 줘야할 선배로서 많이 부끄럽다 혁명과 년 광주 민주화항쟁 그리고 년 월 항쟁의 역사 한가운데에는 우리 청년들이 희망의 역사를 만들었다 그리고 이제 청년들이 또다시 새로운 희망을 만들어가려고 한다 더불어민주당 청년위원회도 함께 가겠다 함께 새로운 역사화 희망을 만들어가겠다 년 우리 선배들이 민주화를 외쳤다 지금 년 다시 민주정부수립을 외치고 있다 우리 더불어민주당과 청년위원회는 반드시 민주정부 수립을 쟁취에 내겠다 내일 수능이 있다 대한민국 수험생 여러분들 시험을 잘 보시고 무엇보다 학부모님들 고생 많으셨다 김민석 특보단장 야 당과 시민사회의 공조에 의한 퇴진운동이 이제 본격적으로 시작될 시점이다 야 당과 시민사회의 공조가 본격화되기 전에 한 가지 정리될 일이 있다 대통령과의 회담을 당내 의원들의 의견과 시민사회의 제언 그리고 다른 야당의 의견을 들어서 당이 철회하는 과정에서 추미애 대표께서 양해를 구하기도 하셨다 그런데 제 야당인 국민의당 박지원 대표께서 그 과정을 놓고 우리당내에 며칠 간 청와대에 한광옥 실장과 영수회담을 추진한 비선 라인이 있다고 하면서 입에 담기 조금 어려운 표현을 쓰셨다 게다가 그러한 잘못된 정보가 당내에 유포되어 의원들 간에도 전달된 것으로 알고 있다 박지원 대표께서는 국민당의 당의 대표이시지만 민주당의 상임고문은 아니시지 않는가 게다가 어떤 분이 현재 민주당의 비선실세인지 저도 궁금하다 정치를 오래하신 박지원 대표님께서 그런 표현을 써서 특정인을 키워주시려고 하는지도 조금 궁금하다 정중하게 요청 드린다 지금은 야권 공조 회복을 통해서 민주정부 수립을 위한 촛불 민심을 받들어야 할 때이다 박지원 대표께 정중히 요청 드린다 알고계신 것이 있다면 소상하게 밝혀주시고 근거가 없으면 정중하게 사과해주시기 바란다 그것이 공조를 해야 할 당이자 책임 있는 제 야당인 민주당이라는 정당과 그리고 추미애 대표와 그 당에 속한 의원들에게 대한 최소한의 예의이자 이 문제 때문에 혼란을 겪고 있는 국민들께 대한 도리가 아닐까 생각한다 차제에 한 가지 더 요청 드린다면 어차피 야권 공조의 끝은 민주정부 수립이다 그래서 김대중 대통령을 오래 함께 모셨고 비록 박지원 대표께서는 최종적으로 다른 선택을 하셨지만 야권 대통합의 의지를 함께 나눴었다 그리고 민주정부 수립을 위해 함께 하고 있다고 믿고 있는 후배로서 그리고 민주당의 특보단장으로서 이참에 제안 드린다 더 확실한 야권 공조의 끝인 야권 대통합의 의지를 함께 한다면 이런 소소한 문제로 야권이 혼선을 겪는 일은 없을 것이다 다시 한 번 정중한 사과 그리고 자체에 야권공조를 뛰어넘는 야권대통합의 의지를 밝혀주실 것을 요청 드린다 존경하는 박지원 대표께서 이 문제로 인해 야권 공조를 이뤄 가는데 설마 걸림돌을 만드시지는 않을 것으로 믿고 기대한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58983,2016-11-16, 이재정 원내대변인 오전 현안 브리핑 일시 수 오전 시 분 장소 국회 정론관 헌법정신 운운하는 대통령과 청와대 검찰은 하루속히 대통령 소환조사하라 박근혜 대통령의 변호를 맡은 유영하 변호사는 박 대통령에 대한 검찰조사 시점과 관련하여 모든 의혹이 정리되는 시점에 수사가 이루어져야 한다고 주장했다 대통령이 임기 중 수사와 재판을 받으면 국정이 마비되고 국론이 분열되는 상황이 예상되기 때문에 직무수행에 지장이 안 되도록 하는 것이 헌법정신에 부합한다는 것이다 대한민국 헌법정신을 유린한 대통령이다 대통령도 청와대도 그 변호인도 감히 헌법정신을 운운할 자격이 없다 스스로 파괴한 법과 원칙을 이제 와서 국정 마비와 국론 분열을 막아야 한다는 명목으로 끌어다 붙이는 파렴치함에 국민은 치가 떨릴 지경이다 최순실과 차은택의 기소가 목전에 있는 상황에서 이번 게이트의 몸통인 박근혜 대통령에 대한 검찰조사가 늦춰질 수 없다 이미 밝혀진 대응문건에 따른 시나리오를 완비하지 않았는가 대통령의 대국민 사과와 각종 관계자의 증언들 모두 증거인멸을 향해 가고 있다 검찰은 법치주의에 따라 하루속히 대통령을 소환조사하라 헌법정신 유린의 주범은 박근혜 대통령이다 국민에 대한 일말의 존중이라도 남아있다면 박근혜 대통령에게 남은 선택지는 퇴진뿐이다 국민 울고 웃고 화내게 만드는 이상한 대통령과 시크릿 청와대 국민 모두를 망연자실하게 만들고 있는 한 편의 막장 드라마만도 못한 박근혜 게이트 사건이 점입가경이다 국가 안보와 다름없는 대통령의 혈액이 최순실로 인해 외부 병원으로 유출되어 검사되고 정유라 한 명을 합격시키기 위해 상위권 학생 명에게 낙제점을 주는가 하면 천억원에 달하는 제 의 미르재단을 만들려고 했던 정황까지 나타났다 무엇보다 국민들이 어이없는 조소를 보냈던 것은 일국의 대통령이 가명으로 병원치료를 받는데 드라마 여주인공 이름을 썼다는 것이다 박근혜 대통령은 국민들을 화나게만 하기에는 미안했나보다 이상한 대통령과 시크릿 청와대가 만든 막장드라마를 국민들은 더 이상 지켜보기 힘들다 시청률 낮은 드라마가 조기종영하듯이 대통령은 민의를 잘 보시고 스스로 퇴진을 결정하기 바란다 가습기 살균제 피해 국가에도 책임 있다 돌잔치도 못하고 보낸 딸에게 판결문이라도 갖다 주고 싶어 여기까지 왔다 가습기 살균제로 어린 딸을 보낸 아비의 회한서린 한마디였다 어제 법원은 처음으로 가습기 살균제 피해에 대한 제조업체 배상 책임을 인정했다 당연한 귀결이다 하지만 국가의 배상 책임은 인정되지 않았다 국가의 철저한 관리감독 의무가 철저히 이루어졌더라면 일어나지 않았을 비극이다 국가는 그 의무를 다하지 않은 책임을 져야만 한다 재판부는 책임을 입증할 자료가 부족하다는 입장이지만 그 책임은 자료로 입증할 것이 아니다 세상을 떠난 피해자들과 여전히 고통 받고 있는 유가족들이 곧 그 책임의 근거임을 외면해서는 안 될 것이다 더불어민주당은 외면하지 않겠다 현재진행형인 피해자들의 아픔을 위로하고 철저한 재발 방지 대책 마련을 위해서 모든 노력을 다할 것이다 퍼주기로 일관한 한일군사정보보호협정 당장 중단하라 박근혜정부의 불통행보가 대한민국 안보까지 위협하고 있다 받을 건 없고 퍼주기만 하는 한일군사보호협정은 결국 군사대국을 꿈꾸는 아베 일본정부의 우경화에날개를 달아주는 꼴이 될 것이다 연일 북한 핵과 잠수함에 대한 위험만을 강조하는 국방부는 정작 이번 협정으로 이런 위협이 상쇄될 수 있는지에 대해서는 제대로 확신하지 못하고 있다 이명박 정부는 대강과 자원외교로 재벌대기업과 해외에 혈세를 퍼주더니 박근혜 정부는 졸속 위안부합의와 한일군사정보보호협정으로 일본의 군국주의 망령을 되살리려 하고 있다 이번 협정은 국민 누구도 동의할 수 없다 더 큰 민심의 이반이 생기기 전에 당장 중단하고 국민의 목소리를 청취할 것을 촉구한다 수능시험 하루 앞둔 대한민국 수험생 모두와 학부모님들을 응원합니다 전국 만 수험생 여러분 아침식사를 꼭 거르지 말고 너무 늦지 않게 고사장에 도착해야 합니다 추운 날씨에 대비해 따뜻한 옷차림도 좋지만 너무 과한 옷차림은 오히려 방해가 됩니다 너무 긴장하지 말고 쉬는 시간 틈틈이 가벼운 스트레칭으로 몸을 풀어주시고 초등학교 년 중학교 년 고등학교 년 지난 년간 여러분이 공부해왔던 것을 차분히 생각하세요 여러분의 노력이 꽃을 피우는 날이 되길 기원합니다 그리고 여러분과 늘 함께 해주신 부모님께 꼭 사랑한다고 말씀해주세요 대한민국 수험생 모두와 학부모님들 모두를 응원합니다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58981,2016-11-15, 박경미 대변인 오후 현안 추가 브리핑 일시 시 분 장소 국회 정론관 만 촛불과 지지율의 뜻을 이정현 대표는 아직도 모르는가 오늘 새누리당 이정현 대표는 최순실 국정농단 사태로 박 대통령 지지율이 까지 하락한 것에 대해 박근혜 대통령의 노력에 따라 회복될 수 있다 고 말했다 또 이정현 대표는 자신에 대한 당내외의 사퇴 요구에 대해 신경질적인 반응을 보이며 합쳐서 도 안 되는 대권주자들은 말도 꺼내지 말라 고 윽박질렀다 그 대통령에 그 대표 라는 말밖에 떠오르지 않는다 꽉 막힌 독불장군식 일방통행과 불통 어쩌면 하나에서 열까지 그렇게도 닮았다는 말인가 시간이 지나면 박 대통령의 지지율이 회복될 것이라는 기대는 현재의 사태 또한 시간에 따라 유야무야될 것이라는 믿음이 아니겠는가 이 또한 지나가리라 는 생각이라면 현 시국의 엄중함과 폭발 직전의 민의를 한참 오판한 것이다 비선실세 국정농단 사태는 반드시 그 죗값을 치러야 하는 실체가 있는 범죄이다 대통령 지지율 또한 더 이상 대통령으로 인정할 수 없다는 국민의 최후통첩이다 아무리 청와대와 새누리당이 간절히 바란다고 해도 이미 떠나간 민심은 돌아오지 않는다 박근혜 대통령의 퇴진 이외에 정국 정상화의 해법은 없다 이정현 대표 또한 자신에 대한 사퇴 요구가 날로 높아지고 있음을 직시해야 한다 영화 내부자들 의 대사 어차피 대중들은 개돼지입니다 적당히 짖어대다가 알아서 조용해질 겁니다 를 떠올렸다면 한참 오산이라는 것을 분명하게 지적한다 국민의 가습기 살균제 피해 국가가 끝까지 책임져야 한다 가습기 살균제 사용으로 인한 피해를 인정하는 법원의 첫 판결이 나왔다 법원이 가습기 살균제 피해 사실을 인정하며 제조업체에 대한 배상 책임을 인정한 것은 지당한 판결이다 그러나 증거가 부족하다는 이유로 국가의 배상 책임을 인정하지 않은 것은 반쪽짜리 판결로 유감스럽다 또한 이번 가습기 살균제 피해보상 판결로 인해 손해배상을 해야 할 제조업체 세퓨 는 이미 없어져 보상을 받을 길이 없다 가습기 살균제 피해자들의 아픔은 현재 진행형이다 국민의 안전을 최우선으로 책임져야 할 국가가 이미 파산해 보상이 불가능한 제조업체의 책임만 확인하며 적당히 넘어간다면 피해자들은 도대체 어디에 호소해야 한다는 말인가 더불어민주당은 가습기 살균제 피해에 대해서 국가가 무한 책임을 져야 한다는 점을 다시 한 번 강조한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58980,2016-11-15, 기동민 원내대변인 오후 현안 서면 브리핑 박근혜 대통령의 검찰조사 연기 요청은 일고의 가치도 없다 박근혜 대통령의 검찰조사 연기요청은 조사를 회피하고 최순실과 문고리 인방 등 측근 보호를 위한 꼼수일 뿐이다 검찰이 일방적으로 일정을 통보했다 며 불평을 늘어놓는 모습에서 성실히 수사받겠다 는 대통령의 사과가 한낱 위기모면용 에 불과했다는 것이 드러났다 선의로 했다 서면조사 운운하는 것 또한 아직도 자신의 죄가 무엇인지 국민한테 무엇을 사죄해야 하는지 모른다는 사실을 보여준다 대통령은 초 사과 분 재사과 분 회동 에서 한 발짝도 나아가지 못했다 수사 하루 전에 진박 유영하씨를 변호사로 임명한 것 또한 국민의 분노와 절규를 한낱 정치 싸움으로 몰고 가겠다는 저열한 수작에 불과하다 대통령은 국민을 그만 우롱하시고 검찰 수사에나 성실히 임하시라 검찰에도 경고한다 시작도 하기 전에 조사 연기 시한부 기소중지 를 검토하는 것은 부실수사를 하겠다는 의지 표명이나 다름이 없다 성실하고 성역 없는 수사 없이 이명박 전 대통령에 대한 곰탕수사 를 재현한다면 국민은 이를 좌시하지 않을 것이다 청와대 출장소 부소장 정진석 원내대표는 자기반성 부터 해라 새누리당 정진석 원내대표의 후안무치 에 말문이 막힌다 청와대 출장소 부소장 역할을 해온 것도 모자라 이젠 정치인으로서 최소한의 체면마저 잃었는가 정 대표는 촛불민심이 답이 아닌 문제를 던졌다고 말했다 틀렸다 박근혜 최순실 게이트 로 국정은 파탄 났고 광장을 메운 만 시민은 박근혜 퇴진 과 새누리당 해체 란 답을 내놨다 그것이 민심이다 정 대표는 통렬한 반성은커녕 대통령 하야는 헌정파괴 노무현 만 달러 추미애 사실상 불신임 등 국민과 야당에 대한 막말만 일삼고 있다 그럴수록 집권여당의 초라한 현실만 드러날 뿐이다 막말 그만하시고 국민의 뜻을 받들어 조속히 퇴진하시라 자당 의원들조차 이정현 정진석 두 분의 사퇴를 촉구하고 있지 않은가 야당 헐뜯기 설익은 개헌론 으로 대충 넘어갈 생각은 꿈도 꾸지 마라 국민의 뜻을 겸허히 받드는 것이 최소한의 도리임을 잊지 말아야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58976,2016-11-15, 박경미 대변인 오후 현안 브리핑 일시 시 분 장소 국회 정론관 청와대는 호위무사 앞세워 검찰 조사 빠져나가려는 것인가 청와대가 박근혜 대통령의 변호인으로 선임한 유영하 변호사가 조금 전 선임계를 제출했다 유영하 변호사는 년 한나라당 대선후보 경선 당시 박근혜 캠프의 법률지원단장을 지낸 진박 중 진박 으로 평가된다 당시 이명박 후보 측이 제기한 각종 의혹에 맞서 네거티브 대응 핵심역할을 담당해 호위무사 로 불렸다 유 변호사는 네거티브가 전문인 호위무사 답게 대통령의 의혹과 검찰 수사에 대해 공격적으로 답했다 유 변호사는 박 대통령이 선의로 추진한 일이었고 긍정적 효과가 적지 않았음에도 이런 일이 일어나 가슴 아파하고 있다 고 주장했다 박 대통령이 여전히 변명으로 일관하며 진실을 호도하고 있다니 그저 기가 막힐 뿐이다 손바닥으로 하늘을 가리려는 대통령의 행태에 개탄을 금할 수 없다 유 변호사는 건건이 조사받는 것은 국정수행에 부담이 될 것이라며 검찰 수사가 마무리되는 시점에서 조사하는게 타당하다고 주장했다 조사를 미뤄달라 조사는 최소화해야한다 는 유 변호사의 주장을 들으며 대통령이 성실하게 조사 받을 의지는 있는지 의심스럽다 유 변호사는 대통령 이전에 여성으로서의 사생활도 있다 고 말했다 대통령 이전에 여성으로서의 사생활이 구체적으로 무엇인지 해명해야 한다 청와대는 검찰 조사를 지연시켜 검찰의 책임 추궁에서 빠져나갈 묘수라도 찾으려는 것인가 필요하다면 검찰 수사에 성실하게 임할 각오 라던 대통령의 사과는 결국 국민의 비판을 잠시 피하려는 새빨간 거짓말임이 분명해졌다 여전히 대통령으로서의 책임을 다하겠다 는 대통령이 정작 자신에게 요구되는 책임은 외면하고 있는 것은 후안무치의 극치이다 박근혜 대통령은 검찰의 법망을 빠져나갈 궁리를 하지 말고 검찰 조사에 적극 협조하고 물러나라는 국민의 요구에 하루빨리 답하기 바란다 박근혜 대통령 국민법정에 서다 긴급토론회 더불어민주당은 내일 오후 박근혜 대통령 국민법정에 서다 긴급토론회를 개최해 박근혜 대통령이 자행한 국헌문란 행위의 실체를 규명하고 법적 책임을 철저히 추궁한다 이번 토론회는 박근혜 최순실 게이트 에서 노정된 대통령 차원의 국헌문란 행위의 실체를 낱낱이 규명하기 위해 마련됐다 또한 미증유의 대통령직 사유화에 따른 헌법가치 파탄과 그 형법적 책임을 기탄없이 따져 묻는 자리가 될 것으로 예상된다 토론회는 조국 서울대 교수 박명림 연세대 교수 임지봉 서강대 교수 하태훈 고려대 교수 정연순 민주사회를 위한 변호사 모임 회장이 참여하며 사회는 박범계 의원이 맡는다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58974,2016-11-15, 박경미 대변인 오전 현안 브리핑 일시 시 분 장소 국회 정론관 박근혜 대통령은 물러나라 는 국민의 요구에 답하라 정연국 청와대 대변인이 오늘 하야나 퇴진의 가능성을 묻는 기자의 질문에 대해 지켜보시라 고 했다가 그건 아니다 정국 정상화를 위한 후속조치 모든 가능성을 열어놓고 고심하고 있다 라고 정정했다 박근혜 대통령이 하야하거나 퇴진할 생각이 여전히 없음을 다시 한 번 밝힌 것으로 보인다 천만이 시위해도 절대 안 물러날 것 이라는 김종필 전 국무총리의 발언이 맞는 것 같다 더욱이 박 대통령은 자신의 거취에 대해서 일언반구 언급도 없다 국민이 뽑은 대통령이 국민의 물음에 답하기를 거부하고 있는 것이다 지난 주말 광화문 광장에 모인 백만의 촛불 민심 무너진 민주주의를 바로 세우자는 주권자들의 도도한 함성이 청와대에 전해지지 않은 모양이다 국민들의 마음속에서 박 대통령은 더 이상 대통령이 아니다 작금의 사태는 헌법과 법률이 정한 책무를 방기하고 비선실세의 국정농단을 방조해 국정을 파탄에 이르게 한 대통령이 자초한 일이다 대통령의 퇴진을 빼고 정국을 정상화할 수 있는 방법은 없다 대통령이 자리를 보전할수록 국정은 더욱 마비되고 혼란에 빠지게 되기 때문이다 박 대통령이 스스로 내려오기를 거부한다면 국민의 분노는 더욱 활화산처럼 타오를 것임을 엄중하게 경고한다 더불어민주당은 국민의 엄중한 민의를 받들어 박근혜 대통령의 퇴진을 위해 진력을 다할 것임을 분명하게 천명한다 증거인멸 시나리오 청와대는 범죄 공모와 은폐의 복마전이었다 청와대가 검찰 수사에 종합적으로 대응하기 위해 시나리오를 만들었다는 보도가 나와 국민을 또 한 번 충격에 빠뜨리고 있다 보도에 따르면 시나리오는 이번 사태의 결정적인 증거물인 태블릿 보도가 나오기 일주일 전에 작성됐으며 증거인멸 내용까지 구체적으로 담겨 있다고 한다 또 박근혜 대통령은 실제 이 지침을 충실하게 따른 것으로 확인됐다는 것이다 국정의 사령탑인 청와대가 범죄 공모와 은폐의 복마전으로 전락했다 필요하다면 검찰 조사에 성실하게 임할 각오 라던 대통령의 대국민사과가 이 시나리오에 기반해서 나온 것이라면 국민은 두 번 속은 것이다 박 대통령은 얼마나 더 국민을 기만하고 우롱할 것인가 여전히 자신의 잘못을 감추고 국민을 속이려는 대통령에게 더 이상 그 무엇도 기대할 수 없음이 분명해졌다 더욱이 시나리오의 작성을 대통령이 지시했다는 의혹에는 분노를 금할 수 없다 대통령은 이번 사태의 몸통이다 성역 없는 수사 가 아니라 성역을 정조준한 수사 가 필요하다 대통령에 대해서 피의자에 준하는 조사가 엄정하고 철저하게 이루어질 것을 다시 한 번 촉구한다 우병우 전 민정수석에 대한 구속수사는 선택이 아닌 필수다 검찰은 우병우 전 민정수석을 곧 재소환할 방침인 것으로 알려졌다 그 다음 수순은 당연히 구속 수사가 되어야 한다 황제 소환 이라는 비판을 받았던 지난번 검찰 조사에서는 우병우 전 수석의 가족회사 자금 횡령 혐의에 대해서만 조사했다 최순실 씨와의 관계나 이로 인한 직무유기 혐의에 대해서는 조사가 이뤄지지 않았다 이는 사태의 핵심을 한참 빗겨간 것이다 우 전 수석은 대통령의 친인척과 최측근들을 감찰하는 본연의 업무를 방임한 것으로도 모자라 최순실 사단 의 일원으로 움직였다는 의혹도 받고 있다 우병우 전 수석은 비선실세 국정농단의 핵심이자 주범이다 작년에 민정수석실이 차은택에 대한 감찰을 하고도 별다른 조치 없이 마무리 지었다는 게 대표적인 사례다 롯데그룹 수사 상황을 최순실에게 누설했다는 혐의도 받고 있다 국정원의 중간 간부로부터 최순실에 대한 정보들을 직보 받았다는 논란도 있다 심지어는 우 전 수석이 청와대에 입성한 직후 그의 장모와 최순실 차은택과 고영태가 함께 골프를 쳤다는 의혹까지 제기되고 있다 우 전 수석과 최순실과의 커넥션 의혹은 지금까지 제기된 것만으로도 차고 넘친다 검찰은 우 전 수석을 즉각 구속해야 한다 더불어민주당은 우병우 구속수사를 촉구하는 천막농성을 일째 이어가고 있다 검찰이 지금처럼 면피성 수사만 한다면 특검을 통해 낱낱이 단죄될 것이다 그때에는 검찰의 직무유기까지도 포함될 것이다 만 촛불의 성난 민심이 박근혜 퇴진 에서 검찰 개혁 으로 옮겨 붙는 것은 순식간임을 명심해야 한다 교총까지 반대하는 역사교과서 국정화 기어이 강행할 것인가 오는 월 일 국정 역사교과서가 전 국민 앞에 공개된다 야당과 시민사회는 지금까지 끊임없이 국정 역사교과서 추진 철회를 주장했으나 불통 정부는 끝까지 강행을 하고 있는 것이다 국정 역사교과서의 전신이라고 할 수 있는 교학사 역사교과서는 독립운동의 역사를 축소하고 친일과 독재를 미화해 학교 현장에서 외면 받았다 이처럼 반민족적 반민주적인 교학사 역사 교과서가 국민들에게 사망 선고를 받자 박근혜 정부는 다른 선택이 가능하지 못하도록 역사교과서를 국정화를 시켜버린 것이다 지난해 월 박근혜 대통령은 기존의 역사교과서들에 대해서 잘못된 역사를 배우면 혼이 없는 인간이 되거나 혼이 비정상이 될 수밖에 없다 는 귀기어린 악평을 한 바 있다 당시 우리 당 원내대표가 현행 역사교과서의 어느 부분이 부끄럽다는 것이냐 고 물었을 때는 구체적 내용 없이 전체 책을 다 읽어보면 그런 기운이 온다 고 발언했다 역사교과서 국정화의 결정은 최순실씨의 측근인 차은택씨의 외삼촌 김종률 전 청와대 교육문화수석 재임 당시 이루어졌기 때문에 일명 최순실 교과서 이다 현재 교육부는 최순실의 국정 농단이 백일하에 밝혀진 상황 하에서도 최순실 교과서의 강행 의지를 꺾지 않고 있다 그러나 최근 최대의 교사 단체인 한국교총까지 역사 국정교과서에 대해 반대 의견을 피력한 바 있다 지난 해 월 교원단체 중에서 거의 유일하게 국정교과서 찬성 의견을 내놨던 교총마저 돌아선 것이다 국민들은 국정 역사교과서 추진 중단을 명령하고 있다 이를 거부한다면 역사의 거대한 수레바퀴 아래 깔릴 뿐 아니라 그 흔적이 다시 역사교과서에 오르게 될 것임을 엄중히 경고한다 한일군사정보보호협정은 나라 팔아먹기 어제 한 일 양국은 한일군사정보보호협정 에 가서명했다 년 월에 체결하려다 무산되었지만 최순실씨의 국정농단 의혹이 제기된 직후에 협상을 개시하여 일만에 초고속으로 합의가 이루어졌다 박근혜 최순실 게이트로 대통령의 국가 운영능력과 권위가 상실되고 대통령까지 검찰수사를 받게 되는 마당에 한일군사정보보호협정을 밀어붙이는 이유는 대체 무엇인가 박근혜 정부는 친일 기조를 따라 역사교과서를 국정화한 데 이어 국민들과 피해 할머니들의 뜻을 무시한 채 단 억 엔으로 일본군 위안부 협상에 졸속 합의를 하지 않았는가 일본은 방위백서와 교과서에서 독도 영유권을 주장하고 있고 전쟁범죄를 부인한 채 전쟁 수행국가로 가기 위한 개헌을 기도하고 있으며 한반도에 대한 야욕을 노골적으로 드러내고 있다 이런 일본에게 군사정보까지 넘기려는 것은 헌법 제 조 항 대통령의 영토보전 책무 규정과 제 조 대통령 취임선서의 국가 보위 책무 규정을 정면으로 위반하는 행위이다 군사정보보호협정은 대통령 재가 가 필수적이기 때문에 대통령이 내치 는 내주더라도 외교와 국방 은 들고 있겠다는 의지의 발로로 추정된다 이제 나라 말아먹기 로도 부족해서 나라 팔아먹기 에 나선 것인가 만 촛불과 지지율이 뜻하는 것은 오직 대통령 퇴진 이다 국민들로부터 이미 해고 선고를 받은 박근혜 대통령은 제발 국정에서 손을 떼고 자숙하시기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58971,2016-11-15, 기동민 원내대변인 오전 현안 브리핑 관련 수정사항 한민구 국방장관 해임건의안 관련 수정사항 우리당을 포함한 야 당은 오는 월 일 전까지 한민구 국방장관 해임건의안을 제출할 예정이다 이후 일 본회의 상정 일 본회의 처리할 계획이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58970,2016-11-15, 제 차 원내대책회의 모두발언 일시 화 오전 시 장소 국회 본청 원내대표 회의실 우상호 원내대표 어제 더불어민주당은 대통령의 선후퇴론을 폐기하고 대통령 퇴진론을 당론으로 결정했다 만 촛불민심과 대통령의 하야와 탄핵을 요구하는 이상의 국민들의 민심을 반영해서 당의 입장을 정리한 것이다 대통령은 민심에 귀 기울여야 한다 대통령이 그 자리에 계속 계시는 것이 오히려 국정혼란이라고 말하는 많은 국민들의 여론을 가슴깊이 새겨야한다 국정 혼란을 최소화하기 위해서 더불어민주당은 질서 있는 퇴진론을 결정한 것이다 어제 추미애 대표와 박근혜 대통령 간의 회담은 무산됐지만 더불어민주당이 결정한 당론을 전달하기 위해서 만나자고 한 것이기 때문에 지금 이 자리에서 다시 대통령에게 정식으로 요구한다 국민의 요구 야당의 요구 시민사회 요구에 귀 기울여서 본인의 거취를 하루빨리 결단해주시기 바란다 대통령이 결단하시면 국회는 후속절차를 빠르게 정리해나가도록 하겠다 어제 여야 간에 특검과 국정조사에 대한 합의가 이뤄졌다 진실을 규명하고 국정을 바로잡기 위한 노력의 일환으로 합의가 잘 이뤄졌다 본회의에서 하루빨리 통과돼서 제대로 된 진상조사가 국회와 특검에서 이뤄질 수 있도록 최대한 노력하겠다 현재 이 상황에서도 각 상임위별로 법안심사가 충실하게 진행되고 있다 예산안 심의도 꼼꼼하게 진행되고 있다 대통령 퇴진 운동도 열심히 하겠지만 국회 안에서 민생을 챙기고 진상을 밝히는 노력도 꼼꼼히 하겠다 더불어민주당은 투트랙을 차질 없이 진행해서 민생도 챙기고 국가 혼란도 막는 최선의 노력을 다하겠다 군사정보보호협정에 대해서 제가 몇 달째 경고하고 국방부장관에게도 경고했다 그런데 촛불 민심이 타오르는 이 엄중한 시국에도 졸속 일방통행식으로 추진하고 있다 어제 가서명이 이루어졌다 지금이라도 관련된 절차를 중단해주시기 바란다 민심을 역행해서 가서명을 강행한 국방부장관에 대해서는 해임 또는 탄핵을 추진하기로 야당 간에 합의한 바 있다 각 당 간의 접촉을 통해서 즉각적으로 이 안을 제출하도록 하겠다 우리가 해임 또는 탄핵안을 추진하는 이유는 특정 장관을 물러나게 하는 것이 목적이 아니라 군사정보보호협정을 중단하라는 취지다 국민과 야당의 반대에도 불구하고 일방적으로 밀어붙인다면 정보보호협정 자체의 문제를 넘어선 국민적 저항이 더 거세질 것이라는 점을 경고한다 윤호중 정책위의장 얼마 전 발표된 조선산업경쟁력강화방안 에 따라 대우조선의 대주주인 산업은행이 보유주식을 로 감자하고 조 천억원 규모의 출자전환을 실행하기로 했다고 한다 수출입은행 역시 로 보유주식을 감자하고 조원의 영구채 매입을 추진하고 있다 결국 정부는 대우조선의 구조조정에 나서기 보다는 폭탄돌리기에 나서고 있는 셈이다 국회에서 임종룡 금융위원장이 추가지원은 절대로 없다 고 당당하게 이야기했지만 결국 출자전환과 영구채 매입을 통해서 추가지원을 하고 있는 셈이다 노사의 고통분담 확약 없이는 재무구조개선이 불가능 하다고 이야기하면서 노조에 노사확약서 제출을 요구하고 있다 그동안 낙하산 인사들에 의해서 초래된 부실경영과 구조조정 지연의 책임을 대우조선 노동자들과 국민에게 전가하고 있는 셈이다 이런 방법을 통해서 대우조선의 생명은 단기적으로 연장될지 모르지만 대우조선은 더 지독한 구조조정의 가시밭길을 걸어갈 수밖에 없다 산업은행도 대주주로서 대우조선의 부실경영의 책임을 져야한다 대우조선에 요구하는 조건인 임원 규모 축소 월급 반납 부장급이상 일반직 명 권고사직 등은 대우조선에만 요구할 것이 아니라 산업은행이 자기들에게 칼을 대야할 자구계획이다 대주주 책임을 방기한 채 혈세낭비로 구조조정을 지연시키고 있는 산업은행과 이것을 관리 감독해야 할 금융위원회 모두 그 책임에서 예외가 될 수 없다 구조조정의 총책을 맡아온 임종룡 금융위원장이 경제부총리로 추천돼있다 과연 이렇게 구조조정 작업을 제대로 실행하지 못한 임종룡 위원장이 경제부총리로서 적합한 인물인지 야당으로서는 재고에 들어가지 않을 수 없다 어제 교육위원회에서 누리과정 예산에 대한 심사가 있었다 정부는 지방교육재정지원특별회계를 설치해서 교육세수 국세분 조 천억원 전액을 특별회계로 편성한 안을 내놨다 여기에서 누리과정과 방과 후 학교 등 그동안 중앙정부가 지방교육청에 강요해오던 예산을 편성해서 내려 보내겠다는 것이다 특별회계법이 제정되기도 전에 예산부터 편성해서 국회에 제출한 것도 잘못된 절차이고 대통령의 공약이었던 누리과정 예산 전액을 지방교육재정에 전가하는 것도 잘못일 뿐만 아니라 대통령의 공약사업을 직접 예산 편성함으로써 교육자치의 원칙을 훼손하고 있는 것이다 우리 당은 지방교육정책지원특별회계의 설치에 기본적으로 반대한다 누리과정예산 문제는 앞으로 당 정책위의장과 교육부총리 경제부총리 자간에 협의를 해나가야 할 문제이다 그리고 이 문제의 해결을 위해서는 무엇보다도 보육기관 누리과정 예산 조 천억을 중앙정부의 일반회계에서 지원하겠다는 원칙을 세우는 것이 출발점이다 오영훈 부대표 어제 교문위에서 누리과정과 관련된 예산심의가 진행됐다 지난 일 각 시도교육청은 시도의회에 누리과정예산의 편성분을 제외한 예산안을 제출했다 대부분의 시도교육청이 누리과정예산을 편성하지 않았기 때문에 이대로 정부안대로 예산심의가 확정될 경우 각 지방 시도교육청과 학부모들이 겪을 혼란은 불을 보듯 뻔한 상황이다 상황이 이러함에도 불구하고 지방교육재정의 여건이 악화됨에도 불구하고 정부와 여당은 이에 대한 대책을 마련하고 있지 않다 우리 당은 이미 지방교육재정 관련 특별회계법안이 통과되지 않은 상태에서 조 천억원을 특별회계로 편성한 예산을 반드시 상임위 단계에서 전액삭감해서 이것을 보통 교부금으로 반영을 하고 어린이집 누리과정 조 천억원을 일반회계로 편성하는 것을 기본 방침으로 하고 있다 교문위 통과과정에서 이 문제를 협의하기 위해 법률이 제정되지 않았기 때문에 특별회계편성에서 조 천억원을 전액 삭감하고 보통 교부금 조 천억원만 반영하는 것으로 의결하되 어린이집 누리과정은 부대의견으로 조정하는 것으로 새누리당에 제안했지만 이마저도 반영되고 있지 못한 상황이다 대 국회가 개원한 이래 누리과정 문제를 해결하기 위해 우리 당에서는 일관되게 경제부총리 교육부총리 당 정책위의장이 참여하는 정책조정회의를 수차례 거듭 제안했지만 여전히 응답하고 있지 않다 상임위에서 심의가 끝나는 시점까지 이 부분에 대한 가이드라인을 반드시 제시해 줄 것을 다시 한 번 강력히 요청 드린다 홍익표 정책위 수석부의장 지난 월 정기국회 당시 대정부질문 때 제가 언급했던 내용이다 노자 도덕경에서 지도자를 크게 몇 단계로 나누고 있다 가장 좋은 지도자는 있는지 없는지 하는 지도자 두 번째는 친근하고 존경받는 지도자 세 번째는 두려운 지도자 마지막은 업신여김을 당하는 지도자 이다 박근혜 대통령은 스스로 자신이 지금 어느 단계에 위치하고 있는지 되돌아보시기를 바란다 왜 만 촛불의 민심이 대통령의 퇴진을 요구하고 있는지를 되돌아봐야 한다 아마 제가 그 당시 발언을 할 때만해도 대통령은 두려운 지도자였을 텐데 이제 업신여김을 당하는 지도자로 전락하고 있다 저는 박근혜 최순실 게이트는 단순히 개인의 문제가 아니라 구시대를 이제 끝내야 하는 역사적 소명이 있다고 생각한다 이미 여러 차례 이야기한 바와 같이 정경유착 친일잔재 미청산 반공 냉전 이데올로기의 유산들을 해체하기 위해서 앞으로 박근혜 시대 즉 지난 박정희 쿠데타 이후에 지금까지 이뤄진 적폐들을 해소하는 구체적인 조치들을 검토하고 발표할 준비를 해 나가겠다 이미 여러 차례 이야기해왔지만 정경유착과 관련하여 전경련 해체 이번 최순실 게이트와 관련된 해당 기업 관계자들에 대한 엄정한 구속수사 노동 개악 중단 등이 반드시 이뤄져야 한다 친일 잔재 청산과 관련해서 국정교과서 사업 중단 한일군사정보보호협정 중단 한일 위안부 합의 백지화가 함께 이뤄져야 한다 반공 냉전 이데올로기와 관련해서 사드 배치 중단 그리고 남북 관계 개선을 위한 개성공단 재개 및 금강산 관광 재개 등을 해결해야 한다 이러한 문제에 대해서 더불어민주당은 단순히 박근혜 최순실 게이트 박근혜 정권 퇴진에 끝나는 것이 아니라 국민들이 원하는 것은 이러한 현실을 바로잡아달라는 것이며 이로 인해 구시대를 끝내달라는 것이 국민의 요구라고 생각한다 이러한 문제를 꼼꼼하게 살펴봐서 반드시 바로잡아 나가도록 하겠다 박완주 원내수석부대표 어제 여야 합의로 최순실 게이트 특검법에 합의를 이뤘다 검찰은 분발하시라 대한민국 검찰에 대하여 이 사건과 관련해 야당은 특히 초기에 증거 은폐 우려를 표명했다 어제 한 언론을 보면 청와대에서 최순실 게이트 수사 대비 대응을 위한 문건에 대한 보도가 있었다 검찰이 수사할 수 있는 기간은 특검이 시작되기 전까지다 최선의 모습을 보여줄 것을 당부 드린다 이미 많은 언론보도가 있었겠지만 특검은 법적 심판을 하는 것이다 현재 진행되고 있는 검찰의 조사 내용을 받아서 부진한 부분에 대해서 일 동안 아마 시작은 월 초가 되고 내년 월 초까지 수사가 이뤄질 것이다 국정조사에 대해서 많은 분들이 의아하게 생각하는데 국정조사는 국회에서 정치적 심판을 하는 것이다 물론 많은 증인들이 출석하지 못하는 상황이 있을지라도 특검에 상당한 영향을 줄 수 있다고 생각한다 두 가지 방법을 통해서 철저하게 수사하고 조사할 수 있게 준비했다는 말씀을 드린다 세 번째로는 이번 특검에 다시 한 번 명백하게 말씀드리지만 지난 월 일 대통령의 차 국민 사과문에서도 발표했듯이 이번 특검법에는 대통령이 수사대상임이 분명하다는 것을 말씀드린다 또한 명시되지는 않았지만 세월호 국정원 김기춘 전 비서실장 최경환 전 부총리 등 이번 농단과 사건들에 있어서 이미 언론에서 제기됐던 부분이 회에 포괄적으로 조사할 수 있는 범위에 들어간다는 말씀을 드린다 마지막으로 이번 특검에 있어서 한 마디로 말씀드리면 수퍼특검 이다 특별 검사 명 검사보 명 파견 검사 명 특별수사관 명 파견 공무원 명 등 명이 일 동안 철저하게 진실을 밝히는데 역할을 할 것이라는 말씀을 드린다 어제도 말씀드렸지만 특검법에 특징은 두 가지가 있다 수사과정에 대해서 피의사실 공표가 아닌 이상 수사과정에 대한 내용은 국민의 알권리를 위해서 보고할 수 있는 조항이 있다 그리고 파견 나온 공무원들이 한마디로 파견 나온 친정에 보고하면 처벌을 강력하게 하는 조항도 삽입되어 있기 때문에 독립적으로 이번 특검을 통해서 철저하게 규명을 해나가는데 최선을 다하겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58969,2016-11-15, 기동민 원내대변인 오전 현안 브리핑 일시 화 장소 국회 정론관 더불어민주당 의사 일정 관련 우리당을 포함한 야 당과 새누리당 의원 일부는 박근혜 정부 최순실 등 민간인에 의한 국정농단 의혹 사건 규명을 위한 특별검사 임명 등에 관한 법률안 과 진상규명을 위한 국정조사 요구서 를 제출하기로 했다 특검법은 일 법사위 일 본회의 의결을 거칠 것이고 국정조사 요구서와 계획서 또한 일 본회의에서 채택할 예정이다 이와 함께 야 당은 한민구 국방부장관 해임건의안을 오늘 제출하고 일 본회의에 보고해 월 일 본회의에서 처리하기로 했다 중고등학교 역사교과서 국정화 추진중단 및 폐기 촉구 결의안도 오늘 제출할 방침이다 더불어민주당은 박근혜 대통령의 퇴진을 요구한다 박근혜 대통령은 퇴진하라 백만 촛불민심과 오천만 국민의 지엄한 명령이다 박근혜 대통령은 국민의 대통령이 아니다 최순실과 그 일파들의 사익을 보장하고 사실상 국정농단을 주도한 형사상 피의자다 대기업의 목을 졸라 돈을 갈취하고 정경유착의 더러운 고리를 더욱 짙게 드리웠다 공교육을 비웃으며 정유라 라는 특권의 상징을 만들어 아이들의 꿈을 짓밟아 버린 죄는 무엇보다 크다 세월호를 수장하고 가습기 살균제 피해자들의 절규를 무시한 대통령이다 비정규직 차별과 성과연봉제를 통한 일터의 차별을 조장하며 대기업 보호에만 혈안이었다 미르 케이 재단을 통한 뇌물 수수와 부정한 청탁 공무상 기밀누설 군사기밀보호법 위반 문화체육계 인사들에 대한 불법 사찰 등 박근혜 대통령이 대통령이어선 안 될 이유는 셀 수 없을 만큼 많다 헌법과 법률을 무시하고 자유민주주의의 기본 질서를 훼손한 박근혜 대통령은 당장 물러나라 검찰에 촉구한다 성역없는 수사로 대통령과 최순실 일파의 국정농단을 방조한 과오를 씻어야 한다 청와대 꼼수에 놀아나거나 간접 정범 이라는 말장난으로 책임을 회피한다면 국민의 심판을 피할 수 없을 것이다 오만과 국민 무시 한일군사정보보호협정 은 무효다 이 나라엔 국민도 없고 국회도 없나 국정운영의 자격을 잃은 파산 정권 이 이토록 엄청난 일을 벌일 수 있단 말인가 민의를 거스른 매국 협정 에 앞장선 한민구 국방장관은 국무위원의 자격을 상실했다 전 국민이 지켜본 국정감사에서 많은 사람들이 지지하고 여건이 성숙해야 추진가능하다는 말은 위증이었다 응분의 대가를 치러야 한다 장막 뒤에서 매국 협정 을 주도한 김관진 안보실장은 가장 무거운 책임을 져야 한다 를 사실상 이끌고 있는 결정권자는 김관진 안보실장이다 졸속 밀실 협상 추진은 위기에 처한 박근혜 대통령 구하기 를 위한 졸렬한 수단일 뿐이다 윤병세 외교부장관 역시 같은 무게의 책임을 져야 한다 매국 협정 을 방치한 책임도 져야 한다 무능도 죄다 우리당은 한민구 장관의 해임을 추진한다 또한 사실상의 실권자인 김관진 안보실장과 윤병세 장관에게도 엄중한 책임을 물을 것이다 아울러 국민의 위임권을 상실한 정부가 추진한 한 일 군사정보보호협정 은 원천 무효임을 선언한다 지금이라도 후속 절차를 당장 중단하라 우리당은 필요하다면 청문회와 국정조사를 통해서라도 바로잡을 것이다 재벌에 대한 검찰의 가림막 조사 오만과 굴종의 끝판이다 대통령도 사과하는데 왜 재벌은 보호돼야 하는가 범죄 행위에 공조한 사실이 분명한데도 왜 참고인이어야 하는가 포토라인도 없고 가림막 이 드리워져 얼굴조차 확인할 수 없는 특권은 왜 재벌에게만 허락되는가 재벌의 오만과 돈 앞에 굴종하는 검찰 굴욕의 끝판을 보는 듯 해 씁쓸하다 하루가 멀다 하고 국정농단에 편승한 재벌들의 사익추구가 드러나고 있다 삼성 현대 포스코 한진 케이티 롯데 등 예외가 없다 대통령과 꾸준한 독대가 이어졌고 수상한 거래 가 이뤄졌다 독대 전에는 정해진 절차에 따른 소원 수리 가 관행적으로 이뤄졌다고 의심되고 있다 검찰 수사에 성역이 없어야 한다 재벌은 공범이다 국정농단의 피의자로 수사하라 가림막 을 치워라 국정농단의 주범 우병우 전 수석을 구속하라 우병우 전 민정수석이 국정 농단의 주범이었다는 사실이 명백하다 최순실의 국정농단에 눈 감은 것도 모자라 수족 처럼 일하며 국정농단을 이끌었다 애초에 최순실 사단 이었다는 의혹은 기정사실이 되고 있다 청와대에 들어가자마자 우 수석의 장모와 최순실이 함께 골프를 쳤고 그 자리에는 차은택과 고영태도 함께 했다는 보도가 나왔다 비선실세의 간택에 대한 보은골프 였던 셈이다 검찰의 제 식구 감싸기 는 여전하다 한 것이라곤 창문에 창호지를 붙인 것 뿐이다 황제수사가 계속되고 있다 우병우 전 수석은 재소환돼야 한다 구속수사로 법의 엄정함을 보여줘야 한다 우리당은 검찰의 철저한 수사를 재차 촉구한다 검찰이 못한다면 특검에서 죄를 물을 것이다 물론 그 대상에는 검찰도 포함된다는 것을 명심해야 할 것이다 또한 검찰 곳곳에 숨어있는 우병우 사단을 도려내고 검찰을 정상화하는 모든 방안을 강구할 것이다 그것이 검찰을 바로세우는 길이고 땅에 떨어진 사법질서를 회복하는 길이다 민주주의자 김근태상 제정을 환영한다 년을 점령하라 삶의 전부가 민주주의였던 고 김근태 의 유언이다 우리는 그의 유언을 지키지 못했고 단 한줌의 도덕과 인격을 갖추지 못한 자들이 우리사회가 이룩한 모든 역사를 우롱하는 요즘을 맞고 있다 고 김근태 선생 주기를 맞아 민주주의자 김근태 상 이 제정된다고 한다 오늘부터 월 일까지 수상대상자 및 심사위원을 모집하는 절차를 밟는다 분노의 시대에도 희망의 근거를 묵묵히 남기는 제 제 의 김근태를 찾는 과정은 소중할 것이다 많은 국민들의 관심과 참여를 부탁드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58965,2016-11-14, 윤관석 수석대변인 추가 현안 서면 브리핑 국민과 국회는 한일군사정보보호협정을 반드시 막아낼 것이다 기어코 국방부가 한일군사정보보호협정에 가서명했다 기어코 국민과 국회의 반대에도 폭주기관차처럼 협정을 밀어붙였다 이제 국방부의 독선과 독단으로 일본 자위대에 대한민국 국군의 군사기밀을 고스란히 내어주게 생겼다 도대체 이런 협정으로 우리나라가 국가안보에 무슨 도움이 된다는 것인지 백번을 생각해도 납득할 수 없다 국민동의가 전제조건 이라던 한민구 장관의 약속은 어디로 갔는가 비선실세의 국정농단에 국정이 파탄 나서 국민에게 퇴출명령까지 받은 정부가 이런 중대한 협정을 이렇게 마구잡이로 밀어붙일 수 있는 것인가 국방부가 일방통행식으로 협정을 추진하고 이를 기정사실로 만들어 국민에게 강요하려는 것 같은데 국민과 국회는 결코 용납하지 않을 것이다 더불어민주당은 한민구 장관에 대한 해임건의안 제출 또는 탄핵소추 의결 등 모든 수단과 방법을 동원하여 협정 체결을 기필코 막을 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58961,2016-11-14, 윤관석 수석대변인 오후 현안 서면 브리핑 국정농단 헌정유린의 몸통 박근혜 대통령에 대한 철저한 수사가 필요하다 지난 주말 박근혜 최순실 게이트를 수사 중인 검찰 특수본이 지난 월 박근혜 대통령과 개별 면담을 한 것으로 확인된 재벌 총수들에 대한 비공개 소환 조사를 실시했다고 한다 최순실 안종범 우병우 차은택 송성각 등 관계자의 소환 구속 수사가 대부분 진행되고 재벌 총수까지 조사가 이뤄졌다 이제 국정농단의 몸통인 박근혜 대통령에 대한 직접 수사는 불가피한 상황이다 현재까지 언론을 통해 드러난 박근혜 대통령의 범죄 의혹은 여 가지에 달한다 최순실에게 건네진 태블릿 문건에는 이명박 전 대통령과의 독대 자료부터 드레스덴 연설문까지 외교 안보 상 상당한 기밀이 유출되었고 이는 외교상 기밀누설죄 군사기밀보호법 위반 대통령기록물 관리법 위반 공무상 비밀 누설죄에 해당한다 미르 재단 강제모금 지시는 공갈 및 사기 직권남용 출연한 재벌의 민원을 해결해 주거나 약속했다면 포괄적 뇌물죄나 뇌물 수뢰에 해당한다 무엇보다 대통령은 본인의 공적 지위를 이용해 비선 최순실 챙기기에 여념이 없었다 공공의 가치를 수호해야할 대통령이 개인의 사적 이익에 매달리고 국헌을 문란케 했으니 국정은 지난 년 반 만에 완전히 절단 났다 이것을 사실상 내란죄에 해당하지 않는다고 말하기 어려울 것이다 지난 주말 타오른 백만의 촛불 민심은 대통령에 대한 철저한 수사와 하야를 촉구하는 것이었다 검찰은 아직까지도 핵심 범죄자인 우병우를 구속하지 않았고 대통령에 대한 수사가 아닌 조사만을 언급하고 있다 검찰이 민심에 역행하는 행태를 보인다면 국민과 국회가 용납하지 않을 것이다 검찰은 국정농단 헌정유린의 몸통인 박근혜 대통령에 대한 철저한 수사를 하라 그리고 그 사실을 낱낱이 국민 앞에 공개하라 최순실 꼬리표 달린 정책 사업 즉각 중단하고 전면 재검토해야 청와대는 월 항쟁 이후 가장 많은 만 시민이 운집한 촛불집회에서 청와대까지 울려 퍼진 박대통령 퇴진 요구 목소리 를 엄중하게 받아들이고 이에 대한 대응 마련을 논의하기 위해 오늘 오전 한광옥 비서실장 주재로 수석비서관회의를 열었다고 한다 어두운 광화문 광장을 밝게 비춘 만 촛불의 염원에 대해 청와대가 대응 마련을 고심하는 것은 다행이라고 생각한다 하지만 그 고심 뒤 발표하는 대책은 통심 대통령의 생각 이 아닌 촛불민심 을 담은 것이어야 한다 지난 토요일 광화문 광장의 촛불민심 은 최순실이라는 한 사인 에 의해 대한민국의 정책이 결정되었고 국민이 뽑아준 대통령은 그 사인의 뜻에 따라 꼭두각시처럼 나라를 통치한 것에 대한 분노였다 박근혜 최순실 두 사람에 의해 대한민국 시스템이 붕괴되었고 대한민국과 헌법과 가치 그리고 국민의 자존심이 짓밟힌 것에 대한 울분이었다 특히 온 국민의 반대에도 불구하고 박근혜 정부가 무리하게 밀어붙인 주요 정책 대부분이 최순실의 입김이 작용한 최순실표 정책 이라는 의혹에 대한 질타의 목소리가 컸다 조 천억원의 피해액이 추정되는 개성공단 폐쇄 대한민국 역사를 왜곡하는 국정교과서 도입 공공복지를 위협하는 의료민영화 정책 굴욕적인 한일 위안부 합의까지 모두 최순실 꼬리표 를 달고 있다 또한 현재 진행되고 있는 년 정부 예산안 심사에서 최순실과 직간접적으로 관련된 예산이 총 억 원이 넘는 것으로 나타났다 내용을 살펴보면 정부가 중점적으로 추진하는 브랜드 사업부터 문화 체육 관광까지 최씨의 손이 닿지 않은 곳이 없다 국민의 혈세로 추진되는 사업이 최씨에 의해 좌지우지되었다는 것이다 실로 참담한 마음이다 정부와 청와대는 최순실 꼬리표 를 달고 있는 정책과 사업을 당장 중단하고 전면적 재검토에 들어가야 한다 또한 아직도 곳곳에 숨겨져 있을 최순실표 사업과 예산을 명명백백히 밝혀내야 한다 그것이 바로 일 광화문 광장을 가득 메운 만 촛불민심이라는 것을 명심해야 할 것이다 박근혜 대통령 국민법정에 서다 긴급토론회 개최 박근혜 대통령이 자행한 국헌문란 행위의 실체를 규명하고 헌법적 형사법적 책임을 철저히 추궁하는 토론회가 열린다 더불어민주당은 일 오후 시 국회의원회관 대회의실에서 박근혜 대통령 국민법정에 서다 긴급토론회를 개최한다 이번 토론회는 박근혜 최순실게이트에서 노정된 대통령 차원의 국헌문란 행위의 실체를 낱낱이 규명하기 위해 마련됐다 아울러 작금 미증유의 대통령직 사유화에 따른 헌법가치 파탄과 그 형법적 책임을 기탄없이 따져 묻는 자리가 될 것으로 예상된다 토론회는 추미애 민주당 대표 우상호 민주당 원내대표 이석현 박근혜 최순실게이트 국민조사위원회 공동위원장의 축사에 이어 조국 서울대학교 교수 박명림 연세대학교 교수 임지봉 서강대학교 교수 하태훈 고려대학교 교수 정연순 민주사회를 위한 변호사모임 회장이 참여하는 발제 및 청문형식 토론이 순차적으로 전개된다 사회는 박범계 의원이 맡는다 세부적으로는 만 촛불시위를 통해 표출된 민심과 사상 초유의 국헌문란 사태에 대한 규정 박근혜 대통령의 구체적인 국헌문란행위 실체 규명 및 그 헌법적 형사법적 책임 포괄적 뇌물죄 등을 포함한 형사법적 범죄행위에 관한 토론이 진행될 예정이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58958,2016-11-14, 기동민 원내대변인 오전 현안 브리핑 일시 월 오전 시 분 장소 국회 정론관 박 대통령은 피의자 신분을 자청 하는 것이 책임을 다하는 것이다 사상 초유의 현직 대통령 검찰 조사를 앞둔 청와대가 대통령의 책임을 다하겠다 고 밝혔다 현 상황의 엄중함을 깊이 인식하고 있다 는 입장은 헛말이었을 뿐이다 만 촛불 에서 확인된 민심도 검찰 조사 도 대통령은 괘념치 않고 자신의 길을 가겠다는 것인가 박근혜 대통령이 책임을 다하는 것은 스스로 피의자 를 자청하여 죄를 청하고 국정 농단의 전모를 밝히는 것뿐이다 박 대통령은 재단 강제 모금 청와대 내부 문건 유출 을 주도한 피의자 다 스스로 국민 앞에 자복했고 최순실 안종범 정호성 등 모두가 대통령을 몸통으로 지목하고 있다 소극적 태도로 일관하는 검찰에게도 경고한다 부실 조사는 용납할 수 없다 대통령이 재벌독대로 거래한 것처럼 검찰도 대통령과 독대 조사 로 거래라도 하겠다는 것인가 철저한 공개 소환조사로 법 앞에 성역이 없다 는 민주주의의 기본을 지켜야 할 것이다 비비케이 꼬리곰탕 조사 가 재현될 경우 모든 후과는 검찰이 감당해야 할 것이다 진실만이 국익이다 검찰은 세월호 시간 의 진실도 밝혀내야 한다 문고리 인방 정호성 전 비서관이 검찰 조사에서 세월호 시간 동안 대통령은 관저에 계셨다고 진술했다 국민이 죽음의 사투를 벌이고 있는데 대통령은 대낮에 집무실도 아닌 관저에서 전화 지시만 하고 있었다는 것이다 도대체 무엇을 한 것인가 자다가도 벌떡 일어나 집무실로 오는 것이 상식 아닌가 대낮에 출근도 하지 않고 관저에 눌러앉아 전화 지시만 해야 하는 아무도 몰라야 할 다른 상황 이라도 있었단 말인가 아니라면 대통령에게 세월호는 그저 언제나 일어날 수 있는 수많은 사고 중 하나였던 것인가 이해할 수 없고 이해를 구할 일도 아니다 검찰은 잃어버린 세월호 시간 의 비밀을 밝혀내는 것 역시 대통령 조사의 과제임을 명심해야 한다 정상 업무를 보고 있었다 는 청와대 해명에 대해 세월호 참사가 정상 업무 축에도 못 낄 만한 중대 사안은 대체 무엇이었는지 밝히고 책임을 물어야 한다 국회 동의 없는 한 일 군사정보보호협정 결코 용납할 수 없다 우리나라는 개국과 군사정보보호협정을 맺고 있다 하지만 일본만은 예외다 불행한 과거사와 한일 관계의 특수성 때문이다 한반도를 총칼로 점령하고 우리 민족을 노예로 만들었던 일본은 아직도 자신의 잘못을 제대로 인정하지 않고 있다 단순한 정보 공유의 차원이 아니다 정보의 공유는 작전의 공유로 이어지고 작전의 공유는 전범국 자위대의 실체를 인정하고 우리 관할권 내의 자위대 진출을 용인하는 사태로 번질 가능성이 농후하다 일본의 군사대국화를 용인하는 첫걸음이다 국민이 동의하지 않고 우리 역사가 용인하지 않는 매국적 굴욕 협상일 뿐이다 우리당은 한 일 군사정보보호협정 을 년 한일협정 년 일본군 위안부 협상에 이은 박근혜 정부의 또 하나의 친일 매국외교로 규정하고 총력을 다해 막아낼 것이다 대통령 유고 상태나 다름없는 국정 혼란을 틈 타 매국외교를 주도하는 김관진 안보실장 한민구 국방부장관 윤병세 외교부장관을 신 친일 적 으로 규정하고 해임 및 탄핵 추진 등 모든 방안을 강구할 것이다 박근혜 최순실 게이트 의 당사자 재벌들을 피의자 신분으로 재조사하라 피의자 이재용 정몽구 구본무 최태원 김승연 손경식 이들은 박근혜 최순실 게이트 의 피해자도 참고인도 아니다 비선실세 국정농단의 든든한 자금줄 역할을 한 추악한 정경유착의 공범이다 우리도 피해자 관례에 따랐다 보험드는 셈 쳤다 는 말에 국민은 분노한다 검찰은 재벌에게 알아서 기었다 만 촛불집회에 온 국민과 언론의 관심이 집중된 주말의 비공개 참고인 조사 는 애초에 단죄할 의사가 없다는 속내를 그대로 드러낸 것이다 권력에 굴종하고 돈 앞에 나약한 검찰의 현실이다 대통령이 재벌을 단독으로 면담해서 거래하니까 검찰도 대통령 따라하기 를 하는 것인가 재벌은 박근혜 최순실 게이트 의 당사자다 피의자 신분으로 공개 재소환하여 썩은 권력과 재벌의 뒷거래를 낱낱이 파헤쳐야 한다 이번 사태를 계기로 전경련을 해체하고 시장경제를 좀먹어온 정경유착의 썩은 고리를 잘라내야 한다 재벌개혁을 통해 올바른 시장 질서를 만들어야 한다 그것이 민심이고 순리이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58957,2016-11-14, 윤관석 수석대변인 오전 현안 브리핑 일시 오전 시 분 장소 국회 정론관 촛불민심에 대해 대통령은 조속히 결자해지의 답 내놔야 지난 토요일 광화문 광장에 모인 백만 시민은 촛불을 들고 대통령의 퇴진을 요구했다 더 이상 박근혜 대통령으로는 안 된다는 민의의 폭발이었다 그러나 박 대통령은 물러나라 는 촛불민심을 전달 받고도 대통령으로서 책임을 다하고 국정을 정상화하기 위해 고심하고 있다 는 입장을 내놓았다 대통령으로서의 책임을 저버린 것은 바로 박 대통령 자신이다 그런 박 대통령이 책임을 다하고 국정을 정상화하겠다는 것은 언어도단이다 그 목적이 권력 유지에 있음이 명확하다 대통령으로서의 책임을 저버리면서 권한은 지키겠다는 민심과 완전히 동떨어진 답변에 분노를 금할 수 없다 더욱이 청와대와 새누리당은 찔끔 사과 찔끔 수습책을 내놓으며 국민들을 기만하고 있다 더 이상 국민에게 인내심을 강요해서는 안 된다 추미애 당대표는 오늘아침 현 비상시국에서 정확한 민심을 전달하고 정국의 해법을 찾기 위해 청와대측에 박 대통령과의 긴급 양자회담을 요청했다 추미애 대표는 양자 영수회담을 통해 박 대통령이 외면하고 있는 국민의 엄중한 민의를 전달할 것이다 박근혜 대통령은 더 이상 찔끔찔끔 수습책으로 책임을 회피하지 말고 국민의 촛불민심에 마지막 결단과 결자해지의 답을 내놓을 것을 촉구한다 대통령 조사 사실상 대통령을 피의자로 한 수사되어야 박근혜 대통령에 대한 검찰 조사가 이르면 내일 이루어질 것으로 전망되고 있다 헌정사상 최초의 현직 대통령에 대한 검찰 조사다 대통령이라는 신분을 고려한 조사라는 점에서 사실상 피의자에 수사와 별 다를 것이 없다 따라서 검찰 조사는 대통령의 범죄행위에 대한 실질적인 수사가 되어야 한다 사실상 대통령을 피의자로 수사해야 한다는 말이다 대통령에 대한 국민의 엄청난 의혹들을 조금의 남김도 없이 확인하고 밝혀내야 한다 만약 검찰 조사가 보여주기를 위한 요식행위나 국면전환용 조사에 그친다면 국민들이 결코 묵과하지 않을 것이다 촛불은 더욱 커질 것이다 더욱이 특검이 예정되어있다 대통령에 대한 검찰의 조사가 부실하다면 특검에게 만천하에 드러날 것이다 범인을 잡지 못하는 검찰 범죄를 밝혀내지 못하는 검찰을 국민은 더 이상 필요로 하지 않는다는 점을 분명히 경고한다 박근혜정부는 매국적이고 졸속적인 한일군사정보보호협정 추진을 즉각 중단하라 국방부가 오늘 한일군사정보보호협정 체결을 위한 차 실무협의를 열고 가서명까지 마무리하겠다고 한다 대통령 퇴진을 요구하는 만 함성이 울려 퍼지는 와중에 한일군사정보보호협정을 졸속적이고 노골적으로 밀어붙이는 저의는 무엇인가 억 엔으로 일본군 위안부 피해 할머니들에게 치욕을 주더니 이번에는 군사정보까지 팔아먹으려 하는지 분노한다 국민이 바라고 국민을 위하는 일은 아무것도 하지 못하면서 국민이 반대하고 국익에 반하는 일에만 이렇게 속전속결이니 국민들은 분통이 터진다 한일군사정보보호협정 체결은 전적으로 국회 비준이 필요한 사안이다 정부는 다른 개 국가와의 사례를 들어 한일군사정보보호협정은 국회 비준 사항이 아니라고 하는데 이는 국민정서상 결코 납득할 수 없다 한일관계의 특수성과 지리적 근접성을 감안할 때 한일군사정보보호협정은 헌법 조에 명시되어있는 중대한 주권에 관한 사항 중요한 안전 보장에 관한 사항이며 국회 비준은 필수다 더불어민주당은 국민과 함께 박근혜정부의 한일군사정보보호협정 체결을 반드시 막아내겠다 한민구 국방부장관에 대한 해임건의안 제출을 비롯해 모든 수단과 방법을 동원하여 협정을 백지화시키겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58956,2016-11-14, 제 차 최고위원회의 모두발언 일시 월 장소 국회 본청 당대표 회의실 추미애 대표 오늘 이른 아침에 제 당 대표로서 이 난국 해쳐나가기 위한 만남이 필요하다고 보고 청와대에 긴급 회담을 요청했다 잘 아시는 것처럼 온 국민이 나라걱정을 하고 있다 학교에서 공부에 집중해야할 학생들도 거리에 나와서 나라와 장래를 걱정하고 있는 지경이다 제 당 대표로서 마음이 참으로 무겁다 제대로 민심이 전달되어야 하는데 집권당 대표를 보아하니 내분에 열중하며 자리보전에 연연하고 있다 목숨을 걸고라도 청와대와 정부에 민심을 전달해야할 집권당이 목숨을 버리기는커녕 자리에만 연연하며 당 정 청이 제대로 굴러가지 않는 상태에서 민심을 전달할 막중한 역할이 오직 제 당 대표에게 있다는 무거운 책임감을 느끼고 있다 지금까지는 봇물처럼 터진 민심을 보면서 절제하고 인내해왔다 그러나 이제 그 절제와 인내를 성숙된 민주주의로 발전시켜서 새로운 민주 역량을 가지고 우리 사회를 바로 설계해야하는 기로에 있다는 느낌을 받고 있다 그래서 대통령을 만나서 모든 것을 열어놓고 허심탄회하게 민심을 전하면서 해법을 모색하는 자리를 갖고자 한다 우상호 원내대표 지난 주말에 있었던 촛불집회에 대해서 많은 사람들이 시민혁명이다 명예혁명에 가깝다 민심이 폭발했다 고 평가하고 있다 더불어민주당은 광장의 민심을 전향적으로 수용해서 앞으로의 방침을 정해나갈 계획이다 분명한 것은 박근혜 대통령이 이런 상황을 내년 월까지 끌고 가는 건 불가능하다는 것이다 어떤 형태로든 국가혼란 국정혼란을 최소화해서 하루빨리 조기 수습하는 것이 바람직하다고 보고 있다 국민의 민심을 거역해서는 안 된다는 점을 다시 한 번 강조하면서 앞으로 더불어민주당은 최고위원회 의총 등 각종단위를 거쳐서 대응방침을 분명하게 정해나가도록 하겠다 이런 과정에서 청와대와 집권당 대표의 상황인식이 너무 안이한 것이 아닌지 말씀드리고자 한다 특히 새누리당 이정현 대표가 어제 월 일 전당대회를 통해 이 문제를 해결하겠다고 발표하신 걸 보면서 정말 한가한 판단을 하고 있다는 생각을 했다 하루하루가 급한데 내까지 새누리당을 현 상태를 끌고 가겠다는 인식에서는 절망을 느꼈다 분명히 말씀드리지만 더불어민주당은 최순실 게이트를 은폐하고 비호하는데 앞장서며 이 게이트의 국정농단이 한참 진행되는 시절에 청와대 수석을 역임하고 있었던 이정현 대표와는 대화할 수 없다는 점을 분명히 밝힌다 정부 부처의 대응에 대해서도 어이가 없다는 말씀을 드린다 이런 판국에 한일군사정보보호협정을 맺겠다고 하면서 오늘 가서명을 하겠다고 발표를 했는데 제정신이냐고 묻고 싶다 거리에 나온 만 촛불 민심이 대통령의 지난 년간 국정실패와 일방통행에 대해 분노하며 대한민국의 국정운영을 근본적으로 바꾸자고 분출하고 있는데 촛불이 진행되는 이 과정에서 국민이 반대하는 정보보호협정을 또 일방적으로 관철시키겠다는 태도를 어떻게 보일 수 있는가 민심에 대한 정면 역행이라고 본다 만약 오늘 가서명을 진행한다면 가서명에 참여한 국방장관에 대해 해임 또는 탄핵 절차를 밟을 것이다 분명히 말씀드리지만 국민의 민심을 거스르고 일방통행식 정책을 관철하려는 관료도 용서할 수 없다는 것을 분명히 경고한다 철도파업을 중단해야 한다 국민들의 불편이 극에 달한 상황이고 노사 대립도 이렇게 혼란스럽게 가서는 안 된다 더불어민주당이 여러 번 말씀드렸지만 성과연봉제는 노사합의에 의해 진행되어야 한다 내로 되어있는 실시 시기를 유보하고 노조의 파업을 철회시키는 타협이 필요하다는 점을 다시 한 번 강조한다 코레일과 국토교통부 그리고 기재부의 전향적인 입장 전환을 부탁드리고 싶다 간단하다 실시 시기를 유보하고 국회에 사회적 논의기구를 만들어서 노사 간의 대화를 중재할 수 있도록 합의하자고 제안한다 전해철 최고위원 광화문에서의 국민들의 외침은 민주주의를 위해 국가시스템의 재건을 위해 더 이상 박근혜 대통령을 나라의 대통령으로 인정하지 않겠다는 것이며 이제 국민이 대통령에게 준 권한을 거둬들이겠다는 뜻으로 보인다 국민과의 약속을 배신한 대통령이 종국에까지 국민의 뜻을 거스르며 권력에 집착하는 모습으로 국민들을 더욱 고통스럽게 하지 않기를 바란다 검찰수사에 대해 이야기하겠다 검찰이 대통령에 대한 조사를 하겠다고 예정하고 있다 대통령의 범죄행위에 대해서는 실질적인 조사가 이뤄져야 한다 시기와 방식을 조정하겠다고 하는데 내용까지 조정하고 있는 것은 아닌지 의심스럽다 청와대 문건 유출에 대해 대통령이 지시했다는 사실이 이미 밝혀지고 있다 재벌들에 대한 자금출연 강요행위에 대해서도 대통령의 지시여부가 상당부분 의혹에서 사실로 밝혀지고 있다 재벌 총수와 박 대통령 간의 독대자리에서 어떤 이야기를 했는지에 대해서도 검찰수사가 상당히 진전된 것으로 알고 있다 그렇다면 대통령에 대해서 포괄적 뇌물죄를 반드시 적용해야 할 것이다 뿐만 아니라 참고인이 아닌 피의자 신분으로 대통령에 대한 조사가 필요하다 대통령의 주변 인사들에 대한 감찰을 소홀히 하여 직무유기의 의혹을 받았던 우병우 전 수석이 이제는 적극적인 개입을 한 게 아니냐는 정황까지도 포착되고 있다 우 전 수석에 대해서는 황제 소환이라는 비난이 있었는데 거기에 더해 고발접수 된지 일 민정수석에서 사퇴한지 일 만에 자택을 압수수색을 해놓고도 참고할 단서가 아무것도 없는 깡통 휴대폰 을 확보했을 뿐이라 또 하나의 부실수사였다는 비난이 있다 검찰이 우 전 수석에 대해서 보여주기식 수사 뒷북 수사를 계속 한다면 이 역시 비난을 면치 못할 것임을 분명히 말씀드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58952,2016-11-13, 최고위원 중진의원 연석회의 모두발언 일시 일 장소 국회 당대표회의실 추미애 대표 어제 우리는 도도한 역사의 물결을 현장에서 보았다 위대한 국민이 만든 승리의 역사이고 민주주의의 새 역사의 기운을 느꼈다 박근혜 대통령께서 늘 애국을 강조했다 대통령이 이 상황에서 할 수 있는 애국이란 하나 뿐인 것 같다 촛불을 들고 나온 국민의 마음을 헤아리고 받드는 것 아니겠는가 시민의 큰 함성 비탄 한숨은 어린아이 노약자 할 것 없다 어린 중고생들까지 나라 걱정하는 마음 장래를 걱정하는 마음 이대로 안 되겠다는 마음이었다 지척에 있는 청와대에서 도저히 안 들을래야 안들을 수 없는 국민의 목소리였다 그래도 못들었다 모르겠다 하신다면 마음으로 들어봐라 대통령이 먼저 국민을 버리고 헌정질서를 무너뜨리고 이제 국민이 나라를 세우겠다고 나선 이 거대한 물결을 안보셨고 안 들으셨다면 마음으로 들어봐라 대통령께서 마지막 하실 일은 불상사가 일어나기 전에 국민이 다치기 전에 평화롭고 순조롭게 순리대로 정국정상화에 결자해지하시는 것이다 그렇지 않다면 국민의 손으로 헌법이 대통령께 드린 권한을 돌려받는 절차가 남았을 뿐이다 오늘은 중진의원들과 당 지도부가 책임 있는 수권정당으로서 국민의 뜻을 실현하고 붕괴된 헌정질서를 회복하기 위한 방안에 대해 다각도로 논의하는 자리가 될 것이다 좋은 말씀을 주시기 바란다 문희상 의원 이러려고 정치했나 하는 생각이 날이면 날마다 드는 그런 시간들이다 앞에 세 분 사진이 새로 걸렸는데 오늘 처음 봤다 그 분들이 현역이었던 당시 항쟁 당시 그 현장에 참여했던 한사람으로서 참으로 감회가 남다르게 뜨거웠다 순자의 군주민수 라는 말이 있다 임금은 배고 백성은 물이다 물의 힘에 의해 배는 뜨지만 그 물이 성이나 뒤집으면 배는 뒤집힌다는 말이다 요즘 새삼스레 그 고사성어가 생각나는 시간들이다 노자에 보면 임금의 격이 네 가지가 있다고 한다 최상은 부지유지다 임금이 있는지 없는지 모르는 경지이다 그건 아마 현대에 없을 것이다 두번째는 친이예지다 존경 자랑스레 생각하는 임금이다 대통령 국민에게 존경받고 사랑받는 경지의 대통령 그게 두번째 격이다 세번째는 외지다 임금을 두려워하는 따라서 질서는 잡힐지 모르지만 존경받지 못하는 경지의 대통령과 임금이다 마지막은 모지다 모든 백성이 임금을 업신여기고 모멸하는 경지다 부끄러운 경지다 요즘 부끄럽다 이 격랑이 내주 간에 우리가 해법을 제시하지 못하면 여야 없이 정치권 전체가 그럴만한 자격도 없고 국민에 의해서 또 한번 크게 격랑 속에 휩쓸릴 수 있다 그런 차원에서 우리 모두의 갈길을 우리만의 살길이 아니라 국민의 입장에서 국민과 함께 나라를 건지는 구국의 마음으로 힘을 합쳐야 한다 이석현 의원 어제 백만 촛불이 완벽한 비폭력으로 평화행진을 했다 끝난 후에 말끔히 거리 청소까지 하는 수준 높은 시민의식을 외신들도 높이 평가했다 우리 국민은 명예혁명 수준으로 열기가 고조되고 있다 과거 이명박 대통령은 청와대 뒷산에 올라서 촛불을 바라보며 뼈저리게 반성했다고 말했는데 박대통령은 그런 말도 없다 우리는 그동안 박대통령의 선 후퇴와 거국내각을 요구해 왔지만 박 대통령이 실기를 하고 있다 이제 국민들이 그런 주장에 동의 해줄지 우려되는 상황이다 촛불민심은 하나같이 한목소리로 하야하라는 것이었다 하야하라는 국민의 무거운 요구를 귓전에 흘리면서 제 야당인 우리가 언제까지나 선후퇴만 주장해야할 것인지 이제 고민해볼 시점이다 김부겸 의원 공교롭게도 저와 제 세대들은 년 서울의 봄 년 월 민주항쟁 탄핵 촛불 또 쇠고기 촛불 그리고 어제까지 모두 현장에 있었다 열기를 비교한다는 것이 어리석지만 어제는 참 많이 두려웠다 많이 왔다는 것이 두려운게 아니라 그분들이 국민의 주권자로서 당당히 요구하는 목소리 국정을 책임질 수없는 대통령은 물러가라는 그분들의 목소리가 바로 정확하게 나왔다는 것이 두려웠다 또 그렇게 많은 세월동안 부패와 특권 반칙 그리고 이 고르지 못한 여러 사회 조건 때문에 억눌렸던 국민의 분노가 그 지경에 이르렀는데 여의도에서 저희들이 제대로 몰랐던게 아닌가 그게 부끄러웠다는 고백을 드린다 대통령과 대통령을 보좌하는 분들을 정확하게 보셨을 것이다 이 단계가 되면 이것은 어느 정치세력이 적절하게 조정할 수 있는 단계는 지났다고 생각한다 그런 점에서 대통령께서 마지막으로 국민과 국가에 대한 예의있는 결단을 촉구한다 그러면서도 한편 국민들의 분노를 다음 에너지로 소화해낼 수 있는지는 이제 국회와 야 당에게 주어진 문제라고 생각한다 어찌보면 시민들의 목소리는 저기까지 가있지만 저희들은 못난 임금의 인족 때문이 아니라 굶주리는 백성을 위해서 항서를 쓰는 심정으로 다음 단계를 준비해야 되는 것이 아닌가 하는 생각을 했다 박영선 의원 어제 국민의 함성은 새로운 대한민국을 만들자 새로운 대한민국 만들어달라 는 함성이었다고 생각한다 부정부패 기득권에 찌든 낡은 대한민국이 아니라 누구에게나 기회가 골고루 주어지는 정의로운 새 대한민국을 만들어달라는 함성이었다 그런 국민 함성에도 지금 이 시간까지 침묵하며 응답없는 대통령은 더이상 우리들의 대통령이 아니다 그래서 이제 국회가 국민의 명령에 따라서 안정적 하야 질서있는 퇴진 요구를 위한 로드맵을 제시해야 한다고 생각한다 그리고 새로운 대한민국 만들기 위한 로드맵을 제시할 때가 바로 지금이라고 생각한다 그래서 국회법에 따라서 비상시국 전원위원회 개최를 요구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58951,2016-11-13, 금태섭 대변인 오전 현안 브리핑 일시 일 장소 국회 정론관 대통령은 온 국민이 원하는 결단을 하길 바란다 어젯밤 광화문은 만개의 촛불로 빛이 났다 국민들의 단결된 힘을 보여준 뜨거운 밤이었다 대통령이 학생들에 민주주의를 학습할 기회를 선사한 밤이기도 했다 사상 최대의 인원이 모였지만 시위는 그 어느 때보다도 평화로웠다 정부는 오히려 폭력 사태를 바랐겠지만 시민들은 비폭력 을 외치며 정부의 구상을 비웃었다 외신들도 촛불 집회를 보도하며 시위대 목소리는 어느 때보다 컸지만 매우 평화로운 방식으로 시위가 이뤄졌다 고 강조했다 대한민국의 성숙한 민주주의를 세계에 알린 국민들이 자랑스러우면서도 왜 우리가 이런 집회를 해야 하는지 부끄럽고 자괴감이 든다 정부가 사건을 덮고자 시도했던 모든 것들이 실패했다 북풍으로도 물타기로도 사건은 수습되지 않았다 지금의 기득권이 시도하고자 하는 고루하고 비상식적인 악습으로는 절대 정국을 수습할 수 없다 대통령이 산산히 부숴놓은 나라를 국민이 나서서 구하려고 하고 있다 대통령에게 일말의 애국심이라도 남아 있다면 국민들이 바라는 결단을 내리시기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58950,2016-11-13, 기동민 원내대변인 오전 현안 추가 브리핑 일시 일 장소 국회 정론관 재벌과 돈에 굴종하는 검찰은 어느 나라 검찰인가 박근혜 최순실 게이트 수사 중인 검찰 특수본이 대통령 개별면담에 참석한 것으로 확인된 재벌 총수들을 비공개 소환 조사 중이라고 한다 최순실 고영태 안종범 우병우 차은택까지 포토라인에 세웠던 검찰이 재벌만은 예외였다 억의 댓가가 비공개소환인가 이러니 대통령 권력 위에 군림하는 재벌이라는 소리를 듣는 것 아닌가 박근혜 최순실 게이트 에 있어 재벌들은 피해자가 아니다 재벌은 최순실을 비롯한 비선실세들과 짬짜미 행각을 보였고 대통령과 공모하여 사익을 추구한 국정농단의 당사자들이다 국정 혼란을 틈 타 자신들의 이익만을 추구하는 속물적 행각만 보였을 뿐이다 재벌에게 알아서 기는 검찰은 각성해야 한다 법의 심판대에 예외가 있을 수 없다 공개 수사해야 한다 죄가 있다면 엄정하게 단죄해야 한다 차제에 재벌 역시 바로 세워야 한다 대기업 모금창구로 전락한 전경련 역시 해체해야 한다 그것이 국민의 뜻이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58949,2016-11-13, 기동민 원내대변인 오전 현안 브리핑 일시 일 장소 국회 정론관 박근혜 대통령은 촛불 민심을 겸허히 받아들여야 한다 광화문 부산 대구 광주 등 전국 방방곡곡 세계 각국에서 거대한 촛불의 물결이 흘러넘쳤다 유모차 어린아이 중 고생 대학생 어르신까지 온 국민의 하나된 목소리가 뜨겁게 넘쳐흘렀다 민주 평화 정의 질서 등 민주주의의 가치를 몸소 실천한 대한민국 국민 모두가 세계시민이었음을 만방에 보여준 의로운 항쟁이었다 백만 촛불 시민과 오천만 국민의 성숙한 시민 의식에 경의를 표한다 더불어민주당은 이 같은 국민의 뜻을 하늘 같이 받들어 마지막까지 국민과 함께 할 것이다 뜨거운 국민들의 외침이 넘쳐나고 있지만 대통령만 여전히 정신 못 차리고 계신 것 같다 대통령을 면담한 종교인의 입에서 밖은 영하 도인데 청와대는 영상 도 라는 말이 나오고 수능 일 앞둔 고 수험생은 나라가 걱정이다 며 날밤 세우고 있는데 대통령은 잠이 보약 이란 말을 하고 계신다 한심하고 부끄러울 뿐이다 박근혜 대통령은 촛불 민심을 겸허하게 받아들여야 한다 하야 건 퇴진 이건 대통령의 결단만 남았다 청와대를 비선 놀이터 로 만들고 국정을 망가뜨린 죄를 청해야 한다 국민 앞에 진상을 자복하고 법에 따라 철저하게 수사받아야 한다 법정의를 세우는 첫 번째 길이다 둘째 국정에서 완전히 손을 떼고 물러나라 최순실을 정점으로 한 비선실세들의 농간에 놀아나고 편승했던 죄인이 국정을 책임질 수 없다 국회가 추천하고 국민이 인정하는 총리와 내각을 새롭게 만들어 무너진 국정을 바로 세워야 한다 셋째 별도 특검 국정조사를 통해 부끄러운 역사가 반복되지 않도록 대못을 박아야 한다 이를 부정하는 그 누구도 역사의 단죄에서 자유로울 수 없다는 것을 알아야 할 것이다 대통령 조사를 앞둔 검찰에도 경고한다 성역없는 수사와 단죄로 비선실세에 놀아나고 부역했던 과오를 조금이라도 씻기 바란다 국민의 더 큰 철퇴를 자초하지 말라 일각에서는 대통령이 측은지심을 자아내기 위해 검찰 직접 출두조사를 자청한다는 말까지 회자되고 있는 실정이다 검찰 정신 똑바로 차려라 국민의 분노를 외면하고 얕은 술수와 농간으로 민의를 흩트리고 있는 보이지 않는 손들 에게도 경고한다 지금 하려는 모든 것을 그만두고 스스로 죄를 청해야 할 것이다 더 큰 혼란과 화만 불러일으킬 따름이다 대한민국은 민주주의 국가라고 우리가 배워왔는데 돈과 권력만 있으면 다 된다는 거잖아요 고등학생 채린이와 민석이가 말하는 당신들의 죄다 세월호 시간 차라리 몰랐다고 해라 세월호 아이들이 차가운 물 속에서 숨을 아끼며 안간힘으로 죽음과 싸워가고 있을 때 대통령은 어디서 무엇을 했나 정상집무를 봤고 차례나 보고를 받았다 면서 아무 지시도 안했단 말인가 전화보고만 받았다고 하지 말고 직접 무엇을 어떻게 했는지 투명하게 밝혀야 할 것 아닌가 성형시술은 안 받았다 는 해명이 지금 이 시국에 할 소리인가 대통령이란 직책에 있는 분이 알면서도 그리 방치했다는 사실을 국민이 이해하라는 말인가 차라리 몰랐다 고 해라 군대라도 동원했어야 하지 않나 그 참사를 방치하고도 나라가 정상적으로 굴러갔다는 것인가 최소한의 염치도 없는 대통령과 청와대의 해명에 분노할 뿐이다 아이들이 떠난 지 년 반이 흘렀다 연내 인양은 불가능하다고 한다 수습과 진상 규명도 더 멀어져 버렸다 이 모든 역사의 책임은 누가 질 것인지 두렵다 대통령과 청와대 해수부 등 세월호 관련자들은 역사적 책임을 져야 할 것이다 알면서 그렇게 했다면 더 큰 죄를 짓는 것이다 모두가 직무 유기 이고 국가를 믿었던 국민을 배신한 범죄자들이다 낱낱이 진상을 밝히고 책임을 물을 것이다 최순실이 임명했다고 의심받는 부역 장관들 공직자 들은 스스로 물러나라 차은택씨가 김종덕 문화관광부 장관 김상률 교육문화수석 송성각 한국콘텐츠진흥원장의 임명과 관련하여 최순실씨에게 청탁했다 고 진술했다 어디 이들뿐이겠나 문화계 블랙리스트 작성 주범으로 지목되는 조윤선 장관 어처구니 없는 한일군사정보보호협정을 주도하고 있는 한민구 장관 남북관계를 절벽으로 몰아넣은 김관진 안보실장과 홍용표 통일부 장관 경제 파탄에서 자유로울 수 없는 임종룡 내정자 등 국정을 어지럽히며 비선실세에 놀아나고 부역한 관련자 모두 그 자리에 있을 자격이 없다 스스로 물러나 국민의 심판을 받아야 할 것이다 한 일 군사정보보호협정 즉각 중단하고 원점 재검토하라 김관진 안보실장 한민구 장관에게 경고한다 정당성도 없고 국민정서에도 반하는 한 일 군사정보보호협정 즉각 중단하라 정부에서도 못 한 일이다 국정 운영의 정당성을 상실한 박근혜 정부가 추진할 일은 더더욱 아니다 대통령께서도 국민적 공감대 부족으로 거부한 바 있다 박근혜 최순실 게이트 로 나라가 혼란한데 번갯불에 콩 볶아 먹듯 날림 추진으로 국민을 우롱하지 말라 국민은 이 협정의 득실에 대한 당신들의 판단을 신뢰하지 않는다 국민도 무시하고 국회 뜻도 무시하는 한 일 군사정보보호협정 은 결코 용납할 수 없다 나라 안팎이 혼란한 틈을 이용해 졸속 추진 할 문제는 더욱 아니다 나라 걱정은 안중에도 없는 소수 안보마피아들만의 매국행위로 기록될 뿐이다 신중히 판단하고 국민여론을 모아 결정해야 할 문제다 즉각 중단하기 바란다 집회참여자 명을 당장 석방하고 국정농단 공범 우병우 전수석을 구속하라 민정수석실이 최순실 국정농단을 최소 년 전부터 묵인해준 것으로 나타났다 그 핵심에는 우병우 전 수석이 있다 우병우 전 수석은 최순실 국정농단을 알고도 묵인했을 뿐 아니라 청와대 문건 유출을 은폐했다는 의혹을 받고 있다 심지어 정윤회 문건 사건 이 터졌을 때 민정수석실 직원을 통해 한일 전 경위를 회유한 혐의도 받고 있다 직무유기 월권 직권남용의 죄가 명백하다 즉각 구속하여 엄정한 수사를 받도록 해야 한다 검찰과 경찰 모두 본연의 업무에 충실하기 바란다 평화시위 참여자 명을 연행하는 것이 지금 할 일인가 당장 석방해야 한다 법망 밖에서 법질서를 우롱하고 조롱하고 있는 우병우 전 수석을 즉각 구속하여 단죄하는 것이 지금 할 일임을 명심해야 할 것이다 조폭 의리 골프 접대 새누리당은 각성해야 한다 이정현 대표는 여전히 대통령의 참모알 뿐이다 밀려서는 절대 사퇴 안한다 은 뻔뻔함으로 조폭의 의리만 지킬 뿐이다 집권 여당 대표의 모습은 온데간데 없다 오로지 자신을 제값 으로 대접해준 박근혜 대통령에 대한 의리만 지키겠다고 한다 그를 뽑아준 국민에 대한 의리는 단 한 번도 언급하지 않았다 국민의 대표 자격을 가진 사람인지 의심스럽다 이정현 대표는 지금이라도 대표직을 그만두고 청와대로 가시기 바란다 국회는 이정현 대표가 더 이상 머물 곳이 아니다 이 와중에 할인골프에 저녁접대를 받고 있는 일부 새누리당 의원 여러분들도 대오각성해야 한다 지금이 그럴 때입니까 국회 부끄러운 짓들 이제 그만 두기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58947,2016-11-12, 박근혜 최순실 게이트 규탄대회 인사말 일시 토 오후 시 장소 청계광장 무교동사거리 추미애 대표 전국 각지에서 우리 대한민국을 지키기 위해 오신 당원동지 여러분 존경하고 사랑한다 대통령이 나라를 버렸다 그래서 우리 국민도 이미 박근혜 대통령을 버렸다 헌법을 파괴하고 국민을 배신한 사람이 누구인가 대통령의 배역이 공주에서 꼭두각시로 바뀌었다고 국제적으로 조롱받으면서 대한민국 얼굴에 먹칠한 사람이 누구인가 대통령이 국법을 무너뜨렸다 대통령이 헌정질서를 파괴했다 대통령이 직접 나서서 반칙과 특권을 조장하고 비겁하고 비열한 자들이 득세하도록 방조했다 법과 원칙을 철저하게 파괴한 박근혜 대통령이 더 이상 국정운영을 못하도록 해야 한다 청와대와 새누리당은 내치는 국회가 추천해주면 대통령이 임명장을 준 국무총리에게 맡기고 외치는 대통령 자신이 꼭 해야겠다고 말한다 어쨌든 내가 대통령이라는 것이다 박근혜 대통령에게 더 이상 나라의 외치를 맡길 수 있는가 국가 외교안보의 중요 기밀문서를 무자격자 최순실에게 넘기고 최순실의 말만 믿고 개성공단을 폐쇄했다는 것이 대통령이다 나라의 생존을 결정하고 나라의 방향을 결정하는 것이 바로 외교이다 우리나라같이 주요 강의 힘에서 벗어날 수 없고 영향을 받고 있는 나라 지정학적으로 늘 균형을 잡지 않으면 안 되는 나라의 입장에서는 첫째도 외교 둘째도 외교 셋째도 외교이다 이런 중차대한 외교를 박근혜 대통령에게 한시라도 맡길 수 없다 최순실이 챙겨주는 색색옷 입고 최순실이 써준 대로 행동하고 웃으며 해외 순방을 다니는 것이 외교가 아니다 위험천만한 대통령 충동적으로 일을 저지를 수 있는 대통령에게 군 통수권도 내려놓으라는 것이 국민의 명령이다 국가 안위를 최순실에게 박근혜 대통령에게 맡겨놓을 수가 없다 그런데 새누리당은 대통령의 군 통수권 포기는 위헌이다 라며 대통령의 방패막이를 하고 있다 헌법을 파괴한 공동정범 새누리당의 궤변이다 최순실한테 권한을 넘기는 것은 위헌이 아니고 국민과 야당에게 권한을 넘기는 것은 위헌이라는 말인가 손바닥으로 하늘을 가릴 수는 없다 새누리당과 박근혜 대통령은 헌법을 부정하고 헌정질서를 파괴한 공동정범이라고 선언한다 존경하는 당원동지 여러분 대통령을 향한 국민의 분노는 폭발직전인데 민주당의 입장은 너무 조심스럽고 신중하지 않느냐고 답답해하신다 그러나 민주당의 입장은 초지일관 확고하다 박근혜 대통령은 국정에서 손을 떼라는 것이다 수사를 받아야할 대통령이 국정에서 손을 떼야만 검찰 수사도 국정조사도 특검도 제대로 될 것이다 국민이 요구하는 국회 추천 총리도 대통령이 국정에서 손을 떼야만 가능하다 그래서 우리는 박근혜 대통령께 국민에 대한 마지막 도리는 국정에서 조속히 손을 떼고 평화롭고 순조롭게 국정정상화에 협조를 하라고 하는 것이다 박근혜 대통령은 대통령은 자기 자신이라면서 검찰 권력을 이용해 이 사태를 모면하려는 꿈은 깨시기 바란다 국정농단의 몸통이 대통령 자신임을 증명하는 국정농단 부역자들의 진술과 증거가 나날이 쏟아지고 있다 그런데 여전히 검찰과 국정원에는 우병우 전 민정수석의 라인이 포진돼 있다 철저한 진상규명은 말로만 하면서 국민을 속이려 하고 있다 검찰에게도 분명하게 경고한다 검찰권은 국민들로부터 위임받은 것이지 그들 개인의 것이나 그 집단의 것이 아니다 국민이 이렇게 두 눈을 부릅뜨고 검찰 수사를 낱낱이 지켜보고 있다는 것을 똑똑히 알아두라 무엇보다 아무도 대통령을 믿지 못한다 생업을 접고 전국 각지에서 들불처럼 일어서고 우리 아이들이 공부를 손 놓고 일어서고 어르신과 아이들 할 것 없이 나라 걱정에 수많은 국민이 삼삼오오 모여서 외치고 있다 그것은 바로 이제 국민들이 헌법이 대통령에게 부여한 권한을 회수하겠다는 의지의 표현이다 대통령과 새누리당에 경고한다 역사의 수레바퀴를 거꾸로 돌리려고 하지 마라 이제 여러분의 함성으로 요구하자 당당하게 요구하자 대한민국의 주권은 국민 여러분의 것이다 국민 여러분이 명령해주시라 박근혜 대통령은 국정에서 손을 떼라 박근혜 대통령이 지속적으로 국민의 요구를 무시하고 국민의 명령을 거부한다면 더불어민주당은 전면적으로 정권 퇴진 운동에 들어갈 것이다 박근혜 대통령에게 책임을 엄중히 묻는 것은 물론 국권을 파괴한 무도한 세력에게 권력의 주인이 바로 국민이라는 것을 국민이 이제 곧 그 권력을 회수한다는 것을 국민주권 확립운동으로 나아갈 것이다 이것이야말로 우리 대한민국을 공정하고 정의로운 사회로 재구성하는 주권자에 의한 대통합의 역사를 우리가 써나가는 것이다 이제 우리는 위대한 대한민국 국민의 자격으로 명예혁명을 시작하는 것이다 여기에 계신 자랑스러운 민주당 당원동지 여러분 이제 우리 한 분 한 분 손을 잡고 힘을 합쳐서 대한민국 민주공화국을 바로 세우고 헌정질서를 바로 세우며 대한민국의 새로운 역사를 함께 만들어가자 우상호 원내대표 년 전에 저는 살의 나이로 연세대학교 총학생회장으로서 월항쟁을 주도했다 그때 같이 싸웠던 학생들에게 우리의 후배들과 아들딸들이 우리처럼 독재정권하에서 죽어가면서 학업을 포기하고 쓰러져가면서 감옥에 가지 않는 세상을 만들기 위해 싸우자 고 했다 년이 지난 지금 이 약속을 지키지 못하게 됐다 오늘 저의 아들과 딸이 촛불집회에 나오겠다고 했다 그들에게만큼은 더 좋은 대한민국 민주주의가 꽃피고 정의가 살아 숨 쉬는 그런 대한민국을 물려주고 싶었다 그런데 다시 아버지와 아들딸이 거리에 나와 촛불집회를 할 수밖에 없는 다시 민주주의여 만세 를 노래 부르며 눈물을 흘릴 수밖에 없는 지금 이 시국이 너무도 참담하고 개탄스럽다 그러나 더불어민주당은 시민과 함께 국민과 함께 다시 시작해야한다 허물어진 민주주의를 바로 세우고 이 땅을 유린한 자들을 처단하고 제대로 된 정의로운 대한민국을 만들기 위해 다함께 모이신 것 아닌가 많은 국민이 민주당 좀 잘하라고 말씀하신다 잘 알고 있다 그러나 한 가지만큼은 우리 더불어민주당 당원과 국민 여러분에게 제대로 보고 드리겠다 만일 더불어민주당이 없었다면 만일 더불어민주당이 이번 국정감사에서 최순실 게이트를 제대로 파헤치지 않았다면 단언코 이 사건은 역사 속에 묻혔을 것이다 그리고 박근혜는 회심의 미소를 지으며 너희들이 무엇을 알겠느냐 내 마음대로 해먹는다 고 씩 웃고 있었을 것이다 바로 이 최순실 게이트는 더불어민주당 명의 국회의원들이 밤을 새워가며 자료를 찾고 제보를 받고 국정감사에서 새누리당의 방해공작을 뚫고 밝혀내기 시작했기 때문에 이 세상에 나온 것이라고 보고한다 이것이 제 야당의 역할이다 앞으로 더 잘하겠다 국민과 함께 거리에서 싸우고 의회에서 제대로 진실을 파헤쳐서 국민 여러분이 야당 더 잘해라 잘한다 정말 잘한다 는 이야기가 올 때까지 선두에 서서 함께하겠다 우리의 요구는 첫째 박근혜 대통령이 이 진상을 국민에게 소상히 보고하고 자백하고 검찰의 조사를 받으라는 것이다 지금 자기는 관련되지 않았다 잘 모른다 기억나지 않는다 고 이야기하던 수없이 많은 사람들이 다 구속되고 있다 정작 이 사건을 제일 잘 알고 있을 사람이 누구겠는가 대통령이다 바로 그렇기 때문에 가장 잘 아는 사람이 국민에게 자백하고 검찰의 조사를 받아야하는데 입을 닫고 있다 입을 닫고 있을 때 어떻게 해야 하는가 수백만의 국민들이 자백하라고 요구했을 때 자백하게 된다 뭘 잘했다고 입을 다물고 있는 것인가 두 번째는 국정에서 손을 떼라는 것이다 지금까지 최순실에 의지해서 국가를 잘못 이끌어왔기 때문에 손을 떼라고 하는 것이다 잘못을 저지른 사람은 그 잘못을 고칠 자격이 없다 박근혜 대통령이 국정에서 손을 떼야 박근혜 정권이 년간 잘못 이끌었던 국정을 바로 잡을 수 있다 자기 아버지를 미화시키기 위해서 아이들 교과서까지 바꾸려는 잘못된 국정 일본과 만나서 국민의 동의도 받지 않고 덜컥 위안부 합의해주고 돈 억 달랑 받아온 합의 바로 잡아야한다 자기가 했던 정책을 자기가 바로잡을 수 있는가 그렇기 때문에 박근혜 국정농단을 바로 잡는 길은 바로 박근혜 대통령부터 손을 떼게 하는 것이다 이정도 요구도 듣지 않는다면 양심 없는 사람이다 이 요구조건을 받아들여주면 시쳇말로 만화에 나오는 말로 목숨만은 살려주마 다 그러나 이 주장을 받아들이지 않고 청와대에서 버티고 있는다면 더불어민주당은 정권퇴진운동에 나설 것이고 더불어민주당이 나선다면 박근혜 대통령 반드시 퇴진하게 될 것이다 다음 주부터 국회에서 별도의 특검과 국정조사를 관철하기 위해 노력해서 반드시 성과를 내겠다 국회는 국회의 할 일을 하고 거리의 국민과 함께 더불어민주당이 국민의 요구를 성사시킬 때까지 끝까지 함께하겠다 승리하자 +http://theminjoo.kr/briefingDetail.do?bd_seq=58946,2016-11-12, 검찰은 우병우를 즉각 구속 수사하라 박근혜 최순실 게이트는 청와대와 최순실 검찰 새누리당의 합작품이다 청와대와 최순실 그리고 검찰 사이엔 항상 우병우 전 수석이 있었다 이미 우병우 전 수석은 최순실의 국정농단 사건들 미르 스포츠 재단 기금 모금 수사 기밀 유출 등을 알면서도 덮어주었다는 의혹을 받고 있다 문화계 황태자 차은택 씨의 비위 사실들을 알면서도 덮어주었다는 의혹이 밝혀지고 있는 와중에 최순실의 스포츠재단이 문체부의 사업인 스포츠클럽 사업에 개입한 정황을 알고서도 이를 덮어버린 의혹 또한 제기되고 있다 지난 월 경 민정수석실이 스포츠클럽 운영의 투명성 문제를 점검하기 위해 공직 감찰 을 계획했다가 여명 직원들의 출장 당일 갑작스럽게 중단시켰다는 증언이 나온 것이다 우병우 전 수석은 박근혜 최순실 게이트가 드러나는 것도 막으려 하고 사실로 밝혀진 것은 검찰을 통해 축소하려는 방패막이 역할을 해왔다 사회정의를 바로 세워야 될 공직자가 사회정의를 무너뜨렸다 우병우에게 대한민국은 어떤 의미인가 대통령은 무엇인가 우병우를 즉각 구속수사해야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58945,2016-11-12, 진정 애국심이 남아 있다면 박근혜 대통령은 국민의 민심을 받으라 국민들 마음속에 박근혜 대통령은 없다 박근혜 대통령의 해명에도 국정지지도는 이다 아무리 막으려 해도 박근혜 최순실 게이트의 공범들은 대통령의 지시라고 한다 아무리 덮으려 해도 박근혜 최순실 게이트의 비리는 끝이 없다 연설문 고치기 부터 문화계와 체육계를 뒤집다 못해 의료계까지 뒤집어 놓았다 장관들의 인사 뿐 아니라 기업의 인사까지도 사적인 이익을 위해 개입했다 심지어 개성공단 폐쇄와 사드 배치 까지도 관여했다는 의혹을 받고 있다 세월호 시간은 아무리 변명해도 설마 하는 상상만 불러일으키고 있다 이제 박근혜 대통령은 이게 나라냐 는 국민의 질문에 제대로 답해야 할 때이다 박근혜 대통령의 애국심이 조금이나마 남아 있다면 선 후퇴만이 답이다 박근혜 대통령은 국민의 민심을 받으라 +http://theminjoo.kr/briefingDetail.do?bd_seq=58943,2016-11-11, 추미애 대표 전국상인대회 축사 일시 금 오후 시 장소 국회 의원회관 대회의실 추미애 대표 우리 당에 안민석 선의원이 있다 정유라 학생이 경상북도 상주에서 열린 승마대회에서 준우승을 했다 잘하는 선수가 우승하지 못했다고 보고를 받았는지 그 사건 이후에 심판들이 모조리 조사를 받았다 결국 직업공무원제 아래서 자기 직분에 충실한 공무원이 그 사람들 아직 목숨부지하고 있느냐 며 격노한 대통령의 한마디에 년이 지나서 강제 퇴직을 당하는 일이 있었다 대한민국을 벌집 쑤시듯 쑤셔 놓은 최순실 정유라 모녀가 멀리 독일에서 호텔을 구입해놓고 한국에 있는 지인들까지 초청해서 아이 돌잔치를 하는 사진이 오늘 중앙일보 일면에 실렸다 처음 문제제기를 했던 안민석 의원이 이렇게 말했다 최순실이 독일로부터 급거 귀국한 것은 독일에서 자금세탁 범죄는 중범죄여서 엄청난 벌을 감수해야 하니까 그것을 피해서 대한민국으로 도망을 온 것이다 귀국이 곧 도망이었던 것이다 최순실이 우주의 기운을 빌었다는 박 대통령을 팔아서 팔았다기보다는 한 몸이다 대한민국을 말아 먹었다 하지만 결국에는 갈 데가 없어 돌아올 곳은 대한민국이었다 그들이 말아먹은 대한민국의 모습은 어떠한가 청년들은 일자리가 없고 중소상인들은 장사를 하면 할수록 나락으로 빠져들어서 내일이 안보이고 비정규직들은 오늘 잘릴까 내일 잘릴까 전전긍긍하는 생존의 지옥 같은 곳이 됐다 이 모든 것에 아랑곳 하지 않았고 군통수권을 놓기 싫다던 대통령이 만약 세월호 참사 그날 즉시 해군에 출동하라고 명령했으면 아이들을 다 건졌을 것 같다 그런데 그 시간을 대통령은 아직도 대답하지 못하고 있다 어느 날 하루아침에 개성공단 문 닫으라고 그것이 결단이라 했다 이제와서 알고 봤더니 그 결정은 우리가 뽑지도 않은 최순실씨가 했다는 것이다 이제 최순실이 구속되고 나서 아무것도 하지 못하는 대통령이 저 먼 나라에서 트럼프 당선자가 등장하니 갑자기 외치를 해야 한다고 한다 여러분은 인정할 수 있는가 대한민국 국민은 대통령 자격을 인정하지 않은지 오래다 대통령이 혼이 비정상인 사람들을 걱정해서 국정교과서를 만들어야 한다고 했는데 그것이 얼마나 억지이고 황당한 것인지 묻고 있는 것이다 이런 나라에서 이제 나라를 바로세우는 것은 민주시민의 역량인 것이다 여러분의 분노가 하늘을 찌른다 나라의 미래를 우리 스스로 만들고자 하는 마음으로 여러분께서 모이셨다고 생각한다 우원식 을지로위원장과 우리 을지로위원들에게 많이 환호해주셨는데 더불어민주당은 상가 임차인들을 보호하고 상가임대차보호법 제대로 다듬는 일을 계속 할 것이다 여러분 말씀 하시는 카드 수수료 인하도 우리당 정책의 우선순위에 있다 홍미영 구청장이 많이 격려해주셨는데 재벌들이 하는 복합쇼핑몰을 못하게 우리가 힘을 합치겠다 부산에서 마산에서 저 멀리서 오셔서 이렇게 구호를 외칠 때 그 마음을 왜 제가 모르겠는가 아까 나온 노래에서 내일도 해가 뜬다 고 했듯 우리의 미래를 포기할 수 없다 함께 하겠다 축하한다 힘내시기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58940,2016-11-11, 윤관석 수석대변인 추가 현안 브리핑 일시 오후 시 분 장소 국회 정론관 더불어민주당은 촛불민심과 함께 무너진 민주공화국 바로 세우겠다 더불어민주당은 내일 오후 시 청계광장에서 당 지도부와 전국각지에서 모인 수만명의 당원들이 함께 박근혜 대통령은 국정에서 손 떼라 를 외치며 박근혜 최순실 게이트 전국당원규탄대회 를 개최한다 민주당은 당원규탄대회를 통해 대통령이 몸통으로 드러난 전대미문의 국정농단 국기문란 게이트로 무너진 대한민국의 기틀을 바로 세우기 위해 당의 의지를 하나로 결집할 것이다 또한 직후에 예정된 차 촛불집회에 당 지도부와 전국의 당원들이 모두 참여하여 주권자인 국민의 민심을 경청하기로 했다 한 가지 강조하겠다 내일 집회는 전국 각지에서 수많은 인파가 모일 것으로 예상된다 집회는 평화적이고 질서 있게 성숙한 민주주의의 참모습을 보여주어야 한다 오늘 촛불행사 주최 측도 철저하게 평화행진을 하겠다고 선언했다 어떠한 폭력적 행위나 시도도 단호히 배격한다 촛불집회에 참여하는 국민들께서 깨어있는 시민의식으로 민주공화국을 파탄에 이르게 한 박근혜 대통령에게 진정한 민주주의가 무엇인지 똑똑히 보여주실 것으로 기대한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58939,2016-11-11, 금태섭 대변인 오후 현안 브리핑 일시 오후 시 분 장소 국회 정론관 더불어민주당은 언제나 국민 편에 서겠다 심상정 정의당 대표가 더불어민주당의 대통령 선 후퇴 주장은 박근혜 대통령과 동거하는 내각을 만들겠다는 뜻 이라고 말씀했다 야 당 대표가 함께 모여 박근혜 대통령의 국회 추천 총리 수용 제안을 거부하고 오는 일 촛불집회에 참여하기로 하는 등 공동 행보를 하기로 합의한 지 며칠 지나지도 않아서 우리 당의 행보에 대해서 오해를 초래할 소지가 있는 발언을 한 점에 대해서 유감을 표한다 더불어민주당은 제 야당으로서 항상 국민들의 뜻에 따라 책임 있는 행보를 해왔다 당 지도부와 의원 전체가 촛불집회에 적극적으로 참여하기로 한 것도 언제나 국민 편에 서겠다는 의지의 표명이다 박근혜 대통령의 선 후퇴의 시기와 절차에 대해 야권이 머리를 맞대야 하고 힘을 합쳐서 국민들의 바람을 이루어내야 한다 국정 정상화 해법은 정부만 모르는 것인가 이준식 사회부총리 겸 교육부장관이 오후에 내일 집회에 관련된 담화를 했다 박근혜 정부 출범 이후 최대 규모로 예상되는 집회가 평화적이고 합법적으로 치러졌으면 하는 것은 우리 모두의 바람이다 정부도 집회에 참여한 국민들의 안전과 자유로운 의사표현을 위한 지원을 아낌없이 하길 바란다 이 부총리가 걱정하는 국정 정상화 도 마찬가지이다 우리 국민들이 진정으로 바라는 바이다 오늘 모두가 지켜보았듯이 대통령이 직접 나서지 못하고 국무총리도 직접 나서지 못하는 상황이다 국민들을 불안하게 하는 것은 바로 정부 자신이다 내일 우리 국민들은 가장 큰 촛불로 민심을 보여줄 것이다 헌법 유린 세력은 위헌을 거론할 자격이 없다 대통령의 선 후퇴에 대해서 청와대와 새누리당은 위헌 이라고 규정했다 청와대의 한 참모는 헌법상 규정돼 있는 것을 하지 말라고 하는 것은 대통령에게 위헌적 행동을 하라는 것과 같다 라고 했다 이정현 새누리당 대표는 문재인 전 대표의 국군 통수권 이양 주장에 대해 위헌이자 반헌법적 주장 이라고 했다 정진석 원내대표는 원내대책회의에서 인쇄물까지 나눠주며 위헌적 주장이 두 야당 사이에서 난무하고 있다 라고 했다 그러나 헌법 학자들은 대통령의 선 후퇴가 위헌이 아니라고 입을 모아 말하고 있다 선 후퇴는 총리에게 제반의 실질적인 권한을 위임하겠다는 정치적 의미를 갖는 것이어서 헌법에 위배되지 않는다 헌법을 위반한 것은 국기문란을 일으킨 대통령을 비롯한 청와대와 그에 동조한 새누리당이다 헌법 유린 세력은 헌법을 거론할 자격이 없다 청와대와 새누리당은 뒤늦게 헌법 공부하지 말고 대통령의 선 후퇴를 설득하기 바란다 수사 가이드라인 제시하는 청와대 아직도 정신 못차렸나 대통령이 검찰 조사가 임박해왔다 그 가운데 청와대에서 법률 검토가 거의 완료되었다고 한다 한 언론보도에 따르면 대통령은 최측근에게 원론적인 이야기를 했는데 이들이 호가호위하거나 권력을 남용했다는 쪽으로 가닥을 잡았다고 한다 명백한 수사 가이드라인이다 회장님이 좋아하는 일은 연설문 고치기 였는데 대통령이 좋아하는 일은 선 긋기 와 수사가이드라인 제시 인 모양이다 국민이 인정하지 않는 대통령이다 검찰은 더 이상 대통령의 가이드라인에 따라서는 안 된다 검찰 역시 현 시국에서 국민의 심판을 받고 있다는 점을 잊어서는 안 된다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58937,2016-11-11, 금태섭 대변인 오전 현안 브리핑 일시 금 장소 국회 정론관 정부는 국민에 법치를 얘기할 자격이 없다 최순실의 국정농단에 주로 대포폰이 사용되었다 안종범의 압수수색에서도 대포폰이 나왔다 정호성은 대포폰으로 대통령과 통화까지 했다 대포폰이 불법이라는 것은 일반 국민들도 잘 알고 있다 박근혜 대통령은 년 월 대포폰과의 전쟁을 선포한 일도 있다 하지만 뒤에서는 불법 대포폰으로 온갖 불법을 저지르고 있었다 조직폭력배나 마약사범들이 수사기관의 추적을 피하고 신분을 감추기 위해 사용하는 대포폰을 청와대 고위공직자들은 매일같이 사용하였다 대통령과 청와대는 법 위에 군림하고 국민을 속였다 정부가 국민들에 법을 지키라 고 말할 수 있는 정당성조차 잃었다 무너진 법치를 세우는 길은 대통령의 선후퇴 뿐이다 외교안보를 국내정치용 땔감으로 사용하려는가 박근혜 최순실 게이트는 종착역도 모를 지경으로 새로운 범죄사실이 속속 드러나고 있다 하지만 청와대는 박대통령의 선퇴진이라는 해법은 무시한 채 미국대선 결과를 빌미로 국민을 상대한 위험한 도박을 시작했다 국가안전보장회의 상임위 개최 트럼프 당선인에게 전화 정상회담 진행 등을 하며 외치 는 대통령이 할테니 국회는 총리 추천을 해서 정국을 안정시키자는 것이다 여전히 국정을 대통령 중심으로 운영하겠다는 것이다 트럼프 당선 대외적인 상황 변화 안보 불안을 내세워 국정 주도권을 찾겠다는 청와대의 너무나 뻔히 들여다 보이는 셈법이다 내치 외치 구분은 아무런 의미없다 대통령의 외교안보 행보에 지지와 신뢰를 보낼 국민은 없다 국민은 아직 대통령을 용서하지 않았다 정부가 나서서 갈등을 조장하는가 내일 있을 박근혜 최순실 게이트 규탄 대규모 집회를 앞두고 정부의 행태가 수상하다 행정자치부는 집회에 참여하는 공무원들을 징계하겠다고 한다 경찰은 근무복 대신 기동복과 군화를 착용한다고 한다 교육부총리는 법무부장관과 행자부 장관을 대동하여 공무원과 교사들의 불법행위를 엄단하겠다는 대국민담화를 예고했다 촛불집회를 강경대응하여 평화로운 집회를 갈등의 계기로 삼으려는 것인가 대통령의 사과 이전으로 돌아가겠다는 너무나 섬뜩한 상황인식이다 정부는 더 이상 국민들을 자극해서는 안된다 갈등을 봉합하고 해법을 제시하는 것이 정부의 역할이지 갈등을 조장하여 정권의 위기를 모면하려는 것은 정부의 역할이 아니다 국민들은 바보가 아니다 검찰은 최순득과 장시호를 즉각 수사하라 최순실씨 일가는 범죄조직을 방불케 하는 온갖 범죄를 저질렀다 구속된 최순실 외에도 최순득과 장시호가 있다 최씨 자매의 측근은 세상 사람들은 최순실을 비선실세라고 하는데 사실 최순득이 진정한 실세 라고 밝혔다고 한다 최순득 역시 대통령을 대신해 주사제를 대리 처방 받았고 최순득 아들의 베트남 사업을 도운 사람이 베트남 대사가 되기도 했다 최순득의 딸 장시호 역시 국정 농단의 핵심적 역할을 수행했다는 의혹을 받고 있다 박근혜 최순실 게이트 수사를 한 검찰은 항상 한 발 느린 수사를 해왔다 언론이 의혹을 제기하고 나서야 관련자를 소환하고 구속하는 식이다 박근혜 최순실 게이트의 모든 공범들에 대해 즉각 수사를 촉구한다 정유라의 자퇴 진상조사가 우선이다 최순실의 딸 정유라가 이화여대에 자퇴서를 제출했다 검찰조사와 특별감사가 이루어지는 상황에서 본인의 입학과 학사관리에 대한 불법행위를 자퇴로 덮으려는 모양이다 불법행위에 대한 조치는 입학취소나 출교 제적이다 재입학이 가능한 자퇴서는 절대 수리해서는 안된다 지금 정유라가 해야할 일은 도피생활을 그만두고 국내로 들어오는 것이다 검찰조사에 성실히 응하고 불법행위에 대한 해명을 해야 한다 그 이후의 조치는 그다음에 결정 될 일이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58936,2016-11-11, 이재정 원내대변인 오전 현안 서면 브리핑 국정농단의 몸통은 박근혜 대통령이다 헌정 질서를 파괴하는 국정농단이 대통령에 의해 최순실을 통해 자행되었음이 드러나고 있다 국정농단의 몸통이 결국 박근혜 대통령 본인이었음을 증명하는 국정농단 부역자들의 진술과 증거가 쏟아지고 있다 재단의 모금을 세세하게 지시했다는 안종범 수석의 진술 청와대가 생산한 문건을 최순실에게 검토 받으라고 대통령이 직접 지시한 정호성 부속비서관과의 통화녹음에 이어 김종덕 문체부장관과 김상률 교육문화수석 송성각 콘텐츠진흥원의 인사를 최순실에게 청탁했다는 차은택의 진술이 나왔다 법령과 시스템을 통해 원칙대로 투명하게 이루어져야 하는 장관 인사 청와대 인사 공공기관 인사 절차가 대통령과 그 비선들에 의해 무너졌다 대통령이 법을 무너뜨렸다 대통령이 헌정 질서를 파괴했다 대통령이 직접 나서 반칙과 특권이 판을 치고 비겁하고 비열한 자들이 득세하도록 적극 방조했다 법과 원칙을 파괴한 대통령의 존재 자체가 곧 국정의 마비이자 국정의 공백이다 박근혜 대통령 국정에서 손 떼라 우병우를 구속수사하지 않는 것은 검찰의 직무유기다 우병우 전 민정수석에 대한 검찰의 구속 수사가 조속히 이뤄져야 한다 최순실 차은택 등 비선실세들의 국정농단을 우병우 전 수석이 묵인 방치 은폐한 직무유기의 증거들이 속속 드러나고 있다 년 말 정윤회 문건 수사 당시 관련 경찰에 대한 회유와 협박 차은택과 이성한의 전횡 묵인 롯데 압수수색 정보의 미르 측 사전 유출 의혹 등은 빙산의 일각에 불과하다 박근혜 정권 내내 이뤄진 최순실 일파와 문고리 청와대 수석들의 국정농단을 실세 민정수석인 우병우가 모를 수 없다 오히려 우병우 본인이 국정농단의 조정자 역할을 했다는 강력한 의심마저 지울 수 없다 검찰의 늦장 수사로 이미 상당량의 증거들이 폐기 훼손되었을 것이다 지금 이 순간에도 우 전 수석은 관련자들과 말을 맞추고 증거를 지우고 있을지 모른다 검찰은 국정농단과 직무유기의 진실을 파묻으려는 우병우를 당장 구속해야 한다 우병우 불구속은 검찰의 직무유기이다 우병우 살리면 검찰이 죽다는 세간의 경고를 검찰은 명심해야 할 것이다 민중총궐기 불법행위 엄단하겠다는 정부 적반하장이다 이준식 부총리가 오늘 대국민담화를 통해 민중총궐기 집회의 평화적 진행 당부와 불법행위는 엄단하겠다는 입장을 밝힐 예정이다 집회시위의 자유보장을 위한 대안적 해결방안이라며 행진 제한통고를 결정했던 경찰도 근무복 대신 기동복과 군화를 착용시키며 강경모드로 돌변하고 있다 적반하장이다 지금 전방위적 불법을 일삼고 국정을 농단하고 있는 이가 누구인가 국민들의 집단적인 상실감과 분노 앞에 감히 불법을 운운하는가 엄단을 이야기 하는가 정부의 반성의지가 진정 라도 있었던 것인지 의심스럽다 불법이란 이름으로 국민을 겁박하지 말라 평범한 시민 과 좌파 시민단체 라는 전형적 선긋기 프레임으로 민심을 호도할 생각도 하지 말라 이미 법원은 청와대 행진으로 인한 교통불편이 국민의 집회와 결사의 자유보장 보다 클 수 없다는 결정을 내렸다 대한민국의 모든 권력은 국민으로부터 나온다는 헌법의 조문보다 더 우월한 가치는 있을 수 없다 황교안 총리와 국무위원들은 진실을 요구하는 국민에 답하라 진실을 요구하는 국민의 눈이 국회를 향하고 있다 오늘 박근혜 최순실 게이트의 진상을 규명하기 위한 국회 긴급현안질문이 열린다 질문에는 여당 의원의 참여 없이 야당 의원 인이 나선다 그간 사실이 아니다 모른다 확인된 바가 없다 수사 중인 사안이라 말씀드릴 수 없다 는 식의 답변으로 박근혜 최순실 게이트의 실체를 감추는데 급급했던 황교안 총리와 박근혜 정부의 국무위원들이 언제까지 모르쇠로 일관할 수 있을 것인지 분노한 국민이 지켜보고 있다 오로지 대통령의 안위만을 위한 부역자로 남을 것인지 진실을 밝힌 공직자로 남을 것인지 이제는 선택하라 +http://theminjoo.kr/briefingDetail.do?bd_seq=58935,2016-11-11, 제 차 최고위원회의 모두발언 일시 금 장소 국회 본청 당대표 회의실 추미애 대표 국민들이 대한민국 국민 노릇하기가 힘들다고 한다 주말을 쉬지 못하고 오늘을 걱정해야하고 나라의 장래를 걱정해야하고 내 자식의 미래를 걱정해야하는 위기의 세상에 살고 있는 대한민국 국민이다 다시 한 번 말씀드린다 국민이 창피해하는 대통령 국민이 대통령을 향해서 대통령 자격이 없다고 외치는 대통령은 한시바삐 국정에서 손을 떼시라 국정에서 확실하게 손을 떼야지만 국정조사와 특검도 의미가 있는 것이다 국정에서 한시바삐 손을 떼고 국회 추천 총리를 받으셔야 한다 그저 헌법에 있는 대로 대통령의 명령을 받드는 국회 추천 총리를 말하는 것이 결코 아니었다 자고 일어나면 대통령의 퇴진 사유가 눈덩이처럼 수북이 쌓여있다 스스로는 아무것도 하지 못했던 대통령 헌법과 법률을 다 어긴 대통령 외교 안보의 중요한 기밀을 무자격자에게 넘긴 대통령 최순실씨가 전쟁하라고 하면 전쟁도 할 수 있겠다는 위험스런 대통령 대통령이 최순실씨의 말만 듣고 개성공단을 폐쇄했다고 하니 그런 걱정이 무리가 아닌 것이 드러났다 그런 대통령을 믿지 못하니 군 통수권도 내려놔야 한다고 하는 것은 너무나 당연한 것이다 외교는 더욱 중요하다 우리나라 같이 작은 나라 주요 강의 영향을 크게 받는 나라 지정학적으로 늘 균형을 잡지 않으면 안 되는 나라의 입장에서는 첫째도 외교 둘째도 외교 셋째도 외교이다 외교는 나라의 생존을 결정하고 나라의 방향을 결정하는 대통령의 일 중 가장 중요한 일이다 그런데 대통령은 외교만 붙들고 있겠다하고 부역자 집단 새누리당은 군 통수권을 내려놓으라고 하는 것은 위헌적인 발상이라며 방패 역할을 자처하고 있다 트럼프 당선자가 대한민국의 박근혜 대통령을 구할 수 없다 박근혜 대통령의 국민에 대한 마지막 남은 도리는 국정에서 손을 떼고 수사를 제대로 받으면서 국민을 더 이상 지치게 하지 말고 평화롭고 순조롭게 국정 정상화에 협조하는 길 뿐이다 우상호 원내대표 나라가 매우 어지럽고 혼란스럽다 국민의 불안도 가중되고 있다 그러나 국회에서는 지금 이 시간에도 열심히 예산 소위가 열리고 있고 각 상임위별로 민생법안들이 빠르게 통과되고 있다 각 상임위별로 적게는 건 많게는 건 가까운 법안들이 연일 심의되고 통과되고 있다 더불어민주당은 민생예산 민생법안 심의에 만전을 기하고 있다는 점을 국민께 보고 드린다 이 혼란을 조기에 진화하고 수습해야할 새누리당 지도부의 행태가 점입가경이다 오로지 친박 지도부로만 이뤄진 새누리당이 대통령 보호에만 혈안이 되서 국민들의 민심을 외면하고 있다 최순실 게이트의 진상규명을 방해하고 일방적인 국정 운영의 하수인 홍위병 역할을 했던 사람들이 왜 아직까지 버티고 있는지 이해할 수가 없다 저 타오르는 불꽃 민심은 새누리당의 변화도 촉구하고 있는 것이다 민심보다 대통령 보호가 더 우선인 친박 지도부는 국민의 심판을 면치 못할 것이다 변화를 위해서 친박 지도부도 모든 것을 내려놓으시라 한줌도 안 되는 저 권력을 움켜쥐고 얼마나 더 버틸 수 있다고 생각하시는가 국민의 민심을 따라주시기를 바란다 어제 제가 철저한 수사를 촉구하고 있던 검찰청 앞 더불어민주당 의원들의 농성장에 방문했다 어떻게 알고 그 시간에 어버이연합이 버스 대로 몰려와서 이루 말할 수 없는 폭언과 정말 상상할 수 없는 행위들을 했다 제가 태어나서 가장 많은 욕을 들었다 왜 이런 행태가 벌어지고 있는가 전경련이 어버이연합에 자금을 대주고 그 어버이연합이 야당을 능멸하고 욕하고 우리를 빨갱이로 매도하는 행위를 지원해왔기 때문에 이런 일이 생긴 것 아닌가 이 사람들이 해왔던 수없이 많은 폭력적인 집회나 폭력적인 행위를 아무도 처벌하지 않았기 때문에 생긴 일이 아닌가 검찰은 즉시 어버이연합에 대한 수사에 착수하라 어제 제가 그 자리에서 보면서 이런 무법천지가 있는지 황당했다 검찰이 어버이연합에 대한 수사를 하지 않는다면 저는 반드시 상임위에서 이 문제를 제기하겠다 철도파업 해결을 위해서 국토위원회 조정식 위원장 등 여러 사람들이 노력하고 있다 코레일이 이 문제에 대해서 여전히 소극적이다 약간 변화된 타협안이 있지만 그러나 노사 합의가 원만하게 이뤄질 수준은 아니라고 판단된다 장기화된 철도파업을 빨리 해결해야 한다 금주 중에 다시 한 번 전향적인 입장을 가지고 노사가 머리를 맞대서 국민들의 불편이 최소화되도록 해야 한다 코레일 사장은 그동안 상임위에서 고압적인 태도로 일관했다 원만한 타협을 촉구하는 야당 의원들에게 왜 노조 편을 드냐 고 오히려 대들었던 사람이다 그런 태도로 어떻게 원만한 자율 협상이 이뤄질 수 있는지 경고하면서 차제에 이번 주 내에 철도파업이 원만히 해결돼서 철도 운영이 정상화 될 수 있도록 협조해 줄 것을 당부 드린다 김영주 최고위원 내일 서울 광화문 광장을 비롯한 전국 곳곳에서는 박근혜 최순실 게이트 의 진상규명과 대통령의 퇴진을 요구하는 수십만이 넘는 시민들이 모일 예정이다 우리당도 내일 집회에 시민들과 함께할 것이다 정부가 내일 집회를 앞두고 잠시 뒤에 대국민 담화 를 발표한다고 한다 교육부 장관 법무부 장관 등이 나와 평화적 집회를 당부하고 불법 행위가 있으면 엄단하겠다는 내용의 담화를 발표할 것이라고 한다 제대로 된 정부였다면 그와 같은 내용의 대국민 담화 가 논란이 되지도 않을 것이다 그러나 대통령에서부터 청와대 수석 장관 차관을 비롯한 고위공직자들이 헌법과 법률을 위반해 검찰의 수사를 받고 있는 정부가 과연 그와 같은 대국민 담화 를 발표할 자격이나 있는지 국민들은 실소를 금치 못하고 있다 법을 지키지 않은 것은 대통령과 정부이지 국민들이 아니다 국민들은 불법은 대통령이 저질렀는데 국민 보고 불법행위 하지 말라고 하는가 법무부 장관은 당신들 정부의 불법이나 엄단하라 라고 말씀하고 계신다 국정농단을 넘어서 국정파탄에 이른 지금의 상황에 분명한 책임이 있는 각 부처 장관들은 대국민 담화 를 할 게 아니라 대국민 사과 부터 해야 한다 내일 시민들이 모일 예정인 광화문 광장에는 국가의 잘못으로 자식을 떠나보내고도 일이 넘도록 광장을 떠나지 못하고 계신 세월호 참사 희생자 유가족 분들과 아직도 돌아오지 못하고 있는 명의 실종자 가족들이 계신다 정치인으로써 아이들을 지키지 못하고 아직까지도 진상을 제대로 규명하지 못하고 있는 데 대해 부끄럽고 죄송할 따름이다 세월호 참사에서 국가의 책임을 논할 때 아직도 밝혀야 할 것들이 많이 남아 있다 최근 국민들께서는 세월호 참사의 진상규명과 관련해 박근혜 대통령이 참사 당시 어떤 역할을 하셨는지 궁금해 하고 있다 바로 세월호 참사 당시 시간 동안 대통령이 어디서 누구와 무엇을 했고 어떤 지시를 내렸느냐는 문제이다 그런데 박근혜 대통령은 아직도 이를 밝히지 않고 있다 세월호 특별법 제정 과정과 세월호 특별조사위원회의 조사과정에서도 문제의 시간의 벽은 넘지 못했다 대통령과 정부 여당이 세월호 특별법을 위헌적으로 무력화 시켰고 여당에서 추천한 세월호 특조위원들은 대통령의 시간 을 덮기 위해 온몸을 던졌다 그러나 진실은 그것을 감추려는 자들이 미처 생각하지 못한 방식으로 더 빨리 모습을 드러내는 법이다 대통령의 시간 에 대한 진상규명 요구는 단순한 호기심이나 정치적 공세의 차원에서 나온 것이 아니다 과연 헌법에 따라 재난에서 국민의 생명을 보호해야 할 국가의 최고책임자인 대통령이 국민이 가장 국가를 필요로 할 때 대통령으로써 마땅히 해야 할 헌법적 의무를 다 했느냐는 것이다 그리고 국민은 대통령이 헌법에 따라 그러한 의무를 다했는지 알 권리가 있다 이제 대통령이 스스로 밝혀주십시오 그리고 만약 국민의 생명을 지킬 헌법적 의무를 시간이 아니라 단 초도 방기했다면 국민들께 사과하십시오 도대체 대통령은 아이들이 죽어가고 있던 오전 시부터 오후 시까지 도대체 어디서 누구와 무엇을 하셨는지 이제 국민들께 직접 밝히시기 바랍니다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58930,2016-11-10, 금태섭 대변인 추가 현안 서면 브리핑 행정자치부는 공무원들의 집회 참여를 막지 말라 행정자치부가 일 서울 광화문에서 열리는 민중총궐기 에 공무원이 참여하지 않도록 하라고 중앙 부처와 지방자치단체에 공문을 보냈다고 한다 집회의 자유는 헌법 상 국민의 기본권이다 공무원이라고 해서 헌법상의 권리를 제약받을 이유가 하등 없다 국정농단의 진실에 누구보다 큰 충격에 빠진 사람들이 바로 공무원들이다 자신들이 국가와 국민을 위해 일한 줄 알았더니 국정농단 국기문란에 협조한 꼴이 되었기 때문이다 그런데 그런 공무원들은 항의의 목소리조차 낼 수 없다는 말인가 행자부는 언론의 취재에 참가하지 말라는 의미가 아니라 공무원들 스스로 조심하라는 의미였다 고 주장했다고 한다 어처구니없는 해명이다 행자부는 공무원들이 국민의 한 사람으로서 보장된 헌법상의 기본권을 보장받도록 할 것을 엄중히 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58929,2016-11-10, 검찰은 우병우를 즉각 구속 수사하라 박근혜 최순실 게이트 핵심의 한사람이 우병우 전 민정수석이다 이미 우병우 전 민정수석은 가족회사 정강 자금횡령 의혹 아들 의경 보직 이동과정의 직권남용 의혹 등으로 조사를 받았지만 최순실 국정농단 공범 혐의에 대해서는 아직도 조사를 받지 않았다 이미 우병우 전 민정수석은 최순실의 국정농단 사건들 미르 스포츠 재단 기금 모금 수사 기밀 유출 등을 알면서도 덮어주었다는 의혹을 받고 있다 문화계 황태자 차은택 씨에 대해 내사를 하여 비위 사실들을 알면서도 덮어주었다는 의혹 또한 받고 있다 검찰은 도대체 무얼 하는가 우병우 황제 조사 로 검찰의 위상은 땅바닥으로 떨어졌다 오늘에야 검찰은 우병우 전 민정수석의 자택을 압수수색했다 이제 남은 것은 구속 수사이다 정치검찰의 오명을 벗으려면 우병우 전 민정수석의 혐의들을 낱낱이 조사하여 국정농단의 진실을 밝히길 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58927,2016-11-10, 금태섭 대변인 오후 현안 브리핑 일시 목 장소 국회 정론관 국민들은 이러려고 세금을 낸 것이 아니다 기획재정부가 국회에 최순실 예산 자료를 제출하였다 년 정부예산안에 억원이 배정 됐다고 한다 역시나 문화체육관광부 예산이 억으로 가장 많았다 최순실은 정부를 완전히 통제하면서 한 부처를 본인 것으로 만들었다 이른바 문화최순실관광부 이다 국정농단의 진실이 드러나지 않았다면 국민들의 소중한 혈세 억원이 최순실 일당의 재산 부풀리기에 사용될 뻔 했다 정부가 스스로 밝힌 규모만 해도 이 정도이니 실제로 얼마나 될 지 걱정이 된다 얼마나 많은 공무원들이 본인들도 모른 채 박근혜 최순실 게이트의 실무역할을 하고 있었는지 상상조차 어려울 지경이다 국민들은 내가 이러려고 세금을 냈나 자괴감이 들고 괴롭다 는 말을 하고 있다 박근혜 최순실 게이트는 대한민국을 화장시킬 장작더미이다 불길이 더 커지기 전에 꺼뜨려야 한다 년 정부예산은 단 한 푼도 박근혜 최순실 게이트를 위해서 사용될 수 없다 순실트레이너 순실성형외과 의사 순실미용사까지 순실공화국은 끝났다 최순실이 박근혜 대통령의 사생활 전반을 좌지우지했다는 정황이 속속 드러나고 있다 이번에는 순실미용사 이다 대통령의 올림머리가 최순실 단골 미용사의 작품이고 여러 차례 해외 순방에도 동행했다고 한다 순실트레이너 순실성형외과 의사 순실미용사는 최순실과의 인연으로 대통령에게 낙점되었다 최순실의 트레이너였던 윤전추 행정관은 청와대 급 행정관에 특채되었다 최순실의 단골 성형외과 원장은 대통령의 해외 순방에 여러 차례 동행했고 병원 제품이 청와대 명절 선물세트로 들어가기도 했다 최순실의 단골 미용사 역시 대통령 해외 순방에 동행했다 최순실에게 박근혜 대통령은 소꿉놀이용 바비인형이었나 라는 언론의 비아냥은 국민 모두를 부끄럽게 만들었다 이제 박근혜 대통령의 순실공화국은 무너졌다 국민 모두가 아는 사실을 청와대도 인정해야 한다 대통령은 선 후퇴 입장을 분명히 밝히고 세 번째 사과를 준비하라 대통령의 두 번째 사과가 있은 지 일주일이 지났다 대통령 하야를 촉구하는 촛불집회에는 만 명의 국민들이 모였고 까도까도 끝을 모를 박근혜 최순실 게이트에 성난 민심은 가라않지 않고 있다 국민들은 이미 대통령을 포기하였다 그런데도 대통령은 국정 주도권을 놓지 않겠다는 입장을 고집하고 있다 대통령은 투아웃이 된 상태이다 선 후퇴 입장이 선행되지 않은 채 세 번째 사과를 하거나 세 번째 사과에서 선 후퇴 입장을 밝히지 않는다면 국민들은 이제 삼진 아웃 카드를 꺼낼 것이다 기다린다고 변할 것은 아무것도 없다 미르와 대기업 모금은 민원의 댓가인가 지난해 월 대통령이 대기업 총수들과 독대하기 전에 청와대 경제수석실이 해당 기업의 민원을 받았다고 한다 일부 기업은 경영권 승계나 총수 사면과 관련한 협조가 필요하다는 요구를 노골적으로 했다고 한다 최대주주인 국민연금공단은 삼성물산의 합병에 찬성해 총수 일가의 경영권 승계를 도왔다 최태원 회장과 이재현 회장은 특별사면 되었다 대통령은 년 대선 후보 토론회에서 역대 정권마다 반복되어 온 권력형 비리 정말 부끄러운 일이다 하루하루 성실하게 살아가시는 국민들이 살맛 안 나시게 하는 그런 일 또 국가적으로도 얼마나 망신인가 라고 말씀하셨다 그런데 그런 박 대통령은 최순실을 위해 대기업 민원 창구 역할까지 한 것이다 지금은 그 누구도 아닌 대통령 때문에 망신스럽다 보건복지부는 의료법과 마약류 관리법 위반 사실을 즉각 조사하라 의사도 아닌 최순실씨가 대통령의 의료에 관여하였다고 한다 기밀로 취급되는 대통령의 건강문제나 대통령 주치의가 담당하는 건강관리도 최순실이 최종 관여자였다 이 과정에서 많은 불법이 저질러졌다 최순실의 성형외과는 향정신성의약품 관리대장을 파쇄하였고 최순실은 최보정이라는 가명으로 진료를 받았다고 한다 차움의원은 보호자도 아닌 최순실에게 대리처방을 하였고 주사제를 직접 주었다고 한다 성형외과는 진료기록부를 허위로 작성하고 마약류 대장을 폐기한 것이다 의료법 및 마약류 관리에 관한 법률을 위반한 것이다 차움의원은 약을 직접 조제할 수도 없고 더구나 주사제를 환자나 보호자에게 건낸 것은 중대한 의료법 위반이다 보건복지부는 그동안 언론에 보도된 내용만으로도 즉각 조사에 나서야 한다 때늦은 조사로 기록들이 모두 폐기된 후 자료폐기를 이유로 관련의사들에 대해 가벼운 행정처분만으로 끝난다면 보건복지부도 박근혜 최순실 게이트의 공범이 되는 것이다 서울대병원장 출신이 장관이라서 그런가 라는 의혹이 되지 않도록 하길 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58925,2016-11-10, 이정현 대표는 박근혜 최순실 게이트가 반헌법적임을 직시하라 우리당의 문재인 전 대표가 어제 시민사회 관계자들과 만난 자리에서 내치와 외치를 구분할 수 없다 국가정보원 군통수권 계엄권 사법부나 헌법재판소 대법원장등 많은 인사권을 포함해 전반을 거국 중립 내각에 맡겨야 한다 민심이 요구하는 하야는 아니더라도 적어도 그 정도는 가야 민심에 그나마 부응하는 길이 아닐까 생각한다 라고 지적한 바 있다 이에 대해 새누리당 이정현 대표가 오늘 반헌법적 이며 군 통수권과 계엄권까지 국무총리에게 이양해야 한다고 주장한 것은 도저히 납득할 수 없다 헌법과 국정을 완전히 중단시키겠다는 의지를 갖고 있는 것인지 꼭 해명을 들어야 할 것 이라고 말했다고 한다 새누리당은 대통령의 선 후퇴 가 헌법적 용어가 아니라고 하면서 마찬가지로 헌법에서 찾아볼 수 없는 거국중립내각 은 수용하겠다고 강변하고 있다 그렇다면 내치를 총리에게 위임하는 것은 헌법에 입각한 행위이고 외치까지 총리에게 위임하는 것은 반헌법적 행위란 말인가 대통령의 선후퇴도 거국중립내각도 헌법과 국정을 중단시키는 반헌법적 주장이 절대 아니다 대통령이 사태의 책임을 지고 거국중립내각의 국무총리에게 전권을 위임하겠다는 정치적 선언이며 정치적 책임을 지는 행위인 것이다 이 대표는 대통령의 권한을 국무총리에게 위임하는 행위를 반헌법적으로 호도하기 전에 최순실이 국정을 이 지경까지 농단할 때까지 그 원인을 제공한 박근혜 대통령의 반헌법적 행위나 제대로 돌이켜 보기 바란다 적반하장도 유만부동이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58924,2016-11-10, 박근혜 대통령 혹은 최순실이 이해한 외교의 책임과 역할 언론 보도에 따르면 전대주 전 주베트남 한국대사는 외교 경험이 전무한 기업인이었다고 한다 년에 임명 돼서 올 월까지 베트남 대사를 지낸 전대주 대사는 취임 이후 현지 한일들에게 본인도 왜 대사로 임명됐는지 모르겠다고 해 교민들이 상당히 당황스러워 했던 것으로 알려졌다 재외국민들의 권익과 이익을 대변해야 할 자리에 기업인인 본인이 왜 임명 되었는지 전대주 대사스스로는 모르겠다고 했으나 그가 최순실 조카 즉 최순득 아들의 베트남 유치원 사업을 적극 도왔던 은인이었던 점을 고려해 보면 왜 대사로 임명됐는지 어렵지 않게 짐작 할 수 있을 것 같다 박근혜 정부 혹은 최순실이 이해한 외교의 책임과 역할은 건전한 상식과는 매우 동떨어져 보인다 물론 박근혜 정부와 최순실이 비정상으로 이해한 것이 외교의 책임과 역할 뿐이겠냐 만은 대한민국을 대표하여 외교교섭을 행하며 자국민에 대한 보호 감독의 임무를 수행하는 상주외교사절단의 장 의 자리를 외교 경험이 전무한 본인 조카의 사업을 적극 도왔던 은인에게 선물한 의혹은 대한민국의 얼굴에 먹칠을 하고 이를 진흙탕 속으로 던진 것과 진배 없다 박근혜 정부가 새로 쓰고 있는 외교의 이해는 비단 전대주 베트남 대사 뿐만이 아니다 다자외교 쪽을 전담하는 외교부 제 차관 후임은 외교부의 요구에도 불구하고 청와대 측에서 나중에 정하자고 해 한 달 넘게 표류 중이고 제 차관 인사와 맞물려 유엔 회원국을 상대로 북핵 대응을 이끌어내고 외교전을 치뤄야 하는 주 유엔 대사 현지 부임 또한 늦어지고 있다 사드 배치 발표 당시 백화점에 있었던 외교부 장관을 필두로 최근 드러난 전대주 대사 사태와 외교 공백까지 박근혜 정부 년간의 외교정책은 온 우주의 실패를 보는 듯 하다 속수무책으로 방관하고 있는 외교 공백을 하루 빨리 메워야 한다 또한 전대주 전 대사가 베트남 대사로 임명 되었던 것이 유치원 사업 후견인에 대한 단순한 보은 인사였는지 혹은 더 나아가 재임 기간 동안 외교관의 지위를 이용한 여타의 불법 탈법성 부역 행위가 있었는지 철저한 조사와 진상 규명이 있어야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58922,2016-11-10, 금태섭 대변인 오전 현안 브리핑 일시 목 장소 국회 정론관 트럼프 당선 새로운 리더십 구축이 필요하다 미국 차기 대통령에 트럼프 후보가 당선되면서 우리에게 미칠 영향을 걱정하는 목소리가 크다 트럼프 당선자는 미국 우선주의 를 전면에 내걸고 대외적 고립주의와 보호무역주의를 주장해왔다 한국경제연구원은 트럼프 당선자의 대선 공약인 한미 재협상이 현실화될 경우 년간 총 수출손실은 약 조원 일자리 손실은 만개에 달할 것으로 추정했다 국민들은 불안하다 국정이 정상적인 상황에서도 대처가 쉽지 않다 하지만 국정농단을 주도하고 공식조직은 액세서리 취급하며 대면도 안 하는 박근혜 리더십으로는 대한민국호 를 정상적으로 이끌 수 없다 외치의 측면에서 보더라도 우리나라가 한미관계의 계속적인 안정을 도모하고 국제사회에서 국익을 보호하기 위해서는 방안은 단 한 가지 밖에 없다 대통령은 신속히 국정에서 손을 떼겠다고 선언해야 한다 리더십을 재구축해야 한다 지금은 대통령이 결단할 차례이다 최순실 안종범의 기소전에 대통령에 대한 수사가 반드시 필요하다 검찰은 다음 주에 최순실 안종범 정호성 등 핵심 피의자들을 기소할 예정이라고 한다 그동안의 수사는 국정농단이 대통령의 지시였다는 점을 구체적으로 밝히고 있다 최순실은 연설문을 미리 받아봤다는 점을 인정했다 안종범은 미르 스포츠 재단의 대기업 모금을 박근혜 대통령이 세세하게 지시했다 고 진술했다 정호성의 휴대전화에서는 대통령이 청와대 문건을 최순실에게 보여주라고 지시하는 녹음파일이 발견되었다 이러한 증거만 보더라도 대통령은 국기문란의 중추적 역할을 한 것을 알 수 있다 현재 구속수사 중인 명과 사실상 공범인 것이다 이제 검찰은 대통령을 철저하게 수사해야 한다 임기 중 소추를 못하더라도 철저한 조사와 진상 규명을 해야 한다 대통령의 조사 이전에 최순실과 안종범을 기소하는 것은 불완전한 수사이다 대통령에 대한 신속한 수사가 검찰도 살고 나라도 사는 길이다 검찰은 당장 우병우를 구속 수사 하라 더불어민주당 의원들이 우병우 구속 농성을 시작한 지 일 째에 접어들었다 현재까지 약 여명의 의원께서 참석해주셨다 그동안 알려진 범죄사실 외에도 민정수석의 전면적 직무유기가 속속 밝혀지고 있다 우병우는 차은택의 이권 개입과 인사 개입에 대한 내사를 벌여 구체적인 비위 단서를 발견했으면서도 어떠한 조치도 취하지 않았다 비선실세의 힘과 인사 관여에 직접 작용했다는 의혹도 있다 우병우 특별수사팀이 꾸려진 것은 지난 월 일이다 특별수사팀은 두 달이 넘게 미적대다가 우병우가 민정수석비서관직에서 내려와서야 수사를 시작했다 그나마도 황제 조사 논란이 일었다 검찰총장은 지금 당장 우병우 구속 을 지시해야 한다 우병우 구속은 더불어민주당 의원들만의 요구가 아닌 국민들의 요구이다 나 몰라라 새누리당 내일 긴급현안질의를 지켜보겠다 여야는 내일 정부를 상대로 박근혜 최순실 게이트에 대한 긴급현안질의를 하기로 합의한 바 있다 하지만 새누리당은 의사일정을 합의하고도 단 한 명의 의원도 질의신청을 하지 않았다고 한다 긴급현안질문을 외면하는 것은 새누리당의 박근혜 최순실 게이트의 공범이거나 방관자였음을 보여주는 것이다 대한민국을 절망에 빠뜨린 박근혜 최순실 게이트는 어느 정당도 외면할 수 없고 더구나 친박 비박의 계파이익과도 전혀 무관하다 국민들은 내일 국회 본회의장을 지켜볼 것이다 질의신청을 보이콧한 새누리당이 본회의장에도 나오지 않는다면 국정농단의 공동책임을 자임하는 것이다 박승주 안전처 장관 후보자 사퇴 청와대 리더십의 현실이다 박승주 국민안전처 장관 후보자가 어제 밤 자진 사퇴를 하였다 박근혜 대통령이 지명한 지 일주일 만에 국회에 인사청문요구서도 보내지 못한 상황에서 벌어진 일이다 이임식 소동을 벌인 황교안 국무총리 총리후보자의 위치에 있는지도 불명확한 김병준 교수 도심 굿판 소동 끝에 사퇴한 장관 후보자 국민들을 불안으로 몰아넣고 있는 것은 박근혜 대통령의 몰락한 리더십이다 박 대통령은 더 이상 우리 국민들에게 수고와 눈물을 강요하지 마라 국정에서 손을 떼는 것이 국민을 살리고 나라도 살리는 길이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58923,2016-11-10, 기동민 원내대변인 의총 결과 브리핑 일시 목 오전 시 분 장소 국회 정론관 의총 결과 브리핑 오늘 의총에서는 오는 일 박근혜 최순실 게이트 당원보고대회와 관련된 내용이 논의됐다 당원대회 이후 촛불집회까지 최대한 참여해 현 시국에 대한 우리 당의 입장을 명확히 전달하기로 의견을 모았다 다만 촛불집회에 지도부가 어떻게 참여할 것인지에 대해서는 좀 더 논의를 거쳐서 확정하기로 했다 또한 기존 우리 당의 당론을 다시 한 번 확인했다 국정조사와 별도특검 그리고 박근혜 대통령의 선 후퇴 국회가 추천한 총리에게의 전권 위임 등이 이뤄지지 않으면 대통령 퇴진투쟁으로 나갈 수밖에 없다는 점을 재확인했다 얼마 전에 있었던 대통령의 제안은 형식과 내용 측면에서 진정성도 없었고 구체적인 내용도 없었다 이 때문에 대통령의 제안은 현 상황을 모면하기 위한 국면전환용 카드 에 불과하다는 것에 인식을 함께했다 마지막으로 어제 미국 대선 결과에 대한 토론도 있었다 변화에 대한 미국민들의 열망이 드러났지만 동시에 불확실성 역시 증폭된 선거 결과였다 특히 한미 관계에 미칠 영향이 클 것으로 전망돼 이에 대한 확고한 대응태세 마련이 중요하다는 의견이었다 불확실성을 조속히 타개하기 위해서는 국정공백을 하루빨리 수습하는 것이 필요하고 이를 위해선 대통령이 선 후퇴하고 국회 추천 총리에게 전권을 위임하는 것이 시급하다는 결론을 내렸다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58921,2016-11-10, 제 차 의원총회 모두발언 일시 +http://theminjoo.kr/briefingDetail.do?bd_seq=58920,2016-11-10, 제 차 정책조정회의 모두발언 일시 목 오전 시 분 장소 국회 본청 원내대표 회의실 우상호 원내대표 미국 대선 결과 때문에 많은 국민들이 불안해하고 계시다 그러나 자세히 들여다보면 이것은 미국 국민들이 변화를 선택한 것이다 변화로 선택한 사람이 트럼프 대통령 당선자여서 어색한 감이 없지 않다 하지만 미국 국민들은 빈부 격차와 기득권 세력에 의한 닫힌 사회에서 미국을 변화시키자고 외친 것이다 당선된 사람보다는 찍어준 사람의 민심에 주목해야한다 대한민국의 빈부 격차 심화와 최순실 게이트로 인한 국민들의 절망이 변화를 원하는 민심으로 폭발할 것이라고 저는 한국 정국과 관련해서 미국 대선의 결과를 해석한다 더불어민주당이 제대로 된 변화의 열망을 받아 담을 수 있는 수권정당으로 거듭나고 제대로 된 대통령 후보들의 정책으로 국민들의 절망과 분노를 담아낼 수 있는 정당이 돼야겠다고 다짐한다 미국 대선결과로 인해서 국민들이 과도하게 불안을 느끼시지 않는 것이 좋겠다 지난번에 국회의장과 당 원내대표가 미국을 방문했을 때 트럼프가 당선될 경우 한미관계에 급속한 변화가 오는 것이 아니냐는 우려를 미 의회 지도자들에게 전달했다 애드 로이스 외교위원장 폴 라이언 하원의장은 트럼프의 발언은 대선용 발언이다 선거를 의식한 발언에 과민반응하지 말아 달라 설사 트럼프가 대통령이 돼서 한미관계의 변화를 시도한다 하더라도 모든 정책의 승인권은 의회에 있고 미 의회 지도자들은 한미관계의 변화를 원하지 않는다 따라서 군사와 경제적인 협정 등 한미 간에 맺어진 기존 협정을 변화시킬 생각이 없다 한국 국민들에게 안심해도 좋다고 이야기해 달라 고 이야기했다 저는 미 의회 지도자들의 균형감각과 전통적 한미관계를 해칠만한 어떠한 제도변화도 미 의회가 승인하지 않겠다고 했던 그들의 약속을 믿는다 향후 대한민국은 의회 지도자들 간의 교류를 강화함으로써 그들의 약속이 미 의회에서 지켜지도록 만드는 노력을 의회 차원에서 같이 해야겠다 이 문제로 인한 여러 가지 영향력을 면밀히 분석하고 대책을 세워야겠지만 한편으로 불안이 너무 증폭돼서 국내경제에 영향을 미치지 않도록 관리하는 일도 야당이 같이 해나가겠다 대한민국 국민들께서는 너무 불안해하지 않으셔도 되겠다 최순실 게이트 때문에 평창올림픽이 뜻하지 않게 폭탄을 맞고 있다 장시호씨가 이권사업에 개입했다는 것은 분노를 일으킬만한 사안이다 하지만 최순실 때문에 올림픽까지 망칠 수는 없다 대한민국이 유치한 국제행사이기 때문에 대한민국 정부와 의회는 평창올림픽의 성공을 위해서 예산과 각종 정책적 지원을 아끼지 않을 것이다 이번 예산심의 과정에서 평창올림픽의 성사를 위해 적극적인 지원과 노력을 아끼지 않겠다 윤호중 정책위의장 미국의 대선 결과를 놓고 한국증시가 폭락했다 그러나 저는 이것이 충격이라기보다는 놀라움의 표시라고 생각한다 미국 증시는 오늘 올라간 것으로 알려지고 있다 미국 대선 결과가 세계경제에 미치는 영향은 별로 없다는 것을 미국 증시가 보여준 것이 아닌가 생각한다 미국의 새로운 행정부가 들어서면서 트럼프 차기 대통령의 정책이 하나하나 현실화될 것이다 여러 가지 우려가 있지만 북핵문제와 미국의 동북아정책 변화 미중관계는 어떻게 변화하고 한국에 어떤 영향을 미칠 것인가 우리나라와 관련한 한미 재협상 방위비 분담 문제 등 많은 관심이 있다 미국의 정책 변화의 시기에 우리가 어떻게 대처하는가에 따라서 오히려 우리에게는 기회가 될 수도 있다 기회를 만들어 나가야하는 것이 한국 정부의 임무이다 그러나 박근혜 대통령이 과연 외교무대에서 국가정상으로서의 역할을 할 수 있는지 매우 의심스럽다 보통 월 일이 미국 대통령의 취임일이고 월부터 각 나라 정상들과 정상회담을 시작한다 우리 정부는 보통 월 또는 월 정도에 회담을 하게 된다 정상회담을 통해서 우리의 국익을 새 행정부의 정책에 최대한 반영시켜야 하는 시기다 과연 박근혜 대통령이 정상회담을 통해서 제대로 우리 국익을 반영할 수 있겠는가 과연 정상회담이 제대로 이루어질까 하는 것이 우리 국민들의 우려이다 국정에서 손을 떼라는 우리 당의 주장이 단지 내정을 의미하는 것이 아니다 외교와 국방 안보에 관한 부분에까지 대통령의 결단이 필요하다 정부가 한일군사정보보호협정 체결에 박차를 가하고 있다 마치 서둘러서 땡처리를 하려는 자세다 우리 당에서는 여러 차례에 걸쳐서 한일군사정보보호협정이 절대로 이루어져서는 안 된다고 경고했다 야 당은 한일군사정보보호협정 논의를 중단하라는 결의안을 제출하기로 했다 국민과 야당이 요구하고 있는 한일군사정보보호협정 논의 중지 의사를 무시한 채 계속 논의를 해나간다면 야 당은 국방장관에 대한 해임건의도 할 수 있다는 것을 미리 경고해둔다 박근혜 최순실 게이트의 양상이 매우 심각해져가고 있다 최순실의 국정개입이 내정뿐 아니라 외교 분야에까지 곳곳에 미쳤다는 것이 드러나고 있다 대표적인 사례로 최순실 모녀가 단골로 드나들던 강남의 성형외과 병원 원장이 대통령 해외순방에 따라나섰다는 것이다 또 해외진출을 위해서 청와대까지 직접 나서서 도왔다는 것이다 해외진출이 무산되자 경제수석을 해임하고 해외진출과 관련해 부정적 의견을 냈던 병원컨설팅 업체에 대해서 세무조사까지 시켰다 중소기업에 대한 세무조사는 보통 일 정도 기간에 마치게 되어 있는데 개월 동안 부당하게 세무조사가 진행된 것으로 밝혀지고 있다 최순실의 조카를 도와주었던 사기업의 해외지사장을 베트남 대사로 임명하기도 했다 외교무대에 최순실이 부탁한 사람을 끌고 다니고 최순실이 부탁한 사람을 심지어 대사로까지 임명하는 있을 수 없는 일들이 벌어졌다는 것이 하나하나 드러나고 있다 이렇게 외교무대를 오염시킨 자리에 박근혜 대통령이 있었다는 것은 정말 충격이 아닐 수 없다 더 이상 박근혜 대통령에게 외교를 맡길 수 없다는 것이 이런 사건에서도 드러나고 있다 박근혜 대통령은 국정의 전 분야에서 손을 떼고 선으로 물러나주시기 바란다 박완주 원내수석부대표 어제 새로운 미국 대통령의 선출로 한미동맹에 많은 관심이 생기고 있다 이런 와중에 국방부가 일방적으로 한일군사정보보호협정의 날치기 체결에 나서고 있다 어제 차 실무 협의를 마쳤다고 한다 다음 차 실무협의 이후 사실상 마무리 수순이라는 소식이다 정부 이후 또다시 국민적 동의도 없이 제 의 밀실협정이 자행되고 있다 심각한 국정혼란 속에서 마치 군사작전을 방불케 하는 묻지마식 속도전에 국민들은 동의할 수 없다 국방부는 국회와 국민의 이해가 필요하다는 입장을 표명한지 불과 한 달 만에 돌연 손바닥 뒤집듯 입장을 뒤바꿨다 지난 해 일본군 위안부 합의를 졸속으로 처리할 때와 같다 민의는 실종되고 갈등만 야기되고 있다 심지어 일본의 집단 자위권 인정 선언이라도 하는 것이냐는 비판도 일고 있다 박근혜 정부 들어 지속적으로 반복되는 대일 굴욕외교는 가히 충격적이다 지난 운영위에서 국가안보실장은 대통령의 재가를 받았다는 증언도 했다 이번 협정 체결 시도는 대한민국의 군사정보를 일본에 바치는 퍼주기식 안보무능의 종결판이다 특히 삼성의 방위산업체 매각 정부 승인 과정 중 최순실씨가 방위산업에도 관여한 정황이 포착되면서 국방부의 무능에 대한 국민적 비판이 고조되고 있다 국가안보와 직결된 방위산업마저 민간인에게 좌지우지 당한 죄를 물어도 모자랄 마당에 일제 강점기 이후 최초로 체결되는 군사협정마저 졸속 처리하려는 시도에 국민들은 분노하고 있다 최순실 게이트로 인해 혼탁해진 정국에서 꼼수 협정은 절대 용납할 수 없다 어제 야 당이 당론으로 한일군사보호협정 반대 결의안을 제출했다 한일군사보호협정을 당장 중단할 것을 박근혜 정부에 강력히 경고한다 김병욱 부대표 최순실의 새로운 최측근 장순호를 즉각 소환 수사하길 촉구한다 장순호는 최순실의 강남 아지트인 카페 테스타로사의 건물주이자 카페 운영업체인 존앤룩씨앤씨의 이사로 알려졌다 장순호는 차은택이 실질적으로 운영한 플레이그라운드의 재무이사로도 알려져 있다 또한 장순호는 비밀법인 개 지부를 소유하고 있으며 장씨의 아들은 최순실이 독일로 도피할 때 현지에서 최순실을 보좌했다고 한다 미르 스포츠재단의 입출금내역을 확인해봤더니 스포츠재단은 월 일에 만원의 독일 출장 항공료를 장순호에게 송금했고 미르재단은 월 일에 천만원의 파리 출장 항공료를 장순호에게 송금했다 최순실과 관련된 모든 부분에서 장순호라는 이름이 나타나고 있다 그런데도 검찰에서는 아직까지 장순호에 대한 수사가 전혀 이루어지지 않고 있다 검찰이 늑장을 부리는 사이에 증거는 은폐되고 국민적 의혹은 더 커질 뿐이다 검찰은 최순실 일당들이 증거를 은폐할 시간을 주지 말고 즉각 수사에 나설 것을 촉구한다 문화체육부로부터 제보 받은 자료에 따르면 스포츠재단은 월 일 임시이사회를 개최해 갑자기 하남 거점 체육시설 건립이 불투명해졌다며 기부금을 롯데에 다시 반환하기로 결의했다 스포츠재단은 롯데 측에 돈을 반환하기 위해서 정기예금 억원까지 해지했다 이사회 소집 통지가 주일 전에 이루어져야 한다는 점을 고려할 때 스포츠재단이 롯데의 검찰 수사를 압수수색이 있기 최소 열흘 전에 인지하고 있었다는 의혹이 제기되고 있다 검찰 조사에서 안종범 전 청와대 정책조정수석의 지시에 따라 검찰 압수수색 전에 돈이 반환된 것으로 알려지고 있다 즉 안 전 수석의 지시에 전광석화처럼 임시이사회가 개최됐고 억원을 일사불란하게 반납한 스포츠재단의 모습은 청와대가 이 재단을 완벽하게 통제하고 있었고 검찰의 각종 수사정보가 실시간으로 스포츠재단에 중계되었다는 증거다 검찰은 그동안 박근혜 최순실 게이트를 늑장수사하고 증거인멸의 시간을 줬으며 정보마저 당사자에게 유출하지 않았나 하는 의혹이 제기되고 있다 수사 정보의 유출을 막고 공정한 수사를 위해서 김현웅 법무부장관과 김수남 검찰총장의 즉시 사퇴를 촉구하며 검찰 내의 우병우 전 민정수석 라인을 하루속히 제거할 것을 촉구한다 김한정 부대표 미국 대통령 리더십의 변화에 조응하는 대미 초당외교 태세를 갖춰야한다 트럼프 대통령 당선은 전세계적에 충격으로 받아들여지고 있다 충격의 원인은 기본적으로 불확실성 즉 예측 불가능성에 있다 한국 국민들이 걱정하는 대목도 이 대목인 것 같다 한미관계에서 우리의 안보이익과 교역을 비롯한 경제이익에 긍정적일 것인지 부정적일 것인지 모르기 때문이다 불안감은 오히려 우리 국익에 불리한 방향으로 작동할 가능성이 크다는 우려에서 나온다고 생각한다 그러나 기본적으로 전통적 한미관계는 상호이익을 추구해왔고 우리는 우리대로 한미관계가 상호이익에 부합되는 방향으로 적극적으로 주도하고 노력해야 한다 역사학자 아놀드 토인비는 역사는 도전과 응전의 결과 라고 했다 우리 앞에는 지금 도전이 놓여있다 그러나 도전에 대처할 수 있는 위기대응의 리더십이 진공상태 공백상태 혼란상태이다 새로운 도전에 조응할 수 있는 리더십이 필요한 상황이다 대통령이 리더십을 발휘하는 것이 아니라 국정운영에 대해서 미련을 버리고 새로운 환경에 제대로 대응할 수 있는 리더십에 협조하고 협력하라는 것이 국민의 요구이고 민심이다 어제 청와대에서 를 소집했다 미국의 정치변화가 우리에게 미칠 영향에 대한 대비와 점검 차원이라고 들었다 이러한 자세와 노력은 평가하지만 여기서 나오는 것은 빈 알맹이이다 로 대통령이 외교안보를 챙길 것이 아니라 초당적 외교안보대책협의체를 구성하는 것이 맞다 앞으로 무수한 도전들이 있을 것이다 특히 미국 대통령 취임 이후에 적어도 반년 정도는 새로운 미국의 대외정책이 결정되는 골든타임이 될 것이다 한미관계의 긍정적 변화든 불리한 변화든 이 시기에 결정된다 우리는 클린턴 대통령 이후에 등장한 조지 부시 대통령의 정책 이 우리 국익과 안보환경 경제에 얼마나 부정적 영향을 미쳤는지 똑똑히 기억하고 있다 다시는 이런 과오를 반복해서는 안 된다 새로운 리더십을 에서 찾을 것이 아니라 대야 초당적 대책회의에서 찾아야 한다 홍익표 정책위 수석부의장 이번 미국 대선의 결과는 의 위기이며 자유무역과 세계화의 어두운 미래라고 생각한다 는 년대의 제국주의론 세계체제론을 부정하는 데 큰 역할을 했다 즉 중심부와 주변국가 간의 일방적 관계에서 를 통해 선진국에서도 자유무역을 통해서 혜택을 보는 개도국에서도 그로 인해 이득을 보는 전 세계에서 그로인해 손해를 보는 가 생기면서 양극화 현상이 세계적으로 나타난 것이다 그 원인을 몇 가지로 말씀드리고 싶다 첫 번째는 초국적 기업의 자본집중이 이루어졌다 둘째로 자산소득이 노동소득을 앞섰고 세 번째는 해외이전에 따른 각국의 국내실업률이 증가했다 네 번째로 금융규제완화에 따른 각종 경제혼란과 위기가 반복적으로 이루어지고 있다 세계 각국에서 조세감면과 세제혜택을 통해서 복지혜택이 크게 위축됐다 이런 현상은 전 세계적으로 자유무역이 가져다 준 폐해다 물론 자유무역은 확대해야 되고 우리 국가의 미래라고 생각한다 우리 모두가 자유롭고 공정한 무역 따뜻하고 인간적인 세계화가 미국 대선이 한국은 물론 인류 전체에 주는 새로운 과제라고 생각한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58917,2016-11-10, 이재정 원내대변인 오전 현안 브리핑 일시 목 오전 시 분 장소 국회 정론관 국정공백 책임 떠넘기기 시작한 청와대 청와대가 국정공백이 우려된다며 국회의 조속한 총리추천을 요구했다 그러나 국정공백의 책임은 전적으로 박근혜 대통령에게 있다 우리 당은 총리의 권한을 분명히 하고 대통령은 국정에서 손을 뗄 것을 요구한 바 있다 하지만 청와대는 이에 대한 답은 일절 내놓지 않고 남 탓 야당 탓을 하기 시작했다 오만과 불통이라는 나쁜 버릇이 또다시 고개를 들고 있는 것이다 작금의 국정공백을 초래한 당사자는 국회가 아니라 박근혜 대통령이다 책임을 떠넘겨 국면을 전환하려는 꼼수는 더 이상 통하지 않는다 순실증 앓고 있는 고 수험생들 우리 모두가 답 할 때 열심히 공부해서 수능 점수 좀 잘 받는다 한들 무슨 소용인가요 대학수학능력시험을 일주일 앞둔 고교 학년 학생의 말이다 이른바 순실증 으로 인한 자괴감과 무력감이 공부만으로도 버거운 수험생들을 괴롭히고 있다 노력 성실 희망이라는 삶의 우선 가치와 사회정의라는 그간의 배움이 최순실 게이트 정국 속에 산산히 무너진 탓이다 금수저로 태어났으면 좋았겠다 원하는 대학에 들어간다 해도 그들만의 리그가 지배하는 이 나라에서 버텨낼 수 있을지 걱정이다 이들의 좌절감과 분노 앞에 우리는 언제까지 미안한 어른으로만 남아있을 것인가 년 겨울의 문턱에서 청년들이 묻고 있다 우리가 바라는 세상을 바로 잡을 수 있다는 자신감을 달라고 이제 우리 모두가 답할 때이다 우병우에 벌벌떠는 검찰 더불어민주당은 더이상 좌시하지 않는다 더불어민주당은 지난 월 일부터 박근혜 게이트의 핵심인 우병우의 구속수사를 촉구하는 일환으로 서울중앙지검 앞에서 릴레이 천막농성을 이어가고 있다 이번 천막농성은 더불어민주당 법사위 의원 박근혜 최순실게이트 국민조사위원회 소속 의원 민주주의 소속의원들이 돌아가며 중앙지검 앞 천막을 지키며 우병우의 구속수사를 촉구하고 있다 황제조사 논란을 야기하며 이름 석 자 만으로도 현직 검사들을 벌벌떨게 만드는 우병우 전 청와대 민정수석에 대한 검찰의 봐주기 수사에 국민들의 분노는 걷잡을 수 없다 검찰은 왜 어떤 연유로 국민의 대표인 국회의원이 중앙지검 앞에서 천막농성까지 하는지 생각해 보길 바란다 만약 계속적으로 형식적이고 기계적인 검찰수사로 일관한다면 이제 국민의 분노는 우병우를 넘어 검찰로 향할 것이다 철도노조 파업 장기화 성과연봉제 밀어붙이기 중단하라 철도노조의 파업이 더욱 장기화될 전망이다 어제 노사간 집중교섭에서도 성과연봉제 도입을 둘러싼 이견을 좁히지 못했다 코레일 측이 여전히 일방적인 성과연봉제 도입을 강요하고 있기 때문이다 정부는 노사의 자율적인 도입 추진 약속을 파기한데 그치지 않고 여전히 일방적인 성과연봉제 도입을 강요하고 있다 사정이 이렇다 보니 사측마저도 입장이 곤란할 지경이라고 한다 여전히 민생경제위기극복의 의지는 없고 갈등만 조장하는 박근혜 정부의 태도는 결코 국민의 동의를 받을 수 없을 것이다 정부는 성과연봉제 밀어붙이기를 멈추어야 할 것이다 이제는 국회를 통한 사회적 합의로 문제를 풀어갈 때이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58915,2016-11-09, 박경미 대변인 추가 현안 브리핑 일시 오후 시 장소 국회 정론관 도널드 트럼프 미 대통령 당선을 축하하며 도널드 트럼프 공화당 후보의 미국 제 대 대통령 당선을 축하한다 향후 한미관계가 더욱 발전하는 계기가 되길 기대한다 미국이 시스템으로 운영되는 국가인 만큼 짧은 시간에 정책이 급변하지는 않을 것으로 보이지만 우리 국익과 한반도 평화를 최우선에 놓고 경제 안보 외교 특히 동북아정세의 변화에 선제적으로 대응하는 것이 필요하다 정부는 한미관계를 더욱 굳건히 하는 동시에 철저한 상황 점검 및 대책 마련을 통해 국민의 우려가 없도록 최선을 다해주기 바란다 더불어민주당은 이해찬 전 총리를 중심으로 외교통일안보자문회의와 경제안보상황실을 통해 안보 경제 환경의 변화에 대응한 대비책 마련에 진력할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58911,2016-11-09, 박경미 대변인 오후 현안 브리핑 일시 장소 국회 정론관 미 대선 결과는 정치권에 변화와 혁신을 위한 노력을 요구하고 있다 미국 대통령선거에서 대다수 언론의 예측을 깨고 도널드 트럼프 공화당 후보의 당선이 확실시되고 있다 이런 결과는 기성정치에 대한 실망과 변화에 대한 열망이 이뤄낸 대이변이라고 해석할 수 있다 기성 정치권이 결코 과거에 매몰되거나 현재에 안주해서는 안 된다는 준엄한 경고로 받아들여야 한다 더불어민주당은 국민의 요구를 반영하기 위해 변화와 혁신을 위한 노력을 더욱 굳건히 실천해나갈 것이다 트럼프 후보는 미국의 고립주의를 표방해왔기 때문에 세계 경제 및 안보 환경에 큰 변화가 예상되는 만큼 철저한 사전적 대응이 필요하다 한미동맹을 공고히 하는 가운데 대북 정책과 안보 문제 등에 있어서 우리의 국익을 지켜내는 현명함이 절실하다 특히 방위비 분담 문제에 대한 철저한 대비가 필요하다 경제에 있어서도 통상마찰이 예상되고 있어 국내외 경제상황을 실시간으로 점검하고 향후 미국내 통상정책 변화에 유의하여 대비해야 한다 더불어민주당은 외교통일안보자문회의와 경제안보상황실을 통해 미 대선 이후 노정되는 안보 경제 환경의 변화를 점검해 대응전략을 마련해나갈 것이다 박근혜 대통령이 자초한 국정 공백으로 국가경제의 근간이 무너지고 있다 부쩍 추워진 날씨만큼 우리 경제와 민생에 한파가 몰아치고 있다 오늘 통계청의 발표에 따르면 청년실업률이 년 만에 최고치를 기록했고 전체 실업률 또한 년 이후 가장 높은 것으로 나타났다 박근혜 대통령의 국정 동력 상실과 이에 따른 경제 컨트롤 타워의 부재로 인해 우리 경제의 불확실성이 높아지면서 산업 전반이 얼어붙고 있다 전 영역에 걸쳐 생산과 수출 부진 소비와 투자 위축이 이어지며 고용 불안이 한층 더 심화되는 양상이다 대외 경제 상황도 녹록치 않다 당장 미국 대선 결과에 따른 전 세계적 여파가 감지되고 보호무역주의의 강화라는 악재도 예고되어 있다 가장 심각한 문제는 박근혜 대통령이 모호한 태도로 국정 정상화의 해법을 외면하는 동안 경제사령탑 또한 둘로 나뉘어져 경제위기 상황에 제대로 대처를 못하고 있다는 것이다 이런 상황이 계속된다면 한국 경제는 회복 불가능한 경제 빙벽 의 수렁에 빠져들 것이다 하루라도 빨리 경제 컨트롤 타워를 정상화하여 우리 경제를 위기에서 건져 올려야 한다 정경유착의 고리도 이참에 끊어내야 한다 결국 문제 해결의 단초는 박근혜 대통령이 쥐고 있다 국가경제를 위해서라도 대통령의 빠른 결단이 시급하다 최순실의 영향력은 도대체 어디까지인가 최순실 정유라 모녀의 단골 성형외과와 관련된 뉴스로 국민들은 또 한번 경악을 금치 못한다 언론 보도에 따르면 해당 성형외과의 김 원장은 박 대통령의 해외순방에 동행했고 이 병원의 화장품은 청와대 명절선물로 납품되는가 하면 유명 면세점에 입점까지 한 것으로 전해졌다 박근혜 대통령은 년 당시 조원동 경제수석에게 이 병원의 해외진출을 추진하라고 지시했고 조 수석은 전문 컨설팅업체에게 이를 의뢰했다고 한다 그로부터 몇 달 뒤 조원동 수석이 해임되었는데 조 수석은 해당 병원의 해외진출 무산이 해임 사유 중 하나라고 이야기하고 다녔다고 한다 더불어 수임을 거부했던 컨설팅업체는 이후 세무조사와 국정원 조사 등을 심하게 받았다고 한다 한편 김 원장은 지난 월 서울대병원 강남센터의 외래교수로 위촉되었는데 관계자의 증언에 따르면 김 원장이 위촉되는 데 서울대병원 서창석 원장의 압력이 있었다 고 한다 서창석 원장은 백남기 농민 사망 원인을 병사 라고 기록한 것의 최종 책임자로 이미 지탄의 대상이 되어 왔다 그가 비난 받을 이유가 하나 더 추가된 셈이다 최순실의 영향력은 도대체 어디까지인가 앞으로 어떤 뉴스를 더 접하며 가슴을 쓸어내려야 할까 이러려고 대한민국 국민이 됐나 라는 질문을 대통령에게 되돌려 드린다 차은택은 문화계 황태자 가 아니라 문화계 대도 비선실세 최순실 씨의 최측근인 차은택 씨가 어제 공항에서 체포된 뒤 검찰 조사를 받았다 차 씨는 현 정부 들어 문화융성위원회 위원 민관합동 창조경제추진단장 등을 통해 문화계의 실세로 급부상하면서 문화계의 황태자 라는 이름을 얻었다 차 씨는 최순실 씨와 손잡고 국정을 농단했고 문화예술계의 각종 비리에 개입했으며 옛 포스코 계열 광고회사인 포레카 의 지분 강탈에 가담한 혐의도 받고 있다 차 씨는 문화창조융합벨트 등 대형 정부 사업을 독식하고 자신의 회사를 통해 대기업과 공공기관 광고를 쓸어 담고 횡령을 하는 등 불법 편법으로 사익을 챙겼다는 의혹의 주인공이다 더 나아가 자신의 지인들을 정부 고위직에 앉히고 다각도로 지원사격 을 받은 정황까지 차 씨가 마치 마법같은 전횡을 무차별적으로 저질렀음이 속속 밝혀지고 있다 차은택을 비롯한 국정 농단 세력이 사회를 혼돈에 빠트린 내용이 드러날 때마다 국민들이 느끼시는 허탈감과 분노가 앞으로 국가의 성장동력을 약화시키지 않을지 우려가 된다 검찰은 문화계 대도 인 차은택을 철저하게 수사하여 응분의 대가를 치르게 함으로써 이 땅에 정의가 살아 있음을 국민들에게 입증해주기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58909,2016-11-09, 야 당 대표 회동결과 브리핑 일시 장소 국회 사랑재 야 당 대표는 먼저 이번 사건의 성격을 박근혜 최순실 게이트로 명명하기로 확정했다 두 번째 야 당은 오는 일 국민집회에 당력을 집중하여 적극 참여하고 국민과 함께 하기로 했다 세 번째 강력한 검찰수사를 촉구하고 국회는 국정조사와 별도특검을 신속하게 추진한다 네 번째 대통령의 어제 국회 제안은 일고의 가치가 없음을 확인한다 다섯 번째 야 당은 박근혜 대통령이 초래한 국정마비사태에도 불구하고 국회 상임위 예결위 등을 통해 민생과 국가안보를 챙기는 데에 최선을 다하기로 합의했다 여섯 번째 야 당 대표는 일 이후 정국현안과 경제안보 논의를 위해 다시 회동하기로 했다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58906,2016-11-09, 추미애 대표 종교인협의회 면담 인사말 일시 수 오후 시 장소 정동 달개비 식당 추미애 대표 지난 주말과 다가오는 주말 우리 국민들이 주말마다 뜻을 모으고 있다 대통령이 나라를 버렸다 그 나라를 우리가 지키겠다 는 마음인 것 같다 정치권도 국민의 뜻을 받들어야 할 때인 것이다 적폐가 쌓인 이 나라에 대해서 단순히 정치권만의 해법이 중요한 것이 아니다 대통령이 경제가 어렵다면서 도와달라고 하시는데 기업의 팔목을 비틀어서 경제를 망치신 분이 대통령이었다 민생이 피폐하고 양극화가 심해지고 청년들도 희망이 아무데도 없는 가운데 이런 일을 겪고 보니까 더욱 분노하는 것이다 정치권이 미봉책으로 총리를 누구를 만드느냐 하는 문제가 아니다 대통령은 마치 국정을 탁구공처럼 어디에 넘기면 책임이 면해지고 수습이 되리라고 아직도 그렇게 여기는 것 같다 하지만 지금은 국민주권에 보답해야 하는 때이다 민주주의의 원칙과 기본으로 돌아가서 국민 앞에 대통령이 결자해지하는 마음으로 고해성사를 하시든가 사죄를 하시든가 하는 것이 정국 해법의 첫 순서이다 아직 그런 기미는 보이지 않는다 사회가 맑아야만 종교도 설 수 있는 것이다 사회를 혼탁하게 한 집권세력을 단죄해내고 사회를 바로세우고 종교의 교권이 제대로 확립될 수 있어야 그 속에서 정치도 바로 설 수 있는 것이다 그런 길을 찾기 위해서 제가 마음을 비우고 여쭤보고 큰 가르침을 듣고 싶어서 청을 드리게 됐다 바쁘신 가운데 참석해주셔서 감사하다 저도 오늘 아침부터 계속 마음과 몸이 무겁지만 오늘 많은 기운을 얻어갔으면 좋겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58905,2016-11-09, 정진석 원내대표는 본질 흐리기 사실왜곡을 중단하라 새누리당 정진석 원내대표가 오늘 국회 개헌특위 설치 최순실 국정개입 파문 개별특검 거국중립내각 구성 거국내각 총리의 국회추천권 등 야당이 요구한 모든 것을 다 받았다 고 주장했다 도대체 무슨 소리를 하는지 모르겠다 개헌은 박대통령이 참 나쁜 대통령 이라고 말할 때부터 최근까지 기회 있을 때 마다 논의를 억누르다가 최근 최순실게이트가 폭로되기 시작하자 물타기용으로 개헌논의를 시작하겠다고 한 것에 편승한 정략적 수용이었다 최순실 개별특검 또한 애초에 대통령을 조사해야 할 특검을 우습게도 대통령 자신이 임명하겠다는 상설특검을 주장하다가 국민들의 촛불민심이 걷잡을 수 없을 정도로 활활 타오르자 허겁지겁 수용을 언급한 것이며 이 또한 정대표가 언급했을 뿐 정작 대통령의 입에서는 특별법에 의한 특검을 수용하겠다는 입장이 나온 적이 없는 것이다 거국중립내각이란 대통령의 선후퇴와 탈당을 전제하고 사실상 국정운영의 전권을 위임받는 내각을 말하는데 어제 대통령의 국회방문에서는 이에 대한 그 어떤 명시적 언급이 없었기도 하다 그럼에도 정대표는 마치 야당의 요구를 모두 들어준 것처럼 사실을 왜곡하고 있다 대통령이나 새누리당 원내대표나 성난 민심을 제대로 수용하고 진정성 있게 받아들이려는 노력은 전혀 보이지 않고 오로지 본질 흐리기 물 타기 사실 왜곡 등의 꼼수로만 대응하고 있다 이런 방식으로는 민심을 되돌릴 수 없고 사태를 수습할 수도 없다 정도를 외면하고 꼼수에 전력투구하는 정진석 대표의 모습 눈살을 찌푸리게 한다 덩치 값 좀 하시라 +http://theminjoo.kr/briefingDetail.do?bd_seq=58904,2016-11-09, 한일 군사정보보호협정 총체적 안보무능의 현재진행형 오늘 일 한일 군사정보보호협정 차 실무회의가 열린다고 한다 년 이명박 정부 시절 한 일 양국 간 포괄적인 군사정보 공유가 가능한 한일 군사정보보호협정을 공론화 절차 없이 밀실 처리를 시도하려다 국민적 저항에 부딪혀 무산된 것을 다시 추진하려는 것이다 국방부는 한일 군사정보보호협정이 대북 위협이 증가함에 따라 일본과 직접 정보를 공유할 경우 정보 공유 범위가 확대되고 정보 분석 능력이 향상된다고 주장하고 있다 국방부에게 묻는다 국방부는 어느 나라의 국방부인가 지금 도대체 무슨 일이 벌어지고 있는가 협정 체결은 일본에게 우리 군사정보를 송두리째 바치겠다는 것에 다름 아니다 한일 군사정보보호협정은 일제강점기 이후 최초로 한일 양국 간에 체결되는 군사협정이다 지난해 졸속으로 처리된 일본군 위안부 합의로 갈등은 계속되고 있고 일본은 올해 방위백서에도 독도가 일본 땅이라고 주장하는 등 역사 영토 왜곡을 멈추지 않는다 한일 군사정보보호협정은 일본이 군사력 사용의 범위를 확대하는 이른바 집단 자위권 을 추구하는 상황에서 일본 자위대를 정규군으로 인정하는 협정이고 한 미 일간의 군사정보 공유로 미국의 체계 편입 논란과 함께 한반도에 신냉전 구도가 형성될 우려가 제기된다 최근 박근혜 최순실 게이트의 혼란한 정국 속에 국방부는 국민적 합의도 없이 군사작전 하듯 일방적으로 밀어붙이고 있다 국방부장관이 국회와 국민적 이해가 필요 하다며 신중한 입장을 표명한 지 불과 한달 만에 갑자기 말을 바꾸었다 왜 지금 이것을 해야 하는지 명확한 답변을 하지 못하고 있다 사드 배치 때도 마찬가지였다 갑작스럽고 오락가락하고 예측불가능한 이것이 지금 우리 국방의 현주소이다 이명박 박근혜 보수정권 년 북한의 핵과 탄도미사일 발사 기술이 실전배치가 가능한 단계로 고도화 되었음에도 무능한 정부는 북한의 도발에 대응하지 못했다 방위산업비리와 군납비리는 근절되기는커녕 국가 안보의 큰 위협이 되고 있다 국방부는 한 군사정보보호협정 논의를 당장 중단하고 외부의 군사적 위협과 침략으로부터 국가를 보위 하는 본연의 역할에 충실하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58902,2016-11-09, 박경미 대변인 오전 현안 브리핑 일시 장소 국회 정론관 사태 수습의 시작은 박근혜 대통령의 선 후퇴 박 대통령은 어제 국회를 기습 방문하여 국정에서 손을 떼겠다는 선언도 없이 애매모호한 총리 요청 제안만 하고 황황히 떠났다 국회에서 추천 받은 총리의 권한이 무엇인지 명확하게 밝히지 않은 채 총리 추천권만 국회에 넘긴 셈이다 대통령의 제안은 총리 추천을 둘러싸고 정당 간에 대선 주자 간에 또 정당 내부의 논란을 촉발해 대통령에 대한 비판 여론을 국회로 돌리려는 술책이라고 볼 수밖에 없다 첫 단추를 제대로 꿰어야 한다 단추를 잘못 꿰면 정국은 더욱 혼란스러워질 뿐이다 어렵더라도 제대로 된 시발점을 만들어야 한다 정국 수습의 출발이자 요체는 대통령의 결자해지뿐이다 선 후퇴에 대한 분명한 입장 천명 이외에는 그 어떤 수습책도 미봉책에 불과하다는 점을 다시 한 번 강조한다 전대미문의 국정농단 국기문란의 중심은 대통령이었음이 확인됐다 최순실씨는 박근혜 대통령이 먼저 연설문 등 문서를 봐달라고 부탁했다고 진술했고 정호성 전 비서관은 대통령의 지시로 최씨에게 문서를 전달했다고 진술했다 이들의 증언을 통해 확인된 박근혜 대통령의 민낯은 충격적이다 박 대통령이 국기문란 국정파탄을 주도하고 비선실세들의 국정농단을 불러일으킨 장본인임이 확실해졌다 대통령의 국정에 대한 무지함과 무책임함을 적나라하게 확인하며 이런 대통령에게 국정을 맡겼다는 것인지 우리 국민들은 개탄을 넘어 집단 패닉에 빠졌다 박근혜 대통령에게 더 이상 무엇을 바랄 수 있는지 참담하기 그지없다 이 시점에서 우리는 헌법 조 항 대한민국의 주권은 국민에게 있고 모든 권력은 국민으로부터 나온다 를 되새겨야 한다 국민들은 대통령에게 더 이상 국정을 맡길 수 없다는 분명한 메시지를 전달했다 이제 남은 것은 민의를 수용한 대통령의 결정뿐이다 새누리당은 국민 기만하고 혼란 부추기는 정략적 행태를 중단하라 새누리당 정진석 원내대표가 박근혜 대통령의 제안은 여야 합의에 의한 거국중립내각을 수용한 것인데 야당은 또 반대하고 있다 고 강하게 비난하고 나섰다 새누리당은 또다시 국정 발목잡기 프레임으로 정국을 더 큰 혼란으로 몰아넣으려는 것인지 묻고 싶다 국정을 파탄시키고 마비상태로 몰아넣은 장본인이 누구인가 석고대죄하고 국민의 처분을 기다려야할 사람들이 오히려 큰 소리를 치다니 적반하장도 유분수다 대통령의 선 퇴진과 국회 추천 총리의 권한을 명확하게 하지 않고 사태를 수습하겠다는 것 자체가 어불성설이다 그런데도 새누리당이 국정 수습을 핑계로 합의를 독촉하는 것은 그 책임을 야당에 전가하고 국민여론을 분열시키려는 술책으로 볼 수밖에 없다 새누리당은 사안의 엄중함이나 국민의 분노 수위를 전혀 파악하지 못한 채 또다시 국민여론을 왜곡하며 선동을 하려는 것인가 새누리당은 제발 정신 차리기 바란다 이번 사태를 정략으로 풀려는 새누리당의 행태는 스스로의 존립기반을 위태롭게 만드는 결과가 될 것임을 엄중히 경고한다 조윤선 장관과 정관주 차관은 즉각 사퇴하라 조윤선 문화체육부장관이 청와대 정무수석 재직 때 문화예술인 블랙리스트 작성을 주도했음을 방증하는 증언이 추가 보도됐다 복수의 문체부 전 현직 공무원들의 증언에 따르면 청와대 교육문화수석실을 통해 좌 우파 문화계 인사 명단이 내려왔는데 교문수석실에선 정무수석실을 통해 받았다고 설명했다 는 것이다 더 나아가 이 같은 블랙리스트 관리 지시에 소극적 태도를 보인 박민권 차관이 전격 경질됐다는 의혹도 보도됐다 실제로 박 차관은 차관 부임 넉 달 만에 경질됐다 증언에 따르면 정무수석실 내 국민소통비서관 라인이 실무 작업을 했다고 들었다 는 것인데 당시 정무수석은 조윤선 장관이고 국민소통비서관은 정관주 차관이었다 조윤선 장관과 문체부는 블랙리스트 의혹을 강하게 부인하고 있지만 이를 입증하는 증거들이 추가되고 있다 그런데도 오보라고 강변하다니 가증스럽다 조윤선 장관과 정관주 차관은 더 이상 낯부끄러운 변명하지 말고 즉각 자리에서 물러날 것을 촉구한다 안종범과 우병우가 최순실을 몰랐다고 검찰 조사 과정에서 안종범과 우병우가 최순실을 알지 못한다는 진술을 하고 있어 국민들의 공분을 자아내고 있다 안종범 전 수석은 우병우 전 민정수석을 비롯한 민정 라인 의 직무유기에 대해 원망을 토로한 것으로 전해졌다 민정라인에서 아무 얘기를 해주지 않아 미르 스포츠재단에 비선실세인 최순실씨가 개입돼 있는지 몰랐고 정당한 사업인줄 알았다는 것이다 대기업들을 상대로 억 원을 모금하면서 누구를 위해 일하는 지도 몰랐다는 변명은 참으로 낯 뜨거운 궤변이다 이런 사람이 청와대 정책조정수석으로 국가의 각종 정책을 조율해왔으니 대한민국 사회와 경제가 더욱 깊은 수렁으로 빠질 수밖에 없었던 것이다 한편 우병우 전 민정수석에 대한 특별수사팀이 출범한 지 두 달 반이 넘도록 아직도 압수수색이나 계좌추적조차 이뤄지지 않고 있다 우병우가 비선실세의 국정농단에 관여하거나 묵인한 일이 없는지 수사팀부터 교체하고 구속 수사해야 한다 온 국민이 두 눈을 부릅뜨고 지켜보고 있음을 명심하고 검찰의 수사의지를 믿을 수 있는 조치를 하기 바란다 최고위원회 결과 오늘 아침 최고위원회에서는 경제안보상황실 운영과 관련해서 경제상황실장에 최운열 정책위 부의장을 안보상황실장에 진성준 민주연구원 부원장을 선임했다 경제안보상황실은 경제 및 외교안보 분야를 강화하여 주요 이슈 및 상황을 실시간 파악하고 적극적인 대처와 대응방안을 마련할 수 있도록 하였다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58901,2016-11-09, 추미애 대표 야 당 대표 회동 인사말 일시 수 장소 국회 사랑재 추미애 대표 오늘 제가 우리 국민의당 박지원 대표와 심상정 대표를 모셨다 대통령은 국정이 혼란한 이 순간에도 국민을 속이고 야당을 속이는 공작정치와 언론플레이를 하고 있다 오늘이 수요일이다 월요일 오후 시 분에 유력한 모 경제지에 면 톱으로 대통령이 화요일 국회에 야 당대표를 만나러 온다는 기사가 나갔다 야당 반응도 이미 써져 있었다 야당 썰렁 이라고 쓰여 있었다 그런데 오후 시 분에 언론 지면에는 나갔지만 야당은 통보조차 받지 못했다 그리고 저는 아침 출근길에 부재중 전화를 확인했다 시 직전이었고 아마도 그 전화가 신임 정무수석의 전화였던 모양이다 부재중 전화를 남기고 야당 대표를 우회하고 국회의장을 만나서 던지신 말씀은 딱 세 문장이었다 기존 헌법에 있는 그대로였다 헌법상 주권자인 국민은 대통령의 퇴진을 요구하고 있다 국민이 강경해서가 아니다 대통령이 이미 국정운영의 능력과 도덕적 자격을 상실했다고 객관적으로 판단했기 때문이다 그런데 대통령은 선 후퇴도 퇴진도 아니 하고 그냥 눈감아 달라는 것이다 이런 자세에 국민은 더욱 분노하고 있다 야당이 지금까지 절제력을 가지고 대통령은 국정에서 한시 빨리 손을 떼고 국회 추천 총리에게 권한을 넘기라 고 분명히 말씀드렸다 그런데 대통령은 그 뜻을 이해하기는커녕 모호한 말장난만 하실 뿐이다 박근혜 대통령은 이제 내치든 외치든 자격이 없다 세세한 권한을 따질 때도 총리 후보를 거론하면서 여권이 갑론을박할 때도 아니다 대통령은 주권자인 국민에게 무릎을 꿇으셔야 한다 민주당은 국민의 뜻을 존중하며 민주주의와 참다운 역사 신뢰와 통합이 존재하는 국정 정상화의 길을 반드시 찾겠다 그래서 오늘 다른 두 야당 대표님과 심도 있는 논의를 하겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58900,2016-11-09, 제 차 최고위원회의 모두발언 일시 수 장소 국회 당대표 회의실 추미애 대표 뒤에 있는 이 자막으로 오늘 말씀을 대신하겠다 우상호 원내대표 국정공백이 장기화돼서는 안 된다 국정공백을 최소화하기 위해서는 대통령의 빠른 결단이 필요하다 국정공백이 장기화되는 것은 대통령의 국정운영 동력이 상실되었기 때문이다 지금 어느 부처도 또 어느 단위도 대통령의 지시를 듣지 않는다 이 상황이 어떻게 정리되는지 지켜볼 뿐이다 더불어민주당은 국정해법에 대해서 이미 당론으로 결정해 놓은바 있다 정당 중에서 국정수습의 해법을 당론으로 결정한 당은 더불어민주당밖에 없다 대통령께서 조기에 모든 권한을 내려놓고 국회가 추천하는 총리에게 국정 수습을 맡기겠다고 선언해 주는 것이 가장 빠른 수습 방안이다 다른 꼼수나 시간 끌기가 필요 없다 모든 국민이 명백히 알고 있는 해법을 청와대만 모르고 있는 것이 아닌지 우려된다 야당은 하루빨리 이 정국 수습되어서 나라가 정상화되기를 바란다 최순실에 의해서 농단된 국정이 정상화되기를 바란다 그런 측면에서 이 사건에 연루되어있는 박근혜 대통령이 하루 빨리 결단해주시기 바란다 이 와중에 한일군사정보보호협정을 추진하고 있는 국방부와 이 정권에 대해서 정말 뭐라고 말해야 할지 모르겠다 한일정보군사보호협정은 년 전에도 국민들의 강한 반대에 부딪혀서 무산된바 있다 일본으로부터 받을 군사정보는 없고 오로지 대한민국의 군사정보를 바치는 협정이다 도대체 대한민국의 군사정보를 일본에게 갖다 바치는 것이 왜 북한 핵무기를 막는데 도움이 된다고 말씀하시는가 저는 이해할 수 없다 한미군사동맹을 강화하는 것은 북핵문제의 해법이 될 수 있지만 어떻게 대한민국의 군사정보를 송두리째 일본에게 주는 것이 북한의 핵을 막는데 도움이 된다고 주장하시는가 일본이 북핵을 막는데 무슨 도움을 줄 수 있나 왜 이런 짓을 하나 한일군사정보보호협정은 절대 용납할 수 없다 당장 중단하라 새누리당의 내분이 갈수록 악화되고 있다 남의 당 이야기를 할 사정은 아니지만 향후에 총리 추천을 두고 협상해야 할 대상이기 때문에 한 말씀 드리겠다 하루빨리 이 문제가 해결되어야 한다 그래야 여야 협상이 가능할 수 있다 적어도 최순실 국정농단의 진실을 은폐하려 했거나 비호했던 분이 지도부에 계속 계신다면 우리는 협상하기가 어렵다 지금은 최순실 국정농단을 제대로 규명하고 그것으로 인해 농단된 국정을 정상화하는 게 우리의 과제이다 그런 측면에서 본다면 새누리당 지도부에서 이 문제와 연루된 분들을 하루 빨리 정리해주시는 것이 정상적인 여야 협상에 도움이 된다는 점을 강조한다 김영주 최고위원 어제 박근혜 대통령이 기습적으로 국회를 찾아 정세균 국회의장을 만나면서 국회에서 총리를 추천해 달라고 했다 분 만에 끝난 이 회동을 보고 저는 참으로 이 나라가 걱정이 됐다 박근혜 대통령은 아직도 이번 사태의 엄중함과 심각성을 깨닫지 못하고 있다 불과 일주일 전에는 들끓는 민심에 기름을 붓듯 김병준 총리 내정자를 지명하고 거짓사과 감성팔이 사과 를 하시더니 어제는 국회를 찾아 국면전환 행보에 나섰다 국민들께 진심이 담긴 사과와 반성도 하지 않았다 국민의 의사를 반영한 야당의 최소한의 요구인 대통령 선 후퇴에 대한 언급도 전혀 없었다 마치 우는 아이에게 뭐 하나 주듯 여야가 총리를 추천하면 실질적으로 내각을 통할하도록 하겠다 는 아무 의미 없는 말을 던지고 돌아갔다 더구나 국정을 농단한 최순실을 비호 했던 새누리당 친박 지도부와 합의 를 해서 총리를 추천하라고 한다 이는 야당에 허수아비 총리 제 의 김병준 을 추천하라는 것에 지나지 않다 국회를 총리 추천 게임장 으로 만들겠다는 것이다 대한민국이 동서고금에 유례를 찾기 힘든 세계적인 수치를 당하고 있는데도 대통령은 국민과 야당의 명확한 요구를 외면하고 어떻게든 이 국면을 모면하기 위한 정치공학을 아직도 고수하고 있다 특히 박 대통령은 아직까지도 본인이 국정을 챙기고 수습하려는 의지를 버리지 않고 있다 청와대와 정부 여당에 남아있는 최순실 비호세력 과 국정을 운영하실 생각인가 국민이 아닌 대통령이 불쌍하다 는 친박 정치인들과 정국을 수습할 것인가 박근혜 최순실 게이트의 본질이 무엇인가 국민의 위임을 받아 헌법을 수호해야 할 대통령이 헌법을 위반한 것이다 대통령 스스로 국민이 선출하지도 않은 최순실에게 국정 전반에 걸쳐 대통령 권한을 행사하도록 해 국정을 농단한 것이다 이는 대통령이 본인 입으로 시인한 것이다 검찰이 놀랄 정도로 최순실의 국정 지시사항이 담긴 휴대전화 녹음파일을 통해 확인된 것이다 이 근본적인 문제를 해결해야 한다 그러기 위해서는 국민과 야당의 최소한의 요구대로 대통령이 국정에서 완전히 손을 떼고 선으로 후퇴해야 한다 한 말씀만 더 드리겠다 어제 언론 보도를 통해 박근혜 대통령과 최순실의 국정 농단이 또 하나 드러났다 최순실 모녀가 다니던 강남의 성형외과 의사와 관계자들이 박근혜 대통령의 해외순방에 여러 차례 동행했다고 한다 이 성형외과 원장은 최순실의 요구로 서울대학교병원의 외래교수가 됐다 이뿐 아니라 청와대 경제수석의 업무가 이 성형외과의 해외진출을 돕는 것이었다 조원동 전 청와대 경제수석은 대통령의 지시를 받아 이 성형외과의 해외진출을 돕다가 일이 제대로 진행되지 않자 해임됐다고 한다 성형외과의 해외진출을 성사시키지 못한 컨설팅업체는 세무조사를 받고 업체 대표의 가족들까지 피해를 입었다 정말 슬프고 분노를 넘어 참담하기까지 하다 대통령이 금실로 최순실의 빵빵한 얼굴을 만들고 관리해 준 성형외과 사람들까지 호가호위하게 만든 나라 대한민국이 참으로 부끄럽다 박근혜 최순실 게이트에는 앞으로 더 밝혀질 것들이 많은 것으로 알고 있다 과연 선 후퇴조차 받아들이지 않고 있는 대통령을 언제까지 이대로 보고만 있어야 하는지 심각하게 고민하지 않을 수 없다 전해철 최고위원 박근혜 대통령이 국회를 방문해 분간 국회의장을 만나 국회에서 추천하는 총리에게 실질적인 내각 통할권을 주겠다고 말하고 갔다 이 같은 대통령의 행보를 보면서 대통령은 국민의 뜻을 전혀 알지 못하고 있다는 것을 재확인할 수 있었다 이는 지난 두 번의 사과와 같이 진정성이 전혀 없는 정치적 위기를 모면하기 위해 대통령을 향한 국민의 분노를 국회로 돌리려는 의도가 아닌지 짐작하게 한다 국회에서 추천하는 총리가 어떤 권한을 갖는지 전혀 언급하지 않은 채 공만 국회에 넘겨서 총리지명을 놓고 야당끼리의 분란을 유발하려는 것은 아닌지 의심스럽다 이러한 정치적 수사에 속을 만큼 국민들은 어리석지 않다 박근혜 대통령이 제안한 실질적 내각 통할권 이양은 완전한 허구에 불과하다 현행법상 총리의 권한은 대통령의 명을 받아 통할하게 되어있기 때문에 총리는 대통령의 명에 따라야할 의무가 있다 야당이 추천한 총리와 대통령 간의 신뢰관계나 존중이 있을 수 없고 상호 대립되는 부분이 많을 것이다 대통령은 총리에게 명령할 수 있기 때문에 추후에 언제든지 대통령은 자의에 따라 국정에 개입하고 책임총리의 권한을 무력화할 수 있다 총리에게 인사상 제청권과 해임건의권이 있다고 하지만 이 또한 기속적 권한이 아니기 때문에 대통령은 언제든지 이를 거부할 수 있을 것이므로 결국 대통령의 의지에 따라 총리는 유명무실해질 우려가 굉장히 많다 그래서 대통령의 제안이 진정성을 얻기 위해서는 다음과 같은 전제조건을 수용하고 이를 국민 앞에 천명해야 할 것이다 먼저 대통령의 공식적인 국정권한에 대한 완전 위임 선언 이 있어야 한다 내치와 외치의 구분은 정부 업무상 구분할 수 없는 것이므로 이를 분리하는 역시 무의미하다 따라서 내치와 외치를 불문하고 국무총리의 결정사항인 인사에 이의를 제기하지 않겠다는 것을 공식적으로 선언해야 한다 다음으로 박근혜 대통령이 임명해서 여전히 영향력을 미칠 수 있는 현 국무위원 국정원장 감사원장 검찰총장 등 권력기관장들의 사임 내지 교체도 당연히 필요하다 다시 한 번 강조하지만 박근혜 대통령이 제시한 실질적 내각 통할권 이양은 하야와 탄핵까지 요구하는 국민의 민심은 전혀 읽지 못하고 이 소나기만 피해 국정을 계속 장악하려는 시도에 불과하다 질서 있는 정국 수습의 첫 걸음은 대통령이 국정에서 손을 떼는 것이다 지금 상황에서는 대통령이 솔직하고 명확하게 자신의 모든 권한을 국회가 추천하는 총리에게 넘기고 자신은 완전히 손을 떼겠다고 선언할 때만이 수습 가능할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58899,2016-11-09, 검찰은 정유라도 소환 조사하라 온 나라가 박근혜 최순실 게이트로 인한 분노와 자괴감에 힘들어하고 있다 심지어 평범한 부모들과 청소년 청년들까지 모두 지금의 사태를 지켜보며 분노하고 있다 미래의 세대까지 분노하는 이유는 무엇인가 헬조선 이라는 말이 있을 만큼 치열한 경쟁과 취업 입시전쟁을 치르고 있는 청년들과 청소년들은 정유라의 특혜 입학과 부당한 출결관리와 학점 으로 미래에 대한 모든 의욕이 꺾이었다 박근혜 대통령과 최순실은 정유라를 위해 승마협회를 통한 지원 정부부처의 고위관료 사퇴 압력 재단을 만들어 지원하고 심지어 기업까지 동원하였다 온 국민은 이에 대한 진실규명과 책임져야 할 관련자들에 대한 공정한 처벌을 원하고 있다 검찰은 범죄 혐의를 부인하고 있는 오만한 최순실의 가면을 벗기고 사건의 진실을 밝혀내기 위해서라도 해외에 체류중인 정유라를 소환 조사해야 할 것이다 검찰이 황제수사 라는 오명을 벗고 싶다면 박근혜 최순실 게이트의 진실을 낱낱이 밝혀내고 책임자를 처벌하는 데 최선을 다해야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58898,2016-11-09, 이재정 원내대변인 오전 현안 브리핑 일시 수 오전 시 장소 국회 정론관 국민 무서운 줄 모르는 국방부의 한일군사정보보호협정 체결강행 시도 박근혜 게이트로 인한 정국혼란 속에서 국방부는 한일군사정보보호협정 체결강행을 위해 속도를 내고 있다 모든 이목이 박근혜 최순실로 몰리는 것을 역이용하겠다는 국방부의 모습을 보면서 진정 국민 무서운 줄 모르는 한심한 정부라는 지적을 피할 수 없다 과거에 대한 반성과 사과 없는 일본과의 협정체결이 우리의 국익보다는 타국의 이익을 위한 일이라는 것을 국민 모두가 잘 알고 있다 이는 제 의 밀실협정과 다름없는 행위다 국방부는 한일군사정보보호협정 체결시도를 중단하라 국정수습 의지 없는 박근혜 대통령의 국정방해 꼼수 행태 박근혜 대통령이 국정을 수습하기는커녕 국정을 방해하며 시간벌기용 꼼수를 부리고 있다 국정에서 손을 떼라는 요구사항에 대한 입장은 쏙 빼놓은 채 일방적으로 국회를 찾아와 국회가 추천하는 총리를 임명해 내각을 통할하도록 하겠다는 모호한 발언으로 또다시 국회와 국민이 대통령의 진의를 해석하라는 문제를 던져주고 갔다 그리고는 본인은 모든 요구를 수용했으나 국회가 국정공백을 초래하고 있다는 핑계를 댈 심산임을 국민은 알고 있다 국정수습 의지는 없고 권력유지 욕망으로만 가득 찬 대통령의 꼼수에 더 이상 속을 국민은 없다 박근혜 대통령은 권력에 대한 미련을 버리고 결단을 내려야한다 국민은 오늘도 칼바람 부는 광장에서 촛불을 들고 하야를 외치고 있다 더 이상 국민의 염원을 외면하고 욕되게 하지 마라 +http://theminjoo.kr/briefingDetail.do?bd_seq=58893,2016-11-08, 박경미 대변인 오후 현안 브리핑 일시 장소 국회 정론관 더불어민주당의 대 선결조건은 여전히 충족되지 않았다 박근혜 대통령은 오늘 오전 정세균 국회의장과 만나 국회에서 여야 합의로 좋은 분을 추천해준다면 그분을 총리로 임명해서 실질적으로 내각을 통할할 수 있도록 하겠다 고 밝혔다 그러나 박 대통령의 제안이 우리당의 대 선결조건을 충족했다고 보기는 어렵다 우리 당이 기대하는 총리는 실질적으로 조각권까지도 갖는 명실상부한 거국내각의 책임총리이다 그러나 박근혜 대통령의 언급은 총리의 권한에 대해서 헌법 규정을 원용한 정도이다 뿐만 아니라 대통령이 국정에서 손을 떼고 선으로 물러날 지에 대해서 분명한 입장 표명도 없었다 이런 상황에서 국회가 추천한 총리가 안정적으로 국정 전반을 운영하고 책임 있게 국정 공백을 해소해나갈 수 있을지 의문스럽다 국정 마비사태를 부른 대통령은 국정에서 물러나라는 것이 민의이다 국민의 바람을 실현하기 위해서는 이에 대한 대통령의 분명한 확약이 있어야 한다 몸통이 깃털 코스프레 한다고 누가 속겠는가 박근혜 최순실 게이트 라는 명칭에 대통령이 최순실보다 앞에 있는 것에는 중요한 의미가 담겨 있다 국정농단 국기문란 헌법유린 자유민주주의 훼손의 주범이 박근혜 대통령이라는 점을 적시한 것이다 이를 뒷받침하는 단서와 정황들이 속속 드러나고 있다 안종범 전 수석에 대한 수사과정에서 밝혀진 바에 따르면 박 대통령이 작년 월 대기업 총수들을 청와대로 불러 한류 확산 취지에서 대기업들이 재단을 만들어 지원하면 좋겠다는 취지의 발언을 했다고 한다 한편 박 대통령이 신동빈 회장을 직접 불러 독대 를 했고 롯데는 그 이후 미르 스포츠 재단에 대해 거액의 추가 지원이 있었다는 의혹도 제기됐다 이처럼 박 대통령이 직접 기업의 손목을 비틀어 미르 스포츠 재단의 자금을 조성했다는 분석이 뒤따르고 있다 검찰 특별수사본부에 따르면 압수한 정호성 전 비서관의 휴대전화의 음성 녹음 파일에는 박 대통령과의 통화 내용도 있고 청와대 핵심 기밀인 수석비서관 회의 안건 등에 관한 최순실 씨와의 대화도 담겼다고 한다 이런 정황들을 종합해 볼 때 게이트의 몸통이 박근혜 대통령이라는 점은 자명하다 그럼에도 불구하고 박 대통령은 지난 두 차례 담화에서 슬픈 목소리로 최순실 씨에게 책임을 떠넘기기에 바빴다 몸통 이 깃털 코스프레를 한 것이다 분노한 민심의 온도가 비등점을 향해 올라가고 있는데 박 대통령은 아직도 상황 파악조차 제대로 하고 있지 못하는 것 같아 안타까울 따름이다 한일군사협정 연내 타결하겠다는 국방부 제정신인가 국방부가 한일 군사정보보호협정의 체결이 임박했음을 시사했다 국방부는 국회와 국민의 요구가 들리지 않는지 정말 기가 막힌다 국회와 국민이 허락하지 않는데 국방부가 무슨 권한으로 양국 간의 군사협정을 체결하겠다는 것인지 어처구니가 없다 지금처럼 국정이 마비된 상태에서 도대체 누구의 의지와 권한으로 졸속협상을 밀어붙이려는 것인가 박근혜 정부가 진정 국가 안보를 걱정한다면 침략의 역사를 정당화하며 군사대국화를 획책하는 일본에게 우리 군의 정보를 통째로 넘기겠다는 발상 자체를 하지 않을 것이다 국방부는 당장 한일 군사정보보호협정 추진을 중단하라 만약 국방부가 협정을 강행한다면 국민의 분노에 기름을 붙는 격이 될 것임을 엄중히 경고한다 오만한 우병우 제대로 수사하려거든 수사팀부터 교체하고 구속수사 하라 검찰 조사를 받는 피고발인 우병우 전 수석의 여유로운 모습이 담긴 사진기사에 온 국민이 분노하고 있다 수사의뢰 일 만에 늑장 소환을 한 검찰은 각종 비리와 국정농단에 연루되어 조사를 받으러 온 사람에게 차 대접까지 했다 팔짱을 끼고 이야기 하는 우 전 수석의 말을 일어서서 손을 모으고 공손히 경청하는 검찰 수사팀의 모습은 검찰을 쥐락펴락했던 우 전 수석의 위세를 그대로 보여준다 엄중한 상황에서 어느 때보다 진지하게 수사에 임하겠다 는 검찰의 모습이 고작 이런 비굴한 모습이었나 자기 사무실처럼 활개 치고 다니며 후배 검사에게 수고 많다 는 덕담까지 건넨다고 하니 할 말을 잊는다 우려했던 황제 소환 황제 조사는 현실이 되었다 우병우 전 수석이 조사받으러 가서 대우받고 나오도록 한 대한민국 검찰을 국민은 더 이상 믿지 못한다 검찰총장이 뒤늦게 수사를 지시했다고 하는데 제대로 수사하려거든 수사팀부터 교체해야 하고 우병우 전 수석의 구속수사는 필수다 마지막으로 정치검사들에게 경고한다 이제 당신들의 축제는 끝났다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58884,2016-11-08, 박경미 대변인 추가 현안 브리핑 일시 장소 국회 정론관 박근혜 대통령의 국회 방문 역시 국면전환용이 아닌가 박근혜 대통령이 오늘 오전 국회를 방문했다 박 대통령은 국회에서 총리 후보자를 추천하면 실질적으로 내각을 통할하도록 하겠다고 요청했다 그러나 가장 핵심적인 문제인 자신의 선 후퇴문제에 대해서는 아무런 언급도 없이 분여 만에 국회를 떠났다 여전히 국정 주도권에 대한 미련을 버리지 못한 것으로 보인다 사전에 야당과의 협의도 없이 일방적으로 전격적으로 국회를 방문한 것은 절차적으로 적절하지 않았다 자신은 수습을 위한 노력을 다했지만 야당이 거부했다는 명분 쌓기용이라면 오늘의 제안 역시 국면전환을 위한 것이 아닌지 합리적인 의심을 제기할 수밖에 없다 국민들은 국정 농단을 묵인하고 국정을 마비시킨 대통령의 퇴진을 요구하고 있다 더불어민주당의 선 후퇴 요구는 민의를 반영한 최소한의 요구사항이다 박근혜 대통령께서 더 늦기 전에 국민의 요구를 수용해 자신의 문제에 대해서 결자해지할 것을 촉구한다 조윤선 장관의 예술계 블랙리스트 작성 의혹 윗선의 개입 여부까지 모두 밝혀야 조윤선 문화관광체육부 장관이 청와대 정무수석 시절에 문화예술인 블랙리스트 작성을 주도했다는 언론 보도는 대단히 충격적이다 조 장관의 부인에도 불구하고 정권에 밉보인 문화예술계 인사들을 표적 관리하는 블랙리스트가 존재한다는 의혹이 계속되어 왔다 그런데 그 리스트를 현재 장관 자리에 앉아있는 조윤선 장관이 주도해 작성했다니 의혹이 사실이라면 분노를 금할 수 없다 게다가 당시 김기춘 대통령 비서실장과의 교감 아래 작업이 이뤄졌다는 의혹도 제기되었는데 실제는 그보다 더 윗선의 입김이 작용했던 것은 아닌지 의심이 든다 문체부는 절대 오보라며 법적 대응도 불사하겠다고 밝혔지만 문체부와 문예위 전 현직 관료들의 증언을 아니 땐 굴뚝의 연기 로 치부할 수는 없다 박근혜 대통령이 문화융성과 한류를 홍보하는 뒤편에서 문화예술 영역을 억압하고 탄압하려 했다면 절대 묵과할 수 없다 이로써 박근혜 대통령이 스스로 답해야 할 문제가 또 하나 늘어났다 더불어민주당은 문화예술계 전반에 대한 정치검열과 탄압 의혹을 밝혀 그 책임을 명명백백히 물을 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58883,2016-11-08, 기동민 원내대변인 오전 현안 브리핑 일시 화 오전 시 분 장소 국회 정론관 의원간담회 브리핑 우리 당은 국회차원의 국정조사 특별법에 의한 별도 특검 국회 현안질의 등을 협의하고 있다 우리 당은 박근혜 최순실 게이트 의 진실이 밝혀질 때까지 국민과 소통하고 함께 행동할 것이다 국회 차원에서도 민심을 반영한 조치들을 꾸준히 진행해 나갈 것을 약속드린다 또한 민생 법안과 민생 예산도 꼼꼼하게 챙겨나갈 계획이다 박근혜 대통령의 국회의장 면담 관련 어렵게 발걸음 하셨는데 하신 말씀은 달랑 세 문장이었다 대통령의 책임이다 여야 합의로 국회에서 총리를 추천해주시면 그분을 총리로 임명해 실질적으로 내각을 통할하는 권한을 드리겠다 총리가 내각을 통할할 수 있는 실질적 권한을 보장하는 취지를 살릴 수 있도록 하겠다 며 고작 분 동안 회담했다 박근혜 대통령은 변하지 않았다고 본다 국민의 대의기관인 국회에 와서 진솔한 반성도 사과도 없었다 초 사과 분 재사과의 재판일 뿐이었다 국회 수장을 만나는 자리에서 민심을 묻고 국회의 의견을 경청하는 자세를 보이는 것은 기본이다 자기 말과 요구만 일방적으로 쏟아놓고 돌아서버리는 대통령의 뒷모습에 또 한 번 절망한다 대통령의 말씀은 모호했다 실제로 총리에게 조각권을 주고 일체 간섭하지 않겠다는 것인지 국회가 추천한 총리에게 조각권과 운영권한을 주겠다는 것인지 알 수 없다 또한 국회가 추천한 총리가 국정을 운영하는 과정에서 청와대가 감 놔라 배 놔라 간섭하지 않겠다는 약속 또한 없었다 이 약속이 있어야 국회가 추천하는 총리가 실제로 국정을 운영할 수 있는 권한을 가질 수 있다 국민과 야당은 대통령의 이선후퇴를 요구했는데 이것을 받아들이겠다는 것인지 아니면 계속해서 실제 권한을 행사하는 대통령으로 남아있겠다는 것인지 책임있는 말씀이 없었다 그 진의를 분명히 할 수 있는 추가적인 확인 과정이 필요하다 물음표만 남았다 국민의 마음에서 대통령은 이미 대한민국의 대통령이 아니다 더 이상의 집착은 미련일 뿐이다 국민의 외침에 귀를 기울이고 받아들이길 바란다 정략과 음모만 남은 이정현 대표는 공당의 대표 자격을 상실했다 새누리당 이정현 대표가 신임총리를 물색한다며 동교동계 인사들을 접촉했다고 한다 야당의 분열시켜 국면을 전환해 보겠다는 정략과 음모일 뿐이다 공당의 대표가 할 일이 아니다 참으로 한심한 노릇이다 이정현 대표는 이제 대통령 경호실장 노릇을 그만두길 바란다 민심에 이반되고 국회를 욕되게 하며 새누리당을 사당화시키는 행위다 모든 국민의 시선이 국회를 바라보고 있다 무너진 청와대 권력과 국정공백을 메울 수 있는 유일한 대안이 국회다 여 야가 함께 머리를 맞대고 난국을 헤쳐나가도 모자랄 판에 오로지 이정현 대표만이 대통령 구하기에 사활을 걸고 있는 듯하다 이런 분을 상대로 어떤 협상이 있을 수 있고 타협의 정치가 이뤄질 수 있겠나 이정현 대표가 물러나야 국회가 제대로 일할 수 있다 이제 그만 집착을 버리고 물러나시길 강권한다 국회의 일은 국회에 맡기고 대통령 구하기는 청와대에 가서 하시길 바란다 문화계 블랙리스트 작성 의혹 조윤선 문체부 장관은 사퇴하라 불과 얼마 전까지 문화예술인 블랙리스트 의 존재를 잡아떼던 조윤선 장관이 정무수석 시절 리스트 작성을 주도했다는 의혹이 제기됐다 박근혜 대통령과 최순실이 사주하고 조윤선 장관이 주도한 박근혜 최순실판 매카시즘 이 자행된 것이다 정권 입맛에 안 맞는 인사들을 좌파로 낙인찍어 몰아내겠다는 반시대적 반민주적 발상에 경악을 금할 수 없다 조윤선 장관은 당장 사퇴해야 한다 문화예술인 죽이기에 앞장섰던 홍위병이 문화체육부 장관 자리에 앉아있다는 건 어떤 이유로도 정당화되기 어렵다 명분은커녕 최소한의 양심조차 없는 현 정권의 인사 행태에 할 말이 없다 검찰은 철저하게 수사하여 진실을 밝혀야 한다 필요하다면 특검 국회 차원의 국정조사와 청문회를 통해 진상을 반드시 규명해야 한다 다시는 이런 전근대적 반인권적 반민주적 발상이 발을 못 붙이도록 엄단을 촉구한다 대통령과 재벌의 짬짜미 성역없이 수사하여 단죄하라 최순실씨와 안종범 전 수석의 강요 그리고 박근혜 대통령과 재벌의 의심스러운 만남 그 결과로 미르 스포츠의 억원이 모였다 안종범 전 수석은 대통령의 업무상 지시를 적법하게 따랐을 뿐 이라지만 대통령 최순실 안종범 재벌 모두가 공범이다 성역없는 수사와 단죄만이 남았다 민주주의 국가에서 기업의 약점을 이용해 모금을 강요한 것도 문제고 이에 편승해 돈으로 편의와 특혜를 얻어보겠다는 재벌들의 꼼수도 단죄의 대상이다 선의 라 해도 지탄받을 일이고 모종의 거래 가 있었다면 더욱 엄정하게 처벌해야 한다 국가경제의 어려움 경제성장 기여도 등 관용구처럼 되풀이되는 사유로 관용과 선처를 언급해선 안 된다 철저하게 진상을 파악해야 하고 법에 따라 처벌하는 것이 더 큰 국익에 부합한다 최순실 안종범은 물론 대통령도 성역이 있을 수 없다 삼성 현대 롯데 한화는 물론이고 공조하고 편승한 모든 기업들도 예외는 없어야 한다 임종룡 경제부총리 내정자도 여리박빙 의 공범이다 우리 경제가 살얼음판을 걷는 것과 마찬가지의 어려움에 처했다는 것에 전적으로 동의한다 앞으로 다가올 어려움이 더 크다는 위기의식도 공감한다 하지만 그 해결사가 임종룡 내정자라는 것은 동의할 수 없다 임 내정자는 박근혜 정부 경제 파탄 의 공범 중 한 사람이고 김병준 박승주 임종룡으로 이어지는 위장 개각 의 한 조각일 뿐이다 그토록 경고했고 조심하라 일렀지만 무시로 일관해왔다 아집과 독선 무능으로 국민의 먹고사는 문제를 망가뜨린 당사자에게 치유책을 맡긴다는 건 어불성설이다 임 내정자는 경제 파탄을 바로잡을 적임자가 아니다 책임지고 물러나야 할 사람 중 하나일 뿐이다 우리나라에 아무리 사람이 없다고 해도 이보다 최악일 수는 없다 스스로 판단하여 거취를 결단하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58882,2016-11-08, 의원간담회 모두발언 일시 화 장소 국회 본청 호 추미애 대표 국민들은 이게 나라냐 고 하면서도 걱정이 참으로 많다 소는 누가 키우지 하는 걱정이다 조금 전 우리는 비상한 이 상태에서 안보가 불안을 야기하지 않고 민생경제가 제대로 일어날 수 있도록 하겠다는 막중한 책임감으로 경제 안보상황실을 만들고 현판식을 했다 또 이해찬 국정자문위원장과 김진표 의원을 모시고 경제 대책에 대한 비상경제회의를 열고 이 자리에 왔다 아침에는 우리 당의 희망인 주요 대선 후보자들을 모시고 조찬간담회를 하며 시국에 대해 깊은 대화를 했다 지난 의총에서 여러 의원들이 주신 소중한 의견들을 전했고 당을 중심으로 힘을 모아 이 정국을 주도해나가자는 말씀들을 주셨다 첫 한파주의보가 발령되었다 더불어민주당은 박근혜 최순실 게이트의 시작부터 지금까지 오직 국민만을 바라보고 대한민국 헌정질서를 바로잡기 위해 책임을 다 할 것이다 국회 광장 검찰청 앞에서의 대한민국을 살리기 위한 우리 당 소속 의원들의 결기에 찬 모든 행동들에 대해서 존경과 감사의 말씀을 드린다 민주주의 회복과 대한민국 정상화를 희망하는 국민들께 더불어민주당이 책임정당 수권정당임을 보여드려야 될 때이다 대통령께서 국회의장실에 오는 길에 언론을 통해서 야당 대표를 모이라고 하시는 모양이다 그렇게 불러들여서 민심을 읽겠다고 하시지 말고 대문 열고 나가시면 시민을 만날 수 있다 무엇이 겁나나 문을 열고 나가서 시민을 직접 만날 것을 권유 드린다 박근혜 대통령과 최순실 부역자 집단은 국민의 강력한 요구를 배신의 정치로 돌려주고 있다 민심에 반하는 폭주 개각으로 국회 추천 총리 요구를 묵살해왔다 계속 일방적으로 불통을 고집한다면 더 이상 국민도 인내하기가 어려울 것이다 우리 당이 제 야당으로서 국민의 뜻에 따라 비상한 각오로 이 엄중한 국면을 단일대오로 잘 헤쳐 나갈 수 있기를 바란다 우상호 원내대표 하루하루 새로운 뉴스가 생산되고 있다 우리 의원들 사이에 긴밀한 상황 공유와 견해를 통일시키기 위해 늘 대화가 필요할 것 같다 오늘은 그런 취지로 무엇을 결정하는 의원총회가 아니라 상황을 공유하고 우리의 후속대책을 논의하는 취지로 의원간담회를 열었다 우리가 의원간담회를 연다고 해서인지는 모르겠지만 오늘 대통령이 국회를 방문한다 형식은 국회의장님만 면담하고 본인이 가지고 있는 생각을 전달할 모양이다 오늘 국회의장 비서실장에게 전화를 받았다 국회의장께서 야당의 의견을 가감 없이 전달하겠다고 하셨다 무엇보다 중요한 것은 진정성 있는 대통령의 고백이다 대통령이 실수건 고의건 자신이 했던 많은 잘못에 대해 솔직하게 고백하는 진정성 있는 접근이 우리 국민과 야당을 설득할 수 있는 있는 첫 번째 전제조건이다 오늘 대통령과 국회의장과의 대화과정에서 어떤 대화가 오가는지를 지켜보겠다 하지만 더불어민주당은 지난 의총에서 결정했던 내용에서 흔들림 없이 이 상황에 대처해나가며 국민들의 민심을 대변하는 제 야당의 역할을 해야겠다 한편으로 더불어민주당은 우리가 찾고 있는 후속대책인 토요일 범국민대회에 진정성을 가지고 당원들과 함께 민심을 반영하는 노력을 하는 것부터 국회 내에서 국정조사 특검 법안 통과 등 여야 협상을 통해서 진실을 규명하고 국민들의 민심을 국회에서 반영하는 노력을 차질 없이 해나가겠다 상임위가 매일 열리고 있고 끊임없이 예산과 법안을 다루기 시작했다 오늘부터 시작되는 여러 법안 심의과정에서 국회가 특히 더불어민주당이 민생을 챙기고 국민들에게 도움이 되는 예산과 법안을 챙기는데 흔들림 없이 잘 하고 있다는 평가를 받을 수 있도록 최선을 다해주실 것을 부탁드린다 특히 법안은 비쟁점 법안부터 시작해서 국민들의 생활에 밀접한 관련이 있는 법안 통과에 만전을 기해주실 것을 당부 드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58881,2016-11-08, 추미애 대표 비상경제 점검회의 인사말 일시 화 장소 국회 당대표 회의실 추미애 대표 박근혜 정부 들어서 먹고사는 것과 관련된 모든 지표가 악화되고 있다 성장률은 년 연속 세계 평균을 밑돌고 일자리가 사라지고 특히 청년 일자리 문제는 더욱 심각해지고 있다 조선 해운 산업은 정부의 무능과 무책임에 공중 분해되거나 표류중이다 이런 상황에서 정부는 문제 해결은커녕 문제의 원인 제공자였다 박근혜 정부 년 창조경제는 순실 부역경제 였음이 드러났다 창조경제라는 포장지를 씌워서 재벌로부터 돈을 뜯어내고 최순실 일가를 엄청나게 챙기게 한 구조였다 서민들에게는 빚내서 집사라고 해서 가계부채만 급등시켜놓은 것도 이 정부다 국민은 밤늦게까지 일해서 꼬박꼬박 세금 낸 줄 알았더니 결국은 복채를 낸 것이었다고 한탄을 하고 있다 이러려고 대한민국 국민 했나 자괴감이 든다 고 한다 경제를 위기로 내몬 대통령에게 국가 경제를 맡길 수 없다는 것이 국민의 뜻이다 대한민국호가 중심을 잃고 표류하지 않도록 비상한 각오가 필요하다 더불어민주당은 민생을 꼼꼼히 챙겨서 수권정당의 모습을 보여드리겠다 부동산 대책 가계부채 문제 청년일자리 해법 등 민생위기를 극복할 수 있는 방안을 내놓고 경제와 안보상황을 수시로 챙기면서 국민 불안을 덜어드리는 막중한 역할을 해내겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58880,2016-11-08, 추미애 대표 경제안보상황실 현판식 인사말 일시 화 장소 국회 본청 호 추미애 대표 박근혜 최순실 게이트가 점차 박근혜 대통령으로 향하고 있다 재벌 대기업의 팔목을 남을 시켜서 한 것이 아니라 당신께서 직접 독대하면서 기업을 요리해낸 흔적들이 발견되고 있는 상황이다 이런 국정농단의 위중한 상황 대한민국의 통째로 좌지우지 해버린 엄중한 상황에서 국민들은 이렇게 묻고 있다 이렇게 되면 주권자들인 우리 국민이 촛불을 들고 대통령 하야운동을 하는데 그래도 불안하다 소는 누가 키우나 하는 걱정을 하신다 더불어민주당이 제 당으로 무너져가는 경제를 되살려내고 민생을 지키고 안보를 튼튼히 하는 일에 진력을 하겠다 그래서 오늘 현판식에 국무총리를 역임하시고 통일 평화 안보에 깊은 지식을 가지고 계신 이해찬 전 총리 우리당의 경제정책을 이끌어 가시는 김진표 전 부총리 김용익 민주정책연구원장까지 합류를 했다 정책위원회와의 공조 하에 한쪽으로는 안보 외교를 챙기고 한쪽으로는 경제를 지키는 정당의 역할을 하겠다 국민 여러분 힘내십시오 +http://theminjoo.kr/briefingDetail.do?bd_seq=58879,2016-11-08, 제 차 원내대책회의 모두발언 일시 화 오전 시 장소 국회 본청 원내대표 회의실 우상호 원내대표 박근혜 최순실 게이트에서 국가적으로 바로잡아야 할 가장 첫 번째 과제는 정경유착이라고 어제 말씀드렸다 박근혜 최순실 게이트는 대통령과 청와대 측근 참모들이 국민으로부터 권력을 위임받지 않은 자들과 함께 국정을 농단한 사건인 동시에 정경유착 사건이다 검찰은 최순실 안종범을 구속하면서 뇌물죄 적용을 피하려는 모습을 보이고 있다 그러나 재벌들이 거액의 돈을 낸 것은 단순히 강요에 의한 것만이 아니다 일정한 대가를 기대하고 돈을 낸 정황이 많이 있다 이것을 수사해야 한다 삼성은 년 월말 미르재단이 설립되기도 전인 년 월경에 최순실의 딸 정유라를 지원하기 위해 억원을 송금하고 또 거래업체를 통해서 억원을 별도로 보냈다 삼성 사장이 회장직을 맡고 있는 승마협회차원에서 수백억원에 이르는 지원계획도 세웠다 문제는 대가성이다 년 삼성은 이재용 부회장 등 총수 일가의 그룹 지배권과 관련해 절대적인 이해관계가 걸린 삼성물산과 구 제일모직간의 합병을 추진했다 국민연금은 같은 해 월 와 와의 합병을 반대했다 그런데 같은 해 월에는 삼성의 합병에 대해서 기금운용본부가 독단적으로 찬성을 결정했다 당시 국민연금은 삼성물산 지분의 를 보유하고 있었고 결과적으로 주총에서 차이로 합병이 승인됐다 국민연금이 반대했다면 부결되는 것이었다 이 합병 찬성으로 국민연금 기금은 막대한 투자손실을 입었다 그로부터 두 달 뒤에 삼성은 최순실의 딸 정유라를 위해서 거액의 자금을 독일로 송금했다 이것을 대가성이 없다고 할 수 있겠는가 검찰은 진경준 전 검사장이 년 한진그룹 내사를 종결하고 난 뒤에 그룹 임원을 만나서 처남회사에 일감을 줘서 백억원대의 이익을 얻도록 부탁해서 제 자 뇌물공여죄로 기소했다 무엇이 다른가 롯데의 경우를 보겠다 총수일가에 대해서 검찰의 내사가 진행 중이었던 올해 월초 재단 출연금과는 별도로 억원을 줬다가 검찰의 압수수색 직전에 돌려받았다 돌려받았다고는 하지만 검찰 수사를 무마하기 위한 대가성 있는 뇌물공여라고 의심하지 않을 수 없다 또한 롯데가 사활을 걸고 있는 면세점 인허가 과정이 지금도 추가로 진행 중에 있다 부영의 사례도 있다 부영의 이중근 회장은 지난 월 안종범 수석이 참석한 회의에서 재단에 대한 억원의 자금지원을 대가로 세무조사와 관련된 부정한 청탁을 한 것으로 드러나고 있다 부정한 청탁이 있었고 뇌물죄는 의사표시만으로도 범죄가 성립된다는 점에서 명백히 제 자 뇌물공여죄를 적용할 수 있는 사례다 의 경우에는 성사는 되지 않았지만 총수일가의 사면문제와 관련해서 이야기가 오가지 않았는지 확인해야 한다 지난해 광복절에 이루어진 재벌건설사들의 대규모 특사 역시 미르 스포츠재단에 대한 재벌기업의 거액 출연과의 인과관계를 규명하기 위해서 수사해야 한다 이렇듯 정경유착의 사실과 정황이 속속 드러나고 있는 상황에서 안종범 수석이 이것을 대통령의 지시에 따른 일이라고 진술했다면 만일 박근혜 대통령이 직접 재벌총수들을 만나서 두 재단에 대한 협조를 요청한 것이 사실이라면 이 정경유착의 몸통은 다름 아닌 박근혜 대통령이다 박근혜 대통령이 국정에서 손을 떼고 국회가 추천하는 총리를 임명해서 법무장관 검찰총장 등 권력기관의 수장들을 교체하고 중립적인 인사를 구성해야 하는 이유가 바로 여기에 있는 것이다 이 정권 들어와서 있었던 정경유착은 우리가 수십년간 그토록 해결하려고 노력했던 국가의 중대과제였다 대한민국 경제를 왜곡하고 시장원리를 제약한 반시장적 범죄행위이다 우리가 경제민주화를 그토록 외쳤던 것은 재벌과 권력의 유착관계를 해체하고 제대로 된 시장원리가 작동해서 중소기업 중소상공인들이 제대로 된 시장질서 속에서 성장할 수 있도록 도와야하는 정책 목표 때문이다 그런데 박근혜 대통령 임기 내내 바로 이렇게 운영돼왔던 것이다 김종인 전 대표께서 박근혜 대통령이 왜 자신을 밀어내고 경제민주화 정책을 포기했는지 이제 알겠다고 말했다 최순실을 통해서 재벌들에게 특혜를 주고 갈취할 목적으로 경제민주화 정책을 포기한 것이다 경제민주화가 답이다 정경유착 재벌특혜가 답이 아니고 경제민주화가 답이다 엄정히 수사하시기 바란다 최순실 게이트를 감추고 비호하려고 한 세력은 새누리당에만 있었던 것이 아니다 이른바 공영방송을 자처하는 일부 방송사들이 최순실 게이트를 일체 보도하지 않고 오히려 정부의 편을 들어 진실을 호도하고 은폐했던 것을 바로잡아야 한다 언론이 바로서야 진실이 밝혀지고 민주주의가 꽃필 수 있다 언론이 진실을 보도하는데 입을 닫고 오히려 진실을 보도하려고 하는 언론인을 억압한다면 대한민국은 바로 최순실 공화국이 되는 것이다 주요 공영방송사들은 반성하시기 바란다 대통령의 입이 되어서 진실을 은폐하고 기자들을 해고한 결과로 결국 대한민국이 망하는 길로 갔다 이 점에 대해 책임이 없는가 저는 이번 남은 정기국회 기간 중에 방송의 공정성을 회복하기 위한 제도 개선에 전력을 다하겠다 방송국들의 솔직한 자기고백 국민에 대한 사과가 필요하다고 생각한다 윤호중 정책위의장 박근혜 최순실 게이트는 희대의 헌정문란 국정농단사건이다 아울러 신정경유착의 실태를 낱낱이 보여준 사건이다 권력실세들에 대한 검찰의황제수사 논란까지 벌어지고 있다 우리 당에서는 희대의 국정농단 사건인 박근혜 최순실 게이트와 관련해 확실한 진상규명과 재발방지를 위한 제도적 장치를 마련하는데 앞장서겠다 지난 일 정책위원회는 최순실 예산을 삭감하겠다고 다짐했고 이번 사태에서 명백히 드러난 신정경유착 사례를 시민공익위원회 설치 등을 통해 근절하겠다고 밝혔다 우선 정경유착 방지법을 조속히 발의하겠다 경제민주화를 위해서 이미 제출돼있는 다중대표소송제 도입 등을 규정한 상법 개정에도 앞장서겠다 최태민 최순실 일가가 부정한 방법으로 축적한 재산과 범죄적 수단으로 축적한 재산을 환수하기 위해서 우리 당 민병두 의원이 최태민 최순실 특별법을 발의할 예정이다 이것을 범죄수익환수법 또는 부정축재방지법으로 이번 정기국회에서 다루어지도록 앞장서겠다 최순실 우병우 수사와 관련해서 셀프개혁 자정노력이라는 것을 무색하게 만든 검찰 개혁을 위해서 공수처법과 전관예우방지법도 적극 추진해서 검찰개혁의 고삐를 조이겠다 최순실 예산과 관련해서 정부의 말이 오락가락하고 있다 최순실 예산이라는 것은 없다고 하다가 있다고 하면서 스스로 찾아보고 그 결과를 국회에 제출하겠다고 하더니 어제 늦게는 최순실 예산이라는 것은 없다고 다시 말을 바꾸고 있다 도대체 있는 것인가 없는 것인가 정부 특히 기재부는 예산심의를 통해서 년 예산에 스며들어와 있는 최순실 예산을 낱낱이 조사해서 예결위와 기재위에 반드시 자료로 제출해야 할 것이다 이런 노력과 아울러 우리 당은 국정과 민생을 챙기는 노력을 게을리 하지 않겠다 제 야당으로서 책임을 지고 민생과 안보를 챙겨야 한다는 당연한 책무를 다하겠다 이를 위해 오늘 경제안보상황실 현판식을 한다 그리고 바로 이어서 차 비상경제점검회의를 열어서 경제 안보 지킴이 로써의 우리 당의 첫 행보를 시작한다 백혜련 부대표 우병우 전 민정수석이 시민단체가 고발한지 일 만에 수사팀이 구성된 지 일 만에 검찰에 출석했다 소환 당시 우병우 전 수석의 태도와 모습은 검찰 출신인 저도 처음 보는 피고발인의 모습이었다 지금 검찰은 조직의 존폐 위기에 놓여있다 검찰이 조직의 명운을 걸고 수사해야 하는 시점에서 이렇게 했다는 것은 온 국민의 공분을 살 일이다 검찰에서 제대로 수사를 하지 못하기 때문에 국민과 국회가 검찰에 대해서 수사 지휘의 방향을 말씀드리겠다 우병우 전 수석 사건과 관련해서는 무엇보다도 수사팀이 교체돼야한다 이미 우병우 전 수석에 대한 사건에서 윤갑근 팀장이 이끄는 특별수사팀은 국민의 신뢰를 완전히 상실했다 우병우 전 수석에 대해서 박근혜 최순실 게이트와 관련해 수사하기로 했기 때문에 우병우 전 수석 사건을 특별수사팀에서 특별수사본부로 이관하기를 요청한다 우병우 전 수석의 개인비리에 대해서 전면적으로 재수사해야 한다 검찰조차 민정수석 신분인 우병우를 수사하면서 눈치 보기에 급급했다 경찰은 그 눈치 보기가 더욱 심했을 것이다 아들 꽃보직 논란과 관련해서 민정수석일 때의 참고인 조사와 지금의 참고인 조사는 진술이 엇갈릴 가능성이 매우 크다 강남땅 거래부분도 마찬가지다 그렇기 때문에 개인비리와 관련해서도 전면적인 재수사가 필요하다 박근혜 최순실 게이트와 관련해서도 우병우 전 수석에 대해 강도 높은 수사를 해야 한다 우병우 전 수석이 지휘하는 민정수석실에서 최순실씨에게 언론보도동향을 보고했다는 보도가 있었다 또 년 정윤회 문건 파동이 발생했을 때 사건처리를 우병우 당시 민정비서관이 했다는 보도도 있었다 당시 십상시 문제가 불거졌었고 박관천 경정의 대한민국 권력서열 순위는 최순실 순위는 정윤회 순위가 대통령 이라는 발언도 있었다 민정수석이었던 우병우는 그 사실에 대해서 잘 알고 있었을 것으로 보인다 최순실의 국정농단에 대해 충분히 인지했을 가능성이 높다 미르 스포츠재단과 관련해서 롯데 부영그룹 등은 사면 수사 세무조사 등과 얽힌 여러 가지 개연성이 있고 민정수석실이 깊이 개입되어있기 때문에 이 부분에 대한 철저한 수사가 필요하다 우병우 전 수석을 최소한 직무유기 공무상 비밀 누설혐의 나아가서는 공범으로까지 볼 수 있는 상황이다 그렇기 때문에 이 부분에 대한 수사가 확실히 돼야한다 마지막으로 전면적인 압수수색이 다시 시작돼야 한다 우병우 전 수석과 관련해서는 핸드폰 자택 압수수색 등 어떤 것도 이루어지지 않았다 비록 늦었지만 휴대폰과 자택 기흥골프장에 대한 압수수색이 필요하다 그리고 청와대도 재압수수색해서 반드시 증거를 확보해야 한다 검찰은 더 이상 좌고우면해서는 안 된다 대한민국의 모든 국민이 검찰을 예의주시하고 있다는 점을 명심해서 한 점 의혹도 남기지 않고 수사해야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58877,2016-11-08, 박경미 대변인 오전 현안 브리핑 일시 장소 국회 정론관 이정현 대표 야당 분열 공작으로 대통령을 보위하려는가 국민의당 박지원 대표는 이정현 새누리당 대표가 막후에서 물밑 접촉을 해왔음을 폭로했다 박 대표에 따르면 저와 가까운 동교동계 한 인사가 새누리당 이정현 대표로부터 전화를 받아 제가 그 인사를 총리로 추천하면 여당도 제안하겠다는 이야기를 들었다 고 한다 국회 차원의 총리 추천권을 대가로 야당 분열 공작을 했다는 사실에 분노를 금할 수 없다 이정현 대표는 어제 한광옥 청와대 비서실장을 만나 가장 먼저 박근혜 대통령의 건강을 물었다 집권여당의 대표라는 분이 국민은 뒷전으로 한 채 대통령의 건강만 신경 쓰다니 참으로 개탄스럽다 대통령이 국정 마비 국정 진공상태를 만든 장본인인데 이정현 대표의 발언은 박 대통령에 대한 충성심으로 가득 차 있다 이정현 대표는 그동안 이번 사태의 공범인 새누리당 대표로서 한 번도 사과다운 사과를 한 적이 없다 박지원 대표의 폭로로 이 대표가 당내의 사퇴요구에도 버티는 목적이 사태 수습이 아니라 대통령을 보위하기 위한 것임이 선명하게 드러났다 이정현 대표는 박근혜 대통령에 대한 충성심으로 사태를 직시하지 못하는 것 같은데 국민보다 대통령이 우선이라면 차라리 박근혜 경호실장으로 가시길 바란다 배신당한 것은 대통령이 아니라 국민이다 언론보도에 따르면 박근혜 대통령이 전대미문의 사태를 일으킨 최순실씨에 대해 최악의 배신을 당했다 고 주변에 토로한 것으로 알려졌다 대통령이 비선실세들의 국정농단을 묵인해서 국정을 마비 상태에 이르게 해놓고 여전히 자신의 잘못은 깨닫지 못하는 것 같다 자신이 피해자라고 인식하고 있으니 물러나라는 국민의 요구도 받아들이기 어렵고 여전히 정국 주도권에 미련을 갖는 것으로 보인다 이처럼 대통령이 사태를 제대로 보지 못하고 있으니 어찌 문제를 풀 수 있겠는가 박 대통령은 먼저 자신의 잘못부터 되돌아보시기 바란다 박 대통령이 비선실세들의 국정농단을 방조한 순간 이미 대통령은 스스로 국정에 대한 책임을 내팽개친 것이다 또 최순실도 없는데 앞으론 누구에게 의지해 국정을 이끌겠다는 말인가 또 다른 비선실세라도 있다는 말인가 대통령의 배신 발언은 과거에도 여러 차례 나왔다 대통령이 배신의 트라우마 에 갇혀 국정을 망쳐놓고도 여전히 인식을 바꾸지 못하다니 개탄스럽다 박 대통령은 이번 사태의 장본인이다 배신의 피해자 코스프레로 책임을 외면하려하지 말고 결자해지할 것을 촉구한다 국정농단세력이 만든 역사교과서를 우리 아이들에게 가르치려고 학년도 국정 역사교과서가 일 공개 예정이다 그러나 아예 공개조차 하지 말라는 목소리가 거세지고 있다 교육부가 집필진도 편찬기준도 은폐한 채 신속히 작업하여 마무리 단계에 왔지만 박근혜 최순실 게이트 파문으로 역사교과서 국정화의 의도가 의심받고 있다 지난해 역사교과서 국정화를 주도했던 김상률 전 청와대 교육문화수석이 최순실의 최측근인 차은택 씨의 외삼촌 아닌가 이러니 국정 역사교과서를 최순실 교과서 라 비판하는 것은 당연하다 김병준 국무총리 내정자마저 국정교과서 추진에 반대해 온 자신의 입장을 재차 강조하고 있을 정도이니 역사교과서 국정화에 대한 정부의 동력은 거의 상실했다고 볼 수 있다 이러한 궁절시진 상태에서도 원래 계획대로 추진할 예정 이라는 입장만 고수하고 있는 교육부는 대체 어느 나라 기관인가 국민을 무시한 채 박근혜 신화를 여전히 떠받드는 모습에서 또 한번 공직사회의 무개념에 절망하게 된다 역사학계와 시민사회에서 시작된 역사교과서 국정화 철회 요구가 지금 시 도 교육감 교사 학생으로 확산되고 있다 극우세력의 건국절 주장을 받아들여 대한민국 정부 수립 대신 대한민국 수립 이란 표현을 사용하고 친일 을 미화하며 독재 를 독재 라 서술하지 않는 반민족적 반민주적 위헌적 국정 역사교과서를 당장 중단하라 그렇지 않으면 역사를 농단한 죄인으로 기록되어 대대손손 악명을 떨치게 될 것이라는 점을 경고한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58876,2016-11-07, 윤관석 수석대변인 추가 현안 서면 브리핑 결국 게이트의 몸통은 박근혜 대통령이다 정호성 전 비서관의 휴대전화에서 압수한 각종 통화 내역은 최순실씨가 국정에 직접 관여한 증거이다 동시에 이 통화 내역은 박근혜 대통령의 혐의를 입증할 수 있는 단서로 보아야 한다 대통령만을 모시는 부속실 비서관이 민간인인 최씨의 지시를 따른 이유가 도대체 무엇이겠는가 통화내역에 따르면 정 전 비서관은 최씨의 지시에 절대적으로 따르고 복종했다고 한다 이러한 정 전 비서관의 태도는 박 대통령의 묵인과 지지 없이는 불가능하다 박 대통령이 도움 수준은 아득하게 초월한 최씨의 국정 관여를 인정하고 이를 적극 반영했기에 정 전 비서관이 이러한 태도를 취한 것이다 결국 박근혜 최순실 게이트의 또 하나의 몸통이 박 대통령임이 분명해지고 있는 것이다 대통령에 대한 성역 없는 철저한 수사가 전제되어야 한다 게이트에 대한 충격적인 의혹들이 사실로 밝혀지며 대통령에 대한 의혹은 의심이 의심을 낳는 형국이다 조금의 의혹이라도 남는다면 국민들은 납득하지 못할 것이다 검찰은 이점을 명심하고 대통령에 대한 철저한 수사를 통해 국민의 의혹 해소에 조직의 명운을 걸어야 한다는 점을 엄중히 경고한다 청와대 경호팀은 누굴 경호했는지 납득할 해명해야 한다 언론보도를 통해 박근혜 대통령 취임 직후 청와대 경호팀이 최순실씨의 거처 맞은편에 숙소를 구해놓고 상주한 것으로 드러났다 이에 대해 청와대 측은 박지만 씨의 초등생 아들을 경호하기 위해 배치했다 며 최씨와의 관련성을 부인했다 그러나 경호팀의 숙소는 최씨의 거처에서 불과 미터 거리인데 비해 박지만씨의 자택과는 미터나 떨어져 있다고 한다 차로 분 거리의 박지만씨의 자택을 경호하기 위한 목적이라기엔 상당한 거리가 있다 최씨의 경호를 위한 것이라는 의심이 오히려 합리적이다 대통령경호법의 기본 경호대상은 대통령과 대통령의 직계 가족이다 경호팀이 자격 없는 최씨를 경호해놓고 얼버무리고 있다고 볼 개연성이 높다 만약 의혹이 사실이라면 최씨가 박 대통령에게 어떤 사람이었기에 이렇게 극진하게 경호까지 했다는 말인지 기가 막힐 노릇이다 정말 청와대가 최씨를 경호했다면 최씨는 밤의 대통령이 아니라 시간 상시적인 대통령이자 또 하나의 대통령이었다는 말이다 청와대 경호팀의 어설픈 해명으로 끝날 일이 아니다 청와대가 일개 민간인을 경호했다는 충격적인 의혹은 분명한 규명이 필요하다 더불어민주당은 국회 운영위를 통한 의혹 규명에 앞장 설 것이다 청와대 경호팀도 납득하기 어려운 해명 대신 국민이 납득할 만한 증거를 내놓아야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58872,2016-11-07, 최경환 의원은 지금 누가 누구에게 사과해야 한다는 것인가 최경환 새누리당 의원이 우리당 김영주 최고위원이 박근혜 대통령과 함께 대기업에 미르재단과 스포츠재단 기금을 요청했다고 제기한 의혹을 반박한 데 이어 오늘 박지원 의원의 같은 주장에 정중히 사과하라고 했다는데 과연 새누리당 전체 의원이 참여한 대국민 사과에도 나서지 않은 친박 실세의원의 해명답다 최의원은 년 월부터 올해 월까지 경제부총리로서 아베노믹스를 흉내낸 초이노믹스 란 부동산 경기 부양책으로 가계부채 뇌관을 심각한 위기에 빠뜨렸다 거품을 감수하고 펼친 정책에도 경제성장률은 년 년 에 그쳤다 총선을 앞두고는 감이 그렇게 떨어져서 어떻게 정치를 하느냐 며 노골적으로 공천에 개입한 것이 밝혀졌고 자신의 사무실에서 일했던 인턴 직원을 중소기업진흥공단에 채용되도록 압력을 행사한 것 또한 박철규 전 중진공 이사장의 법정 진술에서 밝혀졌다 또 지난해 경제부총리로 있을 때 대폭 늘어난 이른 바 최경환표 도로 예산 은 최순실 정국에서도 수천억 증액되는 등 해명해야 될 일이 한 두 가지가 아니다 국민 앞에 엎드려 몇 날 며칠 사죄만 해도 모자란 판에 야당 의원들의 합리적 문제제기를 허위사실 정중한 사과 운운하는 것은 적반하장이다 햇살처럼 따뜻한 권력의 온기를 쬐며 자신의 인턴을 결혼도 시키고 취직도 시킨 공천도 좌지우지한 최의원이 지금 박근혜 대통령에게 향한 화살 끝에 자신은 떨어져 있는 듯 착각해서는 안 된다 아무리 큰 소리를 쳐도 국가 경제를 책임졌던 전 경제부총리로서 이 정부가 잔인하게 농단해온 정경유착을 묵과하거나 방조했던 책임은 도저히 면할 수 없을 것이다 겸허하게 국민 앞에 사죄하는 것이 마땅하다 자신은 혼자 깨끗하다고 항변하면 할수록 국민의 의혹은 더 깊어지고 있다는 사실을 명심하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58870,2016-11-07, 윤관석 수석대변인 오후 현안 브리핑 일시 오후 시 분 장소 국회 정론관 선결요건의 해결 없는 영수회담은 현 시국에서 불필요하다 민주당은 여러 차례 청와대의 영수회담 제안과 관련한 논란에 대해서 입장을 밝혀왔다 최순실 국정농단으로 비롯된 국정마비 국정붕괴의 비상한 시국에서 영수회담은 문제 해결의 새로운 출발점이자 국정운영의 중심축을 다시 세우는 계기가 되어야 한다 그래야만 의미가 있고 영수회담에 수용할 수 있다 이것이 수십만 촛불민심에 대한 정치권의 책임이다 추미애 대표와 시민사회 원로의 시국회동에서도 함세웅 신부를 비롯한 시민사회 원로들과 지도자들은 이구동성으로 민주당이 영수회담의 선결요건으로 제시한 일방적 총리지명 철회 국회 추천 총리 수용 박근혜 대통령이 국정운영에서 손을 떼야 한다는 민주당의 입장을 전폭적으로 지지했다 따라서 선결요건에 대한 답변과 해결이 없는 영수회담은 현 시국에서 불필요하다는 입장을 강력하게 제시했다 청와대는 박근혜 최순실 게이트로 인한 비상시국에서도 아무 내용이 확인되지 않은 영수회담을 억지로 추진하겠다며 언론플레이만 연출하고 있다 이러한 태도와 방식으로 위기국면을 수습할 해결책을 만들 수는 없다 즉각 무리한 추진을 중단하기 바란다 민주당의 대답은 간단하다 일방적 총리지명 철회 국회 추천 총리 수용 박근혜 대통령이 국정운영에서 손을 떼는 실질적인 조치와 답을 만든 이후에 필요하면 영수회담에 응하겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58868,2016-11-07, 윤관석 수석대변인 오전 현안 브리핑 일시 오전 시 분 장소 국회 정론관 대통령의 결단만이 사태 수습의 길이다 지난 주말 촛불미심 여만개가 박근혜 최순실 게이트로 캄캄한 대한민국 민주공화국의 밤을 밝혔다 민주당은 지난 일 별도 특검과 즉각적인 국정조사 일방적인 총리 지명 철회 국회 추천 총리 수용 및 대통령의 선 후퇴라는 대 요구조건을 명확히 밝혔다 또 빠른 시기에 요구조건이 수용되지 않는다면 단계적 퇴진운동에 돌입할 수밖에 없음을 명확히 했다 이번 주 민주당은 하나의 중심 기조에 집중하겠다 일방적인 총리지명을 즉각 철회하고 국회 추천 총리를 수용하고 대통령의 선 후퇴를 촉구한다 대통령의 결단만이 민심의 분노에 답하고 대한민국을 구할 수 있는 길이라는 점을 명확히 밝힌다 우리당은 이번 주 일 오후에 전국당원보고대회를 개최하여 당의 의지를 결집하고 민심의 차 촛불에 호응해나갈 예정이다 검찰 수사가 진행되며 최순실이 국정에 직접 관여한 증거들이 추가로 쏟아져 나오고 있다 밤의 대통령 이라는 말이 과장된 비유가 아니라 상시 대통령 이었다는 실제하는 사실이 명명백백하게 밝혀지는지 지켜보겠다 속속 드러나는 진실들을 보고 있으면 박근혜 대통령이 최순실의 도움 없이 과연 국정을 이끌 능력이 있기는 한 것인지 극도의 회의감이 든다 이런 상황에서 박 대통령이 국정 운영의 주도권에 집착을 보이는 것은 무대책 무개념 후안무치이다 국정을 이끌 비전도 진정성도 모두 국민에게 부정당한 현실이 아닌가 결국 대통령은 조속히 야당의 요구를 수용하는 결단을 내리는 것이 하루 빨리 국정을 안정시키는 길이다 대통령의 결자해지만이 답이다 대통령이 결단하시면 더불어민주당은 제 야당으로서 국민을 설득할 수 있고 국정을 안정시키는데 온 힘을 다할 것이다 우병우 전 수석 앞에 굴종한 검찰의 비굴함에 분노한다 우병우 전 민정수석이 검찰 소환조사를 마치고 귀가했다 우병우 전 수석은 피고발인이 아니라 검찰에 업무보고를 받으러온 상관의 모습이었다 포토라인 앞에 서서 소회를 묻는 기자에게 눈을 부라리던 우 전 수석이 정작 검찰 조사 과정에서는 활짝 웃었다니 억장이 무너진다 우 전 수석은 민정수석으로서 비선실세의 국정농단을 막기는커녕 직무유기 혐의까지 받고 있는 당사자이다 작금의 사태에 고위공직자로서 일말의 책임감이라도 느꼈다면 이렇게 오만방자하게 행동하지는 않았을 것이다 우 수석이 그런 모습을 보이도록 만든 검찰도 문제다 검찰이 도대체 어떤 기관인가 검사들이 그 앞에서 도대체 어떤 모습을 보였기에 우 전 수석이 이렇게 방약무인한 모습을 보였다는 말인지 개탄스럽다 다시 한 번 검찰의 굴종적인 모습에 개탄을 금할 수 없다 물러난 권력 앞에서조차 굽실거리는 비굴한 검찰이 도대체 어떤 수사인들 제대로 할 수 있을지 의문스럽다 검찰이 우 전 수석의 변명대로 면죄부를 주는 하나마나한 수사결과를 내놓는다면 국민의 지탄을 피할 수 없다 검찰은 개인 의혹들만이 아니라 최순실의 국정농단에 관여한 점은 없는지 철저히 파헤쳐야 한다 지금 대한민국 검찰에는 출세와 권력에 대한 욕망만 품은 검찰만이 존재하는가 엄격한 사회정의의 실현과 부패와 비리에 맞선 정의의 검찰로 다시 국민에게 돌아올 것을 엄중히 촉구한다 더 이상 권력 앞에 굴종적인 모습을 국민은 용납하지 않을 것임을 분명히 경고한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58866,2016-11-07, 제 차 최고위원회의 모두발언 일시 월 장소 국회 본청 당대표 회의실 추미애 대표 오늘은 이해찬 전 총리께서 최고위원회의에 함께해주셨다 경제도 걱정이고 나라 안보도 신경을 써야 할 때이다 국가 통치를 외면하고 국정농단을 야기한 대통령으로 인한 국정공백 속에서 우리 야당이 신경써야할 부분이 안보와 경제인 것 같다 그래서 오늘은 이해찬 전 총리께서 깊이 있는 말씀을 주시도록 하겠다 대한민국 건국 이래 전례가 없는 거대한 분노가 일렁이고 있다 교복 입은 중고생 아이들이 외치는 절규 앞에 참으로 부끄러웠다 얼른 해답을 찾아야 한다 노구의 어르신들까지 나라 걱정이 태산이어서 당이 꺼지게 한숨을 쉬시며 모이셨다 분노한 민심 시민들의 절규를 대통령도 보셨는지 모르겠다 대통령이 사태의 인식을 제대로 하셔야 해법도 나올 것이다 대통령은 이미 국민에게 불신임을 받았다 민심은 박근혜 대통령의 하야를 요구하고 있고 국정에서 한시 빨리 손을 떼야 한다고 요구하고 있다 배신 이라는 단어를 입에 달고 사시는 대통령님 이제는 국민이 당신을 배신한 대통령 이라고 여기고 있다 경제 안보 민생을 위기로 내몬 사람이 바로 대통령 아닌가 문제를 시급히 수습하고 국정을 정상화시키는 것은 오로지 대통령의 조속한 결단에 달려고 있다 민심에 반하는 폭주 개각을 철회하고 국회에서 추천하는 총리를 수용해서 정국을 수습해나가야 한이다 끝까지 외면하면 불행하게도 정권 퇴진 운동에 들어갈 수밖에 없다 검찰수사는 이제 콩으로 메주를 쑨다고 해도 국민이 믿지 않는다 대통령이 빠져나갈 퇴로는 다 만들어 놓고 검찰 수사를 받겠다는 이야기가 나온다 최순실씨에게는 시간에 증거인멸의 시간을 줬고 각종 비리와 의혹의 중심인 우병우 전 민정수석만 해도 소환까지 일이 걸렸다 조원동 전 청와대 경제수석이 그룹을 상태로 이미경 부회장의 경영 일선 퇴진을 압박했다는 녹취록까지 나왔는데도 수사할 기미조차 없다 최순실씨에 대해서는 대통령의 담화 내용을 컴퓨터로 다운받아 보여주면서 대통령의 말씀을 최순실에게 일깨워주며 정답을 제시하는 수사를 벌였다 있을 수 없는 일 아닌가 박근혜 최순실 게이트에 대해 검찰이 어떻게 하는지 지켜볼 것이다 검찰이 역사 앞에서 부끄럽지 않도록 가지고 있는 마지막 기회를 잘 살리기 바란다 공자께서는 일찍이 불환빈이환불안 이라는 말씀을 주셨다 가난을 걱정하기 보다 나라의 불안을 더 걱정한다 는 말이다 거리에 나와 민주주의를 지키겠다는 저 민생의 물결은 당장 내일의 일자리와 인생이 고달프지만 나라부터 세우고 보자는 민주시민의 역량이다 대단히 존경하고 감사드린다 제 당 대표로서도 국정안정 정상화 문제에 대해 무거운 책임을 느끼고 있다 더불어민주당은 국가와 민족을 위한 최선의 선택 속에서 국민 속에서 국민과 함께 할 것을 약속드린다 우상호 원내대표 이번 최순실 게이트를 보면서 최순실 일가의 개인비리 혹은 차은택씨에 의한 국정농단이 대단히 충격적인 사건들로 이어져있지만 대한민국 전체로 보면 더 중요한 문제는 결국 정격유착이라고 생각한다 다른 문제야 죄를 지은 자를 처벌하고 정책을 바로잡으면 되는 문제지만 대한민국 경제구조에 있어서의 정경유착 문제는 조금 더 깊이 들여다봐야하는 심각한 문제라고 생각한다 이번 사건에서 드러난 정경유착은 과거와는 사안이 다른 훨씬 더 졸렬한 형태의 정경유착이라는 것이다 포스코로부터 매각되는 광고회사의 지분을 강제로 강탈하려고 했던 태도 광해 라는 영화를 만들었다고 해서 이미경 부회장을 강제로 퇴진시킨 녹취록 수사 대상인 롯데로부터 억을 받았다가 수사가 예정대로 진행되니 다시 돌려준 정황 또 삼성처럼 특정한 공직자도 아닌데 최순실씨의 딸을 돕기 위해서 특별히 독일까지 가서 여러 가지 특혜를 봐준 형태 대한민국의 정경유착이 이렇게 천박한 수준이었나를 돌아보게 한다 강압과 강탈 수사와 연루된 금품 수수 및 반환 알아서 기기 식인 삼성의 지원 이것이 대한민국의 정경유착 재벌과 권력관계의 민낯이었나 하는 생각이 든다 그리고 권력은 이를 대가로 어떤 법안들 어떤 정책들을 통해 특혜를 봐주었는지 국회에서 따져야 할 문제이다 이번 주부터 국회의 법안 심사가 시작된다 그동안 박근혜 정권이 친기업 정책 이라고 하면서 우리 야당을 반기업 정당 으로 몰아붙이며 밀어붙였던 수없이 많은 법안들이 결국 정경유착의 대가로 국회를 압박했던 것이 아니었는지 점검해봐야겠다 그동안 경제활성화 법안 이라고 해서 우리가 통과시켰던 많은 대기업 특혜 법안들 이 결국은 이런 엄청난 정경유착의 특혜이고 대가였던가에 대해서도 다시 한 번 따져봐야겠다 대한민국이 정경유착의 역사 속에서 정책 예산 법안들이 허망하게 무너진 것은 아닌지 국회가 이를 제대로 방어하지 못한 것은 아닌지 다시 한 번 제대로 점검해야겠다는 생각을 한다 검찰은 이러한 잘못된 재벌과 권력의 유착관계에서 드러나 많은 사건들에 대해서 보다 심도 깊은 수사를 통해서 대한민국의 경제 생태계가 다시 정상으로 돌아갈 수 있도록 하는데 기여해야한다 어쨌든 아무리 봐도 해답은 더불어민주당이 추진해온 경제민주화 라는 말씀을 다시 한 번 드린다 이해찬 외교 안보 통일 국정자문회의 의장 당대표와 원내대표께서 말씀하신 것처럼 헌정사상 처음으로 겪는 이런 사태를 보고 걱정이 많다 어떻게 이를 잘 해결할 수 있을지 지혜를 잘 모아야 할 때라고 생각한다 그럼에도 불구하고 외교 안보 통일 문제에서 위기가 발생하지 않도록 당이 잘 대응해나가는 것이 중요하다 특히 내일 미국 대통령 선거에서 결과가 어떻게 되느냐에 따라서 우리는 굉장히 큰 영향을 받는다 현재 민주당 쪽이 조금 우세하다는 여론조사와 견해가 있는데 아직은 불확실한 것 같다 그러나 누가 대통령이 되더라도 경제기조는 보호무역주의가 강화될 것으로 전망하고 있다 요즘처럼 우리의 수출이 저조할 때 미국의 보호무역주의가 강화되면 수출에 상당한 영향을 받기 때문에 경제적으로 어려워지지 않을까하는 걱정을 하고 있다 또 한편으로는 북미회담을 비공식인 차원에서 추진했는데 힐러리에 요청에 의해서 이뤄졌다고 한다 제가 지난 월 미국에 가서 이야기를 들었는데 미국도 더 이상 핵이 고도화되는 것을 방치해서는 안 되겠다는 입장이다 방치해놓은 결과 핵이 계속 고도화되고 조금 더 고도화 되면 핵무장까지도 가능하기 때문에 핵이 수직적으로 확산되는 것을 금지하는 차원의 외교적 노력이 필요하다 힐러리가 대통령이 되면 북미 간의 협상이 진전될 가능성이 높고 그에 따라서 우리와 중국의 관계도 설정될 가능성이 높다 중국 고위지도자들을 제가 얼마 전에 만났는데 중국도 똑같은 생각을 가지고 있다 다만 북에 제재를 하는 과정에서 체제가 타격을 받지 않는 선에서 어느 선에서 제재를 할 것인지 수위에 대해서만 차이가 있고 기본적인 견해는 같다 지금 대통령이 유고상태나 마찬가지다 앞으로 년 개월 동안 걱정이 많다 제가 정부에서 운영을 해본 경험에 따르면 총리가 대신 갈 수 있는 정상회의가 있고 대신 못가는 회의가 많다 특히 이번에 안 가신다고 하는 이나 아세안 등의 회의에는 총리가 가면 아무런 역할이 없다 그때의 현안에 따라서 다자회담도 많이 하지만 양자 회담도 많이 한다 제가 한번은 대통령이 가실 곳에 대신 갔더니 큰 나라의 대통령들은 저를 상대해주지 않았다 작은 나라의 대통령들만 저를 만나주지 정말 우리가 만나고 싶은 나라의 대통령은 총리급이라고 만나주지를 않는다 더군다나 황교안 총리는 이임식을 하려다 취소한 총리다 후임자를 지명해놨기 때문에 정상적인 총리가 아니다 물러날 총리이기 때문에 다자간 정상회의에 가면 아무런 존재 가치가 없어서 외교적으로 큰 타격을 봐야하는 실정이다 년 개월 동안 대통령께서 직접 나가야 하는 정상회담이 개 이상은 될 것이다 외교적으로 큰 문제다 이런 와중에도 한일군사정보보호협정을 추진하고 있다는 보도가 나오고 있다 이 문제는 심각한 문제다 지난 대 국회 때 비공개로 추진하다가 저에게 발각이 돼서 외통위에서 제가 직접 막았던 사안이다 우리나라 군사정보를 전부 일본에게 넘겨주는 것인데 실제로 우리가 일본으로부터 받아야 할 군사정보는 별로 없다 오히려 우리 정보가 일본으로 가는 것이 많다 한미 간에는 군사정보 교류가 굉장히 긴밀하다 왜냐하면 미국이 가지고 있는 레이더망이나 위성을 통해서 우리가 정보를 받아야하기 때문이다 그러나 일본으로부터 받을 것은 거의 없다 군사정보보호협정을 국방위에서 잘 대응해서 막아야 한다는 말씀을 꼭 드리고 싶다 마지막으로 이런 때 제일 중요한 것은 국방부의 자세이다 군의 자세가 제일 중요하다 이런 상황에서 군의 자세가 조금이라도 흔들리면 안 된다 대표께서 국방부와 통일부 장관을 초청해서 다시 한 번 군의 대비태세에 흔들림이 없도록 당부하는 것이 필요하다 대통령은 군 통수권자이기 때문에 중요한데 지금 유고상태나 마찬가지다 당대표께서 초청해서 다시 한 번 당부의 말씀을 드리는 것이 좋을 것 같다 토요일 집회를 보고 저도 걱정을 많이 했다 모든 국민들이 그럴 것이다 일 집회에도 많은 사람들이 참여해서 분명한 주장은 하되 서로 간에 충돌하거나 하는 일이 없게끔 당에서 대응을 잘 해주시기를 부탁드린다 전해철 최고위원 박근혜 최순실 게이트의 진상규명은 여전히 중요하다 근래 검찰의 수사에 대해서 문제점을 말씀드린다 어제 더불어민주당 박근혜 최순실 게이트 조사위원들과 법사위원들은 밤 시에 중앙지검 앞에서 긴급 기자회견을 하고 농성에 들어갔다 우병우 수석에 대한 구속 수사를 요구했다 우병우 이석수 특별수사팀이 꾸려진지 일 사퇴한지 일 만에 소환된 우병우 전 수석에 대한 봐주기 수사를 경고하기 위함이었다 하지만 검찰은 우병우 전 수석을 십 수 시간 조사한 후 귀가시킴으로서 우리당 의원들의 우려를 현실화시켰다 수사팀장실에서 차를 마시며 담소를 나누고 팔짱낀 채 웃으며 수사 받고 취재 중인 기자에게는 고압적인 자세를 보이는 등 검찰을 쥐락펴락했던 우병우 전 수석의 위세가 여전히 남아있음을 확인한 국민들은 또다시 검찰에 실망할 수밖에 없었다 우병우 전 수석은 가족 회사의 자금 횡령과 공직자 재산 신고 등에 대해서만 수사를 받았지만 박근혜 최순실 게이트에서도 핵심적인 피의자이다 대통령의 친인척 및 주변인물을 관리해야 할 민정수석의 역할을 제대로 했다면 이 게이트는 이렇게까지 커지지 않았을 것이다 우병우 전 수석이 최순실씨와는 어떤 관계가 있는지 나아가서 직무유기 혐의에 대해서도 수사 받아야 한다 어제는 우병우 이석수 특별수사팀에서 소환한 것이지만 이제 국정농단에 대한 책임도 드러나고 있는 만큼 최순실 게이트 특별수사본부가 우병우 전 수석 사건을 인계받아 수사해야 할 것이다 특별법에 의한 특별검사 수사대상에는 우병우 전 수석이 당연히 포함되어야 한다 최순실씨에 대한 수사는 더욱 가관이다 국정농단을 주도했던 자의 신병확보 노력도 하지 않았고 귀국 후에는 시간동안 소환하지 않는 특혜를 베풀어 증거를 인멸한 시간을 줬다 최근 보도에서는 정지되지 않은 계좌에서 수억원이 넘는 개인자금까지 인출했다고 한다 일종의 가이드라인을 제시한 것 아니냐는 평가가 있는 박근혜 대통령의 담화까지 수사 중에 보여줬다고 한다 대통령과 직접 연관된 최순실씨는 이 담화를 통해 앞으로 어떻게 수사에 임할지 어떤 변명을 할지 판단했을 것이다 일반 국민이었다면 상상하지도 못할 상식 밖의 일들이 이 중차대한 수사를 하는 검찰에서 벌어지고 있는 것에 대해 국민들은 검찰에 대한 신뢰를 점차 걷고 있다 지난 주말 광화문 광장을 가득 매웠던 국민들의 분노가 유독 검찰의 눈에는 보이지 않는 모양이다 검찰에게는 국정을 파탄내고 헌정중단의 위기까지 불러온 비선실세의 국정농단 실체를 파헤칠 결기가 없어 보인다 만약 검찰이 핵심 실세들을 위한 수사를 통해 몇몇 개인의 일탈로 이 사건을 마무리한다면 검찰은 또다시 수사한 사건에 대한 특별검사의 재수사를 받는 불명예를 안게 될 것이고 검찰 조직 자체의 존립도 위협받을 것임을 경고한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58865,2016-11-07, 기동민 원내대변인 오전 현안 브리핑 일시 월 장소 정론관 늑장 황제 소환 도 모자라 황제 조사 받은 우병우 전 수석 우병우 전 수석에 대한 검찰의 태도가 가관이다 우병우 전 수석은 일만의 늑장 황제 소환 도 모자라 황제 조사 를 받고 나왔다 검찰이 여전히 우 수석에게 장악돼 있다는 말이 헛말이 아니었다 나는 새도 떨어뜨린다 는 검찰청에서 팔짱끼고 웃으며 담소하는 여유까지 보인 우 수석 모습에 기가 막힌다 검찰 조사를 받으러 간 것이 아니라 면죄부를 받으러 간 것 같다 우병우 전 수석은 개인 의혹뿐 아니라 박근혜 최순실 게이트 의 주범이라는 측면에서 처벌받아 마땅하다 대통령 최측근으로 공직기강을 세워야할 민정수석이 사정기관을 발 아래 두고 각종 비위와 국정문란 행위를 방조했다 심지어 최순실 발탁설 차은택 뒷배설 까지 나오고 있다 검찰에 경고한다 짜여진 각본대로 불구속 기소나 약식 기소로 마무리한다면 국민의 저항과 분노를 피할 수 없을 것이다 검찰 스스로 검찰임을 포기하는 행위가 될 것이다 우병우 구속 수사를 통해 정의가 그나마 살아있다는 것을 보여줘야 한다 김병준 총리 지명 철회부터 시작하라 청와대가 진정성을 보이려면 김병준 총리 지명 을 철회하는 것이 우선이다 사람과 자질 문제는 애초 논의의 대상이 아니다 의도가 불순했고 과정도 잘못됐다 꼼수로 시작된 김병준 책임총리 를 수용하라는 것은 박근혜 대통령 중심의 국정 운영을 인정하라는 말과 같다 국민과 우리당은 용납할 수 없다 김병준 총리 지명 은 꼼수와 정략일 뿐이다 아무리 좋은 말과 미사여구로 포장해도 본질은 결코 변하지 않는다 김병준 지명자가 스스로 물러날 수 없다니 청와대가 지명을 철회해야 한다 대통령께서는 다시 한 번 국민 앞에 사죄하고 선 후퇴와 권한 포기를 약속해야 한다 그리고 별도 특검과 국정조사를 수용해 모든 의혹에 대해 낱낱이 밝혀질 수 있도록 협조해야 한다 이 같은 일이 선행돼야 영수회담 도 가능한 일이다 그래야 책임 총리와 거국내각이 본격적으로 논의될 수 있다 대통령과 청와대가 자초한 일이다 결자해지하시길 바란다 국정정상화의 두 번째 조건은 이정현 대표 의 퇴진이다 새누리당에게도 한 말씀 드린다 꼬인 정국을 바로잡고 민심을 수습하기 위한 선결과제 중 하나는 이정현 대표의 퇴진과 새누리당을 좌지우지하고 있는 최경환 서청원 의원 등 친박세력의 입김에서 벗어나는 일이다 청와대 출장소장을 자임했던 이정현 대표와 대통령 호위무사들이 있는 한 대화도 불가능하고 협상도 이뤄질 수 없다 이정현 대표는 박근혜 최순실 게이트 의 공동책임을 지고 조속히 물러나야 한다 국민을 외면하고 대통령만을 보위하겠다는 여당 대표와 어떤 대화와 진전을 이뤄낼 수 있겠나 국민을 우선하는 공당의 모습으로 돌아오길 진심으로 바란다 청와대의 대기업 부회장 퇴진압박 지금이 년이 맞는가 청와대가 의 뜻 이라며 이미경 부회장에게 물러날 것을 종용했다는 소식은 충격적이다 창조경제 기업이 마음껏 뛰노는 나라 등 화려한 수사만 앞세운 채 대기업 삥뜯기 도 모자라 기업의 경영에까지 좌지우지한 박근혜 정권의 민낯이 적나라하게 드러났다 청와대는 보수를 자처하며 좌파 영화를 만들었다 며 물러나라고 했다지만 이는 원칙과 경제주체의 자율성을 보장하는 보수의 원칙과도 맞지 않는다 마치 조폭영화를 보는 것 같다 헌법정신과 시장경제의 질서마저 허물어트린 만행이다 박근혜 정권을 용납할 수 없는 또 하나의 이유다 박근혜 최순실 역사교과서 당장 폐기돼야 한다 만 국민이 촛불을 들며 국정농단 을 규탄했는데 청와대와 정부는 어린이 불장난으로만 치부하는 것 같다 박근혜 최순실게이트 의 산물인 국정 역사교과서 발행을 강행하겠다는 교육부의 모습에 기가 막힌다 위에서 시키면 시키는 대로 하는 것이 국민의 종복 인 공직자의 역할인가 박근혜 최순실 역사교과서는 폐기돼야 마땅하다 애초에 명분도 실익도 없었다 최순실표 예산 낭비 이상도 이하도 아니다 역사 교육은 과거를 통해 현재를 규정하고 미래를 그린다는 측면에서 그 어떤 것보다 중요하다 하지만 국정교과서는 어떤가 대통령의 개인사적 배경 최씨 일가의 내력이 집필의 바로미터가 됐고 친일과 독재에 대한 관대함은 덤이었다 보수 란 이름도 아까운 전문가들만이 만든 교과서에서 우리 청소년들이 무엇을 배울 수 있겠는가 민주공화국 에 걸 맞는 국격을 다시 세워야 할 때다 그 출발점은 국정 역사교과서 폐기이다 각성을 촉구한다 박승주 국민안전처 장관 후보자는 당장 물러나시길 바란다 주요 외신마저 우리나라를 샤머니즘 국가 라고 비웃는 판에 국민안전처 장관 후보자라는 사람이 굿판에 동원되고 전생체험을 했다며 공공연하게 떠들고 다니는 부끄러운 일이 년 대한민국에서 버젓이 벌어졌다 국민안전 운운할 기본자질과 소양조차 없는 사람이다 창피하고 민망해서 더 길게 얘기하기도 싫다 박승주 후보자는 국가와 국민 부끄러운 짓 그만하시고 조용히 물러나시길 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58863,2016-11-06, 긴급 최고위원회의 모두발언 일시 일 장소 국회 본청 당대표 회의실 추미애 대표 어제 시국시위는 만 명 이상의 나라를 걱정하는 시민이 함께하셨다 어린아이에서부터 연세 드신 할머니까지 아이와 함께한 젊은 엄마와 아빠들 정말 성숙한 민주시민의식을 보여주셨다 감사드린다 이렇게 높은 민주시민의식과 민주역량이야말로 대한민국을 지켜주는 희망이다 또한 국가 시스템도 안정적으로 잘 작동되고 있다 나라가 위기에 빠질 때마다 민주주의가 위기에 빠질 때마다 견인해 낸 것은 바로 이런 높은 민주시민의식과 민주역량이다 외신은 대통령이 저지른 샤머니즘적 국정농단에도 놀랐지만 그것을 평화시위로 높은 민주역량을 보여준 대한민국 국민을 보고도 또 한 번 놀랐을 것 같다 이제 결자해지만 남았다 대통령만 결단하면 문제는 풀린다 년 최태민 최순실 늪에서 빠져나오지 못한 채 드디어 국정농단까지 야기된 상태에서 대통령은 더 이상 머뭇거릴 이유가 없다 대통령과 그 부역자들의 문제이지 결코 대한민국의 문제도 아니고 국민의 문제도 아니다 미리 말씀드린 것처럼 대통령이 조속한 결단을 하라 그것이 빨리 국정을 안정시키는 길이다 대통령이 결단하시면 제 당은 국정을 안정시키는데 팔을 걷어붙이고 나설 것이다 우리는 대통령이 먼저 하실 세 가지를 말씀드렸다 다른 야당도 세 가지 요구조건에 덧붙여서 대통령의 탈당도 이야기했다 다 맞는 말씀이다 이것은 국민의 목소리를 대변하는 것이다 다시 한 번 대통령과 집권당의 책임의식을 촉구한다 전해철 최고위원 현재 최순실게이트와 관련해서 검찰 수사가 진행 중에 있지만 수사의 미진함 부실함 때문에 우리당은 특별법에 의한 수사를 독촉했고 새누리당은 이에 빨리 응할 것을 주장한바 있다 그 우려가 현실로 나타나고 있다 먼저 우병우 전 수석의 경우에는 횡령 그리고 자제에 대한 보직 변경 등에 대한 특혜 또 관련된 위법을 저지르지 않았냐는 의혹이 제기된바 있다 횡령에 대해서는 비록 가족회사이거나 인회사라 하더라도 그동안 엄벌에 처해졌다 그런 면에서 결코 가벼운 죄 아니라고 생각한다 나아가서 민정수석으로 있으면서 최순실 문제를 전혀 모르거나 또는 알면서 상당한 주의 의무를 하지 않았다면 그 위법함 역시 적지 않으리라 생각한다 그런 면에서 철저히 수사해야 한다고 생각한다 그런데 오늘 검찰 출두하면서도 아주 고압적 자세로 또 한 번 국민을 우롱했다 우리는 우병우 수석에 대해 엄정한 수사 구속 수사를 촉구하고 이를 만약 이행하지 않을 시 또 하나의 부실한 수사가 되리라 생각한다 이러한 과정에서 구속수사를 촉구하기 위해 국민조사위원에 소속된 의원 명이 오늘 검찰청 앞에서 농성을 계획하고 있기도 하다 최순실씨가 조사를 받던 중에 박근혜 대통령의 담화를 보고 눈물을 흘렸다는 보도가 있었다 인간적으로 안타깝다고 생각할 수도 있지만 이것 역시 굉장히 큰 문제라고 생각한다 박근혜 대통령의 담화는 또 하나의 수사 가이드라인이었다 가장 중요한 것은 기업의 선의가 작용했다 선의로 돈을 냈다고 하면 우리가 주장하는 포괄적 뇌물죄에 대한 공범이나 주범이 전혀 될 수 없다 그런 이야기를 들은 최순실이 어떻게 진술할지에 분명하다 그동안 박근혜 대통령의 수차례의 검찰 수사에 있어서 가이드라인을 제시했고 검찰은 그 가이드라인에 따라서 수미일관하게 수사를 해왔다 이번에도 사실상 최순실씨에게 가이드라인을 제공했다고 생각한다 특히 최순실씨는 귀국 이후에 시간 동안 피의자로서는 도저히 해서는 안 되는 사적으로 은행을 다닌다던지 여러 가지 사적인 활동을 했다는 문제제기마저 있었다 그런 최순실씨에게 또 한 번 수사 내용을 알려주고 가이드라인을 제공했다는 것은 타당하지 않다고 생각한다 지난 금요일 박근혜 최순실 국민조사위원회에서는 수사에 대한 여러 가지 미진함을 이야기하면서 결론적으로 수사 지연 수사 미진에 데해서 검찰총장과 법무부장관이 책임을 져야 한다는 것을 이야기한바 있다 이런 것들이 점점 쌓여갈수록 정당한 올바른 수사지휘를 할 수 없다고 생각하기 때문에 이제는 검찰총장이 물러나야 한다고 생각한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58862,2016-11-06, 박경미 대변인 오후 현안 브리핑 일시 일 장소 정론관 우병우는 아직도 자신이 청와대 민정수석인줄 아는가 우병우 전 청와대 민정수석비서관이 오늘 검찰에 출석했다 우 전 수석은 내내 오만하고 국민을 무시하는 태도를 보였다 고개를 숙이기는커녕 시종일관 당당하고 꼿꼿한 자세였으며 불쾌한 질문을 한 기자를 잠시 쏘아보는 상황까지 있었다 마치 업무보고라도 받으러 가는양 의기양양해 보였다 우 전 수석은 진경준 비리 묵인과 부실검증 의경 아들 보직특혜 가족회사 정강의 탈세 및 횡령 차명 땅 거래 최순실 관련 국정농단 행위 묵인과 공조 등 각종 의혹의 중심에 서있다 우 전 수석은 그 누구보다도 빨리 수사를 받았어야 하는 인물인데 사퇴한 후에야 겨우 소환에 응했다 뿐만 아니라 부인과 아들도 배짱으로 버티며 소환에 불응해 왔으니 우 전 수석 가족 전체가 검찰을 우습게 보는 것 같다 더욱 한심한 것은 검찰이 변호인 의견을 존중하여 서면조사와 비공개 소환을 검토했었다는 사실이다 검찰 공보규정 상 차관급 이상은 포토라인에 세우도록 되어 있는데도 말이다 이러한 검찰의 미온적인 태도에 맞춰 우 전 수석은 검찰에 출두하기 전 자신의 페이스북에 피의자가 아니라 피고발인 이라는 표현을 썼다 본인이 수사 대상이라는 것을 전혀 인정하지 않는 태도다 혹은 자신이 아직도 민정수석이라 착각하고 검찰의 수사 가이드라인을 제시하는 것인지도 모른다 이게 검찰에서 성실하게 조사를 받겠다 는 사람의 태도인가 이러니 국민들은 최순실 대역 논란 까지 거론할 정도로 검찰을 불신하는 것 아니겠는가 검찰이 실추된 명예를 회복하는 길은 하나다 우병우의 구속수사다 우리당 박근혜 최순실 국민조사위원회 민주주의회복 국회 법사위를 중심으로 오늘 저녁 시부터 서울중앙지검 앞에서 우병우 구속수사 촉구 농성을 시작한다 우리당과 국민들의 준엄한 경고이다 검찰은 심기일전하여 한 점 의혹도 없이 철저하게 수사하기 바란다 게이트의 몸통인 박근혜 대통령이 결자해지해야 청와대가 국민의 분노한 민심에 놀라 대책 마련에 부심하고 있다고 한다 언론 보도에 따르면 청와대 관계자는 후속대책 마련을 속도감 있게 진행해야 할 것 같다 고 말했다고 한다 이제야 상황의 엄중함을 인식했다는 것이 개탄스럽다 지금 게이트의 모든 의혹은 대통령을 향하고 있다 단순히 비선실세의 국정농단이 아니라 대통령이 주도적인 역할을 했음이 분명해지고 있다 게이트의 몸통이 대통령이므로 해답도 대통령에게 있다 박 대통령이 스스로 풀지 않고는 어떠한 대책도 백약이 무효인 상황이 됐다 철두철미한 진상 규명 대통령의 진심어린 사과와 실질적으로 권력을 내려놓는 것 말고는 국민이 납득하지 않을 것이다 어제 만 국민이 결집한 집회와 시위는 별다른 충돌이나 사고 없이 마무리되었다 국민들은 분노의 목소리를 선명하게 전달하기 위해 처음부터 끝까지 철저하게 이성을 유지하며 평화적으로 진행한 것이다 이제는 대통령이 국민의 요구에 성실하게 답할 때이다 대통령의 결자해지 만이 사태 수습의 유일한 대책이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58861,2016-11-06, 박경미 대변인 오전 현안 브리핑 일시 일 장소 정론관 국민이 박근혜 대통령 심판에 직접 나섰다 어제 광화문 광장에는 만 명의 국민이 집결하여 박근혜 대통령의 사과와 퇴진을 촉구하는 대규모 촛불집회를 열었다 여당의 전통적 텃밭인 대구와 부산을 비롯하여 광주 제주 등 전국 주요 도시에서 크고 작은 시국선언과 집회가 열리면서 시위는 전국으로 확산됐다 지난 금요일 박근혜 대통령의 담화에는 진정성이 담긴 사과는 없었고 국민들께서 맡겨주신 책임에 공백이 생기지 않도록 하겠다 면서 자신의 권력 의지만 재차 피력했다 김병준 국무총리 내정자 발탁과 같은 국면전환용 이벤트로 인해 비판 여론은 오히려 격해지고 있다 일로 예정된 민중총궐기를 앞두고 폭발 직전의 화약고를 방불케 하고 있다 어제 집회에서는 박근혜 하야 라는 구호를 필두로 못살겠다 갈아엎자 새누리도 공범이다 등 대통령과 정부 여당을 향한 불만과 분노의 목소리가 내내 이어졌다 전국 대학생 시국회의 대표는 과거 일제 치하의 항일투쟁과 혁명에 앞장선 대학생 정신을 이어받아 이 정권을 무너뜨리고 반드시 국민이 주인 되는 나라를 찾겠다 고 언급하기도 했다 어제 집회에는 남녀노소 각계각층이 집결했다 교복을 입은 청소년 대학생 어린 자녀의 손을 잡고 나온 가족 종교인 학자들이 촛불을 들고 시내를 가득 메웠다 중 고등학생 수백 명은 중고생연대 를 구성해 플래카드를 들고 구호를 외치며 행진해 시민들의 박수를 받았다 박 대통령이 진정 국가와 국민을 생각한다면 좀 더 진심어린 사죄 국정조사와 별도 특검수사 수용 김병준 총리 지명 철회 국회 추천 총리 수락 등 권력 내려놓기를 하루 빨리 실행에 옮기기를 다시 한 번 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58860,2016-11-06, 기동민 원내대변인 오전 현안 추가 서면브리핑 우병우 전 민정수석의 구속수사를 촉구한다 진경준 비위 묵인 및 부실검증 의경 아들 보직특혜 탈세 및 횡령 도나도나 몰래 변호 차명 땅 거래 최순실 관련 국정농단행위 묵인 및 공조 등 의혹의 중심인물이다 게다가 황제 소환되면서도 오만한 자세를 보이며 법 정의를 우습게 만들었다 엄정한 수사와 법 정의를 세우기 위해서도 반드시 구속 수사하여 철저하게 진상을 규명해야 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58859,2016-11-06, 기동민 원내대변인 오전 현안 브리핑 일시 일 장소 정론관 더불어민주당은 국민의 뜻을 겸허하게 받아들이겠습니다 대한민국은 년 월 항쟁에 이어 어제 약 만명이 참여한 국민참여 라는 거대한 민주주의 경험을 공유했다 제 의 항쟁으로 기록될 일 국민총궐기 의 전조이자 국민의 거대한 힘을 보여준 역사의 이정표로 명실상부하게 기록될 것이다 시민의 자발적 참여 평화적 집회와 시위에 의한 민주주의 회복 정신은 대한민국이 살아있고 민주공화국임을 여실히 보여줬다 국민들의 절절한 외침과 호소가 비단 현 정권과 여당만을 향해 있지 않다는 걸 잘 알고 있다 야당도 제대로 해라 여소야대 만들어줬는데 이 정도밖에 못하냐 는 말 아프고 가슴깊이 새기겠다고 약속드린다 국민의 뜻에 따라 국민을 위해 더 정진하고 실천하는 더불어민주당이 되겠다 대통령은 더 이상 국민을 불행하게 만들지 마라 국민의 마음에서 대통령은 이미 대통령이 아니다 진심을 찾아볼 수 없는 두 번의 사과는 오히려 화만 불렀다 권력 유지의 망상과 집착만 보였을 따름이다 아프고 상처받은 국민을 더 불행하게 만들었다 최순실 차은택 안종범 우병우 문고리 인방 십상시 손꼽기조차 부끄러운 비리와 전횡 이 모든 것이 대통령이란 뒷배 없이 가당키나 했겠나 특권과 전횡은 부정과 부패를 낳았고 또 다른 악으로 불거져 나라를 병들게 했다 박근혜 최순실 게이트 의 몸통은 대통령이다 아니라 하지 말고 인정하셔야 한다 특검과 국정조사를 수용하여 국민들의 의문에 답해야 한다 둘째 대통령은 국정을 이끌어갈 동력도 권위도 상실했다 선으로 물러나야 한다 국회가 추천하는 국민이 인정할 수 있는 책임총리를 받아들이고 거국내각을 구성해야 한다 셋째 진정성도 없고 무례하기까지 한 꼼수 영수회담 은 받아들일 수 없다 대통령의 진솔한 사죄와 자기고백 국정조사와 별도 특검수사 김병준 총리 지명 철회 및 국회 추천 총리 수락 등 우리당과 국민의 최소한의 요구사항에 대한 성실한 답변이 없는 한 의미 있는 회담이 될 수 없다 위기를 모면하려는 국면전환용 꼼수로 국회와 국민을 우롱하지 말라 김병준 교수님 당신이 있어야 할 자리는 그 자리가 아닙니다 노무현 정신은 국민에게 있다 국민을 외면한 노무현 정신은 듣지도 보지도 못했다 국민의 뜻을 외면한 채 자진사퇴는 없다 고 버티는 김병준 총리지명자의 고집은 이미 노무현 정신에 위배된 것이다 김병준 총리지명자는 국민으로부터 부적격 판정을 받았다 민심을 외면하고 현실을 직시하지 않는 박근혜 대통령의 꼭두각시일 뿐이다 국민이 인정하지 않는 책임총리가 가당키나 한가 무너지는 권력과 야욕에 대한 부역 행위일뿐이다 김병준 총리지명자는 끓고 있는 민심을 있는 직시해야 한다 그 자리에 버티고 있는 것만으로도 국민에 대한 배신이고 노무현 정신을 모독하는 것이다 더 이상 국민을 실망시키지 마라 당장 그 자리에서 내려오시기 바란다 한 점 의혹 없는 대통령 조사 를 촉구한다 박근혜 대통령께서 검찰 조사와 특검에 응하겠다고 했다 조직의 명운을 걸고 엄정 수사할 것을 검찰에 촉구한다 시늉뿐인 조사 짜여진 각본 에 그친다면 국민이 용서치 않을 것이다 성역이 있어선 안 된다 예외도 용납할 수 없다 안종범 전 수석이 대통령의 지시를 받았다 고 진술한 미르 스포츠재단 기금모금 관련 역할 및 직권남용 혐의 최순실씨와 관련한 내부 기밀 유출 대통령기록물법 위반 등 국민적 의혹에 대해 철저한 수사로 응답해야 한다 년 헌정 사상 처음으로 현직 대통령이 수사를 받아야 할 상황이다 이와 같은 일이 다시는 벌어지지 않도록 아프고 쓴 역사의 교훈을 만들어야 한다 그 책임은 이제 검찰 몫이다 권력의 문제를 넘어 역사의 문제이고 대한민국 정체성의 문제다 검찰의 존재이유에 대한 심판대이기도 하다 명운을 걸고 임할 것을 재차 촉구한다 우병우 전 수석 검찰 출석 관련 늦어도 한참 늦었다 부인 아들은 배짱으로 버티며 소환에 불응했고 검찰은 속수무책 아무런 조치를 하지 않았다 우수석이 사퇴한 뒤에야 겨우 소환했을 뿐이다 우병우 전 수석은 의혹이 제기된 뒤 약 개월 수사팀 구성 후 일 만에 소환하는 것이다 한마디로 황제소환 이다 이러니 누가 검찰을 믿고 신뢰할 수 있겠나 이렇게 하니까 최순실 대역 논란 등 말도 안 되는 일들이 벌어지고 있는 것 아니겠나 검찰 스스로 자초한 일이다 입이 열 개라도 할 말이 없을 것이다 우병우 전 수석은 성실히 조사받겠다고 했지만 검찰에 출석하면서도 대단히 오만하고 국민을 무시하는 태도를 보였다 국민과 법 위에 군림하려는 우병우 전 수석을 결코 용서할 수 없다 한참 늦었지만 늦은 만큼 더욱 철저하게 수사하여 성역이 존재할 수 없다는 걸 보여줘야 할 것이다 국민이 지켜보고 있다는 점을 명심해야 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58857,2016-11-05, 추미애 당대표 백남기 농민 영결식 추도사 일시 시 장소 광화문 광장 고인께서는 정의롭고 올바른 사회를 위해 역사의 현장에서 피하지 않고 온 몸으로 살아오셨습니다 농민과 농촌의 이익을 위해서라면 아낌없이 희생하고 헌신하는 현장의 선구자이셨습니다 마지막까지도 무너지는 농민의 삶을 지키기 위한 고인의 절규가 가슴을 먹먹하게 합니다 국가가 어둠에 잠겨 있습니다 어둠이 지나면 새벽이 오는 이치를 누가 거스를 수 있습니까 우리는 국정농단으로 헌정이 마비되어 버린 꽁꽁 언 나라를 바로 바로 세워야 할 책무가 있습니다 폭압적 공권력은 년이 지나도록 국민 목숨을 희생시키고도 사과조차 없었습니다 무너진 헌정질서를 마비시키고 민주주의를 무너뜨린 집권세력은 국가폭력을 비호하며 백남기 농민의 죽음을 능욕했습니다 엄중하고 비상한 시국입니다 국민은 자격 없는 대통령이 국가의 근본을 어떻게 무너뜨렸는지 똑똑히 목도했습니다 그러나 대통령은 오로지 권력을 유지하기 위해 국민과 국정을 볼모로 삼고 있습니다 깊은 실망감과 분노를 억누를 수 없습니다 더불어민주당은 국민의 편에 서겠습니다 국민과 함께 싸우고 국민을 지키겠습니다 대통령과 새누리당은 국민과 야당이 요구하는 별도특검과 국정조사를 받아들어야 합니다 민심에 반하는 총리후보 지명을 철회하고 국회가 추천하는 총리를 수용해야 합니다 박근혜 대통령은 한시바삐 국정에서 손을 떼고 내려와야 할 것입니다 계속 국민의 뜻을 거역한다면 저와 더불어민주당은 국민과 함께 정권 퇴진 운동에 들어 갈 것을 이 자리에서 재차 경고합니다 백남기 농민님 아직도 해맑은 미소로 우리를 지켜보고 계시는 당신의 영전 앞에 우리는 죄인입니다 고인을 보내드리는 것이 아니라 우리 가슴에 묻겠습니다 위기에 빠진 이 나라를 바로 세운 그날 비로소 당신께서 웃으시며 가실 수 있도록 하겠습니다 백남기 농민님 오늘 이 자리에 서니 국민의 가슴에 묻은 우리 생때같은 세월호 아이들이 떠오릅니다 국가의 무책임과 구조적 폭력으로 왜 죽어가야 했는지 영문도 모르는 그 아이들도 우리가 서있는 이 자리를 지켜보고 있을 겁니다 다시는 국민이 뽑아 준 권력이 국민을 희생시키지 않도록 우리가 지키겠습니다 백남기 농민님 당신은 오늘 저희 곁을 떠나지만 세월호 아이들과 억울하게 죽어간 영령들과 함께 지켜봐주십시오 이 나라를 지켜주십시오 더 나은 대한민국을 만들기 위해 국민과 함께 하겠습니다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58850,2016-11-04, 불의 시대 불면 불안 불확실 불신 불길 박근혜 최순실 게이트로 대한민국은 흔들리고 있다 국민들은 불면의 나날을 보내고 있다 선진 민주국가라 믿었던 나라가 비선실세에게 놀아난 데 대해 국민들은 분노했고 한편으로는 이 나라가 어찌 될지 불안하기만 하다 대통령은 식물대통령이 됐고 국정 운영시스템은 붕괴되어 모든 것이 불확실하다 비선실세 국정농단에 맞장구쳤던 이들은 사태의 심각성을 애써 외면한 채 무마시키려 하지만 이미 무너진 집의 기왓장을 붙들고 몸부림을 쳐 봐도 국민은 어떤 것도 믿을 수 없다 불신의 시대다 그리고 현재까지 드러난 현상보다 더욱 두려운 것은 우리경제에 드리운 불길함이다 최근 정부가 발표한 한국경제의 성적표는 온통 빨간불 비상이다 한국은행은 일 통화신용정책보고서 에서 올해 월 가계부채 증가세가 예년의 배 이상이라고 밝혔다 조원대 규모도 문제이지만 저소득 자영업자를 중심으로 증가세가 빨라지고 있어 가계부채의 질 관리가 시급하다는 지적이다 통계청의 산업 활동 동향 에 따르면 소비 생산 투자 모두가 마이너스로 가고 있다 한국은행의 년 기업경영분석 도 국세청 법인세 신고기업인 총 만 개 기업의 성장성을 보여주는 매출액증가율이 지난해 에 그쳐 전년 대비 하락 한국은행이 관련 통계를 집계한 년 이후 가장 낮은 성장세를 기록했다 멈춰 선 정부 경제위기를 타개할 뾰족한 대책을 내놓을 리 없다 얼마 전 정부가 발표한 조선 해운업 위기 대응책은 년까지 조원을 투입해서 일단 살리고 보자는 해운산업 자금 지원이라는 틀에서 벗어나지 못하고 있다 어제 일 정부가 부동산 대책을 발표했지만 실효성이 의문이다 부동산 과열과 가계부채 폭증의 주요원인인 주택담보인정비율 과 총부채상환비율 규제 정상화 및 집단대출 규제 강화 등의 내용이 제외됐기 때문이다 가계부채의 뇌관은 터지기 일보직전이고 노동자의 현실과 반대로 간 박근혜표 노동개혁은 비정규직 만명이라는 참사로 이어졌다 대통령과 정부가 흔들려도 국민의 삶은 계속된다 하루하루 먹고 사는 문제만큼 소중한 것은 없다 반칙이 아닌 실력으로 당당히 인정받고 열심히 일한 사람이 먹고 살 걱정을 하지 않는 정상 국가를 기대하는 것이 너무나도 소박한 바람이 된 듯 하다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58848,2016-11-04, 광화문 광장에 박정희 동상 국민 분노에 기름을 붓는 격 박근혜 최순실 게이트로 온 국민이 분노와 자괴감에 빠지고 있는 상황에 박정희 대통령 기념재단이 광화문광장에 박정희 동상을 세우겠다고 한다 구미시가 억을 들여서 박정희 전 대통령의 기념사업을 하는 것도 어이가 없지만 서울광화문 광장에 동상을 세우겠다는 발상은 제 정신으로는 이해가 되질 않는다 지금이 어느 때인가 박근혜 대통령이 최순실 국정농단의 몸통으로 수사를 받아야 하는 상황이다 박근혜 최순실 게이트로 정부의 정책 학교의 입시 심지어 기업경영에까지 사적 이익을 위해서 난장판을 쳐놓은 것이 다 드러나고 있다 이 와중에 친일과 독재를 미화한 국정교과서를 만들고 탄생 주년 기념우표를 만들겠다는 것도 부족해 동상을 세우겠다니 혼이 비정상 임이 틀림없다 혼이 비정상 이신 분들은 제발 정신을 차리길 바란다 지금은 년이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58847,2016-11-04, 이재정 원내대변인 오후 현안 브리핑 일시 금 오후 시 분 장소 국회 정론관 대국민 훈화로 끝나버린 박근혜 대통령의 대국민담화 자신의 잘못을 남김없이 고하고 잘못을 비는 대통령은 없었다 국민들은 사과할 줄 알았던 대통령에게 오히려 훈계를 들었다 외롭게 살았다 이럴려고 대통령을 했는지 자괴감이 든다 자세한 내용은 검찰수사에 영향을 미칠 수 있으니 하지 않겠다 이것은 대국민담화가 아니다 대국민훈화에 불과하다 아직도 무엇을 잘못했는지 모르니 이런 대국민훈화로 일관하는 것이다 일말의 기대와 선처를 약속했던 국민마저 모두 떠나버리게 만드는 박근혜 대통령을 바라보며 앞으로 어떤 카드와 묘책으로 국민의 실망을 가중시킬지 걱정스러울 따름이다 별도특검과 국정조사 총리후보 철회는 국민의 명령이다 새누리당은 적극 협조하라 더불어민주당 추미애 당대표는 박근혜 대통령의 성의 없는 차 대국민담화에 대해 별도의 개별특별법을 통한 특검도입과 함께 국정조사를 수용할 것과 국무총리 후보 지명철회 후 국회가 추천하는 총리를 받아들일 것을 새누리당과 청와대에 마지막으로 제안했다 대통령 심기보좌에만 열중하며 청와대와 함께 국정운영을 농단한 새누리당은 더 이상 청와대 눈치를 보지 말고 적극 협조하라 정부여당에게 주어진 시간은 이제 얼마 남지 않았다 국민의 뜻이자 명령이다 성난 민심의 향배가 최순실을 넘어 문고리 인방을 넘어 새누리당을 향하고 있음을 명심하기 바란다 내려갈 곳 없는 박근혜 대통령 지지율 국민의 준엄한 심판이 시작됐다 불통과 독선 오만과 편견의 박근혜 대통령이 이제는 더 이상 내려갈 곳조차 없다 오늘 한국갤럽에서 발표한 대통령 직무수행평가에서 박근혜 대통령은 헌정사상 최저의 지지율을 보였다 대 대 대 대 이상 박근혜 대통령의 대통령 직무수행 세대별 긍정평가 결과이다 그동안 국민은 박근혜 대통령에게 수차례 호소했다 소통하라 대화하라 사실 그대로를 남김없이 털어놔라 그리고 진실 되게 국민을 대하라 하지만 박근혜 대통령은 불통과 독선의 정치로 응답했다 이제 모든 국민이 등을 돌렸다 앞으로 박근혜 대통령이 어떤 진실을 말하더라도 국민들은 더 이상 듣지 않을 것이다 이 모든 참사는 박근혜 대통령이 자초한 창조참사 임을 명심하길 바란다 국민의 분노를 외면한 채 인건비 올려달라는 청와대 국회 운영위원회 예산결산심사소위에서 년도 청와대 예산안 중 인건비 인상에 대한 정부여당의 반발로 합의에 이르지 못해 오늘 운영위 전체회의에서 이 문제에 대해 재차 논의하게 되었다 청와대는 내년에 예정된 공무원 인건비 인상분 보다 가 높은 를 인상해 달라고 한다 후안무치하고 뻔뻔한 일이다 이미 더불어민주당은 청년실업과 민생경제 파탄의 아픔에 동참하기 위해 내년도 국회의원 임금 동결을 국민 앞에 약속한 바 있다 일반인 단속조차 제대로 못해 박근혜 게이트라는 초유의 사건을 촉발시킨 청와대 공무원들이 무슨 염치로 인건비를 배로 올려달라는 것인가 국민이 두렵지도 않은가 더불어민주당은 최순실 문고리 인방 십상시 등 대통령을 둘러싼 인의장막을 걷어내기는커녕 대통령이 아닌 그들의 수족이 된 청와대 공무원들의 인건비 인상은 절대 용인할 수 없다는 점을 밝힌다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58846,2016-11-04, 금태섭 대변인 오후 현안 브리핑 일시 오후 시 분 장소 국회 정론관 국민은 대통령의 국가에 대한 책임을 묻고 있는 것이다 오늘 오전 대통령의 담화는 국민들의 실망와 염려를 더 크게 만들었다 국민들은 박근혜 최순실 게이트의 최종 책임은 대통령에게 있다는 사실을 인정하고 국민들에게 진심어린 사과를 하기를 바랐다 하지만 미르 스포츠 재단의 모금을 본인이 직접 요청하고 기업들이 마지못해 응했다는 것이 명백히 밝혀지는 시점에서도 선의의 도움을 주셨던 기업인들 이라며 강제성을 부인했다 또 특정개인이 이권을 챙기고 여러 위법행위까지 저질렀다 며 모든 책임을 최순실 개인의 일탈로 돌렸다 또한 외롭게 지내 와서 최씨로부터 도움을 받고 왕래하게 되었 다며 동정을 구걸하기도 했다 국정혼란과 공백상태가 검찰조사에 임하는 것만으로 다 해결될 것처럼 말했다 국민들은 오늘 대통령의 모습을 보며 과연 대통령이 국정수행 능력이 있는지 더 큰 시름에 빠지게 되었다 박근혜 대통령을 용서할 것인지 앞으로의 국정을 지지할지 것인지 이 모든 것들을 국민들이 판단할 것이다 대통령은 국가에 대한 무한책임을 지는 것이 무엇인지 다시 한 번 숙고하기 바란다 오늘의 대국민담화는 국민을 설득하는데 실패했다 대통령이 직접 챙긴 재단 자금 출연 기업의 선의로 포장하지 말라 안종범 전 수석이 지난해 하반기 박근혜 대통령이 직접 만나 미르 스포츠재단 자금 출연을 요청했다 고 밝혔다 미르 스포츠재단 모금 강압 의혹의 몸통이 대통령이었다는 점이 이제야 명백히 드러나게 됐다 기업들이 문화체육 분야를 지원하기 위해 뜻을 모아 만들게 된 것이 미르 스포츠 재단 이라더니 정작 뒤에서는 기업에 자금 출연을 요구했던 것이다 그런 대통령이 대국민담화에서 기업이 선의의 도움을 주었다고 말하니 헛웃음이 나올 따름이다 대통령은 월 일 수석비서관회의에서 재단 관련 불법행위 누구라도 엄정히 처벌받을 것 이라고 말씀하셨다 대통령은 이제 스스로를 처벌해달라고 해야 할 형편이다 기업 경영까지 간섭한 대통령 대한민국은 개인의 것이 아니다 대통령이 기업 경영까지 간섭한 정황이 드러났다 청와대 전 수석은 그룹 최고위층 인사와 통화하면서 이미경 부회장의 퇴진을 요구했다고 한다 그러면서 대통령의 뜻이라는 점도 분명히 밝혔다고 언론에 보도됐다 청와대 전 수석은 너무 늦으면 진짜 저희가 난리가 난다 고 했다 그런 대통령 때문에 지금 나라가 정말 난리가 났다 도대체 왜 대통령께서 민간 기업 오너까지 갈아치웠는지 궁금하다 여론에서 그 이유로 제기하는 것처럼 한 프로그램의 대통령 희화화 때문이라면 정말 큰 문제다 오락 프로그램조차 꼼꼼히 챙겨서 마음에 안 들면 오너 교체까지 지시하는 대통령 대통령의 헌법상 지위가 무엇인지 이해하지 못하고 있는 것 같다 박근혜 대통령은 후보 시절 토론회에서 그러니까 대통령하려고 하잖아요 라고 서슴지 않고 말했다 대통령은 모든 일을 할 수 있다고 착각하고 있는 것이 아닌지 의심스럽다 기업을 사유화하고 권력을 사유화한 대통령 국가를 사유화하며 국가의 모든 것을 개인의 것인 것 마냥 사용하는 대통령 국민은 봉건제 군주를 선출한 것이 아니다 청와대가 정유라의 입시컨설팅업체인가 최순실이 체육특기자 입시 정보가 담긴 청와대 문건도 미리 받아본 것으로 밝혀졌다 문건에는 단체종목에서 개인기량을 평가할 수 있는 시스템이 필요하다 체육특기생 면접 비중을 줄이고 개인별 기록을 반영해야 한다 는 등의 내용이 적혀 있다 고 수험생의 학부모라면 상당히 민감한 입시 정보가 청와대를 통해서 최순실씨에게 흘러간 것이다 최순실씨이 정보를 받고 개월 후 정유라는 이화여대에 합격했다 그런데 대통령은 오전 발표한 대국민담화에서 이 모든 범죄 혐의를 최순실씨의 개인비리 로 규정지었다 청와대 문건 유출은 특정 개인이 할 수 있는 일이 아니다 대통령의 묵시적 승인이 없었으면 최순실은 청와대 문건을 받을 수 없었을 것이다 이 모든 일의 책임자는 박근혜 대통령 본인이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58843,2016-11-04, 추미애 대표 기자회견 일시 금 장소 국회 본청 당대표 회의실 추미애 대표 존경하는 국민 여러분 더불어민주당 추미애 대표입니다 마음이 참 답답합니다 대통령의 상황인식이 절망적입니다 방금 전 대통령의 대국민담화가 있었지만 분노하는 민심에 전혀 대답이 되지 않았습니다 진정성 없는 개인반성문에 지나지 않았습니다 국기를 문란 시키고 국정을 농단한 박근혜 최순실 게이트를 개인사로 치부했습니다 국정을 붕괴시킨 뿌리가 대통령 자신임을 인식하지 못하고 있습니다 심지어는 검찰수사의 가이드라인까지 제시하고 있습니다 대통령의 상황 인식이 절망적입니다 대한민국의 시스템과 위기를 초래하고도 위중함을 깨닫지 못하고 있습니다 오직 권력 유지에만 골몰하고 있습니다 국민들은 대통령의 모습에 절망감과 분노를 느끼고 있습니다 국정을 정상화 시키겠다며 제일 먼저 한 일이 정치검찰 출신을 민정수석으로 임명했습니다 그리고 일방적으로 민심에 반하는 총리후보지명을 강행했습니다 이는 박근혜 대통령이 얼마나 안이하고 나태하게 민심을 보고 있는지 극명하게 보여주고 있는 것입니다 국정문란을 초래한 책임을 통감한다면 이런 결정을 내릴 수 없습니다 과오를 인정하지 않고 오히려 민심을 공격하고 있습니다 오죽하면 여권 내부에서조차 이번 총리후보지명으로 하야요구를 피할 수 없게 되었다는 말이 나왔겠습니까 게다가 이번 사태의 공범인 새누리당은 석고대죄는커녕 자신들은 아무 관련이 없는 양 사건축소의 들러리로 다시 나서고 있습니다 수습이 필요할 때가 아니라 대수술이 필요할 때입니다 그런 자세를 보여야 합니다 대통령은 지금 막다른 길에 놓여있습니다 오직 미봉책으로 민심의 목소리를 막고자하면 안 되는 것입니다 지금이라도 박근혜 대통령은 국민의 뜻을 따라야 합니다 석고대죄의 심정으로 국민과 야당의 목소리에 귀 기울여 주십시오 더불어민주당은 나라를 바로 세우기 위해서 준엄하게 요구합니다 첫째 박근혜 대통령과 새누리당은 국민과 야당이 요구하는 별도특검과 국정조사를 즉각 받아들이고 대통령은 그 수사에 응하십시오 둘째 권력유지용 일방적 총리후보 지명을 철회하고 대통령은 국정에서 손을 떼고 국회가 추천하는 총리를 수용하십시오 셋째 이상의 요구가 받아들여지지 않을 경우 저와 더불어민주당은 국민과 함께 정권 퇴진 운동에 들어갈 것입니다 더불어민주당은 정부 여당이 국정운영 능력을 사실상 상실한 상태에서 안보와 경제 상황에 대한 국회 차원의 비상점검 태세를 강화하겠습니다 국민의 애국적인 분노를 존중하고 앞으로 시민사회와 긴밀히 협력해 나가며 당원 집회 등을 통해 대한민국을 다시 세우기 위해 총력을 다하겠습니다 감사합니다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58839,2016-11-03, 금태섭 대변인 오후 현안 브리핑 일시 시 분 장소 국회 정론관 국민들이 듣고 싶은 것은 김병준 교수의 정견발표가 아니라 국정농단 경위에 대한 대통령의 소상한 설명과 사과다 국민들이 듣고 싶어 하는 것은 김병준 교수의 장황한 정견발표가 아니다 국민들이 듣고 싶어 하는 것은 국정농단 경위에 대한 대통령의 소상한 설명과 사과이다 김병준 교수는 기자회견에서 헌법이 구성한 총리 권한을 행사할 것 이라고 밝혔다 책임총리에 대한 기대감에 잔뜩 부풀어 있는 모습이다 국민의 가 대통령이 하야해야 된다고 말하고 있다 그런데도 야당과 협의도 없이 국무총리 인사를 단행한 것은 대통령이 국정 주도권을 놓을 생각이 전혀 없다는 뜻을 말한다 그런 시점에 국무총리직을 수락한 것은 대통령의 그런 국면전환 시도를 적극 용인하겠다는 것이다 국민대학교 제자들조차 김병준 교수가 부끄럽다 며 면피성 총리교체에 대해 반대하고 있다 다시 한 번 말씀드리겠다 국민들이 듣고 싶어 하는 것은 국정농단 경위에 대한 대통령의 소상한 설명과 사과이다 김병준 교수의 장황한 정견발표가 아니다 세월호보다 정유라를 선택한 대통령 국민들은 절망한다 박근혜 대통령이 체육개혁을 확실히 하라고 지시를 내린 사실이 밝혀졌다 세월호 참사가 발생한 다음 날이다 언론보도에 따르면 김종 전 차관은 대통령께서 세월호 난 그 다음 날 체육개혁 확실히 하라고 오더 내려왔다 라고 말했다고 한다 꽃 같은 아이들이 세월호 참사로 목숨을 잃어 온 국민이 슬퍼하던 시기였다 아직 생사도 확실하지 않아서 생명 구조에 심혈을 기울여야 할 골든타임이기도 했다 그런데 정작 대통령은 국민이 아닌 정유라를 택했다 생존자가 남아있다면 분 초가 급한 마음 이라던 대통령은 세월호 생존자 구출보다 정유라를 위한 승마계 내부 일에 더 급급한 모습을 보였다 대통령은 세월호 참사로 차가운 바다에 잠들었던 아이들 대신 최순실의 딸을 선택한 것이다 대통령의 선택이 절망스럽다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58837,2016-11-03, 이재정 원내대변인 의원총회 관련 서면 브리핑 더불어민주당 의원총회 관련 오늘 오전에 실시된 더불어민주당 의원총회 주요 결과는 아래와 같다 먼저 당론으로 청년실업과 파탄 난 민생경제 등을 고려하여 년 국회의원 임금을 동결하기로 했다 더불어민주당은 앞으로 어려운 민생경제를 되살리는데 총력을 다 할 것이다 두 번째로 월 일 거행되는 고 백남기 농민 영결식에 추미애 더불어민주당 대표가 공동장례위원장으로 선임되었으며 많은 더불어민주당 의원들도 영결식을 함께 할 예정이다 다시는 국가의 과도한 공권력으로 인해 국민이 희생당하는 일이 발생하지 않도록 철저한 진상규명과 엄중한 검찰수사를 촉구한다 마지막으로 박근혜 최순실 게이트와 관련하여 의원총회를 통해 많은 의원들의 중지를 듣고 공유했다 더불어민주당은 민심의 분노를 함께하고 불안을 위로하며 책임지는 정치로 함께 하기 위해 최선의 노력을 다할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58836,2016-11-03, 이재정 원내대변인 오전 현안 브리핑 일시 목 오전 시 분 장소 국회 정론관 박근혜 대통령에 대한 검찰수사 조속히 이뤄져야한다 밤의 대통령이자 비선실세인 최순실이 대한민국을 그저 한낱 수익모델로 삼아 국민의 혈세와 기업의 돈을 갈취할 수 있었던 뒷배에는 바로 대통령의 지시가 있었음이 드러났다 청와대 왕수석 안종범이 검찰에서 모든 지시가 박근혜 대통령에 의한 것임을 명백하게 밝힌 만큼 이제 검찰의 수사는 대통령을 대상으로 이뤄져야 한다 대통령으로 재직 중에는 소추를 당하지 않는다고 명시한 헌법 조는 대통령 수사배제의 핑계가 될 수 없다 수사와 소추는 엄연히 다르다 국민이 주인인 국가를 한낱 측근실세의 수익모델로 전락시킨 대통령이다 대통령에 대한 조속한 검찰 수사는 국민의 명령이다 문자로 국무총리 해고 통보한 청와대 신의도 없고 예의도 없다 경악스럽다는 이야기밖에 할 수 없는 어제 국무총리 후보자 지명과정을 둘러싼 청와대의 신의 없는 매몰찬 통보가 논란을 야기하고 있다 황교안 국무총리는 김병준 후보자 지명사실을 문자로 통보받았다고 한다 일국의 국무총리 지명을 물러날 국무총리에게 문자로 통보한다는 것이 가당키나 한 것인가 국민이 실소를 금하지 못하게 만드는 여러 가지 이유 중의 하나이다 박근혜 대통령의 그릇이 그 정도밖에 되지 않기 때문에 친박 진박을 자청했던 간신 부역자들이 검찰 앞에서 모든 것은 대통령이 지시했다고 대통령에게 책임을 떠밀고 대통령과 독대한 적이 없다며 대통령과 거리두기를 하고 있다 수신제가 치국평천하 라고 했다 자기 자신조차 사인에게 능멸당한 대통령이다 무엇을 기대하든 기대이하이다 이 정도일 줄은 몰랐다는 국민들의 한탄만큼은 가슴에 깊게 새기기 바란다 신의 없고 예의 없는 국무총리 인선과정이 더 큰 논란을 야기하고 있는 만큼 박근혜 대통령은 당장 총리인선을 중단할 것을 촉구한다 국민의 시각을 운운하는 청와대 국민을 들먹일 자격 없다 박근혜 대통령이 경악스러운 불통인사에 국민들은 지쳐간다 오늘 청와대는 또 다른 불통인사의 일환으로 한광옥 국민대통합위원장을 새로운 대통령 비서실장으로 임명했다 임명과정에서 청와대는 한광옥 비서실장에 대해 어려운 시기에 대통령을 국민적 시각에서 보좌할 적임자 라고 설명했다 국민의 시각을 운운하는 청와대는 똑똑히 알아야 한다 지지율 와 연일 광화문 광장과 청계광장을 가득 메우는 촛불 행렬의 퇴진요구가 바로 국민의 시각이다 어제와 오늘의 내각 불통인사로 청와대와 대통령이 민심의 분노와 불안을 더욱 가속화시키고 있다 국민의 시각 과 국민 을 운운할 자격이 없다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58835,2016-11-03, 금태섭 대변인 오전 현안 브리핑 목 시 분 정론관 대통령은 불통 인사에 국민을 끌어들이지 말라 청와대는 오늘 신임 비서실장에 한광옥 국민대통합위원장을 정무수석에 허원제 전 방송통신위원회 상임위원을 임명했다 또 불통 인사다 어제 일방적으로 김병준 교수를 국무총리로 내정한다는 기습 발표를 한지 하루도 지나지 않아 또 불통 인사를 단행한 것이다 하야 탄핵까지 외치는 국민 여론을 완전히 무시한 것이다 야당은커녕 여당과도 대화하지 않는 모습이다 이런 식의 인사로 어떻게 국정파행을 수습할 수 있겠는가 한광옥 비서실장 지명자는 지난 대선 당시 새누리당에 전격 합류한 분이다 말 갈아타듯 당을 갈아타신 분이다 이런 분을 얼굴마담 비서실장으로 내세운 것은 거국내각 코스프레에 이은 대통합 코스프레로 국민을 기만하려는 것으로 밖에 볼 수 없다 더욱이 이 정부 역대 비서실장의 회한에 찬 육성이 흘러 나오는 상황이다 물러난 이원종 비서실장 역시 허수아비로 불렸다 박 대통령은 비서실장을 임명하기 전에 먼저 민정수석을 임명했다 이 점만 보더라도 신임 한광옥 비서실장 역시 또 한명의 허수아비가 될 것이 틀림없다 청와대는 한광옥 위원장에 대해 대통령을 국민적 시각에서 보좌할 것으로 기대한다 고 밝혔다 국민 여론에는 귀를 닫고 있으면서 뻔뻔스럽게도 불통 인사에 국민을 끌어들이고 있다 국정공백은 긴급불통인사로 수습 되는 것이 아니다 대통령은 자기 입맛에 맞는 허수아비 비서실장을 기용하는데 국민을 이용하지 말라 안종범 최순실 게이트 아니다 대통령을 수사하라 특별수사본부의 수사가 미르와 스포츠를 위한 대기업 강제모금이나 최순실 차은택의 개인적 불법행위 중심으로 가고 있다 출발은 미르 게이트였지만 지금까지 밝혀진 모든 사실들은 분명히 말하고 있다 최순실 안종범 차은택 등 그간의 모든 등장인물들에게 적용되는 죄명은 국정농단죄이다 그리고 모든 것들의 중심에는 박근혜 대통령이 있다 안종범 전 수석이 대통령이 모금을 지시했다 는 발언은 수사의 대상이 박근혜 대통령임을 인정하는 것이다 검찰은 안종범 최순실 게이트가 아니라 박근혜 최순실 게이트임을 분명히 하여야 한다 검찰이 집중해야 할 것은 국정농단죄의 공모자들을 전원 밝혀내야 하는 것이다 청와대의 그 누구도 수사에서 예외가 될 수 없다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58833,2016-11-03, 제 차 정책조정회의 모두발언 일시 목 오전 시 장소 국회 본청 원내대표 회의실 우상호 원내대표 어제 박근혜 대통령이 기습적으로 국무총리와 일부 내각 개편을 발표했다 그러나 오히려 국민은 더 분노하고 있다 지금 대통령께서 하시는 하나하나의 행동은 대한민국의 위기를 극복하느냐 수습하느냐의 중대한 결단이어야 한다 임시방편책으로 상황의 위기를 모면하려하거나 시간을 끌어서 문제를 해결하려는 식으로 접근하면 더 큰 위기가 오게 될 것이다 상황 인식이 너무 안이하다는 점을 다시 한 번 지적한다 지금의 난국을 풀어갈 핵심 키워드는 진정성과 소통이다 진정성 그리고 소통 이 대통령이 가슴에 새겨야 할 두 단어이다 국민을 상대로 진솔하게 진실을 고백해야한다 대통령이 연루된 일은 대통령밖에 알 수 없다 누가 알겠는가 이 상황을 제일 잘 알고 있고 진실을 제일 잘 아는 분이 국민에게 진솔하게 고백해야 한다 내가 최순실을 위해서 안종범 등 참모들을 통해서 기업에 모금을 지시했다 기업인들에게도 협조를 당부했다 고 진상에 대해서 고백하고 사죄해야한다 진솔한 사죄만이 분노한 국민들을 그나마 달랠 수 있다 본인 스스로가 조사받겠다고 용기 있게 국민들에게 보고해야 한다 그렇게 해도 성난 민심이 가라앉을까 말까한 상황이다 진정성으로 국민들을 만나지 않는 한 꼼수나 정략적 수단으로 분노한 민심을 잠재울 수 없다 진정성 있게 접근하시라 두 번째는 소통이다 지금은 여야 정치권 국민들과 소통하지 않은 어떠한 해법도 무효가 될 것이다 백약이 무효이다 그 사람이 좋은가 나쁜가의 문제가 아니다 국정운영의 방식을 바꾸겠다는 신호를 보내야 한다 불통을 소통으로 바꾸겠다는 변화의 진정성을 보여 주셔야한다 그렇게 하지 않는다면 아무리 권력을 쥐고 있는 대통령이라 할지라도 국민의 민심이 이미 떠났기 때문에 어떤 동력도 다시 생길 수 없다 이 점을 왜 모르시는지 답답하다 모든 국민이 알고 여당 중진들도 알고 언론도 다 아는데 대통령만 왜 모르시는가 진정성과 소통이라는 단어를 가슴에 새기고 다시 한 번 접근해주시기 바란다 윤호중 정책위의장 비선실세 최순실씨의 국정농단이 나라예산에까지 손이 뻗쳤다는 것이 하나하나 드러나고 있다 최순실씨가 국정농단을 한 내년도 예산이 국회 상임위와 예결위 심사를 통해서 밝혀지고 있다 지금까지 밝혀진 최순실 국정농단 예산은 여개 사업에 걸쳐서 총 억원에 달하고 있다 대표적인 것을 살펴보면 문화부 소관 문화체육예산 억원 미르재단 스포츠재단이 박근혜 대통령 아프리카 순방시 농단한 예산 억원 최순실씨 측근인 차은택씨가 민관합동창조경제추진단 단장 겸 문화창조융합본부장으로 재직하며 관여한 창고경제예산 억원 등이다 국민의 피 같은 세금으로 만들어진 국가재정을 곶감 꽂이 빼먹듯이 하나하나 빼먹으려했다는 것에 정말 분노하지 않을 수 없다 최순실표 예산을 들여다보면 하나하나가 다 특징을 가지고 있다 첫 번째 특징은 나라재정이 어렵고 부채가 쌓여가고 있는데 최순실 예산은 오히려 대폭 증액되거나 신규로 대거 편성되었다는 것을 알 수 있다 문화창조융합벨트사업도 당초 억 정도였는데 문화창조센터건립 사업으로 변질되면서 전년대비 증가하여 거의 두 배에 이르는 억으로 편성된다 미르재단 스포츠재단이 개입한 코리아에이드 사업은 억이었던 작년 예산에 비해서 억으로 거의 배 가깝게 증가한 것이다 두 번째 특징은 사업계획도 부실하고 사업계획서조차 제출하지 않고 사업성과가 불분명하고 성과평가가 어려운 사업들이 대거 편성되었다는 것이다 특히 지역거점형 문화창조벤처단지 조성 문화창조융합벨트 글로벌 허브화 문화창조융합벨트전시관 컨텐츠멀트유즈랩 등과 같은 사업들은 세부사업 계획도 첨부가 되지 않았다 세 번째 특징은 지금까지 예산편성 과정에서 전혀 찾아볼 수 없었던 전례 없는 편법 편성이 되었다는 것이다 예를 들면 한국관광공사 중구사옥에 한류컨텐츠체험장을 조성하는 사업 같은 경우에는 관광기금을 설계용역비로 쓰고 있고 또 억을 계획변경하면서 기재부가 이례적으로 하루 만에 승인하기도 했다 이렇게 최순실의 국정농단이 재벌기업들을 등쳐서 재단을 만드는 것에 그치지 않고 국가예산을 농단한데까지 이르는 것에 놀라지 않을 수 없다 저희는 예산심사 과정을 통해서 내년도 예산에 들어와 있는 최순실표 예산을 반드시 삭감하겠다 년 예산에 쓱 들어와 있는 것을 싹 삭감시키겠다는 것을 국민께 거듭 약속드린다 쓱 싹 이다 신정경유착으로 드러난 미르 스포츠재단의 사례를 통해서 정경유착을 근절시킬 수 있는 대안을 말씀드리겠다 그동안 우리당이 조사한 바에 따르면 미르재단과 스포츠재단을 통해서 기업의 돈을 거두어들인 것은 기부가 아니라 명백한 약탈이었다고 볼 수 있다 미르 스포츠재단 뿐만 아니라 청년희망재단 억 진흥정보기술연구원 억 창조경제혁신센터펀트 억 등의 경우들도 대기업들에 모금을 강요해서 만든 기금으로 마치 대통령 관심사업인 것처럼 추진했던 일들이다 이것이 가능했던 것은 지금까지 지금기부금 단체를 지정하는 것은 기획재정부의 소관업무이고 각 부처는 재단설립등록 허가권을 가지고 있다 정부 관료들이 이러한 권한을 모두 가지고 있기 때문에 공익을 위한 재단인지 아닌지를 판단하는 판단주체가 정부 관료였다 또한 기업이 사회적책임 투자를 스스로 있는 것이다 시장 권력의 정점이라고 할 수 있는 전경련과 정치권력의 정점이라고 할 수 있는 청와대가 손을 잡는다면 바로 신정경유착이 발생하게 되는데 기업이 사회적책임 투자 공익 투자를 명분으로 내건 새로운 정경유착의 경로가 개설된 셈이다 이렇게 잘못된 제도를 반드시 고쳐야 이러한 새로운 정경유착의 통로를 막을 수 있다 우리당 정책위에서는 신정경유착의 통로로 이용된 지정기부금단체 지정과 관련한 모든 권한을 기재위로부터 시민공익위원회로 바꾸는 법안을 추진할 계획이라는 점을 말씀드린다 시민공익위원회는 중립적인 시민사회의 대표인사들로 구성하고 공익법인의 설립 및 사후 관리 지정기부금단체 지정에 대한 심의의결권을 가지며 공익법인과 지정기부금 단체에 대한 사후관리 및 감독 권한까지 갖는다 더 나아가서 단체에 대한 지정권 취소 철회의 권한을 갖게 될 것이다 또 아울러 지정기부금단체로부터 어느 기업으로부터 기부를 받았는지 이를 어디에 사용했는지 정기적으로 사업결과를 보고 받고 이를 민간에 공개함으로서 시민사회 언론의 감시가 가능하도록 하는 제도이다 영국은 이미 채리티 액트 공익단체법이라는 것을 통해서 채리티 커미션 이 이러한 기능을 수행하고 있고 시민사회의 역할을 통해서 공익사업의 투명성을 보장하고 있다 우리나라도 미르 스포츠재단 사태를 통해서 정부와 경제 권력의 유착관계가 재확인된 만큼 법 제도의 확실한 개혁을 통해서 정부 권력자들의 직권남용과 제 자 뇌물공여 등 더 이상 못된 짓이 재발하지 않도록 철저히 대책을 세우겠다는 것을 약속드린다 송기헌 부대표 최순실 게이트가 평창 동계올림픽에도 개입됐다는 의혹에 개탄하지 않을 수 없다 국가의 역사적 행사를 자신들의 이권을 챙기는 장터로 취급했고 문화체육관광부가 이것을 방조했다 최순실의 조카 장유진은 미르 스포츠재단이 설립되기 개월 전인 에 동계스포츠영재센터를 설립했다 동계스포츠영재센터는 설립과 동시에 지난해 억원 올해 억 천만원을 정부로부터 지원받았다 실적이 전무한 신생단체에게는 이례적인 지원이었다 일각에서는 빙상경기장의 관리주체 결정이 아직도 표류하고 있는 이유가 동계스포츠영재센터 때문이라는 이야기가 있다 동계스포츠영재센터 초대 회장을 맡았던 박모씨는 언론과의 인터뷰를 통해서 기획단계에서부터 최순실 장유진 김종 전 문화체육관광부 차관과 수차례 회의를 했다고 밝혔다 최순실과 그 측근들은 평창 동계올림픽 개폐회식장의 공사 이권에도 개입했다 문화체육관광부는 개폐회식장 공사에 스위스 누슬리 사를 참여시킬 것을 강하게 요구했다 박근혜 대통령도 관련회의에서 언급했다는 보도가 있다 누슬리 사는 최순실 소유인 더블루 와 업무협약을 맺은 회사로 최근 확인됐다 조직위원회의 반대로 누슬리 사의 참여는 무산됐지만 이것 때문에 공사는 개월이나 지연됐고 사업비는 억원이나 들었다 일각에서는 김진선 조양호 전 조직위원장 교체와 사무총장 교체 개폐회식 연출가 교체 등에 모두 최순실과 측근들이 연루되었다는 의혹까지 제기되고 있다 평창 동계올림픽의 준비과정에서 겪은 혼란의 상당부분이 최씨와 측근들 때문이라고 해도 과언이 아닌 정도이다 최씨와 측근들은 국제 스포츠행사마저 국정농단의 제물로 전락시킨 것이다 검찰수사를 통해서 최순실과 측근들의 동계올림픽 농단 행위가 명명백백하게 밝혀져야 한다 평창 동계올림픽은 만 강원도민의 열망을 담은 치열한 유치활동의 결과물이다 결코 훼손되어서는 안 될 중요한 역사적 행사이다 국정동력을 상실한 박근혜 정부에 더 이상 평창 동계올림픽을 맡겨둘 수 없다 더불어민주당은 평창 동계올림픽에 드리워진 최순실의 그림자를 걷어내고 불과 일도 남지 않은 동계올림픽이 국제적인 웃음거리가 되지 않도록 행정적 재정적 지원에 앞장서겠다 우상호 원내대표 지금 검찰 수사가 진행되고 있다 하지만 검찰 수사는 범죄 사실을 특정해서 처벌을 목적으로 조사하기 때문에 박근혜 최순실 게이트의 전모를 국민에게 밝히는 데에는 한계가 있다 과거 국회는 이런 주요현안이 있을 때마다 국회에서의 현안질의 국정조사 등을 병행해 왔다 더불어민주당은 국회 내 긴급현안질의 국정조사를 야 당 합의로 추진하고자 한다 여당은 즉각 협의에 응해서 긴급현안질의가 국회에서 진행될 수 있도록 해주시기 바란다 현안질의와 국정조사는 지금까지 쏟아졌던 모든 의혹을 총정리해서 국민들에게 상세히 설명 드리고 아직 밝혀지지 않은 추가의혹들에 대해서도 따져물어 국민들에게 진상의 전체 흐름과 얼개를 자세히 보고 드릴 수 있는 자리가 될 것이다 원내에 이런 자리를 만들어주셔야 한다 장내에 이런 자리를 만들어 주지 않으면 우리는 바깥에 나가서 국민들에게 직접 보고할 수밖에 없다 그런 점에서 여당이 긴급현안질의와 국정조사를 수락해주실 것을 다시 한 번 말씀드린다 김병준 교수께 말씀드리겠다 김병준 교수가 총리 적임자냐 아니냐에 대해 논란을 펼치고 싶지 않다 스스로 지명 수락의사를 철회해 주시라 어차피 야 당이 이 인준을 거부하고 부결시키기로 합의했다 굳이 명예를 더럽히면서 총리를 하겠다고 하실 이유가 없지 않은가 끊임없는 논쟁과 국회에서의 부결 절차밖에 남아있지 않은데 굳이 그런 절차를 거치셔야 하겠는가 개인적으로 친분이 있기 때문에 그런 선택을 하고 싶지 않는 것을 인간적으로 말씀드리고자 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58831,2016-11-02, 박경미 대변인 오후 현안 추가 브리핑 비극의 포클레인 희망의 포클레인 박근혜 최순실 게이트 가 대한민국을 어둡게 짓누르고 있다 이와 관련하여 두 가지 포클레인이 오버랩 된다 하나는 케이블카 설치를 위해 설악산 대청봉 코앞까지 오르내리는 포클레인이다 정부 때 강으로 향했던 포클레인을 박근혜 정부는 산으로 돌렸다 규제완화와 관광활성화를 이유로 자신의 아버지 때부터 역대 정부가 지켜온 국립공원들마저 개발 대상에 포함시켰다 특히 억 원 규모의 설악산 오색케이블카 사업은 최순실 라인으로 불린 이승철 전경련 부회장이 제안하고 김종 차관이 행정적으로 지원한 사업이다 또 하나는 어제 대검찰청 청사 정문으로 돌진했던 포클레인이다 전북에서 포클레인을 가져온 정 모씨는 그 전날 비선실세 최순실 씨가 검찰에 출두하면서 죽을 죄를 지었다 고 말하는 것을 보고 죽는 것을 도와주겠다는 마음으로 왔다 고 진술했다고 한다 방법은 틀렸으나 국민적 분노 는 확실히 느껴진다 최순실 일당의 사욕을 채우는 사업에 동원된 포클레인 그리고 그들을 응징하려는 시민의 포클레인 이런 비극적 상황에 동원된 포클레인이 아니라 국민에게 희망을 주는 사업에 동원되어 활기차게 일하는 포클레인을 보고 싶다 박근혜 최순실 게이트를 엄호해온 새누리당은 석고대죄 하라 최순실씨 등 비선실세 국정농단 사태를 둘러싸고 거듭되는 새누리당의 적반하장 행태가 갈수록 가관이다 우병우 민정수석의 국회출석은 꿈도 꾸지 말라 고 으름장을 놓았던 것은 바로 새누리당 정진석 원내대표이다 그랬던 사람이 당 지도부는 최순실 관련 증인 채택을 반대하라고 지시한바가 없다 고 말했다 당 지도부의 지침이 없었다면 어떻게 국정감사 내내 새누리당 의원 전원이 최순실 게이트 관련자들을 일사불란하게 비호했겠는가 심지어 오늘 이정현 대표는 사퇴 요구에 대해 내가 도둑질이라도 했느냐 만 명의 당원들이 뽑아준 당대표인데 부족하지만 도와 달라 며 뻔뻔한 발언을 서슴지 않았다 국민들 보기 부끄럽지 않은가 만 표로 당선된 박근혜 대통령에 대해서도 하야하라 탄핵해라 는 국민의 목소리가 추상같은 현실이다 새누리당 지도부는 제발 이성을 찾고 지난 과오부터 되짚어보기 바란다 새누리당은 지금 적반하장으로 큰소리칠 것이 아니라 작금의 국정농단 사태에 대해 국민 앞에 머리를 조아리고 석고대죄 해야 한다 박근혜 대통령의 위기는 박 대통령 스스로 초래한 것이지만 사태를 이 지경으로 키운 것은 대통령 비호와 대리 변명에만 급급했던 새누리당이다 국민을 무시하며 민심을 역행하는 새누리당의 오만한 행태는 국민적 분노를 더욱 격앙시킬 것이다 비선실세에게 돈 상납하는 것이 경제계의 고통 분담 방법인가 박근혜 최순실 게이트가 점차 확산되면서 대기업들의 이름이 줄줄이 나오고 있다 우리나라 간판기업 삼성이 최씨 모녀에게 직접 돈을 건내며 쩔쩔맸다는 의혹에 개탄을 금할 수 없다 심지어 는 차은택에 주도하던 컬쳐밸리사업에 조 원을 투자할 계획이었다고 한다 수감 중이었던 총수의 사면을 위해서라는 추측이 제기될 수밖에 없다 비선실세들이 대기업을 상대로 돈을 쥐어짜는 것이 박근혜 대통령이 말하던 창조경제란 말인가 더 나아가 대기업이 비선실세에게 돈을 상납하는 것이 박근혜 대통령이 생각한 경제계의 고통 분담 방법인가 민주정부 년 동안 그렇게 끊어내고자 노력했던 정경유착의 고리를 대통령이 지시 하에 다시 구축하고 있었다니 참담할 따름이다 국민들이 박근혜 정부의 경제정책 전반을 불신의 눈으로 바라볼 수밖에 없는 현실이 안타깝다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58825,2016-11-02, 박경미 대변인 오후 현안 브리핑 일시 장소 국회 정론관 아이들이 부끄러워하는 대통령 아이들을 화나게 만드는 대통령 서울의 한 중학교 기말시험에서 대통령의 법적 지위에 대해 쓰시오 라는 문제에 최순실의 마리오네트 꼭두각시 최순실한테 조정당하는 사람 이라고 적은 학생의 답안이 화제다 또 국가 살림을 위한 돈을 어떻게 어디에 쓸지 계획한 것 이 무엇이냐는 질문 정답은 예산이지만 최순실 이라고 답한 초등학교 어린이의 답안이 주목을 끌기도 했다 오늘 대학생들의 시국선언이 곳을 돌파할 것으로 전망되는 가운데 최근에는 중 고등학생도 시국선언에 나서고 있다 서울 중동고 일부 학생들은 박 대통령이 민주법치국가의 수장임을 스스로 부정했다 더 이상 대통령이라는 칭호는 어울리지 않는다 는 선언문을 냈다 전북 김제의 중학생 여 명은 직접 장외집회를 개최하고 박 대통령과 최순실 사건에 관련된 사람들의 진실한 사과와 처벌을 바란다 며 시가행진을 벌였다 자라나는 우리 아이들이 정치풍자를 담은 답안지를 써내고 시국선언문을 발표하고 장외집회까지 열었다니 어른으로서 너무나 미안하고 참담한 심정이다 대통령은 우리 아이들도 번연히 아는 잘못을 저질렀다 비선실세와 짜고 국운을 쇠퇴시킨 그 죄를 박근혜 대통령은 국민들과 우리 아이들에게 어떻게 용서 받을 것인가 박근혜 최순실 게이트 의 공범 새누리당은 자숙하라 새누리당 정진석 원내대표는 이틀 전 국회의장이 주선한 당 원내대표 회담장을 박차고 나가는 적반하장의 극치를 보였다 또 어제는 자신의 페이스북에 야당의 진정한 노림수는 국정 혼란 대통령 하야 아노미 상태일 것 이라는 글을 올렸다 현재의 국정 혼란 과 아노미 상태 를 누가 만들었나 대통령 하야 는 그 누구도 아닌 국민들의 자발적인 목소리가 아닌가 새누리당은 줄곧 거국중립내각 을 주장하다가 책임총리제를 표방한 대통령의 일방적인 개각 발표에 곧바로 공식 환영 논평을 내는 모순적인 행태를 보였다 새누리당의 천연덕스런 뻔뻔함에 어안이 벙벙할 따름이다 대통령만 불통인 줄 알았더니 새누리당 의원들도 똑같다 박근혜 최순실 게이트 의 공범 인 새누리당의 지도자들이 순간적으로 자신의 처지를 망각했나 보다 그렇지 않고서야 어찌 하늘을 우러러 한 점 부끄러움을 모른단 말인가 새누리당에 경고한다 우리 당이 땅바닥까지 떨어진 국격을 바로 세우고 만신창이가 된 국민 자존심을 회복시키는 데 전념할 동안 새누리당은 경박한 언동을 삼가고 자숙하기 바란다 청와대 내부직원까지 사찰한 비선실세 청와대를 둘러싼 비현실적인 각종 의혹들을 접하다 보면 마치 이상한 나라의 앨리스 의 세계에 온 것 같다 최순실씨의 사돈 김모씨가 박근혜 정부 출범과 동시에 청와대에 입성했고 물품 구매 담당으로 근무하며 시계형 몰카 대를 구매해 내부 직원을 사찰했다는 의혹이 제기됐다 비선실세인 민간인 최순실씨가 청와대 직원들을 감찰했다는 의혹은 기가 막히다 누가 누구를 어떤 목적과 무슨 권한으로 감시한다는 말인가 청와대는 거꾸로 된 세상인지 묻고 싶다 청와대는 몰카를 제 부속실에서 사용했고 대통령 면담 기록 확인용으로만 사용했다고 밝혔다 제 부속실은 안봉근 전 비서관과 윤전추 행정관등 이른바 최순실 라인 으로 불리는 인물들이 모여 있던 곳이다 청와대는 김모씨의 청와대 근무배경은 물론 불법 사찰의혹에 대해서 한 점의 의혹이 남지 않도록 명명백백하게 밝혀야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58822,2016-11-02, 추미애 대표 직불금 행복한 미래를 위한 변화 토론회 축사 일시 수 장소 의원회관 제 소회의실 추미애 대표 어제 백남기 어르신의 빈소에 조문을 가서 유족을 위로했다 일에 장례가 진행된다 천사 같은 고인의 삶이었고 남겨진 유족들도 이 땅의 선한 국민이자 농민의 아들딸이었다 폭압적 공권력에 의해서 생명을 잃고 그 죽음마저도 욕보이려고 했던 공권력을 향해서 아직 분노가 가라앉지 않았을 상태일 텐데도 불구하고 위로하는 자리에서 이렇게 말씀하셨다 고인께서는 마지막까지도 절규했다 무너지는 농민의 삶을 지키기 위해서 호소했다 그 목소리가 외면당하고 묵살당하지 않도록 다시 되살려주십시오 라고 말씀하셨다 유족으로서의 슬픔보다 무너지는 농민의 삶과 이 땅의 불평등한 삶의 한 가운데 농민이 있다는 것을 유족들이 먼저 떠올리고 안타까워하는 모습이 또 한 번 저의 가슴을 먹먹하게 했다 오늘은 저에게도 힘든 날이다 대통령이 변명 같은 초짜리 대국민사과를 한 이후에 본인의 변호인처럼 힘이 센 실력을 자랑하던 정치 검사를 민정수석으로 앉혀놓더니 이제 엿 먹으라는 식으로 불통의 방식으로 일방적으로 총리 인선을 발표했다 자신이 지탄했던 전 정부 인사를 앉혀서 야당을 공격해 국면을 전환하겠다는 것이 박근혜식 정치란 말인가 이것의 본질은 박근혜 최순실 게이트를 가리기 위한 방패인사가 아니겠나 반성하라고 했더니 오히려 국민을 향해서 반격을 하고 있는 대통령이다 무너지는 농정을 지키기 위해서 오늘 이 좋은 자리를 마련해준 농민 대표 농심 대표 김현권 국회의원과 충남도정을 꼼꼼하게 이끌면서 더 큰 대한민국호를 이끌어보겠다고 포부를 밝히고 계신 안희정 충남도지사가 오셨다 우리 농업은 농촌이 지키는 곳이다 농업과 농촌은 결코 분리될 수 없다 지속가능한 발전을 위해서 생태보전을 위해서 농업이 제대로 지속 가능해야하고 그속에서 농촌도 지켜진다 저도 일찍이 농촌 어메니티를 소재로 연구를 해서 경제대학원 석사를 받았다 어메니티 자원을 잘 활용하고 있는 도시가 많은 곳이 충청남도이다 오늘 정책자료집에 농촌과 농업의 생태적인 측면에서 농촌과 농업의 공공성 등의 차원에서 많은 내용이 알차게 담겨있는 것을 보니 매우 마음에 든다 이런 일들이 전국적으로 많이 번져나가서 정책에서도 희망을 주는 대권후보가 되어주시기를 바란다 민주당이 쌀값 안정을 위한 대책 마련에 최선을 다하겠다고 말씀드렸다 쌀 만 톤을 시장에서 격리하고 우선지급금을 작년 수준인 원으로 유지를 할 것이다 또 쌀생산 조정제는 국회 예산 심의 과정에서 꼭 반영할 것이다 직접지급보조금도 가구당 연 만원으로 선진국보다 낮은데 선진국 수준으로 끌어올릴 생각이다 국정을 망친 정부를 대신해서 민주당이 농심에 위로를 드리고 농촌과 농민을 지킬 것을 약속드린다 오늘 오셔서 좋은 발제와 토론을 해주시는 여러분께도 더불어민주당의 대표로서 깊은 감사의 말씀을 드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58819,2016-11-02, 이재정 원내대변인 오후 현안 브리핑 일시 수 오후 시 분 장소 국회 정론관 청와대발 불통선언 국민에 대한 폭력이다 모두가 놀랐고 모두가 경악했다 백발이 성성한 노인부터 대 청소년까지 연일 시국선언을 이어가고 최순실과 가신 집단인 정권의 부역자들은 박근혜 게이트에 대한 모든 책임을 대통령에게 미루고 있다 박근혜 대통령은 또다시 불통인사를 자행했다 자신을 둘러싼 게이트 의혹을 희석시키기 위해 국민을 상대로 저급한 술수로 위기를 모면하고자 하는 것이다 전 국민이 망연자실한 가운데 자신을 위한 정치 부역자들을 위한 국정운영을 단행한 박근혜 대통령의 독선의 종착역이 어디로 향할지는 점점 자명해지고 있다 아무것도 할 수 없는 대통령인 것을 거듭 증명하고 있다 더불어민주당은 총리인선을 비롯한 오늘의 청와대발 인사를 절대 받아들일 수 없다 국민은 드러나고 있는 박근혜 최순실 게이트의 실체에 연일 충격에 충격을 거듭하고 있다 오늘의 인사는 국민에 대한 폭력이다 누구도 납득하지 않는다 최순실표 예산은 없다 는 유일호 경제부총리 유일호 경제부총리가 최순실표 예산은 없다고 했다 이전부터 추진되거나 계획된 사업이 있을 뿐이라고 했다 그러나 이미 내년도 정부예산안 곳곳에 빼곡하게 숨겨진 최순실표 예산이 드러나고 있다 어제 국회 교문위 예산심의 과정에서 조윤선 문체부 장관은 최순실과 차은택이 개입한 문제 사업들을 정리하겠다며 최순실표 예산이 존재해 왔음을 스스로 시인했다 또한 유일호 경제부총리가 말한 이전부터 추진되거나 계획된 사업 상당수가 최순실의 주머니를 채우기 위해 추진되고 계획된 것을 국감을 통해 확인했다 민생경제는 하루가 다르게 파탄으로 치닫고 있지만 정부 예산은 국정을 농단한 비선실세의 주머니로 흘러들어갔다 이러한 불편한 진실을 외면하는 것은 곧 민생을 외면하는 것이라는 것을 이제는 아시기 바란다 한일군사정보보호협정 추진 즉각 중단하라 한일군사정보보호협정 추진을 즉각 중단하라 박근혜 정권에게는 한일군사정보보호협정과 같이 민감하고 중대한 외교안보 사안을 다룰 권한과 자격이 없다 군사대국이라는 일본의 야욕을 채우기 위한 협정을 밀어붙여야 할 명분도 없다 정치적 혼란을 틈타 이미 부결된 한일군사정보보호협정을 졸속 추진하는 배경에는 최순실의 관여가 있다는 의혹까지 나오고 있다 국민이 허락하지 않을 협정이다 이제는 만행을 멈추라 박근혜 대통령보다 청와대가 편했던 최순실 청와대의 기강 되돌릴 수 없어 청와대 행정관의 융숭한 호위아래 최순실이 청와대를 드나들었다는 정황이 속속들이 밝혀지고 있다 어제 이철성 경찰청장은 최순실의 청와대 출입 가능성에 대해 청와대 공관차량은 검문을 안 한다 고 말해 최순실의 출입이 자유로울 수 있었음을 인정했다 또한 최순실의 출입을 제지한 일부 경찰은 인사 조치를 당했다는 의혹도 있다 이뿐만이 아니다 최순실의 조카는 물론 조카의 친구까지 국정에 개입했다는 의혹과 함께 최순실의 사돈은 청와대 행정관으로 들어가 근무한 것으로 나타났다 이쯤되면 박근혜 대통령보다 최순실이 더 청와대를 편안하게 여길 수밖에 없었을 것이다 이런 일을 막고 이런 일이 발생하지 않도록 하기 위해 대통령 비서실과 경호실이 존재하는 것이다 최순실 글자 앞에 무너진 청와대의 기강은 사실상 되돌리기 힘든 상황이다 잘못에 동참하는 것만이 정권의 부역자가 아니다 잘못을 눈감고 모른 척 한 것 역시 부역자이다 부역자들의 부인과 변명 결국 박근혜 게이트의 끝은 박근혜 대통령이다 박근혜 게이트가 접입가경이다 대통령 아래서 이권다툼과 재벌 갈취로 아귀다툼을 보인 최순실 안종범 등 부역자들이 일제히 혐의를 부인하고 나섰다 최순실은 내가 무슨 실세냐 며 검찰을 다그쳤고 안종범은 박근혜 대통령과 최순실의 직거래가 있었고 나는 대통령이 시킨대로 했다 며 자신은 작은 꼬리에 불과함을 강조했다 온 종일 계속되는 청와대발 막장드라마의 결말은 결국 박근혜 대통령을 향할 수밖에 없다 최순실은 안했고 안종범은 시켜서 했다면 대통령은 무엇을 이유로 국민 앞에 사과를 하고 어떤 연유로 청와대 수석들에게 사표를 받은 것인가 한 자리대 지지율과 과반을 넘어선 국민의 하야요구가 진정 두렵지 않은가 아직도 이번 일을 단순한 해프닝으로 가볍게 생각하는 박근혜 대통령의 비현실적인 현실인식이 애처롭다 검찰은 애써 대통령은 수사대상이 아니라고 항변하지만 이미 청와대에 대한 영장을 발부한 바 있다 검찰의 대통령 감싸기는 박근혜 대통령 스스로 풀어내야 한다 박근혜 대통령은 지금이라도 자신을 조사하라고 선언해야 한다 그것만이 박근혜 대통령에게 남은 마지막 묘책이다 사과영상 녹화한 대통령 최순실 진술녹화 꺼버린 검찰 지난 월 일 국민을 가장 공분케 한 것은 분짜리 녹화된 대통령의 사과영상이었다 국민에 대한 최소한의 예의와 일말의 양심조차 찾아볼 수 없었던 뻔뻔하게 녹화된 사과영상을 지켜본 국민들은 최순실이 써주지 않으면 코치해주지 않으면 사과도 제대로 못하냐며 성의 없는 대통령을 비난했다 청와대는 대국민사과를 녹화했지만 검찰은 최순실 진술녹화를 꺼버렸다 어제 언론보도에 따르면 검찰은 최순실의 검찰조사 진술녹화를 하지 않았다고 한다 최순실의 입국경위도 모르고 있다가 몸이 안 좋다고 하니 하루의 말미를 준 것도 모자라 맛있는 설렁탕을 대접한 검찰이 카메라까지 꺼줬다 국민들의 크나큰 분노로 대통령의 하야와 탄핵을 주장하는 사건에 있어 조사과정을 녹화할 카메라를 꺼버린 검찰의 사려 깊은 배려에 범인들은 탄복할 것이다 국민들은 한탄할 것이다 검찰의 무능하고 무책임한 조사야 말로 특검의 필요성과 국정조사의 당위성을 그대로 보여주는 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58816,2016-11-02, 박경미 대변인 오전 현안 브리핑 일시 장소 국회 정론관 불통의 극치인 급작스런 개각 오늘 청와대가 단행한 개각은 지지율이 한 자리수로 곤두박질 쳐진 박근혜 대통령의 머릿속이 온통 국면 전환용 이슈 찾기로 꽉 차 있음을 보여준다 대통령의 동떨어진 현실 인식과 여전한 불통만 재확인한 것이다 경제부총리로 내정한 임종룡 금융위원장은 박근혜 정부의 경제 컨트롤타워 붕괴에 한 축을 담당한 인물이다 이런 인물로 비상경제상황을 돌파하겠다는 것은 언어도단이다 또 검찰의 중립성 검찰수사의 엄정함에 대한 불신과 우려가 높은데 법무부장관은 제외된 이유를 납득할 수 없다 더욱이 현 내각에는 최순실 부역자로 의심받는 인물들이 많은데 그들은 또 어찌할 것인가 최순실과의 고리는 결코 끊을 수 없는 것인지 한탄스럽다 이런 개각으로는 전대미문의 국정농단 게이트에 분노한 국민을 달래고 무너진 국가 컨트롤타워를 복구한다는 것은 불가능하다 뿐만 아니라 이건 거국내각도 아니고 중립내각도 아니다 국민들의 의견을 널리 구하고 야당과 협의하지 않았다는 면에서 거국내각도 아니고 대통령이 당적을 유지하고 있는 한 중립내각도 아닌 것이다 최순실의 귀국 후 바로 신병을 확보하지 않고 시간의 여유를 준 이유가 개각을 상의하려고 했던 것인지 대통령에게 묻고 싶다 박근혜 대통령의 직거래 의혹 직접적인 조사 없이는 진실을 밝힐 수 없다 안종범 전 청와대 정책조정수석이 모든 일은 대통령 지시를 받아 한 것이며 최순실씨와 박근혜 대통령의 사이에 직거래 가 있었던 것으로 안다 고 말했다고 한다 이는 이승철 전경련 부회장이 최근 검찰 조사에서 미르 스포츠재단 설립과 모금을 안종범 전 수석이 지시했다 고 진술한 것과도 궤를 같이 한다 전경련은 안종범 전 수석이 시켰다고 하고 안종범 전 수석은 박근혜 대통령이 종용했다고 하니 그 배후는 삼척동자도 알 것이다 심지어는 박근혜 대통령이 해외순방 중에도 미르 스포츠재단의 인사와 운영을 손수 챙길 정도로 깊숙이 개입했다는 증언까지 나왔다 이로서 최순실 게이트 가 아니라 박근혜 최순실 게이트 라는 게 확실해졌다 의혹의 꺼풀이 하나둘씩 벗겨질수록 게이트의 진원지는 박근혜 대통령이라는 점이 자명해지고 있다 이제는 박근혜 대통령을 빼고는 진실을 밝힐 수 없다 박근혜 대통령까지 포함하는 성역 없는 특검은 이제 선택이 아닌 필수다 박근혜 대통령은 지금이라도 안종범 전 수석이 밝힌 직거래 의혹 을 비롯해 자신을 둘러싼 모든 혐의에 대해 고백해야 한다 더 나락으로 떨어지기 전에 진실을 밝히고 용서를 구하는 것이 그나마 국민에게 용서받을 수 있는 길이라는 것을 명심해야 할 것이다 더불어민주당은 별도의 특별법에 의한 특검과 국정조사 청문회 등 모든 수단과 방법을 동원해서 국민 앞에 실체적 진실을 낱낱이 밝혀낼 것이다 최고위원회의 결과 당 국정자문회의를 외교안보통일 자문회의와 국가경제 자문회의로 이원화한데 이어 외교안보통일 국정자문회의 의장에 이해찬 전 총리를 선임했다 이해찬 의장은 참여정부에서 국무총리를 역임하신 분으로 외교 안보 통일 정책에서 우리당의 수권능력을 일신하는데 크게 기여해주실 것으로 기대하고 있다 이해찬 의장은 경제부총리를 지낸 김진표 비상경제대책특별위원장과 함께 외교 안보 통일 분야와 경제 분야에서 각각 당의 중심을 잡아줄 것이다 또한 정책엑스포추진위원장에 김부겸 의원 참좋은지방정부위원장에 안희정 충남도지사를 선임한 바 있다 우리당의 대권주자들이 당이 수권정당으로 혁신하고 변화하는데 크게 기여해주실 것으로 확신한다 우리당은 오늘 홈페이지에 박근혜 최순실게이트 신고센터를 개설했다 새누리당과 정부 청와대 등 박근혜 최순실 게이트와 연루된 인사 및 사건을 신고해주실 것을 국민들께 당부드린다 신고된 내용은 박근혜 최순실 게이트 국민진상조사위원회로 취합하여 검토 대응할 것이다 더불어민주당은 국민과 함께 진실을 밝히고 대한민국을 바로 세울 것임을 다시 한 번 밝힌다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58815,2016-11-02, 제 차 비상 의원총회 모두발언 일시 수 오전 장소 국회 본청 예결위회의장 추미애 대표 정국이 풀려야 하는데 더 꽉 막혀가는 것 같다 의원 여러분의 마음이 착잡하실 것이다 방금 뉴스에 대통령이 국정공백의 진공상태를 만들어놓고 또 쪽지를 내려 보내서 총리 인사를 발표했다 대통령이 아직도 정신을 못 차렸다는 느낌이 드는 순간이다 최순실 내각을 정리하라고 했더니 제 차 최순실 내각을 만든 느낌이다 대한민국의 법치와 정의를 무너뜨리고 헌정질서를 혼돈의 도가니에 밀어 넣은 장본인인 대통령께서 최근에 하신 일은 겨우 최순실은 선거 때 홍보물을 만져주고 연설문을 다듬어준 아는 사이 라는 내용의 초짜리 사과가 한 번 있었을 뿐이다 그 뒤에 한 일은 며칠 전에 정치검찰의 대명사인 최재경 민정수석을 임명한 것이다 이것은 엄청난 의미를 내포하고 있다 검찰을 여전히 손아귀에 쥐고 놓지 않겠다 최순실을 사수하라는 의미였던 것이다 오늘 한 일은 그 코드에 맞춰서 총리를 즉각 임명한 것이다 어제까지 부역당의 대표와 원내대표가 거국내각 쇼를 벌이다가 안 되니까 오늘 총리를 임명했다 그 쇼도 사실은 이런 일을 하려고 짜 맞춘 시나리오와 각본이 있었던 것이다 최순실 내각을 정리하기는커녕 제 차 최순실 내각의 총리를 전격 임명했다 이것은 아직도 정신 못 차린 대통령을 의미하는 것이고 우리가 더욱더 철저한 진상규명을 요구하면서 국민과 함께 싸워야 될 시간이 멀고도 험난하다는 것을 의미하는 것이다 어제 국민과 함께하겠다고 말씀드렸다 대통령은 어제 처음 일성을 내보냈다 나보고 사교를 믿는다고 하더라구요 라고 했다 대통령이 개인을 향한 말시비나 신경 쓸 국정상태인가 새누리당의 친박 대표인물은 국민께 불쌍한 대통령을 위해서 기도해달라는 호소문을 내려 보냈다고 한다 누가 누구를 걱정해야하는가 대통령이 국민을 걱정해야 되고 자신이 혼란에 빠뜨린 국가를 걱정해야하거늘 날아오는 말을 붙잡고 거꾸로 시비를 걸고 대통령을 위해서 기도해달라는 어처구니없는 정신 빠진 집권당을 보면서 이 사람들은 처음부터 이 사태를 엄중하게 인식조차 하지 못하는 집단이라는 생각이 드셨을 것이다 이것은 정국수습이 아니라 정국을 더욱 엉망진창으로 만드는 길이기에 우리는 다시 한 번 원점에서 생각할 때가 왔다 이 엄중한 상황에 대해서 의원 여러분의 고견을 듣겠다 우상호 원내대표 오늘 시 반에 박근혜 대통령이 국무총리에 김병준 경제부총리에 임종룡 국민안전처 장관에 박승주 전 여가부 차관을 지명하고 발표했다 이제 모든 상황이 분명해졌다 박근혜 대통령은 국민의 민심을 거스르고 자기만의 방식으로 정국을 돌파하겠다고 결심한 것이다 야권과 머리를 맞대고 협의하고 성난 민심을 달래기보다는 내 방식으로 이 정국을 돌파하겠다고 결심한 것이다 그 방식이 매우 졸렬했다 여당 원내대표를 앞장세워서 거국내각을 제안하는 모양새를 취하는 척 하면서 과거 야권에 몸담았던 인사를 내세우면 야당이 꼼짝 못할 것이라는 꼼수와 야당을 들러리 세워서 거국내각이라는 모양새를 갖추며 사실은 자기 식의 내각 개편을 통해서 정국을 돌파하려고 했던 것이다 더불어민주당은 바보가 아니다 그런 의도를 모두 꿰뚫고 지금까지 대통령에 대한 조사를 요구하고 더 큰 진상규명을 요구하면서 여기까지 싸워왔던 것이다 박근혜 대통령에게 경고한다 이런 방식과 꼼수로 성난 민심을 잠재울 수 있다고 생각하는가 야당의 협조를 받을 수 있다고 생각하는가 틀렸다 이런 방식으로는 엄청난 권력 게이트에 묶여서 국정동력이 상실된 이 정권이 살아날 수 없다 국민이 용서하지 않을 것이다 이렇게 상황을 안이하게 바라보고 오로지 자신의 국정 주도권만을 걱정하는 저 독선적인 대통령에게 절망을 느낀다 앞으로 박근혜 대통령은 더 큰 시련에 맞닥뜨리게 될 것이라는 점을 경고한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58814,2016-11-02, 제 차 최고위원회의 모두발언 일시 수 장소 국회 본청 당대표 회의실 추미애 대표 현재는 국가 위기가 아니라 무능 부패 정권과 부역 정당 시녀 정당의 위기이다 자고나면 늘 경악을 금할 수가 없다 최순실 가족 일당이 나라 돈을 자기 집 곳간 다루듯이 한 사실이 속속 드러나기 때문이다 조카도 또 등장했다 최순실의 조카가 동계스포츠영재센터를 만들어서 이미 수억 원의 정부예산을 챙겼다 이들 가족이 무려 조원에 달하는 평창올림픽의 이권에 개입하려 했다는 것이다 최순실씨가 전경련을 이용해 대기업의 손목을 비틀어 갈취한 억 원은 새 발의 피가 돼버렸다 박근혜 최순실 게이트와 관련해서 전경련 이승철 부회장도 청와대가 지시해 미르 스포츠재단의 자금을 모았다고 실토했다 이를 지시한 안종범 전 수석도 오늘 검찰의 출석해서 이제 사실이 밝혀지는 것은 시간문제가 됐다 그동안 유일호 경제부총리는 최순실 예산이 없다고 발뺌해왔지만 드러난 것만 수천억 원이다 앞으로 얼마가 더 나올지는 알 수 없다 대통령이 보이지 않는다 이렇게 국정을 진흙탕에 빠뜨려 놓고 국정 진공상태를 만들어놓고 대통령이 어제 겨우 하신 말씀은 나보고 사교를 믿는다는 이야기가 있다 며 섭섭해 했다고 한다 또 대통령을 통해 호가호위한 친박 의원은 안타까운 대통령을 위해서 기도를 해 달라 고 어처구니없는 말을 했다 대통령이 기껏 하신다는 말씀이 당신의 비위를 상하게 하는 말에 반응하는 것이고 또 대한민국이 이렇게 진공상태에 빠졌는데 대통령을 위해 기도해달라는 것은 이 얼마나 상황을 모르는 되도 않는 말인가 저는 야당 대표로서 많이 절제하고 있다 헌법과 법률의 질서를 존중하고 싶기 때문이다 국민감정은 대통령 하야 탄핵이 절반가량 되지만 민주주의를 지켜온 제 당 대표로서 지극히 절제하고 있다고 말씀드린다 결자해지 하는 자세를 대통령이 보여야 할 것이다 그럼에도 대통령은 당신의 비위를 상하게 하는 말에나 날을 세우고 또 새누리당은 스스로 석고대죄를 하기는커녕 적반하장에 여념이 없다 대통령이 먼저 내려놓은 다음에 거국중립내각을 이야기한다면 이에 상의할 수 있다는 야당의 유력후보를 향해 마치 대통령이 다 된 것처럼 착각하고 있다 는 등의 남 탓만 한다면 우리는 다시 생각할 수밖에 없다 국정 공백을 메우고 무너진 법치와 나라의 정의를 바로세우기 위해서 야당도 어떤 방법을 찾는 것이 더 나은 방법인지 고민하고 있다 우리 야당은 선거만 생각하는 잿밥만 생각하는 그런 당이 아니다 헝클어진 난국에 국민이 기댈 곳이 어디 있겠는가 총선 민의에 따라 제 당으로 만들어준 더불어민주당에 국민이 시선을 주고 있다는 것을 너무나 잘 알고 있다 그렇기에 대통령이 먼저 스스로 이 문제를 풀어야겠다는 결자해지의 마음을 가져야한다는 것을 촉구한다 진상규명이 제대로 될 수 있도록 대통령이 나부터 조사하라 수사에 성역은 없다 고 먼저 선언해야 하는 것이다 그런 다음 국정이 국회에서 제대로 논의되고 새 출발을 할 수 있도록 대통령이 먼저 언급을 해야 하는 것이다 스스로의 거취부터 밝혀야 한다 대통령이 숨는다고 일이 해결되는 것이 아니다 국정을 볼모로 삼지 말라 제일 먼저 한 일이 힘센 정치검사를 민정수석으로 불러 앉혀놓고 검찰수사를 좌지우지 하겠다는 발상이라면 민심을 잘못 읽는 것이고 문제를 거꾸로 푸는 것이다 그 인화력이 어디로 튈지 우리도 겁이 난다 법률과 헌법에 따라 질서 있게 국정이 운영될 수 있는 첫 단초는 대통령의 자세에 달려있다는 것을 다시 한 번 말씀드린다 우상호 원내대표 대통령께서 이 게이트의 사실관계를 일부 인정하고 사죄한지 일주일이 지났다 처음에는 경황이 없어서 그러려니 이해했지만 일주일이 지나도록 대통령의 추가 입장 표명이 전혀 없다 국민을 향한 진실한 고백도 사죄도 없고 또 이 시국을 어떻게 수습할 것인지에 대한 방안도 일체 제시한바가 없다 기본적인 방향이라도 흘러나오는 것이 없다 오직 민정수석 한명을 임명한 것 이외에 우리가 알 수 있는 방향이 없다 그래서 국정이 표류하고 정치가 더 혼란스럽다 이런저런 논의는 정치권에서만 무성하다 청와대가 어떤 생각을 갖고 있는지 알 길이 없다 저는 이것이 대한민국이 멈춰선 핵심 이유라고 생각한다 일주일 지난 지금 저는 점점 판단을 내리고 있다 박근혜 대통령은 죽지 않았다 시간을 끌면서 이 상황 모면한 후에 국정 주도권을 다시 쥐기 위한 방안을 모색하고 있는 것이 틀림없다 따라서 이 시점에 박근혜 대통령이 야당에 대해서 어떤 협조와 협력도 어떤 수습 방향에 대한 의견 제시도 요청하지 않은 상황에서 야당만 거국 내각을 어떻게 할 것인지 책임총리를 어떻게 할 것인지에 대한 논의를 할 때가 아니라고 생각한다 떡줄 사람은 생각도 안하는데 야당 구성원들이 이런저런 고민 빠져있는 모습 물론 국가를 생각해서 앞서서 고민하는 모습은 바람직하지만 박근혜 대통령의 노림수가 아직 끝나지 않았다고 생각하기 때문에 조금 더 지혜롭게 대응할 필요가 있다고 생각한다 한편으로 국정이 점점 멈춰서는 이 시점에서 야당이라도 제대로 민생을 챙겨야 되겠다고 생각한다 어제 정책위의장들끼리 이런저런 현안들에 대한 논의를 하셨다고 들었다 앞으로 구조조정 문제 민생 안정과 관련된 각종 문제 가계부채 문제 물가 문제 등 다양한 민생 현안들에 대해서 보도가 되던 보도가 되지 않던 당 차원에서 함께 챙겨가도록 노력하겠다고 국민께 보고드린다 최순실씨가 신병확보된 이후 수사가 급물살을 타고 있지만 한 가지 문제를 더 제기하려한다 차은택씨는 왜 풀어놓는가 왜 차은택씨의 신병은 확보를 안 하는가 도대체 이 나라 검찰은 야당이 신병확보하라고 일주일을 떠들어야 겨우 사람 데려오고 데려와도 공항에서 풀어놓고 입 맞출 시간을 주고 있지 않나 차은택씨는 불과 며칠전만해도 중국 산둥성 연태 지역에 머무르고 있었다 저도 어디 있는지 알고 있는데 검찰과 국정원이 모른단 말인가 왜 차은택씨의 신병확보를 안하는가 차은택씨는 범죄의 하수인으로 너무 많은 증거와 너무 많은 증언이 있기 때문에 추가 조사할 것도 없이 데리고 오면 된다 이 사람이 중국에 머물면서 지인들에게 문자 보내고 전화해서 이것저것 입 맞추고 있다는 정황이 계속 드러나고 있는데 언제까지 입 맞추고 증거를 인멸하도록 방치할 것인가 즉각 신병확보에 나서기 바란다 결국 이 범죄의 모든 끝은 돈 문제이다 대기업의 돈을 강제모금하고 또 별도로 기업들을 쳐서 이런저런 프로젝트를 후원하도록 만들고 그 과정에서 이권 사업에 개입해 자기 것을 챙기고 리베이트가 오간 것이다 결국은 돈이 오고 간 추악한 말로를 정리하는 것이다 이 문제에 대해서도 신속한 수사를 통해서 그 전모 밝혀주시기 바란다 그러나 검찰이 아무리 수사를 열심히 한다고 하더라도 범죄 혐의와 관련된 사실만 공표하게 되어있기 때문에 국민들이 궁금해 하는 이 사건의 전모를 파악하기 위해서는 국정조사를 해야 한다고 생각한다 새누리당은 지금이라도 즉각 국정조사에 합의해서 국민적 관심사에 부응해야 할 것이다 만약 국정조사를 거부한다면 그것은 지난 국정감사 때 미르 스포츠 재단의 증인 채택을 방해한 것처럼 진실을 밝히는 것을 방해하고 범죄 사실을 비호하는 행태로 규정하려 한다 즉각적으로 협의에 나서주실 것을 부탁드린다 김영주 최고위원 박근혜 최순실 게이트의 수습 공작 을 주도하고 있는 인물로 두 분이 언급되고 있다 그 중 한 분은 검찰수사 대상에 추가되어야 할 가능성이 크다 바로 최경환 의원이다 한가하게 박근혜 최순실 게이트를 수습하고 있을 처지가 아닌 것 같다 박 대통령은 지난달 일 수석비서관회의에서 미르 스포츠 재단의 설립경과를 설명하면서 이런 발언을 했다 지난해 월 창조경제혁신센터 지원 기업 대표들을 초청한 행사에서 일자리와 부가가치를 창출하는 핵심이 바로 문화콘텐츠라는 인식을 바탕으로 창조경제와 문화융성의 융 복합 필요성에 대해 논의 했다고 분명히 얘기했다 대통령이 지목한 청와대 행사는 지난해 월 일에 열렸다 그런데 이 날 청와대 행사 이후 열린 오찬 자리에는 이례적으로 청와대 수석이나 대변인 각 부처 장관은 배제됐다 오직 대통령과 최경환 당시 경제부총리 그리고 기업총수들만 참석해 무려 시간 분 동안 비공개로 오찬이 진행됐다 당시 유일하게 이날의 비공개 오찬을 보도한 언론에 따르면 대통령은 기업을 하나하나 호명해 관심을 갖고 깨알 당부 를 했다 기업들로서는 상당한 책임감을 느낄 수밖에 없는 분위기였다 고 했다 대통령이 직접 두 재단의 설립배경으로 지난해 월 청와대 행사를 지목했고 당시 이례적으로 긴 오찬 시간과 더불어 오찬에 참석한 기업인사가 전한 행사 분위기를 볼 때 두 재단 잉태의 몸통은 바로 박 대통령과 최경환 의원일 가능성이 있다 대화 내용이 외부로 새어 나가지 않도록 청와대 수석과 장관도 물리고 오직 최경환 의원만 참석시킨 채 대통령이 도대체 어떤 말을 하셨기에 기업들이 순식간에 억 원 가까운 돈을 내게 되었는지 대통령과 최경환 의원은 국민들께 자백해야 한다 국민들은 친박 실세 최경환 의원이 두 재단의 설립과 불법적인 모금에 관여한 것은 아닌지 의심하지 않을 수 없다 따라서 오늘 피의자 신분으로 검찰에 출석하는 안종범 수석 못지않게 박근혜 최순실 게이트에 연루된 정황이 있는 최 의원도 마땅히 검찰의 수사 대상이 되어야 한다 물론 이러한 의혹에 대해 최경환 의원은 부인하겠지만 안종범 당시 경제수석이 집중하던 일을 최경환 당시 경제부총리가 전혀 몰랐다는 것도 상식적으로 말이 안 된다 경제수석과 경제부총리는 수시로 업무협의를 하는 위치 아닌가 최경환 의원은 이제 박근혜 최순실 게이트에서 자유로울 수 없다 대통령과 최경환 의원은 이제라도 진실을 밝혀야 한다 간단히 한 가지 더 지적하겠다 비서실장 정무수석 임명은 제쳐두고 유독 민정수석만 황급히 임명한 배경은 이 상황에서도 청와대가 검찰수사를 지휘하고 보고를 받기 위함이다 민정수석은 공석으로 두는 것이 성역 없는 검찰수사를 담보하는 첫 단추이다 검찰 출신 민정수석이 있는 한 국민들은 검찰수사를 신뢰하지 않을 것이다 전해철 최고위원 현직 대통령이 직접적으로 개입된 박근혜 최순실 게이트는 우리 헌정역사상 전대미문의 사건이고 국가 운영이 붕괴된 초유의 사태이다 오늘 언론보도에 의하면 안종범 전 수석이 대통령의 지시에 따라서 미르 재단 스포츠 재단 일을 했다는 보도가 있었다 대통령의 구체적인 관여 정도가 나타나고 있다 이제 국민들은 그 실체를 정확히 알고 싶다 또한 이에 응해야할 의무가 대통령과 관련자들에게 있다 그래서 더불어민주당은 진상규명을 강하게 요구하고 있다 하지만 현재 수사를 맡고 있는 검찰의 행태를 보면 이런 국민들의 바람과는 차이가 많다 검찰은 고발 이후 일 동안 거의 아무런 조치를 취하지 않았다 형사 부에 배정해서 형식적인 수사만 하다가 대통령의 사과 이후에 비로소 수사에 착수하여 수사시기를 이미 놓쳤다 언론도 찾아낸 최순실씨에 대한 송환은커녕 소재 파악도 못하고 있다가 최순실씨가 귀국한 이후에는 신병확보를 유보하고 시간의 여유를 줬다 청와대에 대한 압수수색 역시 형식적으로 했다 이렇게 검찰이 부실한 수사를 하고 있는 동안 박근혜 대통령은 수사에 협조하거나 진상규명에 적극 나서지 않고 오히려 수사에 개입하여 진상규명을 방해하는 의도를 보였다 그 의도가 보인 첫 번째 일은 바로 최재경 민정수석의 임명이다 최재경 수석은 주가 조작 사건 무혐의 결정 내곡동 사저 땅 헐값 매입에 대한 무혐의 결정 총리실 민간인 불법 사찰에 대한 면죄부 수사 등 그동안 중수부장 등으로 근무하면서 전혀 공정한 모습을 보이지 않았다 이런 인사를 민정수석에 임명한 것은 검찰에 대한 통제권을 놓지 않고 박근혜 대통령 자신을 수사 대상에서 제외시키겠다는 의지의 표현으로 보인다 또한 민정수석보다 당연히 비서실장 먼저 인선해야함에도 비서실장은 인선하지 않고 민정수석을 먼저 임명한 것 역시 다급한 수사에 대한 대처라고 생각한다 그 과정에서 김기춘 전 실장이 민정수석 임명에 관여했다는 이야기도 있다 사실이라면 아주 적절하지 않다 결국은 어제 야 당이 합의했던 특별법에 의한 특검을 조속히 실시하는 것만이 진상규명의 지름길이라고 생각한다 새누리당은 이러저러한 근거 없는 핑계를 댈 것이 아니라 특별법에 의한 특검을 즉시 합의하고 실시하도록 협조해야할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58797,2016-11-02, 윤관석 수석대변인 청와대 내각 인사 발표 관련 브리핑 일시 오전 시 분 장소 국회 정론관 청와대 내각 인사 발표 청와대가 조금 전 국무총리 경제부총리 국가안전처장관 내정자를 발표했다 그 면면을 보면 국민의 목소리를 완전히 외면하고 오로지 국면전환과 국정주도권 확보만을 노린 개각으로 볼 수밖에 없다 이런 꼼수개각 또 다른 최순실표 개각으로 전대미문의 국정농단 박근혜 최순실 게이트 에 분노한 국민을 달래고 야당의 협조로 무너진 국가 컨트롤타워를 복구한다는 것은 불가능하다 우리당은 박근혜 대통령의 시국인식에 아직도 커다란 문제가 있다는 것을 확인했다 현실과 너무나도 동떨어졌다 이것이 현재 국정 상황에 대한 대통령으로서의 내각 인사인지 의심이 간다 국민은 박근혜 최순실 게이트로 망연자실하고 있는데 대통령은 천하태평인가 보다 국민들이 하야와 탄핵을 외치는 분노의 물결이 전국을 뒤덮는데 대통령은 국정농단을 해왔던 내각인사들을 그대로 놔두고 최순실 차 내각으로 또 다른 국민농단 개각을 했다 또한 야당과 협의가 전혀 없었다 따라서 거국내각이라고 포장하는 것은 포장지도 내용물도 전혀 사실과 다르다 지금 대통령이 답해야할 것은 나부터 조사하라는 성역없는 수사 공개 선언이다 또 국정 수행이 어려우니 국정 공백이 없게 국민과 국회 야당이 협의해서 새로운 국정 중심을 세워달라고 모든 것을 내려놓고 진솔하게 비상수습책을 협의하는 것이다 하지만 대통령은 초짜리 변명성 사과에 이어서 민정수석부터 임명하는 검찰 장악 비선컨트롤 타워를 통한 국정장악을 발표했다 그리고 오늘 드디어 거국내각과 전혀 상관없는 꼼수 내각 차 최순실 내각을 발표했다 기존 내각 중에서도 검찰수사에 대한 책임이 있는 법무부장관이 제외된 것을 국민은 납득하기 어려울 것이다 법치를 실종시킨 장본인이다 그 외에도 최순실표 내각으로 이미 많은 사실이 드러난 책임자들에 대해서도 전혀 조치하지 않았다 오늘 대통령의 나 홀로 국정운영 정면 돌파 의지를 밝힌 내각발표는 국민들의 분노와 더 큰 저항을 불러일으킬 것을 강력히 경고한다 야당은 사전 협의도 전혀 없이 그동안 문제시 되어왔던 최순실표 부역내각 책임자들을 그대로 두고 발표한 오늘 개각 발표를 수용할 수 없다는 점을 명확히 밝힌다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58789,2016-11-01, 박경미 대변인 오후 현안 브리핑 일시 시 분 장소 정론관 최순실 부역자들 정말 책임감 느낀다면 책임지는 모습 보여라 오늘 국회 교문위 전체회의에서 이준식 교육부장관과 조윤선 문화체육관광부 장관이 정유라 특혜의혹 미르 스포츠재단 의혹과 관련해 사과했다 그러나 이들의 사과에서 일말의 책임감도 느껴지지 않는다 자신은 무관하다는 듯 모호한 책임만 인정하고 몇 마디 사과로 때우겠다는 두 장관의 태도는 실망스럽다 못해 가증스럽다 이준식 장관은 이화여대 특별감사를 엄정하게 하겠다고 밝혔다 그러면 그동안은 무엇을 했단 말인가 조윤선 장관은 시정하고 새 출발하는 계기로 삼겠다고 했으나 향후 행보는 두고 볼 일이다 지난 국감에서 교문위 새누리당 간사인 염동열 의원은 야당의 증인 채택 요구를 국감 보이콧과 안건조정위원회 구성 신청 등으로 무산시켰다 이처럼 최순실씨와 관련한 각종 의혹을 온몸으로 막은 새누리당은 비난 받아 마땅하다 일련의 상황에 대해 정부여당은 유체이탈 화법의 사과가 아니라 진정성 있는 공식 사과를 하기 바란다 진정 책임감을 느낀다면 모호한 화법으로 순간을 모면하려 하지 말고 국민이 납득할 수 있도록 분명하게 책임지는 모습을 보이기 바란다 이화여대는 유관순 열사께 부끄럽지 않은가 이화여대 최경희 전 총장의 최측근으로 정유라양을 보필한 신산업융합대학 김경숙 학장의 남편이 최근 한국과학창의재단 이사장 공모에 지원했다 김 학장 남편의 자리를 챙겨주려고 임기가 년 이상 남은 한국과학창의재단 이사장을 찍어낸 것이라는 의혹이 제기되었다 축산식품공학을 전공했지만 승마 전문가이기도 한 김 학장의 남편을 염두에 두고 서울시 승마협회 이사장에게 사퇴를 종용했다는 얘기도 파다했다 이대 신산업융합대학은 박근혜 대통령의 역점사업인 코리아에이드 사업 중 밀 사업 을 미르재단과 함께 추진하기도 했다 이대는 최근 부속유치원을 허물고 그 부지에 스포츠 예술 콤플렉스 를 추진 중인데 가장 넓은 공간을 신산업융합대학이 사용할 예정이라고 한다 최순실 정유라 모녀와 결코 무관해 보이지 않는다 이대는 기독교적 신앙을 바탕으로 여성 고등교육 저변 확대에 기여해 왔다 일제강점기 때는 운동의 상징인 유관순 열사를 위시한 독립운동가들도 많이 배출했던 년 전통의 명문사학이다 국가 지원예산을 타기 위해 유관순 열사를 역사교과서에서 삭제하려는 세력에게 허리를 굽힌 이대 경영진과 교수들은 유관순 열사와 이대 만 졸업생들에게 부끄럽지도 않은가 교육부는 이제서야 이대 특별감사를 시작했지만 감사 대상은 정 씨의 입학 특혜 학사관리 특혜에 한정되어 있다 뒷북감사 반쪽감사가 아닐 수 없다 그동안 국정감사나 언론 등에서 수없이 제기된 이대 교수들에 대한 지원특혜 의혹 정부재정지원 사업에 비선실세가 개입한 의혹도 모두 포함시켜 감사를 철저히 해야 한다 최순실 일당의 마수 평창 동계올림픽을 향하다 최순실 일당의 마수가 어디까지 뻗쳐있는지 가늠하기 어려울 정도이다 최순실씨가 소유한 더블루케이가 억원에 달하는 평창 동계올림픽 오버레이 임시스탠드 및 부속시설 공사 수주에 나선 것으로 확인됐다 더블루케이는 설립 직후에 스위스의 유명 스포츠시설 전문건설회사인 누슬리 와 접촉하여 평창올림픽 시설공사 수주를 위한 협력을 제안했다고 한다 누슬리에 연락을 취한 것은 박헌영 스포츠재단 과장으로 최씨가 가장 신임하고 일을 맡겼던 실무자로 알려졌다 지난 월 누슬리 경영진이 더블루케이와 스포츠재단 관계자들을 만났는데 당시 안종범 경제수석과 김종 문체부 차관도 참석했다고 한다 이처럼 정부 고위 인사가 지원사격하고 박근혜 대통령이 참석한 회의에서까지 관련 내용이 언급됐다는 증언도 나왔다 최씨의 조카인 장시호 씨는 동계스포츠영재센터 를 만들어 국가예산 억 천만 원을 확보했고 강릉 빙상장을 무대로 이권사업을 펼치려 했다는 의혹도 제기되고 있다 이게 국민 세금을 가지고 장난치는 것 아니겠는가 억원 규모의 설악산 오색케이블카 사업도 마찬가지이다 이는 년 이승철 전경련 부회장이 제안하고 김종 차관이 행정적으로 지원하는 양상이었다 이처럼 박근혜 최순실 게이트 관련자들이 미르 스포츠재단을 앞세워 문체부를 숙주 삼아 총 조원의 예산이 투입되는 평창 동계올림픽을 이용해서 이권을 챙기려 한 정황이 속속 드러나고 있다 검찰은 최순실 일당의 평창 동계올림픽 농단과 관련된 실체와 전모도 확실히 밝혀내기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58788,2016-11-01, 박근혜 최순실 게이트 진상규명 국민보고대회 모두발언 일시 화 오후 시 장소 국회 의원회관 대회의실 추미애 대표 지금 우리 대한민국 국민은 분노와 불안을 넘어서 참으로 부끄럽다 국가를 생각하는 정치인과 정당이라면 정파를 떠나서 참으로 울적하다 지난 몇 년간 국민이 통치 받고 야당이 상대하고 여당이 맹종해온 실체가 사이비 종교 집단이요 국가를 상대로 한 가족 사기단이요 영혼 없는 맹신정치였음이 드러났기 때문이다 민주당은 약속드린다 박근혜 최순실 게이트를 철저히 규명해내겠다 그동안 우리당과 의원들은 누구보다 앞장서 일해왔다 조응천 손혜원 안민석 도종환 박범계 박경미 백혜련 의원 등이 밤새워 자료를 수집하고 발로 뛰면서 제보를 취합해 전방위로 노력해서 진상을 밝혀냈다 그 결과 박근혜 최순실 게이트에 대한 언론보도의 을 우리당 의원들이 해냈다 그럼에도 지금까지 드러난 것은 실체의 도 안 되는 것이다 대한민국의 미래 살 길이라고 큰소리치던 창조경제의 앙꼬를 그들이 다 주물렀다 이번 사건의 주범이자 당 정 청 삼위일체인 박근혜 대통령 최순실 새누리당은 국민을 다시 기만하고 조직적으로 은폐하기로 작정하고 움직이기 시작했다 그래서 여러분이 모인 것이다 우병우가 빠진 자리에 정권 지키기 사건정리 전문가 정치검찰 에이스를 최우선 배치했다 국정을 보좌해야 될 비서실장을 임명하는 것보다 먼저 검찰조사를 보고받고 검찰을 통제할 민정수석을 먼저 임명한 박근혜 대통령이다 이번 사건의 공범 피의자인 박근혜 대통령의 입장에서는 자신의 변호사를 먼저 선임한 것이나 마찬가지인 격이다 국민은 화병이 걸릴 지경인데 대통령의 지위를 이용해서 도대체 이래도 되는 것인가 권력 제 위 최순실은 입국과 검찰 출두 과정에서 일반 범죄자는 꿈도 꾸지 못할 예우와 입 맞추기로 시간을 부여받았고 사건축소절차 쇼를 시작했다 과거 내란죄로 수사 받았던 전두환 노태우의 경우보다 훨씬 더 극진한 예우가 아닌가 대통령이 임명한 총리와 법무부장관은 헌법을 들먹이면서 대통령은 조사대상이 아니라고 한다 헌법은 대통령이 현직에 있는 동안은 형법상 소추의 대상이 아니라고 했을 뿐이다 임기 중에도 행정상 민사상 책임은 져야하는 것이고 임기를 마친 후에는 형법상 소추도 가능한 것이다 그래서 임기 중에도 이 엄중한 사태에 대해서 필요한 조사는 꼭 받아야 한다 최순실의 공범이 조사를 받지 않으면 최순실의 핵심 범죄를 어떻게 조사하고 앞으로 어떻게 공소유지를 할 수 있다는 말인가 새누리당은 무능한 권력을 탄생시키고 지난 몇 년간 국회와 정부에서 최순실에게 부역하고 은폐해왔다 그런데 지금 새누리당은 책임을 회피하기 위해서 입이 달린 분은 누구나 나는 최순실을 모른다 나는 아니다 라고 발뺌부터 하고 있다 심지어 대통령이 임명하는 특검을 받아라 새누리당과 협력하는 사이비 거국중립내각을 받아라 라고 오히려 큰소리를 떵떵 치고 있다 아직 정신이 제대로 안 돌아온 모양이다 이런 사람들과 제대로 된 특검과 중립내각을 이야기하는 것이 가당하겠는가 새누리당은 먼저 국민 앞에 석고대죄하고 정신부터 차리시라 이런 황당한 검찰 조사는 무의미하기조차 하다 박근혜 대통령은 반드시 조사받아야 한다 대통령 스스로 조사받겠다고 밝혀주시라 총리와 법무부장관을 즉각 해임하라 성역 없는 특검 대통령을 조사할 수 있는 특검 별도의 특별법에 의한 특검과 국정조사를 받아들여라 당 정 청에 깔려있는 최순실 부역자들을 모조리 정리하라 진심어린 사과와 책임자 정리가 박근혜 대통령과 새누리당이 먼저 국민 앞에 해야 할 최소한의 도리가 아니겠는가 민주당은 거리에 나선 국민들의 심정을 충분히 이해한다 분노를 억누르고 계신 국민의 원성에 귀 기울이고 있다 국민이 얼마나 나라 걱정을 하시면서 절제하고 있는지도 잘 알고 있다 그래서 현 상황은 국가의 위기가 아니다 오히려 무능하고 부패한 정권과 시녀정당의 위기이자 그들 스스로 무너진 것이다 현 상황은 국가의 혼란이 아니다 오히려 무능하고 부패한 집단이 자중지란의 혼란에 빠진 것이다 분노한 국민이 문제인 것이 아니라 대통령과 새누리당이 문제인 것이다 나라의 정의를 세우고자 하는 민주 대한민국의 국민은 여전히 건재하다 민주공화국 대한민국의 주권자인 국민 여러분이 계시기 때문에 대한민국도 건재할 수 있는 것이다 민주당은 주권자인 국민의 뜻을 실현하기 위해 모든 일을 다 할 것이다 먼저 진상규명에 총력을 기울이겠다 은폐조작 시도에 맞서 싸우겠다 박근혜 대통령의 법적 정치적 책임을 철저히 묻겠다 국민과 민주당은 모든 애국적 노력과 절제를 깡그리 무시하고 정권과 여당이 반성과 사과는커녕 오히려 정권의 생존과 연장 음모에 나선다면 결단코 용납하지 않을 것이다 더불어민주당의 당대표인 저 추미애는 정치인이기 이전에 대한민국의 헌법과 법률을 수호해 온 법조인의 양심에 따라 행동할 것이다 김대중 노무현 두 대통령을 만들고 그 분들의 유지인 행동하는 양심 과 깨어있는 시민 을 정치의 사명으로 삼아왔던 제 야당으로써 판단하고 행동하자 이번 엄중한 사태에는 국민들의 뜻을 받들어 국민과 함께 하자 민주당은 오늘 이후 자멸의 길을 걷고 있는 정부여당의 행태로 생기는 국정 공백을 빈틈없이 주시하고 대비하기 위해 비상대응 체계를 갖추겠다 박근혜 최순실 게이트 국민조사위원회를 가동하겠다 전국적으로 당원들에게 보고대회도 가지면서 국민들께도 상황을 적극 알려드리겠다 국민여러분 당원여러분 대한민국을 지켜 달라 더불어민주당을 격려해 달라 대한민국의 법치와 정의를 바로 세울 수 있도록 힘을 모으자 우상호 원내대표 사랑하고 존경하는 당원동지 여러분 더불어민주당이 해냈다 권력의 비리를 밝혀냈다 수많은 국회의원들이 밤을 새워가면서 자료를 찾고 제보를 받고 언론이 관심을 기울이지 않던 시절에도 국정감사에서 끊임없이 의혹을 제기해서 결국은 대통령이 무릎을 꿇고 범죄 사실을 시인하고 국민에게 사과하도록 만들었다 더불어민주당이 아니었다면 이 사실은 영원히 역사 속에 묻혔을 것이다 더불어민주당이 해냈다 비록 명을 약간 넘기는 국회의원 숫자였지만 명 명의 몫을 해냈다 그동안 수고하신 우리 당 국회의원들에게 뜨거운 박수를 부탁드린다 그러나 아직 밝혀야 할 진실이 많이 남아있다 증거를 인멸하고 범죄인들이 도피하고 대통령은 모르쇠로 일관해도 아직 밝혀지지 않은 진실을 밝힐 때까지 우리는 다시 또 뛸 것이다 오늘부터 원내지도부 전원이 국회에서 시간 비상체제로 대기하면서 추가적으로 진실을 밝히고 나라를 바로 세울 때까지 최선을 다해서 밤잠을 안자고 노력하겠다고 보고 드린다 지금 우리는 진실을 감추고 은폐하려는 자들과의 투쟁을 하고 있다 모든 언론이 명명백백하게 이 혐의들을 보도하고 있지만 모른다 아니다 라는 부인으로 일관하고 있다 지난 국정감사 때 새누리당 의원들이 하신 행태를 자세히 말씀드리겠다 미르 스포츠재단 핵심관계자들을 국회에 출석시켜서 따져 물으려고 할 때 증인채택을 반대하고 방해했다 우리는 증인들을 제대로 불러 세우지 못했다 지금 그들이 검찰에 출두하고 있다 그들은 다 범죄자들이다 바로 새누리당은 이런 권력형 비리 범죄자들을 비호하고 은폐한 공범들이다 오늘 교육문화위원회에서 새누리당 전 모 의원이 이렇게 이야기했다 우리 당 의원들이 지난번에 최순실 딸의 부정입학 특례와 지도교수 교체 등 학칙개정에 항의하기 위하여 이화여대를 현장 조사했다 수많은 국민들이 분노하고 있는데 오늘 전 모 의원이 우리 당 의원들을 상대로 사과하라고 했다 왜 여야합의 없이 이화여대를 조사했냐는 것이다 제정신이 아닌 것이다 수많은 국민들이 대통령은 하야하라고 하고 탄핵하라고까지 분노하고 있다 그런데 석고대죄해도 모자랄 새누리당 의원이 진실을 파헤친 우리 당 의원들에게 사과하라고 요구하는 적반하장이 새누리당의 지금 모습이다 보수정권 년 만에 나라 경제는 파탄 나고 안보는 위기이다 권력비리집단에게 나라를 송두리째 바친 것이다 이 나라는 국민들의 나라가 아니고 최순실의 나라로 전락했던 것이다 마음 같아서는 하야와 탄핵을 이야기하고 싶지만 야당도 대한민국을 책임져야 되기 때문에 더 큰 혼란이 올까봐 꾹 참고 있다 그러나 진실을 밝히는 일만큼은 참을 수 없다 더불어민주당은 앞으로 당원동지 여러분 국민 여러분과 더불어 진실을 밝히고 이 나라의 민주주의를 바로 세우는데 앞장서겠다 당원동지 여러분께서는 국민들에게 이 사태의 진상과 새누리당의 뻔뻔한 작태를 널리 알려주시고 홍보해 달라 이제 보수에게 나라를 맡길 수 없다 이제는 더불어민주당에게 나라를 맡겨야겠다는 이야기가 나올 때까지 싸우고 행동하고 노력해서 반드시 정권교체를 해내자 끝까지 여러분과 함께 하겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58780,2016-11-01, 제 차 원내대책회의 모두발언 일시 화 장소 국회 원내대표 회의실 우상호 원내대표 더불어민주당은 오늘부터 비상체제로 전환한다 원내지도부는 오늘부터 국회에 시간 상시 대기하면서 박근혜 최순실 게이트에 관한 검찰수사 그리고 국회 대응 방안 등에 대한 일일 점검을 계속해서 해나가겠다 매일 아침 시 분 비상의원총회를 통해서 상황을 공유하고 더불어민주당의 대응방안에 대한 당내 중론을 모으는 일도 진행해나가겠다 또한 오늘 시 당원보고대회를 필두로 해서 전국을 순회하면서 시도당별로 박근혜 최순실 게이트에 대한 당원보고대회를 진행해나갈 계획이다 검찰 수사가 진행되고 있지만 이 문제의 가장 핵심 증인은 사실 박근혜 대통령이다 박근혜 대통령이 최순실씨와 친분이 없었고 최순실씨에게 힘을 실어주지 않았다면 생기지 않았을 사건이다 청와대가 나서서 최순실씨가 원하는 재벌모금을 강요하고 각 부처 인사를 최순실씨가 원하는 방향으로 진행한 일련의 흐름 속에서 당연히 비선 권력이 커나갔던 것이다 따라서 이 문제는 대통령 스스로 국민에게 고백하고 스스로 조사를 받으시는 것이 반드시 필요하다 대통령을 조사하지 않으면 최순실씨를 포함한 각종 피의자들의 범죄가 확정되기 어렵다 그렇게 되면 처벌도 어려워질 가능성이 있다 대통령은 검찰수사가 탄력을 받고 현재 신병을 확보하고 있는 피의자와 앞으로 처벌해야할 대상자들에 대한 범죄행위가 보다 명료해지도록 조사받으시기를 바란다 검찰 수사는 처벌을 목적으로 하기 때문에 국민적 관심사를 다 밝혀낼 수 없다 그동안 많은 언론에서 보도된 내용 또 야당이 파헤쳤던 많은 내용들은 사실 범죄행위가 아닌 의혹들도 꽤 많이 있다 이런 의혹들은 처벌과 별개로 낱낱이 밝혀져서 국민들에게 보고되어야 한다 이것이 바로 국회가 해야 할 일이다 국회에서는 설사 처벌대상이 아니라고 할지라도 국정농단의 전모가 드러나고 국민들이 이해할 수 있는 절차를 거쳐야 한다 이 문제에 대해서는 야 당 원내대표 회동에서 논의해나가겠지만 여당이 협조해야 할 것이다 그런데 어제 국회의장께서 주재하신 여야 당 대표 회담이 시작도 하기 전에 결렬되었다 어제 상황을 보신 분들은 어안이 벙벙했을 것이다 정세균 의장 박지원 대표 그리고 제가 먼저 와서 기다리고 있는데 정진석 대표가 들어와서 포토라인에 서지도 않고 그대로 의자에 앉아서 언론을 상대로 야당에 대한 비난과 비판을 쏟아내고는 그냥 나가버렸다 이게 어찌 박근혜 최순실 게이트를 대하는 집권여당의 태도란 말인가 겸손까지는 바라지도 않는다 사과와 반성을 하고 국민들에게 죄송하다는 말 한마디로 시작해야 하는 것 아닌가 들어오자마자 야당에 대해 심각한 비난의 말을 쏟아놓고 그렇게 나가버리는 태도는 정말 국민들을 실망시키는 태도였다 저는 그동안 가급적 곤란에 빠진 여당에 대한 비난과 비판을 삼갔지만 오늘부터는 이야기를 해야겠다 미르 스포츠재단의 증인 채택을 막은 자들이 누군가 국정감사 증인채택 막은 사람들이 누군가 박근혜 대통령이 아니라 새누리당이다 연설문을 고쳐줬다고 하니까 나도 내 친구들의 조력을 받아 고친다 고 말한 사람이 누군가 집권당 대표 아닌가 비호와 은폐에 협조한 사람들이 지금의 새누리당이 아닌가 뭘 잘했다고 나가고 화를 내고 야당을 비난하는가 거국내각을 제안하시려면 적어도 제 야당 대표에게 사전에 이런 제안을 하려한다고 전화 한통은 있어야 하는 것 아니가 야당의 협조를 받아서 내각을 구성하신다면서요 그렇다면 야당 지도부와 사전에 의논해야 하는 것 아닌가 저는 전화 한통 받은 적이 없다 새누리당이 말하는 거국내각이 무엇인지 잘 모르겠다 어떤 방식으로 어떻게 짜자는 건지 전혀 들은 바가 없다 그런데 들어오자마자 화를 내나 설명을 들으려고 갔는데 설명을 안 하고 화를 내고 나간다 이런 태도로 박근혜 최순실 게이트에 대한 야당의 협조를 받을 수 있다고 생각하나 이런 태도의 변화 없이는 야당이 협조할 수 없다 먼저 새누리당이 그동안 최순실 게이트의 진상이 밝혀지는 것을 막기 위해서 은폐에 협조하고 비호했던 태도부터 국민께 사과하라 윤호중 정책위의장 정부가 어제 조선 및 해운업 경쟁력 강화 방안 이라는 것을 발표했다 그동안 논의해온 구조조정 방안이라고 발표했는데 한마디로 부실 그 자체다 조선 해운산업의 부실 그렇게 만든 산업은행 등 국책은행의 문제점이 무엇인지 또 그것에 대해서 책임지는 자도 없고 책임 있는 해법도 없었다 한마디로 미봉책이고 당장 닥친 위기만 넘기고 보자는 그야말로 생명연장식 단기지원책으로 일관했다 언 발에 오줌 누기였다 무엇보다 잘못된 것은 어려운 것은 남 탓하고 그나마 잘된 것은 자화자찬으로 일관하고 있다는 것이다 조선 해운산업 위기의 원인은 모두 대외여건 때문이고 외부환경 때문이라고 돌리고 있다 그러면서 실제로 구체적인 구조조정 경쟁력 강화의 청사진은 제대로 제시하고 있지 못한 발표였다 정부가 내놓은 경쟁력활성화 방안이라는 것은 기존 정책의 재탕삼탕에 불과했다 조선산업 강화방안만 봐도 이미 조선 사가 자구안으로 제시했던 내용을 그대로 인용하고 있다 지난 개월 동안 억이나 들여서 국제컨설팅회사의 컨설팅 보고서가 나오면 구조조정 방안을 내놓겠다고 이야기했다 그 핑계는 어디로 갔나 실제로 컨설팅보고서는 휴지조각이 된 것이 아닌가 생각한다 해운경쟁력강화 방안도 별다를 바가 없다 지난 년 해운사 구조조정의 시급성을 명분으로 국민의 혈세를 동원했던 선박펀드 조성을 다시 내놓은 것에 불과하다 선박펀드야말로 그동안 한진해운의 예에서 드러나듯이 이익은 사유화하고 손실은 사회하는 잘못된 결과를 낳았다 국민혈세를 구조조정 시행이 아닌 구조조정 연장에 낭비했다는 불명예를 받았던 정책이다 이렇게 낡은 카드를 들고 와서 산업 활성화라는 명분으로 국민의 눈을 다시 한 번 속이고 있는 것이다 선박펀드 조성 등을 통해서 조 이상 선박 발주 등을 포함해서 조원 이상의 국고를 집어넣을 양이면 무엇 때문에 한진해운을 법정 관리시키면서 사실상 폐업과 파산으로 몰아갔는가 대마 죽은 뒤에 뒷북치기 대책이라고 아니할 수 없다 산업은행 혁신안도 역시 재탕과 면피 위주의 대책으로 일관하고 있다 산업은행의 잘못된 구조조정 개입이 왜 일어났는지 산업은행의 지배구조를 바꿀 생각은 하지 않고 산업은행이 지금까지 해왔던 혁신안을 입 아프게 되풀이한 것에 불과하다 이런 이상한 구조조정 대책으로는 조선 해운산업의 정상화와 구조조정은 요원하다 이제라도 정부는 구조조정의 칼자루를 다시 한 번 단단히 잡고 정부의 책임을 완수해야 할 것이다 최순실 사건으로 무너진 국민의 신뢰를 조금이나마 만회하고 경제를 안정시키려면 제대로 된 조선 해운산업 구조조정 방안을 다시 마련하라고 요구한다 서민들이 최후의 보루라고 이야기하는 적금을 깨기 시작했다고 한다 개 시중은행의 통계에 따르면 적금 중도해지 비율이 올해 월까지 를 넘어섰다고 한다 일반적으로 가계가 경제적 어려움을 느끼면 보험을 해약하고 그 다음에 펀드를 해지하고 마지막으로 적금을 해지하는데 이런 상황에 이르게 된 것이다 특히 주요산업이 집중되어있는 영남 지역의 적금 해지율이 높다고 한다 그런가 하면 오늘 통계청은 년 월 산업활동동향을 내 놓는다 생산 소비 투자 등 경제지표가 일제히 전월 대비 감소세를 기록하고 있다 여기에 설상가상으로 최순실 게이트까지 겹치면서 한국경제는 말 그대로 아노미 상태에 빠져있고 경제를 끌어갈 컨트롤 타워가 붕괴되어있는 상태이다 이제 월이면 내년도 경제정책방향을 발표하게 된다 경제정책방향을 만들어나갈 정신이 정부에 있는지 의문이다 경제정책방향의 중심을 잡아줄 컨트롤타워의 재건이 시급하다 지금이라도 경제부총리를 비롯해서 경제 각료들은 다시 한 번 각오를 다지고 서민들의 삶을 보살피는 내년도 경제정책을 세워주기 바란다 홍익표 정책위부의장 정부가 한일군사정보보호협정의 실무 협의를 오늘 시작한다고 한다 지난 월까지만 해도 국방부장관이 부정적이었는데 갑자기 전격적으로 이루어진 것은 무슨 의미인가 이것도 비선실세가 개입했던 것인가 우리가 잘 아는 바와 같이 년 월에 한일군사정보보호협정을 비밀리에 추진하다가 청와대 대외전략비서관과 외교부 담당 국장이 자리에서 물러났다 그 당시와 변한 것이 하나도 없다 이렇게 하려고 일본군 위안부 문제를 졸속으로 처리하고 돈 몇 푼에 그분들을 팔아먹으신 것인가 일본의 식민주의 정책과 전쟁으로 인해서 피해를 입으신 분들께 다시 일본을 전쟁을 하는 나라로 만들어주는 것이 박근혜 정부의 대일본정책인가 한일군사정보보호협정이 이렇게 졸속으로 체결되면 안 된다 이 문제에 사실상 정부의 컨트롤타워가 제대로 작동되지 못한 것이라면 국방부는 해당 상임위를 비롯해서 여야 지도부 및 국회의원들에게 이 문제를 충분히 상의하고 협의해서 추진할 것을 당부한다 동북아를 둘러싼 외교 안보 지형이 대단히 빠르게 변하고 있다 클래퍼 국가정보국 국장이 북한 핵문제를 사실상 해결할 비핵화가 쉽지 않고 북한 핵능력의 제한이 현실적인 목표라고 뉴욕에서 발표했다 미국은 지난 월 일과 일 양일간 쿠알라룸푸르에서 전직 관료들과 북한 외교부 관계자들이 접촉했다 또 금에는 북 일간의 접촉이 마카오에서 있었다 한반도와 북핵 문제를 둘러싼 주변 관련국의 대화와 접촉이 빈번해지고 속도감 있게 진행되고 있다 대한민국은 어디에 있는가 대한민국의 외교는 무엇을 하고 있는가 박근혜 대통령은 한반도 정세의 변화에 대해서 어떤 판단을 가지고 있는가 북핵은 물론 북한문제는 우리에게 가장 중요한 사안이다 이러한 문제를 해결하는 데 있어서 대한민국 외교는 실종됐고 대한민국의 역할은 보이지 않는다 주변국들의 대북정책 한반도 비핵화 정책이 빠르게 변화하고 있다 현재 변화된 상황에 대해서 한국 정부는 그 입장을 빨리 정리해야한다 대통령과 청와대가 제 역할을 못하면 국회와 대화해주기 바란다 외교부장관 국방부장관 청와대 안보실장은 이 문제에 대해서 머리를 맞대고 국회와 협의해줄 것을 다시 한 번 당부 드린다 최근 판문점을 둘러싼 남 북간의 군사적 충돌에 대한 우려가 높아지고 있다 불필요하게 북한군을 자극하는 행태를 군사당국이 해서는 안 된다 이와 마찬가지로 북한은 최근 남한 내의 정세불안을 활용해서 한국의 정치에 개입하려는 시도를 해서는 안 된다 지난 수십년간 남 북한간의 평화와 안정을 유지해왔던 핵심은 상호 내정 불간섭과 상호 체제에 대한 존중이었다 남쪽의 문제는 남쪽의 정치권과 국민이 하겠다 북한은 자신들의 일만 잘 하도록 하시라 내정간섭을 하려는 불순한 시도에 대해서는 단호히 반대한다 김한정 부대표 박근혜 정부의 비선실세 국정농단으로 인해 대통령이 국정을 제대로 운영하기 어려운 상황에 빠졌다 국민의 충격도 바로 이 지점에 있는 것 같다 청와대를 기업으로 치면 부실 불법 경영으로 법정관리상태에 들어간 기업이다 대통령은 부실기업 파탄난 기업의 최고경영자로서 책임을 져야 될 사람이다 그런 대통령에게 부도난 대한민국의 국정 회생을 다시 책임지라고 맡길 수 없다 이것이 국민 대다수의 여론 아닌가 현재 대한민국은 과거 김영삼 정부 말기의 외환위기보다 더 심각한 경제 위기상황을 맞고 있다 년 김영삼 청와대는 국가 경제관리 실패로 대한민국 경제를 부도냈다 닥친 외환위기로 인해 기업들은 파산했고 국민들은 해고됐고 심지어 가정파탄과 자살이 속출하는 악몽과 같은 고통을 겪었다 김대중 정부가 인수한 대한민국은 부도난 대한민국이었다 풍전등화의 경제였다 피와 눈물의 구조조정을 통해 위기를 극복했다 국민이 협조했다 장롱 속 금붙이를 모아서 달러 빚을 갚았다 결국 김대중 정부의 청와대는 경제 파탄을 막아냈고 국민의 협력 속에서 위기를 극복할 수 있었다 그래서 임기 말 안팎의 도전에도 불구하고 국정을 안정적으로 마무리했고 월드컵을 성공시켰고 남북관계도 감히 대한민국을 도발하거나 도전할 수 없는 상황으로 관리했다 대선도 안정적으로 관리했다 일체의 부정선거 청와대의 선거개입논란이 없었다 그런데 년 뒤의 오늘의 대한민국을 보라 박근혜 정부의 청와대는 국정을 부도위기로 몰았다 정치적 외환위기사태의 책임은 박근혜 대통령에게 있다 소비 생산 투자 모든 면에서 우리 경제는 마이너스로 돌아섰다 경기 하강이 더 심해질 것이라는 예고가 있다 이대로 가면 내년이면 가계부채가 조에 달할 전망이다 한마디로 년의 국가부도사태보다 더 심각하고 더 파멸적일 수도 있는 국가 위기를 눈앞에 두고 있는 것이다 더 심각한 문제는 이 위기상태를 우리가 뻔히 보고 있으면서도 이 위기를 극복해 낼 리더십을 갖고 있지 않다는 데 있다 국가의 중요 경제정책을 책임지고 결정할 대통령이 지금 사실상 법정관리 상태이고 그런 능력과 국민의 지지를 받을 수 없는 상태다 앞으로 박근혜 정부가 김대중 정부처럼 구조조정의 고통 분담과 제 의 정치적 금모으기를 국민에게 호소할 수 있겠는가 법정관리 상태의 청와대가 어떻게 스스로의 회생을 국민에게 약속할 수 있겠는가 지금의 정치적 외환위기 상황에 대처하고 앞으로 닥쳐올지도 모르는 경제적 제 의 외환위기 사태를 막아내기 위해서라도 대통령은 경제정책과 안보정책의 중요한 결정에서 손을 떼야 한다 그 길만이 위기를 막는 길이다 지금부터 정부는 안보위기 경제위기에 대한 대처와 관리를 위해서 비상관리체제로 전환해야한다 박근혜 게이트라는 암 덩어리를 제거하지 않으면 대한민국 자체가 말기 암 상태로 갈 것이다 임기 말은 물론 년 안에 대한민국 전체에 돌이킬 수 없는 심각한 상황을 가져오게 될 것이다 오늘의 위기는 이제 시작이다 최순실 구속으로 넘어갈 상황이 아니다 대통령이 결심해야 한다 대통령이 스스로 초래한 엄청난 국가위기사태에 책임 지는 모습을 국민들에게 보여주셔야 한다 더 이상 늦춰서는 안 된다 박완주 수석부대표 새누리당의 유체이탈 방식은 대통령과 너무도 닮은꼴이다 박근혜 대통령 최순실 그리고 새누리당은 한 몸이다 어제 새누리당 정진석 원내대표가 당 원내대표 회담에서 보인 모습은 한마디로 유체이탈 그 자체였다 누구 한 분 집권당으로써 국민에게 진솔한 사죄를 아직까지 하지 않았다 먼저 하라는 것이 그렇게 무리한 요구인가 국민 앞에서 통렬한 반성의 모습을 보여도 모자랄 마당에 적반하장식의 태도로 책임을 전가하고 나섰다 사상 초유의 국가 리더십 부재 속에서 예산안 등 민생을 챙기려는 야당의 노력에 집권 여당은 자리를 박차고 나섰다 백번 양보해서 정진석 원내대표가 야당의 요구를 다 들었다고 하는 내용을 들여다보면 납득하기 어렵다 특검 요구에 대해서 셀프 특검으로 맞섰다 거국중립내각에 대해서는 셀프 총리를 야당과 논의 없이 청와대에 먼저 제안했다 청와대 인적 쇄신 요구안에 대해서 야당이 뻔히 반대할 인사를 민정수석으로 비서설장보다 먼저 임명했다 이런 모습은 진정으로 야당과 함께 수습을 하려고 하는 모습은 아니다 새누리당의 손바닥 뒤집기 식에 국민들은 경악을 금치 못할 지경이다 지난 년 정윤회 게이트 일명 문고리 인방 비선 십상시 사건 당시 새누리당은 청와대의 호위무사를 자처하면서 오직 국민이 아닌 대통령만 바라보며 방어를 했다 호미로 막을 것을 가래로도 막지 못 할 상황은 집권여당이 만들었다 올해 국정감사에서도 최순실 게이트의 실체를 파헤치기 위한 우리 당의 증인채택 요구에 안건조정 요구로 훼방을 놓았다 이제 더 이상 새누리당은 피해자 코스프레를 하지 말라 진정으로 야당과 함께 수습할 것을 요구 드린다 오늘부터 박근혜 최순실 게이트의 진실 규명을 위한 특별법에 의한 특검 논의 협상을 재개하겠다 특별법에 의한 특검만이 명명백백한 진상규명의 시작이다 새누리당도 더 이상 검찰의 증거인멸의 우려 속에 진행되는 수사 국민이 의혹을 보이고 있는 검찰에 대해서보다는 여야가 합의하여 특별법에 의한 특검을 진행할 수 있도록 전향적 자세를 요청드린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58781,2016-11-01, 차 비상 의원총회 모두발언 일시 화 장소 본청 예결위회의장 추미애 대표 대한민국 국민은 월의 마지막 밤도 잊은 채 공황장애에 걸려 있는 것 같은데 피의자 최순실이 공황장애를 호소했다고 한다 지금 대한민국은 헌정 초유의 박근혜 최순실 게이트 로 만신창이가 되어버렸다 국민이 선출한 적 없는 최순실과 그 부역자들이 국가권력의 정점에서 국권을 파괴하고 총체적 국정마비를 초래했다 의혹을 제기하고 몇 달이 지나 어제 겨우 수건을 두른 채 나왔다 최순실은 대통령과 마찬가지로 모든 의혹을 전면 부인하며 국민 분노에 기름을 부었다 지금 눈물 흘려야할 사람은 최순실이 아니라 우리 국민들이다 상상을 초월하는 박근혜 정권의 국기문란에 분노를 넘어서 공황상태에 빠질 지경인데 최순실이 그런 말을 한다 끝까지 어이가 없다 문제는 박근혜 대통령이다 대통령의 대국민 해명을 요구했더니 철저하게 국민을 무시하고 있다 분노한 민심 앞에 한 일이라고는 정치검찰 카드를 꺼내는 것이었다 이명박 정권의 우병우 행세를 했던 최재경 민정수석을 새로운 정권의 부역자로 임명했다 검찰 수사권을 직접 휘두르겠다는 것이다 이대로라면 최순실 일가와 그 부역자들이 모든 증거를 은닉할 것이다 검찰이 최순실과 그 부역자들과 장단 맞추지 않는다는 것을 증명하려면 최순실을 비롯한 모든 혐의자들을 즉각 구속 수사해야 마땅하다 대통령도 예외가 아니다 대통령을 조사하지 않고 어떻게 수사 실마리를 찾을 수 있겠나 지금 대통령이 해야 할 일은 국민께 석고대죄하고 국민을 향해서 나부터 조사하라 성역 없는 검찰 조사를 받겠다 고 선언하는 것이다 새누리당 역시 국민 앞에 사죄하고 성역 없는 진상조사를 위한 특검 협상에 적극 협조해야 할 것이다 가관이었다 어제 이정현 대표의 사퇴 거부 정진석 원내대표의 적반하장식 피해자 코스프레를 보면서 국민들은 정말 새누리당은 박근혜 최순실의 호위대구나 확신하는 순간이었다 새누리당은 박근혜 정권 국정농단의 공범이다 이제 여당의 예산과 민생현안 협상파기 얼렁뚱땅 꼬리자르기식 책임회피를 결코 용납되지 않을 것이다 아직 밝혀내야할 의혹들이 가득하다 우리당이 국민의 대안이 되어야 한다 이번 국정감사에서 보여준 우리당 의원들의 진실규명 노력은 계속 되어야 한다 오늘부터 당이 직접 국민과 소통하며 대국민 보고대회를 이어갈 것이다 박근혜정권이 만든 국정 혼란이 국가 위기로 내몰리지 않도록 우리 당이 단단하게 닻을 내리고 비상한 자세로 대처해 나가겠다 무너진 국정 리더십을 뒷걸음친 민주주의를 국민과 함께 우리 민주당이 지켜내자 우상호 원내대표 오늘부터 더불어민주당 원내지도부는 국회에서 시간 상시 대기하기로 결정을 내렸다 저는 원내대표실에 간이침대를 옮겨 놨다 매일매일 바깥 상황과 검찰수사 상황 국회 상황을 실시간 점검해서 더불어민주당의 대응체제를 더욱 강화하겠다 특히 각 상임위별 예산안 심사과정 예산결산위원회의 심사과정을 면밀히 점검해서 내년도 예산이 차질 없이 심의될 수 있도록 지원 하겠다 박근혜 최순실 게이트에 대한 검찰 수사상황을 실시간 감시하면서 조금이라도 허점은 없는지 증거인멸을 하고 있지 않은지 수시로 점검해나가겠다 어제 국회의장이 주재한 당 원내대표회동이 결렬됐다 결렬이 아니라 시작도 못했다 정진석대표가 들어와서 난장판을 치고 오히려 화를 내고 나갔다 사과하고 반성을 해도 모자란 새누리당의 태도가 바로 그렇게 오만한 태도이다 뭘 잘했다고 야당을 질타하고 화를 내고 나갈 수 있나 오늘부로 공식적으로 말씀드린다 새누리당 안의 십상시도 척결하라 청와대 안에 있는 십상시만의 문제가 아니다 새누리당 안에 있는 소위 박근혜 최순실 호위병들도 책임을 져야 한다 그동안 대화 상대방이라서 새누리당에 대한 비판과 공격을 자제해왔다 어떤 형태로든 원만한 타협을 통해 국정을 수습하고 싶었기 때문이다 그러나 지금 새누리당의 태도는 그대로 묵과할 수 없다 이 사태가 이뤄진 일 동안 국감에서 안건조정이라는 제도를 활용해 핵심증인 전부 채택하지 못하게 만들었다 미르 스포츠 재단에 관한 증인들도 새누리당이 방해해서 채택을 못했다 진실을 은폐하고 범죄자들을 비호한 것이다 청와대 안종범 수석을 비롯해 각 부처 장관들이 위증으로 일관했고 야당의원들이 질타할 때 그것을 막고 오히려 비아냥거렸다 무얼 잘했다고 얼굴을 들고 다닐 수 있는가 저는 새누리당의 대국민 사과와 당내 최순실 홍위병 척결부터 강력하게 요구한다 새누리당의 태도 변화가 없으면 더욱 강력한 국민 심판을 맞이할 것이라고 경고한다 오늘 시 분에 야 당 원내대표 회담이 있다 거기서 야당 전체의 요구조건을 정식화해서 여당과 협상해 나가도록 할 계획이다 비공개회의 때 우리당 수습방안에 대해 지혜를 빌려주시고 좋은 말씀을 해주시기 바란다 보도를 보면 새누리당은 과거 야권에 몸담았던 인사들을 이미 총리 후보로 추천했다고 한다 기가 막힌다 자기들이 이미 다 총리후보를 내정해놓고 더불어민주당을 들러리 세워서 거국내각이라고 포장하려고 했던 것이다 우리 야당이 거기에 들러리 설 리 없다 야당이 주장하는 거국내각은 이게 아니지 않나 그런 면에서 오늘 이러한 사태를 맞이한 의원들의 말씀을 경청하겠다 좋은 말씀을 통해서 당의 중론이 모아지면 의원총회에서 모아진 중론대로 따르겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58779,2016-11-01, 박경미 대변인 오전 현안 브리핑 일시 장소 국회 정론관 대통령에 대한 조사 더 이상 거부해서는 안 된다 박근혜 대통령은 최순실씨로부터 연설문 등에 대해 도움을 받았다고 해명했다 그러나 박 대통령과 최순실씨의 관계가 그 이상이었음을 보여주는 증언이 쏟아지고 있다 오늘 아침 최씨가 청와대 행정관의 차를 타고 청와대를 내집처럼 드나들었다는 증언이 보도됐다 최씨의 출입을 막았던 경호책임자들은 좌천됐다고 한다 국가핵심기관인 청와대의 경호와 보안이 완전히 뚫린 것이다 최씨가 직통 폴더폰으로 대통령에게 일일이 훈수를 두었다는 동계올림픽 금메달리스트의 증언도 있다 이 금메달리스트는 최씨의 집에서 묵었을 정도로 가까운 사이였다니 매우 신빙성이 높은 증언으로 보인다 최씨는 무기 로비스트 린다 김과도 오랜 친분을 가지고 있었고 사업 등 무기 거래에 손을 댔다는 의혹도 제기되고 있어 경악을 금할 수 없다 더 나아가 최순실 씨가 실제 소유한 더블루케이는 억원에 달하는 평창올림픽 시설공사 사업 수주에 나섰던 것으로 확인됐다 대통령이 일개 민간인에게 그것도 사이비 종교인의 딸에게 도대체 얼마나 광범위한 국정을 상의했단 말인가 이제 박근혜 최순실 게이트의 전모를 밝히기 위해서는 대통령에 대한 조사를 피할 수 없는 상황이 됐다 대통령을 빼고 이루어지는 수사결과를 국민이 납득할리 만무하다 박근혜 대통령은 자신부터 수사를 해달라고 공개 천명하기를 바란다 새누리당은 박근혜 최순실 게이트에 대해서 국민에게 사과부터 하라 새누리당이 진정성이 없는 거국중립내각을 내세워 정치공세를 하고 있다 내각에 야권 인사 몇 명 끼워 넣어 사태를 무마하겠다는 새누리당의 발상이 정말 어처구니없다 새누리당이 거국중립내각을 거론하는 것은 국민기만책이다 정쟁을 촉발해 국면을 전환하려는 이슈를 이슈로 덮으려는 하책을 버리기 바란다 최순실 씨가 은밀한 비선실세가 아니라 알고보니 공공연한 비선실세였다 김무성 전 대표나 전여옥 전 의원은 다 알고 있었다 고 표현했다 년 전 우리 당 안민석 의원이 제기한 정유라 양 의혹에 대해 교문위 여당 의원 명은 근거없는 정치공세라며 반박하기도 했다 새누리당은 최순실의 존재와 위험한 행태를 알면서도 비호한 순간부터 상황 수습 의 자격을 이미 상실했다 새누리당은 왕관의 무게를 단 년도 이겨낼 자신도 의지도 능력도 없었던 것이다 더욱이 새누리당은 최순실의 국정농단을 은폐하기 위해 단식 쇼를 하고 박근혜 최순실 게이트 관련 증인채택을 방해하며 국감을 방탄했던 자신들의 과거에 대해서 이제껏 사과 한마디 없었다 새누리당은 박근혜 최순실 게이트의 공범이라는 점을 명심하고 국민들에게 석고대죄 하기 바란다 박근혜정부는 한일군사정보보호협정 강행을 즉시 중단하라 년 전 이명박 정권에서 추진하다가 국민의 반발로 무산됐던 한일군사정보보호협정 실무협의가 오늘 재개된다 국방부는 올해 안에 신속하게 협의를 마무리할 방침이라고 한다 단도직입적으로 묻겠다 대체 박근혜 정부는 무슨 속셈으로 친일미화 국정역사교과서 강행부터 굴욕적인 위안부 합의까지 국민이 반대하는 일만 골라서 하는가 박근혜 정부는 대한민국정부인가 일본정부인가 불통도 이런 불통은 없다 군사정보협정이 체결되면 한일 양국은 핵심 군사기밀을 주고받게 된다 일본은 과거사에 대한 반성 없이 군사대국화를 추진하고 독도영유권을 주장하고 있다 일본의 입장이 조금도 개선되지 않았는데 대중국 관계를 크게 악화시킬 수도 있는 한일군사정보보호협정을 왜 체결해야하는지 국민 정서상 도저히 납득할 수 없다 더욱이 박근혜 최순실 게이트로 그 어느 때보다 나라가 혼란스러운데 왜 이 시점에 하겠다는 것인지 의문이다 박근혜 정부는 당장 한일군사정보협정을 중단하라 한일군사정보협정의 체결은 국회의 비준이 필요한 사안이며 더불어민주당은 결코 이를 용납하지 않을 것임을 분명히 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58778,2016-11-01, 기동민 원내대변인 오전 현안 서면 브리핑 제 차 비상의총 브리핑 오늘부터 원내 비상체계가 가동된다 원내대표를 비롯한 원내대표단 전원이 비상 대기하기로 했다 대표단 명씩 조를 이뤄 상시 대기 즉시 대응 시스템을 운영한다 매일 아침 비상의원총회 저녁 시 상황점검회의를 진행한다 당 차원의 최순실 부역자 신고센터 를 설치 운영하고 내일부터 가동하기로 했다 정부 부처 및 산하기관 등에 숨어있는 이들을 밝혀내 책임을 묻는 일에 만전을 기할 것이다 우리당은 현 상황이 국가 비상상황이라는 인식 하에 철저한 진상규명 거국중립내각 하야 탄핵까지 분출되고 있는 국민의 목소리에 귀 기울이고 당차원의 신속하고 적절한 대응책이 마련돼야 한다고 의견을 모았다 또한 오늘 있을 야 당 원내대표 회동에서 국정조사 추진을 제안하는 등 국회차원의 진상규명을 위한 다양한 노력을 병행하기로 했다 새누리당은 박근혜 최순실 게이트 의 공범이다 국민에게 사과해도 모자랄 판에 정진석 원내대표는 국회협상을 난장판으로 만들었다 국민을 우습게 여기고 국회를 무시하는 용서할 수 없는 망동이다 새누리당 내 박근혜 대통령과 최순실 호위병들 친박세력과 소위 십상시라 일컫는 국정농단의 핵심들은 모두 국민 앞에 사죄해야 한다 핵심 증인 채택을 방해하고 국정감사를 무력화시켜 진실을 은폐하고 범죄자를 비호하며 박근혜 대통령과 최순실의 홍위병을 자처했던 죄는 결코 씻을 수 없다 이상 헌정 사상 초유의 국정농단 본질은 대통령이다 온 나라가 시국선언 중이다 국민의 분노는 하늘을 찌르고 허탈한 마음으로 땅이 꺼질 지경이다 대통령과 새누리당은 때 이른 수습책 논란 으로 더 큰 분노만 일으키고 있다 첫 단추부터 잘못됐다 영혼없는 사과 로 의혹만 가중됐고 검찰 출신 민정수석을 임명하고 홍보수석 자리를 서둘러 채운 것은 검찰을 장악하고 어설픈 대국민 여론작업으로 국민을 호도하려는 꼼수에 불과하다 아직도 미련과 망상에서 벗어나지 못한 대통령의 속내를 만천하에 보여줬을 뿐이다 국민이 대통령께 원하는 건 진심어린 사과다 기업들을 동원해 모금했고 월 일 수석비서관회의 자료 유출도 인정 월 일 대국민사과 한 만큼 솔직하게 고백하고 용서를 비는 것이 첫 번째다 그리고 스스로 수사를 자청하여 의혹을 해소하는 것이 도리이다 둘째 검찰을 장악하여 국정을 유지하겠다는 구시대적 발상을 버려야 한다 검찰 출신 민정수석 임명 철회하고 국민이 납득할 수 있는 후임 인사를 해야 한다 셋째 내각 무력화와 국정농단을 초래한 비서실의 과도한 권한을 축소해야 한다 김관진 안보실장 현대원 수석 등 부적절 인사 및 최순실 인사들을 모두 내보내고 순수 보좌기능으로 축소 개편해야 한다 넷째 최순실이 추천하고 우병우 전 수석이 부실 검증한 내각 인사들을 모두 해임하고 국민이 납득할 수 있는 인물로 전원 교체해야 한다 박근혜 대통령은 피해자가 아니다 최순실의 국정개입을 허락한 박근혜 대통령이 스스로 자초한 일이다 이 난국을 풀어낼 수 있는 건 최순실도 아니고 검찰도 아니다 박근혜 최순실 게이트 의 몸통은 대통령이다 비전도 능력도 의욕도 이젠 자존심조차 없어진 유일호 최소한의 비전도 찾아볼 수 없었다 정부의 조선업 구조조정 대책은 구조조정 시늉 만 낸 땜질 처방이다 년여를 끌고 수십억원을 들여 컨설팅 받은 결과가 뻔하디 뻔한 레퍼토리 의 무한반복뿐이다 연명치료만 해놓고 모든 짐은 차기 정부로 미루겠다는 무책임의 결정판이다 근본적인 개선책 없이 건설과 부동산 투기에 목매달았던 박근혜 경제의 민낯이다 생산 투자 소비 등 대 지표는 끝없이 추락하고 박근혜 정부 가계부채 증가액은 노무현 정부 때를 합친 것과 맞먹을 정도로 급증했다 또 다른 폭탄만 만들었을 뿐이다 경제가 이지경이 나도록 무능한 경제부총리는 대통령 대면보고조차 못했다고 하니 충분히 예견된 재앙이다 비전도 능력도 의욕도 이젠 최소한의 자존심조차 없어진 무능한 유일호 경제 는 갈아엎어야 한다 침몰하고 있는 우리 경제를 살려야 한다 국민의 먹고사는 문제가 걸렸다 특단의 조치가 필요하다 청와대를 제 집 드나들 듯 한 최순실 국가안보 차원에서 단죄해야 한다 최순실씨가 청와대를 제 집 드나들 듯 했고 제 부속실은 앞장 서 그 일을 도맡아 왔다고 한다 최순실씨가 영부인도 아니고 어떻게 이런 일들이 벌어질 수 있었는지 기가 막힌다 청와대는 대통령과 직원 소수의 허락된 사람들에게만 허락되는 우리나라 최고 보안시설이다 그나마 복잡한 검문검색과 신분확인을 거쳐야 가능하다 관광하러 간 것도 아니고 민간인 최순실씨가 청와대를 마음대로 드나들 수 있었다는 건 국가보안에 심각한 구멍이 뚫렸다는 의미이다 특권의 차원을 넘어 국가 안보 차원에서 따져 묻고 단죄해야 한다 심지어 검문검색을 하겠다는 경호원들을 좌천시키고 한직으로 밀어내기까지 했다니 할 말이 없다 청와대 보안 규정을 위반한 모든 관련자들 이를 방조한 책임자 모두 법에 따라 처벌해야 한다 국가 안보를 지키고 나라의 기강을 세우는 일이다 한 일 군사정보 보호협정 재개 즉각 중단하라 년 밀실협상 논란으로 무산된 한 일 군사정보 보호협정 은 중단돼야 한다 국민 정서도 용납하지 못하고 시기도 부적절하다 게다가 협상을 주도한 김관진 안보실장은 이 일을 책임질 수 없는 사람이다 정부의 대북강경책과 오락가락 외교정책이 북한은 년 안에 망한다 는 최순실씨의 허언에서 비롯됐다고 의심되고 있다 나라가 혼란한 틈을 이용해 은근슬쩍 넘어가려는 꼼수 는 용납할 수 없다 도쿄 실무협상 즉각 중단하고 원점 재검토해야 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58773,2016-10-31, 윤관석 수석대변인 오후 현안 브리핑 일시 오후 시 분 장소 국회 정론관 제기된 의혹 확인도 못하는 검찰이라면 국민이 퇴출할 것 오늘 오후 국정농단의 주범 최순실씨가 검찰에 출석했다 최씨는 년 승마협회 운영에 깊숙이 관여했다는 의혹이 제기됐을 때인 년 전에 검찰 포토라인에 섰어야 한다 검찰이 이제야 최씨를 소환하고 포토라인 앞에 세운 것은 한마디로 직무 유기이다 검찰은 이번만큼은 꼬리 자르기 수사가 아니라 국민이 완전히 납득할 수사 결과를 내놓아야 한다 최씨는 포토라인 앞에서 죽을 죄를 지었다 고 울먹였지만 순순히 자신의 죄를 자백하지는 않을 것으로 보인다 변호인에 따르면 최씨는 내 셀카가 어떻게 그 에 갔나 하더라 고 주장했다고 한다 이미 드러난 사실조차 인정하지 않겠다는 뻔뻔한 태도다 최씨의 변호인은 어제 기자회견에서도 죄가 인정되면 처벌받겠다 고 말했다 검찰이 죄를 입증해보라는 어깃장이다 더욱 걱정스러운 것은 수사를 책임지는 검찰의 태도다 검찰은 친절하게도 어제 극비귀국한 최씨가 하루만 시간을 달라는 요구하자 이를 순순히 받아들였다 최씨가 증거인멸을 시도한 정황이 곳곳에서 확인되는 상황에서 검찰의 소환 연기는 최씨의 건강을 도운 것이 아니라 최씨의 증거인멸을 도운 것이다 검찰의 석연치 않은 온정을 보며 제대로 수사할 수 있을지 최씨가 저지른 국정농단의 전모를 밝혀낼 수 있을지 국민은 강한 의문을 제기한다 이미 차고 넘칠 만큼 많은 의혹들이 드러났지만 아직도 빙산의 일각이다 검찰수사는 사건의 전모를 확인하고 법의 심판대에 세워야 한다 검찰은 지금부터라도 다시 시작한다는 사명감으로 조직의 명운을 걸고 수사 결과를 통해 검찰 조직의 존재 이유를 설명할 것을 엄중히 요구한다 새누리당은 국정운영의 동반자로 국민에게 석고대죄해야할 죄인이다 새누리당 정진석 원내대표가 야당은 딴지걸기 갈지자 행보를 보이고 있다 며 여야 당 원내대표 회동을 분 만에 박차고 나가버렸다 정진석 원내대표는 대통령을 끌어 내려서 하야정국 탄핵정국으로 몰고 가겠다는 것 아닌가 라고 주장했다 적반하장도 유분수다 민심의 분노가 어디로 향하고 있는지 아직도 모른다는 말인가 또 민심을 무시하고 야당을 협박까지 하는 것인가 일방적인 새누리당의 제안에 야당은 모조건 따라야 한다는 말인가 여당의 제안을 거부하는 것이 반국가적 행태 라는 새누리당의 오만에 경악한다 더욱이 새누리당이 사태 수습을 논할 자격이 있는지 다시 묻는다 새누리당은 집권여당로서 국정운영 동반자로서 박근혜 최순실 게이트의 공범으로서 국민의 심판을 받아야 할 죄인일 뿐이다 당내에서조차 오늘 지도부 사퇴가 커다란 목소리로 분출되고 있지 않은가 전여옥 전 의원은 언론 인터뷰에서 년 당시 이미 최태민 목사와 최순실씨 이야기는 다들 알고 있었다 자기들은 귀머거리 장님이란 얘기냐 고 말했다 김무성 전 대표도 박근혜 후보 옆에 최순실 씨가 있다는 것은 다 알고 있었다 그것을 몰랐다는 것은 다 거짓말이다 고 말한 바 있다 특히 이정현 대표는 현 청와대에서 홍보수석과 정무수석을 지냈다 대통령의 입 대통령의 복심으로 불리며 대통령을 지근거리에서 모신 사람으로서 대통령과 최씨의 관계를 모른다고 할 수 있는가 이혜훈 의원은 말리다가 이렇게 공천도 못 받고 당에서 쫓겨난 것 아니냐 고 말했다 이들의 증언은 새누리당이 최순실씨의 국정농단과 국기문란을 알고도 방조해왔음을 확인시켜준다 이번 국감 상임위 곳곳에서 새누리당이 최씨의 비호를 위해 얼마나 헌신적으로 방탄에 몸을 던졌는지 국민은 똑똑히 기억한다 새누리당은 국정의 공동책임을 진 집권여당이며 최씨의 국정농단을 방조하고 은폐해온 공범이다 국민의 심판을 받아야할 죄인 새누리당이 당면한 사태의 수습책을 주도하겠다며 정치공세를 펼치고 있으니 참으로 뻔뻔함에 할 말을 잊는다 새누리당이 내놓는 수습책이라는 것이 결국 최순실 게이트의 책임을 회피하고 국면을 전환하자는 것이 아니고 무엇인가 새누리당은 최씨의 국정농단을 방조했을 때 이미 사태를 수습할 자격을 스스로 내버렸다는 점을 분명히 지적한다 최순실 게이트 증거인멸 보이지 않는 손이 작동하고 있다 국정운영의 컨트롤타워는 부재하거나 농단당했다 하지만 아직도 비선 컨트롤타워는 건재한 것 같다 청와대는 지난 주말 사이 검찰의 압수수색을 거부하다 상자 분의 자료를 골라서 검찰에 나놨다 이것을 압수수색이라고 누가 믿겠는가 청와대가 골라서 내준 자료를 가지고 제대로 된 수사가 이루어질 가능성은 이다 청와대의 증거인멸 시도도 드러났다 안종범 전 정무수석이 대포폰을 통해 정현식 전 스포츠재단 사무총장을 회유하려 했다는 보도가 나왔다 이런 일이 안종범 전 수석 한 사람에 그칠 리 없다 국정의 중심인 청와대가 국정농단과 국기문란의 중심이 된 것도 부족해 자신들의 죄악을 은폐하기 위해 증거를 인멸하고 수사를 방해하다니 분노를 금할 수 없다 최순실씨의 극비귀국을 전후해서 조직적인 증거인멸과 짜맞추기 흔적이 곳곳에서 확인되고 있다 박근혜 최순실 게이트 의 진상을 은폐하려는 각본에 따른 조직적 움직임이 있고 보이지 않는 손이 비선 컨트롤타워의 지휘 하에 작동하고 있다는 의심을 떨치기 어렵다 최재경 민정수석 임명도 그 연장선에 있다는 것 같다 그러나 사건을 조기에 마무리하려는 정권의 시도는 더 큰 국민의 저항을 부를 뿐이다 국민들은 박근혜 대통령에게 모든 진상을 스스로 조사받고 성역 없는 수사를 공개적으로 밝힐 것을 요구하고 있다 국민이 대통령과 청와대에게 준 시간은 얼마 남지 않았다는 점을 엄중하게 경고한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58772,2016-10-31, 기동민 원내대변인 오후 현안 브리핑 일시 월 오후 시 분 장소 국회 정론관 최순실 씨 검찰 출석 관련 대통령 조사 를 포함한 몸통수사를 촉구 한다 최순실 씨가 검찰에 출두했다 죽을 죄를 지었다 고 했다 죽을 죄 를 진 것은 맞는 것 같다 이제 남은 일은 죽을 죄가 무엇인지 국민 앞에 낱낱이 고백하고 몸통을 털어놓는 것뿐이다 박근혜 최순실 게이트 는 현직 대통령이 직접 개입된 역사상 유래 없는 사건이다 국민들이 느끼고 있는 허탈감 좌절감 절망감은 상상할 수 없을 정도이다 희대의 국정농단 사건에 대한 근본적인 치유가 없는 한 대한민국은 단 한 발짝도 나아갈 수 없다 미래를 바로 세우는 전기로 삼아야 한다 검찰은 철저한 수사로 한 점 의혹도 남기지 말아야 한다 최순실 인터뷰와 기획 입국 안종범 수석의 증인 회유 등 보이지 않는 손에 의해 기획되고 짜맞춰지고 있다는 의혹을 지울 수 없다 국민의 검찰로 다시 태어나고 싶다면 이번 사건의 몸통인 대통령에 대한 조사를 비롯한 국정농단의 전모를 모두 파헤쳐야 할 것이다 모든 정황들이 대통령을 향하고 있는 상황에서 대통령 조사 없는 검찰 수사는 깃털 수사 에 불과하다 대통령 조사 를 포함한 우병우 안종범 문고리 인방 등을 긴급 소환해 조사하고 성역 없는 몸통 수사 로 진실을 규명해야 한다 검찰은 권력 눈치 보기로 사건을 축소 은폐해서는 안 된다 국민들의 더 큰 분노만 살뿐이다 명운을 건 수사를 촉구한다 최재경 민정수석 해임하고 청와대를 근본적으로 쇄신하라 최재경 민정수석은 세간의 평을 종합했을 때 우병우 전 수석보다 더 검찰을 통제할 위험성이 큰 인물이다 검찰을 계속 쥐고 흔들기 위해 우병우 최경환 김기춘 등이 추천했다는 의혹이 파다하다 서둘러 민정수석부터 임명한 것 자체가 그 의혹을 증폭시키고 있다 최재경 수석을 통해 검찰을 지휘하고 박근혜 최순실 게이트 의 실체적 진실을 청와대의 의도대로 통제하겠다는 시도이다 결코 용납할 수 없다 최재경 민정수석 임명을 취소하고 다시 적임자를 찾아야 한다 최순실에 의해 왜곡되고 단절돼버린 남북관계와 외교 전략을 책임진 김관진 실장 역시 교체해야 한다 이 와중에 한일군사정보보호협정을 추진하는 등 급변해온 외교안보정책 실패에 대한 모든 책임을 지는 것이 마땅하다 이밖에 각종 비리의혹에 휩싸였던 현대원 수석과 김한수 비서관 등 청와대 내 최순실 인사들도 모조리 색출하여 교체해야 한다 대통령의 국정복귀 의지 국민이 받아들이지 못 한다 대통령께서 청와대 참모진과 내각을 개편한 후 국정에 복귀하겠다는 의지를 표명하고 있다 상황이 어떻게 돌아가고 있는지 모르는 현실과 동떨어진 판단이다 국민이 결코 납득할 수도 받아들일 수 없을 것이다 박근혜 최순실 게이트 는 대통령께서 자초한 일이고 책임져야 할 문제다 보좌진 몇 명을 경질하고 내각을 개편한다고 용서받을 수 없다 성난 민심을 직시하기 바란다 이들의 분노가 누구를 향하고 있는지 잘 판단해야 한다 대통령께서 선택할 수 있는 길은 국기 문란의 진상을 낱낱이 고백하고 진심어린 사과와 용서를 구하는 것뿐이다 그리고 국정에서 손을 떼야 한다 나라꼴을 이 지경으로 만들어놓고 무언가를 해보겠다는 망상과 미련은 더 큰 분노와 저항을 불러일으킬 뿐이다 더 이상 나라꼴을 우습게 만들지 말라 새누리당은 어설픈 국면전환용 거국내각 으로 국민을 우롱하지 말라 박근혜 최순실 게이트 의 동조자였던 새누리당이 상황이 불리해지자 방관자 로 변하더니 면피에 급급한 거국내각 제안으로 국민을 호도하고 있다 박근혜 최순실 게이트 의 본질은 대통령과 비선실세 청와대 참모진 이정현 대표를 비롯한 친박 세력 모두에게 원죄가 있다 헌법과 법률을 무시한 국정농단 행위가 자행됐고 새누리당은 이를 오래 전부터 옹호하고 방조해왔다 모든 것을 참회하지 않고 책임지지 않는 수습책은 불리한 국면을 벗어나기 위한 정략적 꼼수에 불과하다 특별법에 의한 특검 실시 검찰 바로세우기와 공수처 설치 어버이연합 청문회 세월호 진상규명 경제관료 전면 교체 및 국민 먹고사는 문제 해결 등이 선결되지 않는 한 그 어떤 수습책을 내놔도 용납할 수 없다 앞뒤 과정은 다 빼먹고 실체 없는 여론 호도책으로 국민을 우롱하는 새누리당을 용서할 수 없다 여당이면 여당답게 국민의 외침에 귀 기울이기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58769,2016-10-31, 기동민 원내대변인 오전 현안 브리핑 일시 월 장소 정론관 의원총회 브리핑 오늘 의총에서 우리당은 박근혜 대통령이 더 이상 정상적인 국정운영을 할 수 있는 자격도 능력도 없다는 점에 대해 의견을 모았다 우리당은 지금을 국가비상시국으로 규정하고 매일 아침 시 분에 비상의총을 진행하기로 했다 우리당은 의원들의 결의와 실천을 이행하는 첫걸음으로 내일 오후 시 의원회관 대회의실에서 박근혜 최순실 게이트 진상규명 및 나라바로세우기 국민결의대회 를 개최함을 알려드린다 이후 전국을 순회하며 당원보고대회를 갖고 국민과 소통하며 국민의 힘을 모아나갈 것이다 박근혜 최순실 게이트 진상규명을 위한 특별법에 따른 특검을 진행하기로 했다 특검협상을 재개할 것이다 새누리당 정진석 원내대표가 국회의장이 주선한 당 원내대표 회담장을 박차고 나가버렸다 황당하고 기가 막힌 노릇이다 박근혜 최순실 게이트 가 어디 남 일인가 대통령과 비선실세 측근 참모가 일을 벌였고 새누리당 친박세력은 이를 방조하고 옹호하면서 불거진 일이다 정진석 원내대표는 이정현 대표와 함께 청와대 출장소 소장 부소장을 나눠 맡은 사건 책임자 중 한 사람이다 반성해도 모자랄 판에 자신 뜻대로 안된다고 판을 깨버리는 이런 행위가 국민을 무시하고 국회를 무시하는 행위 아닌가 엄중하게 규탄한다 박근혜 최순실 게이트 의 공동주범인 새누리당의 맹성을 촉구한다 국민 앞에 석고대죄하며 죄를 빌어도 시원찮은 판에 아무런 사과와 반성도 없는 새누리당은 각성해야 한다 또한 이정현 정진석 최경환 서청원 등 친박실세들은 책임지고 물러나는 것이 그나마 국민에 대한 도리를 다하는 것임을 명심해야 할 것이다 총 명의 의원들 중 상당한 의원들은 지금 시기 국면을 풀어나갈 수 있는 유력한 방법으로 국회가 주도하는 거국중립내각이 국민 분노와 불안을 타개할 수 있는 방법임을 주장했다 또한 국민들의 분노가 대통령의 하야와 탄핵에 이르고 있다는 점을 주목해야 한다고 했다 마지막으로 의원들은 박근혜 최순실 게이트의 진상규명이 최우선되어야 하고 검찰 개혁의 고삐를 늦추지 말아야 한다는 점에 의견을 모았다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58768,2016-10-31, 윤관석 수석대변인 오전 현안 서면 브리핑 최순실 안종범 등 비선실세 국정농단 관련 고발장 제출 더불어민주당은 오늘 오전 시 서울중앙지검에 최순실 안종범 김기춘 김종 등 비선실세 국정농단에 관한 고발장을 제출한다 첫째 국가기밀을 유출하고 국정을 농단한 최순실씨와 그 가담자들에 대해서 공무상비밀누설죄 대통령기록물관리법 위반죄 범죄수익은닉규제법 위반죄 국외재산도피죄 외국환거래법위반죄 범인도피은닉죄로 고발했다 둘째 기업들로부터 자금을 강제 모금해 미르재단 등의 설립을 주도한 최순실씨와 안종범 청와대 정책조정수석에 대해서 특정범죄 가중처벌 등에 관한 법률 위반 수뢰 및 제 자 뇌물공여 죄를 적용했다 셋째 직권을 남용하여 문체부 인사에 압력을 가한 김기춘 전 청와대 비서실장에 대해서 직권남용권리행사방해죄 부정한 인사 청탁을 한 김종 전 문체부 차관에 대해서는 국가공무원법 위반죄를 적시했다 또한 이들을 비롯해 관련자들의 추가 법 위반이 확인 되는대로 이에 대해서도 추가 고발할 계획이다 더불어민주당은 국민과 함께 비선실세 국정농단의 진상을 낱낱이 파헤치고 그 관련자들에게 법적 사회적 도의적 차원을 망라해 모든 책임을 묻기 위해 당력을 집중할 것이다 아울러 검찰의 봐주기 수사 와 청와대의 압수수색 거부 등으로 드러난 정권 차원의 증거은폐 및 조작의혹 박근혜 대통령의 법률 위반 사항에 대해서도 면밀히 검토하고 조사해 나갈 것이다 최고위원회의 결과 오늘 최고위원회에서는 어제 발표한대로 최순실게이이트 편파기소 대책특별위원회를 박근혜 최순실 게이트 국민조사위원회 로 확대 개편하고 공동위원장에 전해철 최고위원과 이석현 의원을 선임했다 또한 정책 대안 정당으로서 면모를 더욱 굳건히 하기 위해 정책엑스포를 개최하기로 결정하고 정책엑스포추진위원회를 설치했다 위원장에는 김부겸 의원을 선임했다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58766,2016-10-31, 제 차 긴급의원총회 모두발언 일시 월 오전 시 분 장소 국회 본청 호 추미애 대표 국권이 파괴되고 헌정이 특정 사교에 봉헌된 지 년이 됐다 국민은 분노하며 경천동지할 이 사태에 대해서 오로지 대통령의 진실에 관한 언급을 듣고 싶을 뿐이다 국권파괴 박근혜 최순실 게이트에 대해서 대통령이 직접 해명할 것을 요구한다 국민은 모두 알고 있다 최순실 혼자만의 전횡이 아니라 청와대와 여당까지 얽힌 공동책임이고 한통속이라는 것을 잘 알고 있다 즉각 우병우 전 수석을 조사해야 하고 청와대도 제대로 압수수색돼야 한다 이런 국헌문란 범죄에 대해서 청와대가 입맛대로 골라주는 압수수색이 웬말인가 최순실은 즉시 체포돼야 한다 이 순간에도 특권 휴가를 누리고 있는 최순실은 악의 세력과 입을 맞추고 있을 것이다 대통령은 국민 앞에 모든 사실을 해명하는 대국민 보고대회를 가져야 한다 검찰은 정의의 여신이 들고 있는 저울과 칼처럼 공정하고 엄정한 수사를 해야 한다 대통령이 문제의 시발이고 문제의 본질이다 그래서 대통령부터 조사해야 하는 것이다 성역이 없는 수사란 바로 이 사태에서 대통령에 대한 수사를 말하는 것이다 최순실 게이트에 협조한 정부 국정농단을 방조한 여당은 뻔뻔하기조차 하다 대통령의 유체이탈 화법에 여당까지 감염된 것 같다 공범인 집권여당은 이제 와서 상설특검으로 뻗대기 하거나 입으로만 거국내각 구성을 외치는데 그런 말을 할 자격조차 없다 국정혼란을 운운할 자격조차 없다 그들이 만든 국정 혼란이다 어제 박근혜 대통령의 멘토 그룹인 친박 인방 멤버의 조카이자 사건과 박연차 게이트로 충성했던 최재경 전 인천지검장을 민정수석으로 앉혔다 입맛대로 수사하고 끌고 가겠다는 의지가 확인되는 장면이다 뻔히 속이 보이는 술책이다 이 와중에 검찰은 증거인멸하고 말맞추기 하는 집단을 일부러 배려하고 있다 이제는 붕괴된 헌정질서와 민주주의를 국민과 함께 바로 세울 때이다 우리가 해야 한다 김대중 대통령께서는 우리 모두가 행동하는 양심이 될 때 민주주의는 우리의 것이라고 하셨다 국민을 분노케 했음에도 구렁이 담 넘어가듯 위기만 넘기려는 뻔뻔한 당 정 청을 철저히 감시하고 국민과 함께 민주주의를 지키는 대열에 모두 나서야 할 것이다 우상호 원내대표 이번 박근혜 최순실 게이트는 더불어민주당 의원들이 국정감사 내내 밤잠을 자지 않고 파헤쳐서 만들어낸 성과이다 그래서 야당의 존재 가치가 있는 것이다 여러분들이 밤을 새워 보좌관들과 만들어내고 파헤치고 제보 받은 의혹들이 하나하나 사실로 드러나고 있다 더불어민주당 의원들이 파헤쳐서 밝혀낸 진실을 박근혜 대통령과 검찰이 다시 은폐하기 시작했다 진실을 감추려는 어둠의 세력들과 더불어민주당의 싸움이 다시 시작되는 것이다 박근혜 대통령의 국정운영 동력이 상실되었다고 좋아할 일이 아니다 진실을 감추고 있는 세력들과의 싸움을 소홀히 해서는 안 될 것이다 다시 밤을 새우라고는 말씀 안 드리겠으나 그동안 해왔던 진실규명 노력을 더 가열차게 진행해주시기 바란다 광장에서 싸우는 방식이 있고 제도권에서 싸우는 방식이 있다 광장은 광장의 방식으로 이야기하고 제도권 안에 있는 우리는 제도권의 방식으로 싸워야한다 그것이 더불어민주당에 주어진 책무이다 진실을 은폐하려는 자들과 싸우는 방식은 더 지혜로워야 한다 더 많은 근거와 사실관계를 확인하는 노력을 계속해야 한다 국감은 끝난 것이 아니다 오늘부터 더불어민주당은 전국을 순회하면서 당원보고대회를 갖기로 했다 당원들과 함께 진실을 알리고 국민들에게 박근혜 정권 년간의 무능과 실정 비선실세의 진실들을 낱낱이 보고하고 다닐 것이다 국민과 함께 할 것이다 다만 저는 이런 걱정을 하고 있다 월 항쟁은 성공했지만 월 대선에서 패배했던 년의 경험을 잘 기억해야 한다 우리는 정권교체가 목적이다 쓰러뜨리는 것이 목적이 아니고 건설하는 것이 목표가 돼야한다 선거를 통해 심판하고 선거를 통해 희망을 세워야 한다 그것이 민주주의이고 더불어민주당의 과제이다 여기에 집중해주시기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58765,2016-10-31, 제 차 최고위원회의 모두발언 일시 월 장소 국회 본청 당대표 회의실 추미애 대표 예전에 어떤 대통령께서 서울을 봉헌하겠다고 말씀했다 그 말을 듣고 상당히 놀랐다 그런데 이제 그런 놀라움은 하찮은 것이 됐다 알고 보니 박근혜 대통령이 지난 년 동안 대한민국을 사교에 봉헌했다 대한민국 국권과 국헌을 사교에 봉헌했던 것이다 검찰은 이런 초법적인 범죄자 최순실이 그 부역자들과 입을 맞출 수 있게 허용해줬다 최순실에게 헌납한 시간의 휴가는 검찰 수사 사상 범죄자에 대한 최고의 배려일 것이다 사이비 교주에게 요설의 자유를 허용해서 범죄자 집단 간의 입맞춤을 허용하고 말았다 도대체 이 땅의 검찰은 무슨 생각을 하고 있는 것인가 종전에 진경준 등 고위직 검사가 엄청난 범죄를 저질러서 검찰의 최대 위기를 초래하더니 국권을 파괴시킨 사이비 교주는 체포하지 않았다 이런 검찰이 이제 무슨 수사를 어떻게 한다고 한들 신뢰를 얻기 어려울 것이다 오늘 사이비 교주가 출두한다고 하는데 출두가 아닌 실세의 행차처럼 되어버렸다 새누리당은 국권을 사교에 봉헌하도록 방조하고 울타리를 쳐준 공범집단이다 국민 앞에 석고대죄를 해야 할 집단이 거국내각을 입에 올리면서 야당인사를 징발해 발표한다 새누리당은 거국내각을 말할 자격조차 없는 집단이다 거국내각은 무엇을 전제로 하던 진상규명이 먼저여야 한다 거국내각 이전에 국권을 유린시키고 헌정질서를 교란시킨데 대해 제대로 된 진상규명이 선행되어야 한다 헌법에 아무 근거가 없는 거국내각이 이유가 있고 정당한 것은 정치적 혼란으로 더 이상 대통령이 헌정질서를 이끌어갈 자격과 상황이 되지 못할 때 정치적 지도자간의 합의로 분위기가 조성되어야지 할 수 있는 것이다 국민의 동의가 있어야지 가능한 것이다 국민은 새누리당이 하자고 하고 야권인사를 마음대로 징발하는 면피용 국면가리기용 거국내각은 동의하지 않는다 진상규명을 할 수 있는 특별법에 의한 특검을 통해서 납득할만한 조치가 있을 때 논의가 가능할 것이다 아무런 진상규명 없이 국권 파괴자인 대통령이 임명장을 주고 또 대통령이 결재권을 여전히 가지고 있어서 아무런 법적 권한도 없는 거국내각이 출발한다면 이는 장식용 내각에 불과하고 국면탈출용 껍데기 내각이 될 것이라는 것을 다시 한 번 강조한다 이렇게 당 정 청이 가관인데 어제 또 검찰은 청와대 압수수색 쇼를 했고 청와대는 상자의 박스를 골라서 내줬다고 한다 도대체 국권을 문란하게 하고 국권을 파괴시킨 아지트에 있는 범죄자 집단 청와대가 증거를 일일이 골라주는 압수수색이 무슨 의미가 있겠는가 하루 빨리 진상규명을 할 수 있는 별도 특별법에 의한 특별검사를 임명할 수 있도록 해야 한다 또 나부터 먼저 조사하라 는 대통령의 초심 없이는 국면 타개는 어려울 것이다 우상호 원내대표 이번 사건의 본질은 비선실세에 의한 국정농단이다 다시 말하면 박근혜 대통령이 국정운영 시스템인 헌법과 법률에 기초하지 아니하고 자의적으로 자신이 신뢰하고 의지할 만한 사람에게 국정을 농단할 기회를 줬다는 것이다 이를 바로잡자는 것이 국민의 뜻이고 야당의 목소리이다 그렇다면 이 문제의 진상을 규명하고 수습하는 과정 역시 제대로 된 시스템을 복원하는 길로 가야한다 그런데 지금 보면 이 수사에 대한 짜맞추기식 시나리오조차도 외부에서 진행된 의혹이 강하고 청와대 인사나 수습책도 또 다른 비선실세에 의지하고 있는 것이 아닌가라는 의구심이 있다 혹자는 김기춘씨라고 하고 혹자는 다른 이름의 이름을 거명한다 바로 이런 식의 국정운영을 하지 말라는 것이다 끊임없이 비선에 의지하고 끊임없이 또 다른 실세를 만들어내는 방식이 박근혜 대통령이 불신 받는 근본 원인인데 또 비슷한 방식을 택하고 있다 비서실장부터 임명하지 않고 민정수석부터 임명한 것도 문제이다 우병우를 최재경으로 교체한들 이 시스템을 바꾸지 않으면 또 다른 문제가 생겨날 것이다 국무총리를 먼저 임명하고 내각 추천을 받고 비서실장을 먼저 임명하고 수석들을 추천해 같이 의논하는 것이 제대로 된 시스템이 아닌가 또 민정수석부터 임명한다 이렇게 하지 마시라 검찰은 진상을 제대로 규명하기 위한 골든타임을 이미 놓쳤다 수사 의지도 빈약해 보인다 청와대의 조직적인 방해를 이겨내지 못했다 미국 는 일주일 후면 대통령이 될 것이 확실한 힐러리에 대해서도 재수사 결정을 내렸다 그러니 신뢰하는 것이다 성역 없이 단서와 근거가 있으면 언제든지 그가 강한 권력자라고 할지라도 수사를 개시하는 이런 경찰과 검찰을 보고 싶은 것이다 잔챙이들 다 잡아놓고 정작 권력에 가까운 사람들은 수사도 못하는 검찰의 자화상으로 어찌 국민들의 신뢰를 받을 수 있겠는가 우리는 특별법에 의한 특검을 통해서만 진상을 규명할 수 있다고 생각한다 또한 이 검찰을 바로세우기 위해서 공위공직자비리수사처를 이번 정기국회 때 반드시 만들어야 한다고 생각한다 새누리당이 이런 주장을 받아들여야만 거국내각을 제안한 진실성이 있다고 할 것이다 야당의 주장은 한마디도 받아들여주지 않으면서 내각만 같이 구성하자는 것을 어떻게 신뢰할 수 있나 특별법에 의한 특검도 반대하고 세월호 진상규명도 반대하고 미르 재단 증인채택도 반대했던 새누리당이 야당과 손을 잡고 내각을 같이 구성하자는 것인가 그러면 특검부터 받으라 세월호 진상규명부터 같이하자 야당이 하자고 한 내용들을 받아들여줄 의사가 있을 때 같이 내각도 구성할 수 있는 것이지 야당이 지난 년간 주장해왔던 내용들에 대해서는 모르쇠하면서 내각만 같이 구성하자는 것인가 그런 국면전환용 카드에 야당이 응할 것이라고 생각하나 어떤 사과와 반성도 없는 집권당이 국면전환용 카드로 거국내각카드를 꺼낸 것에 대해서 분노한다 오늘 시 분에 정진석 대표를 만나게 되어있다 그동안 여야가 합의하지 못했던 어버이연합 청문회 세월호 진상규명 특검법에 의한 특별법에 합의하라 그러면 태도 변화에 대해 판단해보겠다 그러나 이런 야당의 주장은 일체 받아들여주지 않으면서 중립내각을 하자 거국내각을 하자고 한다면 받아들일 수 없다 야당은 바보가 아니다 그렇게 이용당할 생각이 없다 진실로 국정운영의 틀을 바꾸고 새롭게 대한민국에서 여야가 손잡고 각종 현안들을 해결하자고 나온다면 몰라도 지금은 아닌 것 같다 유일호 부총리가 조선해운 구조조정안을 오늘 발표한다 자세히 들여다보면 뼈를 깎는 구조조정을 하겠다고 했던 분들이 뼈를 깎기는커녕 피 한 방울 손이 묻히지 않고 오로지 지원책밖에 없는 방안들로 채워져 있는 것 같다 이런 식으로 하면 더 큰 경제 위기가 온다 더불어민주당이 올 월부터 구조조정을 하라고 그렇게 이야기했는데 지금 월 말이다 오늘 유일호 부총리가 발표하는 안은 결국 방법도 틀렸고 시기도 놓친 그래서 더 큰 경제위기를 불러올 가능성이 있는 미봉책일 가능성이 크다 이럴 때일수록 경제수장이 중심을 잡고 경제의 컨트롤타워가 되어야 하는데 이런 식으로 폭탄돌리기식 정책만 발표한다면 대한민국 경제가 어떻게 돌아가겠는가 정말 걱정이다 제대로 된 대책을 강구하고 국민들을 안심시키고 각 경제 주체들이 흔들리지 않도록 경제부총리가 더 신경을 써야 한다는 점을 지적한다 양향자 최고위원 수능이 일 앞으로 다가왔다 지난 주말 촛불집회에 분 초를 아껴가며 공부하던 수험생들과 엄마들까지도 참석했다 우리 국민들은 사회의 다른 부분은 부패하고 무너져도 대학 입시만큼은 공정할 것을 기대하고 믿었다 그러나 수능을 앞둔 우리 아이들은 자괴감에 빠졌다 오죽하면 말 타고 시험장에 가던지 금메달을 매고가야 하는 것이 아닌가 하는 소리까지 나온다 몇 년 전 요즘 같은 수능기간에 새벽부터 실기 준비 밤늦도록 수능 준비하느라 하루가 멀다 하고 코피를 쏟아내던 딸을 보았다 일하는 엄마로서 제대로 챙겨주지 못해 가슴 쓰라린 밤을 보냈던 기억으로 지금도 먹먹하다 소위 돈 많고 백 있는 부모의 힘으로 상식으로는 도저히 이해할 수 없는 특권으로 입학하고 도저히 받아들일 수 없는 특혜로 학점관리를 받은 어떤 아이를 생각하면 분노가 치밀어 오른다 아무런 특혜도 없었다는 그 대학 총장의 해명은 더욱 분노케 한다 학생을 지도하기는커녕 상전으로 모신 교수들의 행태를 보고 절망했다 그래서인지 모르겠지만 그 대학과 교수들은 그 후에 온갖 지원을 받았다 만약 조사 결과 불법과 비리가 밝혀지면 법적 책임은 말할 것도 없고 죽을 때까지 따라다닐 오명을 자초한 선택에 후회하게 될 것이다 국가가 무너지고 있다 공직과 아무 상관도 없는 사람들이 국가 기밀을 마음대로 들여다보고 국가의 인사정책을 자기들 마음대로 결정했다는 혐의를 받고 있다 이들의 사적 비즈니스를 돕기 위해 국민이 땀으로 낸 세금을 쏟아 부었다 장관 청와대 수석비서관 그리고 놀랍게도 대통령도 그런 경악할 불법과 비리 당사자로 지목되고 있다 무서운 대통령도 있었고 나쁜 대통령도 있었다 무능한 대통령도 있었고 비리에 연루된 대통령도 있었다 그러나 대통령이기를 포기한 대통령은 처음이다 대통령 장관 수석들이 이렇게 하면서 깨끗한 나라를 만들겠다고 김영란법을 만들었다니 얼마나 우스운 일인가 최순실의 돈을 받지 않은 사람들은 학교 선생님들이다 그런 선생님들께 커피가 되네 안 되네 카네이션이 되네 안 되네 참으로 가소로운 일들이다 공권력에 의한 죽음 앞에 사인조차 소신껏 말하지 못하는 나라 대학이 유린당했는데도 용기있게 고백하지 못하는 나라에 우리가 살고 있다 그런 나라를 대통령과 새누리당이 함께 만들었다 대통령에게 맹목적으로 충성한 사람들이 이 슬픈 나라를 만들었다 대통령의 말을 빗댄다면 박근혜 최순실 게이트 는 온 우주가 통탄할 일이다 박근혜 대통령에게 촉구한다 우리 국민들에게 우리 엄마들에게 우리 아이들에게 사죄하시라 침묵의 커튼 뒤에 숨지 말고 국민 앞에 진실을 고백하시라 새누리당 대표와 탈출구를 의논할 때가 아니라 국민 앞에 진실을 밝힐 때이다 그것이 상처 입은 우리 아이들과 엄마들을 위한 최소한의 예의일 것이다 심기준 최고위원 불통의 이 정권만 아직도 모르고 있는 것 같다 아직도 감출 수 있고 짜맞출 수 있다고 생각하는 것 같다 수십 가지 비리의혹의 당사자인 최순실에 대한 검찰의 매우 친절한 배려가 그렇다 최순실의 끄나풀들이 동시다발적으로 오리발을 들고 입을 맞추며 준동하기 시작했다 대규모 인적 쇄신을 하는 척 책임총리제 실시 등으로 국민을 현혹하고 짜맞추기식 수사로 대통령을 희생자인양 최순실의 단순한 국정개입으로 이 국면을 전환해 이 모든 것을 잠시의 분노 표출로 마무리하려 한다면 아버지는 군대로 정권을 잡았지만 그 딸은 국민에 의해서 정권을 내놓아야 할지도 모른다는 것을 명심해야할 것이다 평창동계올림픽에도 최순실이 개입된 정황이 속속 드러나고 있다 올림픽 개 폐막식장 건설 동계스포츠영재센터 올림픽 마스코트와 홍보 동영상 문제 그리고 조직위원장 문제에서부터 부동산 투기까지 최순실이 올림픽을 준비하는 것 같다 평창동계올림픽이 년 앞으로 다가왔지만 다른 부분과 다르게 개 폐막식장 공정률은 밖에 되지 않는다 그 이유는 문체부가 스위스의 누슬리 사를 사업에 참여시킬 것을 강요했고 콘셉트에 맞지 않는다고 조직위에서 반대했기 때문이다 그러나 문체부의 압력은 계속되었다 결국 누슬리 사는 배제되었지만 이로 인해 최종결정이 무려 개월 이상 지연되었고 사업비는 억 원이 늘었다 최근에 알려진 바로 스위스 누슬리 사는 최순실 소유의 더블루 가 를 체결했던 회사였다 최순실의 실세로 알려진 조카 장시호가 사무총장을 맡은 동계스포츠영재센터도 심각하다 그런데 장시호는 동계스포츠와는 무관한 승마선수 출신이다 이 사단법인도 준비에서부터 설립까지 개월밖에 걸리지 않았고 설립 년 남짓한 기간에 억에 가까운 문체부 예산을 지원받았다 그동안 영재육성사업을 해오던 설상과 빙상협회는 이러한 법인이 설립되었는지도 모르고 있었다 이 법인의 예산 운영에 많은 문제가 제기되었지만 문체부는 지원만 할 뿐 운영은 관여하지 않는다는 무책임한 발언을 하고 있다 철저한 사후정산이 필요하다 최근 문체부가 억 천만 원을 들여 졸속으로 제작한 평창동계올림픽 홍보영상 아라리요 평창 은 차은택이 연루되어있다 이 영상은 공개되자마자 네티즌 사이에서 싫어요 테러를 당했다 전문가들은 만원도 들지 않는 수준이라고 한다 올림픽 마스코트는 당초 호랑이와 곰이 선정되었지만 문체부 김종덕 전 장관이 느닷없이 진돗개로 바꾸라고 지시했고 조직위는 물론 까지 반대해서 수호랑 반다비 를 확정했다 그 과정에서 최종 발표까지 수개월의 시간과 예산을 낭비했다 이 석연치 않은 조직위원장 교체 마스코트 조 원의 규모로 치러지는 동계올림픽의 시설 행사 홍보 등에 최순실에 입김이 작용하지 않은 곳이 없다는 의혹이 강하게 일고 있다 국가대사인 동계올림픽이 최순실과 그 실세들의 농단 대상이 되었다는 사실에 분노를 감출 수 없다 동계올림픽준비와 지원사업들에 최순실의 검은 그림자가 스며들어 성공적 개최에 차질을 빚지 않을까 걱정이 된다 이제라도 평창동계올림픽이 국제적 망신거리로 전락하지 않도록 남은 기간 명명백백하게 사실들을 밝히고 새롭게 준비해나가야 할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58762,2016-10-30, 최순실 블랙홀에도 국가 외교안보는 바로 서야한다 비선실세 국정농단의 주인공 최순실씨가 전격 귀국했다 또 어떤 회오리바람이 몰아칠지 알 수 없는 정국이다 최씨의 전 방위적 국정농단에 온 국민이 망연자실한 가운데 국방 통일 외교 분야 등 국가 존립의 근간이 되는 정책마저 그 손에 놀아났다는 데 할 말을 잃었다 최씨가 대통령 용어로는 매우 낯설었던 통일 대박 단어 이후 나왔던 드레스덴 선언 연설문 수정은 물론이고 독도와 위안부 문제까지 관여한 사실이 드러났다 대외비로 다루어져야 할 남북접촉 사실이 언론에 공개되는가 하면 년 동안 남북협력의 최후보루였던 개성공단 폐쇄가 비선 논의 모임에서 결정되었다는 보도까지 국가의 외교안보 정책 전 분야가 의혹투성이다 개성공단 기업 비상대책위원회는 일 국회에서 기자회견을 열고 개성공단 폐쇄 전면중단 결정 과정 이면에 비선 개입 보도를 접하고 분노와 개탄을 금할 길이 없다 며 철저한 진상 규명을 촉구했다 북한 차 핵실험 이후 월 일 정부의 일방적인 폐쇄조치는 개의 개성기업과 여개 협력업체의 피해와 희생만을 남겼다 개성공단은 북한 근로자 만여 명에게는 시장경제의 교육장이었고 남북근로자가 서로의 다름을 이해하는 통일준비 공간이었다 박근혜 대통령이 진정 통일대박을 부르짖으며 북한주민의 인권을 걱정하고 북한 주민의 귀순을 희망했다면 개성공단의 가치를 이리도 모르지는 않았을 것이다 국가 안보가 비선실세의 손아귀에서 놀아날 때 대통령을 보좌하는 대통령 안보실 국방부 외교부 통일부는 도대체 무엇을 하고 있었는가 안보 무능을 은폐하기 위해 북한붕괴론에 얼씨구나 맞장구나 치고 있었던 것은 아닌가 지금 최순실 블랙홀이 온 나라를 빨아들이고 있는 동안 국내 경제는 악화되고 있고 한반도 주변 정세는 더욱 요동치고 있다 한국 미국 일본과 북한 중국 러시아의 협력과 경쟁 구도는 공고화되고 있다 이 시각에도 북한 핵능력 고도화 시계는 멈추지 않고 있다 그런데 우리 외교안보의 현재와 미래는 보이지 않는다 아무리 대한민국이 난파선처럼 표류하고 있다고 해도 국가 안보는 흔들리지 않아야 한다 갑자기 한일 군사정보보호협정 개정을 추진한다는 건 무슨 소리인가 국방 무능력이 드러나도 부끄러워 할 줄 모르는 정부당국에게 북 도발 대응 은 전가의 보도다 북한과 미국이 제 국에서 접촉을 가졌다 지난 일 말레이시아 쿠알라룸푸르에서 열린 북미간 트랙 형식의 대화에 참여한 로버트 갈루치 전 미 국무부 북핵특사가 회동 결과를 미 차기 행정부뿐 아니라 차기 행정부 인수팀에도 전달할 것 이라고 밝혔다 북미는 당장 접촉의 성과가 없더라도 미국의 새 정부 출범에 앞서 상호 탐색전이라도 하는데 우리의 남북대화는 요원하기만 하다 매일 방송과 신문보기가 두렵다 어떤 치부가 드러날까 부끄럽다 세상을 움직이는 힘은 우주의 기운 이 아니다 국민의 힘 이다 지금이라도 국민의 소리를 들어라 저 아우성 절규가 들리지 않는가 +http://theminjoo.kr/briefingDetail.do?bd_seq=58761,2016-10-30, 윤관석 수석대변인 추가 현안 서면 브리핑 긴급 최고위원 간담회 결과 최순실 게이트 대책위원회를 박근혜 최순실 게이트 국민조사위원회 로 확대 개편하기로 했다 확대 개편하게 된 취지는 최순실씨의 극비 귀국 최근 빨라진 검찰 조사 청와대의 검찰 압수수색 불응 등 국정농단의 진상을 덮고 은폐하려는 정황들에 적극 대응하기 위한 것이다 또한 박근혜 최순실 게이트는 최씨가 국정농단의 장본인이지만 박근혜 대통령의 국정 책임도 똑같이 엄중하다 박근혜 대통령의 문제까지 국민조사위원회에서 조사할 것이고 특히 대통령의 법률 위반 사항에 대해서 검토 조사하기로 했다 새누리당의 거국내각 제안은 일고의 가치도 없다 새누리당은 거국중립내각을 제안할 것이 아니라 박근혜 정부의 국정 동반자로서 박근혜 최순실 게이트를 사실상 비호했다는 점에서 국민들께 석고대죄하고 확실하게 책임지는 자세를 보여야 한다 내일 오전 의원총회를 열고 모레 오후에는 전국지역위원장 중앙위원 수도권 지방의원들 함께 참여하는 박근혜 최순실 게이트 진상규명 및 나라세우기 국민 보고대회 를 개최한다 아울러 전국적 시도당별로 같은 국민보호대회를 개최해 박근혜 최순실 게이트 진상규명을 추진 계획이다 박근혜 대통령이 제일 먼저 해야 할 일은 본인을 포함해 성역 없는 수사에 대해서 공개적으로 입장을 밝히는 것이다 그래야 청와대에 대한 압수수색이 가능하고 최순실의 극비 귀국에 따른 또 다른 은폐 왜곡 수사를 막을 수 있다 박근혜 대통령은 성역 없는 수사를 공개적으로 천명할 것을 강력하게 촉구한다 청와대 인사 개편은 너무 늦은 만시지탄 우병우 시즌 돼서는 안돼 정말 청와대 수석 몇 명을 바꾸고 비서관 바꾸는 것이 이래 힘든지 몰랐다 문고리 인방은 년 전부터 교체를 요청했다 우병우 민정수석 또한 즉각 교체됐어야 한다 그런 점에서 오늘 인사 개편은 너무 늦은 만사지탄의 교체이다 또한 단순 교체에 그쳐서는 안 되며 위법사항이 있는 인사는 철저하게 책임을 물어 처벌해야 한다 최재경 민정수석 임명자는 우병우 시즌 의 역할을 해서는 안 된다 최재경 임명자는 사건 수사를 맡았던 것으로 알고 있다 혹시라도 박근혜 최순실 게이트 수습용 인선이 아닌지 주시해서 지켜보겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58760,2016-10-30, 긴급 최고위원 간담회 모두발언 일시 오후 시 장소 국회 당대표 회의실 추미애 대표 국민이 화병이 나있다 최순실이 대통령인 것처럼 범죄인이면서 영국을 통해서 몰래 귀국을 하고 지금 안가에 가있는지 어디 있는지 출입국을 뻔히 알 수 있는 법무부는 손 놓고 있으며 변호인을 통해서 먼저 성명 발표를 하는 짜고 치는 쇼를 보면서 국민들이 대단히 분노하고 화병이 날 지경이다 새누리당이 거국내각을 언급했다고 하는데 이제 와서 새누리당의 이야기는 듣고 싶지도 않고 중요하지도 않다 중요한 것은 거국내각 운운하기보다 해야할 것을 먼저 하는 것이다 이제 와서 모래성 위에 집을 짓겠는가 헌정을 파괴하고 헌법상 권리를 통째로 사교의 교주 최순실에게 헌납해온 지가 년이 넘었다 그런데 이제 와서 오물 같은데다가 다시 집을 짓겠다는 말인가 집이 지어지겠나 우선 우병우를 즉각 해임하고 조사하십시오 그리고 최순실도 빼간 청와대 외교문서 기밀문서다 청와대 압수수색 거부에 무슨 궤변이 많은가 청와대는 제대로 압수수색을 할 수 있게 해야 한다 최순실 즉각 체포하십시오 그리고 대통령이 직접 나서서 화병 난 국민에게 상세 보고를 하셔야 한다 이제 대통령 말씀 말고는 어느 누구의 말도 아무런 효력이 없다 제가 미리 말씀드린 것처럼 이제 이 국면은 국권을 파괴하고 헌정질서를 교란시킨 대통령이 문제의 본질이고 책임자이다 답변을 기다린다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58759,2016-10-30, 윤관석 수석대변인 오후 현안 브리핑 일시 오후 시 분 장소 국회 정론관 검찰은 지금 즉시 최순실을 즉각 긴급체포하고 구속수사해야 한다 검찰은 지금 즉시 최순실을 즉각 긴급체포하고 구속수사해야 한다 국민들은 검찰이 오늘 아침 극비리에 귀국한 최순실을 수사하려는 것인지 보호하려는 것인지 의아해하며 비판하고 있다 박근혜 대통령은 최순실 게이트의 당사자이며 국정농단 국정파괴의 책임자다 박근혜 대통령은 진상규명을 위해 성역 없는 수사를 공개 천명하고 본인부터 수사 받겠다는 의지를 국민에게 밝혀야 한다 청와대에 대한 압수수색에도 즉각 협조하고 응할 것임을 밝히기 바란다 아울러 청와대 비서진의 전면 개편이 즉각 단행되어야 한다 특히 우병우 수석 정호성 비서관 등 문고리 인방 안종범 수석은 이번 사태의 책임을 물어 해임하고 처벌해야 한다 국민들은 청와대가 아직도 진상규명을 가로막고 증거물을 폐기한 것이 아닌가하는 의혹을 강하게 갖고 있다 국정운영 능력을 상실한 황교안 총리를 비롯한 최순실표 허수아비 부역내각은 즉각 사퇴하고 교체되어야 한다 새누리당과 박근혜 대통령의 정무수석 홍보수석을 지낸 이정현 대표는 국정을 함께 책임졌던 집권여당으로서 이번 사태에 대해서 발 빼고 책임을 회피하는 정치쇼를 중단하고 공동책임을 통감하고 국민에게 석고대죄해야 한다 어제 청계광장에서 보았듯 국민의 분노는 걷잡을 수 없다 각본에 의한 수사 위기 수습용 조치로는 더 큰 국민적 저항을 불러올 뿐이다 박근혜 대통령은 결단하고 검찰은 신속하게 국민의 요구에 답하기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58758,2016-10-30, 윤관석 수석대변인 추가 현안 서면 브리핑 검찰은 지금이라도 즉각 최순실씨의 신병을 확보하라 검찰이 급거 귀국한 최순실씨를 오늘 당장 조사하지는 않겠다고 입장을 밝혔다 자기 범죄에 대해서는 증거인멸죄가 성립하지 않는다는 점에서 검찰이 최씨의 증거인멸 시간을 벌어준 것이다 애초에 출입국사무소와 검찰이 최순실씨의 입국사실을 몰랐을 리 만무하다 검찰이 최씨의 입국장에 나와있다는 언론의 의혹 제기까지 있다 결국 최씨의 신병을 확보하지 않은 것은 검찰이 신병 확보 의사가 없었던 것이라고 볼 수밖에 없다 조사가 어려운 건강상태라면 최씨를 공항에서 체포해 신병을 확보한 후에 병원에 격리하면 될 일이었다 아니 검찰이 최씨의 건강상태를 걱정할 이유조차 없다 검찰의 행태로 보아 어제 청와대에 대한 압수수색 시도도 그저 보여주기 위한 깜짝쇼가 아닌지 의심스럽다 무어라고 항변하더라도 결과는 청와대와 최순실씨의 증거 인멸을 검찰이 방조한 것이다 국민의 분노를 누그러뜨리고 사태를 컨트롤 범위하려는 청와대와 검찰의 음모가 있다고 볼 수밖에 없다 전대미문의 국기문란을 저지른 장본인이 공항을 통해 유유히 입국하고 몸이 아프니 나중에 출석하겠다는 피의자와 그런 피의자를 그냥 두는 검찰을 본 적이 없다 경찰이 진정 진상 규명의 의지가 있다면 지금이라도 즉각 최순실씨의 신병을 확보할 것을 강력히 촉구한다 박근혜 대통령 또한 나부터 수사하라 고 공개 선언해 검찰 수사가 성역 없는 수사가 될 수 있도록 할 것을 다시 한 번 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58757,2016-10-30, 우상호 원내대표 기자간담회 모두발언 일시 오전 시 장소 국회 정론관 우상호 원내대표 모두발언 몸이 너무 안 좋아서 하루 쉬려고 했는데 저보다 오히려 몸이 더 안 좋은 분 때문에 나왔다 최근 일 흐름을 보면 진상을 조직적으로 은폐하려고 하는 시도가 매우 노골적으로 진행되고 있다 관련 당사자들이 입도 맞추고 행동도 맞춰서 무언가 정해져 있는 시나리오대로 움직여가는 흐름이 포착되고 있다고 규정한다 또한 정권 차원에서 진상의 정확한 파악을 막으려는 세력들이 비호하는 흐름들도 보이는 게 아닌가 하는 의구심을 말씀 드린다 첫째 의혹당사자인 고 아무개 중국에 있던 차은택 독일에 있던 최순실의 귀국 시점과 일정들이 너무 딱 떨어지고 있다 이것은 서로 연락하지 않고서는 이뤄지기 어려운 공동행동이라고 본다 변호인까지 준비해서 변호인이 브리핑을 하면서 다가오는 검찰수사에 대비하는 모양새들이 우려스럽다 한편 청와대에 대한 압수수색이 어제 무산됐다 명분은 기밀유출을 막기 위해서라고 한다 대한민국 검찰이 자신들이 확보한 기밀을 유출할 리도 없고 외부에 알릴 리도 없다 말하자면 대한민국 최고의 수사기관을 못 믿겠다는 것인지 압수수색을 거부한 명분도 국민이 납득하기 어렵다고 본다 자신들과 압수수색 일정을 상의하지 않고 왔기 때문에 받아들이지 않은 것으로 본다 그러나 법원이 발부한 영장의 집행을 막은 것은 같은 대한민국 기관인 청와대로서 아무런 명분이 없다 진실을 은폐하기 위한 시간을 벌기 위해 압수수색을 받아들이지 않고 있다고 받아들일 수밖에 없다 이런 식으로 나오신다면 야당의 대응 강도를 높일 수밖에 없다고 경고한다 대통령이 직접 자신의 혐의를 부분적으로 인정한 기자회견을 했는데 왜 검찰의 수사를 방해하나 도대체 누가 관련된 증인들의 귀국 및 출석을 조율하고 있는가 저는 이것은 국가기관이 일부 관여한 게 아닌가 라고밖에는 설명할 수 없다 더 큰 국민의 저항이 있을 수밖에 없는 수습책을 내놓고 있다고 생각한다 그래서 다시 말한다 최순실씨의 신병을 즉각 검찰이 확보하시기 바란다 건강이 안 좋다면 검찰 안에서 편하게 쉬십시오 안 괴롭힐 테니까 모처에서 관련된 사람들끼리 입을 맞추고 진실을 은폐하기 위한 시간을 벌고 있다면 검찰이 그 시간을 벌어주고 있는 꼴이 된다는 점에서 즉각 최순실씨의 신병 확보부터 먼저 하라고 주장한다 두 번째 청와대에 대한 압수수색을 즉각 성역 없이 진행해야 한다 영장집행 과정에서 관련 자료가 국가기밀에 가까운 것이면 현장에서 상의해라 그러면 검찰이 그건 빼줄 것이 아닌가 저는 지금 청와대와 관련된 분들이 이 상황을 이런 식으로 덮고 가려고 한다면 야당은 가만히 있지 않겠다는 것을 경고하고자 한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58756,2016-10-30, 윤관석 수석대변인 오전 현안 서면 브리핑 최순실씨 귀국은 진상규명의 시작이 되어야 한다 최순실씨가 오늘 오전 극비리에 귀국했다 최순실씨의 귀국은 진상규명의 시작이 되어야 한다 검찰의 신속하고 철저한 수사를 촉구한다 최씨의 변호인은 기자회견을 통해 국민들께 좌절과 허탈감을 가져온 데 대해 깊이 사죄드리는 심경 이라면서도 수사해서 진상을 규명하면 될 일 이라고 말했다 이것이 전대미문의 국정농단 국기문란사태의 주범으로 지목된 사람이 할 수 있는 말인지 어처구니없다 또 최씨는 곧바로 검찰에 출두하지 않고 몸을 추스를 시간을 달라고 했다 최씨가 입 맞출 시간을 벌려는 시도가 아닌지 매우 의심스럽다 최씨의 귀국이 또 다른 각본에 의한 수사나 왜곡 수사의 시작이 된다면 결코 국민이 용서하지 않을 것이다 어제 청와대가 검찰의 압수수색을 거부한 것 또한 국정농단의 진상 규명을 방해하려는 움직임으로 볼 수밖에 없다 청와대 인사들이 최순실씨와 직간접적으로 연계된 것으로 드러나고 있는 상황에서 압수수색 거부가 증거인멸이나 은폐로 이어지지 않을까 우려스럽다 무엇보다 이 모든 사태는 대통령으로 인해 비롯된 일이다 박근혜 대통령은 나부터 수사하라고 공개 선언해 검찰 수사가 성역 없는 수사가 될 수 있도록 해야 한다 또한 박근혜 대통령은 즉각 검찰의 압수수색을 받아들이고 최순실표 청와대와 내각을 전면 교체해야 한다 진상 규명을 가로막는 행위나 증거 은폐 및 인멸 시도는 국민들이 묵과하지 않을 것이다 검찰에 철저한 수사를 촉구한다 아울러 더불어민주당은 오늘 오후 시 긴급 최고위원간담회를 열어 향후 대응방안을 논의할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58755,2016-10-30, 기동민 원내대변인 오전 현안 브리핑 일시 오전 시 분 장소 국회 정론관 최순실씨 귀국 관련 최순실씨가 귀국했다고 한다 변호인을 통해 몸을 추스를 시간을 달라고 한다 여전히 법위에 군림하는 존재다 언론에 자신의 입장을 강변하는 인터뷰를 진행할 힘은 남아 있고 검찰수사를 받을 정도의 건강상태는 되지 않는다는 게 말이 되나 지금 당장이라도 검찰에 출두해서 엄정한 수사를 받아야 한다 국기 문란 비리와 부패 혐의자 최순실씨는 국정농단의 전모를 밝히고 국민에게 엎드려 사죄해야 한다 공권력을 우롱하며 유수의 언론사를 이용한 기획인터뷰와 입국과정 등 세간의 의심대로 범죄행위를 축소하고 은폐하려는 어떠한 시도도 용납할 수 없음을 분명히 한다 우리는 지금도 어떤 보이지 않는 거대한 존재가 최순실씨를 보호하고 조정하고 있다는 의심을 지울 수 없다 마치 피해자인양 언론플레이로 국민을 우롱한다면 더 큰 죄를 짓는 것임을 명심해야 한다 청와대 전면 개편 내각 총사퇴 만이 답이다 강남 호스트바 마담과 종교집단까지 등장했다 조카에 언니까지 참으로 가관이 따로 없다 문체부를 식민지 처럼 농락하고 대기업 사정 정보를 이용해 돈을 뜯어내는 파렴치한 짓이 버젓이 자행됐다 전경련과 대기업은 최순실 패거리의 마름과 호구로 전락했다 이화여대부터 김앤장까지 대한민국의 모든 특권층이 부역 행위에 동원되고 부패와 비리의 온상으로 전락해 버렸다 일개 감독이 나랏돈을 주무르고 장관직을 대가로 주겠다 할 정도로 망가진 이 나라를 어찌 되살려야 할지 걱정이다 국민의 분노와 허탈감은 하늘을 치솟고 있는데 흔들림 없이 국정운영을 해나가겠다 니 이리도 국민을 무시하는 정부를 어떻게 인정하고 받아들일 수 있겠나 청와대는 전면 개편돼야 한다 이원종 비시설장을 비롯해 우병우 안종범 수석 문고리 인방 조인근 연설비서관을 비롯한 청와대 내 최순실 부역자들을 모두 색출하여 법의 심판대에 세워야 한다 예외가 있을 수 없다 내각은 총사퇴하라 허수아비 국무총리를 비롯한 무능력한 경제부처 최순실이 낙점하고 우병우가 검증했다는 의혹을 받고 있는 조윤선 장관을 비롯한 최순실 인사들이 장악한 정부는 믿을 수 없다 총사퇴하고 중립 내각을 구성해야 한다 남은 임기를 그나마 버틸 수 있는 유일한 길이다 박승춘 보훈처장 등 정부 내 최순실 연루 인사들 역시 스스로 물러나 국민의 심판을 기다려야 한다 이정현 대표와 친박세력도 책임을 면할 수 없다 청와대 출장소장 이정현 대표는 수습을 논할 자격이 없다 청와대 홍보수석으로 기밀 누설 책임자 중 한 사람이다 스스로 책임지는 자세를 보여야 한다 자기 일 아닌 것처럼 강 건너 불 보듯 하는 서청원 최경환 의원 등 새누리당 내 친박세력 역시 책임을 면할 수 없음을 명심하기 바란다 스스로 거취를 고민하기 바란다 새누리당 역시 국민 앞에 석고대죄해야 한다 대통령도 예외는 없다 대통령께서는 피해자가 아니다 모든 사태의 원인은 대통령께서 비호하고 방조한 결과다 스스로 자초하셨다 대통령 조사 는 필수 사항이다 지금 대한민국에서 대통령 말씀을 믿을 사람은 하나도 없다 스스로 과오를 인정하고 조사를 자청하셔야 한다 국민이 됐다 고 할 때까지 그 누구도 수습을 말할 자격이 없다 우리당은 처음부터 끝까지 국민과 함께 할 것이다 철저한 진상 조사 책임자와 부역자 처벌 청와대와 정부 쇄신 등이 이뤄지고 이 나라가 정상궤도로 돌아올 때까지 국민과 함께 할 것이다 청와대 압수 수색 검찰총장과 법무부 장관이 나서야 한다 청와대의 증거인멸 행위가 노골적으로 진행되는데 무기력한 검찰이 안타깝다 비리와 범죄 행위를 국가기밀이라며 우기는 청와대의 역시 용서받지 못 할 것이다 형사소송법 조 조는 국가 중대이익이나 군사상 기밀을 보호해야 한다는 것이지 비리를 보호하라는 것이 아니다 최순실에게는 막 주던 정보를 대한민국 검찰에게는 줄 수 없단 말인가 청와대의 압수수색 방해 행위는 명백한 공무집행 방해 행위다 처벌의 대상임을 명심해야 한다 언제부터 청와대가 범죄자를 비호하는 보호막이었단 말인가 검찰 수사에 적극 협조하는 것이 그나마 용서받을 수 있는 길이다 청와대 조사 일개 검사가 할 수 있는 일이 아니다 검찰총장과 법무부 장관이 직접 나서라 이석수 특감은 소환하면서 우병우 수석 부인과 아들은 소환조차 못한다는 것이 말이 되는가 성역 없는 조사와 진상 규명으로 국민의 검찰로 다시 태어나야 할 것이다 한 일 군사정보보호협정 즉각 중단하라 국방부와 에 경고한다 한 일 군사정보보호협정 즉각 중단하라 오얏나무 아래서 갓 끈도 고쳐 매지 않는 법이다 국민 공감대 형성이 우선 이라는 국회 경고가 그리도 우스운가 시키는 대로 대사만 읊고 있는 국방부장관도 딱하지만 나라가 어수선한 틈을 이용해 국민이 용납할 수 없는 일을 추진하겠다는 김관진 안보실장과 의 꼼수 역시 용납할 수 없다 국회 비준 대상이 아니라는 이유로 은근슬쩍 넘어가려 한다면 결코 용서할 수 없다 즉각 중단하라 +http://theminjoo.kr/briefingDetail.do?bd_seq=58754,2016-10-29, 새누리당은 국민배신의 정치 로 또다시 심판 받으려는가 새누리당이 최순실 특검 에 반대하면서 대통령과 새누리를 고사시키려는 의도 라고 말한 것은 자신들이 뽑은 원내대표를 갈아치우며 배신의 정치를 심판하라 는 대통령 지시에만 충실했던 그 간의 집권여당 모습을 다시 떠오르게 한다 박대통령의 사과 이후 닷새가 지난 오늘까지도 새로운 비리와 의혹이 줄줄이 보도되고 있지만 이정현 당대표는 집권여당의 책임을 인정하는 공식발언 조차 하지 않고 있다 지난 월 새누리당 전당대회는 누가 박근혜 대통령과 가까우며 그 뜻을 대신하고 있는 지 경쟁하는 경연장이었다 당 대표 후보 최고위원 후보들까지 나서 저마다 박 대통령과의 인연을 강조했다 총선을 앞두고 이른 바 실세 의원들이 이게 다 대통령 뜻 이라며 공천에 개입했던 사실이 전화녹취가 폭로되면서 만천하에 드러나기도 했다 엊그제까지 대통령 연설문이 민간인에게 전달되는 것이 말이 되느냐 며 전 청와대 대변인 출신의 새누리당 의원은 언성을 높였지만 지금 그 누구 하나 국민 앞에 엎드려 진정한 참회와 사죄의 목소리를 내는 이는 없다 아무런 권한 없이 대통령 뒤에서 그림자처럼 국정을 농단해온 한 민간인이 있었다면 대통령의 지시에 따라 권력만 향유하려고 했던 새누리당이 있었다 지금부터 모든 판단 기준은 국민이다 국민이 어떻게 생각하느냐 국민이 뭘 바라느냐가 될 것 이라던 말씀 돌려드리겠다 바로 이정현 당 대표 취임 일성이다 오늘 때 이른 추위 앞에 성난 국민이 촛불을 들고 나선다 새누리당은 특별법 특검 에 즉시 합의하고 최순실 게이트 진실규명에 적극 나서야 한다 그것만이 집권여당 새누리당이 국민을 배신하지 않는 길이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58753,2016-10-29, 윤관석 수석대변인 오전 현안 서면 브리핑 대통령 자신부터 조사받겠다는 자세로 전면쇄신 대책 내놔야 어젯밤 박근혜 대통령이 청와대 수석비서관들에게 일괄사표 제출을 지시했다고 한다 의 최순실 파일 보도 이후 일만에야 수습에 나선 것은 전대미문의 의혹에 대한 국민의 분노에 비추어 너무 너무 늦은 조치이다 이제 시작이다 먼저 청와대 비서진을 전면교체해야 한다 특히 이번 사태에 책임이 있는 우병우 수석 정호성비서관을 비롯한 문고리 인방 안종범 수석을 반드시 교체하고 위법한 일에 대해서는 확실하게 처벌해야 한다 최순실 국정농단에 함께 장단을 맞춘 황교안 총리를 비롯한 최순실표 허수아비 내각도 책임을 물어 즉각 교체해야 한다 새누리당은 집권여당으로 공동운명체이다 이정현 대표는 청와대 수석 출신으로 박 대통령의 복심이 아니었던가 새누리당은 공동책임을 무겁게 느끼고 엄정한 대국민사과를 해야 한다 진상규명을 위한 국민과 야당 주도 특검 및 제반조치에 당리당략을 버리고 조건 없이 협조해야 한다 어제부터 이번 사태 관련자들에 대한 검찰조사가 동시다발적으로 이루어지고 있다 최순실 차은택씨가 귀국한다는 소식도 들려오고 있다 검찰이 뒤늦게 속도를 내는 것인지 아니면 또 다른 가이드라인과 시나리오에 따라 사태수습용 꼬리자르기 수사 부실 수사 왜곡수사를 하는 것은 아닌지 경계하며 특별히 경고한다 국민은 각본 없는 성역 없는 철저한 수사를 요구하고 있다 지금 최순실 국정농단 사태에 대한 국민의 분노는 고도 깊다 꼼수나 미봉책으로는 결코 해결할 수 없다 사상 초유의 헌정파괴 국정농단 사태는 한마디로 최순실과 박근혜 대통령의 합작품이다 따라서 위기모면용 면피대책은 더 큰 저항을 부를 것이다 대통령 자신부터 조사받겠다는 자세로 근본적이고 전면적인 쇄신 대책에 온 몸을 던져야 한다 그것이 이번 사태로 충격을 받은 국민에 대한 최소한의 예의이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58752,2016-10-28, 금태섭 대변인 오후 현안 브리핑 일시 장소 국회 정론관 조인근의 부인 책임은 대통령이 져야 한다 연설문 유출 의혹이 보도되고 나흘 동안 잠적했던 조인근 전 청와대 연설기록비서관이 입장을 밝혔다 최순실과는 전혀 모르는 사이이고 연설문이 고쳐서 돌아온 적이 없다 청와대와 상의한 바는 없다 는 것이다 예상했던 답변이다 다만 연설문 작성 후 정호성 비서관에게 넘겼다는 것으로 책임을 미뤘다 박근혜 대통령의 녹화 사과 이후 최순실에 이어 조인근 전 비서관도 대통령이 인정한 사실조차 부인으로 일관하고 있다 최순실 게이트 관련자들은 이제 대통령의 사과조차도 웃음거리로 만들고 대통령이 국정농단의 중심에 있었다는 사실만 확인해주고 있다 최순실도 조인근도 우주의 기운 도 모르고 일이고 혼이 비정상 도 모르는 일이라고 한다 모든 책임은 이제 대통령에게로 돌려졌다 대통령 스스로 밝혀야 한다 비선실세와 그 부역자들이 거짓을 반복할수록 민심의 분노는 대통령으로 향한다는 것을 잊지 말길 바란다 진실만이 해법이다 최순실 게이트를 박근혜 게이트로 부를 것을 제안한다 지금까지 드러난 국정농단 파문의 중심에 최순실씨가 있었다 그래서 우리는 지금까지 이 사태를 최순실 게이트 로 불러왔다 그러나 이제는 최순실 게이트가 아닌 박근혜 게이트 로 부를 것을 제안한다 국정농단의 주연은 최순실씨인지 몰라도 권력의 사유화를 용인한 것은 대통령 자신이다 이는 박근혜 대통령을 피해자로 둔갑시키려는 시도에 대한 경고 이자 이번 사태의 본질에 대한 확인 이다 우리 더불어민주당과 국민들은 정부에 요구한다 대한민국 민주주의를 무너뜨린 박근혜 게이트 의 진상을 부족함 없이 철저히 규명해주기 바란다 흔들림 없이 국정운영한다는 대통령 언제까지 침묵할 것인가대통령의 녹화사과 이후 침묵하던 청와대가 드디어 입을 열었다 청와대 고위관계자는 오늘 오전 박 대통령은 국민들의 불안을 해소하고 흔들림 없는 국정운영을 하기 위해 다각적인 방향에서 심사숙고 하고 있다 고 말했다 청와대의 답변은 청와대 내부의 조사는 없다 검찰조사에 협조하겠다 정치권의 중립 거국내각 이나 책임총리 같은 제안도 사실상 거부한다는 것이다 일주일 내내 상실감과 절망에 빠진 국민들은 청와대의 답변을 기다리고 있었다 고위관계자의 답변은 대통령이 일부 인적 쇄신을 고민한다는 것이 전부이다 파탄 난 대한민국 정치의 해법을 문고리 인방 과 우병우 안종범 수석과 상의하고 일부 참모진 개편으로 살리려는 것이 청와대가 국민에게 들려줄 수 있는 답변인가 성난 민심은 마냥 대통령을 기다려 주지 않을 것이다 두 수석과 최순실 부역자 전원 사퇴는 문제 해결의 첫 단추에 불과하다 대통령의 결단을 촉구한다 박근혜정부는 무모한 역사전쟁의 시도를 즉각 중단하라 언론 보도를 통해 다음 달 공개될 국정역사교과서에 년을 대한민국 수립 의 해로 기술하는 것으로 알려졌다 이는 대한민국 임시정부의 법통을 계승한다 고 명시한 헌법에 정면으로 위배되는 것이다 교과서 집필진 인이 년 남짓의 시간 동안 날림으로 만든 교과서는 역시나 부실 편향교과서 역사왜곡 교과서에 불과했다 우리 민족의 자랑스러운 항일운동과 임시정부 수립의 의미를 폄훼하고 친일과 독재를 미화하려는 뉴라이트 역사교과서의 연장선에 다름 아니다 애초에 역사교과서를 국정화한다는 발상 자체가 획일적이고 전체주의적인 것으로 자유민주주의에 대한 부정이다 박근혜정부는 최순실 게이트로 불리는 비선실세 국정농단도 모자라서 이제는 국민들과 역사전쟁까지 벌이려고 하는가 만약 박근혜정부가 역사왜곡 국정교과서를 계속 밀어붙인다면 이 또한 최순실씨 등 비선실세의 입김이 작용한 것이라고 의심할 것이다 박근혜정부에 엄중히 경고한다 역사왜곡과 친일 독재 미화의 역사교과서 국정화를 당장 중단하기 바란다 더 이상의 사회적 갈등을 조장하지 말고 민심을 겸허하게 수용하라 브레이크 없는 일방통행식 국정운영은 국민들이 더 이상 용납하지 않을 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58749,2016-10-28, 제 차 최고위원회의 모두발언 일시 목 장소 국회 본청 당대표 회의실 추미애 대표 한마디로 국가가 비상사태이자 비정상사태에 돌입했다 최순실 박근혜의 국정 유린 사건으로 국가가 비정상 상태가 되었다 대통령의 정치적 도덕적 권위는 상실되었다 헌법상 형사상 현직대통령은 불소추 특권이 있는 것이지만 그럼에도 불구하고 이 사태에 대한 대통령의 행정적 책임은 엄중하다 대통령으로부터 시작된 일이다 그래서 국민적인 조사 요구도 봇물처럼 터지고 있다 심지어 국민은 대통령이 하야해야하는 것 아니냐는 심정이다 그래서 국가 정상화가 현재로서는 최우선 과제가 되었다 야당은 국가 정상화의 적극 협조할 것이다 그러나 우선 정부 여당이 해야 할 최소한의 선결조건이 있기 때문이다 왜냐하면 대통령의 녹화 사과를 통해서 보았듯이 현재 상태에 대한 상황인식이 너무나 안이하다 또 최순실 인터뷰를 보면 꼬리 자르기를 시도하고 있다는 것을 국민들이 알고 있다 또한 문제의 핵심인사들이 문제의 핵심인사들이 여전히 활보하고 국정을 쥐고 있다 국정의 맥을 틀어쥐고 있는 우병우 수석이 책임감 운운하면서 청와대 비서진의 사퇴를 가로막고 허수아비 총리가 장관을 모아 국정정상화 간담회를 갖고 최순실 부역의 공동 책임자인 새누리당이 한마디 사과 조차 없이 여야 협상장에 나와 조사에 협력해야할 대통령에게 특검을 임명하라고 하는 코메디같은 이 현상을 보고 국민이 다시 분노하고 있다 그래서 민주당은 현재 새누리당과 벌이고 있는 모든 협상을 다시 생각해보겠다 대 선결 조건이 먼저 이뤄져야지만 우리도 협상을 생각해보겠다 첫 번째 새누리당의 대국민 석고대죄가 이뤄져야 한다 두 번째 우병우 민정수석의 사퇴가 선행되어야 한다 세 번째 최순실 부역자의 전원 사퇴가 이뤄져야 하는 것이다 이렇게 해서 청와대와 정부 집권당이 먼저 사죄하는 마음으로 국민들의 상처를 이해하고 국정위기를 수습하겠다는 자세가 보인다면 우리는 적극적으로 새누리당과 마주하고 정국 정상화에 협조할 것이다 새누리당이 계속 침묵으로 국민 민심을 억누르면서 집단적 반발을 한다면 새누리당의 부역자들을 필요에 따라 우리가 먼저 정리해서 발표할 수도 있다 더불어민주당은 국가 정상화를 위한 비상시국 안정체제에 돌입하겠다 제 야당으로서 총선 민의를 받들어서 현 상황에 대해서 국민의 대한 송구함과 대한민국 미래에 대한 무거운 책임감을 갖고 대처해 나가겠다 우선 정부여당의 국정 컨트롤 능력이 사실상 붕괴된 이 마당에 외교 안보 및 경제 등의 국정 위기로 번지는 것을 막기 위해 야당으로서 책임 있는 국정감시 역할을 대폭 강화해 나가겠다 이를 위해 경제 외교 안보 등 국정자문단을 중심으로 전직에 국정 경험이 있는 분들을 모셔서 역량을 총 동원하는 체제로 만들겠다 정부 부처별 대응도 해내고 당내에서도 비상체제를 구축해 신속하게 현안 문제를 다루고 활발한 제안도 할 것이다 또한 범민주 세력의 단일한 대응과 지혜 수렴을 위해서도 적극적으로 임하겠다 마지막으로 현 상황의 엄중함을 대통령이 깊이 인식하고 최소한의 숙제인 범여권 전면 개편과 책임자 정리 등을 단행하기를 계속 촉구할 것이다 우리는 이러한 초유의 국가 기강 헌법 파괴 사태를 국회를 중심으로 풀어가되 가능 그것이 가능할지 국민과 함께 돌파해가야 하는 무거운 책임을 갖고 지혜를 모아나가겠다 우상호 원내대표 어제 우연한 기회에 나이가 지긋하신 성향은 보수적인 언론인을 한분 뵈었다 나라가 매우 흔들리고 청와대와 내각이 매우 흔들리고 있다 집권당 정신 못차리고 있는 것 같다 국민들이 기댈 곳은 민주당밖에 없다 잘 해 달라 고 말씀하셨다 마음이 매우 무거웠다 비록 야당이지만 국민들의 분노를 담아 진상 제대로 규명하는 일 그러나 또 한편으로 국가의 혼란이 극대화 되어 경제 위기로 치닫지 않게 만들기 위한 길에 더불어민주당이 안정감을 갖고 잘 대처하겠다고 국민들게 약속드리겠다 보도에 따르면 정말 희한한 일이 발생해서 사실이라고 믿고 싶지 않은 일들이 계속 보도되고 있다 롯데로부터 억을 재단이 모금을 했다가 롯데가 압수수색 들어가기 주일 전에 억 돌려줬다는 보도가 나왔다 이는 정경유착의 정점의 달하는 일일뿐더러 롯데에 대한 수사가 이뤄질 것을 재단이 알고 돈을 돌려줬다는 것이다 이를 알려줄 사람이 우병우 밖에 없지 않나 검찰이 재단에게 알려줬을리 없다 재벌에 대한 핵심 수사 정보까지 재단에 보고해서 재단이 돈을 먼저 돈을 돌려주게 만든 무슨 이런 일이 벌어질 수 있는지에 대해 정말 믿을 수 없다 딱 떨어진다 돈을 모금 받은 재단이 돈을 왜 돌려받는가 나중에 사단이 날까봐 돌려준 것이다 그러면 처음에 돈을 뜯을 때 혹시 롯데는 봐주겠다고 보장해준 것은 아닌지 의심을 하지 않을 수 없는 것이다 그래서 정경유착에 대해서 강도 높게 비판해 왔던 것이다 이는 수사밖에는 밝혀낼 수가 없기 때문에 이 문제는 매우 중대한 사항이라고 생각한다 또 다른 보도에 따르면 차은택씨가 광고회사를 뺏으려고 압박을 넣었고 여기에 송성각 한국컨탠츠진흥원장이 크게 다칠 수 있으니 광고회사를 주라고 이야기했다는 것 아닌가 이런 날강도 같은 짓을 하는가 권력을 몰아주니 광고회사를 뺏고 그 광고회사에서 재벌광고를 몰아서 하려고 했다는 것이다 정황을 보면 광고와 다른 재벌광고들을 독점을 했는데 다 그런 음모에 일환인 것이다 무슨 이런 사람들이 있나 이런 날강도 같은 짓들을 하는가 대한민국이 이렇게까지 추락할 수 있는가 검찰이 이렇게 더디게 수사할 문제가 아니다 온갖 증거물을 전국에서 인멸하고 있는데 언론들이 이렇게 증거를 몰아주고 있는지 뭐하는 것인지 모르겠다 지금이라도 전 인력을 동원해서라도 관련된 기관 사무실에 대한 압수수색을 전면적으로 시행해서 증거가 인멸되지 않도록 해야 한다 청와대에 대한 압수수색도 해야 한다 관련자들이 다 부인하고 있는 것 아닌가 정호성씨가 부인하고 있고 안종범씨가 부인하고 있다 부인은 증거인멸의 징후이기 때문에 바로 압수수색에 들어가야 한다 이런 와중에 국방부는 한일군사정보보호협정을 체결하겠다는 입장을 발표했다 년 전에 이미 이명박 정권에서 추진하다가 거센 국민들의 반발로 무산된바 있다 한국과 일본은 아직 과거사에 대한 명확한 정리가 되어있지 않다 우리는 년간 일본군의 군화발이 수없이 많은 민간인들이 유린당하고 희생되었다 무엇이 바뀌었고 개선되었는가 그런데 일본과 군사적으로 손을 잡겠다는 것인가 절대로 용납할 수 없다 더불어민주당은 야권공조를 통해서 정보보호협정의 체결을 저지하겠다 국방부는 또 다시 국방부를 분노하게 만드는 정보보호협정의 추진을 중단하라 분명히 경고했다 국회에서 통과되기 어렵다 김영주 최고위원 지난 화요일 초 녹화 거짓사과를 한 지 이틀 만에 박근혜 대통령이 어제 부산에 내려갔다 아침 신문에 난 최순실 인터뷰를 보고 안심이 되셨나 그리고 어제 대통령은 지방자치의 날 기념식에서 지차체장들을 치하하는 연설을 하셨다 평소와 다름없는 모습으로 청중들을 둘러보며 분 초 동안 연설을 했다 국민들에게는 초 동안 거짓사과를 하더니 의미 없는 연설은 분 초 동안 이어졌다 사과가 거짓임을 입증하는 증거가 나온 뒤에도 아무 일 없었다는 듯 했다 지금이 그럴 때인가 국민들을 철저히 농락한 것을 반성해도 모자랄 판에 아무 일 없다는 듯이 연설 후에는 행사장에 들러 관계자들을 격려까지 했다 많은 국민들께서 지금 대한민국 현실이 참담하다고 하신다 대통령의 지지율이 대로 떨어졌다 그러나 대통령은 아랑곳하지 않는 것 같다 멘붕에 빠진 국민은 나몰라라 하면서 즉시 검찰 수사를 받아야 할 안종범 우병우를 따뜻하게 품는 대통령 기가 막힐 지경이다 언제까지 청와대를 국기문란 범죄혐의자들의 은신처로 만들 것인가 최순실 보좌체계가 완비 된 청와대를 국민들은 단 하루도 용납할 수 없다 최근 일 사이 최순실 게이트 의 파장을 최소한으로 관리하려는 움직임이 감지되고 있다 여당이 갑자기 특검을 수용하겠다고 하자 청와대는 이를 즉각 받아들인다 하루만에 아무 의미 없는 상설특검을 하자고 한다 예상된 수순이지만 시간을 버는 효과가 있다 그리고 한 언론이 갑자기 최순실과의 인터뷰가 성사돼 최순실의 말을 그대로 전한다 최순실의 인터뷰를 전후해 극우사이트 강성친박 일부 공영방송에서 최순실의 국정농단 도구인 태블릿 에 대해 입수경위를 트집 잡고 있다 기다렸다는 듯 검찰도 이를 조사하겠다고 한다 해외로 출국했던 최순실의 측근 고영태가 갑자기 국내로 자진해 오더니 밤 시가 넘어 조사를 받겠다고 자청했다 우병우 수석이 말한 수습 이 이런 것인가 분명히 경고한다 이제 그런 수법이 더 이상 통하지 않는다 이 장면은 어제 대통령이 참석한 행사장의 모습이다 명이 들어가야 할 장소에 명이 모였다 이것이 민심이다 끝으로 한가지 꼭 집고 넘어가야할 문제가 있다 오늘 아침 언론 보도를 보면 최순실은 언론 인터뷰 도중 누군가와 수시로 통화를 했다고 한다 도피중인 사람이 언론과 인터뷰를 한다는 것도 의아스럽지만 언론 앞에서 보란 듯 수시로 누군가의 전화를 받고 있다는 사실이 매우 놀랍다 이 장면은 독일 현지와 국내에서 조직적으로 누군가 최순실의 독일 도피를 돕고 있다는 것이며 아직도 비선실세로 군림하고 있다는 것을 증명하고 있다 또한 공범들과 국정농단 국기문란 범죄를 무마하기 위한 계책을 꾸며 증거를 인멸하고 입을 맞추고 있을 가능성이 매우 높다는 것을 암시한다 검찰은 조속한 최순실 신병확보 뿐만 아니라 한국으로 송환해야한다 해외도피를 돕고 있는 국정농단의 공범 역시 반드시 색출해 법의 심판을 받게 해야 할 것이다 전해철 최고위원 미르 스포츠재단의 설립 비리로 촉발된 의혹이 비선실세 국정개입 청와대 문건 유출 등으로 번지면서 이제 최순실 게이트는 끝을 가늠하기 어려운 실정이다 최순실과 안종범 수석이 롯데와 를 압박해 억과 억을 받아내려고 한 정황이 담긴 스포츠재단의 문건과 관계자의 제보가 폭로되었다 교육문화수석과 문화부 차관까지 협조했다고 한다 한 나라의 정책을 총괄 보좌하는 청와대 수석들과 고위 공무원들이 최순실의 개인 사업을 위해 발 벗고 나선 것은 충격적이다 현재까지 최순실 게이트에서 확인되는 내용만으로도 대통령기록물 관리법 위반 군사기밀보호법 위반 포괄적 뇌물죄 업무상 배임횡령 등 여개의 죄목이 적용될 수 있다 즉각적인 특검 수사가 필요한 상황이다 하지만 상설특검법에 의한 특검을 주장하는 여당의 현실인식은 국민정서와 너무 동떨어져있다 여당은 특검에 동의하면서도 상설특검법에 따를 것을 주장하고 있지만 최순실 게이트의 특검 대상은 청와대이다 피조사자가 조사자를 결정하는 것은 언어도단이며 국민을 우롱하는 처사이다 전형적인 셀프 특검 주장이다 최순실 게이트는 반드시 특별법에 의한 특검을 실시해야 하며 특별법에 의해 특별검사는 야당의 추천으로 결정되어야 한다 전례가 없는 것도 아니다 년 청와대가 조사 대상이었던 내곡동 특검도 야당의 추천으로 특검이 임명된바 있다 특검 추천권을 고집하는 새누리당과의 협상은 더 이상 의미가 없다 새누리당과 청와대의 태도변화가 없는 한 협상은 중단되어야한다 특별법에 따른 특검에서는 대통령도 반드시 조사 대상이 되어야 한다 이미 대통령이 최순실 게이트의 상당 부분을 직접 인정한 바 있으므로 관련 범죄 사실의 소명을 위해서는 대통령에 대한 조사 역시 불가피하다 여야합의로 특검이 이루어지기전까지 검찰은 신속하고 엄중하게 수사해야 할 것이다 먼저 신원 확보를 위해 최순실의 여권효력을 중지시켜야 한다 이는 최순실의 해외 체류와 이동을 막고 국내로 송환할 수 있는 가장 효과적인 방법이다 법무부와 외교부에서 즉각적인 조치를 취할 것을 요구한다 대한민국은 민주공화국이며 모든 권력은 국민으로부터 나온다는 것을 명시하고 있다 선출되지 않은 권력이 국정을 농단한 사실에 대해 국민들은 더 이상 주권자로서의 분노를 인내하지 않고 있다 대학생과 시민단체의 시국선언이 줄을 잇고 있다 박근혜 정부가 이 사태의 심각성을 인지하지 못한다면 더욱 상황은 악화 될 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58746,2016-10-28, 금태섭 대변인 오전 현안 브리핑 일시 금 장소 정론관 새누리당의 셀프특검 국민특검만이 해답이다 결국 덮일 것이다 최순실 게이트를 접한 국민 대다수의 생각이다 한 여론조사에 따르면 청와대 압수수색 및 대통령 검찰 조사에 찬성한다는 여론이 에 달한다고 한다 동시에 핵심 인물에 대한 수사가 제대로 되지 않을 것이라고 걱정을 하고 있다 검찰수사는 필요한데 검찰은 믿지 못하겠다는 것이다 참담하다 이런 상황에서 새누리당은 상설특검법 에 의한 특검을 하자고 주장한다 대통령을 특별검사후보추천위원회가 명 중 법무차관 법원행정처장 여당 추천 명 등 과반수가 정부 여당측 인사로 구성되기 때문이다 그리고 대통령 수사 불가 방침을 내세운 김현웅 법무부장관의 통제를 받게 된다 셀프특검을 하겠다는 새누리당의 주장은 뻔뻔스럽기 그지없다 사건의 진실을 낱낱이 파헤치기 위해서는 특별법에 의한 특검이 필요하다 내곡동 사저 사건이 발생했을 때 야당이 추천한 특별검사는 청와대를 압수수색한 전례가 있다 별도의 특별법에 의한 특검만이 국민들이 원하는 국민특검 이다 정부여당의 국민에 대한 석고대죄 사건의 주범인 우병우 수석 사퇴 최순실 부역자 전원 사퇴가 우선이다 우리당은 국민들과 함께 국민특검 을 통해 국민들이 바라는 진실을 밝히겠다 또 드러난 최순실 국정개입 현 정부 최순실 정책 전부 점검해야 한다 최순실 씨가 국민 세금 수천억원을 주물렀다는 증거가 또 발견되었다 최순실 씨와 그의 측근인 차은택 씨가 박근혜 대통령의 국정기조인 문화융성의 전반전인 틀을 짠 것이다 박근혜 정부는 국정 전반적으로 창조 를 강조했지만 전혀 창조적이지 않은 국가 새 브랜드인 크리에이티브 코리아 도 역시 최순실씨 작품이었던 것으로 드러났다 박 대통령의 대국민 사과와 최순실 씨의 언론 인터뷰는 일관되게 정권 초기 연설문을 고쳐주는 수준이었다고 말하고 있다 사실은 정부 정책 설계에 깊숙이 개입하고 있었던 것이다 문화 정책의 기틀을 마련해야 할 문화체육관광부는 최순실씨가 기획 설계한 사업 예산의 집행부로 전락했다 문화최순실관광부 라 불릴만 하다 국민의 수천억의 세금이 최순실씨 단 한명에 의해 좌지우지 되었다고 해도 과언이 아니다 또 어디에 얼마만큼의 세금이 최순실씨로 인하여 사용되고 있는지 불안하다 현 정부가 추진하고 있는 또 추진해온 업무 전반에 대해서 경위를 조사해야한다 청와대 문건 유출 일벌백계 청와대가 직접 고발하라 이재만 총무비서관은 청와대 서류를 잔뜩 싸들고 밤에 외출하였다 정호성 부속비서관은 두께의 청와대 보고자료를 최순실씨에게 전달하였다 언론과 정치권에서 제기된 의혹이지만 정작 본인들은 부인하고 있다 사실을 밝혀야 할 사람은 청와대 비서실장이다 그런데 이원종 비서실장은 청와대 보고자료가 유출되었다는 언론 보도에 대해 본인은 그런 적이 없다 면서 문고리 인방의 대변인 같은 모습을 보였다 청와대 비서실장은 유출 혐의 받는 사람들의 변명을 전달할 것이 아니라 제대로 된 자체조사 결과 내놓아야 한다 박근혜 대통령은 년 정윤회 문건 이 유출되었을 때 누구든지 부적절한 처신이 확인될 경우 지위고하를 막론하고 일벌백계로 조치할 것 이라고 강하게 말씀하셨다 두께의 대통령 보고자료 매일 유출한 사람도 최순실씨에게 국가안보 기밀 인사 관련 자료를 보고한 사람도 그것을 지시한 최종 라인에 있는 사람도 국정을 농락한 모든 사람을 일벌백계 해야한다 청와대가 직접 고발해라 수습은 그렇게 하는 것이다 조폭도 울고 갈 공갈협박범 한국콘텐츠진흥원장 즉각 수사하라 송성각 한국콘텐츠진흥원장이 중소 광고업체를 상대로 공갈 협박한 정황이 드러났다 녹취록도 있다고 한다 송 원장은 광고업체 대표를 만나 지분 를 그들 에게 넘기지 않으면 당신 회사와 광고주를 세무조사하고 당신도 묻어버린다는 얘기까지 나온다 며 협박했다 송 원장은 한 인터뷰에서 정부 은 소통 이다 라고 말한 바 있다 그러나 정작 본인은 소통보다는 공갈과 협박을 택했다 치졸하고 부끄럽다 콘텐츠산업을 창조경제를 이끌어가는 대표산업으로 적극 육성하겠다 며 국민세금 천억을 넘게 사용하는 콘텐츠진흥원이 사실은 거대한 광고회사를 키우기 위한 조폭 조직에 불과했다 여기서 말하는 그들 은 누구인가 누가 국가기관의 원장을 공갈협박의 공범으로 만든 것인가 항상 한 타이밍 늦는 검찰 수사로 관련자들이 증거를 인멸하고 잠적하고 있는 상황이다 송 원장 역시 잠적하기 전에 즉각 수사해야 한다 공갈협박조직의 실체를 밝힐 첫걸음이다 국민이 반대하는 한일 군사정보보호협정 협상 즉각 중단해야 년 밀실 처리하려다 분노한 국민의 반대로 무산됐던 한일 군사정보보호협정 협상을 재개하겠다는 것은 절대 있을 수 없다 전대미문의 국정농단 국기문란 사건으로 국가 시스템이 흔들리는 와중에 국방부가 국민 모두가 반대하는 한일군사정보보호협정을 재개하겠다니 기가 막힌다 작년 월 졸속적인 한 일 위안부 합의와 소녀상 이전 문제로 국민의 분노가 높은데 또다시 일본과 군사협정을 하겠다니 도대체 무슨 말인지 모르겠다 더욱이 각종 국가기밀문서 및 연설문이 유출되는 초유의 비선실세 게이트로 인해 정부가 국정 붕괴에 준하는 사태에 빠져 있다 이런 때에 지금 한 일 군사보보협정 재개를 발표한 의도가 무엇인지 의심하지 않을 수 없다 일본은 군사력 사용 범위를 확대하는 이른바 집단 자위권 을 추구하고 있다 이런 상황에서 한일군사정보보호협정 재개로 동북아의 갈등을 확산하는 결과를 초래할 뿐이다 국방부는 즉각 국민 모두가 반대하는 한일 군사정보보호협정 협상을 중단할 것을 요구한다 최고위원회의 결과 오늘 아침 최고위원회의에서는 안보특별위원장에 송영무 전 해군참모총장을 임명했다 이를 통해 우리당은 든든한 안보정당 믿음직한 수권정당으로서 지속적인 국방개혁 방위역량 강화 등 국방안보관련 상시 과제들을 꾸준히 실행해 나갈 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58744,2016-10-28, 이재정 원내대변인 오전 현안 서면 브리핑 대한민국 역사마저 부정하려 드는 박근혜 정부의 역사인식 부재 다음 달 공개될 국정교과서에 년을 대한민국 수립의 해로 기술하는 것이 확정되었다고 한다 년 세워진 대한민국 임시정부의 법통을 계승한다는 대한민국 헌법정신을 정면으로 부정하는 잘못되고 왜곡된 역사를 우리 아이들에게 가르치겠다는 것이다 이해할 수도 이해해서도 안 되는 박근혜 정부의 잘못된 역사인식에 대해 국민은 이것마저도 최순실이 지시한 것 아니냐는 걱정 어린 목소리가 나오고 있다 박근혜 정부는 대한민국 역사교과서를 바꾸기에 열중할 것이 아니라 박근혜 정부가 역사교과서에 어떻게 쓰여질지 국민에게 박근혜 대통령이 어떤 대통령으로 남을지를 먼저 생각하고 국민을 두려워할 줄 알아야 한다 비선실세 국면전환을 위한 국민기만 한일군사정보보호협정 협상 당장 중단하라 오늘 국회 국방위에서는 한일군사보호협정 협상과 관련한 현안보고가 있었다 대통령의 비선실세 의혹으로 국정이 마비된 상황에서 한일군사정보보호협정을 추진한다는 것은 비선실세 정국을 전환하고 국민을 기만하겠다는 것에 불과하다 이미 지난 년 밀실추진으로 부결된 사안을 이 시점에 공론의 장으로 가져오겠다는 것 자체가 문제다 지난 년간 한일관계가 무엇이 바뀌었는가 일본은 위안부 협상의 선행과제인 사죄를 거부하고 오히려 돈으로 해결했다는 입장을 연일 주창하고 있는데 무슨 이유로 군사정보까지 교류하겠다는 것인지 이해할 수 없다 현 정부의 무능하고 정체성 없는 외교안보 정책에 국가기조마저 흔들리고 있다 한일군사정보보호협정 체결은 전적으로 국회의 비준이 필요한 사안이다 더불어민주당은 졸속으로 국면전환을 위해 추진되는 한일군사정보보호협정을 절대 허락하지 않을 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58740,2016-10-27, 이재정 원내대변인 오후 현안 서면 브리핑 텅 빈 대통령 축사현장 진정 민심이 무엇인지 모르는 것인가 오늘 박근혜 대통령은 부산을 찾아 제 회 지방자치의 날 기념식에 참석했다 최순실과 정유라에 대한 분짜리 녹화사과 이후 일언반구 입장표명이 없는 대통령의 실망스러운 행보를 반영하듯이 행사장 뒤편 좌석은 텅 비어 있었다 우리 국민의 마음이 저 텅 빈 좌석과 같다 국민들은 박근혜 대통령에게 따뜻한 정치를 기대했지만 돌아온 것은 차갑고 냉혹한 유신같은 공포정치였을 뿐이다 거기에 신분조차 불명확한 비선실세에게 조종당했다는 의혹까지 받고 있다 박근혜 대통령에게 진심으로 고언 드린다 국민이 원하는 것은 진심을 담은 사과와 다시는 이런 일을 하지 않겠다는 철저한 재발방지 약속이다 말이 아닌 행동으로 보여줘야 한다 인회 십상시 문고리 인방 김기춘 정윤회 최순실 선녀 등 대통령을 둘러싼 오명이 재발되지 않도록 국민 앞에 약속해야만 정상적인 국정운영이 될 수 있다는 것을 다시 한 번 말씀드린다 한일군사보호협정 논의 재개 박근혜 정부는 논란을 잊었나 국방부는 지난 년 전 불발되었을 뿐만 아니라 국민적 저항과 비난을 자초했던 한일군사보호협정에 대한 논의를 재개한다고 밝혔다 박근혜정부의 외교와 안보정책 부재가 심각하다 지난 년에 왜 한일군사보호협정이 불발되었는지 국민은 아직도 생생하게 기억하고 있다 단순히 밀실협정으로 추진해서만이 아니다 일본은 아직도 과거사에 대한 사죄는커녕 정당성만을 강조하고 있는데 어떤 이유로 일본과 군사협력협정을 맺을 수 있단 말인가 또한 년 군사정보 공유 약정을 체결한지 년도 채 지나지 않았다 이번 논의 재개는 사드배치와 무관하지 않을 것이다 동북아 정세의 패권을 둘러싸고 벌어지는 외교와 안보의 각축전에서 대한민국은 주도권을 쥐기는커녕 오히려 물주 역할만을 자처하고 있다 최순실 씨와 박근혜 대통령을 둘러싼 의혹이 증폭되고 있는 시점에서 과연 청와대가 제대로 된 판단을 내렸는지도 의문이다 무리한 협정추진은 더 큰 국민적 저항을 초래할 것이다 청와대는 제발 자중자애하라 더불어민주당은 대한민국의 중심 되는 외교 국민의 안전을 최대한 담보할 수 있는 안보를 위해 이번 협정체결과정이 과연 올바른 길이지 국민 앞에 소상히 설명드릴 것이다 결혼도 출산도 포기한 채 희망을 잃은 청년층 청년지원 대책 절실하다 통계청이 발표한 월 인구동향에 따르면 출생아 수가 전년대비 감소했으며 올해 월까지 혼인건수는 만 천 백건으로 역대 가장 낮은 수치를 기록했다고 한다 포 포를 넘어 모든 것으로 포기해야 하는 포 시대에 내몰려서 치열한 생존경쟁을 펼쳐야 하는 청년층에게 최순실의 딸 정유라가 받은 특혜와 특권은 그저 먼 나라 이야기이며 억울하면 부모 잘 만나라는 비아냥이 비수처럼 가슴에 꽂히는 이유이다 정부는 그동안 수십조원을 청년지원정책에 투자했다고 하나 진정 청년들에게 필요한 정책과 동떨어진 대응으로 일관하고 있다 청년이 없는 대한민국은 없다 결혼과 출생을 포기한 청년들에게 희망을 안겨줄 정책이 절실하다 정부는 서울시와 성남시의 적극적인 청년지원책을 방해하려고 들 것이 아니라 오히려 벤치마킹하는 적극성을 보여라 더불어민주당은 청년이 중심 되는 나라 부모의 돈과 지위 학벌로부터 청년이 자유로운 나라를 만들기 위해 모든 방안을 강구할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58733,2016-10-27, 금태섭 대변인 오후 현안 브리핑 일시 목 장소 정론관 김현웅장관은 수사 축소 지시를 중단하라 김현웅 법무장관이 최순실 게이트 수사범위에 대한 입장을 밝혔다 박근혜 대통령에 대한 수사는 없다는 것이다 대통령은 재직 중 형사소추의 대상이 되지 않기 때문에 수사의 대상조차 되지 않는다고 한다 그러나 헌법학자들에 의하면 대통령은 재직 중 형사소추를 면제받을 뿐 수사의 대상이 된다는 것이 압도적 다수의 견해다 심지어 새누리당 소속인 정종섭 의원이 쓴 헌법학원론 년도판 페이지 에도 대통령에 대한 수사기관의 수사는 가능하다 라고 명시되어 있다 시간이 경과하면 증거를 수집하기 어려우므로 대통령의 재직 중에 행해진 범죄행위에 대해서도 수사기관은 언제나 수사할 수 있어야 한다 라고도 한다 다만 재직 중에 기소를 할 수 없으므로 체포 구속 등은 금지되고 압수 수색 등 강제수사도 할 수 없다는 견해가 있을 뿐이다 즉 수사의 방법이 문제될 뿐 수사의 대상이 된다는 사실 특히 임의수사의 대상이라는 점에 대해서는 이론이 없다 그럼에도 불구하고 법무부장관은 아무 근거도 없이 검찰에 수사가이드라인을 제시하려고 하고 있다 최순실 게이트에 등장하는 대부분의 인물들은 조력자 이거나 아첨꾼 이다 이들의 역할은 맞장구를 치거나 악역을 담당할 뿐이다 국민들은 최순실 게이트의 전말을 궁금해하고 있다 법무부 장관은 스스로의 역할을 잘 찾기를 바란다 우병우 안종범 수석 셀프수습 어림없다 이원종 대통령 비서실장이 안타깝다 이원종 실장은 대통령의 사과이후 수석비서관 전원의 자진사퇴를 추진했으나 우병우 민정수석 안종범 정책조정수석의 반대로 무산되었다는 것이다 두 수석의 변명은 지금 다 나가버리면 수습을 할 사람이 없어진다 는 것이다 우병우 수석이 지휘하는 검찰수사 안종범 수석이 지휘하는 미르게이트 은폐가 청와대가 말하는 수습이라는 것인지 묻지 않을 수 없다 새누리당이 요구한 청와대와 정부 내각의 대폭적인 인적 쇄신 이 누구인지 본인들만 모른 척 하려는 것인가 지금 즉시 사퇴하는 것이 수습의 길이다 나만이 할 수 있다는 오만함이 지금 온 국민을 절망에 빠뜨린 것이다 년만에 밝혀진 거짓말 청와대는 양치기 소년 이 되려는가 청와대는 최순실 씨 관련 의혹에 대해 이미 년 전부터 거짓말을 하고 있었음이 밝혀졌다 우리 당 박영선의원은 년 국회 운영위원회에서 청와대 이재만 총무비서관에게 왜 청와대 서류를 잔뜩 싸들고 밤에 외출하는지를 물었다 돌아온 답변은 특정한 목적이 있는 것은 아니고 작업하다 만 서류를 집에서 보기 위해 가지고 간다 였다 이 총무비서관이 서류를 가지고 간 이유는 년 만에 밝혀졌다 바로 최순실씨에게 보고하기 위해서였다 오늘까지도 청와대의 거짓말 릴레이는 이어지고 있다 이원종 비서실장은 최순실 씨의 연설문 빨간펜 의혹에 대해 봉건시대에도 있을 수 없는 일 이라고 했다가 사실로 밝혀지자 몰랐다 며 발뺌하고 있다 안종범 수석 역시 대기업에 거액의 재단 기부를 요구했다는 의혹에 대해 순수한 자발적 모금이었다 며 청와대 개입을 부인하였다 그러나 이 또한 사실로 밝혀졌다 거짓말은 또다른 거짓말을 낳는다 청와대가 양치기 소년 이 될 처지이다 거짓말 릴레이를 중단하고 사실을 떳떳이 밝히는 것만이 유일한 해법이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58727,2016-10-27, 추미애 대표 해공 신익희 정신의 현재적 의미와 계승 방안 모색을 위한 토론회 인사말 일시 목 장소 의원회관 제 세미나실 추미애 대표 민주주의가 무너지고 나라 기강이 무너지는 가운데 오늘날 해공 신익희 선생의 정신을 되살려보는 행사는 정말 의미가 있는 것 같다 지난 번에 저는 민주당 역사에서 처음 당대표로서 해공 신익희 선생의 생가를 방문했다 또 그 자리에서 분열된 당의 힘을 모으는 통합 행사도 있었다 그날 통합의 한 축을 맡아주셨던 김민석 민주당 전 대표가 오늘 나와 계신다 세월이 참 빠르다 그 사이 많은 일이 있었다 임종성 의원이 오늘 의미 있는 행사를 하셔서 감회가 새롭다 제가 오늘 입장하면서 임종성 의원님께 안경만 끼면 해공 신익희 선생과 모습이 꼭 닮았다고 말했다 움푹 들어간 눈매 살짝 나온 턱 꽉 다문 입이 선생께서 끼고 계신 둥근 안경만 착용하면 그대로 재현될 것 같다 해공 신익희 선생의 얼굴은 임종성 의원을 통해서 재현이 될 수 있지만 무너진 이 땅의 민주주의는 어떻게 되살아날 수 있을지 참으로 암울하다 오늘 멀리 독일에서 급조한 코스프레 같은 최순실의 인터뷰를 봤다 그것을 믿을 대한민국 국민이 어디 있는가 코스프레도 정도껏 해야지 수천억대의 모녀가 갑자기 헝클어진 머리를 하고 기억이 하나도 나지 않는다 그런 줄 몰랐다 고 하는 얼토당토 않는 인터뷰를 보면서 국민들은 억장이 무너진다 세월호 참사의 진실의 열쇠를 쥐고 있었던 유병언씨가 막걸리병만 부여안은 채 변사자의 사채로 발견됐던 장면이 오버랩 되는 것이 저만의 마음인가 아니다 대한민국의 모든 국민이 암울한 데자뷰를 갖고 있는 순간 같다 그때 대통령이 어떻게 했나 유병언을 세 번이나 붙잡으라고 불호령을 내리지 않았나 그것이 쇼가 아니라면 유병언 같이 배 하나에 온갖 생명을 수장시킨 그 문제 그 이상으로 심각한 대한민국의 모든 국민과 민주주의와 국가 안전을 쥐고 있는 최순실에 대해서는 당장 직접 쫓아가서라도 잡아와야 할 것이 아닌가 이는 독재정치도 아니고 한마디로 무서운 신정 정치라고 할 수 있다 제가 어제 여당 원로이자 국회의장께서 제 옆에 앉아계시기에 집권당의 원로로서 이 난국을 타개하기 위해 빨리 모이셔서 대통령에게 지혜를 주셔야 할 것 아닌가라고 말했다 그분은 그렇게 하고 싶다 그런데 대통령이 그런 말을 들어주는 사람인가 라고 한탄했다 마지막 고리 최종 종착역은 결국 소통하지 못하는 대통령이다 해공 신익희 선생은 대화와 타협 상대방의 동의가 민주주의 요체라고 일찍이 말씀하셨다 국민과 대화하지 않고 심지어 자신이 임명장을 준 공무원 장차관과도 대화하지 않고 오로지 최순실과 심령 대화를 했던 대통령 최순실이 떠나자 제대로 된 말도 이어가지 못하시는 대통령을 두고 대한민국 국민은 이제 허탈이 아니라 패닉에 빠져있다 이제와서 최순실을 코스프레시켜서 인터뷰를 적당히 무마하려는 것은 누구의 머리에서 나오는 것인가 그것마저도 최순실 본인의 자작극인가 우병우가 시킨 것인가 우병우는 나라 안의 병 덩어리고 최순실은 나라밖 망신거리이다 하루 속히 두 남녀를 정리해서 국정의 실타래를 풀 수 있는 출발을 해야 한다 오늘 해공 신익희 선생의 교훈을 다시 더듬는 이 자리가 몹시 부끄럽다 제대로 하지 못한 것이 몹시 부끄럽다 학생들이 출근하는 아버지에게 우리 대한민국이 망하는 것 아니냐는 질문했다는 소리를 듣고 마음이 미어진다 이제 해쳐나가야 할 막중한 시기이다 다시 한 번 옷깃을 여미면서 마음을 가다듬는 자리를 만들어주신 임종성 의원께 감사드린다 또 오랜만에 뵌 손학규 전 대표도 반갑다 오늘 모두 다시 민주주의를 새기면서 다시 민주주의가 부활할 수 있도록 힘을 합치자 +http://theminjoo.kr/briefingDetail.do?bd_seq=58726,2016-10-27, 제 차 정책조정회의 모두발언 일시 목 오전 시 장소 국회 본청 원내대표 회의실 우상호 원내대표 국가가 혼란스럽다 국민들이 매우 불안해하고 분노하고 있다 이 문제에 대한 범국가적 대책이 조속히 나와야할 때이다 더불어민주당은 어제 의원총회에서 청와대의 전면 개편과 특검 실시를 당론으로 정했다 새누리당도 의총에서 특검을 결정했다 조속히 만나서 특검의 내용들을 다듬고 진상규명을 위해 제대로 된 수사가 진행될 수 있도록 거당적으로 협력해야할 때이다 많은 분들이 청와대 전면 개편 혹은 내각 총사퇴를 주장하고 있다 그런데 이 문제를 논의한 청와대 수석회의에서 안종범 우병우 두 수석이 일괄사퇴를 반대했다고 한다 수사대상에 들어가야 할 사람들이 먼저 사퇴하겠다고 하지는 못할망정 청와대 비서진들의 일괄 사퇴를 반대했다는 것에 어안이 벙벙하다 문제가 된 우리들이 물러날 테니 당신들은 남아라 라고 했다면 이해가 가지만 본인들의 거취를 포함해서 전체적으로 사퇴를 반대했다고 보도되고 있다 이런 뻔뻔한 수석들이 어디 있는가 지금 대한민국이 누구 때문에 여기까지 왔나 언론보도가 사실이라면 안종범 수석은 거의 대부분의 모금에 직접적 노골적으로 관련됐다 사실상 이승철씨보다 더 심한 모금책으로 전락했다는 의혹을 받고 있다 청와대 안에 숨어서 수사를 회피할 생각인가 본인들이 거기에 계시면 제대로 사태를 수습할 수 있다고 생각하는가 이 문제를 계속 수석비서관회의에 맡기고 있는 대통령도 한심하다 대통령이 임명한 사람은 대통령이 사임시키면 된다 오늘이라도 특히 문제가 된 수석부터 전면적으로 모두 사퇴시키고 개편하시기 바란다 청와대 개편에 적극적으로 나서지 않는다면 시간을 끌며 이 문제를 회피할 의도가 있다고 의심할 수밖에 없다 대통령은 오늘이라도 청와대 개편의 의지라도 명백히 국민에게 밝혀주시기 바란다 사람 구하는 일이 빨리 안 되면 개편 자체는 단계적으로 할 수 있다 하지만 청와대를 전면 개편하겠다는 의지라도 오늘 밝혀야한다 여러 보도를 보면 외교 안보 문제까지 최순실씨가 개입했다고 나온다 정말 이건 아닐 것이라고 설마설마 했다 옷이나 골라드리고 청담동 보석들이나 갖다 바치는 수준이 아니었겠는가 생각했다 그런데 통일정책을 포함한 외교 안보정책까지 최순실씨가 개입했다는 보도에 절망할 수밖에 없었다 년 안에 북한이 붕괴한다는 말을 하고 다녔다고 한다 최순실씨는 주술적 예언가임에 틀림없다 최순실씨가 그런 주술적 예언을 무슨 근거로 했는지는 알 수 없으나 만약 대통령이 이 말에 현혹되어 남북문제나 외교정책을 펼쳤다면 심각한 문제다 주술적 예언은 과학적이고 합리적인 정보 분석에 기초한 정책 판단을 해친다 만약 년 안에 통일이 된다 북한 망한다 는 예언 때문에 지금의 대북강경정책이 펼쳐진 것이라면 이것은 정말 믿을 수 없는 이야기다 무엇이 사실인지 대통령이 고백해야한다 최순실씨가 외교안보정책까지 점검할 수 있는 전문성과 경험이 있다고 봐야하는가 지금도 믿고 싶지 않은 보도들이다 진실은 밝혀지겠지만 대한민국이 주술적 예언에 사로잡혀서 지금까지 외교 안보 정책이 흘러온 것이고 외교부와 통일부는 단지 이 주술적 예언을 실천하는 실행부서였다면 대한민국은 정말 엉망인 나라였던 것이다 믿고 싶지 않다 진실을 밝히는데 있어서 가장 중요한 것은 최순실 차은택씨의 신병을 확보하는 것이다 제가 며칠 동안 계속 이 분들이 어디에 있는지 알고 있다고 경고하고 국정원이 어떻게 최순실 씨를 도와주고 있는지 말씀드렸다 신병 확보를 왜 못하는가 어떤 언론사는 최순실씨를 만나서 인터뷰까지 했는데 대한민국 국정원과 검찰은 인터뷰는커녕 이 사람들의 소재 파악을 못하는가 인터폴과 협력을 해야만 알 수 있나 그 정도면 차라리 언론인들을 통해서 신병을 확보하는 것이 훨씬 빠르겠다는 생각이 든다 정 안되면 개라도 풀어서 추적을 해야 되는 상황이 아닌가 싶을 정도이다 하루빨리 최순실 차은택씨의 신병을 확보하는 데 앞장서주기 바란다 특검법을 발의하고 특검을 구성하는 데 상당한 시간이 필요하기 때문에 그 전에 검찰이 할 수 있는 최선의 일은 이들의 신병을 확보하고 최소한의 증거물이라도 확보하는 역할이다 제가 일간 증거인멸이 진행되고 있는데 검찰은 무엇을 하냐고 항의를 여러 번했다 다 없애버렸는데 이제 와서 압수수색하면 무엇하나 검찰이 두 사람의 신병 확보에 소극적으로 나와서는 안 된다는 점을 다시 한 번 강조한다 윤호중 정책위의장 온 나라가 최순실 쓰나미 에 휩싸여서 국정은 실종되고 민생은 표류하고 국민은 불안해하고 있다 대통령은 물론이고 정부여당이 최순실 지키기에 골몰한 나머지 경제를 포기하고 민생을 내팽개치고 있기 때문이다 부동산 문제 구조조정 문제 등 산적해있는 민생현안들에 대해서 해법을 내놔야하는데 정부는 아무런 일을 하고 있지 않는 것 같다 부동산 대책을 검토하겠다고 애드벌룬을 띄워놓은 지 열흘이 넘고 있다 그런데 정부가 내놓는다는 부동산 대책은 어디에 가있는지 모르겠다 월 말에 조선업 구조조정 방안을 발표하겠다고 했다 지난 일 우리 당이 구조조정과 관련해 각 정부 부처들의 진행상황을 점검하려고 했지만 정부는 보고할 내용이 없다 준비가 되지 않았다 는 답변밖에 내놓지 못했다 과연 현재 이 나라의 경제와 민생을 살피는 컨트롤타워가 존재하고 있는 것인지 의문스럽다 경제부총리가 경제관련 장관회의를 매주 열겠다고 방침을 밝히고 첫 회의를 열었는데 명의 장관 중에 명이 불참했다고 한다 도대체 경제리더십은 있는 것인가 경제가 곳곳에서 빨간불이 켜지고 국민은 참담한 정치상황과 힘겨운 경제현실의 이중고에 시달리고 있다 어제 한국금융연구원이 내놓은 우리나라 내년도 경제성장률 예측치는 였다 정부가 예산을 편성할 당시 예상했던 나 한국은행의 예측치인 보다 훨씬 떨어지는 수치다 금융연구원이 발표한 자영업자의 금융부채 상환 현황에 따르면 대에서 대 자영업자의 평균 금융부채비율이 년 사이에 포인트 증가해서 를 넘었다고 한다 심각한 상황이 하루하루 반복되고 있다 정부는 경제와 민생에 더욱 고삐를 당겨야한다 우리 당은 이런 때일수록 민생을 꼼꼼히 챙기고 안보는 더 튼튼하게 다지는 정책정당 수권정당의 모습을 보여드리겠다고 다짐한다 그런 의미에서 우리 당은 내일 오전 비상경제 일자리 최고위원회 를 개최한다 부동산 및 가계부채 문제 청년 일자리의 해법 등 민생위기를 극복할 수 있는 방안을 내놓을 것이다 이뿐만 아니라 앞으로 경제상황 점검회의와 안보상황 점검회의를 수시로 열어서 국정을 야당에서도 챙겨나가겠다 지난 화요일 농해수위원회에서 조원 규모의 농어촌 상생기금법이 여야합의로 가결되었다고 한다 참으로 다행스러운 일이다 한 중 의 후속 대책으로 여야정이 합의했던 것을 이제야 법안으로 마련할 수 있게 된 것은 천만다행한 일이다 정부가 당초 주장하던 천억의 기금 규모를 우리 당 소속의원들이 노력해서 조원 규모로 늘린 것은 잘한 일이라고 생각한다 법이 시행되더라도 기금이 조성되고 사업이 집행되려면 년 정도의 시간이 걸린다고 한다 한 시라도 빨리 본회의에서 처리해서 로 어려움을 겪고 있는 농어민들에게 혜택이 돌아갈 수 있도록 희망의 메시지를 전해야 한다 농해수위에서 여야 만장일치로 가결된 만큼 정부여당도 본회의에서 적극적으로 협조해주시기 바란다 우병우 민정수석과 안종범 정책조정수석 두 분이 청와대 비서진 개편을 가로막았다고 하는 보도를 접했다 우병우 수석은 최순실 씨에게 대통령 기록물과 청와대 기밀문서가 유출되는 정황을 파악해서 대책을 세워야하는 위치에 있다 만약에 이것을 몰랐다면 직무를 유기한 것이고 알고도 그대로 방치했다면 대통령 기록물의 유출에 방조행위를 한 것이다 안종범 수석은 미르 스포츠재단의 기부금 모집에 직접적으로 관여한 것으로 되어있다 기부금품 모집 및 사용에 관한 법률에 따르면 기부금품을 강요하는 행위는 년 이하 천만원이하의 징역과 벌금형의 대상이 된다 이 두 분이야말로 경찰 수사대상에 올랐어야 한다 검찰이 어제 뒤늦게 뒷북치기 압수수색을 통해서 증거를 확보하겠다고 나섰다고 한다 검찰이 제대로 수사하려면 우병우 안종범 수석을 먼저 소환조사해야 한다 그 이전에 우병우 안종범 수석 스스로 사퇴해서 검찰수사에 적극 응해야 할 것이다 박정 부대표 민주당은 최순실 국정농단 속에서도 민생 예산을 반드시 지키겠다 어제와 오늘 최순실의 국정 파괴 의혹이 점차 사실로 드러나고 있다 충격을 금할 수 없다 국정은 마비되고 국민들은 분노를 넘어 자괴감과 허탈함에 빠져있다 하지만 민주당은 이런 혼란 속에서도 민생을 지켜내기 위해 예산안 심의에 심혈을 기울이고 있다 특히 우리 아이들 교육 예산에 대한 쟁점이 혼란 속에 묻혀서는 안 된다 박근혜 정부는 지방교육으로 가야할 교부금을 지방교육정책지원특별회계에 담았다 그리고 이 돈으로 누리과정 방과 후 학교 및 초등 돌봄 사업 그밖에 장관이 정하는 사업을 모두 추진할 수 있다고 주장한다 하지만 이는 두 가지 측면에서 말도 안 된다 첫째 일단 지방교육정책지원특별회계 법안은 상임위에서 논의조차 되지 않은 법이다 그런데 이것을 이미 통과된 것으로 간주해 예산을 담았다는 것은 국회의 입법권을 완전히 무시한 것이다 둘째 지방교육정책지원특별회계 법안이 교육 재정을 파탄 낼 소지가 크다 지방교육정책지원특별회계의 재원은 지방교육청에 돌아갈 교부금 중 교육세이다 이는 지방교육청에 교부되어야 할 돈을 따로 떼어내 누리과정에 편성하고 정부의 입맛대로 교육청을 길들이겠다는 의도이다 가뜩이나 어려운 교육재정을 그야말로 거덜 내는 처사라고 할 수 있다 박근혜 대통령은 수십 년 친구한 사람을 구하는데 신경 쓸 것이 아니라 수십 년 미래를 책임질 우리 아이들의 미래에 신경을 써야 한다 지금은 국민들과의 약속에 책임을 져야 할 때이다 무상보육은 박근혜 대통령의 대선 공약이다 당선 후에도 보육의 국가적 책임을 여러 차례 밝힌 바 있다 무상보육은 특정 지역에만 시행하는 사업이 아니라 전국 사업이기 때문에 당연히 중앙정부가 책임져야 한다 민주당은 이번 정부 예산안에 대해 더욱 꼼꼼히 살피고 이러한 잘못된 꼼수 법안이 통과되지 않도록 하겠다 교육재정을 파탄 위기로 몰아넣고 있는 누리과정 문제를 반드시 해결하겠다 박완주 원내수석부대표 어제 황교안 국무총리와 이원종 비서실장이 예결위에 오셔서 국민께 송구하고 자리에 연연하지 않겠다고 했다 국민들이 요구하는 것은 청와대와 내각의 총사퇴를 요구하고 있다 이 부분이 허언이 아니라는 것을 행동으로 보여주실 것을 촉구한다 박근혜 대통령께 온 국민이 바라는 것을 말씀드리겠다 나를 수사하라고 공개 선언하시라 대통령 수사 없이 어떻게 진상규명을 할 수 있겠나 진상규명이 불가능하다 성역 없는 수사를 받겠다고 국민 앞에 약속하시라 그리고 최순실씨가 귀국해 수사 받게 해주시는 것이야말로 이 사태를 수습할 수 있는 길이다 더불어민주당은 어제 오전 의총을 통해서 특검을 당론화했다 오후에 새누리당도 마찬가지로 당론으로 결정했다 다만 언론에서 약간의 이견이 있는 것으로 보도를 하는데 특별법에 의한 특검을 추진하는 것이 더불어민주당의 입장이다 그 이유는 특검 대상에 청와대가 포함되어있다 또 이번 특검은 검찰의 늑장 수사로 증거인멸의 우려가 있기 때문에 검찰은 속도를 내서 더 이상 증거인멸이 일어나지 않도록 노력해주시기를 바란다 특별법에 의한 특검과 상설 특검의 차이는 몇 가지가 있다 기술적인 것은 오늘부터 여당 수석과 협의를 하겠지만 제일 큰 것은 그 대상이 청와대라는 것이다 지난 에는 이명박 정부의 내곡동 사저부지 매입 의혹 사건 진상규명을 위한 특별검사 임명 등에 관한 법률 을 발의했다 이번에도 가칭으로 아직 협의가 된 것은 아니지만 헌법유린 국정농단 민간인 최순실 의혹사건 진상규명을 위한 특별 검사 임명 등의 관한 법률 로 될 수 있다 큰 차이는 특별검사 임명에 대한 문제이다 지난 정부 사저 문제도 야당이 추천한 분을 대통령이 지명한 형식이다 일반 상설특검은 여야가 추천하여 두 명중에 대통령이 특별검사를 임명하는 방식에서 큰 차이가 있다 특별검사부 파견검사 특별수사관 파견 공무원 등 지난 상설특검에는 이미 법적으로 규정되어있다 특별검사보가 명 파견검사가 명 수사관이 명 이내 등으로 되어있다 이 법도 내곡동 특별법을 치르고 나서 만들어진 것인데 그때는 단일 사건이었다 그러나 이번에는 연루된 피의자들이 많기 때문에 규모와 일정도 특별법에 의해서 여야가 합의를 하면 일이 아니라 필요하다면 그 이상의 기간과 구성에 있어서도 여야가 합의하여 철저하게 진상을 규명하는데 특별법이 더 타당하기 때문이다 이 부분에 있어서 여당도 충분히 받아들일 수 있는 상황이다 그렇지 않고 상설특검을 하자고 한다면 국민들은 또 다시 여당이 청와대를 옹호하려는 꼼수가 아니냐는 의혹을 가질 수 있다 국회에서 철저하게 특별법에 의한 특검을 진행하겠다는 말씀을 드린다 다시 한 번 마지막으로 대통령에게 촉구한다 나를 수사하라고 공개적으로 발표해주시라 대통령 수사 없이 진상 규명은 불가하다 성역 없는 수사를 받겠다는 말씀을 국민 앞에 해주실 것을 다시 한 번 촉구한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58725,2016-10-27, 금태섭 대변인 오전 현안 브리핑 일시 목 장소 정론관 최순실은 대통령의 사과문마저 고치려 드는가 최순실이 한 언론을 통해 입장을 밝혔다 박근혜 대통령의 사과가 있은 지 이틀만이다 박 대통령은 취임 후에도 일정 기간 동안 최순실의 의견을 들었다고 국민들 앞에서 인정하였다 하지만 최순실은 대선 당시 혹은 대선 이전 이라며 이마저도 부인하였다 최순실의 발언은 그동안의 국정농단이 어느 정도 수준이었는지 단적으로 보여주는 것이다 대통령이 말한 최소한의 사실인정도 받아들이지 못하겠다는 것이고 그동안 밝혀진 모든 사실은 다 허위라고 호통치는 모습이다 최순실은 이제 공개적으로 대통령의 사과문조차 빨간펜을 든 것이다 과거 여러 차례 청문회에 단골답변은 기억이 안난다 였다 최순실은 그동안 모르쇠로 일관하던 청문회 증인들이 법정과 역사에서 어떠한 처벌을 받았는지 기억하길 바란다 대한민국 검찰 무능의 끝은 어디인가 김현웅 법무부장관은 바로 어제 최순실의 소재 파악을 위해 형사 공조 절차를 밟고 있다 고 말했다 하지만 바로 그 순간 국정농단의 주인공인 최순실은 언론과 인터뷰를 하고 있었다 대한민국 검찰의 무능함을 다시 한 번 확인시켜주는 망신스런 순간이다 언론도 파악한 최순실의 소재를 검찰은 모르고 있었던 것이다 의혹이 불거진 지 한 달이 다되도록 대통령의 가이드라인에 충실히 따르며 수사 속도를 조절해 왔던 검찰은 이제 더 이상 물러날 곳이 없다 청와대의 눈치를 보며 수사에 미온적인 태도를 보이는 동안 언론이 나서서 증거를 확보해 주었고 최순실의 소재도 마저 파악해 주었다 검찰은 최순실의 소환마저 언론이 해 주길 기대하는가 검찰은 약 먹고 죽을 수도 있다 며 국민을 상대로 협박하고 있는 최순실 씨를 당장 소환해야 한다 국민들은 지금 이 순간에도 대한민국 검찰의 무능함에 절망을 느끼고 있다 최순실 대변하는 청와대 전면 교체해야 언론보도에 따르면 정연국 청와대 대변인이 최순실씨와 관련해 빠른 시일 내 귀국해 의혹을 해소시켜야 한다 면서도 귀국 문제에 대해 본인이 판단한다는데 라고 말했다고 한다 정 대변인이 자신의 발언을 정정했다지만 당장 국내로 송환해도 모자랄 판국에 알아서 귀국하라니 청와대의 인식은 놀랍다는 말로도 표현할 수 없을 정도이다 청와대가 국민적 의혹의 당사자인 최순실씨를 감싸는 모습을 보인 것이다 청와대의 최순실 눈치보기는 청와대와 최순실 관계가 어느 정도인지 확실히 보여준다 더욱이 오늘 최씨는 언론과의 인터뷰에서 현재 신경쇠약 등 건강상태가 좋지 않다 며 사실상 당분간 귀국하지 않겠다는 태도를 보였다 최씨는 당분간은 돌아오지 않겠다고 하고 청와대는 본인 판단을 지켜보자니 둘이 짜기라도 한 것인지 의구심마저 든다 국정농단 국기문란의 핵심인 최씨에 대한 청와대의 태도는 정말 한심하다 청와대 비서진을 전면 교체해야하는 이유가 무엇인지 스스로 확인시킨 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58724,2016-10-27, 이재정 원내대변인 오전 현안 브리핑 일시 목 장소 정론관 최순실을 위한 나라 국민은 없었다 분단국가에서 남북 간 비밀접촉 사실까지 보고받은 최순실에게 극비 비밀사안이었어야 할 외교문서까지 전달됐다 박근혜 대통령 당선인 시절 일본 특사와의 만남을 위해 작성된 외교문서를 최순실이 먼저 검토한 것이다 다보스포럼 특사를 위한 정치인 평가보고도 역시 최순실이 사전 검토했다 이뿐만이 아니다 최순실이 구입한 땅에 대한 청와대 보고문서와 최순실의 딸의 대학입학을 위한 교육부 입시전형 사전보고 등 대한민국 국민은 지금 최순실의 나라에 살고 있다 최순실을 위해서라면 무소불위의 권력이 비호하는 나라 국민의 안위보다 최순실의 안위가 우선되는 나라 대통령이 최순실에게 조종 받는다는 믿을 수 없는 허무맹랑한 이야기가 현실로 반영되는 그런 나라에서 살고 있다 하지만 아직도 청와대는 민의가 무엇인지 국민의 분노가 얼마나 크고 깊은지 제대로 파악조차 하지 못하고 있다 청와대에 묻는다 최순실이 없어서 민의를 파악하지 못하는 것인가 청와대가 생각하는 국민은 누구이며 이 나라의 주인은 누구인가 언론 통해 사실 호도하는 최순실 무능한 검찰은 최순실 신병확보라도 해라 사상초유의 국정농단사건으로 국민의 공분을 자아낸 최순실이 언론인터뷰에서 각종 수사와 연민을 자아내며 사실을 호도하러 나섰다 정작 국내로 들어와 증명하라는 이야기에는 신경쇠약으로 비행기를 탈 수 없다며 거부했다 최순실은 신의로 연설문을 일부 수정한 것 외에는 나머지 모든 사실을 부정했다 그리고 마치 자신이 언론의 희생양인 것처럼 포장했다 최순실에게 충고한다 한국에서의 언론보도부터 잘 참고하고 인터뷰하라 문제가 된 테블릿 컴퓨터는 청와대 행정관이 개통해서 최순실에게 전달했으며 해당 컴퓨터 안에 담긴 수많은 자료들이 최순실과 자녀인 정유라의 이름으로 작성되고 수정되었음을 이미 모든 국민들이 확인했다 안보 외교 인사까지 최순실이 사전보고를 받았음이 드러났음에도 이를 부정하는 철면피스러운 최순실의 인터뷰에 국민의 분노는 더욱 커져가고 있다 무능한 검찰은 뒷짐 지고 신발장만 뒤질 것이 아니라 최순실에 대한 신변확보라도 하길 바란다 우병우 안종범과 문고리 인방 해임은 청와대 개혁의 시작일 뿐이다 박근혜 대통령의 불통인사가 낳은 기형적 권력구조와 인사체계의 혁신만이 청와대 개혁의 첫걸음이 될 것이다 하지만 아직까지도 청와대는 우병우 안종범 문고리 인방 해임에 갈팡질팡하고 있다 최순실 사건 특검도입이 진상규명을 위한 시작인 것처럼 우병우 안종범 문고리 인방 해임은 청와대의 개혁을 위한 시작일 뿐이다 개혁의 시작조차 주저하는 청와대의 한심한 모습을 보며 청와대가 직접 하지 못한다면 국회가 앞장서 그동안의 폐해를 적극적으로 밝혀낼 것임을 경고한다 청와대는 오늘 박근혜 대통령의 책임방식을 묻는 국민의 여론조사 결과가 무엇을 의미하는지 국민들이 지금 대통령을 어떻게 생각하는지 진심으로 숙고하길 바란다 특검무용론 주장하는 국민의 당 검찰만 바라보고 가자는 것인가 오늘 국민의 당 박지원 비대위원장은 더불어민주당의 최순실 특검결정을 이해할 수 없다며 최순실 특검은 박근혜 대통령과 최순실만 좋은 일이라는 입장을 내놓았다 박지원 대표의 발언 이후 검찰은 특수수사본부를 설치해 최순실 국정농단 사건을 수사하기로 발표했다 국민의 당에게 묻고 싶다 검찰을 믿을 수 있는가 검찰을 신뢰하는가 국정농단 사건과 관련된 고소장이 접수된 지 일 만에 보여주기식 압수수색을 단행한 검찰을 어떻게 믿고 맡길 수 있는가 그렇다면 잘못을 인정하지 않는 박근혜대통령 입만 바라보자는 것인가 박근혜 대통령의 그동안의 행보만으로도 국민이 원하는 답변이 나오지 않을 것이 자명하다 그렇다면 국회는 특검을 비롯한 국정조사 등 진상규명을 위한 모든 방안을 강구하는 것만이 국민에 대한 예의이자 책무이다 현행법상 대통령이 수사대상이 맞다 아니다가 중요한 것이 아니다 외교 안보 인사까지 비선실세에게 좌지우지당한 박근혜 대통령은 이번 사건의 명백한 수사대상이다 국민의 당은 특검 무용론을 말하기 전에 이번 사건이 국민에게 얼마나 큰 충격이고 상심을 안겨줬는지 민심을 헤아리기 바란다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58721,2016-10-26, 이재정 원내대변인 오후 추가 현안 브리핑 일시 수 오후 시 분 장소 국회 정론관 새누리당의 특검수용 결정에 대해 특검은 시작일 뿐이다 오늘 새누리당이 최순실 특검을 수용하겠다는 입장을 밝혔다 만시지탄이다 지난 한 달여간의 국정감사를 최순실 감싸기에만 몰입한 새누리당이 거센 파도와 같은 민의 앞에 무릎을 꿇은 것이다 분명히 경고한다 새누리당은 이번 특검수용을 당장의 어려움을 피해가려는 수단으로 생각해서는 안 될 것이다 비선실세이자 밤의 대통령이라 불리는 최순실과 박근혜 대통령이 자초한 사상 초유의 국정운영농단에 대해 뼈를 깎는 반성과 총체적인 점검이 반드시 뒷받침 되어야 한다 더불어민주당은 분명히 밝힌다 특검은 시작일 뿐이다 국민 모두를 공분케 한 최순실 게이트의 진상규명을 위해 특검은 물론 국정조사 등 진상규명을 위한 모든 방안을 열어놓고 이를 실현하기 위해 최선을 다할 것이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58719,2016-10-26, 추미애 대표 최순실 게이트 편파기소 대책특별위원회 차 회의 인사말 일시 화 장소 국회 본청 당대표 회의실 추미애 대표 국민은 패닉 상태이다 국가 시스템은 최순실 사단에 의해서 철저하게 유린당하고 농락당해왔다 검찰의 뒷북치는 압수수색으로 이미 최순실 도당은 증거인멸을 치밀하게 했을 가능성이 높다 뒤늦은 압수수색에서 무엇이 건져 올려 질지 모르겠지만 쥐똥을 흘려놓듯 여러 곳에 흘려놓은 흔적들이 너무 많다 일단 소통하는 방법을 모르는 대통령이 더 문제다 평소에 소통을 하지 않았기 때문에 이 비상시국에서 어느 누구를 붙잡고 어떻게 문제를 풀어야 할지 모르는 상황 같다 오늘 차 최순실 게이트 편파기소 대책위원회에서는 제대로 된 수사를 통해서 하루빨리 국정을 수습할 수 있는 대책과 제안이 있어야 하고 대책위를 통해서 발 빠르게 국정 난국의 헝클어진 실태래를 풀 해법을 나올 것 같다 여당도 호들갑이다 여태까지 대통령의 철저한 방패노릇을 해온 이정현 대표는 입이 열 개라도 할 말이 없을 것이다 철저히 국정감사를 했으면 하는 아쉬움이 많을 것이다 초기 단식 쇼를 통해서 국정감사를 못하게 훼방 놓고 이제 와서 호들갑인들 무슨 소용이 있겠나 쉬운 것부터 해내자 오늘 외통위에서는 윤병세 장관에 대해서 최순실 모녀의 여권효력정지를 질문했다 윤병세 장관은 아무런 답변을 내놓지 못했다 최순실 게이트에 대해서 여당이 진심이라면 두 모녀의 여권효력정지를 통해서 조속히 신병을 확보하는 것이 급선무다 최순실 모녀가 국외를 돌아다닐수록 나라의 격은 떨어지고 나라꼴이 말이 아니게 된다 최순실 모녀의 여권효력정지를 통한 신병 확보와 소환이 가장 먼저 이뤄져야 할 일이다 두 번째는 이 수사를 틀어쥐고 막고 있는 우병우 민정수석을 즉각 해임하는 것이다 여당도 수사가 제대로 이뤄지고 국민적 신뢰를 회복하려면 우병우 수석의 해임이 먼저라고 말하고 있다 이 말이 괜한 호들갑이 아니라면 우병우 수석을 해임하는데 있어서 여야가 일치된 의견인 것이다 이에 대해 대통령은 즉각 수용해야 한다 이로 인해 수사의 단초가 풀어지고 신뢰와 신의를 먼저 보인다면 우리 야당도 적극 협조할 것이라고 이 자리에서 밝힌다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58718,2016-10-26, 이재정 원내대변인 오후 현안 서면 브리핑 전화기 닦아서 최순실에게 건네는 청와대 행정관 박근혜 대통령은 무엇을 걱정하고 있나 어제 대한민국 국민은 전화기 액정을 닦아 최순실에게 건네는 청와대 행정관의 모습을 보았다 그게 박근혜정부의 실체다 최순실의 손가락질 한 번에 재빨리 알아서 대처하는 청와대 최순실이 고쳐준 문구를 읽는데 급급했던 대통령 년 월 국민은 박근혜 대통령을 뽑았지 최순실을 뽑지 않았다 대통령은 왜 무슨 이유로 최순실의 꼭두각시 노릇을 한 것인가 박근혜 대통령에게 국민은 안중에도 없었던 것인가 박근혜 대통령은 지금 자신이 무엇을 걱정해야 하는지 알아야 한다 개헌을 걱정할 때가 아니다 개헌은 국회의 몫이다 한류를 걱정할 때가 아니다 한류는 문화예술인의 몫이다 지금 걱정해야 할 것은 국정농단의 중심에 대통령이 있었고 국민이 더 이상 대통령을 신뢰하지 않는다는 것이다 괜한 걱정만 할 것이 아니라 현재 상황에 대한 실질적인 해법을 강구하길 촉구한다 빈 사무실가서 압수수색 하는 검찰 국민을 상대로 성동격서하나 오늘 검찰은 미르재단과 스포츠재단 사건을 접수한 지 일 만에 관련 사무실에 대한 압수수색을 실시했다 이미 재단은 해산됐고 잔여재산도 처분 중이다 사무실은 폐쇄된 지 한 달도 넘은 텅 빈 사무실이다 검찰의 파란 압수수색 박스에 과연 무엇을 담을 수 있었을지 의문이다 검찰이 국민을 상대로 성동격서 하는 꼴이다 검찰의 무능함과 무책임함 무지함이국민들에게 또 다른 비웃음을 사고 있다 대한민국 최고 지성집단인 검찰의 현 모습을 보며 대한민국 정의가 어디로 갔는지 되물을 수밖에 없다 더불어민주당은 검찰의 엄정한 수사를 기대하지 않는다 대신 검찰이 사건을 비호하거나 덮으려는 모습이 조금이라도 나타난다면 모든 방법을 동원해서라도 국민을 대신해 단죄할 것임을 경고한다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58717,2016-10-26, 박경미 대변인 오후 현안 브리핑 일시 장소 국회 정론관 검찰의 늑장 수사 만회할 길은 최순실 신병 확보와 증거 인멸 차단 검찰이 미르 스포츠재단 전경련 사무실 등을 동시에 압수수색했다 고발 일만이다 국민의 분노에 검찰이 이제야 반응을 보인 것이다 진실을 앞장서 밝혀야 할 검찰이 뒤늦게 의혹을 따라가고 있다 그러나 이미 상당한 양의 자료가 폐기된 것으로 알려지고 있고 핵심관계자인 최순실씨 등은 외국으로 도피한 상태이다 검찰의 늑장 수사가 부른 참사가 아닐 수 없다 권력의 하수인을 자처해온 검찰의 한심하기 이를 데 없는 행태에 분노를 금할 수 없다 언론에 따르면 독일 검찰이 최순실씨를 추적하기 시작했다고 하니 대한민국 사건을 수사하는데 우리의 검찰이 독일 검찰만도 못하다는 조롱 섞인 이야기가 나오고 있다 이 상황에서 제대로 된 검찰 수사를 기대하는 국민은 거의 없다 결국 특검으로 갈 수밖에 없다는 점을 검찰도 잘 알고 있을 것이다 검찰이 방치한 증거 인멸과 범인 도주에 대해서는 특검을 통해 혹독하게 평가받을 것이다 검찰이 조금이라도 죄를 면하는 길은 지금이라도 서둘러 외국의 사법기관과 공조해 최순실씨 등 핵심관계자의 신병을 확보하고 증거 인멸을 차단하는 것뿐이다 검찰의 이후 행보를 국민들이 지켜보고 있음을 명심 또 명심하기 바란다 지식인의 양심에 호소한다 이화여대 최경희 총장과 그 측근 교수 인방이 국책 연구를 셀프기획하고 셀프수주한 정황이 드러났다 대통령의 비선실세 최순실의 딸 정유라 양의 입학과 맞춤형 학사관리를 담당했다는 의혹을 받고 있는 만큼 그 대가 차원은 아닌지 의심이 된다 이화여대는 올해 교육부 지원 총 개의 연구과제 가운데 개를 따내 최다선정의 영예를 받았음은 이미 주지의 사실이다 이 중 개의 과제책임자로 총장의 최측근인 이인성 교수가 이름을 올렸다 이 세 과제의 연구비는 총 억 천만 원에 달한다 정양이 다닌 체육학과가 소속된 신산업융합대학 김경숙 학장의 경우 년에 개 받기도 어렵다는 체육계에서 년도 안 되는 기간에 무려 개의 과제를 수주했다 이런 이화여대 교수들의 정부연구과제 수주실력은 어디서 온 것일까 지식의 상아탑으로 자부해 온 명문사학 이화여대의 체면이 말이 아니다 깨어있는 지식인으로서 학생들에게 롤 모델이 되어도 모자랄 판국에 대통령의 비선실세가 얽힌 비리의혹에 연루된 모습은 부끄럽기 짝이 없다 강화유리도 단숨에 박살내는 물대포에 사망한 백남기 농민의 사인을 두고 병사라고 우기는 서울대학교 백선하 교수의 모습과 시종일관 모르는 일이라고 버티고 있는 이화여대 최경희 총장과 교수 인방의 똑 닮은 모습에 소름이 끼칠 지경이다 오늘의 민주사회를 만든 지식인의 양심은 어디에 있는가 당 홈페이지의 트래픽 초과 관련 원인을 알 수 없는 트래픽 초과 접속 폭주 로 인해 당 홈페이지가 마비된 상태이다 디도스 공격이 의심되지만 구체적인 정황은 아직 밝혀진 게 없다 일단 서버를 한국인터넷진흥원의 사이버대피소로 입주시켜서 홈페이지 보호에 나설 방침이다 또한 서버관리업체를 통해 디도스 공격 여부를 분석 중이고 디도스 공격으로 판단될 경우 사법당국에 수사 의뢰할 예정이다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58711,2016-10-26, 이재정 원내대변인 의원총회 결과 브리핑 일시 수 오전 시 분 장소 국회 정론관 의원총회 결과 관련 더불어민주당은 의원총회를 통해 최순실 게이트 전반에 대한 다양한 의견을 교환했다 사태의 심각성과 시시각각 변하고 있는 국민 여론에 대해서 아주 무겁게 공유했다 우리 당은 우병우 수석을 비롯한 문고리 인회를 포함한 청와대의 전면 쇄신을 요구하는 바이다 국정감사 과정에서 사태의 진실을 드러낸 바와 같이 예정된 예결위 일정과 상임위 일정을 충실히 진행함으로써 관련된 내용에 보다 가까이 다가가도록 하겠다 이후 특검 국정조사 등 전방위적 수단을 고려하고 있다 향후 사태 전개에 따른 점검과 대응을 기민하게 하면서 당 차원에서 최선을 다해 사태에 대응하겠다 +http://theminjoo.kr/briefingDetail.do?bd_seq=58712,2016-10-26, 박경미 대변인 오전 현안 브리핑 일시 장소 국회 정론관 검찰 위에 우병우 우병우 위에 최순실 제대로 된 검찰 수사 기대할 수 있나 청와대에서 검토해야 할 민정수석 추천 보고서가 최순실 씨의 사무실에서 나온 것은 경악을 넘어 분노를 느끼게 한다 판도라의 상자가 열린 것이다 대통령 측근을 감찰하는 청와대 민정수석을 대통령 측근이 낙점한 꼴이니 민정수석의 고유 업무가 제대로 이뤄졌을 리 만무하다 우병우 민정수석은 최씨가 인사에 개입한 년 월 청와대 민정비서관으로 발탁됐고 개월 뒤 민정수석으로 승진했다 언론보도에 따르면 애초에 청와대 공식 문건에 민정비서관으로 우병우라는 이름은 없었다 우리당 조응천 의원도 최순실 씨가 우병우 민정수석 인사에 관여했다는 의혹이 있다 고 폭로한 바 있다 우병우 수석에 대한 검찰수사를 우병우 수석이 보고받고 지휘하는 것도 말이 안 되는데 최순실 씨에 대한 청와대 감찰을 최순실 씨가 보고받고 지휘하는 기가 막힌 상황이다 정권에 큰 부담이 되는 것을 알면서도 박근혜 대통령과 청와대 새누리당이 그토록 우병우 수석을 감싼 것은 이 정권의 최상층에 최씨가 있었기 때문은 아닌지 묻는다 검찰 위에 우병우 우병우 위에 최순실 씨가 있다면 검찰의 제대로 된 수사는 불가능하다 우병우 민정수석과 청와대에 엄중히 경고한다 이제는 다 내려놓고 진실의 심판대에 오를 때이다 베일 속에 가려진 청와대 제 부속실 최 씨의 수족이었나 어제 밤 보도를 통해 청와대의 윤전추 행정관과 이영선 행정관이 최순실 씨를 도와 의상 업무를 하는 영상이 공개됐다 특히 이 행정관이 최씨에게 휴대전화 화면을 옷으로 닦아 전달하고 통화가 끝난 휴대전화를 두 손으로 받는 모습은 상전을 대하는 듯하다 이들은 모두 청와대 제 부속실에 소속되어 있어 제 부속실이 사실상 최 씨를 보좌해왔던 것은 아닌지 강한 의구심이 든다 사실 청와대 제 부속실은 과거 정부에서 영부인 수행업무를 관장하던 부서였다 그래서 이 정부 들어 제 부속실과 합쳐야 한다는 주장이 제기됐지만 결국 유지됐다 이후 제 부속실은 무슨 일을 하는지 알 수 없는 부서로 존재하면서 아무런 견제도 받지 않고 활동해왔다 그동안에도 제 부속실이 전횡을 한다는 얘기들이 심심치 않게 들렸다 그 전횡의 주체가 제 부속실이 아니라 최순실이라면 이는 정말 충격적이다 국민들이 모르는 청와대의 주인이 있고 문고리 권력이 최씨의 뜻에 따라 대통령을 보좌해왔다면 이는 결코 용인될 수 없다 최씨가 어떻게 청와대를 장악했는가 하는 의혹은 반드시 밝혀져야 한다 하루도 못가 들통 난 대통령의 거짓 사과 스스로 해명 기회를 놓쳐버렸다 박근혜 대통령은 어제 최순실씨로부터 연설문 등에 일부 도움을 받았으나 보좌체제를 갖추고 나서 그만두었다고 해명했지만 반나절도 지나지 않아 거짓 사과였음이 드러났다 보도에 따르면 최씨는 박 대통령이 당선인이던 시절부터 지속적으로 외교 안보 경제 등 국가 기밀 사항들을 보고받았고 장 차관 등 정부 인사에도 광범위하게 개입한 정황이 드러났다 심지어 대통령 취임식과 기념우표 대통령의 휴가와 패션 대통령의 일정과 국무회의 발언까지 대통령의 일거수일투족을 관리했다는 의혹마저 제기되었다 이쯤 되면 박 대통령의 눈물겨운 최순실 구출작전이 그 어떤 아침드라마보다도 막장이다 대통령의 해명에도 불구하고 새누리당에서조차 특검 도입과 탈당 요구까지 나오고 있는 상황이다 국민들은 우리가 지난 대선에서 박근혜 대통령이 아니라 최순실씨를 뽑았냐고 분개하고 있다 더 이상의 해명은 무의미하다 박 대통령은 이제 수사를 통해서 최씨와 관련한 모든 의혹들에 답해야 할 것임을 분명히 지적한다 최고위원회의 결과 오늘 아침 최고위원회의에서 추미애 대표는 김민석 전 의원을 특보단장으로 임명했다 diff --git a/Result/healthmgmt.graphml b/Result/healthmgmt.graphml new file mode 100644 index 0000000..63bd662 --- /dev/null +++ b/Result/healthmgmt.graphml @@ -0,0 +1,94457 @@ + + + + + + + + abil + + + abl + + + abli + + + abovemarket + + + absolut + + + acceler + + + accept + + + access + + + accord + + + account + + + achiev + + + acknowledg + + + aclastareclast + + + acquir + + + acquisit + + + across + + + act + + + actemra + + + action + + + activ + + + actual + + + acz + + + adapt + + + add + + + addi + + + addit + + + address + + + adequ + + + adher + + + adjunct + + + administr + + + adult + + + advanc + + + advantag + + + advisori + + + affair + + + affect + + + afford + + + african + + + aftertax + + + age + + + agenc + + + agerel + + + aggress + + + agil + + + agm + + + ago + + + agre + + + agreement + + + ahead + + + aid + + + aim + + + alfa + + + align + + + alis + + + allianc + + + almost + + + along + + + alreadi + + + altern + + + although + + + altruist + + + alway + + + alzheim + + + ambiti + + + america + + + among + + + amount + + + anc + + + anchor + + + angelin + + + anim + + + announc + + + annual + + + anoth + + + ant + + + antibodi + + + anticip + + + antimalaria + + + anxieti + + + anxious + + + apart + + + appear + + + appoint + + + appreci + + + approach + + + appropri + + + approv + + + approxi + + + approxim + + + april + + + area + + + arimidex + + + arm + + + around + + + array + + + arteri + + + arthriti + + + asia + + + asian + + + aspect + + + asset + + + assign + + + associ + + + assur + + + asthma + + + astrazeneca + + + ate + + + atherosclerosi + + + attain + + + attitud + + + attract + + + author + + + autom + + + avail + + + avandia + + + avandiai + + + avastin + + + averag + + + avers + + + avoid + + + awar + + + award + + + ayyoubi + + + babi + + + background + + + balanc + + + bangalor + + + base + + + basel + + + basi + + + baxter + + + becam + + + becom + + + begin + + + behalf + + + behavior + + + behaviour + + + believ + + + ben + + + benchmark + + + benefici + + + benefit + + + best + + + better + + + bewellbaxt + + + beyond + + + big + + + biliti + + + billion + + + bind + + + bio + + + biolog + + + biomark + + + biotech + + + biotechnolog + + + ble + + + bledigit + + + blind + + + blood + + + bloxham + + + board + + + bolic + + + bonfield + + + boomer + + + boost + + + boundari + + + brand + + + breakthrough + + + breast + + + brennan + + + bring + + + bristolmy + + + broad + + + broaden + + + broader + + + budget + + + build + + + busi + + + cal + + + call + + + cambridg + + + campaign + + + campus + + + can + + + canada + + + cancer + + + candid + + + capabil + + + capabl + + + capac + + + capit + + + captur + + + car + + + carbon + + + cardiova + + + care + + + career + + + carer + + + case + + + cash + + + cation + + + caus + + + cautious + + + cec + + + celebr + + + cell + + + cellcept + + + cellcultur + + + cent + + + centag + + + center + + + centr + + + central + + + centralis + + + ceo + + + certain + + + cervarix + + + cervic + + + cess + + + chain + + + chair + + + chairman + + + challeng + + + chang + + + charg + + + chief + + + children + + + china + + + chiron + + + choic + + + cholesterol + + + chronic + + + cial + + + cian + + + ciba + + + cienci + + + cine + + + circumst + + + cism + + + citizen + + + citizenship + + + class + + + clear + + + climat + + + clinic + + + close + + + closer + + + coartem + + + cocommercialis + + + code + + + codevelop + + + collabor + + + collaps + + + colleagu + + + com + + + combin + + + come + + + commercialis + + + commit + + + committe + + + common + + + communiti + + + compa + + + compact + + + compani + + + compar + + + compet + + + competit + + + complet + + + complex + + + complianc + + + composit + + + compris + + + comrespons + + + con + + + conceiv + + + concentr + + + concern + + + conclud + + + conclus + + + condi + + + condit + + + conduct + + + confi + + + confid + + + confirm + + + confront + + + confus + + + cons + + + consecut + + + conservat + + + consid + + + consider + + + consist + + + construct + + + consult + + + consum + + + contest + + + continu + + + contract + + + contrari + + + contrast + + + contribut + + + control + + + convict + + + convinc + + + cope + + + copi + + + cor + + + core + + + coronari + + + corpor + + + corporatelevel + + + correspond + + + cost + + + costa + + + council + + + counterintuit + + + countri + + + coupl + + + courag + + + cours + + + court + + + creas + + + creat + + + creation + + + credit + + + crestor + + + criti + + + critic + + + cross + + + csr + + + cular + + + cult + + + cultur + + + currenc + + + current + + + cush + + + custom + + + cut + + + cycl + + + daniel + + + dapagliflozin + + + data + + + david + + + day + + + deal + + + dear + + + death + + + debat + + + debt + + + decad + + + decentr + + + decis + + + decisionmak + + + declin + + + decreas + + + dedic + + + deepli + + + defend + + + degen + + + degener + + + degre + + + delay + + + delight + + + deliv + + + deliveri + + + demand + + + dementia + + + demograph + + + demonstr + + + denc + + + dengu + + + departur + + + depress + + + deriv + + + design + + + despit + + + detail + + + determin + + + detriment + + + devalu + + + devalua + + + devel + + + develop + + + devic + + + diabet + + + diac + + + diagno + + + diagnost + + + dialysi + + + diesel + + + diet + + + dietari + + + differ + + + differenti + + + diffi + + + difficult + + + difficultto + + + digniti + + + dilem + + + dilemma + + + diovan + + + diovascular + + + dioxid + + + direct + + + director + + + dis + + + disabl + + + disadvantag + + + disappoint + + + disast + + + discov + + + discoveri + + + discuss + + + diseas + + + disfigur + + + disord + + + distinguish + + + distribut + + + distrust + + + divers + + + diversifi + + + divest + + + dividend + + + divis + + + division + + + dna + + + doctor + + + dollar + + + donat + + + dosag + + + dou + + + doubl + + + doubledigit + + + dow + + + downturn + + + dramat + + + draw + + + driv + + + drive + + + driven + + + driver + + + drug + + + dual + + + due + + + duti + + + dynam + + + earli + + + earlier + + + earn + + + eas + + + easi + + + eastern + + + ebel + + + econom + + + economi + + + effect + + + effi + + + efficaci + + + effici + + + effort + + + efit + + + elder + + + element + + + elev + + + elimin + + + elsewher + + + embrac + + + emerg + + + emiss + + + emphasi + + + employe + + + enabl + + + enceph + + + encompass + + + encourag + + + end + + + endang + + + endur + + + energet + + + energi + + + engag + + + engin + + + enhanc + + + enjoy + + + enorm + + + ensur + + + ent + + + enter + + + entir + + + entireti + + + entri + + + environ + + + environment + + + epoetin + + + equal + + + equiti + + + erna + + + erod + + + eros + + + error + + + escap + + + especi + + + est + + + establish + + + esti + + + estim + + + ethnic + + + europ + + + european + + + even + + + event + + + ever + + + everi + + + everyon + + + evolv + + + examin + + + exampl + + + exceed + + + excel + + + except + + + excess + + + excit + + + exclud + + + exclus + + + execut + + + exelon + + + exforg + + + exist + + + expan + + + expand + + + expans + + + expect + + + expens + + + experi + + + experienc + + + expert + + + expertis + + + expiri + + + express + + + extend + + + extent + + + extern + + + externalis + + + eye + + + face + + + facil + + + facili + + + facilit + + + fact + + + factor + + + fail + + + fair + + + famili + + + famvir + + + far + + + farewel + + + fast + + + faster + + + fastgrow + + + fatal + + + fda + + + featur + + + feel + + + fest + + + fever + + + field + + + fight + + + filariasi + + + fill + + + filter + + + final + + + finan + + + financi + + + find + + + firm + + + first + + + firstinclass + + + five + + + flagship + + + fleet + + + flow + + + flu + + + fluid + + + focetria + + + focus + + + folio + + + follow + + + followon + + + food + + + forc + + + forecast + + + forefront + + + foremost + + + form + + + formanc + + + forward + + + found + + + foundat + + + four + + + fourth + + + framework + + + franc + + + franchis + + + franz + + + free + + + fresh + + + fti + + + full + + + fulli + + + fullyear + + + function + + + fund + + + funda + + + fundament + + + futur + + + gain + + + galvus + + + garnier + + + gas + + + gave + + + gener + + + general + + + generalis + + + generat + + + generic + + + geograph + + + gerber + + + germani + + + gie + + + give + + + given + + + glaxosmithklin + + + gleevec + + + gleevecglivec + + + glivec + + + glob + + + global + + + globalis + + + gloss + + + goal + + + goe + + + good + + + govern + + + grant + + + great + + + greater + + + greatest + + + greenhous + + + greenhousega + + + grew + + + group + + + groupwid + + + grow + + + growth + + + gsk + + + gsks + + + guarante + + + guidanc + + + habit + + + half + + + halfyear + + + handl + + + hardest + + + head + + + headlin + + + headquart + + + health + + + healthcar + + + healthi + + + healthiest + + + healthrel + + + heartland + + + heavili + + + help + + + hemophilia + + + heparin + + + hepat + + + herceptin + + + high + + + higher + + + highest + + + highlight + + + highpric + + + highqual + + + histor + + + histori + + + hivaid + + + hold + + + home + + + honour + + + hooper + + + hope + + + hormon + + + hospit + + + hostil + + + howev + + + human + + + humanitarian + + + humer + + + hybrid + + + ibm + + + ical + + + icin + + + ideal + + + identifi + + + ignor + + + iii + + + illconsid + + + immun + + + impact + + + imped + + + impetus + + + implement + + + implic + + + import + + + impress + + + improv + + + inc + + + incent + + + incid + + + inclu + + + includ + + + inclus + + + incom + + + increas + + + inde + + + independ + + + index + + + india + + + indic + + + individu + + + indus + + + industri + + + inevit + + + infecti + + + inflammatori + + + influenza + + + inform + + + infrastructur + + + infus + + + ing + + + inhal + + + inher + + + inhibitor + + + initi + + + initia + + + innov + + + innova + + + input + + + instanc + + + instead + + + instrument + + + integr + + + intellectu + + + intend + + + inter + + + interact + + + intercel + + + interest + + + interim + + + intern + + + intraven + + + introduct + + + invest + + + investor + + + involv + + + issu + + + istent + + + item + + + iti + + + januari + + + japan + + + japanes + + + jimenez + + + job + + + joe + + + join + + + jon + + + jone + + + joseph + + + jrgen + + + judgment + + + juli + + + june + + + just + + + keep + + + ket + + + key + + + kidney + + + know + + + kyoto + + + label + + + laboratori + + + labour + + + lamisil + + + languag + + + lar + + + larg + + + largest + + + last + + + late + + + later + + + latin + + + launch + + + law + + + lead + + + leader + + + leadership + + + lean + + + learn + + + least + + + led + + + legaci + + + legitim + + + lent + + + leprosi + + + less + + + let + + + letter + + + leukemia + + + level + + + leverag + + + lie + + + life + + + lifesav + + + lifestyl + + + lifethreaten + + + like + + + limit + + + line + + + link + + + lion + + + littl + + + live + + + lobbi + + + local + + + locat + + + long + + + longer + + + longstand + + + longterm + + + look + + + loss + + + lot + + + lotrel + + + loui + + + lower + + + lowth + + + loyal + + + lucenti + + + lymphat + + + lynn + + + macular + + + made + + + main + + + maintain + + + mainten + + + major + + + make + + + malaria + + + man + + + manag + + + mandat + + + mani + + + mankind + + + manufac + + + manufactur + + + mar + + + march + + + margin + + + mark + + + market + + + marketplac + + + martin + + + mask + + + mass + + + massiv + + + mate + + + matur + + + maximis + + + may + + + mean + + + measur + + + mechan + + + med + + + medi + + + medic + + + medicin + + + medimmun + + + medium + + + meet + + + member + + + mening + + + meningococc + + + ment + + + mental + + + mentregul + + + mercial + + + merger + + + met + + + meta + + + metabol + + + michel + + + microarray + + + microparticl + + + middl + + + might + + + mil + + + mileston + + + million + + + mindset + + + minim + + + minimis + + + mircera + + + mission + + + mistrust + + + mitig + + + mller + + + modern + + + molecul + + + mon + + + month + + + moreov + + + motor + + + mott + + + move + + + much + + + mucklewel + + + multipl + + + must + + + mutual + + + myeloid + + + nation + + + natur + + + near + + + necessari + + + need + + + negat + + + neglect + + + neither + + + ner + + + nervous + + + net + + + netherland + + + network + + + neurolog + + + neurosci + + + neutral + + + never + + + new + + + newli + + + news + + + nexium + + + next + + + nicklasson + + + nine + + + nition + + + nolog + + + non + + + noncor + + + none + + + nonetheless + + + nonexecut + + + nonvot + + + norbert + + + north + + + note + + + novarti + + + novel + + + novemb + + + now + + + number + + + nutrit + + + obes + + + object + + + occur + + + occurr + + + offer + + + offic + + + often + + + ogi + + + older + + + omeprazol + + + omnitrop + + + oncol + + + oncolog + + + ond + + + one + + + onetim + + + ongo + + + ope + + + open + + + oper + + + opera + + + opinion + + + opportun + + + opportuni + + + oppos + + + optaflu + + + optim + + + option + + + oral + + + order + + + ordinari + + + organ + + + organi + + + organis + + + osteoporosi + + + otc + + + other + + + ous + + + ousli + + + outsid + + + outstand + + + overal + + + overdepend + + + overlap + + + oversight + + + pace + + + pandem + + + pant + + + paramount + + + part + + + parti + + + partici + + + particu + + + particular + + + partner + + + past + + + patch + + + patent + + + path + + + patient + + + patron + + + pattern + + + pave + + + pay + + + payer + + + payout + + + pediatr + + + penc + + + penzberg + + + peopl + + + per + + + perform + + + period + + + peripher + + + person + + + perspect + + + peter + + + pharmaceu + + + pharmaceut + + + pharmaci + + + phase + + + philanthrop + + + physi + + + physician + + + pile + + + pioneer + + + pipelin + + + place + + + plan + + + planet + + + play + + + pleas + + + pleasur + + + point + + + polici + + + polit + + + pollut + + + popul + + + popular + + + porat + + + port + + + portfolio + + + pos + + + pose + + + posi + + + posit + + + possi + + + possibl + + + post + + + postmenopaus + + + potenti + + + power + + + practic + + + precis + + + predict + + + prepar + + + prequalif + + + pres + + + prescript + + + presenc + + + present + + + presid + + + pressur + + + prevent + + + previ + + + previous + + + prexig + + + price + + + priceearn + + + pride + + + principl + + + prioriti + + + prise + + + privileg + + + pro + + + proactiv + + + process + + + prod + + + produc + + + product + + + profession + + + profit + + + program + + + programm + + + progress + + + project + + + promin + + + promis + + + promot + + + proper + + + properti + + + propos + + + prospect + + + protect + + + protein + + + protocol + + + proton + + + proud + + + prove + + + provement + + + provid + + + provis + + + public + + + pulmonari + + + pump + + + purchas + + + purpos + + + pursu + + + pursuit + + + push + + + put + + + qab + + + qua + + + qualiti + + + quarter + + + quenc + + + question + + + quick + + + rad + + + ramp + + + rang + + + rapid + + + rare + + + rasileztekturna + + + rate + + + rather + + + ratio + + + ration + + + reach + + + reaction + + + read + + + reaffirm + + + real + + + realiti + + + reason + + + receiv + + + recent + + + recog + + + recogn + + + recognis + + + recognit + + + recommend + + + record + + + redefin + + + redesign + + + reduc + + + reduct + + + refin + + + reflect + + + regard + + + region + + + regul + + + regulatori + + + reinforc + + + relat + + + releas + + + relev + + + relief + + + reliev + + + remain + + + rememb + + + renew + + + replac + + + report + + + repres + + + represen + + + repurchas + + + requir + + + research + + + researchbas + + + reshap + + + resid + + + resign + + + resist + + + resourc + + + respect + + + respiratori + + + respond + + + respons + + + responsi + + + restruc + + + restructur + + + result + + + resumpt + + + retain + + + retir + + + return + + + revenu + + + review + + + reward + + + rica + + + riedel + + + right + + + rigor + + + ris + + + rise + + + risen + + + risk + + + rnai + + + robust + + + roch + + + role + + + room + + + rose + + + rough + + + russia + + + safeti + + + said + + + sale + + + sandoz + + + sation + + + save + + + saxagliptin + + + say + + + scapegoat + + + scarc + + + schedul + + + schizophrenia + + + schwan + + + schweitzer + + + schwiezer + + + scienc + + + scientif + + + scientist + + + sclerosi + + + scottish + + + sebivo + + + sec + + + second + + + section + + + sector + + + secur + + + sedentari + + + see + + + seek + + + seem + + + seen + + + sek + + + select + + + sell + + + senior + + + sequenc + + + seroquel + + + serv + + + servat + + + servic + + + set + + + setback + + + seven + + + seventh + + + sever + + + severin + + + shall + + + shanghai + + + share + + + sharehold + + + sharpli + + + sheet + + + shortag + + + shortterm + + + show + + + sibl + + + side + + + sign + + + signal + + + signatori + + + signific + + + silvia + + + similar + + + simon + + + simpli + + + simplif + + + simplifi + + + sinc + + + sincer + + + sine + + + singl + + + singledigit + + + singlemind + + + sion + + + sistent + + + site + + + situat + + + sive + + + six + + + skill + + + skyrocket + + + slight + + + slow + + + small + + + smart + + + social + + + societ + + + societi + + + sole + + + solut + + + som + + + someth + + + sometim + + + soon + + + sooner + + + sort + + + sourc + + + span + + + speak + + + specif + + + split + + + squibb + + + staff + + + stage + + + stake + + + stakehold + + + stand + + + standard + + + stark + + + statement + + + statin + + + status + + + stay + + + steadfast + + + steadili + + + stem + + + step + + + stepup + + + still + + + stock + + + stood + + + stop + + + stori + + + stoxx + + + straight + + + strate + + + strateg + + + strategi + + + streamlin + + + strength + + + strengthen + + + strict + + + strong + + + strongest + + + structur + + + studi + + + style + + + subject + + + submiss + + + submit + + + substanti + + + suc + + + succeed + + + success + + + suffer + + + sup + + + suppli + + + support + + + sure + + + surmis + + + survey + + + suspicion + + + sustain + + + swiss + + + switch + + + switzerland + + + symbicort + + + symond + + + syndrom + + + synergi + + + sys + + + system + + + tackl + + + take + + + taken + + + talent + + + tamiflu + + + tangibl + + + target + + + tasigna + + + task + + + tax + + + team + + + tech + + + technolog + + + tem + + + ten + + + tendenc + + + term + + + test + + + tetrault + + + thank + + + therapeut + + + therapi + + + therefor + + + think + + + thinner + + + third + + + thoma + + + threat + + + three + + + throughout + + + thus + + + tic + + + tical + + + tickborn + + + tie + + + time + + + ting + + + tion + + + tional + + + tissuebas + + + tive + + + today + + + togeth + + + tomak + + + tomedicin + + + toni + + + took + + + top + + + tori + + + total + + + tougher + + + toward + + + toxic + + + track + + + tradictori + + + tradit + + + transact + + + transform + + + translat + + + treat + + + treatment + + + treatmentresist + + + trend + + + tri + + + trial + + + trializ + + + trilept + + + tripl + + + true + + + trust + + + tualli + + + tuberculosi + + + turbu + + + ture + + + turn + + + twelfth + + + twelv + + + twice + + + two + + + tykerb + + + type + + + tyzeka + + + uct + + + ulti + + + ultim + + + ume + + + unafford + + + uncertain + + + unchang + + + underpin + + + undertak + + + underway + + + unduli + + + unfold + + + unforeseen + + + unfortun + + + unifi + + + unimagin + + + uniqu + + + unit + + + unmet + + + unparallel + + + untreat + + + updat + + + urgent + + + usag + + + usbas + + + usd + + + use + + + util + + + vac + + + vaccin + + + valu + + + valuabl + + + variabl + + + varieti + + + various + + + vasella + + + vehicl + + + vendor + + + ventana + + + vention + + + version + + + vertic + + + viabl + + + vicepresid + + + vide + + + view + + + vigor + + + virolog + + + visibl + + + vision + + + vital + + + vitro + + + vol + + + volatil + + + volum + + + voluntari + + + vote + + + want + + + warm + + + wast + + + water + + + way + + + weak + + + weaken + + + weaker + + + websit + + + weigh + + + weight + + + welcom + + + well + + + wellacknowledg + + + went + + + wet + + + wherev + + + whilst + + + whole + + + whose + + + wide + + + win + + + wish + + + withdraw + + + within + + + without + + + woman + + + women + + + work + + + workforc + + + world + + + worldlead + + + worldwid + + + worth + + + wrestl + + + year + + + yet + + + younger + + + your + + + zelnorm + + + zook + + + 것 같아서 확인 + + + 년부터는 + + + 부탁드려요 + + + 식으로 나오는데 + + + 에모모호하게 + + + 제목이 annual + + + 포함하는 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 7 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 7 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 4 + + + 1 + + + 2 + + + 1 + + + 3 + + + 5 + + + 3 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 2 + + + 5 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 7 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 3 + + + 3 + + + 1 + + + 5 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 7 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 5 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 7 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 2 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 10 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 3 + + + 5 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 2 + + + 10 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 10 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 5 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 6 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 4 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 8 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 9 + + + 3 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 7 + + + 6 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 4 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 4 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 4 + + + 5 + + + 5 + + + 1 + + + 1 + + + 3 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 3 + + + 6 + + + 1 + + + 1 + + + 2 + + + 4 + + + 3 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 6 + + + 1 + + + 1 + + + 7 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 4 + + + 2 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 6 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 7 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 8 + + + 5 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 5 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 5 + + + 1 + + + 3 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 4 + + + 1 + + + 1 + + + 1 + + + 10 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 6 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 2 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 3 + + + 3 + + + 1 + + + 1 + + + 6 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 3 + + + 1 + + + 10 + + + 1 + + + 1 + + + 4 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 12 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 5 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 4 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 4 + + + 3 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 5 + + + 2 + + + 1 + + + 6 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 6 + + + 1 + + + 1 + + + 6 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 8 + + + 3 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 8 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 3 + + + 7 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 8 + + + 4 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 8 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 4 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 2 + + + 1 + + + 2 + + + 4 + + + 4 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 7 + + + 2 + + + 1 + + + 1 + + + 6 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 5 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 6 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 3 + + + 1 + + + 7 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 8 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 4 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 6 + + + 2 + + + 1 + + + 1 + + + 2 + + + 4 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 3 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 7 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 9 + + + 1 + + + 1 + + + 3 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 6 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 10 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 9 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 5 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 4 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 4 + + + 1 + + + 1 + + + 3 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 7 + + + 1 + + + 4 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 8 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 4 + + + 2 + + + 1 + + + 7 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 7 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 9 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 3 + + + 4 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 5 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 9 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 2 + + + 9 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 8 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 5 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 3 + + + 2 + + + 2 + + + 1 + + + 2 + + + 4 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 2 + + + 7 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 14 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 4 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 8 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 5 + + + 2 + + + 4 + + + 1 + + + 4 + + + 2 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 5 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 4 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 6 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 5 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 5 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 5 + + + 1 + + + 2 + + + 4 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 6 + + + 1 + + + 3 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 2 + + + 2 + + + 4 + + + 4 + + + 3 + + + 1 + + + 2 + + + 1 + + + 4 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 6 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 13 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 9 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 2 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 8 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 3 + + + 3 + + + 3 + + + 3 + + + 3 + + + 3 + + + 3 + + + 9 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 6 + + + 6 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 5 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 3 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 2 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 4 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 5 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 8 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 13 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 7 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 2 + + + 4 + + + 3 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 5 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 5 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 4 + + + 6 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 12 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 9 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 2 + + + 5 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 3 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 5 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 7 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 7 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 5 + + + 6 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 2 + + + 4 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 6 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 4 + + + 1 + + + 7 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 6 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 4 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 4 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 9 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 3 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 7 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 3 + + + 2 + + + 2 + + + 3 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 3 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 3 + + + 9 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 9 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 5 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 3 + + + 2 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 5 + + + 1 + + + 3 + + + 1 + + + 3 + + + 2 + + + 1 + + + 1 + + + 2 + + + 2 + + + 1 + + + 1 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 3 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 2 + + + 5 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 4 + + + 2 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + 1 + + + diff --git a/beginnersR.Rmd b/beginnersR.Rmd new file mode 100644 index 0000000..f82c9f2 --- /dev/null +++ b/beginnersR.Rmd @@ -0,0 +1,127 @@ +--- +title: "biginnersR" +output: html_document +--- + +R은 근래 데이터 분석 분야에서 널리 사용되고 있는 통계 분석 솔루션이자 프로그래밍 언어입니다. 이번 워크샵은 R을 사용해서 텍스트 데이터를 처리하고, 이를 바탕으로 단어와 단어 사이의 공출현 빈도를 측정한 다음 이를 의미연결망 네트워크로 만드는 것까지 진행할 예정입니다. 시간이 제한되어 있는 관계로, R의 기초만 간단하게 다룬 다음에 바로 의미연결망 분석에 필요한 단계로 넘어가도록 하겠습니다. + +이번 강의에 사용되는 프로그램은 RStudio로, 프로그래밍 언어 R을 유저가 좀 더 사용하기 편하고 작업 효율을 올려줄 수 있도록 만들어진 Integrated Development Environment(IDE)입니다. 여러분이 보고 계신 글이 쓰여져 있는 공간은 '에디터'라고 불리며, 코드를 작성하고 수정하며 한 눈에 볼 수 있게 만들어진 공간입니다. 그 아래에 있는 것은 '콘솔'인데, 실행한 코드와 함께 그 결과물이 출력되는 공간입니다. 에디터에 입력한 코드를 드래그해서 선택한 다음, Ctrl+Enter/R 을 해주면 에디터의 코드가 그대로 콘솔에서 실행되는 것을 알 수 있습니다. 예를 들어 a라는 변수에 "hello world"라는 문자열을 할당하고, 이를 콘솔에 출력하는 코드를 짜서 실행해 봅시다. + +a="hello world" +a +print(a) + +이를 실행하면 콘솔 화면에 코드가 그대로 실행되고, "hello world"라는 문자열이 출력된 것을 알 수 있습니다. 변수로 할당된 데이터의 경우 굳이 print 명령어를 입력하지 않아도 그대로 출력되는 것을 알 수 있습니다. + +오른쪽을 보도록 합시다. Environment라는 패널이 있고, 그 아래의 values라는 항목에 변수 a와 그 a에 할당된 "hello world"라는 문자열을 확인할 수 있습니다. 이는 현재 프로그램 내에 할당된 변수와 함수 등을 유저가 쉽게 찾아보고 살펴볼 수 있도록 해 주는 패널입니다. + +그 아래를 살펴보면 Files라는 패널이 있습니다. 말 그대로 파일을 다룰 수 있는 패널인데, 작업 디렉토리인 kdiworkshop2016과 그 하위 폴더인 Script, Result, Data가 보입니다. 각각을 클릭해서 안에 있는 파일을 살펴보고, 스크립트의 경우 에디터로 그대로 띄워서 살펴볼 수도 있습니다. + +다만 이번 워크샵에서는 RMarkdown이라는 형태의 문서 작성 툴을 활용해 진행하려 합니다. RMD를 사용하면 굳이 콘솔 없이도 직접 코드를 작성하고 바로바로 그 실행 결과를 확인할 수 있습니다. RMD에서 코드를 입력하고 실행하기 위해서는 Chunk를 만들어야 합니다. 키보드의 esc키 아래에 있는 `를 세 번 입력하고 뒤에 {r}을 붙이면 chunk가 생기며 이를 닫아줄 때에는 다시 세 번 입력하면 됩니다. 아니면 에디터 위쪽 상단의 Insert를 눌러서 R을 선택해도 됩니다. + +예를 들어서 다음 예시를 통해 방금 실행해 본 변수 할당과 출력을 실험해 보도록 합시다. chunk에 있는 코드를 실행하려면 오른쪽의 녹색 화살표를 누르거나, Ctrl+Alt+C를 누르면 됩니다. + +```{r} +a="hello world" +a +print(a) +``` + +chunk의 아래에 결과값 출력을 위한 공간이 생기고, 여기에 결과값이 그대로 출력되는 것을 알 수 있습니다. RMD를 사용하면 굳이 콘솔이 필요하지 않으므로, 콘솔 창의 상단부를 드래그해서 내린 다음 에디터만 가지고 워크샵을 진행하도록 하겠습니다. 다음은 R의 데이터 타입에 대해서 설명해 드리도록 하겠습니다. + + +Scalar & Vector + +위에서 a에 hello world라는 문자열을 할당했던 것처럼, R에서는 숫자나 문자열, 불리언(True/False)등의 데이터를 변수에 할당할 수 있습니다. + +```{r} +a=5 +b="I like R" +c=TRUE + +a +b +c +``` + +문자열 데이터의 경우 반드시 작은 따옴표나 큰 따옴표를 붙여야 합니다. 변수에 이러한 데이터를 여러 개 할당할 때에는 '벡터'라는 가장 기초적인 데이터 타입을 사용할 수 있습니다. 벡터 형식으로 변수를 할당할 때에는 c()라는 형식으로 묶어 줘야 합니다. 이렇게 벡터 안에 들어간 데이터들은 대괄호 안에 숫자를 붙임으로써 호출할 수 있습니다. 하나만을 호출할 경우엔 숫자를 넣어주고, 특정한 범위로 불러올 때에는 콜론을 사용해 범위를 설정합니다. 한 변수에 저장된 여러 데이터 가운데 특정 요소만 빼고 불러오려 할 경우 그 순서의 숫자에 -를 붙이며, 범위를 설정할 경우에도 가능합니다. + +```{r} +a <- c(1,2,5.3,6,-2,4) # numeric vector +b <- c("one","two","three") # character vector +c <- c(TRUE,TRUE,TRUE,FALSE,TRUE,FALSE) #logical vector + +a +b +c + +a[1] +b[1:3] +c[-1:-3] +``` + +이러한 단순한 형태의 데이터가 아니라 설문지 데이터와 같은 구조화된 자료를 다루기 위한 데이터 타입으로는 데이터 프레임이 있습니다. + +```{r} +d <- c(1,2,3,4) +e <- c("red", "white", "red", NA) +f <- c(TRUE,TRUE,TRUE,FALSE) +df <- data.frame(d,e,f) + +print(df) +``` + +4*3 행렬 형식의 표가 만들어지며, 각각의 행과 열 안에는 다른 타입의 데이터를 포함시킬 수 있습니다. + +```{r} +names(df)=c("numeric","character","bool") + +df$numeric +df[1] +df[[1]] +df[1,] +df[1,3] +df[1:2] +``` + +행마다 이름을 지정해 주려면 names라는 함수를 사용하면 되며, 이렇게 이름을 지정하면 데이터 프레임 변수 뒤에 $를 붙이고 행 이름을 지정해서 그대로 불러올 수 있습니다. 대괄호 안에 여러 가지 숫자를 넣어서 특정 셀의 데이터를 불러오거나 행, 열, 혹은 범위를 지정해서 불러오는 것 역시 가능합니다. 다만 행 이름을 지정해서 불러오거나 대괄호를 두 번 쓰는 경우(벡터로 변환)를 제외하면 모두 데이터 프레임 형식을 유지하고 있습니다. + +데이터 프레임은 장점이 많고 다루기 편리하지면 n*m 표의 개별 셀에는 하나의 데이터만을 집어넣을 수 있으며, 결과적으로 길이가 다른 데이터를 다루기에는 무리가 있습니다. 그래서 온갖 종류의 데이터를 다 넣거나 길이가 애매한 경우 리스트를 씁니다. + +```{r} +w <- list(name="Kim", mynumbers=a, mymatrix=df, bool=c) +w +w$name +w[[1]] +w[1] +w[[3]][1:3,2:3] +``` + +RMD의 결과창에는 잘려서 나오지만, 실제로 4가지 다른 타입의 데이터(문자열 스칼라, 숫자 벡터, 데이터 프레임, 불리언 벡터)가 각각 잘 저장되었음을 확인할 수 있습니다. 이를 호출할 때에는 데이터 프레임과 같은 방식을 사용하면 됩니다. 마지막 예시의 경우 변수 df가 저장된 세 번째 구간을 불러오고, df에 대해서 대괄호를 사용해 그 안의 데이터를 불러온 것입니다. + +마지막으로 반복문을 살펴보아야 합니다. 반복문은 말 그대로 반복적인 명령어를 수행하게 해 주는 것인데요, R의 반복문은 다음과 같은 구조를 갖고 있습니다. + +```{r} +for(i in 1:10){ + print(i) +} +a <- c("one","two","three") +for(i in b){ + print(i) +} +``` + +(i in 1:10)의 경우 반복문을 수행할 때 활용하는 데이터로, 일정한 길이를 가진 변수를 뒤 쪽에 입력하면 그 변수의 값이 하나씩 순서대로 i라는 변수에 할당되어 반복문 속에서 변수로 작동하게 됩니다. 위의 예제의 경우 1:10이라는 숫자 벡터와 "one","two","three"라는 문자열 벡터가 for문 속에서 i변수에 할당되어 출력된 것을 알 수 있습니다. 그 다음으로는 조건문을 살펴보겠습니다. + + +```{r} +if(a[1]=="two"){ + print("TRUE") +} else{ + print("FALSE") +} +``` + +조건문은 괄호 안에 있는 문장이 참일 경우에 중괄호 안의 명령어를 실행하는 형식입니다. 위의 예시에서는 a[1]에 있는 데이터는 "two"가 아니라 "one"이기 때문에 a[1]=="two"라는 조건은 거짓이며, 따라서 if문 뒤의 중괄호에 있는 "TRUE"가 아니라 그것이 틀릴 경우에 실행되는 else 뒤의 괄호가 출력되었습니다. + +이제 바로 데이터 분석 단계로 넘어가도록 하겠습니다. 오른쪽 파일 패널에서 preprocess.Rmd를 열어주세요. diff --git a/korean.Rmd b/korean.Rmd new file mode 100644 index 0000000..e8412fc --- /dev/null +++ b/korean.Rmd @@ -0,0 +1,107 @@ +--- +title: "korean" +output: html_document +--- + +앞서 살펴본 데이터 전처리와 네트워크 분석 코드는 모두 영어를 대상으로 하고 있었습니다. R은 물론 한글 문자열 처리 역시 완벽하게 지원합니다. 여기서는 데이터가 한국어일 경우화데이터 전처리와 공출현 빈도 행렬 생성, 그리고 네트워크 데이터로의 전환을 어떻게 하면 되는지 간단하게 다룹니다. + +여기에서 예제로 사용할 데이터는 제가 수집했던 민주당의 2016년 논평 200여 개입니다. 데이터 크롤링 단계에서부터 한글을 제외한 숫자, 영문자, 특수문자 등은 모두 제거되어 있는 상태입니다. + +먼저 데이터를 읽어와야 합니다. 제 데이터는 csv 파일 형식으로 1열에는 논평의 url, 2열에는 발표된 날짜, 3열에 논평 본문을 저장해 놓았습니다. R에서 데이터 프레임 형식으로 이 파일을 읽어온 다음, 3열에 있는 본문 텍스트만을 분석 대상으로 사용하면 됩니다. 먼저 파일을 읽어오도록 하겠습니다. csv 파일을 저장할 때에는 크게 문제가 안 되나, 읽어올 때에는 readr 패키지를 불러와서 read_csv(.이 아니라 _입니다) 함수를 사용하는 것이 좋습니다. + +```{r} +library(readr) +data <- read_csv("~/Git/kdiworkshop2016/Data/kor/minjoo2016.csv", col_names = FALSE) +data[1,] +``` + +data 변수에 데이터를 불러왔습니다. 이제 이 데이터 프레임의 3열에 있는 자료만을 변수에 할당합니다. + +```{r} +data<-data[[3]] +data[1] +``` + +총 200개의 논평 데이터가 모였습니다. 이 논평 데이터를 활용해서 아까와 같은 단어의 공출현 빈도 행렬을 만들 것입니다. 그런데 여기에서 한 가지 문제가 생깁니다. 영어의 경우 tm 패키지를 사용해서 같은 의미를 가진 단어들을 골라냈지만, 한글의 경우에는 어떻게 그러한 작업을 수행할 수 있을까요. 여기에서는 KoNLP 패키지를 사용하면 됩니다. + +```{r} +library(KoNLP) + +t="이재정 원내대변인 오전 현안 추가 서면 브리핑 의원총회 결과 서면 브리핑 박근혜 대통령 탄핵소추안 발의 일정과 담길 내용에 관한 논의들이 있었다" + +extractNoun(t) +SimplePos22(t) +SimplePos09(t) +``` + + +KoNLP 패키지는 텍스트 데이터를 받아서 형태소 단위로 분리해 주는 유용한 함수를 제공합니다. 명사만을 추출하는 extractNoun, 형용사나 부사 등 다른 문장 성분들까지 추출하고 형태소 단위로 분리해 주는 SimplePos09,22 함수가 있습니다. 보통 텍스트의 의미를 파악할 때에는 명사만을 추출해서 사용하는 경우가 대부분입니다. 동사나 형용사, 부사의 경우 부분적으로 의미가 있는 경우도 있지만 한국어 서술어는 대부분 '명사 + 하다'와 같은 형식으로 결합되어 있기 때문입니다. + +그런데 여기에서 한 가지 문제가 있습니다. 이는 고유명사 처리에 관한 것인데, 예를 들어서 다음과 같은 텍스트를 명사 추출 함수로 처리해 보겠습니다. + +```{r} +w='선거관리위원회.' +extractNoun(w) +``` + +고유명사에 해당하는 선거관리위원회라는 단어가 분리된 단어로 취급되어 나뉘어진 것을 알 수 있습니다. 이러한 상황을 방지하기 위해서는 KoNLP 패키지에 내장된 말뭉치와 유저 사전을 만들어야 합니다. 내장 사전과 말뭉치 데이터를 불러오기 위해선 다음과 같은 함수를 사용해야 합니다. + +```{r} +useNIADic() +term=c("선거관리위원회") +tag=rep("ncn",times=length(term)) +user_dic=data.frame(term=term, tag=tag) +buildDictionary(ext_dic = c('sejong','insighter', 'woorimalsam'), user_dic=user_dic,replace_usr_dic = T) +extractNoun(w) +``` + +유저 사전을 통해 '선거관리위원회'라는 단어를 고유명사로 등록하자 명사를 추출해도 단어가 나뉘어지지 않고 그대로 남겨지는 것을 알 수 있습니다. 단어를 추가하려 할 경우 유저 사전의 term이라는 변수에 할당하는 문자열 벡터에 새로운 단어들을 추가하면 됩니다. 그러면 이러한 KoNLP의 함수를 사용해서 본격적으로 co-occurence matrix를 만들어 보도록 하겠습니다. 영어 자료를 처리할 때에는 stemDocument라는 함수를 사용했다면, 여기서는 extractNoun함수를 사용하게 됩니다. extractNoun 함수를 활용해 + +```{r} +ko.words <- function(doc){ + token="" + library(stringr) + splited=str_split(doc, " ")[[1]] + for(i in splited){ + extracted=extractNoun(paste0(i,".")) + token=c(token, extracted) + } + token[nchar(token)>=1] +} +``` + + +```{r} +t=data[1:100] +cps=Corpus(VectorSource(t)) + +stopwords=c("") +tdm <- TermDocumentMatrix(cps, + control=list(tokenize=ko.words, + removePunctuation=T, + removeNumbers=T, + #weighting=weightTf, + #stopwords=stopwords, + wordLengths=c(2, 15))) +``` + +이렇게 co-occurence matrix를 만든 다음의 과정은 이전의 네트워크 만들기 과정과 완전히 동일합니다. + +```{r} +mat<-as.matrix(tdm) +mat2<-mat %*% t(mat) +``` + +term-document matrix를 adjacency matrix로 바꿔주고, + +```{r} +library(igraph) +gra <- graph.adjacency(mat2, weighted=TRUE, mode="undirected") +gra<-simplify(gra) +``` + +igraph 패키지를 활용해 그래프 파일 형식으로 바꿔주시면 됩니다. + +```{r} +write.graph(gra, 'Result/partyannouncement.graphml', format="graphml") +``` diff --git a/network.Rmd b/network.Rmd new file mode 100644 index 0000000..d6af323 --- /dev/null +++ b/network.Rmd @@ -0,0 +1,125 @@ +--- +title: "network" +output: html_document +--- + +텍스트 데이터를 연도별로 나눠서 처리하는 데 성공하였고, 연도별로 연설문 데이터를 구했습니다. 이제 이를 활용해서 의미연결망 그래프를 만들어야 합니다. 한번 2007년의 연설문 자료를 사용해서 그래프를 만들어 보도록 하겠습니다. 여기서는 SnowballC와 tm이라는 패키지를 사용합니다. 이 패키지를 사용해서 문장이나 문서 단위로 끊어진 텍스트 데이터에서 단어 사이의 공출현 빈도(co-occurence frequency)를 구할 수 있습니다. tm 패키지에 필요한 말뭉치 데이터 형태로 연설문 데이터를 변환하고, 대문자를 소문자로 바꿔주고 구두점과 숫자를 모두 제거합니다. + +```{r} +library(tm) +library(SnowballC) +library(igraph) + +t=year[[2007-2002]] + +cps<-Corpus(VectorSource(t)) +cps <- tm_map(cps, content_transformer(tolower)) +cps <- tm_map(cps, content_transformer(removePunctuation)) +cps <- tm_map(cps, content_transformer(removeNumbers)) +``` + +그 다음으로는 불용어(stopwords)를 설정하고 단어의 어근을 추출(stemming)하는 과정을 진행합니다. 불용어는 실제 문서의 의미와는 큰 관련이 없는 조사 등의 의미 없는 단어들을 의미하며, tm 패키지가 기본적으로 제공하는 불용어 리스트인 stopwords("english") 이외의 단어를 연구자가 직접 추가해서 사용할 수 있습니다. + +단어의 어근 추출은 같은 의미를 가졌으나 다르게 쓰여져 있는 단어들을 어근의 형태로 추출해 주는 역할을 합니다. 복수형이나 과거형 등으로 인해 같은 의미의 단어임에도 불구하고 다른 단어로 취급될 경우 네트워크 구성 과정에서 제대로 단어의 의미를 담아낼 수 없으며, 이를 보완하기 위해선 stemming이 필수입니다. + +```{r} +cps <- tm_map(cps, removeWords, c(stopwords("english"),'also','year','help','area','will')) +cps <- tm_map(cps, stemDocument) + +stemDocument('efficiency') +stemDocument('efficient') +stemDocument('efficients') +stemDocument('efficiently') +``` + +이렇게 말뭉치에 대한 간단한 전처리를 마친 다음에 공출현 빈도 행렬(co-occurence matrix)을 구합니다. 우측의 values 패널을 통해 이 행렬을 저장한 mat이라는 변수를 클릭해 보면 각각의 문장마다 등장한 단어와 그 빈도수를 행렬의 형태로 나타내고 있습니다. 그러나 네트워크를 만들 때에는 이러한 n행, m열 형식의 행렬이 아니라 단어와 단어가 서로 몇 번 연결되어 있는지를 살펴볼 수 있는 정방형 행렬(adjacency matrix)이 필요합니다. 행렬곱 연산자인 %*% 를 사용해 mat와 mat의 행과 열을 뒤바꾼 t(mat)를 계산하면 이러한 정방형의 행렬을 구할 수 있게 됩니다. + +```{r} +tdm=TermDocumentMatrix(cps) +mat<-as.matrix(tdm) +mat2<-mat %*% t(mat) +``` + +이렇게 구한 정방형 행렬은 igraph 패키지의 graph.adjacency 함수를 통해 그래프 데이터 형태로 바로 전환할 수 있습니다. 의미연결망 그래프의 경우 방향이 없는 그래프이기 때문에 undirected 옵션을 줘야 하며, 단어와 단어 사이의 연결 강도가 존재(여러 번 함께 등장한 단어끼리는 강한 연결)하는 weighted graph이므로 weighted=TRUE라 설정하게 됩니다. simplify 함수의 경우 그래프를 단순화시켜주는 역할을 합니다. + +```{r} +library(igraph) +gra <- graph.adjacency(mat2, weighted=TRUE, mode="undirected") +gra<-simplify(gra) +``` + +이렇게 구한 그래프 데이터는 다양한 형식의 그래프 파일로 만들어 외부 분석 프로그램을 통해서 분석하거나 시각화할 수 있습니다. 여기서는 graphml 파일을 사용하여 저장하겠습니다. + +```{r} +write.graph(gra, 'Result/healthmgmt.graphml', format="graphml") +``` + +이렇게 출력한 graphml 파일은 추후 Gephi를 통해 시각화할 것입니다. 일단 파일은 잊어두고, 이 그래프의 전반적인 통계량을 구하는 방법을 살펴보도록 하겠습니다. + +그래프 이론에서 네트워크의 개별 구성 요소는 노드(혹은 vortex), 그 노드와 노드 사이의 연결은 엣지라고 부릅니다. 아래 명령어를 사용해서 네트워크의 다양한 속성을 구할 수 있습니다. 모든 노드의 숫자와 엣지의 숫자, 그리고 네트워크의 밀도와 군집화 계수(Clustering Coefficient, Transitivity와 같은 개념), 한 노드로부터 다른 노드로 이동하는 데에 필요한 평균 거리(mean distance) 등을 계산할 수 있습니다. + +```{r} +nodes=vcount(gra) +edges=ecount(gra) +density=graph.density(gra) +transitivity=transitivity(gra) +meandistance=mean_distance(gra) +``` + +군집 탐색(Community Detection) 알고리즘을 사용한 군집 숫자 탐색 역시 가능한데, 여기에 사용할 수 있는 알고리즘은 노드 단위의 CD, 엣지 단위의 CD에 따라 매우 다양합니다. 여기서는 multilevel algorithm(Blondel, Gullaume, Lambiotte and Lefebvre 2008)을 사용합니다. 이러한 군집화가 얼마나 효과적이고 강하게 이뤄졌는지 판별할 수 있는 지표인 Modularity 역시 계산 가능합니다. 마지막으로 이러한 군집 가운데 가장 큰 군집 3개를 골라 전체 노드 가운데 해당 군집이 차지하는 비중을 구할 수 있습니다. + +```{r} +comm<-multilevel.community(gra) +numcom=length(comm) +mod<-modularity(comm) +bigcom3<-as.numeric(sort(sizes(comm), decreasing=T)[1:3]/nodes) +``` + +이렇게 구한 네트워크의 속성들을 데이터 프레임 변수 하나에 정리하면 다음과 같습니다. + +```{r} +property=data.frame(matrix(ncol=10)) +property[1,]=c(nodes, edges, density, transitivity, meandistance, numcom, mod, bigcom3) +names(property)=c('Nodes','Edges','Density','Clustering Coefficient','Mean Distance','Number of Communities','Modularity','Size of 1st Community','Size of 2nd Community','Size of 3rd Community') +property +``` + +마지막으로 전체 네트워크의 단어들 가운데 높은 중심성(centrality)을 가진 단어들을 찾아낼 수 있습니다. 그래프 이론에서의 중심성 개념은 보통 연결(degree), 사이(betweenness), 위세(eigenvalue) 중심성으로 나뉘는데, 이 역시 어렵지 않게 구할 수 있습니다. 여기서는 벡터의 결과값을 내놓는 각 중심성 함수의 결과 데이터를 sort라는 함수를 사용해 내림차순으로 정렬한 다음에 상위 30개만 추려서 나타냈습니다. + +```{r} +deg30=sort(degree(gra), decreasing=T)[1:30] +btw30=sort(betweenness(gra), decreasing=T)[1:30] +ec30=sort(eigen_centrality(gra)$vector, decreasing=T)[1:30] +deg30 +btw30 +ec30 +``` + +개별 단어들이 전체 단어 가운데 차지하는 비율을 살펴보고자 할 경우 해당 단어의 degree centrality를 전체 엣지의 숫자*2로 나눠주면 됩니다. 예를 들어 'new'가 전체 문서에서 얼마나 등장했는지 알고 싶다면, new의 연결 중심성인 340을 총 엣지 숫자인 29891에 2를 곱한 59782로 나눠주면 됩니다. 결과는 0.0065로, 퍼센테이지로 나타내면 0.65%입니다. 이는 엄밀한 의미에서의 '등장 빈도'는 아니지만, 문서를 구성하는 다른 단어들과 해당 단어가 총 몇 번 함께 등장했느냐를 카운트하는 것이므로 그 단어의 문서에서의 의미론적 중요성을 판별하는 데에는 더욱 적절한 기준이라 볼 수 있습니다. + +이를 전체 30개 단어로 확대해서 정리하려면 다음과 같은 형식으로 데이터 프레임을 만들어서 정리하면 됩니다. + +```{r} +deg30=sort(degree(gra), decreasing=T)[1:30] +degwords=names(deg30) +deg30=paste0(deg30,", ",round(100*deg30/(edges*2),digits=2),"%") +btw30=sort(betweenness(gra), decreasing=T)[1:30] +btwwords=names(btw30) +btw30=paste0(degree(gra)[btwwords],", ",round(100*degree(gra)[btwwords]/(edges*2),digits=2),"%") +ec30=sort(eigen_centrality(gra)$vector, decreasing=T)[1:30] +ecwords=names(ec30) +ec30=paste0(degree(gra)[ecwords],", ",round(100*degree(gra)[ecwords]/(edges*2),digits=2),"%") +words=rbind(degwords,deg30,btwwords,btw30,ecwords,ec30) +colnames(words)=c(1:30) +row.names(words)=c('Degree Centrality Words',"Words Frequency & Proportion",'Betweenness Centrality Words',"Frequency & Proportion","Eigenvalue Centrality Words","Frequency & Proportion") +words +``` + +최종적으로 구한 중심성 상위 30개 단어와 네트워크 속성 데이터를 엑셀 데이터로 저장해서 분석하려 할 경우, write.csv 함수를 사용해야 합니다. 저장할 데이터 프레임 변수명, 그리고 파일명으로 사용할 문자열을 괄호 안에 입력하면 됩니다. + +```{r} +write.csv(words,"top30centralitywords.csv") +write.csv(property,"networkproperty.csv") +``` + +다음으로는 앞서 저장했던 graphml 파일을 Gephi를 통해 시각화하는 방법을 살펴보도록 하겠습니다. \ No newline at end of file diff --git a/networkproperty.csv b/networkproperty.csv new file mode 100644 index 0000000..1b2c6ac --- /dev/null +++ b/networkproperty.csv @@ -0,0 +1,2 @@ +"","Nodes","Edges","Density","Clustering Coefficient","Mean Distance","Number of Communities","Modularity","Size of 1st Community","Size of 2nd Community","Size of 3rd Community" +"1",1591,29891,0.023632144650135,0.250102316709236,2.42843360336399,21,0.315635783528165,0.147705845380264,0.133878064110622,0.106222501571339 diff --git a/preprocess.Rmd b/preprocess.Rmd new file mode 100644 index 0000000..a683319 --- /dev/null +++ b/preprocess.Rmd @@ -0,0 +1,104 @@ +--- +title: "preprocess" +output: html_document +--- + +프로그래밍 언어로서 R의 세계는 정말 무궁무진합니다. 저 역시 R이라는 언어에 대해서 알고 있는 것은 극도로 일부에 불과합니다. 따라서 이번 워크샵에서는 R이라는 언어 전반에 대해 가르쳐드리는 것이 아니라 텍스트 데이터를 읽어오고, 전처리하고, 이를 네트워크(그래프)로 만드는 데에 필요한 함수와 패키지를 사용하는 것만을 목표로 합니다. R은 자체 내장 함수가 아니라 유저가 만들고 업로드한 패키지를 중심으로 돌아가는 언어입니다. 패키지를 사용하기 위해서는 이를 다운받고 설치해서 불러와야만 합니다. install.packages라는 함수 앞에 있는 주석 표시(#)을 지운 다음 chunk를 실행해 주세요. + +```{r} +#install.packages(c("stringr","tm","SnowballC","igraph","KoNLP")) +library(stringr) + +``` + +실행하면 R 패키지를 저장하고 배포하는 CRAN이라는 곳에서 패키지를 받아와서 컴퓨터에 설치해 줍니다. 이렇게 설치가 끝난 다음에는 library라는 함수를 사용해서 불러오면 됩니다. 한 번 설치한 다음에는 재차 설치할 필요는 없고, library나 require를 사용해서 불러오기만 하면 바로 사용할 수 있습니다. + +이번 워크샵에서 영어 데이터 전처리를 위해 다룰 예제 데이터는 이번 프로젝트에서 작업했던 산업별 CEO 연설문 자료 가운데 Health Management Industry 자료입니다. Data/eng/Health Management Industry 폴더에 들어가 있습니다. 특정 단어만을 뽑아낸 자료(JHY가 파일 이름 뒤에 붙여진 것)가 아니라 연설문 데이터 그대로 읽어와서 작업한다고 가정하도록 하겠습니다. 일단 워드를 통해 총 10개의 파일(5개 기업, 두 시기로 나눠짐)을 하나로 합친 다음 txt파일로 바꿔서 merged.txt라는 새로운 파일에 저장하였습니다. 이 파일을 읽어오도록 하겠습니다. + +```{r} +fl<-readLines("Data/eng/Health Management Industry/merged.txt") +``` + +readLines 함수는 txt파일을 그대로 줄마다 읽어서 문자열 벡터에다가 넣어주는 역할을 합니다. 오른쪽 Values 패널을 보면, 3140줄짜리 파일을 읽어와서 각 줄마다 벡터로 넣어준 것을 알 수 있습니다. 예를 들어서 + +```{r} +fl[37:110] +``` + +모든 파일을 열어보는 것은 부담이 되니 일부의 범위만 정해서 파일 구조를 살펴봅시다. 하이픈 여러 개의 우측에 기업의 이름과 연도가 나와 있고, 그 아래에 CEO의 연설문이 나와 있으며 다음번 하이픈이 나오면 끝납니다. 기업 단위로 나눌 필요 없이 연도별로 연설문 데이터를 정리하면 되므로, 벡터의 구성 요소로 끊겨 있는 전체 문서를 하나의 문자열로 합쳐준 다음에 -----------------을 기준으로 나눠주도록 합시다. + +```{r} +p=paste(fl, collapse=" ") +nchar(p) +``` +벡터를 하나의 문자열로 합쳐줄 때에는 paste 함수를 씁니다. 벡터로 나뉜 문자열을 합칠 때 중간에 넣어줄 구분자를 collapse= 이라는 옵션을 지정해서 정해줄 수 있는데, 여기서는 중간에 whitespace만을 넣어주기로 했습니다. 만일 공백 없이 붙일 경우 ""를 넣어주면 되며, 슬래시나 쉼표 등을 넣어야 하는 상황에서는 따옴표로 그러한 문자열을 넣어주면 됩니다. + +nchar은 문자열의 길이를 계산해 주는 함수인데, 총 47만 자가 넘어가는 문자열 하나에 모든 연설문이 들어갔네요. 그럼 앞서 말한 것처럼 ----------------를 기준으로 이 문자열을 나눠줍니다. + +```{r} +s<-str_split(p,'----------------')[[1]] +s[5:10] +``` + +str_split은 문자열을 나눠주는 함수로, 괄호 안에 나눌 문자열을 넣어주고 그 다음에 나눌 기준이 될 문자열을 넣어주면 리스트의 형태로 데이터를 반환해 줍니다. 리스트 형태의 데이터를 벡터로 받기 위해 뒤에 [[1]]을 넣어줍니다. 출력된 데이터를 끊어서 살펴보면 공백이었던 줄의 ""을 제외하면 깔끔하게 연도에 따라 연설문이 정리되었음을 알 수 있습니다. + +이제 ""를 제거해 줍니다. ""의 경우 문자열 길이가 0이기 때문에 s[nchar(s)>2]의 형식으로 문자열을 호출하면 모두 사라지게 됩니다. 이를 다시 s라는 변수에 할당해 줍니다. + +```{r} +s=s[nchar(s)>2] +s[5:10] +``` + +이제 연도에 따라 연설문을 모아야 합니다. 또한 하이픈 뒤에 기업 이름과 연도가 나와있는 것이 아니라 Supplementary Information이라 되어 있는 항목 역시 따로 처리해 줘야 합니다. 예를 들어 위에 출력된 Supplementary Information의 경우 Astrazeneca 2004에 병합시키거나, 연설문 본문으로 취급하기 어려운 데이터이므로 버려야만 합니다. 일단 여기서는 버리는 방향으로 진행하도록 하겠습니다. + +아쉽게도 nchar과 같은 단순한 함수가 아니라 문자열을 활용한 경우 위와 같이 깔끔한 방식으로 대괄호 안에서 조건문을 처리할 수 없습니다. 반복문을 만들어서 변수 s를 처리하도록 하겠습니다. + +```{r} +s2="" +for(i in s){ + if(str_detect(i, "-- Supplementary|-- supplementary|없음|No message")==FALSE){ + print(i) + s2=c(s2, i) + } +} +``` + +반복문을 수행하기 전에 s2라는 문자열 변수를 하나 만들어 놓아야 합니다. 그 다음 154개의 문자열 벡터 s의 구성 요소들이 하나씩 i라는 변수에 할당되어 for문 안쪽으로 들어갑니다. 이렇게 들어간 s의 구성 요소들을 if문을 사용해서 처리합니다. + +str_detect(i, '-- Supplementary|-- supplementary|없음|No message')!=TRUE 의 경우 문자열에 따옴표 안의 문자열이 있을 경우 TRUE, 없을 경우 FALSE를 반환하는 조건문입니다. 이를 통해 하이픈과 함께 Supplementary Information이라는 글자가 들어간 문자열을 모두 잡아낼 수 있습니다. + +이를 만족하는 문자열은 ---- Astrazeneca 2004 와 같은 형태로 깔끔하게 기업 이름과 연도, 그리고 CEO 연설 본문이 뒤따라 나오는 문자열 뿐입니다. 제대로 문자열이 걸러졌는지 확인하기 위해 i를 print를 통해 출력하고 나서, 이러한 문자열을 for문 바깥에서 선언했던 변수인 s2에 넣어줍니다. + +```{r} +s2[1:10] +s2=s2[-1] +``` + +s2를 확인해 보면 정확히 기업 이름과 연도, 연설문 내용만이 문자열 벡터 s2에 저장되었음을 알 수 있습니다. 첫 번째 원소로 ""가 여전히 남아있는데, 기초 부분에서 다뤘던 [-1]을 사용해 지워주면 드디어 데이터 정리가 끝나게 됩니다. 결과적으로 총 55개의 연설문을 s2에 저장하게 되었습니다. 이제 각 연설문의 연도를 파악해서 정리해 주는 작업만이 남았습니다. s2에 저장된 연설문들을 보면 s2[1]의 경우, + +"------------------------ Astrazeneca 2003 Chief Executive’s message Our reputation is built on the trust and confidence of all our stakeholders and is one of AstraZeneca’s most valuable assets. Along with our commitment to competitiveness and performance, we will continue to be led by our core values to achieve sustainable success. Stakeholder expectations are constantly evolving and we continuously monitor our internal and external environment for issues relating to our business that affect or concern society today. We use a formal risk assessment process to identify both the opportunities and the challenges that these issues present, and to plan the actions needed to ensure our response is appropriate and consistent. Our current Priority Action Plan is shown on page 4. Corporate responsibility (CR) is not an optional extra ? it must be integral to all that we do. Our strategy to include considerations of corporate responsibility across all our activities is beginning to take..." + +다음과 같은 형태로 저장되어 있는 것을 확인할 수 있습니다. 첫 번째 부분이 ---------- 기업이름 연도 형식으로 구성되어 있는데, 여기에서 연도만을 추출해야 합니다. 이를 위해 str_extract라는 함수를 사용합니다. 이 함수의 경우 문자열에서 큰 따옴표 안에 해당하는 조건의 문자열을 반환합니다. 예를 들면 다음과 같습니다. + +```{r} +str_extract(s2[1], "\\d{4}") +as.integer(str_extract(s2[1], "\\d{4}")) +``` + +str_extract의 따옴표 안에 들어간 것은 '정규식'이라는 문자 표현 방식인데, 특정한 조건에 해당하는 문자열을 표현하는 방식입니다. 2003년부터 2014년까지 모든 연도를 다 입력하는 것은 지나치게 비효율적이기 때문에 사용한 것인데, 매우 복잡하고 어려운 성격을 갖고 있으므로 시간이 남을 때 다루도록 하겠습니다. 이렇게 추출한 "2003"은 겉으로 보기에 숫자처럼 보이지만 실제로는 숫자가 아니라 "2003"이라는 문자열 데이터입니다. 이를 계산이 가능한 숫자로 바꿔주려면 as.integer라는 변수 타입 변경을 해 줘야 합니다. + +그러면 이를 응용해서 s2에 저장된 문자열을 연도에 따라 분류하도록 하겠습니다. 데이터가 다루고 있는 시간 범위는 2003년부터 2014년까지이므로, 총 12개의 저장 공간을 가진 리스트를 만들어서 연도별 연설문을 저장합니다. 연설문에서 뽑아낸 연도에서 2002를 빼준 값을 index라는 변수에 저장하고 리스트 변수의 인덱스로 사용하면 2003년(1번)부터 2014년(12번)까지 순서대로 리스트에 넣어줄 수 있게 됩니다. 또한 의미연결망 네트워크를 만들 때에는 문서가 아닌 문장 단위에서 함께 출현한 단어들끼리 서로 연결을 해 주게 되므로, 연설문을 마침표 단위로 끊어서 sentences라는 벡터에 나눠서 저장한 다음 모으도록 하겠습니다. 이 때에는 str_split을 마침표를 기준으로 사용하면 됩니다. 다만 마침표의 경우 특수한 문자에 해당하기 때문에 앞에 반드시 \\를 붙여줘야 합니다. 또 이렇게 마침표 단위로 문장을 나눌 경우 Dr. Jp Granier와 같은 요소들도 개별 문장처럼 취급될 수 있는데, 이를 위해서 문장 내부의 지나치게 긴 띄어쓰기 공백을 제거한 다음(str_replace_all 사용) 길이가 10글자 이하인 문장을 제거하였습니다. + +```{r} +year=vector("list",12) +for(i in s2){ + index=as.integer(str_extract(i, '\\d{4}'))-2002 + sentences=str_split(i,'\\.')[[1]] + sentences=str_replace_all(sentences, "\\s{2,}"," ") + sentences[nchar(sentences)>10] + year[[index]]=c(year[[index]], sentences) +} +year[[1]] +``` + +year[[1]]을 호출해 보면 2003년 연설문이 문장 단위로 끊어져서 잘 저장되었음을 알 수 있습니다. 이제 다음으로는 이렇게 정리한 데이터를 바탕으로 의미연결망 그래프를 만드는 방법을 알아봅니다. network.Rmd 파일을 열어 주세요. \ No newline at end of file diff --git a/top30centralitywords.csv b/top30centralitywords.csv new file mode 100644 index 0000000..b35effb --- /dev/null +++ b/top30centralitywords.csv @@ -0,0 +1,7 @@ +"","1","2","3","4","5","6","7","8","9","10","11","12","13","14","15","16","17","18","19","20","21","22","23","24","25","26","27","28","29","30" +"Degree Centrality Words","new","medicin","busi","product","develop","market","challeng","healthcar","continu","sale","patient","novarti","compani","one","innov","time","pharmaceut","diseas","includ","year","chang","import","invest","increas","well","growth","improv","world","provid","global" +"Words Frequency & Proportions","390, 0.65%","353, 0.59%","318, 0.53%","317, 0.53%","310, 0.52%","294, 0.49%","288, 0.48%","288, 0.48%","278, 0.47%","275, 0.46%","271, 0.45%","267, 0.45%","263, 0.44%","256, 0.43%","243, 0.41%","240, 0.4%","235, 0.39%","233, 0.39%","232, 0.39%","228, 0.38%","224, 0.37%","223, 0.37%","223, 0.37%","222, 0.37%","218, 0.36%","212, 0.35%","207, 0.35%","207, 0.35%","205, 0.34%","198, 0.33%" +"Betweenness Centrality Words","new","develop","patient","innov","includ","market","novarti","one","product","compani","time","import","medicin","sale","busi","pharmaceut","challeng","diseas","invest","increas","healthcar","chang","improv","year","industri","follow","countri","first","continu","global" +"Frequency & Proportions","390, 0.65%","310, 0.52%","271, 0.45%","243, 0.41%","232, 0.39%","294, 0.49%","267, 0.45%","256, 0.43%","317, 0.53%","263, 0.44%","240, 0.4%","223, 0.37%","353, 0.59%","275, 0.46%","318, 0.53%","235, 0.39%","288, 0.48%","233, 0.39%","223, 0.37%","222, 0.37%","288, 0.48%","224, 0.37%","207, 0.35%","228, 0.38%","181, 0.3%","167, 0.28%","177, 0.3%","181, 0.3%","278, 0.47%","198, 0.33%" +"Eigenvalue Centrality Words","medicin","continu","busi","challeng","new","product","sale","healthcar","market","develop","growth","patient","increas","invest","world","compani","novarti","sustain","make","time","focus","work","provid","deliv","pharmaceut","futur","one","result","demand","chang" +"Frequency & Proportions","353, 0.59%","278, 0.47%","318, 0.53%","288, 0.48%","390, 0.65%","317, 0.53%","275, 0.46%","288, 0.48%","294, 0.49%","310, 0.52%","212, 0.35%","271, 0.45%","222, 0.37%","223, 0.37%","207, 0.35%","263, 0.44%","267, 0.45%","178, 0.3%","196, 0.33%","240, 0.4%","189, 0.32%","180, 0.3%","205, 0.34%","166, 0.28%","235, 0.39%","169, 0.28%","256, 0.43%","188, 0.31%","142, 0.24%","224, 0.37%"